PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shi, QM; Chien, YH; Leckband, D				Shi, Quanming; Chien, Yuan-Hung; Leckband, Deborah			Biophysical properties of cadherin bonds do not predict cell sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-CADHERIN; FUNCTIONAL-ANALYSIS; ADHESION MOLECULES; STRUCTURAL BASIS; KINETICS; BINDING; SPECIFICITY	Differential binding between cadherin subtypes is widely believed to mediate cell sorting during embryogenesis. However, a fundamental unanswered question is whether cell sorting is dictated by the biophysical properties of cadherin bonds, or by broader, cadherin-dependent differences in intercellular adhesion or membrane tension. This report describes atomic force microscope measurements of the strengths and dissociation rates of homophilic and heterophilic cadherin (CAD) bonds. Measurements conducted with chicken N-CAD, canine E-CAD, and Xenopus C-CAD demonstrated that all three cadherins cross-react and form multiple, intermolecular bonds. The mechanical and kinetic properties of the heterophilic bonds are similar to the homophilic interactions. The thus quantified bond parameters, together with previously reported adhesion energies were further compared with in vitro cell aggregation and sorting assays, which are thought to mimic in vivo cell sorting. Trends in quantified biophysical properties of the different cadherin bonds do not correlate with sorting outcomes. These results suggest that cell sorting in vivo and in vitro is not governed solely by biophysical differences between cadherin subtypes.	[Shi, Quanming; Leckband, Deborah] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Chien, Yuan-Hung; Leckband, Deborah] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Leckband, Deborah] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Leckband, D (corresponding author), 600 S Mathews Ave, Urbana, IL 61820 USA.	Leckband@uiuc.edu	Shi, Quanming/J-8390-2014	Shi, Quanming/0000-0003-2109-5048	National Institutes of Health [RO1 GM51338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM51338. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bayas MV, 2007, J BIOL CHEM, V282, P5589, DOI 10.1074/jbc.M607968200; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; Beck J.V, 1977, PARAMETER ESTIMATION; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BRONNERFRASER M, 1992, DEV BIOL, V153, P291, DOI 10.1016/0012-1606(92)90114-V; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chien YH, 2008, J BIOL CHEM, V283, P1848, DOI 10.1074/jbc.M708044200; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hukkanen EJ, 2005, BIOPHYS J, V89, P3434, DOI 10.1529/biophysj.105.061606; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; ROTH SA, 1967, P NATL ACAD SCI USA, V58, P974, DOI 10.1073/pnas.58.3.974; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sivasankar S, 2001, BIOPHYS J, V80, P1758, DOI 10.1016/S0006-3495(01)76146-2; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M., 2001, CURR PROTOC CELL BIO; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Wieland JA, 2005, J BIOL CHEM, V280, P41037, DOI 10.1074/jbc.M503975200; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	51	50	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28454	28463		10.1074/jbc.M802563200	http://dx.doi.org/10.1074/jbc.M802563200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18552401	Green Published, hybrid			2022-12-27	WOS:000259969300047
J	Wilsbacher, JL; Zhang, Q; Tucker, LA; Hubbard, RD; Sheppard, GS; Bamaung, NY; Fidanze, SD; Wang, GT; Hu, XM; Davidsen, SK; Bell, RL; Wang, J				Wilsbacher, Julie L.; Zhang, Qian; Tucker, Lora A.; Hubbard, Robert D.; Sheppard, George S.; Bamaung, Nwe Y.; Fidanze, Steve D.; Wang, Gary T.; Hu, Xiaoming; Davidsen, Steven K.; Bell, Randy L.; Wang, Jieyi			Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; HUMAN BREAST; HEMATOLOGIC MALIGNANCIES; ANTITUMOR-ACTIVITY; RESISTANCE; EXPRESSION; PATHWAY; HETERODIMERIZATION; TRANSACTIVATION; SENSITIVITY	The insulin-like growth factor-1 receptor (IGF-1R) and ErbB family of receptors are receptor tyrosine kinases that play important roles in cancer. Lack of response and resistance to therapies targeting ErbB receptors occur and are often associated with activation of the IGF-1R pathway. Combinations of agents that inhibit IGF-1R and ErbB receptors have been shown to synergistically block cancer cell proliferation and xenograft tumor growth. To determine the mechanism by which targeting both IGF-1R and ErbB receptors causes synergistic effects on cell growth and survival, we investigated the effects of combinations of selective IGF-1R and ErbB kinase inhibitors on proliferative and apoptotic signaling. We identified A431 squamous cell carcinoma cells as most sensitive to combinations of ErbB and IGF-1R inhibitors. The inhibitor combinations resulted in not only blockade of A431 cell proliferation, but also induced apoptosis, which was not seen with either agent alone. Upon examining phosphorylation states and expression levels of proteins in the IGF-1R and ErbB signaling pathways, we found a correlation between the ability of combinations to inhibit proliferation and to decrease levels of phosphorylated Akt and cyclin D1. In addition, the massive cell death induced by combined IGF-1R/ErbB inhibition was associated with Mcl-1 reduction and Bax activation. Thus, targeting both IGF-1R and ErbB receptors simultaneously results in cell cycle arrest and apoptosis through combined effects on Akt, cyclin D1, and Bax activation.	[Wilsbacher, Julie L.; Zhang, Qian; Tucker, Lora A.; Hubbard, Robert D.; Sheppard, George S.; Bamaung, Nwe Y.; Fidanze, Steve D.; Wang, Gary T.; Hu, Xiaoming; Davidsen, Steven K.; Bell, Randy L.; Wang, Jieyi] Abbott Labs, GPRD Canc Res, Abbott Pk, IL 60064 USA	Abbott Laboratories	Wang, J (corresponding author), Abbott Labs, GPRD Canc Res, R47A,AP9-2124, Abbott Pk, IL 60064 USA.	Jieyi.Wang@abbott.com						Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Armstrong RC, 1997, J NEUROSCI, V17, P553; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Bohula EA, 2003, ANTI-CANCER DRUG, V14, P669, DOI 10.1097/01.cad.0000092782.37568.04; Camirand A, 2005, BREAST CANCER RES, V7, pR570, DOI 10.1186/bcr1028; Camirand Anne, 2002, Med Sci Monit, V8, pBR521; CAPRARO H, 2002, Patent No. 02092599; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Cui XJ, 2006, CANCER RES, V66, P5304, DOI 10.1158/0008-5472.CAN-05-2858; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Germain M, 2008, J BIOL CHEM, V283, P6384, DOI 10.1074/jbc.M707762200; GIBSON K, 1996, Patent No. 96033980; Gilmore AP, 2002, J BIOL CHEM, V277, P27643, DOI 10.1074/jbc.M108863200; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hubbard RD, 2007, CHEMMEDCHEM, V2, P41, DOI 10.1002/cmdc.200600174; Hurbin A, 2005, J BIOL CHEM, V280, P19757, DOI 10.1074/jbc.M413516200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lu D, 2004, J BIOL CHEM, V279, P2856, DOI 10.1074/jbc.M310132200; Mandelin AM, 2007, EXPERT OPIN THER TAR, V11, P363, DOI 10.1517/14728222.11.3.363; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; Mitsiades CS, 2005, EXPERT REV ANTICANC, V5, P487, DOI 10.1586/14737140.5.3.487; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; O'Connor R, 2003, HORM METAB RES, V35, P771; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Rabindran SK, 2005, CANCER LETT, V227, P9, DOI 10.1016/j.canlet.2004.11.015; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	50	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23721	23730		10.1074/jbc.M708360200	http://dx.doi.org/10.1074/jbc.M708360200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18559346	Green Published, hybrid			2022-12-27	WOS:000258638900026
J	Feng, W; Wu, H; Chan, LN; Zhang, MJ				Feng, Wei; Wu, Hao; Chan, Ling-Nga; Zhang, Mingjie			Par-3-mediated junctional localization of the lipid phosphatase PTEN is required for cell polarity establishment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-DOMAIN; TUMOR-SUPPRESSOR; C-ELEGANS; PROTEIN STRUCTURES; PAR-3; MEMBRANE; NMR; COMPLEX; CDC42; MORPHOGENESIS	PDZ domain-containing scaffold protein Par-3 is the central organizer of the evolutionarily conserved cell polarity-regulatory Par-3.Par-6.atypical protein kinase C complex. The PDZ domains of Par-3 have also been implicated as potential phosphoinositide signaling integrators, since its second PDZ domain binds to phosphoinositides, and the third PDZ interacts with phosphoinositide phosphatase PTEN. However, the molecular basis of Par-3/PTEN interaction is still poorly understood. Additionally, it is not known whether the regulatory function of PTEN in cell polarity is specifically mediated by its interaction with Par-3. The structures of Par-3 PDZ3 in both its free and PTEN tail peptide-bound forms determined in this work reveal that Par-3 PDZ3 binds to PTEN with two discrete binding sites: a canonical PDZ-ligand interaction site and a distal, opposite charge-charge interaction site. This distinct target recognition mechanism confers the interaction specificity of the Par-3.PTEN complex. We show that the Par-3 PDZ3-PTEN binding is required for the enrichment of PTEN at the junctional membranes of Madin-Darby canine kidney cells. Finally, we demonstrate that the junctional membrane-localized PTEN is specifically required for the polarization of Madin-Darby canine kidney cells. These results, together with earlier data, firmly establish that Par-3 functions as a scaffold in integrating phosphoinositide signaling events during cellular polarization.	[Feng, Wei; Wu, Hao; Chan, Ling-Nga; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wu, Hao/B-6557-2012; FENG, WEI/C-8966-2012	Zhang, Mingjie/0000-0001-9404-0190	Research Grants Council of Hong Kong [HKUST6419/05M, 6442/06M, 663407, AoE/B-15/01-II, CA07/08.SC01]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Research Grants Council of Hong Kong Grants HKUST6419/05M, 6442/06M, 663407, AoE/B-15/01-II, and CA07/ 08.SC01 (to M. Z.).	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Comer FI, 2007, CELL, V128, P239, DOI 10.1016/j.cell.2007.01.010; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Feng W, 2007, EMBO J, V26, P2786, DOI 10.1038/sj.emboj.7601702; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hung TJ, 1999, DEVELOPMENT, V126, P127; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Jan YN, 2000, CELL, V100, P599, DOI 10.1016/S0092-8674(00)80695-9; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nicholls A., 1992, GRASP GRAPHICAL REPR; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	48	96	98	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23440	23449		10.1074/jbc.M802482200	http://dx.doi.org/10.1074/jbc.M802482200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550519	hybrid			2022-12-27	WOS:000258455400053
J	Sczaniecka, M; Feoktistova, A; May, KM; Chen, JS; Blyth, J; Gould, KL; Hardwick, KG				Sczaniecka, Matylda; Feoktistova, Anna; May, Karen M.; Chen, Jun-Song; Blyth, Julie; Gould, Kathleen L.; Hardwick, Kevin G.			The spindle checkpoint functions of Mad3 and Mad2 depend on a Mad3 KEN box-mediated interaction with Cdc20-anaphase-promoting complex (APC/C)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CHROMOSOME SEGREGATION ROLES; FISSION YEAST; ASSEMBLY CHECKPOINT; DESTRUCTION BOX; MITOTIC CHECKPOINT; SACCHAROMYCES-CEREVISIAE; PSEUDOSUBSTRATE INHIBITOR; GENETICALLY INTERACTS; PROTEIN BUBR1	Mitotic progression is driven by proteolytic destruction of securin and cyclins. These proteins are labeled for destruction by an ubiquitin-protein isopeptide ligase (E3) known as the anaphase-promoting complex or cyclosome (APC/C). The APC/C requires activators (Cdc20 or Cdh1) to efficiently recognize its substrates, which are specified by destruction ( D box) and/or KEN box signals. The spindle assembly checkpoint responds to unattached kinetochores and to kinetochores lacking tension, both of which reflect incomplete biorientation of chromosomes, by delaying the onset of anaphase. It does this by inhibiting Cdc20-APC/C. Certain checkpoint proteins interact directly with Cdc20, but it remains unclear how the checkpoint acts to efficiently inhibit Cdc20-APC/C activity. In the fission yeast, Schizosaccharomyces pombe, we find that the Mad3 and Mad2 spindle checkpoint proteins interact stably with the APC/C in mitosis. Mad3 contains two KEN boxes, conserved from yeast Mad3 to human BubR1, and mutation of either of these abrogates the spindle checkpoint. Strikingly, mutation of the N-terminal KEN box abolishes incorporation of Mad3 into the mitotic checkpoint complex (Mad3-Mad2-Slp1 in S. pombe, where Slp1 is the Cdc20 homolog that we will refer to as Cdc20 hereafter) and stable association of both Mad3 and Mad2 with the APC/C. Our findings demonstrate that this Mad3 KEN box is a critical mediator of Cdc20-APC/C inhibition, without which neither Mad3 nor Mad2 can associate with the APC/C or inhibit anaphase onset.	[Sczaniecka, Matylda; May, Karen M.; Blyth, Julie; Hardwick, Kevin G.] Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Feoktistova, Anna; Chen, Jun-Song; Gould, Kathleen L.] Vanderbilt Univ, Howard Hughes Med Inst, Sch Med, Nashville, TN 37232 USA; [Feoktistova, Anna; Chen, Jun-Song; Gould, Kathleen L.] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37232 USA	University of Edinburgh; Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University	Hardwick, KG (corresponding author), Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	Kevin.Hardwick@ed.ac.uk		Hardwick, Kevin/0000-0002-6462-1047; Gould, Kathleen/0000-0002-3810-4070	HHMI; Wellcome Trust	HHMI(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the HHMI (to J.S.C., A.F., and K.L.G.) and the Wellcome Trust (to J.B., K.M., and K.G.H.).	Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; He XW, 1998, J CELL SCI, V111, P1635; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Ikui AE, 2002, J CELL SCI, V115, P1603; Kadura S, 2005, MOL BIOL CELL, V16, P385, DOI 10.1091/mbc.E04-07-0558; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Kominami K, 1998, EMBO J, V17, P5388, DOI 10.1093/emboj/17.18.5388; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Matsumoto T, 1997, MOL CELL BIOL, V17, P742, DOI 10.1128/MCB.17.2.742; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nabetani A, 2001, CHROMOSOMA, V110, P322, DOI 10.1007/s004120100153; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tange Y, 2007, GENETICS, V175, P1571, DOI 10.1534/genetics.106.061309; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Vanoosthuyse V, 2004, MOL CELL BIOL, V24, P9786, DOI 10.1128/MCB.24.22.9786-9801.2004; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Warren CD, 2002, MOL BIOL CELL, V13, P3029, DOI 10.1091/mbc.E02-04-0203; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172	60	73	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23039	23047		10.1074/jbc.M803594200	http://dx.doi.org/10.1074/jbc.M803594200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556659	hybrid, Green Published			2022-12-27	WOS:000258455400017
J	Yao, XH; Chen, XC; Cottonham, C; Xu, L				Yao, Xiaohao; Chen, Xiaochu; Cottonham, Charisa; Xu, Lan			Preferential utilization of Imp7/8 in nuclear import of Smads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA; PROTEINS; SIGNAL; COMPLEXES; CYTOPLASM; DYNAMICS; RECEPTOR; EXPORT	Trafficking of Smad proteins between the cytoplasm and nucleus is a critical component of transforming growth factor beta(TGF-beta) signal transduction. Smad4 translocates into the nucleus either in response to TGF-beta stimulation or when its nuclear export is blocked by leptomycin B (LMB). We demonstrate that both TGF-beta-induced and basal state spontaneous nuclear import of Smad4 require importin 7 and 8 (Imp7,8). Our data suggest that in the nuclear import of Smad4, the role of Imp8 is irreplaceable by Imp7, and that Smads preferentially bind Imp8. Interestingly, in contrast to its mammalian counterpart Smad4, Drosophila Medea appears to utilize different mechanisms for TGF-beta-induced or basal state nuclear accumulation, with the latter independent of Msk (Drosophila Imp7/8) function. In addition, overexpression of Imp8 alone was sufficient to cause an increased concentration of Smad1,3 and 4 in the nucleus, but had very limited effects on Smad2. These observations suggest selective involvement of Imp8/Msk in nuclear import of different Smads under different conditions.	[Yao, Xiaohao; Chen, Xiaochu; Cottonham, Charisa; Xu, Lan] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Xu, L (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Rm 308, Worcester, MA 01605 USA.	lan.xu@umassmed.edu			NATIONAL CANCER INSTITUTE [R01CA108509] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA108509] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker SE, 2002, GENETICS, V162, P285; Chen HB, 2005, J BIOL CHEM, V280, P21329, DOI 10.1074/jbc.M500362200; Das P, 1998, DEVELOPMENT, V125, P1519; Dean KA, 2001, J CELL SCI, V114, P3479; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Itoh S, 1998, J BIOL CHEM, V273, P29195, DOI 10.1074/jbc.273.44.29195; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Reguly T, 2003, TRENDS CELL BIOL, V13, P216, DOI 10.1016/S0962-8924(03)00075-8; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	26	55	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22867	22874		10.1074/jbc.M801320200	http://dx.doi.org/10.1074/jbc.M801320200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18519565	hybrid, Green Published			2022-12-27	WOS:000258321000054
J	Hashemy, SI; Holmgren, A				Hashemy, Seyed Isaac; Holmgren, Arne			Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTISCHEMIC MYOCARDIAL APOPTOSIS; PROTEIN-TYROSINE PHOSPHATASES; NITRIC-OXIDE; HYDROGEN-PEROXIDE; PHYSIOLOGICAL MESSENGER; DISULFIDE-ISOMERASE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; REDOX REGULATION	The mammalian cytosolic/nuclear thioredoxin system, comprising thioredoxin (Trx), selenoenzyme thioredoxin reductase (TrxR), and NADPH, is the major protein-disulfide reductase of the cell and has numerous functions. The active site of reduced Trx comprises Cys(32)-Gly-Pro-Cys(35) thiols that catalyze target disulfide reduction, generating a disulfide. Human Trx1 has also three structural Cys residues in positions 62, 69, and 73 that upon diamide oxidation induce a second Cys(62)-Cys(69) disulfide as well as dimers and multimers. We have discovered that after incubation with H2O2 only monomeric two-disulfide molecules are generated, and they are inactive but able to regain full activity in an autocatalytic process in the presence of NADPH and TrxR. There are conflicting results regarding the effects of S-nitrosylation on Trx antioxidant functions and which residues are involved. We found that S-nitrosoglutathione-mediated S-nitrosylation at physiological pH is critically dependent on the redox state of Trx. Starting from fully reduced human Trx, both Cys(69) and Cys(73) were nitrosylated, and the active site formed a disulfide; the nitrosylated Trx was not a substrate for TrxR but regained activity after a lag phase consistent with autoactivation. Treatment of a two-disulfide form of Trx1 with S-nitrosoglutathione resulted in nitrosylation of Cys(73), which can act as a trans-nitrosylating agent as observed by others to control caspase 3 activity (Mitchell, D. A., and Marletta, M. A. (2005) Nat. Chem. Biol. 1, 154158). The reversible inhibition of human Trx1 activity by H2O2 and NO donors is suggested to act in cell signaling via temporal control of reduction for the transmission of oxidative and/or nitrosative signals in thiol redox control.	[Hashemy, Seyed Isaac; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	Hashemy, Seyed Isaac/A-2693-2017	Hashemy, Seyed Isaac/0000-0002-1323-5250				Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bizzarri C, 2005, ANTIOXID REDOX SIGN, V7, P1189, DOI 10.1089/ars.2005.7.1189; Boje KMK, 2004, FRONT BIOSCI-LANDMRK, V9, P763, DOI 10.2741/1268; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Holmgren A, 2008, SCIENCE, V320, P1019, DOI 10.1126/science.1159246; KEISARI Y, 1983, IMMUNOBIOLOGY, V165, P78, DOI 10.1016/S0171-2985(83)80048-5; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kuster GM, 2006, ANTIOXID REDOX SIGN, V8, P2153, DOI 10.1089/ars.2006.8.2153; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; RAND MJ, 1995, ANNU REV PHYSIOL, V57, P659; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Sayre Lawrence M, 2005, Ann Ist Super Sanita, V41, P143; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Sumbayev VV, 2003, ARCH BIOCHEM BIOPHYS, V415, P133, DOI 10.1016/S0003-9861(03)00199-1; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tao L, 2006, BRIT J PHARMACOL, V149, P311, DOI 10.1038/sj.bjp.0706853; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Tao L, 2006, CIRCULATION, V114, P1395, DOI 10.1161/CIRCULATIONAHA.106.625061; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thippeswamy T, 2006, HISTOL HISTOPATHOL, V21, P445, DOI 10.14670/HH-21.445; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Weichsel A, 2007, BIOCHEMISTRY-US, V46, P1219, DOI 10.1021/bi061878r; Yasinska IM, 2004, ARCH BIOCHEM BIOPHYS, V428, P198, DOI 10.1016/j.abb.2004.06.004; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	60	144	146	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21890	21898		10.1074/jbc.M801047200	http://dx.doi.org/10.1074/jbc.M801047200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544525	hybrid			2022-12-27	WOS:000258114700008
J	Bartos, JD; Willmott, LJ; Binz, SK; Wold, MS; Bambara, RA				Bartos, Jeremy D.; Willmott, Lyndsay J.; Binz, Sara K.; Wold, Marc S.; Bambara, Robert A.			Catalysis of strand annealing by replication protein A derives from its strand melting properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 NUCLEOCAPSID PROTEIN; NUCLEIC-ACID CHAPERONE; OKAZAKI FRAGMENT MATURATION; DNA-BINDING PROTEIN; COMPLEX-FORMATION; RAD52 PROTEIN; RECA PROTEIN; IN-VITRO; HELICASE; RPA	Eukaryotic DNA-binding protein replication protein A (RPA) has a strand melting property that assists polymerases and helicases in resolving DNA secondary structures. Curiously, previous results suggested that human RPA (hRPA) promotes undesirable recombination by facilitating annealing of flaps produced transiently during DNA replication; however, the mechanism was not understood. We designed a series of substrates, representing displaced DNA flaps generated during maturation of Okazaki fragments, to investigate the strand annealing properties of RPA. Until cleaved by FEN1 (flap endonuclease 1), such flaps can initiate homologous recombination. hRPA inhibited annealing of strands lacking secondary structure but promoted annealing of structured strands. Apparently, both processes primarily derive from the strand melting properties of hRPA. These properties slowed the spontaneous annealing of unstructured single strands, which occurred efficiently without hRPA. However, structured strands without hRPA displayed very slow spontaneous annealing because of stable intramolecular hydrogen bonding. hRPA appeared to transiently melt the single strands so that they could bind to form double strands. In this way, melting ironically promoted annealing. Time course measurements in the presence of hRPA suggest that structured single strands achieve an equilibrium with double strands, a consequence of RPA driving both annealing and melting. Promotion of annealing reached a maximum at a specific hRPA concentration, presumably when all structured single-stranded DNA was melted. Results suggest that displaced flaps with secondary structure formed during Okazaki fragment maturation can be melted by hRPA and subsequently annealed to a complementary ectopic DNA site, forming recombination intermediates that can lead to genomic instability.	[Bartos, Jeremy D.; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Willmott, Lyndsay J.] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Binz, Sara K.; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Rochester; University of Rochester; University of Iowa	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_Bambara@urmc.rochester.edu	Wold, Marc/F-5806-2010	Wold, Marc/0000-0002-4580-1624	NCI NIH HHS [T32 CA 09363] Funding Source: Medline; NIGMS NIH HHS [GM 024441, R01 GM044721, GM 44721] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721, R01GM024441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bartos JD, 2006, J BIOL CHEM, V281, P32227, DOI 10.1074/jbc.M606310200; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Beltz H, 2004, J MOL BIOL, V338, P711, DOI 10.1016/j.jmb.2004.03.019; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Daughdrill GW, 2001, NUCLEIC ACIDS RES, V29, P3270, DOI 10.1093/nar/29.15.3270; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Iftode C, 2000, BIOCHEMISTRY-US, V39, P11970, DOI 10.1021/bi0005761; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; LONN U, 1990, CANCER RES, V50, P3141; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-1; MacNeill SA, 2001, CURR BIOL, V11, pR842, DOI 10.1016/S0960-9822(01)00500-0; MUNIYAPPA K, 1984, P NATL ACAD SCI-BIOL, V81, P2757, DOI 10.1073/pnas.81.9.2757; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Pestryakov PE, 2004, NUCLEIC ACIDS RES, V32, P1894, DOI 10.1093/nar/gkh346; Peyret N, 2000, THESIS WAYNE STATE U; Ranalli TA, 2002, J BIOL CHEM, V277, P1719, DOI 10.1074/jbc.M109053200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; TSUCHIHASHI Z, 1994, J VIROL, V68, P5863, DOI 10.1128/JVI.68.9.5863-5870.1994; Urbaneja MA, 2002, J MOL BIOL, V318, P749, DOI 10.1016/S0022-2836(02)00043-8; Van Komen S, 2003, J BIOL CHEM, V278, P44331, DOI 10.1074/jbc.M307256200; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; YOU JC, 1994, J BIOL CHEM, V269, P31491; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21758	21768		10.1074/jbc.M800856200	http://dx.doi.org/10.1074/jbc.M800856200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522944	Green Published, hybrid			2022-12-27	WOS:000257898800049
J	Nabavi, S; Nellimarla, S; Nazar, RN				Nabavi, Sadeq; Nellimarla, Srinivas; Nazar, Ross N.			Post-transcriptional regulation of the U3 small nucleolar RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMIDS; RIBONUCLEOPROTEIN; GENES; TRANSFORMATION; MATURATION; PROTEIN; CLONING	A high copy shuttle vector was used to express a "tagged" U3 small nucleolar RNA (snoRNA) gene in Schizosaccharomyces pombe to examine regulatory responses to a high gene dosage. RNA analyses utilizing reverse transcription-PCR amplification and restriction fragment length polymorphism indicated that the tagged gene was both proportionally and highly expressed and that downstream processing and/or termination were critical to U3 snoRNA stability. In contrast, direct measurements of the total cellular U3 snoRNA showed essentially normal levels of mature RNA, although measurements of precursor levels confirmed a highly expressed gene construct. Taken together, the results indicated that the steady state amounts of mature U3 snoRNA were primarily regulated at the post-transcriptional level. This regulatory mechanism prevents over-accumulation of the cellular U3 snoRNA and can efficiently degrade mutant RNA molecules. Together with past studies on other 3' extended RNA precursors, the results support post-transcriptional regulation as a quality control mechanism in which appropriate amounts of functional RNA are stabilized by protein interaction while excess or defective RNA is rapidly degraded. Precursor processing in vitro and mutational analyses were consistent with this model.	[Nabavi, Sadeq; Nellimarla, Srinivas; Nazar, Ross N.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rnnazar@uoguelph.ca		Nabavi, Sadegh/0000-0002-3940-1210				ABOUELELA S, 1998, EMBO J, V13, P3738; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dunbar DA, 1997, MOL CELL BIOL, V17, P5803, DOI 10.1128/MCB.17.10.5803; Granneman S, 2004, MOL CELL BIOL, V24, P8600, DOI 10.1128/MCB.24.19.8600-8610.2004; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Kienzle N, 1996, BIOTECHNIQUES, V20, P612; Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904; LEADER DJ, 1994, BBA-GENE STRUCT EXPR, V1219, P145, DOI 10.1016/0167-4781(94)90257-7; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Lee Y, 2003, J BIOL CHEM, V278, P6635, DOI 10.1074/jbc.M212220200; LEE Y, 1995, J BIOL CHEM, V270, P28003; Lee Y, 1997, J BIOL CHEM, V272, P15206, DOI 10.1074/jbc.272.24.15206; LOSSON R, 1983, CELL, V32, P371, DOI 10.1016/0092-8674(83)90456-7; MANGIN M, 1985, SCIENCE, V229, P272, DOI 10.1126/science.2409601; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Nabavi S, 2005, ANAL BIOCHEM, V345, P346, DOI 10.1016/j.ab.2005.06.033; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; NAZAR RN, 1991, J BIOL CHEM, V266, P4562; NAZAR RN, 2007, FASEB J, V21; Noonberg SB, 1996, J BIOL CHEM, V271, P10477, DOI 10.1074/jbc.271.18.10477; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Rose M. D., 1990, METHODS YEAST GENETI, P140; Samarsky DA, 1998, MOL CELL BIOL, V18, P3431, DOI 10.1128/MCB.18.6.3431; Sambrook J., 2001, MOL CLONING LAB MANU; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; SELINGER DA, 1992, MOL BIOL EVOL, V9, P297; STEELE WJ, 1965, J BIOL CHEM, V240, P1742; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Watkins NJ, 1996, RNA, V2, P118; Zhou DW, 1999, RNA, V5, P1083, DOI 10.1017/S1355838299990726	37	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21404	21410		10.1074/jbc.M802189200	http://dx.doi.org/10.1074/jbc.M802189200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522942	hybrid			2022-12-27	WOS:000257898800011
J	Steiner, K; Novotny, R; Werz, DB; Zarschler, K; Seeberger, PH; Hofinger, A; Kosma, P; Schaffer, C; Messner, P				Steiner, Kerstin; Novotny, Rene; Werz, Daniel B.; Zarschler, Kristof; Seeberger, Peter H.; Hofinger, Andreas; Kosma, Paul; Schaeffer, Christina; Messner, Paul			Molecular basis of S-layer glycoprotein glycan biosynthesis in Geobacillus stearothermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; BINDING CASSETTE TRANSPORTER; L-RHAMNOSE BIOSYNTHESIS; ESCHERICHIA-COLI; NRS 2004/3A; PROTEIN GLYCOSYLATION; GENE-CLUSTER; BACTERIAL OLIGOSACCHARYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY	The Gram-positive bacterium Geobacillus stearothermophilus NRS 2004/3a possesses a cell wall containing an oblique surface layer ( S-layer) composed of glycoprotein subunits. O-Glycans with the structure [-> 2)-alpha-L-Rhap-(1 -> 3)-beta-L-Rhap-(1 -> 2)-alpha-L-Rhap-(1 ->](n) (=) (13-18), a 2-O-methyl group capping the terminal repeating unit at the nonreducing end and a -> 2)-alpha-L- Rhap-[(1 -> 3)-alpha-L-Rhap](n) (=) (1-2)(1 -> 3)- adaptor are linked via a beta-D-Galp residue to distinct sites of the S-layer protein SgsE. S-layer glycan biosynthesis is encoded by a polycistronic slg ( surface layer glycosylation) gene cluster. Four assigned glycosyltransferases named WsaC-WsaF, were investigated by a combined biochemical and NMR approach, starting from synthetic octyl-linked saccharide precursors. We demonstrate that three of the enzymes are rhamnosyltransferases that are responsible for the transfer of L-rhamnose from a dTDP-beta-L-Rha precursor to the nascent S-layer glycan, catalyzing the formation of the alpha 1,3-(WsaC and WsaD) and beta 1,2-linkages (WsaF) present in the adaptor saccharide and in the repeating units of the mature S-layer glycan, respectively. These enzymes work in concert with a multifunctional methylrhamnosyltransferase (WsaE). The N-terminal portion of WsaE is responsible for the Sadenosylmethionine-dependent methylation reaction of the terminal alpha 1,3- linked L-rhamnose residue, and the central and C-terminal portions are involved in the transfer of L-rhamnose from dTDP-beta-L-rhamnose to the adaptor saccharide to form the alpha 1,2- and alpha 1,3- linkages during S-layer glycan chain elongation, with the methylation and the glycosylation reactions occurring independently. Characterization of these enzymes thus reveals the complete molecular basis for S-layer glycan biosynthesis.	[Steiner, Kerstin; Novotny, Rene; Zarschler, Kristof; Schaeffer, Christina; Messner, Paul] Univ Nat Resources & Appl Life Sci, Ctr NanoBiotechnol, Vienna, Austria; [Hofinger, Andreas; Kosma, Paul] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Werz, Daniel B.; Seeberger, Peter H.] Swiss Fed Inst Technol, Organ Chem Lab, Zurich, Switzerland	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schaffer, C (corresponding author), Univ Nat Resources & Appl Life Sci, Ctr NanoBiotechnol, Vienna, Austria.	christina.schaeffer@boku.ac.at; paul.messner@boku.ac.at	Kosma, Paul/Y-7443-2019; Zarschler, Kristof/A-3276-2015; Schäffer, Christina/V-3404-2018; Messner, Paul/Q-5345-2017	Kosma, Paul/0000-0001-5342-7161; Zarschler, Kristof/0000-0002-7571-4732; Schäffer, Christina/0000-0003-1613-7258; Messner, Paul/0000-0002-3246-5801	Austrian Science Fund FWF [P 18013, P 19047] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		ADACHI S, 1965, J CHROMATOGR, V17, P295, DOI 10.1016/S0021-9673(00)99871-6; BOCK K, 1994, J BIOL CHEM, V269, P7137; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furstner A, 1999, J AM CHEM SOC, V121, P7814, DOI 10.1021/ja991361l; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Graninger M, 2002, APPL ENVIRON MICROB, V68, P3708, DOI 10.1128/AEM.68.8.3708-3715.2002; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Kahlig H, 2005, J BIOL CHEM, V280, P20292, DOI 10.1074/jbc.M501724200; Keenleyside WJ, 2001, J BACTERIOL, V183, P77, DOI 10.1128/JB.183.1.77-85.2001; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Love KR, 2004, ANGEW CHEM INT EDIT, V43, P602, DOI 10.1002/anie.200352539; Messner P, 2008, CARBOHYD RES, V343, P1934, DOI 10.1016/j.carres.2007.12.025; MORONA R, 1995, MOL MICROBIOL, V18, P209, DOI 10.1111/j.1365-2958.1995.mmi_18020209.x; Novotny R, 2003, GLYCOCONJUGATE J, V20, P435, DOI 10.1023/B:GLYC.0000038290.74944.65; Novotny R, 2004, MICROBIOL-SGM, V150, P953, DOI 10.1099/mic.0.26672-0; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Riley JG, 2005, GLYCOBIOLOGY, V15, P605, DOI 10.1093/glycob/cwi038; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Rush JS, 1997, GLYCOBIOLOGY, V7, P315, DOI 10.1093/glycob/7.2.315; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Schaffer C, 2007, SMALL, V3, P1549, DOI 10.1002/smll.200700200; Schaffer C, 1999, GLYCOBIOLOGY, V9, P407, DOI 10.1093/glycob/9.4.407; Schaffer C, 2004, GLYCOBIOLOGY, V14, p31R, DOI 10.1093/glycob/cwh064; Schaffer C, 2002, J BIOL CHEM, V277, P6230, DOI 10.1074/jbc.M108873200; Schuster B, 2006, MINI-REV MED CHEM, V6, P909, DOI 10.2174/138955706777935026; Seeberger PH, 2007, NATURE, V446, P1046, DOI 10.1038/nature05819; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Sleytr UB, 2007, FEMS MICROBIOL LETT, V267, P131, DOI 10.1111/j.1574-6968.2006.00573.x; Sleytr UB, 2007, FEBS J, V274, P323, DOI 10.1111/j.1742-4658.2006.05606.x; STEINER K, 2007, SMALL IN PRESS; Steiner K, 2007, J BACTERIOL, V189, P2590, DOI 10.1128/JB.01592-06; Steiner K, 2006, J BACTERIOL, V188, P7914, DOI 10.1128/JB.00802-06; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sugiyama T, 1998, J BACTERIOL, V180, P2775, DOI 10.1128/JB.180.10.2775-2778.1998; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang QH, 2007, BIOTECHNOL BIOENG, V98, P842, DOI 10.1002/bit.21462; Weerapana E, 2005, J AM CHEM SOC, V127, P13766, DOI 10.1021/ja054265v; Werz DB, 2007, ACS CHEM BIOL, V2, P685, DOI 10.1021/cb700178s; Werz DB, 2005, ANGEW CHEM INT EDIT, V44, P6315, DOI 10.1002/anie.200502615; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wolucka BA, 1998, GLYCOBIOLOGY, V8, P955, DOI 10.1093/glycob/8.10.955; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	61	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21120	21133		10.1074/jbc.M801833200	http://dx.doi.org/10.1074/jbc.M801833200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515358	hybrid, Green Published			2022-12-27	WOS:000257746100054
J	Bugreev, DV; Brosh, RM; Mazin, AV				Bugreev, Dmitry V.; Brosh, Robert M., Jr.; Mazin, Alexander V.			RECQ1 possesses DNA branch migration activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; ROTHMUND-THOMSON-SYNDROME; BLOOMS-SYNDROME HELICASE; REPLICATION PROTEIN-A; SYNDROME GENE-PRODUCT; HUMAN RAD54 PROTEIN; HOMOLOGOUS RECOMBINATION; BIOCHEMICAL-CHARACTERIZATION; HOLLIDAY JUNCTIONS; WERNERS-SYNDROME	RecQ helicases are essential for the maintenance of genome stability. Five members of the RecQ family have been found in humans, including RECQ1, RECQ5, BLM, WRN, and RECQ4; the last three are associated with human diseases. At this time, only BLM and WRN helicases have been extensively characterized, and the information on the other RecQ helicases has only started to emerge. Our current paper is focused on the biochemical properties of human RECQ1 helicase. Recent cellular studies have shown that RECQ1 may participate in DNA repair and homologous recombination, but the exact mechanisms of how RECQ1 performs its cellular functions remain largely unknown. Whereas RECQ1 possesses poor helicase activity, we found here that the enzyme efficiently promotes DNA branch migration. Further analysis revealed that RECQ1 catalyzes unidirectional three- stranded branch migration with a 3'-> 5' polarity. We show that this RECQ1 activity is instrumental in specific disruption of joint molecules (D- loops) formed by a 5' single- stranded DNA invading strand, which may represent dead end intermediates of homologous recombination in vivo. The newly found enzymatic properties of the RECQ1 helicase may have important implications for the function of RECQ1 in maintenance of genomic stability.	[Bugreev, Dmitry V.; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Bugreev, Dmitry V.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia; [Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,NCB Rm 10103, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu			NATIONAL CANCER INSTITUTE [R56CA100839, R01CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA 100839] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bjergbaek L, 2002, SWISS MED WKLY, V132, P433; Branzei D, 2007, GENE DEV, V21, P3019, DOI 10.1101/gad.1624707; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; BUGREEV DV, 2006, NATURE PROTOCOLS; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Harrigan JA, 2003, BIOCHIMIE, V85, P1185, DOI 10.1016/j.biochi.2003.10.006; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Ozsoy AZ, 2001, NUCLEIC ACIDS RES, V29, P2986, DOI 10.1093/nar/29.14.2986; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Seki T, 1997, BIOCHEM BIOPH RES CO, V234, P48, DOI 10.1006/bbrc.1997.6535; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Wang LL, 2001, AM J MED GENET, V102, P11, DOI 10.1002/1096-8628(20010722)102:1<11::AID-AJMG1413>3.0.CO;2-A; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	68	61	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20231	20242		10.1074/jbc.M801582200	http://dx.doi.org/10.1074/jbc.M801582200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18495662	Green Published, hybrid			2022-12-27	WOS:000257565300039
J	Cambi, A; Netea, MG; Mora-Montes, HM; Gow, NAR; Hato, SV; Lowman, DW; Kullberg, BJ; Torensma, R; Williams, DL; Figdor, CG				Cambi, Alessandra; Netea, Mihai G.; Mora-Montes, Hector M.; Gow, Neil A. R.; Hato, Stanleyson V.; Lowman, Douglas W.; Kullberg, Bart-Jan; Torensma, Ruurd; Williams, David L.; Figdor, Carl G.			Dendritic cell interaction with Candida albicans critically depends on N-linked mannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; TOLL-LIKE RECEPTORS; LECTINS DC-SIGN; WALL MANNAN; SEROTYPE-B; SACCHAROMYCES-CEREVISIAE; SURFACE HYDROPHOBICITY; MONOCLONAL-ANTIBODY; PATHOGENIC YEASTS; STRUCTURAL BASIS	The fungus Candida albicans is the most common cause of mycotic infections in immunocompromised hosts. Little is known about the initial interactions between Candida and immune cell receptors, because a detailed characterization at the structural level is lacking. Antigen-presenting dendritic cells (DCs), strategically located at mucosal surfaces and in the skin, may play an important role in anti-Candida protective immunity. However, the contribution of the various Candida-associated molecular patterns and their counter-receptors to DC function remains unknown. Here, we demonstrate that two C-type lectins, DC-SIGN and the macrophage mannose receptor, specifically mediate C. albicans binding and internalization by human DCs. Moreover, by combining a range of C. albicans glycosylation mutants with receptor-specific blocking and cytokine production assays, we determined that N-linked mannan but not O-linked or phosphomannan is the fungal carbohydrate structure specifically recognized by both C-type lectins on human DCs and directly influences the production of the proinflammatory cytokine IL-6. Better insight in the carbohydrate recognition profile of C-type lectins will ultimately provide relevant information for the development of new drugs targeting specific fungal cell wall antigens.	[Cambi, Alessandra; Hato, Stanleyson V.; Torensma, Ruurd; Figdor, Carl G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands; [Netea, Mihai G.; Kullberg, Bart-Jan] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Netea, Mihai G.; Kullberg, Bart-Jan] Radboud Univ Nijmegen, Univ Nijmegen, Nijmegen Med Ctr, Ctr Infect Dis, NL-6500 HB Nijmegen, Netherlands; [Mora-Montes, Hector M.; Gow, Neil A. R.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland; [Lowman, Douglas W.] Eastman Chem Co, Corp Analyt Serv, Kingsport, TN 37662 USA; [Lowman, Douglas W.; Williams, David L.] E Tennessee State Univ, James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Aberdeen; Eastman Chemical Company; East Tennessee State University	Figdor, CG (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, Postbox 9101, NL-6500 HB Nijmegen, Netherlands.	c.figdor@ncmls.ru.nl	Mora-Montes, Hector/A-8312-2010; Montes, Hector Manuel Mora/H-1729-2014; Torensma, Ruurd/C-2853-2009; Netea, Mihai/N-5155-2014; Kullberg, BJ/C-8520-2013; Figdor, Carl G/A-4232-2010; GOW, Neil/AAS-5323-2021; Cambi, Alessandra/L-4242-2015	Montes, Hector Manuel Mora/0000-0001-6973-0595; Torensma, Ruurd/0000-0002-0555-7903; Kullberg, BJ/0000-0002-6813-8167; Figdor, Carl G/0000-0002-2366-9212; GOW, Neil/0000-0002-2776-5850; Cambi, Alessandra/0000-0003-1597-1582	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI045829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053522] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 45829] Funding Source: Medline; NIGMS NIH HHS [GM 53522] Funding Source: Medline; Wellcome Trust [080088] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Bates EEM, 1999, J IMMUNOL, V163, P1973; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Bleijs DA, 2000, J CELL SCI, V113, P391; Bystricky S, 2003, IMMUNOL LETT, V85, P251, DOI 10.1016/S0165-2478(02)00241-9; Calderone Richard A., 1993, Trends in Microbiology, V1, P55, DOI 10.1016/0966-842X(93)90033-N; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Choi W, 2003, YEAST, V20, P1053, DOI 10.1002/yea.1022; Chorvatovicova D, 1999, MUTAT RES-GEN TOX EN, V444, P117, DOI 10.1016/S1383-5718(99)00102-3; Coleman DC, 1997, AIDS, V11, P557, DOI 10.1097/00002030-199705000-00002; Cutler JE, 2005, CURR MOL MED, V5, P383, DOI 10.2174/1566524054022576; Dromer F, 2002, ANTIMICROB AGENTS CH, V46, P3869, DOI 10.1128/AAC.46.12.3869-3876.2002; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; FONZI WA, 1993, GENETICS, V134, P717; Forsyth CB, 1996, CELL IMMUNOL, V170, P91, DOI 10.1006/cimm.1996.0138; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; HOFFMAN RE, 1988, MAGN RESON CHEM, V26, P523, DOI 10.1002/mrc.1260260617; HUCKERBY TN, 1983, ORG MAGN RESONANCE, V21, P67, DOI 10.1002/omr.1270210118; Kath F, 1999, ANGEW MAKROMOL CHEM, V268, P69; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; KOBAYASHI H, 1992, CARBOHYD RES, V231, P317, DOI 10.1016/0008-6215(92)84028-Q; KOGAN G, 1988, CARBOHYD RES, V172, P243, DOI 10.1016/S0008-6215(00)90858-9; KOGAN G, 1990, CARBOHYD POLYM, V14, P65, DOI 10.1016/0144-8617(90)90007-F; Lam JS, 2005, J IMMUNOL, V175, P7496, DOI 10.4049/jimmunol.175.11.7496; Lowman DW, 2003, CARBOHYD RES, V338, P1491, DOI 10.1016/S0008-6215(03)00169-1; MARODI L, 1991, J IMMUNOL, V146, P2783; Masuoka J, 2004, INFECT IMMUN, V72, P6230, DOI 10.1128/IAI.72.11.6230-6236.2004; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154, DOI 10.4049/jimmunol.178.1.154; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; MULLER A, 1995, J CHROMATOGR B, V666, P283, DOI 10.1016/0378-4347(94)00575-P; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Netea MG, 2004, MICROBES INFECT, V6, P985, DOI 10.1016/j.micinf.2004.05.013; Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Newman SL, 2001, INFECT IMMUN, V69, P6813, DOI 10.1128/IAI.69.11.6813-6822.2001; PRETUS HA, 1991, J PHARMACOL EXP THER, V257, P500; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SHIBATA N, 1995, J BIOL CHEM, V270, P1113, DOI 10.1074/jbc.270.3.1113; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; THOMPSON HL, 1992, CLIN EXP IMMUNOL, V87, P316, DOI 10.1111/j.1365-2249.1992.tb02994.x; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Van Liempt E, 2004, J BIOL CHEM, V279, P33161, DOI 10.1074/jbc.M404988200; Wu XY, 2005, J ORG CHEM, V70, P7381, DOI 10.1021/jo051065t	59	167	170	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20590	20599		10.1074/jbc.M709334200	http://dx.doi.org/10.1074/jbc.M709334200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482990	Green Published, hybrid			2022-12-27	WOS:000257565300071
J	Evans, JP; Niemevz, F; Buldain, G; de Montellano, PO				Evans, John P.; Niemevz, Fernando; Buldain, Graciela; de Montellano, Paul Ortiz			Isoporphyrin intermediate in heme oxygenase catalysis - Oxidation of alpha-meso-phenylheme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSERADISH-PEROXIDASE; CHEMICAL OXIDATION; REACTION REGIOSPECIFICITY; ELECTRONIC CONTROL; PROTOPORPHYRIN-IX; MECHANISM; BILIVERDIN; INHIBITION; INACTIVATION; COMPLEX	Human heme oxygenase-1 (hHO-1) catalyzes the O-2- and NADPH-dependent oxidation of heme to biliverdin, CO, and free iron. The first step involves regiospecific insertion of an oxygen atom at the alpha-meso carbon by a ferric hydroperoxide and is predicted to proceed via an isoporphyrin pi-cation intermediate. Here we report spectroscopic detection of a transient intermediate during oxidation by hHO-1 of alpha-meso-phenylheme-IX, alpha-meso-(p-methylphenyl)-mesoheme-III, and alpha-meso-(p-trifluoromethylphenyl)mesoheme-III. In agreement with previous experiments (Wang, J., Niemevz, F., Lad, L., Huang, L., Alvarez, D. E., Buldain, G., Poulos, T. L., and Ortiz de Montellano, P. R. (2004) J. Biol. Chem. 279, 42593-42604), only the alpha-biliverdin isomer is produced with concomitant formation of the corresponding benzoic acid. The transient intermediate observed in the NADPH-P450 reductase-catalyzed reaction accumulated when the reaction was supported by H2O2 and exhibited the absorption maxima at 435 and 930 nm characteristic of an isoporphyrin. Product analysis by reversed phase high performance liquid chromatography and liquid chromatography electrospray ionization mass spectrometry of the product generated with H2O2 identified it as an isoporphyrin that, on quenching, decayed to benzoylbiliverdin. In the presence of H-2 O-18(2), one labeled oxygen atom was incorporated into these products. The hHO-1-isoporphyrin complexes were found to have half-lives of 1.7 and 2.4 h for the p-trifluoromethyl- and p- methyl-substituted phenylhemes, respectively. The addition of NADPH-P450 reductase to the H2O2-generated hHO-1-isoporphyrin complex produced alpha-biliverdin, confirming its role as a reaction intermediate. Identification of an isoporphyrin intermediate in the catalytic sequence of hHO-1, the first such intermediate observed in hemoprotein catalysis, completes our understanding of the critical first step of heme oxidation.	[Evans, John P.; de Montellano, Paul Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Niemevz, Fernando; Buldain, Graciela] Univ Buenos Aires, Dept Quim Organ, Fac Farm & Bioquim, Buenos Aires, DF, Argentina	University of California System; University of California San Francisco; University of Buenos Aires	de Montellano, PO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu			NIDDK NIH HHS [R01 DK030297, DK30297] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asano N, 2007, J ORG CHEM, V72, P5320, DOI 10.1021/jo070692a; ATOR MA, 1989, J BIOL CHEM, V264, P9250; BAGGER S, 1971, ACTA CHEM SCAND, V25, P976, DOI 10.3891/acta.chem.scand.25-0976; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; BONNETT R, 1973, J CHEM SOC PERK T 1, P881, DOI 10.1039/p19730000881; CHOE YS, 1991, J BIOL CHEM, V266, P8523; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; Davydov R, 2003, J AM CHEM SOC, V125, P16208, DOI 10.1021/ja038923s; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; DOCHERTY JC, 1984, J BIOL CHEM, V259, P3066; DOLPHIN D, 1970, J AM CHEM SOC, V92, P743, DOI 10.1021/ja00706a076; FRYDMAN RB, 1981, BIOCHEMISTRY-US, V20, P5177, DOI 10.1021/bi00521a012; Furci LM, 2007, J MED CHEM, V50, P3804, DOI 10.1021/jm0700969; GOLD A, 1984, INORG CHEM, V23, P2932, DOI 10.1021/ic00187a007; Hildebrandt A G, 1978, Methods Enzymol, V52, P342; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kumar D, 2005, J AM CHEM SOC, V127, P8204, DOI 10.1021/ja0446956; Lad L, 2003, J MOL BIOL, V330, P527, DOI 10.1016/S0022-2836(03)00578-3; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; Liu Y, 1997, J BIOL CHEM, V272, P6909, DOI 10.1074/jbc.272.11.6909; NAKAJIMA R, 1980, J BIOL CHEM, V255, P2067; Niemevz F, 2004, J PORPHYR PHTHALOCYA, V8, P989, DOI 10.1142/S1088424604000350; Niemevz F, 2002, HETEROCYCLES, V57, P697; Niemevz F, 2008, SYNTHESIS-STUTTGART, P875, DOI 10.1055/s-2008-1032203; Ongayi O, 2003, CHEM COMMUN, P2298, DOI 10.1039/b306586c; Raner GM, 2000, J INORG BIOCHEM, V81, P153, DOI 10.1016/S0162-0134(00)00098-2; Robinsohn AE, 2000, HETEROCYCLES, V53, P2127; SANO S, 1986, P NATL ACAD SCI USA, V83, P531, DOI 10.1073/pnas.83.3.531; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Sugishima M, 2004, J MOL BIOL, V341, P7, DOI 10.1016/j.jmb.2004.05.048; TAKAHASHI S, 1995, J AM CHEM SOC, V117, P6002, DOI 10.1021/ja00127a013; Torpey J, 1996, J AM CHEM SOC, V118, P9172, DOI 10.1021/ja9623469; Torpey J, 1997, J BIOL CHEM, V272, P22008, DOI 10.1074/jbc.272.35.22008; Torpey J, 1996, J BIOL CHEM, V271, P26067, DOI 10.1074/jbc.271.42.26067; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Wang JL, 2006, BIOCHEMISTRY-US, V45, P61, DOI 10.1021/bi051645k; Wang JL, 2004, J BIOL CHEM, V279, P42593, DOI 10.1074/jbc.M406346200; WILKS A, 1995, BIOCHEMISTRY-US, V34, P4421, DOI 10.1021/bi00013a034; WILKS A, 1994, J BIOL CHEM, V269, P29553; WILKS A, 1993, J BIOL CHEM, V268, P22357; WISEMAN JS, 1982, J BIOL CHEM, V257, P6328; Yamauchi T, 2005, CHEM COMMUN, P1309, DOI 10.1039/b414299c; Zhou H, 2000, J AM CHEM SOC, V122, P8311, DOI 10.1021/ja0002868	48	25	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19530	19539		10.1074/jbc.M709685200	http://dx.doi.org/10.1074/jbc.M709685200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487208	hybrid, Green Published			2022-12-27	WOS:000257387600039
J	Macia, E; Partisani, M; Favard, C; Mortier, E; Zimmermann, P; Carlier, MF; Gounon, P; Luton, F; Franco, M				Macia, Eric; Partisani, Mariagrazia; Favard, Cyril; Mortier, Eva; Zimmermann, Pascale; Carlier, Marie-France; Gounon, Pierre; Luton, Frederic; Franco, Michel			The pleckstrin homology domain of the Arf6-specific exchange factor EFA6 localizes to the plasma membrane by interacting with phosphatidylinositol 4,5-bisphosphate and F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR-6; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; ARF6; PHOSPHOINOSITIDES; PROTEINS; BINDING; GOLGI; ASSOCIATION; ACTIVATION	The Arf6-specific exchange factor EFA6 coordinates membrane trafficking with actin cytoskeleton remodeling. It localizes to the plasma membrane where it catalyzes Arf6 activation and induces the formation of actin-based membrane ruffles. We have shown previously that the pleckstrin homology (PH) domain of EFA6 was responsible for its membrane localization. In this study we looked for the partners of the PH domain at the plasma membrane. Mutations of the conserved basic residues suspected to be involved in the binding to phosphoinositides redistribute EFA6-PH to the cytosol. In addition, phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) breakdown also leads to the solubilization of EFA6-PH. Direct binding measured by surface plasmon resonance gives an apparent affinity of similar to 0.5 mu M EFA6-PH for PI(4,5)P-2. Moreover, we observed in vitro that the catalytic activity of EFA6 is strongly increased by PI(4,5)P-2. These results indicate that the plasma membrane localization of EFA6-PH is based on its interaction with PI(4,5) P2, and this interaction is necessary for an optimal catalytic activity of EFA6. Furthermore, we demonstrated by fluorescence recovery after photobleaching and Triton X-100 detergent solubility experiments that in addition to the phophoinositides, EFA6-PH is linked to the actin cytoskeleton. We observed both in vivo and in vitro that EFA6-PH interacts directly with F-actin. Finally, we demonstrated that EFA6 could bind simultaneously filamentous actin and phospholipids vesicles. Our results explain how the exchange factor EFA6 via its PH domain could coordinate at the plasma membrane actin cytoskeleton organization with membrane trafficking.	[Macia, Eric; Partisani, Mariagrazia; Luton, Frederic; Franco, Michel] Univ Nice Sophia Antipolis, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Favard, Cyril] CNRS, UMR 6133, Inst Fresnel, F-13397 Marseille 20, France; [Mortier, Eva; Zimmermann, Pascale] Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; [Carlier, Marie-France] CNRS Univ, UPR 3082, Lab Enzymol & Biol Struct, F-91198 Gif Sur Yvette, France; [Gounon, Pierre] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06103 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Cote d'Azur	Franco, M (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	franco@ipmc.cnrs.fr	Luton, Frederic/N-7673-2017; Macia, Eric/AAW-2964-2021; Zimmermann, Pascale/P-4190-2017; FRANCO, michel/AAA-9735-2021; Favard, Cyril/P-6392-2016; Franco, Michel/ABH-4993-2020	Favard, Cyril/0000-0002-8304-2980; Franco, Michel/0000-0003-1853-8661; macia, eric/0000-0003-3686-2000				AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Chavrier P, 2001, METHOD ENZYMOL, V329, P272; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Franco M, 1998, P NATL ACAD SCI USA, V95, P9926, DOI 10.1073/pnas.95.17.9926; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; FRANCO M, 1993, J BIOL CHEM, V268, P24531; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Sakagami H, 2007, EUR J NEUROSCI, V25, P618, DOI 10.1111/j.1460-9568.2007.05345.x; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TOCANNE JF, 1994, PROG LIPID RES, V33, P203, DOI 10.1016/0163-7827(94)90027-2; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	44	40	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19836	19844		10.1074/jbc.M800781200	http://dx.doi.org/10.1074/jbc.M800781200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18490450	hybrid			2022-12-27	WOS:000257387600067
J	Komiya, Y; Kurabe, N; Katagiri, K; Ogawa, M; Sugiyama, A; Kawasaki, Y; Tashiro, F				Komiya, Yuko; Kurabe, Nobuya; Katagiri, Kumiko; Ogawa, Makiko; Sugiyama, Akinori; Kawasaki, Yasushi; Tashiro, Fumio			A novel binding factor of 14-3-3 beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION; PROTEIN; CANCER; PHOSPHORYLATION; MECHANISMS; EXPRESSION; TUMOR; GENE; METALLOPROTEINASES; DIFFERENTIATION	The 14-3-3 proteins form a highly conserved family of dimeric proteins that interact with various signal transduction proteins and regulate cell cycle, apoptosis, stress response, and malignant transformation. We previously demonstrated that the beta isoform of 14-3-3 proteins promotes tumorigenicity and angiogenesis of rat hepatoma K2 cells. In this study, to analyze the mechanism of 14-3-3 beta-induced malignant transformation, yeast two-hybrid screening was performed, and a novel 14-33 beta-binding factor, FBI1 (fourteen-three-three beta interactant 1), was identified. In vitro binding and co-immunoprecipitation analyses verified specific interaction of 14-3-3 beta with FBI1. The strong expression of FBI1 was observed in several tumor cell lines but not in non-tumor cell lines. Forced expression of antisense FBI1 in K2 cells inhibited anchorage-independent growth but had no significant effect on cell proliferation in monolayer culture. Down-regulation of FBI1 also inhibited tumorigenicity and metastasis accompanying a decrease in MMP-9 ( matrix metalloproteinase-9) expression. In addition, the duration of ERK1/2 activation was curtailed in antisense FBI1-expressing K2 cells. A luciferase reporter assay revealed that the FBI1-14-3-3 beta complex could act as a transcriptional silencer, and MKP-1 (MAPK phosphatase-1) was one of the target genes of the FBI1-14-3-3 beta complex. Moreover, chromatin immunoprecipitation analysis demonstrated that FBI1 and 14-3-3 beta were presented on the MKP-1 promoter. These results indicate that FBI1 promotes sustained ERK1/2 activation through repression of MKP-1 transcription, resulting in promotion of tumorigenicity and metastasis.	[Komiya, Yuko; Kurabe, Nobuya; Katagiri, Kumiko; Ogawa, Makiko; Sugiyama, Akinori; Kawasaki, Yasushi; Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 2788510, Japan	Tokyo University of Science	Tashiro, F (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Yamazaki 2641, Noda, Chiba 2788510, Japan.	ftashir@rs.noda.tus.ac.jp						Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Akiyama H, 2003, J BIOL CHEM, V278, P10752, DOI 10.1074/jbc.M209856200; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Baldin V, 2002, J BIOL CHEM, V277, P35176, DOI 10.1074/jbc.M204430200; BOS JL, 1989, CANCER RES, V49, P4682; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; BROWN PD, 1993, KIDNEY INT, V43, P163, DOI 10.1038/ki.1993.27; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Giles N, 2003, J BIOL CHEM, V278, P28580, DOI 10.1074/jbc.M304027200; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MORIMURA S, 1990, CHEM PHARM BULL, V38, P460, DOI 10.1248/cpb.38.460; Muda M, 1996, J BIOL CHEM, V271, P4319; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; REUTHER GW, 1994, SCIENCE, V266, P129, DOI 10.1126/science.7939633; Ryser S, 2004, BIOCHEM J, V378, P473, DOI 10.1042/BJ20031022; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Shoji Masahiro, 1994, Human Antibodies and Hybridomas, V5, P123; Sinha P, 2000, ELECTROPHORESIS, V21, P3048, DOI 10.1002/1522-2683(20000801)21:14<3048::AID-ELPS3048>3.0.CO;2-W; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Sugiyama A, 2003, CARCINOGENESIS, V24, P1549, DOI 10.1093/carcin/bgg113; TAKAI R, 1995, J BIOCHEM, V118, P1045, DOI 10.1093/jb/118.5.1045; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Urano Y, 2006, J BIOL CHEM, V281, P7498, DOI 10.1074/jbc.M510881200; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Hoeven PCJ, 2000, BIOCHEM J, V347, P781, DOI 10.1042/0264-6021:3470781; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151	47	62	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18753	18764		10.1074/jbc.M802530200	http://dx.doi.org/10.1074/jbc.M802530200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18460465	hybrid			2022-12-27	WOS:000257165600032
J	Simonetti, M; Giniatullin, R; Fabbretti, E				Simonetti, Manuela; Giniatullin, Rashid; Fabbretti, Elsa			Mechanisms mediating the enhanced gene transcription of P2X(3) receptor by calcitonin gene-related peptide in trigeminal sensory neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-MODIFYING PROTEIN-1; ELEMENT-BINDING PROTEIN; NITRIC-OXIDE; DEPENDENT TRANSCRIPTION; ANTAGONIST BIBN4096BS; NEUROTROPHIC FACTOR; BLOOD-FLOW; C-FOS; CREB; MIGRAINE	The molecular mechanisms underlying migraine pain remain unclear and probably require sustained facilitation in pain-sensing P2X(3) receptors gated by extracellular ATP in nociceptive sensory neurons. The major migraine mediator calcitonin gene-related peptide ( CGRP) is known to sensitize P2X3 receptors to increase impulse flow to brainstem trigeminal nuclei. This process is mediated via changes in the expression and function of P2X3 receptors initially through enhanced trafficking and, later, perhaps through augmented synthesis of P2X3 receptors. To clarify the mechanisms responsible for CGRP-evoked long lasting alterations in P2X3 receptors, we used as a model mouse trigeminal ganglion neurons in culture. CGRP activated Ca2+-calmodulin- dependent kinase II, which became localized to the perimembrane region and neuronal processes, a phenomenon already apparent after 30 min and accompanied by a parallel increase in cAMP-response element-binding protein ( CREB) phosphorylation and nuclear translocation. These effects triggered increased P2X3 receptor transcription and were prevented by expressing a dominant negative form of CREB. Increased P2X3 receptor synthesis was partly mediated by endogenous brain-derived neurotrophic factor ( BDNF) because of its block by anti-BDNF antibodies and mimicry by exogenous BDNF. Immunocytochemistry experiments indicated distinct subpopulations of BDNF- or CGRP-sensitive trigeminal neurons with only partial overlap. The present data indicate a novel mechanism for enhancing P2X3 receptor expression and function in trigeminal sensory neurons by CGRP via CREB phosphorylation. BDNF was an intermediate to extend the sensitizing effect of CGRP also to CGRP-insensitive neurons. This combinatorial action could serve as a powerful process to amplify and prolong pain mediated by P2X3 receptors.	[Simonetti, Manuela; Giniatullin, Rashid; Fabbretti, Elsa] SISSA, Neurobiol Sector, I-34014 Trieste, Italy; [Simonetti, Manuela; Giniatullin, Rashid; Fabbretti, Elsa] SISSA, Italian Inst Technol Unit, I-34014 Trieste, Italy; Univ Kuopio, AI Virtanen Inst, FIN-70211 Kuopio, Finland	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Eastern Finland	Fabbretti, E (corresponding author), SISSA, Neurobiol Sector, Beirut 2-4, I-34014 Trieste, Italy.	fabbre@sissa.it	Giniatullin, Rashid/Y-9687-2018	Giniatullin, Rashid/0000-0002-1580-6280	Telethon [GGP07032] Funding Source: Medline	Telethon(Fondazione Telethon)		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Anderson LE, 2004, J NEUROCHEM, V91, P1417, DOI 10.1111/j.1471-4159.2004.02833.x; Arulmani U, 2004, EUR J PHARMACOL, V500, P315, DOI 10.1016/j.ejphar.2004.07.035; Blandini F, 2006, CEPHALALGIA, V26, P136, DOI 10.1111/j.1468-2982.2005.01006.x; Buldyrev I, 2006, J NEUROCHEM, V99, P1338, DOI 10.1111/j.1471-4159.2006.04161.x; Chawla S, 2002, EUR J PHARMACOL, V447, P131, DOI 10.1016/S0014-2999(02)01837-X; Chen MJ, 2007, LIFE SCI, V81, P1280, DOI 10.1016/j.lfs.2007.09.003; COCKAYNE DA, 2002, J PHYSL, V567, P621; Cohen JE, 2006, CELL CALCIUM, V39, P445, DOI 10.1016/j.ceca.2006.01.005; Cottrell GS, 2005, J COMP NEUROL, V490, P239, DOI 10.1002/cne.20669; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; D'Arco M, 2007, J NEUROSCI, V27, P8190, DOI 10.1523/JNEUROSCI.0713-07.2007; Drissi H, 1998, J BIOL CHEM, V273, P20168, DOI 10.1074/jbc.273.32.20168; Drissi H, 1999, CYTOKINE, V11, P200, DOI 10.1006/cyto.1998.0415; Durham PL, 2006, HEADACHE, V46, pS3, DOI 10.1111/j.1526-4610.2006.00483.x; Edvinsson L, 2005, CNS DRUG REV, V11, P69; Fabbretti E, 2006, J NEUROSCI, V26, P6163, DOI 10.1523/JNEUROSCI.0647-06.2006; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; GALLAI V, 1995, CEPHALALGIA, V15, P384, DOI 10.1046/j.1468-2982.1995.1505384.x; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Goadsby PJ, 2005, DRUGS, V65, P2557, DOI 10.2165/00003495-200565180-00002; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gozalov A, 2007, CEPHALALGIA, V27, P1120, DOI 10.1111/j.1468-2982.2007.01409.x; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Iovino M, 2004, CEPHALALGIA, V24, P645, DOI 10.1111/j.1468-2982.2004.00726.x; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mandolesi G, 2002, FEBS LETT, V510, P50, DOI 10.1016/S0014-5793(01)03227-6; Messlinger K, 2000, BRIT J PHARMACOL, V129, P1397, DOI 10.1038/sj.bjp.0703220; Miletic G, 2004, NEUROSCI LETT, V361, P269, DOI 10.1016/j.neulet.2003.12.029; Miyabe T, 2005, NEUROSCI LETT, V381, P80, DOI 10.1016/j.neulet.2005.02.001; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mogil JS, 2000, J PAIN, V1, P66, DOI 10.1054/jpai.2000.9821; North R Alan, 2003, Curr Opin Investig Drugs, V4, P833; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; RUBINSTEIN C, 1993, CLIN EXP PHARMACOL P, V20, P477, DOI 10.1111/j.1440-1681.1993.tb01728.x; Sarchielli P, 2007, J PAIN, V8, P737, DOI 10.1016/j.jpain.2007.05.002; Schwenger N, 2007, CEPHALALGIA, V27, P481, DOI 10.1111/j.1468-2982.2007.01321.x; Seybold VS, 2006, J NEUROCHEM, V97, P397, DOI 10.1111/j.1471-4159.2006.03744.x; Seybold VS, 2003, J NEUROSCI, V23, P1816; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; Sjostrand C, 2006, HEADACHE, V46, P1518, DOI 10.1111/j.1526-4610.2006.00611.x; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Souslova V, 1997, GENE, V195, P101, DOI 10.1016/S0378-1119(97)00225-4; Ulmann L, 2007, EUR J NEUROSCI, V26, P113, DOI 10.1111/j.1460-9568.2007.05649.x; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woolf CJ, 2004, ANN INTERN MED, V140, P441, DOI 10.7326/0003-4819-140-8-200404200-00010; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	61	77	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18743	18752		10.1074/jbc.M800296200	http://dx.doi.org/10.1074/jbc.M800296200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18460469	hybrid			2022-12-27	WOS:000257165600031
J	Koenig, P; Oreb, M; Rippe, K; Muhle-Goll, C; Sinning, I; Schleiff, E; Tews, I				Koenig, Patrick; Oreb, Mislav; Rippe, Karsten; Muhle-Goll, Claudia; Sinning, Irmgard; Schleiff, Enrico; Tews, Ivo			On the significance of Toc-GTPase homodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST PROTEIN IMPORT; SIGNAL-RECOGNITION PARTICLE; CRYSTAL-STRUCTURE; PREPROTEIN RECEPTOR; ALUMINUM FLUORIDE; OUTER ENVELOPE; BINDING; TRANSLOCON; DIMERIZATION; INSIGHTS	Precursor protein translocation across the outer chloroplast membrane depends on the action of the Toc complex, containing GTPases as recognizing receptor components. The G domains of the GTPases are known to dimerize. In the dimeric conformation an arginine contacts the phosphate moieties of bound nucleotide in trans. Kinetic studies suggested that the arginine in itself does not act as an arginine finger of a reciprocal GTPase-activating protein (GAP). Here we investigate the specific function of the residue in two GTPase homologues. Arginine to alanine replacement variants have significantly reduced affinities for dimerization compared with wild-type GTPases. The amino acid exchange does not impact on the overall fold and nucleotide binding, as seen in the monomeric x-ray crystallographic structure of the Arabidopsis Toc33 arginine-alanine replacement variant at 2.0 A. We probed the catalytic center with the transition state analogue GDP/AlFx using NMR and analytical ultracentrifugation. AlFx binding depends on the arginine, suggesting the residue can play a role in catalysis despite the non-GAP nature of the homodimer. Two non-exclusive functional models are discussed: 1) the coGAP hypothesis, in which an additional factor activates the GTPase in homodimeric form; and 2) the switch hypothesis, in which a protein, presumably the large Toc159 GTPase, exchanges with one of the homodimeric subunits, leading to activation.	[Koenig, Patrick; Sinning, Irmgard; Tews, Ivo] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Oreb, Mislav; Schleiff, Enrico] JWGU Frankfurt Main, Cluster Excellence Macromol Complexes, Dept Biosci, D-60439 Frankfurt, Germany; [Rippe, Karsten] Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; [Rippe, Karsten] Res Grp Genome Org & Funct, BIOQUANT, D-69120 Heidelberg, Germany; [Muhle-Goll, Claudia] Karlsruhe Inst Technol, Inst Biol Grenzflachen, D-76021 Karlsruhe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Tews, I (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ivo.tews@bzh.uni-heidelberg.de	Muhle-Goll, Claudia/AAM-6070-2021; Schleiff, Enrico/C-5105-2017; Tews, Ivo/A-2750-2010; Rippe, Karsten/A-3562-2012; Sinning, Irmgard/A-2982-2010	Schleiff, Enrico/0000-0002-0518-3489; Tews, Ivo/0000-0002-4704-1139; Rippe, Karsten/0000-0001-9951-9395; Oreb, Mislav/0000-0002-6118-1517	Deutsche Forschungsgemeinschaft [SFB594-B11]; Volkswagenstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen)	The work was supported by Deutsche Forschungsgemeinschaft Grant SFB594-B11 (to E. S.) and by a grant from the Volkswagenstiftung (to E. S. and K. R.).	Ahmadian MR, 1997, FEBS LETT, V408, P315, DOI 10.1016/S0014-5793(97)00422-5; Aronsson H, 2003, FEBS LETT, V544, P79, DOI 10.1016/S0014-5793(03)00478-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bange G, 2007, P NATL ACAD SCI USA, V104, P13621, DOI 10.1073/pnas.0702570104; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chen KH, 2000, PLANT PHYSIOL, V122, P813, DOI 10.1104/pp.122.3.813; Dam J, 2004, METHOD ENZYMOL, V384, P185; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jelic M, 2003, BIOCHEMISTRY-US, V42, P5906, DOI 10.1021/bi034001q; Jelic M, 2002, BIOL CHEM, V383, P1875, DOI 10.1515/BC.2002.211; Kessler F, 2004, TRENDS CELL BIOL, V14, P334, DOI 10.1016/j.tcb.2004.05.004; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kikuchi S, 2006, PLANT CELL PHYSIOL, V47, P363, DOI 10.1093/pcp/pcj002; Koenig P, 2008, STRUCTURE, V16, P585, DOI 10.1016/j.str.2008.01.008; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MARUTA S, 1993, J BIOL CHEM, V268, P7093; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Oreb M, 2008, J EXP BOT, V59, P2309, DOI 10.1093/jxb/ern095; Oreb M, 2008, TRENDS CELL BIOL, V18, P19, DOI 10.1016/j.tcb.2007.10.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Praefcke GJK, 1999, J MOL BIOL, V292, P321, DOI 10.1006/jmbi.1999.3062; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Reddick LE, 2007, J BIOL CHEM, V282, P11410, DOI 10.1074/jbc.M609491200; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sun YJ, 2002, NAT STRUCT BIOL, V9, P95, DOI 10.1038/nsb744; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vojta A, 2004, J BIOL CHEM, V279, P21401, DOI 10.1074/jbc.M401968200; Wallas TR, 2003, J BIOL CHEM, V278, P44289, DOI 10.1074/jbc.M307873200; Weibel P, 2003, J BIOL CHEM, V278, P37321, DOI 10.1074/jbc.M305946200; Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200	54	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23104	23112		10.1074/jbc.M710576200	http://dx.doi.org/10.1074/jbc.M710576200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18541539	hybrid			2022-12-27	WOS:000258455400023
J	Park, HJ; Ding, L; Dai, MQ; Lin, RC; Wang, HY				Park, Hee-Jin; Ding, Lei; Dai, Mingqiu; Lin, Rongcheng; Wang, Haiyang			Multisite phosphorylation of Arabidopsis HFR1 by casein kinase II and a plausible role in regulating its degradation rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-DEPENDENT DEGRADATION; TRANSCRIPTION FACTOR; PHYTOCHROME-A; SHADE AVOIDANCE; OSCILLATOR FUNCTION; CIRCADIAN CLOCK; GENE-EXPRESSION; LIGHT; PROTEIN; CK2	Arabidopsis Long Hypocotyl in Far-Red Light 1 (HFR1), a bHLH transcription factor, plays a critical role in promoting seedling photomorphogenesis and in balancing the shade-avoidance response under canopy shade conditions. Previous studies have established that HFR1 protein is degraded in darkness and is stabilized under light conditions to promote light signaling. How light regulates HFR1 stability is not well understood. In this study, we show that Arabidopsis HFR1 can be phosphorylated by recombinant casein kinase II (CKII) and plant extract in vitro and that phosphorylation of HFR1 can be effectively reduced by treatments with two CKII-specific inhibitors, 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole (DRB) and heparin. We demonstrate that HFR1 physically interacts with the CKB1 and CKB2 regulatory subunits of CKII. Mutagenesis studies indicate that HFR1 is phosphorylated at multiple serine (Ser) residues in the N-terminal regulatory domain of HFR1. We also show that phosphorylation of HFR1 is promoted by light and that a predicted CKII site, Ser(122), represents a major phosphorylation site of HFR1 under both dark and light conditions. Comparison of wild-type, phosphorylation-deficient, and phosphorylation-mimic mutant proteins suggests that phosphorylation acts to reduce the degradation rate of HFR1. Together, our results suggest that CKII-mediated phosphorylation represents an important post-translational modification influencing the stability and signaling activity of Arabidopsis HFR1.	[Park, Hee-Jin; Ding, Lei; Dai, Mingqiu; Lin, Rongcheng; Wang, Haiyang] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research	Wang, HY (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	hw75@cornell.edu	Lin, Rongcheng/I-8105-2014	Lin, Rongcheng/0000-0001-8346-3390; Dai, Mingqiu/0000-0001-6737-8209	Div Of Molecular and Cellular Bioscience [1004808] Funding Source: National Science Foundation	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Andronis C, 2008, MOL PLANT, V1, P58, DOI 10.1093/mp/ssm005; Briggs WR, 2001, PLANT PHYSIOL, V125, P85, DOI 10.1104/pp.125.1.85; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Duek PD, 2003, PLANT J, V34, P827, DOI 10.1046/j.1365-313X.2003.01770.x; Fairchild CD, 2000, GENE DEV, V14, P2377; Fittinghoff K, 2006, PLANT J, V47, P577, DOI 10.1111/j.1365-313X.2006.02812.x; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Huq E, 2006, TRENDS PLANT SCI, V11, P4, DOI 10.1016/j.tplants.2005.11.005; Hussain A, 2005, PLANT J, V44, P88, DOI 10.1111/j.1365-313X.2005.02512.x; Itoh H, 2003, TRENDS PLANT SCI, V8, P492, DOI 10.1016/j.tplants.2003.08.002; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; KLIMCZAK LJ, 1992, PLANT CELL, V4, P87, DOI 10.1105/tpc.4.1.87; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lee Y, 1999, PLANT PHYSIOL, V119, P989, DOI 10.1104/pp.119.3.989; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; MCNELLIS TW, 1995, PLANT CELL, V7, P1749, DOI 10.1105/tpc.7.11.1749; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Perales M, 2006, PLANT J, V46, P849, DOI 10.1111/j.1365-313X.2006.02744.x; Portoles S, 2007, PLANT J, V51, P966, DOI 10.1111/j.1365-313X.2007.03186.x; Riera M, 2001, MOL CELL BIOCHEM, V227, P119, DOI 10.1023/A:1013141713277; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; Shalitin D, 2002, NATURE, V417, P763, DOI 10.1038/nature00815; Shen H, 2005, PLANT J, V44, P1023, DOI 10.1111/j.1365-313X.2005.02606.x; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; Soh MS, 2000, PLANT CELL, V12, P2061, DOI 10.1105/tpc.12.11.2061; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Yang JP, 2006, PLANT J, V47, P564, DOI 10.1111/j.1365-313X.2006.02811.x; Yang JP, 2005, PLANT J, V43, P131, DOI 10.1111/j.1365-313X.2005.02433.x; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797	54	35	39	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23264	23273		10.1074/jbc.M801720200	http://dx.doi.org/10.1074/jbc.M801720200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556661	hybrid			2022-12-27	WOS:000258455400039
J	Pratt, WB; Morishima, Y; Osawa, Y				Pratt, William B.; Morishima, Yoshihiro; Osawa, Yoichi			The Hsp90 chaperone machinery regulates signaling by modulating ligand binding clefts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							NITRIC-OXIDE SYNTHASE; 7-AMINO ACID SEQUENCE; HEAT-SHOCK-PROTEIN; GLUCOCORTICOID-RECEPTOR; DEPENDENT ACTIVATION; MOLECULAR TARGET; AMINO-TERMINUS; KINASE DOMAIN; IN-VITRO; GELDANAMYCIN		[Pratt, William B.; Morishima, Yoshihiro; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	osawa@umich.edu			NIDA NIH HHS [DA022354] Funding Source: Medline; NIGMS NIH HHS [GM077430] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022354] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Billecke SS, 2004, J BIOL CHEM, V279, P30252, DOI 10.1074/jbc.M403864200; Billecke SS, 2002, J BIOL CHEM, V277, P20504, DOI 10.1074/jbc.M201940200; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dong DD, 2006, J STEROID BIOCHEM, V101, P106, DOI 10.1016/j.jsbmb.2006.06.010; Gee AC, 2001, MOL ENDOCRINOL, V15, P421, DOI 10.1210/me.15.3.421; Giannoukos G, 1999, J BIOL CHEM, V274, P36527, DOI 10.1074/jbc.274.51.36527; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kaul S, 2002, J BIOL CHEM, V277, P36223, DOI 10.1074/jbc.M206748200; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2003, J BIOL CHEM, V278, P48754, DOI 10.1074/jbc.M309814200; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Murphy PJM, 2003, J BIOL CHEM, V278, P34764, DOI 10.1074/jbc.M304469200; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; NEMOTO T, 1990, BIOCHEMISTRY-US, V29, P1880, DOI 10.1021/bi00459a031; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; OSAWA Y, 1993, J BIOL CHEM, V268, P2953; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt William B., 2007, V2, P1; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Tikhomirov O, 2003, CANCER RES, V63, P39; Vuletich JL, 2002, MOL PHARMACOL, V62, P110, DOI 10.1124/mol.62.1.110; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	50	116	123	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22885	22889		10.1074/jbc.R800023200	http://dx.doi.org/10.1074/jbc.R800023200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18515355	Green Published, hybrid			2022-12-27	WOS:000258455400001
J	Raman, J; Fritz, TA; Gerken, TA; Jamison, O; Live, D; Liu, M; Tabak, LA				Raman, Jayalakshmi; Fritz, Timothy A.; Gerken, Thomas A.; Jamison, Oliver; Live, David; Liu, Mian; Tabak, Lawrence A.			The catalytic and lectin domains of UDP-GalNAc: Polypeptide alpha-N-acetylgalactosaminyltransferase function in concert to direct glycosylation site selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-D-GALACTOSAMINE; MUCIN TANDEM REPEAT; O-GLYCOSYLATION; STREPTOMYCES-LIVIDANS; SUBMAXILLARY-GLAND; KINETIC MECHANISM; XYLAN-BINDING; IN-VIVO; GLYCOPEPTIDE; FAMILY	UDP-GalNAc: polypeptide alpha-N-Acetylgalactosaminyltransferases (ppGalNAcTs), a family (EC 2.4.1.41) of enzymes that initiate mucin-type O-glycosylation, are structurally composed of a catalytic domain and a lectin domain. Previous studies have suggested that the lectin domain modulates the glycosylation of glycopeptide substrates and may underlie the strict glycopeptide specificity of some isoforms (ppGalNAcT-7 and -10). Using a set of synthetic peptides and glycopeptides based upon the sequence of the mucin, MUC5AC, we have examined the activity and glycosylation site preference of lectin domain deletion and exchange constructs of the peptide/glycopeptide transferase ppGalNAcT-2 (hT2) and the glycopeptide transferase ppGal-NAcT- 10 (hT10). We demonstrate that the lectin domain of hT2 directs glycosylation site selection for glycopeptide substrates. Pre-steady-state kinetic measurements show that this effect is attributable to two mechanisms, either lectin domain-aided substrate binding or lectin domain-aided product release following glycosylation. We find that glycosylation of peptide substrates by hT10 requires binding of existing GalNAcs on the substrate to either its catalytic or lectin domain, thereby resulting in its apparent strict glycopeptide specificity. These results highlight the existence of two modes of site selection used by these ppGalNAcTs: local sequence recognition by the catalytic domain and the concerted recognition of distal sites of prior glycosylation together with local sequence binding mediated, respectively, by the lectin and catalytic domains. The latter mode may facilitate the glycosylation of serine or threonine residues, which occur in sequence contexts that would not be efficiently glycosylated by the catalytic domain alone. Local sequence recognition by the catalytic domain differs between hT2 and hT10 in that hT10 requires a pre-existing GalNAc residue while hT2 does not.	[Raman, Jayalakshmi; Fritz, Timothy A.; Tabak, Lawrence A.] NIDDK, Sect Biol Chem, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Gerken, Thomas A.; Jamison, Oliver] Case Western Reserve Univ, Sch Med, WA Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; [Live, David; Liu, Mian] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University System of Georgia; University of Georgia	Tabak, LA (corresponding author), NIDDK, Sect Biol Chem, NIH, US Dept HHS, Bethesda, MD 20892 USA.	tabakl@mail.nih.gov			National Institutes of Health; NIDDK;  [NCI-RO1 CA-78834];  [NIGMS-RO1 GM-066148]; NATIONAL CANCER INSTITUTE [R01CA078834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK070012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health, through funds of the intramural program of the NIDDK and Grants NCI-RO1 CA-78834 (to T.A.G.) and NIGMS-RO1 GM-066148 (to D.L.).	Bashor C, 2002, BIOCHEMISTRY-US, V41, P4020, DOI 10.1021/bi0158730; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2000, BIOCHEM J, V350, P933, DOI 10.1042/0264-6021:3500933; Dupont C, 1998, BIOCHEM J, V330, P41, DOI 10.1042/bj3300041; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Gerken TA, 1998, J BIOL CHEM, V273, P26580, DOI 10.1074/jbc.273.41.26580; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Liu M, 2005, CARBOHYD RES, V340, P2111, DOI 10.1016/j.carres.2005.05.023; Nakagawa T, 2007, CLIN CANCER RES, V13, P4105, DOI 10.1158/1078-0432.CCR-07-0419; Nehrke K, 1997, GLYCOBIOLOGY, V7, P1053, DOI 10.1093/glycob/7.8.1053-c; Nehrke K, 1998, GLYCOBIOLOGY, V8, P367, DOI 10.1093/glycob/8.4.367; OCONNELL BC, 1992, J BIOL CHEM, V267, P25010; OCONNELL BC, 1993, ANAL BIOCHEM, V210, P423, DOI 10.1006/abio.1993.1219; ROTH J, 1994, P NATL ACAD SCI USA, V91, P8935, DOI 10.1073/pnas.91.19.8935; Rottger S, 1998, J CELL SCI, V111, P45; Sparrow LG, 2007, PROTEINS, V66, P261, DOI 10.1002/prot.21261; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tenno M, 2002, J BIOL CHEM, V277, P47088, DOI 10.1074/jbc.M207369200; Tetaert D, 2001, BIOCHEM J, V357, P313, DOI 10.1042/0264-6021:3570313; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; WRAGG S, 1995, J BIOL CHEM, V270, P16947, DOI 10.1074/jbc.270.28.16947; Xu YM, 1997, BIOCHEMISTRY-US, V36, P3700, DOI 10.1021/bi9616007	36	63	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22942	22951		10.1074/jbc.M803387200	http://dx.doi.org/10.1074/jbc.M803387200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562306	Green Published, hybrid			2022-12-27	WOS:000258455400007
J	Yamamoto, S; Fukumoto, E; Yoshizaki, K; Iwamoto, T; Yamada, A; Tanaka, K; Suzuki, H; Aizawa, S; Arakaki, M; Yuasa, K; Oka, K; Chai, Y; Nonaka, K; Fukumoto, S				Yamamoto, Shinya; Fukumoto, Emiko; Yoshizaki, Keigo; Iwamoto, Tsutomu; Yamada, Aya; Tanaka, Kojiro; Suzuki, Hiroharu; Aizawa, Shizuko; Arakaki, Makiko; Yuasa, Kenji; Oka, Kyoko; Chai, Yang; Nonaka, Kazuaki; Fukumoto, Satoshi			Platelet-derived growth factor receptor regulates salivary gland morphogenesis via fibroblast growth factor expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL NEURAL CREST; SUBMANDIBULAR-GLAND; BRANCHING MORPHOGENESIS; PDGF-A; DENTAL EPITHELIUM; LAMININ ALPHA-5; IN-VIVO; MOUSE; LUNG; FGF10	A coordinated reciprocal interaction between epithelium and mesenchyme is involved in salivary gland morphogenesis. The submandibular glands (SMGs) of Wnt1-Cre/R26R mice have been shown positive for mesenchyme, whereas the epithelium is beta-galactosidase-negative, indicating that most mesenchymal cells are derived from cranial neural crest cells. Platelet-derived growth factor (PDGF) receptor alpha is one of the markers of neural crest-derived cells. In this study, we analyzed the roles of PDGFs and their receptors in the morphogenesis of mouse SMGs. PDGF-A was shown to be expressed in SMG epithelium, whereas PDGF-B, PDGFR alpha, and PDGFR beta were expressed in mesenchyme. Exogenous PDGF-AA and -BB in SMG organ cultures demonstrated increased levels of branching and epithelial proliferation, although their receptors were found to be expressed in mesenchyme. In contrast, short interfering RNA for Pdgfa and -b as well as neutralizing antibodies for PDGF-AB and -BB showed decreased branching. PDGF-AA induced the expression of the fibroblast growth factor genes Fgf3 and -7, and PDGF-BB induced the expression of Fgf1, -3, -7, and -10, whereas short interfering RNA for Pdgfa and Pdgfb inhibited the expression of Fgf3, -7, and -10, indicating that PDGFs regulate Fgf gene expression in SMG mesenchyme. The PDGF receptor inhibitor AG-17 inhibited PDGF-induced branching, whereas exogenous FGF7 and -10 fully recovered. Together, these results indicate that fibroblast growth factors function downstream of PDGF signaling, which regulates Fgf expression in neural crest-derived mesenchymal cells and SMG branching morphogenesis. Thus, PDGF signaling is a possible mechanism involved in the interaction between epithelial and neural crest-derived mesenchyme.	[Yamada, Aya; Tanaka, Kojiro; Suzuki, Hiroharu; Aizawa, Shizuko; Arakaki, Makiko; Fukumoto, Satoshi] Tohoku Univ, Div Pediat Dent, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Yamamoto, Shinya; Yoshizaki, Keigo; Iwamoto, Tsutomu; Yamada, Aya; Yuasa, Kenji; Oka, Kyoko; Nonaka, Kazuaki; Fukumoto, Satoshi] Kyushu Univ, Sect Pediat Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 8128582, Japan; [Fukumoto, Emiko] Nagasaki Univ, Div Prevent Dent, Dept Dev & Reconstruct Med, Grad Sch Biomed Sci, Nagasaki 8528588, Japan; [Chai, Yang] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA	Tohoku University; Kyushu University; Nagasaki University; University of Southern California	Fukumoto, S (corresponding author), Tohoku Univ, Div Pediat Dent, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Sendai, Miyagi 9808575, Japan.	fukumoto@mail.tains.tohoku.ac.jp	Iwamoto, Tsutomu/AAA-6597-2019; Iwamoto, Tsutomu/AAI-8952-2021	Iwamoto, Tsutomu/0000-0001-8472-605X; Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891				Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; Chai Y, 2000, DEVELOPMENT, V127, P1671; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Fukumoto E, 2003, J DENT RES, V82, P17, DOI 10.1177/154405910308200105; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Govindarajan V, 2000, DEV BIOL, V225, P188, DOI 10.1006/dbio.2000.9812; HANSCH GM, 1995, J CELL PHYSIOL, V163, P451, DOI 10.1002/jcp.1041630304; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; Jaskoll T, 2002, CELLS TISSUES ORGANS, V170, P83, DOI 10.1159/000046183; Kashimata M, 2000, DEV BIOL, V220, P183, DOI 10.1006/dbio.2000.9639; Kashimata M, 1997, DEV DYNAM, V208, P149, DOI 10.1002/(SICI)1097-0177(199702)208:2<149::AID-AJA2>3.0.CO;2-I; Kingsley K, 2002, BIOCHEM BIOPH RES CO, V294, P1017, DOI 10.1016/S0006-291X(02)00592-2; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Larsen M, 2003, DEV BIOL, V255, P178, DOI 10.1016/S0012-1606(02)00047-7; Li J, 2001, DEV BIOL, V239, P338, DOI 10.1006/dbio.2001.0441; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Lindahl P, 1998, CURR OPIN NEPHROL HY, V7, P21, DOI 10.1097/00041552-199801000-00004; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Melnick M, 2000, CRIT REV ORAL BIOL M, V11, P199, DOI 10.1177/10454411000110020401; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Milunsky JM, 2006, CLIN GENET, V69, P349, DOI 10.1111/j.1399-0004.2006.00597.x; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Morita K, 1999, DEV DYNAM, V215, P148; MORRISONGRAHAM K, 1992, DEVELOPMENT, V115, P133; Nishiguchi M, 2007, ARCH ORAL BIOL, V52, P237, DOI 10.1016/j.archoralbio.2006.09.016; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Payne J, 1997, DEV DYNAM, V209, P105; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Robbins JR, 1999, DEV BIOL, V212, P255, DOI 10.1006/dbio.1999.9373; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Simian M, 2001, DEVELOPMENT, V128, P3117; Soriano P, 1997, DEVELOPMENT, V124, P2691; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; TAN SS, 1986, J EMBRYOL EXP MORPH, V98, P21; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; Yamada A, 2005, ARCH ORAL BIOL, V50, P393, DOI 10.1016/j.archoralbio.2004.09.014; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200	60	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23139	23149		10.1074/jbc.M710308200	http://dx.doi.org/10.1074/jbc.M710308200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18559345	hybrid			2022-12-27	WOS:000258455400027
J	Oakley, AJ; Yamada, T; Liu, D; Coggan, M; Clark, AG; Board, PG				Oakley, Aaron J.; Yamada, Tetsuo; Liu, Dan; Coggan, Marjorie; Clark, Alan G.; Board, Philip G.			The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase - An essential enzyme in the gamma-glutamyl cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-MODIFICATION; HUMAN-ERYTHROCYTES; PROTEIN; GLUTAMYLCYCLOTRANSFERASE; INTEGRATION; ACID; AMINOPEPTIDASE; CLASSIFICATION; PURIFICATION; GLUTATHIONE	The hypothetical protein C7orf24 has been implicated as a cancer marker with a potential role in cell proliferation. We have identified C7orf24 as gamma-glutamyl cyclotransferase (GGCT) that catalyzes the formation of 5-oxoproline (pyroglutamic acid) from gamma-glutamyl dipeptides and potentially plays a significant role in glutathione homeostasis. In the present study we have identified the first cDNA clones encoding a gamma-glutamyl cyclotransferase. The GGCT gene is located on chromosome 7p14-15 and consists of four exons that span 8 kb. The primary sequence is 188 amino acids in length and is unlike any protein of known function. We crystallized functional recombinant gamma-glutamyl cyclotransferase and determined its structure at 1.7 angstrom resolution. The enzyme is a dimer of 20,994-Da subunits. The topology of GGCT is unrelated to other enzymes associated with cyclotransferase-like activity. The fold was originally classified as "BtrG-like," a small family that only includes structures of hypothetical proteins from Mus musculus, Escherichia coli, Pyrococcus horikoshii, and Arabidopsis thaliana. Since this is the first member of this family with a defined function, we propose to refer to this structure as the gamma-glutamyl cyclotransferase fold. We have identified a potential active site pocket that contains a highly conserved glutamic acid (Glu(98)) and propose that it acts as a general acid/base in the reaction mechanism. Mutation of Glu(98) to Ala or Gln completely inactivates the enzyme without altering the overall fold.	[Yamada, Tetsuo; Liu, Dan; Coggan, Marjorie; Board, Philip G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Oakley, Aaron J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Clark, Alan G.] Victoria Univ Wellington, Sch Biol Sci, Wellington 6140, New Zealand	Australian National University; John Curtin School of Medical Research; Australian National University; Victoria University Wellington	Board, PG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Philip.Board@anu.edu.au	Oakley, Aaron/A-9464-2013	Oakley, Aaron/0000-0002-4764-014X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOARD PG, 1980, HUM HERED, V30, P248, DOI 10.1159/000153137; BOARD PG, 1978, J LAB CLIN MED, V91, P127; BOARD PG, 1978, BIOCHEM J, V173, P427, DOI 10.1042/bj1730427; Bzymek KP, 2004, J BIOL CHEM, V279, P31018, DOI 10.1074/jbc.M404035200; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fundoiano-Hershcovitz Y, 2004, FEBS LETT, V571, P192, DOI 10.1016/j.febslet.2004.07.001; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kageyama S, 2007, PROTEOM CLIN APPL, V1, P192, DOI 10.1002/prca.200600468; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Li YY, 2005, CHEM BIOL, V12, P665, DOI 10.1016/j.chembiol.2005.04.010; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1973, SCIENCE, V180, P33, DOI 10.1126/science.180.4081.33; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ORLOWSKI M, 1969, BIOCHEMISTRY-US, V8, P1048, DOI 10.1021/bi00831a036; ORLOWSKI M, 1973, J BIOL CHEM, V248, P2836; ORLOWSKI M, 1971, BIOCHEMISTRY-US, V10, P372, DOI 10.1021/bi00779a003; Ristoff E, 1998, CHEM-BIOL INTERACT, V112, P113, DOI 10.1016/S0009-2797(97)00155-5; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; STEINKAMP R, 1987, PHYSIOL PLANTARUM, V69, P499, DOI 10.1111/j.1399-3054.1987.tb09231.x; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TULCHIN N, 1981, GENETICS, V99, P109; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WELLNER VP, 1974, P NATL ACAD SCI USA, V71, P2505, DOI 10.1073/pnas.71.6.2505; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029; WOLFERSBERGER MG, 1974, J INVEST DERMATOL, V62, P587, DOI 10.1111/1523-1747.ep12679440; Xu L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-275; Zhang CL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-202	37	98	102	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22031	22042		10.1074/jbc.M803623200	http://dx.doi.org/10.1074/jbc.M803623200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18515354	hybrid			2022-12-27	WOS:000258114700022
J	Betzenhauser, MJ; Wagner, LE; Iwai, M; Michikawa, T; Mikoshiba, K; Yule, DI				Betzenhauser, Matthew J.; Wagner, Larry E., II; Iwai, Miwako; Michikawa, Takayuki; Mikoshiba, Katsuhiko; Yule, David I.			ATP modulation of Ca2+ release by type-2 and type-3 inositol (1,4,5)-triphosphate receptors - Differing ATP sensitivities and molecular determinants of action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING-SITES; 1,4,5-TRISPHOSPHATE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; ADENINE-NUCLEOTIDES; PLASMA-MEMBRANE; CALCIUM-RELEASE; CHANNELS; PHOSPHORYLATION; ACTIVATION; PROTEIN	ATP enhances Ca2+ release from inositol (1,4,5)-trisphosphate receptors (InsP(3)R). However, the three isoforms of InsP(3)R are reported to respond to ATP with differing sensitivities. Ca2+ release through InsP(3)R(1) is positively regulated at lower ATP concentrations than InsP(3)R(3), and InsP(3)R(2) has been reported to be insensitive to ATP modulation. We have reexamined these differences by studying the effects of ATP on InsP(3)R(2) and InsP(3)R(3) expressed in isolation on a null background in DT40 InsP(3)R knock-out cells. We report that the Ca2+-releasing activity as well as the single channel open probability of InsP(3)R(2) was enhanced by ATP, but only at submaximal InsP(3) levels. Further, InsP(3)R(2) was more sensitive to ATP modulation than InsP(3)R(3) under similar experimental conditions. Mutations in the ATPB sites of InsP(3)R(2) and InsP(3)R(3) were generated, and the functional consequences of these mutations were tested. Surprisingly, mutation of the ATPB site in InsP(3)R(3) had no effect on ATP modulation, suggesting an additional locus for the effects of ATP on this isoform. In contrast, ablation of the ATPB site of InsP(3)R(2) eliminated the enhancing effects of ATP. Furthermore, this mutation had profound effects on the patterns of intracellular calcium signals, providing evidence for the physiological significance of ATP binding to InsP(3)R(2).	[Betzenhauser, Matthew J.; Wagner, Larry E., II; Yule, David I.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Iwai, Miwako] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Mol Neurobiol, Tokyo, Japan; [Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Brain Dev Res Grp, Dev Neurobiol Lab, Saitama, Japan	University of Rochester; University of Tokyo; RIKEN	Yule, DI (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14625 USA.	David_Yule@urmc.rochester.edu	Mikoshiba, Katsuhiko/N-7943-2015		NIDCR NIH HHS [R01 DE 016999, T32 DE 07202] Funding Source: Medline; NIDDK NIH HHS [R01 DK 054568] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202, R01DE016999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; Dellis O, 2008, J BIOL CHEM, V283, P751, DOI 10.1074/jbc.M706960200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Dong K, 2005, EMBO J, V24, P1318, DOI 10.1038/sj.emboj.7600626; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; Hiratsuka T, 2003, EUR J BIOCHEM, V270, P3479, DOI 10.1046/j.1432-1033.2003.03748.x; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Maes K, 1999, CELL CALCIUM, V25, P143, DOI 10.1054/ceca.1998.0011; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Maes K, 2000, CELL CALCIUM, V27, P257, DOI 10.1054/ceca.2000.0121; Mak DOD, 1999, J BIOL CHEM, V274, P22231, DOI 10.1074/jbc.274.32.22231; Mak DOD, 2001, J GEN PHYSIOL, V117, P447, DOI 10.1085/jgp.117.5.447; Missiaen L, 1997, BIOCHEM J, V325, P661, DOI 10.1042/bj3250661; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tu HP, 2002, BIOPHYS J, V82, P1995, DOI 10.1016/S0006-3495(02)75548-3; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Vanoye CG, 2002, J BIOL CHEM, V277, P23260, DOI 10.1074/jbc.M112004200; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Zhang XJ, 1999, BIOCHEM J, V340, P519, DOI 10.1042/0264-6021:3400519	46	61	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21579	21587		10.1074/jbc.M801680200	http://dx.doi.org/10.1074/jbc.M801680200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18505727	hybrid, Green Published			2022-12-27	WOS:000257898800031
J	Basilico, C; Arnesano, A; Galluzzo, M; Comoglio, PM; Michieli, P				Basilico, Cristina; Arnesano, Addolorata; Galluzzo, Maria; Comoglio, Paolo M.; Michieli, Paolo			A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of met	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; RECEPTOR TYROSINE KINASE; C-MET; FACTOR/SCATTER FACTOR; SCATTER-FACTOR; MONOCLONAL-ANTIBODIES; LIVER-REGENERATION; LENTIVIRAL VECTORS; ANTITUMOR-ACTIVITY; GENE-TRANSFER	Hepatocyte growth factor (HGF) and its high affinity receptor, the tyrosine kinase Met, play a key role in embryo development and tumor invasion. Both HGF and Met are established targets for cancer therapy. However, the mechanism of their interaction is complex and remains elusive. HGF is secreted as a monomeric precursor (pro-HGF) that binds to but does not activate Met. Mature HGF is a alpha/beta heterodimer containing a high affinity Met-binding site in the alpha-chain (HGF-alpha) and a low affinity Met-binding site in the alpha-chain (HGF-alpha). The extracellular portion of Met contains a semaphorin (Sema) domain, a cysteine-rich hinge (plexin-semaphorin-integrin), and four immunoglobulin-like domains ( immunoglobulin-like regions in plexins and transcription factors (IPT) 1-4). HGF-beta binds to Sema through a low affinity contact. The domain of Met responsible for high affinity binding to HGF-alpha has not been identified yet. Here we show that this long sought after binding site lies in the immunoglobulin-like region of Met and more precisely in IPT 3 and 4. We also show that IPT 3 and 4 are sufficient to transmit the signal for kinase activation to the cytoplasm, although the lack of Sema makes the receptor equally sensitive to mature HGF and pro-HGF. Finally, we provide evidence that soluble Met-derived proteins containing either the low affinity or high affinity HGF-binding site antagonize HGF-induced invasive growth both in vitro and in xenografts. These data suggest that the immunoglobulin-like region of Met cooperates with the Sema domain in binding to HGF and in controlling Met kinase activity. Although the IPT-HGF-alpha interaction provides binding strength, the Sema-HGF-beta contact confers selective sensitivity to the active form of the ligand.	[Basilico, Cristina; Arnesano, Addolorata; Galluzzo, Maria; Comoglio, Paolo M.; Michieli, Paolo] Univ Turin, Sch Med, Div Mol Oncol, Inst Canc Res & Treatment, I-10060 Turin, Italy	University of Turin	Michieli, P (corresponding author), Univ Turin, Sch Med, Div Mol Oncol, Inst Canc Res & Treatment, SP 142,Km 3-95, I-10060 Turin, Italy.	paolo.michieli@ircc.it	Basilico, Cristina/A-3253-2011; Michieli, Paolo/A-2588-2011	Michieli, Paolo/0000-0002-3093-8871; Comoglio, Paolo/0000-0002-7056-5328	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Burgess T, 2006, CANCER RES, V66, P1721, DOI 10.1158/0008-5472.CAN-05-3329; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Christensen JG, 2003, CANCER RES, V63, P7345; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kirchhofer D, 2007, P NATL ACAD SCI USA, V104, P5306, DOI 10.1073/pnas.0700184104; Knudsen BS, 2008, CURR OPIN GENET DEV, V18, P87, DOI 10.1016/j.gde.2008.02.001; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Kozlov G, 2004, BIOCHEM BIOPH RES CO, V321, P234, DOI 10.1016/j.bbrc.2004.06.132; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; LONGATI P, 1994, ONCOGENE, V9, P49; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Matsumoto K, 2001, KIDNEY INT, V59, P2023, DOI 10.1046/j.1523-1755.2001.00717.x; Matsumoto K, 2003, CANCER SCI, V94, P321, DOI 10.1111/j.1349-7006.2003.tb01440.x; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Mazzone M, 2004, J CLIN INVEST, V114, P1418, DOI 10.1172/JCI200422235; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Michieli P, 2002, NAT BIOTECHNOL, V20, P488, DOI 10.1038/nbt0502-488; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P195; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; NALDINI L, 1991, ONCOGENE, V6, P501; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Ohmichi H, 1996, AM J PHYSIOL-LUNG C, V270, pL1031, DOI 10.1152/ajplung.1996.270.6.L1031; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Ruco LP, 1996, J PATHOL, V180, P266, DOI 10.1002/(SICI)1096-9896(199611)180:3<266::AID-PATH658>3.0.CO;2-Q; Sattler M, 2003, CANCER RES, V63, P5462; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; TEMPEST PR, 1988, BRIT J CANCER, V58, P3, DOI 10.1038/bjc.1988.150; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vigna E, 2000, J GENE MED, V2, P308; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	52	94	106	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21267	21277		10.1074/jbc.M800727200	http://dx.doi.org/10.1074/jbc.M800727200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18495663	Green Published, hybrid			2022-12-27	WOS:000257746100068
J	Jia, JM; Chen, Q; Zhou, Y; Miao, S; Zheng, J; Zhang, C; Xiong, ZQ				Jia, Jie-Min; Chen, Qian; Zhou, Yang; Miao, Sheng; Zheng, Jing; Zhang, Chi; Xiong, Zhi-Qi			Brain-derived neurotrophic factor-tropomyosin-related kinase B signaling contributes to activity-dependent changes in synaptic proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; DEGRADATION; BDNF; CREB; MODULATION; EXPRESSION; PLASTICITY; RECEPTORS	The ability of synapses to undergo changes in structure and function in response to alterations of neuronal activity is an essential property of neural circuits. One way that this is achieved is through global changes in the molecular composition of the synapse; however, it is not clear how these changes are coupled to the dynamics of neuronal activity. Here we found that, in cultured rat cortical neurons, bidirectional changes of neuronal activity led to corresponding alterations in the expression of brain-derived neurotrophic factor (BDNF) and phosphorylation of its receptor tropomyosin-related kinase B (TrkB), as well as in the level of synaptic proteins. Exogenous BDNF reversed changes in synaptic proteins induced by chronic activity blockade, while inhibiting Trk kinase activity or depleting endogenous BDNF abolished the concentration changes induced by chronic activity elevation. Both tetrodotoxin and bicuculline had significant, but opposite, effects on synaptic protein ubiquitination in a time-dependent manner. Furthermore, exogenous BDNF was sufficient to increase ubiquitination of synaptic proteins, whereas scavenging endogenous BDNF or inhibiting Trk kinase activity prevented the ubiquitination of synaptic proteins induced by chronic elevation of neuronal activity. Inhibiting the proteasome or blocking protein polyubiquitination mimicked the effect of tetrodotoxin on the levels of synaptic proteins and canceled the effects of BDNF. Our study indicates that BDNF-TrkB signaling acts upstream of the ubiquitin proteasome system, linking neuronal activity to protein turnover at the synapse.	[Xiong, Zhi-Qi] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xiong, ZQ (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	xiongzhiqi@ion.ac.cn	Zhang, Chi/ABB-1176-2021; Jia, Jie-Min/O-1150-2013; Chen, Qian/B-7405-2013	Zhang, Chi/0000-0003-4866-1441; Jia, Jie-Min/0000-0001-8446-3819; 				Aamodt S M, 1999, Adv Neurol, V79, P133; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; BOZZI Y, 1995, NEUROSCIENCE, V69, P1133, DOI 10.1016/0306-4522(95)00321-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chen Q, 2007, J NEUROSCI, V27, P542, DOI 10.1523/JNEUROSCI.3607-06.2007; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Dong X, 2004, AM J PHYSIOL-HEART C, V287, pH1417, DOI 10.1152/ajpheart.01233.2003; Dzeja PP, 2002, P NATL ACAD SCI USA, V99, P10156, DOI 10.1073/pnas.152259999; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; ISHIURA S, 1985, FEBS LETT, V189, P119, DOI 10.1016/0014-5793(85)80854-1; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; LESSMANN V, 1994, NEUROREPORT, V6, P21; Liu CL, 2004, J CEREBR BLOOD F MET, V24, P1219, DOI 10.1097/01.WCB.0000136706.77918.21; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mayer RJ, 2003, DRUG NEWS PERSPECT, V16, P103, DOI 10.1358/dnp.2003.16.2.829327; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patil S, 2005, CELL METAB, V2, P210, DOI 10.1016/j.cmet.2005.09.007; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Spencer ML, 2004, J BIOL CHEM, V279, P37069, DOI 10.1074/jbc.M402507200; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wu H, 2007, FEBS J, V274, P3218, DOI 10.1111/j.1742-4658.2007.05891.x; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	45	36	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21242	21250		10.1074/jbc.M800282200	http://dx.doi.org/10.1074/jbc.M800282200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18474605	Green Published, hybrid			2022-12-27	WOS:000257746100066
J	Nakano, M; Imamura, H; Toei, M; Tamakoshi, M; Yoshida, M; Yokoyama, K				Nakano, Masahiro; Imamura, Hiromi; Toei, Masashi; Tamakoshi, Masatada; Yoshida, Masasuke; Yokoyama, Ken			ATP hydrolysis and synthesis of a rotary motor V-ATPase from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND ATPASE; CATALYTIC SITE; ALPHA(3)BETA(3)GAMMA COMPLEX; INHIBITORY MGADP; BACILLUS PS3; ROTATION; F-1-ATPASE; PURIFICATION; F1-ATPASE; SYNTHASE	Vacuolar-type H+-ATPase (V-ATPase) catalyzes ATP synthesis and hydrolysis coupled with proton translocation across membranes via a rotary motor mechanism. Here we report biochemical and biophysical catalytic properties of V-ATPase from Thermus thermophilus. ATP hydrolysis of V-ATPase was severely inhibited by entrapment of Mg-ADP in the catalytic site. In contrast, the enzyme was very active for ATP synthesis (similar to 70 s(-1)) with the K-m values for ADP and phosphate being 4.7 +/- 0.5 and 460 +/- 30 mu M, respectively. Single molecule observation showed V-ATPase rotated in a 120 degrees stepwise manner, and analysis of dwelling time allowed the binding rate constant k(on) for ATP to be estimated (similar to 1.1 x 10(6) M-1 s(-1)), which was much lower than the k(on) (= V-max/K-m) for ADP (similar to 1.4 x 10(7) M-1 s(-1)). The slower kon ATP than kon ADP and strong Mg-ADP inhibition may contribute to prevent wasteful consumption of ATP under in vivo conditions when the proton motive force collapses.	[Nakano, Masahiro; Toei, Masashi; Yoshida, Masasuke; Yokoyama, Ken] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Imamura, Hiromi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Imamura, Hiromi] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan; [Tamakoshi, Masatada] Tokai Univ Pharm & Life Sci, Dept Mol Biol, Tokyo 1920392, Japan; [Yoshida, Masasuke; Yokoyama, Ken] Natl Musuem Emerging Sci & Innovat, Japan Sci & Technol Agcy, ATP Synthesis Regulat Project, ICORP, Tokyo 1350064, Japan	Tokyo Institute of Technology; Osaka University; Japan Science & Technology Agency (JST); Tokai University; Japan Science & Technology Agency (JST)	Yokoyama, K (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	yokoyama.k.ab@m.titech.ac.jp	Yokoyama, Ken/AAJ-3582-2020; Nakano, Masahiro/A-5249-2012; Imamura, Hiromi/AAD-5109-2019	Yokoyama, Ken/0000-0002-6813-1096; Nakano, Masahiro/0000-0002-1558-3259; Imamura, Hiromi/0000-0002-1896-0443				Allison WS, 1996, J BIOENERG BIOMEMBR, V28, P433, DOI 10.1007/BF02113985; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hirata T, 2000, J BIOL CHEM, V275, P386, DOI 10.1074/jbc.275.1.386; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; INATOMI K, 1986, J BACTERIOL, V167, P837, DOI 10.1128/jb.167.3.837-841.1986; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; Kakinuma Y, 1999, J BIOENERG BIOMEMBR, V31, P7, DOI 10.1023/A:1005499126939; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; KONISHI J, 1987, J BIOCHEM, V102, P1379, DOI 10.1093/oxfordjournals.jbchem.a122184; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; NANBA T, 1987, J BIOCHEM-TOKYO, V102, P591, DOI 10.1093/oxfordjournals.jbchem.a122092; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Tamakoshi M, 1999, FEMS MICROBIOL LETT, V173, P431, DOI 10.1016/S0378-1097(99)00101-9; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; TSUTSUMI S, 1991, BIOCHIM BIOPHYS ACTA, V1098, P13, DOI 10.1016/0005-2728(91)90003-7; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; YOKOYAMA K, 1990, J BIOL CHEM, V265, P21946; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zharova TV, 2004, J BIOL CHEM, V279, P12319, DOI 10.1074/jbc.M311397200; ZHOU JM, 1988, BIOCHEMISTRY-US, V27, P5129, DOI 10.1021/bi00414a027	33	48	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20789	20796		10.1074/jbc.M801276200	http://dx.doi.org/10.1074/jbc.M801276200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18492667	Green Published, hybrid			2022-12-27	WOS:000257746100020
J	Sikorra, S; Henke, T; Galli, T; Binz, T				Sikorra, Stefan; Henke, Tina; Galli, Thierry; Binz, Thomas			Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM TYPE-B; MEMBRANE-PROTEIN; SEROTYPE-A; LIGHT-CHAIN; PLASMA-MEMBRANE; TETANUS TOXIN; CLEAVAGE; RESIDUES; SPECIFICITY; IDENTIFICATION	Botulinum neurotoxins (BoNTs) and tetanus neurotoxin (TeNT) inhibit neurotransmitter release by proteolyzing a single peptide bond in one of the three soluble N-ethylmaleimide- sensitive factor attachment protein receptors SNAP-25, syntaxin, and vesicle-associated membrane protein (VAMP)/synaptobrevin. TeNT and BoNT/B, D, F, and G of the seven known BoNTs cleave the synaptic vesicle protein VAMP/synaptobrevin. Except for BoNT/B and TeNT, they cleave unique peptide bonds, and prior work suggested that different substrate segments are required for the interaction of each toxin. Although the mode of SNAP-25 cleavage by BoNT/A and E has recently been studied in detail, the mechanism of VAMP/synaptobrevin proteolysis is fragmentary. Here, we report the determination of all substrate residues that are involved in the interaction with BoNT/B, D, and F and TeNT by means of systematic mutagenesis of VAMP/synaptobrevin. For each of the toxins, three or more residues clustered at an N-terminal site remote from the respective scissile bond are identified that affect solely substrate binding. These exosites exhibit different sizes and distances to the scissile peptide bonds for each neurotoxin. Substrate segments C-terminal of the cleavage site (P4-P4')do not play a role in the catalytic process. Mutation of residues in the proximity of the scissile bond exclusively affects the turnover number; however, the importance of individual positions at the cleavage sites varied for each toxin. The data show that, similar to the SNAP-25 proteolyzing BoNT/A and E, VAMP/synaptobrevin-specific clostridial neurotoxins also initiate substrate interaction, employing an exosite located N-terminal of the scissile peptide bond.	[Sikorra, Stefan; Henke, Tina; Binz, Thomas] Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany; [Galli, Thierry] INSERM, Avenir Team, F-75005 Paris, France; [Galli, Thierry] Univ Paris 06, CNRS, UMR7592, Inst Jacques Monod, F-75005 Paris, France; [Galli, Thierry] Univ Paris 07, F-75005 Paris, France	Hannover Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Binz, T (corresponding author), Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany.	binz.thomas@mh-hannover.de	Galli, Thierry/G-8842-2011; Galli, Thierry/Q-2249-2019	Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455				Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Agarwal R, 2005, BIOCHEMISTRY-US, V44, P8291, DOI 10.1021/bi050253a; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Cornille F, 1997, J BIOL CHEM, V272, P3459, DOI 10.1074/jbc.272.6.3459; Evans ER, 2005, TOXICON, V46, P446, DOI 10.1016/j.toxicon.2005.06.006; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Fu ZJ, 2006, BIOCHEMISTRY-US, V45, P8903, DOI 10.1021/bi060786z; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jin RS, 2007, BIOCHEMISTRY-US, V46, P10685, DOI 10.1021/bi701162d; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; Pellizzari R, 1997, FEBS LETT, V409, P339, DOI 10.1016/S0014-5793(97)00482-1; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; SCHIAVO G, 1995, J BIOL CHEM, V270, P10566, DOI 10.1074/jbc.270.18.10566; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schiavo Giampietro, 1994, Seminars in Cell Biology, V5, P221, DOI 10.1006/scel.1994.1028; Schmidt JJ, 2005, BIOCHEMISTRY-US, V44, P4067, DOI 10.1021/bi0477642; SHONE CC, 1993, EUR J BIOCHEM, V217, P965, DOI 10.1111/j.1432-1033.1993.tb18327.x; Sikorra S, 2006, J MOL BIOL, V357, P574, DOI 10.1016/j.jmb.2005.12.075; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8; Wictome M, 1996, FEBS LETT, V386, P133, DOI 10.1016/0014-5793(96)00431-0; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764	29	48	57	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21145	21152		10.1074/jbc.M800610200	http://dx.doi.org/10.1074/jbc.M800610200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511418	Green Published, hybrid			2022-12-27	WOS:000257746100056
J	Tacchini, L; Gammella, E; De Ponti, C; Recalcati, S; Cairo, G				Tacchini, Lorenza; Gammella, Elena; De Ponti, Cristina; Recalcati, Stefania; Cairo, Gaetano			Role of HIF-1 and NF-kappa B transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; IRON-REGULATORY PROTEIN-2; NITRIC-OXIDE PRODUCTION; FERRITIN SYNTHESIS; FACTOR-ALPHA; OXIDATIVE STRESS; GENE-EXPRESSION; FACTOR-I; POSTTRANSCRIPTIONAL REGULATION	Inflammation generates various changes in body iron homeostasis, including iron sequestration in the reticuloendothelial system with ensuing hypoferremia and anemia of chronic disease. Increased iron accumulation is caused by hepcidin-mediated down-regulation of the iron export protein ferroportin and higher iron uptake. However, enhanced iron acquisition by macrophages cannot be accounted for by the previously reported transferrin receptor (TfR1) down-regulation in macrophages exposed to lipopolysaccharide (LPS)/interferon gamma (IFN gamma) because it impairs a major iron uptake mechanism. Because TfR1 is up-regulated by the hypoxia-inducible factor (HIF-1), we investigated the effect of inflammatory and anti-inflammatory signals on HIF-1-mediated TfR1 gene expression. Exposure of mouse macrophages (RAW 264.7 and J774A. 1 cells or peritoneal macrophages) to LPS/IFN gamma up-regulated NF-kappa B, which in turn rapidly and transiently activated HIF-1-dependent TfR1 expression and iron uptake. Activation of an anti-inflammatory pathway by pre-exposure to the adenosine A(2A) receptor agonist CGS21680 prevented the inducing effect of LPS/IFN gamma on HIF-1 and TfR1 expression by inhibiting NF-kappa B activity, whereas treatment with CGS21680 alone increased HIF-1-mediated TfR1 expression by means of an NF-kappa B-independent signaling pathway. In conclusion, an interplay of the HIF-1 and NF-kappa B pathways controls TfR1 transcription in inflammation. The consequent changes in TfR1 expression may be involved in modulating iron retention in inflammatory macrophages, thus possibly contributing to the development of hypoferremia in the early phases preceding the down-regulation of macrophage ferroportin by hepcidin.	[Tacchini, Lorenza; Gammella, Elena; De Ponti, Cristina; Recalcati, Stefania; Cairo, Gaetano] Univ Milan, Inst Gen Pathol, I-20133 Milan, Italy	University of Milan	Cairo, G (corresponding author), Univ Milan, Inst Gen Pathol, Via Mangiagalli 31, I-20133 Milan, Italy.	gaetano.cairo@unimi.it	Cairo, Gaetano/M-5104-2016; Gammella, Elena/M-5037-2016; Tacchini, Lorenza/L-1418-2016; recalcati, stefania/M-5045-2016	Cairo, Gaetano/0000-0002-8147-4720; Gammella, Elena/0000-0001-9921-8664; Tacchini, Lorenza/0000-0002-4863-178X; recalcati, stefania/0000-0002-2115-8283				Agani F, 1998, MOL PHARMACOL, V54, P749, DOI 10.1124/mol.54.5.749; Alberghini A, 2005, J BIOL CHEM, V280, P30120, DOI 10.1074/jbc.M500971200; An JB, 2005, MOL CELL BIOL, V25, P7546, DOI 10.1128/MCB.25.17.7546-7556.2005; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; BERTINI R, 1989, J LEUKOCYTE BIOL, V46, P254, DOI 10.1002/jlb.46.3.254; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; GUTTEBERG TJ, 1989, SCAND J INFECT DIS, V21, P709, DOI 10.3109/00365548909021701; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1996, J IMMUNOL, V157, P4634; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Kim S, 1999, J BIOL CHEM, V274, P33035, DOI 10.1074/jbc.274.46.33035; Kim S, 2000, J BIOL CHEM, V275, P6220, DOI 10.1074/jbc.275.9.6220; Kim SW, 2002, P NATL ACAD SCI USA, V99, P12214, DOI 10.1073/pnas.192316099; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; KONIJN AM, 1981, BRIT J HAEMATOL, V49, P361, DOI 10.1111/j.1365-2141.1981.tb07238.x; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Laftah AH, 2006, BIOCHEM J, V397, P61, DOI 10.1042/BJ20060215; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Liu XB, 2005, BLOOD CELL MOL DIS, V35, P47, DOI 10.1016/j.bcmd.2005.04.006; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Ludwiczek S, 2003, BLOOD, V101, P4148, DOI 10.1182/blood-2002-08-2459; Majumdar S, 2003, ONCOGENE, V22, P1206, DOI 10.1038/sj.onc.1206184; Martin L, 2006, J PHARMACOL EXP THER, V316, P71, DOI 10.1124/jpet.105.091868; Mi Z, 2008, CELL CYCLE, V7, P232, DOI 10.4161/cc.7.2.5193; Min HW, 2000, LIFE SCI, V66, P1781, DOI 10.1016/S0024-3205(00)00502-6; MOLDAWER LL, 1989, FASEB J, V3, P1637, DOI 10.1096/fasebj.3.5.2784116; Mulero V, 1999, BLOOD, V94, P2383, DOI 10.1182/blood.V94.7.2383.419k20_2383_2389; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Nemeth ZH, 2003, BIOCHEM BIOPH RES CO, V312, P883, DOI 10.1016/j.bbrc.2003.11.006; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Recalcati S, 1998, BLOOD, V91, P1059, DOI 10.1182/blood.V91.3.1059.1059_1059_1066; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Scortegagna M, 2008, BLOOD, V111, P3343, DOI 10.1182/blood-2007-10-115758; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Tacchini L, 2004, CARCINOGENESIS, V25, P2089, DOI 10.1093/carcin/bgh227; Tacchini L, 2003, EXP CELL RES, V290, P391, DOI 10.1016/S0014-4827(03)00348-3; Tacchini L, 2002, HEPATOLOGY, V36, P103, DOI 10.1053/jhep.2002.33997; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Taramelli D, 2000, LAB INVEST, V80, P1781, DOI 10.1038/labinvest.3780189; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TSUJI Y, 1991, J BIOL CHEM, V266, P7257; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WANG GL, 1993, BLOOD, V82, P3610; Weiss G, 2005, BEST PRACT RES CL HA, V18, P183, DOI 10.1016/j.beha.2004.09.001; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200; Zhou J, 2004, CANCER RES, V64, P9041, DOI 10.1158/0008-5472.CAN-04-1437	72	86	96	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20674	20686		10.1074/jbc.M800365200	http://dx.doi.org/10.1074/jbc.M800365200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18519569	hybrid, Green Published			2022-12-27	WOS:000257746100008
J	Beloglazova, N; Brown, G; Zimmerman, MD; Proudfoot, M; Makarova, KS; Kudritska, M; Kochinyan, S; Wang, S; Chruszcz, M; Minor, W; Koonin, EV; Edwards, AM; Savchenko, A; Yakunin, AF				Beloglazova, Natalia; Brown, Greg; Zimmerman, Matthew D.; Proudfoot, Michael; Makarova, Kira S.; Kudritska, Marina; Kochinyan, Samvel; Wang, Shuren; Chruszcz, Maksymilian; Minor, Wladek; Koonin, Eugene V.; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.			A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROVIDES ACQUIRED-RESISTANCE; MESSENGER-RNA INTERFERASES; ELECTRON-DENSITY MAPS; ESCHERICHIA-COLI; STREPTOCOCCUS-THERMOPHILUS; MYCOBACTERIUM-TUBERCULOSIS; DEFENSE-MECHANISM; CELL-DEATH; IDENTIFICATION; CRISPR	Clustered regularly interspaced short palindromic repeats (CRISPRs) together with the associated CAS proteins protect microbial cells from invasion by foreign genetic elements using presently unknown molecular mechanisms. All CRISPR systems contain proteins of the CAS2 family, suggesting that these uncharacterized proteins play a central role in this process. Here we show that the CAS2 proteins represent a novel family of endoribonucleases. Six purified CAS2 proteins from diverse organisms cleaved single-stranded RNAs preferentially within U-rich regions. A representative CAS2 enzyme, SSO1404 from Sulfolobus solfataricus, cleaved the phosphodiester linkage on the 3'-side and generated 5'-phosphate- and 3'-hydroxyl-terminated oligonucleotides. The crystal structure of SSO1404 was solved at 1.6 angstrom resolution revealing the first ribonuclease with a ferredoxin-like fold. Mutagenesis of SSO1404 identified six residues (Tyr-9, Asp-10, Arg-17, Arg-19, Arg-31, and Phe-37) that are important for enzymatic activity and suggested that Asp-10 might be the principal catalytic residue. Thus, CAS2 proteins are sequence-specific endoribonucleases, and we propose that their role in the CRISPR-mediated anti-phage defense might involve degradation of phage or cellular mRNAs.	[Beloglazova, Natalia; Brown, Greg; Proudfoot, Michael; Kudritska, Marina; Kochinyan, Samvel; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Beloglazova, Natalia; Brown, Greg; Proudfoot, Michael; Kudritska, Marina; Kochinyan, Samvel; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.] Max Bell Res Ctr 5R407, Ontario Canc Inst, Toronto, ON M5G 2C4, Canada; [Zimmerman, Matthew D.; Wang, Shuren; Chruszcz, Maksymilian; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Zimmerman, Matthew D.; Kudritska, Marina; Wang, Shuren; Chruszcz, Maksymilian; Minor, Wladek; Edwards, Aled M.; Savchenko, Alexei] Argonne Natl Lab, Midwest Ctr Struct Gen, Biosci Div, Argonne, IL 60439 USA; [Makarova, Kira S.; Koonin, Eugene V.] Natl Inst Hlth, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Virginia; United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yakunin, AF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	a.iakounine@utoronto.ca	Zimmerman, Matthew D/N-9489-2013; Minor, Wladek/F-3096-2014; Yakunin, Alexander/J-1519-2014; Chruszcz, Maksymilian/E-6407-2011	Zimmerman, Matthew D/0000-0002-6274-9493; Minor, Wladek/0000-0001-7075-7090; Chruszcz, Maksymilian/0000-0001-7521-5485; Edwards, Aled/0000-0002-4782-6016; Yakunin, Alexander/0000-0003-0813-6490	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM 62414, GM 074942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062414, U54GM074942] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Berkner K L, 1980, Methods Enzymol, V65, P28; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Inouye M, 2006, J CELL PHYSIOL, V209, P670, DOI 10.1002/jcp.20801; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATZ ME, 1994, J BACTERIOL, V176, P2663, DOI 10.1128/JB.176.9.2663-2669.1994; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Masepohl B, 1996, BBA-GENE STRUCT EXPR, V1307, P26, DOI 10.1016/0167-4781(96)00040-1; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mironova NL, 2007, NUCLEIC ACIDS RES, V35, P2356, DOI 10.1093/nar/gkm143; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIKAWA S, 1987, BIOCHEMISTRY-US, V26, P8620, DOI 10.1021/bi00400a019; NOVOGRODSKY A, 1966, J BIOL CHEM, V241, P2933; OLINS PO, 1989, J BIOL CHEM, V264, P16973; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Parreira R, 1996, MOL MICROBIOL, V19, P221, DOI 10.1046/j.1365-2958.1996.371896.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Ramakrishnan V, 1998, TRENDS BIOCHEM SCI, V23, P208, DOI 10.1016/S0968-0004(98)01214-6; Redko Y, 2003, J BIOL CHEM, V278, P44001, DOI 10.1074/jbc.M306760200; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Saida F, 2003, NUCLEIC ACIDS RES, V31, P2751, DOI 10.1093/nar/gkg377; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Worrall JAR, 2007, CURR OPIN STRUC BIOL, V17, P128, DOI 10.1016/j.sbi.2006.12.001; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; ZHANG JR, 1992, P NATL ACAD SCI USA, V89, P2605, DOI 10.1073/pnas.89.7.2605; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	64	143	180	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20361	20371		10.1074/jbc.M803225200	http://dx.doi.org/10.1074/jbc.M803225200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482976	hybrid, Green Published			2022-12-27	WOS:000257565300052
J	Heyd, F; Carmo-Fonseca, M; Moroy, T				Heyd, Florian; Carmo-Fonseca, Maria; Moroy, Tarik			Differential isoform expression and interaction with the P32 regulatory protein controls the subcellular localization of the splicing factor U2AF26	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNAS; FACTOR U2AF(35); SR PROTEINS; SITE AG; BINDING; NUCLEUS; VIRUS; KINASE; IDENTIFICATION; RECOGNITION	The U2 auxiliary factor (U2AF) is an integral part of the spliceosome that is important for the recognition of the 3' splice site. U2AF consists of a large and a small subunit, the prototypes of which are U2AF65 and U2AF35. Recent evidence suggests that several homologs of both U2AF subunits exist that are able to regulate alternative splicing. Here we have investigated the expression, intracellular localization, and nucleo-cytoplasmic shuttling of one homolog of the small U2AF subunit, U2AF26, and a splice variant lacking exon 7, U2AF26 Delta E7. In contrast to the nuclear U2AF26, which displays active nucleo-cytoplasmic shuttling, U2AF26 Delta E7 is localized in the cytoplasm. Our studies reveal a nuclear localization sequence in the C-terminal exons 7 and 8 of U2AF26 that differs from the known nuclear localization sequence in U2AF35. In addition, we could identify P32 as a protein that is able to interact with U2AF26 through this domain, and we demonstrate that this interaction is required for the nuclear translocation of U2AF26. Our results suggest the existence of two distinct nuclear import pathways for U2AF26 and U2AF35 that could independently control their intracellular distribution and availability to the splicing machinery. Such a mechanism could work in addition to the differential expression of U2AF homologs to contribute to the regulation of alternative splicing.	[Heyd, Florian; Moroy, Tarik] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Moroy, Tarik] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H2W 1R7, Canada; [Carmo-Fonseca, Maria] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universidade de Lisboa	Moroy, T (corresponding author), Univ Montreal, Inst Rech Clin Montreal, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	Tarik.Moroy@ircm.qc.ca	Moroy, Tarik/D-9923-2011	Carmo-Fonseca, Maria/0000-0002-3402-7143				Berro R, 2006, J VIROL, V80, P3189, DOI 10.1128/JVI.80.7.3189-3204.2006; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 2004, MOL CELL, V14, P775, DOI 10.1016/j.molcel.2004.06.012; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brokstad KA, 2001, BIOCHEM BIOPH RES CO, V281, P1161, DOI 10.1006/bbrc.2001.4473; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Gama-Carvalho M, 2001, J BIOL CHEM, V276, P13104, DOI 10.1074/jbc.M008759200; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Heyd F, 2006, NAT IMMUNOL, V7, P859, DOI 10.1038/ni1361; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Majumdar M, 2002, BIOCHEM BIOPH RES CO, V291, P829, DOI 10.1006/bbrc.2002.6491; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Mollet I, 2006, FEBS J, V273, P4807, DOI 10.1111/j.1742-4658.2006.05502.x; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Pacheco TR, 2004, J BIOL CHEM, V279, P27039, DOI 10.1074/jbc.M402136200; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Robles-Flores M, 2002, J BIOL CHEM, V277, P5247, DOI 10.1074/jbc.M109333200; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Shepard J, 2002, MOL CELL BIOL, V22, P221, DOI 10.1128/MCB.22.1.221-230.2002; SHEPARD J, 2004, THESIS U TEXAS SW ME; Shoya Y, 1998, J VIROL, V72, P9755, DOI 10.1128/JVI.72.12.9755-9762.1998; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; Wang YL, 1997, VIROLOGY, V236, P18, DOI 10.1006/viro.1997.8739; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000; Zolotukhin AS, 2002, J BIOL CHEM, V277, P3935, DOI 10.1074/jbc.M107598200; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	35	14	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19637	19645		10.1074/jbc.M801014200	http://dx.doi.org/10.1074/jbc.M801014200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18460468	hybrid			2022-12-27	WOS:000257387600049
J	Nabavi, N; Urukova, Y; Cardelli, M; Aubin, JE; Harrison, RE				Nabavi, Noushin; Urukova, Yulia; Cardelli, Marco; Aubin, Jane E.; Harrison, Rene E.			Lysosome dispersion in osteoblasts accommodates enhanced collagen production during differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCORBIC-ACID; SECRETORY GRANULES; LUNG FIBROBLASTS; PLASMA-MEMBRANE; MC3T3-E1 CELLS; LATE ENDOSOMES; GOLGI-COMPLEX; PROTEIN RILP; TRANSPORT; MICROTUBULES	Lysosomes are essential organelles for intracellular degradation and are generally sequestered near the cell center to receive vesicles with contents targeted for destruction. During ascorbic acid (AA)-induced differentiation of osteogenic cells (Beck, G. R., Jr., Zerler, B., and Moran, E. (2001) Cell Growth Differ. 12, 61 -83), we saw a marked increase in total lysosome organelles in osteoblastic cells, in addition to an enhanced endocytic rate. Interestingly, lysosomes were dispersed toward the cell periphery in differentiating osteoblasts. We determined that lysosome dispersion in differentiated osteoblasts required intact microtubules for long range transport and was dependent on kinesin motors but did not involve cytosolic acidification. Impairment of lysosome dispersion markedly reduced AA-induced osteoblast differentiation. Lysosomes were not secreted in differentiated osteoblasts, implicating them instead in intracellular degradation. We assayed the degradative capacity and saw a significant increase in DQ-ovalbumin fluorescence in differentiated osteogenic cells compared with undifferentiated control cells. Osteogenic cells are specialized for type I collagen production, and we noted enhanced secreted and intracellular collagen in AA-differentiated osteoblasts versus control cells. Importantly, osteoblasts displayed procollagen-containing vesicles that were distributed throughout the cytoplasm, a portion of which colocalized with lysosomes. Treatment of cells with 2,2'-dipyridyl to inhibit procollagen trimerization enhanced colocalization of lysosomes with procollagen-containing organelles, implicating dispersed lysosomes in collagen processing in osteogenic cells.	[Nabavi, Noushin; Harrison, Rene E.] Univ Toronto Scarborough, Fac Med, Dept Cell & Syst Biol, Toronto, ON M1C 1A4, Canada; [Nabavi, Noushin; Urukova, Yulia; Harrison, Rene E.] Univ Toronto Scarborough, Fac Med, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Cardelli, Marco; Aubin, Jane E.] Univ Toronto Scarborough, Fac Med, Dept Med Biophys, Toronto, ON M1C 1A4, Canada; [Aubin, Jane E.] Univ Toronto Scarborough, Fac Med, Dept Mol Genet, Toronto, ON M1C 1A4, Canada	University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough	Harrison, RE (corresponding author), Univ Toronto Scarborough, Fac Med, Dept Cell & Syst Biol, Toronto, ON M1C 1A4, Canada.	harrison@utsc.utoronto.ca		Nabavi, Noushin/0000-0002-5471-6229; Aubin, Jane E./0000-0002-7268-5235				Andrews NW, 2002, J CELL BIOL, V158, P389, DOI 10.1083/jcb.200205110; AUBIN JE, 1995, BONE, V17, P77; BARILE FA, 1990, ARCH BIOCHEM BIOPHYS, V276, P125, DOI 10.1016/0003-9861(90)90018-T; Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; BERG RA, 1983, ARCH BIOCHEM BIOPHYS, V226, P681, DOI 10.1016/0003-9861(83)90338-7; BIENKOWSKI RS, 1984, J CELL PHYSIOL, V121, P152, DOI 10.1002/jcp.1041210119; Billiard J, 2003, J CELL BIOCHEM, V89, P389, DOI 10.1002/jcb.10514; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; CARMOFONSECA M, 1990, ELECTRON MICROSC REV, V3, P115, DOI 10.1016/0892-0354(90)90017-M; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; CECH S, 1983, CELL TISSUE RES, V230, P661, DOI 10.1007/BF00216209; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; DIEGELMA.RF, 1972, P NATL ACAD SCI USA, V69, P892, DOI 10.1073/pnas.69.4.892; Eng EW, 2007, MOL BIOL CELL, V18, P2389, DOI 10.1091/mbc.e06-12-1128; FRANCESCHI RT, 1995, AM J PHYSIOL-CELL PH, V268, pC1430, DOI 10.1152/ajpcell.1995.268.6.C1430; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; GREEN J, 1988, J GEN PHYSIOL, V92, P239, DOI 10.1085/jgp.92.2.239; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; HARWOOD R, 1976, BIOCHEM J, V156, P81, DOI 10.1042/bj1560081; HELSETH DL, 1984, P NATL ACAD SCI-BIOL, V81, P3302, DOI 10.1073/pnas.81.11.3302; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Hsu YL, 2007, BIOCHEM PHARMACOL, V73, P504, DOI 10.1016/j.bcp.2006.10.020; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; Khumalo H, 1998, CLIN CHEM, V44, P1573; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; LIN SXH, 1992, J CELL SCI, V101, P125; Lu ZM, 2001, MOL BIOL CELL, V12, P795, DOI 10.1091/mbc.12.4.795; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; PARTON RG, 1991, J CELL BIOL, V113, P261, DOI 10.1083/jcb.113.2.261; RALSTON E, 1993, J CELL BIOL, V120, P399, DOI 10.1083/jcb.120.2.399; Ripley CR, 1997, EXP CELL RES, V236, P147, DOI 10.1006/excr.1997.3707; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; RODIONOV VI, 1993, J CELL BIOL, V123, P1811, DOI 10.1083/jcb.123.6.1811; RODIONOV VI, 1991, P NATL ACAD SCI USA, V88, P4956, DOI 10.1073/pnas.88.11.4956; Rodriguez A, 1996, J CELL BIOL, V134, P349, DOI 10.1083/jcb.134.2.349; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200; Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.0.CO;2-6; Stains JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-222; SWANSON J, 1987, P NATL ACAD SCI USA, V84, P1921, DOI 10.1073/pnas.84.7.1921; SWANSON JA, 1992, J CELL SCI, V103, P201; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Wada M, 2004, CURR OPIN PLANT BIOL, V7, P626, DOI 10.1016/j.pbi.2004.09.005; WILSON JX, 1989, J MEMBRANE BIOL, V111, P83, DOI 10.1007/BF01869211; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Zayzafoon M, 2000, J CELL BIOCHEM, V79, P301, DOI 10.1002/1097-4644(20001101)79:2<301::AID-JCB130>3.0.CO;2-0; Zhang YR, 2004, BIOPHYS J, V87, P1795, DOI 10.1529/biophysj.104.039842; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	57	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19678	19690		10.1074/jbc.M802517200	http://dx.doi.org/10.1074/jbc.M802517200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18463099	hybrid			2022-12-27	WOS:000257387600053
J	Sheridan, DL; Kong, Y; Parker, SA; Dalby, KN; Turk, BE				Sheridan, Douglas L.; Kong, Yong; Parker, Sirlester A.; Dalby, Kevin N.; Turk, Benjamin E.			Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; EPIDERMAL-GROWTH-FACTOR; MAP KINASE; STRUCTURAL BASIS; C-JUN; PHOSPHORYLATION; SPECIFICITY; PEPTIDE; SITES; ERK	Mitogen-activated protein kinases (MAPKs) mediate cellular responses to a wide variety of extracellular stimuli. MAPK signal transduction cascades are tightly regulated, and individual MAPKs display exquisite specificity in recognition of their target substrates. All MAPK family members share a common phosphorylation site motif, raising questions as to how substrate specificity is achieved. Here we describe a peptide library screen to identify sequence requirements of the DEF site (docking site for ERK FXF), a docking motif separate from the phosphorylation site. We show that MAPK isoforms recognize DEF sites with unique sequences and identify two key residues on the MAPK that largely dictate sequence specificity. Based on these observations and computational docking studies, we propose a revised model for MAPK interaction with substrates containing DEF sites. Variations in DEF site sequence requirements provide one possible mechanism for encoding complex target specificity among MAPK isoforms.	[Sheridan, Douglas L.; Parker, Sirlester A.; Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kong, Yong] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06520 USA; [Dalby, Kevin N.] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	Yale University; Yale University; University of Texas System; University of Texas Austin	Turk, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	ben.turk@yale.edu	Dalby, Kevin N/A-1905-2013; Kong, Yong/B-5105-2014	Dalby, Kevin N/0000-0001-9272-5129; Kong, Yong/0000-0002-2881-5274	NCI NIH HHS [T32 CA009085-33] Funding Source: Medline; NIGMS NIH HHS [GM59802, GM079498] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802, R01GM079498] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Callaway KA, 2006, BIOCHEMISTRY-US, V45, P13719, DOI 10.1021/bi0610451; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Fernandes N, 2007, ACS CHEM BIOL, V2, P665, DOI 10.1021/cb700158q; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Green Harry M., 2005, BMC Chemical Biology, V5, P1, DOI 10.1186/1472-6769-5-1; Hancock CN, 2005, J MED CHEM, V48, P4586, DOI 10.1021/jm0501174; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Kim YG, 2007, ANGEW CHEM INT EDIT, V46, P5408, DOI 10.1002/anie.200700195; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Ley R, 2005, J BIOL CHEM, V280, P17657, DOI 10.1074/jbc.M412342200; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; LIU S, 2006, P NATL ACAD SCI USA, V281, P38834; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Mitsushima M, 2004, J BIOL CHEM, V279, P34570, DOI 10.1074/jbc.M402304200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pouchain D, 2007, ACS CHEM BIOL, V2, P810, DOI 10.1021/cb700199k; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sato M, 2007, ANAL CHEM, V79, P2570, DOI 10.1021/ac062171d; Schutkowski M, 2004, ANGEW CHEM INT EDIT, V43, P2671, DOI 10.1002/anie.200453900; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tcherkezian J, 2005, MOL CELL BIOL, V25, P6314, DOI 10.1128/MCB.25.15.6314-6329.2005; Turk BE, 2006, NAT PROTOC, V1, P375, DOI 10.1038/nprot.2006.57; Vinciguerra M, 2004, J BIOL CHEM, V279, P9634, DOI 10.1074/jbc.M308721200; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Yang SH, 1999, MOL CELL BIOL, V19, P4028; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang GY, 2005, EXPERT OPIN INV DRUG, V14, P1373, DOI 10.1517/13543784.14.11.1373; Zhao M, 1999, MOL CELL BIOL, V19, P21; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	63	107	107	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19511	19520		10.1074/jbc.M801074200	http://dx.doi.org/10.1074/jbc.M801074200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482985	hybrid, Green Published			2022-12-27	WOS:000257387600037
J	Matsushima-Nishiwaki, R; Takai, S; Adachi, S; Minamitani, C; Yasuda, E; Noda, T; Kato, K; Toyoda, H; Kaneoka, Y; Yamaguchi, A; Kumada, T; Kozawa, O				Matsushima-Nishiwaki, Rie; Takai, Shinji; Adachi, Seiji; Minamitani, Chiho; Yasuda, Eisuke; Noda, Takahiro; Kato, Kanefusa; Toyoda, Hidenori; Kaneoka, Yuji; Yamaguchi, Akihiro; Kumada, Takashi; Kozawa, Osamu			Phosphorylated heat shock protein 27 represses growth of hepatocellular carcinoma via inhibition of extracellular signal-regulated kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; INDUCED CELL-DEATH; TUMOR PROGRESSION; KAPPA-B; GENE-EXPRESSION; ACTIVATION; PATHWAY; ALPHA; STRESS; HSP27	Heat shock protein 27, one of the low molecular weight stress proteins, is recognized as a molecular chaperone; however, other functions have not yet been well established. Phosphorylated heat shock protein 27 levels inversely correlate with the progression of human hepatocellular carcinoma. This study shows that phosphorylated heat shock protein 27 interferes with cell growth of the hepatocellular carcinoma-derived HuH7 cells in the presence of the proinflammatory cytokine, tumor necrosis factor-alpha, via inhibition of the sustained activation of the extracellular signal-regulated kinase signal pathway. The activities of Raf/extracellular signal-regulated kinase and subsequent activator protein-1 transactivation and the induction levels of cyclin D1 were lower in HuH7 cells transfected with phosphorylated heat shock protein 27 than those with unphosphorylated heat shock protein 27. Moreover, phosphorylated heat shock protein 27 up-regulated the levels of p38 mitogen-activated protein kinase and mitogen-activated protein kinase phosphatase-1, an inhibitory protein of extracellular signal-regulated kinase. These results indicate that phosphorylated heat shock protein 27 might suppress the extracellular signal-regulated kinase activity in the hepatocellular carcinoma cells via two separate pathways in an inflammatory state. The extracellular signal-regulated kinase activity is inversely correlated with phosphorylated heat shock protein 27 at serine 15 and also in human hepatocellular carcinoma tissues in vivo. Because the extracellular signal-regulated kinase signal pathway is a major proliferation signal of hepatocellular carcinoma, activator protein-1 activation is an early event in hepatocarcinogenesis. These findings strongly suggest that the control of the phosphorylated heat shock protein 27 levels could be a new therapeutic strategy especially to counter the recurrence of hepatocellular carcinoma.	[Matsushima-Nishiwaki, Rie; Takai, Shinji; Adachi, Seiji; Minamitani, Chiho; Yasuda, Eisuke; Noda, Takahiro; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Yasuda, Eisuke; Noda, Takahiro; Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Gifu 5038502, Japan; [Kaneoka, Yuji; Yamaguchi, Akihiro] Ogaki Municipal Hosp, Dept Surg, Gifu 5038502, Japan; [Kato, Kanefusa] Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Aichi 4800392, Japan	Gifu University; Ogaki Municipal Hospital; Ogaki Municipal Hospital	Kozawa, O (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan.	okozawa@gifu-u.ac.jp						Adachi S, 2002, HEPATOLOGY, V35, P332, DOI 10.1053/jhep.2002.31164; Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; ATASEVEN H, 2006, MEDIAT INFLAMM, P1; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Cho HN, 2002, CELL DEATH DIFFER, V9, P448, DOI 10.1038/sj.cdd.4400979; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Haddad JJ, 2002, BRIT J PHARMACOL, V135, P520, DOI 10.1038/sj.bjp.0704467; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Kim SK, 2005, BIOCHEM PHARMACOL, V70, P1785, DOI 10.1016/j.bcp.2005.07.019; Kojima S, 2004, INT J ONCOL, V24, P797; Kubisch C, 2004, GASTROENTEROLOGY, V127, P275, DOI 10.1053/j.gastro.2004.04.005; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee KH, 2005, J BIOL CHEM, V280, P13179, DOI 10.1074/jbc.M410059200; Lee YJ, 2004, FREE RADICAL BIO MED, V36, P429, DOI 10.1016/j.freeradbiomed.2003.11.009; Liu P, 2002, J HEPATOL, V37, P63, DOI 10.1016/S0168-8278(02)00064-8; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Matsushima-Nishiwaki R, 2001, CANCER RES, V61, P7675; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Noda T, 2007, ONCOL REP, V17, P1309; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Sun XK, 2006, CELL STRESS CHAPERON, V11, P61, DOI 10.1379/CSC-149R.1; Takai S, 2007, LIFE SCI, V81, P585, DOI 10.1016/j.lfs.2007.06.018; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; WELCH WJ, 1985, J BIOL CHEM, V260, P3058; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Yasuda E, 2005, BIOCHEM BIOPH RES CO, V337, P337, DOI 10.1016/j.bbrc.2005.08.273	45	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18852	18860		10.1074/jbc.M801301200	http://dx.doi.org/10.1074/jbc.M801301200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18477563	hybrid			2022-12-27	WOS:000257165600042
J	Saliba, RS; Pangalos, M; Moss, SJ				Saliba, Richard S.; Pangalos, Menelas; Moss, Stephen J.			The ubiquitin-like protein Plic-1 enhances the membrane insertion of GABA(A) receptors by increasing their stability within the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCANS; BETA SUBUNITS; HIPPOCAMPAL-NEURONS; SYNAPTIC INHIBITION; TRAFFICKING; PHOSPHORYLATION; PROTEASOME; GAMMA; IDENTIFICATION; MODULATION	gamma-Aminobutyric acid receptors (GABA(A)R) are the major sites of fast inhibitory neurotransmission in the brain, and a critical determinant for the efficacy of neuronal inhibition is the number of these receptors that are expressed on the neuronal cell surface. GABA(A)Rs are heteropentamers that can be constructed from seven subunit classes with multiple members; alpha, beta, gamma(1-3), delta, epsilon(1-3), theta, and pi. Receptor assembly occurs within the endoplasmic reticulum, and it is evident that transport-competent combinations exiting this organelle can access the cell surface, whereas unassembled subunits are ubiquitinated and subject to proteasomal degradation. In a previous report the ubiquitin-like protein Plic-1 was shown to directly interact with GABA(A)Rs and promote their accumulation at the cell surface. In this study we explore the mechanisms by which Plic-1 regulates the membrane trafficking of GABA(A)Rs. Using both recombinant and neuronal preparations it was apparent that Plic-1 increased the stability of endoplasmic reticulum resident GABA(A)Rs together with an increase in the abundance of poly-ubiquitinated receptor subunits. Furthermore, Plic-1 elevated cell surface expression levels by selectively increasing their rates of membrane insertion. Thus, Plic-1 may play a significant role in regulating the strength of synaptic inhibition by increasing the stability of GABA(A)Rs within the secretory pathway and thereby promoting their insertion into the neuronal plasma membrane.	[Saliba, Richard S.; Moss, Stephen J.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Saliba, Richard S.; Moss, Stephen J.] UCL, Dept Neurosci Pharmacol & Physiol, London WC1E 6BT, England; [Pangalos, Menelas] Wyeth Ayerst Res, Princeton, NJ 08852 USA	University of Pennsylvania; University of London; University College London; Pfizer	Moss, SJ (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	sjmoss@mail.med.upenn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056359, R01NS046478, R01NS051195, P01NS054900, R01NS048045] Funding Source: NIH RePORTER; Medical Research Council Funding Source: Medline; NINDS NIH HHS [NS051195, NS048045, R01 NS051195, NS056359, P01NS054900, R01 NS056359, NS046478, P01 NS054900] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; BUCHSTALLER A, 1991, NEUROSCI LETT, V129, P237, DOI 10.1016/0304-3940(91)90470-E; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Couve A, 2004, J BIOL CHEM, V279, P13934, DOI 10.1074/jbc.M311737200; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; HUH KH, 1995, MOL PHARMACOL, V48, P666; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kleijnen MF, 2003, MOL BIOL CELL, V14, P3868, DOI 10.1091/mbc.E02-11-0766; Luscher B, 2001, NAT CELL BIOL, V3, pE232, DOI 10.1038/ncb1001-e232; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; MOSS SJ, 1995, NATURE, V377, P344, DOI 10.1038/377344a0; N'Diaye EN, 2008, MOL BIOL CELL, V19, P1252, DOI 10.1091/mbc.E07-08-0775; N'Diaye EN, 2003, J CELL BIOL, V163, P1157, DOI 10.1083/jcb.200307155; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9	38	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18538	18544		10.1074/jbc.M802077200	http://dx.doi.org/10.1074/jbc.M802077200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18467327	Green Published, hybrid			2022-12-27	WOS:000257165600009
J	Wassarman, PM				Wassarman, Paul M.			Zona pellucida glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EGG VITELLINE ENVELOPE; FURIN CLEAVAGE-SITE; MOUSE ZP3; GENE-EXPRESSION; SPERM RECEPTOR; STRUCTURAL-CHARACTERIZATION; MAMMALIAN FERTILIZATION; EXTRACELLULAR COAT; HOMOMERIC FIBRILS; MASS-SPECTROMETRY	All mammalian eggs are surrounded by a relatively thick extracellular coat, the zona pellucida, that plays vital roles during oogenesis, fertilization, and preimplantation development. The mouse zona pellucida consists of three glycoproteins that are synthesized solely by growing oocytes and assemble into long fibrils that constitute a matrix. Zona pellucida glycoproteins are responsible for species-restricted binding of sperm to unfertilized eggs, inducing sperm to undergo acrosomal exocytosis, and preventing sperm from binding to fertilized eggs. Many features of mammalian and non-mammalian egg coat polypeptides have been conserved during several hundred million years of evolution.	Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Wassarman, PM (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	paul.wassarman@mssm.edu			National Institutes of Health [HD-35105]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD-35105.	Bauskin AR, 1999, MOL HUM REPROD, V5, P534, DOI 10.1093/molehr/5.6.534; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Chalabi S, 2006, BIOCHEMISTRY-US, V45, P637, DOI 10.1021/bi0512804; Clark GF, 2006, J BIOL CHEM, V281, P13853, DOI 10.1074/jbc.R600001200; Darie CC, 2004, BIOCHEMISTRY-US, V43, P7459, DOI 10.1021/bi0495937; Darie CC, 2008, BBA-PROTEINS PROTEOM, V1784, P385, DOI 10.1016/j.bbapap.2007.10.011; DEAN J, 2007, GAMETE BIOL, P359; EPIFANO O, 1995, J BIOL CHEM, V270, P27254, DOI 10.1074/jbc.270.45.27254; Familiari G, 2006, MICROSC RES TECHNIQ, V69, P415, DOI 10.1002/jemt.20301; FLORMAN HM, 2006, PHYSL REPROD, V1, P55; Hughes DC, 1999, BBA-GENE STRUCT EXPR, V1447, P303, DOI 10.1016/S0167-4781(99)00181-5; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; Jovine L., 2002, Gene expression at the beginning of animal development, P31; Jovine Luca, 2007, Soc Reprod Fertil Suppl, V63, P187; Jovine Luca, 2006, BMC Biochem, V7, P11, DOI 10.1186/1471-2091-7-11; KINLOCH RA, 1995, P NATL ACAD SCI USA, V92, P263, DOI 10.1073/pnas.92.1.263; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lefievre L, 2004, HUM REPROD, V19, P1580, DOI 10.1093/humrep/deh301; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Li D, 2007, MOL REPROD DEV, V74, P1327, DOI 10.1002/mrd.20705; Liang LF, 1997, DEVELOPMENT, V124, P4939; LIANG LF, 1993, DEV BIOL, V156, P399, DOI 10.1006/dbio.1993.1087; LIRA SA, 1993, MOL REPROD DEV, V36, P494, DOI 10.1002/mrd.1080360414; LIRA SA, 1990, P NATL ACAD SCI USA, V87, P7215, DOI 10.1073/pnas.87.18.7215; Litscher ES, 2007, HISTOL HISTOPATHOL, V22, P337, DOI 10.14670/HH-22.337; Litscher ES, 1999, BIOCHEMISTRY-US, V38, P12280, DOI 10.1021/bi991154y; Litscher ES, 2008, J CELL PHYSIOL, V214, P153, DOI 10.1002/jcp.21174; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Mannikko M, 2005, HUM REPROD, V20, P1578, DOI 10.1093/humrep/deh837; MILLAR SE, 1993, DEV BIOL, V158, P410, DOI 10.1006/dbio.1993.1199; Paterson M, 2002, J REPROD IMMUNOL, V53, P99, DOI 10.1016/S0165-0378(01)00105-X; Qi HY, 2002, MOL BIOL CELL, V13, P530, DOI 10.1091/mbc.01-09-0440; Rankin T, 1996, DEVELOPMENT, V122, P2903; Rankin T, 1999, DEVELOPMENT, V126, P3847; Rankin TL, 2001, DEVELOPMENT, V128, P1119; ROLLER RJ, 1989, DEVELOPMENT, V106, P251; SCHICKLER M, 1992, MOL CELL BIOL, V12, P120, DOI 10.1128/MCB.12.1.120; Shur BD, 2004, CURR BIOL, V14, pR691, DOI 10.1016/j.cub.2004.08.037; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Spargo SC, 2003, BIOL REPROD, V68, P358, DOI 10.1095/biolreprod.102.008086; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; WASSARMAN PM, 1991, INT REV CYTOL, V130, P85, DOI 10.1016/S0074-7696(08)61502-8; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wassarman PM, 1998, HISTOL HISTOPATHOL, V13, P293, DOI 10.14670/HH-13.293; Wassarman PM, 1997, P ROY SOC B-BIOL SCI, V264, P323, DOI 10.1098/rspb.1997.0046; Williams Z, 2006, J CELL PHYSIOL, V207, P30, DOI 10.1002/jcp.20532; Williams Z, 2001, BIOCHEMISTRY-US, V40, P929, DOI 10.1021/bi002275x; Yanagimachi R, 1994, PHYSL REPRODUCTION, V1, P189; Zhao M, 2003, MOL CELL BIOL, V23, P8982, DOI 10.1128/MCB.23.24.8982-8991.2003; Zhao M, 2002, MOL CELL BIOL, V22, P3111, DOI 10.1128/MCB.22.9.3111-3120.2002	56	137	145	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24285	24289		10.1074/jbc.R800027200	http://dx.doi.org/10.1074/jbc.R800027200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18539589	Green Published, hybrid			2022-12-27	WOS:000258820000001
J	Li, Y; Anderson, DH; Liu, Q; Zhou, Y				Li, Yang; Anderson, Deborah H.; Liu, Qiang; Zhou, Yan			Mechanism of influenza A virus NS1 protein interaction with the p85 beta, but not the p85 alpha, subunit of phosphatidylinositol 3-kinase (PI3K) and up-regulation of PI3K activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE; CATALYTIC SUBUNIT; PATHWAY; ACTIVATION; DOMAINS; INSULIN; KINASE; BINDS; GENERATION; MUTATIONS	Influenza A virus infection activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by binding influenza A virus NS1 protein to the p85 beta regulatory subunit of PI3K. In this study, we report that NS1 binds to the inter-SH2 (iSH2) domain of p85 beta. Mutational analyses on p85 beta iSH2 domain defined that Val-573 is the critical amino acid (AA) that mediates NS1 and p85 beta interaction. In reciprocal gain of function experiments with p85 alpha, we demonstrated that mutation to Val at Met-582 leads to NS1 binding and increased PI3K activity. Molecular modeling based on our experimental results suggested that, in addition to the interaction interface between the NS1 SH3 binding motif 1 (AA 164-167) and p85 beta Val-573, AA 137-142 in NS1 might interact with p85 beta. Indeed, mutations of AA 141 and 142 in NS1 disrupted the interaction between NS1 and p85 beta. Mutant virus PR8-NS1-141/142 was not able to activate Akt phosphorylation. Furthermore, PI3K assays demonstrated that, in wild-type virus-infected cells, p85 beta-associated PI3K activity was increased significantly. In contrast, in the mutant virus-infected cells containing mutant NS1 unable to interact with p85 beta, the p85 beta-associated PI3K activity up-regulation was not seen, suggesting that PI3K up-regulation is dependent upon the interaction between NS1 and p85 beta. Competition experiments and the immunoprecipitation studies demonstrated that NS1, p85 beta, and p110 form a complex in cells. Finally, the mechanism by which binding of NS1 to p85 beta regulates PI3K activity was discussed based on a predicted structural model of NS1-p85-p110 complex.	[Li, Yang; Liu, Qiang; Zhou, Yan] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada; [Anderson, Deborah H.] Saskatoon Canc Agcy, Canc Res Unit, Hlth Res Div, Saskatoon, SK S7N 4H4, Canada	University of Saskatchewan; University of Saskatchewan	Zhou, Y (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada.	yan.zhou@usask.ca	Li, Yang/GVT-7396-2022	Li, Yang/0000-0002-6065-4706				Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; OKKENHAUG K, 2001, SCI STKE, pE1; Ren SY, 2005, MOL CELL BIOL, V25, P8001, DOI 10.1128/MCB.25.18.8001-8008.2005; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	36	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23397	23409		10.1074/jbc.M802737200	http://dx.doi.org/10.1074/jbc.M802737200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18534979	hybrid			2022-12-27	WOS:000258455400049
J	Burman, JL; Bourbonniere, L; Philie, J; Stroh, T; Dejgaard, SY; Presley, JF; McPherson, PS				Burman, Jonathon L.; Bourbonniere, Lyne; Philie, Jacynthe; Stroh, Thomas; Dejgaard, Selma Y.; Presley, John F.; McPherson, Peter S.			Scyl1, mutated in a recessive form of spinocerebellar neurodegeneration, regulates COPI-mediated retrograde traffic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; TO-GOLGI TRANSPORT; VESICLE FORMATION; BINDING-SITE; PROTEIN; CLATHRIN; ER; KINASE; MOTIFS; COATOMER	Scy1-like 1 (Scyl1), a member of the Scy1-like family of catalytically inactive protein kinases, was recently identified as the gene product altered in muscle- deficient mice, which suffer from motor neuron degeneration and cerebellar atrophy. To determine the function of Scyl1, we have now used a mass spectrometry-based screen to search for Scyl1-binding partners and identified components of coatomer I (COPI) coats. The interaction was confirmed in pull- down assays, and Scyl1 co-immunoprecipitates with beta COP from brain lysates. Interestingly, and unique for a non-transmembrane domain protein, Scyl1 binds COPI coats using a C-terminal RKLD-COO- sequence, similar to the KKXX-COO- COPI- binding motif found in transmembrane endoplasmic reticulum (ER) proteins. Scyl1 co-localizes with beta COP and is localized, in an Arf1-independent manner, to the ER- Golgi intermediate compartment and the cis-Golgi, sites of COPI-mediated membrane budding. The localization and binding properties of Scyl1 strongly suggest a function in COPI transport, and inhibitory RNA-mediated knock down of the protein disrupts COPI- mediated retrograde traffic of the KDEL receptor to the ER without affecting anterograde traffic from the ER. Our data demonstrate a function for Scyl1 as an accessory factor in COPI trafficking and suggest for the first time that alterations in the COPI pathway result in neurodegenerative disease.	[Burman, Jonathon L.; Bourbonniere, Lyne; Philie, Jacynthe; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Dejgaard, Selma Y.; Presley, John F.; McPherson, Peter S.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	McGill University; McGill University	McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca						Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; BLOT S, 1995, J NEUROPATH EXP NEUR, V54, P812; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Cabanes C, 2007, NEUROBIOL DIS, V26, P408, DOI 10.1016/j.nbd.2007.01.008; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Coleman R Edward, 1998, Clin Positron Imaging, V1, P15, DOI 10.1016/S1095-0397(97)00004-6; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Contino G, 2006, EXPERT OPIN PHARMACO, V7, P1849, DOI 10.1517/14656566.7.14.1849; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Dejgaard SY, 2007, J HISTOCHEM CYTOCHEM, V55, P709, DOI 10.1369/jhc.6A7090.2007; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Elsner M, 2003, MOL MEMBR BIOL, V20, P221, DOI 10.1080/0968768031000114024; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kato M, 2002, GENOMICS, V79, P760, DOI 10.1006/geno.2002.6774; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Lippincott-Schwartz J., 2006, TRENDS CELL BIOL, V16, P1; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu SCH, 2000, BBA-GENE STRUCT EXPR, V1517, P148, DOI 10.1016/S0167-4781(00)00234-7; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; McPherson PS, 2005, MOL NEUROBIOL, V32, P73, DOI 10.1385/MN:32:1:073; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142; Murshid A, 2004, CELL MOL LIFE SCI, V61, P133, DOI 10.1007/s00018-003-3352-9; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Olesen LE, 2008, J BIOL CHEM, V283, P5099, DOI 10.1074/jbc.M708621200; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; Scales SJ, 2000, INT REV CYTOL, V195, P67; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001; Storrie B, 2000, TRENDS CELL BIOL, V10, P385, DOI 10.1016/S0962-8924(00)01818-3; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Sullivan BM, 2000, MOL BIOL CELL, V11, P3155, DOI 10.1091/mbc.11.9.3155; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200	65	63	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22774	22786		10.1074/jbc.M801869200	http://dx.doi.org/10.1074/jbc.M801869200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18556652	hybrid			2022-12-27	WOS:000258321000045
J	Gao, ZB; Xiong, QJ; Sun, HY; Li, M				Gao, Zhaobing; Xiong, Qiaojie; Sun, Haiyan; Li, Min			Desensitization of chemical activation by auxiliary subunits - Convergence of molecular determinants critical for augmenting KCNQ1 potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; I-KS CHANNELS; K+ CHANNEL; CARDIAC-ARRHYTHMIA; ANTICONVULSANT RETIGABINE; CHROMANOL 293B; LANGE-NIELSEN; MINK; KVLQT1; RECTIFIER	Chemical openers for KCNQ potassium channels are useful probes both for understanding channel gating and for developing therapeutics. The five KCNQ isoforms (KCNQ1 to KCNQ5, or Kv7.1 to Kv7.5) are differentially localized. Therefore, the molecular specificity of chemical openers is an important subject of investigation. Native KCNQ1 normally exists in complex with auxiliary subunits known as KCNE. In cardiac myocytes, the KCNQ1-KCNE1 (IsK or minK) channel is thought to underlie the I-Ks current, a component critical for membrane repolarization during cardiac action potential. Hence, the molecular and pharmacological differences between KCNQ1 and KCNQ1-KCNE1 channels have been important topics. Zinc pyrithione (ZnPy) is a newly identified KCNQ channel opener, which potently activates KCNQ2, KCNQ4, and KCNQ5. However, the ZnPy effects on cardiac KCNQ1 potassium channels remain largely unknown. Here we show that ZnPy effectively augments the KCNQ1 current, exhibiting an increase in current amplitude, reduction of inactivation, and slowing of both activation and deactivation. Some of these are reminiscent of effects by KCNE1. In addition, neither the heteromultimeric KCNQ1-KCNE1 channels nor native IKs current displayed any sensitivity to ZnPy, indicating that the static occupancy by a KCNE subunit desensitizes the reversible effects by a chemical opener. Site-directed mutagenesis of KCNQ1 reveals that residues critical for the potentiation effects by either ZnPy or KCNE are clustered together in the S6 region overlapping with the critical gating determinants. Thus, the convergence of potentiation effects and molecular determinants critical for both an auxiliary subunit and a chemical opener argue for a mechanistic overlap in causing potentiation.	[Li, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Li, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, BRB311,733 N Broadway, Baltimore, MD 21205 USA.	minli@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070959, R01GM078579] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM078579, GM070959] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott G W, 2001, Mol Interv, V1, P95; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bett GCL, 2006, J PHYSIOL-LONDON, V576, P755, DOI 10.1113/jphysiol.2006.116012; Blackburn-Munro G, 2005, CNS DRUG REV, V11, P1, DOI 10.1111/j.1527-3458.2005.tb00033.x; Busch AE, 1996, PFLUG ARCH EUR J PHY, V432, P1094, DOI 10.1007/s004240050240; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; FATOPE MO, 2001, DRUGS, V4, P93; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jensen HS, 2007, BIOPHYS J, V92, P2747, DOI 10.1529/biophysj.106.101287; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kang JS, 2005, MOL PHARMACOL, V67, P827, DOI 10.1124/mol.104.006577; Kelly BL, 2003, NAT STRUCT BIOL, V10, P280, DOI 10.1038/nsb908; Kerst G, 2002, J MEMBRANE BIOL, V186, P89, DOI 10.1007/s00232-001-0138-6; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; NILIUS B, 1987, GEN PHYSIOL BIOPHYS, V6, P409; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Porter RJ, 2007, NEUROLOGY, V68, P1197, DOI 10.1212/01.wnl.0000259034.45049.00; Porter RJ, 2007, NEUROTHERAPEUTICS, V4, P149, DOI 10.1016/j.nurt.2006.11.012; Pusch M, 1998, PFLUG ARCH EUR J PHY, V437, P172, DOI 10.1007/s004240050765; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Romey G, 1997, J BIOL CHEM, V272, P16713, DOI 10.1074/jbc.272.27.16713; Salata JJ, 1998, MOL PHARMACOL, V54, P220, DOI 10.1124/mol.54.1.220; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, ANN NY ACAD SCI, V868, P406, DOI 10.1111/j.1749-6632.1999.tb11302.x; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Seebohm G, 2001, J BIOL CHEM, V276, P13600, DOI 10.1074/jbc.M008373200; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Tikhonov DB, 2004, BIOPHYS J, V87, P1526, DOI 10.1529/biophysj.103.037770; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Wang HS, 2000, MOL PHARMACOL, V57, P1218; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Xiong QJ, 2008, P NATL ACAD SCI USA, V105, P3128, DOI 10.1073/pnas.0712256105; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Xu J, 1998, TRENDS CARDIOVAS MED, V8, P229, DOI 10.1016/S1050-1738(98)00011-5; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	60	29	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22649	22658		10.1074/jbc.M802426200	http://dx.doi.org/10.1074/jbc.M802426200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18490447	hybrid, Green Published			2022-12-27	WOS:000258321000034
J	Nelson, SW; Kumar, R; Benkovic, SJ				Nelson, Scott W.; Kumar, Ravindra; Benkovic, Stephen J.			RNA primer handoff in bacteriophage T4 DNA replication - The role of single-stranded DNA-binding protein and polymerase accessory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE-LOADING PROTEIN; OKAZAKI FRAGMENT; LEADING-STRAND; COOH TERMINUS; MINICIRCLE SUBSTRATE; PRIMASE-HELICASE; GENE-59 PROTEIN; GP41 HELICASE; T4 HELICASE; COMPLEX	In T4 phage, coordinated leading and lagging strand DNA synthesis is carried out by an eight-protein complex termed the replisome. The control of lagging strand DNA synthesis depends on a highly dynamic replisome with several proteins entering and leaving during DNA replication. Here we examine the role of single-stranded binding protein (gp32) in the repetitive cycles of lagging strand synthesis. Removal of the protein-interacting domain of gp32 results in a reduction in the number of primers synthesized and in the efficiency of primer transfer to the polymerase. We find that the primase protein is moderately processive, and this processivity depends on the presence of full-length gp32 at the replication fork. Surprisingly, we find that an increase in the efficiency of primer transfer to the clamp protein correlates with a decrease in the dissociation rate of the primase from the replisome. These findings result in a revised model of lagging strand DNA synthesis where the primase remains as part of the replisome after each successful cycle of Okazaki fragment synthesis. A delay in primer transfer results in an increased probability of the primase dissociating from the replication fork. The interplay between gp32, primase, clamp, and clamp loader dictates the rate and efficiency of primer synthesis, polymerase recycling, and primer transfer to the polymerase.	[Nelson, Scott W.; Kumar, Ravindra; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sjb1@psu.edu			NIGMS NIH HHS [GM013306] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; ALBERTS BM, 1987, PHILOS T ROY SOC B, V317, P395, DOI 10.1098/rstb.1987.0068; BARRY J, 1994, J BIOL CHEM, V269, P33049; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BURKE RL, 1985, J BIOL CHEM, V260, P1711; BURKE RL, 1980, J BIOL CHEM, V255, P1484; Carver TE, 1997, BIOCHEMISTRY-US, V36, P14409, DOI 10.1021/bi971423p; CHA TA, 1990, BIOCHEMISTRY-US, V29, P1791, DOI 10.1021/bi00459a018; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Dudas KC, 2005, J BIOL CHEM, V280, P21561, DOI 10.1074/jbc.m502351200; GIEDROC DP, 1990, J BIOL CHEM, V265, P11444; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HINTON DM, 1987, J BIOL CHEM, V262, P10873; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Kaboord BF, 1996, BIOCHEMISTRY-US, V35, P1084, DOI 10.1021/bi9520747; KABOORD BF, 1993, P NATL ACAD SCI USA, V90, P10881, DOI 10.1073/pnas.90.22.10881; Kadyrov FA, 2002, NUCLEIC ACIDS RES, V30, P4387, DOI 10.1093/nar/gkf576; Kadyrov FA, 2001, J BIOL CHEM, V276, P29559, DOI 10.1074/jbc.M101310200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; KRASSA KB, 1991, P NATL ACAD SCI USA, V88, P4010, DOI 10.1073/pnas.88.9.4010; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Nossal NG, 1995, METHOD ENZYMOL, V262, P560; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4732; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Sambrook J, 1989, MOL CLONING LAB MANU, P431; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Smiley RD, 2006, BIOCHEMISTRY-US, V45, P7990, DOI 10.1021/bi0603322; Trakselis MA, 2003, J BIOL CHEM, V278, P49839, DOI 10.1074/jbc.M307405200; Villemain JL, 2000, J BIOL CHEM, V275, P31496, DOI 10.1074/jbc.M002902200; Waidner LA, 2001, J BIOL CHEM, V276, P2509, DOI 10.1074/jbc.M007778200; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yang JS, 2005, J BIOL CHEM, V280, P25416, DOI 10.1074/jbc.M501847200; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Zhang ZQ, 2005, P NATL ACAD SCI USA, V102, P3254, DOI 10.1073/pnas.0500327102; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	45	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22838	22846		10.1074/jbc.M802762200	http://dx.doi.org/10.1074/jbc.M802762200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18511422	Green Published, hybrid			2022-12-27	WOS:000258321000051
J	Kappler, U; Bernhardt, PV; Kilmartin, J; Riley, MJ; Teschner, J; McKenzie, KJ; Hanson, GR				Kappler, Ulrike; Bernhardt, Paul V.; Kilmartin, James; Riley, Mark J.; Teschner, Julia; McKenzie, Kirsty J.; Hanson, Graeme R.			SoxAX cytochromes, a new type of heme copper protein involved in bacterial energy generation from sulfur compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; PARACOCCUS-PANTOTROPHUS; THIOSULFATE OXIDATION; SULFITE DEHYDROGENASE; COMPLEX SOXXA; EPR; REDUCTION; IDENTIFICATION; LIGATION; SPECTRUM	SoxAX cytochromes are essential for the function of the only confirmed pathway for bacterial thiosulfate oxidation, the so-called "Sox pathway," in which they catalyze the initial formation of a S-S bond between thiosulfate and the SoxYZ carrier protein. Our work using the Starkeya novella diheme SoxAX protein reveals for the first time that in addition to two active site heme groups, SoxAX contains a mononuclear Cu-II center with a distorted tetragonal geometry and three to four nitrogen ligands, one of which is a histidine. The Cu-II center enhanced SoxAX activity in a newly developed, glutathione-based assay system that mimics the natural reaction of SoxAX with SoxYZ. EPR spectroscopy confirmed that the SoxAX CuII center is reduced by glutathione. At pH 7 a K-m app of 0.19 +/- 0.028 mM and a k(cat app) of 5.7 +/- 0.25s(-1) were determined for glutathione. We propose that SoxAX cytochromes are a new type of heme-copper proteins, with SoxAX-mediated S-S bond formation involving both the copper and heme centers.	[Teschner, Julia] Univ Queensland, Sch Mol & Microbial Sci, Ctr Met Biol, Brisbane, Qld 4072, Australia; [Hanson, Graeme R.] Univ Queensland, Ctr Magnet Resonance, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Teschner, J (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Ctr Met Biol, Cooper Rd,Bldg76, Brisbane, Qld 4072, Australia.	u.kappler@uq.edu.au	/C-3940-2008; Bernhardt, Paul V/J-8008-2013; Riley, Mark/E-1251-2011; Kappler, Ulrike/A-9483-2013	/0000-0003-0306-4360; Bernhardt, Paul V/0000-0001-6839-1763; Kappler, Ulrike/0000-0002-2642-1319				Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Appia-Ayme C, 2001, J BACTERIOL, V183, P6107, DOI 10.1128/JB.183.20.6107-6118.2001; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Bardischewsky F, 2005, BIOCHEMISTRY-US, V44, P7024, DOI 10.1021/bi047334b; Bernhardt PV, 2006, J BIOL INORG CHEM, V11, P930, DOI 10.1007/s00775-006-0148-z; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; Codd R, 2002, J BIOL INORG CHEM, V7, P338, DOI 10.1007/s00775-001-0303-5; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; DASILVA JJR, 2001, BIOL CHEM ELEMENTS I, P345; Dhawan IK, 1999, BIOCHEMISTRY-US, V38, P12805, DOI 10.1021/bi991303c; EATON WA, 1967, J CHEM PHYS, V46, P2533, DOI 10.1063/1.1841081; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; GEUE RJ, 1984, J AM CHEM SOC, V106, P5478, DOI 10.1021/ja00331a016; Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Kappler U, 2005, FEBS LETT, V579, P2491, DOI 10.1016/j.febslet.2005.03.060; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kappler U, 2002, FEBS LETT, V529, P208, DOI 10.1016/S0014-5793(02)03344-6; Kappler U, 2008, MICROBIAL SULFUR METABOLISM, P151, DOI 10.1007/978-3-540-72682-1_13; Klarskov K, 1998, BIOCHEMISTRY-US, V37, P10555, DOI 10.1021/bi9806706; LU WP, 1985, BIOCHIM BIOPHYS ACTA, V828, P116, DOI 10.1016/0167-4838(85)90046-9; MCKNIGHT J, 1993, EUR J BIOCHEM, V213, P683, DOI 10.1111/j.1432-1033.1993.tb17808.x; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; MYER YP, 1979, J BIOL CHEM, V254, P1202; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Quentmeier A, 2003, BIOCHEM BIOPH RES CO, V312, P1011, DOI 10.1016/j.bbrc.2003.11.021; Quentmeier A, 2000, ARCH MICROBIOL, V173, P117, DOI 10.1007/s002039900118; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; Riley MJ, 2003, J INORG BIOCHEM, V96, P217, DOI 10.1016/S0162-0134(03)80749-3; Rother D, 2002, BBA-PROTEINS PROTEOM, V1598, P65, DOI 10.1016/S0167-4838(02)00332-1; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Swem LR, 2003, EMBO J, V22, P4699, DOI 10.1093/emboj/cdg461; TAYLOR CPS, 1977, BIOCHIM BIOPHYS ACTA, V491, P137, DOI 10.1016/0005-2795(77)90049-6; THOMSON AJ, 1993, METHOD ENZYMOL, V226, P232; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; Wodara C, 1997, J BACTERIOL, V179, P5014, DOI 10.1128/jb.179.16.5014-5023.1997; WODARA C, 1994, J BACTERIOL, V176, P6188, DOI 10.1128/jb.176.20.6188-6191.1994; Yatsunyk LA, 2003, J AM CHEM SOC, V125, P15986, DOI 10.1021/ja036398r	40	21	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22206	22214		10.1074/jbc.M800315200	http://dx.doi.org/10.1074/jbc.M800315200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18552405	hybrid			2022-12-27	WOS:000258114700040
J	Bailly, A; Sovero, V; Vincenzetti, V; Santelia, D; Bartnik, D; Koenig, BW; Mancuso, S; Martinoia, E; Geisler, M				Bailly, Aurelien; Sovero, Valpuri; Vincenzetti, Vincent; Santelia, Diana; Bartnik, Dirk; Koenig, Bernd W.; Mancuso, Stefano; Martinoia, Enrico; Geisler, Markus			Modulation of P-glycoproteins by auxin transport inhibitors is mediated by interaction with immunophilins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT ABC TRANSPORTERS; ENERGY-TRANSFER BRET; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; CRYSTAL-STRUCTURE; CUCURBITA-PEPO; TWISTED DWARF1; BINDING SITES; LATERAL ROOT; ACID-BINDING	The immunophilin-like FKBP42 TWISTED DWARF1 (TWD1) has been shown to control plant development via the positive modulation of ABCB/P-glycoprotein (PGP)-mediated transport of the plant hormone auxin. TWD1 functionally interacts with two closely related proteins, ABCB1/PGP1 and ABCB19/PGP19/MDR1, both of which exhibit the ability to bind to and be inhibited by the synthetic auxin transport inhibitor N-1-naphylphtalamic acid (NPA). They are also inhibited by flavonoid compounds, which are suspected modulators of auxin transport. The mechanisms by which flavonoids and NPA interfere with auxin efflux components are unclear. We report here the specific disruption of PGP1-TWD1 interaction by NPA and flavonoids using bioluminescence resonance energy transfer with flavonoids functioning as a classical established inhibitor of mammalian and plant PGPs. Accordingly, TWD1 was shown to mediate modulation of PGP1 efflux activity by these auxin transport inhibitors. NPA bound to both PGP1 and TWD1 but was excluded from the PGP1-TWD1 complex expressed in yeast, suggesting a transient mode of action in planta. As a consequence, auxin fluxes and gravitropism in twd1 roots are less affected by NPA treatment, whereas TWD1 gain-of-function promotes root bending. Our data support a novel model for the mode of drug-mediated P-glycoprotein regulation mediated via protein-protein interaction with immunophilin-like TWD1.	[Bailly, Aurelien; Sovero, Valpuri; Vincenzetti, Vincent; Santelia, Diana; Martinoia, Enrico; Geisler, Markus] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Bailly, Aurelien; Sovero, Valpuri; Vincenzetti, Vincent; Santelia, Diana; Martinoia, Enrico; Geisler, Markus] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Bartnik, Dirk; Koenig, Bernd W.] Res Ctr Julich, Inst Nuerosci & Biophys, D-52425 Julich, Germany; [Mancuso, Stefano] Univ Florence, Dept Hort, I-50019 Sesto Fiorentino, Italy	University of Zurich; University of Zurich; Helmholtz Association; Research Center Julich; University of Florence	Geisler, M (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	markus.geisler@botinst.uzh.ch	Koenig, Bernd W/B-4315-2008; Santelia, Diana/AAQ-3967-2020; Geisler, Markus M/B-3921-2012; Martinoia, Enrico/AAH-8712-2021; Mancuso, Stefano/G-6515-2012	Koenig, Bernd W/0000-0002-5300-6276; Geisler, Markus M/0000-0002-6641-5810; Mancuso, Stefano/0000-0003-1752-3986				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bailly A, 2006, PLANT SIGNAL BEHAV, V1, P277, DOI 10.4161/psb.1.6.3531; Bernasconi P, 1996, PHYSIOL PLANTARUM, V96, P205, DOI 10.1111/j.1399-3054.1996.tb00203.x; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; BRUNN SA, 1992, PLANT PHYSIOL, V98, P101, DOI 10.1104/pp.98.1.101; BUER CS, 2007, PLANT PHYSL; Chelu MG, 2004, TRENDS CARDIOVAS MED, V14, P227, DOI 10.1016/j.tcm.2004.06.003; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; COX DN, 1994, PLANT CELL, V6, P1941, DOI 10.1105/tpc.6.12.1941; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Gehret AU, 2006, J BIOL CHEM, V281, P20698, DOI 10.1074/jbc.M513642200; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2004, MOL BIOL CELL, V15, P3393, DOI 10.1091/mbc.E03-11-0831; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Geisler M, 2007, TRENDS PLANT SCI, V12, P465, DOI 10.1016/j.tplants.2007.08.015; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Granzin J, 2006, J MOL BIOL, V364, P799, DOI 10.1016/j.jmb.2006.09.052; Hemenway CS, 1996, J BIOL CHEM, V271, P18527, DOI 10.1074/jbc.271.31.18527; Hossel D, 2005, PLANT BIOLOGY, V7, P41, DOI 10.1055/s-2004-830475; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Kerr ID, 2007, BIOCHEM J, V401, P613, DOI 10.1042/BJ20061411; LEWIS DR, 2007, PLANT CELL, V19; Lomax Terri L., 1995, P509; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Luschnig C, 2001, CURR BIOL, V11, pR831, DOI 10.1016/S0960-9822(01)00497-3; Mancuso S, 2005, ANAL BIOCHEM, V341, P344, DOI 10.1016/j.ab.2005.03.054; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; MICHALKE W, 1992, PLANTA, V187, P254, DOI 10.1007/BF00201948; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Morris ME, 2006, LIFE SCI, V78, P2116, DOI 10.1016/j.lfs.2005.12.003; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Romano P, 2005, NEW PHYTOL, V166, P753, DOI 10.1111/j.1469-8137.2005.01373.x; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Scheidt HA, 2007, EUR BIOPHYS J BIOPHY, V36, P393, DOI 10.1007/s00249-006-0094-2; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; SUSSMAN MR, 1980, PLANT PHYSIOL, V66, P1074, DOI 10.1104/pp.66.6.1074; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; VERRIER PJ, 2008, TRENDS PLANT SCI; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Weiergraber OH, 2006, FEBS LETT, V580, P251, DOI 10.1016/j.febslet.2005.12.007; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Zhang SZ, 2005, BIOCHEM PHARMACOL, V70, P627, DOI 10.1016/j.bcp.2005.05.017	62	133	138	4	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21817	21826		10.1074/jbc.M709655200	http://dx.doi.org/10.1074/jbc.M709655200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18499676	hybrid, Green Accepted			2022-12-27	WOS:000257898800055
J	Damian, M; Mary, S; Martin, A; Pin, JP; Baneres, JL				Damian, Marjorie; Mary, Sophie; Martin, Aimee; Pin, Jean-Philippe; Baneres, Jean-Louis			G protein activation by the leukotriene B-4 receptor dimer - Evidence for an absence of trans-activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED-RECEPTOR; ALLOSTERIC INTERACTIONS; CONFORMATIONAL-CHANGES; HORMONE-RECEPTORS; GPCR FUNCTION; CROSS-TALK; BINDING; AGONIST; COEXPRESSION; RECONSTITUTION	There is compelling evidence that G protein-coupled receptors exist as homo- and heterodimers, but the way these assemblies function at the molecular level remains unclear. We used here the purified leukotriene B-4 receptor BLT1 stabilized in its dimeric state to analyze how a receptor dimer activates G proteins. For this, we produced heterodimers between the wild-type BLT1 and a BLT1/ALXR chimera. The latter is no longer activated by leukotriene B-4 but is still activated by ALXR agonists. In this heterodimer, agonist binding to either one of the two protomers induced asymmetric conformational changes within the receptor dimer. Of importance, no G protein activation was observed when using a dimer where the ligand-loaded protomer was not able to trigger GDP/GTP exchange due to specific mutations in its third intracellular loop, establishing that the conformation of the agonist-free protomer is not competent for G protein activation. Taken together, these data indicate that although ligand binding to one protomer in the heterodimer is associated with cross-conformational changes, a trans-activation mechanism where the ligand-free subunit would trigger GDP/GTP exchange cannot be considered in this case for G protein activation. This observation sheds light into the way GPCR dimers, in particular heterodimers, could activate their cognate G proteins.	[Baneres, Jean-Louis] Univ Montpellier I, Fac Pharm, CNRS, Inst Biomol Max Mousseron,UMR5247, F-34093 Montpellier 5, France; [Damian, Marjorie; Mary, Sophie; Martin, Aimee; Baneres, Jean-Louis] Univ Montpellier 2, CNRS, Inst Biomol Max Mousseron, UMR5247, F-34093 Montpellier 5, France; [Pin, Jean-Philippe] Univ Montpellier I, CNRS, Inst Genom Fonctionnelle, UMR5203, F-34093 Montpellier 5, France; [Pin, Jean-Philippe] Univ Montpellier 2, CNRS, Inst Genom Fonctionnelle, UMR5203, F-34093 Montpellier 5, France; [Pin, Jean-Philippe] INSERM, U661, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Baneres, JL (corresponding author), Univ Montpellier I, Fac Pharm, CNRS, Inst Biomol Max Mousseron,UMR5247, 15 Av Ch Flahault,BP 14491, F-34093 Montpellier 5, France.	jean-louis.baneres@univ-montp1.fr	Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Baneres, jean-louis/0000-0001-7078-1285				Albizu L, 2006, MOL PHARMACOL, V70, P1783, DOI 10.1124/mol.106.025684; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bockaert J, 2002, INT REV CYTOL, V212, P63; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Carrillo JJ, 2003, J BIOL CHEM, V278, P42578, DOI 10.1074/jbc.M306165200; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Chinault SL, 2004, J BIOL CHEM, V279, P16091, DOI 10.1074/jbc.M311099200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Durroux T, 2005, TRENDS PHARMACOL SCI, V26, P376, DOI 10.1016/j.tips.2005.05.006; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; KUROSE H, 1991, BIOCHEMISTRY-US, V30, P3335, DOI 10.1021/bi00227a024; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; Osuga Y, 1997, J BIOL CHEM, V272, P25006, DOI 10.1074/jbc.272.40.25006; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; ROSS JBA, 1992, P NATL ACAD SCI USA, V89, P12023, DOI 10.1073/pnas.89.24.12023; Snook LA, 2006, J PHARMACOL EXP THER, V318, P683, DOI 10.1124/jpet.106.101220; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Stanasila L, 2003, J BIOL CHEM, V278, P40239, DOI 10.1074/jbc.M306085200; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wilson SJ, 2007, ARTERIOSCL THROM VAS, V27, P290, DOI 10.1161/01.ATV.0000252667.53790.4e; WYMAN J, 1990, BINDING LINKAGE FUNC, P33	48	40	40	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21084	21092		10.1074/jbc.M710419200	http://dx.doi.org/10.1074/jbc.M710419200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18490452	Green Published, hybrid			2022-12-27	WOS:000257746100050
J	Kalman, K; Nemeth-Cahalan, KL; Froger, A; Hall, JE				Kalman, Katalin; Nemeth-Cahalan, Karin L.; Froger, Alexandrine; Hall, James E.			Phosphorylation determines the calmodulin-mediated Ca2+ response and water permeability of AQP0	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-GAMMA; LENS; PROTEIN; AQUAPORIN-0; MOUSE; MICE; DIFFERENTIATION; TRANSPARENCY; ARCHITECTURE; TERMINUS	In Xenopus oocytes, the water permeability of AQP0 (P-f) increases with removal of external calcium, an effect that is mediated by cytoplasmic calmodulin (CaM) bound to the C terminus of AQP0. To investigate the effects of serine phosphorylation on CaM-mediated Ca2+ regulation of Pf, we tested the effects of kinase activation, CaM inhibition, and a series of mutations in the C terminus CaM binding site. Calcium regulation of AQP0 Pf manifests four distinct phenotypes: Group 1, with high Pf upon removal of external Ca2+ (wild-type, S229N, R233A, S235A, S235K, K238A, and R241E); Group 2, with high Pf in elevated ( 5 mM) external Ca2+ (S235D and R241A); Group 3, with high Pf and no Ca2+ regulation (S229D, S231N, S231D, S235N, and S235N/I236S); and Group 4, with low Pf and no Ca2+ regulation ( protein kinase A and protein kinase C activators, S229D/S235D and S235N/I236S). Within each group, we tested whether CaM binding mediates the phenotype, as shown previously for wild-type AQP0. In the presence of calmidazolium, a CaM inhibitor, S235D showed high Pf and no Ca2+ regulation, suggesting that S235D still binds CaM. Contrarily, S229D showed a decrease in recruitment of CaM, suggesting that S229D is unable to bind CaM. Taken together, our results suggest a model in which CaM acts as an inhibitor of AQP0 P-f. CaM binding is associated with a low P-f state, and a lack of CaM binding is associated with a high P-f state. Pathological conditions of inappropriate phosphorylation or calcium/CaM regulation could induce P-f changes contributing to the development of a cataract.	[Kalman, Katalin; Nemeth-Cahalan, Karin L.; Froger, Alexandrine; Hall, James E.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Kalman, K (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	kkalman@uci.edu; jhall@uci.edu	Hall, James E/K-6306-2012		NEI NIH HHS [EY 5661] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Al-Ghoul KJ, 2003, ANAT REC PART A, V273A, P714, DOI 10.1002/ar.a.10080; Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; Donaldson P, 2001, NEWS PHYSIOL SCI, V16, P118; Ervin LA, 2005, INVEST OPHTH VIS SCI, V46, P627, DOI 10.1167/iovs.04-0894; Francis P, 2000, BRIT J OPHTHALMOL, V84, P1376, DOI 10.1136/bjo.84.12.1376; GARLAND D, 1985, P NATL ACAD SCI USA, V82, P653, DOI 10.1073/pnas.82.3.653; GIRSCH SJ, 1991, CURR EYE RES, V10, P839, DOI 10.3109/02713689109013880; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Iyengar L, 2007, DIFFERENTIATION, V75, P662, DOI 10.1111/j.1432-0436.2007.00167.x; JOHNSON KR, 1986, J CELL BIOL, V102, P1334, DOI 10.1083/jcb.102.4.1334; Kalman K, 2006, BBA-BIOMEMBRANES, V1758, P1094, DOI 10.1016/j.bbamem.2006.01.015; Lan L, 1998, BIOCHEM J, V330, P1149, DOI 10.1042/bj3301149; Lin DB, 2006, J EXP BIOL, V209, P4371, DOI 10.1242/jeb.02524; Lin H, 2007, MOL VIS, V13, P1822; Maddala R, 2007, DIFFERENTIATION, V75, P713, DOI 10.1111/j.1432-0436.2007.00173.x; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mathias RT, 2004, EXP EYE RES, V78, P689, DOI 10.1016/j.exer.2003.07.001; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Menko AS, 2002, EXP EYE RES, V75, P485, DOI 10.1006/exer.2002.2057; Nemeth-Cahalan KL, 2007, J GEN PHYSIOL, V130, P457, DOI 10.1085/jgp.200709826; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Rose KML, 2008, BIOCHEMISTRY-US, V47, P339, DOI 10.1021/bi701980t; Shiels A, 2000, FASEB J, V14, P2207, DOI 10.1096/fj.99-1071com; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Zampighi GA, 2005, INVEST OPHTH VIS SCI, V46, P3247, DOI 10.1167/iovs.04-1504	32	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21278	21283		10.1074/jbc.M801740200	http://dx.doi.org/10.1074/jbc.M801740200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508773	hybrid, Green Published			2022-12-27	WOS:000257746100069
J	Sweeney, SM; Orgel, JP; Fertala, A; McAuliffe, JD; Turner, KR; Di Lullo, GA; Chen, S; Antipova, O; Perumal, S; Ala-Kokko, L; Forlino, A; Cabral, WA; Barnes, AM; Marini, JC; Antonio, JDS				Sweeney, Shawn M.; Orgel, Joseph P.; Fertala, Andrzej; McAuliffe, Jon D.; Turner, Kevin R.; Di Lullo, Gloria A.; Chen, Steven; Antipova, Olga; Perumal, Shiamalee; Ala-Kokko, Leena; Forlino, Antonella; Cabral, Wayne A.; Barnes, Aileen M.; Marini, Joan C.; Antonio, James D. San			Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPERFECTA/EHLERS-DANLOS-SYNDROME; AMINO-ACID-SEQUENCE; I COLLAGEN; OSTEOGENESIS-IMPERFECTA; BINDING-SITES; TRIPLE-HELIX; INTEGRINS ALPHA(1)BETA(1); DENTIN PHOSPHOPHORYN; COL1A1 MUTATION; GER SEQUENCE	Type I collagen, the predominant protein of vertebrates, polymerizes with type III and V collagens and non-collagenous molecules into large cable-like fibrils, yet how the fibril interacts with cells and other binding partners remains poorly understood. To help reveal insights into the collagen structure-function relationship, a data base was assembled including hundreds of type I collagen ligand binding sites and mutations on a two-dimensional model of the fibril. Visual examination of the distribution of functional sites, and statistical analysis of mutation distributions on the fibril suggest it is organized into two domains. The "cell interaction domain" is proposed to regulate dynamic aspects of collagen biology, including integrin-mediated cell interactions and fibril remodeling. The "matrix interaction domain" may assume a structural role, mediating collagen cross-linking, proteoglycan interactions, and tissue mineralization. Molecular modeling was used to superimpose the positions of functional sites and mutations from the two-dimensional fibril map onto a three-dimensional x-ray diffraction structure of the collagen microfibril in situ, indicating the existence of domains in the native fibril. Sequence searches revealed that major fibril domain elements are conserved in type I collagens through evolution and in the type II/XI collagen fibril predominant in cartilage. Moreover, the fibril domain model provides potential insights into the genotype-phenotype relationship for several classes of human connective tissue diseases, mechanisms of integrin clustering by fibrils, the polarity of fibril assembly, heterotypic fibril function, and connective tissue pathology in diabetes and aging.	[Turner, Kevin R.; Di Lullo, Gloria A.; Antonio, James D. San] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; [Turner, Kevin R.; Di Lullo, Gloria A.; Antonio, James D. San] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Sweeney, Shawn M.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Orgel, Joseph P.; Antipova, Olga; Perumal, Shiamalee] IIT, Dept Biol Chem & Phys Sci, Ctr Synchrotron Radiat Res & Instrumentat, Chicago, IL 60616 USA; [Fertala, Andrzej] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [McAuliffe, Jon D.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Chen, Steven] Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA; [Ala-Kokko, Leena] Univ Oulu, Bioctr, Collagen Res Unit, Oulu, Finland; [Ala-Kokko, Leena] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu, Finland; [Ala-Kokko, Leena] Connect Tissue Gene Tests, Allentown, PA 18103 USA; [Forlino, Antonella] Univ Pavia, Dept Biochem A Castellani, I-27100 Pavia, Italy; [Forlino, Antonella; Cabral, Wayne A.; Barnes, Aileen M.; Marini, Joan C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, Natl Inst Hlth, Bethesda, MD 20892 USA	Jefferson University; Jefferson University; University of Pennsylvania; Illinois Institute of Technology; Jefferson University; University of Pennsylvania; Chicago Medical School; University of Oulu; University of Oulu; University of Pavia; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Antonio, JDS (corresponding author), Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Rm 809 Curtis,1015 Walnut St, Philadelphia, PA 19107 USA.	james.sanantonio@jefferson.edu	Forlino, Antonella/H-5385-2015	Forlino, Antonella/0000-0002-6385-1182; Barnes, Aileen/0000-0001-8021-4997	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053590, R29HL053590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR049604, R01AR048544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR008630-08, RR 08630, P41 RR008630-127842, P41 RR008630] Funding Source: Medline; NHLBI NIH HHS [R01 HL053590-08, HL 053590] Funding Source: Medline; NIAMS NIH HHS [AR 049604, R01 AR048544, R01 AR048544-04, R21 AR049604-03, AR 048544] Funding Source: Medline; NIGMS NIH HHS [P41 GM103622] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayad S, 1998, EXTRACELLULAR MATRIX; Baronas-Lowell D, 2004, J BIOL CHEM, V279, P952, DOI 10.1074/jbc.M305989200; BRENNAN M, 1989, J BIOL CHEM, V264, P20947; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; Cabral WA, 2005, J BIOL CHEM, V280, P19259, DOI 10.1074/jbc.M414698200; Cabral WA, 2007, HUM MUTAT, V28, P396, DOI 10.1002/humu.20456; CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099; Chen J, 2001, AM J PHYSIOL-RENAL, V281, pF71, DOI 10.1152/ajprenal.2001.281.1.F71; CHEN JM, 1995, J BIOMOL STRUCT DYN, V12, P1129, DOI 10.1080/07391102.1995.10508804; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; Collagen Linsenmayer T. F., 1991, CELL BIOL EXTRACELLU; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; FUJISAWA R, 1994, CONNECT TISSUE RES, V31, P1, DOI 10.3109/03008209409005630; Gensure RC, 2005, J CLIN INVEST, V115, P1250, DOI 10.1172/JCI200522760; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Huq NL, 2005, ARCH ORAL BIOL, V50, P807, DOI 10.1016/j.archoralbio.2005.02.002; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kadler KE, 1996, BIOCHEM J, V316, P1; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lee Kwang-Soo, 2006, Hum Mutat, V27, P599, DOI 10.1002/humu.9423; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Malfait F, 2007, HUM MUTAT, V28, P387, DOI 10.1002/humu.20455; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; McCarthy AD, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-16; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Pallos D, 2001, ARCH ORAL BIOL, V46, P459, DOI 10.1016/S0003-9969(00)00130-8; Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9; Paul RG, 1999, INT J BIOCHEM CELL B, V31, P653, DOI 10.1016/S1357-2725(99)00023-0; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Piez K.A., 1984, EXTRACELLULAR MATRIX; Pollitt R, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9430; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; REIGLE KL, 2008, J CELL BIOC IN PRESS; Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034; SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179; Scott JE, 1997, CELL BIOCHEM FUNCT, V15, P283, DOI 10.1002/(SICI)1099-0844(199712)15:4<283::AID-CBF752>3.0.CO;2-B; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Thomas EK, 2005, J BIOL CHEM, V280, P22596, DOI 10.1074/jbc.M501155200; Tsilibary EC, 2003, J PATHOL, V200, P537, DOI 10.1002/path.1439; VOGEL KG, 1985, J BIOL CHEM, V260, P9298; Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d; Ward L M, 2001, Hum Mutat, V17, P434, DOI 10.1002/humu.1124; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004; Yoneyama T, 2004, STROKE, V35, P443, DOI 10.1161/01.STR.0000110788.45858.DC; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200	68	209	217	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21187	21197		10.1074/jbc.M709319200	http://dx.doi.org/10.1074/jbc.M709319200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18487200	Green Published, hybrid			2022-12-27	WOS:000257746100061
J	Li, Y; Kovach, A; Suino-Powell, K; Martynowski, D; Xu, HE				Li, Yong; Kovach, Amanda; Suino-Powell, Kelly; Martynowski, Dariusz; Xu, H. Eric			Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor gamma to PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTORS; PPAR-GAMMA; TRANSCRIPTION COACTIVATORS; CRYSTAL-STRUCTURE; ALPHA; LIGAND; PGC-1; HETERODIMERIZATION; IDENTIFICATION; ROSIGLITAZONE	The functional interaction between the peroxisome proliferator-activated receptor gamma (PPAR gamma) and its coactivator PGC-1 alpha is crucial for the normal physiology of PPAR gamma and its pharmacological response to antidiabetic treatment with rosiglitazone. Here we report the crystal structure of the PPAR gamma ligand-binding domain bound to rosiglitazone and to a large PGC-1 alpha fragment that contains two LXXLL-related motifs. The structure reveals critical contacts mediated through the first LXXLL motif of PGC-1 alpha and the PPAR gamma coactivator binding site. Through a combination of biochemical and structural studies, we demonstrate that the first LXXLL motif is the most potent among all nuclear receptor coactivator motifs tested, and only this motif of the two LXXLL-related motifs in PGC-1 alpha is capable of binding to PPAR gamma. Our studies reveal that the strong interaction of PGC-1 alpha and PPAR gamma is mediated through both hydrophobic and specific polar interactions. Mutations within the context of the full-length PGC-1 alpha indicate that the first PGC-1 alpha motif is necessary and sufficient for PGC-1 alpha to coactivate PPAR gamma in the presence or absence of rosiglitazone. These results provide a molecular basis for specific recruitment and functional interplay between PPAR gamma and PGC-1 alpha in glucose homeostasis and adipocyte differentiation.	[Li, Yong; Kovach, Amanda; Suino-Powell, Kelly; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Li, Yong; Martynowski, Dariusz] Univ Pittsburgh, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA	Van Andel Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, Y (corresponding author), 709 Salk Hall, Pittsburgh, PA 15261 USA.	yol21@pitt.edu; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021; Martynowski, Dariusz/AAU-6083-2020	Martynowski, Dariusz/0000-0001-7617-7716; Xu, H. Eric/0000-0002-6829-8144	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL089301] Funding Source: Medline; NIDDK NIH HHS [DK066202, DK071662] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hall JM, 2007, MOL ENDOCRINOL, V21, P1756, DOI 10.1210/me.2007-0060; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; NAVAZA J, 1992, MOL REPLACEMENT; Nettles KW, 2004, MOL CELL, V13, P317, DOI 10.1016/S1097-2765(04)00054-1; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008	32	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19132	19139		10.1074/jbc.M802040200	http://dx.doi.org/10.1074/jbc.M802040200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18469005	Green Published, hybrid			2022-12-27	WOS:000257165600068
J	Zhu, H; Xie, G; Liu, MY; Olson, JS; Fabian, M; Dooley, DM; Lei, BF				Zhu, Hui; Xie, Gang; Liu, Mengyao; Olson, John S.; Fabian, Marian; Dooley, David M.; Lei, Benfang			Pathway for heme uptake from human methemoglobin by the iron-regulated surface determinants system of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SHP; HEMOGLOBIN RECEPTOR; BINDING PROPERTIES; CRYSTAL-STRUCTURE; AFFINITY BINDING; IDENTIFICATION; ACQUISITION; ISDC; HTSA; DOMAIN	The iron-regulated surface proteins IsdA, IsdB, and IsdC and transporter IsdDEF of Staphylococcus aureus are involved in heme acquisition. To establish an experimental model of heme acquisition by this system, we have investigated hemin transfer between the various couples of human methemoglobin (metHb), IsdA, IsdB, IsdC, and IsdE by spectroscopic and kinetic analyses. The efficiencies of hemin transfer from hemin-containing donors (holo-protein) to different hemin-free acceptors (apo-protein) were examined, and the rates of the transfer reactions were compared with that of indirect loss of hemin from the relevant donor to H64Y/V68F apomyoglobin. The efficiencies, spectral changes, and kinetics of the transfer reactions demonstrate that: 1) metHb directly transfers hemin to apo-IsdB, but not to apo-IsdA, apo-IsdC, and apo-IsdE; 2) holo-IsdB directly transfers hemin to apo-IsdA and apo-IsdC, but not to apo-IsdE; 3) apo-IsdE directly acquires hemin from holo-IsdC, but not from holo-IsdB and holo-IsdA; and 4) IsdB and IsdC enhance hemin transfer from metHb to apo-IsdC and from holo-IsdB to apo-IsdE, respectively. Taken together with our recent finding that holo-IsdA directly transfers its hemin to apo-IsdC, these results provide direct experimental evidence for a model in which IsdB acquires hemin from metHb and transfers it directly or through IsdA to IsdC. Hemin is then relayed to IsdE, the lipoprotein component of the IsdDEF transporter.	[Zhu, Hui; Xie, Gang; Liu, Mengyao; Lei, Benfang] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59718 USA; [Dooley, David M.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59718 USA; [Olson, John S.; Fabian, Marian] Rice Univ, WM Keck Ctr Computat Biol, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Rice University	Lei, BF (corresponding author), Montana State Univ, Dept Vet Mol Biol, POB 173610, Bozeman, MT 59717 USA.	blei@montana.edu		Lei, Benfang Lei/0000-0001-8133-6021; Olson, John/0000-0002-0760-5403	NCRR NIH HHS [P20 RR020185-037582, P20 RR020185-047743, P20 RR 020185, P20 RR020185] Funding Source: Medline; NHLBI NIH HHS [HL 47020] Funding Source: Medline; NIGMS NIH HHS [GM 35649, GM 27659] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, R01GM027659] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrade MA, 2002, GENOME BIOL, V3; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Ascoli F, 1981, Methods Enzymol, V76, P72; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; Letoffe S, 1999, MOL MICROBIOL, V33, P546, DOI 10.1046/j.1365-2958.1999.01499.x; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Pluym M, 2007, BIOCHEMISTRY-US, V46, P12777, DOI 10.1021/bi7009585; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; REISBERG PI, 1980, J BIOL CHEM, V255, P4144; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Rouault TA, 2004, SCIENCE, V305, P1577, DOI 10.1126/science.1102975; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; ZHANG L, 1991, J BIOL CHEM, V266, P24698; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	42	98	104	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					18450	18460		10.1074/jbc.M801466200	http://dx.doi.org/10.1074/jbc.M801466200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18467329	Green Published, hybrid			2022-12-27	WOS:000256949200073
J	Lipsky, R; Potts, EM; Tarzami, ST; Puckerin, AA; Stocks, J; Schecter, AD; Sobie, EA; Akar, FG; Diverse-Pierluissi, MA				Lipsky, Rachele; Potts, Essie M.; Tarzami, Sima T.; Puckerin, Akil A.; Stocks, Joanne; Schecter, Alison D.; Sobie, Eric A.; Akar, Fadi G.; Diverse-Pierluissi, Maria A.			beta-adrenergic receptor activation induces internalization of cardiac Ca(v)1.2 channel complexes through a beta-arrestin 1-mediated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CALCIUM-CHANNELS; PROTEIN-KINASE; INDUCED TRAFFICKING; ARRESTIN; MYOCYTES; CA2+; CONTRACTILITY; ACETYLCHOLINE; INHIBITION	Voltage-dependent calcium channels (VDCCs) play a pivotal role in normal excitation-contraction coupling in cardiac myocytes. These channels can be modulated through activation of beta-adrenergic receptors (beta-ARs), which leads to an increase in calcium current (ICa-L) density through cardiac Ca(v)1 channels as a result of phosphorylation by cAMP-dependent protein kinase A. Changes in ICa-L density and kinetics in heart failure often occur in the absence of changes in Ca(v)1 channel expression, arguing for the importance of post-translational modification of these channels in heart disease. The precise molecular mechanisms that govern the regulation of VDCCs and their cell surface localization remain unknown. Our data show that sustained beta-AR activation induces internalization of a cardiac macromolecular complex involving VDCC and beta-arrestin 1 (beta-Arr1) into clathrin-coated vesicles. Pretreatment of myocytes with pertussis toxin prevents the internalization of VDCCs, suggesting that G(i/o) mediates this response. A peptide that selectively disrupts the interaction between Ca(V)1.2 and beta-Arr1 and tyrosine kinase inhibitors readily prevent agonist-induced VDCC internalization. These observations suggest that VDCC trafficking is mediated by G protein switching to G(i) of the beta-AR, which plays a prominent role in various cardiac pathologies associated with a hyperadrenergic state, such as hypertrophy and heart failure.	[Lipsky, Rachele; Potts, Essie M.; Puckerin, Akil A.; Sobie, Eric A.; Akar, Fadi G.; Diverse-Pierluissi, Maria A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Tarzami, Sima T.; Stocks, Joanne; Schecter, Alison D.; Akar, Fadi G.] Mt Sinai Sch Med, Cardiovasc Res Inst, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Diverse-Pierluissi, MA (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.	maria.diverse@mssm.edu	Stocks, Joanne/K-4403-2019; Stocks, Joanne/A-3307-2017	Stocks, Joanne/0000-0002-7800-6002; Stocks, Joanne/0000-0002-7800-6002	NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037443] Funding Source: NIH RePORTER; NCI NIH HHS [R24 CA095823] Funding Source: Medline; NHLBI NIH HHS [HL076230, HL7458] Funding Source: Medline; NINDS NIH HHS [NS37443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; Gong HB, 2000, BRIT J PHARMACOL, V131, P594, DOI 10.1038/sj.bjp.0703591; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Herring D, 2003, J BIOL CHEM, V278, P24046, DOI 10.1074/jbc.M301420200; Ho PD, 2001, CIRC RES, V88, P63, DOI 10.1161/01.RES.88.1.63; HOU ZY, 1989, AM J PHYSIOL, V256, pH74, DOI 10.1152/ajpheart.1989.256.1.H74; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; KOPPEN CJ, 2001, BIOCHEM SOC T, V29, P505; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Molkentin JD, 2006, J CLIN INVEST, V116, P623, DOI 10.1172/JCI27824; Nagata K, 2000, CIRC RES, V87, P903, DOI 10.1161/01.RES.87.10.903; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Pyo RT, 2006, J MOL CELL CARDIOL, V41, P834, DOI 10.1016/j.yjmcc.2006.08.008; Schiff ML, 2000, NATURE, V408, P723, DOI 10.1038/35047093; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; WANG YG, 1995, CIRC RES, V76, P634, DOI 10.1161/01.RES.76.4.634; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	26	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2008	283	25					17221	17226		10.1074/jbc.C800061200	http://dx.doi.org/10.1074/jbc.C800061200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	313DF	18458091	Green Published, hybrid			2022-12-27	WOS:000256720600031
J	Unno, H; Yamashita, T; Ujita, S; Okumura, N; Otani, H; Okumura, A; Nagai, K; Kusunoki, M				Unno, Hideaki; Yamashita, Tetsuo; Ujita, Sayuri; Okumura, Nobuaki; Otani, Hiroto; Okumura, Akiko; Nagai, Katsuya; Kusunoki, Masami			Structural basis for substrate recognition and hydrolysis by mouse carnosinase CN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTALLOGRAPHIC CHARACTERIZATION; RENAL SYMPATHETIC-NERVE; CRYSTAL-STRUCTURE; AEROMONAS AMINOPEPTIDASE; LEUCINE AMINOPEPTIDASE; ZINC AMINOPEPTIDASE; REFINEMENT; PROGRAM; ENZYME; IDENTIFICATION	L-Carnosine is a bioactive dipeptide (beta-alanyl-L-histidine) present in mammalian tissues, including the central nervous system, and has potential neuroprotective and neurotransmitter functions. In mammals, two types of L-carnosine-hydrolyzing enzymes (CN1 and CN2) have been cloned thus far, and they have been classified as metallopeptidases of the M20 family. The enzymatic activity of CN2 requires Mn2+, and CN2 is inhibited by a nonhydrolyzable substrate analog, bestatin. Here, we present the crystal structures of mouse CN2 complexed with bestatin together with Zn2+ at a resolution of 1.7 angstrom and that with Mn2+ at 2.3 angstrom. CN2 is a homodimer in a noncrystallographic asymmetric unit, and the Mn2+ and Zn2+ complexes closely resemble each other in the overall structure. Each subunit is composed of two domains: domain A, which is complexed with bestatin and two metal ions, and domain B, which provides the major interface for dimer formation. The bestatin molecule bound to domain A interacts with several residues of domain B of the other subunit, and these interactions are likely to be essential for enzyme activity. Since the bestatin molecule is not accessible to the bulk water, substrate binding would require conformational flexibility between domains A and B. The active site structure and substrate-binding model provide a structural basis for the enzymatic activity and substrate specificity of CN2 and related enzymes.	[Okumura, Nobuaki] Osaka Univ, Lab Homeostat Integrat, Div Integrated Prot Funct, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Okumura, N (corresponding author), Osaka Univ, Lab Homeostat Integrat, Div Integrated Prot Funct, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nokumura@protein.osaka-u.ac.jp; mkusunoki@yamanashi.ac.jp	Hideaki, UNNO/ABG-9471-2020	Hideaki, UNNO/0000-0001-5917-269X				BANDO K, 1984, ANN CLIN BIOCHEM, V21, P510, DOI 10.1177/000456328402100613; Baran EJ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P789; BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P1412; BAYLISS ME, 1986, BIOCHEMISTRY-US, V25, P8113, DOI 10.1021/bi00372a047; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; BURLEY SK, 1991, P NATL ACAD SCI USA, V88, P6916, DOI 10.1073/pnas.88.16.6916; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Copik AJ, 2005, BIOCHEMISTRY-US, V44, P121, DOI 10.1021/bi048123+; De Marchis S, 2000, J COMP NEUROL, V426, P378, DOI 10.1002/1096-9861(20001023)426:3<378::AID-CNE3>3.0.CO;2-1; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W, 2002, PYMOL 0 99; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fundoiano-Hershcovitz Y, 2004, FEBS LETT, V571, P192, DOI 10.1016/j.febslet.2004.07.001; HANGAUER DG, 1984, BIOCHEMISTRY-US, V23, P5730, DOI 10.1021/bi00319a011; HANSON HT, 1949, J BIOL CHEM, V179, P789; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; KIM HD, 1993, J MOL BIOL, V230, P722, DOI 10.1006/jmbi.1993.1193; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNZE N, 1986, EUR J BIOCHEM, V160, P605, DOI 10.1111/j.1432-1033.1986.tb10081.x; MARGOLIS FL, 1983, BIOCHIM BIOPHYS ACTA, V744, P237, DOI 10.1016/0167-4838(83)90196-6; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai K, 2003, EXP BIOL MED, V228, P1138, DOI 10.1177/153537020322801007; Niijima A, 2002, AUTON NEUROSCI-BASIC, V97, P99, DOI 10.1016/S1566-0702(02)00048-6; OTANI H, 2005, J BIOCHEM-TOKYO, V37, P167; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PRESCOTT JM, 1983, BIOCHEM BIOPH RES CO, V114, P646, DOI 10.1016/0006-291X(83)90829-X; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Speno HS, 1999, MOL PHARMACOL, V55, P179, DOI 10.1124/mol.55.1.179; Stamper CC, 2004, BIOCHEMISTRY-US, V43, P9620, DOI 10.1021/bi049126p; STURA EA, 1999, PRACT APPROACH SER, V210, P177; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tanida M, 2005, AM J PHYSIOL-REG I, V288, pR447, DOI 10.1152/ajpregu.00275.2004; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Trombley PQ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P807; VONGERICHTEN KF, 1994, MICROBIOL-SGM, V140, P2591, DOI 10.1099/00221287-140-10-2591; WOLOS A, 1978, INT J BIOCHEM, V9, P57, DOI 10.1016/0020-711X(78)90139-8; WOOD T, 1957, NATURE, V180, P39, DOI 10.1038/180039a0; Yamano T, 2001, NEUROSCI LETT, V313, P78, DOI 10.1016/S0304-3940(01)02231-5; Yamashita T, 2006, ACTA CRYSTALLOGR F, V62, P996, DOI 10.1107/S1744309106034701	44	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27289	27299		10.1074/jbc.M801657200	http://dx.doi.org/10.1074/jbc.M801657200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18550540	hybrid			2022-12-27	WOS:000259586600048
J	Chan, AYM; Dolinsky, VW; Soltys, CLM; Viollet, B; Baksh, S; Light, PE; Dyck, JRB				Chan, Anita Y. M.; Dolinsky, Vernon W.; Soltys, Carrie-Lynn M.; Viollet, Benoit; Baksh, Shairaz; Light, Peter E.; Dyck, Jason R. B.			Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; REGULATES PHOSPHORYLATION; ELONGATION FACTOR-2; HEART; MYOCYTES; INSULIN; ISCHEMIA; GROWTH; LKB1; CARDIOMYOCYTES	Whereas studies involving animal models of cardiovascular disease demonstrated that resveratrol is able to inhibit hypertrophic growth, the mechanisms involved have not been elucidated. Because studies in cells other than cardiomyocytes revealed that AMP-activated protein kinase ( AMPK) and Akt are affected by resveratrol, we hypothesized that resveratrol prevents cardiac myocyte hypertrophy via these two kinase systems. Herein, we demonstrate that resveratrol reduces phenylephrine-induced protein synthesis and cell growth in rat cardiac myocytes via alterations of intracellular pathways involved in controlling protein synthesis (p70S6 kinase and eukaryotic elongation factor-2). Additionally, we demonstrate that resveratrol negatively regulates the calcineurin-nuclear factor of activated T cells pathway thus modifying a critical component of the transcriptional mechanism involved in pathological cardiac hypertrophy. Our data also indicate that these effects of resveratrol are mediated via AMPK activation and Akt inhibition, and in the case of AMPK, is dependent on the presence of the AMPK kinase, LKB1. Taken together, our data suggest that resveratrol exerts anti-hypertrophic effects by activating AMPK via LKB1 and inhibiting Akt, thus suppressing protein synthesis and gene transcription.	[Chan, Anita Y. M.; Dolinsky, Vernon W.; Soltys, Carrie-Lynn M.; Light, Peter E.; Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Grp, Edmonton, AB T6G 2S2, Canada; [Chan, Anita Y. M.; Dolinsky, Vernon W.; Soltys, Carrie-Lynn M.; Baksh, Shairaz; Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada; [Chan, Anita Y. M.; Light, Peter E.; Dyck, Jason R. B.] Univ Alberta, Dept Pharmacol, Fac Med & Dent, Edmonton, AB T6G 2S2, Canada; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] INSERM, U567, F-75014 Paris, France	University of Alberta; University of Alberta; University of Alberta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dyck, JRB (corresponding author), Univ Alberta, Cardiovasc Res Grp, 430 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	jason.dyck@ualberta.ca	Viollet, Benoit/N-2397-2019; Baksh, Shairaz/GRX-2106-2022; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Dyck, Jason/0000-0002-7045-2884	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada (HSFC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This research was supported in part by grants from the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada (HSFC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Barac YD, 2005, CARDIOVASC RES, V68, P75, DOI 10.1016/j.cardiores.2005.05.015; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benjamin EJ, 1999, AM J MED SCI, V317, P168, DOI 10.1097/00000441-199903000-00006; Bertrand L, 2006, AM J PHYSIOL-HEART C, V291, pH239, DOI 10.1152/ajpheart.01269.2005; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Everett AD, 2001, AM J PHYSIOL-HEART C, V281, pH161, DOI 10.1152/ajpheart.2001.281.1.H161; Folmes KD, 2007, AM J PHYSIOL-HEART C, V293, pH3456, DOI 10.1152/ajpheart.00936.2007; FRUMAN DA, 1992, EUR J IMMUNOL, V22, P2513, DOI 10.1002/eji.1830221008; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Horman S, 2003, J BIOL CHEM, V278, P41970, DOI 10.1074/jbc.M302403200; HOU X, 2008, J BIOL CHEM; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Li RF, 2007, FEBS LETT, V581, P3311, DOI 10.1016/j.febslet.2007.06.017; Liu ZP, 2005, CLIN EXP PHARMACOL P, V32, P1049, DOI 10.1111/j.1440-1681.2005.04303.x; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Soltys CLM, 2006, AM J PHYSIOL-HEART C, V290, pH2472, DOI 10.1152/ajpheart.01206.2005; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Wang LJ, 2002, FEBS LETT, V531, P285, DOI 10.1016/S0014-5793(02)03536-6; Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056, DOI 10.1152/ajpheart.2000.278.4.H1056; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	40	196	203	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24194	24201		10.1074/jbc.M802869200	http://dx.doi.org/10.1074/jbc.M802869200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562309	Green Published, hybrid			2022-12-27	WOS:000258638900073
J	Hachet-Haas, M; Balabanian, K; Rohmer, F; Pons, F; Franchet, C; Lecat, S; Chow, KYC; Dagher, R; Gizzi, P; Didier, B; Lagane, B; Kellenberger, E; Bonnet, D; Baleux, F; Haiech, J; Parmentier, M; Frossard, N; Arenzana-Seisdedos, F; Hibert, M; Galzi, JL				Hachet-Haas, Muriel; Balabanian, Karl; Rohmer, Francois; Pons, Francoise; Franchet, Christel; Lecat, Sandra; Chow, Ken Y. C.; Dagher, Rania; Gizzi, Patrick; Didier, Bruno; Lagane, Bernard; Kellenberger, Esther; Bonnet, Dominique; Baleux, Francoise; Haiech, Jacques; Parmentier, Marc; Frossard, Nelly; Arenzana-Seisdedos, Fernando; Hibert, Marcel; Galzi, Jean-luc			Small neutralizing molecules to inhibit actions of the chemokine CXCL12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED FACTOR-1-ALPHA; BREAST-CANCER METASTASIS; TROPIC HIV-1 INFECTION; RECEPTOR CXCR4; FACTOR-I; FLAVONOID BAICALIN; PHARMACOPHORE IDENTIFICATION; CRYSTAL-STRUCTURE; FACTOR 1-ALPHA; T-LYMPHOCYTES	The chemokine CXCL12 and the receptor CXCR4 play pivotal roles in normal vascular and neuronal development, in inflammatory responses, and in infectious diseases and cancer. For instance, CXCL12 has been shown to mediate human immunodeficiency virus-induced neurotoxicity, proliferative retinopathy and chronic inflammation, whereas its receptor CXCR4 is involved in human immunodeficiency virus infection, cancer metastasis and in the rare disease known as the warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis (WHIM) syndrome. As we screened chemical libraries to find inhibitors of the interaction between CXCL12 and the receptor CXCR4, we identified synthetic compounds from the family of chalcones that reduce binding of CXCL12 to CXCR4, inhibit calcium responses mediated by the receptor, and prevent CXCR4 internalization in response to CXCL12. We found that the chemical compounds display an original mechanism of action as they bind to the chemokine but not to CXCR4. The highest affinity molecule blocked chemotaxis of human peripheral blood lymphocytes ex vivo. It was also active in vivo in a mouse model of allergic eosinophilic airway inflammation in which we detected inhibition of the inflammatory infiltrate. The compound showed selectivity for CXCL12 and not for CCL5 and CXCL8 chemokines and blocked CXCL12 binding to its second receptor, CXCR7. By analogy to the effect of neutralizing antibodies, this molecule behaves as a small organic neutralizing compound that may prove to have valuable pharmacological and therapeutic potential.	[Hachet-Haas, Muriel; Rohmer, Francois; Franchet, Christel; Lecat, Sandra; Dagher, Rania; Gizzi, Patrick; Didier, Bruno; Kellenberger, Esther; Bonnet, Dominique; Haiech, Jacques; Hibert, Marcel; Galzi, Jean-luc] Univ Strasbourg 1, Inst Gilbert Laustriat Biomol Biotechnol Innovat, UMR 7175, IFR 85, F-67401 Illkirch Graffenstaden, France; [Balabanian, Karl; Chow, Ken Y. C.; Lagane, Bernard; Baleux, Francoise; Arenzana-Seisdedos, Fernando] Inst Pasteur, Unite Pathogenie Virale Mol, F-75015 Paris, France; [Pons, Francoise; Frossard, Nelly] Fac Pharm, IFR 85, Inflammat & Environm Astheme EA 3771, F-67401 Illkirch Graffenstaden, France; [Parmentier, Marc] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Libre de Bruxelles	Galzi, JL (corresponding author), Ecole Super Biotechnol, CNRS, UMR 7175, IFR 85 Gilbert Laustriat Biomol & Innovat Therape, Bld Sebastien Brant BP 10413, F-67412 Illkirch Graffenstaden, France.	galzi@esbs.u-strasbg.fr	Arenzana-Seisdedos, Fernando/E-5835-2016; Kellenberger, Esther/AFN-2081-2022; Balabanian, Karl/S-6250-2019; Bonnet, Dominique/N-7275-2014; Frossard, Nelly/F-8301-2013; Lagane, Bernard/K-8446-2016; haiech, jacques J/F-2890-2010; Lagane, Bernard/AAA-2205-2019; Balabanian, Karl/I-2990-2016	Kellenberger, Esther/0000-0002-9320-4840; Balabanian, Karl/0000-0002-0534-3198; Bonnet, Dominique/0000-0002-8252-9199; Lagane, Bernard/0000-0002-3459-7867; Balabanian, Karl/0000-0002-0534-3198; Parmentier, Marc/0000-0001-8081-4685; haiech, jacques/0000-0003-2908-8053				Akihisa T, 2006, J NAT PROD, V69, P38, DOI 10.1021/np058080d; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Anuradha V, 2006, BIOORGAN MED CHEM, V14, P6820, DOI 10.1016/j.bmc.2006.06.048; Arakaki R, 1999, J VIROL, V73, P1719, DOI 10.1128/JVI.73.2.1719-1723.1999; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chen S, 2001, CELL PROLIFERAT, V34, P293, DOI 10.1046/j.0960-7722.2001.00213.x; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; De Leon EJ, 2003, INFLAMM RES, V52, P246, DOI 10.1007/s00011-003-1164-x; De Leon EJ, 2003, J PHARM PHARMACOL, V55, P1313, DOI 10.1211/0022357021747; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Delayre-Orthez C, 2005, INT ARCH ALLERGY IMM, V138, P298, DOI 10.1159/000088867; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; GranelliPiperno A, 1996, J EXP MED, V184, P2433, DOI 10.1084/jem.184.6.2433; Herencia F, 1999, FEBS LETT, V453, P129, DOI 10.1016/S0014-5793(99)00707-3; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Ilien B, 2003, J NEUROCHEM, V85, P768, DOI 10.1046/j.1471-4159.2003.01717.x; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kitamura K, 1998, ANTIVIR RES, V37, P131, DOI 10.1016/S0166-3542(97)00069-7; Krier M, 2006, J CHEM INF MODEL, V46, P512, DOI 10.1021/ci050352v; Kuhn I, 2006, BIOCHEMISTRY-US, V45, P11867, DOI 10.1021/bi060930g; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li BQ, 2000, IMMUNOPHARMACOLOGY, V49, P295, DOI 10.1016/S0162-3109(00)00244-7; LI BQ, 1993, CELL MOL BIOL RES, V39, P119; Li RS, 1995, J MED CHEM, V38, P5031, DOI 10.1021/jm00026a010; Lin YM, 2002, BIOORGAN MED CHEM, V10, P2795, DOI 10.1016/S0968-0896(02)00094-9; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagase H, 2001, J ALLERGY CLIN IMMUN, V108, P563, DOI 10.1067/mai.2001.118292; Ohnishi Y, 2000, J INTERF CYTOK RES, V20, P691, DOI 10.1089/10799900050116390; Palanche T, 2001, J BIOL CHEM, V276, P34853, DOI 10.1074/jbc.M104363200; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Schols D, 1997, ANTIVIR RES, V35, P147, DOI 10.1016/S0166-3542(97)00025-9; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tamamura H, 2000, BIOORG MED CHEM LETT, V10, P2633, DOI 10.1016/S0960-894X(00)00535-7; Tamamura H, 1998, BIOORGAN MED CHEM, V6, P1033, DOI 10.1016/S0968-0896(98)00061-3; Taylor R, 2002, ACTA CRYSTALLOGR D, V58, P879, DOI 10.1107/S090744490200358X; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Vollmer JY, 1999, J BIOL CHEM, V274, P37915, DOI 10.1074/jbc.274.53.37915; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	58	77	87	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23189	23199		10.1074/jbc.M803947200	http://dx.doi.org/10.1074/jbc.M803947200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556651	Green Published, hybrid			2022-12-27	WOS:000258455400032
J	Liu, P; Li, K; Garofalo, RP; Brasier, AR				Liu, Ping; Li, Kui; Garofalo, Roberto P.; Brasier, Allan R.			Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I center dot NF-kappa B-inducing kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; EPITHELIAL-CELLS; RIG-I; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTOR; RNA VIRUSES; ACTIVATION; PROTEIN; P100; EXPRESSION	Respiratory syncytial virus (RSV) is a primary cause of severe lower respiratory tract infection in children world wide. RSV infects airway epithelial cells, where it activates inflammatory genes via the NF-kappa B pathway. NF-kappa B is controlled by two pathways, a canonical pathway that releases sequestered RelA complexes from the I kappa B alpha inhibitor, and a second, the noncanonical pathway, that releases RelB from the 100-kDa NF-kappa B2 complex. Recently we found that the retinoic acid-inducible gene I (RIG-I) is a major intracellular RSV sensor upstream of the canonical pathway. In this study, we surprisingly found that RIG-I silencing also inhibited p100 processing to 52-kDa NF-kappa B2 ("p52"), suggesting that RIG-I was functionally upstream of the noncanonical regulatory kinase complex composed of (NIKIKK)-I-.alpha subunits. Co-immunoprecipitation experiments not only demonstrated that NIK associated with RIG-I and its downstream adaptor, mitochondrial antiviral signaling (MAVS), but also showed the association between IKK alpha and MAVS. To further understand the role of the (NIKIKK)-I-.alpha pathway, we compared RSV-induced NF-kappa B activation using wild type, Ikk gamma(-/-), Nik(-/-), and Ikk alpha(-/-)-deficient MEF cells. Interestingly, we found that in canonical pathway-defective Ikk gamma(-/-) cells, RSV induced RelA by liberation from p100 complexes. RSV was still able to activate IP10, Rantes, and Gro beta gene expression in Ikk gamma(-/-) cells, and this induction was inhibited by small interfering RNA-mediated RelA knockdown but not RelB silencing. These data suggest that part of the RelA activation in response to RSV infection was induced by a "cross-talk" pathway involving the noncanonical (NIKIKK)-I-.alpha complex downstream of RIG-I(.)MAVS. This pathway may be a potential target for RSV treatment.	[Liu, Ping; Brasier, Allan R.] Univ Texas Galveston, Dept Med, Med Branch, Galveston, TX 77555 USA; [Liu, Ping; Brasier, Allan R.] Univ Texas Galveston, Dept Biochem & Mol Biol, Med Branch, Galveston, TX 77555 USA; [Li, Kui; Garofalo, Roberto P.] Univ Texas Galveston, Dept Microbiol & Immunol, Med Branch, Galveston, TX 77555 USA; [Garofalo, Roberto P.] Univ Texas Galveston, Dept Pediat, Med Branch, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Galveston, Sealy Ctr Mol Med, Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brasier, AR (corresponding author), Univ Texas Galveston, Dept Med, Med Branch, MRB 8-128,301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Garofalo, Roberto P./ABL-2322-2022; Garofalo, Roberto P./AAF-7385-2022	Brasier, Allan/0000-0002-5012-4090	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NHLBI NIH HHS [BAA-HL-02-04] Funding Source: Medline; NIAID NIH HHS [AI062885] Funding Source: Medline; NIEHS NIH HHS [P30 ES06676] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; GAROUFALIS E, 1994, J VIROL, V68, P4707, DOI 10.1128/JVI.68.8.4707-4715.1994; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Haeberle HA, 2004, J VIROL, V78, P2232, DOI 10.1128/JVI.78.5.2232-2241.2004; Hu WH, 2004, J BIOL CHEM, V279, P35975, DOI 10.1074/jbc.M405699200; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; KANNO T, 1994, P NATL ACAD SCI USA, V91, P12634, DOI 10.1073/pnas.91.26.12634; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim YS, 2005, MOL CELL BIOL, V25, P2130, DOI 10.1128/MCB.25.6.2130-2137.2005; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Liu TS, 2004, J BIOL CHEM, V279, P2461, DOI 10.1074/jbc.M307251200; Luftig MA, 2001, J BIOL CHEM, V276, P14602, DOI 10.1074/jbc.C100103200; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; NAUMANN M, 1993, ONCOGENE, V8, P2275; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Paramore LC, 2004, PHARMACOECONOMICS, V22, P275, DOI 10.2165/00019053-200422050-00001; SCHEINMAN RI, 1993, MOL CELL BIOL, V13, P6089, DOI 10.1128/MCB.13.10.6089; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2000, J BIOL CHEM, V275, P21081, DOI 10.1074/jbc.M002552200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	44	54	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23169	23178		10.1074/jbc.M802729200	http://dx.doi.org/10.1074/jbc.M802729200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550535	hybrid, Green Published			2022-12-27	WOS:000258455400030
J	Ranuncolo, SM; Wang, L; Polo, JM; Dell'Oso, T; Dierov, J; Gaymes, TJ; Rassool, F; Carroll, M; Melnick, A				Ranuncolo, Stella Maris; Wang, Ling; Polo, Jose M.; Dell'Oso, Tania; Dierov, Jamil; Gaymes, Terry J.; Rassool, Feyruz; Carroll, Martin; Melnick, Ari			BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER B-CELLS; LYMPHOMA-CELLS; BCL6; EXPRESSION; DIFFERENTIATION; ACTIVATION; ATR; APOPTOSIS; TUMORIGENESIS; PATHOGENESIS	The BCL6 oncogenic transcriptional repressor is required for development of germinal center centroblasts, which undergo simultaneous genetic recombination and massive clonal expansion. Although BCL6 is required for survival of centroblasts, its expression in earlier B-cells is toxic. Understanding these opposing effects could provide critical insight into normal B-cell biology and lymphomagenesis. We examined the transcriptional and biological effects of BCL6 in various primary cells. BCL6 repression of ATR was previously shown to play a critical role in the centroblast phenotype. Likewise, we found that BCL6 could impose an ATR-dependent phenotype of attenuated DNA damage sensing and repair in primary fibroblasts and B-cells. BCL6 induced true genomic instability because DNA repair was delayed and was qualitatively impaired, which could be critical for BCL6-induced lymphomagenesis. Although BCL6 can directly repress TP53 in centroblasts, BCL6 induced TP53 expression in primary fibroblasts and B-cells, and these cells underwent p53-dependent growth arrest and senescence in the presence of physiological levels of BCL6. This differential ability to trigger a functional p53 response explains at least in part the different biological response to BCL6 expression in centroblasts versus other cells. The data suggest that targeted re-activation of TP53 could be of therapeutic value in centroblast-derived lymphomas.	[Ranuncolo, Stella Maris; Wang, Ling; Polo, Jose M.; Dell'Oso, Tania; Melnick, Ari] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Dierov, Jamil; Carroll, Martin] Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Rassool, Feyruz] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Gaymes, Terry J.] Kings Coll London, Dept Haematol Med, Leukaem Sci Labs, Rayne Inst, London SE5 9NU, England	Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; University System of Maryland; University of Maryland Baltimore; University of London; King's College London	Melnick, A (corresponding author), Weill Cornell Sch Med, Div Hematol & Med Oncol, 1300 York Ave, New York, NY 10065 USA.	amm2014@med.cornell.edu	Melnick, Ari/AAA-5763-2020	Polo, Jose M/0000-0002-2531-778X; Ranuncolo, Stella/0000-0001-7775-9048	NCI NIH HHS [R01 CA104348, R01 CA100885] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100885, R01CA104348] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Albagli-Curiel O, 2003, ONCOGENE, V22, P507, DOI 10.1038/sj.onc.1206152; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Baron BW, 2004, P NATL ACAD SCI USA, V101, P14198, DOI 10.1073/pnas.0406138101; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boggs K, 2006, ONCOGENE, V25, P555, DOI 10.1038/sj.onc.1209076; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gil VS, 2007, BLOOD, V110, p118A; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kumagai T, 1999, ONCOGENE, V18, P467, DOI 10.1038/sj.onc.1202306; Kuo TC, 2007, J EXP MED, V204, P819, DOI 10.1084/jem.20062104; Kusam S, 2004, ONCOGENE, V23, P839, DOI 10.1038/sj.onc.1207065; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Oh SM, 2004, ONCOGENE, V23, P8282, DOI 10.1038/sj.onc.1208021; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Shechter D, 2005, CELL CYCLE, V4, P235; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334; Ye BH, 2000, CANCER INVEST, V18, P356, DOI 10.3109/07357900009012179; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8	35	30	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22565	22572		10.1074/jbc.M803490200	http://dx.doi.org/10.1074/jbc.M803490200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18524763	hybrid, Green Published			2022-12-27	WOS:000258321000025
J	Udagawa, T; Nemoto, N; Wilkinson, CRM; Narashimhan, J; Jiang, L; Watt, S; Zook, A; Jones, N; Wek, RC; Bahler, J; Asano, K				Udagawa, Tsuyoshi; Nemoto, Naoki; Wilkinson, Caroline R. M.; Narashimhan, Jana; Jiang, Li; Watt, Stephen; Zook, Aaron; Jones, Nic; Wek, Ronald C.; Bahler, Jurg; Asano, Katsura			Int6/eIF3e promotes general translation and Atf1 abundance to modulate Sty1 MAPK-dependent stress response in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTIONAL RESPONSE; 2-CYS PEROXIREDOXIN; PROTEIN-KINASE; EIF3; INTEGRATION; ACTIVATION; RESISTANCE; EXPRESSION; INT-6	int-6 is one of the frequent integration sites for mouse mammary tumor viruses. Although its product is the e-subunit of translation initiation factor eIF3, other evidence indicates that it interacts with proteasomes or other proteins to regulate protein stability. Here we report that the fission yeast int6(+) is required for overcoming stress imposed by histidine starvation, using the drug 3-aminotriazole (3AT). Microarray and complementary Northern studies using wild-type, int6 Delta or gcn2 Delta mutants indicate that 3AT-treated wild-type yeast induces core environmental stress response (CESR) genes in addition to typical general amino acid control (GAAC) genes whose transcription depends on the eIF2 kinase, Gcn2. In agreement with this, Sty1 MAPK and its target transcription factor Atf1, which signal the CESR, are required for overcoming 3AT-induced starvation. We find that Int6 is required for maintaining the basal level of Atf1 and for rapid transcriptional activation of the CESR on 3AT-insult. Pulse labeling experiments indicate that int6 Delta significantly slows down de novo protein synthesis. Moreover, Atf1 protein half-life was reduced in int6 Delta cells. These effects would account for the compromised Atf1 activity on 3AT-induced stress. Thus, the robust protein synthesis promoted by intact eIF3 appears to be a part of the requisites for sound Sty1 MAPK-dependent signaling governed by the activity of the Atf1 transcription factor.	[Udagawa, Tsuyoshi; Nemoto, Naoki; Zook, Aaron; Asano, Katsura] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA; [Wilkinson, Caroline R. M.; Jones, Nic] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Cell Regulat Lab, Manchester M20 4BX, Lancs, England; [Narashimhan, Jana; Jiang, Li; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Watt, Stephen; Bahler, Jurg] Wellcome Trust Sanger Inst, Canc Res UK Fiss Yeast Funct Genom Grp, Cambridge CB10 1HH, England	Kansas State University; Paterson Institute for Cancer Research; University of Manchester; Indiana University System; Indiana University-Purdue University Indianapolis; Wellcome Trust Sanger Institute	Asano, K (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Ackert Hall, Manhattan, KS 66506 USA.	kasano@ksu.edu	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532	Cancer Research UK [12485] Funding Source: researchfish; Cancer Research UK [A6517, C9546/A6517] Funding Source: Medline; NCRR NIH HHS [P20 RR016475] Funding Source: Medline; NIGMS NIH HHS [GM49164, GM67481] Funding Source: Medline; Wellcome Trust [077118] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bhoumik A, 2004, P NATL ACAD SCI USA, V101, P4222, DOI 10.1073/pnas.0400195101; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Buchsbaum S, 2007, ONCOGENE, V26, P5132, DOI 10.1038/sj.onc.1210314; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; Crane R, 2000, MOL BIOL CELL, V11, P3993, DOI 10.1091/mbc.11.11.3993; Degols G, 1996, MOL CELL BIOL, V16, P2870; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Durand-Dubief M, 2007, EMBO J, V26, P2477, DOI 10.1038/sj.emboj.7601690; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harrison C, 2005, EMBO J, V24, P599, DOI 10.1038/sj.emboj.7600536; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huguier S, 1998, MOL CELL BIOL, V18, P7020, DOI 10.1128/MCB.18.12.7020; Humphrey T, 1998, GENETICS, V148, P1731; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; KEENEY JB, 1994, GENETICS, V136, P849; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Penkett CJ, 2006, NUCLEIC ACIDS RES, V34, pW330, DOI 10.1093/nar/gkl311; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Ueda M, 2003, FEMS MICROBIOL LETT, V219, P93, DOI 10.1016/S0378-1097(02)01201-6; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1998, GENE DEV, V12, P1391, DOI 10.1101/gad.12.10.1391; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	48	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22063	22075		10.1074/jbc.M710017200	http://dx.doi.org/10.1074/jbc.M710017200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18502752	Green Published, hybrid			2022-12-27	WOS:000258114700025
J	Cloutier, P; Toutant, J; Shkreta, L; Goekjian, S; Revil, TE; Chabot, B				Cloutier, Philippe; Toutant, Johanne; Shkreta, Lulzim; Goekjian, Serge; Revil, Timothee E.; Chabot, Benoit			Antagonistic effects of the SRp30c protein and cryptic 5 ' splice sites on the alternative splicing of the apoptotic regulator Bcl-x	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MOTOR-NEURON SMN; EXON-7 INCLUSION; HNRNP-G; SELECTION; EXPRESSION; IDENTIFICATION; ENHANCERS; MECHANISM; CERAMIDE	Alternative 5' splice site selection allows Bcl-x to produce two isoforms with opposite effects on apoptosis. The pro-apoptotic Bcl-x(S) variant is up-regulated by ceramide and down-regulated by protein kinase C through specific cis-acting exonic elements, one of which is bound by SAP155. Splicing to the Bcl-xS 5' splice site is also enforced by heterogeneous nuclear ribonucleoprotein (hnRNP) F/H proteins and by Sam68 in cooperation with hnRNP A1. Here, we have characterized exon elements that influence splicing to the 5' splice site of the anti-apoptotic Bcl-x(L) isoform. Within a 86-nucleotide region (B3) located immediately upstream of the Bcl-x(L) donor site we have identified two elements (ML2 and AM2) that stimulate splicing to the Bcl-x(L) 5' splice site. SRp30c binds to these elements and can shift splicing to the 5' splice site of Bcl-xL in an ML2/AM2-dependent manner in vitro and in vivo. The B3 region also contains an element that represses the use of Bcl-x(L). This element is bound by U1 small nuclear ribonucleoprotein and contains two 5' splice sites that can be used when the Bcl-x(L) 5' splice site is mutated or the ML2/AM2 elements are deleted. Conversely, mutating the cryptic 5' splice sites stimulates splicing to the Bcl-x(L) site. Thus, SRp30c stimulates splicing to the downstream 5' splice site of Bcl-x(L), thereby attenuating the repressive effect of upstream U1 snRNP binding sites.	[Cloutier, Philippe; Toutant, Johanne; Shkreta, Lulzim; Revil, Timothee E.; Chabot, Benoit] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada; [Goekjian, Serge] Bishops Univ, Dept Biochem, Lennoxville, PQ J1M 1Z7, Canada	University of Sherbrooke; Bishops University	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada.	Benoit.Chabot@USherbrooke.ca		Chabot, Benoit/0000-0003-0994-0042				Amundson SA, 2000, CANCER RES, V60, P6101; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; CHABOT B, 1992, NUCLEIC ACIDS RES, V20, P5197, DOI 10.1093/nar/20.19.5197; CHABOT B, 1994, RNA PROCESSING PRACT, P1; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; CUNNINGHAM SA, 1991, J MOL BIOL, V217, P265, DOI 10.1016/0022-2836(91)90541-D; Decaudin D, 1997, CANCER RES, V57, P62; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gendron D, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-5; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Krajewska M, 1996, CANCER RES, V56, P2422; Krajewska M, 1996, AM J PATHOL, V148, P1567; Li CY, 2004, CELL RES, V14, P473, DOI 10.1038/sj.cr.7290250; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Nasim FUH, 2002, RNA, V8, P1078, DOI 10.1017/S1355838202024056; Nasim MT, 2003, HUM MOL GENET, V12, P1337, DOI 10.1093/hmg/ddg136; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Park E, 2006, J BIOL CHEM, V281, P401, DOI 10.1074/jbc.M505814200; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Reeve JG, 1996, BRIT J CANCER, V73, P1193, DOI 10.1038/bjc.1996.230; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; Simard MJ, 2002, MOL CELL BIOL, V22, P4001, DOI 10.1128/MCB.22.12.4001-4010.2002; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Taylor JK, 1999, ONCOGENE, V18, P4495, DOI 10.1038/sj.onc.1202836; Tu YP, 1998, CANCER RES, V58, P256; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhuo DG, 2007, P NATL ACAD SCI USA, V104, P882, DOI 10.1073/pnas.0604777104	59	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21315	21324		10.1074/jbc.M800353200	http://dx.doi.org/10.1074/jbc.M800353200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18534987	hybrid			2022-12-27	WOS:000257898800003
J	Lopez-Contreras, AJ; Ramos-Molina, B; Cremades, A; Penafiel, R				Lopez-Contreras, Andres J.; Ramos-Molina, Bruno; Cremades, Asuncion; Penafiel, Rafael			Antizyme inhibitor 2 (AZIN2/ODCp) stimulates polyamine uptake in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; ARGININE DECARBOXYLASE; FEEDBACK REPRESSION; HOMOLOGOUS PROTEIN; GENE-EXPRESSION; TISSUE-CULTURE; INHIBITOR; TRANSPORT; GROWTH; CANCER	One of the processes that regulate intracellular levels of polyamines in mammalian cells is polyamine uptake. We have measured polyamine uptake in COS7 cells for putrescine, spermidine, and spermine, obtaining K-m values of 4.5, 1.0, and 0.8 mu M, respectively. Treatment of nonconfluent cells with cycloheximide stimulated polyamine uptake and prevented the inhibitory effect found in cells preloaded with polyamines, suggesting the existence of a feedback repression mechanism mediated by antizymes. Transient transfected cells with mutated antizyme forms of AZ1, AZ2, and AZ3, which do not require frameshifting, showed a total blockade of polyamine uptake. Transfection of COS7 cells with mouse or human AZIN2, a novel member of the antizyme inhibitor family, recently characterized by our group, markedly stimulated polyamine uptake and counteracted the action of any of the three antizymes in co-transfected cells. The stimulatory effect of AZIN2 on polyamine uptake was abrogated when the putative antizyme binding sequence, formed by residues 117-140 in AZIN2, was deleted. Real time reverse transcriptionPCR analysis of antizyme inhibitor transcripts revealed that in brain and testes AZIN2 is more expressed than AZIN1, especially in the testes where the relative expression was about 25-fold higher. Collectively, our results clearly indicate that AZIN2 affects polyamine homeostasis not only by increasing ornithine decarboxylase activity but also by stimulating polyamine uptake, through negating the inhibitory effect of the antizymes. This finding may have physiological relevance, mostly in testes where AZ3 and AZIN2 are mainly expressed.	[Lopez-Contreras, Andres J.; Ramos-Molina, Bruno; Penafiel, Rafael] Univ Murcia, Fac Med, Dept Biochem & Mol Biol B & Immunol, E-30100 Murcia, Spain; [Cremades, Asuncion] Univ Murcia, Fac Med, Dept Pharmacol, E-30100 Murcia, Spain	University of Murcia; University of Murcia	Penafiel, R (corresponding author), Univ Murcia, Fac Med, Dept Biochem & Mol Biol B & Immunol, Campus Espinardo, E-30100 Murcia, Spain.	rapegar@um.es	Ramos-Molina, Bruno/K-8303-2019; Lopez-Contreras, Andres J/AAA-1110-2020; Molina, Bruno Ramos/A-4574-2017; Penafiel, Rafael/H-2660-2015; Ramos-Molina, Bruno/L-7876-2015	Ramos-Molina, Bruno/0000-0001-6804-5449; Molina, Bruno Ramos/0000-0001-6804-5449; Penafiel, Rafael/0000-0002-5816-1056; Lopez-Contreras, Andres Joaquin/0000-0002-5517-7327				AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Choi KS, 2005, BIOCHEM BIOPH RES CO, V328, P206, DOI 10.1016/j.bbrc.2004.11.172; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; HAKOVIRTA H, 1993, MOL ENDOCRINOL, V7, P1430, DOI 10.1210/me.7.11.1430; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Johnson TD, 1996, TRENDS PHARMACOL SCI, V17, P22, DOI 10.1016/0165-6147(96)81566-5; Jung MH, 2000, GENOMICS, V69, P281, DOI 10.1006/geno.2000.6338; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; KITANI T, 1989, BIOCHIM BIOPHYS ACTA, V991, P44, DOI 10.1016/0304-4165(89)90026-3; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Lopez-Contreras AJ, 2006, J BIOL CHEM, V281, P30896, DOI 10.1074/jbc.M602840200; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mangold U, 2005, BIOCHEM J, V385, P21, DOI 10.1042/BJ20040547; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MITCHELL JLA, 1992, BIOCHEM BIOPH RES CO, V186, P81, DOI 10.1016/S0006-291X(05)80778-8; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Mitchell JLA, 2004, BIOCHEM J, V384, P271, DOI 10.1042/BJ20040972; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schaner ME, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-26; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; Snapir Z, 2008, BIOCHEM J, V410, P613, DOI 10.1042/BJ20071423; Soulet D, 2002, BIOCHEM J, V367, P347, DOI 10.1042/BJ20020764; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; van Duin M, 2005, GENE CHROMOSOME CANC, V44, P438, DOI 10.1002/gcc.20259; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Zhu C, 1999, J BIOL CHEM, V274, P26425, DOI 10.1074/jbc.274.37.26425; Zhu MY, 2004, BBA-GEN SUBJECTS, V1670, P156, DOI 10.1016/j.bbagen.2003.11.006	49	31	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20761	20769		10.1074/jbc.M801024200	http://dx.doi.org/10.1074/jbc.M801024200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508777	Green Published, hybrid			2022-12-27	WOS:000257746100017
J	Telci, D; Wang, Z; Li, X; Verderio, EAM; Humphries, MJ; Baccarini, M; Basaga, H; Griffin, M				Telci, Dilek; Wang, Zhuo; Li, Xiaoling; Verderio, Elisabetta A. M.; Humphries, Martin J.; Baccarini, Manuela; Basaga, Huveyda; Griffin, Martin			Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta(1) integrin co-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 FIBROBLASTS; HEPARIN-BINDING SITE; KINASE-C-ALPHA; EXTRACELLULAR-MATRIX; PKC-ALPHA; DOMAIN; EXPRESSION; MIGRATION; MOTILITY; ENZYME	Human ChlR1 (hChlR1), a member of the DEAD/DEAH subfamily of helicases, was shown to interact with components of the cohesin complex and play a role in sister chromatid cohesion. In order to study the biochemical and biological properties of hChlR1, we purified the protein from 293 cells and demonstrated that hChlR1 possesses DNA-dependent ATPase and helicase activities. This helicase translocates on single-stranded DNA in the 5' to 3' direction in the presence of ATP and, to a lesser extent, dATP. Its unwinding activity requires a 5'-single-stranded region for helicase loading, since flush-ended duplex structures do not support unwinding. The helicase activity of hChlR1 is capable of displacing duplex regions up to 100 bp, which can be extended to 500 bp by RPA or the cohesion establishment factor, the Ctf18-RFC (replication factor C) complex. We show that hChlR1 interacts with the hCtf18-RFC complex, human proliferating cell nuclear antigen, and hFen1. The interactions between Fen1 and hChlR1 stimulate the flap endonuclease activity of Fen1. Selective depletion of either hChlR1 or Fen1 by targeted small interfering RNA treatment results in the precocious separation of sister chromatids. These findings are consistent with a role of hChlR1 in the establishment of sister chromatid cohesion and suggest that its action may contribute to lagging strand processing events important in cohesion.	[Telci, Dilek; Wang, Zhuo; Li, Xiaoling; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Telci, Dilek; Basaga, Huveyda] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Verderio, Elisabetta A. M.] Nottingham Trent Univ, Sch Biomed & Nat Sci, Nottingham NG11 8NS, England; [Humphries, Martin J.] Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; [Baccarini, Manuela] Max F Perutz Labs, Dept Microbiol & Immunol, A-1030 Vienna, Austria	Aston University; Sabanci University; Nottingham Trent University; University of Manchester; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	M.Griffin@aston.ac.uk	Verderio, Elisabetta/H-2789-2016; Telci, Dilek/N-5053-2019; Baccarini, Manuela/B-6481-2014; Telci, Dilek/B-5880-2017	Verderio, Elisabetta/0000-0001-9153-8997; Telci, Dilek/0000-0002-2793-6533; Baccarini, Manuela/0000-0002-3033-391X; Telci, Dilek/0000-0002-2793-6533; Griffin, Martin/0000-0003-3824-306X; WANG, ZHUO/0000-0002-2212-8318; Humphries, Martin/0000-0002-4331-6967				AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Couchman JR, 2001, INT REV CYTOL, V207, P113; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fok JY, 2006, MOL CANCER THER, V5, P1493, DOI 10.1158/1535-7163.MCT-06-0083; FREUND KF, 1994, BIOCHEMISTRY-US, V33, P10109, DOI 10.1021/bi00199a039; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; HARSFALVI J, 1987, BIOCHIM BIOPHYS ACTA, V923, P42, DOI 10.1016/0304-4165(87)90123-1; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Johnson TS, 1999, J AM SOC NEPHROL, V10, P2146; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; McFall AJ, 1997, J BIOL CHEM, V272, P12901, DOI 10.1074/jbc.272.20.12901; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mirza A, 1997, AM J PHYSIOL-GASTR L, V272, pG281, DOI 10.1152/ajpgi.1997.272.2.G281; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Mostafavi-Pour Z, 2001, MATRIX BIOL, V20, P63, DOI 10.1016/S0945-053X(00)00131-1; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Piacentini M, 2005, PROG EXP TUMOR RES, V38, P58; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Thomazy VA, 1999, CELL DEATH DIFFER, V6, P146, DOI 10.1038/sj.cdd.4400464; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607	50	97	100	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20937	20947		10.1074/jbc.M801763200	http://dx.doi.org/10.1074/jbc.M801763200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499669	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000257746100036
J	Wang, IC; Chen, YJ; Hughes, DE; Ackerson, T; Major, ML; Kalinichenko, VV; Costa, RH; Raychaudhuri, P; Tyner, AL; Lau, LF				Wang, I-Ching; Chen, Yi-Ju; Hughes, Douglas E.; Ackerson, Timothy; Major, Michael L.; Kalinichenko, Vladimir V.; Costa, Robert H.; Raychaudhuri, Pradip; Tyner, Angela L.; Lau, Lester F.			FoxM1 regulates transcription of JNK1 to promote the G(1)/S transition and tumor cell invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; CYCLIN D1 EXPRESSION; TERMINAL KINASE JNK; C-JUN; PROTEIN-KINASE; MATRIX METALLOPROTEINASES; P53-DEPENDENT SENESCENCE; LIVER-REGENERATION; GLIOMA-CELLS; A PROMOTER	The Forkhead box M1 (FoxM1) protein is a proliferation-specific transcription factor that plays a key role in controlling both the G(1)/S and G(2)/M transitions through the cell cycle and is essential for the development of various cancers. We show here that FoxM1 directly activates the transcription of the c-Jun N-terminal kinase (JNK1) gene in U2OS osteosarcoma cells. Expression of JNK1, which regulates the expression of genes important for the G(1)/S transition, rescues the G(1)/S but not the G(2)/M cell cycle block in FoxM1-deficient cells. Knockdown of either FoxM1 or JNK1 inhibits tumor cell migration, invasion, and anchorage-independent growth. However, expression of JNK1 in FoxM1-depleted cells does not rescue these defects, indicating that JNK1 is a necessary but insufficient downstream mediator of FoxM1 in these processes. Consistent with this interpretation, FoxM1 regulates the expression of the matrix metalloproteinases MMP-2 and MMP-9, which play a role in tumor cell invasion, through JNK1-independent and -dependent mechanisms in U2OS cells, respectively. Taken together, these findings identify JNK1 as a critical transcriptional target of FoxM1 that contributes to FoxM1-regulated cell cycle progression, tumor cell migration, invasiveness, and anchorage-independent growth.	[Wang, I-Ching; Chen, Yi-Ju; Hughes, Douglas E.; Ackerson, Timothy; Major, Michael L.; Costa, Robert H.; Raychaudhuri, Pradip; Tyner, Angela L.; Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Kalinichenko, Vladimir V.] Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cincinnati Children's Hospital Medical Center	Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet MC 669, 900 S Ashland Ave, Chicago, IL 60607 USA.	LFLau@uic.edu		Wang, I-Ching/0000-0003-4398-2975; Tyner, Angela/0000-0001-7448-8625; Lau, Lester/0000-0002-4364-2914	NATIONAL CANCER INSTITUTE [R01CA124488, R01CA100035, R01CA046565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044525, R01DK056283, R01DK044525, R01DK068503, R01DK054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021842] Funding Source: NIH RePORTER; NCI NIH HHS [CA 124488, CA 46565, CA 100035] Funding Source: Medline; NHLBI NIH HHS [HL 081390] Funding Source: Medline; NIA NIH HHS [AG 21842, R01 AG021842-05, R01 AG021842] Funding Source: Medline; NIDDK NIH HHS [R01 DK056283-04, DK 68503, R01 DK044525, R01 DK054687-09, R01 DK044525-14, R01 DK054687, DK 54687, R01 DK056283, DK 44525] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Beier F, 2000, J BIOL CHEM, V275, P12948, DOI 10.1074/jbc.275.17.12948; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Dai Y, 2005, BLOOD, V105, P1706, DOI 10.1182/blood-2004-07-2767; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Hall JF, 2000, P NATL ACAD SCI USA, V97, P14022, DOI 10.1073/pnas.97.26.14022; Hennigan RF, 2001, MOL BIOL CELL, V12, P2352, DOI 10.1091/mbc.12.8.2352; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kaestner KH, 2000, GENE DEV, V14, P142; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Katabami M, 2005, J BIOL CHEM, V280, P16728, DOI 10.1074/jbc.M413892200; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Keum YS, 2003, PHARM RES-DORDR, V20, P1351, DOI 10.1023/A:1025737622815; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Kuntzen C, 2005, CANCER RES, V65, P6780, DOI 10.1158/0008-5472.CAN-04-2618; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Leaner VD, 2003, ONCOGENE, V22, P5619, DOI 10.1038/sj.onc.1206644; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; MINDEN A, 1997, BIOCHIM BIOPHYS ACTA, V10, P205; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Robinson WP, 2006, AM J PHYSIOL-HEART C, V290, pH1988, DOI 10.1152/ajpheart.00344.2005; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Teh MT, 2002, CANCER RES, V62, P4773; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; WANT IC, 2008, ONCOGENE; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xie ZL, 2004, J BIOL CHEM, V279, P39513, DOI 10.1074/jbc.M405844200; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	63	106	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20770	20778		10.1074/jbc.M709892200	http://dx.doi.org/10.1074/jbc.M709892200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524773	hybrid, Green Published			2022-12-27	WOS:000257746100018
J	Moulton, VR; Kyttaris, VC; Juang, YT; Chowdhury, B; Tsokos, GC				Moulton, Vaishali R.; Kyttaris, Vasileios C.; Juang, Yuang-Taung; Chowdhury, Bhabadeb; Tsokos, George C.			The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; SPLICED 3'-UNTRANSLATED REGION; MESSENGER-RNA; TCR-ZETA; DECREASED EXPRESSION; BINDING-PROTEINS; TCR/CD3 COMPLEX; IL-2 PRODUCTION; DOWN-REGULATION	T cell dysfunction is crucial to the pathogenesis of systemic lupus erythematosus (SLE); however, the molecular mechanisms involved in the deficient expression of the T cell receptor-associated CD3 zeta chain in SLE are not clear. SLE T cells express abnormally increased levels of an alternatively spliced isoform of CD3 zeta that lacks a 562-bp region in its 3'-untranslated region (UTR). We showed previously that two adenosine/uridine-rich elements (ARE) in this splice-deleted region of CD3 zeta transcript are critical for the mRNA stability and protein expression of CD3 zeta. In this study we show for the first time that the mRNA-stabilizing protein HuR binds to these two ARE bearing regions of CD3 zeta 3'-UTR. Knockdown of HuR resulted in decreased expression of the CD3 zeta chain, whereas overexpression led to the increase of CD3 zeta chain levels. Additionally, overexpression of HuR in human T cells resulted in increased mRNA stability of CD3 zeta. Our results identify the 3'-UTR of CD3 zeta as a novel target for the mRNA-stabilizing protein HuR. Thus, the absence of two critical AREs in the alternatively spliced CD3 zeta 3'-UTR found in SLE T cells may result in decreased HuR binding, representing a possible molecular mechanism contributing to the reduced stability and expression of CD3 zeta zeta in SLE.	[Moulton, Vaishali R.; Kyttaris, Vasileios C.; Juang, Yuang-Taung; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Chowdhury, Bhabadeb] NIAID, NIH, Lab Mol Immunol, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tsokos, GC (corresponding author), 3330 Brookline Ave,E-CLS 937, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360	NIAID NIH HHS [R01 AI 42269, R01 AI042269] Funding Source: Medline; NIAMS NIH HHS [K23 AR055672-01A1, K23 AR055672] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055672] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; Chowdhury B, 2005, J BIOL CHEM, V280, P18959, DOI 10.1074/jbc.M501048200; Chowdhury B, 2006, J IMMUNOL, V177, P8248, DOI 10.4049/jimmunol.177.11.8248; Cok SJ, 2004, J BIOL CHEM, V279, P8196, DOI 10.1074/jbc.M308475200; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Juang YT, 2002, J IMMUNOL, V169, P6048, DOI 10.4049/jimmunol.169.10.6048; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kiledjian M, 1997, MOL CELL BIOL, V17, P4870, DOI 10.1128/MCB.17.8.4870; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2005, J IMMUNOL, V175, P3417, DOI 10.4049/jimmunol.175.5.3417; Kyttaris VC, 2005, CURR OPIN RHEUMATOL, V17, P518, DOI 10.1097/01.bor.0000170479.01451.ab; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; Nambiar MP, 2001, J AUTOIMMUN, V16, P133, DOI 10.1006/jaut.2000.0475; Nambiar MP, 2001, ARTHRITIS RHEUM, V44, P1336, DOI 10.1002/1529-0131(200106)44:6<1336::AID-ART226>3.0.CO;2-8; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Tolnay M, 2000, BIOCHEM J, V348, P151, DOI 10.1042/0264-6021:3480151; Tsokos GC, 2003, TRENDS IMMUNOL, V24, P259, DOI 10.1016/S1471-4906(03)00100-5; Tsuzaka K, 2005, J IMMUNOL, V174, P3518, DOI 10.4049/jimmunol.174.6.3518; VASSILOPOULOS D, 1995, J IMMUNOL, V155, P2269; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709	44	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20037	20044		10.1074/jbc.M710434200	http://dx.doi.org/10.1074/jbc.M710434200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18505733	Green Published, hybrid			2022-12-27	WOS:000257565300019
J	Zhang, NY; Tang, ZY; Liu, CW				Zhang, Nan-Yan; Tang, Zhiyong; Liu, Chang-Wei			alpha-synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation - Understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; SOLUBLE AMYLOID OLIGOMERS; INCLUSION-BODY FORMATION; LEWY BODIES; POLYUBIQUITIN CHAINS; LOCUS TRIPLICATION; CELL-DEATH; AGGREGATION; MUTATION; PATHWAY	The impaired ubiquitin- proteasome activity is believed to be one of the leading factors that contribute to Parkinson disease pathogenesis partially by causing alpha-synuclein aggregation. However, the relationship between alpha- synuclein aggregation and the impaired proteasome activity is yet unclear. In this study, we examined the effects of three soluble alpha-synuclein species (monomer, dimer, and protofibrils) on the degradation activity of the 26 S proteasome by reconstitution of proteasomal degradation using highly purified 26 S proteasomes and model substrates. We found that none of the three soluble alpha-synuclein species impaired the three distinct peptidase activities of the 26 S proteasome when using fluorogenic peptides as substrates. In striking contrast, alpha-synuclein protofibrils, but not monomer and dimer, markedly inhibited the ubiquitin-independent proteasomal degradation of unstructured proteins and ubiquitin-dependent degradation of folded proteins when present at 5-fold molar excess to the 26 S proteasome. Together these results indicate that alpha-synuclein protofibrils have a pronounced inhibitory effect on 26 S proteasome-mediated protein degradation. Because alpha-synuclein is a substrate of the proteasome, impaired proteasomal activity could further cause alpha-synuclein accumulation/aggregation, thus creating a vicious cycle and leading to Parkinson disease pathogenesis. Furthermore we found that alpha-synuclein protofibrils bound both the 26 S proteasome and substrates of the 26 S proteasome. Accordingly we propose that the inhibitory effect of alpha-synuclein protofibrils on 26 S proteasomal degradation might result from impairing substrate translocation by binding the proteasome or sequestrating proteasomal substrates by binding the substrates.	[Zhang, Nan-Yan; Liu, Chang-Wei] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Tang, Zhiyong] Natl Ctr Nanosci & Technol, Beijing 10080, Peoples R China	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Liu, CW (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, POB 6511,Mail Stop 8101, Aurora, CO 80045 USA.	Changwei.liu@uchsc.edu	tang, zhiyong/A-8563-2008; li, zhiyuan/HGD-9581-2022	tang, zhiyong/0000-0003-0610-0064; 				Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Fornai F, 2003, J NEUROSCI, V23, P8955; Fujita M, 2007, J BIOL CHEM, V282, P5736, DOI 10.1074/jbc.M606175200; Ghee M, 2000, J NEUROCHEM, V75, P2221, DOI 10.1046/j.1471-4159.2000.0752221.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lin Pei-Yin, 2007, Mol Cancer, V6, P16, DOI 10.1186/1476-4598-6-16; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Roy S, 2007, MOL CANCER THER, V6, P2696, DOI 10.1158/1535-7163.MCT-07-0104; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; TSENG BP, 2007, NEUROBIOL A IN PRESS; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	69	84	87	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20288	20298		10.1074/jbc.M710560200	http://dx.doi.org/10.1074/jbc.M710560200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502751	hybrid			2022-12-27	WOS:000257565300045
J	Belova, L; Brickley, DR; Ky, B; Sharma, SK; Conzen, SD				Belova, Larissa; Brickley, Deanna R.; Ky, Betty; Sharma, Sanjay K.; Conzen, Suzanne D.			Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; RECEPTOR LIGAND-BINDING; PROGESTERONE-RECEPTOR; ANDROGEN RECEPTOR; MUTATIONAL ANALYSIS; CHAPERONE; DEGRADATION; HEAT-SHOCK-PROTEIN-90; INHIBITION; COMPLEX	SGK-1 (serum- and glucocorticoid-regulated kinase-1), a member of the AGC protein kinase family, plays an important role in regulating ion channel expression and contributes to malignant epithelial cell proliferation and survival. SGK-1 activity is regulated on three levels: transcriptional induction following a variety of environmental and intracellular stresses, proteasomal degradation, and phosphorylation. Here we report that phosphoinositide 3-kinase (PI3K)-dependent phosphorylation of SGK-1 requires formation of a complex between SGK-1 and heat-shock protein 90 (Hsp90). Inactivation of Hsp90 by geldanamycin led to decreased SGK-1 phosphorylation independently of increased proteasomal protein degradation, and inhibition of PI3K activity by LY294002 appeared to eliminate SGK-1 phosphorylation at the same residues as those affected by geldanamycin treatment. Interestingly, geldanamycin-targeted phosphorylation sites were not limited to the known conserved PI3K-dependent sites Thr-256 and Ser-422 in SGK-1 but included additional unknown PI3K-dependent residues. Inhibition of Hsp90 also resulted in a complete loss of SGK-1 kinase activity, suggesting that Hsp90 activity is essential for regulating the PI3K/SGK-1 pathway.	[Belova, Larissa; Brickley, Deanna R.; Ky, Betty; Sharma, Sanjay K.; Conzen, Suzanne D.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Conzen, Suzanne D.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Conzen, Suzanne D.] Univ Chicago, Ben May Dept Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Conzen, SD (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 2115, Chicago, IL 60637 USA.	sdconzen@uchicago.edu		Sharma, Sanjeev Kumar/0000-0002-3273-0708	NCI NIH HHS [P30CA014599-32, R01CA089208] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089208, P30CA014599] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		An WG, 2000, CELL GROWTH DIFFER, V11, P355; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Aumais JP, 1997, J BIOL CHEM, V272, P12229, DOI 10.1074/jbc.272.18.12229; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Boehmer C, 2003, CARDIOVASC RES, V57, P1079, DOI 10.1016/S0008-6363(02)00837-4; BOGUSZ A, 2006, THESIS U CHICAGO CHI; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Boudeau J, 2003, BIOCHEM J, V370, P849, DOI 10.1042/BJ20021813; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; CARSONJURICA MA, 1989, J STEROID BIOCHEM, V34, P1, DOI 10.1016/0022-4731(89)90060-5; Chene P, 2002, NAT REV DRUG DISCOV, V1, P665, DOI 10.1038/nrd894; Chiosis G, 2003, MOL CANCER THER, V2, P123; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Haverinen M, 2001, CELL STRESS CHAPERON, V6, P256, DOI 10.1379/1466-1268(2001)006<0256:HSPATN>2.0.CO;2; Hayashi M, 2001, J BIOL CHEM, V276, P8631, DOI 10.1074/jbc.C000838200; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; HOWARD KJ, 1990, J BIOL CHEM, V265, P11928; HURD C, 1991, MOL CELL BIOCHEM, V105, P73; HUTCHISON KA, 1992, J BIOL CHEM, V267, P13952; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; MARIVOET S, 1992, MOL CELL ENDOCRINOL, V88, P165, DOI 10.1016/0303-7207(92)90021-W; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meng X, 1996, J CELL SCI, V109, P1677; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; NEMOTO T, 1992, J STEROID BIOCHEM, V42, P803, DOI 10.1016/0960-0760(92)90088-Z; OHARANEMOTO Y, 1990, J STEROID BIOCHEM, V37, P481, DOI 10.1016/0960-0760(90)90391-W; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; PERDEW GH, 1991, J BIOL CHEM, V266, P6708; Sahoo S, 2005, EUR J CANCER, V41, P2754, DOI 10.1016/j.ejca.2005.07.018; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SCHOWALTER DB, 1991, J BIOL CHEM, V266, P21165; Shiotsu Y, 2000, BLOOD, V96, P2284, DOI 10.1182/blood.V96.6.2284; Skach WR, 2006, CELL, V127, P673, DOI 10.1016/j.cell.2006.11.002; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; SULLIVAN WP, 1993, J BIOL CHEM, V268, P20373; TUOHIMAA P, 1993, P NATL ACAD SCI USA, V90, P5848, DOI 10.1073/pnas.90.12.5848; Vallon V, 2005, CURR OPIN NEPHROL HY, V14, P59, DOI 10.1097/00041552-200501000-00010; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2003, CANCER RES, V63, P7777; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang LP, 2005, CANCER RES, V65, P457; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	72	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18821	18831		10.1074/jbc.M803289200	http://dx.doi.org/10.1074/jbc.M803289200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18456663	hybrid, Green Published			2022-12-27	WOS:000257165600039
J	Kan, QM; Jinno, S; Kobayashi, K; Yamamoto, H; Okayama, H				Kan, Qiuming; Jinno, Shigeki; Kobayashi, Kohei; Yamamoto, Hanako; Okayama, Hiroto			Cdc6 determines utilization of p21(WAF1/CIP1)-dependent damage checkpoint in S phase cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-SYNTHESIS; P53; REPLICATION; INHIBITOR; P27(KIP1); ANCHORAGE; PROTEIN; CDK2	When cells traversing G(1) are irradiated with UV light, two parallel damage checkpoint pathways are activated: Chk1-Cdc25A and p53-p21(WAF1/CIP1), both targeting Cdk2, but the latter inducing a long lasting arrest. In similarly treated S phase-progressing cells, however, only the Cdc25A-dependent checkpoint is active. We have recently found that the p21-dependent checkpoint can be activated and induce a prolonged arrest if S phase cells are damaged with a base-modifying agent, such as methyl methanesulfonate (MMS) and cisplatin. But the mechanistic basis for the differential activation of the p21-dependent checkpoint by different DNA damaging agents is not understood. Here we report that treatment of S phase cells with MMS but not a comparable dose of UV light elicits proteasome-mediated degradation of Cdc6, the assembler of pre-replicative complexes, which allows induced p21 to bind Cdk2, thereby extending inactivation of Cdk2 and S phase arrest. Consistently, enforced expression of Cdc6 largely eliminates the prolonged S phase arrest and Cdk2 inactivation induced with MMS, whereas RNA interference-mediated Cdc6 knockdown not only prolongs such arrest and inactivation but also effectively activates the p21-dependent checkpoint in the UV-irradiated S phase cells.	Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Okayama, H (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	okayama@m.u-tokyo.ac.jp						ADAM SA, 1992, METHOD ENZYMOL, V219, P97; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; EAGLE H, 1955, P SOC EXP BIOL MED, V89, P362; Gottifredi V, 2004, J BIOL CHEM, V279, P5802, DOI 10.1074/jbc.M310373200; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Ji C, 1997, ONCOGENE, V15, P2749, DOI 10.1038/sj.onc.1201441; Jinno S, 2002, ONCOGENE, V21, P1777, DOI 10.1038/sj.onc.1205249; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kan Q, 2007, FEBS LETT, V581, P5879, DOI 10.1016/j.febslet.2007.11.075; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Koff A, 1995, Prog Cell Cycle Res, V1, P141; Komarova EA, 1997, CANCER RES, V57, P5217; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; KUME K, 1992, NEW BIOL, V4, P504; Lei M, 2001, J CELL SCI, V114, P1447; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mattia M, 2007, MOL CELL BIOL, V27, P1309, DOI 10.1128/MCB.01520-06; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; TERADA Y, 1995, NATURE, V376, P358, DOI 10.1038/376358a0; Waga S, 1998, MOL CELL BIOL, V18, P4177, DOI 10.1128/MCB.18.7.4177	30	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					17864	17872		10.1074/jbc.M802055200	http://dx.doi.org/10.1074/jbc.M802055200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18458079	hybrid			2022-12-27	WOS:000256949200014
J	Figueiredo, AC; Wasmeier, C; Tarafder, AK; Ramalho, JS; Baron, RA; Seabra, MC				Figueiredo, Ana C.; Wasmeier, Christina; Tarafder, Abul K.; Ramalho, Jose S.; Baron, Rudi A.; Seabra, Miguel C.			Rab3GEP is the non-redundant guanine nucleotide exchange factor for Rab27a in melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL G-PROTEINS; MELANOSOME TRANSPORT; REGULATED SECRETION; COILED-COIL; GTPASES; FAMILY; SPECIFICITY; EXOCYTOSIS; DOMAIN; GERANYLGERANYLATION	Rab GTPases regulate discrete steps in vesicular transport pathways. Rabs require activation by specific guanine nucleotide exchange factors (GEFs) that stimulate the exchange of GDP for GTP. Rab27a controls motility and regulated exocytosis of secretory granules and related organelles. In melanocytes, Rab27a regulates peripheral transport of mature melanosomes by recruiting melanophilin and myosin Va. Here, we studied the activation of Rab27a in melanocytes. We identify Rab3GEP, previously isolated as a GEF for Rab3a, as the non-redundant Rab27a GEF. Similar to Rab27a-deficient ashen melanocytes, Rab3GEP-depleted cells show both clustering of melanosomes in the perinuclear area and loss of the Rab27a effector Mlph. Consistent with a role as an activator, levels of Rab27a-GTP are decreased in cells lacking Rab3GEP. Recombinant Rab3GEP exhibits guanine nucleotide exchange activity against Rab27a and Rab27b in vitro, in addition to its previously documented activity against Rab3. Our results indicate promiscuity in Rab GEF action and suggest that members of related but functionally distinct Rab subfamilies can be controlled by common activators.	[Figueiredo, Ana C.; Wasmeier, Christina; Tarafder, Abul K.; Baron, Rudi A.; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Ramalho, Jose S.] Univ Coimbra, Ctr Ophthalmol Biomed, Inst Res Light & Image, P-3004548 Coimbra, Portugal	Imperial College London; Universidade de Coimbra	Seabra, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.	m.seabra@imperial.ac.uk	Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019; Ramalho, Jose/M-6415-2015; Figueiredo, Ana/K-1384-2013	Seabra, Miguel C/0000-0002-6404-4892; Ramalho, Jose/0000-0002-1927-164X; Figueiredo, Ana/0000-0001-8386-8216; Tarafder, Abul/0000-0002-0368-6111	Wellcome Trust [075498] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Araki K, 2000, PIGM CELL RES, V13, P332, DOI 10.1034/j.1600-0749.2000.130505.x; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Izumi T, 2003, CELL STRUCT FUNCT, V28, P465, DOI 10.1247/csf.28.465; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Miyoshi J, 2004, TRENDS MOL MED, V10, P476, DOI 10.1016/j.molmed.2004.08.002; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Munro S, 2002, CURR OPIN CELL BIOL, V14, P506, DOI 10.1016/S0955-0674(02)00350-2; Oishi H, 1998, J BIOL CHEM, V273, P34580, DOI 10.1074/jbc.273.51.34580; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Yamaguchi K, 2002, P NATL ACAD SCI USA, V99, P14536, DOI 10.1073/pnas.212511399; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	40	45	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23209	23216		10.1074/jbc.M804134200	http://dx.doi.org/10.1074/jbc.M804134200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18559336	Green Published, hybrid			2022-12-27	WOS:000258455400034
J	Hong, K; Lou, L; Gupta, S; Ribeiro-Neto, F; Altschuler, DL				Hong, Kyoungja; Lou, Liguang; Gupta, Sandhya; Ribeiro-Neto, Fernando; Altschuler, Daniel L.			A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; AKT/PROTEIN-KINASE-B; PLECKSTRIN HOMOLOGY DOMAIN; PP2A CATALYTIC SUBUNIT; CYCLIC-AMP; PHOSPHATIDYLINOSITOL 3-KINASE; CARBOXYL METHYLATION; CELL-PROLIFERATION; CROSS-TALK; MEMBRANE LOCALIZATION	Rap1b has been implicated in the transduction of the cAMP mitogenic signal. It is phosphorylated and activated by cAMP, and its expression in models where cAMP is mitogenic leads to proliferation and tumorigenesis. Akt is a likely downstream effector of cAMP-Rap1 action. cAMP elevation induced a rapid and transient Akt inhibition that required activated and phosphorylated Rap1b. However, the mechanism(s) by which cAMP-Rap regulates Akt remains unclear. Here we show that (i) upstream regulators, PIK and PDK1, are not the target(s) of the cAMP inhibitory action; (ii) constitutively active Akt and calyculin A-stimulated Akt are resistant to cAMP inhibition, suggesting the action of a phosphatase; (iii) cAMP increases the rate of Akt dephosphorylation, directly implicating an Akt-phosphatase; (iv) Epac- and protein kinase A(PKA)-specific analogs synergistically inhibit Akt, indicating the involvement of both cAMP-dependent effector pathways; (v) H89 and dominant negative Epac 279E block cAMP-inhibitory action; (vi) Epac associates in a complex with Akt and PP2A, and the associated-phosphatase activity is positively modulated by cAMP in a PKA- and Rap1-dependent manner; (vii) like its action on Akt inhibition, PKA- and Epac- specific analogs synergistically activate Epac- associated PP2A; and (viii) dominant negative PP2A blocks cAMP-inhibitory action. Thus, we uncovered a novel cAMP-Epac/PKA-Rap1b-PP2A signaling module involved in Akt regulation that may represent a physiological event in the process of cAMP stimulation of thyroid mitogenesis.	[Hong, Kyoungja; Lou, Liguang; Gupta, Sandhya; Ribeiro-Neto, Fernando; Altschuler, Daniel L.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Altschuler, DL (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, 200 Lothrop St,W1346 BSTWR, Pittsburgh, PA 15261 USA.	altschul@pitt.edu			NATIONAL CANCER INSTITUTE [R01CA071649, R29CA071649] Funding Source: NIH RePORTER; NCI NIH HHS [CA071649] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; Brennesvik EO, 2005, CELL SIGNAL, V17, P1551, DOI 10.1016/j.cellsig.2005.03.011; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Coulonval K, 2000, BIOCHEM J, V348, P351, DOI 10.1042/0264-6021:3480351; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Filippa N, 1999, MOL CELL BIOL, V19, P4989; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fujita H, 2006, BRAIN RES, V1113, P10, DOI 10.1016/j.brainres.2006.06.079; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Grader-Beck T, 2003, BLOOD, V101, P998, DOI 10.1182/blood-2002-06-1665; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kagawa T, 2002, AM J PHYSIOL-CELL PH, V283, pC1655, DOI 10.1152/ajpcell.00041.2002; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee HT, 2003, INVEST OPHTH VIS SCI, V44, P3816, DOI 10.1167/iovs.03-0147; Lei HT, 2007, J BIOL CHEM, V282, P9364, DOI 10.1074/jbc.M608985200; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Li LW, 2006, J BIOL CHEM, V281, P3237, DOI 10.1074/jbc.M512167200; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Machida K, 2005, AM J PHYSIOL-LUNG C, V288, pL860, DOI 10.1152/ajplung.00131.2004; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Meroni SB, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740195; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Mora A, 2002, CELL SIGNAL, V14, P557, DOI 10.1016/S0898-6568(01)00282-0; Morisco C, 2005, CIRC RES, V96, P180, DOI 10.1161/01.RES.0000152968.71868.c3; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Poser S, 2003, J NEUROSCI, V23, P4420; Remy I, 2004, MOL CELL BIOL, V24, P1493, DOI 10.1128/MCB.24.4.1493-1504.2004; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Ribeiro-Neto F, 2004, J BIOL CHEM, V279, P46868, DOI 10.1074/jbc.M406858200; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Roger PP, 1995, VITAM HORM, V51, P59, DOI 10.1016/S0083-6729(08)61038-9; Saito J, 2001, THYROID, V11, P339, DOI 10.1089/10507250152039073; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schild A, 2006, MECH DEVELOP, V123, P362, DOI 10.1016/j.mod.2006.03.003; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Wang L, 2001, J BIOL CHEM, V276, P37242, DOI 10.1074/jbc.M105089200; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xu WP, 2003, CANCER RES, V63, P7777; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; YAMAMOTO K, 1992, J BIOL CHEM, V267, P11337; Yellaturu CR, 2002, J BIOL CHEM, V277, P40148, DOI 10.1074/jbc.M206376200; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348; Zmuda-Trzebiatowska E, 2007, CELL SIGNAL, V19, P81, DOI 10.1016/j.cellsig.2006.05.024; Zuluaga S, 2007, CELL SIGNAL, V19, P62, DOI 10.1016/j.cellsig.2006.05.032	97	44	44	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23129	23138		10.1074/jbc.M800478200	http://dx.doi.org/10.1074/jbc.M800478200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550542	hybrid, Green Published			2022-12-27	WOS:000258455400026
J	Ichimura, Y; Kumanomidou, T; Sou, YS; Mizushima, T; Ezaki, J; Ueno, T; Kominami, E; Yamane, T; Tanaka, K; Komatsu, M				Ichimura, Yoshinobu; Kumanomidou, Taichi; Sou, Yu-shin; Mizushima, Tsunehiro; Ezaki, Junji; Ueno, Takashi; Kominami, Eiki; Yamane, Takashi; Tanaka, Keiji; Komatsu, Masaaki			Structural basis for sorting mechanism of p62 in selective autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN P62; CONSTITUTIVE AUTOPHAGY; MAMMALIAN HOMOLOG; CRYSTAL-STRUCTURE; ELECTRON-DENSITY; GENE-EXPRESSION; GABARAP; INCLUSIONS; SYSTEM; YEAST	Impairment of autophagic degradation of the ubiquitin- and LC3-binding protein "p62" leads to the formation of cytoplasmic inclusion bodies. However, little is known about the sorting mechanism of p62 to autophagic degradation. Here we identified a motif of murine p62 consisting of 11 amino acids (Ser(334)-Ser(344)) containing conserved acidic and hydrophobic residues across species, as an LC3 recognition sequence (LRS). The crystal structure of the LC3-LRS complex at 1.56 angstrom resolution revealed interaction of Trp(340) and Leu(343) of p62 with different hydrophobic pockets on the ubiquitin fold of LC3. In vivo analyses demonstrated that p62 mutants lacking LC3 binding ability accumulated without entrapping into autophagosomes in the cytoplasm and subsequently formed ubiquitin- positive inclusion bodies as in autophagy-deficient cells. These results demonstrate that the intracellular level of p62 is tightly regulated by autophagy through the direct interaction of LC3 with p62 and reveal that selective turnover of p62 via autophagy controls inclusion body formation.	[Ichimura, Yoshinobu; Sou, Yu-shin; Ezaki, Junji; Ueno, Takashi; Kominami, Eiki; Komatsu, Masaaki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Kumanomidou, Taichi; Mizushima, Tsunehiro; Yamane, Takashi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Sou, Yu-shin; Tanaka, Keiji; Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Juntendo University; Nagoya University; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Komatsu, M (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan.	mkomatsu@rinshoken.or.jp	Kominami, Eiki/D-3802-2009; Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722; Sou, Yu-shin/0000-0002-7219-9106; Mizushima, Tsunehiro/0000-0002-6631-2889				Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; DeLano W.L, PYMOL MOL GRAPHICS S; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; LEE GH, 1995, AM J PATHOL, V147, P1811; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano T, 2004, ACTA NEUROPATHOL, V107, P359, DOI 10.1007/s00401-004-0821-7; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Watsuji T, 1997, BIOCHEM BIOPH RES CO, V234, P769, DOI 10.1006/bbrc.1997.6705; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	44	567	586	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22847	22857		10.1074/jbc.M802182200	http://dx.doi.org/10.1074/jbc.M802182200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18524774	hybrid			2022-12-27	WOS:000258321000052
J	Li, M; Gustchina, A; Alexandratos, J; Wlodawer, A; Wunschmann, S; Kepley, CL; Chapman, MD; Pomes, A				Li, Mi; Gustchina, Alla; Alexandratos, Jerry; Wlodawer, Alexander; Wunschmann, Sabina; Kepley, Christopher L.; Chapman, Martin D.; Pomes, Anna			Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRASS-POLLEN ALLERGEN; IGE-BINDING EPITOPES; MAJOR ALLERGEN; BIRCH POLLEN; PROTEIN; ASTHMA; CRYSTALLOGRAPHY; SENSITIZATION; REFINEMENT; REACTIVITY	The crystal structure of a 1: 1complex between the German cockroach allergen Bla g 2 and the Fab' fragment of a monoclonal antibody 7C11 was solved at 2.8-angstrom resolution. Bla g 2 binds to the antibody through four loops that include residues 60 -70, 83 -86, 98 -100, and 129 -132. Cation-Pi interactions exist between Lys65, Arg-83, and Lys-132 in Bla g 2 and several tyrosines in 7C11. In the complex with Fab ', Bla g 2 forms a dimer, which is stabilized by a quasi-four-helix bundle comprised of an alpha-helix and a helical turn from each allergen monomer, exhibiting a novel dimerization mode for an aspartic protease. A disulfide bridge between C51a and C113, unique to the aspartic protease family, connects the two helical elements within each Bla g 2 monomer, thus facilitating formation of the bundle. Mutation of these cysteines, as well as the residues Asn-52, Gln-110, and Ile-114, involved in hydrophobic interactions within the bundle, resulted in a protein that did not dimerize. The mutant proteins induced less beta hexosaminidase release from mast cells than the wild-type Bla g 2, suggesting a functional role of dimerization in allergenicity. Because 7C11 shares a binding epitope with IgE, the information gained by analysis of the crystal structure of its complex provided guidance for site-directed mutagenesis of the allergen epitope. We have now identified key residues involved in IgE antibody binding; this information will be useful for the design of vaccines for immunotherapy.	[Li, Mi; Gustchina, Alla; Alexandratos, Jerry; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Li, Mi] SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA; [Wunschmann, Sabina; Chapman, Martin D.; Pomes, Anna] INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA; [Kepley, Christopher L.] Univ Hlth Syst, Sch Med, Richmond, VA 23298 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; INDOOR Biotechnologies	Gustchina, A (corresponding author), NCI, Macromol Crystallog Lab, NIH, Bldg 539, Frederick, MD 21702 USA.	alla@ncifcrf.gov	Pomés, Anna/H-7010-2019	Pomés, Anna/0000-0002-8729-1829; Chapman, Martin/0000-0002-0845-3632	NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NIAID NIH HHS [R01 AI077653] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Ball T, 1999, FASEB J, V13, P1277, DOI 10.1096/fasebj.13.11.1277; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; de Halleux S, 2006, J ALLERGY CLIN IMMUN, V117, P571, DOI 10.1016/j.jaci.2005.11.032; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flicker S, 2000, J IMMUNOL, V165, P3849, DOI 10.4049/jimmunol.165.7.3849; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Guruprasad K, 1996, PROTEIN ENG, V9, P849, DOI 10.1093/protein/9.10.849; Gustchina A, 2005, J MOL BIOL, V348, P433, DOI 10.1016/j.jmb.2005.02.062; Jaskolski M, 2007, ACTA CRYSTALLOGR D, V63, P611, DOI 10.1107/S090744490700978X; Kaiser L, 2007, J MOL BIOL, V370, P714, DOI 10.1016/j.jmb.2007.04.074; Kepley CL, 2004, J BIOL CHEM, V279, P35139, DOI 10.1074/jbc.M404318200; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036; Pomes A, 2002, EUR J BIOCHEM, V269, P3086, DOI 10.1046/j.1432-1033.2002.02990.x; Pomes A, 2002, AM J RESP CRIT CARE, V165, P391, DOI 10.1164/ajrccm.165.3.2104027; Ponstingl H, 2000, PROTEINS, V41, P47; Reese G, 2007, J ALLERGY CLIN IMMUN, V119, P944, DOI 10.1016/j.jaci.2006.11.699; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; SIELECKI AR, 1990, J MOL BIOL, V214, P143, DOI 10.1016/0022-2836(90)90153-D; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Wunschmann S, 2005, J ALLERGY CLIN IMMUN, V116, P140, DOI 10.1016/j.jaci.2005.04.024	35	67	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22806	22814		10.1074/jbc.M800937200	http://dx.doi.org/10.1074/jbc.M800937200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18519566	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000258321000048
J	Le Rouzic, E; Morel, M; Ayinde, D; Belaidouni, N; Letienne, J; Transy, C; Margottin-Goguet, F				Le Rouzic, Erwann; Morel, Marina; Ayinde, Diana; Belaidouni, Nadia; Letienne, Justine; Transy, Catherine; Margottin-Goguet, Florence			Assembly with the Cul4A-DDB1(DCAF1) ubiquitin ligase protects HIV-1 vpr from proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; E7 ONCOPROTEIN; X-PROTEIN; BETA-TRCP; COMPLEX; BINDING; INTERACTS; STATE; DDB1	Many viruses subvert the host ubiquitin-proteasome system to optimize their life cycle. We recently documented such a mechanism for the human immunodeficiency virus type 1 Vpr protein, which promotes cell cycle arrest by recruiting the DCAF1 adaptor of the Cul4A-DDB1 ubiquitin ligase, a finding now confirmed by several groups. Here we examined the impact of Cul4A-DDB1(DCAF1) on Vpr stability. We show that the Vpr(Q65R) mutant, which is defective in DCAF1 binding, undergoes proteasome-mediated degradation at a higher rate than wild-type Vpr. DCAF1 overexpression stabilizes wild-type Vpr and leads to its cytoplasmic accumulation, whereas it has no effect on the Vpr(Q65R) mutant. Conversely, small interfering RNA-mediated silencing of DCAF1 decreases the steady state amount of the viral protein. Stabilization by DCAF1, which is conserved by Vpr species from human immunodeficiency virus type 2 and the SIVmac strain, results in increased G(2) arrest and requires the presence of DDB1, indicating that it occurs through assembly of Vpr with a functional Cul4A-DDB1(DCAF1) complex. Furthermore, in human immunodeficiency virus type 1-infected cells, the Vpr protein, issued from the incoming viral particle, is destabilized under DCAF1 or DDB1 silencing. Together with our previous findings, our data suggest that Cul4A-DDB1(DCAF1) acts at a dual level by providing Vpr with the equipment for the degradation of specific host proteins and by counteracting its proteasome targeting by another cellular E3 ubiquitin ligase. This protection mechanism may represent an efficient way to optimize the activity of Vpr molecules that are delivered by the incoming virus before neosynthesis takes place. Targeting the Vpr-DCAF1 interaction might therefore present therapeutic interest.	[Transy, Catherine] Univ Paris 05, CNRS, UMR 8104, Inst Cochin,Dept Malad Infect, F-75014 Paris, France; [Le Rouzic, Erwann; Morel, Marina; Ayinde, Diana; Belaidouni, Nadia; Letienne, Justine; Transy, Catherine] INSERM, U567, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Transy, C (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin,Dept Malad Infect, Batiment Gustave Roussy,27 Rue Faubourg St Jacque, F-75014 Paris, France.	transy@cochin.inserm.fr; margottin-goguet@cochin.inserm.fr	Margottin-Goguet, Florence/F-9272-2013	Margottin-Goguet, Florence/0000-0002-3124-6690; Morel, Marina/0000-0001-6610-3772				Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Barry Michele, 2006, Sci STKE, V2006, ppe21; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bergametti F, 2002, J BIOMED SCI, V9, P706, DOI 10.1159/000067287; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Estrabaud E, 2007, PLOS PATHOG, V3, P995, DOI 10.1371/journal.ppat.0030104; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Kehmeier E, 2002, VIROLOGY, V299, P72, DOI 10.1006/viro.2002.1502; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leupin O, 2003, J VIROL, V77, P6274, DOI 10.1128/JVI.77.11.6274-6283.2003; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Oh KJ, 2004, J VIROL, V78, P5338, DOI 10.1128/JVI.78.10.5338-5346.2004; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Precious BL, 2007, VIROLOGY, V368, P114, DOI 10.1016/j.virol.2007.06.024; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wu JT, 2006, TRENDS CELL BIOL, V16, P362, DOI 10.1016/j.tcb.2006.05.001; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001	33	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21686	21692		10.1074/jbc.M710298200	http://dx.doi.org/10.1074/jbc.M710298200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524771	hybrid			2022-12-27	WOS:000257898800042
J	Moniot, S; Bruno, S; Vonrhein, C; Didierjean, C; Boschi-Muller, S; Vas, M; Bricogne, G; Branlant, G; Mozzarelli, A; Corbier, C				Moniot, Sebastien; Bruno, Stefano; Vonrhein, Clemens; Didierjean, Claude; Boschi-Muller, Sandrine; Vas, Maria; Bricogne, Gerard; Branlant, Guy; Mozzarelli, Andrea; Corbier, Catherine			Trapping of the thioacylglyceraldehyde-3-phosphate dehydrogenase intermediate from Bacillus stearothermophilus - Direct evidence for a flip-flop mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHATE-BINDING SITES; CRYSTAL-STRUCTURE; HOLO-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ESCHERICHIA-COLI; MICROSPECTROPHOTOMETRY; REACTIVITY; NAD	The crystal structure of the thioacylenzyme intermediate of the phosphorylating glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from Bacillus stearothermophilus has been solved at 1.8 angstrom resolution. Formation of the intermediate was obtained by diffusion of the natural substrate within the crystal of the holoenzyme in the absence of inorganic phosphate. To define the soaking conditions suitable for the isolation and accumulation of the intermediate, a microspectrophotometric characterization of the reaction of GAPDH in single crystals was carried out, following NADH formation at 340 nm. When compared with the structure of the Michaelis complex (Didierjean, C., Corbier, C., Fatih, M., Favier, F., Boschi-Muller, S., Branlant, G., and Aubry, A. (2003) J. Biol. Chem. 278, 12968-12976) the 206-210 loop is shifted and now forms part of the so-called "new P-i" site. The locations of both the O1 atom and the C3-phosphate group of the substrate are also changed. Altogether, the results provide evidence for the flipping of the C3-phosphate group occurring concomitantly or after the redox step.	[Moniot, Sebastien; Didierjean, Claude; Corbier, Catherine] Univ Henri Poincare, CNRS, UMR 7036, Lab Cristallog & Modelisat Mat & Biol, F-54506 Vandoeuvre Les Nancy, France; [Boschi-Muller, Sandrine; Branlant, Guy] Univ Henri Poincare, CNRS, UMR 7567, Lab Maturat ARN & Enzymol Mol, F-54506 Vandoeuvre Les Nancy, France; [Corbier, Catherine] Nancy Univ, Fac Sci,EA 3998, Univ Henri Poincare,Unite Rech Anim & Fonctionnal, Equipe Proteolyse & Biofonctional Proteines & Pep, F-54506 Vandoeuvre Les Nancy, France; [Mozzarelli, Andrea] Univ Parma, Unit Natl Inst Biostruct & Biosyst, I-43100 Parma, Italy; [Vonrhein, Clemens; Bricogne, Gerard] Global Phasing Ltd, Sheraton House, Cambridge CB3 0AX, England; [Vas, Maria] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1518 Budapest, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine; University of Parma; Global Phasing Limited; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Corbier, C (corresponding author), Univ Henri Poincare, CNRS, UMR 7036, Lab Cristallog & Modelisat Mat & Biol, F-54506 Vandoeuvre Les Nancy, France.	catherine.corbier@scbiol.uhp-nancy.fr	Mozzarelli, Andrea/C-3615-2014; DIDIERJEAN, Claude/L-1493-2013; Bruno, Stefano/A-4582-2011	Mozzarelli, Andrea/0000-0003-3762-0062; DIDIERJEAN, Claude/0000-0002-3176-8974; Bruno, Stefano/0000-0002-7890-2472; Boschi, Sandrine/0000-0001-8962-4749				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERNI R, 1977, J MOL BIOL, V110, P405, DOI 10.1016/S0022-2836(77)80079-X; Boschi-Muller S, 1999, ARCH BIOCHEM BIOPHYS, V363, P259, DOI 10.1006/abbi.1998.1080; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Bricogne G., 1996, MACROMOLECULAR REFIN, P85; BUEHNER M, 1974, J MOL BIOL, V82, P563, DOI 10.1016/0022-2836(74)90249-6; BYERS LD, 1978, ARCH BIOCHEM BIOPHYS, V186, P335, DOI 10.1016/0003-9861(78)90443-5; Castilho MS, 2003, BIOCHEMISTRY-US, V42, P7143, DOI 10.1021/bi0206107; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; CORBIER C, 1994, BIOCHEMISTRY-US, V33, P3260, DOI 10.1021/bi00177a017; Didierjean C, 2003, J BIOL CHEM, V278, P12968, DOI 10.1074/jbc.M211040200; Duee E, 1996, J MOL BIOL, V257, P814, DOI 10.1006/jmbi.1996.0204; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; HARRIGAN PJ, 1974, BIOCHEM J, V143, P353, DOI 10.1042/bj1430353; HARRIS JI, 1976, ENZYMES, pCH13; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KIM HD, 1995, BIOCHEMISTRY-US, V34, P14975, DOI 10.1021/bi00046a004; KORNDORFER I, 1995, J MOL BIOL, V246, P511, DOI 10.1006/jmbi.1994.0103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Michels S, 1996, EUR J BIOCHEM, V235, P641, DOI 10.1111/j.1432-1033.1996.00641.x; MORAS D, 1975, J BIOL CHEM, V250, P9137; MOZZARELLI A, 1982, J BIOL CHEM, V257, P6739; MOZZARELLI A, 1989, J BIOL CHEM, V264, P15774; Mozzarelli A, 1996, ANNU REV BIOPH BIOM, V25, P343; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pearson AR, 2004, CURR OPIN STRUC BIOL, V14, P656, DOI 10.1016/j.sbi.2004.10.007; RACKER E, 1952, J BIOL CHEM, V198, P731; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; ROSSI GL, 1971, J MOL BIOL, V55, P215, DOI 10.1016/0022-2836(71)90193-8; SEGAL HL, 1953, J BIOL CHEM, V204, P265; SKARZYNSKI T, 1987, J MOL BIOL, V193, P171, DOI 10.1016/0022-2836(87)90635-8; SOUKRI A, 1989, BIOCHEMISTRY-US, V28, P2586, DOI 10.1021/bi00432a036; Talfournier F, 1998, EUR J BIOCHEM, V252, P447, DOI 10.1046/j.1432-1327.1998.2520447.x; TRENTHAM DR, 1971, BIOCHEM J, V122, P59, DOI 10.1042/bj1220059; TRENTHAM DR, 1971, BIOCHEM J, V122, P71, DOI 10.1042/bj1220071; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VAS M, 1979, J BIOL CHEM, V254, P8480; Yun M, 2000, BIOCHEMISTRY-US, V39, P10702, DOI 10.1021/bi9927080	39	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21693	21702		10.1074/jbc.M802286200	http://dx.doi.org/10.1074/jbc.M802286200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18480053	hybrid, Green Published			2022-12-27	WOS:000257898800043
J	Pandey, MS; Harris, EN; Weigel, JA; Weigel, PH				Pandey, Madhu S.; Harris, Edward N.; Weigel, Janet A.; Weigel, Paul H.			The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER ENDOTHELIAL-CELLS; DENSITY-LIPOPROTEIN RECEPTOR; FACTOR-II RECEPTOR; RAPID INTERNALIZATION; ALPHA-ADAPTIN; NPXY MOTIFS; BINDING; PROTEIN; ACID; SIGNALS	The hyaluronic acid (HA) receptor for endocytosis (HARE) is the primary scavenger receptor for HA and chondroitin sulfates in mammals. The two human isoforms of HARE (full-length 315-kDa and a 190-kDa proteolytic cleavage product), which are type I single-pass membrane proteins, are highly expressed in sinusoidal endothelial cells of lymph nodes, liver, and spleen. Their identical HARE cytoplasmic domains contain four candidate AP-2/clathrin-mediated endocytic signaling motifs as follows: YSYFRI2485, FQHF(2495), NPLY2519, and DPF2534 (315-HARE numbering). Stably transfected cells expressing 190-HARE(Delta YSYFRI), 190-HARE(Delta FQHF), or 190-HARE(Delta NPLY) (lacking Motifs 1,2, or 3) had decreased I-125-HA endocytosis rates of similar to 49, similar to 39, and similar to 56%, respectively (relative to wild type). In contrast, 190-HARE(Delta DPF) cells (lacking Motif 4) showed no change in HA endocytic rate. Deletions of motifs 1 and 2 or of 1, 2, and 4 decreased the rate of HA endocytosis by only similar to 41%. Endocytosis was similar to 95% decreased in mutants lacking all four motifs. Cells expressing a 190-HARE(Y2519A) mutant of the NPLY motif retained 85-90% of wild type endocytosis, whereas this mutation in the triple motif deletant decreased endocytosis to similar to 7% of wild type. Tyr in NPLY2519 is thus important for endocytosis. All HARE mutants showed similar HA binding and degradation of the internalized HA, indicating that altering endocytic motifs did not affect ectodomain binding of HA or targeting of internalized HA to lysosomes. We conclude that, although NPLY may be the most important motif, it functions together with two other endocytic motifs; thus three signal sequences (YSYFRI, FQHF, and NPLY) provide redundancy to mediate coated pit targeting and endocytosis of HARE.	Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	paul-weigel@ouhsc.edu	Harris, Edward N/A-1596-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069961] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 69961, R01 GM069961] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Clague MJ, 2001, J CELL SCI, V114, P3075; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; FILARDO EJ, 1995, J CELL BIOL, V130, P441, DOI 10.1083/jcb.130.2.441; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hjalm G, 1996, EUR J BIOCHEM, V239, P132, DOI 10.1111/j.1432-1033.1996.0132u.x; HSU D, 1994, ENDOCRINOLOGY, V134, P744, DOI 10.1210/en.134.2.744; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; IACOPETTA BJ, 1988, CELL, V54, P485, DOI 10.1016/0092-8674(88)90069-4; JADOT M, 1992, J BIOL CHEM, V267, P11069; Kawakami K, 2001, J BIOL CHEM, V276, P25114, DOI 10.1074/jbc.M100936200; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; McDonald J, 2002, J BIOL CHEM, V277, P4575, DOI 10.1074/jbc.R100064200; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; McGary CT, 2003, METHOD ENZYMOL, V363, P354; MCGARY CT, 1993, HEPATOLOGY, V18, P1465, DOI 10.1002/hep.1840180628; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; RAJA RH, 1984, ANAL BIOCHEM, V139, P168, DOI 10.1016/0003-2697(84)90402-0; RAJA RH, 1988, J BIOL CHEM, V263, P16661; RAJASEKARAN AK, 1994, MOL BIOL CELL, V5, P1093, DOI 10.1091/mbc.5.10.1093; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SMEDSROD B, 1988, CELL TISSUE RES, V253, P39; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; THOMAS WG, 1995, J BIOL CHEM, V270, P22153, DOI 10.1074/jbc.270.38.22153; Vignoud L, 1997, J CELL SCI, V110, P1421; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Weigel JA, 2003, J BIOL CHEM, V278, P42802, DOI 10.1074/jbc.M307201200; WEIGEL PH, 1983, ANAL BIOCHEM, V133, P437, DOI 10.1016/0003-2697(83)90106-9; Weigel PH, 2003, METHOD ENZYMOL, V363, P382; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; YannarielloBrown J, 1997, GLYCOBIOLOGY, V7, P15, DOI 10.1093/glycob/7.1.15; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029; Zhou B, 2002, MOL BIOL CELL, V13, P2853, DOI 10.1091/mbc.02-03-0048; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	64	50	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21453	21461		10.1074/jbc.M800886200	http://dx.doi.org/10.1074/jbc.M800886200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539600	Green Published, hybrid			2022-12-27	WOS:000257898800017
J	Wagner, MW; Li, LS; Morales, JC; Galindo, CL; Garner, HR; Bornmann, WG; Boothman, DA				Wagner, Mark W.; Li, Long Shan; Morales, Julio C.; Galindo, Cristi L.; Garner, Harold R.; Bornmann, William G.; Boothman, David A.			Role of c-Abl kinase in DNA mismatch repair-dependent G(2) cell cycle checkpoint arrest responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; APOPTOTIC RESPONSE; METHYLATING AGENTS; DEFICIENT CELLS; PROTEIN-KINASE; COLON-CANCER; DAMAGE; BRCA1; PHOSPHORYLATION; ACTIVATION	Current published data suggest that DNA mismatch repair (MMR) triggers prolonged G(2) cell cycle checkpoint arrest after alkylation damage from N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) by activating ATR (ataxia telangiectasia-Rad3-related kinase). However, analyses of isogenic MMR-proficient and MMR-deficient human RKO colon cancer cells revealed that although ATR/Chk1 signaling controlled G(2) arrest in MMR-deficient cells, ATR/Chk1 activation was not involved in MMR-dependent G(2) arrest. Instead, we discovered that disrupting c-Abl activity using STI571 (Gleevec (TM), a c-Abl inhibitor) or stable c-Abl knockdown abolished MMR-dependent p73 alpha stabilization, induction of GADD45 alpha protein expression, and G(2) arrest. In addition, inhibition of c-Abl also increased the survival of MNNG-exposed MMR-proficient cells to a level comparable with MMR-deficient cells. Furthermore, knocking down GADD45 alpha( but not p73 alpha) protein levels affected MMR-dependent G(2) arrest responses. Thus, MMR-dependent G(2) arrest responses triggered by MNNG are dependent on a human MLH1/c-Abl/GADD45 alpha signaling pathway and activity. Furthermore, our data suggest that caution should be taken with therapies targeting c-Abl kinase because increased survival of mutator phenotypes may be an unwanted consequence.	[Wagner, Mark W.; Li, Long Shan; Morales, Julio C.; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses, Dallas, TX 75390 USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dept Biochem, Div Translat Res, Dallas, TX 75390 USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; [Wagner, Mark W.] Case Western Reserve Univ, Dept Environm Hlth Sci, Cleveland, OH 44106 USA; [Bornmann, William G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses, 5323 Harry Hines Blvd,ND2-210K, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Boothman, David/Q-7776-2019	Morales, Julio/0000-0002-0854-7866	NCI NIH HHS [R01 CA 83196, P30 CA142543] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083196, P30CA142543] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Bacher JW, 2004, DIS MARKERS, V20, P237, DOI 10.1155/2004/136734; Bawa S, 2003, GENE, V315, P177, DOI 10.1016/S0378-1119(03)00737-6; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Burgess MR, 2006, THESCIENTIFICWORLDJO, V6, P918, DOI 10.1100/tsw.2006.184; Davis TW, 1998, CANCER RES, V58, P767; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Foray N, 2002, MOL CELL BIOL, V22, P4020, DOI 10.1128/MCB.22.12.4020-4032.2002; Gong JG, 1999, NATURE, V399, P806; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; HAWN MT, 1995, CANCER RES, V55, P3721; Hirose Y, 2004, J NEUROSURG, V100, P1060, DOI 10.3171/jns.2004.100.6.1060; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; Kamath R, 2007, MOL PHARMACOL, V71, P61, DOI 10.1124/mol.106.026575; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim WJ, 2007, J BIOL CHEM, V282, P32021, DOI 10.1074/jbc.M701451200; Li LS, 2008, J BIOL CHEM, V283, P21394, DOI 10.1074/jbc.M709954200; Loeb LA, 1997, SCIENCE, V277, P1449, DOI 10.1126/science.277.5331.1449; Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.3.CO;2-Q; Meyers M, 2001, CANCER RES, V61, P5193; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Nehme A, 1997, CANCER RES, V57, P3253; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tront JS, 2006, CANCER RES, V66, P8448, DOI 10.1158/0008-5472.CAN-06-2013; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Vella V, 2003, J BIOL CHEM, V278, P25151, DOI 10.1074/jbc.M301962200; Wang Q, 2001, ONCOGENE, V20, P4640, DOI 10.1038/sj.onc.1204625; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wang Y, 2000, GENE DEV, V14, P927; Yamane K, 2007, CANCER RES, V67, P6286, DOI 10.1158/0008-5472.CAN-06-2205; Yi W, 2006, CANCER RES, V66, P151, DOI 10.1158/0008-5472.CAN-05-3019; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704	41	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21382	21393		10.1074/jbc.M709953200	http://dx.doi.org/10.1074/jbc.M709953200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18480061	Green Published, hybrid			2022-12-27	WOS:000257898800009
J	Ulijasz, AT; Cornilescu, G; von Stetten, D; Kaminski, S; Mroginski, MA; Zhang, JR; Bhaya, D; Hildebrandt, P; Vierstra, RD				Ulijasz, Andrew T.; Cornilescu, Gabriel; von Stetten, David; Kaminski, Steve; Mroginski, Maria Andrea; Zhang, Junrui; Bhaya, Devaki; Hildebrandt, Peter; Vierstra, Richard D.			Characterization of two thermostable cyanobacterial phytochromes reveals global movements in the chromophore-binding domain during photoconversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; RESONANCE RAMAN ANALYSIS; HISTIDINE KINASES; AGROBACTERIUM-TUMEFACIENS; RECOMBINANT PHYTOCHROME; STRUCTURAL-CHANGES; CPH1 PHYTOCHROME; MICROBIAL MAT; PROTEIN; LIGHT	Photointerconversion between the red light-absorbing (Pr) form and the far-red light-absorbing (Pfr) form is the central feature that allows members of the phytochrome (Phy) superfamily to act as reversible switches in light perception. Whereas the chromophore structure and surrounding binding pocket of Pr have been described, those for Pfr have remained enigmatic for various technical reasons. Here we describe a novel pair of Phys from two thermophilic cyanobacteria, Synechococcus sp. OS-A and OS-B', that overcome several of these limitations. Like other cyanobacterial Phys, SyA-Cph1 and SyB-Cph1 covalently bind the bilin phycocyanobilin via their cGMP phosphodiesterase/ adenyl cyclase/FhlA (GAF) domains and then assume the photointerconvertible Pr and Pfr states with absorption maxima at 630 and 704 nm, respectively. However, they are naturally missing the N-terminal Per/Arndt/Sim domain common to others in the Phy superfamily. Importantly, truncations containing only the GAF domain are monomeric, photochromic, and remarkably thermostable. Resonance Raman and NMR spectroscopy show that all four pyrrole ring nitrogens of phycocyanobilin are protonated both as Pr and following red light irradiation, indicating that the GAF domain by itself can complete the Pr to Pfr photocycle. H-1-N-15 two-dimensional NMR spectra of isotopically labeled preparations of the SyB-Cph1 GAF domain revealed that a number of amino acids change their environment during photoconversion of Pr to Pfr, which can be reversed by subsequent photoconversion back to Pr. Through three-dimensional NMR spectroscopy before and after light photoexcitation, it should now be possible to define the movements of the chromophore and binding pocket during photoconversion. We also generated a series of strongly red fluorescent derivatives of SyB-Cph1, which based on their small size and thermostability may be useful as cell biological reporters.	[Ulijasz, Andrew T.; Zhang, Junrui; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Cornilescu, Gabriel] Univ Wisconsin, Natl Magnet Resonance Facil, Madison, WI 53706 USA; [von Stetten, David; Kaminski, Steve; Mroginski, Maria Andrea; Hildebrandt, Peter] Tech Univ Berlin, D-10623 Berlin, Germany; [Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Technical University of Berlin; Carnegie Institution for Science	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu	Zhang, Junrui/J-2684-2012; Cornilescu, Gabriel/H-3113-2011; Hildebrandt, Peter/J-5658-2014	Cornilescu, Gabriel/0000-0002-1204-8904; Hildebrandt, Peter/0000-0003-1030-5900; von Stetten, David/0000-0001-7906-9788; Ulijasz, Andrew/0000-0003-0739-1297; Kaminski, Steve/0000-0002-0047-8819	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008438, S10RR002781, P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; CHERRY JR, 1993, PLANT CELL, V5, P565, DOI 10.1105/tpc.5.5.565; Collins BK, 2004, ACTA CRYSTALLOGR D, V60, P1674, DOI 10.1107/S090744490401844X; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EDGERTON MD, 1992, PLANT CELL, V4, P161, DOI 10.1105/tpc.4.2.161; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Falk H., 1989, CHEM LINEAR OLIGOPYR; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; FODOR SPA, 1990, BIOCHEMISTRY-US, V29, P11141, DOI 10.1021/bi00502a018; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; GRIMM R, 1988, PLANTA, V174, P396, DOI 10.1007/BF00959526; Hahn J, 2006, FEBS J, V273, P1415, DOI 10.1111/j.1742-4658.2006.05164.x; Hahn J, 2007, CHEMBIOCHEM, V8, P2249, DOI 10.1002/cbic.200700256; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2004, J BACTERIOL, V186, P445, DOI 10.1128/JB.186.2.445-453.2004; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kilian O, 2007, APPL ENVIRON MICROB, V73, P4268, DOI 10.1128/AEM.00201-07; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; LAGARIAS JC, 1985, J BIOL CHEM, V260, P2415; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; Lapko VN, 1998, BIOCHEMISTRY-US, V37, P12526, DOI 10.1021/bi980834i; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; LIMBACH HH, 1984, J AM CHEM SOC, V106, P4059, DOI 10.1021/ja00326a044; Miller AE, 2006, P NATL ACAD SCI USA, V103, P11136, DOI 10.1073/pnas.0604724103; MIZUTANI Y, 1994, BIOCHEMISTRY-US, V33, P153, DOI 10.1021/bi00167a020; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Mroginski MA, 2007, ACCOUNTS CHEM RES, V40, P258, DOI 10.1021/ar6000523; Murgida DH, 2007, BIOPHYS J, V93, P2410, DOI 10.1529/biophysj.107.108092; Natori C, 2007, PHOTOCH PHOTOBIO SCI, V6, P83, DOI 10.1039/b611077k; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Park CM, 2000, BIOCHEMISTRY-US, V39, P10840, DOI 10.1021/bi992831r; Park CM, 2000, BIOCHEMISTRY-US, V39, P6349, DOI 10.1021/bi992916s; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Quail PH, 1997, PLANT CELL ENVIRON, V20, P657, DOI 10.1046/j.1365-3040.1997.d01-108.x; Remberg A, 1997, BIOCHEMISTRY-US, V36, P13389, DOI 10.1021/bi971563z; Riek R, 1999, P NATL ACAD SCI USA, V96, P4918, DOI 10.1073/pnas.96.9.4918; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rohmer T, 2006, J PHYS CHEM B, V110, P20580, DOI 10.1021/jp062454+; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Scheer H., 1984, TECHNIQUES PHOTOMORP, P227, DOI [10.5282/ubm/epub.2167, DOI 10.5282/UBM/EPUB.2167]; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; Shlyk-Kerner O, 2006, NATURE, V442, P827, DOI 10.1038/nature04947; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Strauss HM, 2005, FEBS LETT, V579, P3970, DOI 10.1016/j.febslet.2005.06.025; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Ulijasz AT, 1996, J BACTERIOL, V178, P6305, DOI 10.1128/jb.178.21.6305-6309.1996; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; VENTERS RA, 1991, BIOCHEMISTRY-US, V30, P4491, DOI 10.1021/bi00232a017; Vierstra RD, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P171, DOI 10.1002/352760510X.ch8; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; VONSTETTEN D, 2008, ANGEW CHEM IN PRESS; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yu HT, 1999, P NATL ACAD SCI USA, V96, P332, DOI 10.1073/pnas.96.2.332	76	46	50	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21251	21266		10.1074/jbc.M801592200	http://dx.doi.org/10.1074/jbc.M801592200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18480055	hybrid, Green Published			2022-12-27	WOS:000257746100067
J	Coffin, SR; Reich, NO				Coffin, Stephanie R.; Reich, Norbert O.			Modulation of Escherichia coli DNA methyltransferase activity by biologically derived GATC-flanking sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION-ENDONUCLEASE ECORV; SEQA PROTEIN; ADENINE METHYLTRANSFERASE; REPLICATION INITIATION; HAEMOPHILUS-INFLUENZAE; DAM METHYLTRANSFERASE; FACILITATED DIFFUSION; PYRIMIDINE REGULATION; METHYLATION STATUS; CRYSTAL-STRUCTURE	Escherichia coli DNA adenine methyltransferase (EcoDam) methylates the N-6 position of the adenine in the sequence 5'-GATC-3' and plays vital roles in gene regulation, mismatch repair, and DNA replication. It remains unclear how the small number of critical GATC sites involved in the regulation of replication and gene expression are differentially methylated, whereas the similar to 20,000 GATCs important for mismatch repair and dispersed throughout the genome are extensively methylated. Our prior work, limited to the pap regulon, showed that methylation efficiency is controlled by sequences immediately flanking the GATC sites. We extend these studies to include GATC sites involved in diverse gene regulatory and DNA replication pathways as well as sites previously shown to undergo differential in vivo methylation but whose function remains to be assigned. EcoDam shows no change in affinity with variations in flanking sequences derived from these sources, but methylation kinetics varied 12-fold. A-tracts immediately adjacent to the GATC site contribute significantly to these differences in methylation kinetics. Interestingly, only when the poly(A) is located 5' of the GATC are the changes in methylation kinetics revealed. Preferential methylation is obscured when two GATC sites are positioned on the same DNA molecule, unless both sites are surrounded by large amounts of nonspecific DNA. Thus, facilitated diffusion and sequences immediately flanking target sites contribute to higher order specificity for EcoDam; we suggest that the diverse biological roles of the enzyme are in part regulated by these two factors, which may be important for other enzymes that sequence-specifically modify DNA.	[Coffin, Stephanie R.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Reich, Norbert O.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu			NIGMS NIH HHS [GM 53763] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053763] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan BW, 1999, J BIOL CHEM, V274, P19269, DOI 10.1074/jbc.274.27.19269; Alonso A, 2005, J BACTERIOL, V187, P7901, DOI 10.1128/JB.187.23.7901-7911.2005; Bach T, 2005, J MOL BIOL, V350, P7, DOI 10.1016/j.jmb.2005.04.055; BERGERAT A, 1989, J BIOL CHEM, V264, P4064; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; Brendler T, 1999, EMBO J, V18, P2304, DOI 10.1093/emboj/18.8.2304; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; CHARLIER D, 1995, J MOL BIOL, V250, P383, DOI 10.1006/jmbi.1995.0384; CHARLIER D, 1995, J MOL BIOL, V250, P392, DOI 10.1006/jmbi.1995.0385; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eberhard J, 2001, FEMS MICROBIOL LETT, V195, P223, DOI 10.1016/S0378-1097(01)00014-3; Ellenberger T, 1997, STRUCTURE, V5, P153, DOI 10.1016/S0969-2126(97)00174-3; Faiger H, 2006, NUCLEIC ACIDS RES, V34, P104, DOI 10.1093/nar/gkj414; Hales LM, 1996, NUCLEIC ACIDS RES, V24, P1780, DOI 10.1093/nar/24.9.1780; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HALFORD SE, 1980, BIOCHEM J, V191, P581, DOI 10.1042/bj1910581; Han JS, 2004, J BIOL CHEM, V279, P30236, DOI 10.1074/jbc.M402612200; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Horton JR, 2006, J MOL BIOL, V358, P559, DOI 10.1016/j.jmb.2006.02.028; JACK WE, 1982, P NATL ACAD SCI-BIOL, V79, P4010, DOI 10.1073/pnas.79.13.4010; Jeltsch A, 1996, EMBO J, V15, P5104, DOI 10.1002/j.1460-2075.1996.tb00891.x; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; Kang S, 1999, J BIOL CHEM, V274, P11463, DOI 10.1074/jbc.274.17.11463; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; LOBNEROLESEN A, 1992, MOL MICROBIOL, V6, P1841, DOI 10.1111/j.1365-2958.1992.tb01356.x; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; MacDonald D, 2001, J MOL BIOL, V306, P1081, DOI 10.1006/jmbi.2001.4447; Mashhoon N, 2004, J BIOL CHEM, V279, P52075, DOI 10.1074/jbc.M408182200; Mashhoon N, 2006, J BIOMOL SCREEN, V11, P497, DOI 10.1177/1087057106287933; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; PIEKAROWICZ A, 1975, ACTA MICROBIOL POL, V7, P51; Polaczek P, 1998, MOL GEN GENET, V258, P488, DOI 10.1007/s004380050759; RUSSELL DW, 1987, CELL, V50, P1071, DOI 10.1016/0092-8674(87)90173-5; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Skarstad K, 2000, MOL MICROBIOL, V36, P1319, DOI 10.1046/j.1365-2958.2000.01943.x; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; SMITH DW, 1985, EMBO J, V4, P1319, DOI 10.1002/j.1460-2075.1985.tb03779.x; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2209, DOI 10.1021/bi951884f; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2201, DOI 10.1021/bi951883n; SURBY MA, 1992, ABSTRACTS PAPERS AM, V203; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; TAYLOR JD, 1992, BIOCHEMISTRY-US, V31, P90, DOI 10.1021/bi00116a014; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Travers AA, 2004, PHILOS T R SOC A, V362, P1423, DOI 10.1098/rsta.2004.1390; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; VANCLEVE MD, 1992, BIOCHEMISTRY-US, V31, P334, DOI 10.1021/bi00117a004; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WANG MX, 1992, NATURE, V360, P606, DOI 10.1038/360606a0; Watson ME, 2004, MOL MICROBIOL, V53, P651, DOI 10.1111/j.1365-2958.2004.04140.x; Wenz C, 1998, BIOCHEMISTRY-US, V37, P2234, DOI 10.1021/bi9719197; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Wu H, 2006, ORAL MICROBIOL IMMUN, V21, P238, DOI 10.1111/j.1399-302X.2006.00284.x; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973; Youngblood B, 2006, J BIOL CHEM, V281, P26821, DOI 10.1074/jbc.M603388200; Zinoviev VV, 2007, BIOL CHEM, V388, P1199, DOI 10.1515/BC.2007.142; ZYSKIND JW, 1986, CELL, V46, P489, DOI 10.1016/0092-8674(86)90873-1	72	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20106	20116		10.1074/jbc.M802502200	http://dx.doi.org/10.1074/jbc.M802502200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502761	hybrid, Green Published			2022-12-27	WOS:000257565300027
J	De Donatis, A; Comito, G; Buricchi, F; Vinci, MC; Parenti, A; Caselli, A; Camici, G; Manao, G; Ramponi, G; Cirri, P				De Donatis, Alina; Comito, Giusy; Buricchi, Francesca; Vinci, Maria C.; Parenti, Astrid; Caselli, Anna; Camici, Guido; Manao, Giampaolo; Ramponi, Giampietro; Cirri, Paolo			Proliferation versus migration in platelet-derived growth factor signaling - The key role of endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL-ADHESION KINASE; FACTOR BETA-RECEPTOR; CELL-MIGRATION; PROTEIN-KINASE; IN-VIVO; PDGF; INHIBITION; ENDOSOMES; GTPASES; INTERNALIZATION	It is common knowledge that platelet-derived growth factor (PDGF) is a critical regulator of mesenchymal cell migration and proliferation. Nevertheless, these two cellular responses are mutually exclusive. To solve this apparent contradiction, we studied the behavior of NIH3T3 fibroblasts in response to increasing concentrations of PDGF. We found that there is strong cell proliferation induction only with PDGF concentrations > 5 ng/ml, whereas the cell migration response arises starting from 1 ng/ml and is negligible at higher PDGF concentrations. According to these phenotypic evidences, our data indicate that cells display a differential activation of the main signaling pathways in response to PDGF as a function of the stimulation dose. At low PDGF concentrations, there is maximal activation of signaling pathways linked to cytoskeleton rearrangement needed for cell motility, whereas high PDGF concentrations activate pathways linked to mitogenesis induction. Our results suggest a mechanism by which cells switch from a migrating to a proliferating phenotype sensing the increasing gradient of PDGF. In addition, we propose that the cell decision to proliferate or migrate relies on different endocytotic routes of the PDGF receptor in response to different PDGF concentrations.	[De Donatis, Alina; Comito, Giusy; Buricchi, Francesca; Caselli, Anna; Camici, Guido; Manao, Giampaolo; Ramponi, Giampietro; Cirri, Paolo] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy; [Vinci, Maria C.; Parenti, Astrid] Univ Florence, Dipartimento Farmacol Preclin & Clin, I-50134 Florence, Italy	University of Florence; University of Florence	Cirri, P (corresponding author), Univ Florence, Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.	paolo.cirri@unifi.it	Caselli, Anna/O-7512-2014; Vinci, Maria Cristina/E-7401-2016; Camici, Giovanni/H-1631-2018	Caselli, Anna/0000-0001-8140-3415; Vinci, Maria Cristina/0000-0001-6323-147X; Camici, Giovanni/0000-0002-0523-0695; Parenti, Astrid/0000-0002-7980-6853; Comito, Giuseppina/0000-0002-4614-067X				Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MORI S, 1992, J BIOL CHEM, V267, P6429; MORI S, 1994, J BIOL CHEM, V269, P4917; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Parenti A, 1996, BRIT J PHARMACOL, V119, P619, DOI 10.1111/j.1476-5381.1996.tb15718.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 2000, J CELL SCI, V113, P3673; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	36	102	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19948	19956		10.1074/jbc.M709428200	http://dx.doi.org/10.1074/jbc.M709428200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499659	hybrid			2022-12-27	WOS:000257565300010
J	Watanabe, S; Saimura, M; Makino, K				Watanabe, Seiya; Saimura, Masayuki; Makino, Keisuke			Eukaryotic and bacterial gene clusters related to an alternative pathway of nonphosphorylated L-rhamnose metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-FUCOSE METABOLISM; L-ARABINOSE METABOLISM; CLASS-II ALDOLASE; ENZYMATIC-ACTIVITIES; ENOLASE SUPERFAMILY; ESCHERICHIA-COLI; 2-KETO-3-DEOXY-L-ARABONATE ALDOLASE; BIOCHEMICAL-CHARACTERIZATION; GLUCOSE-DEHYDROGENASE; EVOLUTIONARY INSIGHT	The Entner-Doudoroff (ED) pathway is a classic central pathway of D-glucose metabolism in all three phylogenetic domains. On the other hand, Archaea and/or bacteria possess several modified versions of the ED pathway, in which non-phosphorylated intermediates are involved. Several fungi, including Pichia stipitis and Debaryomyces hansenii, possess an alternative pathway of L-rhamnose metabolism, which is different from the known bacterial pathway. Gene cluster related to this hypothetical pathway was identified by bioinformatic analysis using the metabolic enzymes involved in analogous sugar pathways to the ED pathway. Furthermore, the homologous gene cluster was found not only in many other fungi but also several bacteria, including Azotobacter vinelandii. Four putative metabolic genes, LRA1-4, were cloned, overexpressed in Escherichia coli, and purified. Substrate specificity and kinetic analysis revealed that nonphosphorylated intermediates related to L-rhamnose are significant active substrates for the purified LRA1-4 proteins. Furthermore, L-2-keto-3-deoxyrhamnonate was structurally identified as both reaction products of dehydration by LRA3 and aldol condensation by LRA4. These results suggested that the LRA1-4 genes encode L-rhamnose 1-dehydrogenase, L-rhamnono-gamma-lactonase, L-rhamnonate dehydratase, and L-KDR aldolase, respectively, by which L-rhamnose is converted into pyruvate and L-lactaldehyde through analogous reaction steps to the ED pathway. There was no evolutionary relationship between L-KDR aldolases from fungi and bacteria.	[Watanabe, Seiya; Saimura, Masayuki; Makino, Keisuke] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Watanabe, Seiya; Saimura, Masayuki; Makino, Keisuke] New Energy & Ind Technol Dev Org Gokasho, Kyoto 6110011, Japan; [Makino, Keisuke] Kyoto Univ, Innovat Collaborat Ctr, Sakyo Ku, Kyoto 6068501, Japan; [Watanabe, Seiya; Makino, Keisuke] Japan Sci & Technol Agcy, CREST, Kyoto 6110011, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Watanabe, S (corresponding author), Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan.	irab@iae.kyoto-u.ac.jp						Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; BADIA J, 1991, J BACTERIOL, V173, P5144, DOI 10.1128/jb.173.16.5144-5150.1991; Barbosa JARG, 2000, J MOL BIOL, V303, P405, DOI 10.1006/jmbi.2000.4138; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; DAHMS AS, 1972, J BIOL CHEM, V247, P2228; DAHMS AS, 1972, J BIOL CHEM, V247, P2233; DAHMS AS, 1969, BIOCHEM BIOPH RES CO, V36, P809, DOI 10.1016/0006-291X(69)90681-0; DAHMS AS, 1972, J BIOL CHEM, V247, P2222; DAHMS AS, 1972, J BIOL CHEM, V247, P2238; EGAN SM, 1993, J MOL BIOL, V234, P87, DOI 10.1006/jmbi.1993.1565; Elshafei AM, 2001, ENZYME MICROB TECH, V29, P76, DOI 10.1016/S0141-0229(01)00346-5; GENNADY PM, 2002, HDB DETECTION ENZYME, P27; Halak S, 2007, J BACTERIOL, V189, P6998, DOI 10.1128/JB.00611-07; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Hosoya S, 2002, FEMS MICROBIOL LETT, V210, P193, DOI 10.1111/j.1574-6968.2002.tb11180.x; HUFF E, 1959, J BIOL CHEM, V234, P1060; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACGEE J, 1954, J BIOL CHEM, V210, P617; Masai E, 1999, J BACTERIOL, V181, P55, DOI 10.1128/JB.181.1.55-62.1999; Moore S, 1940, J BIOL CHEM, V133, P293; OTANI M, 1986, J BACTERIOL, V167, P148, DOI 10.1128/jb.167.1.148-152.1986; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Poysti NJ, 2007, MICROBIOL-SGM, V153, P727, DOI 10.1099/mic.0.29148-0; Rakus JF, 2007, BIOCHEMISTRY-US, V46, P12896, DOI 10.1021/bi701703w; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; RIGO LU, 1985, CAN J MICROBIOL, V31, P817, DOI 10.1139/m85-153; Sambrook J., 2001, MOL CLONING LAB MANU; Samland AK, 2006, APPL MICROBIOL BIOT, V71, P253, DOI 10.1007/s00253-006-0422-6; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Toda Tosifusa, 1997, Japanese Journal of Electrophoresis, V41, P13; TWERDOCHLIB AL, 1994, CAN J MICROBIOL, V40, P896, DOI 10.1139/m94-144; Wang WJ, 2005, BIOCHEMISTRY-US, V44, P9447, DOI 10.1021/bi050607y; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Watanabe S, 2007, J BIOL CHEM, V282, P6685, DOI 10.1074/jbc.M611057200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200; Yamamoto K, 2001, J BIOCHEM, V129, P303, DOI 10.1093/oxfordjournals.jbchem.a002858; Yew WS, 2007, BIOCHEMISTRY-US, V46, P9564, DOI 10.1021/bi7008882; Yew WS, 2006, BIOCHEMISTRY-US, V45, P14582, DOI 10.1021/bi061687o	46	52	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20372	20382		10.1074/jbc.M801065200	http://dx.doi.org/10.1074/jbc.M801065200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18505728	hybrid			2022-12-27	WOS:000257565300053
J	Cohen, A; Ben-Abu, Y; Hen, S; Zilberberg, N				Cohen, Asi; Ben-Abu, Yuval; Hen, Shelly; Zilberberg, Noam			A novel mechanism for human K(2P)2.1 channel Gating - Facilitation of C-type gating by protonation of extracellular histidine residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN K+ CHANNELS; POLYUNSATURATED FATTY-ACIDS; SHAKER POTASSIUM CHANNELS; 2-PORE DOMAIN; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; TREK-1; PORE; PH; INHIBITION	The mammalian K(2P)2.1 potassium channel (TREK-1, KCNK2) is highly expressed in excitable tissues, where it plays a key role in the cellular mechanisms of neuroprotection, anesthesia, pain perception, and depression. Here, we report that external acidification, within the physiological range, strongly inhibits the human K(2P)2.1 channel by inducing "C-type" closure. We have identified two histidine residues (i.e. His-87 and His-141), located in the first external loop of the channel, that govern the response of the channel to external pH. We demonstrate that these residues are within physical proximity to glutamate 84, homologous to Shaker Glu-418, KcsA Glu-51, and KCNK0 Glu-28 residues, all previously argued to stabilize the outer pore gate in the open conformation by forming hydrogen bonds with pore-adjacent residues. We thus propose a novel mechanism for pH sensing in which protonation of His-141 and His-87 generates a local positive charge that serves to draw Glu-84 away from its natural interactions, facilitating the collapse of the selectivity filter region. In accordance with this proposed mechanism, low pH modified K(2P)2.1 selectivity toward potassium. Moreover, the proton-mediated effect was inhibited by external potassium ions and was enhanced by a mutation (S164Y) known to accelerate C-type gating. Furthermore, proton-induced current inhibition was more pronounced at negative potentials. Thus, voltage-dependent C-type gating acceleration by protons represents a novel mechanism for K(2P)2.1 outward rectification.	[Zilberberg, Noam] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Zilberberg, N (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	noamz@bgu.ac.il	Zilberberg, Noam/F-2005-2012; Abu, Yuval Ben/AAD-1402-2020	Zilberberg, Noam/0000-0002-7848-2391				Aimond F, 2000, J BIOL CHEM, V275, P39110, DOI 10.1074/jbc.M008192200; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Claydon TW, 2004, BIOPHYS J, V87, P2407, DOI 10.1529/biophysj.103.039073; Cohen A, 2006, J NEUROSCI METH, V153, P62, DOI 10.1016/j.jneumeth.2005.10.005; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Harinath S, 2005, EPILEPSY RES, V64, P127, DOI 10.1016/j.eplepsyres.2005.03.002; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Koh SD, 2001, J BIOL CHEM, V276, P44338, DOI 10.1074/jbc.M108125200; La JH, 2006, NEUROSCI LETT, V406, P244, DOI 10.1016/j.neulet.2006.07.039; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2002, BIOCHEM BIOPH RES CO, V292, P339, DOI 10.1006/bbrc.2002.6674; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Morton MJ, 2005, P NATL ACAD SCI USA, V102, P16102, DOI 10.1073/pnas.0506870102; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347; Ortega-Saenz P, 2000, J GEN PHYSIOL, V116, P181, DOI 10.1085/jgp.116.2.181; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Starkus JG, 2003, PFLUG ARCH EUR J PHY, V447, P44, DOI 10.1007/s00424-003-1121-0; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; Steidl JV, 1999, MOL PHARMACOL, V55, P812; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	46	69	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19448	19455		10.1074/jbc.M801273200	http://dx.doi.org/10.1074/jbc.M801273200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18474599	hybrid			2022-12-27	WOS:000257387600031
J	Huang, J; Shelton, JM; Richardson, JA; Kamm, KE; Stull, JT				Huang, Jian; Shelton, John M.; Richardson, James A.; Kamm, Kristine E.; Stull, James T.			Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; SMOOTH-MUSCLE; CA2+ SENSITIVITY; Z-LINES; CALMODULIN; KINASE; KINETICS; PROTEIN; CONTRACTION; CALCIUM	Hyperphosphorylation of myosin regulatory light chain (RLC) in cardiac muscle is proposed to cause compensatory hypertrophy. We therefore investigated potential mechanisms in genetically modified mice. Transgenic (TG) mice were generated to overexpress Ca2+/calmodulin-dependent myosin light chain kinase specifically in cardiomyocytes. Phosphorylation of sarcomeric cardiac RLC and cytoplasmic nonmuscle RLC increased markedly in hearts from TG mice compared with hearts from wild-type (WT) mice. Quantitative measures of RLC phosphorylation revealed no spatial gradients. No significant hypertrophy or structural abnormalities were observed up to 6 months of age in hearts of TG mice compared with WT animals. Hearts and cardiomyocytes from WT animals subjected to voluntary running exercise and isoproterenol treatment showed hypertrophic cardiac responses, but the responses for TG mice were attenuated. Additional biochemical measurements indicated that overexpression of the Ca2+/calmodulin-binding kinase did not perturb other Ca2+/calmodulin-dependent processes involving Ca2+/calmodulin-dependent protein kinase II or the protein phosphatase calcineurin. Thus, increased myosin RLC phosphorylation per se does not cause cardiac hypertrophy and probably inhibits physiological and pathophysiological hypertrophy by contributing to enhanced contractile performance and efficiency.	[Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Stull, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			NHLBI NIH HHS [HL06296, HL080536] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080536, P01HL006296] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; Buck SH, 1999, AM J PHYSIOL-HEART C, V276, pH1167, DOI 10.1152/ajpheart.1999.276.4.H1167; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Dudnakova TV, 2006, CELL MOTIL CYTOSKEL, V63, P375, DOI 10.1002/cm.20127; Epstein ND, 2006, CIRC RES, V98, P1110, DOI 10.1161/01.RES.0000223888.99864.3c; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; HIGH CW, 1980, AM J PHYSIOL, V239, pH756, DOI 10.1152/ajpheart.1980.239.6.H756; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Maier LS, 2006, J MOL CELL CARDIOL, V41, P451, DOI 10.1016/j.yjmcc.2006.04.020; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Metrich M, 2008, CIRC RES, V102, P959, DOI 10.1161/CIRCRESAHA.107.164947; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; Moss RL, 2006, CIRC RES, V99, P225, DOI 10.1161/01.RES.0000236793.88131.dc; Nart P, 2004, J COMP PATHOL, V130, P235, DOI 10.1016/j.jcpa.2003.11.002; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Patel JR, 1998, BIOPHYS J, V74, P360, DOI 10.1016/S0006-3495(98)77793-8; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; SEGUCHI O, J CLIN INVESTIG, V117, P2812; SHEEHAN DC, 1980, THEORY PRACTICE HIST, P40; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; STULL JT, 1990, J BIOL CHEM, V265, P16683; STULL JT, 1982, J MOL CELL CARDIOL, V14, P105, DOI 10.1016/0022-2828(82)90137-7; STULL JT, 1986, ENZYMES, P113; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P414, DOI 10.1073/pnas.87.1.414; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Takeda K, 2000, CELL MOTIL CYTOSKEL, V46, P59, DOI 10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; WALSH MP, 1979, J BIOL CHEM, V254, P2136; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; WOLF H, 1980, P NATL ACAD SCI-BIOL, V77, P5852, DOI 10.1073/pnas.77.10.5852; Woods A, 1994, LAB HISTOPATHOLOGY C; Wu X, 2007, CELL CALCIUM, V41, P353, DOI 10.1016/j.ceca.2006.07.011; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102; ZHI G, 1994, J BIOL CHEM, V269, P24723; Zhi G, 1998, J BIOL CHEM, V273, P8951, DOI 10.1074/jbc.273.15.8951; ZIMMERMANN B, 1995, J BIOL CHEM, V270, P23966, DOI 10.1074/jbc.270.41.23966	50	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19748	19756		10.1074/jbc.M802605200	http://dx.doi.org/10.1074/jbc.M802605200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18474588	hybrid, Green Published			2022-12-27	WOS:000257387600059
J	Miller, BM; Trybus, KM				Miller, Becky M.; Trybus, Kathleen M.			Functional effects of nemaline myopathy mutations on human skeletal alpha-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN; MUSCLE ACTIN; WILD-TYPE; HYPERTROPHIC CARDIOMYOPATHY; PROTEOLYTIC REMOVAL; CRYSTAL-STRUCTURE; MONOMERIC ACTIN; BETA-ACTIN; MYOSIN; POLYMERIZATION	Mutations in human alpha-skeletal actin have been implicated in causing congenital nemaline myopathy, a disease characterized histopathologically by nemaline bodies in skeletal muscle and manifested in the patient as skeletal muscle weakness. Here we investigate the functional effects of three severe nemaline myopathy mutations (V43F, A138P, and R183G) in human alpha-skeletal actin. Wild-type and mutant actins were expressed and purified from the baculovirus/insect cell expression system. The mutations are located in different subdomains of actin; Val-43 is located in a flexible loop of subdomain 2, Ala-138 is near a hydrophobic cleft in the "hinge" region between subdomains 1 and 3, and Arg-183 is near the nucleotide-binding site. None of the three mutations affected the folding of the actin monomer, the velocity at which skeletal myosin moves actin in an in vitro motility assay, or the relative average isometric force supported by F-actin. Defects in fundamental actomyosin interactions are, therefore, unlikely to account for the muscle weakness observed in affected patients. There were, however, significant changes observed in the polymerization kinetics of V43F and A138P and in the rate of nucleotide release for V43F. No detectable defect was found for R183G. If these subtle changes in polymerization observed in vitro are amplified in the context of the sarcomere, it could in principle be one of the primary insults that triggers the development of nemaline myopathy.	[Miller, Becky M.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Phys & Biophys, Burlington, VT 05405 USA	University of Vermont	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Phys & Biophys, 149 Beaumont Ave, Burlington, VT 05405 USA.	trybus@physiology.med.uvm.edu			NHLBI NIH HHS [HL059408, T32 HL07647, T32 HL007944] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408, T32HL007647, T32HL007944] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Akkari PA, 2003, BIOCHEM BIOPH RES CO, V307, P74, DOI 10.1016/S0006-291X(03)01133-1; Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Bathe FS, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-2; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Bing W, 2000, BIOCHEM J, V350, P693, DOI 10.1042/0264-6021:3500693; BLIKSTAD I, 1978, CELL, V15, P935, DOI 10.1016/0092-8674(78)90277-5; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Brault V, 1999, MOL BIOL CELL, V10, P135, DOI 10.1091/mbc.10.1.135; Buzan J, 1999, P NATL ACAD SCI USA, V96, P2823, DOI 10.1073/pnas.96.6.2823; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; CONEN PE, 1963, CAN MED ASSOC J, V89, P983; Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172; D'Amico A, 2006, NEUROMUSCULAR DISORD, V16, P548, DOI 10.1016/j.nmd.2006.07.005; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Dominguez R, 2003, BIOPHYS J, V85, P2073, DOI 10.1016/S0006-3495(03)74635-9; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Ilkovski B, 2004, HUM MOL GENET, V13, P1727, DOI 10.1093/hmg/ddh185; Joel PB, 2004, BIOCHEMISTRY-US, V43, P11554, DOI 10.1021/bi048899a; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KARPATI G, 1972, ARCH NEUROL-CHICAGO, V27, P237, DOI 10.1001/archneur.1972.00490150045008; KAWABUCHI M, 1982, J NEUROPATH EXP NEUR, V41, P298, DOI 10.1097/00005072-198205000-00005; Kim E, 2002, BIOCHEMISTRY-US, V41, P86, DOI 10.1021/bi0113824; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Malmqvist UP, 2004, BIOCHEMISTRY-US, V43, P15058, DOI 10.1021/bi0495329; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Marston S, 2004, NEUROMUSCULAR DISORD, V14, P167, DOI 10.1016/j.nmd.2003.11.003; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MOSSAKOWSKA M, 1993, BIOCHEM J, V289, P897, DOI 10.1042/bj2890897; Nowak KJ, 2007, ANN NEUROL, V61, P175, DOI 10.1002/ana.21035; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Procaccio V, 2006, AM J HUM GENET, V78, P947, DOI 10.1086/504271; Rommelaere Heidi, 2004, Biol Proced Online, V6, P235, DOI 10.1251/bpo94; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Rutkevich LA, 2006, CAN J PHYSIOL PHARM, V84, P111, DOI 10.1139/Y05-140; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Sanoudou D, 2006, HUM MOL GENET, V15, P2603, DOI 10.1093/hmg/ddl186; Schuler H, 2000, EUR J BIOCHEM, V267, P476, DOI 10.1046/j.1432-1327.2000.01023.x; SHY GM, 1963, BRAIN, V86, P793, DOI 10.1093/brain/86.4.793; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; SPARROW JC, 1992, SYM SOC EXP BIOL, V46, P111; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; WERTMAN KF, 1992, GENETICS, V132, P337; YAMAGUCHI M, 1982, J NEUROL SCI, V56, P35, DOI 10.1016/0022-510X(82)90059-4	61	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19379	19388		10.1074/jbc.M801963200	http://dx.doi.org/10.1074/jbc.M801963200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18477565	Green Published, hybrid			2022-12-27	WOS:000257387600024
J	Mor-Cohen, R; Rosenberg, N; Landau, M; Lahav, J; Seligsohn, U				Mor-Cohen, Ronit; Rosenberg, Nurit; Landau, Meytal; Lahav, Judith; Seligsohn, Uri			Specific cysteines in beta 3 are involved in disulfide bond exchange-dependent and -independent activation of alpha IIb beta 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; GPIIB-IIIA; GLYCOPROTEIN-IIB; DOMAIN BINDS; EGF-LIKE; REVEALS; THROMBASTHENIA; DISRUPTION; INTEGRINS; ISOMERASE	Disulfide bond exchange among cysteine residues in epidermal growth factor (EGF)-like domains of beta 3 was suggested to be involved in activation of alpha IIb beta 3. To investigate the role of specific beta 3 cysteines in alpha IIb beta 3 expression and activation, we expressed in baby hamster kidney cells normal alpha IIb with normal beta 3 or beta 3 with single or double cysteine substitutions of nine disulfide bonds in EGF-3, EGF-4, and beta-tail domains and assessed alpha IIb beta 3 surface expression and activation state by flow cytometry using P2 or PAC-1 antibodies, respectively. Most mutants displayed reduced surface expression of alpha IIb beta 3. Disruptions of disulfide bonds in EGF-3 yielded constitutively active alpha IIb beta 3, implying that these bonds stabilize the inactive alpha IIb beta 3 conformer. Mutants of the Cys-567-Cys-581 bond in EGF-4 were inactive even after exposure to alpha IIb beta 3-activating antibodies, indicating that this bond is necessary for activating alpha IIb beta 3. Disrupting Cys-560-Cys-583 in the EGF-3/EGF-4 or Cys-608-Cys-655 in beta-tail domain resulted in alpha IIb beta 3 activation only when Cys-560 or Cys-655 of each pair was mutated but not when their partners (Cys-583, Cys-608) or both cysteines were mutated, suggesting that free sulfhydryls of Cys-583 and Cys-608 participate in alpha IIb beta 3 activation by a disulfide bond exchange-dependent mechanism. The free sulfhydryl blocker dithiobisnitrobenzoic acid inhibited 70% of anti-LIBS6 antibody-induced activation of wild-type alpha IIb beta 3 and had a smaller effect on mutants, implicating disulfide bond exchange-dependent and -independent mechanisms in alpha IIb beta 3 activation. These data suggest that different disulfide bonds in beta 3 EGF and beta-tail domains play variable structural and regulatory roles in alpha IIb beta 3.	[Seligsohn, Uri] Chaim Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Landau, Meytal] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Lahav, Judith] Beilinson Med Ctr, Hemostasis Lab, IL-49100 Petah Tiqwa, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Rabin Medical Center	Seligsohn, U (corresponding author), Chaim Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel.	seligson@sheba.health.gov.il	Mor-Cohen, Ronit/AAB-8657-2020; Landau, Meytal/AAF-3479-2021; Landau, Meytal/J-3075-2012	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430				Ambo H, 1998, BIOCHEM BIOPH RES CO, V251, P763, DOI 10.1006/bbrc.1998.9526; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Butta N, 2003, BLOOD, V102, P2491, DOI 10.1182/blood-2003-01-0213; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x; Chen P, 2001, J BIOL CHEM, V276, P38628, DOI 10.1074/jbc.M105737200; Chen VM, 2006, J THROMB HAEMOST, V4, P2533, DOI 10.1111/j.1538-7836.2006.02236.x; DU XP, 1993, J BIOL CHEM, V268, P23087; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Robinson A, 2006, BRIT J HAEMATOL, V132, P339, DOI 10.1111/j.1365-2141.2005.05878.x; Ruiz C, 2001, BLOOD, V98, P2432, DOI 10.1182/blood.V98.8.2432; SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; Yatuv R, 2001, BLOOD, V98, P1063, DOI 10.1182/blood.V98.4.1063	43	48	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19235	19244		10.1074/jbc.M802399200	http://dx.doi.org/10.1074/jbc.M802399200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18458089	hybrid			2022-12-27	WOS:000257387600009
J	Faisal, A; Saurin, A; Gregory, B; Foxwell, B; Parker, PJ				Faisal, Amir; Saurin, Adrian; Gregory, Bernard; Foxwell, Brian; Parker, Peter J.			The scaffold MyD88 acts to couple protein kinase C epsilon to toll-like receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; PKC-EPSILON; MACROPHAGE ACTIVATION; REGULATORY FACTOR-3; LIPOPOLYSACCHARIDE; ALPHA; CELLS; ZETA; PHOSPHORYLATION	Mice lacking protein kinase C epsilon(PKC epsilon) are hypersensitive to both Gram-positive and Gram-negative bacterial infections; however, the mechanism of PKC epsilon coupling to the Toll-like receptors (TLRs), responsible for pathogen detection, is poorly understood. Here we sought to investigate the mechanism of PKC epsilon involvement in TLR signaling and found that PKC epsilon is recruited to TLR4 and phosphorylated on two recently identified sites in response to lipopolysaccharide (LPS) stimulation. Phosphorylation at both of these sites (Ser-346 and Ser-368) resulted in PKC epsilon binding to 14-3-3 beta. LPS-induced PKC epsilon phosphorylation, 14-3-3 beta binding, and recruitment to TLR4 were all dependent on expression of the scaffold protein MyD88. In mouse embryo fibroblasts and activated macrophages from MyD88 knock-out mice, LPS-stimulated PKC epsilon phosphorylation was reduced compared with wild type cells. Acute knockdown of MyD88 in LPS-responsive 293 cells also resulted in complete loss of Ser-346 phosphorylation and TLR4/PKC epsilon association. By contrast, MyD88 overexpression in 293 cells resulted in constitutive phosphorylation of PKC epsilon. A general role for MyD88 was evidenced by the finding that phosphorylation of PKC epsilon was induced by the activation of all TLRs tested that signal through MyD88 (i.e. all except TLR3) both in RAW cells and in primary human macrophages. Functionally, it is established that phosphorylation of PKC epsilon at these two sites is required for TLR4- and TLR2-induced NF kappa B reporter activation and I kappa B degradation in reconstituted PKC epsilon(-/-) cells. This study therefore identifies the scaffold protein MyD88 as the link coupling TLRs to PKC epsilon recruitment, phosphorylation, and downstream signaling.	[Faisal, Amir; Saurin, Adrian; Parker, Peter J.] London Res Inst, Prot Phosphorylat Lab, London WC2A 3PX, England; [Gregory, Bernard; Foxwell, Brian] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Kennedy Inst, London SW7 2AZ, England; [Parker, Peter J.] Kings Coll London, Guys Hosp, Div Canc Studies, London SE1 1UL, England	Imperial College London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Parker, PJ (corresponding author), 44 Lincolns Inn Fields, London WC2A 3PX, England.	peter.parker@cancer.org.uk	Parker, Peter j/D-5192-2013; Faisal, Amir/AAE-8992-2020	Faisal, Amir/0000-0002-7376-8286; Saurin, Adrian/0000-0001-9317-2255; parker, peter/0000-0002-6218-2933				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aksoy E, 2002, EUR J IMMUNOL, V32, P3040, DOI 10.1002/1521-4141(200211)32:11<3040::AID-IMMU3040>3.0.CO;2-M; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Chano F, 2002, EUR J IMMUNOL, V32, P2897, DOI 10.1002/1521-4141(2002010)32:10<2897::AID-IMMU2897>3.0.CO;2-J; Cuschieri J, 2004, J SURG RES, V121, P76, DOI 10.1016/j.jss.2004.04.005; Dallot E, 2005, BIOCHIMIE, V87, P513, DOI 10.1016/j.biochi.2005.02.009; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Durgan J, 2008, BIOCHEM J, V411, P319, DOI [10.1042/BJ20071348, 10.1042/bj20071348]; Durgan J, 2007, FEBS LETT, V581, P3377, DOI 10.1016/j.febslet.2007.06.035; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foxwell B, 1998, P NATL ACAD SCI USA, V95, P8211, DOI 10.1073/pnas.95.14.8211; Giroux M, 2000, J IMMUNOL, V165, P3985, DOI 10.4049/jimmunol.165.7.3985; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Johnson J, 2007, J BIOL CHEM, V282, P15022, DOI 10.1074/jbc.M700421200; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Monick MM, 2000, J IMMUNOL, V165, P4632, DOI 10.4049/jimmunol.165.8.4632; Monick MM, 1999, J IMMUNOL, V162, P3005; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Sheedy FJ, 2007, J LEUKOCYTE BIOL, V82, P196, DOI 10.1189/jlb.1206750; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tschaikowsky K, 1998, J PHARMACOL EXP THER, V285, P800; Valledor AF, 2000, J IMMUNOL, V164, P29, DOI 10.4049/jimmunol.164.1.29; Xu SJ, 2005, ACTA PHARMACOL SIN, V26, P1497, DOI 10.1111/j.1745-7254.2005.00217.x; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	43	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18591	18600		10.1074/jbc.M710330200	http://dx.doi.org/10.1074/jbc.M710330200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18458086	hybrid			2022-12-27	WOS:000257165600015
J	Kumar, KGS; Varghese, B; Banerjee, A; Baker, DP; Constantinescu, SN; Pellegrini, S; Fuchs, SY				Kumar, K. G. Suresh; Varghese, Bentley; Banerjee, Anamika; Baker, Darren P.; Constantinescu, Stefan N.; Pellegrini, Sandra; Fuchs, Serge Y.			Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MONOCLONAL-ANTIBODIES; TYK2; SIGNALS; BINDING; REGION; PHOSPHORYLATION; JANUS-KINASE-2; LOCALIZATION; DEGRADATION	Linear endocytic motifs of signaling receptors as well as their ubiquitination determine the rate of ligand-induced endocytosis that mediates down-regulation of these receptors and restricts the magnitude and duration of their respective signal transduction pathways. We previously hypothesized that, in the absence of its cognate ligand, type I interferon (IFN), the IFN alpha receptor chain 1 (IFNAR1) receptor chain is protected from basal endocytosis by a hypothetical masking complex that prevents the Tyr-based endocytic motif within IFNAR1 from interacting with components of the adaptin protein complex 2 (AP2). Here we identify a member of the Janus kinase (Jak) family, Tyk2, as a component of such a masking complex. In the absence of ligand or of receptor chain ubiquitination, binding of Janus kinase Tyk2 within the proximity of the Tyr-based linear motif of IFNAR1 is required to prevent IFNAR1 internalization and to maintain its cell surface expression. Furthermore, interaction experiments revealed that Tyk2 physically shields this Tyr-based motif from the recognition by the AP50 subunit of AP2. These data delineate a long-sought ligand- and ubiquitin-independent mechanism by which Tyk2 contributes to both the regulation of total IFNAR1 levels as well as the regulation of the cell surface density of this receptor chain.	[Kumar, K. G. Suresh; Varghese, Bentley; Banerjee, Anamika; Fuchs, Serge Y.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [Kumar, K. G. Suresh; Varghese, Bentley; Banerjee, Anamika; Fuchs, Serge Y.] Univ Penn, Mari Lowe Ctr Comparat Oncol Res, Philadelphia, PA 19104 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Constantinescu, Stefan N.] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Constantinescu, Stefan N.] Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium; [Pellegrini, Sandra] Inst Pasteur, CNRS, URA 1961, Unite Signalisat Cytokines, F-75724 Paris, France	University of Pennsylvania; University of Pennsylvania; Biogen; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fuchs, SY (corresponding author), Univ Penn, Dept Anim Biol, 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Pellegrini, Sandra -/G-5546-2015; Pellegrini, Sandra/Y-6351-2019; Constantinescu, Stefan N/E-5277-2012	Pellegrini, Sandra -/0000-0001-5837-7589; Pellegrini, Sandra/0000-0001-5837-7589; 	NATIONAL CANCER INSTITUTE [R01CA092900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073347] Funding Source: NIH RePORTER; NCI NIH HHS [CA92900, R01 CA092900-08, R01 CA092900] Funding Source: Medline; NIAID NIH HHS [R21 AI073347, R21 AI073347-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; GalchevaGargova Z, 1995, ONCOGENE, V11, P2649; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; He K, 2005, ENDOCRINOLOGY, V146, P4755, DOI 10.1210/en.2005-0514; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Holler D, 2004, BIOCHEM PHARMACOL, V67, P1013, DOI 10.1016/j.bcp.2004.01.003; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Jabbour H N, 1997, Rev Reprod, V2, P14; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jung N, 2007, TRAFFIC, V8, P1129, DOI 10.1111/j.1600-0854.2007.00595.x; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2003, EMBO J, V22, P5480; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Radtke S, 2006, J BIOL CHEM, V281, P4024, DOI 10.1074/jbc.M511779200; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Ragimbeau J, 2001, J BIOL CHEM, V276, P30812, DOI 10.1074/jbc.M103559200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; SMYTHE E, 1991, EUR J BIOCHEM, V202, P689, DOI 10.1111/j.1432-1033.1991.tb16424.x; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yan H, 1996, MOL CELL BIOL, V16, P2074	41	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18566	18572		10.1074/jbc.M800991200	http://dx.doi.org/10.1074/jbc.M800991200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18474601	hybrid, Green Published			2022-12-27	WOS:000257165600012
J	El-Sayed, A; Khalil, IA; Kogure, K; Futaki, S; Harashima, H				El-Sayed, Ayman; Khalil, Ikramy A.; Kogure, Kentaro; Futaki, Shiroh; Harashima, Hideyoshi			Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; ARGININE-RICH PEPTIDES; TAT-FUSION PROTEINS; HUMAN IMMUNODEFICIENCY VIRUS; INTRACELLULAR TRAFFICKING; NUCLEAR DELIVERY; MEMBRANE-FUSION; ENTERS CELLS; NANO DEVICE; TRANSDUCTION	The present study examines the role of surface modification with an octaarginine peptide (R8) in liposomal escape from endocytic vesicles, using octalysine (K8) as a control cationic peptide; the mechanism of endosomal escape of liposomes was also investigated. Gene expression of condensed plasmid DNA encapsulated in R8-modified nanoparticles was more than 1 order of magnitude higher than that of K8-modified nanoparticles, and 2 orders of magnitude higher than gene expression using unmodified nanoparticles. The difference in gene expression could not be attributed to differences in uptake, as R8- and K8-modified liposomes were taken up primarily via macropinocytosis with comparable efficiency. The extent of R8-nanoparticle escape to the cytosol was double that of K8-nanoparticles. Suppression of endosome acidification inhibited R8-nanoparticle endosomal escape, but enhanced that of K8-nanoparticles. Using spectral imaging in live cells, we showed that R8- and K8-liposomes escaped from endocytic vesicles via fusion between the liposomes and the endosomal membrane. R8- liposomes fused efficiently at both acidic and neutral pH, whereas K8- liposomes fused only at neutral pH. Similar behavior was observed during in vitro lipid mixing and calcein-release experiments. Co-incubation of cells with distinctly labeled K8- and R8-modified nanoparticles confirmed a common uptake pathway and different rates of endosomal escape particularly at longer time intervals. Therefore, it was concluded that R8 on the liposome surface stimulates efficient escape from endocytic vesicles via a fusion mechanism that works at both neutral and acidic pH; in contrast, K8 mediates escape mainly at neutral pH.	[El-Sayed, Ayman; Khalil, Ikramy A.; Kogure, Kentaro; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0608012, Japan; [Kogure, Kentaro] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078414, Japan; [Futaki, Shiroh] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [El-Sayed, Ayman; Khalil, Ikramy A.; Harashima, Hideyoshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Futaki, Shiroh] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Kyoto Pharmaceutical University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Harashima, H (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0608012, Japan.	harasima@pharm.hokudai.ac.jp	Harashima, Hideyoshi/D-8390-2012; khalil, ikramy A./T-7523-2019	khalil, ikramy A./0000-0001-9417-7437; Futaki, Shiroh/0000-0002-0124-4002; El-Sayed, Ayman/0000-0001-6740-7639	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by grants-in-aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by grants-in-aid for Scientific Research on Priority Areas from the Japan Society for the Promotion of Science.	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Akita H, 2004, MOL THER, V9, P443, DOI 10.1016/j.ymthe.2004.01.005; Al-Taei S, 2006, BIOCONJUGATE CHEM, V17, P90, DOI 10.1021/bc050274h; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brabec M, 2005, J VIROL, V79, P1008, DOI 10.1128/JVI.79.2.1008-1016.2005; Caron NJ, 2004, BIOCHEM BIOPH RES CO, V319, P12, DOI 10.1016/j.bbrc.2004.04.180; Cryan SA, 2006, MOL PHARMACEUT, V3, P104, DOI 10.1021/mp050070i; DEKRUIJFF B, 1985, BIOCHIM BIOPHYS ACTA, V820, P295, DOI 10.1016/0005-2736(85)90124-5; DEKRUIJFF B, 1980, BIOCHIM BIOPHYS ACTA, V601, P235, DOI 10.1016/0005-2736(80)90528-3; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Hitz T, 2006, BIOCHEMISTRY-US, V45, P5817, DOI 10.1021/bi060285d; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Iwasa A, 2006, BBA-BIOMEMBRANES, V1758, P713, DOI 10.1016/j.bbamem.2006.04.015; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kogure K, 2004, J CONTROL RELEASE, V98, P317, DOI 10.1016/j.jconrel.2004.04.024; Magzoub M, 2005, BIOCHEMISTRY-US, V44, P14890, DOI 10.1021/bi051356w; Mai JC, 2002, J BIOL CHEM, V277, P30208, DOI 10.1074/jbc.M204202200; Malecki J, 2002, EMBO J, V21, P4480, DOI 10.1093/emboj/cdf472; MEERS P, 1988, BIOCHEMISTRY-US, V27, P4430, DOI 10.1021/bi00412a033; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Midoux P, 1999, BIOCONJUGATE CHEM, V10, P406, DOI 10.1021/bc9801070; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakamura Y, 2007, J CONTROL RELEASE, V119, P360, DOI 10.1016/j.jconrel.2007.03.010; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Potocky TB, 2005, J AM CHEM SOC, V127, P3686, DOI 10.1021/ja042566j; Potocky TB, 2003, J BIOL CHEM, V278, P50188, DOI 10.1074/jbc.M308719200; Potocky TB, 2007, CHEMBIOCHEM, V8, P917, DOI 10.1002/cbic.200600563; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; ROUX M, 1988, EUR BIOPHYS J BIOPHY, V16, P267, DOI 10.1007/BF00254062; Sakai N, 2003, J AM CHEM SOC, V125, P14348, DOI 10.1021/ja037601l; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; SUBTIL A, 1994, J CELL SCI, V107, P3461; Tachibana R, 2003, METHOD ENZYMOL, V372, P349; Thoren PEG, 2005, BIOPHYS CHEM, V114, P169, DOI 10.1016/j.bpc.2004.11.016; Tilstra J, 2007, BIOCHEM SOC T, V35, P811, DOI 10.1042/BST0350811; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; Yang LL, 2003, CANCER RES, V63, P831	53	162	164	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23450	23461		10.1074/jbc.M709387200	http://dx.doi.org/10.1074/jbc.M709387200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550548	hybrid			2022-12-27	WOS:000258455400054
J	Laurence, TA; Kwon, Y; Johnson, A; Hollars, CW; O'Donnell, M; Camarero, JA; Barsky, D				Laurence, Ted A.; Kwon, Youngeun; Johnson, Aaron; Hollars, Christopher W.; O'Donnell, Mike; Camarero, Julio A.; Barsky, Daniel			Motion of a DNA sliding clamp observed by single molecule fluorescence spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III HOLOENZYME; CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI; LAGGING-STRAND; COMPLEX; PCNA; BETA; PROTEINS; TRANSCRIPTION; REPLICATION	DNA sliding clamps attach to polymerases and slide along DNA to allow rapid, processive replication of DNA. These clamps contain many positively charged residues that could curtail the sliding due to attractive interactions with the negatively charged DNA. By single-molecule spectroscopy we have observed a fluorescently labeled sliding clamp (polymerase III beta subunit or beta clamp) loaded onto freely diffusing, single-stranded M13 circular DNA annealed with fluorescently labeled DNA oligomers of up to 90 bases. We find that the diffusion constant for the beta clamp diffusing along DNA is on the order of 10(-14) m(2)/s, at least 3 orders of magnitude less than that for diffusion through water alone. We also find evidence that the beta clamp remains at the 3' end in the presence of Escherichia coli single-stranded-binding protein. These results may imply that the clamp not only acts to hold the polymerase on the DNA but also prevents excessive drifting along the DNA.	[Laurence, Ted A.; Kwon, Youngeun; Hollars, Christopher W.; Camarero, Julio A.; Barsky, Daniel] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Johnson, Aaron; O'Donnell, Mike] Rockefeller Univ, New York, NY 10065 USA; [Johnson, Aaron; O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10065 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Rockefeller University; Howard Hughes Medical Institute	Laurence, TA (corresponding author), Lawrence Livermore Natl Lab, POB 5508, Livermore, CA 94550 USA.	laurence2@llnl.gov; barsky@llnl.gov	Camarero, Julio A./A-9628-2015; Laurence, Ted A/E-4791-2011	Camarero, Julio A./0000-0001-9150-0665; Laurence, Ted A/0000-0003-1474-779X; O'Donnell, Michael/0000-0001-9002-4214	Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; National Institutes of Health [GM38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed under the auspices of the United States Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. We thank Ceslovas Venclovas, Michael E. Colvin, and Kenneth S. Kim for valuable input on this project.; This work was supported, in whole or in part, by National Institutes of Health Grant GM38839 (to M.O.D.). This work was also supported by the laboratory directed research and development program at Lawrence Livermore National Laboratory (to T.A.L., J.A.C., and D.B.).	Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; FAY PJ, 1981, J BIOL CHEM, V256, P976; FRADKIN LG, 1992, J BIOL CHEM, V267, P10318; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; GRIEP MA, 1990, J BIOL CHEM, V265, P20356; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Laurence TA, 2004, J PHYS CHEM B, V108, P3051, DOI 10.1021/jp036499b; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Laurence TA, 2007, BIOPHYS J, V92, P2184, DOI 10.1529/biophysj.106.093591; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Redner S, 2001, GUIDE 1 PASSAGE PROC, P39; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Smiley RD, 2006, BIOCHEMISTRY-US, V45, P7990, DOI 10.1021/bi0603322; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Turner J, 1995, METHOD ENZYMOL, V262, P442; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Vivona JB, 2003, FEBS LETT, V546, P167, DOI 10.1016/S0014-5793(03)00622-7; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421	38	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22895	22906		10.1074/jbc.M800174200	http://dx.doi.org/10.1074/jbc.M800174200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556658	hybrid, Green Published			2022-12-27	WOS:000258455400003
J	Mak, BC; Wang, Q; Laschinger, C; Lee, W; Ron, D; Harding, HP; Kaufman, RJ; Scheuner, D; Austin, RC; McCulloch, CA				Mak, Baldwin C.; Wang, Qin; Laschinger, Carol; Lee, Wilson; Ron, David; Harding, Heather P.; Kaufman, Randal J.; Scheuner, Donalyn; Austin, Richard C.; McCulloch, Christopher A.			Novel function of PERK as a mediator of force-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTOR; MESSENGER-RNA; ER STRESS; ACTIN; ATF6; MECHANOPROTECTION	Induction of apoptosis by tensile forces is an important determinant of connective tissue destruction in osteoarthritis and periodontal diseases. We examined the role of molecular components of the unfolded protein response in force-induced apoptosis. Magnetic fields were used to apply tensile force through integrins to cultured fibroblasts bound with collagen-coated magnetite beads. Tensile force induced caspase 3 cleavage, DNA fragmentation, depolarization of mitochondria, and induction of CHOP10, all indicative of activation of apoptosis. Immunoblotting, immunocytochemistry, and release of Ca2+ from the endoplasmic reticulum showed evidence for both physical and functional associations between bound beads and the endoplasmic reticulum. Force-induced apoptosis was not detected in PERK null cells, but reconstitution of wild-type PERK in PERK null cells restored the apoptotic response. Force-induced apoptosis did not require PKR, GCN2, eIF2 alpha, or CHOP10. Furthermore, force more than 24 h did not activate other initiators of the unfolded protein response including IRE-1 and ATF6. However, force-induced activation of caspase 3 was dependent on caspase 9 but was independent of mitochondria. We conclude that force-induced apoptosis depends on a novel function of PERK that occurs in addition to its canonical role in the unfolded protein response.	[Mak, Baldwin C.; Wang, Qin; Laschinger, Carol; Lee, Wilson; McCulloch, Christopher A.] Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; [Ron, David; Harding, Heather P.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Kaufman, Randal J.; Scheuner, Donalyn] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.; Scheuner, Donalyn] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.; Scheuner, Donalyn] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Austin, Richard C.] McMaster Univ, Div Nephrol, Hamilton, ON L8N 4A6, Canada	University of Toronto; New York University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; McMaster University	McCulloch, CA (corresponding author), Univ Toronto, CIHR Grp Matrix Dynam, Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	mcculloch@utoronto.ca		Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636	National Institutes of Health [DK47119, ES08681, HL052173, DK42394]; Canadian Institutes of Health Research [418386]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173, P01HL057346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK047119, R29DK047119, R01DK042394, R37DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK47119 and ES08681 (to D. R. and H. P. H.) and HL052173 and DK42394 (to R. J. K.). This work was also supported by Canadian Institutes of Health Research Grant 418386 (to B. C. M., Q. W., C. L., W. L., and C. A. M.).	Arora PD, 2001, J BIOL CHEM, V276, P14100, DOI 10.1074/jbc.M010298200; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; GLOGAUER M, 1995, AM J PHYSIOL-CELL PH, V269, pC1093, DOI 10.1152/ajpcell.1995.269.5.C1093; Glogauer M, 1997, J CELL SCI, V110, P11; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; KULKARNI GV, 1995, J CELL PHYSIOL, V165, P119, DOI 10.1002/jcp.1041650115; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Malek AM, 1996, J CELL SCI, V109, P713; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; PENDER N, 1991, J CELL SCI, V100, P187; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; ROBERTS WE, 1974, ARCH ORAL BIOL, V19, P665, DOI 10.1016/0003-9969(74)90135-6; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Tran H, 2002, J CELL SCI, V115, P2031; Wang J, 2005, BIOCHEM BIOPH RES CO, V330, P123, DOI 10.1016/j.bbrc.2005.02.140; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi M, 2005, ARCH IMMUNOL THER EX, V53, P388; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	38	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23462	23472		10.1074/jbc.M803194200	http://dx.doi.org/10.1074/jbc.M803194200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550523	hybrid, Green Published			2022-12-27	WOS:000258455400055
J	Wang, LK; Nair, PA; Shuman, S				Wang, Li Kai; Nair, Pravin A.; Shuman, Stewart			Structure-guided mutational analysis of the OB, HhH, and BRCT domains of Escherichia coli DNA ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE INTERMEDIATE; MYCOBACTERIUM-TUBERCULOSIS; LIGATION; POLYNUCLEOTIDES; CRYSTAL; RV3014C; BINDING	NAD(+)-dependent DNA ligases (LigAs) are ubiquitous in bacteria and essential for growth. LigA enzymes have a modular structure in which a central catalytic core composed of nucleotidyltransferase and oligonucleotide-binding (OB) domains is linked via a tetracysteine zinc finger to distal helix-hairpin-helix (HhH) and BRCT (BRCA1-like C-terminal) domains. The OB and HhH domains contribute prominently to the protein clamp formed by LigA around nicked duplex DNA. Here we conducted a structure-function analysis of the OB and HhH domains of Escherichia coli LigA by alanine scanning and conservative substitutions, entailing 43 mutations at 22 amino acids. We thereby identified essential functional groups in the OB domain that engage the DNA phosphodiester backbone flanking the nick (Arg(333)); penetrate the minor grove and distort the nick (Val(383) and Ile(384)); or stabilize the OB fold (Arg(379)). The essential constituents of the HhH domain include: four glycines (Gly(455), Gly(489), Gly(521), Gly(553)), which bind the phosphate backbone across the minor groove at the outer margins of the LigA-DNA interface; Arg(487), which penetrates the minor groove at the outer margin on the 3'-OH side of the nick; and Arg(446), which promotes protein clamp formation via contacts to the nucleotidyltransferase domain. We find that the BRCT domain is required in its entirety for effective nick sealing and AMP-dependent supercoil relaxation.	[Wang, Li Kai; Nair, Pravin A.; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63611] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benarroch D, 2006, VIROLOGY, V353, P133, DOI 10.1016/j.virol.2006.04.032; Feng H, 2004, BIOCHEMISTRY-US, V43, P12648, DOI 10.1021/bi049451c; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; GUMPORT RI, 1971, P NATL ACAD SCI USA, V68, P2559, DOI 10.1073/pnas.68.10.2559; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; Kaczmarek FS, 2001, J BACTERIOL, V183, P3016, DOI 10.1128/JB.183.10.3016-3024.2001; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; Lim JH, 2001, ARCH BIOCHEM BIOPHYS, V388, P253, DOI 10.1006/abbi.2001.2291; LITTLE JW, 1967, P NATL ACAD SCI USA, V58, P2004, DOI 10.1073/pnas.58.5.2004; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; Lu J, 2004, BBA-PROTEINS PROTEOM, V1701, P37, DOI 10.1016/j.bbapap.2004.06.008; MODRICH P, 1972, J BIOL CHEM, V247, P6370; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; OLIVERA BM, 1968, P NATL ACAD SCI USA, V61, P237, DOI 10.1073/pnas.61.1.237; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Singleton MR, 1999, STRUCTURE, V7, P35, DOI 10.1016/S0969-2126(99)80007-0; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 2001, NUCLEIC ACIDS RES, V29, P4930, DOI 10.1093/nar/29.24.4930; Sriskanda V, 2001, J BIOL CHEM, V276, P36100, DOI 10.1074/jbc.M105643200; SRISKANDA V, 2002, J BIOL CHEM, V277, P9685; Srivastava SK, 2007, PROTEINS, V69, P97, DOI 10.1002/prot.21457; Srivastava SK, 2005, J BIOL CHEM, V280, P30273, DOI 10.1074/jbc.M503780200; Timson DJ, 1999, J MOL BIOL, V285, P73, DOI 10.1006/jmbi.1998.2302; Wilkinson A, 2005, BBA-PROTEINS PROTEOM, V1749, P113, DOI 10.1016/j.bbapap.2005.03.003; Zhu H, 2005, J BIOL CHEM, V280, P12137, DOI 10.1074/jbc.M413685200	25	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23343	23352		10.1074/jbc.M802945200	http://dx.doi.org/10.1074/jbc.M802945200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18515356	hybrid, Green Published			2022-12-27	WOS:000258455400044
J	Sumandea, MP; Rybin, VO; Hinken, AC; Wang, C; Kobayashi, T; Harleton, E; Sievert, G; Balke, CW; Feinmark, SJ; Solaro, RJ; Steinberg, SF				Sumandea, Marius P.; Rybin, Vitalyi O.; Hinken, Aaron C.; Wang, Chaojian; Kobayashi, Tomoyoshi; Harleton, Erin; Sievert, Gail; Balke, C. William; Feinmark, Steven J.; Solaro, R. John; Steinberg, Susan F.			Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP PHOSPHORYLATION; OXIDATIVE STRESS; PKC-EPSILON; CARDIOMYOCYTES; SITES; CONTRACTILITY; MYOFILAMENTS; MYOCARDIUM; MECHANISMS; KNOCKOUT	Our study identifies tyrosine phosphorylation as a novel protein kinase C delta(PKC delta) activation mechanism that modifies PKC delta-dependent phosphorylation of cardiac troponin I (cTnI), a myofilament regulatory protein. PKC delta phosphorylates cTnI at Ser(23)/Ser(24) when activated by lipid cofactors; Src phosphorylates PKC delta at Tyr(311) and Tyr(332) leading to enhanced PKC delta autophosphorylation at Thr(505) (its activation loop) and PKC delta-dependent cTnI phosphorylation at both Ser(23)/Ser(24) and Thr(144). The Src-dependent acquisition of cTnI-Thr(144) kinase activity is abrogated by Y311F or T505A substitutions. Treatment of detergent-extracted single cardiomyocytes with lipid-activated PKC delta induces depressed tension at submaximum but not maximum [Ca2+] as expected for cTnI-Ser(23)/ Ser(24) phosphorylation. Treatment of myocytes with Src-activated PKC delta leads to depressed maximum tension and cross-bridge kinetics, attributable to a dominant effect of cTnI-Thr144 phosphorylation. Our data implicate PKC delta-Tyr311/ Thr505 phosphorylation as dynamically regulated modifications that alter PKC delta enzymology and allow for stimulus-specific control of cardiac mechanics during growth factor stimulation and oxidative stress.	[Rybin, Vitalyi O.; Wang, Chaojian; Harleton, Erin; Feinmark, Steven J.; Steinberg, Susan F.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10032 USA; [Sumandea, Marius P.; Sievert, Gail; Balke, C. William] Univ Kentucky, Cardiovasc Res Ctr, Dept Internal Med, Lexington, KY 40536 USA; [Hinken, Aaron C.; Kobayashi, Tomoyoshi; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Cardiovasc Res Ctr, Chicago, IL 60612 USA	Columbia University; University of Kentucky; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Steinberg, SF (corresponding author), Columbia Univ, Dept Pharmacol, Coll Phys & Surg, 630 W 168 St, New York, NY 10032 USA.	sfs1@columbia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064035, R01HL071865, P01HL062426, R01HL077860, T32HL007692] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 62426, P01 HL062426, HL 71865, T32 HL007692, HL 64035, R01 HL077860, R01 HL064035, HL 77860] Funding Source: Medline; PHS HHS [T32 007692] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Hinken AC, 2004, AM J PHYSIOL-CELL PH, V287, pC500, DOI 10.1152/ajpcell.00049.2004; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Huang XP, 1999, CIRC RES, V84, P1; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; LeWinter MM, 2002, J CARD FAIL, V8, pS271, DOI 10.1054/jcaf.2002.129276; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Newton AC, 2004, TRENDS PHARMACOL SCI, V25, P175, DOI 10.1016/j.tips.2004.02.010; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Westfall MV, 2005, J BIOL CHEM, V280, P41324, DOI 10.1074/jbc.M506043200; Wolska BM, 1996, AM J PHYSIOL-HEART C, V270, pH24, DOI 10.1152/ajpheart.1996.270.1.H24	28	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22680	22689		10.1074/jbc.M802396200	http://dx.doi.org/10.1074/jbc.M802396200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550549	Green Published, hybrid			2022-12-27	WOS:000258321000037
J	Bourajjaj, M; Armand, AS; Martins, PADC; Weijts, B; van der Nagel, R; Heeneman, S; Wehrens, XH; De Windt, LJ				Bourajjaj, Meriem; Armand, Anne-Sophie; Martins, Paula A. da Costa; Weijts, Bart; van der Nagel, Roel; Heeneman, Sylvia; Wehrens, Xander H.; De Windt, Leon J.			NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; IN-VIVO; NUCLEAR FACTOR; TRANSCRIPTION FACTORS; TARGETED INHIBITION; DYSFUNCTION; EXPRESSION; STRESS; FAMILY; HOMEOSTASIS	One major intracellular signaling pathway involved in heart failure employs the phosphatase calcineurin and its downstream transcriptional effector nuclear factor of activated T-cells ( NFAT). In vivo evidence for the involvement ofNFATfactors in heart failure development is still ill defined. Here we reveal that nfatc2 transcripts outnumber those from other nfat genes in the unstimulated heart by severalfold. Transgenic mice with activated calcineurin in the postnatal myocardium crossbred with nfatc2-null mice revealed a significant abrogation of calcineurin-provoked cardiac growth, indicating that NFATc2 plays an important role downstream of calcineurin and validates the original hypothesis that calcineurin mediates myocyte hypertrophy through activation of NFAT transcription factors. In the absence of NFATc2, a clear protection against the geometrical, functional, and molecular deterioration of the myocardium following biomechanical stress was also evident. In contrast, physiological cardiac enlargement in response to voluntary exercise training was not affected in nfatc2-null mice. Combined, these results reveal a major role for the NFATc2 transcription factor in pathological cardiac remodeling and heart failure.	[De Windt, Leon J.] Univ Utrecht, Med Ctr, Div Heart & Lungs, Dept Med Physiol, NL-3584 CM Utrecht, Netherlands; [Bourajjaj, Meriem; Armand, Anne-Sophie; Martins, Paula A. da Costa; Weijts, Bart; van der Nagel, Roel; De Windt, Leon J.] Royal Netherlands Acad Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Bourajjaj, Meriem; Armand, Anne-Sophie; Martins, Paula A. da Costa; Weijts, Bart; van der Nagel, Roel; De Windt, Leon J.] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, NL-3584 CT Utrecht, Netherlands; [Heeneman, Sylvia] Univ Hosp Maastricht, Dept Pathol, NL-6229 HX Maastricht, Netherlands; [Wehrens, Xander H.] Baylor Coll Med, Houston, TX 77030 USA	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Maastricht University; Maastricht University Medical Centre (MUMC); Baylor College of Medicine	De Windt, LJ (corresponding author), Univ Utrecht, Med Ctr, Div Heart & Lungs, Dept Med Physiol, Yalelaan 50, NL-3584 CM Utrecht, Netherlands.	L.J.deWindt@umcutrecht.nl	de Windt, Leon/AAO-6395-2020; Weijts, Bart/O-7107-2019; Wehrens, Xander/AAQ-9574-2020	de Windt, Leon/0000-0002-7793-2856; Weijts, Bart/0000-0003-4843-3019; Wehrens, Xander/0000-0001-5044-672X; Armand, Anne-Sophie/0000-0002-0291-6421				Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Chuvpilo S, 1999, J IMMUNOL, V162, P7294; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Hill JA, 2002, J BIOL CHEM, V277, P10251, DOI 10.1074/jbc.M110722200; HO KKL, 1993, J AM COLL CARDIOL  S, V22, P6; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Imamura R, 1998, J IMMUNOL, V161, P3455; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Mathew J, 2001, CIRCULATION, V104, P1615, DOI 10.1161/hc3901.096700; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Oakley D, 2001, HEART, V86, P722, DOI 10.1136/heart.86.6.722; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; van Empel VPM, 2006, J AM COLL CARDIOL, V48, P824, DOI 10.1016/j.jacc.2006.02.075; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474; Zou YZ, 2001, CIRCULATION, V104, P97, DOI 10.1161/01.CIR.104.1.97	34	116	121	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22295	22303		10.1074/jbc.M801296200	http://dx.doi.org/10.1074/jbc.M801296200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18477567	hybrid			2022-12-27	WOS:000258114700048
J	Luo, RB; Randazzo, PA				Luo, Ruibai; Randazzo, Paul A.			Kinetic analysis of Arf GAP1 indicates a regulatory role for coatomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTOR; COPI VESICLES; N-TERMINUS; ARFGAP1; DOMAIN; HYDROLYSIS; ASAP1; PURIFICATION; DYNAMICS	Arf GAPs are a family of enzymes that catalyze the hydrolysis of GTP bound to Arf. Arf GAP1 is one member of the family that has a critical role in membrane traffic at the Golgi apparatus. Two distinct models for the regulation of Arf GAP1 in membrane traffic have been proposed. In one model, Arf GAP1 functions in a ternary complex with coat proteins and is inhibited by cargo proteins. In another model, Arf GAP1 is recruited to a membrane surface that has defects created by the increased membrane curvature that accompanies transport vesicle formation. Here we have used kinetic and mutational analysis to test predictions of models of regulation of Arf GAP1. We found that Arf GAP1 has a similar affinity for Arf1.GTP as another Arf GAP, ASAP1, but the catalytic rate is approximate to 0.5% that of ASAP1. Coatomer stimulated Arf GAP1 activity; however, different from that predicted from the current model, coatomer affected the K-m and not the k(cat) values. Effects of most mutations in Arf GAP1 paralleled those in ASAP1. Mutation of an arginine that aligned with an arginine presumed to be catalytic in ASAP1 abrogated activity. Peptide from the cytoplasmic tail of cargo proteins inhibited Arf GAP1; however, the unrelated Arf GAP ASAP1 was also inhibited. The curvature of the lipid bilayer had a small effect on activity of Arf GAP1 under the conditions of our experiments. We conclude that coatomer is an allosteric regulator of Arf GAP1. The relevance of the results to the two models of Arf GAP1-mediated regulation of Arf1 is discussed.	[Luo, Ruibai; Randazzo, Paul A.] NCI, NIH, Cellular & Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Randazzo, PA (corresponding author), NCI, NIH, Cellular & Mol Biol Lab, Ctr Canc Res, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzo@helix.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC007365, Z01BC007365] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; CASSEL D, 2003, ARF FAMILY GTPASES, P157; CHA S, 1968, J BIOL CHEM, V243, P820; Che MM, 2005, METHOD ENZYMOL, V404, P147, DOI 10.1016/S0076-6879(05)04015-2; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786; Huber I, 2001, METHOD ENZYMOL, V329, P307; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Luo RB, 2005, CURR BIOL, V15, P2164, DOI 10.1016/j.cub.2005.10.065; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; NIXON AE, 1995, BIOCHEMISTRY-US, V34, P15592, DOI 10.1021/bi00047a026; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; RANDAZZO PA, 1994, J BIOL CHEM, V269, P29490; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Yoon HY, 2004, CELL SIGNAL, V16, P1033, DOI 10.1016/j.cellsig.2004.02.008; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zhang CJ, 1998, J BIOL CHEM, V273, P19792, DOI 10.1074/jbc.273.31.19792; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	50	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21965	21977		10.1074/jbc.M802268200	http://dx.doi.org/10.1074/jbc.M802268200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18541532	hybrid, Green Published			2022-12-27	WOS:000258114700016
J	Reddy, T; Ding, J; Li, XJ; Sykes, BD; Rainey, JK; Fliegel, L				Reddy, Tyler; Ding, Jie; Li, Xiuju; Sykes, Brian D.; Rainey, Jan K.; Fliegel, Larry			Structural and functional characterization of transmembrane segment IX of the NHE1 isoform of the Na+/H+ exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; PROTEIN SECONDARY STRUCTURE; SYNTHETIC PEPTIDES; LACTOSE PERMEASE; PORE; RESIDUES; CHANNEL; HELIX; IDENTIFICATION; RECEPTOR	The Na+/H+ exchanger isoform 1 (NHE1) is an integral membrane protein that regulates intracellular pH by removing one intracellular H+ in exchange for one extracellular Na+. It has a large N-terminal membrane domain of 12 transmembrane segments and an intracellular C-terminal regulatory domain. We characterized the cysteine accessibility of amino acids of the putative transmembrane segment IX ( residues 339-363). Each residue was mutated to cysteine in a functional cysteine-less NHE1 protein. Of 25 amino acids mutated, 5 were inactive or nearly so after mutation to cysteine. Several of these showed aberrant targeting to the plasma membrane and reduced expression of the intact protein, whereas others were expressed and targeted correctly but had defective NHE1 function. Of the active mutants, Glu(346) and Ser(351) were inhibited >70% by positively charged [2-( trimethylammonium)ethyl] methanethiosulfonate but not by anionic [2-sulfonatoethyl] methanethiosulfonate, suggesting that they are pore lining and make up part of the cation conduction pathway. Both mutants also had decreased affinity for Na+ and decreased activation by intracellular protons. The structure of a peptide representing amino acids 338-365 was determined by using high resolution NMR in dodecylphosphocholine micelles. The structure contained two helical regions ( amino acids Met(340)-Ser(344) and Ile(353)-Ser(359)) kinked with a large bend angle around a pivot point at amino acid Ser(351). The results suggest that transmembrane IX is critical with pore-lining residues and a kink at the functionally important residue Ser(351).	[Ding, Jie; Li, Xiuju; Sykes, Brian D.; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Rainey, Jan K.] Dalhousie Univ, Dept Chem, Halifax, NS B3H 1X5, Canada; [Reddy, Tyler; Rainey, Jan K.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	University of Alberta; Dalhousie University; Dalhousie University	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, 347 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca	Rainey, Jan K/C-1927-2008; Reddy, Tyler/GPJ-9670-2022	Rainey, Jan K/0000-0003-0793-5573; 				AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DAVIS JH, 1983, BIOCHEMISTRY-US, V22, P5298, DOI 10.1021/bi00292a008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dibrov P, 1998, FEBS LETT, V424, P1, DOI 10.1016/S0014-5793(98)00119-7; Ding J, 2007, CAN J PHYSIOL PHARM, V85, P319, DOI 10.1139/Y06-081; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; DUNTEN RL, 1993, BIOCHEMISTRY-US, V32, P12644, DOI 10.1021/bi00210a012; Fliegel L, 2001, BASIC RES CARDIOL, V96, P301, DOI 10.1007/s003950170036; GODDARD TD, 2001, SPARKY, V3; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Karmazyn M, 2003, HYPERTENSION, V42, P1171, DOI 10.1161/01.HYP.0000102863.23854.0B; Katragadda M, 2001, BIOPHYS J, V81, P1029, DOI 10.1016/S0006-3495(01)75760-8; Katragadda M, 2001, J PEPT RES, V58, P79, DOI 10.1034/j.1399-3011.2001.00904.x; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lang HJ, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P239; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Naider F, 2005, BIOPOLYMERS, V80, P199, DOI 10.1002/bip.20183; Noel J, 2003, BIOCHEMISTRY-US, V42, P15361, DOI 10.1021/bi035296a; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Rainey JK, 2006, BIOCHEM CELL BIOL, V84, P918, DOI 10.1139/O06-178; REITHMEIER RAF, 1992, STRUCTURE BIOL MEMBR, P337; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHORODE L, 1996, NA H EXCHANGER, P101; Silva NLCL, 1997, PFLUG ARCH EUR J PHY, V433, P792, DOI 10.1007/s004240050347; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; Sreerama N, 1999, PROTEIN SCI, V8, P370; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wigley WC, 1998, BIOCHEMISTRY-US, V37, P844, DOI 10.1021/bi972293n; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973	65	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22018	22030		10.1074/jbc.M803447200	http://dx.doi.org/10.1074/jbc.M803447200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508767	hybrid			2022-12-27	WOS:000258114700021
J	Farina, A; Shin, JH; Kim, DH; Bermudez, VP; Kelman, Z; Seo, YS; Hurwitz, J				Farina, Andrea; Shin, Jae-Ho; Kim, Do-Hyung; Bermudez, Vladimir P.; Kelman, Zvi; Seo, Yeon-Soo; Hurwitz, Jerard			Studies with the human cohesin establishment factor, ChlR1 - Association of ChlR1 with Ctf18-RFC and Fen1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA-POLYMERASE-ALPHA; NONRANDOM CHROMOSOME LOSS; IN-SITU HYBRIDIZATION; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; REPLICATION FORK; COMPLEX REQUIRES; BINDING PROTEIN; FISSION YEAST	Human ChlR1 (hChlR1), a member of the DEAD/DEAH subfamily of helicases, was shown to interact with components of the cohesin complex and play a role in sister chromatid cohesion. In order to study the biochemical and biological properties of hChlR1, we purified the protein from 293 cells and demonstrated that hChlR1 possesses DNA-dependent ATPase and helicase activities. This helicase translocates on single-stranded DNA in the 5' to 3' direction in the presence of ATP and, to a lesser extent, dATP. Its unwinding activity requires a 5'-single-stranded region for helicase loading, since flush-ended duplex structures do not support unwinding. The helicase activity of hChlR1 is capable of displacing duplex regions up to 100 bp, which can be extended to 500 bp by RPA or the cohesion establishment factor, the Ctf18-RFC (replication factor C) complex. We show that hChlR1 interacts with the hCtf18-RFC complex, human proliferating cell nuclear antigen, and hFen1. The interactions between Fen1 and hChlR1 stimulate the flap endonuclease activity of Fen1. Selective depletion of either hChlR1 or Fen1 by targeted small interfering RNA treatment results in the precocious separation of sister chromatids. These findings are consistent with a role of hChlR1 in the establishment of sister chromatid cohesion and suggest that its action may contribute to lagging strand processing events important in cohesion.	[Farina, Andrea; Bermudez, Vladimir P.; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Shin, Jae-Ho; Kelman, Zvi] Univ Maryland, Inst Biotechnol, Rockville, MD 20850 USA; [Kim, Do-Hyung; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Memorial Sloan Kettering Cancer Center; University System of Maryland; University of Maryland Baltimore; Korea Advanced Institute of Science & Technology (KAIST)	Hurwitz, J (corresponding author), 1275 York Ave,Box 97, New York, NY 10065 USA.	j-hurwitz@ski.mskcc.org	Seo, Yeonsoo/C-1605-2011		NIGMS NIH HHS [GM 27440, GM 34559] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034559, R01GM034559] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amann J, 1997, J BIOL CHEM, V272, P3823, DOI 10.1074/jbc.272.6.3823; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; HABER JE, 1974, GENETICS, V78, P843; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Holloway SL, 2000, NUCLEIC ACIDS RES, V28, P3056, DOI 10.1093/nar/28.16.3056; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Ishiai M, 1996, J BIOL CHEM, V271, P20868, DOI 10.1074/jbc.271.34.20868; Kim J, 2005, NUCLEIC ACIDS RES, V33, P4078, DOI 10.1093/nar/gki728; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kohler A, 1997, J CELL SCI, V110, P1051; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Leversha MA, 2001, METH MOL B, V175, P109; LIRAS P, 1978, GENETICS, V88, P651; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; ROCCHI M, 1991, GENOMICS, V9, P517, DOI 10.1016/0888-7543(91)90419-F; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Shiomi Y, 2004, GENES CELLS, V9, P279, DOI 10.1111/j.1356-9597.2004.00724.x; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Uhlmann F, 1996, P NATL ACAD SCI USA, V93, P6521, DOI 10.1073/pnas.93.13.6521; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Zheng L, 2007, MOL CELL BIOL, V27, P3176, DOI 10.1128/MCB.01652-06; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	44	81	86	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20925	20936		10.1074/jbc.M802696200	http://dx.doi.org/10.1074/jbc.M802696200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499658	hybrid, Green Published			2022-12-27	WOS:000257746100035
J	Thiele, B; Rieder, O; Jehmlich, N; von Bergen, M; Muller, M; Boll, M				Thiele, Baerbel; Rieder, Oliver; Jehmlich, Nico; von Bergen, Martin; Mueller, Michael; Boll, Matthias			Aromatizing cyclohexa-1,5-diene-1-carbonyl-coenzyme a oxidase - Characterization and its role in anaerobic aromatic metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZOYL-COA REDUCTASE; OLD-YELLOW-ENZYME; DRIVEN ELECTRON-TRANSFER; GEOBACTER-METALLIREDUCENS; SYNTROPHUS-ACIDITROPHICUS; NITROGEN-FIXATION; CLOSTRIDIUM-AMINOVALERICUM; AZOTOBACTER-VINELANDII; CRYSTAL-STRUCTURE; KEY ENZYME	Benzoyl-CoA reductases (BCRs) are key enzymes of anaerobic aromatic metabolism in facultatively anaerobic bacteria. The highly oxygen-sensitive enzymes catalyze the ATP-dependent reductive dearomatization of the substrate, yielding cyclohexa-1,5- diene-1-carbonyl-CoA (1,5-dienoyl-CoA). In extracts from anaerobically grown denitrifying Thauera aromatica, we detected a benzoate-induced, benzoyl-CoA-forming, 1,5-dienoylCoA: acceptor oxidoreductase activity. This activity co-purified with BCR but could be partially separated from it by hydroxyapatite chromatography. After activity staining on native gels, a monomeric protein with a subunit molecular weight of M-r 76,000 was identified. Mass spectrometric analysis of tryptic digests identified peptides from NADH oxidases/2,4dienoyl- CoA reductases/"old yellow" enzymes. The UV-visible spectrum of the enriched enzyme suggested the presence of flavin and Fe/S-cofactors, and it was bleached upon the addition of 1,5-dienoyl-CoA. The enzyme had a high affinity for dioxygen as electron acceptor (K-m = 10 mu M) and therefore is referred to as 1,5-dienoyl-CoA oxidase (DCO). The likely product formed from dioxygen reduction was H2O. DCO was highly specific for 1,5-dienoyl-CoA (K-m = 27 mu M). The initial rate of DCO followed a Nernst curve with half-maximal activity at + 10 mV. We propose that DCO provides protection for the extremely oxygen-sensitive BCR enzyme when the bacterium degrades aromatic compounds at the edge of steep oxygen gradients. The redox-dependent switch in DCO guarantees that DCO is only active during oxidative stress and circumvents futile dearomatization/rearomatization reactions catalyzed by BCR and DCO.	[Thiele, Baerbel; Boll, Matthias] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany; [Rieder, Oliver; Mueller, Michael] Univ Freiburg, Inst Pharmaceut & Med Chem, D-79104 Freiburg, Germany; [Jehmlich, Nico; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany	Leipzig University; University of Freiburg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Boll, M (corresponding author), Univ Leipzig, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.	boll@uni-leipzig.de	Jehmlich, Nico/B-5403-2009; Jehmlich, Nico/D-9041-2015; von Bergen, Martin/D-7960-2011	Jehmlich, Nico/0000-0002-5638-6868; Jehmlich, Nico/0000-0002-5638-6868; von Bergen, Martin/0000-0003-2732-2977				ANDERS HJ, 1995, INT J SYST BACTERIOL, V45, P327, DOI 10.1099/00207713-45-2-327; Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; BLANC PY, 1961, HELV CHIM ACTA, V44, P607, DOI 10.1002/hlca.19610440227; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; Boll M, 2000, J BIOL CHEM, V275, P21889, DOI 10.1074/jbc.M001833200; Boll M, 2005, J MOL MICROB BIOTECH, V10, P132, DOI 10.1159/000091560; Boll M, 2005, BBA-BIOENERGETICS, V1707, P34, DOI 10.1016/j.bbabio.2004.01.009; Boll M, 1998, EUR J BIOCHEM, V251, P946, DOI 10.1046/j.1432-1327.1998.2510946.x; Boll M, 2000, J BIOL CHEM, V275, P31857, DOI 10.1074/jbc.M001508200; Brige A, 2006, BIOCHEM J, V394, P335, DOI 10.1042/BJ20050979; Buckel W, 2004, CURR OPIN CHEM BIOL, V8, P462, DOI 10.1016/j.cbpa.2004.07.001; Diaz E, 2004, INT MICROBIOL, V7, P173; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; EIKMANNS U, 1991, EUR J BIOCHEM, V198, P263, DOI 10.1111/j.1432-1033.1991.tb16010.x; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; GIBSON KJ, 1992, APPL ENVIRON MICROB, V58, P696, DOI 10.1128/AEM.58.2.696-698.1992; GROSS GG, 1966, Z NATURFORSCH PT B, VB 21, P683; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; Kawasaki S, 2005, APPL ENVIRON MICROB, V71, P8442, DOI 10.1128/AEM.71.12.8442-8450.2005; Kengen SWM, 2003, EUR J BIOCHEM, V270, P2885, DOI 10.1046/j.1432-1033.2003.03668.x; KUEHNE ME, 1959, J AM CHEM SOC, V81, P4278, DOI 10.1021/ja01525a042; Liang XQ, 2000, ARCH BIOCHEM BIOPHYS, V380, P373, DOI 10.1006/abbi.2000.1941; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Mobitz H, 2004, BIOCHEMISTRY-US, V43, P1376, DOI 10.1021/bi0358871; Mobitz H, 2002, BIOCHEMISTRY-US, V41, P1752, DOI 10.1021/bi0113770; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Mouttaki H, 2007, APPL ENVIRON MICROB, V73, P930, DOI 10.1128/AEM.02227-06; Peters F, 2004, J BACTERIOL, V186, P2156, DOI 10.1128/JB.186.7.2156-2163.2004; Peters F, 2007, J BACTERIOL, V189, P1055, DOI 10.1128/JB.01467-06; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; RIGBY JH, 1989, J ORG CHEM, V54, P224, DOI 10.1021/jo00262a047; SCHACHTER D, 1953, J BIOL CHEM, V203, P925; Schmitz RA, 2002, J MOL MICROB BIOTECH, V4, P235; STOTT K, 1993, J BIOL CHEM, V268, P6097; Tolosa L, 2002, BIOTECHNOL BIOENG, V80, P594, DOI 10.1002/bit.10409; Unciuleac M, 2001, P NATL ACAD SCI USA, V98, P13619, DOI 10.1073/pnas.241375598; VAZ ADN, 1995, BIOCHEMISTRY-US, V34, P4246, DOI 10.1021/bi00013a014; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; Wischgoll S, 2005, MOL MICROBIOL, V58, P1238, DOI 10.1111/j.1365-2958.2005.04909.x; Zhang DY, 2001, J BIOL CHEM, V276, P13622, DOI 10.1074/jbc.M011315200	47	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20713	20721		10.1074/jbc.M802841200	http://dx.doi.org/10.1074/jbc.M802841200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18505724	Green Published, hybrid			2022-12-27	WOS:000257746100012
J	Yoshikawa, F; Sato, Y; Tohyama, K; Akagi, T; Hashikawa, T; Nagakura-Takagi, Y; Sekine, Y; Morita, N; Baba, H; Suzuki, Y; Sugano, S; Sato, A; Furuichi, T				Yoshikawa, Fumio; Sato, Yumi; Tohyama, Koujiro; Akagi, Takumi; Hashikawa, Tsutomu; Nagakura-Takagi, Yuko; Sekine, Yukiko; Morita, Noriyuki; Baba, Hiroko; Suzuki, Yutaka; Sugano, Sumio; Sato, Akira; Furuichi, Teiichi			Opalin, a transmembrane sialylglycoprotein located in the central nervous system myelin paranodal loop membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITE; TIGHT JUNCTIONS; E-CADHERIN; LANTERMAN INCISURES; ADHERENS JUNCTIONS; GAP-JUNCTIONS; SCHWANN-CELLS; PROTEIN; BRAIN; ACID	In contrast to compact myelin, the series of paranodal loops located in the outermost lateral region of myelin is non-compact; the intracellular space is filled by a continuous channel of cytoplasm, the extracellular surfaces between neighboring loops keep a definite distance, but the loop membranes have junctional specializations. Although the proteins that form compact myelin have been well studied, the protein components of paranodal loop membranes are not fully understood. This report describes the biochemical characterization and expression of Opalin as a novel membrane protein in paranodal loops. Mouse Opalin is composed of a short N-terminal extracellular domain (amino acid residues 1-30), a transmembrane domain (residues 31-53), and a long C-terminal intracellular domain (residues 54-143). Opalin is enriched in myelin of the central nervous system, but not that of the peripheral nervous system of mice. Enzymatic deglycosylation showed that myelin Opalin contained N-and O-glycans, and that the O-glycans, at least, had negatively charged sialic acids. We identified two N-glycan sites at Asn-6 and Asn-12 and an O-glycan site at Thr-14 in the extracellular domain. Site-directed mutations at the glycan sites impaired the cell surface localization of Opalin. In addition to the somata and processes of oligodendrocytes, Opalin immunoreactivity was observed in myelinated axons in a spiral fashion, and was concentrated in the paranodal loop region. Immunogold electron microscopy demonstrated that Opalin was localized at particular sites in the paranodal loop membrane. These results suggest a role for highly sialylglycosylated Opalin in an intermembranous function of the myelin paranodal loops in the central nervous system.	[Yoshikawa, Fumio; Sato, Yumi; Nagakura-Takagi, Yuko; Sekine, Yukiko; Morita, Noriyuki; Sato, Akira; Furuichi, Teiichi] RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan; [Akagi, Takumi; Hashikawa, Tsutomu] RIKEN, Brain Sci Inst, Lab Neural Architecture, Wako, Saitama 3510198, Japan; [Tohyama, Koujiro; Akagi, Takumi] Iwate Med Univ, Ctr Electron Microscopy & Bio Imaging Res, Morioka, Iwate 0208505, Japan; [Baba, Hiroko] Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920392, Japan; [Sugano, Sumio] Univ Tokyo, Dept Frontier Sci, Tokyo 1088639, Japan	RIKEN; RIKEN; Iwate Medical University; Tokyo University of Pharmacy & Life Sciences; University of Tokyo	Furuichi, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan.	tfuruichi@brain.riken.jp	Furuichi, Teiichi/B-5086-2014	Furuichi, Teiichi/0000-0002-9676-1888				Akagi T, 2006, J NEUROSCI METH, V153, P276, DOI 10.1016/j.jneumeth.2005.11.007; Aruga J, 2007, J NEUROCHEM, V102, P1533, DOI 10.1111/j.1471-4159.2007.04583.x; Bangsow T, 1998, EUR J BIOCHEM, V256, P24, DOI 10.1046/j.1432-1327.1998.2560024.x; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Filbin MT, 2003, NAT REV NEUROSCI, V4, P1019, DOI 10.1038/nrn1288; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Huang J, 2006, MOL BIOL CELL, V17, P3187, DOI 10.1091/mbc.E05-12-1122; Itoh K, 2002, BRAIN RES PROTOC, V10, P23; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Kleopa KA, 2004, GLIA, V47, P346, DOI 10.1002/glia.20043; Li X, 2004, NEUROSCIENCE, V126, P611, DOI 10.1016/j.neuroscience.2004.03.063; MATTHIEU JM, 1986, J CELL BIOL, V103, P2673, DOI 10.1083/jcb.103.6.2673; Menichella DM, 2001, MOL CELL NEUROSCI, V18, P606, DOI 10.1006/mcne.2001.1041; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nobile C, 2002, GENE, V282, P87, DOI 10.1016/S0378-1119(01)00846-0; Norton W T, 1974, Methods Enzymol, V31, P435; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Otto VI, 2004, J BIOL CHEM, V279, P35201, DOI 10.1074/jbc.M404947200; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; ROACH A, 1983, CELL, V34, P799, DOI 10.1016/0092-8674(83)90536-6; Rosenbluth J, 2006, GLIA, V54, P172, DOI 10.1002/glia.20370; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Scherer SS, 1995, J NEUROSCI, V15, P8281; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Spiegel I, 2002, MOL MEMBR BIOL, V19, P95, DOI 10.1080/09687680210130009; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Tiwari-Woodruff SK, 2001, J CELL BIOL, V153, P295, DOI 10.1083/jcb.153.2.295; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; Tricaud N, 2005, J NEUROSCI, V25, P3259, DOI 10.1523/JNEUROSCI.5168-04.2005; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Yoshikawa F, 1999, J BIOL CHEM, V274, P328, DOI 10.1074/jbc.274.1.328; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Young P, 2002, MOL CELL NEUROSCI, V21, P341, DOI 10.1006/mcne.2002.1177	47	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20830	20840		10.1074/jbc.M801314200	http://dx.doi.org/10.1074/jbc.M801314200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18490449	hybrid, Green Published			2022-12-27	WOS:000257746100025
J	Chavez-Gutierrez, L; Tolia, A; Maes, E; Li, T; Wong, PC; de Strooper, B				Chavez-Gutierrez, Lucia; Tolia, Alexandra; Maes, Elke; Li, Tong; Wong, Philip C.; de Strooper, Bart			Glu(332) in the Nicastrin ectodomain is essential for gamma-secretase complex maturation but not for its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; EXOPEPTIDASE SPECIFICITY; TERMINAL FRAGMENT; FOLD RECOGNITION; PRESENILIN; PEN-2; TRAFFICKING; APH-1; TELENCEPHALIN; GENTHREADER	The gamma-secretase complex is responsible for the proteolysis of integral membrane proteins. Nicastrin has been proposed to operate as the substrate receptor of the complex with the glutamate 332 (Glu(333) in human) serving as the anionic binding site for the alpha-amino-terminal group of substrates. The putative binding site is located within the aminopeptidase-like domain of Nicastrin. The Glu(332) is proposed to function as the counterpart of the exopeptidase Glu located in the active site of these peptidases. Although Glu(332) could bind the alpha-amino-terminal group of substrates, we hypothesized, in analogy with M28-aminopeptidases, that other residues in the putative binding site of Nicastrin should participate in the interaction as well. Surprisingly, mutagenesis of these residues affected the in vivo processing of APP and Notch substrates only weakly. In addition, the E332Q mutation, which completely abolishes the anionic alpha-amino-terminal binding function, remained fully active. When we introduced the previously characterized E332A mutation, we found strongly decreased gamma-secretase complex levels, but the remaining complex appeared as active as the wild-type complex. We confirmed in two independent in vitro assays that the specific enzymatic activity of the E332A mutant was comparable with that of the wild-type complex. Thus, Glu(332) crucially affects complex maturation rather than substrate recognition. Moreover other Nicastrin mutants, designed to either impede or alter substantially the putative binding pocket, affected only marginally gamma-secretase activity. Consequently, these studies indicate that the main role of the Glu(332) is in the maturation and assembly of gamma-secretase rather than in the recognition of the substrates.	[Chavez-Gutierrez, Lucia; Tolia, Alexandra; Maes, Elke; de Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Chavez-Gutierrez, Lucia; Tolia, Alexandra; Maes, Elke; de Strooper, Bart] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	KU Leuven; Flanders Institute for Biotechnology (VIB); Johns Hopkins University	de Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Herestr 49, B-3000 Louvain, Belgium.	Bart.deStrooper@med.kuleuven.be	Chávez-Gutiérrez, Lucía/E-2657-2017; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819				Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Giannetti AM, 2003, PLOS BIOL, V1, P341, DOI 10.1371/journal.pbio.0000051; Goutte C, 2002, DEV CELL, V3, P6, DOI 10.1016/S1534-5807(02)00213-7; Goutte C, 2000, DEVELOPMENT, V127, P2481; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Li T, 2003, J NEUROSCI, V23, P3272; Lleo A, 2008, CURR TOP MED CHEM, V8, P9; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Reiland V, 2004, ACTA CRYSTALLOGR D, V60, P1738, DOI 10.1107/S0907444904018281; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tholander F, 2005, J BIOL CHEM, V280, P33477, DOI 10.1074/jbc.M506821200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yuan H, 1999, J NEUROSCI METH, V88, P45, DOI 10.1016/S0165-0270(99)00011-4	47	96	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20096	20105		10.1074/jbc.M803040200	http://dx.doi.org/10.1074/jbc.M803040200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502756	hybrid, Green Published			2022-12-27	WOS:000257565300026
J	Lauer-Fields, JL; Whitehead, JK; Li, S; Hammer, RP; Brew, K; Fields, GB				Lauer-Fields, Janelle L.; Whitehead, John K.; Li, Shunzi; Hammer, Robert P.; Brew, Keith; Fields, Gregg B.			Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-MATRIX METALLOPROTEINASE-2; FIBRONECTIN-LIKE DOMAIN; C-TERMINAL DOMAIN; TISSUE INHIBITOR; COLLAGENOLYTIC ACTIVITY; FLUOROGENIC SUBSTRATE; MODEL PEPTIDES; GELATINASE-A; I COLLAGEN; ACTIVATION	Unregulated activities of the matrix metalloproteinase (MMP) family have been implicated in primary and metastatic tumor growth, angiogenesis, and pathological degradation of extracellular matrix components, such as collagen and laminin. However, clinical trials with small molecule MMP inhibitors have been largely unsuccessful, with a lack of selectivity considered particularly problematic. Enhanced selectivity could be achieved by taking advantage of differences in substrate secondary binding sites (exosites) within the MMP family. In this study, triple-helical substrates and triple-helical transition state analog inhibitors have been utilized to dissect the roles of potential exosites in MMP-9 collagenolytic behavior. Substrate and inhibitor sequences were based on either the alpha 1(V) 436-450 collagen region, which is hydrolyzed at the Gly down arrow Val bond selectively by MMP-2 and MMP-9, or the Gly down arrow Leu cleavage site within the consensus interstitial collagen sequence alpha 1(I-III) 769-783, which is hydrolyzed by MMP-1, MMP-2, MMP-8, MMP-9, MMP-13, and MT1-MMP. Exosites within the MMP-9 fibronectin II inserts were found to be critical for interactions with type V collagen model substrates and inhibitors and to participate in interactions with an interstitial (types I-III) collagen model inhibitor. A triple-helical peptide incorporating a fibronectin II insert-binding sequence was constructed and found to selectively inhibit MMP-9 type V collagen-based activities compared with interstitial collagen-based activities. This represents the first example of differential inhibition of collagenolytic activities and was achieved via an exosite-binding triple-helical peptide.	[Lauer-Fields, Janelle L.; Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Lauer-Fields, Janelle L.; Brew, Keith] Florida Atlantic Univ, Coll Biomed Sci, Boca Raton, FL 33431 USA; [Whitehead, John K.; Li, Shunzi; Hammer, Robert P.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; Louisiana State University System; Louisiana State University	Fields, GB (corresponding author), Florida Atlantic Univ, Dept Chem & Biochem, 777 Glades Rd, Boca Raton, FL 33431 USA.	fieldsg@fau.edu	Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019	Brew, Keith/0000-0003-1306-1032; 	NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098799, CA 98799] Funding Source: Medline; NIAMS NIH HHS [R01 AR040994-15A1, R01 AR040994] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; DeSouza SJ, 1996, FASEB J, V10, P927, DOI 10.1096/fasebj.10.8.8666171; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Falconi M, 2003, J COMPUT AID MOL DES, V17, P837, DOI 10.1023/B:JCAM.0000021883.44532.75; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; GIOLA M, 2007, J MOL BIOL, V368, P1101; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849; Lauer-Fields Janelle L, 2004, J Biomol Tech, V15, P305; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; LAUERFIELDS JL, 2008, BIOORG MED IN PRESS; Luque I, 2000, PROTEINS, P63; Malkar NB, 2003, BIOMACROMOLECULES, V4, P518, DOI 10.1021/bm0256597; Malkar NB, 2002, BIOCHEMISTRY-US, V41, P6054, DOI 10.1021/bi012071w; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; MURPHY G, 1992, J BIOL CHEM, V267, P9612; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; O'Farrell TJ, 2000, J BIOL CHEM, V275, P27964; OHARE MC, 1995, BIOCHEM BIOPH RES CO, V216, P329, DOI 10.1006/bbrc.1995.2628; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D; Pickford AR, 1997, STRUCTURE, V5, P359, DOI 10.1016/S0969-2126(97)00193-7; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Ruben AJ, 2006, CHEM BIOL DRUG DES, V67, P2, DOI 10.1111/j.1747-0285.2005.00314.x; Song FY, 2006, FRONT BIOSCI-LANDMRK, V11, P3100, DOI 10.2741/2036; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Woessner J.F., 2000, PROTEIN PROFILE SER; Xu XP, 2007, BIOCHEM J, V406, P147, DOI 10.1042/BJ20070591; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656	66	76	79	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20087	20095		10.1074/jbc.M801438200	http://dx.doi.org/10.1074/jbc.M801438200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499673	Green Published, hybrid			2022-12-27	WOS:000257565300025
J	Yue, XP; Li, X; Nguyen, HT; Chin, DR; Sullivan, DE; Lasky, JA				Yue, Xinping; Li, Xian; Nguyen, Hong T.; Chin, Dawn R.; Sullivan, Deborah E.; Lasky, Joseph A.			Transforming growth factor-beta 1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PULMONARY-FIBROSIS; TUMOR-GROWTH; BINDING; QSULF1; SITES; FGF; IDENTIFICATION; PROLIFERATION; MYOFIBROBLAST	Transforming growth factor (TGF)-beta 1 plays an important role in the development of pulmonary fibrosis. In this study we examined the relationship between TGF-beta 1 stimulation and the expression of heparan sulfate (HS) 6-O-endosulfatase 1 (Sulf1) in cultured normal human lung fibroblasts (NHLFs) and in murine lungs in vivo. By removing 6-O-sulfates from specific HS intrachain sites on the cell surface, Sulf1 has been shown to modulate the activities of many HS binding growth factors and morphogens including fibroblast growth factor (FGF)-2. Real time reverse transcription-PCR analysis revealed that TGF-beta 1 increased Sulf1 expression in NHLFs in a dose- and time-dependent manner which was accompanied by a decrease in 6-O-sulfated disaccharides as revealed by high performance liquid chromatography analysis. Decreased ERK activation after FGF-2 stimulation was observed in TGF-beta 1-treated NHLFs compared with control cells without changes in HS-dependent FGF-2 binding or FGF-2 center dot FR1c complex formation. To study the function of Sulf1, negative control or Sulf1-specific small interference RNA (siRNA)-transfected NHLFs were stimulated with TGF-beta 1. Enhanced Smad2/3 phosphorylation and elevated total Smad2 protein level were observed in Sulf1 siRNA-transfected cells and were accompanied by enhanced expression of alpha-smooth muscle actin and fibronectin. In addition, Sulf1 siRNA transfection enhanced the anti-proliferative effect of TGF-beta 1. Finally Sulf1 expression was up-regulated in the lungs of mice treated with adenovirus encoding active TGF-beta 1. Taken together, our data indicate that Sulf1 is a TGF-beta 1-responsive gene both in vitro and in vivo and may function as a negative regulator of TGF-beta 1-induced fibrogenesis.	[Yue, Xinping; Li, Xian; Nguyen, Hong T.; Chin, Dawn R.; Lasky, Joseph A.] Tulane Univ, Hlth Sci Ctr, Dept Med, Sect Pulm Dis Crit Care & Environm Med, New Orleans, LA 70112 USA; [Sullivan, Deborah E.] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University	Lasky, JA (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Med, Pulm Sect, SL-9,1430 Tulane Ave, New Orleans, LA 70112 USA.	jlasky@tulane.edu			NHLBI NIH HHS [T32 HL 007973, HL 083480] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007973, R01HL083480] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KUHN C, 1991, AM J PATHOL, V138, P1257; Lai JP, 2006, GASTROENTEROLOGY, V130, P2130, DOI 10.1053/j.gastro.2006.02.056; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lasky JA, 2000, ENVIRON HEALTH PERSP, V108, P751, DOI 10.2307/3454412; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; RAGHOW R, 1989, J CLIN INVEST, V84, P1836, DOI 10.1172/JCI114369; Rapraeger AC, 2002, METHOD CELL BIOL, V69, P83, DOI 10.1016/S0091-679X(02)69009-0; Safaiyan F, 1998, EUR J BIOCHEM, V252, P576, DOI 10.1046/j.1432-1327.1998.2520576.x; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sullivan DE, 2005, AM J RESP CELL MOL, V32, P342, DOI 10.1165/rcmb.2004-0288OC; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Walz A, 1997, DEVELOPMENT, V124, P2421; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Warshamana GS, 2002, INT J EXP PATHOL, V83, P183, DOI 10.1046/j.1365-2613.2002.00229.x; Yue XP, 2004, GLYCOBIOLOGY, V14, P745, DOI 10.1093/glycob/cwh083; Zhang HY, 1996, AM J PATHOL, V148, P527; Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720; ZHANG K, 1994, AM J PATHOL, V145, P114; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	49	50	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20397	20407		10.1074/jbc.M802850200	http://dx.doi.org/10.1074/jbc.M802850200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18503048	Green Published, hybrid			2022-12-27	WOS:000257565300055
J	Handa, N; Mizohata, E; Kishishita, S; Toyama, M; Morita, S; Uchikubo-Kamo, T; Akasaka, R; Omori, K; Kotera, J; Terada, T; Shirouzu, M; Yokoyama, S				Handa, Noriko; Mizohata, Eiichi; Kishishita, Seiichiro; Toyama, Mitsutoshi; Morita, Satoshi; Uchikubo-Kamo, Tomomi; Akasaka, Ryogo; Omori, Kenji; Kotera, Jun; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki			Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CGMP BINDING; PDE10A; LOCALIZATION; ORGANIZATION; DIMERIZATION; INHIBITION; GENE; PDES	Cyclic nucleotide phosphodiesterases (PDEs) catalyze the degradation of the cyclic nucleotides cAMP and cGMP, which are important second messengers. Five of the 11 mammalian PDE families have tandem GAF domains at their N termini. PDE10A may be the only mammalian PDE for which cAMP is the GAF domain ligand, and it may be allosterically stimulated by cAMP. PDE10A is highly expressed in striatal medium spiny neurons. Here we report the crystal structure of the C-terminal GAF domain (GAF-B) of human PDE10A complexed with cAMP at 2.1-angstrom resolution. The conformation of the PDE10A GAF-B domain monomer closely resembles those of the GAF domains of PDE2A and the cyanobacterium Anabaena cyaB2 adenylyl cyclase, except for the helical bundle consisting of alpha 1, alpha 2, and alpha 5. The PDE10A GAF-B domain forms a dimer in the crystal and in solution. The dimerization is mainly mediated by hydrophobic interactions between the helical bundles in a parallel arrangement, with a large buried surface area. In the PDE10A GAF-B domain, cAMP tightly binds to a cNMP-binding pocket. The residues in the alpha 3 and alpha 4 helices, the alpha 6 strand, the loop between 3(10) and alpha 4, and the loop between alpha 4 and beta 5 are involved in the recognition of the phosphate and ribose moieties. This recognition mode is similar to those of the GAF domains of PDE2A and cyaB2. In contrast, the adenine base is specifically recognized by the PDE10A GAF-B domain in a unique manner, through residues in the beta 1 and beta 2 strands.	[Handa, Noriko; Mizohata, Eiichi; Kishishita, Seiichiro; Toyama, Mitsutoshi; Morita, Satoshi; Uchikubo-Kamo, Tomomi; Akasaka, Ryogo; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Yokohama Inst, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Omori, Kenji; Kotera, Jun] Mitsubishi Tanabe Pharma Corp, Adv Med Res Lab, Saitama 3358505, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	RIKEN; Mitsubishi Tanabe Pharma Corporation; University of Tokyo	Yokoyama, S (corresponding author), RIKEN, Yokohama Inst, Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Kishishita, Seiichiro/H-1836-2011; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kishishita, Seiichiro/0000-0001-7587-2581; 				Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 2000, EUR J BIOCHEM, V267, P5943, DOI 10.1046/j.1432-1327.2000.01661.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; HURLEY JH, 2003, SCI STKE, pPE1; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa T, 1999, Tanpakushitsu Kakusan Koso, V44, P598; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov KG, 2003, J BIOL CHEM, V278, P10594, DOI 10.1074/jbc.M208456200; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Rodefer JS, 2005, EUR J NEUROSCI, V21, P1070, DOI 10.1111/j.1460-9568.2005.03937.x; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wada T, 2003, ACTA CRYSTALLOGR D, V59, P1213, DOI 10.1107/S0907444903010515; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	48	51	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19657	19664		10.1074/jbc.M800595200	http://dx.doi.org/10.1074/jbc.M800595200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18477562	hybrid			2022-12-27	WOS:000257387600051
J	Iijima-Ando, K; Hearn, SA; Granger, L; Shenton, C; Gatt, A; Chiang, HC; Hakker, I; Zhong, Y; Iijima, K				Iijima-Ando, Kanae; Hearn, Stephen A.; Granger, Linda; Shenton, Christopher; Gatt, Anthony; Chiang, Hsueh-Cheng; Hakker, Inessa; Zhong, Yi; Iijima, Koichi			Overexpression of neprilysin reduces Alzheimer amyloid-beta 42 (A beta 42)-induced neuron loss and intraneuronal A beta 42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; A-BETA; PLAQUE-FORMATION; TRANSGENIC MICE; DEGRADING ENDOPEPTIDASE; PRECURSOR PROTEIN; DISEASE; BRAIN; ACCUMULATION; NEURODEGENERATION	The amyloid-beta 42 (A beta 42) peptide has been suggested to play a causative role in Alzheimer disease (AD). Neprilysin (NEP) is one of the rate-limiting A beta-degrading enzymes, and its enhancement ameliorates extracellular amyloid pathology, synaptic dysfunction, and memory defects in mouse models of A beta amyloidosis. In addition to the extracellular A beta, intraneuronal A beta 42 may contribute to AD pathogenesis. However, the protective effects of neuronal NEP expression on intraneuronal A beta 42 accumulation and neurodegeneration remain elusive. In contrast, sustained NEP activation may be detrimental because NEP can degrade many physiological peptides, but its consequences in the brain are not fully understood. Using transgenic Drosophila expressing human NEP and A beta 42, we demonstrated that NEP efficiently suppressed the formation of intraneuronal A beta 42 deposits and A beta 42-induced neuron loss. However, neuronal NEP overexpression reduced cAMP-responsive element-binding protein-mediated transcription, caused age-dependent axon degeneration, and shortened the life span of the flies. Interestingly, the mRNA levels of endogenous fly NEP genes and phosphoramidon-sensitive NEP activity declined during aging in fly brains, as observed in mammals. Taken together, these data suggest both the protective and detrimental effects of chronically high NEP activity in the brain. Down-regulation of NEP activity in aging brains may be an evolutionarily conserved phenomenon, which could predispose humans to developing late-onset AD.	[Iijima-Ando, Kanae; Granger, Linda; Shenton, Christopher] Thomas Jefferson Univ, Lab Neurogenet & Pathobiol, Farber Inst Neurosciences, Philadelphia, PA 19107 USA; [Granger, Linda; Gatt, Anthony; Iijima, Koichi] Thomas Jefferson Univ, Lab Neurodegenerat Dis & Gene Discovery, Farber Inst Neurosciences, Philadelphia, PA 19107 USA; [Iijima-Ando, Kanae; Iijima, Koichi] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Hearn, Stephen A.; Chiang, Hsueh-Cheng; Hakker, Inessa; Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chiang, Hsueh-Cheng] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Jefferson University; Jefferson University; Jefferson University; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Iijima-Ando, K (corresponding author), 900 Walnut St JHN410, Philadelphia, PA 19107 USA.	Kanae.Iijima-Ando@jefferson.edu; Koichi.Iijima@jefferson.edu		Zhong, Yi/0000-0001-7810-9899; Zhong, Yi/0000-0002-7927-5976; Hearn, Stephen/0000-0002-2489-2424				BARNES K, 1992, J NEUROCHEM, V58, P2088, DOI 10.1111/j.1471-4159.1992.tb10950.x; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; CARREL S, 1982, ACTA NEUROPATHOL, V57, P158, DOI 10.1007/BF00685384; Carter TL, 2006, NEUROSCI LETT, V392, P235, DOI 10.1016/j.neulet.2005.09.022; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; HELLSTROMLINDAH.E, 2006, NEUROBIOL AGING; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LI CW, 1995, METHOD ENZYMOL, V248, P253; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Marr RA, 2003, J NEUROSCI, V23, P1992; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Papandreou CN, 1998, NAT MED, V4, P50, DOI 10.1038/nm0198-050; Poirier R, 2006, NEUROBIOL DIS, V24, P475, DOI 10.1016/j.nbd.2006.08.003; Rodrigo J, 2004, NEUROSCIENCE, V128, P73, DOI 10.1016/j.neuroscience.2004.06.030; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Russo R, 2005, FEBS LETT, V579, P6027, DOI 10.1016/j.febslet.2005.09.054; SAITO T, 2003, SCI AGING KNOWLEDGE, pPE1; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sudoh S, 2002, BIOCHEMISTRY-US, V41, P1091, DOI 10.1021/bi011193l; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thomas JE, 2005, BIOCHEM J, V386, P357, DOI 10.1042/BJ20041753; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Wang DS, 2003, BIOCHEM BIOPH RES CO, V310, P236, DOI 10.1016/j.bbrc.2003.09.003; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; YIN JCP, 1995, MOL CELL BIOL, V15, P5123; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	72	65	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19066	19076		10.1074/jbc.M710509200	http://dx.doi.org/10.1074/jbc.M710509200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18463098	Green Published, hybrid			2022-12-27	WOS:000257165600062
J	Toledo, JC; Bosworth, CA; Hennon, SW; Mahtani, HA; Bergonia, HA; Lancaster, JR				Toledo, Jose C., Jr.; Bosworth, Charles A.; Hennon, Seth W.; Mahtani, Harry A.; Bergonia, Hector A.; Lancaster, Jack R., Jr.			Nitric Oxide-induced Conversion of Cellular Chelatable Iron into Macromolecule-bound Paramagnetic Dinitrosyliron Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON SPIN RESONANCE; GLUTATHIONE TRANSFERASE SUPERFAMILY; CYTOTOXIC ACTIVATED MACROPHAGES; THIOL-CONTAINING LIGANDS; INTRACELLULAR FREE IRON; IN-VIVO; OXIDATIVE STRESS; S-NITROSOTHIOLS; STIMULATED MACROPHAGES; MAMMALIAN-CELLS	One of the most important biological reactions of nitric oxide (nitrogen monoxide, (NO)-N-center dot) is its reaction with transition metals, of which iron is the major target. This is confirmed by the ubiquitous formation of EPR-detectable g = 2.04 signals in cells, tissues, and animals upon exposure to both exogenous and endogenous (NO)-N-center dot. The source of the iron for these dinitrosyliron complexes (DNIC), and its relationship to cellular iron homeostasis, is not clear. Evidence has shown that the chelatable iron pool (CIP) may be at least partially responsible for this iron, but quantitation and kinetic characterization have not been reported. In the murine cell line RAW 264.7, (NO)-N-center dot reacts with the CIP similarly to the strong chelator salicylaldehyde isonicotinoyl hydrazone (SIH) in rapidly releasing iron from the iron-calcein complex. SIH pretreatment prevents DNIC formation from (NO)-N-center dot, and SIH added during the (NO)-N-center dot treatment "freezes" DNIC levels, showing that the complexes are formed from the CIP, and they are stable (resistant to SIH). DNIC formation requires free (NO)-N-center dot, because addition of oxyhemoglobin prevents formation from either (NO)-N-center dot donor or S-nitrosocysteine, the latter treatment resulting in 100-fold higher intracellular nitrosothiol levels. EPR measurement of the CIP using desferroxamine shows quantitative conversion of CIP into DNIC by (NO)-N-center dot. In conclusion, the CIP is rapidly and quantitatively converted to paramagnetic large molecular mass DNIC from exposure to free (NO)-N-center dot but not from cellular nitrosothiol. These results have important implications for the antioxidative actions of (NO)-N-center dot and its effects on cellular iron homeostasis.	[Toledo, Jose C., Jr.; Bosworth, Charles A.; Mahtani, Harry A.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Toledo, Jose C., Jr.; Mahtani, Harry A.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Bosworth, Charles A.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Hennon, Seth W.] Mt Union Coll, Dept Biol, Alliance, OH 44601 USA; [Hennon, Seth W.] Mt Union Coll, Dept Chem, Alliance, OH 44601 USA; [Bergonia, Hector A.] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Mount Union; University of Mount Union; Utah System of Higher Education; University of Utah	Lancaster, JR (corresponding author), Univ Alabama Birmingham, Ctr Free Rad Biol, 901,19th St, Birmingham, AL 35294 USA.	doctorno@uab.edu	Toledo, Jose C/J-4360-2015; Sochanowicz, Barbara/V-3890-2018	Sochanowicz, Barbara/0000-0002-7348-8356; Toledo Junior, Jose Carlos/0000-0003-0818-0846	National Institutes of Health [HL71189, HL074391]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074391, R01HL071189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL71189 and HL074391 (to J.R.L.). This work was also supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant (to J.C.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bezerra CWB, 1999, INORG CHEM, V38, P5660, DOI 10.1021/ic990210g; Branca M, 1997, MAGN RESON CHEM, V35, P687, DOI 10.1002/(SICI)1097-458X(199711)35:10<687::AID-OMR152>3.0.CO;2-Z; BRENNAN MJ, 1966, P SOC EXP BIOL MED, V123, P715; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; BUTLER AR, 1988, ADV INORG CHEM, V32, P335, DOI 10.1016/S0898-8838(08)60235-4; BUTLER AR, 1985, POLYHEDRON, V4, P303, DOI 10.1016/S0277-5387(00)84503-9; Cabantchik ZI, 1996, ANAL BIOCHEM, V233, P221, DOI 10.1006/abio.1996.0032; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; Cook JA, 1996, ANAL BIOCHEM, V238, P150, DOI 10.1006/abio.1996.0268; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Costanzo S, 2001, INORG CHIM ACTA, V318, P1, DOI 10.1016/S0020-1693(01)00402-9; D'Autreaux B, 2004, J AM CHEM SOC, V126, P6005, DOI 10.1021/ja031671a; Dalsgaard T, 2007, AM J PHYSIOL-HEART C, V292, pH3072, DOI 10.1152/ajpheart.01298.2006; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; EMERY T, 1980, NATURE, V287, P776, DOI 10.1038/287776a0; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Ford PC, 2002, CHEM REV, V102, P993, DOI 10.1021/cr0000271; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HENRY Y, 1991, EUR BIOPHYS J, V20, P1; HENRY Y, 1997, EPR SPECTROSCOPY NIT; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; ISENBERG I, 1964, PHYSIOL REV, V44, P487, DOI 10.1152/physrev.1964.44.3.487; Kagan VE, 2001, ANTIOXID REDOX SIGN, V3, P189, DOI 10.1089/152308601300185160; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; KENNEDY MC, 1993, BIOCHEM BIOPH RES CO, V196, P632, DOI 10.1006/bbrc.1993.2296; KOSAKA H, 1989, CARCINOGENESIS, V10, P563, DOI 10.1093/carcin/10.3.563; KOZLOV AV, 1992, FREE RADICAL BIO MED, V13, P9, DOI 10.1016/0891-5849(92)90159-E; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; LANGREHR JM, 1993, TRANSPLANTATION, V55, P1205, DOI 10.1097/00007890-199306000-00001; LEAF CD, 1989, CANCER SURV, V8, P323; Lewandowska H, 2007, J BIOL INORG CHEM, V12, P345, DOI 10.1007/s00775-006-0192-8; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; MCDONALD CC, 1965, J AM CHEM SOC, V87, P3319, DOI 10.1021/ja01093a007; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955; Muller B, 1996, BRIT J PHARMACOL, V119, P1281, DOI 10.1111/j.1476-5381.1996.tb16034.x; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; PELLAT C, 1990, BIOCHEM BIOPH RES CO, V166, P119, DOI 10.1016/0006-291X(90)91919-J; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SALERNO JC, 1976, BIOCHEM BIOPH RES CO, V73, P833, DOI 10.1016/0006-291X(76)90884-6; STADLER J, 1993, ARCH BIOCHEM BIOPHYS, V302, P4, DOI 10.1006/abbi.1993.1173; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; Vanin AF, 1997, BIOFIZIKA+, V42, P10; VANIN AF, 1992, BIOCHIM BIOPHYS ACTA, V1135, P275, DOI 10.1016/0167-4889(92)90231-Y; Vanin AF, 2007, NITRIC OXIDE-BIOL CH, V16, P82, DOI 10.1016/j.niox.2006.07.005; VITHAYATHIL AJ, 1965, NATURE, V207, P1246, DOI 10.1038/2071246a0; Wang J, 2005, MOL CELL BIOL, V25, P1347, DOI 10.1128/MCB.25.4.1347-1353.2005; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; WOOLUM JC, 1968, BIOCHIM BIOPHYS ACTA, V160, P311, DOI 10.1016/0005-2795(68)90204-3; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101	66	85	87	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28926	28933		10.1074/jbc.M707862200	http://dx.doi.org/10.1074/jbc.M707862200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18480062	Green Published, hybrid			2022-12-27	WOS:000260179900018
J	Weissbach, H				Weissbach, Herbert			The isolation of the vitamin B-12 coenzyme and the role of the vitamin in methionine synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENZYMATIC-SYNTHESIS; PROTEIN SYNTHESIS; FACTOR-TS; N5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE TRANSMETHYLASE; 5-HYDROXYTRYPTAMINE SEROTONIN; POLYPEPTIDE SYNTHESIS; S-ADENOSYLMETHIONINE; COBAMIDE COENZYMES; N-ACETYLSEROTONIN		Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Weissbach, H (corresponding author), Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA.	hweissba@fau.edu						ALLENDE JE, 1967, BIOCHEM BIOPH RES CO, V28, P82, DOI 10.1016/0006-291X(67)90410-X; ALLENDE JE, 1967, P NATL ACAD SCI USA, V58, P1566, DOI 10.1073/pnas.58.4.1566; AXELROD J, 1960, SCIENCE, V131, P1312, DOI 10.1126/science.131.3409.1312; AXELROD J, 1961, J BIOL CHEM, V236, P211; BARCHAS J, 1964, BIOCHEMISTRY-US, V3, P1684, DOI 10.1021/bi00899a014; BARKER HA, 1958, P NATL ACAD SCI USA, V44, P1093, DOI 10.1073/pnas.44.11.1093; BARKER HA, 1959, J BIOL CHEM, V234, P320; BARKER HA, 1960, J BIOL CHEM, V235, P480; BARKER HA, 1960, J BIOL CHEM, V235, P181; BRADY RO, 1962, J BIOL CHEM, V237, P2325; BROT N, 1965, BIOCHEM BIOPH RES CO, V18, P18, DOI 10.1016/0006-291X(65)90875-2; BROT N, 1969, BIOCHEM BIOPH RES CO, V34, P843, DOI 10.1016/0006-291X(69)90257-5; BROT N, 1972, ARCH BIOCHEM BIOPHYS, V148, P148, DOI 10.1016/0003-9861(72)90125-7; BROT N, 1970, Biochemical and Biophysical Research Communications, V41, P1388, DOI 10.1016/0006-291X(70)90541-3; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; BROT N, 1966, J BIOL CHEM, V241, P2024; CALDWELL P, 1978, P NATL ACAD SCI USA, V75, P5349, DOI 10.1073/pnas.75.11.5349; CASKEY CT, 1967, ARCH BIOCHEM BIOPHYS, V120, P119, DOI 10.1016/0003-9861(67)90605-4; CLARK BFC, 1965, NATURE, V207, P1038, DOI 10.1038/2071038b0; CLARK CT, 1954, J BIOL CHEM, V210, P139; DICKERMA.HW, 1967, J BIOL CHEM, V242, P1522; DOWNING M, 1956, J BIOL CHEM, V220, P521; ERTEL R, 1968, ARCH BIOCHEM BIOPHYS, V128, P331, DOI 10.1016/0003-9861(68)90039-8; ERTEL R, 1968, P NATL ACAD SCI USA, V59, P861, DOI 10.1073/pnas.59.3.861; HACHMANN J, 1971, ARCH BIOCHEM BIOPHYS, V147, P457, DOI 10.1016/0003-9861(71)90401-2; HELLEINER CW, 1956, BIOCH J, V63; KATZ E, 1962, J BIOL CHEM, V237, P882; KUNG H, 1977, J BIOL CHEM, V252, P6889; LENHERT PG, 1961, NATURE, V192, P937, DOI 10.1038/192937a0; MATTHEWS RG, 2009, METAL IONS IN PRESS, V6; MILLER DL, 1969, ARCH BIOCHEM BIOPHYS, V132, P146, DOI 10.1016/0003-9861(69)90346-4; MILLER DL, 1970, BIOCHEM BIOPH RES CO, V38, P1016, DOI 10.1016/0006-291X(70)90341-4; MILLER DL, 1970, ARCH BIOCHEM BIOPHYS, V141, P26, DOI 10.1016/0003-9861(70)90102-5; PETERKOFSKY A, 1963, J BIOL CHEM, V238, P1491; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; TAKEYAMA S, 1961, J BIOL CHEM, V236, P1102; TAYLOR RT, 1966, J BIOL CHEM, V241, P3641; TAYLOR RT, 1967, J BIOL CHEM, V242, P1502; TAYLOR RT, 1967, J BIOL CHEM, V242, P1517; TAYLOR RT, 1967, BIOCHEM BIOPH RES CO, V27, P398, DOI 10.1016/S0006-291X(67)80113-X; UDENFRIEND S, 1955, J BIOL CHEM, V215, P337; WACHSMAN JT, 1956, J BIOL CHEM, V223, P19; WEISSBACH A, 1986, METHODS ENZYMOLOGY P, V118; WEISSBACH H, 1960, BIOCHIM BIOPHYS ACTA, V43, P352, DOI 10.1016/0006-3002(60)90453-4; WEISSBACH H, 1964, BIOCHEM BIOPH RES CO, V17, P17, DOI 10.1016/0006-291X(64)90293-1; WEISSBACH H, 1964, J BIOL CHEM, V239, P146; WEISSBACH H, 1957, J BIOL CHEM, V229, P953; WEISSBACH H., 1959, PROC NATL ACAD SCI, V45, P521, DOI 10.1073/pnas.45.4.521; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; WEISSBACH H, 1962, J BIOL CHEM, V237, P3217; WEISSBACH H, 1963, J BIOL CHEM, V238, P3318; WEISSBACH H, 1970, ARCH BIOCHEM BIOPHYS, V137, P262, DOI 10.1016/0003-9861(70)90433-9; WEISSBACH H, 1965, PHYSIOL REV, V45, P80, DOI 10.1152/physrev.1965.45.1.80; WEISSBACH H, 1957, J BIOL CHEM, V227, P617; WEISSBACH H, 1961, J BIOL CHEM, V236, P40; WHITFIELD CD, 1970, J BIOL CHEM, V245, P390	56	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23497	23504		10.1074/jbc.X800006200	http://dx.doi.org/10.1074/jbc.X800006200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18524762	Green Published, hybrid			2022-12-27	WOS:000258638900001
J	Helms, MN; Jain, L; Self, JL; Eaton, DC				Helms, My N.; Jain, Lucky; Self, Julie L.; Eaton, Douglas C.			Redox regulation of epithelial sodium channels examined in alveolar type 1 and 2 cells patch-clamped in lung slice tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I CELLS; SUPEROXIDE; EXPRESSION; CLEARANCE; TRANSPORT	The alveolar surface of the lung is lined by alveolar type 1 (AT1) and type 2 (AT2) cells. Using single channel patch clamp analysis in lung slice preparations, we are able to uniquely study AT1 and AT2 cells separately from intact lung. We report for the first time the Na+ transport properties of type 2 cells accessed in live lung tissue (as we have done in type 1 cells). Type 2 cells in lung tissue slices express both highly selective cation and nonselective cation channels with average conductances of 8.8 +/- 3.2 and 22.5 +/- 6.3 picosiemens, respectively. Anion channels with 10-picosiemen conductance are also present in the apical membrane of type 2 cells. Our lung slice studies importantly verify the use of cultured cell model systems commonly used in lung epithelial sodium channel (ENaC) studies. Furthermore, we identify novel functional differences between the cells that make up the alveolar epithelium. One important difference is that exposure to the nitric oxide (NO) donor, PAPA-NONOate (1.5 mu M), significantly decreases average ENaC NPo in type 2 cells (from 1.38 +/- 0.26 to 0.82 +/- 0.16; p < 0.05 and n = 18) but failed to alter ENaC activity in alveolar type 1 cells. Elevating endogenous superoxide (O-2(radical anion)) levels with Ethiolat, a superoxide dismutase inhibitor, prevented NO inhibition of ENaC activity in type 2 cells, supporting the novel hypothesis that O-2(radical anion) and NO signaling plays an important role in maintaining lung fluid balance.	[Eaton, Douglas C.] Emory Univ, Dept Physiol, Ctr Cell & Mol Signaling, Sch Med, Atlanta, GA 30322 USA; [Jain, Lucky; Eaton, Douglas C.] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University	Eaton, DC (corresponding author), Emory Univ, Dept Physiol, Ctr Cell & Mol Signaling, Sch Med, 615 Michael St, Atlanta, GA 30322 USA.	deaton@emory.edu		Eaton, Douglas/0000-0002-2686-6692	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037963, R24DK064399] Funding Source: NIH RePORTER; NHLBI NIH HHS [2R01 HL063306-05A2, R01 HL063306] Funding Source: Medline; NIDDK NIH HHS [4R37 DK-37963, DK064399] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baines DL, 2001, J PHYSIOL-LONDON, V532, P105, DOI 10.1111/j.1469-7793.2001.0105g.x; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; CHEEK JM, 1989, EXP CELL RES, V184, P375, DOI 10.1016/0014-4827(89)90337-6; Chen JW, 2006, J PHYSIOL-LONDON, V572, P625, DOI 10.1113/jphysiol.2005.103465; Chen XJ, 2002, AM J PHYSIOL-LUNG C, V282, pL609, DOI 10.1152/ajplung.00356.2001; DANTO SI, 1992, AM J RESP CELL MOL, V6, P296, DOI 10.1165/ajrcmb/6.3.296; DANTO SI, 1995, AM J RESP CELL MOL, V12, P497, DOI 10.1165/ajrcmb.12.5.7742013; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dobbs LG, 1997, AM J PHYSIOL-LUNG C, V273, pL347, DOI 10.1152/ajplung.1997.273.2.L347; DOBBS LG, 1988, BIOCHIM BIOPHYS ACTA, V970, P146, DOI 10.1016/0167-4889(88)90173-5; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Elias N., 2006, AM ACAD PEDIAT, V7, pE88, DOI DOI 10.1542/neo.7-2-e88; Fang XH, 2004, AM J PHYSIOL-LUNG C, V287, pL104, DOI 10.1152/ajplung.00176.2003; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; FENG ZP, 1993, AM J RESP CELL MOL, V9, P248, DOI 10.1165/ajrcmb/9.3.248; FOUBERT L, 1992, LANCET, V339, P1615, DOI 10.1016/0140-6736(92)91886-D; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Helms MN, 2006, AM J PHYSIOL-LUNG C, V290, pL710, DOI 10.1152/ajplung.00486.2004; Helms MN, 2005, AM J PHYSIOL-CELL PH, V289, pC717, DOI 10.1152/ajpcell.00006.2005; Helms MN, 2006, AM J PHYSIOL-LUNG C, V291, pL610, DOI 10.1152/ajplung.00426.2005; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; Jain L, 1998, AM J PHYSIOL-LUNG C, V274, pL475, DOI 10.1152/ajplung.1998.274.4.L475; Liebler JM, 2004, J HISTOCHEM CYTOCHEM, V52, P759, DOI 10.1369/jhc.3A6184.2004; Matalon S, 2002, J APPL PHYSIOL, V93, P1852, DOI 10.1152/japplphysiol.01241.2001; Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC; Planes C, 1997, AM J RESP CELL MOL, V17, P508, DOI 10.1165/ajrcmb.17.4.2680; Rafii B, 1998, AM J PHYSIOL-LUNG C, V275, pL764, DOI 10.1152/ajplung.1998.275.4.L764; Sheppard David N, 2004, J Cyst Fibros, V3 Suppl 2, P101, DOI 10.1016/j.jcf.2004.05.046; Thome UH, 2003, AM J PHYSIOL-LUNG C, V284, pL376, DOI 10.1152/ajplung.00218.2002; Wang PM, 2002, AM J PHYSIOL-LUNG C, V282, pL912, DOI 10.1152/ajplung.00303.2001; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006; Yue HW, 2000, J BIOL CHEM, V275, P10030, DOI 10.1074/jbc.275.14.10030	33	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22875	22883		10.1074/jbc.M801363200	http://dx.doi.org/10.1074/jbc.M801363200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18541535	Green Published, hybrid			2022-12-27	WOS:000258321000055
J	Buglino, JA; Resh, MD				Buglino, John A.; Resh, Marilyn D.			Hhat is a palmitoylacyltransferase with specificity for N-palmitoylation of Sonic Hedgehog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL MODIFICATION; RAT-LIVER; PROTEIN PALMITOYLATION; ENDOPLASMIC-RETICULUM; LIPID MODIFICATIONS; SIGNALING PROTEINS; FATTY-ACYLATION; L-CARNITINE; ACYLTRANSFERASE; FAMILY	Palmitoylation of Sonic Hedgehog (Shh) is critical for effective long- and short-range signaling. Genetic screens uncovered a potential palmitoylacyltransferase (PAT) for Shh, Hhat, but the molecular mechanism of Shh palmitoylation remains unclear. Here, we have developed and exploited an in vitro Shh palmitoylation assay to purify Hhat to homogeneity. We provide direct biochemical evidence that Hhat is a PAT with specificity for attaching palmitate via amide linkage to the N-terminal cysteine of Shh. Other palmitoylated proteins (e. g. PSD95 and Wnt) are not substrates for Hhat, and Porcupine, a putative Wnt PAT, does not palmitoylate Shh. Neither autocleavage nor cholesterol modification is required for Shh palmitoylation. Both the Shh precursor and mature protein are N-palmitoylated by Hhat, and the reaction occurs during passage through the secretory pathway. This study establishes Hhat as a bona fide Shh PAT and serves as a model for understanding how secreted morphogens are modified by distinct PATs.	[Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Biochem Cell & Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	m-resh@ski.mskcc.org		Resh, Marilyn/0000-0001-6118-9466	NIGMS NIH HHS [GM008539, GM57966] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966, T32GM008539] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGE RK, 1979, BIOCHEM J, V181, P119, DOI 10.1042/bj1810119; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Bhatnagar RS, 1997, BIOCHEMISTRY-US, V36, P6700, DOI 10.1021/bi970311v; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Gooding JM, 2004, EUR J BIOCHEM, V271, P954, DOI 10.1111/j.1432-1033.2004.03997.x; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Ho KS, 2002, CURR OPIN NEUROBIOL, V12, P57, DOI 10.1016/S0959-4388(02)00290-8; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kleuss C, 2003, EMBO J, V22, P826, DOI 10.1093/emboj/cdg095; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; MENTLEIN R, 1988, BIOCHIM BIOPHYS ACTA, V964, P319, DOI 10.1016/0304-4165(88)90032-3; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Miura GI, 2006, CELL CYCLE, V5, P1184, DOI 10.4161/cc.5.11.2804; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roessler E, 1997, HUM MOL GENET, V6, P1847, DOI 10.1093/hmg/6.11.1847; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Rys-Sikora KE, 1998, J BIOL CHEM, V273, P32627, DOI 10.1074/jbc.273.49.32627; Sang SLW, 2005, J PEPT RES, V66, P169, DOI 10.1111/j.1399-3011.2005.00285.x; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	53	175	182	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22076	22088		10.1074/jbc.M803901200	http://dx.doi.org/10.1074/jbc.M803901200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18534984	Green Published, hybrid			2022-12-27	WOS:000258114700026
J	Yang, LL; Kasumov, T; Kombu, RS; Zhu, SH; Cendrowski, AV; David, F; Anderson, VE; Kelleher, JK; Brunengraber, H				Yang, Lili; Kasumov, Takhar; Kombu, Rajan S.; Zhu, Shu-Han; Cendrowski, Andrea V.; David, France; Anderson, Vernon E.; Kelleher, Joanne K.; Brunengraber, Henri			Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle - II. Heterogeneity of metabolite labeling pattern	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED-RAT-LIVER; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HEPATOCYTES; INHIBITION; MECHANISM; GLUCOSE; AMINOOXYACETATE; SPECTROMETRY; LIPOGENESIS; (CO2)-C-14	In this second of two companion articles, we compare the mass isotopomer distribution of metabolites of liver gluconeogenesis and citric acid cycle labeled from (NaHCO3)-C-13 or dimethyl [1,4-C-13(2)] succinate. The mass isotopomer distribution of intermediates reveals the reversibility of the isocitrate dehydrogenase + aconitase reactions, even in the absence of a source of alpha-ketoglutarate. In addition, in many cases, a number of labeling incompatibilities were found as follows: (i) glucose versus triose phosphates and phosphoenolpyruvate; (ii) differences in the labeling ratios C-4/C-3 of glucose versus (glyceraldehyde 3-phosphate)/(dihydroxyacetone phosphate); and (iii) labeling of citric acid cycle intermediates in tissue versus effluent perfusate. Overall, our data show that gluconeogenic and citric acid cycle intermediates cannot be considered as sets of homogeneously labeled pools. This probably results from the zonation of hepatic metabolism and, in some cases, from differences in the labeling pattern of mitochondrial versus extramitochondrial metabolites. Our data have implications for the use of labeling patterns for the calculation of metabolic rates or fractional syntheses in liver, as well as for modeling liver intermediary metabolism.	[Brunengraber, Henri] Case Western Reserve Univ, Sch Med WG48, Dept Nutr, Cleveland, OH 44106 USA; [Anderson, Vernon E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kelleher, Joanne K.] MIT, Dept Chem Engn, Cambridge, MA 02154 USA	Case Western Reserve University; Case Western Reserve University; Massachusetts Institute of Technology (MIT)	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med WG48, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxb8@case.edu	Lorkiewicz, Pawel/A-2126-2011; Kombu, Rajan/A-6752-2008; Anderson, Vernon/W-2673-2019	Lorkiewicz, Pawel/0000-0002-1755-9826; Anderson, Vernon Emmett/0000-0002-1699-7621	NIDDK NIH HHS [R33DK070291] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bederman IR, 2004, J BIOL CHEM, V279, P43207, DOI 10.1074/jbc.M403838200; BEYLOT M, 1993, ANAL BIOCHEM, V212, P526, DOI 10.1006/abio.1993.1363; BLACKSHEAR PJ, 1975, BIOCHEM J, V148, P353, DOI 10.1042/bj1480353b; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; CHANG HC, 1966, J BIOL CHEM, V241, P2421; CORNELL NW, 1984, BIOCHEM J, V220, P707, DOI 10.1042/bj2200707; DEBEER LJ, 1982, FEBS LETT, V140, P159, DOI 10.1016/0014-5793(82)80884-3; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; ESENMO E, 1992, AM J PHYSIOL, V263, pE36, DOI 10.1152/ajpendo.1992.263.1.E36; FOLCH J, 1951, J BIOL CHEM, V191, P819; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; HELLERSTEIN MK, 1991, J BIOL CHEM, V266, P10920; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; JUNGERMANN K, 1987, Diabetes Metabolism Reviews, V3, P269; LANDAU BERNARD R., 1955, JOUR BIOL CHEM, V214, P525; LANDAU BR, 1995, AM J PHYSIOL-ENDOC M, V269, pE18, DOI 10.1152/ajpendo.1995.269.1.E18; OCHS RS, 1980, BIOCHIM BIOPHYS ACTA, V632, P260, DOI 10.1016/0304-4165(80)90084-7; Previs SF, 1996, J MASS SPECTROM, V31, P643, DOI 10.1002/(SICI)1096-9888(199606)31:6<643::AID-JMS335>3.0.CO;2-B; PREVIS SF, 1995, J BIOL CHEM, V270, P19806, DOI 10.1074/jbc.270.34.19806; Puchowicz MA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1022, DOI 10.1152/ajpendo.1999.277.6.E1022; ROGNSTAD R, 1974, ARCH BIOCHEM BIOPHYS, V161, P638, DOI 10.1016/0003-9861(74)90348-8; ROGNSTAD R, 1984, ARCH BIOCHEM BIOPHYS, V230, P605, DOI 10.1016/0003-9861(84)90441-7; ROGNSTAD R, 1982, J BIOL CHEM, V257, P1486; ROSE IA, 1962, J BIOL CHEM, V237, P3325; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Yang L, 2006, METABOLOMICS, V2, P85, DOI 10.1007/s11306-006-0019-1	28	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21988	21996		10.1074/jbc.M803455200	http://dx.doi.org/10.1074/jbc.M803455200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544526	hybrid, Green Published			2022-12-27	WOS:000258114700018
J	Liu, Y; Matthews, KS; Bondos, SE				Liu, Ying; Matthews, Kathleen S.; Bondos, Sarah E.			Multiple intrinsically disordered sequences alter DNA binding by the homeodomain of the Drosophila Hox protein Ultrabithorax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-COMPOSITION; FUNCTIONAL SPECIFICITY; TRANSCRIPTION FACTORS; LAC REPRESSOR; TARGET GENE; IN-VITRO; EXTRADENTICLE; RECOGNITION; EVOLUTION; BODY	During animal development, distinct tissues, organs, and appendages are specified through differential gene transcription by Hox transcription factors. However, the conserved Hox homeodomains bind DNA with high affinity yet low specificity. We have therefore explored the structure of the Drosophila melanogaster Hox protein Ultrabithorax and the impact of its nonhomeodomain regions on DNA binding properties. Computational and experimental approaches identified several conserved, intrinsically disordered regions outside the homeodomain of Ultrabithorax that impact DNA binding by the homeodomain. Full-length Ultrabithorax bound to target DNA 2.5-fold weaker than its isolated homeodomain. Using N-terminal and C-terminal deletion mutants, we demonstrate that the YPWM region and the disordered microexons (termed the I1 region) inhibit DNA binding similar to 2-fold, whereas the disordered I2 region inhibits homeodomain-DNA interaction a further similar to 40-fold. Binding is restored almost to homeodomain affinity by the mostly disordered N-terminal 174 amino acids (R region) in a length-dependent manner. Both the I2 and R regions contain portions of the activation domain, functionally linking DNA binding and transcription regulation. Given that (i) the I1 region and a portion of the R region alter homeodomain-DNA binding as a function of pH and (ii) an internal deletion within I1 increases Ultrabithorax-DNA affinity, I1 must directly impact homeodomain-DNA interaction energetics. However, I2 appears to indirectly affect DNA binding in a manner countered by the N terminus. The amino acid sequences of I2 and much of the I1 and R regions vary significantly among Ultrabithorax orthologues, potentially diversifying Hox-DNA interactions.	[Bondos, Sarah E.] Texas A& M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Liu, Ying; Matthews, Kathleen S.; Bondos, Sarah E.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Rice University	Bondos, SE (corresponding author), Texas A& M Hlth Sci Ctr, Dept Mol & Cellular Med, 258 Reynolds Med Bldg, College Stn, TX 77843 USA.	SEBondos@medicine.tamhsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 22441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batra-Safferling R, 2006, J BIOL CHEM, V281, P1449, DOI 10.1074/jbc.M505012200; BEACHY PA, 1993, MOL CELL BIOL, V13, P6941, DOI 10.1128/MCB.13.11.6941; Billeter M, 1996, PROG BIOPHYS MOL BIO, V66, P211, DOI 10.1016/S0079-6107(97)00006-0; Bondos SE, 2006, MOL CELL PROTEOMICS, V5, P824, DOI 10.1074/mcp.M500256-MCP200; Bondos SE, 2006, CURR ANAL CHEM, V2, P157, DOI 10.2174/157341106776359140; Bondos SE, 2004, J BIOL CHEM, V279, P26433, DOI 10.1074/jbc.M312842200; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Bondos SE, 2001, CRIT REV EUKAR GENE, V11, P145; Brooks DJ, 2002, MOL CELL PROTEOMICS, V1, P125, DOI 10.1074/mcp.M100001-MCP200; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; Chang CP, 1997, MOL CELL BIOL, V17, P81, DOI 10.1128/MCB.17.1.81; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P173; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; DRAGANESCU A, 1995, J MOL BIOL, V250, P595, DOI 10.1006/jmbi.1995.0401; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Frazee RW, 2002, J MOL BIOL, V323, P665, DOI 10.1016/S0022-2836(02)00996-8; FURUKUBOTOKUNAGA K, 1993, P NATL ACAD SCI USA, V90, P6360, DOI 10.1073/pnas.90.13.6360; GALANG CK, 1993, MOL CELL BIOL, V13, P4609, DOI 10.1128/MCB.13.8.4609; Galant R, 2002, DEVELOPMENT, V129, P3115; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; HOLMQUIS.B, 1973, BIOCHEMISTRY-US, V12, P4409, DOI 10.1021/bi00746a018; Hubbard S, 2001, PROTEOLYTIC ENZYMES, P248; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; JOHNSON FB, 1992, GENE DEV, V6, P2177, DOI 10.1101/gad.6.11.2177; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KALIONIS B, 1993, MECH DEVELOP, V43, P57, DOI 10.1016/0925-4773(93)90023-Q; Karsten R., 1997, BIF FUTURA, V12, P20; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; LARONDELEBLANC NA, 2008, GENE DEV, V17, P2060; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li LK, 1997, BIOCHEMISTRY-US, V36, P7003, DOI 10.1021/bi962966m; Li LK, 1996, BIOCHEMISTRY-US, V35, P9832, DOI 10.1021/bi9606049; Li XL, 1999, DEVELOPMENT, V126, P5581; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lopez AJ, 1996, ROUX ARCH DEV BIOL, V205, P450, DOI 10.1007/BF00377226; LOPEZ AJ, 1991, P NATL ACAD SCI USA, V88, P9924, DOI 10.1073/pnas.88.22.9924; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Marshall SA, 2002, J MOL BIOL, V316, P189, DOI 10.1006/jmbi.2001.5326; MASTICK GS, 1995, GENETICS, V139, P349; Merabet S, 2005, TRENDS GENET, V21, P477, DOI 10.1016/j.tig.2005.07.001; Merabet S, 2003, DEV CELL, V4, P761, DOI 10.1016/S1534-5807(03)00126-6; Merabet S, 2007, P NATL ACAD SCI USA, V104, P16946, DOI 10.1073/pnas.0705832104; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2; OGATA RT, 1978, P NATL ACAD SCI USA, V75, P5851, DOI 10.1073/pnas.75.12.5851; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Petukhov M, 1998, J MOL BIOL, V278, P279, DOI 10.1006/jmbi.1998.1682; PLATT T, 1973, J BIOL CHEM, V248, P110; QIAN YQ, 1992, P NATL ACAD SCI USA, V89, P10738, DOI 10.1073/pnas.89.22.10738; Remacle S, 2002, NUCLEIC ACIDS RES, V30, P2663, DOI 10.1093/nar/gkf372; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Sen TZ, 2005, BIOINFORMATICS, V21, P2787, DOI 10.1093/bioinformatics/bti408; Shiga Y, 2002, DEVELOPMENT, V129, P3555; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; SUBRAMANIAM V, 1994, GENETICS, V136, P979; Swint-Kruse L, 2004, METHOD ENZYMOL, V379, P188; Tan XX, 2002, BIOCHEMISTRY-US, V41, P2774, DOI 10.1021/bi011967y; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Vigano MA, 1998, MOL CELL BIOL, V18, P6201, DOI 10.1128/MCB.18.11.6201; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WHITE SH, 1994, ANNU REV BIOPH BIOM, V23, P407, DOI 10.1146/annurev.bb.23.060194.002203; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; ZHANG W, 1994, ONCOGENE, V9, P2513; ZHOU NE, 1992, BIOCHEMISTRY-US, V31, P5739, DOI 10.1021/bi00140a008	99	70	72	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20874	20887		10.1074/jbc.M800375200	http://dx.doi.org/10.1074/jbc.M800375200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508761	hybrid, Green Published			2022-12-27	WOS:000257746100030
J	Shimada, M; Greer, PA; McMahon, AP; Bouxsein, ML; Schipani, E				Shimada, Masako; Greer, Peter A.; McMahon, Andrew P.; Bouxsein, Mary L.; Schipani, Ernestina			In vivo targeted deletion of calpain small subunit, Capn4, in cells of the osteoblast lineage impairs cell proliferation, differentiation, and bone formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; C-FOS EXPRESSION; PARATHYROID-HORMONE; BINDING PROTEIN; TRABECULAR BONE; GROWTH; MOUSE; MICE; RECEPTOR; SYSTEM	Calpains are intracellular cysteine proteases, which include widely expressed mu- and m-calpains (1). Both mu-calpains and m-calpains are heterodimers consisting of a large catalytic subunit and a small regulatory subunit. The calpain small subunit encoded by the gene Capn4 directly binds to the intracellular C-terminal tail (C-tail) of the receptor for parathyroid hormone and parathyroid hormone-related peptide and modulates its cellular functions in osteoblasts in vitro (2). To investigate a potential role of the calpain small subunit in osteoblasts in vivo, we generated osteoblast-specific Capn4 knock-out mice using the Cre-LoxP system (3). Mutant mice had smaller bodies with shorter limbs, reduced trabecular bone with thinner cortices, and decreased osteoblast number. In vitro analysis confirmed that deletion of Capn4 in osteoblasts severely affected multiple osteoblast functions including proliferation, differentiation, and matrix mineralization. Collectively, our findings provide the first in vivo demonstration that the calpain small subunit is essential for proper osteoblast activity and bone remodeling.	[Shimada, Masako; Schipani, Ernestina] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Shimada, Masako; Schipani, Ernestina] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Greer, Peter A.] Queens Univ, Canc Res Inst, Kingston, ON K7L 3N6, Canada; [McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Queens University - Canada; Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Shimada, M (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	shimada@helix.mgh.harvard.edu	McMahon, Andrew P/ABE-7520-2020		NCRR NIH HHS [S10 RR017868] Funding Source: Medline; NIDDK NIH HHS [R01 DK072102, R01 DK 72102] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072102] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahdjoudj S, 2005, EXP CELL RES, V303, P138, DOI 10.1016/j.yexcr.2004.09.013; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Arthur JSC, 1998, BBA-PROTEIN STRUCT M, V1388, P247, DOI 10.1016/S0167-4838(98)00166-6; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; CAUBET JF, 1988, BIOL CELL, V64, P101, DOI 10.1016/0248-4900(88)90100-1; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; CONG JY, 1989, J BIOL CHEM, V264, P10096; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P283; Lee K, 1996, ENDOCRINOLOGY, V137, P5109, DOI 10.1210/en.137.11.5109; LEE K, 1994, ENDOCRINOLOGY, V134, P441, DOI 10.1210/en.134.1.441; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; MURRAY EJB, 1994, EXP CELL RES, V215, P241, DOI 10.1006/excr.1994.1339; Murray EJB, 1997, METABOLISM, V46, P1090, DOI 10.1016/S0026-0495(97)90284-5; Murray SS, 1997, EXP CELL RES, V233, P297, DOI 10.1006/excr.1997.3550; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; REEVE J, 1976, LANCET, V1, P1035; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schipani Ernestina, 2003, Birth Defects Research, V69, P352, DOI 10.1002/bdrc.10028; Shimada M, 2005, ENDOCRINOLOGY, V146, P2336, DOI 10.1210/en.2004-1637; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; TRAM KKT, 1993, KIDNEY INT, V43, P693, DOI 10.1038/ki.1993.99; TRAM KKT, 1993, BIOCHEM MOL BIOL INT, V29, P981; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; Zhang WL, 1997, ONCOGENE, V14, P255, DOI 10.1038/sj.onc.1200841; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	39	34	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21002	21010		10.1074/jbc.M710354200	http://dx.doi.org/10.1074/jbc.M710354200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515801	hybrid, Green Published			2022-12-27	WOS:000257746100042
J	Tran, AX; Trent, MS; Whitfield, C				Tran, An X.; Trent, M. Stephen; Whitfield, Chris			The LptA protein of Escherichia coli is a periplasmic lipid a-binding protein involved in the lipopolysaccharide export pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; CELL-ENVELOPE BIOGENESIS; GRAM-NEGATIVE BACTERIA; SALMONELLA-TYPHIMURIUM; POLYACRYLAMIDE GELS; INNER-MEMBRANE; MSBA; IDENTIFICATION; BIOSYNTHESIS; TRANSPORT	The LptA protein of Escherichia coli has been implicated in the transport of lipopolysaccharide (LPS) from the inner membrane to the outer membrane. Here we provide evidence that LptA binds structurally diverse LPS substrates in vitro and demonstrate that it interacts specifically with the lipid A domain of LPS. These results are consistent with LptA playing a chaperone role in the transport of LPS across the periplasm and have implications for possible assembly models.	[Tran, An X.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Trent, M. Stephen] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	University of Guelph; University System of Georgia; Augusta University	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064184, R01AI076322] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 076322, R01 AI076322-01, R01 AI 064184, R01 AI064184, R01 AI076322, R01 AI064184-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APEL D, 2007, BIOCH BIOPH IN PRESS; Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; BAYER ME, 1968, J GEN MICROBIOL, V53, P395, DOI 10.1099/00221287-53-3-395; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BINOTTO J, 1991, CAN J MICROBIOL, V37, P474, DOI 10.1139/m91-078; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Ghosh AS, 2005, J BACTERIOL, V187, P1913, DOI 10.1128/JB.187.6.1913-1922.2005; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; KELLENBERGER E, 1990, MOL MICROBIOL, V4, P697, DOI 10.1111/j.1365-2958.1990.tb00640.x; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; KUNZ DA, 1981, J BACTERIOL, V146, P179, DOI 10.1128/JB.146.1.179-191.1981; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; MUHLRADT PF, 1973, EUR J BIOCHEM, V35, P471, DOI 10.1111/j.1432-1033.1973.tb02861.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPERANDEO P, 2008, J BACTERIOL IN PRESS; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Taniguchi N, 2008, J BIOL CHEM, V283, P8538, DOI 10.1074/jbc.M800026200; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tefsen B, 2005, J BIOL CHEM, V280, P35961, DOI 10.1074/jbc.M509026200; Tefsen B, 2005, J BIOL CHEM, V280, P4504, DOI 10.1074/jbc.M409259200; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	58	66	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20342	20349		10.1074/jbc.M802503200	http://dx.doi.org/10.1074/jbc.M802503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18480051	Green Published, hybrid			2022-12-27	WOS:000257565300050
J	Giudici, C; Raynal, N; Wiedemann, H; Cabral, WA; Marini, JC; Timpl, R; Bachinger, HP; Farndale, RW; Sasaki, T; Tenni, R				Giudici, Camilla; Raynal, Nicolas; Wiedemann, Hanna; Cabral, Wayne A.; Marini, Joan C.; Timpl, Rupert; Baechinger, Hans Peter; Farndale, Richard W.; Sasaki, Takako; Tenni, Ruggero			Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL PEPTIDES; VON-WILLEBRAND-FACTOR; MATRIX PROTEIN BM-40; BINDING-SITES; I COLLAGEN; AFFINITY BINDING; STRUCTURAL BASIS; PROCOLLAGEN-I; OSTEOGENESIS IMPERFECTA; DIRECTED MUTAGENESIS	The 33-kDa matrix protein SPARC (BM-40, osteonectin) binds several collagen types with moderate affinity. The collagen-binding site resides in helix alpha A of the extracellular calcium-binding domain of SPARC and is partially masked by helix alpha C. Previously, we found that the removal of helix alpha C caused a 10-fold increase in the affinity of SPARC for collagen, and we identified amino acids crucial for binding by site-directed mutagenesis. In this study, we used rotary shadowing, CNBr peptides, and synthetic peptides to map binding sites of SPARC onto collagens I, II, and III. Rotary shadowing and electron microscopy of SPARC-collagen complexes identified a major binding site similar to 180 nm from the C terminus of collagen. SPARC binding was also detected with lower frequency near the matrix metalloproteinase cleavage site. These data fit well with our analysis of SPARC binding to CNBr peptides, denaturation of which abolished binding, indicating triple-helical conformation of collagen to be essential. SPARC binding was substantially decreased in two of seven alpha 2(I) mutant procollagen I samples and after N-acetylation of Lys/Hyl side chains in wild-type collagen. Synthetic peptides of collagen III were used to locate the binding sites, and we found SPARC binding activity in a synthetic triple-helical peptide containing the sequence GPOGPSGPRGQOGVMGFOGPKGNDGAO (where O indicates 4-hydroxyproline), with affinity for SPARC comparable with that of procollagen III. This sequence is conserved among alpha chains of collagens I, II, III, and V. In vitro collagen fibrillogenesis was delayed in the presence of SPARC, suggesting that SPARC might modulate collagen fibril assembly in vivo.	[Baechinger, Hans Peter; Sasaki, Takako] Shriners Hosp Children, Portland Res Ctr, Portland, OR 97239 USA; [Giudici, Camilla; Wiedemann, Hanna; Sasaki, Takako] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Giudici, Camilla; Tenni, Ruggero] Univ Pavia, Dept Biochem A Castellani, I-27100 Pavia, Italy; [Raynal, Nicolas; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Cabral, Wayne A.; Marini, Joan C.] NICHD, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD 20892 USA; [Baechinger, Hans Peter; Sasaki, Takako] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Max Planck Society; University of Pavia; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Oregon Health & Science University	Sasaki, T (corresponding author), Shriners Hosp Children, Portland Res Ctr, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	txs@shcc.org			Medical Research Council [G0400701] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408] Funding Source: NIH RePORTER; MRC [G0400701] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brodsky B, 1995, FASEB J, V9, P1537, DOI 10.1096/fasebj.9.15.8529832; BROWM JC, 1995, INT ARCH ALLERGY IMM, V107, P484, DOI 10.1159/000237090; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; ENGEL J, 1994, METHOD ENZYMOL, V245, P469; FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031; Forlino A, 1998, MATRIX BIOL, V17, P575, DOI 10.1016/S0945-053X(98)90109-3; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; Giudici C, 2003, FEBS LETT, V547, P170, DOI 10.1016/S0014-5793(03)00715-4; GUERMAH M, 1991, P NATL ACAD SCI USA, V88, P4503, DOI 10.1073/pnas.88.10.4503; Hohenester E, 1996, NAT STRUCT BIOL, V3, P67, DOI 10.1038/nsb0196-67; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; HOHENESTER E, 2004, HDB METALLOPROTEINS, V3, P509; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Hosokawa N, 1998, J BIOCHEM-TOKYO, V124, P654, DOI 10.1093/oxfordjournals.jbchem.a022162; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L; Kaufmann B, 2004, GLYCOBIOLOGY, V14, P609, DOI 10.1093/glycob/cwh063; KELM RJ, 1991, J BIOL CHEM, V266, P9632; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; LIGHTFOOT SJ, 1992, J BIOL CHEM, V267, P25521; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Maurer P, 1997, CELL MOL LIFE SCI, V53, P478, DOI 10.1007/s000180050059; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; OLSEN BR, 1999, GUIDEBOOK EXTRACELLU, P380; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151; Rossi A, 1997, J MOL BIOL, V269, P488, DOI 10.1006/jmbi.1997.1046; Sasaki T, 1997, J BIOL CHEM, V272, P9237; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Sasaki T, 1999, MATRIX BIOL, V18, P499, DOI 10.1016/S0945-053X(99)00041-4; Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Sullivan MM, 2006, J BIOL CHEM, V281, P27621, DOI 10.1074/jbc.M510507200; Tenni R, 2002, EUR J BIOCHEM, V269, P1428, DOI 10.1046/j.1432-1033.2002.02784.x; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; VOGEL BE, 1988, J BIOL CHEM, V263, P19249; Wang H, 2006, MATRIX BIOL, V25, P20, DOI 10.1016/j.matbio.2005.09.004; Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d; WANG Q, 1993, J BIOL CHEM, V268, P25162; XIE RL, 1995, J BIOL CHEM, V270, P23212, DOI 10.1074/jbc.270.39.23212; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201	63	75	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19551	19560		10.1074/jbc.M710001200	http://dx.doi.org/10.1074/jbc.M710001200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487610	hybrid, Green Published			2022-12-27	WOS:000257387600041
J	Qi, J; Forgac, M				Qi, Jie; Forgac, Michael			Function and subunit interactions of the N-terminal domain of subunit a (Vph1p) of the yeast V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; MEDIATED CROSS-LINKING; 3-DIMENSIONAL STRUCTURE; MUTATIONAL ANALYSIS; 100-KDA; LOCALIZATION; DISSOCIATION; EXPRESSION; ROTATION; ISOFORMS	The vacuolar (H+)-ATPases (V-ATPases) are ATP-dependent proton pumps that operate by a rotary mechanism in which ATP hydrolysis drives rotation of a ring of proteolipid subunits relative to subunit a within the integral V-0 domain. In vivo dissociation of the V-ATPase (an important regulatory mechanism) generates a V-0 domain that does not passively conduct protons. EM analysis indicates that the N-terminal domain of subunit a approaches the rotary subunits in free V-0, suggesting a possible mechanism of silencing passive proton transport. To test the hypothesis that the N-terminal domain inhibits passive proton flux by preventing rotation of the proteolipid ring in free V-0, factor Xa cleavage sites were introduced between the N- and C-terminal domains of subunit a (the Vph1p isoform in yeast) to allow its removal in vitro after isolation of vacuolar membranes. The mutant Vph1p gave rise to a partially uncoupled V-ATPase complex. Cleavage with factor Xa led to further loss of coupling of proton transport and ATP hydrolysis. Removal of the N-terminal domain by cleavage with factor Xa and treatment with KNO3 and MgATP did not, however, lead to an increase in passive proton conductance by free V-0, suggesting that removal of the N-terminal domain is not sufficient to facilitate passive proton conductance through V-0. Photoactivated cross-linking using the cysteine reagent maleimido benzophenone and single cysteine mutants of subunit a demonstrated the proximity of specific sites within the N-terminal domain and subunits E and G of the peripheral stalk. These results suggest that a localized region of the N-terminal domain (residues 347-369) is important in anchoring the peripheral stator in V1V0.	[Qi, Jie; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	Michael.forgac@tufts.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK034928, DK34928] Funding Source: Medline; NIGMS NIH HHS [R01 GM034478, GM34478, R37 GM034478] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI I, 1990, J BIOL CHEM, V265, P960; Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; FENG Y, 1992, J BIOL CHEM, V267, P5817; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; Qi J, 2007, J BIOL CHEM, V282, P24743, DOI 10.1074/jbc.M700663200; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vik SB, 2000, BBA-BIOENERGETICS, V1458, P457, DOI 10.1016/S0005-2728(00)00094-3; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	53	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19274	19282		10.1074/jbc.M802442200	http://dx.doi.org/10.1074/jbc.M802442200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18492665	hybrid, Green Published			2022-12-27	WOS:000257387600013
J	Droga-Mazovec, G; Bojic, L; Petelin, A; Ivanova, S; Romih, R; Repnik, U; Salvesen, GS; Stoka, V; Turk, V; Turk, B				Droga-Mazovec, Gabriela; Bojic, Lea; Petelin, Ana; Ivanova, Saska; Romih, Rok; Repnik, Urska; Salvesen, Guy S.; Stoka, Veronika; Turk, Vito; Turk, Boris			Cysteine cathepsins trigger caspase-dependent cell death through cleavage of Bid and antiapoptotic Bcl-2 homologues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL-MEMBRANE PERMEABILIZATION; ESCHERICHIA-COLI; OXIDATIVE STRESS; CYTOCHROME-C; FACTOR AIF; APOPTOSIS; PROTEASE; ACTIVATION; PROTEINS; SPECIFICITY	As a model for defining the role of lysosomal cathepsins in apoptosis, we characterized the action of the lysosomotropic agent LeuLeuOMe using distinct cellular models. LeuLeuOMe induces lysosomal membrane permeabilization, resulting in release of lysosomal cathepsins that cleave the proapoptotic Bcl-2 family member Bid and degrade the antiapoptotic member Bcl-2, Bcl-xL, or Mcl-1. The papain-like cysteine protease inhibitor E-64d largely prevented apoptosis, Bid cleavage, and Bcl-2/Bcl-xL/Mcl-1 degradation. The pancaspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp(OMe) fluoromethyl ketone failed to prevent Bid cleavage and degradation of anti-apoptotic Bcl-2 homologues but substantially decreased cell death, suggesting that cathepsin-mediated apoptosis in these cellular models mostly follows a caspase-dependent pathway. Moreover, in vitro experiments showed that one or more of the cysteine cathepsins B, L, S, K, and H could cleave Bcl-2, Bcl-xL, Mcl-1, Bak, and BimEL, whereas no Bax cleavage was observed. On the basis of inhibitor studies, we demonstrate that lysosomal disruption triggered by LeuLeuOMe occurs before mitochondrial damage. We propose that degradation of anti-apoptotic Bcl-2 family members by lysosomal cathepsins synergizes with cathepsin-mediated activation of Bid to trigger a mitochondrial pathway to apoptosis. Moreover, XIAP (X-chromosome-linked inhibitor of apoptosis) was also found to be a target of cysteine cathepsins, suggesting that cathepsins can mediate caspase-dependent apoptosis also downstream of mitochondria.	[Droga-Mazovec, Gabriela; Bojic, Lea; Petelin, Ana; Ivanova, Saska; Repnik, Urska; Stoka, Veronika; Turk, Vito; Turk, Boris] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Romih, Rok] Univ Ljubljana, Fac Med, Inst Cell Biol, SI-1105 Ljubljana, Slovenia; [Salvesen, Guy S.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; Sanford Burnham Prebys Medical Discovery Institute	Turk, B (corresponding author), Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia.	boris.turk@ijs.si	Stoka, Veronika/AAM-2283-2021; Ivanova, Saska/AAJ-1283-2021	Turk, Boris/0000-0002-9007-5764; Ivanova, Saska/0000-0003-0080-6680				Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Barbosa CMV, 2006, EUR J PHARMACOL, V542, P37, DOI 10.1016/j.ejphar.2006.06.004; Barlic-Maganja D, 1998, BIOL CHEM, V379, P1449; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Brunk UT, 1997, FREE RADICAL BIO MED, V23, P616, DOI 10.1016/S0891-5849(97)00007-5; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; CHARLEY M, 1986, J CLIN INVEST, V78, P1415, DOI 10.1172/JCI112730; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; D'Alessio KJ, 1999, PROTEIN EXPRES PURIF, V15, P213, DOI 10.1006/prep.1998.1013; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Guncar G, 1998, STRUCTURE, V6, P51; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Houseweart MK, 2003, CELL DEATH DIFFER, V10, P1329, DOI 10.1038/sj.cdd.4401309; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kirschke H, 1995, PROTEIN PROFILE, V2, P1587; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kobayashi Y, 2000, BIOCHEM BIOPH RES CO, V272, P687, DOI 10.1006/bbrc.2000.2836; Kopitar-Jerala N, 2001, BIOL CHEM, V382, P867, DOI 10.1515/BC.2001.106; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KUHELJ R, 1995, EUR J BIOCHEM, V229, P533, DOI 10.1111/j.1432-1033.1995.0533k.x; Mijatovic T, 2006, NEOPLASIA, V8, P402, DOI 10.1593/neo.05850; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Murahashi H, 2003, J LEUKOCYTE BIOL, V73, P399, DOI 10.1189/jlb.0702335; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; OLLINGER K, 1995, FREE RADICAL BIO MED, V19, P565, DOI 10.1016/0891-5849(95)00062-3; Ostenfeld MS, 2005, CANCER RES, V65, P8975, DOI 10.1158/0008-5472.CAN-05-0269; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Roberg K, 1999, FREE RADICAL BIO MED, V27, P1228, DOI 10.1016/S0891-5849(99)00146-X; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; THIELE DL, 1992, J IMMUNOL, V148, P3950; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Turk B., 2005, MED CHEM REV, V2, P283, DOI [10.2174/1567203054637524, DOI 10.2174/1567203054637524]; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Uchimoto T, 1999, APOPTOSIS, V4, P357, DOI 10.1023/A:1009695221038; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200	68	278	285	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19140	19150		10.1074/jbc.M802513200	http://dx.doi.org/10.1074/jbc.M802513200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18469004	hybrid			2022-12-27	WOS:000257165600069
J	Toso, R; Zhu, H; Camire, RM				Toso, Raffaella; Zhu, Hua; Camire, Rodney M.			The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE FACTOR-XA; TICK ANTICOAGULANT PEPTIDE; COAGULATION-FACTOR-XA; RUSSELLS VIPER VENOM; SODIUM-BINDING-SITE; FACTOR VA BINDING; SERINE PROTEASES; ACTIVE-SITE; PLASMINOGEN-ACTIVATOR; SUBSTRATE-SPECIFICITY	Zymogens of the chymotrypsin-like serine protease family are converted to the protease state following insertion of a newly formed, highly conserved N terminus. This transition is accompanied by active site formation and ordering of several surface loops in the catalytic domain. Here we show that disruption of this transition in factor X through mutagenesis (FXa(I16L) and FXa(V17A)) not only alters active site function, but also significantly impairs Na+ and factor Va binding. Active site binding was improved in the presence of high NaCl or with saturating amounts of factor Va membranes, suggesting that allosteric linkage exists between these sites. In line with this, irreversible stabilization of FXa(I16L) with Glu-Gly-Arg-chloromethyl ketone fully rescued FVa binding. Furthermore, the K-m for prothrombin conversion with the factor Xa variants assembled into prothrombinase was unaltered, whereas the k(cat) was modestly reduced (3- to 4-fold). These findings show that intramolecular activation of factor X following the zymogen to protease transition not only drives catalytic site activation but also contributes to the formation of the Na+ and factor Va binding sites. This structural plasticity of the catalytic domain plays a key role in the regulation of exosite expression and prothrombinase assembly.	[Toso, Raffaella; Zhu, Hua; Camire, Rodney M.] Childrens Hosp Philadelphia, Div Hematol, Dept Pediat, Abramson Res Ctr 302E, Philadelphia, PA 19104 USA; [Camire, Rodney M.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Dept Pediat, Abramson Res Ctr 302E, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Toso, Raffaella/I-5202-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, T32HL007439] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL-74124-01, T32 HL-07439-26] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bevington PR., 2002, DATA REDUCTION ERROR; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1979, J MOL BIOL, V127, P357, DOI 10.1016/0022-2836(79)90227-4; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; DAHLBACK B, 1978, BIOCHEMISTRY-US, V17, P4938, DOI 10.1021/bi00616a013; DAVIDSON DJ, 1990, BIOCHEMISTRY-US, V29, P3585, DOI 10.1021/bi00466a023; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; Eigenbrot C, 2001, STRUCTURE, V9, P627, DOI 10.1016/S0969-2126(01)00624-4; EVANS SA, 1982, J BIOL CHEM, V257, P3014; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Gombos L, 2008, BIOCHEMISTRY-US, V47, P1675, DOI 10.1021/bi701454e; GOWDA DC, 1994, J BIOL CHEM, V269, P10644; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; HEMKER HC, 1975, BIOCHIM BIOPHYS ACTA, V379, P180, DOI 10.1016/0005-2795(75)90020-3; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; KALAFATIS M, 1993, METHOD ENZYMOL, V222, P224; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KAWABATA S, 1985, J BIOCHEM, V98, P1603, DOI 10.1093/oxfordjournals.jbchem.a135430; KEYT B, 1982, J BIOL CHEM, V257, P8687; Khan AR, 1998, PROTEIN SCI, V7, P815; Kirchhofer D, 2007, P NATL ACAD SCI USA, V104, P5306, DOI 10.1073/pnas.0700184104; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P3319, DOI 10.1021/bi9623993; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Larson PJ, 1998, BIOCHEMISTRY-US, V37, P5029, DOI 10.1021/bi972428p; Levigne S, 2007, J BIOL CHEM, V282, P31569, DOI 10.1074/jbc.M704837200; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lundblad R L, 1976, Methods Enzymol, V45, P156; Madoiwa S, 2001, BLOOD, V97, P3783, DOI 10.1182/blood.V97.12.3783; Mann K G, 1976, Methods Enzymol, V45, P123; MANN KG, 1990, BLOOD, V76, P1; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; Pasternak A, 1998, BIOCHEMISTRY-US, V37, P16201, DOI 10.1021/bi980951d; PERSSON E, 1993, J BIOL CHEM, V268, P22531; PLAPP BV, 1971, J BIOL CHEM, V246, P939; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P1817, DOI 10.1021/bi992006a; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; ROBISON DJ, 1980, J BIOL CHEM, V255, P2014; Rudolph AE, 2001, J BIOL CHEM, V276, P5123, DOI 10.1074/jbc.M006961200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; SEGAL IH, 1975, ENZYME KINETICS BEHA; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; Tachias K, 1996, J BIOL CHEM, V271, P28749, DOI 10.1074/jbc.271.46.28749; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Underwood MC, 2000, J BIOL CHEM, V275, P36876, DOI 10.1074/jbc.M001386200; Venkateswarlu D, 2002, BIOPHYS J, V82, P1190, DOI 10.1016/S0006-3495(02)75476-3; Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069; Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2	64	35	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18627	18635		10.1074/jbc.M802205200	http://dx.doi.org/10.1074/jbc.M802205200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18460471	Green Published, hybrid			2022-12-27	WOS:000257165600019
J	Cole, AR; Soutar, MPM; Rembutsu, M; van Aalten, L; Hastie, CJ; Mclauchlan, H; Peggie, M; Balastik, M; Lu, KP; Sutherland, C				Cole, Adam R.; Soutar, Marc P. M.; Rembutsu, Makoto; van Aalten, Lidy; Hastie, C. James; Mclauchlan, Hilary; Peggie, Mark; Balastik, Martin; Lu, Kun Ping; Sutherland, Calum			Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE MEDIATOR PROTEIN-2; PROLYL ISOMERASE PIN1; GLYCOGEN-SYNTHASE KINASE-3; GROWTH-CONE COLLAPSE; ALZHEIMERS-DISEASE; TAU-PROTEIN; NEUROFIBRILLARY TANGLES; HIPPOCAMPAL-NEURONS; PHOSPHATASE 2A; OKADAIC ACID	Collapsin response mediator protein 2 (CRMP2) binds to microtubules and regulates axon outgrowth in neurons. This action is regulated by sequential phosphorylation by the kinases cyclin-dependent kinase 5 (Cdk5) and glycogen synthase kinase 3 (GSK3) at sites that are hyperphosphorylated in Alzheimer disease. The increased phosphorylation in Alzheimer disease could be due to increases in Cdk5 and/or GSK3 activity or, alternatively, through decreased activity of a CRMP phosphatase. Here we establish that dephosphorylation of CRMP2 at the residues targeted by GSK3 (Ser-518/Thr-514/Thr-509) is carried out by a protein phosphatase 1 family member in vitro, in neuroblastoma cells, and primary cortical neurons. Inhibition of GSK3 activity using insulin-like growth factor-1 or the highly selective inhibitor CT99021 causes rapid dephosphorylation of CRMP2 at these sites. In contrast, pharmacological inhibition of Cdk5 using purvalanol results in only a gradual and incomplete dephosphorylation of CRMP2 at the site targeted by Cdk5 (Ser-522), suggesting a distinct phosphatase targets this residue. A direct comparison of dephosphorylation at the Cdk5 versus GSK3 sites in vitro shows that the Cdk5 site is comparatively resistant to phosphatase treatment. The presence of the peptidylprolyl isomerase enzyme, Pin1, does not affect dephosphorylation of Ser-522 in vitro, in cells, or in Pin1 transgenic mice. Instead, the relatively high resistance of this site to phosphatase treatment is at least in part due to the presence of basic residues located nearby. Similar sequences in Tau are also highly resistant to phosphatase treatment. We propose that relative resistance to phosphatases might be a common feature of Cdk5 substrates and could contribute to the hyperphosphorylation of CRMP2 and Tau observed in Alzheimer disease.	[Cole, Adam R.; Soutar, Marc P. M.; Rembutsu, Makoto; van Aalten, Lidy; Sutherland, Calum] Univ Dundee, Ninewells Hosp, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; [Hastie, C. James; Mclauchlan, Hilary; Peggie, Mark] Univ Dundee, Coll Life Sci, Div Signal Transduct Therapy, Dundee DD1 4HN, Scotland; [Balastik, Martin; Lu, Kun Ping] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Biol Program, Boston, MA 02115 USA	University of Dundee; University of Dundee; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Sutherland, C (corresponding author), Univ Dundee, Ninewells Hosp, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.	c.d.sutherland@dundee.ac.uk	Balastik, Martin/C-4410-2014; Soutar, Marc P M/G-3637-2011; Cole, Adam/B-9785-2011	Balastik, Martin/0000-0001-5833-9996; Soutar, Marc P M/0000-0003-0008-9423; Hastie, James/0000-0001-7164-4098; Sutherland, Calum/0000-0003-4398-7434	Biotechnology and Biological Sciences Research Council [C18727] Funding Source: Medline; Medical Research Council Funding Source: Medline; Alzheimers Research UK [ART-PG2007-4, ART-PG2005-1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))		Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Fukata Y, 2002, NEUROSCI RES, V43, P305, DOI 10.1016/S0168-0102(02)00062-7; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hamdane M, 2006, MOL CELL NEUROSCI, V32, P155, DOI 10.1016/j.mcn.2006.03.006; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Rembutsu M, 2008, BIOCHEMISTRY-US, V47, P2153, DOI 10.1021/bi702030w; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; TAKAI A, 1995, BIOCHEM J, V306, P657, DOI 10.1042/bj3060657; Tandon A, 2003, J NEUROCHEM, V86, P572, DOI 10.1046/j.1471-4159.2003.01865.x; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; YANG SD, 1981, FEBS LETT, V126, P57, DOI 10.1016/0014-5793(81)81032-0; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	43	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					18227	18237		10.1074/jbc.M801645200	http://dx.doi.org/10.1074/jbc.M801645200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18460467	Green Published, hybrid			2022-12-27	WOS:000256949200051
J	Wagner, S; Pop, O; Haan, GJ; Baars, L; Koningstein, G; Klepsch, MM; Genevaux, P; Luirink, J; de Gier, JW				Wagner, Samuel; Pop, Ovidio; Haan, Gert-Jan; Baars, Louise; Koningstein, Gregory; Klepsch, Mirjam M.; Genevaux, Pierre; Luirink, Joen; de Gier, Jan-Willem			Biogenesis of MalF and the MalFGK(2) maltose transport complex in Escherichia coli requires YidC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; INNER MEMBRANE-PROTEINS; TRIGGER FACTOR; CONDUCTING CHANNEL; YIELDS MUTATIONS; SEC-TRANSLOCASE; RIBOSOME; INSERTION; SITE; BINDING	The polytopic inner membrane protein MalF is a constituent of the MalFGK(2) maltose transport complex in Escherichia coli. We have studied the biogenesis of MalF using a combination of in vivo and in vitro approaches. MalF is targeted via the SRP pathway to the Sec/YidC insertion site. Despite close proximity of nascent MalF to YidC during insertion, YidC is not required for the insertion of MalF into the membrane. However, YidC is required for the stability of MalF and the formation of the MalFGK2 maltose transport complex. Our data indicate that YidC supports the folding of MalF into a stable conformation before it is incorporated into the maltose transport complex.	[Pop, Ovidio; Haan, Gert-Jan; Koningstein, Gregory; Luirink, Joen] Vrije Univ Amsterdam, Dept Mol Microbiol, Inst Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands; [Wagner, Samuel; Baars, Louise; Klepsch, Mirjam M.; de Gier, Jan-Willem] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Genevaux, Pierre] Univ Toulouse 3, CNRS, Inst Biol Cellulaire & Genet, Lab Microbiol & Genet Mol, F-31062 Toulouse 09, France	Vrije Universiteit Amsterdam; Stockholm University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Luirink, J (corresponding author), Vrije Univ Amsterdam, Dept Mol Microbiol, Inst Mol Cell Biol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl; degier@dbb.su.se	Luirink, Joen/AAB-8658-2021; Genevaux, Pierre/A-4851-2015	GENEVAUX, Pierre/0000-0001-7539-3126; Luirink, J./0000-0001-8431-0804				Adams H, 2002, EUR J BIOCHEM, V269, P5564, DOI 10.1046/j.1432-1033.2002.03262.x; Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Clemons WM, 2004, CURR OPIN STRUC BIOL, V14, P390, DOI 10.1016/j.sbi.2004.07.006; Dalbey RE, 2004, BBA-MOL CELL RES, V1694, P37, DOI 10.1016/j.bbamcr.2004.03.009; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Gier JWL, 2003, EMBO REP, V4, P939, DOI 10.1038/sj.embor.embor921; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Ehrmann M, 1998, MOL MICROBIOL, V29, P685, DOI 10.1046/j.1365-2958.1998.00915.x; Facey SJ, 2004, BBA-MOL CELL RES, V1694, P55, DOI 10.1016/j.bbamcr.2004.03.012; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Froderberg L, 2003, MOL MICROBIOL, V47, P1015, DOI 10.1046/j.1365-2958.2003.03346.x; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; Gu SQ, 2003, RNA, V9, P566, DOI 10.1261/rna.2196403; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Hashemzadeh-Bonehi L, 1998, MOL MICROBIOL, V30, P676, DOI 10.1046/j.1365-2958.1998.01116.x; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Houben ENG, 2005, J CELL BIOL, V170, P27, DOI 10.1083/jcb.200503035; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Houben ENG, 2000, FEBS LETT, V476, P229, DOI 10.1016/S0014-5793(00)01735-X; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jander G, 1996, J BACTERIOL, V178, P3049, DOI 10.1128/jb.178.11.3049-3058.1996; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; KIETER D, 2007, INT REV CYTOL, V259, P113; Kota J, 2005, J CELL BIOL, V168, P79, DOI 10.1083/jcb.200408106; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Newitt JA, 1998, J BIOL CHEM, V273, P12451, DOI 10.1074/jbc.273.20.12451; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; RIBES V, 1990, CELL, V63, P591, DOI 10.1016/0092-8674(90)90454-M; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Shimohata N, 2002, GENES CELLS, V7, P653, DOI 10.1046/j.1365-2443.2002.00554.x; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; Tian HP, 2002, J BACTERIOL, V184, P111, DOI 10.1128/JB.184.1.111-118.2002; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; TRAXLER B, 1992, P NATL ACAD SCI USA, V89, P10852, DOI 10.1073/pnas.89.22.10852; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	61	49	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					17881	17890		10.1074/jbc.M801481200	http://dx.doi.org/10.1074/jbc.M801481200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18456666	Green Published, hybrid			2022-12-27	WOS:000256949200016
J	Hoffmann, M; Wagner, M; Abbadi, A; Fulda, M; Feussner, I				Hoffmann, Mareike; Wagner, Martin; Abbadi, Amine; Fulda, Martin; Feussner, Ivo			Metabolic engineering of omega 3-very long chain polyunsaturated fatty acid production by an exclusively acyl-CoA-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONT-END DESATURASES; FUNCTIONAL-CHARACTERIZATION; EICOSAPENTAENOIC ACID; BIOSYNTHESIS; OMEGA-3-FATTY-ACIDS; IDENTIFICATION; MICROALGA; ELONGASES; CLONING; OMEGA-3	omega 3-Very long chain polyunsaturated fatty acids (VLCPUFA) are essential for human development and brain function and, thus, are indispensable components of the human diet. The current main source of VLCPUFAs is represented by ocean fish stocks, which are in severe decline, and the development of alternative, sustainable sources of VLCPUFAs is urgently required. Our research aims at exploiting the powerful infrastructure available for the large scale culture of oilseed crops, such as rapeseed, to produce VLCPUFAs such as eicosapentaenoic acid in transgenic plants. VLCPUFA biosynthesis requires repeated desaturation and repeated elongation of long chain fatty acid substrates. In previous experiments the production of eicosapentaenoic acid in transgenic plants was found to be limited by an unexpected bottleneck represented by the acyl exchange between the site of desaturation, endoplasmic reticulum-associated phospholipids, and the site of elongation, the cytosolic acyl-CoA pool. Here we report on the establishment of a coordinated, exclusively acyl-CoA-dependent pathway, which avoids the rate-limiting transesterification steps between the acyl lipids and the acyl-CoA pool during VLCPUFA biosynthesis. The pathway is defined by previously uncharacterized enzymes, encoded by cDNAs isolated from the microalga Mantoniella squamata. The conceptual enzymatic pathway was established and characterized first in yeast to provide proof-of-concept data for its feasibility and subsequently in seeds of Arabidopsis thaliana. The comparison of the acyl-CoA-dependent pathway with the known lipid-linked pathway for VLCPUFA biosynthesis showed that the acyl-CoA-dependent pathway circumvents the bottleneck of switching the Delta 6-desaturated fatty acids between lipids and acyl-CoA in Arabidopsis seeds.	[Hoffmann, Mareike; Wagner, Martin; Fulda, Martin; Feussner, Ivo] Albrecht von Haller Inst Pflanzenwissensch, Abt Biochem Pflanze, D-37077 Gottingen, Germany; [Abbadi, Amine; Fulda, Martin] Hans Georg Lembke KG, Norddeutsch Pflanzenzucht, D-24363 Holtsee, Germany		Feussner, I (corresponding author), Albrecht von Haller Inst Pflanzenwissensch, Abt Biochem Pflanze, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003				Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Abbadi A., 2007, P 12 INT RAP C SUST, VII, P152; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BAUMLEIN H, 1991, MOL GEN GENET, V225, P459; BUTTE W, 1982, CLIN CHEM, V28, P1778; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Domergue F, 2005, BIOCHEM J, V389, P483, DOI 10.1042/BJ20050111; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Domergue F, 2002, EUR J BIOCHEM, V269, P4105, DOI 10.1046/j.1432-1033.2002.03104.x; DONAHUE TF, 1990, METHOD ENZYMOL, V185, P366; Garcia-Maroto F, 2006, PHYTOCHEMISTRY, V67, P540, DOI 10.1016/j.phytochem.2005.12.005; Goyens PL, 2006, AM J CLIN NUTR, V84, P44, DOI 10.1093/ajcn/84.1.44; Graham IA, 2007, CURR OPIN BIOTECH, V18, P142, DOI 10.1016/j.copbio.2007.01.014; Hites RA, 2004, ENVIRON SCI TECHNOL, V38, P4945, DOI 10.1021/es049548m; Hornung E, 2005, BBA-MOL CELL BIOL L, V1686, P181, DOI 10.1016/j.bbalip.2004.11.001; KINNEY AJ, 2004, Patent No. 2004071467; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; MANTON I, 1960, J MAR BIOL ASSOC UK, V39, P275, DOI 10.1017/S0025315400013321; Meyer A, 2004, J LIPID RES, V45, P1899, DOI 10.1194/jlr.M400181-JLR200; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; Napier JA, 1999, TRENDS PLANT SCI, V4, P2, DOI 10.1016/S1360-1385(98)01357-0; Napier JA, 2007, ANNU REV PLANT BIOL, V58, P295, DOI 10.1146/annurev.arplant.58.032806.103811; OKAYASU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P21, DOI 10.1016/0003-9861(81)90061-8; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Qi BX, 2002, FEBS LETT, V510, P159, DOI 10.1016/S0014-5793(01)03247-1; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sayanova O, 2006, FEBS LETT, V580, P1946, DOI 10.1016/j.febslet.2006.02.062; Sayanova O, 2006, PLANTA, V224, P1269, DOI 10.1007/s00425-006-0306-0; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; SPERLING P, 1995, EUR J BIOCHEM, V232, P798, DOI 10.1111/j.1432-1033.1995.0798a.x; Sprecher H, 1999, LIPIDS, V34, pS153, DOI 10.1007/BF02562271; Tocher DR, 1998, PROG LIPID RES, V37, P73, DOI 10.1016/S0163-7827(98)00005-8; Wallis JG, 1999, ARCH BIOCHEM BIOPHYS, V365, P307, DOI 10.1006/abbi.1999.1167; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Zank TK, 2002, PLANT J, V31, P255, DOI 10.1046/j.1365-313X.2002.01354.x	37	78	89	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22352	22362		10.1074/jbc.M802377200	http://dx.doi.org/10.1074/jbc.M802377200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18556660	hybrid			2022-12-27	WOS:000258321000003
J	Mi, LX; Xiao, Z; Hood, BL; Dakshanamurthy, S; Wang, XT; Govind, S; Conrads, TP; Veenstra, TD; Chung, FL				Mi, Lixin; Xiao, Zhen; Hood, Brian L.; Dakshanamurthy, Sivanesan; Wang, Xiantao; Govind, Sudha; Conrads, Thomas P.; Veenstra, Timothy D.; Chung, Fung-Lung			Covalent binding to tubulin by isothiocyanates - A mechanism of cell growth arrest and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENETHYL ISOTHIOCYANATE; CYCLE ARREST; ANTIPROLIFERATIVE ACTIVITY; SULFORAPHANE; INHIBITION; INDUCTION; PHOSPHORYLATION; MICROTUBULES; MITOCHONDRIA; PROTEINS	Isothiocyanates (ITCs) found in cruciferous vegetables, including benzyl-ITC (BITC), phenethyl-ITC (PEITC), and sulforaphane (SFN), inhibit carcinogenesis in animal models and induce apoptosis and cell cycle arrest in various cell types. The biochemical mechanisms of cell growth inhibition by ITCs are not fully understood. Our recent study showed that ITC binding to intracellular proteins may be an important initiating event for the induction of apoptosis. However, the specific protein target(s) and molecular mechanisms were not identified. In this study, two-dimensional gel electrophoresis of human lung cancer A549 cells treated with radiolabeled PEITC and SFN revealed that tubulin may be a major in vivo binding target for ITC. We examined whether binding to tubulin by ITCs could lead to cell growth arrest. The proliferation of A549 cells was significantly reduced by ITCs, with relative activities of BITC > PEITC > SFN. All three ITCs also induced mitotic arrest and apoptosis with the same order of activity. We found that ITCs disrupted microtubule polymerization in vitro and in vivo with the same order of potency. Mass spectrometry demonstrated that cysteines in tubulin were covalently modified by ITCs. Ellman assay results indicated that the modification levels follow the same order, BITC > PEITC > SFN. Together, these results support the notion that tubulin is a target of ITCs and that ITC-tubulin interaction can lead to downstream growth inhibition. This is the first study directly linking tubulin-ITC adduct formation to cell growth inhibition.	[Mi, Lixin; Dakshanamurthy, Sivanesan; Wang, Xiantao; Govind, Sudha; Chung, Fung-Lung] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Xiao, Zhen; Veenstra, Timothy D.] NCI Frederick, SAIC Frederick Inc, Lab Prote & Analyt Technol, Frederick, MD 21702 USA; [Hood, Brian L.; Conrads, Thomas P.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Hood, Brian L.; Conrads, Thomas P.] Univ Pittsburgh, Sch Med, Inst Canc, Clin Prote Facil, Pittsburgh, PA 15213 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mi, LX (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3800 Reservoir Rd,LL 129,Box 571465, Washington, DC 20057 USA.	lm293@georgetown.edu; flc6@georgetown.edu	Dakshanamurthy, Sivanesan/CAF-4258-2022	Dakshanamurthy, Sivanesan/0000-0003-3681-4121	NCI NIH HHS [CA100853] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100853] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonnesen C, 2001, CANCER RES, V61, P6120; Britto PJ, 2005, BIOCHEM J, V389, P549, DOI 10.1042/BJ20042118; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chiao JW, 2002, INT J ONCOL, V20, P631; Choi S, 2005, CANCER RES, V65, P2035, DOI 10.1158/0008-5472.CAN-04-3616; Conaway CC, 1996, CARCINOGENESIS, V17, P2423, DOI 10.1093/carcin/17.11.2423; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; COWAN N, 1984, OXFORD SURVEYS EUKAR, P26; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Hosono T, 2005, J BIOL CHEM, V280, P41487, DOI 10.1074/jbc.M507127200; Jackson SJT, 2004, CARCINOGENESIS, V25, P219, DOI 10.1093/carcin/bgg192; Jakubikova J, 2005, ANTICANCER RES, V25, P3375; Jiao D, 1996, CHEM RES TOXICOL, V9, P932, DOI 10.1021/tx9502094; Jordan MA, 1996, CANCER RES, V56, P816; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Ling YH, 2002, MOL PHARMACOL, V62, P529, DOI 10.1124/mol.62.3.529; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p; Moreno RL, 2001, ARCH BIOCHEM BIOPHYS, V391, P99, DOI 10.1006/abbi.2001.2390; MORSE MA, 1989, CARCINOGENESIS, V10, P1757, DOI 10.1093/carcin/10.9.1757; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Nakamura Y, 2002, J BIOL CHEM, V277, P8492, DOI 10.1074/jbc.M109760200; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Rose P, 2005, INT J BIOCHEM CELL B, V37, P100, DOI 10.1016/j.biocel.2004.05.018; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Simpson R. J, 2003, PROTEINS PROTEOMICS, P143; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Suh SK, 2004, PROTEOMICS, V4, P3401, DOI 10.1002/pmic.200400971; Tang L, 2005, MOL CANCER THER, V4, P1250, DOI 10.1158/1535-7163.MCT-05-0041; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tseng E, 2004, EXP BIOL MED, V229, P835, DOI 10.1177/153537020422900817; von Weymarn LB, 2006, CARCINOGENESIS, V27, P782, DOI 10.1093/carcin/bgi301; von Weymarn LB, 2007, CHEM RES TOXICOL, V20, P1252, DOI 10.1021/tx700078v; *WHO, 2004, IARC HDB CANC PREV, V9, P43; Widrow RJ, 2000, CYTOMETRY, V39, P126, DOI 10.1002/(SICI)1097-0320(20000201)39:2<126::AID-CYTO5>3.0.CO;2-V; Xiao D, 2005, CLIN CANCER RES, V11, P2670, DOI 10.1158/1078-0432.CCR-04-1545; Xiao D, 2004, MOL CANCER THER, V3, P567; Yang YM, 2005, CANCER RES, V65, P8538, DOI 10.1158/0008-5472.CAN-05-0236; Yao S, 2006, MOL CARCINOGEN, V45, P605, DOI 10.1002/mc.20206; Zhang YS, 2006, P NUTR SOC, V65, P68, DOI 10.1079/PNS2005475; Zhang YS, 2003, MOL CANCER THER, V2, P1045; Zhang YS, 1998, CANCER RES, V58, P4632	47	173	176	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22136	22146		10.1074/jbc.M802330200	http://dx.doi.org/10.1074/jbc.M802330200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18524779	Green Published, hybrid			2022-12-27	WOS:000258114700033
J	Curfs, DMJ; Ghesquiere, SAI; Vergouwe, MN; van der Made, I; Gijbels, MJJ; Greaves, DR; Verbeek, JS; Hofker, MH; De Winther, MPJ				Curfs, Danielle M. J.; Ghesquiere, Stijn A. I.; Vergouwe, Monique N.; van der Made, Ingeborg; Gijbels, Marion J. J.; Greaves, David R.; Verbeek, J. Sjef; Hofker, Marten H.; De Winther, Menno P. J.			Macrophage secretory phospholipase A(2) group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-DEFICIENT MICE; LOW-DENSITY-LIPOPROTEIN; ARACHIDONIC-ACID; PULMONARY SURFACTANT; PROSTAGLANDIN E-2; GENE-EXPRESSION; GROUP-V; A(2); IIA; CELLS	Secreted phospholipase A2 group X (sPLA(2)-X) is one of the most potent enzymes of the phospholipase A(2) lipolytic enzyme superfamily. Its high catalytic activity toward phosphatidylcholine (PC), the major phospholipid of cell membranes and low-density lipoproteins (LDL), has implicated sPLA(2)-X in chronic inflammatory conditions such as atherogenesis. We studied the role of sPLA(2)-X enzyme activity in vitro and in vivo, by generating sPLA(2)-X-overexpressing macrophages and transgenic macrophage-specific sPLA(2)-X mice. Our results show that sPLA(2)-X expression inhibits macrophage activation and inflammatory responses upon stimulation, characterized by reduced cell adhesion and nitric oxide production, a decrease in tumor necrosis factor (TNF), and an increase in interleukin (IL)-10. These effects were mediated by an increase in IL-6, and enhanced production of prostaglandin E-2 (PGE(2)) and 15-deoxy-Delta 12,14-prostaglandin J(2) (PGJ(2)). Moreover, we found that overexpression of active sPLA(2)-X in macrophages strongly increases foam cell formation upon incubation with native LDL but also oxidized LDL (oxLDL), which is mediated by enhanced expression of scavenger receptor CD36. Transgenic sPLA(2)-X mice died neonatally because of severe lung pathology characterized by interstitial pneumonia with massive granulocyte and surfactant-laden macrophage infiltration. We conclude that overexpression of the active sPLA(2)-X enzyme results in enhanced foam cell formation but reduced activation and inflammatory responses in macrophages in vitro. Interestingly, enhanced sPLA(2)-X activity in macrophages in vivo leads to fatal pulmonary defects, suggesting a crucial role for sPLA(2)-X in inflammatory lung disease.	[Curfs, Danielle M. J.; Ghesquiere, Stijn A. I.; Vergouwe, Monique N.; van der Made, Ingeborg; Gijbels, Marion J. J.; Hofker, Marten H.; De Winther, Menno P. J.] Maastricht Univ, Cardiovasc Res Inst, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands; [Gijbels, Marion J. J.] Maastricht Univ, Cardiovasc Res Inst, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands; [Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Verbeek, J. Sjef] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Pathol Lab, NL-9713 AV Groningen, Netherlands; [Hofker, Marten H.] Univ Med Ctr Groningen, Lab Med, NL-9713 AV Groningen, Netherlands	Maastricht University; Maastricht University; University of Oxford; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen	Curfs, DMJ (corresponding author), Maastricht Univ, Cardiovasc Res Inst, Dept Mol Genet, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.	d.curfs@gen.unimaas.nl	de Winther, Menno/E-8721-2012	de Winther, Menno/0000-0002-4038-6636; Greaves, David/0000-0003-2856-9410				Arbibe L, 1998, J CLIN INVEST, V102, P1152, DOI 10.1172/JCI3236; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Cernak I, 1996, J TRAUMA, V40, pS148, DOI 10.1097/00005373-199603001-00032; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Cuzzocrea S, 2004, INTENS CARE MED, V30, P1935, DOI 10.1007/s00134-004-2353-y; Daniels CB, 2001, COMP BIOCHEM PHYS A, V129, P9, DOI 10.1016/S1095-6433(01)00303-8; Ghesquiere SAI, 2005, CARDIOVASC TOXICOL, V5, P161, DOI 10.1385/CT:5:2:161; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Helliwell RJA, 2004, PROSTAG LEUKOTR ESS, V70, P101, DOI 10.1016/j.plefa.2003.04.002; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hendriks WL, 1996, BIOCHEM J, V314, P563, DOI 10.1042/bj3140563; Hinson RM, 1996, P NATL ACAD SCI USA, V93, P4885, DOI 10.1073/pnas.93.10.4885; Hogan B, 1994, MANIPULATING MOUSE E; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Laine VJO, 1999, J IMMUNOL, V162, P7402; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Saiga A, 2001, BBA-MOL CELL BIOL L, V1530, P67, DOI 10.1016/S1388-1981(00)00167-0; Schmidt H. H. W., 1996, METHODS NITRIC OXIDE, P491; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Simpson KS, 1999, MOL REPROD DEV, V53, P179, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;179::AID-MRD7&gt;3.0.CO;2-P; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Tietge UJF, 2005, J LIPID RES, V46, P1604, DOI 10.1194/jlr.M400469-JLR200; Touqui L, 2003, ACTA PHARMACOL SIN, V24, P1292; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Wang HB, 2002, J CLIN ENDOCR METAB, V87, P2629, DOI 10.1210/jc.87.6.2629; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Williams JA, 1997, J BIOL CHEM, V272, P25693, DOI 10.1074/jbc.272.41.25693; Yan ZP, 2004, CELL IMMUNOL, V232, P116, DOI 10.1016/j.cellimm.2005.03.001	40	59	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21640	21648		10.1074/jbc.M710584200	http://dx.doi.org/10.1074/jbc.M710584200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18511424	hybrid			2022-12-27	WOS:000257898800037
J	Drose, S; Brandt, U				Droese, Stefan; Brandt, Ulrich			The mechanism of mitochondrial superoxide production by the cytochrome bc(1) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; CYCLE BYPASS REACTIONS; Q(O) SITE; UBIHYDROQUINONE OXIDATION; HEART-MITOCHONDRIA; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; REDOX STATE; BEEF-HEART; COENZYME-Q	Production of reactive oxygen species (ROS) by the mitochondrial respiratory chain is considered to be one of the major causes of degenerative processes associated with oxidative stress. Mitochondrial ROS has also been shown to be involved in cellular signaling. It is generally assumed that ubisemiquinone formed at the ubiquinol oxidation center of the cytochrome bc(1) complex is one of two sources of electrons for superoxide formation in mitochondria. Here we show that superoxide formation at the ubiquinol oxidation center of the membrane-bound or purified cytochrome bc(1) complex is stimulated by the presence of oxidized ubiquinone indicating that in a reverse reaction the electron is transferred onto oxygen from reduced cytochrome b(L) via ubiquinone rather than during the forward ubiquinone cycle reaction. In fact, from mechanistic studies it seems unlikely that during normal catalysis the ubisemiquinone intermediate reaches significant occupancies at the ubiquinol oxidation site. We conclude that cytochrome bc(1) complex-linked ROS production is primarily promoted by a partially oxidized rather than by a fully reduced ubiquinone pool. The resulting mechanism of ROS production offers a straightforward explanation of how the redox state of the ubiquinone pool could play a central role in mitochondrial redox signaling.	[Droese, Stefan; Brandt, Ulrich] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Brandt, U (corresponding author), Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, Cluster Excellence Frankfurt Macromol Complexes, D-60590 Frankfurt, Germany.	brandt@zbc.kgu.de	Dröse, Stefan/E-4903-2010; Brandt, Ulrich/GLV-1242-2022; Brandt, Ulrich/C-4406-2008	Dröse, Stefan/0000-0002-9361-9034; Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811				ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; BENZI G, 1995, NEUROBIOL AGING, V16, P661, DOI 10.1016/0197-4580(95)00066-N; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Brandt U, 1998, BBA-BIOENERGETICS, V1365, P261, DOI 10.1016/S0005-2728(98)00078-4; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Cape JL, 2005, J BIOL CHEM, V280, P34654, DOI 10.1074/jbc.M507616200; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Crofts AR, 2004, BBA-BIOENERGETICS, V1655, P77, DOI 10.1016/j.bbabio.2003.10.012; DEVRIES S, 1981, J BIOL CHEM, V256, P1996; Drose S, 2006, J BIOL CHEM, V281, P23733, DOI 10.1074/jbc.M602570200; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; ENGEL WD, 1983, H-S Z PHYSIOL CHEM, V364, P1753, DOI 10.1515/bchm2.1983.364.2.1753; ERECINSKA M, 1976, ARCH BIOCHEM BIOPHYS, V174, P143, DOI 10.1016/0003-9861(76)90333-7; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Galinier A, 2004, FEBS LETT, V578, P53, DOI 10.1016/j.febslet.2004.10.067; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Horvat S, 2006, J NEUROCHEM, V99, P937, DOI 10.1111/j.1471-4159.2006.04134.x; Kudin AP, 2005, BIOMED PHARMACOTHER, V59, P163, DOI 10.1016/j.biopha.2005.03.012; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; WAN YP, 1975, BIOCHEM BIOPH RES CO, V63, P11, DOI 10.1016/S0006-291X(75)80003-9; WIKSTROM MK, 1972, BIOCHIM BIOPHYS ACTA, V283, P403, DOI 10.1016/0005-2728(72)90258-7; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004	35	279	284	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21649	21654		10.1074/jbc.M803236200	http://dx.doi.org/10.1074/jbc.M803236200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522938	hybrid			2022-12-27	WOS:000257898800038
J	Piskounova, E; Viswanathan, SR; Janas, M; LaPierre, RJ; Daley, GQ; Sliz, P; Gregory, RI				Piskounova, Elena; Viswanathan, Srinivas R.; Janas, Maja; LaPierre, Robert J.; Daley, George Q.; Sliz, Piotr; Gregory, Richard I.			Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK DOMAIN; ZINC-FINGER PROTEINS; POSTTRANSCRIPTIONAL REGULATION; MICROPROCESSOR COMPLEX; CRYSTAL-STRUCTURE; EXPRESSION; LET-7; CELLS; RECOGNITION; CANCERS	The developmentally regulated RNA-binding protein Lin28 blocks processing of let-7 family microRNAs (miRNAs) in embryonic cells. The molecular basis for this selective miRNA processing block is unknown. Here we find that Lin28 selectively binds the terminal loop region of let-7 precursors in vitro and that the loop mediates miRNA processing inhibition in vivo. Additionally, we identify the domains of Lin28 required for this inhibition. These findings establish a regulatory role for the terminal loop of precursors in miRNA maturation and provide insight into the mechanism by which Lin28 negatively regulates let-7 processing.	Harvard Stem Cell Inst, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Biol Chem & Mol Pharmacol,Stem Cell Program, Boston, MA 02115 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School	Gregory, RI (corresponding author), Karp Bldg 09212,1 Blackfan Circle, Boston, MA 02115 USA.	rgregory@enders.tch.harvard.edu	Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023; Sliz, Piotr/0000-0002-6522-0835; Piskounova, Elena/0000-0002-8554-8475				Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; LANDSMAN D, 1992, NUCLEIC ACIDS RES, V20, P2861, DOI 10.1093/nar/20.11.2861; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	33	268	286	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21310	21314		10.1074/jbc.C800108200	http://dx.doi.org/10.1074/jbc.C800108200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18550544	hybrid			2022-12-27	WOS:000257898800002
J	Kollner, TG; Schnee, C; Li, S; Svatos, A; Schneider, B; Gershenzon, J; Degenhardt, J				Koellner, Tobias G.; Schnee, Christiane; Li, Shenghong; Svatos, Ales; Schneider, Bernd; Gershenzon, Jonathan; Degenhardt, Joerg			Protonation of a neutral (S)-beta-bisabolene intermediate is involved in (S)-beta-macrocarpene formation by the maize sesquiterpene synthases TPS6 and TPS11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-HUMULENE SYNTHASE; DELTA-SELINENE SYNTHASE; BACTERIAL EXPRESSION; 5-EPI-ARISTOLOCHENE SYNTHASE; ARISTOLOCHENE SYNTHASE; GENE FAMILY; BIOSYNTHESIS; (E)-BETA-FARNESENE; (E)-NEROLIDOL; HYDROCARBONS	Terpene synthases are responsible for the large diversity of terpene carbon skeletons found in plants. The unique, carbocationic reaction mechanism of these enzymes can form multiple products from a single prenyl diphosphate substrate. Two maize genes were isolated that encode very similar sesquiterpene synthases, TPS6 and TPS11, which both produce beta-bisabolene, a common monocyclic sesquiterpene, and beta-macrocarpene, an uncommon bicyclic olefin. Investigation of the reaction mechanism showed that the formation of beta-macrocarpene proceeds via a neutral beta-bisabolene intermediate and requires reprotonation by a proton that may ultimately be abstracted from water. This reprotonation is dependent on the pH and the presence of a Mg2+ cofactor. Mutational analysis of the enzyme demonstrated that a highly conserved tyrosine residue in the active center of the enzymes is important for the protonation process. TPS6 and TPS11 are transcribed both in leaves and roots of maize, but the respective terpene products were only detected in roots. The expression in roots was up-regulated by herbivore damage to the leaves, suggesting a long distance signal transduction cascade between leaves and roots.	[Koellner, Tobias G.; Schnee, Christiane; Li, Shenghong; Svatos, Ales; Schneider, Bernd; Gershenzon, Jonathan; Degenhardt, Joerg] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Max Planck Society	Degenhardt, J (corresponding author), Max Planck Inst Chem Ecol, Hans Knoll Str 8, D-07745 Jena, Germany.	degenhardt@ice.mpg.de	Svatos, Ales/A-3305-2014; Schneider, Bernd/A-3287-2014; Köllner, Tobias G/H-3375-2014; Gershenzon, Jonathan/K-1331-2013	Svatos, Ales/0000-0003-1032-7288; Schneider, Bernd/0000-0003-4788-1565; Köllner, Tobias G/0000-0002-7037-904X; Gershenzon, Jonathan/0000-0002-1812-1551; Schnee, Christiane/0000-0001-7643-9114				Allemann RK, 2007, J AM CHEM SOC, V129, P13008, DOI 10.1021/ja0722067; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; BACK K, 1995, J BIOL CHEM, V270, P7375, DOI 10.1074/jbc.270.13.7375; Basse CW, 2005, PLANT PHYSIOL, V138, P1774, DOI 10.1104/pp.105.061200; BURR B, 1991, TRENDS GENET, V7, P55, DOI 10.1016/0168-9525(91)90232-F; Cane D.E., 1999, COMPR NAT PROD CHEM, V2, P155, DOI [10.1016/B978-0-08-091283-7.00039-4, DOI 10.1016/B978-0-08-091283-7.00039-4]; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; CANE DE, 1990, J AM CHEM SOC, V112, P3209, DOI 10.1021/ja00164a051; Cool LG, 2005, PHYTOCHEMISTRY, V66, P249, DOI 10.1016/j.phytochem.2004.11.002; Crock J, 1997, P NATL ACAD SCI USA, V94, P12833, DOI 10.1073/pnas.94.24.12833; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; Degenhardt J, 2000, PLANTA, V210, P815, DOI 10.1007/s004250050684; Erb M, 2008, PLANT PHYSIOL, V146, P867, DOI 10.1104/pp.107.112169; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Gershenzon J., 1999, BIOCH PLANT SECONDAR, V2, P222; Iijima Y, 2004, PLANT PHYSIOL, V136, P3724, DOI 10.1104/pp.104.051318; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kollner TG, 2006, ARCH BIOCHEM BIOPHYS, V448, P83, DOI 10.1016/j.abb.2005.10.011; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Kollner TG, 2004, PHYTOCHEMISTRY, V65, P1895, DOI 10.1016/j.phytochem.2004.05.021; KONIG WA, 1994, HRC-J HIGH RES CHROM, V17, P315; Little DB, 2002, ARCH BIOCHEM BIOPHYS, V402, P120, DOI 10.1016/S0003-9861(02)00068-1; MacMillan J, 1997, NAT PROD REP, V14, P221, DOI 10.1039/np9971400221; Marschener H, 1998, FIELD CROP RES, V56, P203, DOI 10.1016/S0378-4290(97)00131-7; Picaud S, 2005, ARCH BIOCHEM BIOPHYS, V436, P215, DOI 10.1016/j.abb.2005.02.012; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Rising KA, 2000, J AM CHEM SOC, V122, P1861, DOI 10.1021/ja993584h; Schnee C, 2006, P NATL ACAD SCI USA, V103, P1129, DOI 10.1073/pnas.0508027103; Schnee C, 2002, PLANT PHYSIOL, V130, P2049, DOI 10.1104/pp.008326; Sharon-Asa L, 2003, PLANT J, V36, P664, DOI 10.1046/j.1365-313X.2003.01910.x; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; YUAN YS, 2008, PLANT J IN PRESS	35	72	78	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20779	20788		10.1074/jbc.M802682200	http://dx.doi.org/10.1074/jbc.M802682200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524777	Green Published, hybrid			2022-12-27	WOS:000257746100019
J	Laukkarinen, JM; Weiss, ER; van Acker, GJD; Steer, ML; Perides, G				Laukkarinen, Johanna M.; Weiss, Eric R.; van Acker, Gijs J. D.; Steer, Michael L.; Perides, George			Protease-activated receptor-2 exerts contrasting model-specific effects on acute experimental pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINAR-CELLS; RAT; CHOLECYSTOKININ; TAUROCHOLATE; OSCILLATIONS; PROTECTION; SECRETION; CARBACHOL; RESPONSES; DISEASE	Protease-activated receptor-2 (PAR2) is a 7-transmembrane G-protein-coupled tethered ligand receptor that is expressed by pancreatic acinar and ductal cells. It can be physiologically activated by trypsin. Previously reported studies (Namkung, W., Han, W., Luo, X., Muallem, S., Cho, K. H., Kim, K. H., and Lee, M. G. (2004) Gastroenterology 126, 1844-1859; Sharma, A., Tao, X., Gopal, A., Ligon, B., Andrade-Gordon, P., Steer, M. L., and Perides, G. (2005) Am. J. Physiol. 288, G388-G395) have shown that PAR2 activation exerts a protective effect on the experimental model of pancreatitis induced by supramaximal secretagogue (caerulein) stimulation. We now show that PAR2 exerts a worsening effect on a different model of experimental pancreatitis, i. e. one induced by retrograde pancreatic ductal infusion of bile salts. In vitro studies using freshly prepared pancreatic acini show that genetic deletion of PAR2 reduces bile salt-induced pathological calcium transients, acinar cell injury, and activation of c-Jun N-terminal kinase, whereas genetic deletion of PAR2 has the opposite or no effect on these pancreatitis-related events when they are elicited, in vitro, by caerulein stimulation. Studies employing a combination of trypsin inhibition and activation of PAR2 with the activating peptide SLIGRL show that all these differences indeed depend on the activation of PAR2. These studies are the first to report that a single perturbation can have model-specific and opposite effects on pancreatitis, and they underscore the importance of performing mechanistic pancreatitis studies using two dissimilar models of the disease to detect idiosyncratic, model-specific events. We suggest PAR2 activation exerts a worsening effect on the severity of clinical pancreatitis and that interventions interfering with PAR2 activation may be of benefit in the treatment of patients with severe pancreatitis.	[Laukkarinen, Johanna M.; Weiss, Eric R.; van Acker, Gijs J. D.; Steer, Michael L.; Perides, George] Tufts Med Ctr, Dept Surg 37, Boston, MA 02111 USA; [Laukkarinen, Johanna M.] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, Tampere 33520, Finland	Tufts Medical Center; Tampere University; Tampere University Hospital	Perides, G (corresponding author), Tufts Med Ctr, Dept Surg 37, 750 Washington St, Boston, MA 02111 USA.	gperides@tufts-nemc.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031396, R37DK031396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015410] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA 015410] Funding Source: Medline; NIDDK NIH HHS [DK 031396] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACOSTA JM, 1974, NEW ENGL J MED, V290, P484, DOI 10.1056/NEJM197402282900904; AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Fischer L, 2007, AM J PHYSIOL-GASTR L, V292, pG875, DOI 10.1152/ajpgi.00558.2005; Frossard JL, 1999, GASTROENTEROLOGY, V116, P694, DOI 10.1016/S0016-5085(99)70192-7; GLASBRENNER B, 1993, HEPATO-GASTROENTEROL, V40, P517; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Kim JY, 2002, GASTROENTEROLOGY, V122, P1941, DOI 10.1053/gast.2002.33617; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Laukkarinen JM, 2007, GUT, V56, P1590, DOI 10.1136/gut.2007.124230; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; LIGNON MF, 1988, GASTRIN CHOLECYSTOKI, P57; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Namkung W, 2004, GASTROENTEROLOGY, V126, P1844, DOI 10.1053/j.gastro.2004.03.019; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; Opie EL, 1901, B JOHNS HOPKINS HOSP, V12, P182; Opie EL, 1901, AM J MED SCI, V121, P27, DOI 10.1097/00000441-190101000-00002; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Sharma A, 2005, AM J PHYSIOL-GASTR L, V289, pG686, DOI 10.1152/ajpgi.00342.2004; Sharma A, 2005, AM J PHYSIOL-GASTR L, V288, pG388, DOI 10.1152/ajpgi.00341.2004; Singh VP, 2007, GUT, V56, P958, DOI 10.1136/gut.2006.094268; SJODIN L, 1991, J PHYSIOL-LONDON, V444, P763; Steer ML, 2005, CLINICAL PANCREATOLOGY: FOR PRACTISING GASTROENTEROLOGISTS AND SURGEONS, P10; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Wittel UA, 2008, PANCREAS, V36, pE9, DOI 10.1097/MPA.0b013e3181575103; YULE DI, 1992, J BIOL CHEM, V267, P13830	27	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20703	20712		10.1074/jbc.M801779200	http://dx.doi.org/10.1074/jbc.M801779200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511423	hybrid, Green Published			2022-12-27	WOS:000257746100011
J	Lin, CP; Ban, Y; Lyu, YL; Desai, SD; Liu, LF				Lin, Chao-Po; Ban, Yi; Lyu, Yi Lisa; Desai, Shyamal D.; Liu, Leroy F.			A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; RNA-POLYMERASE-II; CLEAVABLE COMPLEXES; REPLICATION FORKS; PROTEIN-KINASE; TUMOR-CELLS; CAMPTOTHECIN; PHOSPHORYLATION; DEGRADATION; DAMAGE	Reversible topoisomerase I (Top1)-DNA cleavage complexes are the key DNA lesion induced by anticancer camptothecins (e.g. topotecan and irinotecan) as well as structurally perturbed DNAs (e.g. oxidatively damaged DNA, UV-irradiated DNA, alkylated DNA, uracil-substituted DNA, mismatched DNA, gapped and nicked DNA, and DNA with abasic sites). Top1 cleavage complexes arrest transcription and trigger transcription-dependent degradation of Top1, a phenomenon termed Top1 down-regulation. In the current study, we have investigated the role of Top1 down-regulation in the repair of Top1 cleavage complexes. Using quiescent (serum-starved) human WI-38 cells, camptothecin (CPT) was shown to induce Top1 down-regulation, which paralleled the induction of DNA single-strand breaks (SSBs) (assayed by comet assays) and ATM autophosphorylation (at Ser-1981). Interestingly, Top1 down-regulation, induction of DNA SSBs and ATM autophosphorylation were all abolished by the proteasome inhibitor MG132. Furthermore, studies using immunoprecipitation and dominant-negative ubiquitin mutants have suggested a specific requirement for the assembly of Lys-48-linked polyubiquitin chains for CPT-induced Top1 down-regulation. In contrast to the effect of proteasome inhibition, inactivation of PARP1 was shown to increase the amount of CPT-induced SSBs and the level of ATM autophosphorylation. Together, these results support a model in which Top1 cleavage complexes arrest transcription and activate a ubiquitin-proteasome pathway leading to the degradation of Top1 cleavage complexes. Degradation of Top1 cleavage complexes results in the exposure of Top1-concealed SSBs for repair through a PARP1-dependent process.	[Lin, Chao-Po; Ban, Yi; Lyu, Yi Lisa; Desai, Shyamal D.; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Lin, Chao-Po/0000-0002-1457-1635; Liu, Leroy/0000-0001-9396-763X	NCI NIH HHS [CA 39662] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039662] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Daroui P, 2004, J BIOL CHEM, V279, P14587, DOI 10.1074/jbc.M311370200; DARPA P, 1990, CANCER RES, V50, P6919; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; El-Khamisy SF, 2007, DNA REPAIR, V6, P1485, DOI 10.1016/j.dnarep.2007.04.015; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; HOLM C, 1989, CANCER RES, V49, P6365; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; HSIANG YH, 1988, CANCER RES, V48, P3230; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Ismail IH, 2005, J BIOL CHEM, V280, P4649, DOI 10.1074/jbc.M411588200; KATYAL S, 2007, EMBO J; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Malanga M, 2004, J BIOL CHEM, V279, P5244, DOI 10.1074/jbc.C300437200; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; TSAO YP, 1992, CANCER RES, V52, P1823; TSAO YP, 1993, CANCER RES, V53, P5908; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; ZHANG H, 1990, CANCER CELL-MON REV, V2, P23; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858	48	79	79	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21074	21083		10.1074/jbc.M803493200	http://dx.doi.org/10.1074/jbc.M803493200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515798	hybrid, Green Published			2022-12-27	WOS:000257746100049
J	Singh, A; Gebhart, M; Fritsch, R; Sinnegger-Brauns, MJ; Poggiani, C; Hoda, JC; Engel, J; Romanin, C; Striessnig, J; Koschak, A				Singh, Anamika; Gebhart, Mathias; Fritsch, Reinhard; Sinnegger-Brauns, Martina J.; Poggiani, Chiara; Hoda, Jean-Charles; Engel, Jutta; Romanin, Christoph; Striessnig, Joerg; Koschak, Alexandra			Modulation of voltage- and Ca2+-dependent gating of Ca(v)1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUDITORY HAIR-CELLS; CA2+ CHANNELS; AUTOINHIBITORY DOMAIN; ALPHA(1C) SUBUNIT; BINDING-PROTEINS; SKELETAL-MUSCLE; BETA-SUBUNIT; RAT-BRAIN; INACTIVATION; MICE	Low voltage activation of Ca(V)1.3 L-type Ca2+ channels controls excitability in sensory cells and central neurons as well as sinoatrial node pacemaking. Ca(V)1.3-mediated pacemaking determines neuronal vulnerability of dopaminergic striatal neurons affected in Parkinson disease. We have previously found that in Ca(V)1.4 L-type Ca2+ channels, activation, voltage, and calcium-dependent inactivation are controlled by an intrinsic distal C-terminal modulator. Because alternative splicing in the Ca(V)1.3 alpha 1 subunit C terminus gives rise to a long (Ca(V)1.3(42)) and a short form (Ca(V)1.3(42A)), we investigated if a C-terminal modulatory mechanism also controls Ca(V)1.3 gating. The biophysical properties of both splice variants were compared after heterologous expression together with beta 3 and alpha 2 delta 1 subunits in HEK-293 cells. Activation of calcium current through Ca(V)1.3(42A) channels was more pronounced at negative voltages, and inactivation was faster because of enhanced calcium-dependent inactivation. By investigating several Ca(V)1.3 channel truncations, we restricted the modulator activity to the last 116 amino acids of the C terminus. The resulting Ca(V)1.3(Delta C116) channels showed gating properties similar to Ca(V)1.3(42A) that were reverted by co-expression of the corresponding C-terminal peptide C-116. Fluorescence resonance energy transfer experiments confirmed an intramolecular protein interaction in the C terminus of Ca(V)1.3 channels that also modulates calmodulin binding. These experiments revealed a novel mechanism of channel modulation enabling cells to tightly control Ca(V)1.3 channel activity by alternative splicing. The absence of the C-terminal modulator in short splice forms facilitates Ca(V)1.3 channel activation at lower voltages expected to favor Ca(V)1.3 activity at threshold voltages as required for modulation of neuronal firing behavior and sinoatrial node pacemaking.	[Singh, Anamika; Gebhart, Mathias; Sinnegger-Brauns, Martina J.; Poggiani, Chiara; Hoda, Jean-Charles; Striessnig, Joerg; Koschak, Alexandra] Univ Innsbruck, Inst Pharm Pharmacol & Toxicol, A-6020 Innsbruck, Austria; [Singh, Anamika; Gebhart, Mathias; Sinnegger-Brauns, Martina J.; Poggiani, Chiara; Hoda, Jean-Charles; Striessnig, Joerg; Koschak, Alexandra] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Fritsch, Reinhard; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Engel, Jutta] Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; [Engel, Jutta] Univ Tubingen, Tubingen Hearing Res Ctr, D-72076 Tubingen, Germany	University of Innsbruck; University of Innsbruck; Johannes Kepler University Linz; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Singh, A (corresponding author), Univ Innsbruck, Inst Pharm Pharmacol & Toxicol, Peter Mayr Str 1-1, A-6020 Innsbruck, Austria.		Romanin, Christoph/D-5399-2009; Striessnig, Joerg/S-9334-2017; Tuluc, Petronel/C-2527-2011	Romanin, Christoph/0000-0003-3756-4136; Striessnig, Joerg/0000-0002-9406-7120; Bhargava, Anamika/0000-0002-1048-3427; Brauns, Martina/0000-0002-0547-2731	Austrian Science Fund FWF [P 17159] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Bean BP, 2007, NATURE, V447, P1059, DOI 10.1038/4471059a; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; HALLING DB, 2006, SCI STKE, pERU; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Kepplinger KJF, 2000, FEBS LETT, V477, P161, DOI 10.1016/S0014-5793(00)01791-9; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Koschak A, 2007, J NEUROSCI, V27, P3855, DOI 10.1523/JNEUROSCI.4028-06.2007; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Matthes J, 2004, N-S ARCH PHARMACOL, V369, P554, DOI 10.1007/s00210-004-0940-7; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Qu YX, 2005, AM J PHYSIOL-HEART C, V288, pH2123, DOI 10.1152/ajpheart.01023.2004; Safa P, 2001, J BIOL CHEM, V276, P38727, DOI 10.1074/jbc.M103724200; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Striessnig J, 2007, J PHYSIOL-LONDON, V585, P643, DOI 10.1113/jphysiol.2007.147140; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x	43	95	97	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20733	20744		10.1074/jbc.M802254200	http://dx.doi.org/10.1074/jbc.M802254200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18482979	hybrid, Green Published			2022-12-27	WOS:000257746100014
J	Dutta, D; Chalissery, J; Sen, R				Dutta, Dipak; Chalissery, Jisha; Sen, Ranjan			Transcription termination factor Rho prefers catalytically active elongation complexes for releasing RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RHO; STRUCTURAL BASIS; DEPENDENT TERMINATION; BINDING DOMAIN; POLYMERASE; MECHANISM; INHIBITION; PROTEIN; SITE; SEQUENCE	RNA polymerase pauses at different DNA sequences during transcription elongation, and this pausing is associated with distinct conformational state(s) of the elongation complex (EC). Transcription termination by the termination factor Rho, an RNA- dependent molecular motor, requires pausing of the EC in the termination zone of Rho- dependent terminators. We hypothesized that the conformational state(s) of the EC associated with this pausing would influence the action of Rho. Analyses of the pausing behavior of the EC at the termination points of two well known Rho- dependent terminators revealed that Rho prefers actively transcribing complexes for termination. RNA release kinetics from stalled ECs showed that the rate of RNA release by Rho was reduced if the EC was irreversibly backtracked, if its RNA exit channel was modified by an RNA hairpin, or the bridge helix/trigger loop movement in its active site was perturbed. These defects were overcome significantly by enhancing the rate of ATP hydrolysis either by increasing the concentration of ATP or by using a Rho mutant with higher ATPase activity. We propose that the force generated from ATP hydrolysis of Rho is the key factor in dislodging the EC through its molecular motor action, and this process is facilitated when the EC is in a catalytically competent state, undergoing rapid "Brownian ratchet" motion.	[Dutta, Dipak; Chalissery, Jisha; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Lab Transcript Biol, Hyderabad 500076, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Transcript Biol, ECIL Rd,Nacharam, Hyderabad 500076, Andhra Pradesh, India.	rsen@cdfd.org.in	Chalissery, Jisha/AAI-3438-2021	Chalissery, Jisha/0000-0002-1738-2987	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALIFANO P, 1991, CELL, V64, P553; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Banerjee S, 2006, J MICROBIOL, V44, P11; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BEAR DG, 1988, J MOL BIOL, V199, P623, DOI 10.1016/0022-2836(88)90306-3; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Cheeran A, 2005, J MOL BIOL, V352, P28, DOI 10.1016/j.jmb.2005.06.052; CHEN CYA, 1987, J BIOL CHEM, V262, P11292; Ciampi M.S., 2006, MICROBIOLOGY, V152, P2525; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; HOWARD BH, 1976, J BIOL CHEM, V251, P2520; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; King RA, 2003, METHOD ENZYMOL, V371, P207; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; LAUS LF, 1983, J BIOL CHEM, V258, P9391; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MODRAK D, 1994, BIOCHEMISTRY-US, V33, P8292, DOI 10.1021/bi00193a016; Mooney RA, 1998, J BACTERIOL, V180, P3265, DOI 10.1128/JB.180.13.3265-3275.1998; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; MORGAN WD, 1983, J BIOL CHEM, V258, P9553; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Pani B, 2006, J BIOL CHEM, V281, P26491, DOI 10.1074/jbc.M603982200; PERIERA S, 1995, J MOL BIOL, V251, P36; RICHARDSON JP, 1993, CRIT REV BIOCHEM MOL, V28, P1, DOI 10.3109/10409239309082571; Richardson JP, 2003, CELL, V114, P157, DOI 10.1016/S0092-8674(03)00554-3; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Richardson LV, 1996, J BIOL CHEM, V271, P21597, DOI 10.1074/jbc.271.35.21597; Schwartz A, 2007, J BIOL CHEM, V282, P31469, DOI 10.1074/jbc.M706935200; SHIGESADA K, 1980, NUCLEIC ACIDS RES, V8, P3355, DOI 10.1093/nar/8.15.3355; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wei RR, 2001, J MOL BIOL, V314, P1007, DOI 10.1006/jmbi.2000.5207; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; WILSON KS, 1994, J MOL BIOL, V244, P36, DOI 10.1006/jmbi.1994.1702; Xu Y, 2002, J BIOL CHEM, V277, P30023, DOI 10.1074/jbc.M111009200; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; ZALATAN F, 1993, J BIOL CHEM, V268, P17051	49	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20243	20251		10.1074/jbc.M801926200	http://dx.doi.org/10.1074/jbc.M801926200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482981	hybrid			2022-12-27	WOS:000257565300040
J	Gratz, N; Siller, M; Schaljo, B; Pirzada, ZA; Gattermeier, I; Vojtek, I; Kirschning, CJ; Wagner, H; Charpentier, E; Kovarik, P; Akira, S				Gratz, Nina; Siller, Maria; Schaljo, Barbara; Pirzada, Zaid A.; Gattermeier, Irene; Vojtek, Ivo; Kirschning, Carsten J.; Wagner, Hermann; Charpentier, Emmanuelle; Kovarik, Pavel; Akira, Shizuo			Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; TANK-BINDING KINASE-1; NF-KAPPA-B; STREPTOLYSIN-O; VIRAL-INFECTION; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; INTRACELLULAR BACTERIA; HUMAN MACROPHAGES; GENE-EXPRESSION	Bacterial pathogens are recognized by the innate immune system through pattern recognition receptors, such as Toll-like receptors (TLRs). Engagement of TLRs triggers signaling cascades that launch innate immune responses. Activation of MAPKs and NF-kappa B, elements of the major signaling pathways induced by TLRs, depends in most cases on the adaptor molecule MyD88. In addition, Gram-negative or intracellular bacteria elicit MyD88-independent signaling that results in production of type I interferon (IFN). Here we show that in mouse macrophages, the activation of MyD88-dependent signaling by the extracellular Gram-positive human pathogen group A streptococcus (GAS; Streptococcus pyogenes) does not require TLR2, a receptor implicated in sensing of Gram-positive bacteria, or TLR4 and TLR9. Redundant engagement of either of these TLR molecules was excluded by using TLR2/4/9 triple-deficient macrophages. We further demonstrate that infection of macrophages by GAS causes IRF3 (interferon-regulatory factor 3)-dependent, MyD88-independent production of IFN. Surprisingly, IFN is induced also by GAS lacking slo and sagA, the genes encoding cytolysins that were shown to be required for IFN production in response to other Gram-positive bacteria. Our data indicate that (i) GAS is recognized by a MyD88-dependent receptor other than any of those typically used by bacteria, and (ii) GAS as well as GAS mutants lacking cytolysin genes induce type I IFN production by similar mechanisms as bacteria requiring cytoplasmic escape and the function of cytolysins.	[Gratz, Nina; Siller, Maria; Schaljo, Barbara; Pirzada, Zaid A.; Gattermeier, Irene; Vojtek, Ivo; Charpentier, Emmanuelle; Kovarik, Pavel] Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, A-1030 Vienna, Austria; [Kirschning, Carsten J.; Wagner, Hermann] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Technical University of Munich; Osaka University	Charpentier, E (corresponding author), Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	emanuelle.charpentier@univie.ac.at; pavel.kovarik@univie.ac.at	Akira, Shizuo/C-3134-2009; Kovarik, Pavel/D-1184-2014	Kovarik, Pavel/0000-0003-2956-0944	Austrian Science Fund FWF [I 288, F 2805, P 17238] Funding Source: Medline; Austrian Science Fund (FWF) [F 2805] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; BACCARINI M, 1985, J IMMUNOL, V134, P2658; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; CAPARON MG, 1991, INFECT IMMUN, V59, P1811, DOI 10.1128/IAI.59.5.1811-1817.1991; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chhatwal GS, 2005, TRENDS MOL MED, V11, P152, DOI 10.1016/j.molmed.2005.02.001; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gao JJ, 1998, J IMMUNOL, V161, P4803; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Glomski IJ, 2007, CELL MICROBIOL, V9, P502, DOI 10.1111/j.1462-5822.2006.00806.x; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Hakansson A, 2005, P NATL ACAD SCI USA, V102, P5192, DOI 10.1073/pnas.0408721102; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Hoshino K, 1999, J IMMUNOL, V162, P3749; HUG H, 1988, MOL CELL BIOL, V8, P3065, DOI 10.1128/MCB.8.8.3065; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Levy DE, 2002, J EXP MED, V195, pF15, DOI 10.1084/jem.20020075; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Medina Eva, 2005, Briefings in Functional Genomics & Proteomics, V4, P248, DOI 10.1093/bfgp/4.3.248; Miettinen M, 2000, J IMMUNOL, V164, P3733, DOI 10.4049/jimmunol.164.7.3733; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sierig G, 2003, INFECT IMMUN, V71, P446, DOI 10.1128/IAI.71.1.446-455.2003; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thulin P, 2006, PLOS MED, V3, P371, DOI 10.1371/journal.pmed.0030053; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Wei XQ, 1999, J IMMUNOL, V163, P2821; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129	76	69	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19879	19887		10.1074/jbc.M802848200	http://dx.doi.org/10.1074/jbc.M802848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18480050	hybrid, Green Published			2022-12-27	WOS:000257565300002
J	Mullen, JR; Brill, SJ				Mullen, Janet R.; Brill, Steven J.			Activation of the Slx5-Slx8 ubiquitin ligase by poly-small ubiquitin-like modifier conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SGS1 DNA HELICASE; SUMO ISOPEPTIDASE; PROTEIN; COMPLEX; RECOMBINATION; REPAIR; SUMOYLATION; PCNA; REPLICATION; PATHWAY	Protein sumoylation is a regulated process that is important for the health of human and yeast cells. In budding yeast, a subset of sumoylated proteins is targeted for ubiquitination by a conserved heterodimeric ubiquitin (Ub) ligase, Slx5-Slx8, which is needed to suppress the accumulation of high molecular weight small ubiquitin-like modifier (SUMO) conjugates. Structure-function analysis indicates that the Slx5-Slx8 complex contains multiple SUMO-binding domains that are collectively required for in vivo function. To determine the specificity of Slx5-Slx8, we assayed its Ub ligase activity using sumoylated Siz2 as an in vitro substrate. In contrast to unsumoylated or multisumoylated Siz2, substrates containing poly-SUMO conjugates were efficiently ubiquitinated by Slx5-Slx8. Although Siz2 itself was ubiquitinated, the bulk of the Ub was conjugated to SUMO residues. Slx5-Slx8 primarily mono-ubiquitinated the N-terminal SUMO moiety of the chain. These data indicate that the Slx5-Slx8 Ub ligase is stimulated by poly-SUMO conjugates and that it can ubiquitinate a poly-SUMO chain.	[Mullen, Janet R.; Brill, Steven J.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Brill, SJ (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.	brill@mbcl.rutgers.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071268] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071268, R01 GM071268-09, GM 071268] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li T, 2007, DNA REPAIR, V6, P1679, DOI 10.1016/j.dnarep.2007.06.004; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Mullen JR, 2001, GENETICS, V157, P103; Mullen JR, 2000, GENETICS, V154, P1101; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rose MD., 1990, METHODS YEAST GENETI; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	41	79	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19912	19921		10.1074/jbc.M802690200	http://dx.doi.org/10.1074/jbc.M802690200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499666	hybrid, Green Published			2022-12-27	WOS:000257565300006
J	Rezaie, AR; Bae, JS; Manithody, C; Qureshi, SH; Yang, LK				Rezaie, Alireza R.; Bae, Jong-Sup; Manithody, Chandrashekhara; Qureshi, Shabir H.; Yang, Likui			Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-X/XA; ACTIVE-SITE; FACTOR-XA; COMPLEX; PLASMA; ACTIVATION; THROMBIN; MUTANTS; CALCIUM; SERPIN	Protein Z (PZ) is a multidomain vitamin K-dependent plasma protein that functions as a cofactor to promote the inactivation of factor Xa (fXa) by PZ-dependent protease inhibitor (ZPI) by three orders of magnitude. To understand the mechanism by which PZ improves the reactivity of fXa with ZPI, we expressed wild-type PZ, PZ lacking the gamma-carboxyglutamic acid domain (GD-PZ), and a chimeric PZ mutant in which both Gla and EGF-like domains of the molecule were substituted with identical domains of fXa. The ZPI binding and the cofactor function of the PZ derivatives were characterized in both binding and kinetic assays. The binding assay indicated that all PZ derivatives interact with ZPI with a similar dissociation constant (KD) of similar to 7 nM. However, the apparent KD for the chimeric PZ-mediated ZPI inhibition of fXa was elevated 6-fold on PC/PS vesicles and its capacity to function as a cofactor to accelerate the ZPI inhibition of fXa was also decreased 6-fold. The cofactor activity of GD-PZ was dramatically impaired; however, the deletion mutant exhibited a normal cofactor function in solution. A chimeric activated protein C mutant containing the Gla domain of fXa was susceptible to inhibition by ZPI in the presence of PZ. These results suggest that: (i) the ZPI interactive site of PZ is located within the C-terminal domain of the cofactor and (ii) a specific interaction between the Gla domains of PZ and fXa contributes similar to 6-fold to the acceleration of the ZPI inhibition of fXa on phospholipid membranes.	St Louis Univ, Sch Med, Dept Biochem & Mol Biol, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, Edward A Doisy Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu	Bae, Jong-Sup/AAU-9724-2020; Qureshi, Shabir H/B-3610-2014		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062565, R01HL068571] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 68571, HL 62565] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Chen L, 2004, PROTEIN SCI, V13, P431, DOI 10.1110/ps.03406904; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Heeb MJ, 2005, J BIOL CHEM, V280, P33819, DOI 10.1074/jbc.M506502200; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; ICHINOSE A, 1990, BIOCHEM BIOPH RES CO, V172, P1139, DOI 10.1016/0006-291X(90)91566-B; Kemkes-Matthes B, 2002, THROMB RES, V106, P183, DOI 10.1016/S0049-3848(02)00181-0; Kittur FS, 2004, J BIOL CHEM, V279, P24189, DOI 10.1074/jbc.M402302200; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Qureshi SH, 2007, BIOCHEM J, V407, P427, DOI 10.1042/BJ20070735; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P9427, DOI 10.1021/bi060820+; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; SEJIMA H, 1990, BIOCHEM BIOPH RES CO, V171, P661, DOI 10.1016/0006-291X(90)91197-Z; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; WATER N, 2005, BRIT J HAEMATOL, V129, P561; Yang LK, 2007, THROMB HAEMOSTASIS, V97, P899, DOI 10.1160/TH06-12-0697	20	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19922	19926		10.1074/jbc.M802639200	http://dx.doi.org/10.1074/jbc.M802639200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502758	Green Published, hybrid			2022-12-27	WOS:000257565300007
J	Tur, V; van der Sloot, AM; Reis, CR; Szegezdi, E; Cool, RH; Samali, A; Serrano, L; Quax, WJ				Tur, Vicente; van der Sloot, Almer M.; Reis, Carlos R.; Szegezdi, Eva; Cool, Robbert H.; Samali, Afshin; Serrano, Luis; Quax, Wim J.			DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-SELECTIVE MUTANTS; FADD-DEPENDENT APOPTOSIS; NF-KAPPA-B; COMPUTATIONAL REDESIGN; MONOCLONAL-ANTIBODIES; BINDING; DEATH; DR5; SPECIFICITY; CASPASE-8	Tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL) is a potential anticancer agent that selectively induces apoptosis in a variety of cancer cells by interacting with death receptors DR4 and DR5. TRAIL can also bind to decoy receptors ( DcR1, DcR2, and osteoprotegerin receptor) that cannot induce apoptosis. Different tumor types respond either to DR4 or to DR5 activation, and chemotherapeutic drugs can increase the expression of DR4 or DR5 in cancer cells. Thus, DR4 or DR5 receptor-specific TRAIL variants would permit new and tumor-selective therapies. Previous success in generating a DR5-selective TRAIL mutant using computer-assisted protein design prompted us to make a DR4-selective TRAIL variant. Technically, the design of DR4 receptor-selective TRAIL variants is considerably more challenging compared with DR5 receptor-selective variants, because of the lack of a crystal structure of the TRAIL-DR4 complex. A single amino acid substitution of Asp at residue position 218 of TRAIL to His or Tyr was predicted to have a favorable effect on DR4 binding specificity. Surface plasmon resonance-based receptor binding tests showed a lowered DR5 affinity in concert with increased DR4 specificity for the designed variants, D218H and D218Y. Binding to DcR1, DcR2, and osteoprotegerin was also decreased. Cell line assays confirmed that the variants could not induce apoptosis in DR5-responsive Jurkat and A2780 cells but were able to induce apoptosis in DR4-responsive EM-2 and ML-1 cells.	[Reis, Carlos R.; Cool, Robbert H.; Quax, Wim J.] Univ Groningen, Dept Pharmaceut Biol, NL-9713 AV Groningen, Netherlands; [Tur, Vicente; van der Sloot, Almer M.] Ctr Gen Regulat, CRG EMBL Syst Biol Unit, Barcelona 08003, Spain; [Szegezdi, Eva; Samali, Afshin] Natl Univ Ireland, Dept Biochem, Cell Stress & Apoptosis Res Grp, Galway, Ireland; [Szegezdi, Eva; Samali, Afshin] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Cool, Robbert H.] Triskel Therapeut BV, NL-9713 AV Groningen, Netherlands; [Serrano, Luis] Univ Pompeu Fabra, CRG, ICREA, EMBL CRG Syst Biol Res Unit, Barcelona 08003, Spain	University of Groningen; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Quax, WJ (corresponding author), Univ Groningen, Dept Pharmaceut Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	w.j.quax@rug.nl	Quax, Wim/K-2802-2012; van der Sloot, Almer/M-7083-2015; Samali, Afshin/A-9571-2008; Serrano, Luis/B-3355-2013; Quax, Wim/O-2875-2019; Szegezdi, Eva/B-7142-2008	Quax, Wim/0000-0002-5162-9947; van der Sloot, Almer/0000-0003-0049-2044; Samali, Afshin/0000-0002-8610-8375; Serrano, Luis/0000-0002-5276-1392; Quax, Wim/0000-0002-5162-9947; Szegezdi, Eva/0000-0002-5708-3535; Cool, Robbert/0000-0002-9845-2202	ICREA Funding Source: Custom	ICREA(ICREA)		Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Griffith TS, 1999, J IMMUNOL, V162, P2597; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kiel C, 2004, J MOL BIOL, V340, P1039, DOI 10.1016/j.jmb.2004.05.050; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; MacFarlane M, 2005, CELL DEATH DIFFER, V12, P773, DOI 10.1038/sj.cdd.4401649; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shifman JM, 2002, J MOL BIOL, V323, P417, DOI 10.1016/S0022-2836(02)00881-1; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; van der Sloot AM, 2004, PROTEIN ENG DES SEL, V17, P673, DOI 10.1093/protein/gzh079; Wen JH, 2000, BLOOD, V96, P3900, DOI 10.1182/blood.V96.12.3900.h8003900_3900_3906; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x	38	53	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20560	20568		10.1074/jbc.M800457200	http://dx.doi.org/10.1074/jbc.M800457200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18474604	Green Published, hybrid			2022-12-27	WOS:000257565300068
J	Miller, CA; Leonard, HS; Pinsky, IG; Turner, BM; Williams, SR; Harrison, L; Fletcher, AF; Shen, GZ; Bryant, DA; Schluchter, WM				Miller, Crystal A.; Leonard, Heidi S.; Pinsky, Ivan G.; Turner, Brandy M.; Williams, Shervonda R.; Harrison, Leon, Jr.; Fletcher, Ariane F.; Shen, Gaozhong; Bryant, Donald A.; Schluchter, Wendy M.			Biogenesis of phycobiliproteins - III. CpcM is the asparagine methyltransferase for phycobiliprotein beta-subunits in cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-N-METHYLASPARAGINE; SYNECHOCOCCUS SP PCC-7002; MASTIGOCLADUS-LAMINOSUS; ENERGY-TRANSFER; C-PHYCOCYANIN; ALPHA-SUBUNIT; POSTTRANSLATIONAL METHYLATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BILIN LYASE	All phycobiliproteins contain a conserved, post-translational modification on asparagine 72 of their beta-subunits. Methylation of this Asn to produce gamma-N-methylasparagine has been shown to increase energy transfer efficiency within the phycobilisome and to prevent photoinhibition. We report here the biochemical characterization of the product of sll0487, which we have named cpcM, from the cyanobacterium Synechocystis sp. PCC 6803. Recombinant apo-phycocyanin and apo-allophycocyanin subunits were used as the substrates for assays with [methyl-H-3]S-adenosylmethionine and recombinant CpcM. CpcM methylated the beta-subunits of phycobiliproteins (CpcB, ApcB, and ApcF) and did not methylate the corresponding alpha-subunits (CpcA, ApcA, and ApcD), although they are similar in primary and tertiary structure. CpcM preferentially methylated its CpcB substrate after chromophorylation had occurred at Cys(82). CpcM exhibited lower activity on trimeric phycocyanin after complete chromophorylation and oligomerization had occurred. Based upon these in vitro studies, we conclude that this post-translational modification probably occurs after chromophorylation but before trimer assembly in vivo.	[Miller, Crystal A.; Leonard, Heidi S.; Pinsky, Ivan G.; Turner, Brandy M.; Williams, Shervonda R.; Harrison, Leon, Jr.; Fletcher, Ariane F.; Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Shen, Gaozhong; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Louisiana System; University of New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schluchter, WM (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	wschluch@uno.edu	Schluchter, Wendy/G-9662-2013					Adir N, 2003, J BIOL CHEM, V278, P25926, DOI 10.1074/jbc.M302838200; [Anonymous], [No title captured]; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; Ashby MK, 1999, PHOTOSYNTH RES, V61, P169, DOI 10.1023/A:1006217201666; BRYANT DA, 1979, ARCH MICROBIOL, V123, P113, DOI 10.1007/BF00446810; Cai YA, 2001, ANAL BIOCHEM, V290, P186, DOI 10.1006/abio.2000.4979; Clarke S, 2002, P NATL ACAD SCI USA, V99, P1104, DOI 10.1073/pnas.042004099; DELORIMIER RM, 1992, PLANT PHYSIOL, V98, P1003, DOI 10.1104/pp.98.3.1003; Ducret A, 1996, EUR J BIOCHEM, V236, P1010, DOI 10.1111/j.1432-1033.1996.01010.x; DUCRET A, 1994, EUR J BIOCHEM, V221, P563, DOI 10.1111/j.1432-1033.1994.tb18769.x; DUERRING M, 1988, FEBS LETT, V236, P167, DOI 10.1016/0014-5793(88)80308-9; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FUGLISTALLER P, 1987, BIOL CHEM H-S, V368, P353, DOI 10.1515/bchm3.1987.368.1.353; GANTT E, 1972, J CELL BIOL, V54, P313, DOI 10.1083/jcb.54.2.313; GLAUSER M, 1993, PHOTOCHEM PHOTOBIOL, V57, P344, DOI 10.1111/j.1751-1097.1993.tb02298.x; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; GLAZER AN, 1989, J BIOL CHEM, V264, P1; KEHRY MR, 1982, J BIOL CHEM, V257, P378; KLOTZ AV, 1987, J BIOL CHEM, V262, P17350; KLOTZ AV, 1993, J ORG CHEM, V58, P6985, DOI 10.1021/jo00077a014; KLOTZ AV, 1986, J BIOL CHEM, V261, P5891; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAXSON P, 1989, BIOCHIM BIOPHYS ACTA, V977, P40, DOI 10.1016/S0005-2728(89)80007-6; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; RAPS S, 1990, PLANT PHYSIOL, V92, P358, DOI 10.1104/pp.92.2.358; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; RUMBELI R, 1987, BIOL CHEM H-S, V368, P1, DOI 10.1515/bchm3.1987.368.1.1; RUMBELI R, 1987, FEBS LETT, V221, P1, DOI 10.1016/0014-5793(87)80341-1; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; SCHIRMER T, 1986, J MOL BIOL, V188, P651, DOI 10.1016/S0022-2836(86)80013-4; Schluchter WM, 1997, J BIOL CHEM, V272, P13562, DOI 10.1074/jbc.272.21.13562; SHEN G, 2008, J BACTERIOL IN PRESS; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SWANSON RV, 1990, J MOL BIOL, V214, P787, DOI 10.1016/0022-2836(90)90293-U; THOMAS BA, 1995, BIOCHEMISTRY-US, V34, P3758, DOI 10.1021/bi00011a034; THOMAS BA, 1993, BIOCHIM BIOPHYS ACTA, V1143, P104, DOI 10.1016/0005-2728(93)90222-2; Tooley AJ, 2001, P NATL ACAD SCI USA, V98, P10560, DOI 10.1073/pnas.181340998; WEHRMEYER W, 1983, PHOTOSYNTHETIC PROKA, P1; WESTERMANN M, 1994, ARCH MICROBIOL, V162, P222, DOI 10.1007/s002030050129; WILBANKS SM, 1989, J BIOL CHEM, V264, P17860; YAMANAKA G, 1978, J BIOL CHEM, V253, P8303; Zhao J., 1992, RES PHOTOSYNTHESIS, V1, P25; Zhao JD, 2001, BBA-BIOENERGETICS, V1505, P248, DOI 10.1016/S0005-2728(01)00175-X; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	50	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19293	19300		10.1074/jbc.M802734200	http://dx.doi.org/10.1074/jbc.M802734200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482977	hybrid			2022-12-27	WOS:000257387600015
J	Reyes-Turcu, FE; Shanks, JR; Komander, D; Wilkinson, KD				Reyes-Turcu, Francisca E.; Shanks, John R.; Komander, David; Wilkinson, Keith D.			Recognition of polyubiquitin isoforms by the multiple ubiquitin binding modules of isopeptidase T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBA DOMAIN; DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; PROTEIN; CHAINS; COMPLEX; FAMILY; TETRAUBIQUITIN; MONOUBIQUITIN	The conjugation of polyubiquitin to target proteins acts as a signal that regulates target stability, localization, and function. Several ubiquitin binding domains have been described, and while much is known about ubiquitin binding to the isolated domains, little is known with regard to how the domains interact with polyubiquitin in the context of full-length proteins. Isopeptidase T(IsoT/USP5) is a deubiquitinating enzyme that is largely responsible for the disassembly of unanchored polyubiquitin in the cell. IsoT has four ubiquitin binding domains: a zinc finger domain (ZnF UBP), which binds the proximal ubiquitin, a UBP domain that forms the active site, and two ubiquitin-associated (UBA) domains whose roles are unknown. Here, we show that the UBA domains are involved in binding two different polyubiquitin isoforms, linear and K48-linked. Using isothermal titration calorimetry, we show that IsoT has at least four ubiquitin binding sites for both polyubiquitin isoforms. The thermodynamics of the interactions reveal that the binding is enthalpy-driven. Mutation of the UBA domains suggests that UBA1 and UBA2 domains of IsoT interact with the third and fourth ubiquitins in both polyubiquitin isoforms, respectively. These data suggest that recognition of the polyubiquitin isoforms by IsoT involves considerable conformational mobility in the polyubiquitin ligand, in the enzyme, or in both.	[Reyes-Turcu, Francisca E.; Shanks, John R.; Wilkinson, Keith D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Komander, David] Inst Canc Res, London SW3 6JB, England	Emory University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Wilkinson, KD (corresponding author), Emory Univ, Sch Med, Dept Biochem, 4017 Rollins Res Bldg,1510 Clifton Rd, Atlanta, GA 30322 USA.	genekdw@emory.edu			NIGMS NIH HHS [GM075426, GM30308] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075426, R01GM030308] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 1997, EMBO J, V16, P4826; AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Haririnia A, 2007, J MOL BIOL, V368, P753, DOI 10.1016/j.jmb.2007.02.037; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Hunter CA, 2003, CHEM BIOL, V10, P1023, DOI 10.1016/j.chembiol.2003.10.009; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Lacombe T, 2002, FEBS LETT, V531, P469, DOI 10.1016/S0014-5793(02)03586-X; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lindsey DF, 1998, J BIOL CHEM, V273, P29178, DOI 10.1074/jbc.273.44.29178; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Melandri F, 1996, BIOCHEMISTRY-US, V35, P12893, DOI 10.1021/bi9612935; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Phillips CL, 2001, ACTA CRYSTALLOGR D, V57, P341, DOI 10.1107/S090744490001800X; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi Shahri, 2005, V301, P47; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Russell Nathaniel S., 2005, V301, P207; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Timms KM, 1998, GENE, V217, P101, DOI 10.1016/S0378-1119(98)00341-2; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Williams DH, 2004, J MOL BIOL, V340, P373, DOI 10.1016/j.jmb.2004.04.056	55	100	101	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19581	19592		10.1074/jbc.M800947200	http://dx.doi.org/10.1074/jbc.M800947200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482987	hybrid, Green Published			2022-12-27	WOS:000257387600044
J	Ui, M; Tanaka, Y; Tsumuraya, T; Fujii, I; Inoue, M; Hirama, M; Tsumoto, K				Ui, Mihoko; Tanaka, Yoshikazu; Tsumuraya, Takeshi; Fujii, Ikuo; Inoue, Masayuki; Hirama, Masahiro; Tsumoto, Kouhei			How protein recognizes ladder-like polycyclic ethers - Interactions between ciguatoxin (CTX3C) fragments and its specific antibody 10C9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMBIERDISCUS-TOXICUS; PTYCHODISCUS-BREVIS; MAXIMUM-LIKELIHOOD; CRYSTAL-STRUCTURE; SODIUM-CHANNELS; MARINE TOXINS; CIGUATERA; BINDING; COMPLEMENTARITY; BREVETOXINS	Ciguatoxins are a family of marine toxins composed of transfused polycyclic ethers. It has not yet been clarified at the atomic level on the pathogenic mechanism of these toxins or the interaction between a polycyclic ether compounds and a protein. Using the crystal structures of anti-ciguatoxin antibody 10C9 Fab in ligand-free form and in complexes with ABCD-ring (CTX3C-ABCD) and ABCDE-ring (CTX3C-ABCDE) fragments of the antigen CTX3C at resolutions of 2.6, 2.4, and 2.3 angstrom, respectively, we elucidated the mechanism of the interaction between the polycyclic ethers and the antibody. 10C9 Fab has an extraordinarily large and deep binding pocket at the center of the variable region, where CTX3C-ABCD or CTX3C-ABCDE binds longitudinally in the pocket via hydrogen bonds and van der Waals interactions. Upon antigen-antibody complexation, 10C9 Fab adjusts to the antigen fragments by means of rotational motion in the variable region. In addition, the antigen fragment lacking the E-ring induces a large motion in the constant region. Consequently, the thermostability of 10C9 Fab is enhanced by 10 degrees C upon complexation with CTX3C-ABCDE but not with CTX3C-ABCD. The crystal structures presented in this study also show that 10C9 Fab recoginition of CTX3C antigens requires molecular rearrangements over the entire antibody structure. These results further expand the fundamental understanding of the mechanism by which ladder-like polycyclic ethers are recognized and may be useful for the design of novel therapeutic agents by antibodies, marine toxins, or new diagnostic reagents for the detection and targeting of members of the polycyclic ether family.	[Ui, Mihoko; Tanaka, Yoshikazu; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 113003, Japan; [Tsumuraya, Takeshi; Fujii, Ikuo] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5998570, Japan; Japan Sci & Technol Agcy, SORST, Sendai, Miyagi 9808578, Japan; [Inoue, Masayuki; Hirama, Masahiro] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan	University of Tokyo; University of Tokyo; Osaka Metropolitan University; Japan Science & Technology Agency (JST); Tohoku University	Tsumoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan.	tsumoto@k.u-tokyo.ac.jp	Tsumuraya, Takeshi/W-1080-2019; Tanaka, Yoshikazu/B-7056-2009	Tsumuraya, Takeshi/0000-0001-8979-2160				AREVALO JH, 1993, NATURE, V365, P859, DOI 10.1038/365859a0; Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Haruyama H, 2002, BIOL PHARM BULL, V25, P1537, DOI 10.1248/bpb.25.1537; Hirama M, 2005, CHEM REC, V5, P240, DOI 10.1002/tcr.20049; Hirama M, 2001, SCIENCE, V294, P1904, DOI 10.1126/science.1065757; Isbister GK, 2005, LANCET NEUROL, V4, P219, DOI 10.1016/S1474-4422(05)70041-7; JEFFREY PD, 1995, J MOL BIOL, V248, P344, DOI 10.1016/S0022-2836(95)80055-7; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levine David Z., 1995, Journal of the American Osteopathic Association, V95, P193; Lewis RJ, 2006, TOXICON, V48, P799, DOI 10.1016/j.toxicon.2006.07.019; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oguri H, 2003, J AM CHEM SOC, V125, P7608, DOI 10.1021/ja034990a; Oishi T, 2001, SYNLETT, P952; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POLI MA, 1986, MOL PHARMACOL, V30, P129; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; SATAKE M, 1993, TETRAHEDRON LETT, V34, P1975, DOI 10.1016/S0040-4039(00)91978-6; SATAKE M, 1993, J AM CHEM SOC, V115, P361, DOI 10.1021/ja00054a061; SHIMIZU Y, 1986, J AM CHEM SOC, V108, P514, DOI 10.1021/ja00263a031; Tanaka F, 1996, J AM CHEM SOC, V118, P2332, DOI 10.1021/ja952220w; Vasudevan S, 2004, BLOOD CELL MOL DIS, V32, P176, DOI 10.1016/j.bcmd.2003.04.001; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; Yasumoto T, 2001, CHEM REC, V1, P228, DOI 10.1002/tcr.1010; 1994, ACTA CRYSTALLOGR, V50, P760	38	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19440	19447		10.1074/jbc.M801282200	http://dx.doi.org/10.1074/jbc.M801282200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18463096	hybrid			2022-12-27	WOS:000257387600030
J	Mowrer, KR; Wolfe, MS				Mowrer, Karen R.; Wolfe, Michael S.			Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CLEAVING ENZYME; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; HUMAN BRAIN; SECRETASE ACTIVITY; SITE; INHIBITOR; MICE; PURIFICATION; MYELINATION	Production of the amyloid beta-peptide (A beta) via sequential proteolytic cleavage of the amyloid precursor protein by beta- and gamma-secretases is strongly implicated in the pathogenesis of Alzheimer disease. The beta-secretase that executes the first cleavage event is a transmembrane aspartyl protease known as beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1). BACE1 pre-mRNA is alternatively spliced through the use of alternative splice sites in exons 3 and 4, although the significance of these splicing events is unclear. Here, we quantitatively measured relative levels of BACE1 transcripts and identified a novel splice variant of BACE1. We found a subtle but significant difference in BACE1 splicing between brain and pancreas, indicating the cellular environment can affect BACE1 alternative splicing. Furthermore, we have shown that BACE1 proteins translated from alternatively spliced transcripts have dramatically reduced beta-secretase activity and promotion of BACE1 alternative splicing reduces A beta production. These findings illustrate the importance of BACE1 alternative splicing in affecting the level of A beta produced in cells and suggest that targeting regulation of BACE1 alternative splicing is a potential therapeutic strategy for lowering beta-secretase activity.	[Wolfe, Michael S.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, MS (corresponding author), 77 Ave Louis Pasteur,HIM 754, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu						Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Bodendorf U, 2001, J BIOL CHEM, V276, P12019, DOI 10.1074/jbc.M008861200; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Ehehalt R, 2002, BIOCHEM BIOPH RES CO, V293, P30, DOI 10.1016/S0006-291X(02)00169-9; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Ghosh AK, 2007, CURR ALZHEIMER RES, V4, P418, DOI 10.2174/156720507781788864; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hills ID, 2007, CURR OPIN DRUG DISC, V10, P383; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huse JT, 2003, J BIOL CHEM, V278, P17141, DOI 10.1074/jbc.M213303200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tanahashi H, 2001, NEUROSCI LETT, V307, P9, DOI 10.1016/S0304-3940(01)01912-7; Tanahashi H, 2007, NEUROSCI LETT, V428, P103, DOI 10.1016/j.neulet.2007.09.033; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zohar O, 2003, MOL BRAIN RES, V115, P63, DOI 10.1016/S0169-328X(03)00182-7	36	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18694	18701		10.1074/jbc.M801322200	http://dx.doi.org/10.1074/jbc.M801322200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18468996	hybrid			2022-12-27	WOS:000257165600026
J	Zhang, MY; Wu, XF; Lee, AJ; Jin, W; Chang, M; Wright, A; Imaizumi, T; Sun, SC				Zhang, Minying; Wu, Xuefeng; Lee, Andrew J.; Jin, Wei; Chang, Mikyoung; Wright, Ato; Imaizumi, Tadaatsu; Sun, Shao-Cong			Regulation of I kappa B kinase-related kinases and antiviral responses by tumor suppressor CYLD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME CYLD; TANK-BINDING KINASE-1; VIRAL-INFECTION; INNATE IMMUNITY; IKK-EPSILON; MEDIATED ACTIVATION; CELLS; PATHWAYS; TBK1; LIPOPOLYSACCHARIDE	The I kappa B kinase (IKK)-related kinases, IKK epsilon and TBK1, participate in the induction of type I interferons (IFNs) during viral infections. Deregulated activation of IKK epsilon and TBK1 also contributes to the abnormal cell survival and transformation. However, how these kinases are negatively regulated remains unclear. We show here that the tumor suppressor CYLD has an essential role in preventing aberrant activation of IKK epsilon/TBK1. CYLD deficiency causes constitutive activation of IKK epsilon/TBK1, which is associated with hyper-induction of IFNs in virus-infected cells. We further show that CYLD targets a cytoplasmic RNA sensor, RIG-I, and inhibits the ubiquitination of this IKK epsilon/TBK1 stimulator. Consistent with the requirement of ubiquitination in RIG-I function, CYLD potently inhibits RIG-I-mediated activation of the IFN-beta promoter. These findings establish CYLD as a key negative regulator of IKK epsilon/TBK1 and suggest a role for CYLD in the control of RIG-I ubiquitination.	[Zhang, Minying; Wu, Xuefeng; Lee, Andrew J.; Jin, Wei; Chang, Mikyoung; Wright, Ato; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Lee, Andrew J.; Wright, Ato] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Imaizumi, Tadaatsu] Hirosaki Univ, Sch Med, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan	University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Hirosaki University	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	Lee, Andrew/GVU-2817-2022; Wu, Xuefeng/F-5003-2011		NCI NIH HHS [CA94922] Funding Source: Medline; NIAID NIH HHS [AI057555, AI064639, R37 AI064639, R01 AI057555] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA094922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R37AI064639, R01AI057555] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Agami R, 2007, CELL, V129, P1043, DOI 10.1016/j.cell.2007.05.048; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Crow Mary K, 2005, Curr Rheumatol Rep, V7, P463, DOI 10.1007/s11926-005-0053-4; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Good L, 1996, BIOCHEM BIOPH RES CO, V223, P123, DOI 10.1006/bbrc.1996.0856; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Imaizumi T, 2004, ENDOTHELIUM-J ENDOTH, V11, P169, DOI 10.1080/10623320490512156; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Nordmark G, 2006, NAT CLIN PRACT RHEUM, V2, P262, DOI 10.1038/ncprheum0173; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	45	100	108	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18621	18626		10.1074/jbc.M801451200	http://dx.doi.org/10.1074/jbc.M801451200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18467330	hybrid, Green Published			2022-12-27	WOS:000257165600018
J	Morley, S; Cecchini, M; Zhang, W; Virgulti, A; Noy, N; Atkinson, J; Manor, D				Morley, Samantha; Cecchini, Matt; Zhang, Wendy; Virgulti, Alessandro; Noy, Noa; Atkinson, Jeffrey; Manor, Danny			Mechanisms of ligand transfer by the hepatic tocopherol transfer protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-E-DEFICIENCY; PHOSPHOLIPID TRANSFER PROTEIN; ACID-BINDING PROTEIN; ALPHA-TOCOPHEROL; RETINITIS-PIGMENTOSA; GAMMA-TOCOPHEROL; RAT-LIVER; ATAXIA; GENE; MUTATION	alpha-Tocopherol is a member of the vitamin E family that functions as the principal fat-soluble antioxidant in vertebrates. Body-wide distribution of tocopherol is regulated by the hepatic alpha-tocopherol transfer protein (alpha TTP), which stimulates secretion of the vitamin from hepatocytes to circulating lipoproteins. This biological activity of alpha TTP is thought to stem from its ability to facilitate the transfer of vitamin E between membranes, but the mechanism by which the protein exerts this activity remains poorly understood. Using a fluorescence energy transfer methodology, we found that the rate of tocopherol transfer from lipid vesicles to alpha TTP increases with increasing alpha TTP concentration. This concentration dependence indicates that ligand transfer by alpha TTP involves direct protein-membrane interaction. In support of this notion, equilibrium analyses employing filtration, dual polarization interferometry, and tryptophan fluorescence demonstrated the presence of a stable alpha TTP-bilayer complex. The physical association of alpha TTP with membranes is markedly sensitive to the presence of vitamin E in the bilayer. Some naturally occurring mutations in alpha TTP that cause the hereditary disorder ataxia with vitamin E deficiency diminish the effect of tocopherol on the protein-membrane association, suggesting a possible mechanism for the accompanying pathology.	[Noy, Noa; Manor, Danny] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Morley, Samantha] Cornell Univ, Ithaca, NY 14853 USA; [Cecchini, Matt; Zhang, Wendy; Virgulti, Alessandro; Atkinson, Jeffrey] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada	Case Western Reserve University; Cornell University; Brock University	Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, WG-48, Cleveland, OH 44106 USA.	dxm178@case.edu		Atkinson, Jeffrey/0000-0003-3710-4893	NIDDK NIH HHS [DK 067494, R01 DK067494, R01 DK067494-06, T32 DK 715827] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067494] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1983, PRINCIPLES FLUORESCE, P354; Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; ARITA M, 1995, BIOCHEM J, V306, P437, DOI 10.1042/bj3060437; BEHRENS WA, 1986, J AM COLL NUTR, V5, P91; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; Desrumaux C, 2001, J BIOL CHEM, V276, P5908, DOI 10.1074/jbc.M008420200; GARGOURI Y, 1989, BIOCHIM BIOPHYS ACTA, V1006, P255, DOI 10.1016/0005-2760(89)90012-X; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; Hentati A, 1996, ANN NEUROL, V39, P295, DOI 10.1002/ana.410390305; Horiguchi M, 2003, GENES CELLS, V8, P789, DOI 10.1046/j.1365-2443.2003.00676.x; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Hsu KT, 1996, J BIOL CHEM, V271, P13317, DOI 10.1074/jbc.271.23.13317; Huang H, 1999, BIOCHEM J, V344, P593, DOI 10.1042/0264-6021:3440593; Leonard SW, 2002, AM J CLIN NUTR, V75, P555, DOI 10.1093/ajcn/75.3.555; Lowe ME, 2002, J LIPID RES, V43, P2007, DOI 10.1194/jlr.R200012-JLR200; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Morley S, 2006, BIOCHEMISTRY-US, V45, P1075, DOI 10.1021/bi052271y; Morley S, 2004, BIOCHEMISTRY-US, V43, P4143, DOI 10.1021/bi0363073; MOWRI H, 1981, EUR J BIOCHEM, V117, P537; MURPHY DJ, 1981, J BIOL CHEM, V256, P464; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Pang JJ, 2001, JPN J OPHTHALMOL, V45, P672, DOI 10.1016/S0021-5155(01)00425-7; Ponsin G, 2003, BIOCHEMISTRY-US, V42, P4444, DOI 10.1021/bi027006g; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; Qian JH, 2006, BIOCHEMISTRY-US, V45, P8236, DOI 10.1021/bi060522c; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Swanson JE, 1999, J LIPID RES, V40, P665; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; TRABER MG, 1989, AM J CLIN NUTR, V49, P517, DOI 10.1093/ajcn/49.3.517; VERDON CP, 1988, ANAL BIOCHEM, V169, P109, DOI 10.1016/0003-2697(88)90261-8; WEINBERG RB, 1994, J BIOL CHEM, V269, P29588; WOOTAN MG, 1993, BIOCHEMISTRY-US, V32, P8622, DOI 10.1021/bi00084a033; Wu F, 2001, BIOCHEMISTRY-US, V40, P1976, DOI 10.1021/bi002252i; Yokota T, 1997, ANN NEUROL, V41, P826, DOI 10.1002/ana.410410621; Yokota T, 1996, NEW ENGL J MED, V335, P1770, DOI 10.1056/NEJM199612053352315; Yokota T, 2000, J NEUROL NEUROSUR PS, V68, P521, DOI 10.1136/jnnp.68.4.521; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098	43	44	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					17797	17804		10.1074/jbc.M800121200	http://dx.doi.org/10.1074/jbc.M800121200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18458085	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000256949200007
J	Nesmelova, IV; Sham, Y; Gao, JL; Mayo, KH				Nesmelova, Irina V.; Sham, Yuk; Gao, Jiali; Mayo, Kevin H.			CXC and CC chemokines form mixed heterodimers - Association free energies from molecular dynamics simulations and experimental correlations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NMR SOLUTION STRUCTURE; SUBUNIT ASSOCIATION; BACKBONE DYNAMICS; CONTINUUM SOLVENT; 3-DIMENSIONAL STRUCTURE; BINDING AFFINITIES; PROGENITOR CELLS; PLATELET-FACTOR-4; INTERLEUKIN-8	CXC and CC chemokines are involved in numerous biological processes, and their function in situ may be significantly influenced by heterodimer formation, as was recently reported, for example, for CXC chemokines CXCL4/PF4 and CXCL8/IL8 that interact to form heterodimers that modulate chemotactic and cell proliferation activities. Here we used molecular dynamics simulations to determine relative association free energies (overall average and per residue) for homo- and heterodimer pairs of CXC (CXCL4/PF4, CXCL8/IL8, CXCL1/Gro-alpha, and CXCL7/NAP-2) and CC (CCL5/RANTES, CCL2/MCP-1, and CCL8/MCP-2) chemokines. Even though structural homology among monomer folds of all CXC and CC chemokines permits heterodimer assembly, our calculated association free energies depend upon the particular pair of chemokines in terms of the net electrostatic and nonelectrostatic forces involved, as well as (for CC/CXC mixed chemokines) the selection of dimer type (CC or CXC). These relative free energies indicate that association of some pairs of chemokines is more favorable than others. Our approach is validated by correlation of calculated and experimentally determined free energies. Results are discussed in terms of CXC and CC chemokine function and have significant biological implications.	[Nesmelova, Irina V.; Mayo, Kevin H.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sham, Yuk] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA; [Gao, Jiali; Mayo, Kevin H.] Univ Minnesota, Inst Supercomp, Minneapolis, MN 55455 USA; [Gao, Jiali] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mayo, KH (corresponding author), 6-155 Jackson Hall,321 Church St, Minneapolis, MN 55455 USA.	mayox001@umn.edu	Nesmelova, Irina/D-6033-2015; Sham, Yuk Y/A-6472-2011	Nesmelova, Irina/0000-0002-1835-1533; Sham, Yuk Y/0000-0003-2601-8930	National Institutes of Health NRSA [HL 07062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007062] Funding Source: NIH RePORTER	National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NRSA training Grant HL 07062 ( to I.V.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROXMEYER HE, 1993, J IMMUNOL, V150, P3448; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; CHEN MJ, 1991, BIOCHEMISTRY-US, V30, P6402, DOI 10.1021/bi00240a009; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; Cornell W, 2001, J MOL GRAPH MODEL, V19, P136, DOI 10.1016/S1093-3263(00)00124-8; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dudek AZ, 2003, BLOOD, V101, P4687, DOI 10.1182/blood-2002-08-2363; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gouwy M, 2004, J LEUKOCYTE BIOL, V76, P185, DOI 10.1189/jlb.1003479; Gouwy M, 2002, MOL PHARMACOL, V62, P173, DOI 10.1124/mol.62.1.173; GRASBERGER BL, 1993, J MOL BIOL, V230, P364, DOI 10.1006/jmbi.1993.1152; Guan E, 2001, J BIOL CHEM, V276, P12404, DOI 10.1074/jbc.M006327200; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Hanzawa H, 1997, J BIOCHEM-TOKYO, V121, P835; Karlsson M, 2005, BIOCHEMISTRY-US, V44, P3487, DOI 10.1021/bi048610p; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lazaridis T, 2003, BIOPHYS CHEM, V100, P367, DOI 10.1016/S0301-4622(02)00293-4; LiWang AC, 1999, BIOCHEMISTRY-US, V38, P442, DOI 10.1021/bi9812726; Lowman HB, 1997, PROTEIN SCI, V6, P598; Luo HB, 2002, P NATL ACAD SCI USA, V99, P10399, DOI 10.1073/pnas.162365999; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAYO KH, 1991, BIOCHEMISTRY-US, V30, P925, DOI 10.1021/bi00218a007; MAYO KH, 1995, BIOCHEMISTRY-US, V34, P11399, DOI 10.1021/bi00036a012; MAYO KH, 1989, BIOCHEMISTRY-US, V28, P9469, DOI 10.1021/bi00450a034; Nesmelova IV, 2005, J BIOL CHEM, V280, P4948, DOI 10.1074/jbc.M405364200; Paoletti S, 2005, BLOOD, V105, P3405, DOI 10.1182/blood-2004-04-1648; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; Rajarathnam K, 1997, J BIOL CHEM, V272, P1725, DOI 10.1074/jbc.272.3.1725; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHNITZEL W, 1994, J LEUKOCYTE BIOL, V55, P763, DOI 10.1002/jlb.55.6.763; Sham YY, 2000, PROTEINS, V39, P393, DOI 10.1002/(SICI)1097-0134(20000601)39:4<393::AID-PROT120>3.3.CO;2-8; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; STCHARLES R, 1989, J BIOL CHEM, V264, P2092; STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Villa J, 2000, P NATL ACAD SCI USA, V97, P11899, DOI 10.1073/pnas.97.22.11899; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; Wang W, 2000, J MOL BIOL, V303, P567, DOI 10.1006/jmbi.2000.4057; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; Warshel A, 2002, ACCOUNTS CHEM RES, V35, P385, DOI 10.1021/ar010033z; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Xu Y, 2006, PROTEINS, V64, P1058, DOI 10.1002/prot.21044; YANG YQ, 1994, J BIOL CHEM, V269, P20110; Ye JQ, 1999, J BIOMOL NMR, V15, P115, DOI 10.1023/A:1008376728947; Ye JQ, 2001, BIOCHEMISTRY-US, V40, P7820, DOI 10.1021/bi010252s; Youn BS, 2000, IMMUNOL REV, V177, P150, DOI 10.1034/j.1600-065X.2000.17701.x; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	64	55	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24155	24166		10.1074/jbc.M803308200	http://dx.doi.org/10.1074/jbc.M803308200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550532	Green Published, hybrid			2022-12-27	WOS:000258638900069
J	Hartleben, B; Schweizer, H; Lubben, P; Bartram, MP; Moller, CC; Herr, R; Wei, CL; Neumann-Haefelin, E; Schermer, B; Zentgraf, H; Kerjaschki, D; Reiser, J; Walz, G; Benzing, T; Huber, TB				Hartleben, Bjoern; Schweizer, Heiko; Luebben, Pauline; Bartram, Malte P.; Moeller, Clemens C.; Herr, Ronja; Wei, Changli; Neumann-Haefelin, Elke; Schermer, Bernhard; Zentgraf, Hanswalter; Kerjaschki, Dontscho; Reiser, Jochen; Walz, Gerd; Benzing, Thomas; Huber, Tobias B.			Neph-nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR SLIT DIAPHRAGM; ADHESION MOLECULE JAM; NEURONAL POLARITY; KIDNEY; GENE; MECHANISM; PAR-3; MICE	The kidney filter represents a unique assembly of podocyte epithelial cells that tightly enwrap the glomerular capillaries with their foot processes and the interposed slit diaphragm. So far, very little is known about the guidance cues and polarity signals required to regulate proper development and maintenance of the glomerular filtration barrier. We now identify Par3, Par6, and atypical protein kinase C( aPKC) polarity proteins as novel Neph1-Nephrin-associated proteins. The interaction was mediated through the PDZ domain of Par3 and conserved carboxyl terminal residues in Neph1 and Nephrin. Par3, Par6, and aPKC localized to the slit diaphragm as shown in immunofluorescence and immunoelectron microscopy. Consistent with a critical role for aPKC activity in podocytes, inhibition of glomerular aPKC activity with a pseudosubstrate inhibitor resulted in a loss of regular podocyte foot process architecture. These data provide an important link between cell recognition mediated through the Neph1-Nephrin complex and Par-dependent polarity signaling and suggest that this molecular interaction is essential for establishing the three-dimensional architecture of podocytes at the kidney filtration barrier.	[Bartram, Malte P.; Schermer, Bernhard; Benzing, Thomas] Univ Hosp Cologne, Div Renal, D-50937 Cologne, Germany; [Hartleben, Bjoern; Schweizer, Heiko; Luebben, Pauline; Herr, Ronja; Neumann-Haefelin, Elke; Walz, Gerd; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Moeller, Clemens C.; Wei, Changli; Reiser, Jochen] Massachusetts Gen Hosp East, Div Nephrol, Boston, MA 02129 USA; [Moeller, Clemens C.; Wei, Changli; Reiser, Jochen] Massachusetts Gen Hosp East, Program Glomerular Dis, Boston, MA 02129 USA; [Zentgraf, Hanswalter] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Kerjaschki, Dontscho] German Canc Res Ctr, Dept Tumor Virol, D-69120 Heidelberg, Germany	University of Cologne; University of Freiburg; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Medical University of Vienna; Helmholtz Association; German Cancer Research Center (DKFZ)	Benzing, T (corresponding author), Univ Hosp Cologne, Div Renal, Kerpener Str 62, D-50937 Cologne, Germany.	thomas.benzing@uk-koeln.de; tobias.huber@uniklinik-freiburg.de	Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; Neumann-Haefelin, Elke/ABC-3089-2021	Schermer, Bernhard/0000-0002-5194-9000; Huber, Tobias B./0000-0001-7175-5062	National Institutes of Health [DK073495]; Kristyna M. Driehaus foundation; Deutsche Forschungsgemeinschaft [BE 2212, HU 1016/2-1]; Deutsche Forschungsgemeinschaft Sonderforschungsbereich [592]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kristyna M. Driehaus foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK073495 (to J.R). This work was also supported by a grant from the Kristyna M. Driehaus foundation (to J.R.), by Deutsche Forschungsgemeinschaft Grants BE 2212 (to T.B.) and HU 1016/2-1) (to T.B.H.), and by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 592 (to T.B.H.).	Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Standaert ML, 1999, J BIOL CHEM, V274, P14074, DOI 10.1074/jbc.274.20.14074; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696	31	84	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23033	23038		10.1074/jbc.M803143200	http://dx.doi.org/10.1074/jbc.M803143200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18562307	Green Published, hybrid			2022-12-27	WOS:000258455400016
J	Singh, S; Mccoy, JG; Zhang, C; Bingman, CA; Phillips, GN; Thorson, JS				Singh, Shanteri; McCoy, Jason G.; Zhang, Changsheng; Bingman, Craig A.; Phillips, George N., Jr.; Thorson, Jon S.			Structure and mechanism of the rebeccamycin sugar 4 '-O-Methyltransferase RebM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; ADENOSYL-L-METHIONINE; CRYSTAL-STRUCTURE; O-METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; TANDEM ACTION; INDOLOCARBAZOLE; STAUROSPORINE; GENERATION; REFINEMENT	The 2.65-angstrom crystal structure of the rebeccamycin 4'-O-methyltransferase RebM in complex with S-adenosyl-L-homocysteine revealed RebM to adopt a typical S-adenosylmethionine-binding fold of small molecule O-methyltransferases (O-MTases) and display a weak dimerization domain unique to MTases. Using this structure as a basis, the RebM substrate binding model implicated a predominance of nonspecific hydrophobic interactions consistent with the reported ability of RebM to methylate a wide range of indolocarbazole surrogates. This model also illuminated the three putative RebM catalytic residues (His(140)/(141) and Asp(166)) subsequently found to be highly conserved among sequence-related natural product O-MTases from GC-rich bacteria. Interrogation of these residues via sitedirected mutagenesis in RebM demonstrated His(140) and Asp(166) to be most important for catalysis. This study revealsRebMto be a member of the general acid/ base-dependent O-MTases and, as the first crystal structure for a sugar O-MTase, may also present a template toward the future engineering of natural product MTases for combinatorial applications.	[McCoy, Jason G.; Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Singh, Shanteri; Zhang, Changsheng; Thorson, Jon S.] Univ Wisconsin, Natl Drug Discovery Grp, Madison, WI 53705 USA; [Singh, Shanteri; Zhang, Changsheng; Thorson, Jon S.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Phillips, GN (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	phillips@biochem.wisc.edu; jsthorson@pharmacy.wisc.edu	Zhang, Changsheng/B-5965-2012; Thorson, Jon S/L-3696-2013	Zhang, Changsheng/0000-0003-2349-3138; Thorson, Jon S/0000-0002-7148-0721; Singh, Shanteri/0000-0003-0960-4794	NATIONAL CANCER INSTITUTE [R01CA084374, U19CA113297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052218] Funding Source: NIH RePORTER; NCI NIH HHS [CA84374, U19 CA113297] Funding Source: Medline; NIAID NIH HHS [AI52218] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akinaga S, 2000, ANTI-CANCER DRUG DES, V15, P43; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailly C, 2000, CURR MED CHEM, V7, P39, DOI 10.2174/0929867003375489; BAUER NJ, 1988, J BIOL CHEM, V263, P15619; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m; Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; INOUYE M, 1994, GENE, V141, P121; Jansson A, 2004, J BIOL CHEM, V279, P41149, DOI 10.1074/jbc.M407081200; Jansson A, 2003, J MOL BIOL, V334, P269, DOI 10.1016/j.jmb.2003.09.061; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Klimasauskas S, 2007, TRENDS BIOTECHNOL, V25, P99, DOI 10.1016/j.tibtech.2007.01.006; KREUZMAN AJ, 1988, J BIOL CHEM, V263, P15626; Long BH, 2000, EXPERT OPIN THER PAT, V10, P635, DOI 10.1517/13543776.10.5.635; Lukinavicius G, 2007, J AM CHEM SOC, V129, P2758, DOI 10.1021/ja0691876; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Martin JL, 2001, STRUCTURE, V9, P977, DOI 10.1016/S0969-2126(01)00662-1; Meyers CLF, 2004, BIOCHEMISTRY-US, V43, P15022, DOI 10.1021/bi048457z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishizawa T, 2005, J BACTERIOL, V187, P2084, DOI 10.1128/JB.187.6.2084-2092.2005; Onaka H, 2003, BIOSCI BIOTECH BIOCH, V67, P127, DOI 10.1271/bbb.67.127; Oster LM, 2006, J MOL BIOL, V358, P546, DOI 10.1016/j.jmb.2006.02.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Palma PN, 2006, MOL PHARMACOL, V70, P143, DOI 10.1124/mol.106.023119; Pi N, 2004, P NATL ACAD SCI USA, V101, P10036, DOI 10.1073/pnas.0403526101; Prudhomme M, 2003, EUR J MED CHEM, V38, P123, DOI 10.1016/S0223-5234(03)00011-4; Prudhomme M, 2000, CURR MED CHEM, V7, P1189, DOI 10.2174/0929867003374138; Prudhomme Michelle, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P509; Rodriguez L, 2001, J BACTERIOL, V183, P5358, DOI 10.1128/JB.183.18.5358-5363.2001; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Salas AP, 2005, MOL MICROBIOL, V58, P17, DOI 10.1111/j.1365-2958.2005.04777.x; Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6; Sanchez C, 2006, NAT PROD REP, V23, P1007, DOI 10.1039/b601930g; Sanchez C, 2006, J IND MICROBIOL BIOT, V33, P560, DOI 10.1007/s10295-006-0092-5; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Weeks CM, 2003, METHOD ENZYMOL, V374, P37, DOI 10.1016/S0076-6879(03)74003-8; Weller RL, 2005, ORG LETT, V7, P2141, DOI 10.1021/ol0504749; Xu J, 2003, ARCH BIOCHEM BIOPHYS, V411, P277, DOI 10.1016/S0003-9861(03)00004-3; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Zhang C, 2006, CHEMBIOCHEM, V7, P795, DOI 10.1002/cbic.200500504; Zhang CS, 2006, J AM CHEM SOC, V128, P2760, DOI 10.1021/ja056231t; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	56	48	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22628	22636		10.1074/jbc.M800503200	http://dx.doi.org/10.1074/jbc.M800503200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18502766	Green Published, hybrid			2022-12-27	WOS:000258321000032
J	Jiang, DW; Chen, WQ; Xiao, JM; Wang, RW; Kong, HH; Jones, PP; Zhang, L; Fruen, B; Chen, SRW				Jiang, Dawei; Chen, Wenqian; Xiao, Jianmin; Wang, Ruiwu; Kong, Huihui; Jones, Peter P.; Zhang, Lin; Fruen, Bradley; Chen, S. R. Wayne			Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL CORE DISEASE; MUSCLE RYANODINE RECEPTOR; SKELETAL SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE CHANNEL; DANTROLENE SODIUM; VENTRICULAR-TACHYCARDIA; SUDDEN-DEATH; MUTATIONS; HALOTHANE; STORE	Naturally occurring mutations in the skeletal muscle Ca2+ release channel/ryanodine receptor RyR1 are linked to malignant hyperthermia (MH), a life-threatening complication of general anesthesia. Although it has long been recognized that MH results from uncontrolled or spontaneous Ca2+ release from the sarcoplasmic reticulum, how MH RyR1 mutations render the sarcoplasmic reticulum susceptible to volatile anestheticinduced spontaneous Ca2+ release is unclear. Here we investigated the impact of the porcine MH mutation, R615C, the human equivalent of which also causes MH, on the intrinsic properties of the RyR1 channel and the propensity for spontaneous Ca2+ release during store Ca2+ overload, a process we refer to as store overload-induced Ca2+ release (SOICR). Single channel analyses revealed that the R615C mutation markedly enhanced the luminal Ca2+ activation of RyR1. Moreover, HEK293 cells expressing the R615C mutant displayed a reduced threshold for SOICR compared with cells expressing wild type RyR1. Furthermore, the MH-triggering agent, halothane, potentiated the response of RyR1 to luminal Ca2+ and SOICR. Conversely, dantrolene, an effective treatment for H, suppressed SOICR in HEK293 cells expressing the R615C mutant, but not in cells expressing an RyR2 mutant. These data suggest that the R615C mutation confers MH susceptibility by reducing the threshold for luminal Ca2+ activation and SOICR, whereas volatile anesthetics trigger MH by further reducing the threshold, and dantrolene suppresses MH by increasing the SOICR threshold. Together, our data support a view in which altered luminal Ca2+ regulation of RyR1 represents a primary causal mechanism of MH.	[Jiang, Dawei; Chen, Wenqian; Xiao, Jianmin; Wang, Ruiwu; Kong, Huihui; Jones, Peter P.; Zhang, Lin; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Biophys, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Jiang, Dawei; Chen, Wenqian; Xiao, Jianmin; Wang, Ruiwu; Kong, Huihui; Jones, Peter P.; Zhang, Lin; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Fruen, Bradley] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Minnesota System; University of Minnesota Twin Cities	Chen, SRW (corresponding author), 3300 Hosp Dr, NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Jones, Peter P/G-2618-2013; Kong, Huihui/F-9024-2012	Jones, Pete/0000-0001-7977-1737	NHLBI NIH HHS [1R01 HL 75210, R01 HL 076433] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075210, R01HL076433] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balog EM, 2001, BIOPHYS J, V81, P2050, DOI 10.1016/S0006-3495(01)75854-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Dietze B, 2000, J PHYSIOL-LONDON, V526, P507, DOI 10.1111/j.1469-7793.2000.t01-1-00507.x; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI 10.1529/biophysj.104.049447; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FILL M, 1990, BIOPHYS J, V57, P471, DOI 10.1016/S0006-3495(90)82563-7; FOSTER PS, 1989, BRIT J ANAESTH, V62, P566, DOI 10.1093/bja/62.5.566; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; HAINAUT K, 1974, NATURE, V252, P728, DOI 10.1038/252728a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Housmans PR, 2000, ANAL BIOCHEM, V284, P60, DOI 10.1006/abio.2000.4688; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Laver DR, 1997, BIOPHYS J, V73, P1913, DOI 10.1016/S0006-3495(97)78222-5; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Louis CF, 2001, BIOSCIENCE REP, V21, P155, DOI 10.1023/A:1013644107519; Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Mickelson JR, 1996, PHYSIOL REV, V76, P537, DOI 10.1152/physrev.1996.76.2.537; Murayama T, 2007, BIOCHEM J, V402, P349, DOI 10.1042/BJ20061040; Nelson TE, 1996, ANESTHESIOLOGY, V84, P1368, DOI 10.1097/00000542-199606000-00013; NELSON TE, 1975, ANESTHESIOLOGY, V42, P301, DOI 10.1097/00000542-197503000-00011; NELSON TE, 1991, J PHARMACOL EXP THER, V256, P645; NELSON TE, 1983, J CLIN INVEST, V72, P862, DOI 10.1172/JCI111057; Nelson Thomas E., 2002, Current Molecular Medicine (Hilversum), V2, P347, DOI 10.2174/1566524023362429; OHNISHI ST, 1983, FEBS LETT, V161, P103; OKUMURA F, 1980, BRIT J ANAESTH, V52, P377, DOI 10.1093/bja/52.4.377; OTSU K, 1994, J BIOL CHEM, V269, P9413; Owen VJ, 1997, AM J PHYSIOL-CELL PH, V272, pC203, DOI 10.1152/ajpcell.1997.272.1.C203; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Priori SG, 2005, J CLIN INVEST, V115, P2033, DOI 10.1172/JCI25664; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; Sampieri A, 2005, J BIOL CHEM, V280, P24804, DOI 10.1074/jbc.M501487200; SHOMER NH, 1993, AM J PHYSIOL, V264, pC125, DOI 10.1152/ajpcell.1993.264.1.C125; Sitsapesan R, 1997, J MEMBRANE BIOL, V159, P179, DOI 10.1007/s002329900281; Szentesi P, 2001, J GEN PHYSIOL, V118, P355, DOI 10.1085/jgp.118.4.355; Tong JF, 1999, BIOCHEM J, V343, P39, DOI 10.1042/0264-6021:3430039; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; TREVES S, 1994, BIOCHEM J, V301, P661, DOI 10.1042/bj3010661; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; VANWINKLE WB, 1976, SCIENCE, V193, P1130, DOI 10.1126/science.959824; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200	52	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20813	20820		10.1074/jbc.M801944200	http://dx.doi.org/10.1074/jbc.M801944200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18505726	Green Published, hybrid			2022-12-27	WOS:000257746100023
J	Hou, XY; Xu, SQ; Maitland-Toolan, KA; Sato, K; Jiang, BB; Ido, YS; Lan, F; Walsh, K; Wierzbicki, M; Verbeuren, TJ; Cohen, RA; Zang, MW				Hou, Xiuyun; Xu, Shanqin; Maitland-Toolan, Karlene A.; Sato, Kaori; Jiang, Bingbing; Ido, Yasuo; Lan, Fan; Walsh, Kenneth; Wierzbicki, Michel; Verbeuren, Tony J.; Cohen, Richard A.; Zang, Mengwei			SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; FATTY-ACID OXIDATION; GLUCOSE-HOMEOSTASIS; HEPG2 CELLS; MITOCHONDRIAL-FUNCTION; MASTER SWITCH; LIFE-SPAN; METFORMIN; LKB1; PHOSPHORYLATION	Resveratrol may protect against metabolic disease through activating SIRT1 deacetylase. Because we have recently defined AMPK activation as a key mechanism for the beneficial effects of polyphenols on hepatic lipid accumulation, hyperlipidemia, and atherosclerosis in type 1 diabetic mice, we hypothesize that polyphenol-activated SIRT1 acts upstream of AMPK signaling and hepatocellular lipid metabolism. Here we show that polyphenols, including resveratrol and the synthetic polyphenol S17834, increase SIRT1 deacetylase activity, LKB1 phosphorylation at Ser(428), and AMPK activity. Polyphenols substantially prevent the impairment in phosphorylation of AMPK and its downstream target, ACC (acetyl-CoA carboxylase), elevation in expression of FAS (fatty acid synthase), and lipid accumulation in human HepG2 hepatocytes exposed to high glucose. These effects of polyphenols are largely abolished by pharmacological and genetic inhibition of SIRT1, suggesting that the stimulation of AMPK and lipid-lowering effect of polyphenols depend on SIRT1 activity. Furthermore, adenoviral overexpression of SIRT1 stimulates the basal AMPK signaling in HepG2 cells and in the mouse liver. AMPK activation by SIRT1 also protects against FAS induction and lipid accumulation caused by high glucose. Moreover, LKB1, but not CaMKK beta, is required for activation of AMPK by polyphenols and SIRT1. These findings suggest that SIRT1 functions as a novel upstream regulator for LKB1/AMPK signaling and plays an essential role in the regulation of hepatocyte lipid metabolism. Targeting SIRT1/LKB1/AMPK signaling by polyphenols may have potential therapeutic implications for dyslipidemia and accelerated atherosclerosis in diabetes and age-related diseases.	[Hou, Xiuyun; Xu, Shanqin; Maitland-Toolan, Karlene A.; Jiang, Bingbing; Cohen, Richard A.; Zang, Mengwei] Boston Univ, Sch Med, Vasc Biol Unit, Boston, MA 02118 USA; [Sato, Kaori; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Mol Cardiol Unit, Boston, MA 02118 USA; [Ido, Yasuo; Lan, Fan] Boston Univ, Endocrinol Sect, Boston, MA 02118 USA; [Wierzbicki, Michel; Verbeuren, Tony J.] Inst Rech Servier, F-92150 Suresnes, France	Boston University; Boston University; Boston University; Servier; Institut de Recherches Internationales Servier	Zang, MW (corresponding author), Boston Univ, Sch Med, Vasc Biol Unit, X704,650 Albany St, Boston, MA 02118 USA.	mwzang1@bu.edu		Ido, Yasuo/0000-0002-3036-9971; Zang, Mengwei/0000-0002-2502-2586; /0000-0002-1070-6408	NHLBI NIH HHS [P01 HL 68758] Funding Source: Medline; NIA NIH HHS [R01 AG 27080] Funding Source: Medline; NIDDK NIH HHS [R01 DK 76942] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027080] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chau-Van C, 2007, ENDOCRINOLOGY, V148, P507, DOI 10.1210/en.2006-1237; CIANFLONE K, 1992, ARTERIOSCLER THROMB, V12, P271, DOI 10.1161/01.ATV.12.3.271; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hirao M, 2003, J BIOL CHEM, V278, P52773, DOI 10.1074/jbc.M308966200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200; Zang MW, 2001, J BIOL CHEM, V276, P25157, DOI 10.1074/jbc.M100152200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	57	618	657	5	109	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20015	20026		10.1074/jbc.M802187200	http://dx.doi.org/10.1074/jbc.M802187200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482975	Green Published, hybrid			2022-12-27	WOS:000257565300017
J	Cao, JS; Shan, DD; Revett, T; Li, DM; Wu, LY; Liu, W; Tobin, JF; Gimeno, RE				Cao, Jingsong; Shan, Dandan; Revett, Tracy; Li, Dongmei; Wu, Leeying; Liu, Wei; Tobin, James F.; Gimeno, Ruth E.			Molecular identification of a novel mammalian brain isoform of acyl-CoA : lysophospholipid acyltransferase with prominent ethanolamine lysophospholipid acylating activity, LPEAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; COENZYME-A; CLONING; ENZYME; METABOLISM; GLYCEROLIPIDS; PHOSPHOLIPIDS; CATALYZES; CELLS	Acyl-CoA-dependent lysophospholipid acyltransferases play an important role in attaining the appropriate molecular species of phospholipids. A number of genes encoding these activities were recently identified. It has become clear that multiple genes can encode one enzymatic activity and that a given gene may encode multiple activities. Here we report the identification of a gene encoding a mammalian acyl-CoA-dependent lysophospholipid acyltransferase with prominent activity toward ethanolamine-containing lysophospholipids, which we termed acyl-CoA: lysophosphatidylethanolamine acyltransferase 2, LPEAT2 (previously annotated as AYTL3 or AGPAT7). LPEAT2 is predominantly expressed in brain, coinciding with an enrichment of phosphatidylethanolamine in this tissue. Ectopic expression of LPEAT2 in mammalian HEK293T cells led to a dramatic increase (up to 9-fold) in LPEAT activity when compared with cells transfected with empty vector or an unrelated acyltransferase. LPEAT2 also exhibited significant acyl-CoA-dependent acyltransferase activity toward 1-O-alkenyl-lysophosphatidylethanolamine, lysophosphatidylglycerol, 1-O-alkyl-lysophosphatidylcholine, lysophosphatidylserine, and lysophosphatidylcholine but lacked appreciable acylating activity toward glycerol 3-phosphate, lysophosphatidic acid, lysophosphatidylinositol, and diacylglycerol, demonstrating multiple but selective functions of LPEAT2 as an enzyme involved in phospholipid remodeling. LPEAT2 recognizes a broad range of medium and long chain fatty acyl-CoA, and its activity was not affected by Ca2+. When overexpressed in mammalian cells, LPEAT2 is localized to the endoplasmic reticulum. siRNA-mediated knockdown of LPEAT2 in HEK293T cells significantly decreased LPEAT and 1-alkenyl-LPEAT activities but did not affect other lysophospholipid acylating activities. These findings identify LPEAT2 as an important enzyme in the biosynthesis of ethanolamine-containing phospholipids, especially in brain.	[Cao, Jingsong; Shan, Dandan; Revett, Tracy; Li, Dongmei; Tobin, James F.; Gimeno, Ruth E.] Wyeth Res, Dept Cardiovasc & Metab Dis, Cambridge, MA 02140 USA; [Wu, Leeying; Liu, Wei] Wyeth Res, Dept Bioinformat, Cambridge, MA 02140 USA	Pfizer; Pfizer	Cao, JS (corresponding author), Wyeth Res, Dept Cardiovasc & Metab Dis, Cambridge, MA 02140 USA.	jcao@wyeth.com; rgimeno@wyeth.com						Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Guan ZZ, 2001, ANAL BIOCHEM, V297, P137, DOI 10.1006/abio.2001.5303; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1963, J BIOL CHEM, V238, P898; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; MERKL I, 1963, J BIOL CHEM, V238, P905; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NITSCH R, 1991, ANN NY ACAD SCI, V640, P110; NITSCH RM, 1992, P NATL ACAD SCI USA, V89, P1671, DOI 10.1073/pnas.89.5.1671; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Vance DE, 2007, J BIOL CHEM, V282, P33237, DOI 10.1074/jbc.R700028200; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; Ye GM, 2005, DNA SEQUENCE, V16, P386, DOI 10.1080/10425170500213712; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	32	60	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19049	19057		10.1074/jbc.M800364200	http://dx.doi.org/10.1074/jbc.M800364200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18458083	hybrid			2022-12-27	WOS:000257165600060
J	Roy, B; Halvey, EJ; Garthwaite, J				Roy, Brijesh; Halvey, Edward J.; Garthwaite, John			An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YC-1 BINDING-SITE; CARBON-MONOXIDE; FUNCTIONAL-CHARACTERIZATION; COUPLED RECEPTORS; CEREBELLAR CELLS; RESONANCE RAMAN; GTP ANALOGS; NO; INHIBITION; ATP	Nitric oxide (NO) exerts physiological effects by activating specialized receptors that are coupled to guanylyl cyclase activity, resulting in cGMP synthesis from GTP. Despite its widespread importance as a signal transduction pathway, the way it operates is still understood only in descriptive terms. The present work aimed to elucidate a formal mechanism for NO receptor activation and its modulation by GTP, ATP, and allosteric agents, such as YC-1 and BAY 41-2272. The model comprised a module in which NO, the nucleotides, and allosteric agents bind and the protein undergoes a conformational change, dovetailing with a catalytic module where GTP is converted to cGMP and pyrophosphate. Experiments on NO-activated guanylyl cyclase purified from bovine lung allowed values for all of the binding and isomerization constants to be derived. The catalytic module was a modified version of one describing the kinetics of adenylyl cyclase. The resulting enzyme-linked receptor mechanism faithfully reproduces all of the main functional properties of NO-activated guanylyl cyclase reported to date and provides a thermodynamically sound interpretation of those properties. With appropriate modification, it also replicates activation by carbon monoxide and the remarkable enhancement of that activity brought about by the allosteric agents. In addition, the mechanism enhances understanding of the behavior of the receptor in a cellular setting.	[Roy, Brijesh; Halvey, Edward J.; Garthwaite, John] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Garthwaite, J (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	john.garthwaite@ucl.ac.uk			Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Attwell D, 2005, NAT REV NEUROSCI, V6, P841, DOI 10.1038/nrn1784; Becker E M, 2001, BMC Pharmacol, V1, P13, DOI 10.1186/1471-2210-1-13; Bellamy TC, 2000, P NATL ACAD SCI USA, V97, P2928, DOI 10.1073/pnas.97.6.2928; Bellamy TC, 2002, P NATL ACAD SCI USA, V99, P507, DOI 10.1073/pnas.012368499; Bellamy TC, 2002, J BIOL CHEM, V277, P31801, DOI 10.1074/jbc.M205936200; Bellamy TC, 2002, BRIT J PHARMACOL, V136, P95, DOI 10.1038/sj.bjp.0704687; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Bellamy TC, 2002, MOL CELL BIOCHEM, V230, P165, DOI 10.1023/A:1014204426331; BRANDWEIN HJ, 1982, J BIOL CHEM, V257, P1309; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; CHA S, 1968, J BIOL CHEM, V243, P820; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; CHRISMAN TD, 1975, J BIOL CHEM, V250, P374; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D, 2004, BIOPHYS J, V86, P3510, DOI 10.1529/biophysj.103.038679; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Costa T, 2005, TRENDS PHARMACOL SCI, V26, P618, DOI 10.1016/j.tips.2005.10.009; Denninger JW, 2000, BIOCHEMISTRY-US, V39, P4191, DOI 10.1021/bi992332q; Dessauer CW, 1999, TRENDS PHARMACOL SCI, V20, P205, DOI 10.1016/S0165-6147(99)01310-3; Dessauer CW, 1997, J BIOL CHEM, V272, P27787, DOI 10.1074/jbc.272.44.27787; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Friebe A, 1999, BIOCHEMISTRY-US, V38, P15253, DOI 10.1021/bi9908944; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Friebe A, 1998, MOL PHARMACOL, V54, P962, DOI 10.1124/mol.54.6.962; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1998, MOL PHARMACOL, V53, P123, DOI 10.1124/mol.53.1.123; Friebe A, 1996, NATURE, V382, P120, DOI 10.1038/382120a0; Garthwaite J, 2005, FRONT BIOSCI-LANDMRK, V10, P1868; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Griffiths C, 2003, MOL PHARMACOL, V64, P1349, DOI 10.1124/mol.64.6.1349; HATAKEYAMA K, 1992, J BIOL CHEM, V267, P20734; Hoenicka M, 1999, J MOL MED-JMM, V77, P14, DOI 10.1007/s001090050292; HORIE M, 1989, J PHYSIOL-LONDON, V408, P313, DOI 10.1113/jphysiol.1989.sp017461; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23; Kazerounian S, 2002, BIOCHEMISTRY-US, V41, P3396, DOI 10.1021/bi0110894; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kharitonov VG, 1999, BIOCHEMISTRY-US, V38, P10699, DOI 10.1021/bi990277f; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Makino R, 1999, J BIOL CHEM, V274, P7714, DOI 10.1074/jbc.274.12.7714; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Mo E, 2004, J BIOL CHEM, V279, P26149, DOI 10.1074/jbc.M400916200; MONCADA S, 1991, PHARMACOL REV, V43, P109; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mullershausen F, 2004, CIRCULATION, V109, P1711, DOI 10.1161/01.CIR.0000126286.47618.BD; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; Pal B, 2005, J INORG BIOCHEM, V99, P267, DOI 10.1016/j.jinorgbio.2004.09.027; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Ruiz-Stewart I, 2004, P NATL ACAD SCI USA, V101, P37, DOI 10.1073/pnas.0305080101; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Russwurm M, 2005, METHOD ENZYMOL, V396, P492, DOI 10.1016/S0076-6879(05)96041-2; Russwurm M, 2002, J BIOL CHEM, V277, P24883, DOI 10.1074/jbc.M110570200; Schmidt K, 2001, MOL PHARMACOL, V59, P220, DOI 10.1124/mol.59.2.220; Schmidt P, 2003, EUR J PHARMACOL, V468, P167, DOI 10.1016/S0014-2999(03)01674-1; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Stasch JP, 2002, BRIT J PHARMACOL, V135, P333, DOI 10.1038/sj.bjp.0704484; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Stone JR, 1995, BIOCHEMISTRY-US, V34, P16397, DOI 10.1021/bi00050a021; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Suzuki T, 2001, FEBS LETT, V507, P49, DOI 10.1016/S0014-5793(01)02943-X; Teng CM, 1997, EUR J PHARMACOL, V320, P161, DOI 10.1016/S0014-2999(96)00911-9; Tsoukias NM, 2004, AM J PHYSIOL-HEART C, V286, pH1043, DOI 10.1152/ajpheart.00525.2003; Vogel KM, 1999, J BIOL INORG CHEM, V4, P804, DOI 10.1007/s007750050354; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; Wykes V, 2004, BRIT J PHARMACOL, V141, P1087, DOI 10.1038/sj.bjp.0705745; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	77	44	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18841	18851		10.1074/jbc.M801712200	http://dx.doi.org/10.1074/jbc.M801712200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18463095	hybrid			2022-12-27	WOS:000257165600041
J	Reynolds, CH; Garwood, CJ; Wray, S; Price, C; Kellie, S; Perera, T; Zvelebil, M; Yang, A; Sheppard, PW; Varndell, IM; Hanger, DP; Anderton, BH				Reynolds, C. Hugh; Garwood, Claire J.; Wray, Selina; Price, Caroline; Kellie, Stuart; Perera, Timothy; Zvelebil, Marketa; Yang, Alice; Sheppard, Paul W.; Varndell, Ian M.; Hanger, Diane P.; Anderton, Brian H.			Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase C gamma 1, Grb2, and Src family kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMERS-DISEASE BRAIN; HELICAL FILAMENT-TAU; NANOELECTROSPRAY MASS-SPECTROMETRY; ACTIVATED PROTEIN-KINASES; N-TERMINAL KINASE; SH3 DOMAIN; IN-VITRO; TYROSINE PHOSPHORYLATION; INDUCED NEUROTOXICITY	The microtubule-associated protein tau can associate with various other proteins in addition to tubulin, including the SH3 domains of Src family tyrosine kinases. Tau is well known to aggregate to form hyperphosphorylated filamentous deposits in several neurodegenerative diseases (tauopathies) including Alzheimer disease. We now report that tau can bind to SH3 domains derived from the p85 alpha subunit of phosphatidylinositol 3-kinase, phospholipase C gamma 1, and the N-terminal (but not the C-terminal) SH3 of Grb2 as well as to the kinases Fyn, cSrc, and Fgr. However, the short inserts found in neuron-specific isoforms of Src prevented the binding of tau. The experimentally determined binding of tau peptides is well accounted for when modeled into the peptide binding cleft in the SH3 domain of Fyn. After phosphorylation in vitro or in transfected cells, tau showed reduced binding to SH3 domains; no binding was detected with hyperphosphorylated tau isolated from Alzheimer brain, but SH3 binding was restored by phosphatase treatment. Tau mutants with serines and threonines replaced by glutamate, to mimic phosphorylation, showed reduced SH3 binding. These results strongly suggest that tau has a potential role in cell signaling in addition to its accepted role in cytoskeletal assembly, with regulation by phosphorylation that may be disrupted in the tauopathies including Alzheimer disease.	[Reynolds, C. Hugh; Garwood, Claire J.; Wray, Selina; Hanger, Diane P.; Anderton, Brian H.] Kings Coll London, MRC Ctr Neurodegenerat Res, Dept Neurosci, Inst Psychiat, London SE5 8AF, England; [Price, Caroline; Kellie, Stuart; Perera, Timothy] Yamanouchi Res Inst, Oxford OX4 4XS, England; [Kellie, Stuart] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia; [Zvelebil, Marketa; Yang, Alice] UCL, Ludwig Inst Canc Res, London WC1E 6BT, England; [Zvelebil, Marketa] Inst Canc Res, London SW3 6JB, England; [Sheppard, Paul W.; Varndell, Ian M.] Biomol Int, Exeter EX2 8NL, Devon, England	University of London; King's College London; University of Queensland; Ludwig Institute for Cancer Research; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Reynolds, CH (corresponding author), Kings Coll London, MRC Ctr Neurodegenerat Res, Dept Neurosci, Inst Psychiat, Box O37,De Crespigny Pk, Denmark Hill, London SE5 8AF, England.	h.reynolds@iop.kcl.ac.uk	Kellie, Stuart/A-6036-2010; Wray, Selina/C-3682-2009; Hanger, Diane/C-5697-2009	Wray, Selina/0000-0003-3062-7050; Hanger, Diane/0000-0002-3044-9816; Garwood, Claire/0000-0001-8611-177X; Kellie, Stuart/0000-0002-8163-1474; Zvelebil, Marketa/0000-0001-8018-5591	Medical Research Council [G0300408] Funding Source: Medline; MRC [G0300408] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BRANDT R, 2008, NEUROBIOL A IN PRESS; Brandt Roland, 2004, Current Alzheimer Research, V1, P255, DOI 10.2174/1567205043332054; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Burton EA, 1997, J BIOL CHEM, V272, P16189, DOI 10.1074/jbc.272.26.16189; Chohan MO, 2006, J ALZHEIMERS DIS, V10, P81; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; DAVIS DR, 1995, BIOCHEM J, V309, P941, DOI 10.1042/bj3090941; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Ekinci FJ, 2000, CELL MOL NEUROBIOL, V20, P497, DOI 10.1023/A:1007075115574; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FINAN P, 1994, J BIOL CHEM, V269, P13752; Finan P, 1996, J MOL BIOL, V261, P173, DOI 10.1006/jmbi.1996.0450; Finan PM, 1996, J BIOL CHEM, V271, P26291, DOI 10.1074/jbc.271.42.26291; Finan PM, 1996, FEBS LETT, V389, P141, DOI 10.1016/0014-5793(96)00552-2; GARVER TD, 1994, J NEUROCHEM, V63, P2279; Gillham H, 1999, J CELL BIOL, V146, P869, DOI 10.1083/jcb.146.4.869; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gross BS, 1999, EUR J BIOCHEM, V263, P612, DOI 10.1046/j.1432-1327.1999.00560.x; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hanger DP, 2002, FEBS LETT, V531, P538, DOI 10.1016/S0014-5793(02)03611-6; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Hwang SC, 1996, J BIOL CHEM, V271, P18342, DOI 10.1074/jbc.271.31.18342; Jascur T, 1997, J BIOL CHEM, V272, P14483, DOI 10.1074/jbc.272.22.14483; Jenkins SM, 1998, NEUROREPORT, V9, P67, DOI 10.1097/00001756-199801050-00014; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; KOSIK KS, 1993, BRAIN PATHOL, V3, P39, DOI 10.1111/j.1750-3639.1993.tb00724.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee G, 1998, J CELL SCI, V111, P3167; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; LEVY JB, 1987, MOL CELL BIOL, V7, P4142, DOI 10.1128/MCB.7.11.4142; Li T, 2007, NEUROSCI LETT, V414, P203, DOI 10.1016/j.neulet.2006.11.073; Liao H, 1998, J BIOL CHEM, V273, P21901, DOI 10.1074/jbc.273.34.21901; Lin YT, 2007, J NEUROCHEM, V103, P802, DOI 10.1111/j.1471-4159.2007.04792.x; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lu PJ, 1999, NATURE, V399, P784; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Mayer BJ, 2001, J CELL SCI, V114, P1253; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; MULOT SFC, 1994, FEBS LETT, V349, P359, DOI 10.1016/0014-5793(94)00702-0; PYPER JM, 1990, MOL CELL BIOL, V10, P2035, DOI 10.1128/MCB.10.5.2035; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; REEDQUIST KA, 1994, P NATL ACAD SCI USA, V91, P4135, DOI 10.1073/pnas.91.10.4135; Renzoni DA, 1996, BIOCHEMISTRY-US, V35, P15646, DOI 10.1021/bi9620969; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; SELDEN SC, 1983, J BIOL CHEM, V258, P7064; Smith MJ, 2000, FEBS LETT, V484, P265, DOI 10.1016/S0014-5793(00)02169-4; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741; Vega IE, 2005, MOL BRAIN RES, V138, P135, DOI 10.1016/j.molbrainres.2005.04.015; WATANABE A, 1993, J BIOL CHEM, V268, P25712; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WENG ZG, 1993, J BIOL CHEM, V268, P14956; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Yanagawa H, 1998, BIOCHEMISTRY-US, V37, P1979, DOI 10.1021/bi9724265; YANG SD, 1994, J NEUROCHEM, V63, P1416; YANG SD, 1993, J NEUROCHEM, V61, P1742, DOI 10.1111/j.1471-4159.1993.tb09811.x; Zamora-Leon SP, 2001, J BIOL CHEM, V276, P39950, DOI 10.1074/jbc.M107807200; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	84	174	186	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					18177	18186		10.1074/jbc.M709715200	http://dx.doi.org/10.1074/jbc.M709715200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18467332	hybrid			2022-12-27	WOS:000256949200046
J	Jiang, LI; Collins, J; Davis, R; Fraser, ID; Sternweis, PC				Jiang, Lily I.; Collins, Julie; Davis, Richard; Fraser, Iain D.; Sternweis, Paul C.			Regulation of cAMP responses by the G(12/13) pathway converges on adenylyl cyclase VII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ERYTHROLEUKEMIA CELL-LINE; SIGNAL-TRANSDUCTION; RNA INTERFERENCE; P115 RHOGEF; BETA-GAMMA; CROSS-TALK; G-PROTEINS; G-ALPHA(13); ACTIVATION	Regulation of intracellular cAMP by multiple pathways enables differential function of this ubiquitous second messenger in a context-dependent manner. Modulation of G(s)-stimulated intracellular cAMP has long been known to be modulated by the G(i) and Gq/Ca2+ pathways. Recently, the G(13) pathway was also shown to facilitate cAMP responses in murine macrophage cells. We report here that this synergistic regulation of cAMP synthesis by the G(s) and G(13) pathways is mediated by a specific isoform of adenylyl cyclase, AC7. Furthermore, this signaling paradigm exists in several hematopoietic lineages and can be recapitulated by exogenous expression of AC7 in HEK 293 cells. Mechanistic characterization of this synergistic interaction indicates that it occurs downstream of receptor activation and it can be mediated by the alpha subunit of either G(12) or G(13). Our results demonstrate that AC7 is a specific downstream effector of the G(12/13) pathway.	[Jiang, Lily I.; Collins, Julie; Davis, Richard; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Fraser, Iain D.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; California Institute of Technology	Jiang, LI (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lily.jiang@utsouthwestern.edu; paul.sternweis@utsouthwestern.edu	Fraser, Iain DC/L-4735-2017; Centeno, Patricia Pacios/O-8368-2016	Fraser, Iain DC/0000-0003-2272-3907; 	National Institutes of Health [GM62114, GM31954]; Robert A. Welch Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062114, R01GM031954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62114 and GM31954 (to P. C. S.). This work was also supported by grants from the Robert A. Welch Foundation (to P. C. S.) and the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).	Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BRASS LF, 1992, BIOCHEM J, V281, P73, DOI 10.1042/bj2810073; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; Chin KV, 2002, ANN NY ACAD SCI, V968, P49, DOI 10.1111/j.1749-6632.2002.tb04326.x; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; Diel S, 2006, J BIOL CHEM, V281, P288, DOI 10.1074/jbc.M511045200; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HELLEVUO K, 1993, BIOCHEM BIOPH RES CO, V192, P311, DOI 10.1006/bbrc.1993.1415; Hines LM, 2006, J NEUROSCI, V26, P12609, DOI 10.1523/JNEUROSCI.1040-06.2006; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Lania A, 2001, EUR J ENDOCRINOL, V145, P543, DOI 10.1530/eje.0.1450543; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Movsesian MA, 2005, CURR TOP DEV BIOL, V68, P25, DOI 10.1016/S0070-2153(05)68002-7; Niu JX, 2001, CURR BIOL, V11, P1686, DOI 10.1016/S0960-9822(01)00530-9; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Patel TB, 2001, GENE, V269, P13, DOI 10.1016/S0378-1119(01)00448-6; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; SINGER WD, 1994, J BIOL CHEM, V269, P19796; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; SUTKOWSKI EM, 1994, BIOCHEMISTRY-US, V33, P12852, DOI 10.1021/bi00209a017; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; TANG WJ, 1995, SCIENCE, V268, P1769, DOI 10.1126/science.7792604; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TURNER JT, 1992, J PHARMACOL EXP THER, V263, P708; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; Yoshimura M, 1996, MOL PHARMACOL, V50, P43; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	48	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23429	23439		10.1074/jbc.M803281200	http://dx.doi.org/10.1074/jbc.M803281200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18541530	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000258455400052
J	Sordet, O; Goldman, A; Redon, C; Solier, S; Rao, VA; Pommier, Y				Sordet, Olivier; Goldman, Abby; Redon, Christophe; Solier, Stephanie; Rao, V. Ashutosh; Pommier, Yves			Topoisomerase I requirement for death receptor-induced apoptotic nuclear fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DNA-DAMAGE; CARCINOMA CELL-LINES; TRAIL/APO2L-INDUCED APOPTOSIS; MITOCHONDRIAL-FUNCTION; RESISTANCE MECHANISM; CLEAVAGE COMPLEXES; ANTICANCER AGENTS; OXYGEN RADICALS; CYTOCHROME-C; CANCER-CELLS	Topoisomerase I (Top1) is known to relax DNA supercoiling generated by transcription, replication, and chromatin remodeling. However, it can be trapped on DNA as cleavage complexes (Top1cc) by oxidative and carcinogenic DNA lesions, base damage, and camptothecin treatment. We show here that Top1 is also functionally involved in death receptor-induced programmed cell death. In cells exposed to TRAIL or Fas ligand, Top1cc form at the onset of apoptosis. Those apoptotic Top1cc are prevented by caspase inhibition and Bax inactivation, indicating that both caspases and the mitochondrial death pathway are required for their formation. Accordingly, direct activation of the mitochondrial pathway by BH3 mimetic molecules induces apoptotic Top1cc. We also show that TRAIL-induced apoptotic Top1cc are preferentially formed by caspase-3-cleaved Top1 at sites of oxidative DNA lesions with an average of one apoptotic Top1cc/100 kbp. Examination of Top1 knockdown cells treated with TRAIL revealed similar DNA fragmentation but a marked decrease in apoptotic nuclear fission with reduced formation of nuclear bodies. Thus, we propose that Top1 contributes to the full apoptotic responses induced by TRAIL.	[Sordet, Olivier; Goldman, Abby; Redon, Christophe; Solier, Stephanie; Rao, V. Ashutosh; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bldg 37,Rm 5068, Bethesda, MD 20892 USA.	pommier@nih.gov	Rao, V Ashutosh/A-3569-2013; SOLIER, STEPHANIE/AAA-6851-2020; Sordet, Olivier/M-3271-2014	Rao, V Ashutosh/0000-0001-6817-8049; Sordet, Olivier/0000-0001-6027-4925; SOLIER, Stephanie/0000-0003-3867-4644	NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006161, Z01BC006150, Z01BC006161] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; BERTRAND R, 1995, DRUG DEVELOP RES, V34, P138, DOI 10.1002/ddr.430340206; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daroui P, 2004, J BIOL CHEM, V279, P14587, DOI 10.1074/jbc.M311370200; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Desai SD, 2001, CANCER RES, V61, P5926; Durrieu F, 2000, CURR BIOL, V10, P923, DOI 10.1016/S0960-9822(00)00620-5; Gabler C, 2004, ANN RHEUM DIS, V63, P1135, DOI 10.1136/ard.2003.011452; Ganguly A, 2007, CANCER RES, V67, P11848, DOI 10.1158/0008-5472.CAN-07-1615; GOLDWASSER F, 1995, CANCER RES, V55, P2116; Grad JM, 2001, DRUG RESIST UPDATE, V4, P85, DOI 10.1054/drup.2001.0192; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; KOHN KW, 1981, DNA REPAIR LABORATOR, P379; Lee MW, 2002, FEBS LETT, V512, P313, DOI 10.1016/S0014-5793(02)02225-1; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MATTERN MR, 1993, ONCOL RES, V5, P467; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Mo YY, 2000, J BIOL CHEM, V275, P41107, DOI 10.1074/jbc.M003135200; MOHR A, 2007, ONCOGENE; Morham SG, 1996, MOL CELL BIOL, V16, P6804; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nathan I, 2000, CYTOKINE, V12, P881, DOI 10.1006/cyto.1999.0638; Park SY, 2005, CANCER RES, V65, P3894, DOI 10.1158/0008-5472.CAN-04-4014; Pommier Y, 2000, P NATL ACAD SCI USA, V97, P10739, DOI 10.1073/pnas.190312697; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Rallabhandi P, 2002, J BIOL CHEM, V277, P40020, DOI 10.1074/jbc.M200388200; Ravi R, 2002, CANCER RES, V62, P1583; Reinhold WC, 2003, CANCER RES, V63, P1000; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rockstroh A, 2007, ONCOGENE, V26, P123, DOI 10.1038/sj.onc.1209766; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Samejima K, 1999, J BIOL CHEM, V274, P4335, DOI 10.1074/jbc.274.7.4335; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sen N, 2007, CELL DEATH DIFFER, V14, P358, DOI 10.1038/sj.cdd.4402002; Shakibaei M, 2005, ANTIOXID REDOX SIGN, V7, P482, DOI 10.1089/ars.2005.7.482; Shykind BM, 1997, GENE DEV, V11, P397, DOI 10.1101/gad.11.3.397; Sirikantaramas S, 2008, P NATL ACAD SCI USA, V105, P6782, DOI 10.1073/pnas.0801038105; Soe K, 2004, DNA REPAIR, V3, P387, DOI 10.1016/j.dnarep.2003.12.003; Sordet O, 2004, CELL CYCLE, V3, P1095; Sordet O, 2004, J BIOL CHEM, V279, P50499, DOI 10.1074/jbc.M410277200; Sordet O, 2004, J BIOL CHEM, V279, P33968, DOI 10.1074/jbc.M404620200; Sordet O, 2006, MOL CANCER THER, V5, P3139, DOI 10.1158/1535-7163.MCT-06-0463; Soret J, 2003, CANCER RES, V63, P8203; SUBRAMANIAN D, 1995, CANCER RES, V55, P2097; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wei MC, 2000, GENE DEV, V14, P2060; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	64	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23200	23208		10.1074/jbc.M801146200	http://dx.doi.org/10.1074/jbc.M801146200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556653	Green Published, hybrid			2022-12-27	WOS:000258455400033
J	Chen, Z; Gallie, DR				Chen, Zhong; Gallie, Daniel R.			Dehydroascorbate reductase affects non-photochemical quenching and photosynthetic performance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAF ASCORBATE CONTENT; ELECTRON-TRANSPORT; CHLOROPHYLL FLUORESCENCE; PHOTOOXIDATIVE STRESS; ARABIDOPSIS MUTANTS; THYLAKOID LUMEN; PHOTOSYSTEM-II; SHADE LEAVES; HIGH LIGHT; ACID	Ascorbic acid (Asc) is a major antioxidant involved in photo-protection and photosynthetic function in plants. Dehydroascorbate reductase (DHAR) catalyzes the regeneration of Asc from its oxidized state and serves as an important regulator of Asc recycling. In this work, we used a molecular biochemical approach to investigate how the efficiency of Asc recycling affects non-photochemical quenching (NPQ). Suppression of DHAR expression resulted in a lower induction of NPQ that correlated with reductions in chlorophyll and xanthophyll pigments, quantum yield of photosystem II, and CO2 assimilation, whereas the level of reactive oxygen species increased. The quickly reversible component of NPQ decreased and the slowly reversible or irreversible component of NPQ increased following a reduction in DHAR expression. Significant photoinhibition was also observed following exposure to high light. Direct feeding with Asc restored the appropriate induction of NPQ in DHAR-suppressed leaves. In contrast, increasing DHAR expression increased the pool size of xanthophyll and chlorophyll pigments as well as the rate of CO2 assimilation, particularly at high light intensities, whereas the level of reactive oxygen species was reduced. Leaves with increased DHAR expression experienced less photoinhibition than did wild-type plants following exposure to high light. DHAR activity, therefore, can affect the appropriate induction of NPQ and level of photoprotection during exposure to high light.	[Chen, Zhong; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu						ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1987, PHOTOINHIBITION, P227; Asada K, 1994, PHOTOINHIBITION PHOT, P129; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Chen Z, 2005, PLANT PHYSIOL, V138, P1673, DOI 10.1104/pp.105.062000; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; DEMMIGADAMS B, 1990, PHOTOSYNTH RES, V25, P187, DOI 10.1007/BF00033160; DEMMIGADAMS B, 1992, PLANT CELL ENVIRON, V15, P411, DOI 10.1111/j.1365-3040.1992.tb00991.x; DEMMIGADAMS B, 1989, PLANT PHYSIOL, V90, P881, DOI 10.1104/pp.90.3.881; FORTI G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P408, DOI 10.1016/0005-2728(93)90246-C; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; Gay CA, 2002, ANAL BIOCHEM, V304, P42, DOI 10.1006/abio.2001.5566; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; GRACE S, 1995, BBA-BIOENERGETICS, V1229, P155, DOI 10.1016/0005-2728(94)00183-6; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Horemans N, 2000, PLANT PHYSIOL BIOCH, V38, P531, DOI 10.1016/S0981-9428(00)00782-8; HOREMANS N, 1999, DIFFERENT PATHWAYS L, P217; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ivanov BN, 2001, ARCH BIOCHEM BIOPHYS, V385, P145, DOI 10.1006/abbi.2000.2156; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kiddle G, 2003, ANTIOXID REDOX SIGN, V5, P23, DOI 10.1089/152308603321223513; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Mano J, 2004, ARCH BIOCHEM BIOPHYS, V429, P71, DOI 10.1016/j.abb.2004.05.022; Mano J, 1997, PHOTOSYNTH RES, V53, P197, DOI 10.1023/A:1005832022204; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Muller-Moule P, 2003, PLANT PHYSIOL, V133, P748, DOI 10.1104/pp.103.026252; Muller-Moule P, 2002, PLANT PHYSIOL, V128, P970, DOI 10.1104/pp.010924; NISHIYAMA Y, 2006, BIOCHIM BIOPHYS ACTA, V7157, P742; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Noctor G, 2000, PHILOS T R SOC B, V355, P1465, DOI 10.1098/rstb.2000.0707; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; Pignocchi C, 2003, PLANT PHYSIOL, V132, P1631, DOI 10.1104/pp.103.022798; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Siendones E, 1999, PLANT PHYSIOL, V120, P907, DOI 10.1104/pp.120.3.907; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; Veljovic-Jovanovic SD, 2001, PLANT PHYSIOL, V127, P426, DOI 10.1104/pp.010141; WALTERS RG, 1991, PHOTOSYNTH RES, V27, P121, DOI 10.1007/BF00033251	54	31	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21347	21361		10.1074/jbc.M802601200	http://dx.doi.org/10.1074/jbc.M802601200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539599	hybrid			2022-12-27	WOS:000257898800006
J	Garcia-Dominguez, M; March-Diaz, R; Reyes, JC				Garcia-Dominguez, Mario; March-Diaz, Rosana; Reyes, Jose C.			The PHD domain of plant PIAS proteins mediates sumoylation of bromodomain GTE proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO E3 LIGASE; UBIQUITIN LIGASE; ARABIDOPSIS; NUCLEAR; UBC9; IDENTIFICATION; RECOGNITION; BINDING; ADAPTER	Covalent attachment of small ubiquitin-like modifier ( SUMO) to proteins regulates multiple processes in the eukaryotic cell. In numerous cases sumoylation is facilitated by protein inhibitor of activated STAT(PIAS) proteins, characterized by the presence of a SP-RING domain related to the RING finger of many ubiquitin E3 ligases. The importance of SP-RING relies on its capacity to bind the E2 enzyme of the pathway. Additional domains may participate in SUMO ligase function and target selection. We have studied the Arabidopsis SUMO ligase AtSIZ1, belonging to the PIAS family, and describe self-sumoylation and AtSIZ1-mediated sumoylation of the E2 enzyme AtSCE1 and GTE3, a bromodomain protein interacting with AtSIZ1. Modification of GTE3 modulates its capacity to bind acetyl-histone H3 in vitro. Interestingly, AtSIZ1, as other plant PIAS proteins, also includes a PHD domain. We found that the PHD domain binds AtSCE1 and contributes to the SUMO ligase function, being partially and absolutely required for AtSCE1 and GTE3 sumoylation, respectively. Based on the capacity of AtSCE1 and GTE3 to associate with both the PHD and SP-RING domains, we propose a model of interactions to explain AtSIZ1-mediated sumoylation of GTE3 and ligase function of the PHD domain.	[March-Diaz, Rosana] Consejo Super Invest Cient Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; [Garcia-Dominguez, Mario; Reyes, Jose C.] Consejo Super Invest Cient Univ Sevilla, Ctr Andaluz Biol Mol & Med Regenerat, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Garcia-Dominguez, M (corresponding author), CABIMER, Av Amer Vespucio, Seville 41092, Spain.	mario.garcia@cabimer.es	Reyes, Jose C/K-3699-2014; IBIS, NEURONAL/O-9910-2015; Garcia-Dominguez, Mario/K-3674-2014	Reyes, Jose C/0000-0002-8042-5142; Garcia-Dominguez, Mario/0000-0003-2211-8731				Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Chua YL, 2005, GENE DEV, V19, P2245, DOI 10.1101/gad.352005; Chung TL, 2004, J BIOL CHEM, V279, P39653, DOI 10.1074/jbc.M405637200; Colby T, 2006, PLANT PHYSIOL, V142, P318, DOI 10.1104/pp.106.085415; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Duque P, 2003, PLANT J, V35, P787, DOI 10.1046/j.1365-313X.2003.01848.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jin JB, 2008, PLANT J, V53, P530, DOI 10.1111/j.1365-313X.2007.03359.x; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Miura K, 2007, CURR OPIN PLANT BIOL, V10, P495, DOI 10.1016/j.pbi.2007.07.002; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Saracco SA, 2007, PLANT PHYSIOL, V145, P119, DOI 10.1104/pp.107.102285; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; vanDrunen CM, 1997, NUCLEIC ACIDS RES, V25, P3904, DOI 10.1093/nar/25.19.3904; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383	41	55	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21469	21477		10.1074/jbc.M708176200	http://dx.doi.org/10.1074/jbc.M708176200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18502747	hybrid			2022-12-27	WOS:000257898800019
J	Jewell, JL; Oh, E; Bennett, SM; Meroueh, SO; Thurmond, DC				Jewell, Jenna L.; Oh, Eunjin; Bennett, Sara M.; Meroueh, Samy O.; Thurmond, Debbie C.			The tyrosine phosphorylation of Munc18c induces a switch in binding specificity from syntaxin 4 to Doc2 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRANSLOCATION; INSULIN-INDUCED TRANSLOCATION; NEURONAL SNARE COMPLEX; VESICLE EXOCYTOSIS; 3T3-L1 ADIPOCYTES; SEC1/MUNC18 PROTEINS; CLOSED CONFORMATION; GLUCOSE-TRANSPORT; TRANSGENIC MICE; T-SNARES	Glucose-stimulated insulin secretion is mediated by syntaxin 4-based SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein complexes and the Sec1/Munc18 protein Munc18c. Our laboratory recently reported that Munc18c-syntaxin 4 complexes are further regulated by the competitive binding of the double C2 domain protein Doc2 beta to Munc18c, although the underlying mechanism for this is unknown. Because the Doc2 beta binding region of Munc18c contained residue Tyr-219 and this residue becomes phosphorylated in response to glucose stimulation, we hypothesized that the mechanism would involve Munc18c phosphorylation. Coimmunoprecipitation analyses using detergent lysates prepared from pervanadate-treated MIN6 beta cells revealed that the tyrosine phosphorylation of Munc18c corresponded to a 60% decrease in Munc18c-syntaxin 4 association with a coordinate 2-fold increase in Munc18c-Doc2 beta binding. In vitro binding assays identified syntaxin 4 residues 118-194 as sufficient to confer its interaction with Munc18c; residues 118-194 contain the Hc alpha-helix and flexible linker region controlling transition of syntaxins between closed and open conformations. When overexpressed in MIN6 cells, this Hc-linker region functioned as a competitive inhibitor of endogenous syntaxin 4-Munc18c binding, increased syntaxin 4 binding to VAMP2, and significantly enhanced glucose-stimulated secretion. Molecular modeling of these new interactions yielded the predictions 1) that Tyr-219 of Munc18c remains buried under basal conditions in a conformation that is favorable for interaction with "closed" syntaxin 4 and 2) that stimulation leads to changes in syntaxin 4 contacts to facilitate exposure of Munc18c Tyr-219 for phosphorylation and Doc2 beta binding.	[Jewell, Jenna L.; Oh, Eunjin; Bennett, Sara M.; Meroueh, Samy O.; Thurmond, Debbie C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Thurmond, DC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu			NIDDK NIH HHS [DK 076614, DK 067912] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912, R01DK076614] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki S, 1997, BIOCHEM BIOPH RES CO, V234, P257, DOI 10.1006/bbrc.1997.6560; Betz A, 1997, J BIOL CHEM, V272, P2520; Bracher A, 2001, J MOL BIOL, V306, P7, DOI 10.1006/jmbi.2000.4347; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Chen GL, 2003, FEBS LETT, V534, P54, DOI 10.1016/S0014-5793(02)03774-2; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526; Macaulay SL, 2002, FEBS LETT, V528, P154, DOI 10.1016/S0014-5793(02)03279-9; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2007, J BIOL CHEM, V282, P32613, DOI 10.1074/jbc.M706591200; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; PALMER ZJ, 2008, BIOCH J IN PRESS; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Sassa T, 1999, J NEUROSCI, V19, P4772; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Stenberg A, 1999, ACTA OBSTET GYN SCAN, V78, P436, DOI 10.1034/j.1600-0412.1999.780517.x; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Thurmond Debbie C., 2007, P52, DOI 10.1007/978-0-387-72204-7_3; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	61	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21734	21746		10.1074/jbc.M710445200	http://dx.doi.org/10.1074/jbc.M710445200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541526	Green Published, hybrid			2022-12-27	WOS:000257898800047
J	Wang, X; Hammer, ND; Chapman, MR				Wang, Xuan; Hammer, Neal D.; Chapman, Matthew R.			The molecular basis of functional bacterial amyloid polymerization and nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; AGGREGATIVE FIMBRIAE; ALZHEIMERS-DISEASE; PROTEIN; PRION; MECHANISM; TOXICITY; SCRAPIE; FIBERS	Amyloid fibers are filamentous proteinaceous structures commonly associated with mammalian neurodegenerative diseases. Nucleation is the rate-limiting step of amyloid propagation, and its nature remains poorly understood. Escherichia coli assembles functional amyloid fibers called curli on the cell surface using an evolved biogenesis machine. In vivo, amyloidogenesis of the major curli subunit protein, CsgA, is dependent on the minor curli subunit protein, CsgB. Here, we directly demonstrated that CsgB(+) cells efficiently nucleated purified soluble CsgA into amyloid fibers on the cell surface. CsgA contains five imperfect repeating units that fulfill specific roles in directing amyloid formation. Deletion analysis revealed that the N- and C-terminal most repeating units were required for in vivo amyloid formation. We found that CsgA nucleation specificity is encoded by the N- and C-terminal most repeating units using a blend of genetic, biochemical, and electron microscopic analyses. In addition, we found that the C-terminal most repeat was most aggregation-prone and dramatically contributed to CsgA polymerization in vitro. This work defines the elegant molecular signatures of bacterial amyloid nucleation and polymerization, thereby revealing how nature directs amyloid formation to occur at the correct time and location.	[Wang, Xuan; Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Hammer, Neal D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chapman, MR (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N, Ann Arbor, MI 48109 USA.	chapmanm@umich.edu		Wang, Xuan/0000-0002-2910-8598; Chapman, Matthew/0000-0002-2645-1294; Hammer, Neal/0000-0001-6148-7850	NIAID NIH HHS [R01 AI073847, AI 073847-01, R01 AI073847-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073847] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Collinson SK, 1999, J MOL BIOL, V290, P741, DOI 10.1006/jmbi.1999.2882; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; HAMMER ND, 2007, P NATL ACAD SCI US; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Romling U, 1998, J BACTERIOL, V180, P722; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Yonekura K, 2002, RES MICROBIOL, V153, P191, DOI 10.1016/S0923-2508(02)01308-6	27	98	103	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21530	21539		10.1074/jbc.M800466200	http://dx.doi.org/10.1074/jbc.M800466200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508760	Green Published, hybrid			2022-12-27	WOS:000257898800026
J	Zhang, Y; Teoh, KH; Reed, DW; Maes, L; Goossens, A; Olson, DJH; Ross, ARS; Covello, PS				Zhang, Yansheng; Teoh, Keat H.; Reed, Darwin W.; Maes, Lies; Goossens, Alain; Olson, Douglas J. H.; Ross, Andrew R. S.; Covello, Patrick S.			The molecular cloning of artemisinic aldehyde Delta 11(13) reductase and its role in glandular trichome-dependent biosynthesis of artemisinin in Artemisia annua	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROARTEMISINIC ACID; OLD; EXPRESSION; PLANTS	At some point during biosynthesis of the antimalarial artemisinin in glandular trichomes of Artemisia annua, the Delta 11(13) double bond originating in amorpha-4,11-diene is reduced. This is thought to occur in artemisinic aldehyde, but other intermediates have been suggested. In an effort to understand double bond reduction in artemisinin biosynthesis, extracts of A. annua flower buds were investigated and found to contain artemisinic aldehyde Delta 11(13) double bond reductase activity. Through a combination of partial protein purification, mass spectrometry, and expressed sequence tag analysis, a cDNA clone corresponding to the enzyme was isolated. The corresponding gene Dbr2, encoding a member of the enoate reductase family with similarity to plant 12-oxophytodienoate reductases, was found to be highly expressed in glandular trichomes. Recombinant Dbr2 was subsequently characterized and shown to be relatively specific for artemisinic aldehyde and to have some activity on small alpha,beta-unsaturated carbonyl compounds. Expression in yeast of Dbr2 and genes encoding four other enzymes in the artemisinin pathway resulted in the accumulation of dihydroartemsinic acid. The relevance of Dbr2 to trichome-specific artemisinin biosynthesis is discussed.	[Zhang, Yansheng; Teoh, Keat H.; Reed, Darwin W.; Olson, Douglas J. H.; Ross, Andrew R. S.; Covello, Patrick S.] Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; [Maes, Lies; Goossens, Alain] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Maes, Lies; Goossens, Alain] Univ Ghent, Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium	National Research Council Canada; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Covello, PS (corresponding author), Natl Res Council Canada, Inst Plant Biotechnol, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada.	patrick.covello@nrc-cnrc.gc.ca		Goossens, Alain/0000-0002-1599-551X; Reed, Darwin/0000-0001-8038-8647				[Anonymous], MED CHEM BIOACTIVE N; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Breithaupt C, 2006, P NATL ACAD SCI USA, V103, P14337, DOI 10.1073/pnas.0606603103; Brown GD, 2004, TETRAHEDRON, V60, P1139, DOI 10.1016/j.tet.2003.11.070; Chang YJ, 2000, ARCH BIOCHEM BIOPHYS, V383, P178, DOI 10.1006/abbi.2000.2061; COREY EJ, 1975, TETRAHEDRON LETT, V16, P2647; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; DUKE SO, 1993, INT J PLANT SCI, V154, P107, DOI 10.1086/297096; Ferreira J. F. S., 1997, Horticultural Reviews, V19, P319; FOX BG, 1994, BIOCHEMISTRY-US, V33, P12776, DOI 10.1021/bi00209a008; Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kindermans JM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-125; Liu J., 1979, ACTA CHIM SINICA, V37, P129; Malone TE, 2005, PROTEINS, V58, P243, DOI 10.1002/prot.20162; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Mutabingwa TK, 2005, ACTA TROP, V95, P305, DOI 10.1016/j.actatropica.2005.06.009; Olsen LJ, 1998, PLANT MOL BIOL, V38, P163, DOI 10.1023/A:1006092830670; Rathore D, 2005, EXPERT OPIN INV DRUG, V14, P871, DOI 10.1517/13543784.14.7.871; Ringer KL, 2003, ARCH BIOCHEM BIOPHYS, V418, P80, DOI 10.1016/S0003-9861(03)00390-4; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Sy LK, 2002, TETRAHEDRON, V58, P897, DOI 10.1016/S0040-4020(01)01193-0; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; VON RUDLOFF E., 1963, CANADIAN JOUR CHEM, V41, P2876; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Wallaart TE, 2000, PLANTA MED, V66, P57, DOI 10.1055/s-2000-11115; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; Zeng QP, 2008, BIOTECHNOL LETT, V30, P581, DOI 10.1007/s10529-007-9596-y	30	222	258	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21501	21508		10.1074/jbc.M803090200	http://dx.doi.org/10.1074/jbc.M803090200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18495659	hybrid			2022-12-27	WOS:000257898800023
J	Mantuano, E; Mukandala, G; Li, XQ; Campana, WM; Gonias, SL				Mantuano, Elisabetta; Mukandala, Gatambwa; Li, Xiaoqing; Campana, W. Marie; Gonias, Steven L.			Molecular dissection of the human alpha(2)-macroglobulin subunit reveals domains with antagonistic activities in cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-RELATED PROTEIN; APPARENT EQUILIBRIUM CONDITIONS; PROMOTED NEURITE OUTGROWTH; SMOOTH-MUSCLE-CELLS; HUMAN ALPHA-2-MACROGLOBULIN; TRANSFORMING GROWTH-FACTOR-BETA-1; ALPHA-MACROGLOBULIN; SCHWANN-CELLS; DEPENDENT MECHANISM	alpha(2)-Macroglobulin (alpha M-2) is a plasma protease inhibitor, which reversibly binds growth factors and, in its activated form, binds to low density lipoprotein receptor-related protein (LRP-1), an endocytic receptor with cell signaling activity. Because distinct domains in alpha M-2 are responsible for its various functions, we hypothesized that the overall effects of alpha M-2 on cell physiology reflect the integrated activities of multiple domains, some of which may be antagonistic. To test this hypothesis, we expressed the growth factor carrier site and the LRP-1 recognition domain (RBD) as separate GST fusion proteins (FP3 and FP6, respectively). FP6 rapidly and robustly activated Akt and ERK/MAP kinase in Schwann cells and PC12 cells. This response was blocked by LRP-1 gene silencing or by co-incubation with the LRP-1 antagonist, receptor-associated protein. The activity of FP6 also was blocked by mutating Lys(1370) and Lys(1374), which precludes LRP-1 binding. FP3 blocked activation of Akt and ERK/MAP kinase in response to nerve growth factor-beta (NGF-beta) but not FP6. In PC12 cells, FP6 promoted neurite outgrowth and expression of growth-associated protein-43, whereas FP3 antagonized the same responses when NGF-beta was added. The ability of FP6 to trigger LRP-1-dependent cell signaling in PC12 cells was reproduced by the 18-kDa RBD, isolated from plasma-purified alpha M-2 by proteolysis and chromatography. We propose that the effects of intact alpha M-2 on cell physiology reflect the degree of penetration of activities associated with different domains, such as FP3 and FP6, which may be regulated asynchronously by conformational change and by other regulatory proteins in the cellular microenvironment.	[Gonias, Steven L.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu	Mantuano, Elisabetta/C-1769-2015; Mukandala, Gatambwa D/K-7278-2018	Mantuano, Elisabetta/0000-0001-5728-9261; Mukandala, Gatambwa D/0000-0003-4804-956X	NHLBI NIH HHS [R01 HL 60551] Funding Source: Medline; NINDS NIH HHS [R01 NS 054671] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054671] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Arandjelovic S, 2006, J BIOL CHEM, V281, P17061, DOI 10.1074/jbc.M602217200; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; Bonacci GR, 2007, ARCH BIOCHEM BIOPHYS, V460, P100, DOI 10.1016/j.abb.2007.01.004; Cai ML, 1998, PROTEIN SCI, V7, P2669, DOI 10.1002/pro.5560071221; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campana WM, 2007, BRAIN BEHAV IMMUN, V21, P522, DOI 10.1016/j.bbi.2006.12.008; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Chiabrando GA, 2002, J NEUROSCI RES, V70, P57, DOI 10.1002/jnr.10369; CROOKSTON KP, 1994, J BIOL CHEM, V269, P1533; Doan N, 2007, BIOCHEM J, V407, P23, DOI 10.1042/BJ20070764; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Esadeg S, 2003, PLACENTA, V24, P912, DOI 10.1016/S0143-4004(03)00148-6; GONIAS SL, 1983, ANN NY ACAD SCI, V421, P457, DOI 10.1111/j.1749-6632.1983.tb18139.x; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Gonias SL, 2000, J BIOL CHEM, V275, P5826, DOI 10.1074/jbc.275.8.5826; Gourine AV, 2002, AM J PHYSIOL-REG I, V283, pR218, DOI 10.1152/ajpregu.00746.2001; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hochepied T, 2002, EUR CYTOKINE NETW, V13, P86; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; Kim Y, 2004, MOL CELLS, V18, P353; LAMARRE J, 1991, BIOCHIM BIOPHYS ACTA, V1091, P197, DOI 10.1016/0167-4889(91)90062-3; LAMARRE J, 1991, J CLIN INVEST, V87, P39, DOI 10.1172/JCI114998; Lee PG, 2000, J NEUROCHEM, V74, P81, DOI 10.1046/j.1471-4159.2000.0740081.x; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; LYSIAK JJ, 1995, J BIOL CHEM, V270, P21919, DOI 10.1074/jbc.270.37.21919; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; MISAR UK, 2002, J BIOL CHEM, V44, P42082; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; NELLES LP, 1980, BIOCHIM BIOPHYS ACTA, V623, P46, DOI 10.1016/0005-2795(80)90006-9; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; PHILIP A, 1991, J BIOL CHEM, V266, P22290; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tyson DR, 2003, INT J DEV NEUROSCI, V21, P63, DOI 10.1016/S0736-5748(02)00139-9; UMANS L, 1995, J BIOL CHEM, V270, P19778, DOI 10.1074/jbc.270.34.19778; Waghabi MC, 2002, INFECT IMMUN, V70, P5115, DOI 10.1128/IAI.70.9.5115-5123.2002; Weaver AM, 1995, J BIOL CHEM, V270, P30741, DOI 10.1074/jbc.270.51.30741; Webb DJ, 1995, EUR J BIOCHEM, V234, P714, DOI 10.1111/j.1432-1033.1995.714_a.x; Webb DJ, 1998, LAB INVEST, V78, P939; Webb DJ, 1998, J BIOL CHEM, V273, P13339, DOI 10.1074/jbc.273.21.13339; Webb DJ, 1997, FEBS LETT, V410, P249, DOI 10.1016/S0014-5793(97)00598-X; WILLNOW TE, 1994, J CELL SCI, V107, P719; WOLF BB, 1994, BIOCHEMISTRY-US, V33, P11270, DOI 10.1021/bi00203a024	55	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19904	19911		10.1074/jbc.M801762200	http://dx.doi.org/10.1074/jbc.M801762200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499670	Green Published, hybrid			2022-12-27	WOS:000257565300005
J	McDonnell, MA; Abedin, MJ; Melendez, M; Platikanova, TN; Ecklund, JR; Ahmed, K; Kelekar, A				McDonnell, Maureen A.; Abedin, Md. Joynal; Melendez, Manuel; Platikanova, Teodora N.; Ecklund, Johanna R.; Ahmed, Khalil; Kelekar, Ameeta			Phosphorylation of murine caspase-9 by the protein kinase casein kinase 2 regulates its cleavage by caspase-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; CYTOCHROME-C; IN-VIVO; INDEPENDENT ACTIVATION; MEDIATED APOPTOSIS; PHOSPHATASE 2A; EMERGING ROLE; CANCER-CELLS; CK2; MODULATION	Previous studies from our laboratory had indicated that cytochrome c-independent processing and activation of caspase-9 by caspase-8 contributed to early amplification of the caspase cascade in tumor necrosis factor (TNF)-alpha-treated murine cells. Here we show that murine caspase-9 is phosphorylated by casein kinase 2 (CK2) on a serine near the site of caspase-8 cleavage. CK2 has been shown to regulate cleavage of the pro-apoptotic Bid protein by phosphorylating serine residues near its caspase-8 cleavage site. Similarly, CK2 modification of Ser(348) on caspase-9 appears to render the protease refractory to cleavage by active caspase-8. This phosphorylation did not affect the ability of caspase-9 to autoprocess. Substitution of Ser(348) abolished phosphorylation but not cleavage, and a phospho-site mutant promoted apoptosis in TNF-alpha-treated caspase-9 knock-out mouse embryo fibroblasts. Furthermore, inhibition of CK2 activity and RNA interference-mediated knockdown of the kinase accelerated caspase-9 activation, whereas phosphatase inhibition delayed both caspase-9 activation and death in response to TNF receptor occupation. Taken together, these studies show that TNF receptor cross-linking promotes dephosphorylation of caspase-9, rendering it susceptible to processing by activated caspase-8 protein. Thus, our data suggest that modification of procaspase-9 to protect it from inappropriate cleavage and activation is yet another mechanism by which the oncogenic kinase CK2 promotes survival.	[McDonnell, Maureen A.; Ecklund, Johanna R.; Ahmed, Khalil; Kelekar, Ameeta] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Abedin, Md. Joynal] Univ Minnesota, Dept Renal Med, Minneapolis, MN 55455 USA; [Melendez, Manuel] Univ Minnesota, Coll Liberal Arts, Minneapolis, MN 55455 USA; [Platikanova, Teodora N.] Univ Minnesota, Sch Dent, Minneapolis, MN 55455 USA; [Ahmed, Khalil; Kelekar, Ameeta] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Ahmed, Khalil] Minneapolis Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Kelekar, A (corresponding author), 312 Church St SE,7-122 NHH, Minneapolis, MN 55455 USA.	ameeta@umn.edu			NATIONAL CANCER INSTITUTE [R01CA015062, R37CA015062] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA015062, CA 15062] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Adrain C, 1999, J BIOL CHEM, V274, P20855, DOI 10.1074/jbc.274.30.20855; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Bitzer M, 2002, J BIOL CHEM, V277, P29817, DOI 10.1074/jbc.M111898200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Canton DA, 2006, CELL SIGNAL, V18, P267, DOI 10.1016/j.cellsig.2005.07.008; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Fujita E, 1999, BIOCHEM BIOPH RES CO, V264, P550, DOI 10.1006/bbrc.1999.1387; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Guo CH, 2001, J BIOL CHEM, V276, P5992, DOI 10.1074/jbc.M004862200; Gyrd-Hansen M, 2006, MOL CELL BIOL, V26, P7880, DOI 10.1128/MCB.00716-06; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Krippner-Heidenreich A, 2001, BIOCHEM J, V358, P705, DOI 10.1042/0264-6021:3580705; Lebrin F, 1999, MOL CELL BIOCHEM, V191, P207, DOI 10.1023/A:1006888228156; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; McDonnell MA, 2003, CELL DEATH DIFFER, V10, P1005, DOI 10.1038/sj.cdd.4401271; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meyer K, 2005, VIROLOGY, V336, P198, DOI 10.1016/j.virol.2005.03.016; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Olsen BB, 2003, FEBS LETT, V546, P218, DOI 10.1016/S0014-5793(03)00575-1; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Ruzzene M, 1999, FEBS LETT, V461, P32, DOI 10.1016/S0014-5793(99)01409-X; Sarno S, 2000, BIOCHEMISTRY-US, V39, P12324, DOI 10.1021/bi0011431; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Wang GX, 2005, MOL CELL BIOCHEM, V274, P201, DOI 10.1007/s11010-005-2952-0; Yin XY, 2000, J BIOL CHEM, V275, P6850, DOI 10.1074/jbc.275.10.6850; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	48	41	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20149	20158		10.1074/jbc.M802846200	http://dx.doi.org/10.1074/jbc.M802846200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18467326	hybrid, Green Published			2022-12-27	WOS:000257565300031
J	Anandatheerthavarada, HK; Sepuri, NBV; Biswas, G; Avadhani, NG				Anandatheerthavarada, Hindupur K.; Sepuri, Naresh Babu V.; Biswas, Gopa; Avadhani, Narayan G.			RETRACTED: An unusual TOM20/TOM22 bypass mechanism for the mitochondrial targeting of cytochrome P450 proteins containing N-terminal chimeric signals (Retracted Article. See vol 283, pg 36060, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							IMPORT RECEPTORS TOM20; ENDOPLASMIC-RETICULUM; OUTER-MEMBRANE; MOLECULAR CHAPERONES; SACCHAROMYCES-CEREVISIAE; TRANSLOCATION; BIOGENESIS; PREPROTEINS; ACTIVATION; PATHWAY	Previously we showed that xenobiotic-inducible cytochrome P450 (CYP) proteins are bimodally targeted to the endoplasmic reticulum and mitochondria. In the present study, we investigated the mechanism of delivery of chimeric signal-containing CYP proteins to the peripheral and channel-forming mitochondrial outer membrane translocases (TOMs). CYP + 33/1A1 and CYP2B1 did not require peripheral TOM70, TOM20, or TOM22 for translocation through the channel-forming TOM40 protein. In contrast, CYP + 5/1A1 and CYP2E1 were able to bypass TOM20 and TOM22 but required TOM70. CYP27, which contains a canonical cleavable mitochondrial signal, required all of the peripheral TOMs for its mitochondrial translocation. We investigated the underlying mechanisms of bypass of peripheral TOMs by CYPs with chimeric signals. The results suggested that interaction of CYPs with Hsp70, a cytosolic chaperone involved in the mitochondrial import, alone was sufficient for the recognition of chimeric signals by peripheral TOMs. However, sequential interaction of chimeric signal-containing CYPs with Hsp70 and Hsp90 resulted in the bypass of peripheral TOMs, whereas CYP27 interacted only with Hsp70 and was not able to bypass peripheral TOMs. Our results also show that delivery of chimeric signal-containing client proteins by Hsp90 required the cytosol-exposed N-terminal 143 amino acids of TOM40. TOM40 devoid of this domain was unable to bind CYP proteins. These results suggest that, compared with the unimodal mitochondria-targeting signals, the chimeric mitochondria-targeting signals are highly evolved and dynamic in nature.	[Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-34883, R01 GM034883] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; BARNUN S, 1980, P NATL ACAD SCI-BIOL, V77, P965, DOI 10.1073/pnas.77.2.965; Beddoe T, 2002, BBA-MOL CELL RES, V1592, P35, DOI 10.1016/S0167-4889(02)00262-8; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Brunner M, 1995, COLD SPRING HARB SYM, V60, P619, DOI 10.1101/SQB.1995.060.01.066; Chacinska A, 2002, TRENDS CELL BIOL, V12, P299, DOI 10.1016/S0962-8924(02)02310-3; DESHAIES RJ, 1988, TRENDS BIOCHEM SCI, V13, P384, DOI 10.1016/0968-0004(88)90180-6; Diekert K, 2001, EMBO J, V20, P5626, DOI 10.1093/emboj/20.20.5626; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Ellis RJ, 2003, NATURE, V421, P801, DOI 10.1038/421801a; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; GLICK B, 1991, ANNU REV GENET, V25, P21; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; JAUSSI R, 1995, EUR J BIOCHEM, V228, P551, DOI 10.1111/j.1432-1033.1995.tb20294.x; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Kurz M, 1999, MOL BIOL CELL, V10, P2461, DOI 10.1091/mbc.10.7.2461; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITHGOW T, 1994, J BIOL CHEM, V269, P15325; Ma YL, 2008, J BIOL CHEM, V283, P11743, DOI 10.1074/jbc.M710494200; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; NOTHWEHR SF, 1990, BIOESSAYS, V12, P479, DOI 10.1002/bies.950121005; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; PFALLER R, 1989, J BIOL CHEM, V264, P34; PFANNER N, 1994, TRENDS BIOCHEM SCI, V19, P368, DOI 10.1016/0968-0004(94)90113-9; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; ROSE MD, 1987, METHOD ENZYMOL, V152, P481; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Stan T, 2003, MOL CELL BIOL, V23, P2239, DOI 10.1128/MCB.23.7.2239-2250.2003; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; SU P, 1990, DNA CELL BIOL, V9, P657, DOI 10.1089/dna.1990.9.657; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; SZCZESNASKORUPA E, 1995, J BIOL CHEM, V270, P24327, DOI 10.1074/jbc.270.41.24327; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; VAN AE, 2006, BIOCHIM BIOPHYS ACTA, V1763, P1629; VAN WS, 1999, NATURE, V401, P485; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Voos W, 2003, MOL CELL, V11, P1, DOI 10.1016/S1097-2765(03)00002-9; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; Wilkinson BM, 1997, J MEMBRANE BIOL, V155, P189, DOI 10.1007/s002329900171; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; ZALMAN LS, 1980, J BIOL CHEM, V255, P1771	68	4	4	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19769	19780		10.1074/jbc.M801464200	http://dx.doi.org/10.1074/jbc.M801464200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480056	hybrid, Green Published			2022-12-27	WOS:000257387600061
J	Lee, JH; Jeong, MW; Kim, W; Choi, YH; Kim, KT				Lee, Jong-Hee; Jeong, Min-Woo; Kim, Wanil; Choi, Yoon Ha; Kim, Kyong-Tai			Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; DNA-DAMAGE; TYROSINE PHOSPHORYLATION; ACTIVATION; MDM2; BINDING; PATHWAYS; P35; STABILIZATION; DEGRADATION	The p53 tumor suppressor protein, a critical modulator of cellular stress responses, is activated through diverse mechanisms that result in its stabilization and transcriptional activation. p53 activity is controlled by transcriptional, translational, and post-translational regulation. The major mechanisms of p53 regulation occur primarily through interactions with HDM2, an E3 ubiquitin ligase that leads to p53 nuclear export and degradation. Here, we demonstrate that hydrogen peroxide-induced oxidative stress elicits down-regulation of HDM2. c-Abl mediates down-regulation of HDM2, leading to an increase of p53 level. Moreover, Cdk5 (cyclin-dependent kinase 5), a proline-directed Ser/Thr kinase, additionally increases p53 stability via post-translational modification of p53 in response to hydrogen peroxide. The p53 protein stabilized by c-Abl and Cdk5 is transcriptionally active; however, transcription of its target gene is differentially regulated with selective binding of p53 on promoter regions of its target genes by c-Abl. In addition, c-Abl modulates Cdk5 activity via phosphorylation of tyrosine 15 in cooperation with cleavage of p35 to p25. Our results show that c-Abl and Cdk5 cooperatively regulate maximal activation of p53, resulting in neuronal death in response to oxidative stress by hydrogen peroxide. These findings aid in clarifying the mechanism underlying the occurrence of neuronal apoptosis as a result of c-Abl and Cdk5-mediated p53 stabilization and transcriptional activation.	[Lee, Jong-Hee; Jeong, Min-Woo; Kim, Wanil; Choi, Yoon Ha; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Syst Biodynam Natl Care Res Ctr, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Syst Biodynam Natl Care Res Ctr, San 31, Pohang 790784, South Korea.	ktk@postech.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627				Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; Ben-Yehoyada M, 2003, J BIOL CHEM, V278, P34475, DOI 10.1074/jbc.M301051200; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dias SS, 2006, ONCOGENE, V25, P6666, DOI 10.1038/sj.onc.1209671; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; GUO Q, 2003, SCI AGING KNOWLEDGE, V50, pPE36; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Isaacs JS, 2001, J BIOL CHEM, V276, P18497, DOI 10.1074/jbc.M100638200; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kubo T, 1996, BRAIN RES, V733, P175, DOI 10.1016/0006-8993(96)00542-2; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lee JH, 2007, J CELL SCI, V120, P2259, DOI 10.1242/jcs.03468; Lee JH, 2007, J CELL PHYSIOL, V210, P784, DOI 10.1002/jcp.20899; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Lin H, 2007, CELL DEATH DIFFER, V14, P607, DOI 10.1038/sj.cdd.4402033; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Monaco EA, 2004, CURR ALZHEIMER RES, V1, P33, DOI 10.2174/1567205043480519; Moresco EMY, 2003, CURR OPIN NEUROBIOL, V13, P535, DOI 10.1016/j.conb.2003.08.002; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Nie Y, 2000, MOL CELL BIOL, V20, P741, DOI 10.1128/MCB.20.3.741-748.2000; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Pluquet O, 2001, CANCER LETT, V174, P1, DOI 10.1016/S0304-3835(01)00698-X; Ross S, 2002, J BIOL CHEM, V277, P4455, DOI 10.1074/jbc.M110771200; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Shelton SB, 2004, J NEUROCHEM, V88, P1313, DOI 10.1111/j.1471-4159.2003.02328.x; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Takahashi Y, 2000, GENE DEV, V14, P804; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wei G, 2005, J BIOL CHEM, V280, P12271, DOI 10.1074/jbc.M409522200; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	53	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19826	19835		10.1074/jbc.M706201200	http://dx.doi.org/10.1074/jbc.M706201200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18490454	hybrid			2022-12-27	WOS:000257387600066
J	Michalski, C; Mohagheghi, H; Nimtz, M; Pasteels, J; Ober, D				Michalski, Carmen; Mohagheghi, Hoda; Nimtz, Manfred; Pasteels, Jacques; Ober, Dietrich			Salicyl alcohol oxidase of the chemical defense secretion of two chrysomelid leaf beetles - Molecular and functional characterization of two new members of the glucose-methanol-choline oxidoreductase gene family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTROPHYSA-VIRIDULA COLEOPTERA; CRYSTAL-STRUCTURE; IRIDOID MONOTERPENES; CHOLESTEROL OXIDASE; GMC OXIDOREDUCTASES; DEHYDROGENASE GENE; HOST PLANT; BIOSYNTHESIS; LARVAE; EXPRESSION	Salicyl alcohol oxidase is an extracellular enzyme that occurs in glandular reservoirs of chrysomelid leaf beetle larvae and catalyzes the formation of salicylaldehyde, a volatile deterrent used by the larvae against predators. Salicyl alcohol is the hydrolysis product of salicin, a plant-derived precursor taken up by the beetle larvae from the leaves of willow and poplar trees. The cDNA encoding salicyl alcohol oxidase from two related species Chrysomela tremulae and Chrysomela populi has been identified, cloned, and expressed in an active form in Escherichia coli. The open reading frame of 623 amino acids begins in both enzymes with an N-terminal signal peptide of 21 amino acids. Sequence comparison has revealed that salicyl alcohol oxidase belongs to the family of glucose-methanol-choline oxidoreductase-like sequences with mostly unknown function. Enzymes of this family share similar overall structure with an essentially identical FAD-binding site but possess different catalytic activities. The data suggest that salicyl alcohol oxidase, essential for the activation of the plant-derived precursor salicin, was originally recruited from an oxidase involved in the autogenous biosynthesis of iridoid monoterpenes and found in related chrysomelid leaf beetle species.	[Michalski, Carmen; Ober, Dietrich] Univ Kiel, Inst Bot, D-24098 Kiel, Germany; Univ Kiel, Bot Gardens, D-24098 Kiel, Germany; [Mohagheghi, Hoda] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Biol, D-38106 Braunschweig, Germany; [Nimtz, Manfred] Helmholtz Zentrum Infektionsforchung, D-38124 Braunschweig, Germany; [Pasteels, Jacques] Univ Libre Bruxelles, Lab Biol Anim & Celluaire, B-1050 Brussels, Belgium	University of Kiel; University of Kiel; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Universite Libre de Bruxelles	Ober, D (corresponding author), Univ Kiel, Inst Bot, Olshausenstr 40, D-24098 Kiel, Germany.	dober@bot.uni-kiel.de						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bruckmann M, 2002, INSECT BIOCHEM MOLEC, V32, P1517, DOI 10.1016/S0965-1748(02)00072-3; Burse A, 2007, INSECT BIOCHEM MOLEC, V37, P255, DOI 10.1016/j.ibmb.2006.11.011; CASPERS P, 1994, CELL MOL BIOL, V40, P635; CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S; CAVENER DR, 1983, P NATL ACAD SCI-BIOL, V80, P6286, DOI 10.1073/pnas.80.20.6286; COXFOSTER DL, 1990, GENETICS, V124, P873; COXFOSTER DL, 1994, J INSECT PHYSIOL, V40, P235, DOI 10.1016/0022-1910(94)90047-7; DALOZE D, 1994, J CHEM ECOL, V20, P2089, DOI 10.1007/BF02066245; Dreveny I, 2001, STRUCTURE, V9, P803, DOI 10.1016/S0969-2126(01)00639-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Feld BK, 2001, CHEMOECOLOGY, V11, P191, DOI 10.1007/PL00001851; FELSENSTEIN J, 2001, PHYLIP PHYLOGENY INT; FUTUYMA DJ, 2004, NEW DEV BIOL CHRYSOM, P17; Gross J, 2002, J CHEM ECOL, V28, P317, DOI 10.1023/A:1017934124650; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Iida K, 2004, J EXP BIOL, V207, P675, DOI 10.1242/jeb.00816; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; Jolivet, 1988, BIOL CHRYSOMELIDAE, P233, DOI DOI 10.1007/978-94-009-3105-3_14; Kiess M, 1998, EUR J BIOCHEM, V252, P90, DOI 10.1046/j.1432-1327.1998.2520090.x; KRASNEY PA, 1990, MOL BIOL EVOL, V7, P155; Laurent P, 2003, EUR J ORG CHEM, V2003, P2733, DOI 10.1002/ejoc.200300008; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Lindigkeit R, 1997, EUR J BIOCHEM, V245, P626, DOI 10.1111/j.1432-1033.1997.00626.x; LORENZ M, 1993, ANGEW CHEM INT EDIT, V32, P912, DOI 10.1002/anie.199309121; Mattevi A, 1998, BIOPHYS CHEM, V70, P217, DOI 10.1016/S0301-4622(97)00126-9; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; PASTEELS JM, 1990, J CHEM ECOL, V16, P211, DOI 10.1007/BF01021280; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; Schulz S, 1997, TETRAHEDRON, V53, P9203, DOI 10.1016/S0040-4020(97)00618-2; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takeuchi H, 2005, BIOCHEM J, V389, P637, DOI 10.1042/BJ20050498; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VEITH M, 1994, TETRAHEDRON, V50, P6859, DOI 10.1016/S0040-4020(01)81338-7; Veith M, 1997, J CHEM ECOL, V23, P429, DOI 10.1023/B:JOEC.0000006369.26490.c6; Veith M, 1996, TETRAHEDRON, V52, P6601, DOI 10.1016/0040-4020(96)00298-0; VRIELINK A, 1991, J MOL BIOL, V219, P533, DOI 10.1016/0022-2836(91)90192-9; WALLACE JB, 1969, ANN ENTOMOL SOC AM, V62, P503, DOI 10.1093/aesa/62.3.503; Webb E. C., 1992, ENZYME NOMENCLATURE; Zamocky M, 2004, GENE, V338, P1, DOI 10.1016/j.gene.2004.04.025; Zorn H, 2005, PROTEOMICS, V5, P4832, DOI 10.1002/pmic.200500015	49	24	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19219	19228		10.1074/jbc.M802236200	http://dx.doi.org/10.1074/jbc.M802236200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482980	hybrid			2022-12-27	WOS:000257387600007
J	Wu, ZP; Bowen, WD				Wu, Zhiping; Bowen, Wayne D.			Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation - Constitutive enhancement of calcium signaling in MCF-7 tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INTERNAL CA2+ RELEASE; TYPE-1 SIGMA-RECEPTOR; AMINO-ACID-RESIDUES; LIGAND-BINDING; ANKYRIN; EXPRESSION; IDENTIFICATION; DOMAIN; BRAIN	Sigma-1 receptor (sigma-1R) agonists enhance inositol 1,4,5-trisphosphate (IP3)-dependent calcium release from endoplasmic reticulum by inducing dissociation of ankyrin B 220 (ANK 220) from the IP3 receptor (IP3R-3), releasing it from inhibition. MCF-7 breast tumor cells express little or no sigma-1R and were used here to investigate the effect of receptor overexpression and the role of its N-and C-terminal segments in function. We stably expressed intact sigma-1R (amino acids (aa) 1-223; lines 11 and 41), N-fragment (aa 1-100; line K3), or C-fragment (aa 102-223; line sg101). C-fragment expressed as a peripheral membrane-bound protein that was removable from the endoplasmic reticulum membrane by chaotropic salt wash, consistent with lack of a putative transmembrane domain. The expressed sigma-1R, N-fragment, and C-fragment exhibited normal, low affinity, and no [3H](+)-pentazocine binding activity, respectively. All transfected lines showed constitutive enhancement of bradykinin (BDK)-induced calcium release, because of a decrease in BDK ED50 values. Interestingly, sigma-1R and C-fragment had high activities, whereas the N-fragment was much less active. The antagonist BD1063 behaved as an inverse agonist in sigma-1R cells, whereas C-fragment was insensitive to ligand regulation. Like BDK, vasopressin-and ATP-induced calcium release was enhanced with the same pattern in cell lines. Anti-IP3R-3 immunoprecipitates from cells expressing sigma-1R or C-fragment contained significantly less ANK 220 compared with untransfected or N-fragment cells, indicating a higher amount of ankyrin-free IP3R-3. Anti-ankyrin B immunoprecipitates contained sigma-1R or C-fragment, with markedly lower levels of N-fragment present. These results suggest that sigma-1R overexpression drives sigma agonist-independent dissociation of ANK 220 from IP3R-3, resulting in activation. The C-terminal segment plays a key role in the interaction.	[Wu, Zhiping; Bowen, Wayne D.] Brown Univ, Div Biol & Med, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Bowen, WD (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Pharmacol Physiol & Biotechnol, Box G-B389, Providence, RI 02912 USA.	Wayne_Bowen@brown.edu			2007 Salomon award	2007 Salomon award	This work was supported by a 2007 Salomon award (to W. D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P7257, DOI 10.1074/jbc.270.13.7257; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; Bowen W D, 2000, Pharm Acta Helv, V74, P211; Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117; Brent PJ, 1997, J NEUROCHEM, V68, P2201; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Dixon CJ, 1997, BRIT J CANCER, V75, P34, DOI 10.1038/bjc.1997.6; ELA C, 1994, J PHARMACOL EXP THER, V269, P1300; Frey BM, 1999, FASEB J, V13, P2235, DOI 10.1096/fasebj.13.15.2235; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Greco S, 2006, J ENDOCRINOL, V188, P79, DOI 10.1677/joe.1.06433; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; HELLEWELL SB, 1990, BRAIN RES, V527, P244, DOI 10.1016/0006-8993(90)91143-5; HELLEWELL SB, 1994, EUR J PHARM-MOLEC PH, V268, P9, DOI 10.1016/0922-4106(94)90115-5; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; McConkey DJ, 1996, J LEUKOCYTE BIOL, V59, P775, DOI 10.1002/jlb.59.6.775; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; North WG, 1999, PEPTIDES, V20, P837, DOI 10.1016/S0196-9781(99)00070-4; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; QUIRION R, 1992, TRENDS PHARMACOL SCI, V13, P85, DOI 10.1016/0165-6147(92)90030-A; Sazuka T, 2004, DNA RES, V11, P101, DOI 10.1093/dnares/11.2.101; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Seth P, 1998, J NEUROCHEM, V70, P922; SHARKEY J, 1988, EUR J PHARMACOL, V149, P171, DOI 10.1016/0014-2999(88)90058-1; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; Snyder S H, 1989, J Neuropsychiatry Clin Neurosci, V1, P7; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Vilner B. J., 1995, Society for Neuroscience Abstracts, V21, P1608; Vilner BJ, 2000, J PHARMACOL EXP THER, V292, P900; VILNER BJ, 1995, CANCER RES, V55, P408; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; WALKER JM, 1990, PHARMACOL REV, V42, P355; Wang B, 2004, BREAST CANCER RES TR, V87, P205, DOI 10.1007/s10549-004-6590-0; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867	46	107	112	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28198	28215		10.1074/jbc.M802099200	http://dx.doi.org/10.1074/jbc.M802099200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18539593	hybrid, Green Published			2022-12-27	WOS:000259969300022
J	Manni, S; Mauban, JH; Ward, CW; Bond, M				Manni, Sabrina; Mauban, Joseph H.; Ward, Christopher W.; Bond, Meredith			Phosphorylation of the cAMP-dependent protein kinase (PKA) regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in cardiac cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; HEART-FAILURE PROGRESSION; RAT VENTRICULAR MYOCYTES; SARCOPLASMIC-RETICULUM; ANCHORING PROTEINS; TROPONIN-I; MUSCLE; PHOSPHOLAMBAN; BINDING; PHOSPHODIESTERASES	Subcellular compartmentalization of the cAMP-dependent protein kinase (PKA) by protein kinase A-anchoring proteins (AKAPs) facilitates local protein phosphorylation. However, little is known about how PKA targeting to AKAPs is regulated in the intact cell. PKA binds to an amphipathic helical region of AKAPs via an N-terminal domain of the regulatory subunit. In vitro studies showed that autophosphorylation of type II regulatory subunit (RII) can alter its affinity for AKAPs and the catalytic subunit (PKA(cat)). We now investigate whether phosphorylation of serine 96 on RII regulates PKA targeting to AKAPs, downstream substrate phosphorylation and calcium cycling in primary cultured cardiomyocytes. We demonstrated that, whereas there is basal phosphorylation of RII subunits, persistent maximal activation of PKA results in a phosphatase-dependent loss of RII phosphorylation. To investigate the functional effects of RII phosphorylation, we constructed adenoviral vectors incorporating mutants which mimic phosphorylated (RIIS96D), nonphosphorylated (RIIS96A) RII, or wild-type (WT) RII and performed adenoviral infection of neonatal rat cardiomyocytes. Coimmunoprecipitation showed that more AKAP15/18 was pulled down by the phosphomimic, RIIS96D, than RIIS96A. Phosphorylation of phospholamban and ryanodine receptor was significantly increased in cells expressing RIIS96D versus RIIS96A. Expression of recombinant RII constructs showed significant effects on cytosolic calcium transients. We propose a model illustrating a central role of RII phosphorylation in the regulation of local PKA activity. We conclude that RII phosphorylation regulates PKA-dependent substrate phosphorylation and may have significant implications for modulation of cardiac function.	[Manni, Sabrina; Mauban, Joseph H.; Bond, Meredith] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ward, Christopher W.] Univ Maryland, Sch Nursing, Dept Org Syst & Adult Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bond, M (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	mbond@som.umaryland.edu	Manni, Sabrina/AAE-9182-2021	MANNI, SABRINA/0000-0001-6804-0680	National Institutes of Health [AG16613, HL79134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG16613 and HL79134 ( to M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Dash R, 2001, J MOL CELL CARDIOL, V33, P1345, DOI 10.1006/jmcc.2001.1394; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Eckhart AD, 2002, MOL THER, V5, P74, DOI 10.1006/mthe.2001.0508; ERLICHMAN J, 1974, J BIOL CHEM, V249, P5000; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Freeman K, 2001, J CLIN INVEST, V107, P967, DOI 10.1172/JCI12083; GRANOT J, 1980, J BIOL CHEM, V255, P4569; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Houser SR, 2000, TRENDS CARDIOVAS MED, V10, P101, DOI 10.1016/S1050-1738(00)00057-8; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; LOKUTA A, 1994, J CARDIOVASC ELECTR, V5, P50, DOI 10.1111/j.1540-8167.1994.tb01114.x; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; OTTEN AD, 1989, J BIOL CHEM, V264, P20255; PIESKE B, 2002, BASIC RES CARDIOL S1, V97, P163; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; RANGELALDAO R, 1979, J BIOL CHEM, V254, P2499; RANGELALDAO R, 1977, J BIOL CHEM, V252, P7140; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Rodriguez-Vilarrupla A, 2005, MOL CELL BIOL, V25, P7364, DOI 10.1128/MCB.25.16.7364-7374.2005; ROSEN OM, 1975, J BIOL CHEM, V250, P7788; Ruehr ML, 1999, J BIOL CHEM, V274, P33092, DOI 10.1074/jbc.274.46.33092; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SCOTT CW, 1985, J BIOL CHEM, V260, P2274; Sipido KR, 2005, CARDIOVASC RES, V68, P167, DOI 10.1016/j.cardiores.2005.08.011; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Trafford AW, 2002, FRONT BIOSCI, V7, pD843, DOI 10.2741/trafford; TYTGAT J, 1994, CARDIOVASC RES, V28, P280, DOI 10.1093/cvr/28.2.280; Waggoner Jason R, 2005, Heart Fail Clin, V1, P207, DOI 10.1016/j.hfc.2005.03.008; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2004, ANN MED, V36, P70, DOI 10.1080/17431380410032481; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; YANG SM, 1995, BIOCHEMISTRY-US, V34, P6267, DOI 10.1021/bi00019a002; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495; Zaccolo M, 2006, EUR J CELL BIOL, V85, P693, DOI 10.1016/j.ejcb.2006.01.002; Zakhary DR, 2000, CIRCULATION, V101, P1459, DOI 10.1161/01.CIR.101.12.1459; Zakhary DR, 2000, J BIOL CHEM, V275, P41389, DOI 10.1074/jbc.M004212200	49	60	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24145	24154		10.1074/jbc.M802278200	http://dx.doi.org/10.1074/jbc.M802278200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550536	Green Published, hybrid			2022-12-27	WOS:000258638900068
J	Vanacore, RM; Ham, AJL; Cartailler, JP; Sundaramoorthy, M; Todd, P; Pedchenko, V; Sado, Y; Borza, DB; Hudson, BG				Vanacore, Roberto M.; Ham, Amy-Joan L.; Cartailler, Jean-Philippe; Sundaramoorthy, Munirathinam; Todd, Parvin; Pedchenko, Vadim; Sado, Yoshikazu; Borza, Dorin-Bogdan; Hudson, Billy G.			A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen - Structural basis for the crypticity of B cell epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; ALPHA-3(IV) COLLAGEN; CRYSTAL-STRUCTURE; GLOBULAR DOMAIN; MOLECULAR-BASIS; GRAVES-DISEASE; NC1 DOMAIN; FAS LIGAND; AUTOANTIBODIES; CHAIN	The detailed structural basis for the cryptic nature (crypticity) of a B cell epitope harbored by an autoantigen is unknown. Because the immune system may be ignorant of the existence of such " cryptic" epitopes, their exposure could be an important feature in autoimmunity. Here we investigated the structural basis for the crypticity of the epitopes of the Goodpasture autoantigen, the alpha 3 alpha 4 alpha 5 noncollagenous-1 (NC1) hexamer, a globular domain that connects two triple-helical molecules of the alpha 3 alpha 4 alpha 5 collagen IV network. The NC1 hexamer occurs in two isoforms as follows: the M-isoform composed of monomer subunits in which the epitopes are accessible to autoantibodies, and the D-isoform composed of both monomer and dimer subunits in which the epitopes are cryptic. The D-isoform was characterized with respect to quaternary structure, as revealed by mass spectrometry of dimer subunits, homology modeling, and molecular dynamics simulation. The results revealed that the D-isoform contains two kinds of cross-links as follows: S-hydroxylysylmethionine and S-lysyl-methionine cross-links, which stabilize the alpha 3 alpha 5 heterodimers and alpha 4 alpha 4-homodimers, respectively. Construction and analysis of a three-dimensional model of the D-isoform of the alpha 3 alpha 4 alpha 5 NC1 hexamer revealed that crypticity is a consequence of the following: (a) sequestration of key residues between neighboring subunits that are stabilized by domain-swapping interactions, and (b) by cross-linking of subunits at the trimer-trimer interface, which stabilizes the structural integrity of the NC1 hexamer and protects against binding of autoantibodies. The sequestrated epitopes and crosslinked subunits represent a novel structural mechanism for conferring immune privilege at the level of quaternary structure. Perturbation of the quaternary structure may be a key factor in the etiology of Goodpasture disease.	[Vanacore, Roberto M.; Cartailler, Jean-Philippe; Sundaramoorthy, Munirathinam; Todd, Parvin; Pedchenko, Vadim; Borza, Dorin-Bogdan; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Vanacore, Roberto M.; Cartailler, Jean-Philippe; Sundaramoorthy, Munirathinam; Todd, Parvin; Pedchenko, Vadim; Borza, Dorin-Bogdan; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Ham, Amy-Joan L.; Sundaramoorthy, Munirathinam; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Borza, Dorin-Bogdan; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Ham, Amy-Joan L.] Vanderbilt Univ, Med Ctr, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Sado, Yoshikazu] Shigei Med Res Inst, Div Immunol, Okayama 701, Japan	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, B-3102 Med Ctr N,1161S 21st Ave S, Nashville, TN 37232 USA.	billy.hudson@vanderbilt.edu	Borza, Dorin-Bogdan/AAF-2156-2020; Pedchenko, Vadim/A-6873-2009; Vanacore, Roberto/C-9763-2012; Vanacore, Roberto/AAD-6399-2020; Cartailler, Jean-Philippe/D-2543-2010	Borza, Dorin-Bogdan/0000-0003-4568-279X; Vanacore, Roberto/0000-0002-2886-0606; Vanacore, Roberto/0000-0002-2886-0606; Cartailler, Jean-Philippe/0000-0002-0312-2391; Hudson, Billy/0000-0002-5420-4100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381, P01DK065123, R01DK062524, R37DK018381] Funding Source: NIH RePORTER; NIAID NIH HHS [AI69874, R21 AI069874] Funding Source: Medline; NIDDK NIH HHS [DK065123, P01 DK065123, DK18381, DK62524] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbate M, 1998, KIDNEY INT, V54, P1550, DOI 10.1046/j.1523-1755.1998.00153.x; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; Borza DB, 2002, J BIOL CHEM, V277, P40075, DOI 10.1074/jbc.M207769200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; David M, 2001, J BIOL CHEM, V276, P6370, DOI 10.1074/jbc.M008956200; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; DONAGHY M, 1983, LANCET, V2, P1390; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Ferguson TA, 2006, IMMUNOL REV, V213, P228, DOI 10.1111/j.1600-065X.2006.00430.x; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Giannakopoulos B, 2007, BLOOD, V109, P422, DOI 10.1182/blood-2006-04-001206; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; Hellmark T, 1999, KIDNEY INT, V55, P936, DOI 10.1046/j.1523-1755.1999.055003936.x; Hubbard SJ, 1993, NACCESS COMPUTER PRO; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kahsai TZ, 1997, J BIOL CHEM, V272, P17023, DOI 10.1074/jbc.272.27.17023; KALLURI R, 1994, P NATL ACAD SCI USA, V91, P6201, DOI 10.1073/pnas.91.13.6201; Kalluri R, 2000, J BIOL CHEM, V275, P20027, DOI 10.1074/jbc.M904549199; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KIVIRIKKO KI, 1984, EXTRACELLULAR MATRIX, P83; KLEPPEL MM, 1992, J BIOL CHEM, V267, P4137; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Moudgil KD, 2005, TRENDS IMMUNOL, V26, P355, DOI 10.1016/j.it.2005.05.007; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; NOSSAL GJV, 1991, EUR J BIOCHEM, V202, P729, DOI 10.1111/j.1432-1033.1991.tb16427.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; ROBINS SP, 1975, BIOCHEM J, V149, P381, DOI 10.1042/bj1490381; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; Sercarz EE, 2002, NAT IMMUNOL, V3, P110, DOI 10.1038/ni0202-110; SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x; STEVENSON A, 1995, QJM-MON J ASSOC PHYS, V88, P23; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200; Wang XP, 2005, J AM SOC NEPHROL, V16, P3563, DOI 10.1681/ASN.2005060670; WEBER S, 1984, EUR J BIOCHEM, V139, P401, DOI 10.1111/j.1432-1033.1984.tb08019.x; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016	53	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22737	22748		10.1074/jbc.M803451200	http://dx.doi.org/10.1074/jbc.M803451200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18499662	Green Published, hybrid			2022-12-27	WOS:000258321000042
J	Qiu, HY; Dai, HC; Jain, K; Shah, R; Hong, C; Pain, J; Tian, B; Vatner, DE; Vatner, SF; Depre, C				Qiu, Hongyu; Dai, Huacheng; Jain, Komal; Shah, Rina; Hong, Chull; Pain, Jayashree; Tian, Bin; Vatner, Dorothy E.; Vatner, Stephen F.; Depre, Christophe			Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-INFARCTION; ACTIVATING KINASE; GENE-EXPRESSION; H11 KINASE; APOPTOSIS; SURVIVAL; MECHANISMS; MYOCYTES; PROGRAM; COMPLEX	Myocardial infarction (MI) is often followed by heart failure (HF), but the mechanisms precipitating the transition to HF remain largely unknown. A genomic profile was performed in a monkey model of MI, from the myocardium adjacent to chronic (2-month) MI followed by 3 weeks of pacing to develop HF. The transcript of the gene encoding the cell cycle-related kinase (CCRK) was down-regulated by 50% in HF heart compared with control ( p < 0.05), which was confirmed by quantitative PCR. The CCRK sequence cloned from a heart library showed a conservation of the N-terminal kinase domain when compared with the "generic" isoform cloned previously but a different C-terminal half due to alternative splicing with frameshift. The homology of the cardiac sequence was 100% between mice and humans. Expression of the corresponding protein, measured upon generation of a monoclonal antibody, was limited to heart, liver, and kidney. Upon overexpression in cardiac myocytes, both isoforms promote cell growth and reduce apoptosis by chelerythrine (p < 0.05 versus control). Using a yeast two-hybrid screening, we found an interaction of the generic but not the cardiac CCRK with cyclin H and casein kinase 2. In addition, only the generic CCRK phosphorylates the cyclin-dependent kinase 2, which was accompanied by a doubling of myocytes in the S and G(2) phases of the cell cycle (p < 0.05 versus control). Therefore, the heart expresses a splice variant of CCRK, which promotes cardiac cell growth and survival; differs from the generic isoform in terms of protein-protein interactions, substrate specificity and regulation of the cell cycle; and is downregulated significantly in HF.	[Jain, Komal; Tian, Bin] Univ Med & Dent New Jersey, Sch Med, Dept Biochem, Newark, NJ 07103 USA; [Qiu, Hongyu; Dai, Huacheng; Shah, Rina; Hong, Chull; Pain, Jayashree; Vatner, Dorothy E.; Vatner, Stephen F.; Depre, Christophe] Univ Med & Dent New Jersey, Sch Med, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Depre, C (corresponding author), Univ Med & Dent New Jersey, Sch Med, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, MSB G609,185 S Orange Ave, Newark, NJ 07103 USA.	deprech@umdnj.edu		Tian, Bin/0000-0001-8903-8256	NHLBI NIH HHS [HL069752, HL033107, HL069020, HL059139] Funding Source: Medline; NIA NIH HHS [AG027211, AG014121, AG023137] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069020, P01HL059139, R37HL033107, R01HL033107, T32HL069752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023137, R01AG014121, P01AG027211] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Caligluri M, 2005, CHEM BIOL, V12, P1103, DOI 10.1016/j.chembiol.2005.08.008; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Depre C, 2006, CIRC RES, V98, P280, DOI 10.1161/01.RES.0000201284.45482.e8; Depre C, 2004, CIRC RES, V95, P433, DOI 10.1161/01.RES.0000138301.42713.18; Depre C, 2005, TRENDS CARDIOVAS MED, V15, P101, DOI 10.1016/j.tcm.2005.04.006; Depre C, 2003, CARDIOVASC RES, V58, P126, DOI 10.1016/S0008-6363(02)00845-3; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Depre C, 2001, P NATL ACAD SCI USA, V98, P9336, DOI 10.1073/pnas.171297498; Depre C, 2007, HEART FAIL REV, V12, P307, DOI 10.1007/s10741-007-9040-3; FISHER RP, 1995, CELL, V83, P47, DOI 10.1016/0092-8674(95)90233-3; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; IWAKI K, 1990, J BIOL CHEM, V265, P13809; KENNAWAY NG, 1990, PEDIATR RES, V28, P529; Liao HS, 2001, CIRC RES, V88, P443; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Lu H, 1997, MOL CELL BIOL, V17, P5923, DOI 10.1128/MCB.17.10.5923; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Mori T, 2006, LIFE SCI, V79, P247, DOI 10.1016/j.lfs.2005.12.056; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Qiu H, 2007, CIRCULATION, V116, P669, DOI 10.1161/CIRCULATIONAHA.107.689208; Qiu HY, 2007, PHYSIOL GENOMICS, V29, P169, DOI 10.1152/physiolgenomics.00229.2006; Reiss K, 1996, EXP CELL RES, V225, P44, DOI 10.1006/excr.1996.0155; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Wang L, 2004, MOL CELL BIOCHEM, V265, P71, DOI 10.1023/B:MCBI.0000044311.58653.54; Woo YJ, 2006, CIRCULATION, V114, pI206, DOI 10.1161/CIRCULATIONAHA.105.000455	36	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22157	22165		10.1074/jbc.M710459200	http://dx.doi.org/10.1074/jbc.M710459200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508765	Green Published, hybrid			2022-12-27	WOS:000258114700035
J	Bhaskaran, R; Palmier, MO; Lauer-Fields, JL; Fields, GB; Van Doren, SR				Bhaskaran, Rajagopalan; Palmier, Mark O.; Lauer-Fields, Janelle L.; Fields, Gregg B.; Van Doren, Steven R.			MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE METALLOELASTASE MMP-12; MATRIX-METALLOPROTEINASE; SUBSTRATE-SPECIFICITY; INTERSTITIAL COLLAGENASE; MOLECULAR DETERMINANTS; FLUOROGENIC SUBSTRATE; CRYSTAL-STRUCTURES; ELASTASE MMP-12; CLEAVAGE SITE; GELATINASE-A	Matrix metalloproteinase (MMP)-12 ( or metalloelastase) efficiently hydrolyzed the gelatinase-selective alpha 1(V)436-447 fluorescent triple helical peptide (THP) when the substrate was sub-micromolar. The sequence of this THP was derived from collagen V, a component of collagen I fibrils. The hemopexin domains of MMP-12 and -9 each increased k(cat)/K-m toward this substrate by decreasing K-m, just as the hemopexin domain of MMP-1 enhances its triple helical peptidase activity. Non-fluorescent alpha 1(V) THP subtly perturbed amide NMR chemical shifts of MMP-12 not only in the active site cleft but also at remote sites of the beta-sheet and adjoining loops. The alpha 1(V) THP protected MMP-12 from the NMR line broadening effects of Gd center dot EDTA in the active site cleft and more dramatically in the V-B loop next to the primed subsites. Mutagenesis of the exosite in the V-B loop at Thr-205 and His-206 that vary among MMP sequences established that this site supports the high specific activity toward alpha 1(V) fluorescent THP without affecting general MMP activity. Surprisingly the alpha 1(V) THP also protected novel surfaces in the S-shaped metal-binding loop and beta-strands III and V that together form a pocket on the remote side of the zinc binding site. The patterns of protection suggest bending of the triple helical peptide partly around the catalytic domain to reach novel exosites. Partial unwinding or underwinding of the triple helix could accompany this to facilitate its hydrolysis.	[Bhaskaran, Rajagopalan; Palmier, Mark O.; Van Doren, Steven R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Lauer-Fields, Janelle L.; Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Lauer-Fields, Janelle L.; Fields, Gregg B.] Florida Atlantic Univ, Coll Biomed Sci, Boca Raton, FL 33431 USA	University of Missouri System; University of Missouri Columbia; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Van Doren, SR (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	vandorens@missouri.edu		Van Doren, Steven/0000-0003-2838-4598; Bhaskaran, Raj/0000-0001-8008-9962	NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057289, T32GM008396] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098799, R01 CA 98799] Funding Source: Medline; NIGMS NIH HHS [GM 008396, R01 GM 57289] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Arumugam S, 2003, BIOCHEMISTRY-US, V42, P7950, DOI 10.1021/bi034545s; Arumugam S, 1998, BIOCHEMISTRY-US, V37, P9650, DOI 10.1021/bi980128h; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bertini I, 2003, ANGEW CHEM INT EDIT, V42, P2673, DOI 10.1002/anie.200350957; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bertini I, 2007, J AM CHEM SOC, V129, P2466, DOI 10.1021/ja065156z; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bhaskaran R, 2006, J BIOMOL NMR, V36, P55, DOI 10.1007/s10858-006-9035-8; Bhaskaran R, 2007, J MOL BIOL, V374, P1333, DOI 10.1016/j.jmb.2007.10.028; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Cha J, 1997, BIOCHEMISTRY-US, V36, P16019, DOI 10.1021/bi972223g; Chandler S, 1996, BIOCHEM BIOPH RES CO, V228, P421, DOI 10.1006/bbrc.1996.1677; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P6684, DOI 10.1021/bi00187a039; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Ferreon JC, 2003, PROTEIN SCI, V12, P982, DOI 10.1110/ps.0238003; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fu JY, 2001, PROTEIN EXPRES PURIF, V21, P268, DOI 10.1006/prep.2000.1376; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Goddard T. D., 2000, SPARKY; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Johnson Jason Lee, 2007, Expert Rev Cardiovasc Ther, V5, P265, DOI 10.1586/14779072.5.2.265; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Lang R, 2001, J MOL BIOL, V312, P731, DOI 10.1006/jmbi.2001.4954; Lauer-Fields JL, 2007, J BIOL CHEM, V282, P142, DOI 10.1074/jbc.M605236200; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, ANAL BIOCHEM, V321, P105, DOI 10.1016/S0003-2697(03)00460-3; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Linsenmayer TF, 1998, PROG RETIN EYE RES, V17, P231; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; LIOTTA LA, 1981, BIOCHEM BIOPH RES CO, V98, P184, DOI 10.1016/0006-291X(81)91886-6; LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027; Mannino C, 2006, BIOORGAN MED CHEM, V14, P7392, DOI 10.1016/j.bmc.2006.07.028; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Matsumoto S, 1998, AM J PATHOL, V153, P109, DOI 10.1016/S0002-9440(10)65551-4; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; MURPHY G, 1982, BIOCHEM J, V203, P209, DOI 10.1042/bj2030209; MURPHY G, 1985, BIOCHIM BIOPHYS ACTA, V831, P49, DOI 10.1016/0167-4838(85)90148-7; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nar H, 2001, J MOL BIOL, V312, P743, DOI 10.1006/jmbi.2001.4953; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; NIEDZWIECKI L, 1992, BIOCHEMISTRY-US, V31, P12618, DOI 10.1021/bi00165a011; NIYIBIZI C, 1994, BIOCHEM BIOPH RES CO, V202, P328, DOI 10.1006/bbrc.1994.1931; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Park HI, 2000, J BIOL CHEM, V275, P20540, DOI 10.1074/jbc.M002349200; Parkar AA, 2000, PROTEIN EXPRES PURIF, V20, P152, DOI 10.1006/prep.2000.1280; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RICH EA, 1983, AM REV RESPIR DIS, V128, P166, DOI 10.1164/arrd.1983.128.1.166; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; SAGE H, 1979, BIOCHEMISTRY-US, V18, P3815, DOI 10.1021/bi00584a027; SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5; Sakakura M, 2005, J AM CHEM SOC, V127, P5826, DOI 10.1021/ja047825j; Shapiro SD, 1999, THROMB HAEMOSTASIS, V82, P846; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shipley JM, 1996, J BIOL CHEM, V271, P4335; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Sun HB, 2000, ANAL BIOCHEM, V283, P153, DOI 10.1006/abio.2000.4629; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Wang XF, 2004, AM J PATHOL, V165, P1375, DOI 10.1016/S0002-9440(10)63395-0; Williams J W, 1979, Methods Enzymol, V63, P437; Woessner J.F., 2000, PROTEIN PROFILE SER	96	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21779	21788		10.1074/jbc.M709966200	http://dx.doi.org/10.1074/jbc.M709966200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539597	hybrid, Green Published			2022-12-27	WOS:000257898800051
J	Schaefer, L; Iozzo, RV				Schaefer, Liliana; Iozzo, Renato V.			Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GROWTH-FACTOR RECEPTOR; PROTEIN CORE; EXTRACELLULAR-MATRIX; BIGLYCAN DEFICIENCY; DECORIN DEFICIENCY; UP-REGULATION; LUMICAN; FIBROMODULIN; MUTATIONS; SUPPRESSION	The small leucine-rich proteoglycan (SLRP) family has significantly expanded in the past decade to now encompass five discrete classes, grouped by common structural and functional properties. Some of these gene products are not classical proteoglycans, whereas others have new and unique features. In addition to being structural proteins, SLRPs constitute a network of signal regulation: being mostly extracellular, they are upstream of multiple signaling cascades. They affect intracellular phosphorylation, a major conduit of information for cellular responses, and modulate distinct pathways, including those driven by bone morphogenetic protein/transforming growth factor beta superfamily members, receptor tyrosine kinases such as ErbB family members and the insulin-like growth factor I receptor, and Toll-like receptors. The wealth of mechanistic insights into the molecular and cellular functions of SLRPs has revealed both the sophistication of this family of regulatory proteins and the challenges that remain in uncovering the totality of their functions. This review is focused on novel biological functions of SLRPs with special emphasis on their protein cores, newly described genetic diseases, and signaling events in which SLRPs play key functions.	[Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Schaefer, Liliana] Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	iozzo@mail.jci.tju.edu	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; Schaefer, Liliana/0000-0002-3318-3005	NCI NIH HHS [R01 CA 120975, R01 CA 39481, R01 CA 47282] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA120975, R01CA047282] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Dugan TA, 2006, J BIOL CHEM, V281, P38208, DOI 10.1074/jbc.M607244200; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hocking AM, 1998, MATRIX BIOL, V17, P1; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kuriyama S, 2006, DEVELOPMENT, V133, P75, DOI 10.1242/dev.02178; Majava M, 2007, HUM MUTAT, V28, P336, DOI 10.1002/humu.20444; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Meij JTA, 2007, MOL VIS, V13, P2012; Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615; Morris SA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001004; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Ohta K, 2004, DEV CELL, V7, P347, DOI 10.1016/j.devcel.2004.08.014; Ohta K, 2006, DEVELOPMENT, V133, P3777, DOI 10.1242/dev.02579; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Ross MD, 2003, J BIOL CHEM, V278, P33248, DOI 10.1074/jbc.M301299200; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 2001, J BIOL CHEM, V276, P40687, DOI 10.1074/jbc.M105426200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shimizu-Hirota R, 2004, FEBS LETT, V563, P69, DOI 10.1016/S0014-5793(04)00250-9; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Wang IJ, 2006, MOL VIS, V12, P852; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	58	366	382	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21305	21309		10.1074/jbc.R800020200	http://dx.doi.org/10.1074/jbc.R800020200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18463092	hybrid, Green Published			2022-12-27	WOS:000257898800001
J	Wang, J; Ruan, NJ; Qian, L; Lei, WL; Chen, F; Luo, ZG				Wang, Jia; Ruan, Nan-Jie; Qian, Lei; Lei, Wen-Liang; Chen, Fei; Luo, Zhen-Ge			Wnt/beta-catenin signaling suppresses Rapsyn expression and inhibits acetylcholine receptor clustering at the neuromuscular junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; SYNAPSE FORMATION; WNT; MUSCLE; DIFFERENTIATION; PROTEIN; KINASE; AXON; TRANSCRIPTION; MUSK	The dynamic interaction between positive and negative signals is necessary for remodeling of postsynaptic structures at the neuromuscular junction. Here we report that Wnt3a negatively regulates acetylcholine receptor ( AChR) clustering by repressing the expression of Rapsyn, an AChR-associated protein essential for AChR clustering. In cultured myotubes, treatment with Wnt3a or overexpression of beta-catenin, the condition mimicking the activation of the Wnt canonical pathway, inhibited Agrin-induced formation of AChR clusters. Moreover, Wnt3a treatment promoted dispersion of AChR clusters, and this effect was prevented by DKK1, an antagonist of the Wnt canonical pathway. Next, we investigated possible mechanisms underlying Wnt3a regulation of AChR clustering in cultured muscle cells. Interestingly, we found that Wnt3a treatment caused a decrease in the protein level of Rapsyn. In addition, Rapsyn promoter activity in cultured muscle cells was inhibited by the treatment with Wnt3a or beta-catenin overexpression. Forced expression of Rapsyn driven by a promoter that is not responsive to Wnt3a prevented the dispersing effect of Wnt3a on AChR clusters, suggesting that Wnt3a indeed acts to disperse AChR clusters by down-regulating the expression of Rapsyn. The role of Wnt/beta-catenin signaling in dispersing AChR clusters was also investigated in vivo by electroporation of Wnt3a or beta-catenin into mouse limb muscles, where ectopic Wnt3a or beta-catenin caused disassembly of postsynaptic apparatus. Together, these results suggest that Wnt/beta-catenin signaling plays a negative role for postsynaptic differentiation at the neuromuscular junction, probably by regulating the expression of synaptic proteins, such as Rapsyn.	[Wang, Jia; Ruan, Nan-Jie; Qian, Lei; Lei, Wen-Liang; Chen, Fei; Luo, Zhen-Ge] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, ZG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zgluo@ion.ac.cn	Lei, Wenliang/T-3156-2017; Qian, Lei/N-1796-2019; Qian, Lei/H-1977-2013; Luo, Zhen-Ge/GNM-7635-2022	Lei, Wenliang/0000-0002-7954-7214; Qian, Lei/0000-0002-3480-4248; Qian, Lei/0000-0002-3480-4248; 				Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hippenmeyer S, 2007, NEURON, V55, P726, DOI 10.1016/j.neuron.2007.07.028; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lucas FR, 1998, J CELL SCI, V111, P1351; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohno K, 2003, HUM MOL GENET, V12, P739, DOI 10.1093/hmg/ddg089; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Phillips WD, 1997, MOL CELL NEUROSCI, V10, P16, DOI 10.1006/mcne.1997.0634; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; Qu ZC, 1996, MOL CELL NEUROSCI, V8, P171, DOI 10.1006/mcne.1996.0055; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Salinas PC, 2003, CURR BIOL, V13, pR60, DOI 10.1016/S0960-9822(02)01429-X; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sharma SK, 2003, J NEUROBIOL, V54, P346, DOI 10.1002/neu.10134; Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102; Trinidad JC, 2004, J BIOL CHEM, V279, P31622, DOI 10.1074/jbc.M400044200; Wang JM, 2003, NAT NEUROSCI, V6, P1017, DOI 10.1038/nn1128; Wang ZZ, 1999, J NEUROSCI, V19, P1998; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wells DG, 1999, P NATL ACAD SCI USA, V96, P1112, DOI 10.1073/pnas.96.3.1112; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOODGETT JR, 2001, SCI STKE, pRE12; YOSHIHARA CM, 1993, J CELL BIOL, V122, P169, DOI 10.1083/jcb.122.1.169; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	57	63	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21668	21675		10.1074/jbc.M709939200	http://dx.doi.org/10.1074/jbc.M709939200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541538	hybrid			2022-12-27	WOS:000257898800040
J	Deng, HB; Yu, F; Chen, JQ; Zhao, YM; Xiang, JL; Lin, AN				Deng, Hongbin; Yu, Fei; Chen, Jianqun; Zhao, Yingming; Xiang, Jialing; Lin, Anning			Phosphorylation of bad at Thr-201 by JNK1 promotes glycolysis through activation of phosphofructokinase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-INDUCED APOPTOSIS; PROTEIN-KINASE KINASE; SIGNAL-TRANSDUCTION; GLUCOSE-METABOLISM; TERMINAL KINASE; BCL-2; IDENTIFICATION; INHIBITION; SURVIVAL	The mitogen-activated protein kinase JNK1 suppresses interleukin-3 withdrawal-induced cell death through phosphorylation of the BH3-only pro-apoptotic Bcl-2 family protein Bad at Thr-201. It is unknown whether JNK1 regulates glycolysis, an important metabolic process that is involved in cell survival, and if so, whether the regulation depends on Thr-201 phosphorylation of Bad. Here we report that phosphorylation of Bad by JNK1 is required for glycolysis through activation of phosphofructokinase-1 (PFK-1), one of the key enzymes that catalyze glycolysis. Genetic disruption of Jnk1 alleles or silencing of Jnk1 by small interfering RNA abrogates glycolysis induced by growth/survival factors such as serum or interleukin-3. Proteomic analysis identifies PFK-1 as a novel Bad-associated protein. Although the interaction between PFK-1 and Bad is independent of JNK1, Thr-201 phosphorylation of Bad by JNK1 is required for PFK-1 activation. Thus, our results provide a novel molecular mechanism by which JNK1 promotes glycolysis for cell survival.	[Deng, Hongbin; Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Yu, Fei; Chen, Jianqun; Lin, Anning] Nanjing Univ, Sch Life Sci, Inst Signal Transduct, Nanjing 210093, Peoples R China; [Zhao, Yingming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Xiang, Jialing] IIT, Dept Biol Chem & Phys sci, Chicago, IL 60616 USA	University of Chicago; Nanjing University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Illinois Institute of Technology	Lin, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, Ctr Integrat Sci Bldg,Rm W340,929 E 57th St, Chicago, IL 60637 USA.	alin@huggins.bsd.uchicago.edu	Deng, Hongbin/AAN-3603-2020	Deng, Hongbin/0000-0002-4398-8819	NATIONAL CANCER INSTITUTE [R01CA100460, K01CA090516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071409] Funding Source: NIH RePORTER; NCI NIH HHS [CA 090516, CA 100460] Funding Source: Medline; NIGMS NIH HHS [GM 071409] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Fan G, 1996, J BIOL CHEM, V271, P24788, DOI 10.1074/jbc.271.40.24788; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hammaker DR, 2004, J IMMUNOL, V172, P1612, DOI 10.4049/jimmunol.172.3.1612; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ito M, 1999, MOL CELL BIOL, V19, P7539; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; LAYZER RB, 1969, J BIOL CHEM, V244, P3823; Liang Y, 1997, DIABETOLOGIA, V40, P1018, DOI 10.1007/s001250050783; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lin AN, 2006, DEV CELL, V10, P277, DOI 10.1016/j.devcel.2006.02.006; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2007, ONCOGENE, V26, P3267, DOI 10.1038/sj.onc.1210417; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; RATT MC, 1992, NATURE, V356, P397; Rempel A, 1996, CANCER RES, V56, P2468; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sadoshima J, 2002, J CLIN INVEST, V110, P271, DOI 10.1172/JCI200214938; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; SAPICO V, 1970, J BIOL CHEM, V245, P3252; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	58	47	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20754	20760		10.1074/jbc.M800024200	http://dx.doi.org/10.1074/jbc.M800024200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18469002	Green Published, hybrid			2022-12-27	WOS:000257746100016
J	Hayashida, K; Chen, Y; Bartlett, AH; Park, PW				Hayashida, Kazutaka; Chen, Ye; Bartlett, Allison H.; Park, Pyong Woo			Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; HEPARAN-SULFATE PROTEOGLYCANS; TUMOR-NECROSIS-FACTOR; INDUCED LETHAL SHOCK; T-CELL-ACTIVATION; INTERFERON-GAMMA; PSEUDOMONAS-AERUGINOSA; SOLUBLE SYNDECAN-1; BINDING DOMAIN; GROWTH-FACTOR	Heparan sulfate proteoglycans bind to and regulate many inflammatory mediators in vitro, suggesting that they serve an important role in influencing inflammatory responses in vivo. Here we evaluated the role of syndecan-1, a major heparan sulfate proteoglycan, in modulating inflammatory responses in Gram-positive toxic shock, a systemic disease that is a significant cause of morbidity and mortality. Syndecan-1-null and wild-type mice were injected intraperitoneally with staphylococcal enterotoxin B, a pyrogenic superantigen, and their inflammatory responses were assessed. Syndecan-1-null mice showed significantly increased liver injury, vascular permeability, and death in response to staphylococcal enterotoxin B challenge compared with wild-type mice. Although serum levels of systemic IL-2 and IFN gamma were similar between the two backgrounds, those of TNF alpha and IL-6 were significantly increased in syndecan-1-null mice undergoing Gram-positive toxic shock. Furthermore, syndecan-1-null mice challenged with staphylococcal enterotoxin B showed enhanced T cell accumulation in tissues, whereas immunodepletion of T cells protected syndecan-1-null mice from the magnified systemic cytokine storm, inflammatory tissue injury, and death. Importantly, syndecan-1 shedding was induced in wild-type mice injected with staphylococcal enterotoxin B, and the administration of heparan sulfate, but not syndecan-1 core protein, rescued syndecan-1-null mice from lethal toxic shock by suppressing the production of TNF alpha and IL-6, and attenuating inflammatory tissue injury. Altogether, these data suggest that syndecan-1 shedding is a key endogenous mechanism that protects the host from Gram-positive toxic shock by inhibiting the dysregulation and amplification of the inflammatory response.	[Hayashida, Kazutaka; Park, Pyong Woo] Harvard Univ, Sch Med, Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA; [Chen, Ye] So Med Univ, Nanfang Hosp, Dept Digest Dis, Guangzhou 510515, Guangdong, Peoples R China; [Bartlett, Allison H.] Baylor Coll Med, Div Pediat Infect Dis, Houston, TX 77030 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Southern Medical University - China; Baylor College of Medicine	Park, PW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Resp Dis, 320 Longwood Ave,Enders-144, Boston, MA 02115 USA.	Pyong.Park@childrens.harvard.edu		Bartlett, Allison/0000-0002-4275-5642	NHLBI NIH HHS [HL 69050, R01 HL069050, HL 81474, R01 HL081474] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069050, R01HL081474] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Anderson MR, 2001, CLIN IMMUNOL, V98, P85, DOI 10.1006/clim.2000.4960; Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Bartlett AH, 2007, MOL CELLS, V24, P153; BEAN AGD, 1993, INFECT IMMUN, V61, P4937, DOI 10.1128/IAI.61.11.4937-4939.1993; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Bohach GA, 2000, GRAM-POSITIVE PATHOGENS, P367; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Charnaux N, 2005, GLYCOBIOLOGY, V15, P119, DOI 10.1093/glycob/cwh148; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Davidson BL, 2002, NEW ENGL J MED, V347, P1036, DOI 10.1056/NEJM200209263471316; Day R, 1999, LANCET, V354, P62, DOI 10.1016/S0140-6736(98)09267-8; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Faulkner L, 2005, J IMMUNOL, V175, P6870, DOI 10.4049/jimmunol.175.10.6870; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; FLORQUIN S, 1994, J IMMUNOL, V153, P2618; Fritchley SJ, 2000, CLIN EXP IMMUNOL, V120, P247, DOI 10.1046/j.1365-2249.2000.01178.x; GROSSMAN D, 1992, INFECT IMMUN, V60, P5190, DOI 10.1128/IAI.60.12.5190-5196.1992; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; Henry-Stanley MJ, 2006, CYTOKINE, V34, P252, DOI 10.1016/j.cyto.2006.05.008; Joensuu H, 2002, CANCER RES, V62, P5210; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; KOTB M, 1995, CLIN MICROBIOL REV, V8, P411, DOI 10.1128/CMR.8.3.411; LANTZ M, 1991, J CLIN INVEST, V88, P2026, DOI 10.1172/JCI115530; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; MCINTOSH JK, 1989, J IMMUNOL, V143, P162; McKallip RJ, 2005, INFECT IMMUN, V73, P50, DOI 10.1128/IAI.73.1.50-61.2005; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; MOUNTZ JD, 1995, J IMMUNOL, V155, P4829; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; Najjam S, 1998, GLYCOBIOLOGY, V8, P509, DOI 10.1093/glycob/8.5.509; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Saha B, 1996, J EXP MED, V183, P2675, DOI 10.1084/jem.183.6.2675; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Seidel C, 2003, TRANSPLANTATION, V76, P423, DOI 10.1097/01.TP.0000074316.76104.A5; Simpson KJ, 2003, CLIN SCI, V104, P47, DOI 10.1042/CS20020137; Simpson KJ, 1997, J HEPATOL, V27, P1120, DOI 10.1016/S0168-8278(97)80160-2; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Tang QZ, 2003, J IMMUNOL, V170, P1510, DOI 10.4049/jimmunol.170.3.1510; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Wrenshall LE, 2003, J IMMUNOL, V170, P5470, DOI 10.4049/jimmunol.170.11.5470; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zhang WJ, 1996, J IMMUNOL, V157, P5049	63	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19895	19903		10.1074/jbc.M801614200	http://dx.doi.org/10.1074/jbc.M801614200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499671	Green Published, hybrid			2022-12-27	WOS:000257565300004
J	Mannaioni, G; Orr, AG; Hamill, CE; Yuan, HJ; Pedone, KH; Mccoy, KL; Palmini, RB; Junge, CE; Lee, CJ; Yepes, M; Hepler, JR; Traynelis, SF				Mannaioni, Guido; Orr, Anna G.; Hamill, Cecily E.; Yuan, Hongjie; Pedone, Katherine H.; Mccoy, Kelly L.; Palmini, Rolando Berlinguer; Junge, Candice E.; Lee, C. Justin; Yepes, Manuel; Hepler, John R.; Traynelis, Stephen F.			Plasmin potentiates synaptic N-methyl-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; THROMBIN RECEPTOR; LYSOPHOSPHATIDIC ACID; MICE LACKING; LATE-PHASE; SYSTEM; EXPRESSION; GLUTAMATE; CURRENTS; LOCALIZATION	Protease-activated receptor-1 (PAR1) is activated by a number of serine proteases, including plasmin. Both PAR1 and plasminogen, the precursor of plasmin, are expressed in the central nervous system. In this study we examined the effects of plasmin in astrocyte and neuronal cultures as well as in hippocampal slices. We find that plasmin evokes an increase in both phosphoinositide hydrolysis (EC50 64 nM) and Fura-2/AM fluorescence (195 +/- 6.7% above base line, EC50 65 nM) in cortical cultured murine astrocytes. Plasmin also activates extracellular signal-regulated kinase (ERK1/2) within cultured astrocytes. The plasmin-induced rise in intracellular Ca2+ concentration ([Ca2+](i)) and the increase in phospho-ERK1/2 levels were diminished in PAR1(-/-) astrocytes and were blocked by 1 mu M BMS-200261, a selective PAR1 antagonist. However, plasmin had no detectable effect on ERK1/2 or [Ca2+](i) signaling in primary cultured hippocampal neurons or in CA1 pyramidal cells in hippocampal slices. Plasmin (100-200 nM) application potentiated the N-methyl-D-aspartate (NMDA) receptor-dependent component of miniature excitatory postsynaptic currents recorded from CA1 pyramidal neurons but had no effect on alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate- or gamma-aminobutyric acid receptor-mediated synaptic currents. Plasmin also increased NMDA-induced whole cell receptor currents recorded from CA1 pyramidal cells (2.5 +/- 0.3-fold potentiation over control). This effect was blocked by BMS-200261 (1 mu M; 1.02 +/- 0.09-fold potentiation over control). These data suggest that plasmin may serve as an endogenous PAR1 activator that can increase [Ca2+](i) in astrocytes and potentiate NMDA receptor synaptic currents in CA1 pyramidal neurons.	[Orr, Anna G.; Hamill, Cecily E.; Yuan, Hongjie; Pedone, Katherine H.; Mccoy, Kelly L.; Hepler, John R.; Traynelis, Stephen F.] Emory Univ, Dept Pharmacol, Rollins Res Ctr 5062, Atlanta, GA 30322 USA; [Mannaioni, Guido; Palmini, Rolando Berlinguer] Univ Florence, Dipartimento Farmacol, I-50139 Florence, Italy; [Junge, Candice E.] Agensys Inc, Santa Monica, CA 90404 USA; [Lee, C. Justin] Korea Inst Sci & Technol, Seoul 136791, South Korea; [Yepes, Manuel] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA	Emory University; University of Florence; Korea Institute of Science & Technology (KIST); Emory University	Traynelis, SF (corresponding author), Emory Univ, Dept Pharmacol, Rollins Res Ctr 5062, 1510 Clifton Rd, Atlanta, GA 30322 USA.	strayne@emory.edu	Lee, C. Justin/AAC-1663-2019; Berlinguer Palmini, Rolando/G-7745-2011; Palmini, Rolando Berlinguer/K-8764-2013; Yepes, Manuel/C-3576-2011	Palmini, Rolando Berlinguer/0000-0002-1786-496X; Yuan, Hongjie/0000-0002-8127-7145; Lee, C Justin/0000-0002-3555-0980; Orr, Anna/0000-0002-4036-4277; mannaioni, guido/0000-0002-8273-7377	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS043875, R01NS049478, F31NS054515, R01NS039419] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline; NINDS NIH HHS [NS 039419, NS 049478, NS 43875, NS 530062, NS 054515] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almonte AG, 2007, NEUROBIOL LEARN MEM, V88, P295, DOI 10.1016/j.nlm.2007.04.004; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Basham ME, 2001, J NEUROCHEM, V77, P318, DOI 10.1046/j.1471-4159.2001.t01-1-00239.x; Bernatowicz MS, 1996, J MED CHEM, V39, P4879, DOI 10.1021/jm960455s; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; DASCAL N, 1987, PFLUG ARCH EUR J PHY, V409, P512, DOI 10.1007/BF00583809; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Hollenberg MD, 1997, CAN J PHYSIOL PHARM, V75, P832, DOI 10.1139/cjpp-75-7-832; Holtsberg FW, 1997, J NEUROCHEM, V69, P68; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Ito M, 2006, MOL PHARMACOL, V70, P1720, DOI 10.1124/mol.106.022467; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Mari B, 1996, FASEB J, V10, P309, DOI 10.1096/fasebj.10.2.8641564; Matys T, 2005, NEUROSCIENCE, V135, P715, DOI 10.1016/j.neuroscience.2005.06.076; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; Mizutani A, 1996, BRAIN RES, V739, P276, DOI 10.1016/S0006-8993(96)00834-7; Mizutani A, 1997, BRAIN RES, V761, P93, DOI 10.1016/S0006-8993(97)00338-7; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nagai T, 2006, J NEUROSCI, V26, P12374, DOI 10.1523/JNEUROSCI.3139-06.2006; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; ORON Y, 1985, NATURE, V313, P141, DOI 10.1038/313141a0; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Quinton TM, 2004, J BIOL CHEM, V279, P18434, DOI 10.1074/jbc.M401431200; RALL WILFRID, 1962, BIOPHYS JOUR, V2, P145; Rickard A, 2005, AM J PHYSIOL-RENAL, V288, pF714, DOI 10.1152/ajprenal.00288.2004; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Stricker C, 1996, J PHYSIOL-LONDON, V490, P419, DOI 10.1113/jphysiol.1996.sp021155; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Wang H, 2002, GLIA, V37, P53, DOI 10.1002/glia.10012; Yang YX, 1997, BRAIN RES, V761, P11, DOI 10.1016/S0006-8993(97)00311-9; Zhang L, 2002, THROMB HAEMOSTASIS, V87, P493	53	62	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20600	20611		10.1074/jbc.M803015200	http://dx.doi.org/10.1074/jbc.M803015200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18474593	Green Published, hybrid			2022-12-27	WOS:000257565300072
J	Momcilovic, M; Iram, SH; Liu, Y; Carlson, M				Momcilovic, Milica; Iram, Surtaj H.; Liu, Yang; Carlson, Marian			Roles of the glycogen-binding domain and Snf4 in glucose inhibition of SNF1 protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSON-WHITE-SYNDROME; SACCHAROMYCES-CEREVISIAE; YEAST SNF1; UPSTREAM KINASE; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; GAMMA(2) SUBUNIT; CATALYTIC DOMAIN; STRUCTURAL BASIS; ACTIVATES SNF1	The SNF1/AMP-activated protein kinase (AMPK) family is required for adaptation to metabolic stress and energy homeostasis. The gamma subunit of AMPK binds AMP and ATP, and mutations that affect binding cause human disease. We have here addressed the role of the Snf4 (gamma) subunit in regulating SNF1 protein kinase in response to glucose availability in Saccharomyces cerevisiae. Previous studies of mutant cells lacking Snf4 suggested that Snf4 counteracts autoinhibition by the C-terminal sequence of the Snf1 catalytic subunit but is dispensable for glucose regulation, and AMP does not activate SNF1 in vitro. We first introduced substitutions at sites that, in AMPK, contribute to nucleotide binding and regulation. Mutations at several sites relieved glucose inhibition of SNF1, as judged by catalytic activity, phosphorylation of the activation-loop Thr-210, and growth assays, although analogs of the severe human mutations R531G/Q had little effect. We further showed that alterations of Snf4 residues that interact with the glycogen-binding domain (GBD) of the beta subunit strongly relieved glucose inhibition. Finally, substitutions in the GBD of the Gal83 beta subunit that are predicted to disrupt interactions with Snf4 and also complete deletion of the GBD similarly relieved glucose inhibition of SNF1. Analysis of mutant cells lacking glycogen synthase showed that regulation of SNF1 is normal in the absence of glycogen. These findings reveal novel roles for Snf4 and theGBDin regulation of SNF1.	[Momcilovic, Milica] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Iram, Surtaj H.; Liu, Yang; Carlson, Marian] Columbia Univ, Dept Genet & Dev & Microbiol, New York, NY 10032 USA	Columbia University; Columbia University	Carlson, M (corresponding author), 701 W 168th St,HSC922, New York, NY 10032 USA.	mbc1@columbia.edu	Iram, Surtaj Hussain/T-5510-2019	Iram, Surtaj/0000-0002-0672-0936	NIGMS NIH HHS [GM34095, R01 GM034095] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034095, R37GM034095] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Arad M, 2003, CIRCULATION, V107, P2850, DOI 10.1161/01.CIR.0000075270.13497.2B; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; CARLSON M, 1981, GENETICS, V98, P25; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CELENZA JL, 1989, MOL CELL BIOL, V9, P5045, DOI 10.1128/MCB.9.11.5045; CELENZA JL, 1989, MOL CELL BIOL, V9, P5034, DOI 10.1128/MCB.9.11.5034; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Dubacq C, 2004, MOL CELL BIOL, V24, P2560, DOI 10.1128/MCB.24.6.2560-2572.2004; Elbing K, 2006, J BIOL CHEM, V281, P26170, DOI 10.1074/jbc.M603811200; ESTRUCH F, 1992, GENETICS, V132, P639; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HARDY TA, 1994, J BIOL CHEM, V269, P27907; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hedbacker K, 2004, MOL CELL BIOL, V24, P8255, DOI 10.1128/MCB.24.18.8255-8263.2004; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hedbacker K, 2006, EUKARYOT CELL, V5, P1950, DOI 10.1128/EC.00256-06; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hyman LE, 2002, J BIOL CHEM, V277, P15586, DOI 10.1074/jbc.M200800200; Jackson T, 2000, BBA-GENE STRUCT EXPR, V1491, P161, DOI 10.1016/S0167-4781(00)00052-X; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kuchin S, 2002, MOL CELL BIOL, V22, P3994, DOI 10.1128/MCB.22.12.3994-4000.2002; Leech A, 2003, EUKARYOT CELL, V2, P265, DOI 10.1128/EC.2.2.265-273.2003; MATSUMOTO K, 1981, MOL CELL BIOL, V1, P83, DOI 10.1128/MCB.1.2.83; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; NEIGEBORN L, 1984, GENETICS, V108, P845; NEIGEBORN L, 1987, GENETICS, V115, P247; Orlova M, 2006, EUKARYOT CELL, V5, P1831, DOI 10.1128/EC.00110-06; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Portillo F, 2005, FEBS LETT, V579, P512, DOI 10.1016/j.febslet.2004.12.019; Ramsey KL, 2004, MOL CELL BIOL, V24, P6362, DOI 10.1128/MCB.24.14.6362-6378.2004; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Rudolph MJ, 2007, STRUCTURE, V15, P65, DOI 10.1016/j.str.2006.11.014; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shirra MK, 1999, GENETICS, V152, P73; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; THOMPSONJAEGER S, 1991, GENETICS, V129, P697; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Vincent O, 1999, EMBO J, V18, P6672, DOI 10.1093/emboj/18.23.6672; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wiatrowski HA, 2004, MOL CELL BIOL, V24, P352, DOI 10.1128/MCB.24.1.352-361.2004; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; WOODS A, 1994, J BIOL CHEM, V269, P19509; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zou LQ, 2005, CIRC RES, V97, P323, DOI 10.1161/01.RES.0000179035.20319.c2	82	38	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19521	19529		10.1074/jbc.M803624200	http://dx.doi.org/10.1074/jbc.M803624200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18474591	Green Published, hybrid			2022-12-27	WOS:000257387600038
J	Scott, FL; Fuchs, GJ; Boyd, SE; Denault, JB; Hawkins, CJ; Dequiedt, F; Salvesen, GS				Scott, Fiona L.; Fuchs, Greg J.; Boyd, Sarah E.; Denault, Jean-Bernard; Hawkins, Christine J.; Dequiedt, Franck; Salvesen, Guy S.			Caspase-8 cleaves histone deacetylase 7 and abolishes its transcription repressor function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE-7; APOPTOSIS; ACTIVATION; SPECIFICITY; RECEPTOR; HDAC7; PHOSPHORYLATION; DIFFERENTIATION; ACETYLATION; INHIBITOR	Caspase-8 is the initiator caspase of the extrinsic apoptosis pathway and also has a role in non-apoptotic physiologies. Identifying endogenous substrates for caspase-8 by using integrated bioinformatics and biological approaches is required to delineate the diverse roles of this caspase. We describe a number of novel putative caspase-8 substrates using the Prediction of Protease Specificity (PoPS) program, one of which is histone deacetylase 7 (HDAC7). HDAC7 is cleaved faster than any other caspase-8 substrate described to date. It is also cleaved in primary CD4(+)CD8(+) thymocytes undergoing extrinsic apoptosis. By using naturally occurring caspase inhibitors that have evolved exquisite specificity at concentrations found within the cell, we could unequivocally assign the cleavage activity to caspase-8. Importantly, cleavage of HDAC7 alters its subcellular localization and abrogates its Nur77 repressor function. Thus we demonstrate a direct role for initiator caspase-mediated proteolysis in promoting gene transcription.	[Scott, Fiona L.; Fuchs, Greg J.; Denault, Jean-Bernard; Salvesen, Guy S.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Boyd, Sarah E.] Monash Univ, Fac Informat Technol, Melbourne, Vic 3800, Australia; [Hawkins, Christine J.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Hawkins, Christine J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Parkville, Vic 3050, Australia; [Dequiedt, Franck] Fac Agron, Cellular & Mol Biol Unit, B-5030 Gembloux, Belgium	Sanford Burnham Prebys Medical Discovery Institute; Monash University; La Trobe University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Scott, FL (corresponding author), Burnham Inst Med Res, Program Apoptosis & Cell Death Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fscott@burnham.org	Denault, Jean-Bernard/AAC-5945-2019; Boyd, Sarah E/I-9047-2012; Hawkins, Christine/B-8769-2011	Hawkins, Christine/0000-0001-8120-1071; Boyd, Sarah/0000-0002-7264-8602; Dequiedt, Franck/0000-0003-1234-7477	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NCRR NIH HHS [RR20843] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Ryan CA, 2002, BIOCHEM J, V366, P595, DOI 10.1042/BJ20020863; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Siggs OM, 2006, CURR OPIN IMMUNOL, V18, P175, DOI 10.1016/j.coi.2006.01.001; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wittmann JG, 2004, FEBS LETT, V568, P23, DOI 10.1016/j.febslet.2004.05.004; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	43	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19499	19510		10.1074/jbc.M800331200	http://dx.doi.org/10.1074/jbc.M800331200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18458084	Green Published, hybrid			2022-12-27	WOS:000257387600036
J	Shetty, S; Shetty, P; Idell, S; Velusamy, T; Bhandary, YP; Shetty, RS				Shetty, Sreerama; Shetty, Praveenkumar; Idell, Steven; Velusamy, Thirunavukkarasu; Bhandary, Yashodhar P.; Shetty, Rashmi S.			Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE RECEPTOR EXPRESSION; RNA-BINDING-PROTEIN; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MESSENGER-RNA; DNA-DAMAGE; PAI-1 GENE; INDUCTION; CANCER; CELLS	H1299 lung carcinoma cells lacking p53 (p53(-/-)) express minimal amounts of plasminogen activator inhibitor-1 (PAI-1) protein as well as mRNA. p53(-/-) cells express highly unstable PAI-1 mRNA. Transfection of p53 in p53(-/-) cells enhanced PAI-1 expression and stabilized PAI-1 mRNA. On the contrary, inhibition of p53 expression by RNA silencing in non-malignant human lung epithelial (Beas2B) cells decreased basal as well as urokinase-type plasminogen activator-induced PAI-1 expression because of accelerated degradation of PAI-1 mRNA. Purified p53 protein specifically binds to the PAI-1 mRNA 3'-untranslated region (UTR), and endogenous PAI-1 mRNA forms an immune complex with p53. Treatment of purified p53 protein with anti-p53 antibody abolished p53 binding to the 3'-UTR of PAI-1 mRNA. The p53 binding region maps to a 70-nucleotide PAI-1 mRNA 3'-UTR sequence, and insertion of the p53-binding sequence into beta-globin mRNA destabilized the chimeric transcript. Deletion experiments indicate that the carboxyl-terminal region (amino acid residues 296-393) of p53 protein interacts with PAI-1 mRNA. These observations demonstrate a novel role for p53 as an mRNA-binding protein that regulates increased PAI-1 expression and stabilization of PAI-1 mRNA in human lung epithelial and carcinoma cells.	[Shetty, Sreerama] Univ Texas Hlth Ctr Tyler, Texas Lung Injury Inst, Dept Specialty Care Serv, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Shetty, S (corresponding author), Univ Texas Hlth Ctr Tyler, Texas Lung Injury Inst, Dept Specialty Care Serv, 11937,US Highway 271,Lab C-6, Tyler, TX 75708 USA.	sreerama.shetty@uthct.edu	Velusamy, Thiruanvukkarasu/D-5144-2011; Bhandary, Yashodhar P/J-9078-2017; Shetty, Praveenkumar Shetty Praveenkumar/AAO-1349-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071147, R01HL062453] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL071147, P01HL-62453] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Barua RS, 2002, CIRCULATION, V106, P905, DOI 10.1161/01.CIR.0000029091.61707.6B; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; DANO K, 1994, FIBRINOLYSIS, V8, P189, DOI 10.1016/0268-9499(94)90717-X; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fu LN, 1997, EMBO J, V16, P4117, DOI 10.1093/emboj/16.13.4117; Fu LN, 1999, ONCOGENE, V18, P6419, DOI 10.1038/sj.onc.1203064; Ghosh S, 2002, AM J RESP CRIT CARE, V166, P890, DOI 10.1164/rccm.2109094; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Inoue M, 2005, ONCOL REP, V14, P1445; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Koziczak M, 2000, MOL CELL BIOL, V20, P2014, DOI 10.1128/MCB.20.6.2014-2022.2000; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Lane D, 2004, NEW ENGL J MED, V350, P2711, DOI 10.1056/NEJMcibr041288; Lau HKF, 2002, BRIT J HAEMATOL, V117, P151, DOI 10.1046/j.1365-2141.2002.03402.x; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Mazar A P, 1999, Angiogenesis, V3, P15, DOI 10.1023/A:1009095825561; Mishra A, 2000, AM J RESP CELL MOL, V22, P543, DOI 10.1165/ajrcmb.22.5.3851; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; OLMAN MA, 1995, J CLIN INVEST, V96, P1621, DOI 10.1172/JCI118201; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Parra M, 2001, J BIOL CHEM, V276, P36303, DOI 10.1074/jbc.M103735200; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Shetty S, 2005, J BIOL CHEM, V280, P28133, DOI 10.1074/jbc.M413190200; Shetty S, 2004, AM J RESP CELL MOL, V31, P100, DOI 10.1165/rcmb.2003-0104OC; Shetty S, 2003, J BIOL CHEM, V278, P18124, DOI 10.1074/jbc.M207445200; Shetty S, 1999, MOL CELL BIOCHEM, V199, P189, DOI 10.1023/A:1006914800447; Shetty S, 1997, MOL CELL BIOL, V17, P1075, DOI 10.1128/MCB.17.3.1075; Shetty S, 2001, J BIOL CHEM, V276, P24549, DOI 10.1074/jbc.M101605200; Shetty S, 2000, J BIOL CHEM, V275, P13771, DOI 10.1074/jbc.275.18.13771; SHETTY S, 2006, ENCY RESP MED, P205; Shetty S, 2007, MOL CELL BIOL, V27, P5607, DOI 10.1128/MCB.00080-07; Shmueli A, 2004, MOL CELL, V13, P4, DOI 10.1016/S1097-2765(03)00529-X; Sisson TH, 1999, HUM GENE THER, V10, P2315, DOI 10.1089/10430349950016960; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Swaisgood CM, 2000, AM J PATHOL, V157, P177, DOI 10.1016/S0002-9440(10)64529-4; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tressler RJ, 1999, APMIS, V107, P168, DOI 10.1111/j.1699-0463.1999.tb01540.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; YANAMANDRA N, 2005, CLIN EXP METASTAS, V18, P611	46	51	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19570	19580		10.1074/jbc.M710268200	http://dx.doi.org/10.1074/jbc.M710268200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18469003	Green Published, hybrid			2022-12-27	WOS:000257387600043
J	Polyak, MJ; Li, HD; Shariat, N; Deans, JP				Polyak, Maria J.; Li, Haidong; Shariat, Neda; Deans, Julie P.			CD20 homo-oligomers physically associate with the B cell antigen receptor - Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IG-ALPHA/IG-BETA; MU-HEAVY CHAIN; LIPID RAFTS; MEMBRANE RAFTS; LYMPHOCYTES-B; ACTIVATION; COMPLEX; SURFACE; PHOSPHORYLATION; IDENTIFICATION	B cell antigen receptor (BCR) signaling initiates sustained cellular calcium influx necessary for the development, differentiation, and activation of B lymphocytes. CD20 is a B cell-restricted tetraspanning protein organized in the plasma membrane as multimeric molecular complexes involved in BCR-activated calcium entry. Using coprecipitation of native CD20 with tagged or truncated forms of the molecule, we provide here direct evidence of CD20 homo-oligomerization into tetramers. Additionally, the function of CD20 was explored by examining its association with surface-labeled and intracellular proteins before and after BCR signaling. Two major surface-labeled proteins that coprecipitated with CD20 were identified as the heavy and light chains of cell surface IgM, the antigen-binding components of the BCR. After activation, BCR-CD20 complexes dissociated, and phosphoproteins and calmodulin-binding proteins were transiently recruited to CD20. These data provide new evidence of the involvement of CD20 in signaling downstream of the BCR and, together with the previously described involvement of CD20 in calcium influx, the first evidence of physical coupling of the BCR to a calcium entry pathway.	[Deans, Julie P.] Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Fac Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Deans, JP (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Fac Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jdeans@ucalgary.ca						BERGMAN Y, 1978, EUR J IMMUNOL, V8, P876, DOI 10.1002/eji.1830081210; BILLINGSLEY ML, 1985, P NATL ACAD SCI USA, V82, P7585, DOI 10.1073/pnas.82.22.7585; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; Carter RH, 1997, J IMMUNOL, V158, P3062; DEANS JP, 1995, J BIOL CHEM, V270, P22632, DOI 10.1074/jbc.270.38.22632; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Engelke M, 2007, IMMUNOL REV, V218, P235, DOI 10.1111/j.1600-065X.2007.00539.x; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; HUH YO, 1994, AM J CLIN PATHOL, V101, P283, DOI 10.1093/ajcp/101.3.283; Ishibashi K, 2001, GENE, V264, P87, DOI 10.1016/S0378-1119(00)00598-9; Kanzaki M, 1997, J BIOL CHEM, V272, P4964, DOI 10.1074/jbc.272.8.4964; Kim JH, 2005, J IMMUNOL, V175, P147, DOI 10.4049/jimmunol.175.1.147; Kim JH, 2007, INT IMMUNOL, V19, P1403, DOI 10.1093/intimm/dxm110; Kremyanskaya M, 2005, J IMMUNOL, V174, P1501, DOI 10.4049/jimmunol.174.3.1501; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; LANKESTER AC, 1994, EUR J IMMUNOL, V24, P812, DOI 10.1002/eji.1830240406; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; Li HD, 2004, J BIOL CHEM, V279, P19893, DOI 10.1074/jbc.M400525200; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Liang YH, 2001, GENOMICS, V72, P119, DOI 10.1006/geno.2000.6472; LINTHICUM DS, 1975, J ULTRA MOL STRUCT R, V51, P55, DOI 10.1016/S0022-5320(75)80008-6; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MELCHERS F, 1972, BIOCHEMISTRY-US, V11, P2204, DOI 10.1021/bi00761a031; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mutch CM, 2007, INT IMMUNOL, V19, P19, DOI 10.1093/intimm/dxl118; O'Keefe TL, 1998, IMMUNOGENETICS, V48, P125, DOI 10.1007/s002510050412; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; Petrie RJ, 2002, J IMMUNOL, V169, P2886, DOI 10.4049/jimmunol.169.6.2886; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; PETRIS SD, 1978, NATURE, V272, P66, DOI 10.1038/272066a0; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Polyak MJ, 2002, BLOOD, V99, P3256, DOI 10.1182/blood.V99.9.3256; Polyak MJ, 1998, J IMMUNOL, V161, P3242; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; TEDDER TF, 1988, J BIOL CHEM, V263, P10009; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; VALENTINE MA, 1989, J BIOL CHEM, V264, P11282; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Vilen BJ, 2002, J IMMUNOL, V168, P4344, DOI 10.4049/jimmunol.168.9.4344	42	84	93	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18545	18552		10.1074/jbc.M800784200	http://dx.doi.org/10.1074/jbc.M800784200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18474602	hybrid			2022-12-27	WOS:000257165600010
J	Verdone, G; Doliana, R; Corazza, A; Colebrooke, SA; Spessotto, P; Bot, S; Bucciotti, F; Capuano, A; Silvestri, A; Viglino, P; Campbell, ID; Colombatti, A; Esposito, G				Verdone, Giuliana; Doliana, Roberto; Corazza, Alessandra; Colebrooke, Simon A.; Spessotto, Paola; Bot, Simonetta; Bucciotti, Francesco; Capuano, Alessandra; Silvestri, Alessandra; Viglino, Paolo; Campbell, Iain D.; Colombatti, Alfonso; Esposito, Gennaro			The solution structure of EMILIN1 globular C1q domain reveals a disordered insertion necessary for interaction with the alpha 4 beta 1 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; CRYSTAL-STRUCTURE; CELL-ADHESION; CHEMICAL-SHIFT; NMR ASSIGNMENTS; BINDING; SEQUENCE; COMPONENT; MACROMOLECULES; IDENTIFICATION	The extracellular matrix protein EMILIN1 (elastin microfibril interface located protein 1) is implicated in maintaining blood pressure homeostasis via the N-terminal elastin microfibril interface domain and in trophoblast invasion of the uterine wall via the globular C1q (gC1q) domain. Here, we describe the first NMR-based homology model structure of the human 52-kDa homotrimer of the EMILIN1 gC1q domain. In contrast to all of the gC1q (crystal) structures solved to date, the 10-stranded beta-sandwich fold of the gC1q domain is reduced to nine beta strands with a consequent increase in the size of the central cavity lumen. An unstructured loop, resulting from an insertion unique to EMILIN1 and EMILIN2 family members and located at the trimer apex upstream of the missing strand, specifically engages the alpha 4 beta 1 integrin. Using both Jurkat T and EA.hy926 endothelial cells as well as site-directed mutagenesis, we demonstrate that the ability of alpha 4 beta 1 integrins to recognize the trimeric EMILIN1 gC1q domain mainly depends on a single glutamic acid residue (Glu(933)). Static and flow adhesion of T cells and haptotactic migration of endothelial cells on gC1q is fully dependent on this residue. Thus, EMILIN1 gC1q-alpha 4 beta 1 represents a unique ligand/receptor system, with a requirement for a 3-fold arrangement of the interaction site.	[Doliana, Roberto; Spessotto, Paola; Bot, Simonetta; Bucciotti, Francesco; Capuano, Alessandra; Silvestri, Alessandra; Colombatti, Alfonso] Ctr Riferimento Oncol, Div Oncol Sperimentale 2, I-33081 Aviano, Italy; [Verdone, Giuliana; Corazza, Alessandra; Viglino, Paolo; Colombatti, Alfonso; Esposito, Gennaro] Univ Udine, Dipartimento Sci & Tecnol Biomed, Ctr Eccellenza MATI, I-33100 Udine, Italy; [Colebrooke, Simon A.; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Colebrooke, Simon A.; Campbell, Iain D.] Univ Oxford, Oxford Ctr Mol Sci, Oxford OX1 3QU, England; [Corazza, Alessandra; Viglino, Paolo; Esposito, Gennaro] Consorzio INBB, I-00136 Rome, Italy	IRCCS Aviano (CRO); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine; University of Oxford; University of Oxford	Colombatti, A (corresponding author), Ctr Riferimento Oncol, Div Oncol Sperimentale 2, Via Franco Gallini 2, I-33081 Aviano, Italy.	acolombatti@cro.it	Bucciotti, Francesco/AAZ-1255-2020; Corazza, Alessandra/AGB-1457-2022; Spessotto, Paola/K-5005-2012; Doliana, Roberto/AAA-1479-2019; Capuano, Alessandra/AAC-2129-2020	Bucciotti, Francesco/0000-0002-4253-855X; Corazza, Alessandra/0000-0003-2272-1928; Spessotto, Paola/0000-0002-3033-404X; Doliana, Roberto/0000-0002-8324-7564; Capuano, Alessandra/0000-0002-5443-0570; Silvestri, Alessandra/0000-0003-4891-1826; colombatti, alfonso/0000-0002-3676-2379	Telethon [E.1256] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; CLEMENTS JM, 1994, J CELL SCI, V107, P2127; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; COLOMBATTI A, 1985, J CELL BIOL, V100, P18, DOI 10.1083/jcb.100.1.18; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; Doliana R, 2001, J BIOL CHEM, V276, P12003, DOI 10.1074/jbc.M011591200; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Giacomello E, 1999, BIOTECHNIQUES, V26, P758, DOI 10.2144/99264pf01; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hauzenberger D, 1995, CRIT REV IMMUNOL, V15, P285, DOI 10.1615/CritRevImmunol.v15.i3-4.60; Kilger G, 1997, INT IMMUNOL, V9, P219, DOI 10.1093/intimm/9.2.219; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Machin M, 2006, ANN BIOMED ENG, V34, P833, DOI 10.1007/s10439-006-9086-8; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Spessotto P, 2003, MATRIX BIOL, V22, P351, DOI 10.1016/S0945-053X(03)00050-7; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Spessotto P, 2000, METH MOL B, V139, P321; Spessotto P, 2006, J CELL SCI, V119, P4574, DOI 10.1242/jcs.03232; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; Verdone G, 2004, J BIOMOL NMR, V29, P91, DOI 10.1023/B:JNMR.0000019460.94913.6a; VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215; WISHART DS, 1994, J BIOMOL NMR, V4, P171; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	45	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18947	18956		10.1074/jbc.M801085200	http://dx.doi.org/10.1074/jbc.M801085200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18463100	hybrid			2022-12-27	WOS:000257165600051
J	Block, K; Eid, A; Griendling, KK; Lee, DY; Wittrant, Y; Gorin, Y				Block, Karen; Eid, Assaad; Griendling, Kathy K.; Lee, Duck-Yoon; Wittrant, Yohann; Gorin, Yves			Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II - Role in mesangial cell hypertrophy and fibronectin expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; GROWTH-FACTOR RECEPTOR; HIGH GLUCOSE; NADPH OXIDASES; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; DOWN-REGULATION; RENAL-DISEASE; PATHWAY; MECHANISMS	Activation of glomerular mesangial cells (MCs) by angiotensin II (Ang II) leads to hypertrophy and extracellular matrix accumulation. Here, we demonstrate that, in MCs, Ang II induces an increase in PDK-1 (3-phosphoinositide-dependent protein kinase-1) kinase activity that required its phosphorylation on tyrosine 9 and 373/376. Introduction into the cells of PDK-1, mutated on these tyrosine residues or kinase-inactive, attenuates Ang II-induced hypertrophy and fibronectin accumulation. Ang II-mediated PDK-1 activation and tyrosine phosphorylation ( total and on residues 9 and 373/376) are inhibited in cells transfected with small interfering RNA for Src, indicating that Src is upstream of PDK-1. In cells expressing oxidation-resistant Src mutant C487A, Ang II-induced hypertrophy and fibronectin expression are prevented, suggesting that the pathway is redox-sensitive. Ang II also up-regulates Nox4 protein, and siNox4 abrogates the Ang II-induced increase in intracellular reactive oxygen species (ROS) generation. Small interfering RNA for Nox4 also inhibits Ang II-induced activation of Src and PDK-1 tyrosine phosphorylation ( total and on residues 9 and 373/376), demonstrating that Nox4 functions upstream of Src and PDK-1. Importantly, inhibition of Nox4, Src, or PDK-1 prevents the stimulatory effect of Ang II on fibronectin accumulation and cell hypertrophy. This work provides the first evidence that Nox4-derived ROS are responsible for Ang II-induced PDK-1 tyrosine phosphorylation and activation through stimulation of Src. Importantly, this pathway contributes to Ang II-induced MC hypertrophy and fibronectin accumulation. These data shed light on molecular processes underlying the oxidative signaling cascade engaged by Ang II and identify potential targets for intervention to prevent renal hypertrophy and fibrosis.	[Gorin, Yves] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol MC 7882, San Antonio, TX 78229 USA; [Wittrant, Yohann] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Gorin, Yves] Univ Texas Hlth Sci Ctr San Antonio, George Obrien Kidney Res Ctr, San Antonio, TX 78229 USA; [Griendling, Kathy K.] Emory Univ, Div Cardiol, Atlanta, GA USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Emory University	Gorin, Y (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol MC 7882, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	gorin@uthscsa.edu		Griendling, Kathy/0000-0002-9456-8582; Gorin, Yves/0000-0003-4048-6925	National Institutes of Health [K01DK-076923]; NIDDK; George O'Brien Kidney Center; American Heart Association (National); American Heart Association (South Central Affiliate); Juvenile Diabetes Research Foundation; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); George O'Brien Kidney Center; American Heart Association (National)(American Heart Association); American Heart Association (South Central Affiliate)(American Heart Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K01DK-076923 (to K. B.) and the National Institutes of Health, NIDDK, George O'Brien Kidney Center (to Y.G.). This work was supported in part through an American Heart Association ( National) Scientist Development Grant (to Y.G.), a grant-in-aid from the American Heart Association (South Central Affiliate) (to Y.G.), a Juvenile Diabetes Research Foundation Regular Research Grant (to Y.G.), and a National Kidney Foundation Young Investigator Award (to Y.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Amiri F, 1999, AM J PHYSIOL-RENAL, V276, pF691, DOI 10.1152/ajprenal.1999.276.5.F691; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Block K, 2006, ANTIOXID REDOX SIGN, V8, P1497, DOI 10.1089/ars.2006.8.1497; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brenner BM, 2002, J CLIN INVEST, V110, P1753, DOI 10.1172/JCI200217351; Brewster UC, 2003, AM J MED SCI, V326, P15, DOI 10.1097/00000441-200307000-00003; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chatziantoniou C, 2005, AM J PHYSIOL-RENAL, V289, pF227, DOI 10.1152/ajprenal.00453.2004; Chen H, 2001, BIOCHEMISTRY-US, V40, P11851, DOI 10.1021/bi010743c; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; Geiszt M, 2006, CARDIOVASC RES, V71, P289, DOI 10.1016/j.cardiores.2006.05.004; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gomez-Guerrero Carmen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P341, DOI 10.2174/1568010054022169; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gorin Y, 2001, FASEB J, V15, P1909, DOI 10.1096/fj..01-0165com; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Guo JF, 2006, CIRC RES, V99, P1367, DOI 10.1161/01.RES.0000252830.01581.fd; Hanna IR, 2002, ANTIOXID REDOX SIGN, V4, P899, DOI 10.1089/152308602762197443; Kim DW, 2003, MOL ENDOCRINOL, V17, P1382, DOI 10.1210/me.2002-0402; Kim S, 2000, PHARMACOL REV, V52, P11; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mima A, 2006, LAB INVEST, V86, P927, DOI 10.1038/labinvest.3700445; Mukhin YV, 2000, BIOCHEM J, V347, P61, DOI 10.1042/0264-6021:3470061; Nakashima I, 2002, ANTIOXID REDOX SIGN, V4, P517, DOI 10.1089/15230860260196326; Okada H, 2005, CURR MOL MED, V5, P467, DOI 10.2174/1566524054553478; Orient A, 2007, NEPHROL DIAL TRANSPL, V22, P1281, DOI 10.1093/ndt/gfm077; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i; RINCONCHOLES H, 2002, KIDNEY INT S, V82, P8; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Steiler TL, 2003, ENDOCRINOLOGY, V144, P5259, DOI 10.1210/en.2003-0447; Taal MW, 1999, J HUM HYPERTENS, V13, pS51, DOI 10.1038/sj.jhh.1000742; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yano N, 2007, J BIOL CHEM, V282, P18819, DOI 10.1074/jbc.M610537200	60	115	122	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24061	24076		10.1074/jbc.M803964200	http://dx.doi.org/10.1074/jbc.M803964200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18559349	Green Published, hybrid			2022-12-27	WOS:000258638900061
J	Redzynia, I; Ljunggren, A; Abrahamson, M; Mort, JS; Krupa, JC; Jaskolski, M; Bujacz, G				Redzynia, Izabela; Ljunggren, Anna; Abrahamson, Magnus; Mort, John S.; Krupa, Joanne C.; Jaskolski, Mariusz; Bujacz, Grzegorz			Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROCATHEPSIN-B; CYSTEINE PROTEASE; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; STRUCTURAL BASIS; COMPLEX; MODEL; IDENTIFICATION; SPECIFICITY; PROGRAM	Cathepsin B is a papain-like cysteine protease showing both endo- and exopeptidase activity, the latter due to a unique occluding loop that restricts access to the active site cleft. To clarify the mode by which natural protein inhibitors manage to overcome this obstacle, we have analyzed the structure and function of cathepsin B in complexes with the Trypanosoma cruzi inhibitor, chagasin. Kinetic analysis revealed that substitution of His-110e, which anchors the loop in occluding position, results in 3-fold increased chagasin affinity (K-i for H110A cathepsin B, 0.35 nM) due to an improved association rate (kon, 5 x 105 M(-1)s(-1)). The structure of chagasin in complex with cathepsin B was solved in two crystal forms (1.8 and 2.67 A resolution), demonstrating that the occluding loop is displaced to allow chagasin binding with its three loops, L4, L2, and L6, spanning the entire active site cleft. The occluding loop is differently displaced in the two structures, indicating a large range of movement and adoption of conformations forced by the inhibitor. The area of contact is slightly larger than in chagasin complexes with the endopeptidase, cathepsin L. However, residues important for high affinity to both enzymes are mainly found in the outer loops L4 and L6 of chagasin. The chagasin- cathepsin B complex provides a structural framework for modeling and design of inhibitors for cruzipain, the parasite cysteine protease and a virulence factor in Chagas disease.	[Redzynia, Izabela; Bujacz, Grzegorz] Tech Univ Lodz, Fac Food Sci & Biotechnol, PL-90924 Lodz, Poland; [Ljunggren, Anna; Abrahamson, Magnus] Lund Univ, Div Clin Chem & Pharmacol, Dept Lab Med, SE-22185 Lund, Sweden; [Mort, John S.; Krupa, Joanne C.] Shriners Hosp Children, Joint Dis Lab, Montreal, PQ H3G 1A6, Canada; [Jaskolski, Mariusz] Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, PL-60780 Poznan, Poland; [Jaskolski, Mariusz; Bujacz, Grzegorz] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, PL-61704 Poznan, Poland; [Bujacz, Grzegorz] Tech Univ Lodz, Inst Tech Biochem, PL-90924 Lodz, Poland	Lodz University of Technology; Lund University; McGill University; Adam Mickiewicz University; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Lodz University of Technology	Abrahamson, M (corresponding author), Univ Hosp, S-22185 Lund, Sweden.	Magnus.Abrahamson@med.lu.se; gdbujacz@p.lodz.pl	Bujacz, Grzegorz/M-4446-2018; Szymczak, Izabela/N-3073-2018; Abrahamson, Magnus/CAG-9507-2022	Bujacz, Grzegorz/0000-0002-3787-7522; Szymczak, Izabela/0000-0002-0944-8237; Jaskolski, Mariusz/0000-0003-1587-6489				Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; BLUMBERG S, 1970, EUR J BIOCHEM, V15, P97, DOI 10.1111/j.1432-1033.1970.tb00981.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W, 2002, PYMOL 0 99; dos Reis FCG, 2008, FEBS LETT, V582, P485, DOI 10.1016/j.febslet.2008.01.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GASTEIGER E, 2005, PROTPARAM; Guncar G, 1998, STRUCTURE, V6, P51; HALL A, 1995, J BIOL CHEM, V270, P5115, DOI 10.1074/jbc.270.10.5115; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; HASNAIN S, 1992, J BIOL CHEM, V267, P4713; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; Krupa JC, 2002, BIOCHEM J, V361, P613, DOI 10.1042/0264-6021:3610613; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ljunggren A, 2007, J MOL BIOL, V371, P137, DOI 10.1016/j.jmb.2007.05.005; MACH L, 1994, J BIOL CHEM, V269, P13030; Molgaard A, 2007, BIOCHEM J, V401, P645, DOI 10.1042/BJ20061389; Monteiro ACS, 2001, J CELL SCI, V114, P3933; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Nomura T, 2005, J MED INVESTIG, V52, P1, DOI 10.2152/jmi.52.1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlova A, 2000, FEBS LETT, V487, P156, DOI 10.1016/S0014-5793(00)02337-1; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Salmon D, 2006, J MOL BIOL, V357, P1511, DOI 10.1016/j.jmb.2006.01.064; Sivaraman J, 2000, J MOL BIOL, V295, P939, DOI 10.1006/jmbi.1999.3410; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang SX, 2007, STRUCTURE, V15, P535, DOI 10.1016/j.str.2007.03.012; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013	43	32	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22815	22825		10.1074/jbc.M802064200	http://dx.doi.org/10.1074/jbc.M802064200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18515357	hybrid			2022-12-27	WOS:000258321000049
J	Hauenstein, SI; Perona, JJ				Hauenstein, Scott I.; Perona, John J.			Redundant synthesis of cysteinyl-tRNA(Cys) in Methanosarcina mazei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; DEPENDENT CYSTEINE BIOSYNTHESIS; AEROPYRUM-PERNIX K1; ESCHERICHIA-COLI; SELENOCYSTEINE SYNTHASE; AMINO-ACID; CYS-TRNA(CYS) FORMATION; ARCHAEOGLOBUS-FULGIDUS; STRUCTURAL INSIGHTS; METHANE FORMATION	A subset of methanogenic archaea synthesize the cysteinyl-tRNA(Cys) (Cys-tRNA(Cys)) needed for protein synthesis using both a canonical cysteinyl-tRNA synthetase (CysRS) as well as a set of two enzymes that operate via a separate indirect pathway. In the indirect route, phosphoseryl-tRNA(Cys) (Sep-tRNA(Cys)) is first synthesized by phosphoseryl-tRNA synthetase (SepRS), and this misacylated intermediate is then converted to Cys-tRNA(Cys) by Sep-tRNA: Cys-tRNA synthase (SepCysS) via a pyridoxal phosphate-dependent mechanism. Here, we explore the function of all three enzymes in the mesophilic methanogen Methanosarcina mazei. The genome of M. mazei also features three distinct tRNA(Cys) isoacceptors, further indicating the unusual and complex nature of Cys-tRNACys synthesis in this organism. Comparative aminoacylation kinetics by M. mazei CysRS and SepRS reveals that each enzyme prefers a distinct tRNA(Cys) isoacceptor or pair of isoacceptors. Recognition determinants distinguishing the tRNAs are shown to reside in the globular core of the molecule. Both enzymes also require the S-adenosylmethione-dependent formation of (m1)G37 in the anticodon loop for efficient aminoacylation. We further report a new, highly sensitive assay to measure the activity of SepCysS under anaerobic conditions. With this approach, we demonstrate that SepCysS functions as a multiple-turnover catalyst with kinetic behavior similar to bacterial selenocysteine synthase and the archaeal/ eukaryotic SepSecS enzyme. Together, these data suggest that both metabolic routes and all three tRNA(Cys) species in M. mazei play important roles in the cellular physiology of the organism.	[Hauenstein, Scott I.; Perona, John J.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Perona, John J.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Perona, JJ (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	perona@chem.ucsb.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063713] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63713] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambrogelly A, 2004, CELL MOL LIFE SCI, V61, P2437, DOI 10.1007/s00018-004-4194-9; Ashraf SS, 1999, RNA, V5, P503, DOI 10.1017/S1355838299981931; Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; BARE L, 1983, NATURE, V305, P554, DOI 10.1038/305554a0; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; DIX DB, 1986, J BIOL CHEM, V261, P112; Ehlers C, 2005, MOL GENET GENOMICS, V273, P290, DOI 10.1007/s00438-005-1128-7; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; Hauenstein SI, 2008, J BIOL CHEM, V283, P21997, DOI 10.1074/jbc.M801838200; HIPPE H, 1979, P NATL ACAD SCI USA, V76, P494, DOI 10.1073/pnas.76.1.494; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; HOU YM, 1993, P NATL ACAD SCI USA, V90, P6776, DOI 10.1073/pnas.90.14.6776; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; KOMATSOULIS GA, 1993, BIOCHEMISTRY-US, V32, P7435, DOI 10.1021/bi00080a014; Kruger MK, 1998, J MOL BIOL, V284, P609, DOI 10.1006/jmbi.1998.2197; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P53; Madore E, 1999, EUR J BIOCHEM, V266, P1128, DOI 10.1046/j.1432-1327.1999.00965.x; Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06; Major TA, 2004, FEMS MICROBIOL LETT, V239, P117, DOI 10.1016/j.femsle.2004.08.027; MARKHAM GD, 1980, J BIOL CHEM, V255, P9082; MILHARA H, 2002, APPL MICROBIOL BIOT, V60, P12; Mino K, 2003, J BACTERIOL, V185, P2277, DOI 10.1128/JB.185.7.2277-2284.2003; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; Oda Y, 2005, J MOL BIOL, V351, P334, DOI 10.1016/j.jmb.2005.05.064; PUTZ J, 1994, NAT STRUCT BIOL, V1, P580, DOI 10.1038/nsb0994-580; ROGERS KC, 1993, BIOCHEMISTRY-US, V32, P14210, DOI 10.1021/bi00214a021; Sakurai M, 2005, NUCLEIC ACIDS RES, V33, P1653, DOI 10.1093/nar/gki309; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; SOWERS KR, 1995, ARCHAEA LAB MANUAL, P38; Tormay P, 1998, EUR J BIOCHEM, V254, P655, DOI 10.1046/j.1432-1327.1998.2540655.x; WADA H, 1961, J BIOL CHEM, V236, P2089; WICH G, 1986, NUCLEIC ACIDS RES, V14, P2459, DOI 10.1093/nar/14.6.2459; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423; Zhou XZ, 1999, BIOCHEMISTRY-US, V38, P311, DOI 10.1021/bi981455s	52	33	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22007	22017		10.1074/jbc.M801839200	http://dx.doi.org/10.1074/jbc.M801839200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18559341	Green Published, hybrid			2022-12-27	WOS:000258114700020
J	Urayama, S; Harada, Y; Nakagawa, Y; Ban, S; Akasaka, M; Kawasaki, N; Sawada, H				Urayama, Satoshi; Harada, Yoshito; Nakagawa, Yoko; Ban, Susumu; Akasaka, Mari; Kawasaki, Nana; Sawada, Hitoshi			Ascidian sperm glycosylphosphatidylinositol-anchored CRISP-like protein as a binding partner for an allorecognizable sperm receptor on the vitelline coat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-STERILITY; PHYSIOLOGICAL PROBLEMS; LOW-DENSITY; FERTILIZATION; RECOGNITION; FRACTION; HRVC70; EGGS; SITE	Although ascidians are hermaphroditic, many species including Halocynthia roretzi are self-sterile. We previously reported that a vitelline coat polymorphic protein HrVC70, consisting of 12 EGF (epidermal growth factor)-like repeats, is a candidate allorecognition protein in H. roretzi, because the isolated HrVC70 shows higher affinity to nonself-sperm than to self-sperm. Here, we show that a sperm 35-kDa glycosylphosphatidylinositol-anchored CRISP (cysteine-rich secretory protein)-like protein HrUrabin in a low density detergent-insoluble membrane fraction is a physiological binding partner for HrVC70. We found that HrVC70 specifically interacts with HrUrabin, which had been separated by SDS-PAGE and transferred onto a nitrocellulose membrane. HrUrabin has an N-linked sugar chain, essential for binding to HrVC70. HrUrabin mRNA is expressed in the testis but not in the ovary, and the protein appears to be localized on the surface of sperm head and tail. Anti-HrUrabin antibody, which neutralizes the interaction between HrUrabin and HrVC70, potently inhibited fertilization and allorecognizable sperm-binding to HrVC70-agarose. However, no significant difference in the binding ability of HrUrabin to HrVC70 was observed in autologous and allogeneic combinations by Far Western analyses. These results indicate that sperm-egg binding in H. roretzi is mediated by the molecular interaction between HrUrabin on the sperm surface and HrVC70 on the vitelline coat, but that HrUrabin per se is unlikely to be a direct allorecognition protein.	[Urayama, Satoshi; Harada, Yoshito; Nakagawa, Yoko; Ban, Susumu; Akasaka, Mari; Sawada, Hitoshi] Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan; [Ban, Susumu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Sapporo, Hokkaido 0601206, Japan; [Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan	Nagoya University; Hokkaido University; National Institute of Health Sciences - Japan	Sawada, H (corresponding author), Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan.	hsawada@bio.nagoya-u.ac.jp						ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Ellerman DA, 2006, DEV BIOL, V297, P228, DOI 10.1016/j.ydbio.2006.05.013; Fuke M, 1996, ROUX ARCH DEV BIOL, V205, P391, DOI 10.1007/BF00377219; Fuke M, 1999, MOL REPROD DEV, V52, P99, DOI 10.1002/(SICI)1098-2795(199901)52:1<99::AID-MRD12>3.0.CO;2-N; FUKE MT, 1983, ROUX ARCH DEV BIOL, V192, P347, DOI 10.1007/BF00848815; HARADA H, 2008, INT J DEV B IN PRESS, V52; Harada Y, 2008, SCIENCE, V320, P548, DOI 10.1126/science.1152488; Harada Y, 2007, MOL REPROD DEV, V74, P1178, DOI 10.1002/mrd.20616; Harazono A, 2005, GLYCOBIOLOGY, V15, P447, DOI 10.1093/glycob/cwi033; Hotta K, 1998, DEV GENES EVOL, V208, P164, DOI 10.1007/s004270050169; Jiang D, 2005, BIOL BULL-US, V209, P107, DOI 10.2307/3593128; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kodama E, 2002, EUR J BIOCHEM, V269, P657, DOI 10.1046/j.0014-2956.2001.02696.x; Kuern U, 2007, DEV COMP IMMUNOL, V31, P1242, DOI 10.1016/j.dci.2007.03.011; Matsumoto M, 2002, ZOOL SCI, V19, P43, DOI 10.2108/zsj.19.43; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Morgan TH, 1942, J EXP ZOOL, V90, P199, DOI 10.1002/jez.1400900205; Morgan TH, 1944, J EXP ZOOL, V95, P37, DOI 10.1002/jez.1400950105; Morgan TH, 1923, P NATL ACAD SCI USA, V9, P170, DOI 10.1073/pnas.9.5.170; Morgan TH, 1939, J EXP ZOOL, V80, P19, DOI 10.1002/jez.1400800103; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Ohta K, 2000, GLYCOCONJUGATE J, V17, P205, DOI 10.1023/A:1026589223811; Roberts KP, 2006, MOL CELL ENDOCRINOL, V250, P122, DOI 10.1016/j.mce.2005.12.034; ROSATI F, 1978, EXP CELL RES, V112, P111, DOI 10.1016/0014-4827(78)90531-1; Sawada H, 2004, P NATL ACAD SCI USA, V101, P15615, DOI 10.1073/pnas.0401928101; Sawada H, 2002, ZOOL SCI, V19, P139, DOI 10.2108/zsj.19.139; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; SAWADA H, 1982, GAMETE RES, V5, P291, DOI 10.1002/mrd.1120050309; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Yudin AI, 2002, MOL REPROD DEV, V63, P488, DOI 10.1002/mrd.10193	30	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21725	21733		10.1074/jbc.M802631200	http://dx.doi.org/10.1074/jbc.M802631200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524765	hybrid			2022-12-27	WOS:000257898800046
J	Shrimali, RK; Irons, RD; Carlson, BA; Sano, Y; Gladyshev, VN; Park, JM; Hatfield, DL				Shrimali, Rajeev K.; Irons, Robert D.; Carlson, Bradley A.; Sano, Yasuyo; Gladyshev, Vadim N.; Park, Jin Mo; Hatfield, Dolph L.			Selenoproteins mediate T cell immunity through an antioxidant mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR STIMULATION; HYDROGEN-PEROXIDE; SELENIUM; MICE; ACTIVATION; GENERATION; RESPONSES; HEALTH	Selenium is an essential dietary element with antioxidant roles in immune regulation, but there is little understanding of how this element acts at the molecular level in host defense and inflammatory disease. Selenium is incorporated into the amino acid selenocysteine (Sec), which in turn is inserted into selenoproteins in a manner dependent on Sec tRNA([Ser]Sec). To investigate the molecular mechanism that links selenium to T cell immunity, we generated mice with selenoprotein-less T cells by cell type-specific ablation of the Sec tRNA([Ser]Sec) gene (trsp). Herein, we show that these mutant mice exhibit decreased pools of mature T cells and a defect in T cell- dependent antibody responses. We also demonstrate that selenoprotein deficiency leads to oxidant hyperproduction in T cells and thereby suppresses T cell proliferation in response to T cell receptor stimulation. These findings offer novel insights into immune function of selenium and physiological antioxidants.	[Sano, Yasuyo; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; [Shrimali, Rajeev K.; Irons, Robert D.; Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Nebraska System; University of Nebraska Lincoln	Park, JM (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA.	jmpark@cbrc2.mgh.harvard.edu; hatfield@mail.nih.gov	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Gladyshev, Vadim/0000-0002-0372-7016	Intramural NIH HHS [Z01 BC005317-24] Funding Source: Medline; NCI NIH HHS [CA 080946] Funding Source: Medline; NIGMS NIH HHS [GM 065204] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080946, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beck MA, 2007, J NUTR, V137, P1338, DOI 10.1093/jn/137.5.1338; Copeland PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-221; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Gladyshev VN, 1999, P NATL ACAD SCI USA, V96, P835, DOI 10.1073/pnas.96.3.835; HATFIELD DL, 2006, SELENIUM ITS MOL BIO, P1; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hoffmann PR, 2007, ARCH IMMUNOL THER EX, V55, P289, DOI 10.1007/s00005-007-0036-4; Hoffmann PR, 2007, J IMMUNOL, V179, P3258, DOI 10.4049/jimmunol.179.5.3258; Hooven LA, 2006, BIOL TRACE ELEM RES, V109, P173, DOI 10.1385/BTER:109:2:173; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; KIREMIDJIANSCHUMACHER L, 1992, BIOL TRACE ELEM RES, V33, P23, DOI 10.1007/BF02783989; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Kwon J, 2003, FREE RADICAL BIO MED, V35, P406, DOI 10.1016/S0891-5849(03)00318-6; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Ueno H, 2008, J TRACE ELEM MED BIO, V22, P9, DOI 10.1016/j.jtemb.2007.10.002; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004	23	112	118	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20181	20185		10.1074/jbc.M802559200	http://dx.doi.org/10.1074/jbc.M802559200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487203	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000257565300034
J	Braem, C; Recolin, B; Rancourt, RC; Angiolini, C; Barthes, P; Branchu, P; Court, F; Cathala, G; Ferguson-Smith, AC; Forne, T				Braem, Caroline; Recolin, Benedicte; Rancourt, Rebecca C.; Angiolini, Christopher; Barthes, Pauline; Branchu, Priscillia; Court, Franck; Cathala, Guy; Ferguson-Smith, Anne C.; Forne, Thierry			Genomic matrix attachment region and chromosome conformation capture quantitative real time PCR assays identify novel putative regulatory elements at the imprinted Dlk1/Gtl2 locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENES; CHROMATIN; DOMAIN; GTL2; IGF2; H19; IDENTIFICATION; TRANSCRIPTS; ANTISENSE; MICE	We previously showed that genomic imprinting regulates matrix attachment region activities at the mouse Igf2 (insulin-like growth factor 2) locus and that these activities are functionally linked to neighboring differentially methylated regions (DMRs). Here, we investigate the similarly structured Dlk1/Gtl2 imprinted domain and show that in the mouse liver, the G/C-rich intergenic germ line-derived DMR, a sequence involved in domain-wide imprinting, is highly retained within the nuclear matrix fraction exclusively on the methylated paternal copy, reflecting its differential function on that chromosome. Therefore, not only "classical" A/T-rich matrix attachment region (MAR) sequences but also other important regulatory DNA elements (such as DMRs) can be recovered from genomic MAR assays following a high salt treatment. Interestingly, the recovery of one A/T-rich sequence (MAR4) from the "nuclear matrix" fraction is strongly correlated with gene expression. We show that this element possesses an intrinsic activity that favors transcription, and using chromosome conformation capture quantitative real time PCR assays, we demonstrate that the MAR4 interacts with the intergenic germ line-derived DMR specifically on the paternal allele but not with the Dlk1/Gtl2 promoters. Altogether, our findings shed a new light on gene regulation at this locus.	[Braem, Caroline; Recolin, Benedicte; Barthes, Pauline; Branchu, Priscillia; Court, Franck; Cathala, Guy; Forne, Thierry] Univ Montpellier 2, CNRS, UMR 5535, Inst Genet Mol,IGMM,IFR 122, F-34293 Montpellier 5, France; [Rancourt, Rebecca C.; Angiolini, Christopher; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Cambridge	Forne, T (corresponding author), Univ Montpellier 2, CNRS, UMR 5535, Inst Genet Mol,IGMM,IFR 122, 1919 Route Mende, F-34293 Montpellier 5, France.	forne@igmm.cnrs.fr	Ferguson-Smith, Anne C/G-7534-2011; Forne, Thierry/D-3718-2013	Forne, Thierry/0000-0002-9179-1551; Rancourt, Rebecca/0000-0003-2696-7220; court, franck/0000-0003-0327-9708; Branchu, Priscilla/0000-0002-8127-1181; Ferguson-Smith, Anne/0000-0002-7608-5894	MRC [G0701196] Funding Source: UKRI; Cancer Research UK Funding Source: Medline; Medical Research Council [G0701196] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Kanduri C, 2006, EMBO J, V25, P2096, DOI 10.1038/sj.emboj.7601090; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Milligan L, 2002, EMBO REP, V3, P774, DOI 10.1093/embo-reports/kvf142; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Paulsen M, 2001, GENOME RES, V11, P2085, DOI 10.1101/gr.206901; Purbowasito N, 2004, DNA RES, V11, P391, DOI 10.1093/dnares/11.6.391; RAGHUNANDAN R, 2008, STEM CELLS IN PRESS, V17; Schmidt JV, 2000, GENE DEV, V14, P1997; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smit M, 2003, GENETICS, V163, P453; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Takeda H, 2006, P NATL ACAD SCI USA, V103, P8119, DOI 10.1073/pnas.0602844103; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Weber M, 2005, PROG MOLEC, V38, P207; Weber M, 2003, MOL CELL BIOL, V23, P8953, DOI 10.1128/MCB.23.24.8953-8959.2003; Weber ML, 2003, ANAL BIOCHEM, V320, P252, DOI 10.1016/S0003-2697(03)00396-8	33	26	26	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18612	18620		10.1074/jbc.M801883200	http://dx.doi.org/10.1074/jbc.M801883200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18458080	Green Published, hybrid			2022-12-27	WOS:000257165600017
J	Popolo, L; Ragni, E; Carotti, C; Palomares, O; Aardema, R; Back, JW; Dekker, HL; de Koning, LJ; de Jong, L; de Koster, CG				Popolo, Laura; Ragni, Enrico; Carotti, Cristina; Palomares, Oscar; Aardema, Ronald; Back, Jaap Willem; Dekker, Henk L.; de Koning, Leo J.; de Jong, Luitzen; de Koster, Chris G.			Disulfide bond structure and domain organization of yeast beta(1,3)-glucanosyltransferases involved in cell wall biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; SECONDARY STRUCTURE PREDICTION; ANCHORED PROTEIN GP115; AMINO-ACID-SEQUENCE; SERINE-RICH REGION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; OLIVE POLLEN; ASPERGILLUS-FUMIGATUS; ALLERGENIC ACTIVITY	The Gel/Gas/Phr family of fungal beta(1,3)-glucanosyltransferases plays an important role in cell wall biogenesis by processing the main component beta(1,3)-glucan. Two subfamilies are distinguished depending on the presence or absence of a C-terminal cysteine-rich domain, denoted "Cys-box." The N-terminal domain (NtD) contains the catalytic residues for transglycosidase activity and is separated from the Cys-box by a linker region. To obtain a better understanding of the structure and function of the Cys-box-containing subfamily, we identified the disulfide bonds in Gas2p from Saccharomyces cerevisiae by an improved mass spectrometric methodology. We mapped two separate intra-domain clusters of three and four disulfide bridges. One of the bonds in the first cluster connects a central Cys residue of the NtD with a single conserved Cys residue in the linker. Site-directed mutagenesis of the Cys residue in the linker resulted in an endoplasmic reticulum precursor that was not matured and underwent a gradual degradation. The relevant disulfide bond has a crucial role in folding as it may stabilize the NtD and facilitate its interaction with the C-terminal portion of a Gas protein. The four disulfide bonds in the Cys-box are arranged in a manner consistent with a partial structural resemblance with the plant X8 domain, an independent carbohydrate-binding module that possesses only three disulfide bonds. Deletion of the Cys-box in Gas2 or Gas1 proteins led to the formation of an NtD devoid of any enzymatic activity. The results suggest that the Cys-box is required for proper folding of the NtD and/or substrate binding.	[Popolo, Laura; Ragni, Enrico; Carotti, Cristina] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Palomares, Oscar] Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol, Madrid 28040, Spain; [Aardema, Ronald; Back, Jaap Willem; Dekker, Henk L.; de Koning, Leo J.; de Jong, Luitzen; de Koster, Chris G.] Univ Amsterdam, Swammerdam Inst Life Sci, Biomol Mass Spectrometry Grp, NL-1018 WV Amsterdam, Netherlands	University of Milan; Complutense University of Madrid; University of Amsterdam	Popolo, L (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy.	Laura.Popolo@unimi.it	B, Jw/N-7879-2019; de Jong, Luitzen/E-7882-2011; Back, JW/B-3641-2009; Palomares, Oscar/ABG-5229-2020; Ragni, Enrico/J-4292-2015; de Koning, Leo/HHC-2065-2022; Aardema, Ronald/C-2973-2008; Popolo, Laura/B-1173-2017	B, Jw/0000-0002-1310-4373; Back, JW/0000-0002-1310-4373; Ragni, Enrico/0000-0003-0272-7417; Palomares, Oscar/0000-0003-4516-0369; Popolo, Laura/0000-0002-5590-0167; de Koster, Chris/0000-0003-2872-2796				Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carotti C, 2004, EUR J BIOCHEM, V271, P3635, DOI 10.1111/j.1432-1033.2004.04297.x; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; De Bernardis F, 1998, INFECT IMMUN, V66, P3317, DOI 10.1128/IAI.66.7.3317-3325.1998; de Koning LJ, 2006, FEBS J, V273, P281, DOI 10.1111/j.1742-4658.2005.05053.x; de Medina-Redondo M, 2008, MOL MICROBIOL, V68, P1283, DOI 10.1111/j.1365-2958.2008.06233.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gallegos-Perez JL, 2005, ANAL BIOCHEM, V346, P311, DOI 10.1016/j.ab.2005.08.003; GATTI E, 1994, J BIOL CHEM, V269, P19695; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Hong TY, 2002, MICROBIOL-SGM, V148, P1151, DOI 10.1099/00221287-148-4-1151; Huecas S, 2001, J BIOL CHEM, V276, P27959, DOI 10.1074/jbc.M103041200; INGLIS AS, 1983, METHOD ENZYMOL, V91, P324; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; NAKAGAWA S, 1994, J AM CHEM SOC, V116, P5513, DOI 10.1021/ja00091a083; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; Palomares O, 2003, BIOCHEM J, V369, P593, DOI 10.1042/BJ20020423; Palomares O, 2005, CLIN EXP ALLERGY, V35, P345, DOI 10.1111/j.1365-2222.2004.02186.x; Papaleo E, 2006, J MOL MODEL, V12, P237, DOI 10.1007/s00894-005-0025-7; PERCZEL A, 1991, PROTEIN ENG, V4, P669, DOI 10.1093/protein/4.6.669; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Popolo L, 2001, MED MYCOL, V39, P111, DOI 10.1080/744118881; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ragni E, 2007, EUKARYOT CELL, V6, P302, DOI 10.1128/EC.00321-06; Rees D. A., 1982, POLYSACCHARIDES, P196; REES DA, 1971, J CHEM SOC B, P469, DOI 10.1039/j29710000469; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Sunna A, 2001, BIOCHEM J, V356, P791, DOI 10.1042/0264-6021:3560791; Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5; Trevino MA, 2008, PROTEIN SCI, V17, P371, DOI 10.1110/ps.073230008; VAI M, 1991, J BIOL CHEM, V266, P12242; VAI M, 1990, BIOCHIM BIOPHYS ACTA, V1038, P277, DOI 10.1016/0167-4838(90)90237-A; Valdivieso MH, 2000, J BACTERIOL, V182, P4752, DOI 10.1128/JB.182.17.4752-4757.2000; Wu J, 1997, PROTEIN SCI, V6, P391; Wu Jiang, 2002, Methods Mol Biol, V194, P1; Yin QY, 2007, FEMS YEAST RES, V7, P887, DOI 10.1111/j.1567-1364.2007.00272.x; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	55	29	35	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18553	18565		10.1074/jbc.M801562200	http://dx.doi.org/10.1074/jbc.M801562200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18468997	hybrid, Green Published			2022-12-27	WOS:000257165600011
J	Mangoni, ML; Epand, RF; Rosenfeld, Y; Peleg, A; Barra, D; Epand, RM; Shai, Y				Mangoni, Maria Luisa; Epand, Raquel F.; Rosenfeld, Yosef; Peleg, Adi; Barra, Donatella; Epand, Richard M.; Shai, Yechiel			Lipopolysaccharide, a key molecule involved in the synergism between temporins in inhibiting bacterial growth and in endotoxin neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; TUMOR-NECROSIS-FACTOR; CATIONIC ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; FACTOR-ALPHA; POLYMYXIN-B; IN-VITRO; MEMBRANE; DEFENSINS	Lipopolysaccharide (LPS) is the major structural component of the outer membrane of Gram-negative bacteria and shields them from a variety of host defense factors, including antimicrobial peptides (AMPs). LPS is also recognized by immune cells as a pathogen-associated molecular pattern and stimulates them to secrete pro-inflammatory cytokines that, in extreme cases, lead to a harmful host response known as septic shock. Previous studies have revealed that a few isoforms of the AMP temporin, produced within the same frog specimen, can synergize to overcome bacterial resistance imposed by the physical barrier of LPS. Here we found that temporins can synergize in neutralizing the LPS-induced macrophage activation. Furthermore, the synergism between temporins, to overcome the protective function of LPS as well as its endotoxic effect, depends on the length of the polysaccharide chain of LPS. Importantly, mode of action studies, using spectroscopic and thermodynamic methods, have pointed out different mechanisms underlying the synergism of temporins in antimicrobial and anti-endotoxin activities. To the best of our knowledge, such a dual synergism between isoforms of AMPs from the same species has not been observed before, and it might explain the ability of such amphibians to resist a large repertoire of microorganisms.	[Mangoni, Maria Luisa; Barra, Donatella] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Rosenfeld, Yosef; Peleg, Adi; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Fondazione Cenci Bolognetti; Sapienza University Rome; McMaster University; Weizmann Institute of Science	Mangoni, ML (corresponding author), Azienda Osped S Andrea, Fac Med & Chirurg 2, Unita Diagnost Mol Avanzata, Via Grottarossa 1035, I-00189 Rome, Italy.	marialuisa.mangoni@uniroma1.it	, Richard/R-2316-2019; Barra, Donatella/D-1236-2011	, Richard/0000-0002-9602-9558; Mangoni, Maria Luisa/0000-0002-5991-5868	Canadian Institutes of Health Research [MOP 86608]; Italian Ministero dell'Universita e Ricerca [2005062410]; Universita di Roma La Sapienza; Istituto di Biologia e Patologia Molecolari of the National Research Council; Josef Cohn MINERVA Center for Biomembrane Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Italian Ministero dell'Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita di Roma La Sapienza; Istituto di Biologia e Patologia Molecolari of the National Research Council; Josef Cohn MINERVA Center for Biomembrane Research	This work was supported in part by the Canadian Institutes of Health Research (Grant MOP 86608), the Italian Ministero dell'Universita e Ricerca (PRIN 2005 protocol no. 2005062410), by grants from the Universita di Roma La Sapienza and Istituto di Biologia e Patologia Molecolari of the National Research Council, and by the Josef Cohn MINERVA Center for Biomembrane Research (to Y.S.).	Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aurell CA, 1998, BIOCHEM BIOPH RES CO, V253, P119, DOI 10.1006/bbrc.1998.9773; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; BOMAN HG, 1975, J BACTERIOL, V121, P455, DOI 10.1128/JB.121.2.455-464.1975; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Brandenburg K, 2005, BIOPHYS J, V88, P1845, DOI 10.1529/biophysj.104.047944; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Byl B, 2001, EUR J CLIN MICROBIOL, V20, P804, DOI 10.1007/s100960100609; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Farnaud S, 2004, FEMS MICROBIOL LETT, V233, P193, DOI 10.1016/j.femsle.2004.01.039; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Ghosh JK, 1997, J BIOL CHEM, V272, P31609, DOI 10.1074/jbc.272.50.31609; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Howe J, 2007, BIOPHYS J, V92, P2796, DOI 10.1529/biophysj.106.095711; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Kubo Y, 2007, INFLAMM RES, V56, P70, DOI 10.1007/s00011-006-6064-4; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Lewis RE, 2002, J ANTIMICROB CHEMOTH, V49, P345, DOI 10.1093/jac/49.2.345; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; LINDBERG B, 1981, CARBOHYD RES, V97, P105, DOI 10.1016/S0008-6215(00)80528-5; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Mangoni ML, 2006, CELL MOL LIFE SCI, V63, P1060, DOI 10.1007/s00018-005-5536-y; Mangoni ML, 2007, J PEPT SCI, V13, P603, DOI 10.1002/psc.853; Mangoni ML, 2005, J BIOL CHEM, V280, P984, DOI 10.1074/jbc.M410795200; Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975; Mangoni ML, 2000, EUR J BIOCHEM, V267, P1447, DOI 10.1046/j.1432-1327.2000.01143.x; MARVIN HJP, 1989, J BACTERIOL, V171, P5262, DOI 10.1128/jb.171.10.5262-5267.1989; MCINTIRE FC, 1969, BIOCHEMISTRY-US, V8, P4063, DOI 10.1021/bi00838a024; Mookherjee N, 2007, EXPERT OPIN THER TAR, V11, P993, DOI 10.1517/14728222.11.8.993; MOR A, 1994, J BIOL CHEM, V269, P31635; Mukhopadhyay S, 2004, IMMUNOLOGY, V112, P521, DOI 10.1111/j.1365-2567.2004.01941.x; Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pag U, 2004, J ANTIMICROB CHEMOTH, V53, P230, DOI 10.1093/jac/dkh083; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; PRINS JM, 1995, INFECT IMMUN, V63, P2236, DOI 10.1128/IAI.63.6.2236-2242.1995; RANA FR, 1991, BIOCHEMISTRY-US, V30, P5858, DOI 10.1021/bi00238a008; RIBI E, 1966, J BACTERIOL, V92, P1493, DOI 10.1128/JB.92.5.1493-1509.1966; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; Sitaram N, 2006, CURR MED CHEM, V13, P679, DOI 10.2174/092986706776055689; SORAVIA E, 1988, FEBS LETT, V228, P337, DOI 10.1016/0014-5793(88)80027-9; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; STONE R, 1994, SCIENCE, V264, P365, DOI 10.1126/science.8153620; Tong JH, 2004, BIOPHYS J, V86, P3759, DOI 10.1529/biophysj.103.037507; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	65	92	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22907	22917		10.1074/jbc.M800495200	http://dx.doi.org/10.1074/jbc.M800495200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550541	hybrid			2022-12-27	WOS:000258455400004
J	Zhu, X; Lee, JY; Timmins, JM; Brown, JM; Boudyguina, E; Mulya, A; Gebre, AK; Willingham, MC; Hiltbold, EM; Mishra, N; Maeda, N; Parks, JS				Zhu, Xuewei; Lee, Ji-Young; Timmins, Jenelle M.; Brown, J. Mark; Boudyguina, Elena; Mulya, Anny; Gebre, Abraham K.; Willingham, Mark C.; Hiltbold, Elizabeth M.; Mishra, Nilamadhab; Maeda, Nobuyo; Parks, John S.			Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; CASSETTE TRANSPORTER 1; APOLIPOPROTEIN-A-I; LIPID RAFTS; TANGIER-DISEASE; R230C VARIANT; KAPPA-B; GENE; EXPRESSION; RECEPTOR	Macrophage-specific Abca1 knock-out (Abca1(-M/-M)) mice were generated to determine the role of macrophage ABCA1 expression in plasma lipoprotein concentrations and the innate immune response of macrophages. Plasma lipid and lipoprotein concentrations in chow-fed Abca1(-M/-M) and wild-type (WT) mice were indistinguishable. Compared with WT macrophages, Abca1(-M/-M) macrophages had a > 95% reduction in ABCA1 protein, failed to efflux lipid to apoA-I, and had a significant increase in free cholesterol (FC) and membrane lipid rafts without induction of endoplasmic reticulum stress. Lipopolysaccharide (LPS)-treated Abca1(-M/-M) macrophages exhibited enhanced expression of pro-inflammatory cytokines and increased activation of the NF-kappa B and MAPK pathways, which could be diminished by silencing MyD88 or by chemical inhibition of NF-kappa B or MAPK. In vivo LPS injection also resulted in a higher pro-inflammatory response in Abca1(-M/-M) mice compared with WT mice. Furthermore, cholesterol depletion of macrophages with methyl-beta-cyclodextrin normalized FC content between the two genotypes and their response to LPS; cholesterol repletion of macrophages resulted in increased cellular FC accumulation and enhanced cellular response to LPS. Our results suggest that macrophage ABCA1 expression may protect against atherosclerosis by facilitating the net removal of excess lipid from macrophages and dampening pro-inflammatory MyD88-dependent signaling pathways by reduction of cell membrane FC and lipid raft content.	[Zhu, Xuewei; Lee, Ji-Young; Timmins, Jenelle M.; Brown, J. Mark; Boudyguina, Elena; Mulya, Anny; Gebre, Abraham K.; Parks, John S.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Lipid Sci, Winston Salem, NC 27157 USA; [Willingham, Mark C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Tumor Biol, Winston Salem, NC 27157 USA; [Hiltbold, Elizabeth M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; [Mishra, Nilamadhab] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med Rheumatol, Winston Salem, NC 27157 USA; [Maeda, Nobuyo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Parks, JS (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jparks@wfubmc.edu			National Institutes of Health [HL49373, HL54176, AT27820, HL07115]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, R00HL096166, R01HL094525, R01HL054176, R37HL042630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49373, HL54176, and AT27820 ( to J.S.P.) and HL07115 (cardiovascular pathology training grant; to J.M.T.).	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Attie AD, 2002, J LIPID RES, V43, P1610, DOI 10.1194/jlr.M200223-JLR200; Attie AD, 2001, J LIPID RES, V42, P1717; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Daimon M, 2005, BIOCHEM BIOPH RES CO, V329, P205, DOI 10.1016/j.bbrc.2005.01.119; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Furbee JW, 2002, J LIPID RES, V43, P428; Furbee JW, 2002, J BIOL CHEM, V277, P3511, DOI 10.1074/jbc.M109883200; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Gerbod-Giannone MC, 2006, P NATL ACAD SCI USA, V103, P3112, DOI 10.1073/pnas.0510345103; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Haghpassand M, 2001, J CLIN INVEST, V108, P1315, DOI 10.1172/JCI200112810; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; KORITNIK DL, 1983, J LIPID RES, V24, P1639; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lee JY, 2005, J LIPID RES, V46, P2233, DOI 10.1194/jlr.M500179-JLR200; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Mulligan JD, 2003, J BIOL CHEM, V278, P13356, DOI 10.1074/jbc.M212377200; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Oram JF, 2001, J LIPID RES, V42, P1173; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Porchay I, 2006, OBESITY, V14, P1874, DOI 10.1038/oby.2006.217; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Schiller NK, 2004, J LIPID RES, V45, P1398, DOI 10.1194/jlr.M400036-JLR200; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Triantafilou M, 2002, J CELL SCI, V115, P2603; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Villarreal-Molina MT, 2008, DIABETES, V57, P509, DOI 10.2337/db07-0484; Villarreal-Molina MT, 2007, DIABETES, V56, P1881, DOI 10.2337/db06-0905; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhuang LY, 2002, CANCER RES, V62, P2227	68	279	281	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22930	22941		10.1074/jbc.M801408200	http://dx.doi.org/10.1074/jbc.M801408200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18552351	hybrid, Green Published			2022-12-27	WOS:000258455400006
J	Madsen, L; Petersen, RK; Steffensen, KR; Pedersen, LM; Hallenborg, P; Ma, T; Froyland, L; Doskeland, SO; Gustafsson, JAA; Kristiansen, K				Madsen, Lise; Petersen, Rasmus K.; Steffensen, Knut R.; Pedersen, Lone M.; Hallenborg, Philip; Ma, Tao; Froyland, Livar; Doskeland, Stein Ove; Gustafsson, Jan-Ake; Kristiansen, Karsten			Activation of liver X receptors prevents statin-induced death of 3T3-L1 preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COA REDUCTASE INHIBITORS; ORPHAN NUCLEAR RECEPTORS; ACUTE MYELOID LEUKEMIAS; TUMOR-NECROSIS-FACTOR; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; CELL-DEATH; LXR-ALPHA; P53-DEFICIENT CELLS	The biological functions of liver X receptors (LXRs) alpha and beta have primarily been linked to pathways involved in fatty acid and cholesterol homeostasis. Here we report a novel role of LXR activation in protecting cells from statin-induced death. When 3T3-L1 preadipocytes were induced to differentiate by standard isobutylmethylxanthine/ dexamethasone/ insulin treatment in the presence of statins, they failed to differentiate and underwent massive apoptosis. The simultaneous addition of selective LXR agonists prevented the statin-induced apoptosis. By using mouse embryo fibroblasts from wild-type (LXR alpha (+/+) /LXR beta (+/+)), LXR alpha knock-out mice (LXR alpha (-/-)/LXR beta(+/+)), LXR beta knock-out mice (LXR alpha(+/-)/ LXR beta (-/-)), and LXR double knock-out mice (LXR alpha(+/-)/LXR beta (+/+)) as well as 3T3-L1 cells transduced with retroviruses expressing either wild-type LXR alpha or a dominant negative version of LXR alpha, we demonstrate that the response to LXR agonists is LXR-dependent. Interestingly, LXR-mediated rescue of statin-induced apoptosis was not related to up-regulation of genes previously shown to be involved in the antiapoptotic action of LXR. Furthermore, forced expression of Bcl-2 did not prevent statin-induced apoptosis; nor did LXR action depend on protein kinase B, whose activation by insulin was impaired in statin-treated cells. Rather, LXR-dependent rescue of statin-induced apoptosis in 3T3-L1 preadipocytes required NF-kappa B activity, since expression of a dominant negative version of I kappa B alpha prevented LXR agonist-dependent rescue of statin-induced apoptosis. Thus, the results presented in this paper provide novel insight into the action of statins on and LXR-dependent inhibition of apoptosis.	[Madsen, Lise; Petersen, Rasmus K.; Pedersen, Lone M.; Hallenborg, Philip; Ma, Tao; Kristiansen, Karsten] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Madsen, Lise; Froyland, Livar] Natl Inst Nutr & Seafood Res, N-5817 Bergen, Norway; [Petersen, Rasmus K.] BioLigands, DK-5230 Odense, Denmark; [Steffensen, Knut R.; Gustafsson, Jan-Ake] Karolinska Inst, Dept Biosci & Nutr, NOVUM, S-14157 Huddinge, Sweden; [Doskeland, Stein Ove] Univ Bergen, Fac Med, Dept Biomed, N-5097 Bergen, Norway	University of Southern Denmark; Karolinska Institutet; University of Bergen	Madsen, L (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	lise.madsen@bmb.sdu.dk; kak@bmb.sdu.dk	Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014	Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Doskeland, Stein Ove/0000-0002-4009-4756; Steffensen, Knut/0000-0001-6093-2801				Agarwal B, 1999, CLIN CANCER RES, V5, P2223; Ahn KS, 2008, BIOCHEM PHARMACOL, V75, P907, DOI 10.1016/j.bcp.2007.10.010; Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Annis MG, 2004, BBA-MOL CELL RES, V1644, P115, DOI 10.1016/j.bbamcr.2003.07.001; Ballantyne CM, 2003, AM J CARDIOL, V92, p3K, DOI 10.1016/S0002-9149(03)00768-9; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Blanco-Colio LM, 2003, KIDNEY INT, V64, P181, DOI 10.1046/j.1523-1755.2003.00080.x; BUCHWALD H, 1992, LANCET, V339, P1154, DOI 10.1016/0140-6736(92)90744-N; Carel K, 1996, J BIOL CHEM, V271, P30625, DOI 10.1074/jbc.271.48.30625; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chamberlain LH, 2001, FEBS LETT, V507, P357, DOI 10.1016/S0014-5793(01)03007-1; Chang MY, 1998, BIOCHEM BIOPH RES CO, V248, P62, DOI 10.1006/bbrc.1998.8911; Corsini A, 2004, DRUGS, V64, P1305, DOI 10.2165/00003495-200464120-00004; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Dimitroulakos J, 2000, LEUKEMIA LYMPHOMA, V40, P167, DOI 10.3109/10428190009054894; Elson CE, 1999, P SOC EXP BIOL MED, V221, P294, DOI 10.1046/j.1525-1373.1999.d01-87.x; Evans M, 2004, DRUGS, V64, P1181, DOI 10.2165/00003495-200464110-00003; Fajas L, 1999, MOL CELL BIOL, V19, P5495; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Garcia MJ, 2003, METHOD FIND EXP CLIN, V25, P457; Garcia-Roman N, 2001, MOL CELL NEUROSCI, V17, P329, DOI 10.1006/mcne.2000.0904; Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008; Glasgow JN, 2000, J NEUROCHEM, V75, P1377, DOI 10.1046/j.1471-4159.2000.0751377.x; Goalstone ML, 1996, J BIOL CHEM, V271, P27585, DOI 10.1074/jbc.271.44.27585; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Hansen JB, 2002, J BIOL CHEM, V277, P26335, DOI 10.1074/jbc.M203870200; Heckman CA, 2002, ONCOGENE, V21, P3898, DOI 10.1038/sj.onc.1205483; Hindler K, 2006, ONCOLOGIST, V11, P306, DOI 10.1634/theoncologist.11-3-306; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; Jang JH, 2004, J BIOL CHEM, V279, P38779, DOI 10.1074/jbc.M406371200; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kleemann R, 2004, BLOOD, V103, P4188, DOI 10.1182/blood-2003-11-3791; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Kohro T, 2000, J Atheroscler Thromb, V7, P145; Kubota T, 2004, BIOCHEM PHARMACOL, V67, P2175, DOI 10.1016/j.bcp.2004.02.037; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Larsson O, 1996, CRIT REV ONCOL HEMAT, V22, P197, DOI 10.1016/1040-8428(96)00193-X; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Mauser W, 2007, EUR J PHARMACOL, V564, P37, DOI 10.1016/j.ejphar.2007.02.024; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Mistafa O, 2008, BIOCHEM BIOPH RES CO, V365, P131, DOI 10.1016/j.bbrc.2007.10.148; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Muck AO, 2004, INT J CLIN PHARM TH, V42, P695; Nakata M, 2006, DIABETOLOGIA, V49, P1881, DOI 10.1007/s00125-006-0269-5; Nakata S, 2007, ARTERIOSCL THROM VAS, V27, P92, DOI 10.1161/01.ATV.0000251615.61858.33; Newman A, 1997, LEUKEMIA LYMPHOMA, V24, P533, DOI 10.3109/10428199709055590; Nicholson AC, 2007, BRIT J PHARMACOL, V151, P807, DOI 10.1038/sj.bjp.0707250; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Paumelle R, 2006, CIRC RES, V98, P361, DOI 10.1161/01.RES.0000202706.70992.95; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Poulaki V, 2002, AM J PATHOL, V161, P2229, DOI 10.1016/S0002-9440(10)64499-9; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Roudier E, 2006, MOL CANCER THER, V5, P2706, DOI 10.1158/1535-7163.MCT-06-0352; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Sassano A, 2008, CANCER LETT, V260, P11, DOI 10.1016/j.canlet.2007.11.036; Schmidt F, 2001, ACTA NEUROPATHOL, V101, P217; Siddals KW, 2004, J BIOL CHEM, V279, P38353, DOI 10.1074/jbc.M404838200; Solomon CS, 2003, INT J OBESITY, V27, P40, DOI 10.1038/sj.ijo.0802189; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V310, P589, DOI 10.1016/j.bbrc.2003.08.139; Steffensen KR, 2002, BIOCHEM BIOPH RES CO, V293, P1333, DOI 10.1016/S0006-291X(02)00390-X; Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299; Tanaka T, 2000, J NEUROSCI, V20, P2852; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tomiyama K, 1999, JPN J PHARMACOL, V80, P375, DOI 10.1254/jjp.80.375; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Wang Wei, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P673; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Zhang HB, 2003, J BIOL CHEM, V278, P20906, DOI 10.1074/jbc.M300022200	91	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22723	22736		10.1074/jbc.M800720200	http://dx.doi.org/10.1074/jbc.M800720200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18487205	hybrid			2022-12-27	WOS:000258321000041
J	Haffner, MC; Jurgeit, A; Berlato, C; Geley, S; Parajuli, N; Yoshimura, A; Doppler, W				Haffner, Michael C.; Jurgeit, Andreas; Berlato, Chiara; Geley, Stephan; Parajuli, Nirmala; Yoshimura, Akihiko; Doppler, Wolfgang			Interaction and functional interference of glucocorticoid receptor and SOCS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CYTOKINE SIGNALING-1; NUCLEAR RECEPTORS; GENE-EXPRESSION; ACTIVATION; PROTEIN; DEGRADATION; INHIBITION; MECHANISMS; SUPPRESSOR	Cytokine and glucocorticoid (GC) hormone signaling act in an integrated fashion to control inflammation and immune response. Here we establish a new mode of interaction of these two pathways and propose Suppressor of Cytokine Signaling (SOCS)-1 as an essential player in mediating cross-talk. We observed that glucocorticoid receptor (GR) and SOCS1 form an intracellular complex through an interaction, which required the SH2 domain of SOCS1 and the ligand binding domain of GR. Furthermore, GC stimulation was found to increase the nuclear level of SOCS1. SOCS1 binding to the GR did not require ligand binding of the receptor; however, it was abolished after long term GC stimulation, suggesting a functional role of the interaction for the early phase of GC action. The interaction between GR and SOCS1 appeared to negatively influence the transcription of the two GR-regulated genes, FKBP5 and MKP1, because the GC-dependent expression of these genes was inhibited by the SOCS1 inducer IFN gamma and enhanced in SOCS1-deficient murine embryonic fibroblasts as compared with IFN gamma treated wild-type cells. Our results suggest a prominent role of SOCS1 in the early phase of cross-talk between GR and cytokine signaling.	[Haffner, Michael C.; Jurgeit, Andreas; Berlato, Chiara; Parajuli, Nirmala; Doppler, Wolfgang] Innsbruck Med Univ, Div Med Biochem, Bioctr, A-6020 Innsbruck, Austria; [Geley, Stephan] Innsbruck Med Univ, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Yoshimura, Akihiko] Kyushu Univ, Div Mol & Cellular Immunol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Medical University of Innsbruck; Medical University of Innsbruck; Kyushu University	Doppler, W (corresponding author), Innsbruck Med Univ, Div Med Biochem, Bioctr, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	wolfgang.doppler@i-med.ac.at	Parajuli, Nirmala/V-9901-2019; Yoshimura, Akihiko/K-5515-2013	Parajuli, Nirmala/0000-0003-3994-5338	Austrian Science Fund FWF [W 1101] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aittomaki S, 2000, J IMMUNOL, V164, P5689, DOI 10.4049/jimmunol.164.11.5689; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Doppler W, 2001, MOL CELL BIOL, V21, P3266, DOI 10.1128/MCB.21.9.3266-3279.2001; Engblom D, 2007, GENE DEV, V21, P1157, DOI 10.1101/gad.426007; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Haffner MC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-136; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Hu XY, 2003, J IMMUNOL, V170, P4833, DOI 10.4049/jimmunol.170.9.4833; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Kamio M, 2004, ONCOGENE, V23, P3107, DOI 10.1038/sj.onc.1207453; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; LANZ RB, 1994, ENDOCRINOLOGY, V135, P2183, DOI 10.1210/en.135.5.2183; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; ONATE SA, 1995, SCIENCE, V270, P1354; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rogatsky I, 2006, TISSUE ANTIGENS, V68, P1, DOI 10.1111/j.1399-0039.2006.00599.x; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; Starr DB, 1996, GENE DEV, V10, P1271, DOI 10.1101/gad.10.10.1271; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	35	23	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22089	22096		10.1074/jbc.M801041200	http://dx.doi.org/10.1074/jbc.M801041200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18524780	hybrid			2022-12-27	WOS:000258114700027
J	Chu, MLH; Chavas, LMG; Douglas, KT; Eyers, PA; Tabernero, L				Chu, Matthew L. H.; Chavas, Leonard M. G.; Douglas, Kenneth T.; Eyers, Patrick A.; Tabernero, Lydia			Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITORS; PROTEIN-KINASE; ACTIVATION; PHOSPHORYLATION; FAMILY	Chromosomal instability can result from defective control of checkpoints and is associated with malignant cell growth. Monopolar spindle 1 (Mps1) is a dual-specificity protein kinase that has important roles in the prevention of aneuploidy during the cell cycle and might therefore be a potential target for new therapeutic agents in the treatment of cancer. To gain insights into the molecular mechanism of Mps1 inhibition by small molecules, we determined the x-ray structure of Mps1, both alone and in complex with the ATP-competitive inhibitor SP600125. Mps1 adopts a classic protein kinase fold, with the inhibitor sitting in the ATP-binding site where it is stabilized by hydrophobic interactions. We identified a secondary pocket, not utilized by SP600125, which might be exploited for the rational design of specific Mps1 inhibitors. These structures provide important insights into the interaction of this protein kinase with small molecules and suggest potential mechanisms for Mps1 regulation.	[Chu, Matthew L. H.; Douglas, Kenneth T.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England; [Chavas, Leonard M. G.; Eyers, Patrick A.; Tabernero, Lydia] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Chavas, Leonard M. G.; Eyers, Patrick A.; Tabernero, Lydia] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Chu, Matthew L. H.; Douglas, Kenneth T.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Eyers, PA (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	Patrick.Eyers@manchester.ac.uk; Lydia.Tabernero@manchester.ac.uk	Chavas, Leonard M.G./AAZ-2286-2020; Tabernero, Lydia/F-3795-2018	Tabernero, Lydia/0000-0001-8867-455X	Medical Research Council [G120/1030] Funding Source: Medline; MRC [G120/1030] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1997, JOINT CCP4 ESF EACBM, V33; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fisk HA, 2004, CELL CYCLE, V3, P439; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; LIU ST, 2003, MOL BIOL CELL, V14, P138; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2002, CANCER RES, V62, P4236; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Scapin G, 2003, CHEM BIOL, V10, P705, DOI 10.1016/S1074-5521(03)00159-5; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780	30	45	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21495	21500		10.1074/jbc.M803026200	http://dx.doi.org/10.1074/jbc.M803026200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18480048	hybrid			2022-12-27	WOS:000257898800022
J	Galkin, A; Meyer, B; Wittig, I; Karas, M; Schagger, H; Vinogradov, A; Brandt, U				Galkin, Alexander; Meyer, Bjoern; Wittig, Ilka; Karas, Michael; Schaegger, Hermann; Vinogradov, Andrei; Brandt, Ulrich			Identification of the mitochondrial ND3 subunit as a structural component involved in the active/deactive enzyme transition of respiratory complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-INACTIVE TRANSITION; QUINONE OXIDOREDUCTASE; HYDROGEN-TRANSFER; PARACOCCUS-DENITRIFICANS; DNA MUTATION; NADH; PROTEINS; EPR; UBISEMIQUINONE; ELECTRON	Mitochondrial complex I (NADH: ubiquinone oxidoreductase) undergoes reversible deactivation upon incubation at 30-37 degrees C. The active/deactive transition could play an important role in the regulation of complex I activity. It has been suggested recently that complex I may become modified by S-nitrosation under pathological conditions during hypoxia or when the nitric oxide: oxygen ratio increases. Apparently, a specific cysteine becomes accessible to chemical modification only in the deactive form of the enzyme. By selective fluorescence labeling and proteomic analysis, we have identified this residue as cysteine-39 of the mitochondrially encoded ND3 subunit of bovine heart mitochondria. Cysteine-39 is located in a loop connecting the first and second transmembrane helix of this highly hydrophobic subunit. We propose that this loop connects the ND3 subunit of the membrane arm with the PSST subunit of the peripheral arm of complex I, placing it in a region that is known to be critical for the catalytic mechanism of complex I. In fact, mutations in three positions of the loop were previously reported to cause Leigh syndrome with and without dystonia or progressive mitochondrial disease.	[Galkin, Alexander; Wittig, Ilka; Schaegger, Hermann; Brandt, Ulrich] Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes M, Mol Bioenerget Grp, D-60590 Frankfurt, Germany; [Meyer, Bjoern; Karas, Michael] Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes M, Inst Pharmazeut Chem, D-60438 Frankfurt, Germany; [Vinogradov, Andrei] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119992, Russia	Goethe University Frankfurt; Goethe University Frankfurt; Lomonosov Moscow State University	Brandt, U (corresponding author), Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes M, Mol Bioenerget Grp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	brandt@zbc.kgu.de	Brandt, Ulrich/C-4406-2008; Brandt, Ulrich/GLV-1242-2022	Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811	FOGARTY INTERNATIONAL CENTER [R03TW007825] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW 07825] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Blow D. M., 1971, ENZYMES, VIII, P185, DOI DOI 10.1016/S1874-6047(08)60397-2; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; BURBAEV DS, 1989, FEBS LETT, V254, P47, DOI 10.1016/0014-5793(89)81007-5; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Di Bernardo S, 2000, BIOCHEMISTRY-US, V39, P9411; DIVIRGILIO F, 1982, J BIOL CHEM, V257, P4106; Estabrook R.W., 1968, FLAVINS FLAVOPROTEIN, P268; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Gostimskaya IS, 2006, BBA-BIOENERGETICS, V1757, P1155, DOI 10.1016/j.bbabio.2006.04.016; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; KAMP RM, 1986, ADV METHODS PROTEIN, P8; Kao MC, 2004, BIOCHEMISTRY-US, V43, P3750, DOI 10.1021/bi049927s; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KOTLYAR AB, 1992, BIOCHIM BIOPHYS ACTA, V1098, P144, DOI 10.1016/S0005-2728(05)80329-9; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maklashina E, 2002, BBA-BIOENERGETICS, V1556, P6, DOI 10.1016/S0005-2728(02)00280-3; Maklashina E. O., 1994, Biokhimiya, V59, P946; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; MINAKAMI S, 1964, J BIOL CHEM, V239, P2042; MINAKAMI S, 1964, J BIOL CHEM, V239, P2049; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2005, FEBS LETT, V579, P500, DOI 10.1016/j.febslet.2004.11.107; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schmidt F, 2006, RAPID COMMUN MASS SP, V20, P933, DOI 10.1002/rcm.2382; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yano T, 1999, J BIOL CHEM, V274, P28598, DOI 10.1074/jbc.274.40.28598	41	116	118	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20907	20913		10.1074/jbc.M803190200	http://dx.doi.org/10.1074/jbc.M803190200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502755	Green Published, hybrid			2022-12-27	WOS:000257746100033
J	Costa, MDL; Reis, PAB; Valente, MAS; Irsigler, AST; Carvalho, CM; Loureiro, ME; Aragao, FJL; Boston, RS; Fietto, LG; Fontes, EPB				Costa, Maximiller D. L.; Reis, Pedro A. B.; Valente, Maria Anete S.; Irsigler, Andre S. T.; Carvalho, Claudine M.; Loureiro, Marcelo E.; Aragao, Francisco J. L.; Boston, Rebecca S.; Fietto, Luciano G.; Fontes, Elizabeth P. B.			A new branch of endoplasmic reticulum stress signaling and the osmotic signal converge on plant-specific asparagine-rich proteins to promote cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; LEAF SENESCENCE; GOLGI-APPARATUS; BREFELDIN-A; ARABIDOPSIS; EXPRESSION; BIP; HOMOLOG	NRPs (N-rich proteins) were identified as targets of a novel adaptive pathway that integrates endoplasmic reticulum (ER) and osmotic stress signals based on coordinate regulation and synergistic up-regulation by tunicamycin and polyethylene glycol treatments. This integrated pathway diverges from the molecular chaperone-inducing branch of the unfolded protein response (UPR) in several ways. While UPR-specific targets were inversely regulated by ER and osmotic stresses, NRPs required both signals for full activation. Furthermore, BiP (binding protein) overexpression in soybean prevented activation of the UPR by ER stress inducers, but did not affect activation of NRPs. We also found that this integrated pathway transduces a PCD signal generated by ER and osmotic stresses that result in the appearance of markers associated with leaf senescence. Overexpression of NRPs in soybean protoplasts induced caspase-3-like activity and promoted extensive DNA fragmentation. Furthermore, transient expression of NRPs in planta caused leaf yellowing, chlorophyll loss, malondialdehyde production, ethylene evolution, and induction of the senescence marker gene CP1. This phenotype was alleviated by the cytokinin zeatin, a potent senescence inhibitor. Collectively, these results indicate that ER stress induces leaf senescence through activation of plant-specific NRPs via a novel branch of the ER stress response.	[Costa, Maximiller D. L.; Reis, Pedro A. B.; Valente, Maria Anete S.; Irsigler, Andre S. T.; Carvalho, Claudine M.; Fietto, Luciano G.; Fontes, Elizabeth P. B.] Univ Fed Vicosa, Dept Bioquim & Biol Mol, BIOAGRO, BR-36571000 Vicosa, MG, Brazil; [Loureiro, Marcelo E.] Univ Fed Vicosa, Dept Biol Vegetal, BR-36571000 Vicosa, MG, Brazil; [Aragao, Francisco J. L.] Embrapa Recursos Genet & Biotecnol, BR-70770900 Brasilia, DF, Brazil; [Boston, Rebecca S.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of North Carolina; North Carolina State University	Fontes, EPB (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, BIOAGRO, BR-36571000 Vicosa, MG, Brazil.	bbfontes@ufv.br	Aragão, Francisco J.L./E-6962-2013; Costa, Maximiller/D-8804-2013; Fietto, Luciano G/F-9908-2012; Ding, Cheng-Qiang/B-6287-2011; Reis, Pedro Augusto Braga/U-4103-2019; Dal-Bianco, Maximiller/K-6377-2018; Carvalho, Claudine/J-6347-2014; Fontes, Elizabeth/K-3159-2012	Reis, Pedro Augusto Braga/0000-0003-2396-3662; Dal-Bianco, Maximiller/0000-0002-7001-4841; Fietto, Luciano/0000-0002-2674-6471; Irsigler, Andre/0000-0001-8943-8081; Fontes, Elizabeth/0000-0002-7986-1369				Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Aragao FJL, 2000, THEOR APPL GENET, V101, P1, DOI 10.1007/s001220051441; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Buzeli RAA, 2002, PLANT MOL BIOL, V50, P757, DOI 10.1023/A:1019994721545; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; CARVALHO CM, 2008, PLANT J IN PRESS; Cascardo JCM, 2001, PLANT SCI, V160, P273, DOI 10.1016/S0168-9452(00)00384-8; Cascardo JCM, 2000, J BIOL CHEM, V275, P14494, DOI 10.1074/jbc.275.19.14494; Crosti P, 2001, PROTOPLASMA, V216, P31, DOI 10.1007/BF02680128; Delu-Filho N, 2000, PLANT PHYSIOL BIOCH, V38, P353, DOI 10.1016/S0981-9428(00)00752-X; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Greenberg JT, 1996, P NATL ACAD SCI USA, V93, P12094, DOI 10.1073/pnas.93.22.12094; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2005, PLANTA, V220, P804, DOI 10.1007/s00425-004-1479-z; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Ludwig AA, 2001, EUR J PLANT PATHOL, V107, P323, DOI 10.1023/A:1011202225323; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Malerba M, 2004, PROTOPLASMA, V224, P61, DOI 10.1007/s00709-004-0053-7; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Pagny S, 2000, PLANT CELL, V12, P739, DOI 10.1105/tpc.12.5.739; Pirovani CP, 2002, EUR J BIOCHEM, V269, P3998, DOI 10.1046/j.1432-1033.2002.03089.x; QUIRINO BF, 2003, CURR OPIN PLANT BIOL, V6, P79; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SINGH S, 1992, PHYSIOL PLANTARUM, V86, P388, DOI 10.1111/j.1399-3054.1992.tb01334.x; Tenhaken R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-169; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Wang SY, 2007, P NATL ACAD SCI USA, V104, P3817, DOI 10.1073/pnas.0611735104; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Wertz IE, 1996, TRENDS BIOCHEM SCI, V21, P359, DOI 10.1016/0968-0004(96)40002-0; Woltering EJ, 2002, PLANT PHYSIOL, V130, P1764, DOI 10.1104/pp.006338; Zuppini A, 2004, J CELL SCI, V117, P2591, DOI 10.1242/jcs.01126	45	65	71	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20209	20219		10.1074/jbc.M802654200	http://dx.doi.org/10.1074/jbc.M802654200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18490446	Green Published, hybrid			2022-12-27	WOS:000257565300037
J	Iqbal, J; Rudel, LL; Hussain, MM				Iqbal, Jahangir; Rudel, Lawrence L.; Hussain, M. Mahmood			Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATED CACO-2 CELLS; HAMSTER OVARY CELLS; MAMMALIAN ACYL-COA; ENDOPLASMIC-RETICULUM; APOLIPOPROTEIN-B; ACYLTRANSFERASE ACTIVITY; LIPOPROTEIN SECRETION; DIETARY-CHOLESTEROL; NONHUMAN-PRIMATES; MCA-RH7777 CELLS	Cholesteryl ester synthesis by the acyl-CoA: cholesterol acyltransferase enzymes ACAT1 and ACAT2 is, in part, a cellular homeostatic mechanism to avoid toxicity associated with high free cholesterol levels. In hepatocytes and enterocytes, cholesteryl esters are secreted as part of apoB lipoproteins, the assembly of which is critically dependent on microsomal triglyceride transfer protein (MTP). Conditional genetic ablation of MTP reduces cholesteryl esters and enhances free cholesterol in the liver and intestine without diminishing ACAT1 and ACAT2 mRNA levels. As expected, increases in hepatic free cholesterol are associated with decreases in 3-hydroxy-3-methylglutaryl-CoA reductase and increases in ATP-binding cassette transporter 1 mRNA levels. Chemical inhibition of MTP also decreases esterification of cholesterol in Caco-2 and HepG2 cells. Conversely, coexpression of MTP and apoB in AC29 cells stably transfected with ACAT1 and ACAT2 increases cholesteryl ester synthesis. Liver and enterocyte microsomes from MTP-deficient animals synthesize lesser amounts of cholesteryl esters in vitro, but addition of purified MTP and low density lipoprotein corrects this deficiency. Enrichment of microsomes with cholesteryl esters also inhibits cholesterol ester synthesis. Thus, MTP enhances cellular cholesterol esterification by removing cholesteryl esters from their site of synthesis and depositing them into nascent apoB lipoproteins. Therefore, MTP plays a novel role in regulating cholesteryl ester biosynthesis in cells that produce lipoproteins. We speculate that non-lipoprotein-producing cells may use different mechanisms to alleviate product inhibition and modulate cholesteryl ester biosynthesis.	[Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Rudel, Lawrence L.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27157 USA; [Rudel, Lawrence L.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA.	Mahmood.Hussain@downstate.edu	Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271	NHLBI NIH HHS [HL 49373] Funding Source: Medline; NIDDK NIH HHS [DK 46700] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Anwar K, 2006, J LIPID RES, V47, P1261, DOI 10.1194/jlr.M500523-JLR200; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Buhman KF, 2000, BBA-MOL CELL BIOL L, V1529, P142, DOI 10.1016/S1388-1981(00)00144-X; Burnett JR, 2007, EXPERT OPIN THER TAR, V11, P181, DOI 10.1517/14728222.11.2.181; CADIGAN KM, 1989, J CELL BIOL, V108, P2201, DOI 10.1083/jcb.108.6.2201; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Chang CCY, 2000, J BIOL CHEM, V275, P28083; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang G, 2002, CURR OPIN DRUG DISC, V5, P562; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chang TY, 2001, CURR OPIN LIPIDOL, V12, P289, DOI 10.1097/00041433-200106000-00008; Cheema SK, 1997, J LIPID RES, V38, P315; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; ERICKSON SK, 1980, J LIPID RES, V21, P930; Farese RV, 1998, CURR OPIN LIPIDOL, V9, P119, DOI 10.1097/00041433-199804000-00007; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; HAGAN DL, 1994, J BIOL CHEM, V269, P28737; Hui TY, 2002, J LIPID RES, V43, P785; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P277, DOI 10.1097/MOL.0b013e3282feea85; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Hussain MM, 2003, FRONT BIOSCI, V8, pS500, DOI 10.2741/1071; HUSSAIN MM, 1995, ARTERIOSCL THROM VAS, V15, P485, DOI 10.1161/01.ATV.15.4.485; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2008, CELL METAB, V7, P445, DOI 10.1016/j.cmet.2008.03.005; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lee RG, 2000, J LIPID RES, V41, P1991; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568; Nayak N, 2001, J LIPID RES, V42, P272; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Rava P, 2005, J LIPID RES, V46, P1779, DOI 10.1194/jlr.D400043-JLR200; Rudel LL, 2002, J BIOL CHEM, V277, P31401, DOI 10.1074/jbc.M204106200; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Sakashita N, 2003, LAB INVEST, V83, P1569, DOI 10.1097/01.LAB.0000095687.17383.39; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Seo T, 2001, BIOCHEMISTRY-US, V40, P4756, DOI 10.1021/bi0022947; Smith JL, 2004, J LIPID RES, V45, P686, DOI 10.1194/jlr.M300365-JLR200; SUCKLING KE, 1985, J LIPID RES, V26, P647; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Wang S, 1996, J BIOL CHEM, V271, P14124, DOI 10.1074/jbc.271.24.14124; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; WETTERAU JR, 1992, SCIENCE, V258, P999; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	69	40	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19967	19980		10.1074/jbc.M800398200	http://dx.doi.org/10.1074/jbc.M800398200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502767	hybrid, Green Published			2022-12-27	WOS:000257565300012
J	Kurihara, S; Oda, S; Tsuboi, Y; Kim, HG; Oshida, M; Kumagai, H; Suzuki, H				Kurihara, Shin; Oda, Shinpei; Tsuboi, Yuichi; Kim, Hyeon Guk; Oshida, Mayu; Kumagai, Hidehiko; Suzuki, Hideyuki			gamma-glutamylputrescine synthetase in the putrescine utilization pathway of Escherichia coli K-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-SYNTHETASE; POLYAMINES; PROTEIN; MUTANT; MICROORGANISMS; TRANSPEPTIDASE; ENZYMES; GROWTH; GENES; RANGE	Glutamate-putrescine ligase (gamma-glutamylputrescine synthetase, PuuA, EC 6.3.1.11) catalyzes the gamma-glutamylation of putrescine, the first step in a novel putrescine utilization pathway involving gamma-glutamylated intermediates, the Puu pathway, in Escherichia coli. In this report, the character and physiological importance of PuuA are described. Purified non-tagged PuuA catalyzed the ATP-dependent gamma-glutamylation of putrescine. The K-m values for glutamate, ATP, and putrescine are 2.07, 2.35, and 44.6 mM, respectively. There are two putrescine utilization pathways in E. coli: the Puu pathway and the pathway without gamma-glutamylation. Gene deletion experiments of puuA, however, indicated that the Puu pathway was more critical in utilizing putrescine as a sole carbon or nitrogen source. The transcription of puuA was induced by putrescine and in a puuR-deleted strain. The amino acid sequences of PuuA and glutamine synthetase (GS) show high similarity. The molecular weights of the monomers of the two enzymes are quite similar, and PuuA exists as a dodecamer as does GS. Moreover the two amino acid residues of E. coli GS that are important for the metal-catalyzed oxidation of the enzyme molecule involved in protein turnover are conserved in PuuA, and it was experimentally shown that the corresponding amino acid residues in PuuA were involved in the metal-catalyzed oxidation similarly to GS. It is suggested that the intracellular concentration of putrescine is optimized by PuuA transcriptionally and posttranslationally and that excess putrescine is converted to a nutrient source by the Puu pathway.	[Suzuki, Hideyuki] Kyoto Inst Technol, Grad Sch Sci & Technol, Div Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Kurihara, Shin; Oda, Shinpei; Tsuboi, Yuichi; Kim, Hyeon Guk; Oshida, Mayu] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Kumagai, Hidehiko] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	Kyoto Institute of Technology; Kyoto University; Ishikawa Prefecture University	Suzuki, H (corresponding author), Kyoto Inst Technol, Grad Sch Sci & Technol, Div Appl Biol, Sakyo Ku, Goshokaido Cho Matsugasaki, Kyoto 6068585, Japan.	hideyuki@kit.ac.jp						BENSON JR, 1975, P NATL ACAD SCI USA, V72, P619, DOI 10.1073/pnas.72.2.619; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; CASADEI MA, 1984, J AM CHEM SOC, V106, P1051, DOI 10.1021/ja00316a039; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; FUKUCHI JI, 1995, J BIOL CHEM, V270, P18831, DOI 10.1074/jbc.270.32.18831; FULKS RM, 1985, BIOCHIM BIOPHYS ACTA, V843, P214, DOI 10.1016/0304-4165(85)90142-4; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; KAKEGAWA T, 1991, J BIOCHEM, V109, P627, DOI 10.1093/oxfordjournals.jbchem.a123431; KINGDON HS, 1968, BIOCHEMISTRY-US, V7, P2136, DOI 10.1021/bi00846a016; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; Kurihara S, 2006, FEMS MICROBIOL LETT, V256, P318, DOI 10.1111/j.1574-6968.2006.00137.x; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; LARGE PJ, 1992, FEMS MICROBIOL LETT, V88, P249, DOI 10.1111/j.1574-6968.1992.tb04991.x; LIAW SH, 1993, BIOCHEMISTRY-US, V32, P7999, DOI 10.1021/bi00082a022; Linsalata M, 2002, ANTICANCER RES, V22, P2465; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANNERVIK B, 1989, COENZYMES COFACTORS, V3, P475; Miller J. H., 1992, SHORT COURSE BACTERI, P263; PARK JT, 1996, ESCHERICHIA COLI SAL, P49; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J., 2001, MOL CLONING LAB MANU; Samsonova NN, 2005, FEBS LETT, V579, P4107, DOI 10.1016/j.febslet.2005.06.038; Samsonova NN, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-2; SHAIBE E, 1985, J BACTERIOL, V163, P938, DOI 10.1128/JB.163.3.938-942.1985; SMITH GR, 1971, J BIOL CHEM, V246, P3320; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; SUZUKI H, 1989, J BACTERIOL, V171, P5169, DOI 10.1128/jb.171.9.5169-5172.1989; Suzuki H, 2003, APPL ENVIRON MICROB, V69, P6399, DOI 10.1128/AEM.69.11.6399-6404.2003; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Xaplanteri MA, 2005, NUCLEIC ACIDS RES, V33, P2792, DOI 10.1093/nar/gki557	34	67	90	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19981	19990		10.1074/jbc.M800133200	http://dx.doi.org/10.1074/jbc.M800133200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18495664	hybrid			2022-12-27	WOS:000257565300013
J	Guo, XY; Oshima, H; Kitmura, T; Taketo, MM; Oshima, M				Guo, Xiaoying; Oshima, Hiroko; Kitmura, Takanori; Taketo, Makoto M.; Oshima, Masanobu			Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROSTAGLANDIN-E SYNTHASE-1; BREAST-CANCER; INTESTINAL POLYPOSIS; EPITHELIAL-CELLS; TRANSGENIC MICE; KNOCKOUT MICE; MYOFIBROBLASTS; RECEPTOR; WNT	Myofibroblasts, also known as activated fibroblasts, constitute an important niche for tumor development through the promotion of angiogenesis. However, the mechanism of stromal fibroblast activation in tumor tissues has not been fully understood. A gastric cancer mouse model (Gan mice) was recently constructed by simultaneous activation of prostaglandin (PG) E-2 and Wnt signaling in the gastric mucosa. Because both the PGE(2) and Wnt pathways play a role in human gastric tumorigenesis, the Gan mouse model therefore recapitulates the molecular etiology of human gastric cancer. Microvessel density increased significantly in Gan mouse tumors. Moreover, the expression of vascular endothelial growth factorA(VEGFA) was predominantly induced in the stromal cells of gastric tumors. Immunohistochemistry suggested that VEGFA-expressing cells in the stroma were alpha-smooth muscle actin-positive myofibroblasts. Bone marrow transplantation experiments indicated that a subset of gastric myofibroblasts is derived from bone marrow. Importantly, the alpha-smooth muscle actin index in cultured fibroblasts increased significantly when stimulated with the conditioned medium of Gan mouse tumor cells, indicating that gastric tumor cells activate stromal fibroblasts. Furthermore, conditioned medium of Gan mouse tumor cells induced VEGFA expression both in embryonic and gastric fibroblasts, which further accelerated the tube formation of human umbilical vein endothelial cells in vitro. Notably, stimulation of fibroblasts with PGE2 and/or Wnt1 did not induce VEGFA expression, thus suggesting that factors secondarily induced by PGE2 and Wnt signaling in the tumor cells are responsible for activation of stromal fibroblasts. Such tumor cell-derived factors may therefore be an effective target for chemoprevention against gastric cancer.	[Guo, Xiaoying; Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, Div Genet, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Guo, Xiaoying] China Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Shenyang 110001, Peoples R China; [Kitmura, Takanori; Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Kanazawa University; China Medical University; Kyoto University	Oshima, M (corresponding author), Kanazawa Univ, Div Genet, Canc Res Inst, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.	oshimam@kenroku.kanazawa-u.ac.jp	Oshima, Masanobu/F-9958-2014	Oshima, Masanobu/0000-0002-3304-0004; Guo, Xiaoying/0000-0002-5337-2532; Kitamura, Takanori/0000-0003-2032-3918; Oshima, Hiroko/0000-0001-6855-4008				Adegboyega PA, 2002, ARCH PATHOL LAB MED, V126, P829; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Brittan M, 2005, GASTROENTEROLOGY, V128, P1984, DOI 10.1053/j.gastro.2005.03.028; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Clements WM, 2002, CANCER RES, V62, P3503; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Matsumoto K, 2005, BIOCHEM BIOPH RES CO, V333, P316, DOI 10.1016/j.bbrc.2005.05.131; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakayama H, 2002, J CLIN PATHOL, V55, P741, DOI 10.1136/jcp.55.10.741; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Oshima M, 2005, CANCER RES, V65, P9147, DOI 10.1158/0008-5472.CAN-05-1936; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Roder David M, 2002, Gastric Cancer, V5 Suppl 1, P5, DOI 10.1007/s10120-002-0203-6; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Saukkonen K, 2003, APMIS, V111, P915, DOI 10.1034/j.1600-0463.2003.1111001.x; Seno H, 2002, CANCER RES, V62, P506; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Shao JY, 2006, CANCER RES, V66, P846, DOI 10.1158/0008-5472.CAN-05-2606; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Su JL, 2004, CANCER RES, V64, P554, DOI 10.1158/0008-5472.CAN-03-1301; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; van Rees BP, 2003, INT J CANCER, V107, P551, DOI 10.1002/ijc.11422; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zhang XB, 2001, CANCER RES, V61, P6050	37	138	143	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19864	19871		10.1074/jbc.M800798200	http://dx.doi.org/10.1074/jbc.M800798200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18495668	hybrid, Green Submitted			2022-12-27	WOS:000257387600070
J	Livesey, MR; Cooper, MA; Deeb, TZ; Carland, JE; Kozuska, J; Hales, TG; Lambert, JJ; Peters, JA				Livesey, Matthew R.; Cooper, Michelle A.; Deeb, Tarek Z.; Carland, Jane E.; Kozuska, Janna; Hales, Tim. G.; Lambert, Jeremy J.; Peters, John A.			Structural determinants of Ca2+ permeability and conduction in the human 5-hydroxytryptamine type 3A receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHANNEL CONDUCTANCE; GATED ION-CHANNEL; RECOMBINANT 5-HT3 RECEPTOR; CYS-LOOP FAMILY; NICOTINIC ACETYLCHOLINE; HEK-293 CELLS; SUBUNIT; SELECTIVITY; EXPRESSION; PERMEATION	Cation-selective cysteine (Cys)-loop transmitter-gated ion channels provide an important pathway for Ca2+ entry into neurones. We examined the influence on Ca2+ permeation of amino acids located at intra-and extracellular ends of the conduction pathway of the human 5-hydroxytryptamine type 3A (5-HT3A) receptor. Mutation of cytoplasmic arginine residues 432, 436, and 440 to glutamine, aspartate, and alanine (the aligned residues of the human 5-HT3B subunit (yielding 5-HT3A(QDA)) increased P-Ca/P-Cs from 1.4 to 3.7. The effect was attributable to the removal of an electrostatic influence of the Arg-436 residue. Despite its relatively high permeability to Ca2+, the single channel conductance of the 5-HT3A(QDA) receptor was depressed in a concentration-dependent and voltage-independent manner by extracellular Ca2+. A conserved aspartate, located toward the extracellular end of the conduction pathway and known to influence ionic selectivity, contributed to the inhibitory effect of Ca2+ on macroscopic currents mediated by5-HT3A receptors. We introduced a D293A mutation into the 5HT(3A)(QDA) receptor(yielding the 5-HT3A(QDA D293A) construct) to determine whether the aspartate is required for the suppression of single channel conductance by Ca2+. The D293A mutation decreased the P-Ca/P-Cs ratio to 0.25 and reduced inwardly directed single channel conductance from 41 to 30 pS but did not prevent suppression of single channel conductance by Ca2+. The D293A mutation also reduced P-Ca/P-Cs when engineered into the wild-type 5-HT3A receptor. The data helped to identify key residues in the cytoplasmic domain (Arg-436) and extracellular vestibule (Asp-293) that markedly influence P-Ca/P-Cs and additionally directly demonstrated a depression of single channel conductance by Ca2+.	[Livesey, Matthew R.; Cooper, Michelle A.; Carland, Jane E.; Kozuska, Janna; Lambert, Jeremy J.; Peters, John A.] Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; [Deeb, Tarek Z.; Hales, Tim. G.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20037 USA; [Hales, Tim. G.] George Washington Univ, Dept Anesthesiol & Crit Care Med, Washington, DC 20037 USA	University of Dundee; George Washington University; George Washington University	Peters, JA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.	j.a.peters@dundee.ac.uk		Livesey, Matthew/0000-0002-3441-7977; Carland, Jane/0000-0002-1456-876X	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; BELLELI D, 1995, MOL PHARM, V48, P1054; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Bruss M, 2000, N-S ARCH PHARMACOL, V362, P392, DOI 10.1007/s002100000342; BUTLER JN, 1968, BIOPHYS J, V8, P1426, DOI 10.1016/S0006-3495(68)86564-6; Chameau P, 2006, CELL TISSUE RES, V326, P573, DOI 10.1007/s00441-006-0255-8; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; DEKKER ER, 1990, J NEUROSCI, V10, P3413; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; GILL CH, 1995, BRIT J PHARMACOL, V114, P1211, DOI 10.1111/j.1476-5381.1995.tb13335.x; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu XQ, 2008, J BIOL CHEM, V283, P6826, DOI 10.1074/jbc.M707571200; Hu XQ, 2005, J PHYSIOL-LONDON, V568, P381, DOI 10.1113/jphysiol.2005.092866; Hubbard PC, 2000, EUR J PHARMACOL, V394, P189, DOI 10.1016/S0014-2999(00)00143-6; Ivanov I, 2007, J AM CHEM SOC, V129, P8217, DOI 10.1021/ja070778l; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Karnovsky AM, 2003, GENE, V319, P137, DOI 10.1016/S0378-1119(03)00803-5; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; Krzywkowski K, 2007, PHARMACOGENET GENOM, V17, P255, DOI 10.1097/FPC.0b013e3280117269; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Mochizuki S, 1999, AMINO ACIDS, V17, P243, DOI 10.1007/BF01366923; Niemeyer MI, 2001, EUR J PHARMACOL, V428, P153, DOI 10.1016/S0014-2999(01)01251-1; Niesler B, 2003, GENE, V310, P101, DOI 10.1016/S0378-1119(03)00503-1; Niesler B, 2007, MOL PHARMACOL, V72, P8, DOI 10.1124/mol.106.032144; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Roerig B, 1997, J NEUROSCI, V17, P8353; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Solt K, 2005, J PHARMACOL EXP THER, V315, P771, DOI 10.1124/jpet.105.090621; SUGITA S, 1992, NEURON, V8, P199, DOI 10.1016/0896-6273(92)90121-S; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; WANG JJ, 1994, J CHEM SOC FARADAY T, V90, P3281, DOI 10.1039/ft9949003281; Zhou FM, 1999, J NEUROPHYSIOL, V82, P2989, DOI 10.1152/jn.1999.82.6.2989	51	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19301	19313		10.1074/jbc.M802406200	http://dx.doi.org/10.1074/jbc.M802406200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18474595	Green Published, hybrid			2022-12-27	WOS:000257387600016
J	Malmberg, SE; Adams, CM				Malmberg, Sharon E.; Adams, Christopher M.			Insulin signaling and the general amino acid control response - Two distinct pathways to amino acid synthesis and uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III TRANSCRIPTION; GCN2 EIF2-ALPHA KINASE; ATF4; EXPRESSION; MICE; DEPRIVATION; PROTEIN; LIVER	ATF4 is a transcription factor that induces a genetic program for amino acid synthesis and amino acid uptake. Previous work demonstrated that ATF4 expression is increased either by insulin or by the general amino acid control (GAAC) response, an evolutionarily ancient pathway that is activated when eukaryotic cells are deprived of amino acids. It is not known whether insulin and the GAAC pathway increase ATF4 expression by the same or different mechanisms. In these studies, we demonstrate that insulin-mediated ATF4 expression occurs as part of a coordinated anabolic program that does not require an essential component of the GAAC pathway, the protein kinase GCN2. Moreover, insulin and the GAAC pathway have an additive effect on expression of ATF4 and downstream mRNAs for amino acid synthesis and uptake. These data suggest that the GAAC pathway may facilitate insulin-mediated anabolism when exogenous amino acids are limiting. We conclude that insulin signaling and the GAAC response comprise two distinct yet complimentary pathways to ATF4 expression, allowing anabolism to be finely tuned to amino acid availability.	[Malmberg, Sharon E.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Adams, CM (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Adams, Christopher/0000-0002-5795-7212				Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; BERDANIER CD, 1979, J NUTR, V109, P1766, DOI 10.1093/jn/109.10.1766; Daly NL, 2005, ONCOGENE, V24, P880, DOI 10.1038/sj.onc.1208031; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Foster DW, 1996, TXB ENDOCRINE PHYSL, P309; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Kimball SR, 2005, SEMIN CELL DEV BIOL, V16, P21, DOI 10.1016/j.semcdb.2004.11.009; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; LEUNG K, 1975, ANNU REV PHYSIOL, V37, P245, DOI 10.1146/annurev.ph.37.030175.001333; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; PRATT WB, 1966, J BIOL CHEM, V241, P5244; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; TOWLE HC, 1995, J BIOL CHEM, V270, P23235, DOI 10.1074/jbc.270.40.23235; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	29	34	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19229	19234		10.1074/jbc.M801331200	http://dx.doi.org/10.1074/jbc.M801331200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480057	hybrid			2022-12-27	WOS:000257387600008
J	Vetter, I; Cheng, W; Peiris, M; Wyse, BD; Roberts-Thomson, SJ; Zheng, J; Monteith, GR; Cabot, PJ				Vetter, Irina; Cheng, Wei; Peiris, Madusha; Wyse, Bruce D.; Roberts-Thomson, Sarah J.; Zheng, Jie; Monteith, Gregory R.; Cabot, Peter J.			Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; VANILLOID RECEPTOR TRPV1; ACTIVATED ION-CHANNEL; DORSAL-ROOT GANGLION; CAPSAICIN RECEPTOR; THERMAL HYPERALGESIA; NEUROPATHIC PAIN; CA2+ RELEASE; TISSUE TRANSGLUTAMINASE; ENDOPLASMIC-RETICULUM	TRPV1 is a nociceptive, Ca2+-selective ion channel involved in the development of several painful conditions. Sensitization of TRPV1 responses by cAMP-dependent PKA crucially contributes to the development of inflammatory hyperalgesia. However, the pathways involved in potentiation of TRPV1 responses by cAMP-dependent PKA remain largely unknown. Using HEK cells stably expressing TRPV1 and the mu opioid receptor, we demonstrated that treatment with the adenylate cyclase activator forskolin significantly increased the multimeric TRPV1 species. Pretreatment with the mu opioid receptor agonist morphine reversed this increased TRPV1 multimerization. FRET analysis revealed that treatment with forskolin did not cause multimerization of pre-existing TRPV1 monomers on the plasma membrane and that intracellular pools of TRPV1 exist mostly as monomers in this model. This suggests that increased TRPV1 multimerization occurred from an intracellular store of inactive TRPV1 monomers. Treatment with forskolin also caused an increase in TRPV1 expression on the plasma membrane not resulting from increased TRPV1 expression, and this rapid TRPV1 translocation was inhibited by treatment with morphine. Thus, potentiation of TRPV1 responses by cAMP-dependent PKA involves plasma membrane insertion of functional TRPV1 multimers formed from an intracellular store of inactive TRPV1 monomers. This potentiation occurs rapidly and can be dynamically modulated by activation of the mu opioid receptor under conditions where cAMP levels are raised, such as with inflammation. Increased translocation and multimerization of TRPV1 channels provide a cellular mechanism for fine-tuning of nociceptive responses that allow for rapid modulation of TRPV1 responses independent of transcriptional changes.	[Vetter, Irina; Peiris, Madusha; Wyse, Bruce D.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.; Cabot, Peter J.] Univ Queensland, Sch Pharm, St Lucia, Qld 4072, Australia; [Cheng, Wei; Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of Queensland; University of California System; University of California Davis	Cabot, PJ (corresponding author), Univ Queensland, Sch Pharm, St Lucia, Qld 4072, Australia.	p.cabot@uq.edu.au	Monteith, Gregory/B-1626-2008; Vetter, Irina/A-6035-2010; cheng, wei/F-2135-2011; Roberts-Thomson, Sarah/W-5676-2019; Cabot, Peter John/B-2424-2013; Roberts-Thomson, Sarah J/B-4282-2011	Monteith, Gregory/0000-0002-4345-530X; Vetter, Irina/0000-0002-3594-9588; Roberts-Thomson, Sarah/0000-0001-8202-5786; Cabot, Peter John/0000-0003-1778-3753; Roberts-Thomson, Sarah J/0000-0001-8202-5786	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR012088, C06-RR-12088-01] Funding Source: Medline; PHS HHS [REY016754A] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alebouyeh M, 2002, CYTOKINE, V19, P102, DOI 10.1006/cyto.2002.1947; Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Ballet S, 1998, BRAIN RES, V796, P198, DOI 10.1016/S0006-8993(98)00350-3; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Chang SY, 2002, J CELL SCI, V115, P783; CHAO CC, 1993, INT J IMMUNOPHARMACO, V15, P447, DOI 10.1016/0192-0561(93)90057-6; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Clark JD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-28; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Eun SY, 2001, BIOCHEM BIOPH RES CO, V285, P1114, DOI 10.1006/bbrc.2001.5272; Hebert SS, 2000, J BIOL CHEM, V275, P32482, DOI 10.1074/jbc.M006528200; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Hu HJ, 2002, J NEUROSCI, V22, P7444; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Jung J, 1999, J NEUROSCI, V19, P529; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kim JA, 2005, ARCH PHARM RES, V28, P73, DOI 10.1007/BF02975139; Kuzhikandathil EV, 2001, J NEUROSCI, V21, P8697, DOI 10.1523/JNEUROSCI.21-22-08697.2001; Lee SY, 2005, BIOCHEM BIOPH RES CO, V331, P1445, DOI 10.1016/j.bbrc.2005.04.066; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Luo H, 2004, NEUROREPORT, V15, P655, DOI 10.1097/00001756-200403220-00016; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Mammone T, 1998, SKIN PHARMACOL APPL, V11, P152, DOI 10.1159/000029821; Matsuura B, 2006, J BIOL CHEM, V281, P12390, DOI 10.1074/jbc.M511921200; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; MORRE DJ, 1989, BIOTECHNIQUES, V7, P946; MURTAUGH MP, 1986, J BIOL CHEM, V261, P614; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Rosenbaum T, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-4; Ross RA, 2001, BRIT J PHARMACOL, V132, P631, DOI 10.1038/sj.bjp.0703850; SCHAFER M, 1995, EUR J PHARMACOL, V279, P165, DOI 10.1016/0014-2999(95)00150-J; Stein A, 1999, PAIN, V83, P525, DOI 10.1016/S0304-3959(99)00156-6; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Thomson LM, 2008, J PAIN, V9, P11, DOI 10.1016/j.jpain.2007.07.008; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; Walker JS, 2003, ADV EXP MED BIOL, V521, P148; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200	54	39	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19540	19550		10.1074/jbc.M707865200	http://dx.doi.org/10.1074/jbc.M707865200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482991	Green Published, hybrid			2022-12-27	WOS:000257387600040
J	Matsuura, K; Wakasugi, M; Yamashita, K; Matsunaga, T				Matsuura, Kenkyo; Wakasugi, Mitsuo; Yamashita, Katsumi; Matsunaga, Tsukasa			Cleavage-mediated activation of Chk1 during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE RESPONSE; GENOTOXIC STRESS; SERINE 139; ATR; PATHWAY; CLASPIN; TOPBP1; DEGRADATION; CHECKPOINTS	The Chk1 kinase is highly conserved from yeast to humans and is well known to function in the cell cycle checkpoint induced by genotoxic or replication stress. The activation of Chk1 is achieved by ATR-dependent phosphorylation with the aid of additional factors. Robust genotoxic insults induce apoptosis instead of the cell cycle checkpoint, and some of the components in the ATR-Chk1 pathway are cleaved by active caspases, although it has been unclear whether the attenuation of the ATR-Chk1 pathway has some role in apoptosis induction. Here we show that Chk1 is activated by caspase-dependent cleavage when the cells undergo apoptosis. Treatment of chicken DT40 cells with various genotoxic agents, UV light, etoposide, or camptothecin induced Chk1 cleavage, which was inhibited by a pan-caspase inhibitor, benzyloxycarbonyl-VAD-fluoromethyl ketone. The cleavage of Chk1 was similarly observed in human Jurkat cells treated with a non-genotoxic apoptosis inducer, staurosporine. We have determined the cleavage site(s), Asp-299 in chicken and Asp-299 and Asp- 351 in human cells. We further show that a truncated form of human Chk1 mimicking the N-terminal cleavage fragment (residues 1-299) possesses strikingly elevated kinase activity. Moreover, the ectopic expression of Chk1-(1-299) in human U2OS cells induces abnormal nuclear morphology with localized chromatin condensation and phosphorylation of histone H2AX. These results suggest that Chk1 is activated by caspase-mediated cleavage during apoptosis and might be implicated in enhancing apoptotic reactions rather than attenuating the ATR-Chk1 pathway.	[Matsuura, Kenkyo; Wakasugi, Mitsuo; Yamashita, Katsumi; Matsunaga, Tsukasa] Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Human Mol Genet, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Matsunaga, T (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Human Mol Genet, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	matsukas@kenroku.kanazawa-u.ac.jp	Wakasugi, Mitsuo/D-8417-2015	Wakasugi, Mitsuo/0000-0001-9593-0566; Matsuura, Kenkyo/0000-0003-4612-6031	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Clarke CAL, 2005, J BIOL CHEM, V280, P35337, DOI 10.1074/jbc.M506460200; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2006, CELL CYCLE, V5, P1265, DOI 10.4161/cc.5.12.2834; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lee MW, 2003, ONCOGENE, V22, P6340, DOI 10.1038/sj.onc.1206729; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Okita N, 2007, BIOL PHARM BULL, V30, P359, DOI 10.1248/bpb.30.359; Perera D, 2005, CELL DEATH DIFFER, V12, P827, DOI 10.1038/sj.cdd.4401620; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Semple JI, 2007, CELL DEATH DIFFER, V14, P1433, DOI 10.1038/sj.cdd.4402134; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Wakasugi M, 2007, BIOCHEM BIOPH RES CO, V364, P771, DOI 10.1016/j.bbrc.2007.10.063; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	31	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25485	25491		10.1074/jbc.M803111200	http://dx.doi.org/10.1074/jbc.M803111200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18550533	hybrid			2022-12-27	WOS:000259012700044
J	Kahsai, AW; Cui, J; Kaniskan, HU; Garner, PP; Fenteany, G				Kahsai, Alem W.; Cui, Junru; Kaniskan, H. Uemit; Garner, Philip P.; Fenteany, Gabriel			Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOCARCIN ANALOG; WOUND CLOSURE; PROTEIN; ACTIN; DNA; MOVEMENT; CLEAVAGE; MOTILITY; ADHESION; PROTRUSION	Cell migration is central to a number of normal and disease processes. Small organic molecules that inhibit cell migration have potential as both research probes and therapeutic agents. We have identified two tetrahydroisoquinoline natural product analogs with antimigratory activities on Madin-Darby canine kidney epithelial cells: a semisynthetic derivative of quinocarmycin (also known as quinocarcin), DX-52-1, and a more complex synthetic molecule, HUK-921, related to the naphthyridinomycin family. It has been assumed that the cellular effects of reactive tetrahydroisoquinolines result from the alkylation of DNA. We have reported previously that the primary target of DX-52-1 relevant to cell migration appears to be the membrane-cytoskeleton linker protein radixin. Here we extend the analysis of the protein targets of DX-52-1, reporting that the multifunctional carbohydrate-binding protein galectin-3 is a secondary target of DX-52-1 that may also be relevant to the antimigratory effects of both DX-52-1 and HUK-921. All known inhibitors of galectin-3 target its beta-galactoside-binding site in the carbohydrate recognition domain. However, we found that DX-52-1 and HUK-921 bind galectin-3 outside of its beta-galactoside-binding site. Intriguingly HUK-921, although a less potent inhibitor of cell migration than DX-52-1, had far greater selectivity for galectin-3 over radixin, exhibiting little binding to radixin, both in vitro and in cells. Overexpression of galectin-3 in cells led to a dramatic increase in cell adhesion on different extracellular matrix substrata as well as changes in cell-cell adhesion and cell motility. Galectin-3-overexpressing cells had greatly reduced sensitivity to DX-52-1 and HUK-921, and these compounds caused a change in localization of the overexpressed galectin-3 and reversion of the cells to a more normal morphology. The converse manipulation, RNA interference-based silencing of galectin-3 expression, resulted in reduced cell-matrix adhesion and cell migration. In aggregate, the data suggest that DX-52-1 and HUK-921 inhibit a carbohydrate binding-independent function of galectin-3 that is involved in cell migration.	[Kahsai, Alem W.; Cui, Junru; Fenteany, Gabriel] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Kaniskan, H. Uemit; Garner, Philip P.] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	University of Connecticut; Washington State University	Fenteany, G (corresponding author), Univ Connecticut, Dept Chem, U-60, Storrs, CT 06269 USA.	gabriel.fenteany@uconn.edu	Fenteany, Gabriel/F-4944-2018	Fenteany, Gabriel/0000-0001-7407-2195; Garner, Philip/0000-0002-6503-9550; Kaniskan, Husnu Umit/0000-0001-5327-832X; Fenteany, Gabriel/0000-0003-0335-4587	National Cancer Institute [NSC 607097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077622] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank William S. Lane (Harvard Microchemistry and Proteomics Analysis Facility, Harvard University) for protein identification. We thank William B. Stallcup (Burnham Institute) and Walter Nickel (University of Heidelberg) for human galectin-3 cDNA. We also thank Carol E. Norris (University of Connecticut) for technical assistance with sorting cells by fluorescence-activated cell sorting. We are grateful to the National Cancer Institute for providing quinocarmycin analog DX-52-1 (NSC 607097).	Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chen HY, 2005, ARCH IMMUNOL THER EX, V53, P497; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Dyer KD, 1996, LIFE SCI, V58, P2073, DOI 10.1016/0024-3205(96)00201-9; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; FLANAGAN ME, 1995, CHEM BIOL, V2, P147, DOI 10.1016/1074-5521(95)90069-1; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Gorski JP, 2002, J BIOL CHEM, V277, P18840, DOI 10.1074/jbc.M109578200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Herberich B, 2000, BIOORGAN MED CHEM, V8, P523, DOI 10.1016/S0968-0896(99)00314-4; HILL GC, 1988, J COMPUT AID MOL DES, V2, P91, DOI 10.1007/BF01532085; Hughes RC, 2002, GLYCOCONJUGATE J, V19, P621, DOI 10.1023/B:GLYC.0000014094.39168.fd; Ingrassia L, 2006, CURR MED CHEM, V13, P3513, DOI 10.2174/092986706779026219; JIA SH, 1988, J BIOL CHEM, V263, P6009; Kahsai AW, 2006, CHEM BIOL, V13, P973, DOI 10.1016/j.chembiol.2006.07.011; KANAMARU R, 1988, CANCER CHEMOTH PHARM, V22, P197, DOI 10.1007/BF00273410; Kaniskan HU, 2007, J AM CHEM SOC, V129, P15460, DOI 10.1021/ja077853c; Krzeslak A, 2004, CELL MOL BIOL LETT, V9, P305; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Liu FT, 2007, DRUG NEWS PERSPECT, V20, P455, DOI 10.1358/dnp.2007.20.7.1149628; Mc Henry KT, 2008, J CELL BIOCHEM, V103, P972, DOI 10.1002/jcb.21470; Mc Henry KT, 2002, CHEMBIOCHEM, V3, P1105, DOI 10.1002/1439-7633(20021104)3:11<1105::AID-CBIC1105>3.0.CO;2-S; McFarlane S, 2005, BRIT J OPHTHALMOL, V89, P107, DOI 10.1136/bjo.2004.045914; Nangia-Makker P, 2007, J BIOENERG BIOMEMBR, V39, P79, DOI 10.1007/s10863-006-9063-9; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; OLIVER MH, 1989, J CELL SCI, V92, P513; Patterson RJ, 2002, GLYCOCONJUGATE J, V19, P499, DOI 10.1023/B:GLYC.0000014079.87862.c7; Pieters RJ, 2006, CHEMBIOCHEM, V7, P721, DOI 10.1002/cbic.200600011; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; TOMITA F, 1984, J ANTIBIOT, V37, P1268, DOI 10.7164/antibiotics.37.1268; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; WILLIAMS RM, 1992, J AM CHEM SOC, V114, P733, DOI 10.1021/ja00028a049; WILLIAMS RM, 1991, TETRAHEDRON, V47, P2629, DOI 10.1016/S0040-4020(01)81795-6; WILLIAMS RM, 1994, BIOCHEMISTRY-US, V33, P4086, DOI 10.1021/bi00179a038; Xing CG, 2004, P NATL ACAD SCI USA, V101, P5862, DOI 10.1073/pnas.0307476101; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007	55	28	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24534	24545		10.1074/jbc.M800006200	http://dx.doi.org/10.1074/jbc.M800006200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18556657	Green Published, hybrid			2022-12-27	WOS:000258820000028
J	Alter, J; Rozentzweig, D; Bengal, E				Alter, Joel; Rozentzweig, Dafna; Bengal, Eyal			Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; SKELETAL-MUSCLE DIFFERENTIATION; CELL-CYCLE PROGRESSION; TNF-ALPHA; P38 MAPK; MYOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; MESSENGER-RNA; ACTIVATION; KINASE	The proinflammatory cytokine, TNF alpha plays a major role in muscle wasting occurring in chronic diseases and muscular dystrophies. Among its other functions, TNF alpha perturbs muscle regeneration by preventing satellite cell differentiation. In the present study, the role of c-Jun N-terminal kinase (JNK), a mediator of TNF alpha, was investigated in differentiating myoblast cell lines. Addition of TNF alpha to C2 myoblasts induced immediate and delayed phases of JNK activity. The delayed phase is associated with myoblast proliferation. Inhibition of JNK activity prevented proliferation and restored differentiation to TNF alpha-treated myoblasts. Studies with cell lines expressing MyoD: ER chimera and lacking JNK1 or JNK2 genes indicate that JNK1 activity mediates the effects of TNF alpha on myoblast proliferation and differentiation. TNF alpha does not induce proliferation or inhibit differentiation of JNK1-null myoblasts. However, differentiation of JNK1-null myoblasts is inhibited when they are grown in conditioned medium derived from cell lines affected by TNF alpha. We investigated the induced synthesis of several candidate growth factors and cytokines following treatment with TNF alpha. Expression of IL-6 and leukemia inhibitory factor (LIF) was induced by TNF alpha in wildtype and JNK2-null myoblasts. However, LIF expression was not induced by TNF alpha in JNK1-null myoblasts. Addition of LIF to the growth medium of JNK1-null myoblasts prevented their differentiation. Moreover, LIF-neutralizing antibodies added to the medium of C2 myoblasts prevented inhibition of differentiation mediated by TNF alpha. Hence, TNF alpha promotes myoblast proliferation through JNK1 and prevents myoblast differentiation through JNK1-mediated secretion of LIF.	[Alter, Joel; Rozentzweig, Dafna; Bengal, Eyal] Technion Israel Inst Technol, Dept Biochem, Rappaport Inst Res Med Sci, Fac Med, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Bengal, E (corresponding author), POB 9649, IL-31096 Haifa, Israel.	bengal@tx.technion.ac.il						Alvarez B, 2002, BBA-MOL CELL RES, V1542, P66, DOI 10.1016/S0167-4889(01)00167-7; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; AUSTIN L, 1991, J NEUROL SCI, V101, P193, DOI 10.1016/0022-510X(91)90045-9; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; BARNARD W, 1994, J NEUROL SCI, V123, P108, DOI 10.1016/0022-510X(94)90211-9; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Guttridge DC, 2004, CURR OPIN CLIN NUTR, V7, P443, DOI 10.1097/01.mco.0000134364.61406.26; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Jo C, 2005, BBA-MOL CELL RES, V1743, P187, DOI 10.1016/j.bbamcr.2004.11.002; Kurek J, 1996, NEUROSCI LETT, V212, P167, DOI 10.1016/0304-3940(96)12802-0; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; MacCorkle-Chosnek RA, 2001, BIOCHEM BIOPH RES CO, V289, P173, DOI 10.1006/bbrc.2001.5948; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MILLER SC, 1988, MOL CELL BIOL, V8, P2295, DOI 10.1128/MCB.8.6.2295; Okazaki S, 1996, CELL PROLIFERAT, V29, P173; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Puri PL, 2000, GENE DEV, V14, P574; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; SARTORELLI V, 2004, SCI STKE, pRE11, DOI DOI 10.1126/STKE.2442004RE11; Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387; Strle K, 2006, ENDOCRINOLOGY, V147, P4363, DOI 10.1210/en.2005-1541; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372	45	51	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23224	23234		10.1074/jbc.M801379200	http://dx.doi.org/10.1074/jbc.M801379200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18552402	hybrid			2022-12-27	WOS:000258455400036
J	Jensen, PC; Thiele, S; Ulven, T; Schwartz, TW; Rosenkilde, MM				Jensen, Pia C.; Thiele, Stefanie; Ulven, Trond; Schwartz, Thue W.; Rosenkilde, Mette M.			Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through Allosteric Versus orthosteric binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPEPTIDE ANTAGONISTS; INTERNATIONAL UNION; RECEPTORS CCR1; LIGANDS; PROTEIN; ACTIVATION; NOMENCLATURE; PHARMACOLOGY; EXPRESSION; MECHANISM	7 transmembrane-spanning (7TM) chemokine receptors having multiple endogenous ligands offer special opportunities to understand the molecular basis for allosteric mechanisms. Thus, CC-chemokine receptor 1 (CCR1) binds CC-chemokine 3 and 5 (CCL3 and CCL5) with K-d values of 7.3 and 0.16 nM, respectively, as determined in homologous competition binding assays. However, CCL5 appears to have a > 10,000-fold lower affinity in competition against I-125-CCL3. Mutational mapping revealed that CCL3 and CCL5 both are strongly affected by systematic truncations of the N-terminal extension, whereas only CCL5 and not CCL3 activation is affected by substitutions in the main ligand binding pocket including the conserved GluVII:06 anchor point. A series of metal ion chelator complexes were found to act as full agonists on CCR1 and to be critically affected by the same substitutions in the main ligand binding pocket as CCL5 but not by mutations in the extracellular domain. In agreement with the overlapping binding sites, the small non-peptide agonists displaced radiolabeled CCL5 with high affinity. Interestingly, the same compounds acted as allosteric enhancers of the binding of CCL3, with which they did not overlap in binding site, leading to an increased B-max and affinity of this chemokine mainly due to an increased association rate. It is concluded that a small molecule agonist through binding deep in the main ligand binding pocket can act as an allosteric enhancer for one endogenous chemokine and at the same time as a competitive blocker of the binding of another endogenous chemokine.	[Jensen, Pia C.; Thiele, Stefanie; Schwartz, Thue W.; Rosenkilde, Mette M.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense, Denmark	University of Copenhagen; University of Southern Denmark	Rosenkilde, MM (corresponding author), Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Ulven, Trond/H-5500-2015	Ulven, Trond/0000-0002-8135-1755; Rosenkilde, Mette Marie/0000-0001-9600-3254; Karlshoj, Stefanie/0000-0001-6505-0883; Schwartz, Thue W./0000-0002-0261-6904	Danish Medical Research Council; European Community's Sixth Framework Program [INNOCHEM: LSHB-CT-2005-518167]; NovoNordisk Foundation; AP-Moller foundation; Aase og Einer Danielsen Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's Sixth Framework Program; NovoNordisk Foundation(Novo Nordisk Foundation); AP-Moller foundation; Aase og Einer Danielsen Foundation	This work was supported by the Danish Medical Research Council, the European Community's Sixth Framework Program (INNOCHEM: LSHB-CT-2005-518167), the NovoNordisk Foundation, the AP-Moller foundation, and the Aase og Einer Danielsen Foundation.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Ballesteros J. A., 1995, RECEPTOR MOL BIOL; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Blanpain C, 2001, J LEUKOCYTE BIOL, V69, P977; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Dautzenberg FM, 2005, PHARMACOLOGY, V75, P21, DOI 10.1159/000085897; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; GERALD C, 1995, J BIOL CHEM, V270, P26758, DOI 10.1074/jbc.270.45.26758; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Jakubik J, 1996, P NATL ACAD SCI USA, V93, P8705, DOI 10.1073/pnas.93.16.8705; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Murphy PM, 2000, PHARMACOL REV, V52, P145; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Pease JE, 2005, EXPERT OPIN INV DRUG, V14, P785, DOI 10.1517/13543784.14.7.785; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478; Rosenkilde MM, 2007, J BIOL CHEM, V282, P27354, DOI 10.1074/jbc.M704739200; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Schwarz MK, 2002, NAT REV DRUG DISCOV, V1, P347, DOI 10.1038/nrd795; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Struyf S, 1998, EUR J IMMUNOL, V28, P1262, DOI 10.1002/(SICI)1521-4141(199804)28:04<1262::AID-IMMU1262>3.0.CO;2-G; Thomas EA, 1997, P NATL ACAD SCI USA, V94, P14115, DOI 10.1073/pnas.94.25.14115; Zoffmann S, 2001, J MED CHEM, V44, P215, DOI 10.1021/jm000982i	39	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23121	23128		10.1074/jbc.M803458200	http://dx.doi.org/10.1074/jbc.M803458200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18559339	hybrid			2022-12-27	WOS:000258455400025
J	Ramazzina, I; Cendron, L; Folli, C; Berni, R; Monteverdi, D; Zanotti, G; Percudani, R				Ramazzina, Ileana; Cendron, Laura; Folli, Claudia; Berni, Rodolfo; Monteverdi, Daniela; Zanotti, Giuseppe; Percudani, Riccardo			Logical identification of an allantoinase analog (puuE) recruited from polysaccharide deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIC-ACID DEGRADATION; CHITIN DEACETYLASE; BACILLUS-SUBTILIS; COLLETOTRICHUM-LINDEMUTHIANUM; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS-AERUGINOSA; CARBOHYDRATE ESTERASE; FUNCTIONAL EXPRESSION; ESCHERICHIA-COLI	The hydrolytic cleavage of the hydantoin ring of allantoin, catalyzed by allantoinase, is required for the utilization of the nitrogen present in purine-derived compounds. The allantoinase gene (DAL1), however, is missing in many completely sequenced organisms able to use allantoin as a nitrogen source. Here we show that an alternative allantoinase gene (puuE) can be precisely identified by analyzing its logic relationship with three other genes of the pathway. The novel allantoinase is annotated in structure and sequence data bases as polysaccharide deacetylase for its homology with enzymes that catalyze hydrolytic reactions on chitin or peptidoglycan substrates. The recombinant PuuE protein from Pseudomonas fluorescens exhibits metal-independent allantoinase activity and stereospecificity for the S enantiomer of allantoin. The crystal structures of the protein and of protein-inhibitor complexes reveal an overall similarity with the polysaccharide deacetylase alpha/beta barrel and remarkable differences in oligomeric assembly and active site geometry. The conserved Asp-His-His metal-binding triad is replaced by Glu-His-Trp, a configuration that is distinctive of PuuE proteins within the protein family. An extra domain at the top of the barrel offers a scaffold for protein tetramerization and forms a small substrate-binding cleft by hiding the large binding groove of polysaccharide deacetylases. Substrate positioning at the active site suggests an acid/base mechanism of catalysis in which only one member of the catalytic pair of polysaccharide deacetylases has been conserved. These data provide a structural rationale for the shifting of substrate specificity that occurred during evolution.	[Ramazzina, Ileana; Folli, Claudia; Berni, Rodolfo; Percudani, Riccardo] Univ Parma, Dept Biochem & Mol Biol, Parco Area Sci, I-43100 Parma, Italy; [Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Chem, I-35131 Padua, Italy	University of Parma; University of Padua	Percudani, R (corresponding author), Univ Parma, Dept Biochem & Mol Biol, Parco Area Sci, I-43100 Parma, Italy.	riccardo.percudani@unipr.it	cendron, Laura/A-5202-2014; percudani, riccardo/B-4872-2011	percudani, riccardo/0000-0001-8452-1062; Berni, Rodolfo/0000-0002-1839-0479; Zanotti, Giuseppe/0000-0002-0945-6501; Cendron, Laura/0000-0002-0125-0461; Ramazzina, Ileana/0000-0003-1009-2917				Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; BUCKHOLZ RG, 1991, YEAST, V7, P913, DOI 10.1002/yea.320070903; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; FLURI R, 1985, J GEN MICROBIOL, V131, P527; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Gaines PJ, 2004, INSECT BIOCHEM MOLEC, V34, P203, DOI 10.1016/j.ibmb.2003.10.002; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; HAYASHI S, 1994, J BIOL CHEM, V269, P12269; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; JANSSEN DB, 1982, J BACTERIOL, V151, P1176, DOI 10.1128/JB.151.3.1176-1183.1982; JOHN M, 1993, P NATL ACAD SCI USA, V90, P625, DOI 10.1073/pnas.90.2.625; KAFETZOPOULOS D, 1993, P NATL ACAD SCI USA, V90, P2564, DOI 10.1073/pnas.90.7.2564; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kahn K, 2000, BIOORG CHEM, V28, P62, DOI 10.1006/bioo.2000.1162; Kalia A, 1999, ANAL BIOCHEM, V275, P1, DOI 10.1006/abio.1999.4259; Kim GJ, 2000, J BACTERIOL, V182, P7021, DOI 10.1128/JB.182.24.7021-7028.2000; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; LAPOINTE G, 1994, APPL ENVIRON MICROB, V60, P888, DOI 10.1128/AEM.60.3.888-895.1994; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; MATSUMOTO H, 1978, MOL GEN GENET, V167, P165, DOI 10.1007/BF00266910; Matsuo Y, 2005, FEBS LETT, V579, P2737, DOI 10.1016/j.febslet.2005.04.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulrooney SB, 2003, J BACTERIOL, V185, P126, DOI 10.1128/JB.185.1.126-134.2003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberbarnscheidt L, 2007, PROTEINS, V66, P250, DOI 10.1002/prot.21217; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd CD, 2006, J EXP BOT, V57, P5, DOI 10.1093/jxb/erj013; Tokuyasu K, 2000, BIOCHEMISTRY-US, V39, P8837, DOI 10.1021/bi0005355; Vigetti D, 2002, GENE, V289, P13, DOI 10.1016/S0378-1119(02)00541-3; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Yang JM, 2004, PLANT PHYSIOL, V134, P1037, DOI 10.1104/pp.103.034637; YOO HS, 1992, YEAST, V8, P997, DOI 10.1002/yea.320081202; Yu YM, 2006, J BIOL CHEM, V281, P36929, DOI 10.1074/jbc.M607703200; Zanotti G, 2006, J MOL BIOL, V363, P1, DOI 10.1016/j.jmb.2006.07.079	52	39	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23295	23304		10.1074/jbc.M801195200	http://dx.doi.org/10.1074/jbc.M801195200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550550	hybrid			2022-12-27	WOS:000258455400042
J	Beurel, E; Jope, RS				Beurel, Eleonore; Jope, Richard S.			Differential regulation of STAT family members by glycogen synthase kinase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAY; INTERFERON-GAMMA; NUCLEAR EXPORT; IFN-GAMMA; CYTOKINE RECEPTORS; ALZHEIMERS-DISEASE; BETA-CATENIN; ACTIVATION; ASTROCYTES	Excessive neuroinflammation contributes to many neurological disorders and is poorly controlled therapeutically. The signal transducer and activator of transcription (STAT) family of transcription factors has a central role in inflammatory reactions, being stimulated by multiple cytokines and interferons and regulating the expression of many proteins involved in inflammation. We found that STAT3 activation is highly dependent on glycogen synthase kinase-3 (GSK3). Inhibitors of GSK3 greatly reduced (> 75%) the activating STAT3 tyrosine phosphorylation in mouse primary astrocytes, microglia, and macrophage-derived RAW264.7 cells induced by interferon-gamma (IFN gamma), IFN alpha, interleukin-6, or insulin. GSK3 inhibitors blocked STAT3 DNA binding activity and the expression of STAT3-induced GFAP and Bcl-3. GSK3 dependence was selective for activation of STAT3 and STAT5, whereas STAT1 and STAT6 activation were GSK3-independent. Knockdown of the two GSK3 isoforms showed STAT3 and STAT5 activation were dependent on GSK3 beta, but not GSK3 alpha. The regulatory mechanism involved GSK3 beta binding STAT3 and promoting its association with the IFN gamma receptor-associated intracellular signaling complex responsible for activating STAT3. Furthermore, GSK3 beta associated with the IFN gamma receptor and was activated by stimulation with IFN gamma. Thus, inhibitors of GSK3 reduce the activation of STAT3 and STAT5, providing a mechanism to differentially regulate STATs to modulate the inflammatory response.	[Beurel, Eleonore; Jope, Richard S.] Univ Alabama, Dept Psychiat & Behav Neurobiol, Sparks Ctr 1057, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Jope, RS (corresponding author), Univ Alabama, Dept Psychiat & Behav Neurobiol, Sparks Ctr 1057, 1720,7th Ave 5, Birmingham, AL 35294 USA.	jope@uab.edu			NIA NIH HHS [AG021045] Funding Source: Medline; NIMH NIH HHS [R01 MH038752, MH38752] Funding Source: Medline; NINDS NIH HHS [NS37768] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH038752, R01MH038752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021045] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmed CML, 2003, J CELL SCI, V116, P3089, DOI 10.1242/jcs.00528; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Brocke-Heidrich K, 2006, ONCOGENE, V25, P7297, DOI 10.1038/sj.onc.1209711; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Campbell IL, 2005, BRAIN RES REV, V48, P166, DOI 10.1016/j.brainresrev.2004.12.006; Cardona-Gomez P, 2004, MOL CELL NEUROSCI, V25, P363, DOI 10.1016/j.mcn.2003.10.008; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Coffer PJ, 1997, ONCOGENE, V15, P2529, DOI 10.1038/sj.onc.1201429; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Ginger RS, 2000, EMBO J, V19, P5483, DOI 10.1093/emboj/19.20.5483; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jee Y, 2001, J NEUROIMMUNOL, V114, P40, DOI 10.1016/S0165-5728(00)00446-X; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li L, 2006, J BIOL CHEM, V281, P33172, DOI 10.1074/jbc.M606940200; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nakashima K, 1999, J NEUROSCI, V19, P5429; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Plotnikov A, 2008, CANCER RES, V68, P1354, DOI 10.1158/0008-5472.CAN-07-6094; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Wang Y, 2005, GLIA, V50, P56, DOI 10.1002/glia.20152; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Woodgett J. R., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P281, DOI 10.2174/1568008033340153; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhou W, 2006, BRIT J CANCER, V95, P164, DOI 10.1038/sj.bjc.6603234; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	68	132	135	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21934	21944		10.1074/jbc.M802481200	http://dx.doi.org/10.1074/jbc.M802481200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550525	Green Published, hybrid			2022-12-27	WOS:000258114700013
J	Archer, CT; Burdine, L; Liu, B; Ferdous, A; Johnston, SA; Kodadek, T				Archer, Chase T.; Burdine, Lyle; Liu, Bo; Ferdous, Anwarul; Johnston, Stephen Albert; Kodadek, Thomas			Physical and functional interactions of monoubiquitylated transactivators with the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION DOMAIN; REGULATORY PARTICLE; 26S PROTEASOME; CROSS-LINKING; HISTONE H2B; PROTEIN; TRANSCRIPTION; ASSOCIATION; SUBUNIT; IDENTIFICATION	Destabilization of activator-DNA complexes by the proteasomal ATPases can inhibit transcription by limiting activator interaction with DNA. Modification of the activator by monou-biquitylation protects the activator from this destabilization activity. In this study, we probe the mechanism of this protective effect of monoubiquitylation. Using novel label transfer and chemical cross-linking techniques, we show that ubiquitin contacts the ATPase complex directly, apparently via Rpn1 and Rpt1. This interaction results in the dissociation of the activation domain-ATPase complex via an allosteric process. A model is proposed in which activator monoubiquitylation serves to limit the lifetime of the activator-ATPase complex interaction and thus the ability of the ATPases to unfold the activator and dissociate the protein-DNA complex.	[Archer, Chase T.; Burdine, Lyle; Liu, Bo; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dallas, TX 75390 USA; [Ferdous, Anwarul; Johnston, Stephen Albert; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.Kodadek@utsouthwestern.edu	Burdine, Lyle/GLR-7495-2022	Kodadek, Thomas/0000-0003-1930-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071833] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 71833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Archer CT, 2008, J BIOL CHEM, V283, P12614, DOI 10.1074/jbc.M801050200; Archer CT, 2005, MOL BIOSYST, V1, P366, DOI 10.1039/b510019d; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Denison C, 2004, J PROTEOME RES, V3, P417, DOI 10.1021/pr034071j; ELASSER S, 2002, NATURE CELL BIOL, V4, P725; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Liu B, 2007, J AM CHEM SOC, V129, P12348, DOI 10.1021/ja072904r; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; MATSUMOTO K, 1980, J BACTERIOL, V141, P508, DOI 10.1128/JB.141.2.508-527.1980; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	38	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21789	21798		10.1074/jbc.M803075200	http://dx.doi.org/10.1074/jbc.M803075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18515799	Green Published, hybrid			2022-12-27	WOS:000257898800052
J	Mahmmoud, YA				Mahmmoud, Yasser A.			Capsaicin stimulates uncoupled ATP hydrolysis by the sarcoplasmic reticulum calcium pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-INSENSITIVE PHOSPHOENZYME; 1ST TRANSMEMBRANE HELIX; HEAT-PRODUCTION; SKELETAL-MUSCLE; THERMOGENIC ACTIVITY; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; CA2+ ATPASE; A-DOMAIN; CA2+-ATPASE	In muscle cells the sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA) couples the free energy of ATP hydrolysis to pump Ca2+ ions from the cytoplasm to the SR lumen. In addition, SERCA plays a key role in non-shivering thermogenesis through uncoupled reactions, where ATP hydrolysis takes place without active Ca2+ translocation. Capsaicin (CPS) is a naturally occurring vanilloid, the consumption of which is linked with increased metabolic rate and core body temperature. Here we document the stimulation by CPS of the Ca2+-dependent ATP hydrolysis by SERCA without effects on Ca2+ accumulation. The stimulation by CPS was significantly dependent on the presence of a Ca2+ gradient across the SR membrane. ATP activation assays showed that the drug reduced the nucleotide affinity at the catalytic site, whereas the affinity at the regulatory site increased. Several biochemical analyses indicated that CPS stabilizes an ADP-insensitive E2P-related conformation that dephosphorylates at a higher rate than the control enzyme. Under conditions where uncoupled SERCA was specifically inhibited by the treatment with fluoride, low temperatures, or dimethyl sulfoxide, CPS had no stimulatory effect on ATP hydrolysis by SERCA. It is concluded that CPS stabilizes a SERCA sub-conformation where Ca2+ is released from the phosphorylated intermediate to the cytoplasm instead of the SR lumen, increasing ATP hydrolysis not coupled with Ca2+ transport. To the best of our knowledge CPS is the first natural drug that augments uncoupled SERCA, presumably resulting in thermogenesis. The role of CPS as a SERCA modulator is discussed.	Aarhus Univ, Inst Phys & Biophys, DK-8000 Aarhus C, Denmark	Aarhus University	Mahmmoud, YA (corresponding author), Aarhus Univ, Inst Phys & Biophys, Ole Worms Alle 1185, DK-8000 Aarhus C, Denmark.	yam@biophys.au.dk						Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Barata H, 2002, J BIOL CHEM, V277, P16868, DOI 10.1074/jbc.M200648200; Bartolommei G, 2006, J BIOL CHEM, V281, P9547, DOI 10.1074/jbc.M510550200; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; CORNELIUS F, 1985, BIOCHIM BIOPHYS ACTA, V818, P211, DOI 10.1016/0005-2736(85)90572-3; DAIHO T, 1994, J BIOL CHEM, V269, P11060; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; de Meis L, 2003, J BIOL CHEM, V278, P41856, DOI 10.1074/jbc.M308280200; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005; Fortea MI, 2000, J BIOL CHEM, V275, P12521, DOI 10.1074/jbc.275.17.12521; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Hua SM, 2005, J BIOL CHEM, V280, P17579, DOI 10.1074/jbc.M500472200; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Kobayashi A, 1998, AM J PHYSIOL-REG I, V275, pR92, DOI 10.1152/ajpregu.1998.275.1.R92; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LINDBERG O, 1956, METHODS BIOCHEMICAL, V3, P1; Logan-Smith MJ, 2001, J BIOL CHEM, V276, P46905, DOI 10.1074/jbc.M108778200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mahmmoud YA, 2007, BRIT J PHARMACOL, V150, P200, DOI 10.1038/sj.bjp.0706970; Mahmmoud YA, 2005, BBA-BIOMEMBRANES, V1720, P110, DOI 10.1016/j.bbamem.2005.11.001; Mahmmoud YA, 2005, BRIT J PHARMACOL, V145, P236, DOI 10.1038/sj.bjp.0706185; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MEIS LD, 1971, J BIOL CHEM, V246, P4759; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Reis M, 2001, J BIOL CHEM, V276, P42793, DOI 10.1074/jbc.M107625200; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; STARLING AP, 1995, J BIOL CHEM, V270, P14467, DOI 10.1074/jbc.270.24.14467; Szallasi A, 1999, PHARMACOL REV, V51, P159; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Xin H, 2005, BIOCHEM BIOPH RES CO, V332, P756, DOI 10.1016/j.bbrc.2005.05.016; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361	53	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21418	21426		10.1074/jbc.M803654200	http://dx.doi.org/10.1074/jbc.M803654200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539598	hybrid			2022-12-27	WOS:000257898800013
J	Nievas, GAF; Barrantes, FJ; Antollini, SS				Nievas, Gaspar A. Fernandez; Barrantes, Francisco J.; Antollini, Silvia S.			Modulation of nicotinic acetylcholine receptor conformational state by free fatty acids and steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; PERMEABILITY CONTROL PROPERTIES; MEMBRANE-LIPID-COMPOSITION; ION-CHANNEL FUNCTION; TORPEDO-CALIFORNICA; TRANSMEMBRANE DOMAIN; LAURDAN FLUORESCENCE; GENERALIZED POLARIZATION; CATECHOLAMINE SECRETION; THALAMIC SYNAPTOSOMES	Steroids and free fatty acids (FFA) are noncompetitive antagonists of the nicotinic acetylcholine receptor (AChR). Their site of action is purportedly located at the lipid-AChR interface, but their exact mechanism of action is still unknown. Here we studied the effect of structurally different FFA and steroids on the conformational equilibrium of the AChR in Torpedo californica receptor-rich membranes. We took advantage of the higher affinity of the fluorescent AChR open channel blocker, crystal violet, for the desensitized state than for the resting state. Increasing concentrations of steroids and FFA decreased the K-D of crystal violet in the absence of agonist; however, only cis-unsaturated FFA caused an increase in K-D in the presence of agonist. This latter effect was also observed with treatments that caused the opposite effects on membrane polarity, such as phospholipase A(2) treatment or temperature increase (decreasing or increasing membrane polarity, respectively). Quenching by spin-labeled fatty acids of pyrene-labeled AChR reconstituted into model membranes, with the label located at the gamma M4 transmembrane segment, disclosed the occurrence of conformational changes induced by steroids and cis-unsaturated FFA. The present work is a step forward in understanding the mechanism of action of this type of molecules, suggesting that the direct contact between exogenous lipids and the AChR transmembrane segments removes the AChR from its resting state and that membrane polarity modulates the AChR activation equilibrium by an independent mechanism.	Univ Nacl Sur, CONICET, Inst Invest Bioquim, RA-8000 Bahia Blanca, Buenos Aires, Argentina; UNESCO, Chair Biophys & Mol Neurobiol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Antollini, SS (corresponding author), Univ Nacl Sur, CONICET, Inst Invest Bioquim, CC 857,B8000FWB, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	silviant@criba.edu.ar	Barrantes, Francisco J./HCH-0258-2022	Barrantes, Francisco J./0000-0002-4745-681X				ANDREASEN TJ, 1979, ARCH BIOCHEM BIOPHYS, V194, P468, DOI 10.1016/0003-9861(79)90641-6; ANDREASEN TJ, 1980, BIOCHEMISTRY-US, V19, P4719, DOI 10.1021/bi00561a027; Andreeva IE, 2006, BIOCHEMISTRY-US, V45, P195, DOI 10.1021/bi0516024; Antollini SS, 2002, J BIOL CHEM, V277, P1249, DOI 10.1074/jbc.M106618200; Antollini SS, 1996, BIOPHYS J, V70, P1275, DOI 10.1016/S0006-3495(96)79684-4; Antollini SS, 1998, BIOCHEMISTRY-US, V37, P16653, DOI 10.1021/bi9808215; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Barrantes FJ, 2003, CURR OPIN DRUG DISC, V6, P620; BARRANTES FJ, 1978, J MOL BIOL, V124, P1, DOI 10.1016/0022-2836(78)90144-4; BARRANTES FJ, 1982, NEURORECEPTORS, P315; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; Bouzat C, 1996, J BIOL CHEM, V271, P25835, DOI 10.1074/jbc.271.42.25835; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; BOUZAT C, 1993, NEUROREPORT, V4, P143, DOI 10.1097/00001756-199302000-00007; BOUZAT CB, 1993, RECEPTOR CHANNEL, V1, P251; Bullock AE, 1997, J NEUROCHEM, V68, P2412; Butt CM, 2002, J NEUROCHEM, V83, P48, DOI 10.1046/j.1471-4159.2002.01135.x; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P5750, DOI 10.1021/bi00266a004; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; DILGER JP, 1992, PFLUG ARCH EUR J PHY, V420, P479, DOI 10.1007/BF00374622; Nievas GAF, 2007, BIOCHEMISTRY-US, V46, P3503, DOI 10.1021/bi061388z; Garbus I, 2002, NEUROPHARMACOLOGY, V43, P65, DOI 10.1016/S0028-3908(02)00068-0; Garbus I, 2001, NEUROREPORT, V12, P227, DOI 10.1097/00001756-200102120-00010; GORNETSCHELNOKOW U, 1994, EMBO J, V13, P338, DOI 10.1002/j.1460-2075.1994.tb06266.x; GUTIERREZMERINO C, 1995, BIOCHEMISTRY-US, V34, P4846, DOI 10.1021/bi00014a042; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; HARTIG PR, 1979, BIOCHEMISTRY-US, V18, P1146, DOI 10.1021/bi00574a004; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Ke L, 1996, J NEUROCHEM, V67, P1100; Kudo K, 2002, EUR J PHARMACOL, V456, P19, DOI 10.1016/S0014-2999(02)02623-7; LAKOWICZ RL, 1999, PRINCIPLES FLUORESCE, P239; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; Levi M, 1997, MECH AGEING DEV, V97, P109, DOI 10.1016/S0047-6374(97)00047-X; LI L, 1990, BIOCHEMISTRY-US, V29, P5428, DOI 10.1021/bi00475a003; Liu PS, 2004, J BIOMED SCI, V11, P200, DOI 10.1159/000076032; Liu PS, 1996, NEUROSCI LETT, V204, P181, DOI 10.1016/0304-3940(96)12350-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lurtz MM, 1999, MOL PHARMACOL, V55, P159, DOI 10.1124/mol.55.1.159; MARSH D, 1978, P NATL ACAD SCI USA, V75, P4329, DOI 10.1073/pnas.75.9.4329; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; Minota S, 1997, J NEUROPHYSIOL, V78, P2396, DOI 10.1152/jn.1997.78.5.2396; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; NARAYANASWAMI V, 1993, BIOCHEMISTRY-US, V32, P12413, DOI 10.1021/bi00097a020; Nurowska E, 1996, NEUROREPORT, V8, P77, DOI 10.1097/00001756-199612200-00016; Nurowska E, 2002, BBA-BIOMEMBRANES, V1564, P14, DOI 10.1016/S0005-2736(02)00356-5; OrtizMiranda SI, 1997, J MEMBRANE BIOL, V158, P17, DOI 10.1007/s002329900240; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; PRASAD R, 1996, MANUAL MEMBRANE LIPI, P1; Purohit Y, 2006, J GEN PHYSIOL, V127, P719, DOI 10.1085/jgp.200509438; Ravichandra B, 1999, BIOPHYS CHEM, V76, P117, DOI 10.1016/S0301-4622(98)00222-1; Ryan SE, 2001, J BIOL CHEM, V276, P4796, DOI 10.1074/jbc.M007063200; Shi LJ, 2002, ACTA PHARMACOL SIN, V23, P237; Shi LJ, 2001, ARCH BIOCHEM BIOPHYS, V394, P145, DOI 10.1006/abbi.2001.2519; Shiraishi M, 2002, ANESTH ANALG, V95, P900, DOI 10.1097/00000539-200210000-00020; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Tamamizu S, 1999, J MEMBRANE BIOL, V170, P157, DOI 10.1007/s002329900545; Trisciuoglio D, 2002, TOXICOL IN VITRO, V16, P449, DOI 10.1016/S0887-2333(02)00029-2; VALERA S, 1992, P NATL ACAD SCI USA, V89, P9949, DOI 10.1073/pnas.89.20.9949; Vest R, 2006, J MEMBRANE BIOL, V211, P15, DOI 10.1007/s00232-005-7008-6; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; VILLAR MT, 1988, BIOCHIM BIOPHYS ACTA, V938, P35, DOI 10.1016/0005-2736(88)90119-8; Yonekubo K, 2003, NEUROSCI LETT, V337, P89, DOI 10.1016/S0304-3940(02)01313-7; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zanello LP, 1996, BIOPHYS J, V70, P2155, DOI 10.1016/S0006-3495(96)79781-3	77	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21478	21486		10.1074/jbc.M800345200	http://dx.doi.org/10.1074/jbc.M800345200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18511419	hybrid			2022-12-27	WOS:000257898800020
J	Chen, N; Onisko, B; Napoli, JL				Chen, Na; Onisko, Bruce; Napoli, Joseph L.			The nuclear transcription factor RAR alpha associates with neuronal RNA granules and suppresses translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC PROTEIN-SYNTHESIS; RELATIONAL MEMORY DEFICIT; TERM SYNAPTIC PLASTICITY; VITAMIN-A-DEFICIENCY; RETINOIC ACID; RECEPTORS; BRAIN; TRAFFICKING; INHIBITION; INITIATION	All-trans-retinoic acid stimulates dendritic growth in hippocampal neurons within minutes by activating mitogen-activated protein kinase and mTOR and increasing dendritic translation of calcium calmodulin-dependent protein kinase II alpha and the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole propionate receptor subunit GluR1. Hippocampal neurons express RAR alpha in dendrites, and knocking down RAR alpha prevents all-trans-retinoic acid effects on dendritic growth. Here we show, by liquid chromatography/mass spectrometry analysis of immunoaffinity isolates of hippocampal neurons, that RAR alpha partners with many RNA-binding proteins and translation factors conveyed in dendritic RNA transport granules, including the purine-rich element-binding protein, Pur alpha. The interaction of RAR alpha with Pur alpha, an RNA-binding protein required for dendritic RNA transport, and other RNA-binding proteins was confirmed by tandem affinity purification. Confocal microscopy confirmed localization of neuronal RAR alpha in dendritic RNA granules with Pur alpha and FMRP (the fragile x mental retardation protein). Hippocampal RAR alpha also associates with mRNA, e. g. encoding GluR1 and calcium calmodulin-dependent protein kinase II alpha. Consistent with a granule function of conveying translationally silenced mRNA, RAR alpha inhibits translation initiation, independent of 7-methylguanylate cap or poly(A) tail, and prompts mRNA redistribution to silencing ribonucleoprotein particles. These data afford a mechanism for rapid stimulation of dendritic growth by all-trans-retinoic acid and reveal that the ligand-dependent transcription factor RAR alpha also regulates translation.	[Chen, Na; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Onisko, Bruce] Western Reg Res Ctr, USDA, Albany, CA 94710 USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA)	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 119 Morgan Hall,MC 3104, Berkeley, CA 94720 USA.	jna@berkeley.edu	Cabrera, Mariel/GMX-2706-2022	Onisko, Bruce/0000-0003-4657-8257	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870, R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013566] Funding Source: NIH RePORTER; NIA NIH HHS [AG 13566] Funding Source: Medline; NIDDK NIH HHS [DK 36870, R01 DK090522] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Borman AM, 2000, NUCLEIC ACIDS RES, V28, P4068, DOI 10.1093/nar/28.21.4068; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; KOSIK KS, 2002, SCI STKE, pPE16; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010	32	69	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20841	20847		10.1074/jbc.M802314200	http://dx.doi.org/10.1074/jbc.M802314200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18495661	Green Published, hybrid			2022-12-27	WOS:000257746100026
J	Iwasaki, K; Hayashi, K; Fujioka, T; Sobue, K				Iwasaki, Kazuhiro; Hayashi, Ken'ichiro; Fujioka, Tomoaki; Sobue, Kenji			Rho/Rho-associated kinase signal regulates myogenic differentiation via myocardin-related transcription factor-A/Smad-dependent transcription of the Id3 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MYOBLAST DIFFERENTIATION; CELL-DIFFERENTIATION; C2C12 MYOBLASTS; ACTIN DYNAMICS; RHOA GTPASE; MUSCLE; PROTEIN; MYOD; EXPRESSION	RhoA is known to be involved in myogenic differentiation, but whether it acts as a positive or negative regulator is controversial. To resolve this issue, we investigated the differentiation stage-specific roles of RhoA and its effector, Rho-associated kinase, using C2C12 myoblasts. We found that proliferating myoblasts show high levels of RhoA and serum-response factor activities and strong expression of the downstream target of RhoA, myocardin-related transcription factor-A (MRTF-A or MAL); these activities and expression are markedly lower in differentiating myocytes. We further demonstrated that, in proliferating myoblasts, an increase in MRTF-A, which forms a complex with Smad1/4, strikingly activates the expression level of the Id3 gene; the Id3 gene product is a potent inhibitor of myogenic differentiation. Finally, we found that during differentiation, one of the forkhead transcription factors translocates into the nucleus and suppresses Id3 expression by preventing the association of the MRTF-A-Smad complex with the Id3 promoter, which leads to the enhancement of myogenic differentiation. We conclude that RhoA/Rho-associated kinase signaling plays positive and negative roles in myogenic differentiation, mediated by MRTF-A/Smad-dependent transcription of the Id3 gene in a differentiation stage-specific manner.	[Iwasaki, Kazuhiro; Hayashi, Ken'ichiro; Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Suita, Osaka 5650871, Japan; [Iwasaki, Kazuhiro; Fujioka, Tomoaki] Osaka Univ, Grad Sch Med, Res Ctr Child Mental Dev, Suita, Osaka 5650871, Japan; [Sobue, Kenji] Iwate Med Univ, Dept Urol, Morioka, Iwate 0208505, Japan	Osaka University; Osaka University; Iwate Medical University	Sobue, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp						Atherton GT, 1996, CELL GROWTH DIFFER, V7, P1059; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bois PRJ, 2005, MOL CELL BIOL, V25, P7645, DOI 10.1128/MCB.25.17.7645-7656.2005; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; Carnac G, 1998, MOL BIOL CELL, V9, P1891, DOI 10.1091/mbc.9.7.1891; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; FRENCH BA, 1991, MOL CELL BIOL, V11, P2439, DOI 10.1128/MCB.11.5.2439; GauthierRouviere C, 1996, MOL BIOL CELL, V7, P719, DOI 10.1091/mbc.7.5.719; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Melnikova IN, 1996, CELL GROWTH DIFFER, V7, P1067; Melnikova IN, 1999, EXP CELL RES, V247, P94, DOI 10.1006/excr.1998.4330; Meriane M, 2000, MOL BIOL CELL, V11, P2513, DOI 10.1091/mbc.11.8.2513; MINER JH, 1991, MOL CELL BIOL, V11, P2842, DOI 10.1128/MCB.11.5.2842; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MOHUN T, 1987, EMBO J, V6, P667, DOI 10.1002/j.1460-2075.1987.tb04806.x; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Muscat George E. O., 1992, Gene Expression, V2, P241; Nishiyama T, 2004, J BIOL CHEM, V279, P47311, DOI 10.1074/jbc.M403546200; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Park J, 2003, MOL CELLS, V16, P216; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Travaglione S, 2005, CELL DEATH DIFFER, V12, P78, DOI 10.1038/sj.cdd.4401522; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Wu JM, 2005, BBA-GENE STRUCT EXPR, V1731, P13, DOI 10.1016/j.bbaexp.2005.08.008; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yoshiko Y, 2002, AM J PHYSIOL-CELL PH, V283, pC1278, DOI 10.1152/ajpcell.00168.2002	59	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21230	21241		10.1074/jbc.M710525200	http://dx.doi.org/10.1074/jbc.M710525200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18477564	hybrid, Green Published			2022-12-27	WOS:000257746100065
J	Wan, ZL; Huang, K; Hu, SQ; Whittaker, J; Weiss, MA				Wan, Zhu-li; Huang, Kun; Hu, Shi-Quan; Whittaker, Jonathan; Weiss, Michael A.			The structure of a mutant insulin uncouples receptor binding from protein allostery - An electrostatic block to the TR transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLTEN-GLOBULE HYPOTHESIS; DES-PENTAPEPTIDE-INSULIN; <BETA-143 H21 HIS->ARG>; B-CHAIN; A-CHAIN; METABOLIC-CLEARANCE; CHIRAL MUTAGENESIS; HUMAN PROINSULIN; LOW-PH; HEMOGLOBIN	The zinc insulin hexamer undergoes allosteric reorganization among three conformational states, designated T-6, T3R3f, and R-6. Although the free monomer in solution (the active species) resembles the classical T-state, an R-like conformational change is proposed to occur upon receptor binding. Here, we distinguish between the conformational requirements of receptor binding and the crystallographic TR transition by design of an active variant refractory to such reorganization. Our strategy exploits the contrasting environments of His(B5) in wild-type structures: on the T-6 surface but within an intersubunit crevice in R-containing hexamers. The TR transition is associated with a marked reduction in His(B5) pK(a), in turn predicting that a positive charge at this site would destabilize the R-specific crevice. Remarkably, substitution of His(B5) (conserved among eutherian mammals) by Arg (occasionally observed among other vertebrates) blocks the TR transition, as probed in solution by optical spectroscopy. Similarly, crystallization of Arg(B5)-insulin in the presence of phenol (ordinarily a potent inducer of the TR transition) yields T-6 hexamers rather than R-6 as obtained in control studies of wild- type insulin. The variant structure, determined at a resolution of 1.3 angstrom, closely resembles the wild- type T-6 hexamer. Whereas Arg(B5) is exposed on the protein surface, its side chain participates in a solvent-stabilized network of contacts similar to those involving His(B5) in wild-type T-states. The substantial receptor-binding activity of Arg(B5)-insulin (40% relative to wild type) demonstrates that the function of an insulin monomer can be uncoupled from its allosteric reorganization within zinc-stabilized hexamers.	[Wan, Zhu-li; Huang, Kun; Hu, Shi-Quan; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Whittaker, Jonathan] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012		NIDDK NIH HHS [R01 DK040949, DK 040949] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAJAJ M, 1986, BIOCHEM J, V238, P345, DOI 10.1042/bj2380345; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Becker RHA, 2007, DIABETES TECHNOL THE, V9, P109, DOI 10.1089/dia.2006.0035; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BI RC, 1983, ACTA CRYSTALLOGR B, V39, P90; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BONAVENTURA C, 1975, J BIOL CHEM, V250, P6273; BONAVENTURA J, 1975, J BIOL CHEM, V250, P9250; BONAVENTURA J, 1975, J BIOL CHEM, V250, P6278; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; HEINEMANN L, 1993, DIABETIC MED, V10, P535, DOI 10.1111/j.1464-5491.1993.tb00116.x; HELLMAN U, 1990, BIOCHEM BIOPH RES CO, V169, P571, DOI 10.1016/0006-291X(90)90369-X; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; HUA QX, 1991, BIOCHIM BIOPHYS ACTA, V1078, P101, DOI 10.1016/0167-4838(91)90098-K; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; HUA QX, 1992, P NATL ACAD SCI USA, V89, P2379, DOI 10.1073/pnas.89.6.2379; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN AMM, 1992, J MOL BIOL, V227, P1146, DOI 10.1016/0022-2836(92)90527-Q; KARATAS Y, 1991, BIOL CHEM H-S, V372, P1035, DOI 10.1515/bchm3.1991.372.2.1035; KATSOYAN.PG, 1966, P NATL ACAD SCI USA, V55, P1554, DOI 10.1073/pnas.55.6.1554; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; POYART C, 1980, J BIOL CHEM, V255, P9465; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; ROY M, 1989, J BIOL CHEM, V264, P19081; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; SORENSEN MD, 1994, BIOCHEMISTRY-US, V33, P13727; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Stieglitz KA, 2005, J MOL BIOL, V349, P413, DOI 10.1016/j.jmb.2005.03.073; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TILLIL H, 1990, ENDOCRINOLOGY, V127, P2418, DOI 10.1210/endo-127-5-2418; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; WOLLMER A, 1994, BIOL CHEM H-S, V375, P219; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Zhang YS, 2002, ACTA CRYSTALLOGR D, V58, P186, DOI 10.1107/S0907444901018455; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	72	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21198	21210		10.1074/jbc.M800235200	http://dx.doi.org/10.1074/jbc.M800235200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18492668	Green Published, hybrid			2022-12-27	WOS:000257746100062
J	Wang, Y; Toei, M; Forgac, M				Wang, Yanru; Toei, Masashi; Forgac, Michael			Analysis of the membrane topology of transmembrane segments in the C-terminal hydrophobic domain of the yeast vacuolar ATPase subunit a (Vph1p) by chemical modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; MEDIATED CROSS-LINKING; V-ATPASE; H+-ATPASE; MUTATIONAL ANALYSIS; 100-KDA SUBUNIT; SYNTHASE; INTERACTS; ROTATION; SITE	The integral V-0 domain of the vacuolar (H+)-ATPases (V-ATPases) provides the pathway by which protons are transported across the membrane. Subunit a is a 100-kDa integral subunit of V-0 that plays an essential role in proton translocation. To better define the membrane topology of subunit a, unique cysteine residues were introduced into a Cys-less form of the yeast subunit a (Vph1p) and the accessibility of these cysteine residues to modification by the membrane permeant reagent N-ethylmaleimide (NEM) and the membrane impermeant reagent polyethyleneglycol maleimide (PEG-mal) in the presence and absence of the protein denaturant SDS was assessed. Thirty Vph1p mutants containing unique cysteine residues were constructed and analyzed. Cysteines introduced between residues 670 and 710 and between 807 and 840 were modified by PEG-mal in the absence of SDS, indicating a cytoplasmic orientation. Cysteines introduced between residues 602 and 620 and between residues 744 and 761 were modified by NEM but not PEG-mal in the absence of SDS, suggesting a lumenal orientation. Finally, cysteines introduced at residues 638, 645, 648, 723, 726, 734, and at nine positions between residue 766 and 804 were modified by NEM and PEG-mal only in the presence of SDS, consistent with their presence within the membrane or at a protein-protein interface. The results support an eight transmembrane helix (TM) model of subunit a in which the C terminus is located on the cytoplasmic side of the membrane and provide information on the location of hydrophilic loops separating TM6, 7, and 8.	[Wang, Yanru; Toei, Masashi; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NIDDK NIH HHS [DK 34928] Funding Source: Medline; NIGMS NIH HHS [R01 GM034478, GM 34478, R37 GM034478] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Clarke M, 2002, J CELL SCI, V115, P2893; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Junge W, 1996, BER BUNSEN PHYS CHEM, V100, P2014, DOI 10.1002/bbpc.19961001215; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Vik SB, 2000, BBA-BIOENERGETICS, V1458, P457, DOI 10.1016/S0005-2728(00)00094-3; Vik SB, 2005, J BIOENERG BIOMEMBR, V37, P445, DOI 10.1007/s10863-005-9488-6; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200	47	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20696	20702		10.1074/jbc.M803258200	http://dx.doi.org/10.1074/jbc.M803258200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508769	hybrid, Green Published			2022-12-27	WOS:000257746100010
J	Jung, HY; Seong, HA; Ha, HJ				Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung			Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; CANCER-CELLS; PHYSICAL INTERACTION; GROWTH; MDM2; STABILITY; DEGRADATION; ADENOCARCINOMA; RESPONSES	Macrophage migration inhibitory factor (MIF) is a potent modulator of the p53 signaling pathway, but the molecular mechanisms of the effect of MIF on p53 function have so far remained unclear. Here we show that MIF physically interacts with the p53 tumor suppressor in vitro and in vivo. This association was significantly reduced by a C81S mutation but not C57S or C60S mutations, suggesting that Cys(81) is essential for the in vivo association between MIF and p53. This association also depended on Cys(242) (and, to some extent, on Cys(238)) within the central DNA binding domain of p53. Ectopic expression of MIF, but not MIF(C81S), inhibited p53-mediated transcriptional activation in a dose-dependent manner. Conversely, knockdown of endogenous MIF stimulated p53-mediated transcription. MIF inhibited p53-induced apoptosis and cell cycle arrest, whereas the MIF(C81S) mutant, which is unable to physically associate with p53, had no effect. Consistent with these findings, confocal microscopy showed that MIF prevented p53 translocation from the cytoplasm to the nucleus. We also demonstrated that MIF suppresses p53 activity by stabilizing the physical association between p53 and Mdm2. These results suggest that MIF physically associates with p53 and negatively regulates p53 function.	[Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Biotechnol Res Inst, Dept Biochem, Cheongju 361763, South Korea	Chungbuk National University	Ha, HJ (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Biotechnol Res Inst, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr						Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; del Vecchio MT, 2000, PROSTATE, V45, P51, DOI 10.1002/1097-0045(20000915)45:1<51::AID-PROS6>3.0.CO;2-9; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leung KM, 2002, CANCER RES, V62, P4890; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; Meyer-Siegler K, 2000, J INTERF CYTOK RES, V20, P769, DOI 10.1089/10799900050151030; MICHELL RA, 2002, P NATL ACAD SCI USA, V99, P345; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ogawa H, 2000, CYTOKINE, V12, P309, DOI 10.1006/cyto.1999.0562; Petrenko O, 2005, MOL CELL, V17, P225, DOI 10.1016/j.molcel.2004.11.052; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135	33	73	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20383	20396		10.1074/jbc.M800050200	http://dx.doi.org/10.1074/jbc.M800050200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502749	hybrid			2022-12-27	WOS:000257565300054
J	Martinez-Munoz, GA; Kane, P				Martinez-Munoz, Gloria A.; Kane, Patricia			Vacuolar and plasma membrane proton pumps collaborate to achieve cytosolic pH homeostasis in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE LACKING; H+-ATPASE; NEUROSPORA-CRASSA; CYTOPLASMIC PH; GENE; ACIDIFICATION; GROWTH; IDENTIFICATION; ACTIVATION; TRANSPORT	Vacuolar proton-translocating ATPases (V-ATPases) play a central role in organelle acidification in all eukaryotic cells. To address the role of the yeast V-ATPase in vacuolar and cytosolic pH homeostasis, ratiometric pH-sensitive fluorophores specific for the vacuole or cytosol were introduced into wild-type cells and vma mutants, which lack V-ATPase subunits. Transiently glucose-deprived wild-type cells respond to glucose addition with vacuolar acidification and cytosolic alkalinization, and subsequent addition of K+ ion increases the pH of both the vacuole and cytosol. In contrast, glucose addition results in an increase in vacuolar pH in both vma mutants and wild-type cells treated with the V-ATPase inhibitor concanamycin A. Cytosolic pH homeostasis is also significantly perturbed in the vma mutants. Even at extracellular pH5, conditions optimal for their growth, cytosolic pH was much lower, and response to glucose was smaller in the mutants. In plasma membrane fractions from the vma mutants, activity of the plasma membrane proton pump, Pma1p, was 65-75% lower than in fractions from wildtype cells. Immunofluorescence microscopy confirmed decreased levels of plasma membrane Pma1p and increased Pma1p at the vacuole and other compartments in the mutants. Pma1p was not mislocalized in concanamycin-treated cells, but a significant reduction in cytosolic pH under all conditions was still observed. We propose that short-term, V-ATPase activity is essential for both vacuolar acidification in response to glucose metabolism and for efficient cytosolic pH homeostasis, and long-term, V-ATPases are important for stable localization of Pma1p at the plasma membrane.	[Martinez-Munoz, Gloria A.; Kane, Patricia] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, P (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	gloria_martinez2006@yahoo.com.mx; kanepm@upstate.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 50322, R01 GM050322] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; BENITO B, 1991, BIOCHIM BIOPHYS ACTA, V1063, P265, DOI 10.1016/0005-2736(91)90381-H; Bowman EJ, 2000, J BIOL CHEM, V275, P167, DOI 10.1074/jbc.275.1.167; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; Bowman EJ, 2000, J EXP BIOL, V203, P97; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brett CL, 2006, FEBS LETT, V580, P717, DOI 10.1016/j.febslet.2005.12.103; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Calahorra M, 1998, YEAST, V14, P501, DOI 10.1002/(SICI)1097-0061(19980430)14:6<501::AID-YEA249>3.0.CO;2-6; CONWAY EJ, 1950, BIOCHEM J, V47, P360, DOI 10.1042/bj0470360; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; ERASO P, 1987, FEBS LETT, V224, P187, DOI 10.1016/0014-5793(87)80445-3; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; HAWORTH RS, 1993, MOL CELL BIOCHEM, V124, P131, DOI 10.1007/BF00929205; Hirata R., 2001, RIKEN REV, V41, P90; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Liu Y, 2006, J CELL SCI, V119, P360, DOI 10.1242/jcs.02749; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Martinez-Munoz GA, 2005, YEAST, V22, P689, DOI 10.1002/yea.1238; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Padilla-Lopez S, 2006, J BIOL CHEM, V281, P10273, DOI 10.1074/jbc.M510625200; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PENA A, 1972, ARCH BIOCHEM BIOPHYS, V153, P413, DOI 10.1016/0003-9861(72)90359-1; PENA A, 1969, BIOCHIM BIOPHYS ACTA, V180, P1, DOI 10.1016/0005-2728(69)90187-X; PENA A, 1975, ARCH BIOCHEM BIOPHYS, V167, P397, DOI 10.1016/0003-9861(75)90480-4; PENA A, 1995, J BACTERIOL, V177, P1017, DOI 10.1128/jb.177.4.1017-1022.1995; Perzov N, 2000, J BIOL CHEM, V275, P40088, DOI 10.1074/jbc.M007011200; PICK U, 1990, FEBS LETT, V274, P15, DOI 10.1016/0014-5793(90)81318-I; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; PORTILLO F, 1991, FEBS LETT, V287, P71, DOI 10.1016/0014-5793(91)80018-X; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; SERRANO R, 1991, MOL CELLULAR BIOL YE, V1, P523; SETOYOUNG D, 1991, J BIOL CHEM, V266, P1383; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; SWALLOW CJ, 1993, J CELL PHYSIOL, V157, P453, DOI 10.1002/jcp.1041570304; TANIDA I, 1995, J BIOL CHEM, V270, P10113, DOI 10.1074/jbc.270.17.10113; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Withee JL, 1998, GENETICS, V149, P865; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005	70	186	190	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20309	20319		10.1074/jbc.M710470200	http://dx.doi.org/10.1074/jbc.M710470200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502746	Green Published, hybrid			2022-12-27	WOS:000257565300047
J	Boshoff, HIM; Xu, X; Tahlan, K; Dowd, CS; Pethe, K; Camacho, LR; Park, TH; Yun, CS; Schnappinger, D; Ehrt, S; Williams, KJ; Barry, CE				Boshoff, Helena I. M.; Xu, Xia; Tahlan, Kapil; Dowd, Cynthia S.; Pethe, Kevin; Camacho, Luis R.; Park, Tae-Ho; Yun, Chang-Soo; Schnappinger, Dirk; Ehrt, Sabine; Williams, Kerstin J.; Barry, Clifton E., III			Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosis - An essential role for NAD in nonreplicating bacilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDINE-NUCLEOTIDE CYCLE; ADENINE-DINUCLEOTIDE; CRYSTAL-STRUCTURE; TUBERCLE-BACILLI; ACID PHOSPHORIBOSYLTRANSFERASE; METABOLISM; PROTEIN; KINASE; PERSISTENCE; EXPRESSION	Despite the presence of genes that apparently encode NAD salvage-specific enzymes in its genome, it has been previously thought that Mycobacterium tuberculosis can only synthesize NAD de novo. Transcriptional analysis of the de novo synthesis and putative salvage pathway genes revealed an up-regulation of the salvage pathway genes in vivo and in vitro under conditions of hypoxia. [C-14] Nicotinamide incorporation assays in M. tuberculosis isolated directly from the lungs of infected mice or from infected macrophages revealed that incorporation of exogenous nicotinamide was very efficient in in vivo-adapted cells, in contrast to cells grown aerobically in vitro. Two putative nicotinic acid phosphoribosyltransferases, PncB1 (Rv1330c) and PncB2 (Rv0573c), were examined by a combination of in vitro enzymatic activity assays and allelic exchange studies. These studies revealed that both play a role in cofactor salvage. Mutants in the de novo pathway died upon removal of exogenous nicotinamide during active replication in vitro. Cell death is induced by both cofactor starvation and disruption of cellular redox homeostasis as electron transport is impaired by limiting NAD. Inhibitors of NAD synthetase, an essential enzyme common to both recycling and de novo synthesis pathways, displayed the same bactericidal effect as sudden NAD starvation of the de novo pathway mutant in both actively growing and nonreplicating M. tuberculosis. These studies demonstrate the plasticity of the organism in maintaining NAD levels and establish that the two enzymes of the universal pathway are attractive chemotherapeutic targets for active as well as latent tuberculosis.	[Boshoff, Helena I. M.; Xu, Xia; Tahlan, Kapil; Barry, Clifton E., III] NIAID, Tuberculosis Res Sect, Lab Clin Infect Dis, Natl Inst Hlth, Bethesda, MD 20892 USA; [Pethe, Kevin; Camacho, Luis R.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Park, Tae-Ho; Yun, Chang-Soo] Korea Res Inst Chem Technol, Ctr Anti Infect Agents Res, Drug Discovery Div, Taejon 305600, South Korea; [Schnappinger, Dirk; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Williams, Kerstin J.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis; Korea Research Institute of Chemical Technology (KRICT); Cornell University; Imperial College London	Boshoff, HIM (corresponding author), 33 N Dr,Bldg 33 Rm, Bethesda, MD 20892 USA.	HBOSHOFF@niaid.nih.gov	Pethe, Kevin/F-9495-2015; Pethe, Kevin/D-4505-2011; Ehrt, Sabine/AAU-6449-2020; Barry, III, Clifton/H-3839-2012; Pethe, Kevin/L-1199-2013; Barry, Clifton E/ABE-7992-2020	Barry, III, Clifton/0000-0002-2927-270X; Pethe, Kevin/0000-0003-0297-0150; Barry, Clifton E/0000-0002-2927-270X; Pethe, Kevin/0000-0003-0916-8873	Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000783, ZIAAI000783] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Begley TP, 2001, VITAM HORM, V61, P103; Bellinzoni M, 2002, PROTEIN EXPRES PURIF, V25, P547, DOI 10.1016/S1046-5928(02)00041-4; Bembenek ME, 2005, ASSAY DRUG DEV TECHN, V3, P533, DOI 10.1089/adt.2005.3.533; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Chappie JS, 2005, STRUCTURE, V13, P1385, DOI 10.1016/j.str.2005.05.016; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dawes SS, 2003, INFECT IMMUN, V71, P6124, DOI 10.1128/IAI.71.11.6124-6131.2003; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Dolan KM, 2000, BIOCHEMISTRY-US, V39, P8266, DOI 10.1021/bi992856q; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GOPINATH.KP, 1966, ARCH BIOCHEM BIOPHYS, V113, P376, DOI 10.1016/0003-9861(66)90201-3; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; KASAROV LB, 1972, J BACTERIOL, V110, P600; Katoh A, 2004, FRONT BIOSCI-LANDMRK, V9, P1577, DOI 10.2741/1350; KILBURN JO, 1968, AM J CLIN PATHOL, V50, P582; KONNO K, 1958, AM REV TUBERC PULM, V77, P669; KONNO K, 1957, AM REV TUBERC PULM, V75, P529; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Leder L, 2007, CURR OPIN DRUG DISC, V10, P193; Maggio-Hall LA, 2003, MICROBIOL-SGM, V149, P983, DOI 10.1099/mic.0.26040-0; Mdluli K, 1996, J INFECT DIS, V174, P1085, DOI 10.1093/infdis/174.5.1085; Merdanovic M, 2005, J BACTERIOL, V187, P4410, DOI 10.1128/JB.187.13.4410-4420.2005; O'Sullivan DM, 2005, J ANTIMICROB CHEMOTH, V55, P674, DOI 10.1093/jac/dki069; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; PREISS J, 1958, J BIOL CHEM, V233, P488; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; Shin DH, 2005, J BIOL CHEM, V280, P18326, DOI 10.1074/jbc.M501622200; Singh SK, 2002, J BIOL CHEM, V277, P33291, DOI 10.1074/jbc.M204368200; Velu SE, 2003, J MED CHEM, V46, P3371, DOI 10.1021/jm030003x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; VINITSKY A, 1993, J BIOL CHEM, V268, P26004; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Vu CQ, 1997, ADV EXP MED BIOL, V419, P381; Wayne L G, 2001, Methods Mol Med, V54, P247, DOI 10.1385/1-59259-147-7:247; Wilkinson A, 2001, MOL MICROBIOL, V40, P1241, DOI 10.1046/j.1365-2958.2001.02479.x; YOU KS, 1985, CRC CR REV BIOCH MOL, V17, P313, DOI 10.3109/10409238509113625; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	55	116	127	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19329	19341		10.1074/jbc.M800694200	http://dx.doi.org/10.1074/jbc.M800694200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18490451	Green Published, hybrid			2022-12-27	WOS:000257387600019
J	Coppin, JF; Qu, W; Waalkes, MP				Coppin, Jean-Francois; Qu, Wei; Waalkes, Michael P.			Interplay between cellular methyl metabolism and adaptive efflux during oncogenic transformation from chronic arsenic exposure in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MALIGNANT-TRANSFORMATION; S-ADENOSYLHOMOCYSTEINE-HYDROLASE; PROSTATIC EPITHELIAL-CELLS; DNA METHYLATION; GENE-EXPRESSION; SODIUM ARSENITE; GENOMIC DNA; GLUTATHIONE; HOMOCYSTEINE; HYPOMETHYLATION	After protracted low level arsenic exposure, the normal human prostate epithelial cell line RWPE-1 acquires a malignant phenotype with DNA hypomethylation, indicative of disrupted methyl metabolism, and shows arsenic adaptation involving glutathione overproduction and enhanced arsenic efflux. Thus, the interplay between methyl and glutathione metabolism during this progressive arsenic adaptation was studied. Arsenic-treated cells showed a time-dependent increase in LC50 and a marked increase in homocysteine (Hcy) levels. A marked suppression of S-adenosylmethionine (SAM) levels occurred with decreased methionine adenosyltransferase 2A (converts methionine to SAM) expression and increased negative regulator methionine adenosyltransferase B, suggesting reduced conversion of Hcy to SAM. Consistent with Hcy overproduction, activity and expression of S-adenosylhomocysteine hydrolase (converts S-adenosylhomocysteine to Hcy) were both increased. Expression of cystathionine beta-synthase, a key gene in the transsulfuration pathway, and various glutathione production genes were increased, resulting in a 5-fold increase in glutathione. Arsenic efflux increased along with expression of ATP-binding cassette protein C1, which effluxes arsenic as a glutathione conjugate. Evidence of genomic DNA hypomethylation was observed during early arsenic exposure, indicating that the disruption in methyl metabolism had a potential impact related to oncogenesis. Thus, cellular arsenic adaptation is a dynamic, progressive process that involves decreased SAM recycling and concurrent accumulation of Hcy, which is channeled via transsulfuration to increase glutathione and enhance arsenic efflux but may also impact the carcinogenic process.	[Coppin, Jean-Francois; Qu, Wei; Waalkes, Michael P.] NCI, Inorgan Carcinogenesis Sect, Comparat Carcinogenesis Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waalkes, MP (corresponding author), NIEHS, NCI, POB 12233,Mail Drop F0-09,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	waalkes@niehs.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC005488, Z01BC005488] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Achanzar WE, 2002, JNCI-J NATL CANCER I, V94, P1888, DOI 10.1093/jnci/94.24.1888; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Benbrahim-Tallaa L, 2005, TOXICOL APPL PHARM, V206, P288, DOI 10.1016/j.taap.2004.11.017; Benbrahim-Tallaa L, 2008, ENVIRON HEALTH PERSP, V116, P158, DOI 10.1289/ehp.10423; Brambila EM, 2002, TOXICOL APPL PHARM, V183, P99, DOI 10.1006/taap.2002.9468; BRODIE AE, 1985, ARCH BIOCHEM BIOPHYS, V240, P621, DOI 10.1016/0003-9861(85)90069-4; Brosnan JT, 2004, ACTA BIOCHIM POL, V51, P405; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; CROOKS PA, 1984, J PHARM PHARMACOL, V36, P85, DOI 10.1111/j.2042-7158.1984.tb02999.x; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Davison K, 2003, LEUKEMIA, V17, P931, DOI 10.1038/sj.leu.2402876; GLICK JM, 1975, NUCLEIC ACIDS RES, V2, P1639, DOI 10.1093/nar/2.10.1639; Gonzalgo ML, 1997, CANCER RES, V57, P594; Guerra-Shinohara EM, 2004, AM J CLIN NUTR, V80, P1312, DOI 10.1093/ajcn/80.5.1312; *IARC, 2004, IARC MON EV CARC RIK; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Jiang YD, 2007, DNA CELL BIOL, V26, P603, DOI 10.1089/dna.2007.0584; Kligerman AD, 2003, ENVIRON MOL MUTAGEN, V42, P192, DOI 10.1002/em.10192; Kloor D, 1996, KIDNEY BLOOD PRESS R, V19, P100, DOI 10.1159/000174051; Kojima C, 2006, TOXICOL SCI, V91, P70, DOI 10.1093/toxsci/kfj117; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Lertratanangkoon K, 1996, CANCER RES, V56, P995; Leslie EM, 2004, J BIOL CHEM, V279, P32700, DOI 10.1074/jbc.M404912200; Liu J, 2001, MOL PHARMACOL, V60, P302, DOI 10.1124/mol.60.2.302; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Martinov MV, 2000, J THEOR BIOL, V204, P521, DOI 10.1006/jtbi.2000.2035; Mass MJ, 2001, CHEM RES TOXICOL, V14, P355, DOI 10.1021/tx000251l; *NAT TOX PROGR, 2004, NAT TOX PROGR REP CA; National Research Council, 1999, ARS DRINK WAT, P83; Okoji RS, 2002, CARCINOGENESIS, V23, P777, DOI 10.1093/carcin/23.5.777; Park EI, 1999, J BIOL CHEM, V274, P7816, DOI 10.1074/jbc.274.12.7816; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; Ramirez T, 2003, MUTAT RES-FUND MOL M, V528, P61, DOI 10.1016/S0027-5107(03)00099-X; Razin A, 2005, PROG MOLEC, V38, P151; Reichard JF, 2007, BIOCHEM BIOPH RES CO, V352, P188, DOI 10.1016/j.bbrc.2006.11.001; Romach EH, 2000, TOXICOL SCI, V54, P500, DOI 10.1093/toxsci/54.2.500; Savic-Radojevic A, 2007, EUR UROL, V52, P470, DOI 10.1016/j.eururo.2007.01.046; Serman A, 2006, COLLEGIUM ANTROPOL, V30, P665; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; UELAND PM, 1982, PHARMACOL REV, V34, P223; Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070; WAINFAN E, 1992, CANCER RES, V52, pS2071; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Xie YX, 2004, ENVIRON HEALTH PERSP, V112, P1255, DOI 10.1289/txg.7152; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907; Zhao W, 2006, BIRTH DEFECTS RES A, V76, P230, DOI 10.1002/bdra.20240	51	58	63	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19342	19350		10.1074/jbc.M802942200	http://dx.doi.org/10.1074/jbc.M802942200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487201	Green Published, hybrid			2022-12-27	WOS:000257387600020
J	Houston, SI; McManus, KJ; Adams, MM; Sims, JK; Carpenter, PB; Hendzel, MJ; Rice, JC				Houston, Sabrina I.; McManus, Kirk J.; Adams, Melissa M.; Sims, Jennifer K.; Carpenter, Phillip B.; Hendzel, Michael J.; Rice, Judd C.			Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE LYSINE METHYLATION; NEWLY REPLICATED CHROMATIN; CELL-CYCLE; DNA-DAMAGE; H4 LYS-20; MAMMALIAN CHROMATIN; SILENT CHROMATIN; S-PHASE; METHYLTRANSFERASE; H3	Histone-modifying enzymes play a critical role in modulating chromatin dynamics. In this report we demonstrate that one of these enzymes, PR-Set7, and its corresponding histone modification, the monomethylation of histone H4 lysine 20 (H4K20), display a distinct cell cycle profile in mammalian cells: low at G(1), increased during late S phase and G(2), and maximal from prometaphase to anaphase. The lack of PR-Set7 and monomethylated H4K20 resulted in a number of aberrant phenotypes in several different mammalian cell types. These include the inability of cells to progress past G(2), global chromosome condensation failure, aberrant centrosome amplification, and substantial DNA damage. By employing a catalytically dead dominant negative PR-Set7 mutant, we discovered that its mono-methyltransferase activity was required to prevent these phenotypes. Importantly, we demonstrate that all of the aberrant phenotypes associated with the loss of PR-Set7 enzymatic function occur independently of p53. Collectively, our findings demonstrate that PR-Set7 enzymatic activity is essential for mammalian cell cycle progression and for the maintenance of genomic stability, most likely by monomethylating histone H4K20. Our results predict that alterations of this pathway could result in gross chromosomal aberrations and aneuploidy.	[Houston, Sabrina I.; Sims, Jennifer K.; Rice, Judd C.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [McManus, Kirk J.; Hendzel, Michael J.] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Adams, Melissa M.; Carpenter, Phillip B.] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Southern California; University of Alberta; University of Texas System; University of Texas Health Science Center Houston	Rice, JC (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, 1450 Biggy St,NRT 6506, Los Angeles, CA 90033 USA.	juddrice@usc.edu	Hendzel, Michael/C-3391-2009; McManus, Kirk J./AAE-3521-2020; Rice, Judd C/B-7806-2009	Hendzel, Michael/0000-0002-9603-7945; McManus, Kirk J./0000-0003-0081-8737; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM065812, R01GM075094] Funding Source: NIH RePORTER; NIGMS NIH HHS [R56 GM065812, GM075094, R01 GM075094] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANNUNZIATO AT, 1995, BIOCHEMISTRY-US, V34, P2916, DOI 10.1021/bi00009a023; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BORUN TW, 1972, J BIOL CHEM, V247, P4288; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CAMATO R, 1982, EMBO J, V1, P1529, DOI 10.1002/j.1460-2075.1982.tb01350.x; Cheng AY, 1998, CANCER RES, V58, P3611; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; D'Assoro AB, 2004, ONCOGENE, V23, P4068, DOI 10.1038/sj.onc.1207568; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; HENDZEL MJ, 1989, J BIOL CHEM, V264, P19208; HENDZEL MJ, 1991, BIOCHEM J, V273, P753, DOI 10.1042/bj2730753; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; LEE NM, 1977, J NEUROCHEM, V29, P547, DOI 10.1111/j.1471-4159.1977.tb10704.x; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; McManus KJ, 2005, METHODS, V36, P351, DOI 10.1016/j.ymeth.2005.03.010; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sautel CF, 2007, MOL CELL BIOL, V27, P5711, DOI 10.1128/MCB.00482-07; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shinkai Yoichi, 2007, Subcell Biochem, V41, P337; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; SMITH PA, 1984, BIOCHEMISTRY-US, V23, P1576, DOI 10.1021/bi00302a036; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; THOMAS G, 1975, EUR J BIOCHEM, V51, P609, DOI 10.1111/j.1432-1033.1975.tb03963.x; TIDWELL T, 1968, J BIOL CHEM, V243, P707; Trievel RC, 2004, CRIT REV EUKAR GENE, V14, P147, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.10; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; WORCEL A, 1978, CELL, V15, P969, DOI 10.1016/0092-8674(78)90280-5; Wu SM, 2007, FEBS LETT, V581, P3289, DOI 10.1016/j.febslet.2007.06.025; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200	55	120	123	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19478	19488		10.1074/jbc.M710579200	http://dx.doi.org/10.1074/jbc.M710579200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480059	Green Published, hybrid			2022-12-27	WOS:000257387600034
J	Enesa, K; Ito, K; Luong, LA; Thorbjornsen, I; Phua, C; To, Y; Dean, J; Haskard, DO; Boyle, J; Adcock, I; Evans, PC				Enesa, Karine; Ito, Kazuhiro; Luong, Le A.; Thorbjornsen, Ingvild; Phua, Chee; To, Yasuo; Dean, Jonathan; Haskard, Dorian O.; Boyle, Joseph; Adcock, Ian; Evans, Paul C.			Hydrogen peroxide prolongs nuclear localization of NF-kappa B in activated cells by suppressing negative regulatory mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; SITE-SPECIFIC PHOSPHORYLATION; UBIQUITIN-PROTEASOME PATHWAY; IL-8 GENE-EXPRESSION; ZINC-FINGER PROTEIN; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; DEUBIQUITINATING ENZYME; DISEASE DEVELOPMENT; INDUCED ARTHRITIS	NF-kappa B transcription factors induce pro-inflammatory molecules (e. g. IL-8) in response to cytokines (e. g. TNF alpha, IL-1 beta) or other stimuli. In the basal state, they are sequestered in the cytoplasm by inhibitory I kappa B proteins. Pro-inflammatory signaling triggers polyubiquitination of intermediaries (e. g. RIP1), which activate I kappa B kinases that trigger Ser phosphorylation and degradation of I kappa B alpha, thereby promoting nuclear translocation of NF-kappa B. A negative feedback loop exists whereby NF-kappa B drives resynthesis of I kappa B alpha, which promotes export of NF-kappa B from the nucleus to the cytoplasm. This process relies on Cezanne, a deubiquitinating cysteine protease that stabilizes resynthesized I kappa B alpha by removing polyubiquitin from modified intermediaries. H2O2 is generated during inflammation. Here we examined the effects of H2O2 on NF-kappa B dynamics and pro-inflammatory activation in cultured cells co-stimulated with TNF alpha or IL-1 beta. Quantitative reverse transcription-PCR and enzyme-linked immunosorbent assay revealed that H2O2 enhanced the induction of IL-8 by TNF alpha or IL-1 beta. We demonstrated by using assays of NF-kappa B nuclear localization and by imaging of live cells expressing a fluorescent form of NF-kappa B that H2O2 prolonged NF-kappa B nuclear localization in cells co-stimulated with TNF alpha or IL-1 beta by suppressing its export from the nucleus. We provide evidence that H2O2 suppresses NF-kappa B export by prolonging polyubiquitination of signaling intermediaries, which promotes Ser phosphorylation and destabilization of newly synthesized I kappa B alpha proteins. Finally, we observed that the catalytic activity of Cezanne and its ability to suppress RIP1 polyubiquitination and NF-kappa B transcriptional activity were inhibited by H2O2. We conclude that H2O2 prolongs NF-kappa B activation in co-stimulated cells by suppressing the negative regulatory functions of Cezanne and I kappa B alpha.	[Enesa, Karine; Luong, Le A.; Thorbjornsen, Ingvild; Phua, Chee; Haskard, Dorian O.; Boyle, Joseph; Evans, Paul C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, BHF Cardiovasc Sci Unit, London W12 0NN, England; [Dean, Jonathan] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, London W12 0NN, England	Imperial College London; Imperial College London; University of Oxford	Evans, PC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, BHF Cardiovasc Sci Unit, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	paul.evans@imperial.ac.uk	Ito, Kazuhiro/AAF-5994-2019; Adcock, Ian/L-3217-2019	Adcock, Ian/0000-0003-2101-8843; Dean, Jonathan/0000-0002-0703-2756	Medical Research Council [G0400503B] Funding Source: researchfish; British Heart Foundation Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); British Heart Foundation(British Heart Foundation)		ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Byun MS, 2002, EXP MOL MED, V34, P332, DOI 10.1038/emm.2002.47; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dai L, 2003, GENE THER, V10, P550, DOI 10.1038/sj.gt.3301916; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Folz RJ, 1999, J CLIN INVEST, V103, P1055, DOI 10.1172/JCI3816; Gelderman KA, 2007, ANTIOXID REDOX SIGN, V9, P1541, DOI 10.1089/ars.2007.1569; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; KAKIMOTO K, 1993, CLIN EXP IMMUNOL, V94, P241; Kamata H, 2002, FEBS LETT, V519, P231, DOI 10.1016/S0014-5793(02)02712-6; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nelson G, 2002, J CELL SCI, V115, P1137; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; PATRIDGE J, 2007, FASEB J, V21, P3553; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Tanaka C, 1997, BIOCHEM BIOPH RES CO, V232, P568, DOI 10.1006/bbrc.1997.6264; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Tsaprouni LG, 2007, CLIN EXP IMMUNOL, V150, P151, DOI 10.1111/j.1365-2249.2007.03484.x; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	50	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18582	18590		10.1074/jbc.M801312200	http://dx.doi.org/10.1074/jbc.M801312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18474597	hybrid			2022-12-27	WOS:000257165600014
J	Qiu, X; Aiken, KJ; Chokas, AL; Beachy, DE; Nick, HS				Qiu, Xiaolei; Aiken, Kimberly J.; Chokas, Ann L.; Beachy, Dawn E.; Nick, Harry S.			Distinct functions of CCAAT enhancer-binding protein isoforms in the regulation of manganese superoxide dismutase during interleukin-1 beta stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; C/EBP-BETA ISOFORM; TRANSCRIPTIONAL ACTIVATOR PROTEIN; SMOOTH-MUSCLE-CELLS; FACTOR-ALPHA; GENE-TRANSCRIPTION; MESSENGER-RNA; DNA-BINDING; MALIGNANT PHENOTYPE	The mitochondrial antioxidant enzyme manganese superoxide dismutase (Mn-SOD) is crucial in maintaining cellular and organismal homeostasis. Mn-SOD expression is tightly regulated in a manner that synchronizes its cytoprotective functions during inflammatory challenges. Induction of Mn-SOD gene expression by the proinflammatory cytokine IL-1 beta is mediated through a complex intronic enhancer element. To identify and characterize the transcription factors required for Mn-SOD enhancer function, a yeast one-hybrid assay was utilized, and two CCAAT enhancer-binding protein (C/EBP) members, C/EBP beta and C/EBP delta, were identified. These two transcription factors responded to IL-1 beta treatment with distinct expression profiles, different temporal yet inducible interactions with the endogenous Mn-SOD enhancer, and also opposite effects on Mn-SOD transcription. C/EBP beta is expressed as three isoforms, LAP* (liver-activating protein), LAP, and LIP (liver-inhibitory protein). Our functional analysis demonstrated that only the full-length C/EBP beta/LAP* served as a true activator for Mn-SOD, whereas LAP, LIP, and C/EBP delta functioned as potential repressors. Finally, our systematic mutagenesis of the unique N-terminal 21 amino acids further solidified the importance of LAP* in the induction of Mn-SOD and emphasized the crucial role of this isoform. Our data demonstrating the physiological relevance of the N-terminal peptide also provide a rationale for revisiting the role of LAP* in the regulation of other genes and in pathways such as lipogenesis and development.	[Nick, Harry S.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Qiu, Xiaolei; Aiken, Kimberly J.; Chokas, Ann L.; Nick, Harry S.] Univ Florida, McKnight Brian Inst, Gainesville, FL 32610 USA; [Qiu, Xiaolei; Nick, Harry S.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Nick, HS (corresponding author), Univ Florida, Coll Med, Dept Neurosci, POB 100244, Gainesville, FL 32610 USA.	hnick@ufl.edu			National Institutes of Health [HL39593, HL067456]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL067456, R01HL067456, R01HL039593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL39593 and HL067456 (to H. S. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Amstad PA, 1997, CARCINOGENESIS, V18, P479, DOI 10.1093/carcin/18.3.479; CAI DH, 2007, ONCOGENE; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; CLEUTJENS CBJM, 1993, GENOMICS, V16, P520, DOI 10.1006/geno.1993.1220; Davis CA, 2004, J BIOL CHEM, V279, P12769, DOI 10.1074/jbc.M310623200; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DOUGALL WC, 1991, ENDOCRINOLOGY, V129, P2376, DOI 10.1210/endo-129-5-2376; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Fukuoka T, 1999, J BIOL CHEM, V274, P25576, DOI 10.1074/jbc.274.36.25576; GIBBS LS, 1992, FREE RADICAL BIO MED, V12, P107, DOI 10.1016/0891-5849(92)90003-Y; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Greenberger JS, 2007, IN VIVO, V21, P141; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; INOUYE C, 1994, DNA CELL BIOL, V13, P731, DOI 10.1089/dna.1994.13.731; Ishiguro K, 2004, BLOOD, V103, P2248, DOI 10.1182/blood-2003-08-2671; Izutani R, 1998, J GASTROENTEROL, V33, P816, DOI 10.1007/s005350050181; JOHNSON PF, 1993, MOL CELL BIOL, V13, P6919, DOI 10.1128/MCB.13.11.6919; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; JONES PL, 1995, GENE, V153, P155, DOI 10.1016/0378-1119(94)00666-G; KAGEYAMA R, 1991, J BIOL CHEM, V266, P15525; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li N, 1998, PROSTATE, V35, P221, DOI 10.1002/(SICI)1097-0045(19980515)35:3<221::AID-PROS8>3.0.CO;2-J; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LIN PS, 1993, LYMPHOKINE CYTOK RES, V12, P303; Liu RG, 1997, HUM GENE THER, V8, P585, DOI 10.1089/hum.1997.8.5-585; Liu YM, 2005, CARCINOGENESIS, V26, P1335, DOI 10.1093/carcin/bgi083; Maehara K, 1999, FEBS LETT, V449, P115, DOI 10.1016/S0014-5793(99)00408-1; Maehara K, 2000, J CELL BIOCHEM, V77, P474, DOI 10.1002/(SICI)1097-4644(20000601)77:3<474::AID-JCB12>3.0.CO;2-H; MAGALINI A, 1995, CYTOKINE, V7, P753, DOI 10.1006/cyto.1995.0090; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Martinez-Jimenez CP, 2005, MOL PHARMACOL, V67, P2088, DOI 10.1124/mol.104.008169; MASUDA A, 1988, FASEB J, V2, P3087, DOI 10.1096/fasebj.2.15.3263930; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; OBERLEY LW, 1979, CANCER RES, V39, P1141; Osada S, 1996, J BIOL CHEM, V271, P3891; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Park MH, 2008, FEBS LETT, V582, P415, DOI 10.1016/j.febslet.2008.01.001; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Pomerance M, 2005, THYROID, V15, P197, DOI 10.1089/thy.2005.15.197; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Ranjan P, 2006, APOPTOSIS, V11, P1837, DOI 10.1007/s10495-006-9530-0; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; Rogers RJ, 2000, BIOCHEM J, V347, P233, DOI 10.1042/0264-6021:3470233; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; VALENTINE JF, 1992, GASTROENTEROLOGY, V103, P905, DOI 10.1016/0016-5085(92)90024-S; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VISNER GA, 1991, AM J PHYSIOL, V260, pL444, DOI 10.1152/ajplung.1991.260.6.L444; VISNER GA, 1990, J BIOL CHEM, V265, P2856; WARREN JS, 1988, AM J PATHOL, V130, P489; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Weydert C, 2003, MOL CANCER THER, V2, P361; WHITE JE, 1994, AM J PHYSIOL, V266, pL664, DOI 10.1152/ajplung.1994.266.6.L664; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200; Zhong WX, 1999, FREE RADICAL BIO MED, V27, P1334, DOI 10.1016/S0891-5849(99)00181-1; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	85	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25774	25785		10.1074/jbc.M801178200	http://dx.doi.org/10.1074/jbc.M801178200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18559338	Green Published, hybrid			2022-12-27	WOS:000259200100003
J	Zhang, LL; Smit-McBride, Z; Pan, XY; Rheinhardt, J; Hershey, JWB				Zhang, Lili; Smit-McBride, Zeljka; Pan, Xiaoyu; Rheinhardt, Jeanette; Hershey, John W. B.			An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; MYC-DEPENDENT APOPTOSIS; MALIGNANT-TRANSFORMATION; PROSTATE-CANCER; GENETIC ALTERATIONS; OVARIAN-CANCER; AMPLIFICATION; BREAST; CELLS; CARCINOMAS	Dysregulation of protein synthesis has been implicated in oncogenesis through a mechanism whereby "weak" mRNAs encoding proteins involved in cell proliferation are strongly translated when the protein synthesis apparatus is activated. Previous work has determined that many cancer cells contain high levels of eIF3h, a protein subunit of translation initiation factor eIF3, and overexpression of eIF3h malignantly transforms immortal NIH-3T3 cells. This is a general feature of eIF3h, as high levels also affect translation, proliferation, and a number of malignant phenotypes of CHO-K1 and HeLa cells and, most significantly, of a primary prostate cell line. Furthermore, overexpressed eIF3h inhibits Myc-dependent induction of apoptosis of primary prostate cells. eIF3h appears to function through translation, as the initial appearance of overexpressed eIF3h in rapidly induced NIH-3T3 cells correlates tightly with the stimulation of protein synthesis and the generation of malignant phenotypes. This oncogenic potential of eIF3h is enhanced by phosphorylation at Ser(183). Finally, reduction of eIF3h levels in breast and prostate cancer cell lines by short interfering RNA methods reduces their rates of proliferation and anchorage-independent growth in soft agar. The results provide compelling evidence that high eIF3h levels directly stimulate protein synthesis, resulting in the establishment and maintenance of the malignant state in cells.	[Zhang, Lili; Hershey, John W. B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Smit-McBride, Zeljka] Univ Calif Davis, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA; [Pan, Xiaoyu] Univ Calif Davis, Dept Mol & Cell Biol, Davis, CA 95616 USA; [Rheinhardt, Jeanette] Univ Calif Davis, Dept Pathol, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hershey, JWB (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	jwhershey@ucdavis.edu	Smit-McBride, Zeljka/F-5524-2010	Smit-McBride, Zeljka/0000-0003-0275-8088	National Institutes of Health [GM22135, GM07373]; American Cancer Society [IRG 95-125-04]; Institutional Research Grant Program; University of California Davis School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Institutional Research Grant Program; University of California Davis School of Medicine(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM22135 and GM07373 ( to J.W.B.H.). This work was also supported by American Cancer Society Grant IRG 95-125-04 from the Institutional Research Grant Program ( to Z.S.M.) and by the Dean, University of California Davis School of Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO;2-3; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Forozan F, 1997, TRENDS GENET, V13, P405, DOI 10.1016/S0168-9525(97)01244-4; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; FukuchiShimogori T, 1997, CANCER RES, V57, P5041; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Komarova AV, 2007, NUCLEIC ACIDS RES, V35, P1522, DOI 10.1093/nar/gkl1127; Koo SH, 1999, CANCER GENET CYTOGEN, V110, P87, DOI 10.1016/S0165-4608(98)00193-9; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li S, 2003, J BIOL CHEM, V278, P3015, DOI 10.1074/jbc.M208821200; MAMIKO M, 2007, EMBO J, V26, P3373; Nupponen NN, 2000, GENE CHROMOSOME CANC, V28, P203; Nupponen NN, 1999, AM J PATHOL, V154, P1777, DOI 10.1016/S0002-9440(10)65433-8; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Raught B., 2007, TRANSLATIONAL CONTRO, P369; Rooney PH, 1999, BRIT J CANCER, V80, P862, DOI 10.1038/sj.bjc.6690433; Saramaki O, 2001, AM J PATHOL, V159, P2089, DOI 10.1016/S0002-9440(10)63060-X; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smit-McBride Z, 1998, J VIROL, V72, P6646, DOI 10.1128/JVI.72.8.6646-6656.1998; Sonoda G, 1997, GENE CHROMOSOME CANC, V18, P115, DOI 10.1002/(SICI)1098-2264(199702)18:2<115::AID-GCC6>3.0.CO;2-5; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Tan A, 2000, ONCOGENE, V19, P1437, DOI 10.1038/sj.onc.1203446; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Wong N, 1999, AM J PATHOL, V154, P37, DOI 10.1016/S0002-9440(10)65248-0; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	40	62	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24047	24060		10.1074/jbc.M800956200	http://dx.doi.org/10.1074/jbc.M800956200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18544531	hybrid, Green Published			2022-12-27	WOS:000258638900060
J	Dumon, C; Varvak, A; Wall, MA; Flint, JE; Lewis, RJ; Lakey, JH; Morland, C; Luginbuhl, P; Healey, S; Todaro, T; DeSantis, G; Sun, M; Parra-Gessert, L; Tan, XQ; Weiner, DP; Gilbert, HJ				Dumon, Claire; Varvak, Alexander; Wall, Mark A.; Flint, James E.; Lewis, Richard J.; Lakey, Jeremy H.; Morland, Carl; Luginbuhl, Peter; Healey, Shaun; Todaro, Thomas; DeSantis, Grace; Sun, May; Parra-Gessert, Lilian; Tan, Xuqiu; Weiner, David P.; Gilbert, Harry J.			Engineering hyperthermostability into a GH11 xylanase is mediated by subtle changes to protein structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; THERMOSTABILITY; STABILITY; EVOLUTION; ENDO-1,4-BETA-XYLANASE-II; STABILIZATION; RESIDUES; PHYTASE	Understanding the structural basis for protein thermostability is of considerable biological and biotechnological importance as exemplified by the industrial use of xylanases at elevated temperatures in the paper pulp and animal feed sectors. Here we have used directed protein evolution to generate hyperthermostable variants of a thermophilic GH11 xylanase, EvXyn11. The Gene Site Saturation Mutagenesis (TM) (GSSM) methodology employed assesses the influence on thermostability of all possible amino acid substitutions at each position in the primary structure of the target protein. The 15 most thermostable mutants, which generally clustered in the N-terminal region of the enzyme, had melting temperatures (T-m) 1-8 degrees C higher than the parent protein. Screening of a combinatorial library of the single mutants identified a hyperthermostable variant, EvXyn11(TS), containing seven mutations. EvXyn11TS had a T-m similar to 25 degrees C higher than the parent enzyme while displaying catalytic properties that were similar to EvXyn11. The crystal structures of EvXyn11 and EvXyn11TS revealed an absence of substantial changes to identifiable intramolecular interactions. The only explicable mutations are T13F, which increases hydrophobic interactions, and S9P that apparently locks the conformation of a surface loop. This report shows that the molecular basis for the increased thermostability is extraordinarily subtle and points to the requirement for new tools to interrogate protein folding at non-ambient temperatures.	[Varvak, Alexander; Wall, Mark A.; Luginbuhl, Peter; Healey, Shaun; Todaro, Thomas; DeSantis, Grace; Sun, May; Parra-Gessert, Lilian; Tan, Xuqiu; Weiner, David P.] Verenium Corp, San Diego, CA 92121 USA; [Dumon, Claire; Flint, James E.; Lewis, Richard J.; Lakey, Jeremy H.; Morland, Carl] Univ Newcastle, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Weiner, DP (corresponding author), Verenium Corp, San Diego, CA 92121 USA.	david.weiner@verenium.com; h.j.gilbert@ncl.ac.uk	Claire, Dumon/AAI-2553-2021; Lewis, Richard J./E-8674-2013	Claire, Dumon/0000-0003-4925-7336; Flint, James/0000-0003-2923-7813; Lakey, Jeremy/0000-0003-4646-9085; lewis, richard/0000-0003-2641-8643; Lewis, Richard J./0000-0003-3470-923X				Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Andrews SR, 2004, J BIOL CHEM, V279, P54369, DOI 10.1074/jbc.M409044200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Clarke JH, 2000, APPL MICROBIOL BIOT, V53, P661, DOI 10.1007/s002530000344; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; Eisenthal R, 2006, TRENDS BIOTECHNOL, V24, P289, DOI 10.1016/j.tibtech.2006.05.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS P, 1993, CCP4 DARESBURY STUDY, P114; Garrett JB, 2004, APPL ENVIRON MICROB, V70, P3041, DOI 10.1128/AEM.70.5.3041-3046.2004; Gray KA, 2001, ADV SYNTH CATAL, V343, P607, DOI 10.1002/1615-4169(200108)343:6/7<607::AID-ADSC607>3.0.CO;2-M; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Kawamura S, 1998, J BIOL CHEM, V273, P19982, DOI 10.1074/jbc.273.32.19982; Kretz KA, 2004, METHOD ENZYMOL, V388, P3; Kulkarni N, 1999, BIOCHEM BIOPH RES CO, V255, P274, DOI 10.1006/bbrc.1998.9912; Leslie A, 1992, NEWSLETTER PROTEIN C; Liu ZR, 2005, PHYS BIOL, V2, pS75, DOI 10.1088/1478-3975/2/4/S01; Miyazaki K, 2006, J BIOL CHEM, V281, P10236, DOI 10.1074/jbc.M511948200; Mozo-Villiarias A, 2006, CURR BIOINFORM, V1, P25, DOI 10.2174/157489306775330561; Mueller U, 2000, J MOL BIOL, V297, P975, DOI 10.1006/jmbi.2000.3602; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palackal N, 2004, PROTEIN SCI, V13, P494, DOI 10.1110/ps.03333504; Perl D, 2000, NAT STRUCT BIOL, V7, P380; PFEIL W, 1976, BIOPHYS CHEM, V4, P41, DOI 10.1016/0301-4622(76)80005-1; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P515, DOI 10.1016/S0167-7799(02)02073-5; SHORT JM, 2001, Patent No. 6280926; SHORT JM, 2003, Patent No. 6537776; Solbak AI, 2005, J BIOL CHEM, V280, P9431, DOI 10.1074/jbc.M411838200; SPASSOV VZ, 1994, PROTEIN SCI, V3, P1556, DOI 10.1002/pro.5560030921; Spurway TD, 1997, J BIOL CHEM, V272, P17523, DOI 10.1074/jbc.272.28.17523; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; Xie HF, 2006, J MOL BIOL, V360, P157, DOI 10.1016/j.jmb.2006.05.002; Xiong HR, 2004, EXTREMOPHILES, V8, P393, DOI 10.1007/s00792-004-0400-9; Yang HM, 2007, J IND MICROBIOL BIOT, V34, P213, DOI 10.1007/s10295-006-0188-y; Zhang WM, 2007, APPL ENVIRON MICROB, V73, P3069, DOI 10.1128/AEM.02970-06	44	99	115	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22557	22564		10.1074/jbc.M800936200	http://dx.doi.org/10.1074/jbc.M800936200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18515360	hybrid			2022-12-27	WOS:000258321000024
J	Komenda, J; Nickelsen, J; Tichy, M; Prasil, O; Eichacker, LA; Nixon, PJ				Komenda, Josef; Nickelsen, Joerg; Tichy, Martin; Prasil, Ondrej; Eichacker, Lutz A.; Nixon, Peter J.			The cyanobacterial homologue of HCF136/YCF48 is a component of an early photosystem II assembly complex and is important for both the efficient assembly and repair of photosystem II in Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR D1 PROTEIN; THYLAKOID MEMBRANE; SPLIT-UBIQUITIN; PLASMA-MEMBRANE; MUTANTS; ACCUMULATION; MUTAGENESIS; BIOGENESIS; DYNAMICS; STRAIN	The role of the slr2034 (ycf48) gene product in the assembly and repair of photosystem II (PSII) has been studied in the cyanobacterium Synechocystis PCC 6803. YCF48 (HCF136) is involved in the assembly of Arabidopsis thaliana PSII reaction center (RC) complexes but its mode of action is unclear. We show here that YCF48 is a component of two cyanobacterial PSII RC-like complexes in vivo and is absent in larger PSII core complexes. Interruption of ycf48 slowed the formation of PSII complexes in wild type, as judged from pulse-labeling experiments, and caused a decrease in the final level of PSII core complexes in wild type and a marked reduction in the levels of PSII assembly complexes in strains lacking either CP43 or CP47. Absence of YCF48 also led to a dramatic decrease in the levels of the COOH-terminal precursor (pD1) and the partially processed form, iD1, in a variety of PSII mutants and only low levels of unassembled mature D1 were observed. Yeast two-hybrid analyses using the split ubiquitin system showed an interaction of YCF48 with unassembled pD1 and, to a lesser extent, unassembled iD1, but not with unassembled mature D1 or D2. Overall our results indicate a role for YCF48 in the stabilization of newly synthesized pD1 and in its subsequent binding to a D2-cytochrome b(559) pre-complex, also identified in this study. Besides a role in assembly, we show for the first time that YCF48 also functions in the selective replacement of photodamaged D1 during PSII repair.	[Komenda, Josef; Tichy, Martin; Prasil, Ondrej] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic; [Komenda, Josef; Tichy, Martin; Prasil, Ondrej] Univ S Bohemia, Inst Phys Biol, Nove Hrady 37333, Czech Republic; [Nickelsen, Joerg] Univ Munich, Inst Plant Mol Biol, D-80368 Munich, Germany; [Eichacker, Lutz A.] Univ Munich, Inst Bot, D-80368 Munich, Germany; [Nixon, Peter J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Fac Nat Sci, London SW7 2AZ, England	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Munich; University of Munich; Imperial College London	Komenda, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic.	komenda@alga.cz	Tichy, Martin/B-6545-2008; Nickelsen, Jörg/J-8896-2014; Komenda, Josef/H-4083-2014; Prasil, Ondrej/H-2454-2014	Tichy, Martin/0000-0003-2814-1959; Komenda, Josef/0000-0003-4588-0382; Nixon, Peter/0000-0003-1952-6937; Nickelsen, Joerg/0000-0003-4184-4560; Prasil, Ondrej/0000-0002-0012-4359	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Barber J, 2006, BIOCHEM SOC T, V34, P619, DOI 10.1042/BST0340619; Caldo RA, 2004, PLANT CELL, V16, P2514, DOI 10.1105/tpc.104.023382; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; EATONRYE JJ, 1991, PLANT MOL BIOL, V17, P1165, DOI 10.1007/BF00028733; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Inagaki N, 2001, FEBS LETT, V509, P197, DOI 10.1016/S0014-5793(01)03180-5; Jansen T, 2002, J PLANT PHYSIOL, V159, P1205, DOI 10.1078/0176-1617-00829; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2005, PLANT CELL PHYSIOL, V46, P1477, DOI 10.1093/pcp/pci159; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Komenda J, 2007, BBA-BIOENERGETICS, V1767, P829, DOI 10.1016/j.bbabio.2007.01.005; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; PAKRASI HB, 1988, EMBO J, V7, P325, DOI 10.1002/j.1460-2075.1988.tb02816.x; Pasch JC, 2005, APPL MICROBIOL BIOT, V69, P440, DOI 10.1007/s00253-005-0029-3; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Satoh K, 2007, PHOTOSYNTH RES, V94, P203, DOI 10.1007/s11120-007-9191-z; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Sitte Nicolle, AGING MOL LEVEL, P27, DOI [10.1007/978-94-017-0667-4_3, DOI 10.1007/978-94-017-0667-4_3, DOI 10.1007/978-94-017-6368-4_3]; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Tichy M, 2003, BBA-BIOENERGETICS, V1605, P55, DOI 10.1016/S0005-2728(03)00064-1; VERMAAS WFJ, 1988, PHOTOSYNTH RES, V17, P97, DOI 10.1007/BF00047683; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yokthongwattana K, 2006, ADV PHOTO RESPIRAT, V21, P175; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	42	110	116	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22390	22399		10.1074/jbc.M801917200	http://dx.doi.org/10.1074/jbc.M801917200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550538	hybrid			2022-12-27	WOS:000258321000007
J	Qian, YJ; Chen, XB				Qian, Yingjuan; Chen, Xinbin			ID1, inhibitor of differentiation/DNA binding, is an effector of the p53-dependent DNA damage response pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; BREAST-CANCER CELLS; GROWTH ARREST; ID-1 PROTEIN; P53 PATHWAY; TRANSCRIPTIONAL REPRESSION; NEGATIVE REGULATOR; PROSTATE-CANCER; TP53 MUTATIONS; C-TERMINUS	ID1, inhibitor of differentiation/DNA binding, plays an important role in cell proliferation, differentiation, and tumorigenesis. It has been shown that ID1 is de-regulated in multiple cancers and up-regulation of ID1 is correlated with high grades and poor prognosis of human cancers. In contrast, the p53 tumor suppressor was found to be mutated or inactivated in most human cancers and loss of p53 results in early onset of multiple cancers. Although the biological functions of the ID1 oncogene and the p53 tumor suppressor have been intensively investigated, little is known about the upstream regulators of ID1 and the cross-talk between ID1 and p53. Here, we showed that ID1 is down-regulated in cells treated with various DNA damage agents in a p53-dependent manner. Interestingly, we found that DEC1, which was recently identified as a p53 target and mediates p53-dependent cell cycle arrest and senescence, is capable of inhibiting ID1 expression. Conversely, we found that knockdown of DEC1 attenuates DNA damage-induced ID1 repression. In addition, we identified several potential DEC1 responsive elements in the proximal promoter region of the ID1 gene. Moreover, we showed that overexpression of ID1 or ID1', an isoform of ID1, promotes cell proliferation potentially through inhibition of p21 expression. Finally, we found that the extent of DNA damage-induced premature senescence was substantially decreased by overexpression of ID1 or ID1'. Taken together, our study suggests that p53 trans-repressional activity can be mediated by its own target DEC1 and ID1 is an effector of the p53-dependent DNA damage response pathway.	[Qian, Yingjuan; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA; [Qian, Yingjuan] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham	Chen, XB (corresponding author), 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			NCI NIH HHS [CA081237, CA102188, CA076069] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102188, R01CA081237, R01CA076069, R29CA076069] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alani RM, 1999, P NATL ACAD SCI USA, V96, P9637, DOI 10.1073/pnas.96.17.9637; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; BARONE MV, 1994, P NATL ACAD SCI USA, V91, P4985, DOI 10.1073/pnas.91.11.4985; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; CHEN XB, 1995, CANCER RES, V55, P4257; Damdinsuren B, 2006, ONCOL REP, V15, P401; Desprez PY, 2003, J MAMMARY GLAND BIOL, V8, P225, DOI 10.1023/A:1025957025773; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EL DW, 1993, CELL, V75, P817; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; Gasco M, 2003, HUM MUTAT, V21, P301, DOI 10.1002/humu.10173; HARA E, 1994, J BIOL CHEM, V269, P2139; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; HARPER JW, 1993, CELL, V75, P805; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hernandez-Vargas H, 2006, INT J CANCER, V119, P1164, DOI 10.1002/ijc.21938; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HU QJ, 1991, MOL CELL BIOL, V11, P5792, DOI 10.1128/MCB.11.11.5792; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Lin CQ, 2000, CANCER RES, V60, P1332; Ling MT, 2002, BBA-GEN SUBJECTS, V1570, P145, DOI 10.1016/S0304-4165(02)00189-7; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Nickoloff BJ, 2000, J BIOL CHEM, V275, P27501; Norton JD, 2000, J CELL SCI, V113, P3897; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Prives C, 1999, J PATHOL, V187, P112; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Schindl M, 2003, CLIN CANCER RES, V9, P779; Schindl M, 2001, CANCER RES, V61, P5703; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Seimiya M, 2004, EUR J IMMUNOL, V34, P1322, DOI 10.1002/eji.200324700; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Tamura Y, 1998, FEBS LETT, V436, P169, DOI 10.1016/S0014-5793(98)01117-X; Tepper CG, 2005, PROSTATE, V65, P375, DOI 10.1002/pros.20308; Wilson JW, 2001, CANCER RES, V61, P8803; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999	57	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22410	22416		10.1074/jbc.M800643200	http://dx.doi.org/10.1074/jbc.M800643200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18556654	hybrid, Green Published			2022-12-27	WOS:000258321000009
J	Vanhoose, AM; Samaras, S; Artner, I; Henderson, E; Hang, Y; Stein, R				Vanhoose, Amanda M.; Samaras, Susan; Artner, Isabella; Henderson, Eva; Hang, Yan; Stein, Roland			MafA and MafB regulate Pdx1 transcription through the Area II control region in pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; NUCLEAR FACTOR 3-BETA; TISSUE-SPECIFIC EXPRESSION; SEGMENTATION GENE; ALPHA-CELLS; DIFFERENTIATION; GLUCOSE; SITES; PAX6; PHOSPHORYLATION	Pancreatic-duodenal homeobox factor-1 (Pdx1) is highly enriched in islet beta cells and integral to proper cell development and adult function. Of the four conserved 5'-flanking sequence blocks that contribute to transcription in vivo, Area II (mouse base pairs -2153/-1923) represents the only mammalian specific control domain. Here we demonstrate that regulation of beta-cell-enriched Pdx1 expression by the MafA and MafB transcription factors is exclusively through Area II. Thus, these factors were found to specifically activate through Area II in cell line transfection-based assays, and MafA, which is uniquely expressed in adult islet beta cells was only bound to this region in quantitative chromatin immuno-precipitation studies. MafA and MafB are produced in beta cells during development and were both bound to Area II at embryonic day 18.5. Expression of a transgene driven by Pdx1 Areas I and II was also severely compromised during insulin (+) cell formation in MafB (-)/(-)mice, consistent with the importance of this large Maf in beta-cell production and Pdx1 expression. These findings illustrate the significance of large Maf proteins to Pdx1 expression in beta cells, and in particular MafB during pancreatic development.	[Vanhoose, Amanda M.; Samaras, Susan; Artner, Isabella; Henderson, Eva; Hang, Yan; Stein, Roland] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Stein, R (corresponding author), Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	Roland.Stein@Vanderbilt.edu		Artner, Isabella/0000-0002-2895-5664	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042502, R56DK050203, R01DK050203, T32DK007563, P60DK020593] Funding Source: NIH RePORTER; NIDDK NIH HHS [5T32 DK07563-20, P60 DK20593, P01 DK42502, DK50203] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; GUZ Y, 1995, DEVELOPMENT, V121, P11; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; KERPPOLA TK, 1994, ONCOGENE, V9, P675; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Megason SG, 2002, DEVELOPMENT, V129, P2087; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rawdon BB, 1998, MICROSC RES TECHNIQ, V43, P292, DOI 10.1002/(SICI)1097-0029(19981115)43:4<292::AID-JEMT3>3.0.CO;2-X; Ring BZ, 2000, DEVELOPMENT, V127, P307; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Sadl VS, 2003, DEV DYNAM, V227, P134, DOI 10.1002/dvdy.10279; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Wiebe PO, 2007, MOL CELL BIOL, V27, P4093, DOI 10.1128/MCB.01978-06; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yoshida T, 2005, NUCLEIC ACIDS RES, V33, P3465, DOI 10.1093/nar/gki653; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2000, J BIOL CHEM, V275, P10532, DOI 10.1074/jbc.275.14.10532	47	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22612	22619		10.1074/jbc.M802902200	http://dx.doi.org/10.1074/jbc.M802902200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18522939	hybrid, Green Published			2022-12-27	WOS:000258321000030
J	Zhang, J; Chen, C				Zhang, Jian; Chen, Chu			Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CB1 CANNABINOID RECEPTORS; SYNAPTIC-TRANSMISSION; INHIBITION; SYSTEM; CYCLOOXYGENASE-2; ANANDAMIDE; NEUROPROTECTION; PROSTAGLANDIN; EXPRESSION; 2-ARACHIDONYLGLYCEROL	Endocannabinoids are involved in synaptic signaling and neuronal protection; however, our understanding of the mechanisms by which endocannabinoids protect neurons from harmful insults remains elusive. 2-Arachidonoylglycerol (2-AG), the most abundant endogenous cannabinoid and a full agonist for cannabinoid receptors (CB1 and CB2), is a substrate for cyclooxygenase-2 (COX-2) and can be metabolized by COX-2. Here we show, however, that 2-AG is also capable of suppressing elevation of hippocampal COX-2 expression in response to proinflammatory and excitotoxic stimuli. 2-AG prevents neurodegeneration from toxic assaults that elevate COX-2 expression and inhibits the COX-2 elevation-enhanced excitatory glutamatergic synaptic transmission. The action of 2-AG on suppression of COX-2 appeared to be mediated via the pertussis toxin-sensitive G protein-coupled CB1 receptor and MAPK/NF-kappa B signaling pathways. Our results reveal that 2-AG functions as an endogenous COX-2 inhibitor protecting neurons from harmful insults by preventing excessive expression of COX-2, which provides a mechanistic basis for opening up new therapeutic approaches for protecting neurons from inflammation-and excitotoxicity-induced neurodegeneration.	[Zhang, Jian; Chen, Chu] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Chen, C (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, 2020 Gravier St, New Orleans, LA 70112 USA.	cchen@lsuhsc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054886] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054886] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALGER BE, 2005, SCI STKE, V51, P1; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; BURSTEIN SH, 1989, MOL PHARMACOL, V35, P6; BURSTEIN SH, 1988, FASEB J, V2, P3022, DOI 10.1096/fasebj.2.14.2846397; Cabral GA, 2005, J LEUKOCYTE BIOL, V78, P1192, DOI 10.1189/jlb.0405216; Calandra B, 1999, EUR J PHARMACOL, V374, P445, DOI 10.1016/S0014-2999(99)00349-0; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Chang YH, 2001, J CELL BIOCHEM, V81, P715, DOI 10.1002/jcb.1103; Chen C, 2005, PROSTAG OTH LIPID M, V77, P65, DOI 10.1016/j.prostaglandins.2005.07.001; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; De Petrocellis L, 2005, LIFE SCI, V77, P1651, DOI 10.1016/j.lfs.2005.05.021; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Domoki F, 2000, NEUROREPORT, V11, P3435, DOI 10.1097/00001756-200011090-00007; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Ho L, 1999, J NEUROSCI RES, V57, P295; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Howlett AC, 2006, J NEUROIMMUNE PHARM, V1, P305, DOI 10.1007/s11481-006-9022-6; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kim EJ, 2001, BRAIN RES, V908, P1, DOI 10.1016/S0006-8993(01)02432-5; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Kunz T, 2001, EUR J NEUROSCI, V13, P569, DOI 10.1046/j.1460-9568.2001.01420.x; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Mestre L, 2006, BIOCHEM PHARMACOL, V72, P869, DOI 10.1016/j.bcp.2006.06.037; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Mukhopadhyay S, 2002, CHEM PHYS LIPIDS, V121, P91, DOI 10.1016/S0009-3084(02)00153-6; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Patrignani P, 2005, BRAIN RES REV, V48, P352, DOI 10.1016/j.brainresrev.2004.12.024; PEREZREYES M, 1991, LIFE SCI, V48, P507, DOI 10.1016/0024-3205(91)90465-N; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, NEUROSCIENTIST, V12, P425, DOI 10.1177/1073858406290794; Sarne Y, 2005, CNS NEUROL DISORD-DR, V4, P677, DOI 10.2174/156800705774933005; Sinha D, 1998, J NEUROIMMUNOL, V82, P13, DOI 10.1016/S0165-5728(97)00181-1; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Suplita RL, 2006, NEUROPHARMACOLOGY, V50, P372, DOI 10.1016/j.neuropharm.2005.10.007; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Waksman Y, 1999, J PHARMACOL EXP THER, V288, P1357; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	68	95	98	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22601	22611		10.1074/jbc.M800524200	http://dx.doi.org/10.1074/jbc.M800524200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18534982	Green Published, hybrid			2022-12-27	WOS:000258321000029
J	Piessevaux, J; De Ceuninck, L; Catteeuw, D; Peelman, F; Tavernier, J				Piessevaux, Julie; De Ceuninck, Leentje; Catteeuw, Dominiek; Peelman, Frank; Tavernier, Jan			Elongin B/C recruitment regulates substrate binding by CIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; TUMOR-SUPPRESSOR PROTEIN; GROWTH-HORMONE RECEPTOR; CHRONIC MYELOID-LEUKEMIA; INDUCIBLE SH2 PROTEIN; RNA-POLYMERASE-II; SOCS-BOX MOTIF; LEPTIN RECEPTOR; STAT5 ACTIVATION; ERYTHROPOIETIN RECEPTOR	SOCS proteins play a major role in the regulation of cytokine signaling. They are recruited to activated receptors and can suppress signaling by different mechanisms including targeting of the receptor complex for proteasomal degradation. The activity of SOCS proteins is regulated at different levels including transcriptional control and posttranslational modification. We describe here a novel regulatory mechanism for CIS, one of the members of this protein family. A CIS mutant deficient in recruitment of the Elongin B/C complex completely failed to suppress STAT5 activation. This deficiency was not caused by altered turnover of CIS but by loss of cytokine receptor interaction. Intriguingly, no such effect was seen for binding to MyD88. The interaction between CIS and the Elongin B/C complex, which depends on the levels of uncomplexed Elongin B/C, was easily disrupted. This regulatory mechanism may be unique for CIS, as similar mutations in SOCS1, -2, -3, -6, and -7 had no functional impact. Our findings indicate that the SOCS box not only plays a role in the formation of E3 ligase complexes but, at least for CIS, can also regulate the binding modus of SOCS box-containing proteins.	VIB, Flanders Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Tavernier, J (corresponding author), VIB, Flanders Inst Biotechnol, Dept Med Prot Res, A Baertsoenkaai 3, B-9000 Ghent, Belgium.	Jan.Tavernier@Ugent.be	Tavernier, Jan/AAG-3636-2019					Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Botuyan MV, 1999, P NATL ACAD SCI USA, V96, P9033, DOI 10.1073/pnas.96.16.9033; Bradshaw JM, 1999, J MOL BIOL, V293, P971, DOI 10.1006/jmbi.1999.3190; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; DUAN DR, 1995, P NATL ACAD SCI USA, V92, P6459, DOI 10.1073/pnas.92.14.6459; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Evans MK, 2007, ONCOGENE, V26, P1941, DOI 10.1038/sj.onc.1209993; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Eyckerman S, 1999, EUR CYTOKINE NETW, V10, P549; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; Hansen LH, 1996, J BIOL CHEM, V271, P12669, DOI 10.1074/jbc.271.21.12669; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Ketteler R, 2003, J BIOL CHEM, V278, P2654, DOI 10.1074/jbc.M211236200; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Landsman T, 2005, J BIOL CHEM, V280, P37471, DOI 10.1074/jbc.M504125200; Lavens D, 2007, BIOCHEM J, V401, P257, DOI 10.1042/BJ20060242; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Li Z, 2004, J INVEST DERMATOL, V123, P737, DOI 10.1111/j.0022-202X.2004.23408.x; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Montoye T, 2005, BLOOD, V105, P4264, DOI 10.1182/blood-2004-07-2733; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Piessevaux J, 2006, J BIOL CHEM, V281, P32953, DOI 10.1074/jbc.M600776200; Porkka K, 2002, LAB INVEST, V82, P629, DOI 10.1038/labinvest.3780457; Raccurt M, 2003, BRIT J CANCER, V89, P524, DOI 10.1038/sj.bjc.6601115; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Rose KM, 2004, TRENDS MOL MED, V10, P291, DOI 10.1016/j.molmed.2004.04.008; Schultheis B, 2002, BLOOD, V99, P1766, DOI 10.1182/blood.V99.5.1766; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Tavernier J, 2002, CLIN EXP ALLERGY, V32, P1397, DOI 10.1046/j.1365-2745.2002.01520.x; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Uyttendaele I, 2007, MOL ENDOCRINOL, V21, P2821, DOI 10.1210/me.2006-0541; van de Geijn GJM, 2004, BLOOD, V104, P667, DOI 10.1182/blood-2003-08-2913; Verdier F, 1998, J BIOL CHEM, V273, P28185, DOI 10.1074/jbc.273.43.28185; Wood TJJ, 1997, MOL CELL ENDOCRINOL, V130, P69, DOI 10.1016/S0303-7207(97)00075-0; Wu KL, 2007, AM J PHYSIOL-RENAL, V293, pF1836, DOI 10.1152/ajprenal.00096.2007; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zheng C, 2006, LEUKEMIA, V20, P1028, DOI 10.1038/sj.leu.2404227	74	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21334	21346		10.1074/jbc.M803742200	http://dx.doi.org/10.1074/jbc.M803742200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508766	hybrid			2022-12-27	WOS:000257898800005
J	Daniel, CJ; Conti, B; Johnson, AE; Skach, WR				Daniel, Colin J.; Conti, Brian; Johnson, Arthur E.; Skach, William R.			Control of translocation through the Sec61 translocon by nascent polypeptide structure within the ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL RECOGNITION PARTICLE; PREPRO-ALPHA-FACTOR; ER MEMBRANE; PROTEIN INTEGRATION; SECRETORY PROTEINS; EXIT TUNNEL; COTRANSLATIONAL INTEGRATION; TRANSMEMBRANE SEGMENTS; MOLECULAR-MECHANISMS	During polytopic protein biogenesis, multiple transmembrane segments (TMs) must pass through the ribosome exit tunnel and into the Sec61 translocon prior to insertion into the endoplasmic reticulum membrane. To investigate how movement of a newly synthesized TM along this integration pathway might be influenced by synthesis of a second TM, we used photocross-linking probes to detect the proximity of ribosome-bound nascent polypeptides to Sec61 alpha. Probes were inserted at sequential sites within TM2 of the aquaporin-1 water channel by in vitro translation of truncated mRNAs. TM2 first contacted Sec61 alpha when the probe was positioned similar to 38 residues from the ribosome peptidyltransferase center, and TM2-Sec61 alpha photo-adducts decreased markedly when the probe was > 80 residues from the peptidyltransferase center. Unexpectedly, as nascent chain length was gradually extended, photocross-linking at multiple sites within TM2 abruptly and transiently decreased, indicating that TM2 initially entered, withdrew, and then re-entered Sec61 alpha. This brief reduction in TM2 photocross-linking coincided with TM3 synthesis. Replacement of TM3 with a secretory reporter domain or introduction of proline residues into TM3 changed the TM2 cross-linking profile and this biphasic behavior. These findings demonstrate that the primary and likely secondary structure of the nascent polypeptide within the ribosome exit tunnel can influence the timing with which topogenic determinants contact, enter, and pass through the translocon.	[Daniel, Colin J.; Conti, Brian; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Biochem & Biophys, College Stn, TX 77843 USA	Oregon Health & Science University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, L-224,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	skachw@ohsu.edu	Johnson, Arthur E/G-3457-2012		NHLBI NIH HHS [T32 HL083808] Funding Source: Medline; NIDDK NIH HHS [DK 51818] Funding Source: Medline; NIGMS NIH HHS [GM 26494, GM 53457] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457, R01GM026494] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Belin D, 1996, EMBO J, V15, P468, DOI 10.1002/j.1460-2075.1996.tb00379.x; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Buck TM, 2005, J BIOL CHEM, V280, P261, DOI 10.1074/jbc.M409920200; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Foster W, 2000, J BIOL CHEM, V275, P34157, DOI 10.1074/jbc.M000165200; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HO NS, 1989, GENE, V77, P51; HOFFMAN KE, 1988, J BIOL CHEM, V263, P4381; Ismail N, 2006, J CELL SCI, V119, P2826, DOI 10.1242/jcs.03018; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KOWARIK M, 2003, MOL CELL, V10, P735; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; OBERDORF J, 2002, METHODS MOL MED CYST, P70; OOI CE, 1992, CELL, V71, P87, DOI 10.1016/0092-8674(92)90268-H; PERARA E, 1986, SCIENCE, V232, P348, DOI 10.1126/science.3961485; PICKING W, 1992, BIOCHEMISTRY-US, V331, P2368; Pitonzo D, 2006, BBA-BIOMEMBRANES, V1758, P976, DOI 10.1016/j.bbamem.2006.04.021; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Saksena S, 2004, P NATL ACAD SCI USA, V101, P12537, DOI 10.1073/pnas.0404934101; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; SKACH WR, 1994, J CELL BIOL, V125, P803, DOI 10.1083/jcb.125.4.803; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tsalkova T, 1998, J MOL BIOL, V278, P713, DOI 10.1006/jmbi.1998.1721; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Ziv G, 2005, P NATL ACAD SCI USA, V102, P18956, DOI 10.1073/pnas.0508234102	62	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20864	20873		10.1074/jbc.M803517200	http://dx.doi.org/10.1074/jbc.M803517200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18480044	Green Published, hybrid			2022-12-27	WOS:000257746100029
J	Mathews, CK				Mathews, Christopher K.			Academic life: The whole package - Christopher K. Mathews	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item							DEFECTIVE AMBER MUTANTS; DNA-REPLICATION; POOLS; ACID; T4; BACTERIOPHAGE-T4; BIOSYNTHESIS; BIOCHEMISTRY; METABOLISM		Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	mathewsc@onid.orst.edu						FLANEGAN JB, 1977, J BIOL CHEM, V252, P3019; FLANEGAN JB, 1977, J BIOL CHEM; Mathews CK, 2007, FASEB J, V21, P2294, DOI 10.1096/fj.06-7977rev; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; MATHEWS CK, 1968, J BIOL CHEM, V243, P5610; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; MATHEWS CK, 1964, J BIOL CHEM, V239, P2957; MATHEWS CK, 1960, J BIOL CHEM, V235, P3304; MATHEWS CK, PUBLICATION LIST; NOSSAL NG, 1983, BACTERIOPHAGE T, V4, P71; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; REDDY GPV, 1977, P NATL ACAD SCI USA, V74, P3152, DOI 10.1073/pnas.74.8.3152; Wheeler LJ, 1996, J BIOL CHEM, V271, P11156, DOI 10.1074/jbc.271.19.11156	13	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20613	20620		10.1074/jbc.X800004200	http://dx.doi.org/10.1074/jbc.X800004200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18458074	hybrid, Green Published			2022-12-27	WOS:000257746100001
J	Mauri, F; McNamee, LM; Lunardi, A; Chiacchiera, F; Del Sal, G; Brodsky, MH; Collavin, L				Mauri, Federico; McNamee, Laura M.; Lunardi, Andrea; Chiacchiera, Fulvio; Del Sal, Giannino; Brodsky, Michael H.; Collavin, Licio			Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT MODIFICATION; NUCLEAR-BODIES; DNA-DAMAGE; C-JUN; PROTEIN; STABILITY; UBIQUITIN; MELANOGASTER; CONJUGATION; DAXX	Conjugation to SUMO is a reversible post-translational modification that regulates several transcription factors involved in cell proliferation, differentiation, and disease. The p53 tumor suppressor can be modified by SUMO-1 in mammalian cells, but the functional consequences of this modification are unclear. Here, we demonstrate that the Drosophila homolog of human p53 can be efficiently sumoylated in insect cells. We identify two lysine residues involved in SUMO attachment, one at the C terminus, between the DNA binding and oligomerization domains, and one at the N terminus of the protein. We find that sumoylation helps recruit Drosophila p53 to nuclear dot-like structures that can be marked by human PML and the Drosophila homologue of Daxx. We demonstrate that mutation of both sumoylation sites dramatically reduces the transcriptional activity of p53 and its ability to induce apoptosis in transgenic flies, providing in vivo evidence that sumoylation is critical for Drosophila p53 function.	[Mauri, Federico; Lunardi, Andrea; Chiacchiera, Fulvio; Del Sal, Giannino; Collavin, Licio] LNCIB, AREA Sci Pk, I-34012 Trieste, Italy; [Lunardi, Andrea; Chiacchiera, Fulvio; Del Sal, Giannino; Collavin, Licio] Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34129 Trieste, Italy; [McNamee, Laura M.; Brodsky, Michael H.] Univ Massachusetts, Sch Med, Program Gene Funct, Worcester, MA 01605 USA; [McNamee, Laura M.; Brodsky, Michael H.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Trieste; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Collavin, L (corresponding author), LNCIB, AREA Sci Pk, Padriciano 99, I-34012 Trieste, Italy.	collavin@lncib.it	Collavin, Licio/A-5312-2010; Chiacchiera, Fulvio/ABD-6137-2020; Chiacchiera, Fulvio/K-6740-2016	Collavin, Licio/0000-0001-6815-5381; Chiacchiera, Fulvio/0000-0003-3830-2090; DEL SAL, GIANNINO/0000-0003-2185-6003	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; Bodai L, 2007, J BIOL CHEM, V282, P36386, DOI 10.1074/jbc.M705547200; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gostissa M, 2003, CURR OPIN CELL BIOL, V15, P351, DOI 10.1016/S0955-0674(03)00038-3; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Lehembre F, 2000, MOL CELL BIOL, V20, P1072, DOI 10.1128/MCB.20.3.1072-1082.2000; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Michaelson JS, 2000, APOPTOSIS, V5, P217, DOI 10.1023/A:1009696227420; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Watson IR, 2006, NEOPLASIA, V8, P655, DOI 10.1593/neo.06439	46	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20848	20856		10.1074/jbc.M710186200	http://dx.doi.org/10.1074/jbc.M710186200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18492669	Green Published, hybrid			2022-12-27	WOS:000257746100027
J	Castro, A; Lemos, C; Falcao, A; Glass, NL; Videira, A				Castro, Ana; Lemos, Catarina; Falcao, Artur; Glass, N. Louise; Videira, Arnaldo			Increased resistance of complex I mutants to phytosphingosine-induced programmed cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; NEUROSPORA-CRASSA; OXIDATIVE STRESS; ROS RELEASE; APOPTOSIS; MITOCHONDRIA; SUBUNIT; GENE; DISRUPTION; MECHANISM	We have studied the effects of phytosphingosine (PHS) on cells of the filamentous fungus Neurospora crassa. Highly reduced viability, impairment of asexual spore germination, DNA condensation and fragmentation, and production of reactive oxygen species were observed in conidia treated with the drug, suggesting that PHS induces an apoptosis-like death in this fungus. Interestingly, we found that complex I mutants are more resistant to PHS treatment than the wild type strain. This effect appears to be specific because it was not observed in mutants defective in other components of the mitochondrial respiratory chain, pointing to a particular involvement of complex I in cell death. The response of the mutant strains to PHS correlated with their response to hydrogen peroxide. The fact that complex I mutants generate fewer reactive oxygen species than the wild type strain when exposed to PHS likely explains the PHS-resistant phenotype. As compared with the wild type strain, we also found that a strain containing a deletion in the gene encoding an AIF (apoptosis-inducing factor)-like protein is more resistant to PHS and H2O2. In contrast, a strain containing a deletion in a gene encoding an AMID (AIF-homologous mitochondrion-associated inducer of death)-like polypeptide is more sensitive to both drugs. These results indicate that N. crassa has the potential to be a model organism to investigate the molecular basis of programmed cell death in eukaryotic species.	[Castro, Ana; Lemos, Catarina; Falcao, Artur; Videira, Arnaldo] Univ Porto, IBMC, P-4150180 Oporto, Portugal; [Castro, Ana; Lemos, Catarina; Falcao, Artur] Univ Fernando Pessoa, Fac Ciencias Saude, P-4200150 Oporto, Portugal; [Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Videira, Arnaldo] Univ Porto, ICBAS, P-4099003 Oporto, Portugal	Universidade do Porto; Universidade Fernando Pessoa; University of California System; University of California Berkeley; Universidade do Porto	Videira, A (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	avideira@ibmc.up.pt	Videira, Arnaldo/H-8150-2013; castro, ana/A-9232-2014; Glass, N. Louise/ABA-7303-2021; Lima, Marta T/C-7042-2009	castro, ana/0000-0003-4035-3444; Lemos, Catarina/0000-0003-3468-4191; Videira, Arnaldo/0000-0001-7267-4459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060468] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM60468] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Amin S, 2004, MICROBIOL-SGM, V150, P1937, DOI 10.1099/mic.0.26830-0; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; Cheng JJ, 2003, MOL CELL BIOL, V23, P163, DOI 10.1128/MCB.23.1.163-177.2003; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Dementhon K, 2006, EUKARYOT CELL, V5, P2161, DOI 10.1128/EC.00253-06; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; DUARTE M, 1995, GENETICS, V139, P1211; Duarte M, 2003, BIOCHEM J, V371, P1005, DOI 10.1042/BJ20021374; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Eisler H, 2004, EXP CELL RES, V300, P345, DOI 10.1016/j.yexcr.2004.07.025; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; FECKE W, 1994, EUR J BIOCHEM, V220, P551, DOI 10.1111/j.1432-1033.1994.tb18655.x; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; Ferreirinha F, 1999, BIOCHEM J, V342, P551, DOI 10.1042/0264-6021:3420551; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hamann A, 2007, MOL MICROBIOL, V65, P948, DOI 10.1111/j.1365-2958.2007.05839.x; Hattori N, 1998, GENOMICS, V49, P52, DOI 10.1006/geno.1997.5192; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M; LU B.C.K., 2006, MYCOTA GROWTH DIFFER, P167; Ludovico P, 2005, IUBMB LIFE, V57, P129, DOI 10.1080/15216540500090553; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Marques I, 2005, BBA-BIOENERGETICS, V1707, P211, DOI 10.1016/j.bbabio.2004.12.003; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Perkins D., 2001, NEUROSPORA COMPENDIU; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Robson GD, 2006, MED MYCOL, V44, pS109, DOI 10.1080/13693780600835765; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Semighini CP, 2006, MOL MICROBIOL, V59, P753, DOI 10.1111/j.1365-2958.2005.04976.x; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Span LFR, 2002, CYTOMETRY, V47, P24, DOI 10.1002/cyto.10028; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Videira A, 1998, BBA-BIOENERGETICS, V1364, P89, DOI 10.1016/S0005-2728(98)00020-6; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang XD, 2001, GENE DEV, V15, P2922; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	64	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19314	19321		10.1074/jbc.M802112200	http://dx.doi.org/10.1074/jbc.M802112200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18474589	hybrid, Green Published			2022-12-27	WOS:000257387600017
J	DeHaven, WI; Smyth, JT; Boyles, RR; Bird, GS; Putney, JW				DeHaven, Wayne I.; Smyth, Jeremy T.; Boyles, Rebecca R.; Bird, Gary S.; Putney, James W., Jr.			Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; ACTIVATED CA2+ CHANNELS; EMBRYONIC KIDNEY-CELLS; PLASMA-MEMBRANE; CRAC CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; PHOSPHOLIPASE-C; STIM1; ORAI1; SENSOR	Store-operated Ca2+ entry (SOCE) is likely the most common mode of regulated influx of Ca2+ into cells. However, only a limited number of pharmacological agents have been shown to modulate this process. 2-Aminoethyldiphenyl borate (2-APB) is a widely used experimental tool that activates and then inhibits SOCE and the underlying calcium release-activated Ca2+ current (I-CRAC). The mechanism by which depleted stores activates SOCE involves complex cellular movements of an endoplasmic reticulum Ca2+ sensor, STIM1, which redistributes to puncta near the plasma membrane and, in some manner, activates plasma membrane channels comprising Orai1, -2, and -3 subunits. We show here that 2-APB blocks puncta formation of fluorescently tagged STIM1 in HEK293 cells. Accordingly, 2-APB also inhibited SOCE and I-CRAC-like currents in cells co-expressing STIM1 with the CRAC channel subunit, Orai1, with similar potency. However, 2-APB inhibited STIM1 puncta formation less well in cells co-expressing Orai1, indicating that the inhibitory effects of 2-APB are not solely dependent upon STIM1 reversal. Further, 2-APB only partially inhibited SOCE and current in cells co-expressing STIM1 and Orai2 and activated sustained currents in HEK293 cells expressing Orai3 and STIM1. Interestingly, the Orai3-dependent currents activated by 2-APB showed large outward currents at potentials greater than +50 mV. Finally, Orai3, and to a lesser extent Orai1, could be directly activated by 2-APB, independently of internal Ca2+ stores and STIM1. These data reveal novel and complex actions of 2-APB effects on SOCE that can be attributed to effects on both STIM1 as well as Orai channel subunits.	[DeHaven, Wayne I.; Smyth, Jeremy T.; Boyles, Rebecca R.; Bird, Gary S.; Putney, James W., Jr.] NIEHS, Lab Signal Transduct, Natl Inst Hlth, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Putney, JW (corresponding author), NIEHS, Lab Signal Transduct, Natl Inst Hlth, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	putney@niehs.nih.gov	Putney, James W/F-7247-2019; Bird, Gary/AAI-8186-2021	Putney, James W/0000-0002-3379-4789; Bird, Gary/0000-0003-1389-8748; Boyles, Rebecca/0000-0003-0073-6854	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090087, Z01ES102485, ZIAES090087, ZIAES102485] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Iwasaki H, 2001, RECEPTOR CHANNEL, V7, P429; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PEINELT C, 2008, J PHYSL IN PRESS; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	38	202	204	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19265	19273		10.1074/jbc.M801535200	http://dx.doi.org/10.1074/jbc.M801535200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487204	Green Published, hybrid			2022-12-27	WOS:000257387600012
J	Kroschewski, H; Lim, SP; Butcher, RE; Yap, TL; Lescar, J; Wright, PJ; Vasudevan, SG; Davidson, AD				Kroschewski, Helga; Lim, Siew Pheng; Butcher, Rebecca E.; Yap, Thai Leong; Lescar, Julien; Wright, Peter J.; Vasudevan, Subhash G.; Davidson, Andrew D.			Mutagenesis of the dengue virus type 2 NS5 methyltransferase domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; AMINO-ACID-RESIDUES; MESSENGER-RNA; CRYSTAL-STRUCTURE; CAP METHYLATION; LAMBDA-2 PROTEIN; SEQUENCE MOTIFS; CAPPING ENZYME; GUANINE N-7; IDENTIFICATION	The Flavivirus NS5 protein possesses both (guanine-N7)-methyltransferase and nucleoside-2'-O methyltransferase activities required for sequential methylation of the cap structure present at the 5' end of the Flavivirus RNA genome. Seventeen mutations were introduced into the dengue virus type 2 NS5 methyltransferase domain, targeting amino acids either predicted to be directly involved in S-adenosyl-L-methionine binding or important for NS5 conformation and/or charged interactions. The effects of the mutations on (i) (guanine-N7)methyltransferase and nucleoside-2'-O methyltransferase activities using biochemical assays based on a bacterially expressed NS5 methyltransferase domain and (ii) viral replication using a dengue virus type 2 infectious cDNA clone were examined. Clustered mutations targeting the S-adenosyl-L-methionine binding pocket or an active site residue abolished both methyltransferase activities and viral replication, demonstrating that both methyltransferase activities utilize a single S-adenosyl-L-methionine binding pocket. Substitutions to single amino acids binding S-adenosyl-L-methionine decreased both methyltransferase activities by varying amounts. However, viruses that replicated at wild type levels could be recovered with mutations that reduced both activities by > 75%, suggesting that only a threshold level of methyltransferase activity was required for virus replication in vivo. Mutation of residues outside of regions directly involved in S-adenosyl-L-methionine binding or catalysis also affected methyltransferase activity and virus replication. The recovery of viruses containing compensatory second site mutations in the NS5 and NS3 proteins identified regions of the methyltransferase domain important for overall stability of the protein or likely to play a role in virus replication distinct from that of cap methylation.	[Kroschewski, Helga; Davidson, Andrew D.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Lim, Siew Pheng; Yap, Thai Leong; Vasudevan, Subhash G.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Butcher, Rebecca E.; Wright, Peter J.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Yap, Thai Leong; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Vasudevan, Subhash G.] Duke NUS Grad Med Sch, Singapore, Singapore	University of Bristol; Novartis; Monash University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Davidson, AD (corresponding author), Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England.	andrew.davidson@bristol.ac.uk	Pheng, Lim Siew/AAG-4368-2021; Lim, Siew Pheng/P-8528-2016	Pheng, Lim Siew/0000-0002-7377-5662; Vasudevan, Subhash/0000-0002-5083-3831				Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Assenberg R, 2007, J GEN VIROL, V88, P2228, DOI 10.1099/vir.0.82757-0; Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Delano W.L., 2002, DELANO SCI; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Fabrega C, 2004, MOL CELL, V13, P77, DOI 10.1016/S1097-2765(03)00522-7; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6; Hanley KA, 2002, J VIROL, V76, P525, DOI 10.1128/JVI.76.2.525-531.2002; Hausmann S, 2005, J BIOL CHEM, V280, P20404, DOI 10.1074/jbc.M501073200; HERCYK N, 1988, VIROLOGY, V163, P222, DOI 10.1016/0042-6822(88)90253-X; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Khromykh AA, 1999, J VIROL, V73, P9247, DOI 10.1128/JVI.73.11.9247-9255.1999; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Li JR, 2007, J VIROL, V81, P4104, DOI 10.1128/JVI.02681-06; Li JR, 2006, P NATL ACAD SCI USA, V103, P8493, DOI 10.1073/pnas.0509821103; Li JR, 2005, J VIROL, V79, P13373, DOI 10.1128/JVI.79.21.13373-13384.2005; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luongo CL, 1998, J BIOL CHEM, V273, P23773, DOI 10.1074/jbc.273.37.23773; Luzhkov VB, 2007, BIOORGAN MED CHEM, V15, P7795, DOI 10.1016/j.bmc.2007.08.049; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; MAO XD, 1994, J BIOL CHEM, V269, P24472; Mao XD, 1996, BIOCHEMISTRY-US, V35, P6900, DOI 10.1021/bi960221a; Mao XD, 1996, MOL CELL BIOL, V16, P475; Mastrangelo E, 2007, PROTEIN SCI, V16, P1133, DOI 10.1110/ps.072758107; Ogino T, 2005, J BIOL CHEM, V280, P4429, DOI 10.1074/jbc.M411167200; Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427; Ramadevi N, 1998, P NATL ACAD SCI USA, V95, P13537, DOI 10.1073/pnas.95.23.13537; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Sutton G, 2007, NAT STRUCT MOL BIOL, V14, P449, DOI 10.1038/nsmb1225; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; Wu SG, 2005, BIODRUGS, V19, P383, DOI 10.2165/00063030-200519060-00005; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	54	62	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19410	19421		10.1074/jbc.M800613200	http://dx.doi.org/10.1074/jbc.M800613200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18469001	hybrid			2022-12-27	WOS:000257387600027
J	Singhal, SS; Yadav, S; Drake, K; Singhal, J; Awasthi, S				Singhal, Sharad S.; Yadav, Sushma; Drake, Kenneth; Singhal, Jyotsana; Awasthi, Sanjay			Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER DOXORUBICIN RESISTANCE; HEAT-SHOCK; ERYTHROCYTE GLUTATHIONE; LUNG-CANCER; DEPENDENT TRANSPORT; G-PROTEIN; RLIP76; CELLS; BINDING; STRESS	Hsf-1 (heat shock factor-1) is a transcription factor that is known to regulate cellular heat shock response through its binding with the multispecific transporter protein, Ralbp1. Results of present studies demonstrate that Hsf-1 causes specific and saturable inhibition of the transport activity of Ralbp1 and that the combination of Hsf-1 and POB1 causes nearly complete inhibition through specific bindings with Ralbp1. Augmentation of cellular levels of Hsf-1 and POB1 caused dramatic apoptosis in non-small cell lung cancer cell line H358 through Ralbp1 inhibition. These findings indicate a novel model for mutual regulation of Hsf-1 and Ralbp1 through Ralbp1-mediated sequestration of Hsf-1 in the cellular cytoskeleton and Hsf1-mediated inhibition of the transport activity of membrane-bound Ralbp1.	[Singhal, Sharad S.; Yadav, Sushma; Drake, Kenneth; Singhal, Jyotsana; Awasthi, Sanjay] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Awasthi, S (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, 3500 Camp Bowie Blvd,EAD Rm 552, Ft Worth, TX 76107 USA.	sawasthi@hsc.unt.edu	Awasthi, Sanjay/R-4904-2019	Awasthi, Sanjay/0000-0002-5214-5717	NCI NIH HHS [CA 104661, CA77495] Funding Source: Medline; PHS HHS [ISIORR018999-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077495, R01CA104661] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aumais JP, 1997, J BIOL CHEM, V272, P12229, DOI 10.1074/jbc.272.18.12229; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; Awasthi S, 1999, TOXICOL APPL PHARM, V155, P215, DOI 10.1006/taap.1998.8617; AWASTHI S, 1994, J CLIN INVEST, V93, P958, DOI 10.1172/JCI117102; Awasthi S, 1998, BIOCHEMISTRY-US, V37, P5239, DOI 10.1021/bi972131r; Awasthi S, 2005, CANCER RES, V65, P6022, DOI 10.1158/0008-5472.CAN-05-0968; Awasthi S, 2003, INT J CANCER, V106, P635, DOI 10.1002/ijc.11260; Awasthi S, 2003, INT J ONCOL, V22, P721; Awasthi S, 2003, INT J ONCOL, V22, P713; AWASTHI YC, 1981, BLOOD, V58, P733; Awasthi YC, 2007, CURR DRUG METAB, V8, P315, DOI 10.2174/138920007780655414; BROADWAY NM, 1995, BIOCHEM J, V310, P989, DOI 10.1042/bj3100989; Cheng JZ, 2001, J BIOL CHEM, V276, P41213, DOI 10.1074/jbc.M106838200; Hammill AK, 1999, EXP CELL RES, V251, P16, DOI 10.1006/excr.1999.4581; Hu YZ, 2003, J BIOL CHEM, V278, P17299, DOI 10.1074/jbc.M300788200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Kabakov AE, 2006, RADIAT RES, V165, P410, DOI 10.1667/RR3514.1; Kariya K, 2000, J BIOL CHEM, V275, P18399, DOI 10.1074/jbc.M000521200; Leich F, 2007, J BIOL CHEM, V282, P27640, DOI 10.1074/jbc.M702240200; Li J, 2006, BIOCHEMISTRY-US, V45, P12253, DOI 10.1021/bi060780+; MIVECHI NF, 1992, CANCER RES, V52, P6815; MIVECHI NF, 1995, J CELL BIOCHEM, V59, P266, DOI 10.1002/jcb.240590215; Morinaka K, 1999, ONCOGENE, V18, P5915, DOI 10.1038/sj.onc.1202974; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Oosterhoff JK, 2003, ONCOGENE, V22, P2920, DOI 10.1038/sj.onc.1206397; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Sharma R, 2004, INT J CANCER, V112, P934, DOI 10.1002/ijc.20516; Sharma R, 2008, BIOCHEMISTRY-US, V47, P143, DOI 10.1021/bi701559f; SINGHAL J, 2008, INT J RAD O IN PRESS; Singhal S.S., 2006, TOXICOLOGY GLUTATHIO, P231; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Singhal SS, 2006, BIOCHEM BIOPH RES CO, V348, P722, DOI 10.1016/j.bbrc.2006.07.118; Singhal SS, 2006, CANCER RES, V66, P2354, DOI 10.1158/0008-5472.CAN-05-3534; Singhal SS, 2005, BIOCHEM PHARMACOL, V70, P481, DOI 10.1016/j.bcp.2005.05.005; Stuckler D, 2005, CANCER RES, V65, P991; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Taylor DM, 2007, CELL STRESS CHAPERON, V12, P151, DOI 10.1379/CSC-254R.1; Yadav S, 2005, BIOCHEM BIOPH RES CO, V328, P1003, DOI 10.1016/j.bbrc.2005.01.055; Yadav S, 2004, BIOCHEMISTRY-US, V43, P16243, DOI 10.1021/bi0482811; Yadav S, 2007, CANCER METAST REV, V26, P59, DOI 10.1007/s10555-007-9043-5; Yang YS, 2003, J BIOL CHEM, V278, P41380, DOI 10.1074/jbc.M305766200	44	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19714	19729		10.1074/jbc.M708703200	http://dx.doi.org/10.1074/jbc.M708703200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18474607	Green Published, hybrid			2022-12-27	WOS:000257387600056
J	Grenegard, M; Vretenbrant-Oberg, K; Nylander, M; Desilets, S; Lindstrom, EG; Larsson, A; Ramstrom, I; Ramstrom, S; Lindahl, TL				Grenegard, Magnus; Vretenbrant-Oberg, Karin; Nylander, Martina; Desilets, Stephanie; Lindstrom, Eva G.; Larsson, Anders; Ramstrom, Ida; Ramstrom, Sofia; Lindahl, Tomas L.			The ATP-gated P2X(1) receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT ACTIVATION; AGGREGATION; PAR4; STIMULATION; ADRENALINE; GENERATION; FIBRINOGEN; SECRETION; KINETICS; PROTEIN	Human platelets express protease-activated receptor 1 (PAR1) and PAR4 but limited data indicate for differences in signal transduction. We studied the involvement of PAR1 and PAR4 in the cross-talk between thrombin and epinephrine. The results show that epinephrine acted via alpha(2A)-adrenergic receptors to provoke aggregation, secretion, and Ca2+ mobilization in aspirin-treated platelets pre-stimulated with subthreshold concentrations of thrombin. Incubating platelets with antibodies against PAR4 or the PAR4-specific inhibitor pepducin P4pal-i1 abolished the aggregation. Furthermore, platelets pre-exposed to the PAR4-activating peptide AYPGKF, but not to the PAR1-activating peptide SFLLRN, were aggregated by epinephrine, whereas both AYPGKF and SFLLRN synergized with epinephrine in the absence of aspirin. The roles of released ATP and ADP were elucidated by using antagonists of the purinergic receptors P2X(1), P2Y(1), and P2Y(12) (i.e. NF449, MRS2159, MRS2179, and cangrelor). Intriguingly, ATP, but not ADP, was required for the epinephrine/thrombin-induced aggregation. In Western blot analysis, a low concentration of AYPGKF, but not SFLLRN, stimulated phosphorylation of Akt on serine 473. Moreover, the phosphatidyl inositide 3-kinase inhibitor LY294002 antagonized the effect of epinephrine combined with thrombin or AYPGKF. Thus, in aspirin-treated platelets, PAR4, but not PAR1, interacts synergistically with alpha(2A)-adrenergic receptors, and the PI3-kinase/Akt pathway is involved in this cross-talk. Furthermore, in PAR4-pretreated platelets, epinephrine caused dense granule secretion, and subsequent signaling from the ATP-gated P2X(1)-receptor and the alpha(2A)-adrenergic receptor induced aggregation. These results suggest a new mechanism that has ATP as a key element and circumvents the action of aspirin on epinephrine-facilitated PAR4-mediated platelet activation.	[Grenegard, Magnus; Desilets, Stephanie; Lindstrom, Eva G.; Ramstrom, Ida] Cardiovasc Inflammat Res Ctr, Div Drug Res, Dept Med & Hlth, SE-58185 Linkoping, Sweden; [Vretenbrant-Oberg, Karin; Nylander, Martina; Ramstrom, Sofia; Lindahl, Tomas L.] Cardiovasc Inflammat Res Ctr, Div Clin Chem, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Larsson, Anders] Univ Uppsala Hosp, Dept Med Sci, SE-75105 Uppsala, Sweden	Uppsala University; Uppsala University Hospital	Grenegard, M (corresponding author), Cardiovasc Inflammat Res Ctr, Div Drug Res, Dept Med & Hlth, SE-58185 Linkoping, Sweden.	Magnus.Grenegard@imv.liu.se	Lindahl, Tomas L/H-5150-2012; Ramström, Sofia/F-9798-2011	Lindahl, Tomas L/0000-0003-0174-8152; Ramström, Sofia/0000-0002-1920-3962				AKITA EM, 1993, J IMMUNOL METHODS, V160, P207, DOI 10.1016/0022-1759(93)90179-B; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, THROMB HAEMOSTASIS, V87, P722, DOI 10.1055/s-0037-1613071; CROUCH MF, 1989, J BIOL CHEM, V264, P584; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Erhardt JA, 2003, J THROMB HAEMOST, V1, P2626, DOI 10.1046/j.1538-7836.2003.00453.x; Fung CYE, 2007, J THROMB HAEMOST, V5, P910, DOI 10.1111/j.1538-7836.2007.02525.x; Fung CYE, 2005, THROMB HAEMOSTASIS, V94, P37, DOI 10.1160/TH04-11-0732; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Harper MT, 2006, PLATELETS, V17, P134, DOI 10.1080/09537100500441218; Holinstat M, 2007, MOL PHARMACOL, V71, P686, DOI 10.1124/mol.106.029371; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; JAKOBS KH, 1989, EUR J BIOCHEM, V183, P115, DOI 10.1111/j.1432-1033.1989.tb14903.x; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Keularts IMLW, 2000, J BIOL CHEM, V275, P1763, DOI 10.1074/jbc.275.3.1763; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; LANZA F, 1988, AM J PHYSIOL, V255, pH1276, DOI 10.1152/ajpheart.1988.255.6.H1276; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; LINDAHL TL, 1992, THROMB HAEMOSTASIS, V68, P221; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; Molino M, 1997, J BIOL CHEM, V272, P6011, DOI 10.1074/jbc.272.9.6011; Nylander S, 2003, BLOOD COAGUL FIBRIN, V14, P159, DOI 10.1097/00001721-200302000-00007; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Oury C, 2002, BLOOD, V100, P2499, DOI 10.1182/blood-2002-03-0812; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Roger S, 2004, FEBS LETT, V556, P227, DOI 10.1016/S0014-5793(03)01430-3; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; STEEN VM, 1993, THROMB HAEMOSTASIS, V70, P506; Vretenbrant K, 2007, THROMB HAEMOSTASIS, V97, P417, DOI 10.1160/TH06-07-0397; Wallen NH, 1999, CLIN SCI, V97, P27, DOI 10.1042/CS19990013; Wang XY, 1997, J BIOCHEM-TOKYO, V121, P325; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267	35	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18493	18504		10.1074/jbc.M800358200	http://dx.doi.org/10.1074/jbc.M800358200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18480058	hybrid			2022-12-27	WOS:000257165600004
J	Erridge, C; Kennedy, S; Spickett, CM; Webb, DJ				Erridge, Clett; Kennedy, Simon; Spickett, Corinne M.; Webb, David J.			Oxidized phospholipid inhibition of Toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4 - Roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN-1; LOW-DENSITY-LIPOPROTEIN; LIPID RAFTS; OXIDATION-PRODUCTS; HEME OXYGENASE-1; ACTIVATION; INDUCE; COMPLEX; MD-2	The generation of reactive oxygen species is a central feature of inflammation that results in the oxidation of host phospholipids. Oxidized phospholipids, such as 1-palmitoyl-2-arachidonyl-sn-glycero-3- phosphorylcholine (OxPAPC), have been shown to inhibit signaling induced by bacterial lipopeptide or lipopolysaccharide (LPS), yet the mechanisms responsible for the inhibition of Toll-like receptor (TLR) signaling by OxPAPC remain incompletely understood. Here, we examined the mechanisms by which OxPAPC inhibits TLR signaling induced by diverse ligands in macrophages, smooth muscle cells, and epithelial cells. OxPAPC inhibited tumor necrosis factor-alpha production, I kappa B alpha degradation, p38 MAPK phosphorylation, and NF-kappa B-dependent reporter activation induced by stimulants of TLR2 and TLR4 (Pam(3)CSK(4) and LPS) but not by stimulants of other TLRs (poly(I.C), flagellin, loxoribine, single-stranded RNA, or CpG DNA) in macrophages and HEK-293 cells transfected with respective TLRs and significantly reduced inflammatory responses in mice injected subcutaneously or intraperitoneally with Pam(3)CSK(4). Serum proteins, including CD14 and LPS-binding protein, were identified as key targets for the specificity of TLR inhibition as supplementation with excess serum or recombinant CD14 or LBP reversed TLR2 inhibition by OxPAPC, whereas serum accessory proteins or expression of membrane CD14 potentiated signaling via TLR2 and TLR4 but not other TLRs. Binding experiments and functional assays identified MD2 as a novel additional target of OxPAPC inhibition of LPS signaling. Synthetic phospholipid oxidation products 1-palmitoyl-2-(5-oxovaleryl)-sn-glycero-3-phosphocholine and 1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine inhibited TLR2 signaling from similar to 30 mu M. Taken together, these results suggest that oxidized phospholipid-mediated inhibition of TLR signaling occurs mainly by competitive interaction with accessory proteins that interact directly with bacterial lipids to promote signaling via TLR2 or TLR4.	[Erridge, Clett; Spickett, Corinne M.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G1 1XW, Lanark, Scotland; [Kennedy, Simon] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Webb, David J.] Univ Edinburgh, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Strathclyde; University of Glasgow; University of Edinburgh	Erridge, C (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G1 1XW, Lanark, Scotland.	clett.erridge@strath.ac.uk		Spickett, Corinne Michelle/0000-0003-4054-9279; Kennedy, Simon/0000-0003-0887-5840; Erridge, Clett/0000-0003-2978-346X	British Heart Foundation [FS/03/97]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (FS/03/97). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003; Berliner J, 2002, VASC PHARMACOL, V38, P187, DOI 10.1016/S1537-1891(02)00168-4; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bowie AG, 1997, J BIOL CHEM, V272, P25941, DOI 10.1074/jbc.272.41.25941; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; DELAHOOKE DM, 1995, INFECT IMMUN, V63, P840, DOI 10.1128/IAI.63.3.840-846.1995; Erridge C, 2007, REDOX REP, V12, P76, DOI 10.1179/135100007X162121; Erridge C, 2007, ATHEROSCLEROSIS, V193, P77, DOI 10.1016/j.atherosclerosis.2006.08.032; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Hsu YW, 2001, J IMMUNOL, V166, P5388, DOI 10.4049/jimmunol.166.9.5388; JOSEPH CK, 1994, J BIOL CHEM, V269, P17606; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Larbi A, 2004, EXP GERONTOL, V39, P551, DOI 10.1016/j.exger.2003.10.031; Lee H, 2000, CIRC RES, V87, P516; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Reddy S, 2001, J BIOL CHEM, V276, P17030, DOI 10.1074/jbc.M011663200; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Tobias P, 2005, J LIPID RES, V46, P404, DOI 10.1194/jlr.R400015-JLR200; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tsuneyoshi N, 2006, CELL IMMUNOL, V244, P57, DOI 10.1016/j.cellimm.2007.02.010; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Walton KA, 2006, J LIPID RES, V47, P1967, DOI 10.1194/jlr.M600060-JLR200; Wang PY, 1996, J INFLAMM, V47, P126; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810	53	172	177	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24748	24759		10.1074/jbc.M800352200	http://dx.doi.org/10.1074/jbc.M800352200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18559343	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000258820000043
J	Becker, R; Loll, B; Meinhart, A				Becker, Roland; Loll, Bernhard; Meinhart, Anton			Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl- terminal domain of RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CRYPTIC UNSTABLE TRANSCRIPTS; CAPPING ENZYME; YEAST; BINDING; RECOGNITION; INTERACTS; SNORNA; IICTD; NRD1	Concomitant with RNA polymerase II (Pol II) transcription, RNA maturation factors are recruited to the carboxyl- terminal domain (CTD) of Pol II, whose phosphorylation state changes during a transcription cycle. CTD phosphorylation triggers recruitment of functionally different factors involved in RNA processing and transcription termination; most of these factors harbor a conserved CTD interacting domain (CID). Orchestration of factor recruitment is believed to be conducted by CID recognition of distinct phosphorylated forms of the CTD. We show that the human RNA processing factor SCAF8 interacts weakly with the unphosphorylated CTD of Pol II. Upon phosphorylation, affinity for the CTD is increased; however, SCAF8 is promiscuous to the phosphorylation pattern on the CTD. Employing a combined structural and biophysical approach, we were able to distinguish motifs within CIDs that are involved in a generic CTD sequence recognition from items that confer phospho-specificity.	[Becker, Roland; Loll, Bernhard; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Meinhart, A (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	Anton.Meinhart@mpimf-heidelberg.mpg.de	Meinhart, Anton/M-9647-2014; Becker, Roland/AAD-6900-2020; Loll, Bernhard/J-4815-2019	Loll, Bernhard/0000-0001-7928-4488				Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; DAHMUS ME, 1995, BBA-GENE STRUCT EXPR, V1261, P171, DOI 10.1016/0167-4781(94)00233-S; DeLano W, 2002, PYMOL 0 99; Efron B., 1982, SOC IND APPL MATH CB, V38; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hausmann S, 2005, J BIOL CHEM, V280, P37681, DOI 10.1074/jbc.M505292200; Hirose Y, 2000, GENE DEV, V14, P1415; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Ho CK, 1998, J BIOL CHEM, V273, P9577, DOI 10.1074/jbc.273.16.9577; Hollingworth D, 2006, RNA, V12, P555, DOI 10.1261/rna.2304506; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Liu PD, 2008, MOL BIOL EVOL, V25, P719, DOI 10.1093/molbev/msn017; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; SUZUKI M, 1989, J MOL BIOL, V207, P61, DOI 10.1016/0022-2836(89)90441-5; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; WEST ML, 1995, GENETICS, V140, P1223; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZHANG J, 1991, J BIOL CHEM, V266, P2297; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	62	44	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22659	22669		10.1074/jbc.M803540200	http://dx.doi.org/10.1074/jbc.M803540200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550522	Green Published, hybrid			2022-12-27	WOS:000258321000035
J	Fukuda, K; Watanabe, T; Tokisue, T; Tsujita, T; Nishikawa, S; Hasegawa, T; Seya, T; Matsumoto, M				Fukuda, Kotaro; Watanabe, Tomoya; Tokisue, Takashi; Tsujita, Tadayuki; Nishikawa, Satoshi; Hasegawa, Tsunemi; Seya, Tsukasa; Matsumoto, Misako			Modulation of double-stranded RNA recognition by the N-terminal histidine-rich region of the human toll-like receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-BETA INDUCTION; CPG-DNA; PH; DOMAIN; LOCALIZATION; ECTODOMAIN; ADAPTER	Toll- like receptors (TLRs) are an essential component of the innate immune response to microbial pathogens. TLR3 is localized in intracellular compartments, such as endosomes, and initiates signals in response to virus- derived double-strandedRNA (dsRNA). The TLR3 ectodomain (ECD), which is implicated in dsRNA recognition, is a horseshoe-shaped solenoid composed of 23 leucine- rich repeats (LRRs). Recent mutagenesis studies on the TLR3 ECD revealed that TLR3 activation depends on a single binding site on the nonglycosylated surface in the C-terminal region, comprising H539 and several asparagines within LRR17 to -20. TLR3 localization within endosomes is required for ligand recognition, suggesting that acidic pH is the driving force for TLR3 ligand binding. To elucidate the pH- dependent binding mechanism of TLR3 at the structural level, we focused on three highly conserved histidine residues clustered at the N-terminal region of the TLR3 ECD: His(39) in the N-cap region, His(60) in LRR1, and His(108) in LRR3. Mutagenesis of these residues showed that His(39), His(60), and His(108) were essential for ligand-dependent TLR3 activation in a cell- based assay. Furthermore, dsRNA binding to recombinant TLR3 ECD depended strongly on pH and dsRNA length and was reduced by mutation of His(39), His(60), and His(108), demonstrating that TLR3 signaling is initiated from the endosome through a pH- dependent binding mechanism, and that a second dsRNA binding site exists in the N-terminal region of the TLR3 ECD characteristic solenoid. We propose a novel model for the formation of TLR3 ECD dimers complexed with dsRNA, which incorporates this second binding site.	[Fukuda, Kotaro; Watanabe, Tomoya; Tokisue, Takashi; Hasegawa, Tsunemi] Yamagata Univ, Dept Mat & Biol Chem, Fac Sci, Yamagata 9908560, Japan; [Tsujita, Tadayuki; Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nishikawa, Satoshi] Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba, Ibaraki 3058566, Japan	Yamagata University; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST)	Fukuda, K (corresponding author), Yamagata Univ, Dept Mat & Biol Chem, Fac Sci, Yamagata 9908560, Japan.	kotaro.f@sci.kj.yamagata-u.ac.jp	Seya, Tsukasa/A-4336-2012; Tsujita, Tadayuki/AAH-2347-2019; 美佐子, 松本/A-4497-2012	Tsujita, Tadayuki/0000-0002-7189-0376; 				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; DOI T, 1994, J BIOL CHEM, V269, P25598; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Okahira S, 2005, DNA CELL BIOL, V24, P614, DOI 10.1089/dna.2005.24.614; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Takada E, 2007, MOL IMMUNOL, V44, P3633, DOI 10.1016/j.molimm.2007.04.021; Tsujita T, 2004, J BIOL CHEM, V279, P48588, DOI 10.1074/jbc.M407634200; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	25	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22787	22794		10.1074/jbc.M802284200	http://dx.doi.org/10.1074/jbc.M802284200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18544529	hybrid			2022-12-27	WOS:000258321000046
J	Brooks, WS; Helton, ES; Banerjee, S; Venable, M; Johnson, L; Schoeb, TR; Kesterson, RA; Crawford, DF				Brooks, William S.; Helton, E. Scott; Banerjee, Sami; Venable, Melanie; Johnson, Larry; Schoeb, Trenton R.; Kesterson, Robert A.; Crawford, David F.			G2E3 is a dual function ubiquitin ligase required for early embryonic development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; PROMOTING COMPLEX; GENE-EXPRESSION; PROTEIN; MICE; DOMAIN; PROLIFERATION; INACTIVATION; DEGRADATION; DISRUPTION	G2E3 is a putative ubiquitin ligase (E3) identified in a microarray screen for mitotic regulatory proteins. It shuttles between the cytoplasm and nucleus, concentrating in nucleoli and relocalizing to the nucleoplasm in response to DNA damage. In this study, we demonstrate that G2E3 is an unusual ubiquitin ligase that is essential in early embryonic development to prevent apopotic death. This protein has a catalytically inactive HECT domain and two distinct RING-like ubiquitin ligase domains that catalyze lysine 48-linked polyubiquitination. To address in vivo function, we generated a knock-out mouse model of G2E3 deficiency that incorporates a beta-galactosidase reporter gene under control of the endogenous promoter. Animals heterozygous for G2E3 inactivation are phenotypically normal with no overt change in development, growth, longevity, or fertility, whereas G2E3 null embryos die prior to implantation. Although normal numbers of G2E3(-/-) blastocysts are present at embryonic day 3.5, these blastocysts involute in culture as a result of massive apoptosis. Using beta-galactosidase staining as a marker for protein expression, we demonstrate that G2E3 is predominantly expressed within the central nervous system and the early stages of limb bud formation of the developing embryo. In adult animals, the most intense staining is found in Purkinje cell bodies and cells lining the ductus deferens. In summary, G2E3 is a dual function ubiquitin ligase essential for prevention of apoptosis in early embryogenesis.	[Brooks, William S.; Helton, E. Scott; Crawford, David F.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35233 USA; [Johnson, Larry; Schoeb, Trenton R.; Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA; [Banerjee, Sami; Crawford, David F.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA; [Venable, Melanie] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Crawford, DF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 940 Stanton L Young Blvd,BMSB 311, Oklahoma City, OK 73104 USA.	david-crawford@ouhsc.edu			NATIONAL CANCER INSTITUTE [K08CA086941, P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NCI NIH HHS [K08CA86941, P30 CA13148] Funding Source: Medline; NIAMS NIH HHS [P30 AR48311, P30 AR048311] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allen RT, 1997, J PHARMACOL TOX MET, V37, P215, DOI 10.1016/S1056-8719(97)00033-6; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Artus J, 2008, MOL CELL ENDOCRINOL, V282, P78, DOI 10.1016/j.mce.2007.11.008; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Banerjee S, 2007, ONCOGENE, V26, P6509, DOI 10.1038/sj.onc.1210471; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Brooks WS, 2007, EXP CELL RES, V313, P665, DOI 10.1016/j.yexcr.2006.11.020; Brown EJ, 2000, GENE DEV, V14, P397; Chaudhry MA, 2002, ONCOGENE, V21, P1934, DOI 10.1038/sj.onc.1205264; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Crawford DF, 2001, J BIOL CHEM, V276, P37166, DOI 10.1074/jbc.M103414200; D'Andrea AD, 2003, GENE DEV, V17, P1933, DOI 10.1101/gad.1128303; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Figueroa J, 1998, CHROMOSOMA, V107, P397, DOI 10.1007/s004120050323; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Liu QH, 2000, GENE DEV, V14, P1448; LIU Z, 1992, J BIOL CHEM, V267, P15829; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Nabetani A, 2001, CHROMOSOMA, V110, P322, DOI 10.1007/s004120100153; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Scheel H, 2003, TRENDS CELL BIOL, V13, P285, DOI 10.1016/S0962-8924(03)00102-8; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shedden K, 2002, P NATL ACAD SCI USA, V99, P4379, DOI 10.1073/pnas.062569899; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shi W, 2003, GENETICS, V165, P1869; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xiao JH, 2002, BIOCHEM BIOPH RES CO, V291, P101, DOI 10.1006/bbrc.2002.6396; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	58	28	31	6	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22304	22315		10.1074/jbc.M803238200	http://dx.doi.org/10.1074/jbc.M803238200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18511420	Green Published, hybrid			2022-12-27	WOS:000258114700049
J	Sun, H; Greathouse, DV; Andersen, OS; Koeppe, RE				Sun, Haiyan; Greathouse, Denise V.; Andersen, Olaf S.; Koeppe, Roger E., II			The preference of tryptophan for membrane interfaces - Insights from n-methylation of tryptophans in gramicidin channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE ION-CHANNEL; ACID SIDE-CHAINS; LIPID-BILAYER; SINGLE-CHANNEL; 3-DIMENSIONAL STRUCTURE; HYDROPHOBIC PEPTIDES; MAGNETIC-RESONANCE; CIRCULAR-DICHROISM; LINEAR GRAMICIDINS; CONFORMATION	To better understand the structural and functional roles of tryptophan at the membrane/water interface in membrane proteins, we examined the structural and functional consequences of Trp -> 1-methyl-tryptophan substitutions in membrane-spanning gramicidin A channels. Gramicidin A channels are miniproteins that are anchored to the interface by four Trps near the C terminus of each subunit in a membrane-spanning dimer. We masked the hydrogen bonding ability of individual or multiple Trps by 1-methylation of the indole ring and examined the structural and functional changes using circular dichroism spectroscopy, size exclusion chromatography, solid state H-2 NMR spectroscopy, and single channel analysis. N-Methylation causes distinct changes in the subunit conformational preference, channel-forming propensity, single channel conductance and lifetime, and average indole ring orientations within the membrane-spanning channels. The extent of the local ring dynamic wobble does not increase, and may decrease slightly, when the indole NH is replaced by the non-hydrogen-bonding and more bulky and hydrophobic N-CH3 group. The changes in conformational preference, which are associated with a shift in the distribution of the aromatic residues across the bilayer, are similar to those observed previously with Trp -> Phe substitutions. We conclude that indole N-H hydrogen bonding is of major importance for the folding of gramicidin channels. The changes in ion permeability, however, are quite different for Trp -> Phe and Trp -> 1-methyl-tryptophan substitutions, indicating that the indole dipole moment and perhaps also ring size and are important for ion permeation through these channels.	[Sun, Haiyan; Greathouse, Denise V.; Koeppe, Roger E., II] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Andersen, Olaf S.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	University of Arkansas System; University of Arkansas Fayetteville; Cornell University	Andersen, OS (corresponding author), 119 Chem Bldg, Fayetteville, AR 72701 USA.	sparre@med.cornell.edu; rk2@uark.edu		Greathouse, Denise/0000-0001-7104-8499; Koeppe, Roger/0000-0003-0676-6413	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070971, T32GM007739] Funding Source: NIH RePORTER; NCRR NIH HHS [RR15569] Funding Source: Medline; NIGMS NIH HHS [R01 GM070971, GM70971] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRIBAT G, 1970, CR ACAD SCI C CHIM, V271, P1029; Andersen Olaf S., 2007, P33, DOI 10.1007/0-387-68919-2_2; Andersen Olaf S., 2007, V400, P543; ANDERSEN OS, 1983, BIOPHYS J, V41, P119, DOI 10.1016/S0006-3495(83)84414-2; Andersen OS, 1998, J AM CHEM SOC, V120, P5142, DOI 10.1021/ja980182l; ARSENIEV AS, 1986, BIOL MEMBRANY, V3, P1077; Ashrafuzzaman M, 2006, J PHYS-CONDENS MAT, V18, pS1235, DOI 10.1088/0953-8984/18/28/S08; BAK B, 1967, ACTA CHEM SCAND, V21, P1674, DOI 10.3891/acta.chem.scand.21-1674; BAK B, 1969, ACTA CHEM SCAND, V23, P3051, DOI 10.3891/acta.chem.scand.23-3051; BANO MD, 1988, J CHROMATOGR, V458, P105; BECKER MD, 1991, BIOCHEMISTRY-US, V30, P8830, DOI 10.1021/bi00100a015; Bouchard M, 2000, BIOPHYS J, V78, P1010, DOI 10.1016/S0006-3495(00)76659-8; Burkhart BM, 1998, P NATL ACAD SCI USA, V95, P12950, DOI 10.1073/pnas.95.22.12950; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Busath DD, 1998, BIOPHYS J, V75, P2830, DOI 10.1016/S0006-3495(98)77726-4; Cole CD, 2002, BIOPHYS J, V83, P1974, DOI 10.1016/S0006-3495(02)73959-3; Cotten M, 1997, BIOPHYS J, V73, P614, DOI 10.1016/S0006-3495(97)78097-4; Cotten M, 1999, BIOCHEMISTRY-US, V38, P9185, DOI 10.1021/bi982981m; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; DURKIN JT, 1992, BIOPHYS J, V62, P145, DOI 10.1016/S0006-3495(92)81801-5; DURKIN JT, 1990, J MOL BIOL, V211, P221, DOI 10.1016/0022-2836(90)90022-E; FONSECA V, 1992, BIOCHEMISTRY-US, V31, P5340, DOI 10.1021/bi00138a014; GALL CM, 1981, J AM CHEM SOC, V103, P5039, DOI 10.1021/ja00407a012; Greathouse D V, 1999, Methods Enzymol, V294, P525; GREATHOUSE DV, 1994, BIOCHEMISTRY-US, V33, P4291, DOI 10.1021/bi00180a025; Greathouse DV, 2001, J PEPT RES, V57, P519, DOI 10.1034/j.1399-3011.2001.00849.x; HEITZ F, 1986, BIOPHYS CHEM, V24, P143, DOI 10.1016/0301-4622(86)80007-2; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; HU W, 1995, BIOCHEMISTRY-US, V34, P14138, DOI 10.1021/bi00043a019; HU W, 1995, BIOCHEMISTRY-US, V34, P14147, DOI 10.1021/bi00043a020; Jordan JB, 2006, BIOCHEMISTRY-US, V45, P14012, DOI 10.1021/bi061560z; Jude AR, 1999, BIOCHEMISTRY-US, V38, P1030, DOI 10.1021/bi982043m; KACHEL K, 1995, BIOCHEMISTRY-US, V34, P15475, DOI 10.1021/bi00047a012; KETCHEM RR, 1993, SCIENCE, V261, P1457, DOI 10.1126/science.7690158; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; KILLIAN JA, 1992, BIOCHEMISTRY-US, V31, P11283, DOI 10.1021/bi00161a004; KILLIAN JA, 1988, BIOCHEMISTRY-US, V27, P4848, DOI 10.1021/bi00413a040; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Koeppe RE, 2000, BIOCHEMISTRY-US, V39, P2235, DOI 10.1021/bi9920679; Koeppe RE, 2003, J AM CHEM SOC, V125, P12268, DOI 10.1021/ja035052d; KOEPPE RE, 1990, BIOCHEMISTRY-US, V29, P512, DOI 10.1021/bi00454a027; KOEPPE RE, 1992, PROTEINS, V12, P49, DOI 10.1002/prot.340120107; KOEPPE RE, 1994, BIOPHYS J, V66, P14, DOI 10.1016/S0006-3495(94)80748-9; Koeppe RE, 2007, J GEN PHYSIOL, V130, P223, DOI 10.1085/jgp.200709829; LANGS DA, 1988, SCIENCE, V241, P188, DOI 10.1126/science.2455345; LOGRASSO PV, 1988, BIOPHYS J, V54, P259, DOI 10.1016/S0006-3495(88)82955-2; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; MATTICE GL, 1995, BIOCHEMISTRY-US, V34, P6827, DOI 10.1021/bi00020a029; MAZET JL, 1984, BIOPHYS J, V45, P263, DOI 10.1016/S0006-3495(84)84153-3; McClellan A. L., 1963, TABLES EXPT DIPOLE M, P280; Mobashery N, 1997, FEBS LETT, V412, P15, DOI 10.1016/S0014-5793(97)00709-6; Norman KE, 2006, BIOPHYS J, V91, P2046, DOI 10.1529/biophysj.105.080275; OCONNELL AM, 1990, SCIENCE, V250, P1256, DOI 10.1126/science.1700867; Persson S, 1998, BIOPHYS J, V75, P1365, DOI 10.1016/S0006-3495(98)74054-8; Pulay P, 2005, J AM CHEM SOC, V127, P17488, DOI 10.1021/ja054935x; RUSSELL EWB, 1986, BIOPHYS J, V49, P673, DOI 10.1016/S0006-3495(86)83694-3; Salom D, 1998, BIOCHEMISTRY-US, V37, P14279, DOI 10.1021/bi980733k; Samanta U, 2000, PROTEINS, V38, P288, DOI 10.1002/(SICI)1097-0134(20000215)38:3<288::AID-PROT5>3.3.CO;2-Z; SAWYER DB, 1989, BIOCHEMISTRY-US, V28, P6571, DOI 10.1021/bi00442a007; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Sham SS, 2003, BIOCHEMISTRY-US, V42, P1401, DOI 10.1021/bi0204286; SIEBER P, 1987, TETRAHEDRON LETT, V28, P6147, DOI 10.1016/S0040-4039(00)61832-4; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; Townsley LE, 2001, BIOCHEMISTRY-US, V40, P11676, DOI 10.1021/bi010942w; TURNER GL, 1983, BIOCHIM BIOPHYS ACTA, V756, P133, DOI 10.1016/0304-4165(83)90083-1; van der Wel PCA, 2007, BIOCHEMISTRY-US, V46, P7514, DOI 10.1021/bi700082v; van der Wel PCA, 2002, BIOPHYS J, V83, P1479, DOI 10.1016/S0006-3495(02)73918-0; VEATCH WR, 1974, BIOCHEMISTRY-US, V13, P5249, DOI 10.1021/bi00723a001; Wallace BA, 1999, ADV EXP MED BIOL, V467, P789; WALLACE BA, 1981, BIOCHEMISTRY-US, V20, P5754, DOI 10.1021/bi00523a018; WIMLEY WC, 1993, BIOCHEMISTRY-US, V32, P6307, DOI 10.1021/bi00076a001; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	75	79	80	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22233	22243		10.1074/jbc.M802074200	http://dx.doi.org/10.1074/jbc.M802074200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550546	hybrid, Green Published			2022-12-27	WOS:000258114700043
J	Teghanemt, A; Widstrom, RL; Gioannini, TL; Weiss, JP				Teghanemt, Athmane; Widstrom, Richard L.; Gioannini, Theresa L.; Weiss, Jerrold P.			Isolation of monomeric and dimeric secreted MD-2 - Endotoxin.sCD14 and Toll-like receptor 4 ectodomain selectively react with the monomeric form of secreted MD-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; CRYSTAL-STRUCTURE; CELL ACTIVATION; LIPOPOLYSACCHARIDE RESPONSIVENESS; NEISSERIA-MENINGITIDIS; GM2-ACTIVATOR PROTEIN; BINDING PROTEIN; SOLUBLE MD-2; COMPLEXES; CD14	Potent cell activation by endotoxin requires sequential protein-endotoxin and protein-protein interactions involving lipopolysaccharide-binding protein, CD14, MD-2, and Toll-like receptor 4 (TLR4). MD-2 plays an essential role by bridging endotoxin (E) recognition initiated by lipopolysaccharide-binding protein and CD14 to TLR4 activation by presenting endotoxin as a monomeric E .MD-2 complex that directly and potently activates TLR4. Secreted MD-2 (sMD-2) exists as a mixture of monomers and multimers. Published data suggest that only MD-2 monomer can interact with endotoxin and TLR4 and support cell activation, but the apparent instability of MD-2 has thwarted efforts to more fully separate and characterize the individual species of sMD-2. We have taken advantage of the much greater stability of sMD-2 in insect culture medium to fully separate sMD-2 monomer from dimer by gel sieving chromatography. At low nanomolar concentrations, the sMD-2 monomer, but not dimer, reacted with a monomeric complex of E . sCD14 to form monomeric E . MD-2 and activate HEK293/TLR4 cells. The monomer, but not dimer, also reacted with the ectodomain of TLR4 with an affinity comparable with the picomolar affinity of E . MD-2. These findings demonstrate directly that the monomeric form of sMD-2 is the active species both for reaction with E . CD14 and TLR4, as needed for potent endotoxin-induced TLR4 activation.	[Teghanemt, Athmane; Widstrom, Richard L.; Gioannini, Theresa L.; Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Dept Internal Med, Iowa City, IA 52242 USA; [Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Dept Microbiol, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Dept Biochem, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Weiss, JP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, 2501 Crosspark Rd, Coralville, IA 52241 USA.	jerrold-weiss@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485	NIAID NIH HHS [AI59372, R01 AI059372, P01 AI044642] Funding Source: Medline; PHS HHS [P0144642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372, P01AI044642] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Re F, 2002, J BIOL CHEM, V277, P23427, DOI 10.1074/jbc.M202554200; Shi XZ, 2007, CURR DRUG TARGETS, V8, P1116, DOI 10.2174/138945007782151360; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Teghanemt A, 2007, J BIOL CHEM, V282, P36250, DOI 10.1074/jbc.M705995200; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Viriyakosol S, 2006, J BIOL CHEM, V281, P11955, DOI 10.1074/jbc.M511627200; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Viriyakosol S, 2006, HYBRIDOMA, V25, P349, DOI 10.1089/hyb.2006.25.349; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Wright CS, 2005, BIOCHEMISTRY-US, V44, P13510, DOI 10.1021/bi050668w; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200	37	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21881	21889		10.1074/jbc.M800672200	http://dx.doi.org/10.1074/jbc.M800672200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18519568	Green Published, hybrid			2022-12-27	WOS:000258114700007
J	Johnston, CA; Afshar, K; Snyder, JT; Tall, GG; Gonczy, P; Siderovski, DP; Willard, FS				Johnston, Christopher A.; Afshar, Katayoun; Snyder, Jason T.; Tall, Gregory G.; Goenczy, Pierre; Siderovski, David P.; Willard, Francis S.			Structural determinants underlying the temperature-sensitive nature of a G alpha mutant in asymmetric cell division of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; DISSOCIATION INHIBITOR ACTIVITY; GTPASE-ACTIVATING PROTEINS; C-ELEGANS; GOLOCO MOTIF; CRYSTAL-STRUCTURE; 2.0 ANGSTROM; EMBRYOS; G(I-ALPHA-1); SUBUNITS	Heterotrimeric G-proteins are integral to a conserved regulatory module that influences metazoan asymmetric cell division (ACD). In the Caenorhabditis elegans zygote, GOA-1 (G alpha(o)) and GPA-16 (G alpha(i)) are involved in generating forces that pull on astral microtubules and position the spindle asymmetrically. GPA-16 function has been analyzed in vivo owing notably to a temperature-sensitive allele gpa-16(it143), which, at the restrictive temperature, results in spindle orientation defects in early embryos. Here we identify the structural basis of gpa-16(it143), which encodes a point mutation (G202D) in the switch II region of GPA-16. Using G alpha(i1)(G202D) as a model in biochemical analyses, we demonstrate that high temperature induces instability of the mutant G alpha. At the permissive temperature, the mutant G alpha was stable upon GTP binding, but switch II rearrangement was compromised, as were activation state-selective interactions with regulators involved in ACD, including GoLoco motifs, RGS proteins, and RIC-8. We solved the crystal structure of the mutant G alpha bound to GDP, which indicates a unique switch II conformation as well as steric constraints that suggest activated GPA-16(it143) is destabilized relative to wild type. Spindle severing in gpa-16(it143) embryos revealed that pulling forces are symmetric and markedly diminished at the restrictive temperature. Interestingly, pulling forces are asymmetric and generally similar in magnitude to wild type at the permissive temperature despite defects in the structure of GPA-16(it143). These normal pulling forces in gpa-16(it143) embryos at the permissive temperature were attributable to GOA-1 function, underscoring a complex interplay of G alpha subunit function in ACD.	[Johnston, Christopher A.; Snyder, Jason T.; Siderovski, David P.; Willard, Francis S.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Afshar, Katayoun; Goenczy, Pierre] Swiss Inst Expt Canc Res, CH-1066 Lausanne, Switzerland; [Goenczy, Pierre] Swiss Fed Inst Technol, Sch Life Sci, CH-1066 Lausanne, Switzerland; [Tall, Gregory G.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Rochester	Johnston, CA (corresponding author), 1106 M E Jones Bldg,CB 7365, Chapel Hill, NC 27599 USA.	dsiderov@med.unc.edu	Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Gonczy, Pierre/0000-0002-6305-6883	NIGMS NIH HHS [GM 076944, GM 074268] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076944, R01GM074268] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BRENNER S, 1974, GENETICS, V77, P71; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kimple RJ, 2003, COMB CHEM HIGH T SCR, V6, P399; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LINDER ME, 1990, J BIOL CHEM, V265, P8243; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Sarvazyan NA, 2002, BIOCHEMISTRY-US, V41, P12858, DOI 10.1021/bi026212l; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Snow BE, 2002, METHOD ENZYMOL, V344, P740; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Streiff J, 2004, ANESTH ANALG, V98, P660, DOI 10.1213/01.ANE.0000099367.97415.5F; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Willard FS, 2007, CELL SIGNAL, V19, P428, DOI 10.1016/j.cellsig.2006.07.013; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Willard FS, 2004, METHOD ENZYMOL, V389, P320; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	55	12	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21550	21558		10.1074/jbc.M803023200	http://dx.doi.org/10.1074/jbc.M803023200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18519563	Green Published, hybrid			2022-12-27	WOS:000257898800028
J	Lee, CW; Bhatt, S; Shukla, A; Desnoyer, RW; Yadav, SP; Kim, M; Jang, SH; Karnik, SS				Lee, ChangWoo; Bhatt, Sumantha; Shukla, Anita; Desnoyer, Russell W.; Yadav, Satya P.; Kim, Mijin; Jang, Sei-Heon; Karnik, Sadashiva S.			Site-specific cleavage of G protein-coupled receptor-engaged beta-arrestin - Influence of the AT(1) receptor conformation on scissile site selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASES; ANGIOTENSIN-II; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; ACTIVE-STATE; ACTIVATION; PHOSPHORYLATION; BETA-ARRESTIN-2; INTERNALIZATION; MECHANISM	The discovery of beta-arrestin-related similar to 46-kDa polypeptide in transfected cells and mouse hearts led us to examine angiotensin II type 1 receptor (AT(1)R)-dependent proteolytic cleavage of beta-arrestin(s). Receptor-ligand induced proteolysis of beta-arrestin(s) is novel, especially in the endocrine system, since proteolytic and/or splice variants of nonvisual arrestins are unknown. We used a strategy to retrieve AT(1)R-engaged isoforms of beta-arrestin 1 to confirm direct interaction of fragments with this G protein-coupled receptor and determine cleavage sites. Here we show that the angiotensin II-AT(1)R complex is associated with full-length and similar to 46-kDa beta-arrestin forms. Mass spectrometric analysis of the AT(1)R-associated short form suggested a scissile site located within the Arg(363)-Arg(393) region in the bovine beta-arrestin 1. Edman degradation analysis of a beta-arrestin 1 C-terminal fragment fused to enhanced green fluorescent protein confirmed the major cleavage to be after Phe(388) and a minor cleavage after Asn(375). Rather unexpectedly, the inverse agonist EXP3174-bound AT(1)R generated different fragmentation of bovine beta-arrestin 1, at Pro(276). The angiotensin II-induced cleavage is independent of inositol 1,4,5-trisphosphateand Ca2+-mediated signaling pathways. The proteolysis of beta-arrestin 2 occurs, but the pattern is more complex. Our findings suggest that beta-arrestin cleavage upon AT(1)R stimulation is a part of the unraveling beta-arrestin-mediated G protein-coupled receptor signaling diversity.	[Karnik, Sadashiva S.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Lee, ChangWoo; Kim, Mijin; Jang, Sei-Heon] Daegu Univ, Dept Genet Engn, Gyongsan 712714, South Korea	Cleveland Clinic Foundation; Daegu University	Karnik, SS (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL064845, R01 HL057470, R01 HL 57470, R01 HL083243] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; AZARIAN SM, 1995, J BIOL CHEM, V270, P24375, DOI 10.1074/jbc.270.41.24375; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Diez J, 2006, CLIN THER, V28, P832, DOI 10.1016/j.clinthera.2006.06.002; Feng YH, 2005, HYPERTENSION, V46, P419, DOI 10.1161/01.HYP.0000172621.68061.22; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Groarke DA, 1999, J BIOL CHEM, V274, P23263, DOI 10.1074/jbc.274.33.23263; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Hudson CC, 2006, METHOD ENZYMOL, V414, P63, DOI 10.1016/S0076-6879(06)14005-7; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hupfeld CJ, 2005, J BIOL CHEM, V280, P1016, DOI 10.1074/jbc.M403674200; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; MENDELSON C, 1975, J BIOL CHEM, V250, P8818; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; PALCZEWSKI K, 1994, PROTEIN SCI, V3, P314; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Reid JL, 2005, J RENIN-ANGIO-ALDO S, V6, P15, DOI 10.3317/jraas.2005.002; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; SMITH WC, 1994, J BIOL CHEM, V269, P15407; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; TIMMERMANS PBMWM, 1991, HYPERTENSION, V18, pS136; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	36	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21612	21620		10.1074/jbc.M803062200	http://dx.doi.org/10.1074/jbc.M803062200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18505723	hybrid, Green Published			2022-12-27	WOS:000257898800034
J	Shan, B; Yao, TP; Nguyen, HT; Zhuo, Y; Levy, DR; Klingsberg, RC; Tao, H; Palmer, ML; Holder, KN; Lasky, JA				Shan, Bin; Yao, Tso-Pang; Nguyen, Hong T.; Zhuo, Ying; Levy, Dawn R.; Klingsberg, Ross C.; Tao, Hui; Palmer, Michael L.; Holder, Kevin N.; Lasky, Joseph A.			Requirement of HDAC6 for transforming growth factor-beta(1)-induced epithelial-mesenchymal transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; HISTONE DEACETYLASES; PULMONARY-FIBROSIS; ACTIVATION; RECEPTOR; IDENTIFICATION; POLYUBIQUITIN; ACETYLATION; EXPRESSION; INHIBITOR	The aberrant expression of transforming growth factor (TGF)-beta 1 in the tumor microenvironment and fibrotic lesions plays a critical role in tumor progression and tissue fibrosis by inducing epithelial-mesenchymal transition (EMT). EMT promotes tumor cell motility and invasiveness. How EMT affects motility and invasion is not well understood. Here we report that HDAC6 is a novel modulator of TGF-beta 1-induced EMT. HDAC6 is a microtubule-associated deacetylase that predominantly deacetylates nonhistone proteins, including alpha-tubulin, and regulates cell motility. We showed that TGF-beta 1-induced EMT is accompanied by HDAC6-dependent deacetylation of alpha-tubulin. Importantly, inhibition of HDAC6 by small interfering RNA or the small molecule inhibitor tubacin attenuated the TGF-alpha 1-induced EMT markers, such as the aberrant expression of epithelial and mesenchymal peptides, as well as the formation of stress fibers. Reduced expression of HDAC6 also impaired the activation of SMAD3 in response to TGF-beta 1. Conversely, inhibition of SMAD3 activation substantially impaired HDAC6-dependent deacetylation of alpha-tubulin as well as the expression of EMT markers. These findings reveal a novel function of HDAC6 in EMT by intercepting the TGF-beta-SMAD3 signaling cascade. Our results identify HDAC6 as a critical regulator of EMT and a potential therapeutic target against pathological EMT, a key event for tumor progression and fibrogenesis.	[Shan, Bin; Nguyen, Hong T.; Zhuo, Ying; Levy, Dawn R.; Klingsberg, Ross C.; Tao, Hui; Palmer, Michael L.; Holder, Kevin N.; Lasky, Joseph A.] Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; [Shan, Bin; Lasky, Joseph A.] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Yao, Tso-Pang] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Tulane University; Tulane University; Duke University	Shan, B (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	bshan@tulane.edu		Shan, Bin/0000-0002-6869-2678	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 007973, HL 083901] Funding Source: Medline; NINDS NIH HHS [R01 NS054022-03, R01 NS054022] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Birukova AA, 2005, FEBS LETT, V579, P4031, DOI 10.1016/j.febslet.2005.06.018; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Shan B, 2005, J BIOL CHEM, V280, P1103, DOI 10.1074/jbc.M406293200; Shan B, 2005, EXP CELL RES, V305, P10, DOI 10.1016/j.yexcr.2004.09.033; Shan B, 2003, J BIOL CHEM, V278, P44009, DOI 10.1074/jbc.M302671200; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200	36	124	134	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21065	21073		10.1074/jbc.M802786200	http://dx.doi.org/10.1074/jbc.M802786200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499657	hybrid, Green Published			2022-12-27	WOS:000257746100048
J	Choi, HC; Song, P; Xie, ZL; Wu, Y; Xu, J; Zhang, M; Dong, YZ; Wang, SX; Lau, K; Zou, MH				Choi, Hyoung Chul; Song, Ping; Xie, Zhonglin; Wu, Yong; Xu, Jian; Zhang, Miao; Dong, Yunzhou; Wang, Shuangxi; Lau, Kai; Zou, Ming-Hui			RETRACTED: Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo (Retracted article. See vol. 294, pg. 10742, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							CEREBRAL-ISCHEMIA; C-ZETA; LKB1; PEROXYNITRITE; SIMVASTATIN; EXPRESSION; APOPTOSIS; ATORVASTATIN; CHOLESTEROL; SUPPRESSION	The AMP-activated protein kinase (AMPK) is reported to mediate the beneficial effects of statin on the vascular functions, but the biochemical mechanisms are incompletely understood. The aim of the study was to determine how statin activates AMPK. Exposure of confluent bovine aortic endothelial cells to simvastatin (statin) dose-dependently increased phosphorylation of AMPK at Thr(172) and activities of AMPK, which was in parallel with increased detection of both LKB1 phosphorylation at Ser(428) and LKB1 nuclear export. Furthermore, statin treatment was shown to increase protein kinase C (PKC)-zeta activity and PKC-zeta phosphorylation at Thr(410)/Thr(403). Consistently, inhibition of PKC-zeta either by pharmacological or genetic manipulations abolished statin-enhanced LKB1 phosphorylation at Ser428, blocked LKB1 nucleus export, and prevented the subsequent activation of AMPK. Similarly, in vivo transfection of PKC-zeta-specific small interfering RNA in C57BL/6J mice significantly attenuated statin-enhanced phosphorylation of AMPK-Thr(172), acetyl-CoA carboxylase (ACC)-Ser(79), and LKB1-Ser(428). In addition, statin significantly increased reactive oxygen species, whereas preincubation of mito-TEMPOL, a superoxide dismutase mimetic, abolished statin-enhanced phosphorylation of both AMPK-Thr(172) and ACC-Ser(79). Finally, in vivo administration of statin increased 3-nitrotyrosine and the phosphorylation of AMPK and ACC in C57BL/6J mice but not in mice deficient in endothelial nitric-oxide synthase. Taken together, our data suggest thatAMPKactivation by statin is peroxynitrite-mediated but PKC-zeta-dependent.	[Choi, Hyoung Chul; Song, Ping; Xie, Zhonglin; Wu, Yong; Xu, Jian; Zhang, Miao; Dong, Yunzhou; Wang, Shuangxi; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Endocrinol Sect, Oklahoma City, OK 73104 USA; [Lau, Kai] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Nephrol Sect, Oklahoma City, OK 73104 USA; [Choi, Hyoung Chul] Yeungnam Univ, Coll Med, Dept Pharmacol, Taegu 705717, South Korea	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Yeungnam University	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabetes, BSEB 325, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Song, Ping/N-8456-2018; Song, Ping/D-6972-2011	Song, Ping/0000-0002-6143-4270; Song, Ping/0000-0002-2654-6162	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL080499, R01HL110488, T32HL007439, R01HL079584, R01HL096032, R01HL105157] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL096032, R01 HL079584, HL 07439, R01 HL074399, HL 089220, HL 080499, R01 HL110488, R01 HL105157, R01 HL080499, HL 079584] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Cahoon WD, 2007, ANN PHARMACOTHER, V41, P1687, DOI 10.1345/aph.1K248; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Delbosc S, 2002, HYPERTENSION, V40, P142, DOI 10.1161/01.HYP.0000024348.87637.6F; Dilaveris P, 2007, CURR VASC PHARMACOL, V5, P227; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Stefanec T, 2000, CHEST, V117, P841, DOI 10.1378/chest.117.3.841; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Wagner AH, 2000, ARTERIOSCL THROM VAS, V20, P61, DOI 10.1161/01.ATV.20.1.61; Warnholtz A, 2004, BIOCHEM SOC SYMP, V71, P121; Wassmann S, 2001, MOL PHARMACOL, V59, P646, DOI 10.1124/mol.59.3.646; Wenzel P, 2008, ATHEROSCLEROSIS, V198, P65, DOI 10.1016/j.atherosclerosis.2007.10.003; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Xenos ES, 2005, ANN VASC SURG, V19, P386, DOI 10.1007/s10016-005-0011-7; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2004, ENDOTHELIUM-J ENDOTH, V11, P89, DOI 10.1080/10623320490482619; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x; Zou MH, 2007, PROSTAG OTH LIPID M, V82, P119, DOI 10.1016/j.prostaglandins.2006.05.005	41	80	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20186	20197		10.1074/jbc.M803020200	http://dx.doi.org/10.1074/jbc.M803020200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18474592	hybrid, Green Published			2022-12-27	WOS:000257565300035
J	Ishida, H; Borman, MA; Ostrander, J; Vogel, HJ; MacDonald, JA				Ishida, Hiroaki; Borman, Meredith A.; Ostrander, Janina; Vogel, Hans J.; MacDonald, Justin A.			Solution structure of the calponin homology (CH) domain from the smoothelin-like 1 protein - A unique apocalmodulin-binding mode and the possible role of the C-terminal type-2 CH-domain in smooth muscle relaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING; IQ MOTIF; CALMODULIN-BINDING; MYOSIN-V; F-ACTIN; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; NMR; CONTRACTILITY	The SMTNL1 protein contains a single type-2 calponin homology (CH) domain at its C terminus that shares sequence identity with the smoothelin family of smooth muscle-specific proteins. In contrast to the smoothelins, SMTNL1 does not associate with F-actin in vitro, and its specific role in smooth muscle remains unclear. In addition, the biological function of the C-terminal CH-domains found in the smoothelin proteins is also poorly understood. In this work, we have therefore determined the solution structure of the CH-domain of mouse SMTNL1 (SMTNL1-CH; residues 346-459). The secondary structure and the overall fold for the C-terminal type-2 CH-domain is very similar to that of other CH-domains. However, two clusters of basic residues form a unique surface structure that is characteristic of SMTNL1-CH. Moreover, the protein has an extended C-terminal alpha-helix, which contains a calmodulin (CaM)-binding IQ-motif, that is also a distinct feature of the smoothelins. We have characterized the binding of apo-CaM to SMTNL1-CH through its IQ-motif by isothermal titration calorimetry and NMR chemical shift perturbation studies. In addition, we have used the HADDOCK protein-protein docking approach to construct a model for the complex of apo-CaM and SMTNL1-CH. The model revealed a close interaction of SMTNL1-CH with the two Ca2+ binding loop regions of the C-terminal domain of apo-CaM; this mode of apo-CaM binding is distinct from previously reported interactions of apo-CaM with IQ-motifs. Finally, we comment on the putative role of the CH-domain in the biological function of SMTNL1.	[Ishida, Hiroaki; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 4N1, Canada; [Borman, Meredith A.; Ostrander, Janina; MacDonald, Justin A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	MacDonald, JA (corresponding author), Univ Calgary, Fac Med, Libin Cardiovasc Inst Alberta, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jmacdo@ucalgary.ca		MacDonald, Justin/0000-0002-9238-8473				ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; Borrego-Diaz E, 2006, J STRUCT BIOL, V155, P230, DOI 10.1016/j.jsb.2006.01.013; Bramham J, 2002, STRUCTURE, V10, P249, DOI 10.1016/S0969-2126(02)00703-7; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CASTRESANA J, 1995, FEBS LETT, V374, P149, DOI 10.1016/0014-5793(95)01098-Y; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cui YF, 2003, ANAL BIOCHEM, V315, P175, DOI 10.1016/S0003-2697(03)00007-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickerson JB, 2006, BRAIN RES, V1092, P16, DOI 10.1016/j.brainres.2006.03.048; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; ITAKURA M, 1992, J BIOCHEM, V112, P183, DOI 10.1093/oxfordjournals.jbchem.a123875; JARRETT HW, 1995, J BIOL CHEM, V270, P5578, DOI 10.1074/jbc.270.10.5578; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KOLAKOWSKI J, 1995, BIOCHEM J, V306, P199; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Li QW, 2004, BIOCHEM BIOPH RES CO, V317, P787, DOI 10.1016/j.bbrc.2004.03.119; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Nakashima K, 1996, BIOCHEMISTRY-US, V35, P5602, DOI 10.1021/bi952586l; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Quensel C, 2002, J CELL BIOCHEM, V85, P403, DOI 10.1002/jcb.10143; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SOBEL JS, 1988, DEV BIOL, V126, P47, DOI 10.1016/0012-1606(88)90237-0; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; Sun HB, 2006, J BIOMOL NMR, V36, P295, DOI 10.1007/s10858-006-9062-5; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Szymanski PT, 2004, J MUSCLE RES CELL M, V25, P7, DOI 10.1023/B:JURE.0000021349.47697.bf; TAKAHASHI K, 1986, BIOCHEM BIOPH RES CO, V141, P20, DOI 10.1016/S0006-291X(86)80328-X; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; Tsvetkov PO, 1999, J BIOL CHEM, V274, P18161, DOI 10.1074/jbc.274.26.18161; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; WINDER SJ, 1993, BIOCHEMISTRY-US, V32, P13327, DOI 10.1021/bi00211a046; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	56	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20569	20578		10.1074/jbc.M800627200	http://dx.doi.org/10.1074/jbc.M800627200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18477568	hybrid			2022-12-27	WOS:000257565300069
J	Kim, JW; Song, PI; Jeong, MH; An, JH; Lee, SY; Jang, SM; Song, KH; Armstrong, CA; Choi, KH				Kim, Jung-Woong; Song, Peter I.; Jeong, Mi-Hee; An, Joo-Hee; Lee, So-Youn; Jang, Sang-Min; Song, Ki-Hyun; Armstrong, Cheryl A.; Choi, Kyung-Hee			TIP60 represses transcriptional activity of p73 beta via an MDM2-bridged ternary complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; DNA-DAMAGE; RECEPTOR COACTIVATOR; P53-RELATED PROTEIN; VIRAL ONCOPROTEINS; ANDROGEN RECEPTOR; P73; P53; APOPTOSIS; ACETYLATION	TIP60, a histone acetyl transferase, acts as a p53 coactivator by interfering with MDM2-mediated degradation of p53. However, little is known about its functional regulation of p73, which has structural features similar to p53. In this study we found that TIP60 represses apoptosis, which is induced by exogenous and endogenous p73 beta. TIP60 also negatively regulated the expression of p73 beta downstream target genes such as p21 and Bax. Moreover, the specific repression of p73 beta-mediated transactivation by TIP60 was independent of p53 expression and not due to histone deacetylase recruiting transcriptional machinery. Transcriptional activities of both p73splicing variants, p73 alpha and p73 beta, were also repressed by TIP60. Furthermore, TIP60 markedly enhanced p73 beta binding affinity to MDM2 and physically associated with MDM2 through its zinc finger domain, which is specifically localized in the nucleus. Therefore, we demonstrate that TIP60 forms a ternary complex with p73 beta, which is directly bridged by MDM2. It is important to note that our findings contribute to a functional linkage between TIP60 and p73 beta through MDM2 in the transcriptional regulation of cellular apoptosis.	[Kim, Jung-Woong; Jeong, Mi-Hee; An, Joo-Hee; Lee, So-Youn; Jang, Sang-Min; Song, Ki-Hyun; Choi, Kyung-Hee] Chung Ang Univ, Dept Life Sci, Dongjak Ku, Seoul 156756, South Korea; [Song, Peter I.; Armstrong, Cheryl A.] Univ Colorado, Hlth Sci Ctr, Dept Dermatol, Aurora, CO 80045 USA	Chung Ang University; University of Colorado System; University of Colorado Anschutz Medical Campus	Choi, KH (corresponding author), Chung Ang Univ, Dept Life Sci, Dongjak Ku, 221 Heuksuk Dong, Seoul 156756, South Korea.	khchoi@cau.ac.kr						Ai W, 2007, NUCLEIC ACIDS RES, V35, P6137, DOI 10.1093/nar/gkm656; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Coates PJ, 2006, J PATHOL, V210, P385, DOI 10.1002/path.2080; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hlubek F, 2001, J BIOCHEM-TOKYO, V129, P635, DOI 10.1093/oxfordjournals.jbchem.a002901; Jeong MH, 2006, J BIOL CHEM, V281, P8707, DOI 10.1074/jbc.M513853200; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kang KH, 2002, FEBS LETT, V522, P161, DOI 10.1016/S0014-5793(02)02921-6; Kim KC, 2001, ONCOGENE, V20, P6689, DOI 10.1038/sj.onc.1204839; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Liu L, 1999, MOL CELL BIOL, V19, P1202; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Oberst A, 2005, BIOCHEM BIOPH RES CO, V331, P707, DOI 10.1016/j.bbrc.2005.03.158; Ongkeko WM, 1999, CURR BIOL, V9, P829, DOI 10.1016/S0960-9822(99)80367-4; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Roth J, 1999, J GEN VIROL, V80, P3251, DOI 10.1099/0022-1317-80-12-3251; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Wang JD, 2008, BBA-MOL CELL RES, V1783, P224, DOI 10.1016/j.bbamcr.2007.09.004; Watson IR, 2006, J BIOL CHEM, V281, P34096, DOI 10.1074/jbc.M603654200; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhu JH, 1998, CANCER RES, V58, P5061	42	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20077	20086		10.1074/jbc.M800161200	http://dx.doi.org/10.1074/jbc.M800161200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499675	hybrid			2022-12-27	WOS:000257565300024
J	Musiek, ES; Brooks, JD; Joo, M; Brunoldi, E; Porta, A; Zanoni, G; Vidari, G; Blackwell, TS; Montine, TJ; Milne, GL; McLaughlin, B; Morrow, JD				Musiek, Erik S.; Brooks, Joshua D.; Joo, Myungsoo; Brunoldi, Enrico; Porta, Alessio; Zanoni, Giuseppe; Vidari, Giovanni; Blackwell, Timothy S.; Montine, Thomas J.; Milne, Ginger L.; McLaughlin, BethAnn; Morrow, Jason D.			Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; LIPID-PEROXIDATION; ALZHEIMER-DISEASE; F-RING; EXPRESSION; GAMMA; FISH; INFLAMMATION; ISOPROSTANES; MOUSE	The omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) possesses potent anti-inflammatory properties and has shown therapeutic benefit in numerous inflammatory diseases. However, the molecular mechanisms of these anti-inflammatory properties are poorly understood. DHA is highly susceptible to peroxidation, which yields an array of potentially bioactive lipid species. One class of compounds are cyclopentenone neuroprostanes (A(4)/J(4)-NPs), which are highly reactive and similar in structure to anti-inflammatory cyclopentenone prostaglandins. Here we show that a synthetic A(4)/J(4)-NP, 14-A(4)-NP (A(4)-NP), potently suppresses lipopolysaccharide-induced expression of inducible nitric-oxide synthase and cyclooxygenase-2 in macrophages. Furthermore, A(4)-NP blocks lipopolysaccharide-induced NF-kappa B activation via inhibition of I kappa kinase-mediated phosphorylation of I kappa B alpha. Mutation on I kappa kinase beta cysteine 179 markedly diminishes the effect of A(4)-NP, suggesting that A(4)-NP acts via thiol modification at this residue. Accordingly, the effects of A(4)-NP are independent of peroxisome proliferator-activated receptor-gamma and are dependent on an intact reactive cyclopentenone ring. Interestingly, free radical-mediated oxidation of DHA greatly enhances its anti-inflammatory potency, an effect that closely parallels the formation of A(4)/J(4)-NPs. Furthermore, chemical reduction or conjugation to glutathione, both of which eliminate the bioactivity of A(4)-NP, also abrogate the anti-inflammatory effects of oxidized DHA. Thus, we have demonstrated that A(4)/J(4)-NPs, formed via the oxidation of DHA, are potent inhibitors of NF-kappa B signaling and may contribute to the antiinflammatory actions of DHA. These findings have implications for understanding the anti-inflammatory properties of omega-3 fatty acids, and elucidate novel interactions between lipid peroxidation products and inflammation.	[Musiek, Erik S.; Brooks, Joshua D.; Milne, Ginger L.; Morrow, Jason D.] Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Div Pulm & Crit Care Med, Nashville, TN 37232 USA; [McLaughlin, BethAnn] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Joo, Myungsoo; Brunoldi, Enrico; Porta, Alessio; Zanoni, Giuseppe; Vidari, Giovanni] Univ Pavia, Dept Organ Chem, I-27100 Pavia, Italy; [Montine, Thomas J.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Pavia; University of Washington; University of Washington Seattle	Morrow, JD (corresponding author), Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, 536 RRB,2222 Pierce Ave, Nashville, TN 37232 USA.	jason.morrow@vanderbilt.edu	McLaughlin, BethAnn/D-9580-2012; Milne, Ginger/D-7648-2014	McLaughlin, BethAnn/0000-0003-0228-6500; Milne, Ginger/0000-0003-3890-151X; Musiek, Erik/0000-0002-8873-0360; PORTA, ALESSIO/0000-0002-2564-9696; Vidari, Giovanni/0000-0003-4606-2154	NCI NIH HHS [CA 77839] Funding Source: Medline; NIDDK NIH HHS [DK 48831] Funding Source: Medline; NIEHS NIH HHS [ES 13125] Funding Source: Medline; NIGMS NIH HHS [GM 15431] Funding Source: Medline; NINDS NIH HHS [R01 NS050396, R01 NS050396-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050396] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATSMON J, 1990, CANCER RES, V50, P1879; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Blackwell TS, 2000, AM J RESP CRIT CARE, V162, P1095, DOI 10.1164/ajrccm.162.3.9906129; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; Fam SS, 2002, J BIOL CHEM, V277, P36076, DOI 10.1074/jbc.M205638200; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; GONZALEZ MJ, 1992, J NUTR, V122, P2190, DOI 10.1093/jn/122.11.2190; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Komatsu W, 2003, FREE RADICAL BIO MED, V34, P1006, DOI 10.1016/S0891-5849(03)00027-3; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Massaro M, 2006, P NATL ACAD SCI USA, V103, P15184, DOI 10.1073/pnas.0510086103; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; Milne GL, 2004, CHEM RES TOXICOL, V17, P17, DOI 10.1021/tx034213o; Montine TJ, 2005, AM J PATHOL, V166, P1283, DOI 10.1016/S0002-9440(10)62347-4; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; MORROW JD, 1994, J BIOL CHEM, V269, P4317; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Musiek ES, 2004, J CHROMATOGR B, V799, P95, DOI 10.1016/j.jchromb.2003.10.036; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; Perez-Sala D, 2002, ANN NY ACAD SCI, V973, P533, DOI 10.1111/j.1749-6632.2002.tb04695.x; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Reich EE, 2001, AM J PATHOL, V158, P293, DOI 10.1016/S0002-9440(10)63968-5; Reich EE, 2000, BIOCHEMISTRY-US, V39, P2376, DOI 10.1021/bi992000l; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Volker D, 2000, J RHEUMATOL, V27, P2343; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zanoni G, 2007, J ORG CHEM, V72, P9698, DOI 10.1021/jo701719f	43	111	121	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19927	19935		10.1074/jbc.M803625200	http://dx.doi.org/10.1074/jbc.M803625200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18490445	hybrid, Green Published			2022-12-27	WOS:000257565300008
J	Swietach, P; Wigfield, S; Cobden, P; Supuran, CT; Harris, AL; Vaughan-Jones, RD				Swietach, Pawel; Wigfield, Simon; Cobden, Philip; Supuran, Claudiu T.; Harris, Adrian L.; Vaughan-Jones, Richard D.			Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-IX; CYTOPLASMIC PH; CA-IX; HYPOXIA; EXPRESSION; CARCINOMA; MARKER; OXYGEN; CELLS; PROLIFERATION	CA9 is a membrane-tethered, carbonic anhydrase (CA) enzyme, expressed mainly at the external surface of cells, that catalyzes reversible CO2 hydration. Expression is greatly enhanced in many tumors, particularly in aggressive carcinomas. The functional role of CA9 in tumors is not well established. Here we show that CA9, when expressed heterologously in cultured spheroids (0.5-mm diameter, similar to 25,000 cells) of RT112 cells (derived from bladder carcinoma), induces a near-uniform intracellular pH (pH(i)) throughout the structure. Dynamic pH(i) changes during displacements of superfusate CO2 concentration are also spatially coincident (within 2 s). In contrast, spheroids of wild-type RT112 cells lacking CA9 exhibit an acidic core (similar to 0.25 pH(i) reduction) and significant time delays (similar to 9 s) for pH(i) changes in core versus peripheral regions. pH(i) non-uniformity also occurs in CA9-expressing spheroids after selective pharmacological inhibition of the enzyme. In isolated RT112 cells, pH(i) regulation is unaffected by CA9 expression. The influence of CA9 on pH(i) is thus only evident in multicellular tissue. Diffusion-reaction modeling indicates that CA9 coordinates pH(i) spatially by facilitating CO2 diffusion in the unstirred extracellular space of the spheroid. We suggest that pH(i) coordination may favor survival and growth of a tumor. By disrupting spatial pH(i) control, inhibition of CA9 activity may offer a novel strategy for the clinical treatment of CA9-associated tumors.	[Swietach, Pawel; Cobden, Philip; Vaughan-Jones, Richard D.] Burdon Sanderson Cardiac Sci Ctr, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Wigfield, Simon; Harris, Adrian L.] Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Supuran, Claudiu T.] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy	University of Oxford; University of Oxford; University of Florence	Vaughan-Jones, RD (corresponding author), Burdon Sanderson Cardiac Sci Ctr, Dept Physiol Anat & Genet, Oxford OX1 3PT, England.	richard.vaughan-jones@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020; Supuran, Claudiu T/A-5151-2008; Harris, Adrian L/ABA-3343-2020	Swietach, Pawel/0000-0002-9945-9473; Harris, Adrian L/0000-0003-1376-8409; Supuran, Claudiu/0000-0003-4262-0323	British Heart Foundation Funding Source: Medline; Cancer Research UK Funding Source: Medline; Medical Research Council [G0700698] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; CARLSSON J, 1988, INT J CANCER, V42, P715, DOI 10.1002/ijc.2910420515; Casey JR, 2004, J MED CHEM, V47, P2337, DOI 10.1021/jm031079w; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Generali D, 2006, ENDOCR-RELAT CANCER, V13, P921, DOI 10.1677/erc.1.01216; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Giatromanolaki A, 2001, CANCER RES, V61, P7992; GILLIES R J, 1992, Cellular Physiology and Biochemistry, V2, P159, DOI 10.1159/000154638; Griffiths J R, 2001, Novartis Found Symp, V240, P46; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; HEMING TA, 1994, J APPL PHYSIOL, V77, P697, DOI 10.1152/jappl.1994.77.2.697; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; HOLM E, 1995, CANCER RES, V55, P1373; ISFORT RJ, 1993, EUR J BIOCHEM, V213, P349, DOI 10.1111/j.1432-1033.1993.tb17768.x; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; Kivela AJ, 2001, DIGEST DIS SCI, V46, P2179, DOI 10.1023/A:1011910931210; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Lee AH, 1998, CANCER RES, V58, P1901; Leek RD, 2005, CANCER RES, V65, P4147, DOI 10.1158/0008-5472.CAN-04-2184; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Leem CH, 1998, J PHYSIOL-LONDON, V509, P471, DOI 10.1111/j.1469-7793.1998.471bn.x; Lin TY, 2008, AM J PHYSIOL-CELL PH, V294, pC1250, DOI 10.1152/ajpcell.00021.2008; Loncaster JA, 2001, CANCER RES, V61, P6394; Lu J, 2006, J BIOL CHEM, V281, P19241, DOI 10.1074/jbc.M602181200; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; MUSGROVE E, 1987, EXP CELL RES, V172, P65, DOI 10.1016/0014-4827(87)90093-0; Olive PL, 2001, CANCER RES, V61, P8924; Parkkila S, 2000, P NATL ACAD SCI USA, V97, P2220, DOI 10.1073/pnas.040554897; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; TEICHER BA, 1993, ANTICANCER RES, V13, P1549; VAUPEL P, 1989, CANCER RES, V49, P6449; Wingo T, 2001, BIOCHEM BIOPH RES CO, V288, P666, DOI 10.1006/bbrc.2001.5824; Wykoff CC, 2000, CANCER RES, V60, P7075	48	176	180	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20473	20483		10.1074/jbc.M801330200	http://dx.doi.org/10.1074/jbc.M801330200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482982	hybrid			2022-12-27	WOS:000257565300061
J	Yao, HJ; Li, PX; Venters, BJ; Zheng, S; Thompson, PR; Pugh, BF; Wang, YM				Yao, Hongjie; Li, Pingxin; Venters, Bryan J.; Zheng, Suting; Thompson, Paul R.; Pugh, B. Franklin; Wang, Yanming			Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLATION; STRUCTURAL-CHARACTERIZATION; TRANSCRIPTIONAL ACTIVATION; GROWTH INHIBITOR; PROTEIN; GENE; DEIMINATION; DEATH; METHYLTRANSFERASE; NUCLEOPHOSMIN/B23	Protein Arg methyltransferases function as coactivators of the tumor suppressor p53 to regulate gene expression. Peptidylarginine deiminase 4 (PAD4/PADI4) counteracts the functions of protein Arg methyltransferases in gene regulation by deimination and demethylimination. Here we show that the expression of a tumor suppressor gene, OKL38, is activated by the inhibition of PAD4 or the activation of p53 following DNA damage. Chromatin immunoprecipitation assays showed a dynamic change of p53 and PAD4 occupancy and histone Arg modifications at the OKL38 promoter during DNA damage, suggesting a direct role of PAD4 and p53 in the expression of OKL38. Furthermore, we found that OKL38 induces apoptosis through localization to mitochondria and induction of cytochrome c release. Together, our studies identify OKL38 as a novel p53 target gene that is regulated by PAD4 and plays a role in apoptosis.	[Yao, Hongjie; Li, Pingxin; Venters, Bryan J.; Zheng, Suting; Pugh, B. Franklin; Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA; [Thompson, Paul R.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Wang, YM (corresponding author), 332 S Frear, University Pk, PA 16802 USA.	yuw12@psu.edu	Zheng, Suting/B-7382-2013	Wang, Yanming/0000-0002-0710-043X	NCI NIH HHS [R01 CA136856] Funding Source: Medline; NIGMS NIH HHS [R01 GM079357, R01 GM079357-02, GM 079357] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA136856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079357] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Huynh H, 2001, ENDOCRINOLOGY, V142, P3607, DOI 10.1210/en.142.8.3607; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LI P, 2008, MOL CELL BI IN PRESS; Li RS, 2007, J LIPID RES, V48, P709, DOI 10.1194/jlr.M600501-JLR200; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mund C, 2006, EPIGENETICS-US, V1, P7; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okada M, 2007, J BIOL CHEM, V282, P36744, DOI 10.1074/jbc.M706169200; Ong CK, 2007, ONCOGENE, V26, P1155, DOI 10.1038/sj.onc.1209896; Ong CK, 2004, ENDOCRINOLOGY, V145, P4763, DOI 10.1210/en.2004-0446; Ong CK, 2004, J BIOL CHEM, V279, P743, DOI 10.1074/jbc.M308668200; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang T, 2005, J BIOL CHEM, V280, P4374, DOI 10.1074/jbc.M408708200; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	43	108	111	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20060	20068		10.1074/jbc.M802940200	http://dx.doi.org/10.1074/jbc.M802940200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499678	Green Published, hybrid			2022-12-27	WOS:000257565300022
J	Bjorkblom, B; Vainio, JC; Hongisto, V; Herdegen, T; Courtney, MJ; Coffey, ET				Bjorkblom, Benny; Vainio, Jenni C.; Hongisto, Vesa; Herdegen, Thomas; Courtney, Michael J.; Coffey, Eleanor T.			All JNKs can kill, but nuclear localization is critical for neuronal death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASES; C-JUN PHOSPHORYLATION; CEREBELLAR GRANULE NEURONS; TRANSCRIPTION FACTOR; SYMPATHETIC NEURONS; INDUCED APOPTOSIS; BRAIN-DEVELOPMENT; STRESS; PATHWAY	JNKs are implicated in a range of brain pathologies and receive considerable attention as potential therapeutic targets. However, JNKs also regulate physiological and homeostatic processes. Anattractive hypothesis from the drug development perspective is that distinct JNK isoforms mediate "physiological" and "pathological" responses. However, this lacks experimental evaluation. Here we investigate the isoforms, subcellular pools, and c-Jun/ATF2 targets of JNK in death of central nervous system neurons following withdrawal of trophic support. We use gene knockouts, gene silencing, subcellularly targeted dominant negative constructs, and pharmacological inhibitors. Combined small interfering RNA knockdown of all JNKs 1, 2, and 3, provides substantial neuroprotection. In contrast, knockdown or knock-out of individual JNKs or two JNKs together does not protect. This explains why the evidence for JNK in neuronal death has to date been largely pharmacological. Complete knockdown of c-Jun and ATF2 using small interfering RNA also fails to protect, casting doubt on c-Jun as a critical effector of JNK in neuronal death. Nonetheless, the death requires nuclear but not cytosolic JNK activity as nuclear dominant negative inhibitors of JNK protect, whereas cytosolic inhibitors only block physiological JNK function. Thus any one of the three JNKs is capable of mediating apoptosis and inhibition of nuclear JNK is protective.	[Coffey, Eleanor T.] Univ Turku, Turku Ctr Biotechnol, Abo Akad, FIN-20521 Turku, Finland; [Bjorkblom, Benny; Vainio, Jenni C.; Hongisto, Vesa; Courtney, Michael J.; Coffey, Eleanor T.] Abo Akad Univ, FIN-20521 Turku, Finland; [Herdegen, Thomas] Inst Pharmacol, D-24105 Kiel, Germany; [Courtney, Michael J.] Univ Kuopio, Dept Neurobiol, AI Virtanen Inst, FIN-70211 Kuopio, Finland	Abo Akademi University; University of Turku; Abo Akademi University; University of Eastern Finland	Coffey, ET (corresponding author), Univ Turku, Turku Ctr Biotechnol, Abo Akad, Tykistokatu 6, FIN-20521 Turku, Finland.	ecoffey@btk.fi	Courtney, Michael J/D-6648-2016; herdegen, thomas/E-5135-2010	Courtney, Michael J/0000-0001-8693-3933; Coffey, Eleanor/0000-0002-9717-5610				Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Besirli CG, 2005, J CELL BIOL, V170, P401, DOI 10.1083/jcb.200501138; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Brazil M, 2003, NAT REV DRUG DISCOV, V2, P5, DOI 10.1038/nrd993; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Eilers A, 1998, J NEUROSCI, V18, P1713; Eminel S, 2004, J BIOL CHEM, V279, P55385, DOI 10.1074/jbc.M405858200; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HERR I, 1994, CARCINOGENESIS, V15, P1105, DOI 10.1093/carcin/15.6.1105; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Hu YH, 1997, J BIOL CHEM, V272, P9113; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100; Keramaris E, 2005, J BIOL CHEM, V280, P1132, DOI 10.1074/jbc.M410127200; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nielsen C, 2007, CANCER RES, V67, P178, DOI 10.1158/0008-5472.CAN-06-2801; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Resnick L, 2004, DRUG DISCOV TODAY, V9, P932, DOI 10.1016/S1359-6446(04)03251-9; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Ui M, 1998, FEBS LETT, V429, P289, DOI 10.1016/S0014-5793(98)00618-8; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; Virdee K, 1997, J NEUROCHEM, V69, P550; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Watson A, 1998, J NEUROSCI, V18, P751; Westerlund N, 2008, EXPERT OPIN THER TAR, V12, P31, DOI 10.1517/14728222.12.1.31; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	45	70	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19704	19713		10.1074/jbc.M707744200	http://dx.doi.org/10.1074/jbc.M707744200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18474608	hybrid, Green Published			2022-12-27	WOS:000257387600055
J	Izquierdo, JM				Izquierdo, Jose M.			Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENT; BINDING-PROTEIN; IMMUNE-SYSTEM; ELAV PROTEIN; TIA-1; DIFFERENTIATION; EXPRESSION; PTB; STABILIZATION; REPRESSION	Exclusion of exon 6 by alternative RNA splicing of the primary transcript of the apoptosis receptor Fas produces a soluble isoform that prevents programmed cell death. I report that antiapoptotic regulator Hu antigen R (HuR, ELAVL1), a member of the embryonic lethal, abnormal vision, Drosophila-like (ELAVL) family, promotes Fas exon 6 skipping by binding to an exonic splicing silencer. HuR inhibits the association of U2 small nuclear ribonucleoprotein (snRNP) auxiliary factor 65 kDa (U2AF65) with the upstream 3' splice site, without decreasing recognition of the downstream 5' splice site by U1 snRNP but by antagonizing the role of TIA-1 (T-cell intracellular antigen 1)/TIAR (TIA-1 related protein) on exon definition. Remarkably, U1 snRNP-mediated recognition of the 5' splice site is partially required for efficient U2AF65 inhibition. Further, the silencing capacity of HuR as splicing regulator resides in the RRM1 and hinge-RRM3 domains. Taken together, these results support a functional link between HuR as repressor of alternative Fas splicing and the molecular mechanisms modulating programmed cell death.	Univ Autonoma Madrid, Dept Mol Biol, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Izquierdo, JM (corresponding author), Univ Autonoma Madrid, Dept Mol Biol, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain.	jmizquierdo@cbm.uam.es		Izquierdo, Jose M/0000-0002-7942-4046				Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Atasoy U, 1998, J CELL SCI, V111, P3145; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gao FB, 1996, J CELL SCI, V109, P579; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Inoue M, 2000, NUCLEIC ACIDS RES, V28, P1743, DOI 10.1093/nar/28.8.1743; Isquierdo JM, 2006, BIOCHEM BIOPH RES CO, V348, P703, DOI 10.1016/j.bbrc.2006.7.114; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2007, J BIOL CHEM, V282, P19410, DOI 10.1074/jbc.M700688200; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; McAlinden A, 2007, J BIOL CHEM, V282, P24444, DOI 10.1074/jbc.M702717200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Zhu H, 2003, MOL CELL BIOL, V23, P5959, DOI 10.1128/MCB.23.17.5959-5971.2003; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07; Zhu H, 2006, MOL BIOL CELL, V17, P5105, DOI 10.1091/mbc.E06-02-0099; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; Zuccato E, 2004, J BIOL CHEM, V279, P16980, DOI 10.1074/jbc.M313439200	45	108	110	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19077	19084		10.1074/jbc.M800017200	http://dx.doi.org/10.1074/jbc.M800017200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18463097	hybrid			2022-12-27	WOS:000257165600063
J	Sun, W; Parry, S; Panico, M; Morris, HR; Kjellberg, M; Engstrom, A; Dell, A; Schedin-Weiss, S				Sun, Wei; Parry, Simon; Panico, Maria; Morris, Howard R.; Kjellberg, Margareta; Engstrom, Ake; Dell, Anne; Schedin-Weiss, Sophia			N-glycans and the N terminus of protein C inhibitor affect the cofactor-enhanced rates of thrombin inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING; HUMAN-PLASMA; THROMBOMODULIN; COAGULATION; COMPLEX; ANTITHROMBIN; MECHANISM; SERPINS; GLYCOSYLATION; PURIFICATION	Protein C inhibitor (PCI) is a serine protease inhibitor, displaying broad protease specificity, found in blood and other tissues. In blood, it is capable of inhibiting both procoagulant and anticoagulant proteases. Mechanisms that provide specificity to PCI remain largely unrevealed. In this study we have for the first time provided a full explanation for the marked size heterogeneity of blood-derived PCI and identified functional differences between naturally occurring PCI variants. The heterogeneity was caused by differences in N-glycan structures, N-glycosylation occupancy, and the presence of a Delta 6-N-cleaved form. Bi-, tri-, and tetra-antennary complex N-glycans were identified. Fucose residues were identified both on the core GlcNAc and as parts of sialyl-Le(a/x) epitopes. Moreover, a glycan with a composition that implied a di-sialyl antenna was observed. PCI was N-glycosylated at all three potential N-glycosylation sites, Asn-230, Asn-243, and Asn-319, but a small fraction of PCI lacked the N-glycan at Asn-243. The overall removal of N-glycans affected the maximal heparin- and thrombomodulin-enhanced rates of thrombin inhibition differently in different solution conditions. In contrast, the Delta 6-N-region increased both the heparin- and the thrombomodulin-enhanced rates of thrombin inhibition at all conditions examined. These results thus demonstrate that the N-linked glycans and the N-terminal region of blood-derived PCI in different ways affect the cofactor-enhanced rates of thrombin inhibition and provide information on the mechanisms by which this may be achieved. The findings are medically important, in view of the documented association of PCI with atherosclerotic plaques and the promising effect of PCI on reducing hypercoagulability states.	[Sun, Wei; Engstrom, Ake; Schedin-Weiss, Sophia] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Parry, Simon; Panico, Maria; Morris, Howard R.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Morris, Howard R.] M SCAN Ltd, Wokingham RG4 12TZ, Berks, England; [Kjellberg, Margareta] Lund Univ, Univ Hosp, Dept Clin Chem, SE-20502 Malmo, Sweden	Uppsala University; Imperial College London; Lund University; Skane University Hospital	Schedin-Weiss, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	Sophia.Schedin_Weiss@imbim.uu.se		Schedin Weiss, Sophia/0000-0003-2143-7052	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; Di Cera E, 2007, PHYS CHEM CHEM PHYS, V9, P1292, DOI 10.1039/b616819a; ECKE S, 1992, ANN NY ACAD SCI, V667, P84, DOI 10.1111/j.1749-6632.1992.tb51601.x; Elisen MGLM, 1996, THROMB HAEMOSTASIS, V75, P760; Fortenberry YM, 2007, J THROMB HAEMOST, V5, P1486, DOI 10.1111/j.1538-7836.2007.02574.x; Fujita M, 2000, THROMB HAEMOSTASIS, V84, P54; Fujita M, 2002, THROMB RES, V105, P95, DOI 10.1016/S0049-3848(01)00398-X; Geiger M, 1996, IMMUNOPHARMACOLOGY, V32, P53, DOI 10.1016/0162-3109(96)00013-6; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hayashi T, 2007, J THROMB HAEMOST, V5, P1477, DOI 10.1111/j.1538-7836.2007.02594.x; Izutani W, 2001, THROMB RES, V104, P65, DOI 10.1016/S0049-3848(01)00342-5; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; KAZAMA Y, 1987, THROMB RES, V48, P179, DOI 10.1016/0049-3848(87)90414-2; Krebs M, 1999, J INVEST DERMATOL, V113, P32, DOI 10.1046/j.1523-1747.1999.00644.x; KUHN LA, 1990, P NATL ACAD SCI USA, V87, P8506, DOI 10.1073/pnas.87.21.8506; LAURELL M, 1988, THROMB HAEMOSTASIS, V60, P334; LAURELL M, 1989, THROMB HAEMOSTASIS, V62, P885; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Li W, 2007, J BIOL CHEM, V282, P13759, DOI 10.1074/jbc.M701074200; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; Medzihradszky KF, 2005, METHOD ENZYMOL, V405, P116, DOI 10.1016/S0076-6879(05)05006-8; Nishii Y, 2006, J THROMB HAEMOST, V4, P2331, DOI 10.1111/j.1538-7836.2006.02174.x; OLSON ST, 1988, J BIOL CHEM, V263, P1698; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Pike RN, 2002, IUBMB LIFE, V54, P1, DOI 10.1080/15216540213825; Pineda AO, 2002, J BIOL CHEM, V277, P32015, DOI 10.1074/jbc.M205009200; PRATT CW, 1992, J BIOL CHEM, V267, P8789; REZAIE AR, 1995, J BIOL CHEM, V270, P25336, DOI 10.1074/jbc.270.43.25336; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; SPIK G, 1991, European Journal of Biochemistry, V195, P397, DOI 10.1111/j.1432-1033.1991.tb15719.x; Strandberg K, 2000, BIOCHEMISTRY-US, V39, P15713, DOI 10.1021/bi001640h; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; Strukova S, 2006, FRONT BIOSCI-LANDMRK, V11, P59, DOI 10.2741/1780; SUZUKI K, 1983, J BIOL CHEM, V258, P163; SUZUKI K, 1984, SEMIN THROMB HEMOST, V10, P154, DOI 10.1055/s-2007-1004418; Yang LK, 2003, J BIOL CHEM, V278, P37465, DOI 10.1074/jbc.M307243200	42	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18601	18611		10.1074/jbc.M800608200	http://dx.doi.org/10.1074/jbc.M800608200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18467335	hybrid			2022-12-27	WOS:000257165600016
J	Tomo, T; Kato, Y; Suzuki, T; Akimoto, S; Okubo, T; Noguchi, T; Hasegawa, K; Tsuchiya, T; Tanaka, K; Fukuya, M; Dohmae, N; Watanabe, T; Mimuro, M				Tomo, Tatsuya; Kato, Yuki; Suzuki, Takehiro; Akimoto, Seiji; Okubo, Tatsunori; Noguchi, Takumi; Hasegawa, Koji; Tsuchiya, Tohru; Tanaka, Kazunori; Fukuya, Michitaka; Dohmae, Naoshi; Watanabe, Tadashi; Mimuro, Mamoru			Characterization of highly purified photosystem I complexes from the chlorophyll d-dominated cyanobacterium Acaryochloris marina MBIC 11017	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY ELECTRON-DONOR; TIME-RESOLVED FLUORESCENCE; OXYGENIC PHOTOSYNTHETIC PROKARYOTE; GLOEOBACTER-VIOLACEUS PCC-7421; REACTION CENTERS; SPECIAL PAIR; PIGMENT COMPOSITION; CHARGE-DISTRIBUTION; ENERGY-TRANSFER; CORE ANTENNA	Photochemically active photosystem (PS) I complexes were purified from the chlorophyll (Chl) d-dominated cyanobacterium Acaryochloris marina MBIC 11017, and several of their properties were characterized. PS I complexes consist of 11 subunits, including PsaK1 and PsaK2; a new small subunit was identified and named Psa27. The new subunit might replace the function of PsaI that is absent in A. marina. The amounts of pigments per one molecule of Chld' were 97.0 +/- 11.0 Chl d, 1.9 +/- 0.5 Chl a, 25.2 +/- 2.4 alpha-carotene, and two phylloquinone molecules. The light-induced Fourier transform infrared difference spectroscopy and light-induced difference absorption spectra reconfirmed that the primary electron donor of PS I (P740) was the Chl d dimer. In addition to P740, the difference spectrum contained an additional band at 728 nm. The redox potentials of P740 were estimated to be 439mV by spectroelectrochemistry; thisvalue was comparable with the potential of P700 in other cyanobacteria and higher plants. This suggests that the overall energetics of the PS I reaction were adjusted to the electron acceptor side to utilize the lower light energy gained by P740. The distribution of charge in P740 was estimated by a density functional theory calculation, and a partial localization of charge was predicted to P1 Chl (special pair Chl on PsaA). Based on differences in the protein matrix and optical properties of P740, construction of the PS I core in A. marina was discussed.	[Tomo, Tatsuya; Tsuchiya, Tohru; Mimuro, Mamoru] Kyoto Univ, Dept Technol & Ecol, Kyoto 6068501, Japan; [Suzuki, Takehiro; Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Kato, Yuki; Watanabe, Tadashi] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Akimoto, Seiji] Kobe Univ, Mol Photosci Res Ctr, Kobe, Hyogo 6578501, Japan; [Akimoto, Seiji] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Okubo, Tatsunori; Noguchi, Takumi] Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Hasegawa, Koji] Advancesoft Corp, Tokyo 1070052, Japan; [Tsuchiya, Tohru; Mimuro, Mamoru] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Tanaka, Kazunori; Fukuya, Michitaka] Kobe Univ, Fac Sci, Kobe, Hyogo 6578501, Japan	Kyoto University; RIKEN; University of Tokyo; Kobe University; Kobe University; University of Tsukuba; Kyoto University; Kobe University	Tomo, T (corresponding author), Kyoto Univ, Dept Technol & Ecol, Kyoto 6068501, Japan.	tomo@z05.mbox.media.kyoto-u.ac.jp	Noguchi, Takumi/I-7105-2014; Tomo, Tatsuya/K-7680-2012; Dohmae, Naoshi/C-2040-2011; Suzuki, Takehiro/B-3210-2013	Tomo, Tatsuya/0000-0002-9369-1941; Dohmae, Naoshi/0000-0002-5242-9410; 				Akimoto S, 2005, CHEM PHYS LETT, V409, P167, DOI 10.1016/j.cplett.2005.05.006; Akiyama M, 2002, PHOTOSYNTH RES, V74, P97, DOI 10.1023/A:1020915506409; Akiyama M, 2001, ANAL SCI, V17, P205, DOI 10.2116/analsci.17.205; AKIYAMA M, 2004, JPN J PHYCOL, V52, P67; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Battistuzzi G, 1999, J AM CHEM SOC, V121, P501, DOI 10.1021/ja982126q; Benjamin B, 2007, PHOTOSYNTH RES, V91, P155; BOOTH PJ, 1990, BIOCHIM BIOPHYS ACTA, V1016, P141, DOI 10.1016/0005-2728(90)90053-7; Breton J, 1999, BIOCHEMISTRY-US, V38, P11585, DOI 10.1021/bi991216k; Breton J, 2001, BBA-BIOENERGETICS, V1507, P180, DOI 10.1016/S0005-2728(01)00206-7; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; CHITNIS PR, 1995, PHOTOSYNTH RES, V44, P23, DOI 10.1007/BF00018294; Cohen RO, 2004, BIOCHEMISTRY-US, V43, P4741, DOI 10.1021/bi035633f; Diaz-Quintana A, 2003, PHOTOSYNTH RES, V75, P97, DOI 10.1023/A:1022841513592; FRENCH CS, 1960, HDB PFLANZENPHYSIOLO, V5, P252; Frisch M.J., 2016, GAUSSIAN16 REV B01; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Fujimori T, 2005, J BIOL CHEM, V280, P22191, DOI 10.1074/jbc.M500369200; GOLBECK JH, 1992, ANNU REV PLANT PHYS, V43, P293, DOI 10.1146/annurev.pp.43.060192.001453; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; HASTINGS G, 1994, BIOCHEMISTRY-US, V33, P3193, DOI 10.1021/bi00177a008; HERVAS M, 1993, FEBS LETT, V319, P257, DOI 10.1016/0014-5793(93)80558-C; Holzwarth AR, 2006, BIOPHYS J, V90, P552, DOI 10.1529/biophysj.105.059824; Hu Q, 1998, P NATL ACAD SCI USA, V95, P13319, DOI 10.1073/pnas.95.22.13319; IDE JP, 1987, BIOCHIM BIOPHYS ACTA, V893, P349, DOI 10.1016/0005-2728(87)90056-9; IKEUCHI M, 1988, PLANT CELL PHYSIOL, V29, P1233; IKEUCHI M, 1988, FEBS LETT, V241, P99, DOI 10.1016/0014-5793(88)81039-1; Inoue H, 2004, FEBS LETT, V578, P275, DOI 10.1016/j.febslet.2004.11.013; Itoh S, 2007, BIOCHEMISTRY-US, V46, P12473, DOI 10.1021/bi7008085; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KATO Y, 2008, PHOTOSYNTHE IN PRESS; KE B, 2002, PHOTOSYNTHESIS PHOTO, P463; Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Kumazaki S, 2002, FEBS LETT, V530, P153, DOI 10.1016/S0014-5793(02)03446-4; LORKOVIC ZJ, 1995, P NATL ACAD SCI USA, V92, P8930, DOI 10.1073/pnas.92.19.8930; Lutz M., 1991, CHLOROPHYLLS, P855; Manning WM, 1943, J BIOL CHEM, V151, P1; Marquardt J, 1997, FEBS LETT, V410, P428, DOI 10.1016/S0014-5793(97)00631-5; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; Mi DH, 2003, J PHYS CHEM B, V107, P1452, DOI 10.1021/jp0268260; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Mimuro M, 2005, FEBS LETT, V579, P3493, DOI 10.1016/j.febslet.2005.05.029; Mimuro M, 2004, FEBS LETT, V556, P95, DOI 10.1016/S0014-5793(03)01383-8; Mimuro M, 1999, BBA-BIOENERGETICS, V1412, P37, DOI 10.1016/S0005-2728(99)00048-1; Mimuro M, 2007, BBA-BIOENERGETICS, V1767, P327, DOI 10.1016/j.bbabio.2007.02.012; Mino H, 2005, CHEM PHYS LETT, V411, P262, DOI 10.1016/j.cplett.2005.06.033; Miyachi S, 1997, Z NATURFORSCH C, V52, P636; Miyashita H, 1997, PLANT CELL PHYSIOL, V38, P274, DOI 10.1093/oxfordjournals.pcp.a029163; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Muhiuddin IP, 2001, FEBS LETT, V503, P56, DOI 10.1016/S0014-5793(01)02696-5; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Nakamura A, 2005, FEBS LETT, V579, P2273, DOI 10.1016/j.febslet.2005.02.076; Nakamura A, 2004, CHEM LETT, V33, P688, DOI 10.1246/cl.2004.688; Nakamura A, 2003, EUR J BIOCHEM, V270, P2446, DOI 10.1046/j.1432-1033.2003.03616.x; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Noguchi T, 1998, BIOCHEMISTRY-US, V37, P13614, DOI 10.1021/bi9812975; O'Connor D. V., 1984, TIME CORRELATED SING; Okubo T, 2007, BIOCHEMISTRY-US, V46, P4390, DOI 10.1021/bi700157n; OWENS TG, 1987, P NATL ACAD SCI USA, V84, P1532, DOI 10.1073/pnas.84.6.1532; Patzlaff JS, 1996, BIOCHEMISTRY-US, V35, P7802, DOI 10.1021/bi960056z; Ramesh VM, 2007, BBA-BIOENERGETICS, V1767, P151, DOI 10.1016/j.bbabio.2006.12.013; SANDERSON DG, 1986, BIOCHIM BIOPHYS ACTA, V852, P269, DOI 10.1016/0005-2728(86)90232-X; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shevela D, 2006, PHYS CHEM CHEM PHYS, V8, P3460, DOI 10.1039/b604389e; SIGFRIDSSON K, 1995, BBA-BIOENERGETICS, V1228, P28, DOI 10.1016/0005-2728(94)00158-2; Sivakumar V, 2003, BIOPHYS J, V85, P3162, DOI 10.1016/S0006-3495(03)74734-1; Sun J, 1998, METHOD ENZYMOL, V297, P124; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; Telfer A, 2007, PHOTOSYNTH RES, V91, P143; Tomo T, 2005, PHOTOSYNTH RES, V84, P77, DOI 10.1007/s11120-005-1302-0; Tomo T, 2007, P NATL ACAD SCI USA, V104, P7283, DOI 10.1073/pnas.0701847104; Tomo T, 2006, CHEM PHYS LETT, V423, P282, DOI 10.1016/j.cplett.2006.03.091; WATANABE T, 1984, ANAL CHEM, V56, P251, DOI 10.1021/ac00266a030; Webber AN, 2001, BBA-BIOENERGETICS, V1507, P61, DOI 10.1016/S0005-2728(01)00198-0; Yamasaki H, 2007, CHEM PHYS LETT, V447, P324, DOI 10.1016/j.cplett.2007.08.101	78	53	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					18198	18209		10.1074/jbc.M801805200	http://dx.doi.org/10.1074/jbc.M801805200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18458090	hybrid			2022-12-27	WOS:000256949200048
J	Reichard, JF; Sartor, MA; Puga, A				Reichard, John F.; Sartor, Maureen A.; Puga, Alvaro			BACH1 is a specific repressor of HMOX1 that is inactivated by arsenite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIALLY EXPRESSED GENES; ANTIOXIDANT RESPONSE ELEMENTS; MICROSOMAL HEME OXYGENASE; TRANSCRIPTION FACTOR NRF2; HUMAN SKIN FIBROBLASTS; LOCUS-CONTROL REGION; OXIDATIVE STRESS; ERYTHROID-DIFFERENTIATION; MICROARRAY EXPERIMENTS; BETA-GLOBIN	Intracellular heme is a redox active molecule that can be detrimental to cells at high concentrations or under oxidizing conditions. To prevent accumulation, the inducible enzyme heme oxygenase-1 (HMOX1) catalyzes degradation of heme. In the absence of elevated intracellular heme or oxidative stress, the basic region leucine zipper transcriptional regulator BACH1 binds HMOX1 antioxidant response elements and represses transcription. Conversely, increased intracellular heme or sulfhydryl oxidation inactivate BACH1, permitting transcriptional induction of HMOX1. Here, we investigate the effect of BACH1 inactivation on the induction of HMOX1 and as a mechanism for broader gene induction. We show that BACH1 is inactivated at low micromolar arsenite concentrations and that BACH1 inactivation is necessary and sufficient for transcriptional induction of HMOX1. Because BACH1 is thought to interact with antioxidant response element motifs, we further examined the role of BACH1 as a regulator of inducible antioxidant gene expression by assessing the global profile of gene expression following BACH1 knockdown using small interfering RNA. The loss of BACH1 function in human keratinocytes results almost exclusively in HMOX1 induction, suggesting that BACH1 may function as a rheostat regulating levels of intracellular free heme.	[Reichard, John F.] Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA; [Sartor, Maureen A.; Puga, Alvaro] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Sartor, Maureen A.; Puga, Alvaro] Univ Cincinnati, Ctr Environm Genet, Cincinnati, OH 45267 USA	Harvard University; Boston Children's Hospital; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Reichard, JF (corresponding author), Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA.		Sartor, Maureen/L-2902-2019	Reichard, John/0000-0001-9886-1623	NIEHS NIH HHS [T32 ES07250, P30 ES06096, R01 ES10807, R01 ES010807] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250, R01ES010807, P30ES006096] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALAM J, 1989, J BIOL CHEM, V264, P6371; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Dohl Y, 2006, ANTIOXID REDOX SIGN, V8, P60, DOI 10.1089/ars.2006.8.60; Dudoit S, 2002, STAT SINICA, V12, P111; EISENSTEIN RS, 1990, ENZYME, V44, P42, DOI 10.1159/000468746; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200; Kann S, 2005, TOXICOL SCI, V87, P365, DOI 10.1093/toxsci/kfi253; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Ohira M, 1998, GENOMICS, V47, P300, DOI 10.1006/geno.1997.5080; OKINAGA S, 1993, EUR J BIOCHEM, V212, P167, DOI 10.1111/j.1432-1033.1993.tb17647.x; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SARDANA MK, 1982, J BIOL CHEM, V257, P4806; Sartor M, 2004, BIOTECHNIQUES, V36, P790, DOI 10.2144/04365ST02; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Shan Y, 2004, J BIOL CHEM, V279, P51769, DOI 10.1074/jbc.M409463200; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Spuches AM, 2005, INORG CHEM, V44, P2964, DOI 10.1021/ic048694q; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; SUNDERMAN FW, 1987, ANN NY ACAD SCI, V514, P65; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; TENHUNEN R, 1970, J LAB CLIN MED, V75, P410; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; VILE GF, 1993, J BIOL CHEM, V268, P14678; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	48	54	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22363	22370		10.1074/jbc.M801784200	http://dx.doi.org/10.1074/jbc.M801784200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550526	Green Published, hybrid			2022-12-27	WOS:000258321000004
J	Segers, K; Dahlback, B; Rosing, J; Nicolaes, GAF				Segers, Kenneth; Dahlback, Bjorn; Rosing, Jan; Nicolaes, Gerry A. F.			Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPOSED STRUCTURAL MODELS; PEPTIDE-BOND CLEAVAGES; BINDING-SITE; FACTOR XA; STUART FACTOR; 3-DIMENSIONAL MODEL; FACTOR VA(R506Q); BASIC RESIDUES; ANTICOAGULANT; INACTIVATION	Inactivation of factor Va (FVa) by activated protein C (APC) is a key reaction in the down- regulation of thrombin formation. FVa inactivation by APC is correlated with a loss of FXa cofactor activity as a result of three proteolytic cleavages in the FVa heavy chain at Arg(306), Arg(506), and Arg(679). Recently, we have shown that heparin specifically inhibits the APC- mediated cleavage at Arg(506) and stimulates cleavage at Arg(306). Three- dimensional molecular models of APC docked at the Arg(306) and Arg(506) cleavage sites in FVa have identified several FVa amino acids that may be important for FVa inactivation by APC in the absence and presence of heparin. Mutagenesis of Lys(320), Arg(321), and Arg(400) to Ala resulted in an increased inactivation rate by APC at Arg(306), which indicates the importance of these residues in the FVa- APC interaction. No heparin- mediated stimulation of Arg(306) cleavage was observed for these mutants, and stimulation by protein S was similar to that of wild type FVa. With this, we have now demonstrated that a cluster of basic residues in FVa comprising Lys(320), Arg(321), and Arg(400) is required for the heparin-mediated stimulation of cleavage at Arg(306) by APC. Furthermore, mutations that were introduced near the Arg(506) cleavage site had a significant but modest effect on the rate of APC- catalyzed FVa inactivation, suggesting an extended interaction surface between the FVa Arg(506) site and APC.	[Segers, Kenneth; Rosing, Jan; Nicolaes, Gerry A. F.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; [Dahlback, Bjorn] Malmo Univ Hosp, Wallenberg Lab, SE-20502 Malmo, Sweden; [Dahlback, Bjorn] Lund Univ, Dept Lab Med, S-22100 Lund, Sweden	Maastricht University; Lund University; Skane University Hospital; Lund University	Nicolaes, GAF (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands.	G.Nicolaes@bioch.unimaas.nl	Nicolaes, Gerry A.F./A-8421-2016	Nicolaes, Gerry A.F./0000-0002-2482-0412; Dahlback, Bjorn/0000-0003-1546-0328				Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Cornet AD, 2007, THROMB HAEMOSTASIS, V98, P579, DOI 10.1160/TH07-01-0006; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; Fernandez JA, 1999, THROMB HAEMOSTASIS, V82, P1462; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4892, DOI 10.1021/bi00776a003; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002; Gale AJ, 2000, BLOOD, V96, P585; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Gale AJ, 2002, J BIOL CHEM, V277, P28836, DOI 10.1074/jbc.M204363200; Glasscock LN, 2003, BBA-PROTEINS PROTEOM, V1649, P106, DOI 10.1016/S1570-9639(03)00164-X; Haas S, 2007, Hamostaseologie, V27, P41; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; Lee CJ, 2008, J THROMB HAEMOST, V6, P83; Nicolaes GAF, 2004, EUR J BIOCHEM, V271, P2724, DOI 10.1111/j.1432-1033.2004.04201.x; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Norstrom E, 2002, BLOOD, V100, P524, DOI 10.1182/blood-2002-02-0343; Orban T, 2005, BIOCHEMISTRY-US, V44, P13082, DOI 10.1021/bi050891t; Pellequer JL, 2000, THROMB HAEMOSTASIS, V84, P849, DOI 10.1055/s-0037-1614127; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Rezaie AR, 2003, TRENDS CARDIOVAS MED, V13, P8, DOI 10.1016/S1050-1738(02)00191-3; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; ROSING J, 1980, J BIOL CHEM, V255, P274; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Shen L, 1999, THROMB HAEMOSTASIS, V82, P72, DOI 10.1055/s-0037-1614632; Shen L, 2000, BIOCHEMISTRY-US, V39, P2853, DOI 10.1021/bi992357p; SOBEL M, 1991, J CLIN INVEST, V87, P1787, DOI 10.1172/JCI115198; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; STENFLO J, 1984, SEMIN THROMB HEMOST, V10, P109, DOI 10.1055/s-2007-1004413; Stoilova-Mcphie S, 2008, J THROMB HAEMOST, V6, P76; TANS G, 1991, BLOOD, V77, P2641; TRACY PB, 1982, BLOOD, V60, P59; VANDERNEUT KM, 2004, J BIOL CHEM, V279, P6567; Yang LK, 2002, BIOCHEMISTRY-US, V41, P6149, DOI 10.1021/bi015899r; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013; Yegneswaran S, 2007, J BIOL CHEM, V282, P28353, DOI 10.1074/jbc.M704316200	43	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22573	22581		10.1074/jbc.M801724200	http://dx.doi.org/10.1074/jbc.M801724200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18519572	hybrid			2022-12-27	WOS:000258321000026
J	Shenoy, SK; Xiao, KH; Venkataramanan, V; Snyder, PM; Freedman, NJ; Weissman, AM				Shenoy, Sudha K.; Xiao, Kunhong; Venkataramanan, Vidya; Snyder, Peter M.; Freedman, Neil J.; Weissman, Allan M.			Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta(2)-adrenergic receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DOWN-REGULATION; BETA-ARRESTIN; 7-TRANSMEMBRANE RECEPTORS; PROMOTED UBIQUITINATION; RNA INTERFERENCE; PLASMA-MEMBRANE; ENDOCYTOSIS; TRAFFICKING; LIGASE	Agonist-stimulated beta(2)-adrenergic receptor (beta(2)AR) ubiquitination is a major factor that governs both lysosomal trafficking and degradation of internalized receptors, but the identity of the E3 ubiquitin ligase regulating this process was unknown. Among the various catalytically inactive E3 ubiquitin ligase mutants that we tested, a dominant negative Nedd4 specifically inhibited isoproterenol-induced ubiquitination and degradation of the beta(2)AR in HEK-293 cells. Moreover, siRNA that downregulates Nedd4 expression inhibited beta(2)AR ubiquitination and lysosomal degradation, whereas siRNA targeting the closely related E3 ligases Nedd4-2 or AIP4 did not. Interestingly, beta(2)AR as well as beta-arrestin2, the endocytic and signaling adaptor for the beta(2)AR, interact robustly with Nedd4 upon agonist stimulation. However, beta(2)AR-Nedd4 interaction is ablated when beta-arrestin2 expression is knocked down by siRNA transfection, implicating an essential E3 ubiquitin ligase adaptor role for beta-arrestin2 in mediating beta(2)AR ubiquitination. Notably, beta-arrestin2 interacts with two different E3 ubiquitin ligases, namely, Mdm2 and Nedd4 to regulate distinct steps in beta(2)AR trafficking. Collectively, our findings indicate that the degradative fate of the beta(2)AR in the lysosomal compartments is dependent upon beta-arrestin2-mediated recruitment of Nedd4 to the activated receptor and Nedd4-catalyzed ubiquitination.	[Shenoy, Sudha K.; Xiao, Kunhong; Venkataramanan, Vidya; Freedman, Neil J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Shenoy, Sudha K.; Freedman, Neil J.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Snyder, Peter M.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52422 USA; [Snyder, Peter M.] Univ Iowa, Coll Med, Dept Physiol, Iowa City, IA 52422 USA; [Snyder, Peter M.] Univ Iowa, Coll Med, Dept Biophys, Iowa City, IA 52422 USA; [Weissman, Allan M.] NCI Frederick, Ctr Canc Res, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA	Duke University; Duke University; University of Iowa; University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Shenoy, SK (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	sudha@receptor-biol.duke.edu	Shenoy, Sudha/AAN-4075-2021; Xiao, Kunhong/AAG-4275-2020	Shenoy, Sudha/0000-0002-2565-4663; Xiao, Kunhong/0000-0002-1069-1226	NHLBI NIH HHS [HL080525, R01 HL080525, R01 HL080525-03, T32 HL007101] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC009392] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOUVIER M, 1989, J BIOL CHEM, V264, P16786; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; Cottrell GS, 2006, J BIOL CHEM, V281, P27773, DOI 10.1074/jbc.M603369200; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dohlman HG, 2002, NATURE, V418, P591, DOI 10.1038/418591a; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Mihalik B, 2003, INT J BIOCHEM CELL B, V35, P992, DOI 10.1016/S1357-2725(02)00277-7; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moore RH, 1999, J CELL SCI, V112, P329; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	64	139	147	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22166	22176		10.1074/jbc.M709668200	http://dx.doi.org/10.1074/jbc.M709668200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544533	Green Published, hybrid			2022-12-27	WOS:000258114700036
J	Vandemeulebroucke, A; De Vos, S; Van Holsbeke, E; Steyaert, J; Versees, W				Vandemeulebroucke, An; De Vos, Stefan; Van Holsbeke, Els; Steyaert, Jan; Versees, Wim			A flexible loop as a functional element in the catalytic mechanism of nucleoside hydrolase from Trypanosoma vivax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAVING GROUP ACTIVATION; PRE-STEADY-STATE; CRITHIDIA-FASCICULATA; ENZYME CATALYSIS; CONFORMATIONAL-CHANGES; SUBSTRATE-BINDING; PRODUCT RELEASE; REACTIVITY; COMPLEX	The nucleoside hydrolase of Trypanosoma vivax hydrolyzes the N-glycosidic bond of purine nucleosides. Structural and kinetic studies on this enzyme have suggested a catalytic role for a flexible loop in the vicinity of the active sites. Here we present the analysis of the role of this flexible loop via the combination of a proline scan of the loop, loop deletion mutagenesis, steady state and pre-steady state analysis, and x-ray crystallography. Our analysis reveals that this loop has an important role in leaving group activation and product release. The catalytic role involves the entire loop and could only be perturbed by deletion of the entire loop and not by single site mutagenesis. We present evidence that the loop closes over the active site during catalysis, thereby ordering a water channel that is involved in leaving group activation. Once chemistry has taken place, the loop dynamics determine the rate of product release.	[Steyaert, Jan] Vrije Univ Brussel VIB, Dept Ultrastruct, B-1050 Brussels, Belgium; Vrije Univ Brussel VIB, Dept Mol & Cell Interact, B-1050 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Steyaert, J (corresponding author), Vrije Univ Brussel VIB, Dept Ultrastruct, Pl Laan 2, B-1050 Brussels, Belgium.	jan.steyaert@vub.ac.be	Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022; Versées, Wim/H-5518-2015	Steyaert, Jan/0000-0002-3825-874X; Versees, Wim/0000-0002-4695-696X				Barlow JN, 2007, BBA-PROTEINS PROTEOM, V1774, P1451, DOI 10.1016/j.bbapap.2007.08.027; Chu V, 1998, PROTEIN SCI, V7, P848; Degano M, 1998, BIOCHEMISTRY-US, V37, P6277, DOI 10.1021/bi973012e; Degano M, 1996, BIOCHEMISTRY-US, V35, P5971, DOI 10.1021/bi952999m; DeLano W.L, PYMOL MOL GRAPHICS S; DUNN DB, 1970, CRC HDB BIOCH; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foloppe N, 2005, J PHYS CHEM B, V109, P9119, DOI 10.1021/jp044513u; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GARRETT ER, 1972, J AM CHEM SOC, V94, P8532, DOI 10.1021/ja00779a040; Giabbai B, 2004, STRUCTURE, V12, P739, DOI 10.1016/S0969-2126(04)00122-4; Gopaul DN, 1996, BIOCHEMISTRY-US, V35, P5963, DOI 10.1021/bi952998u; Gutteridge A, 2004, FEBS LETT, V567, P67, DOI 10.1016/j.febslet.2004.03.067; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; HORENSTEIN BA, 1991, BIOCHEMISTRY-US, V30, P10788, DOI 10.1021/bi00108a026; KEMPNER ES, 1993, FEBS LETT, V326, P4, DOI 10.1016/0014-5793(93)81749-P; KLINE PC, 1992, BIOCHEMISTRY-US, V31, P5964, DOI 10.1021/bi00141a003; Loverix S, 2005, J BIOL CHEM, V280, P14799, DOI 10.1074/jbc.M413231200; Mazumder-Shivakumar D, 2005, BIOCHEMISTRY-US, V44, P7805, DOI 10.1021/bi047394h; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKIN DW, 1991, J BIOL CHEM, V266, P20658; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Schramm Vern L, 2003, Nucleic Acids Res Suppl, P107; Vandemeulebroucke A, 2003, BIOCHEMISTRY-US, V42, P12902, DOI 10.1021/bi0347914; Vandemeulebroucke A, 2006, BIOCHEMISTRY-US, V45, P9307, DOI 10.1021/bi060666r; Versees W, 2006, J MOL BIOL, V359, P331, DOI 10.1016/j.jmb.2006.03.026; Versees W, 2003, CURR OPIN STRUC BIOL, V13, P731, DOI 10.1016/j.sbi.2003.10.002; Versees W, 2004, J MOL BIOL, V338, P1, DOI 10.1016/j.jmb.2004.02.049; Versees W, 2002, J BIOL CHEM, V277, P15938, DOI 10.1074/jbc.M111735200; Versees W, 2001, J MOL BIOL, V307, P1363, DOI 10.1006/jmbi.2001.4548; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P5250, DOI 10.1073/pnas.75.11.5250; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106	35	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22272	22282		10.1074/jbc.M803705200	http://dx.doi.org/10.1074/jbc.M803705200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18519562	Green Published, hybrid			2022-12-27	WOS:000258114700046
J	Binz, SK; Wold, MS				Binz, Sara K.; Wold, Marc S.			Regulatory functions of the N-terminal domain of the 70-kDa subunit of replication protein A (RPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; 70 KDA SUBUNIT; NUCLEOTIDE EXCISION-REPAIR; P53 TRANSACTIVATION DOMAIN; S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; IN-VITRO; CONFORMATIONAL-CHANGE; DAMAGE CHECKPOINTS	Replication protein A (RPA) is the major single-stranded DNA-binding protein in eukaryotes. RPA is composed of three subunits of 70, 32, and 14 kDa. The N-terminal domain of the 70-kDa subunit (RPA70) has weak DNA binding activity, interacts with proteins, and is involved in cellular DNA damage response. To define the mechanism by which this domain regulates RPA function, we analyzed the function of RPA forms containing a deletion of the N terminus of RPA70 and mutations in the phosphorylation domain of RPA(N-terminal 40 amino acids of the 32-kDa subunit). Although each individual mutation has only modest effects on RPA activity, a form combining both phosphorylation mimetic mutations and a deletion of the N-terminal domain of RPA70 was found to have dramatically altered activity. This combined mutant was defective in binding to short single-stranded DNA oligonucleotides and had altered interactions with proteins that bind to the DNA-binding core of RPA70. These results indicate that in the absence of the N-terminal domain of RPA70, a negatively charged phosphorylation domain disrupts the activity of the core DNA-binding domain of RPA. We conclude that the N-terminal domain of RPA70 functions by interacting with the phosphorylation domain of the 32-kDa subunit and blocking undesirable interactions with the core DNA-binding domain of RPA. These studies indicate that RPA conformation is important for regulating RPA-DNA and RPA-protein interactions.	[Binz, Sara K.; Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biotechnol, Iowa City, IA 52242 USA	University of Iowa	Wold, MS (corresponding author), 3107 MERF, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu	Wold, Marc/F-5806-2010	Wold, Marc/0000-0002-4580-1624	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044721, GM 44721] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Ariza RR, 1996, NUCLEIC ACIDS RES, V24, P433, DOI 10.1093/nar/24.3.433; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bartrand AJ, 2006, GENETICS, V172, P27, DOI 10.1534/genetics.105.047845; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Blackwell LJ, 1996, MOL CELL BIOL, V16, P4798; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; BRAUN KA, 1998, THESIS U IOWA; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Brush GS, 1995, METHOD ENZYMOL, V262, P522; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; CHEN LC, 1991, P NATL ACAD SCI USA, V88, P3847, DOI 10.1073/pnas.88.9.3847; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; Cruet-Hennequart S, 2008, DNA REPAIR, V7, P582, DOI 10.1016/j.dnarep.2007.12.012; Cuvier O, 2006, CURR BIOL, V16, P516, DOI 10.1016/j.cub.2006.01.059; Daughdrill GW, 2003, NUCLEIC ACIDS RES, V31, P4176, DOI 10.1093/nar/gkg451; Daughdrill GW, 2001, NUCLEIC ACIDS RES, V29, P3270, DOI 10.1093/nar/29.15.3270; Deng XY, 2007, J MOL BIOL, V374, P865, DOI 10.1016/j.jmb.2007.09.074; FANG F, 1993, J CELL SCI, V106, P983; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; FIRMENICH AA, 1995, MOL CELL BIOL, V15, P1620; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P5586, DOI 10.1021/bi9526995; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517; Guo SL, 2006, J BIOL CHEM, V281, P21607, DOI 10.1074/jbc.M603504200; Gupta RC, 1998, P NATL ACAD SCI USA, V95, P9843, DOI 10.1073/pnas.95.17.9843; Han YF, 1999, J VIROL, V73, P4899, DOI 10.1128/JVI.73.6.4899-4907.1999; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Iftode C, 1998, NUCLEIC ACIDS RES, V26, P5636, DOI 10.1093/nar/26.24.5636; Ishibashi T, 2006, J BIOCHEM, V139, P99, DOI 10.1093/jb/mvj014; Jacobs DM, 1999, J BIOMOL NMR, V14, P321, DOI 10.1023/A:1008373009786; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Kim HS, 2003, DNA REPAIR, V2, P1321, DOI 10.1016/j.dnarep.2003.07.004; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Liu JS, 2006, J CELL BIOCHEM, V99, P1452, DOI 10.1002/jcb.21066; Liu JS, 2000, J BIOL CHEM, V275, P1391, DOI 10.1074/jbc.275.2.1391; Liu JS, 2006, DNA REPAIR, V5, P369, DOI 10.1016/j.dnarep.2005.11.007; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; LONGHESE MP, 1994, MOL CELL BIOL, V14, P7884, DOI 10.1128/MCB.14.12.7884; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; Mallory JC, 2003, DNA REPAIR, V2, P1041, DOI 10.1016/S1568-7864(03)00115-0; Maniar HS, 1997, GENETICS, V145, P891; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Nuss JE, 2004, PROTEIN SCI, V13, P1365, DOI 10.1110/ps.04616304; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Olson KE, 2005, J BIOMOL STRUCT DYN, V23, P113, DOI 10.1080/07391102.2005.10507052; PAN ZQ, 1995, P NATL ACAD SCI USA, V92, P4636, DOI 10.1073/pnas.92.10.4636; Pestryakov PE, 2003, J BIOL CHEM, V278, P17515, DOI 10.1074/jbc.M301265200; Pfuetzner RA, 1997, J BIOL CHEM, V272, P430; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; SANTOCANALE C, 1995, J MOL BIOL, V254, P595, DOI 10.1006/jmbi.1995.0641; Soustelle C, 2002, GENETICS, V161, P535; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Teng YM, 1998, J MOL BIOL, V280, P355, DOI 10.1006/jmbi.1998.1872; Treuner K, 1999, J BIOL CHEM, V274, P15556, DOI 10.1074/jbc.274.22.15556; Umezu K, 1998, GENETICS, V148, P989; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wang Y, 1999, J BIOL CHEM, V274, P22060, DOI 10.1074/jbc.274.31.22060; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	95	27	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21559	21570		10.1074/jbc.M802450200	http://dx.doi.org/10.1074/jbc.M802450200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18515800	Green Published, hybrid			2022-12-27	WOS:000257898800029
J	Gao, J; Zhao, N; Knutson, MD; Enns, CA				Gao, Junwei; Zhao, Ningning; Knutson, Mitchell D.; Enns, Caroline A.			The hereditary hemochromatosis protein, HFE, inhibits iron uptake via down-regulation of Zip14 in HepG2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN RECEPTOR; RESPONSIVE ELEMENT; MOUSE MODEL; LIVER; GENE; IDENTIFICATION; MODIFIER; HEPATOCYTES; EXPRESSION; INCREASES	Lack of functional hereditary hemochromatosis protein, HFE, causes iron overload predominantly in hepatocytes, the major site of HFE expression in the liver. In this study, we investigated the role of HFE in the regulation of both transferrin-bound iron (TBI) and non-transferrin-bound iron (NTBI) uptake in HepG2 cells, a human hepatoma cell line. Expression of HFE decreased both TBI and NTBI uptake. It also resulted in a decrease in the protein levels of Zip14 with no evident change in the mRNA level of Zip14. Zip14 (Slc39a14) is a metal transporter that mediates NTBI into cells (Liuzzi, J. P., Aydemir, F., Nam, H., Knutson, M. D., and Cousins, R. J. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 13612-13617). Knockdown of Zip14 with siRNA abolished the effect of HFE on NTBI uptake. To determine if HFE had a similar effect on Zip14 in another cell line, HeLa cells expressing HFE under the tetracycline-repressible promoter were transfected with Zip14. As in HepG2 cells, HFE expression inhibited NTBI uptake by similar to 50% and decreased Zip14 protein levels. Further analysis of protein turnover indicated that the half-life of Zip14 is lower in cells that express HFE. These results suggest that HFE decreases the stability of Zip14 and therefore reduces the iron loading in HepG2 cells.	[Gao, Junwei; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Zhao, Ningning; Knutson, Mitchell D.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	Oregon Health & Science University; State University System of Florida; University of Florida	Enns, CA (corresponding author), 3181 SW Sam Jackson Pk Rd,L215, Portland, OR 97239 USA.	ennsca@ohsu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK065064, R01DK072166] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 065064, DK 072166] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Carlson H, 2005, BLOOD, V105, P2564, DOI 10.1182/blood-2004-03-1204; Chua ACG, 2004, BLOOD, V104, P1519, DOI 10.1182/blood-2003-11-3872; Coppin H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r221; Cruz E, 2006, BLOOD CELL MOL DIS, V37, P33, DOI 10.1016/j.bcmd.2006.04.004; Davies PS, 2004, J BIOL CHEM, V279, P25085, DOI 10.1074/jbc.M400537200; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Enns CA, 2006, BIOL RES, V39, P105, DOI 10.4067/S0716-97602006000100013; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fletcher LM, 2002, J INTERN MED, V251, P181, DOI 10.1046/j.1365-2796.2002.00945.x; Garrick MD, 2006, BIOCHEM J, V398, P539, DOI 10.1042/BJ20051987; Giannetti AM, 2004, J BIOL CHEM, V279, P25866, DOI 10.1074/jbc.M401467200; Gouya L, 2007, GASTROENTEROLOGY, V132, P679, DOI 10.1053/j.gastro.2006.11.024; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Jacolot S, 2004, BLOOD, V103, P2835, DOI 10.1182/blood-2003-10-3366; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; OWEN D, 1987, EMBO J, V6, P1287, DOI 10.1002/j.1460-2075.1987.tb02366.x; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; SARKAR B, 1970, CAN J BIOCHEM CELL B, V48, P1339, DOI 10.1139/o70-208; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Shindo M, 2006, HEPATOL RES, V35, P152, DOI 10.1016/j.hepres.2006.03.011; Spasic MV, 2008, CELL METAB, V7, P173, DOI 10.1016/j.cmet.2007.11.014; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	41	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21462	21468		10.1074/jbc.M803150200	http://dx.doi.org/10.1074/jbc.M803150200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524764	hybrid, Green Published			2022-12-27	WOS:000257898800018
J	Rajabi, M; de Leeuw, E; Pazgier, M; Li, J; Lubkowski, J; Lu, W				Rajabi, Mohsen; de Leeuw, Erik; Pazgier, Marzena; Li, Jing; Lubkowski, Jacek; Lu, Wuyuan			The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-DEFENSINS; HUMAN BETA-DEFENSINS; ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; MAMMALIAN DEFENSINS; NEUTROPHIL DEFENSIN; CHEMICAL LIGATION; MOUSE CRYPTDIN-4; PANETH CELLS; PROTEINS	Mammalian alpha-defensins, expressed primarily in leukocytes and epithelia, play important roles in innate and adaptive immune responses to microbial infection. Six invariant cysteine residues forming three indispensable disulfide bonds and one Gly residue required structurally for an atypical beta-bulge are totally conserved in the otherwise diverse sequences of all known mammalian alpha-defensins. In addition, a pair of oppositely charged residues (Arg/Glu), forming a salt bridge across a protruding loop in the molecule, is highly conserved. To investigate the structural and functional roles of the conserved Arg(6)-Glu(14) salt bridge in human alpha-defensin 5 (HD5), we chemically prepared HD5 and its precursor proHD5 as well as their corresponding salt bridge-destabilizing analogs E14Q-HD5 and E57Q-proHD5. The Glu-to-Gln mutation, whereas significantly reducing the oxidative folding efficiency of HD5, had no effect on the folding of proHD5. Bovine trypsin productively and correctly processed proHD5 in vitro but spontaneously degraded E57Q-proHD5. Significantly, HD5 was resistant to trypsin treatment, whereas E14Q-HD5 was highly susceptible. Further, degradation of E14Q-HD5 by trypsin was initiated by the cleavage of the Arg(13)-Gln(14) peptide bond in the loop region, a catastrophic proteolytic event resulting directly in quick digestion of the whole defensin molecule. The E14Q mutation did not alter the bactericidal activity of HD5 against Staphylococcus aureus but substantially enhanced the killing of Escherichia coli. By contrast, proHD5 and E57Q-proHD5 were largely inactive against both strains at the concentrations tested. Our results confirm that the primary function of the conserved salt bridge in HD5 is to ensure correct processing of proHD5 and subsequent stabilization of mature alpha-defensin in vivo.	[Rajabi, Mohsen; de Leeuw, Erik; Li, Jing; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Rajabi, Mohsen; de Leeuw, Erik; Li, Jing; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Pazgier, Marzena; Lubkowski, Jacek] NCI, Macromol Assembly Struct & Cell Signaling Sect, Natl Inst Hlth, Frederick, MD 21702 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lu, W (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	wlu@ihv.umaryland.edu	Lu, Wuyuan/B-2268-2010; Pazgier, Marzena/B-7295-2012; Lu, Wuyuan/J-8452-2017	Lu, Wuyuan/0000-0003-1318-9968	NATIONAL CANCER INSTITUTE [ZIASC010386, Z01SC010386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R21AI056264] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 056264, AI 061482] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; Dorin JR, 2007, SCIENCE, V318, P1395, DOI 10.1126/science.1151370; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Jia HP, 2001, GENE, V263, P211; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KENT SBH, 1988, ANNU REV BIOCHEM, V57, P957, DOI 10.1146/annurev.bi.57.070188.004521; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; Lu WY, 2000, BIOCHEMISTRY-US, V39, P3575, DOI 10.1021/bi992292q; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1987, INFECT IMMUN, V55, P2281, DOI 10.1128/IAI.55.9.2281-2286.1987; SINGH A, 1988, BIOCHEM BIOPH RES CO, V155, P524, DOI 10.1016/S0006-291X(88)81118-5; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tanabe H, 2007, BIOCHEM BIOPH RES CO, V358, P349, DOI 10.1016/j.bbrc.2007.04.132; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zasloff M, 2002, NAT IMMUNOL, V3, P508, DOI 10.1038/ni0602-508; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	53	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21509	21518		10.1074/jbc.M801851200	http://dx.doi.org/10.1074/jbc.M801851200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18499668	Green Published, hybrid			2022-12-27	WOS:000257898800024
J	Pietsch, EC; Perchiniak, E; Canutescu, AA; Wang, GL; Dunbrack, RL; Murphy, ME				Pietsch, E. Christine; Perchiniak, Erin; Canutescu, Adrian A.; Wang, Guoli; Dunbrack, Roland L.; Murphy, Maureen E.			Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; BH3 DOMAIN; TRANSCRIPTIONAL ACTIVATION; PROAPOPTOTIC ACTIVITY; CASPASE ACTIVATION; INDUCE APOPTOSIS; FAMILY MEMBERS; CYTOCHROME-C; BCL-2 FAMILY; CELL-DEATH	Genotoxic stress triggers a rapid translocation of p53 to the mitochondria, contributing to apoptosis in a transcription-independent manner. Using immunopurification protocols and mass spectrometry, we previously identified the proapoptotic protein BAK as a mitochondrial p53-binding protein and showed that recombinant p53 directly binds to BAK and can induce its oligomerization, leading to cytochrome c release. In this work we describe a combination of molecular modeling, electrostatic analysis, and site-directed mutagenesis to define contact residues between BAK and p53. Our data indicate that three regions within the core DNA binding domain of p53 make contact with BAK; these are the conserved H2 alpha-helix and the L1 and L3 loop. Notably, point mutations in these regions markedly impair the ability of p53 to oligomerize BAK and to induce transcription-independent cell death. We present a model whereby positively charged residues within the H2 helix and L1 loop of p53 interact with an electronegative domain on the N-terminal alpha-helix of BAK; the latter is known to undergo conformational changes upon BAK activation. We show that mutation of acidic residues in the N-terminal helix impair the ability of BAK to bind to p53. Interestingly, many of the p53 contact residues predicted by our model are also direct DNA contact residues, suggesting that p53 interacts with BAK in a manner analogous to DNA. The combined data point to the H2 helix and L1 and L3 loops of p53 as novel functional domains contributing to transcription-independent apoptosis by this tumor suppressor protein.	[Pietsch, E. Christine; Perchiniak, Erin; Murphy, Maureen E.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; [Canutescu, Adrian A.; Wang, Guoli; Dunbrack, Roland L.] Fox Chase Canc Ctr, Program Biomol Struct & Funct, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Murphy, ME (corresponding author), Fox Chase Canc Ctr, Div Med Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Maureen.Murphy@FCCC.edu	Dunbrack, Roland/ABG-7141-2020	Dunbrack, Roland/0000-0001-7674-6667; Murphy, Maureen/0000-0001-7644-7296	NCI NIH HHS [P30 CA006927-44, F32 CA 110713, R01 CA102184, T32 CA 009035, R01 CA102184-04, F32 CA110713-02, F32 CA110713-01, P30 CA 006297, T32 CA009035-33, R01 CA 102184, T32 CA009035] Funding Source: Medline; NIGMS NIH HHS [R01 GM073784-03, R01 GM 73784, R01 GM073784] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102184, T32CA009035, F32CA110713, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073784] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2004, CELL, DOI [DOI 10.1016/S0092-8674(04)00036-4, 10.1016/S0092-8674(04)00036-4]; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Ding HF, 1998, J BIOL CHEM, V273, P28378, DOI 10.1074/jbc.273.43.28378; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Juin P, 2005, CELL CYCLE, V4, P637, DOI 10.4161/cc.4.5.1671; Kakudo Y, 2005, CANCER RES, V65, P2108, DOI 10.1158/0008-5472.CAN-04-2935; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nemajerova A, 2005, FEBS LETT, V579, P6079, DOI 10.1016/j.febslet.2005.09.074; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Palacios G, 2006, ONCOGENE, V25, P6133, DOI 10.1038/sj.onc.1209641; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Shangary S, 2004, MOL CANCER THER, V3, P1343; Simonen M, 1997, EUR J BIOCHEM, V249, P85, DOI 10.1111/j.1432-1033.1997.t01-1-00085.x; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101	51	74	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21294	21304		10.1074/jbc.M710539200	http://dx.doi.org/10.1074/jbc.M710539200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524770	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000257746100071
J	Steen, M; Tran, S; Autin, L; Villoutreix, BO; Tholander, AL; Dahlback, B				Steen, Marten; Tran, Sinh; Autin, Ludovic; Villoutreix, Bruno O.; Tholander, Ann-Louise; Dahlback, Bjorn			Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; COAGULATION-FACTOR VA; AMINO-ACID-RESIDUES; FACTOR-VIIIA A2; BLOOD-COAGULATION; PROTHROMBINASE COMPLEX; COFACTOR FUNCTION; INTERACTIVE SITE; HEMOPHILIA-A; HEAVY-CHAIN	Activated coagulation factor V functions as a cofactor to factor Xa in the conversion of prothrombin to thrombin. Based on the introduction of extra carbohydrate side chains in recombinant factor V, we recently proposed several regions in factor Va to be important for factor Xa binding. To further define which residues are important for factor Xa binding, we prepared fifteen recombinant factor V variants in which clusters of charged amino acid residues were mutated, mainly to alanines. The factor V variants were expressed in COS-1 cells, and their functional properties evaluated in a prothrombinase-based assay, as well as in a direct binding test. Four of the factor V variants, 501A/510A/511D, 501A/510A/511D/513A, 513A/577A/578A, and 501A/510A/511D/513A/577A/578A exhibited markedly reduced factor Xa-cofactor activity tested in the prothrombinase assay, and reduced binding affinity as judged by the direct binding assay. These factor Va variants were normally cleaved at Arg-506 by activated protein C, and the interaction between the factor Xa-factor Va complex and prothrombin was unaffected by the introduced mutations. Based on the integration of all available data, we propose a key factor Xa binding surface to be centered on Arg-501, Arg-510, Ala-511, Asp-513, Asp-577, and Asp-578 in the factor Va A2 domain. These residues form an elongated charged factor Xa binding cluster on the factor Va surface.	[Steen, Marten; Tran, Sinh; Tholander, Ann-Louise; Dahlback, Bjorn] Lund Univ, Dept Lab Med, Div Clin Chem, Wallenberg Lab,MAS, SE-20502 Malmo, Sweden; [Autin, Ludovic; Villoutreix, Bruno O.] Univ Paris 05, INSERM, U648, F-75006 Paris, France	Lund University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dahlback, B (corresponding author), Lund Univ, Dept Clin Chem, Div Lab Med, Wallenberg Lab,MAS, SE-20502 Malmo, Sweden.	bjorn.dahlback@med.lu.se	Villoutreix, Bruno/I-4565-2015	Villoutreix, Bruno/0000-0002-6456-7730; Autin, Ludovic/0000-0002-2197-191X; Dahlback, Bjorn/0000-0003-1546-0328				Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; Celie PHN, 1999, BRIT J HAEMATOL, V106, P792, DOI 10.1046/j.1365-2141.1999.01590.x; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; DAHLBACK B, 1978, BIOCHEMISTRY-US, V17, P4938, DOI 10.1021/bi00616a013; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; Jenkins PV, 2004, J THROMB HAEMOST, V2, P452, DOI 10.1111/j.1538-7933.2004.00625.x; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; KALAFATIS M, 1994, BIOCHEMISTRY-US, V33, P6538, DOI 10.1021/bi00187a022; KANE WH, 1988, BLOOD, V71, P539; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LUNDBLAD RL, 1975, BIOCHEM BIOPH RES CO, V66, P482, DOI 10.1016/0006-291X(75)90536-7; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 2000, BLOOD COAGUL FIBRIN, V11, P89, DOI 10.1097/00001721-200011010-00010; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Norstrom E, 2002, BLOOD, V100, P524, DOI 10.1182/blood-2002-02-0343; Norstrom EA, 2006, J BIOL CHEM, V281, P31486, DOI 10.1074/jbc.M606441200; Pellequer JL, 2000, THROMB HAEMOSTASIS, V84, P849, DOI 10.1055/s-0037-1614127; ROSING J, 1980, J BIOL CHEM, V255, P274; Saleh M, 2004, THROMB HAEMOSTASIS, V91, P16, DOI 10.1160/TH03-04-0222; Singh LS, 2003, J BIOL CHEM, V278, P28335, DOI 10.1074/jbc.M300233200; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Sun YH, 2004, J BIOL CHEM, V279, P47528, DOI 10.1074/jbc.M407366200; Thiec F, 2003, J BIOL CHEM, V278, P10393, DOI 10.1074/jbc.M212144200; Villoutreix BO, 1998, PROTEIN SCI, V7, P1317, DOI 10.1002/pro.5560070607	39	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20805	20812		10.1074/jbc.M802703200	http://dx.doi.org/10.1074/jbc.M802703200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502757	hybrid, Green Published			2022-12-27	WOS:000257746100022
J	Dixon, DP; Lapthorn, A; Madesis, P; Mudd, EA; Day, A; Edwards, R				Dixon, David P.; Lapthorn, Adrian; Madesis, Panagiotis; Mudd, Elisabeth A.; Day, Anil; Edwards, Robert			Binding and glutathione conjugation of porphyrinogens by plant glutathione transferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; S-TRANSFERASE; ANTHOCYANIN SEQUESTRATION; ARABIDOPSIS-THALIANA; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; GENE FAMILY; PROTEIN; CHLOROPHYLL; LIGANDIN	Overexpression in Escherichia coli of a tau (U) class glutathione transferase (GST) from maize (Zea mays L.), termed ZmGSTU1, caused a reduction in heme levels and an accumulation of porphyrin precursors. This disruption was highly specific, with the expression of the closely related ZmGSTU2 or other maize GSTs having little effect. Expression in E. coli of a series of chimeric ZmGSTU1/ZmGSTU2 proteins identified domains responsible for disrupting porphyrin metabolism. In addition to known heme precursors, expression of ZmGSTU1 led to the accumulation of a novel glutathione conjugate of harderoporphyrin(ogen) (2,7,12,18-tetramethyl-3-vinylporphyrin8,13,17-tripropionic acid). Using the related protoporphyrinogen as a substrate, conjugation could be shown to occur on one vinyl group and was actively catalyzed by the ZmGSTU. In plant transgenesis studies, the ZmGSTUs did not perturb porphyrin metabolism when expressed in the cytosol of Arabidopsis or tobacco. However, expression of a ZmGSTU1-ZmGSTU2 chimera in the chloroplasts of tobacco resulted in the accumulation of the harderoporphyrin(ogen)-glutathione conjugate observed in the expression studies in bacteria. Our results show that the well known ability of GSTs to act as ligand binding(ligandin) proteins of porphyrins in vitro results in highly specific interactions with porphyrinogen intermediates, which can be demonstrated in both plants and bacteria in vivo.	[Dixon, David P.; Edwards, Robert] Univ Durham, Sch Biol & Biomed Sci, Ctr Bioact Chem, Durham DH1 3LE, England; [Lapthorn, Adrian] Univ Glasgow, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; [Madesis, Panagiotis; Mudd, Elisabeth A.; Day, Anil] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Durham University; University of Glasgow; University of Manchester	Edwards, R (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Ctr Bioact Chem, Durham DH1 3LE, England.	Robert.Edwards@durham.ac.uk	Dixon, David P/B-5413-2008; Madesis, Panagiotis/AAL-5980-2020	Dixon, David P/0000-0003-4644-8399; Madesis, Panagiotis/0000-0003-1447-3514; Edwards, Robert/0000-0003-0809-5991; Day, Anil/0000-0001-7835-9572; Lapthorn, Adrian/0000-0002-2197-8134	BBSRC [BB/E020445/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBC51227X1, BB/E020445/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alfenito MR, 1998, PLANT CELL, V10, P1135, DOI 10.1105/tpc.10.7.1135; BILANG J, 1995, PLANT PHYSIOL, V109, P253, DOI 10.1104/pp.109.1.253; Danton M, 2006, BIOMED CHROMATOGR, V20, P612, DOI 10.1002/bmc.656; Dixon D. P., 1999, Plant Physiology, V119, P1568; Dixon DP, 2005, PLANT SCI, V168, P873, DOI 10.1016/j.plantsci.2004.11.009; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dixon DP, 2003, J BIOL CHEM, V278, P23930, DOI 10.1074/jbc.M303620200; Dixon DP, 1998, PLANT MOL BIOL, V36, P75, DOI 10.1023/A:1005958711207; Dixon DP, 2000, ARCH BIOCHEM BIOPHYS, V384, P407, DOI 10.1006/abbi.2000.2125; Dixon DP, 1999, PLANT MOL BIOL, V40, P997, DOI 10.1023/A:1006257305725; EDWARDS R, 2000, HERBICIDES THEIR MEC, P39; Frankenberg N, 2003, APPL MICROBIOL BIOT, V63, P115, DOI 10.1007/s00253-003-1432-2; Gonneau J, 1998, PHYSIOL PLANTARUM, V103, P114, DOI 10.1034/j.1399-3054.1998.1030114.x; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; KARAGIANIS G, 1993, AUST J CHEM, V46, P1755, DOI 10.1071/CH9931755; Kode V, 2006, PLANT J, V46, P901, DOI 10.1111/j.1365-313X.2006.02736.x; Kwon SJ, 2003, APPL ENVIRON MICROB, V69, P4875, DOI 10.1128/AEM.69.8.4875-4883.2003; Lederer B, 2005, Z NATURFORSCH C, V60, P166; Lederer B, 2003, BBA-GEN SUBJECTS, V1621, P226, DOI 10.1016/S0304-4165(03)00073-4; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; LISTOWSKY I, 1988, DRUG METAB REV, V19, P305, DOI 10.3109/03602538808994138; LITWACK G, 1971, NATURE, V234, P466, DOI 10.1038/234466a0; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Nakayashiki T, 1997, MOL GEN GENET, V255, P376, DOI 10.1007/s004380050509; Razzaque MA, 2002, RAPID COMMUN MASS SP, V16, P1675, DOI 10.1002/rcm.768; Rea PA, 1998, ANNU REV PLANT PHYS, V49, P727, DOI 10.1146/annurev.arplant.49.1.727; SANO S, 1964, BIOCHEM J, V93, P270, DOI 10.1042/bj0930270; SINGH BR, 1988, FEBS LETT, V234, P379, DOI 10.1016/0014-5793(88)80120-0; SLAMA JT, 1975, J AM CHEM SOC, V97, P6556, DOI 10.1021/ja00855a045; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tewari AK, 1998, PLANT PHYSIOL, V117, P851, DOI 10.1104/pp.117.3.851; TIPPING E, 1978, BIOCHEM J, V169, P509, DOI 10.1042/bj1690509; TIPPING E, 1976, BIOCHEM J, V157, P461, DOI 10.1042/bj1570461; Vargo MA, 2001, J BIOL CHEM, V276, P2031, DOI 10.1074/jbc.M008212200; Vavilin DV, 2002, PHYSIOL PLANTARUM, V115, P9, DOI 10.1034/j.1399-3054.2002.1150102.x; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Zachariah VT, 2000, J PROTEIN CHEM, V19, P425, DOI 10.1023/A:1026513528654; Zubko MK, 2004, TRANSGENIC RES, V13, P523, DOI 10.1007/s11248-004-2374-x	44	41	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20268	20276		10.1074/jbc.M802026200	http://dx.doi.org/10.1074/jbc.M802026200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18492666	hybrid			2022-12-27	WOS:000257565300043
J	Gautier, T; Klein, A; Deckert, V; Desrumaux, C; Ogier, N; Sberna, AL; Paul, C; Le Guern, N; Athias, A; Montange, T; Monier, S; Piard, F; Jiang, XC; Masson, D; Lagrost, L				Gautier, Thomas; Klein, Alexis; Deckert, Valerie; Desrumaux, Catherine; Ogier, Nicolas; Sberna, Anne-Laure; Paul, Catherine; Le Guern, Naig; Athias, Anne; Montange, Thomas; Monier, Serge; Piard, Francoise; Jiang, Xian-Cheng; Masson, David; Lagrost, Laurent			Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; HIGH-DENSITY-LIPOPROTEIN; BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; 3-HYDROXY FATTY-ACIDS; LPS-BINDING; (LPS)-BINDING PROTEIN; IN-VITRO; CHYLOMICRONS ALTER; SOLUBLE CD14; CELLS	Lipopolysaccharides (LPS) are components of Gram-negative bacteria. The cellular response from the host to LPS is mediated through stepwise interactions involving the lipopolysaccharide-binding protein (LBP), CD14, and MD-2, which produces the rearrangement of TLR4. In addition to LBP, the lipid transfer/lipopolysaccharide- binding protein gene family includes the phospholipid transfer protein (PLTP). Here we show that the intravascular redistribution of LPS from the plasma lipoprotein-free fraction toward circulating lipoproteins is delayed in PLTP-deficient mice. In agreement with earlier in vitro studies, which predicted the neutralization of the endotoxic properties of LPS when associated with lipoproteins, significant increases in the plasma concentration of proinflammatory cytokines were found in PLTP-deficient as compared with wild type mice. Similar inflammatory damage occurred in tissues from wild type and PLTP-deficient mice 24 h after one single intraperitoneal injection of LPS but with a more severe accumulation of red blood cells in glomeruli of LPS-injected PLTP-deficient mice. Complementary ex vivo experiments on isolated splenocytes from wild type and PLTP-deficient mice further supported the ability of cell-derived PLTP to prevent LPS-mediated inflammation and cytotoxicity when combined with lipoprotein acceptors. Finally, PLTP deficiency in mice led to a significant increase in LPS-induced mortality. It is concluded that increasing circulating levels of PLTP may constitute a new and promising strategy in preventing endotoxic shock.	[Gautier, Thomas; Klein, Alexis; Deckert, Valerie; Desrumaux, Catherine; Ogier, Nicolas; Sberna, Anne-Laure; Paul, Catherine; Le Guern, Naig; Athias, Anne; Montange, Thomas; Monier, Serge; Piard, Francoise; Masson, David; Lagrost, Laurent] Univ Bourgogne, INSERM, Ctr Rech,UMR866, Fac Med,Inst Federatif Rech Sante STIC, F-21079 Dijon, France; [Piard, Francoise; Masson, David; Lagrost, Laurent] Hop Bocage, CHU Dijon, F-21034 Dijon, France; [Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Lagrost, L (corresponding author), Univ Bourgogne, INSERM, Ctr Rech,UMR866, Fac Med,Inst Federatif Rech Sante STIC, 7 Blvd Jeanne Arc,BP 87900, F-21079 Dijon, France.	laurent.lagrost@u-bourgogne.fr	MASSON, David/AAC-8896-2022; Masson, David/R-6633-2019; MASSON, David/R-4557-2017; Desrumaux, Catherine/O-1925-2018; Gautier, Thomas/Q-5371-2018; Paul, Catherine/F-8376-2019	MASSON, David/0000-0003-1692-0699; MASSON, David/0000-0003-1692-0699; Gautier, Thomas/0000-0003-1119-7382; DECKERT, Valerie/0000-0001-5728-1710; Paul, Catherine/0000-0002-7657-5535				Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Alexander S, 2004, BLOOD, V103, P93, DOI 10.1182/blood-2003-02-0660; Birjmohun RS, 2007, ARTERIOSCL THROM VAS, V27, P1153, DOI 10.1161/ATVBAHA.106.136325; CAVAILLON JM, 1990, INFECT IMMUN, V58, P2375, DOI 10.1128/IAI.58.7.2375-2382.1990; Chaby R, 2004, CELL MOL LIFE SCI, V61, P1697, DOI 10.1007/s00018-004-4020-4; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; DENTENER MA, 1995, J INFECT DIS, V171, P739, DOI 10.1093/infdis/171.3.739; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; EMANCIPATOR K, 1992, INFECT IMMUN, V60, P596, DOI 10.1128/IAI.60.2.596-601.1992; FLEGEL WA, 1989, INFECT IMMUN, V57, P2237, DOI 10.1128/IAI.57.7.2237-2245.1989; FREUDENBERG M A, 1990, International Reviews of Immunology, V6, P207, DOI 10.3109/08830189009056632; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GALLAY P, 1993, P NATL ACAD SCI USA, V90, P9935, DOI 10.1073/pnas.90.21.9935; Gauthier N, 2004, CARCINOGENESIS, V25, P1559, DOI 10.1093/carcin/bgh158; Guyard-Dangremont V, 1998, COMP BIOCHEM PHYS B, V120, P517, DOI 10.1016/S0305-0491(98)10038-X; Hailman E, 1996, J BIOL CHEM, V271, P12172, DOI 10.1074/jbc.271.21.12172; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Harris HW, 1998, HEPATOLOGY, V27, P1341, DOI 10.1002/hep.510270521; HEUMANN D, 1992, J IMMUNOL, V148, P3505; Hickey MJ, 1998, CIRC RES, V83, P1124, DOI 10.1161/01.RES.83.11.1124; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jiang XC, 2002, J BIOL CHEM, V277, P31850, DOI 10.1074/jbc.M205077200; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Jiang Z, 2004, INT IMMUNOPHARMACOL, V4, P527, DOI 10.1016/j.intimp.2004.02.004; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Klein A, 2006, ARTERIOSCL THROM VAS, V26, P2160, DOI 10.1161/01.ATV.0000235699.98024.11; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Levels JHM, 2005, INFECT IMMUN, V73, P2321, DOI 10.1128/IAI.73.4.2321-2326.2005; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; MUNFORD RS, 1982, J CLIN INVEST, V70, P877, DOI 10.1172/JCI110684; Oka T, 2000, J LIPID RES, V41, P1651; OLSSON NO, 1982, ANN INST PASTEUR IMM, VD133, P245; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; REDL H, 1993, IMMUNOBIOLOGY, V187, P330, DOI 10.1016/S0171-2985(11)80348-7; Reisser D, 1996, J LEUKOCYTE BIOL, V59, P728, DOI 10.1002/jlb.59.5.728; Saraf A, 1999, J ENVIRON MONITOR, V1, P163, DOI 10.1039/a809019j; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Settasatian N, 2001, J BIOL CHEM, V276, P26898, DOI 10.1074/jbc.M010708200; Sewnath ME, 2000, HEPATOLOGY, V32, P1289, DOI 10.1053/jhep.2000.20525; Szponar B, 2003, CLIN CHEM, V49, P1149, DOI 10.1373/49.7.1149; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; VANDEVENTER SJH, 1990, BLOOD, V76, P2520; Vesy CJ, 2000, INFECT IMMUN, V68, P2410, DOI 10.1128/IAI.68.5.2410-2417.2000; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WILDE CG, 1994, J BIOL CHEM, V269, P17411; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051	57	54	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18702	18710		10.1074/jbc.M802802200	http://dx.doi.org/10.1074/jbc.M802802200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18458077	hybrid			2022-12-27	WOS:000257165600027
J	Lyssand, JS; Defino, MC; Tang, XB; Hertz, AL; Feller, DB; Wacker, JL; Adams, ME; Hague, C				Lyssand, John S.; Defino, Mia C.; Tang, Xiao-Bo; Hertz, Angie L.; Feller, David B.; Wacker, Jennifer L.; Adams, Marvin E.; Hague, Chris			Blood pressure is regulated by an alpha(1D)-adrenergic receptor/dystrophin signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MYOCARDIAL CONTRACTILE RESPONSES; POSTTRAUMATIC-STRESS-DISORDER; CELL-SURFACE EXPRESSION; ALPHA(1B)-ADRENERGIC RECEPTOR; PDZ DOMAIN; ALPHA(1)-ADRENOCEPTOR SUBTYPES; NA+/PHOSPHATE-COTRANSPORTER; DYSTROPHIN COMPLEX; DIRECTLY INTERACTS	Hypertension is a cardiovascular disease associated with increased plasma catecholamines, overactivation of the sympathetic nervous system, and increased vascular tone and total peripheral resistance. A key regulator of sympathetic nervous system function is the alpha(1D)-adrenergic receptor (AR), which belongs to the adrenergic family of G-protein-coupled receptors (GPCRs). Endogenous catecholamines norepinephrine and epinephrine activate alpha(1D)-ARs on vascular smooth muscle to stimulate vasoconstriction, which increases total peripheral resistance and mean arterial pressure. Indeed, alpha(1D)-AR KO mice display a hypotensive phenotype and are resistant to salt-induced hypertension. Unfortunately, little information exists about how this important GPCR functions because of an inability to obtain functional expression in vitro. Here, we identified the dystrophin proteins, syntrophin, dystrobrevin, and utrophin as essential GPCR-interacting proteins for alpha(1D)-ARs. We found that dystrophins complex with alpha(1D)-AR both in vitro and in vivo to ensure proper functional expression. More importantly, we demonstrate that knock-out of multiple syntrophin isoforms results in the complete loss of alpha(1D)-AR function in mouse aortic smooth muscle cells and abrogation of alpha(1D)-AR-mediated increases in blood pressure. Our findings demonstrate that syntrophin and utrophin associate with alpha(1D)-ARs to create a functional signalosome, which is essential for alpha(1D)-AR regulation of vascular tone and blood pressure.	[Lyssand, John S.; Defino, Mia C.; Tang, Xiao-Bo; Hertz, Angie L.; Feller, David B.; Wacker, Jennifer L.; Hague, Chris] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Adams, Marvin E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hague, C (corresponding author), 1959 NE Pacific St,Box 357280, Seattle, WA 98195 USA.	chague@u.washington.edu			NHLBI NIH HHS [T32 HL07312] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07750, T32 GM07270] Funding Source: Medline; NINDS NIH HHS [R01 NS033145, NS33145] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750, T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams ME, 2004, J NEUROSCI, V24, P10302, DOI 10.1523/JNEUROSCI.3408-04.2004; ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Battaglia G, 2003, J NEUROCHEM, V86, P413, DOI 10.1046/j.1471-4159.2003.01867.x; Cavalli A, 1997, P NATL ACAD SCI USA, V94, P11589, DOI 10.1073/pnas.94.21.11589; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; Diviani D, 2003, J BIOL CHEM, V278, P19331, DOI 10.1074/jbc.M302110200; Faber JE, 2001, J PHARMACOL EXP THER, V298, P441; Gee SH, 1998, J NEUROSCI, V18, P128; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; Hague C, 2006, MOL PHARMACOL, V69, P45, DOI 10.1124/mol.105.014985; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hague C, 2004, J PHARMACOL EXP THER, V309, P388, DOI 10.1124/jpet.103.060509; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kuwasako K, 2001, J BIOL CHEM, V276, P49459, DOI 10.1074/jbc.M108369200; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; McCloskey DT, 2002, J MOL CELL CARDIOL, V34, P1007, DOI 10.1006/jmcc.2002.2049; Minneman KP, 2000, J NEUROCHEM, V74, P2392, DOI 10.1046/j.1471-4159.2000.0742392.x; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Onwochei MO, 1998, J CARDIOVASC PHARM, V31, P10, DOI 10.1097/00005344-199801000-00002; ONWOCHEI MO, 1995, J CARDIOVASC PHARM, V25, P833, DOI 10.1097/00005344-199505000-00021; ONWOCHEI MO, 1993, J CARDIOVASC PHARM, V22, P632, DOI 10.1097/00005344-199310000-00018; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Piascik MT, 1995, J PHARMACOL EXP THER, V275, P1583; Pupo AS, 2003, J RECEPT SIG TRANSD, V23, P185, DOI 10.1081/RRS-120025200; Raskind MA, 2000, J CLIN PSYCHIAT, V61, P129, DOI 10.4088/JCP.v61n0208; Raskind MA, 2002, J CLIN PSYCHIAT, V63, P565, DOI 10.4088/JCP.v63n0705; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Suzuki F, 2007, J BIOL CHEM, V282, P29563, DOI 10.1074/jbc.M702063200; Tanoue A, 2002, HYPERTENSION, V40, P101, DOI 10.1161/01.HYP.0000022062.70639.1C; Tanoue A, 2002, J CLIN INVEST, V109, P765, DOI 10.1172/JCI200214001; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Uberti MA, 2003, MOL PHARMACOL, V64, P1379, DOI 10.1124/mol.64.6.1379; Vicentic A, 2002, J PHARMACOL EXP THER, V302, P58, DOI 10.1124/jpet.302.1.58; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Xu ZJ, 1999, J BIOL CHEM, V274, P21149, DOI 10.1074/jbc.274.30.21149; Yamamoto Y, 2001, EUR J PHARMACOL, V424, P131, DOI 10.1016/S0014-2999(01)01134-7; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	51	56	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18792	18800		10.1074/jbc.M801860200	http://dx.doi.org/10.1074/jbc.M801860200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18468998	hybrid, Green Published			2022-12-27	WOS:000257165600036
J	Nakaya, T; Kawai, T; Suzuki, T				Nakaya, Tadashi; Kawai, Tomoko; Suzuki, Toshiharu			Regulation of FE65 nuclear translocation and function by amyloid beta-protein precursor in osmotically stressed cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR DOMAIN; DEPENDENT REGULATION; CYTOPLASMIC DOMAIN; HISTONE H2AX; PHOSPHORYLATION; TRANSCRIPTION; APP; KINASE; BREAKS; FORMS	FE65, a neural adaptor protein, interacts with amyloid beta-protein precursor (APP) and is known to regulate amyloid beta generation from APP. FE65 also associates with nuclear proteins; however, its physiological function in the nucleus remains unclear. A fixed population of cytoplasmic FE65 is tethered to membranes by binding APP. This membrane-tethered FE65 is liberated from membranes by APP phosphorylation, which is facilitated by a stress-activated protein kinase in sorbitol-treated cells. Here we show that liberated FE65, which is distinct from "virgin" FE65 in the cytoplasm, translocates into the nucleus and accumulates in the nuclear matrix forming a patched structure. Targeting of FE65 into the nuclear matrix was suppressed by the APP intracellular domain fragment, which is generated by consecutive cleavages of APP. Thus, nuclear translocation of FE65 is under the regulation of APP. In the nucleus, FE65 induced gamma H2AX, which plays an important role in DNA repair as a cellular response by stress-damaged cells. These observations suggest that APP-regulated FE65 plays an important role in the early stress response of cells and that FE65 deregulated from APP induces apoptosis.	[Nakaya, Tadashi; Kawai, Tomoko; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Suzuki, Toshiharu/B-5342-2013					Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Aplin AE, 1996, J NEUROCHEM, V67, P699; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; FEY EG, 1986, J CELL BIOL, V102, P1654, DOI 10.1083/jcb.102.5.1654; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Kitagawa D, 2002, J BIOL CHEM, V277, P366, DOI 10.1074/jbc.M107110200; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Muresan Z, 2004, HUM MOL GENET, V13, P475, DOI 10.1093/hmg/ddh054; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Taru H, 2004, J BIOL CHEM, V279, P21628, DOI 10.1074/jbc.M312007200; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128	29	31	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19119	19131		10.1074/jbc.M801827200	http://dx.doi.org/10.1074/jbc.M801827200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18468999	hybrid			2022-12-27	WOS:000257165600067
J	Johnson, KA				Johnson, Kenneth A.			Role of induced fit in enzyme specificity: A molecular forward/reverse switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MITOCHONDRIAL-DNA POLYMERASE; CONFORMATIONAL-CHANGES; TRANSFER-RNA; DIHYDROFOLATE-REDUCTASE; FIDELITY; REPLICATION; CATALYSIS; REEXAMINATION; HYDROLYSIS; MECHANISM	Enzyme structures solved with and without bound substrate often show that substrate-induced conformational changes bring catalytic residues into alignment, alter the local environment, and position the substrate for catalysis. Although the structural data are compelling, the role of conformational changes in enzyme specificity has been controversial in that specificity is a kinetic property that is not easy to predict based upon structure alone. Recent studies on DNA polymerization have illuminated the role of substrate-induced conformational changes in enzyme specificity by showing that the rate at which the enzyme opens to release the bound substrate is a key kinetic parameter. The slow release of a correct substrate commits it to the forward reaction so that specificity is determined solely by the rate of substrate binding, including the isomerization step, and not by the slower rate of the chemical reaction. In contrast, fast dissociation of an incorrect substrate favors release rather than reaction. Thus, the conformational change acts as a molecular switch to select the right substrate and to recognize and disfavor the reaction of an incorrect substrate. A conformational switch may also favor release rather than reverse reaction of the product.	Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [R01 GM071404]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071404, R01GM084741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM071404. This work was also supported by Welch Foundation Grant F-1604. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; Fersht A.R., 1999, ENZYME STRUCTURE MEC; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Koshland D., 1959, ENZYMES, V1, P305; Miller BG, 2002, ANNU REV BIOCHEM, V71, P847, DOI 10.1146/annurev.biochem.71.110601.135446; Post CB, 1995, BIOCHEMISTRY-US, V34, P15881, DOI 10.1021/bi00049a001; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Xiang Y, 2008, PROTEINS, V70, P231, DOI 10.1002/prot.21668	25	141	142	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26297	26301		10.1074/jbc.R800034200	http://dx.doi.org/10.1074/jbc.R800034200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18544537	Green Published, hybrid			2022-12-27	WOS:000259341600001
J	Morin, TJ; Kobertz, WR				Morin, Trevor J.; Kobertz, William R.			Tethering chemistry and K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SHAKER POTASSIUM CHANNEL; GATING-CHARGE; ION CHANNELS; TRANSMEMBRANE MOVEMENT; KCNQ1; S4; RECEPTOR; SUBUNITS; COMPLEX; REARRANGEMENT	Voltage-gated K+ channels are dynamic macromolecular machines that open and close in response to changes in membrane potential. These multisubunit membrane-embedded proteins are responsible for governing neuronal excitability, maintaining cardiac rhythmicity, and regulating epithelial electrolyte homeostasis. High resolution crystal structures have provided snapshots of K+ channels caught in different states with incriminating molecular detail. Nonetheless, the connection between these static images and the specific trajectories of K+ channel movements is still being resolved by biochemical experimentation. Electrophysiological recordings in the presence of chemical modifying reagents have been a staple in ion channel structure/ function studies during both the pre-and post-crystal structure eras. Small molecule tethering agents (chemoselective electrophiles linked to ligands) have proven to be particularly useful tools for defining the architecture and motions of K+ channels. This Minireview examines the synthesis and utilization of chemical tethering agents to probe and manipulate the assembly, structure, function, and molecular movements of voltage-gated K+ channel protein complexes.	[Kobertz, William R.] Univ Massachusetts, Sch Med, Program Neurosci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Prot Chem Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kobertz, WR (corresponding author), Univ Massachusetts, Sch Med, Program Neurosci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	william.kobertz@umassmed.edu			National Institutes of Health [GM-070650, DC-007669]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-070650 and DC-007669. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Aziz QH, 2002, J BIOL CHEM, V277, P42719, DOI 10.1074/jbc.M207258200; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bezanilla F, 2006, BIOL RES, V39, P425, DOI 10.4067/S0716-97602006000300005; Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; Blaustein RO, 2002, J GEN PHYSIOL, V120, P203, DOI 10.1085/jgp.20028613; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Darman RB, 2006, J GEN PHYSIOL, V128, P687, DOI 10.1085/jgp.200609624; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KARLIN A, 1968, P NATL ACAD SCI USA, V60, P668, DOI 10.1073/pnas.60.2.668; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LESTER HA, 1980, J GEN PHYSIOL, V75, P207, DOI 10.1085/jgp.75.2.207; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Morin TJ, 2007, ACS CHEM BIOL, V2, P469, DOI 10.1021/cb700089s; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Rocheleau JM, 2008, J GEN PHYSIOL, V131, P59, DOI 10.1085/jgp.200709816; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069	47	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2008	283	37					25105	25109		10.1074/jbc.R800033200	http://dx.doi.org/10.1074/jbc.R800033200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345QZ	18541528	Green Published, hybrid			2022-12-27	WOS:000259012700001
J	Tchivilev, I; Madamanchi, NR; Vendrov, AE; Niu, XL; Runge, MS				Tchivilev, Igor; Madamanchi, Nageswara R.; Vendrov, Aleksandr E.; Niu, Xi-Lin; Runge, Marschall S.			Identification of a protective role for protein phosphatase 1c gamma 1 against oxidative stress-induced vascular smooth muscle cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; TUMOR-SUPPRESSOR P53; REACTIVE OXYGEN; OKADAIC ACID; PROTEIN PHOSPHATASE-1; ENDOTHELIAL-CELLS; SIGNAL-TRANSDUCTION; EXPRESSION; ACTIVATION; BAX	The development of therapeutic strategies to inhibit reactive oxygen species (ROS)-mediated damage in blood vessels has been limited by a lack of specific targets for intervention. Targeting ROS-mediated events in the vessel wall is of interest, because ROS play important roles throughout atherogenesis. In early atherosclerosis, ROS stimulate vascular smooth muscle cell (VSMC) growth, whereas in late stages of lesion development, ROS induce VSMC apoptosis, causing atherosclerotic plaque instability. To identify putative protective genes against oxidative stress, mouse aortic VSMC were infected with a retroviral human heart cDNA expression library, and apoptosis was induced in virus-infected cells by 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) treatment. A total of 17 different, complete cDNAs were identified from the DMNQ-resistant VSMC clones by PCR amplification and sequencing. The cDNA encoding PP1c gamma 1 ( catalytic subunit of protein phosphatase 1) was present in several independent DMNQ-resistant VSMC clones. DMNQ increased mitochondrial ROS production, caspase-3/7 activity, DNA fragmentation, and decreased mitochondrial transmembrane potential in VSMC while decreasing PP1c gamma 1 activity and expression. Depletion of PP1c gamma 1 expression by short hairpin RNA significantly enhanced basal as well as DMNQ-induced VSMC apoptosis. PP1c gamma 1 overexpression abrogated DMNQ-induced JNK1 activity, p53Ser(15) phosphorylation, and Bax expression and protected VSMC against DMNQ-induced apoptosis. In addition, PP1c gamma 1 overexpression attenuated DMNQ-induced caspase-3/7 activation and DNA fragmentation. Inhibition of p53 protein expression using small interfering RNA abrogated DMNQ-induced Bax expression and significantly attenuated VSMC apoptosis. Together, these data indicate that PP1c gamma 1 overexpression promotes VSMC survival by interfering with JNK1 and p53 phosphorylation cascades involved in apoptosis.	[Tchivilev, Igor; Madamanchi, Nageswara R.; Vendrov, Aleksandr E.; Niu, Xi-Lin; Runge, Marschall S.] Univ N Carolina, Dept Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Runge, MS (corresponding author), Univ N Carolina, Dept Med, Carolina Cardiovasc Biol Ctr, 125 MacNider Hall, Chapel Hill, NC 27599 USA.	mrunge@med.unc.edu	Vendrov, Aleksandr E./AHE-8649-2022; Vendrov, Aleksandr/A-4115-2010; Vendrov, Aleksandr E./ABF-1266-2021	Vendrov, Aleksandr E./0000-0003-4971-8040; Vendrov, Aleksandr/0000-0003-4971-8040; Madamanchi, Nageswara/0000-0003-0590-0908	NHLBI NIH HHS [HL-57352] Funding Source: Medline; NIA NIH HHS [AG 024282] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akakura N, 2001, CANCER RES, V61, P6548; BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Callapina M, 2005, FREE RADICAL BIO MED, V39, P925, DOI 10.1016/j.freeradbiomed.2005.05.009; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Chu SJ, 2006, AM J PHYSIOL-LUNG C, V291, pL983, DOI 10.1152/ajplung.00454.2005; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 2002, J CELL SCI, V115, P241; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; FernandezSanchez MT, 1996, FEBS LETT, V398, P106, DOI 10.1016/S0014-5793(96)01192-1; Flogel U, 2004, FASEB J, V18, P1156, DOI 10.1096/fj.03-1382fje; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GJERTSEN BT, 1995, BBA-MOL CELL RES, V1269, P187, DOI 10.1016/0167-4889(95)00117-B; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HammKunzelmann B, 1997, FEBS LETT, V403, P87, DOI 10.1016/S0014-5793(97)00029-X; Haneda M, 2004, FEBS LETT, V567, P171, DOI 10.1016/j.febslet.2004.04.066; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; KIGUCHI K, 1994, CELL GROWTH DIFFER, V5, P995; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Li DWC, 1998, EUR J BIOCHEM, V257, P351, DOI 10.1046/j.1432-1327.1998.2570351.x; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Lorens JB, 2001, CURR OPIN BIOTECH, V12, P613, DOI 10.1016/S0958-1669(01)00269-5; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Martin-Ventura JL, 2006, ARTERIOSCL THROM VAS, V26, P1337, DOI 10.1161/01.ATV.0000220108.97208.67; MELLGREN G, 1993, EXP CELL RES, V205, P293, DOI 10.1006/excr.1993.1089; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Morana SJ, 1996, J BIOL CHEM, V271, P18263, DOI 10.1074/jbc.271.30.18263; Nagata S, 2003, CELL DEATH DIFFER, V10, P108, DOI 10.1038/sj.cdd.4401161; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Ramachandran A, 2002, BIOL CHEM, V383, P693, DOI 10.1515/BC.2002.071; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sandal T, 2001, CELL DEATH DIFFER, V8, P754, DOI 10.1038/sj.cdd.4400873; Sandau K, 1997, KIDNEY INT, V52, P378, DOI 10.1038/ki.1997.344; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; TAKENAKA I, 1995, J BIOL CHEM, V270, P5405, DOI 10.1074/jbc.270.10.5405; Tamm C, 2004, EUR J NEUROSCI, V19, P2613, DOI 10.1111/j.0953-816X.2004.03391.x; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Turenne GA, 2001, ONCOGENE, V20, P5100, DOI 10.1038/sj.onc.1204665; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Watanabe N, 2003, ARCH BIOCHEM BIOPHYS, V411, P145, DOI 10.1016/S0003-9861(02)00716-6; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yamamoto K, 2001, CANCER LETT, V168, P173, DOI 10.1016/S0304-3835(01)00532-8; Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090	78	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22193	22205		10.1074/jbc.M803452200	http://dx.doi.org/10.1074/jbc.M803452200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18540044	Green Published, hybrid			2022-12-27	WOS:000258114700039
J	Semenov, MV; Zhang, X; He, X				Semenov, Mikhail V.; Zhang, Xinjun; He, Xi			DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MASS; DICKKOPF-1; RECEPTORS; MECHANISM; PROTEINS; GENE; LIGAND; INHIBITION; INDUCTION; PATHWAY	DKK1 is a secreted protein that antagonizes Wnt signaling and plays essential roles in vertebrate embryogenesis including head induction, skeletal development, and limb patterning. DKK1 is also implicated in osteoporosis, arthritis, and cancer and represents a potential therapeutic target for the treatment of these diseases. DKK1 is a high affinity antagonistic ligand for LRP6, which is a Wnt coreceptor that acts together with the Frizzled serpentine receptor to initiate Wnt signal transduction. Two different models have been proposed to account for the mechanism by which DKK1 antagonizes LRP6 function. One model suggests that DKK1 binding to LRP6 disrupts Wnt-induced Frizzled-LRP6 complex formation, whereas the other model proposes that DKK1 interaction with LRP6 promotes LRP6 internalization and degradation, thereby reducing the cell surface LRP6 level. To clarify the molecular basis of DKK1 action, we examined how DKK1 affects the endogenous LRP6 in several mammalian cell lines including mouse embryonic fibroblasts. Here we show that DKK1 inhibits Wnt signaling but induces neither LRP6 down-regulation from the cell surface nor reduction of total LRP6 protein level and that DKK1 has no effect on the rate of continuous internalization of LRP6 and the half-life ( about 4.7 h) of LRP6. We conclude that DKK1 inhibition of LRP6 is independent of LRP6 internalization and degradation.	Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Semenov, MV (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 61 Binney St, Boston, MA 02115 USA.	mikhail.semenov@childrens.harvard.edu	Zhang, Xinjun/H-8034-2012		NIGMS NIH HHS [R01 GM 57603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mikheev AM, 2004, CARCINOGENESIS, V25, P47, DOI 10.1093/carcin/bgg190; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	39	102	112	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21427	21432		10.1074/jbc.M800014200	http://dx.doi.org/10.1074/jbc.M800014200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18505732	Green Published, hybrid			2022-12-27	WOS:000257898800014
J	Skorupinska-Tudek, K; Poznanski, J; Wojcik, J; Bienkowski, T; Szostkiewicz, I; Zelman-Femiak, M; Bajda, A; Chojnacki, T; Olszowska, O; Grunler, J; Meyer, O; Rohmer, M; Danikiewicz, W; Swiezewska, E				Skorupinska-Tudek, Karolina; Poznanski, Jaroslaw; Wojcik, Jacek; Bienkowski, Tomasz; Szostkiewicz, Izabela; Zelman-Femiak, Monika; Bajda, Agnieszka; Chojnacki, Tadeusz; Olszowska, Olga; Grunler, Jacob; Meyer, Odile; Rohmer, Michel; Danikiewicz, Witold; Swiezewska, Ewa			Contribution of the mevalonate and methylerythritol phosphate pathways to the biosynthesis of dolichols in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL-DIPHOSPHATE SYNTHASE; METABOLIC CROSS-TALK; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; ISOPENTENYL DIPHOSPHATE; MOLECULAR-CLONING; NONMEVALONATE PATHWAY; CYTOSOLIC MEVALONATE; CHLOROPLAST ENVELOPE; PLASTIDIAL PATHWAYS	Plant isoprenoids are derived from two biosynthetic pathways, the cytoplasmic mevalonate (MVA) and the plastidial methylerythritol phosphate (MEP) pathway. In this study their respective contributions toward formation of dolichols in Coluria geoides hairy root culture were estimated using in vivo labeling with C-13-labeled glucose as a general precursor. NMR and mass spectrometry showed that both the MVA and MEP pathways were the sources of isopentenyl diphosphate incorporated into polyisoprenoid chains. The involvement of the MEP pathway was found to be substantial at the initiation stage of dolichol chain synthesis, but it was virtually nil at the terminal steps; statistically, 6-8 isoprene units within the dolichol molecule (i.e. 40-50% of the total) were derived from the MEP pathway. These results were further verified by incorporation of [5-H-2] mevalonate or [5,5-H-2(2)] deoxyxylulose into dolichols as well as by the observed decreased accumulation of dolichols upon treatment with mevinolin or fosmidomycin, selective inhibitors of either pathway. The presented data indicate that the synthesis of dolichols in C. geoides roots involves a continuous exchange of intermediates between the MVA and MEP pathways. According to our model, oligoprenyl diphosphate chains of a length not exceeding 13 isoprene units are synthesized in plastids from isopentenyl diphosphate derived from both the MEP and MVA pathways, and then are completed in the cytoplasm with several units derived solely from the MVA pathway. This study also illustrates an innovative application of mass spectrometry for qualitative and quantitative evaluation of the contribution of individual metabolic pathways to the biosynthesis of natural products.	[Bienkowski, Tomasz; Danikiewicz, Witold] Polish Acad Sci, Inst Organ Chem, PL-01224 Warsaw, Poland; [Skorupinska-Tudek, Karolina; Poznanski, Jaroslaw; Wojcik, Jacek; Szostkiewicz, Izabela; Zelman-Femiak, Monika; Bajda, Agnieszka; Chojnacki, Tadeusz; Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Olszowska, Olga] Med Univ Warsaw, PL-02090 Warsaw, Poland; [Grunler, Jacob] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, S-17176 Stockholm, Sweden; [Meyer, Odile; Rohmer, Michel] Univ Strasbourg 1, CNRS, Inst Chim, F-6700 Strasbourg, France	Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Warsaw; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Danikiewicz, W (corresponding author), Polish Acad Sci, Inst Organ Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland.	witold@icho.edu.pl; ewas@ibb.waw.pl	poznanski, jarek/G-7064-2013; Poznanski, Jaroslaw/F-7705-2014; Danikiewicz, Witold/H-2257-2016	Poznanski, Jaroslaw/0000-0003-2684-1775; Wojcik, Jacek/0000-0002-7685-3515; Swiezewska, Ewa/0000-0002-3439-8948; Skorupinska-Tudek, Karolina/0000-0002-3472-2517; Danikiewicz, Witold/0000-0003-0484-2689				ADAIR WL, 1982, J BIOL CHEM, V257, P8990; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Asawatreratanakul K, 2003, EUR J BIOCHEM, V270, P4671, DOI 10.1046/j.1432-1033.2003.03863.x; BACH TJ, 1995, LIPIDS, V30, P191, DOI 10.1007/BF02537822; Barlow AJ, 2003, PHYTOCHEMISTRY, V63, P25, DOI 10.1016/S0031-9422(02)00725-2; Bick JA, 2003, ARCH BIOCHEM BIOPHYS, V415, P146, DOI 10.1016/S0003-9861(03)00233-9; Bouvier F, 2000, PLANT J, V24, P241, DOI 10.1046/j.1365-313x.2000.00875.x; BRANDT S, 1999, DATA ANAL STAT COMPU, P423; CANET D, 1976, J MAGN RESON, V23, P361, DOI 10.1016/0022-2364(76)90220-1; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Cunillera N, 2000, FEBS LETT, V477, P170, DOI 10.1016/S0014-5793(00)01798-1; Disch A, 1998, BIOCHEM J, V331, P615, DOI 10.1042/bj3310615; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Duvold T, 1997, TETRAHEDRON LETT, V38, P6181, DOI 10.1016/S0040-4039(97)01392-0; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; ERICSSON J, 1993, J BIOL CHEM, V268, P832; Ferro M, 2002, P NATL ACAD SCI USA, V99, P11487, DOI 10.1073/pnas.172390399; FREEMAN R, 1972, J MAGN RESON, V7, P327, DOI 10.1016/0022-2364(72)90194-1; Fukusaki E, 2004, BIOSCI BIOTECH BIOCH, V68, P1988, DOI 10.1271/bbb.68.1988; Ge XC, 2005, PLANT SCI, V168, P487, DOI 10.1016/j.plantsci.2004.09.012; GOUGH DP, 1970, BIOCHEM J, V117, P309, DOI 10.1042/bj1170309; Hampel D, 2005, PHYTOCHEMISTRY, V66, P305, DOI 10.1016/j.phytochem.2004.12.010; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; HEMMING FW, 1983, BIOCHEM SOC T, V11, P497, DOI 10.1042/bst0110497; HEMMING FW, 1992, BIOCHEM CELL BIOL, V70, P377, DOI 10.1139/o92-058; Kasahara H, 2002, J BIOL CHEM, V277, P45188, DOI 10.1074/jbc.M208659200; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KELLER RK, 1986, J BIOL CHEM, V261, P2053; Kharel Y, 2003, NAT PROD REP, V20, P111, DOI 10.1039/b108934j; KONTAXIS G, 1994, J MAGN RESON SER A, V111, P70, DOI 10.1006/jmra.1994.1227; KREUZ K, 1984, EUR J BIOCHEM, V141, P531, DOI 10.1111/j.1432-1033.1984.tb08225.x; Kurisaki A, 1997, PHYTOCHEMISTRY, V44, P45, DOI 10.1016/S0031-9422(96)00400-1; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Meyer O, 2004, TETRAHEDRON, V60, P12153, DOI 10.1016/j.tet.2004.10.016; Milborrow BV, 2001, J EXP BOT, V52, P1145, DOI 10.1093/jexbot/52.359.1145; Nagata N, 2002, PLANTA, V216, P345, DOI 10.1007/s00425-002-0871-9; Oh SK, 2000, J BIOL CHEM, V275, P18482, DOI 10.1074/jbc.M002000200; Okada K, 2000, PLANT PHYSIOL, V122, P1045, DOI 10.1104/pp.122.4.1045; Olszowska O, 1996, PLANT CELL TISS ORG, V45, P273, DOI 10.1007/BF00043642; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Piel J, 1998, ANGEW CHEM INT EDIT, V37, P2478, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2478::AID-ANIE2478>3.0.CO;2-Q; Rezanka T, 2001, J CHROMATOGR A, V936, P95, DOI 10.1016/S0021-9673(01)01152-9; Rodriguez-Concepcion M, 2004, PLANT CELL, V16, P144, DOI 10.1105/tpc.016204; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Sakaihara T, 2000, J BIOCHEM-TOKYO, V128, P1073, DOI 10.1093/oxfordjournals.jbchem.a022835; Sanmiya K, 1999, PLANT CELL PHYSIOL, V40, P348, DOI 10.1093/oxfordjournals.pcp.a029549; Schuhr Christoph A., 2003, Phytochemistry Reviews, V2, P3, DOI 10.1023/B:PHYT.0000004180.25066.62; Skorupinska-Tudek K, 2003, LIPIDS, V38, P981, DOI 10.1007/s11745-003-1152-3; SOLER E, 1993, PLANTA, V191, P324, DOI 10.1007/BF00195689; SWIEZEWSKA E, 1993, BIOCHEM BIOPH RES CO, V192, P161, DOI 10.1006/bbrc.1993.1395; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; TANAKA Y, 1987, BIOCHEM J, V243, P481, DOI 10.1042/bj2430481; VOGELI U, 1991, ARCH BIOCHEM BIOPHYS, V288, P157, DOI 10.1016/0003-9861(91)90178-L; Yamazaki Y, 2004, PLANT PHYSIOL, V134, P161, DOI 10.1104/pp.103.029389	60	58	60	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21024	21035		10.1074/jbc.M706069200	http://dx.doi.org/10.1074/jbc.M706069200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502754	Green Published, hybrid			2022-12-27	WOS:000257746100044
J	Steichen, JM; Petty, RV; Sharkey, TD				Steichen, Jon M.; Petty, Ryan V.; Sharkey, Thomas D.			Domain characterization of a 4-alpha-glucanotransferase essential for maltose metabolism in photosynthetic leaves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARCH DEGRADATION; TRANSITORY STARCH; ALPHA-AMYLASE; ARABIDOPSIS LEAVES; R1 PROTEIN; AMYLOMALTASE; PHOSPHORYLASE; CHLOROPLAST; IDENTIFICATION; INTERMEDIATE	Maltose metabolism during the conversion of transitory (leaf) starch to sucrose requires a 4-alpha-glucanotransferase (EC 2.4.1.25) in the cytosol of leaf cells. This enzyme is called DPE2 because of its similarity to the disproportionating enzyme in plastids (DPE1). DPE1 does not use maltose; it primarily transfers a maltosyl unit from one maltotriose to a second maltotriose to make glucose and maltopentaose. DPE2 is a modular protein consisting of a family 77 glycosyl hydrolase domain, similar to DPE1, but unlike DPE1 the domain is interrupted by an insertion of similar to 150 amino acids as well as an N-terminal extension that consists of two carbohydrate binding modules. Phylogenetic analysis shows that the DPE2-type enzyme is present in a limited but highly diverse group of organisms. Here we show that DPE2 transfers the non-reducing glucosyl unit from maltose to glycogen by a ping-pong mechanism. The forward reaction (consumption of maltose) is specific for the beta- anomer of maltose, while the reverse reaction (production of maltose) is not stereospecific for the acceptor glucose. Additionally, through deletion mutants we show that the glycosyl hydrolase domain alone provides disproportionating activity with a much higher affinity for short maltodextrins than the complete wild-type enzyme, while absence of the carbohydrate binding modules completely abolishes activity with large complex carbohydrates, reflecting the presumed function of DPE2 in vivo.	[Sharkey, Thomas D.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Steichen, Jon M.; Sharkey, Thomas D.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Petty, Ryan V.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Michigan State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sharkey, TD (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	tsharkey@msu.edu	Sharkey, Thomas D/B-4032-2009; Sharkey, Thomas/ABF-1317-2020	Sharkey, Thomas D/0000-0002-4423-3223; Sharkey, Thomas/0000-0002-4423-3223				Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Dumez S, 2006, PLANT CELL, V18, P2694, DOI 10.1105/tpc.105.037671; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; KAKEFUDA G, 1989, PLANT PHYSIOL, V91, P136, DOI 10.1104/pp.91.1.136; Kaper T, 2005, APPL ENVIRON MICROB, V71, P5098, DOI 10.1128/AEM.71.9.5098-5106.2005; Kaper T, 2007, BIOCHEMISTRY-US, V46, P5261, DOI 10.1021/bi602408j; KEILIN D, 1952, BIOCHEM J, V50, P341, DOI 10.1042/bj0500341; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Lee SB, 2001, CARBOHYD RES, V336, P47, DOI 10.1016/S0008-6215(01)00247-6; Lloyd JR, 2004, PLANT PHYSIOL, V134, P1347, DOI 10.1104/pp.103.038026; Lu Y, 2006, PLANT CELL ENVIRON, V29, P353, DOI 10.1111/j.1365-3040.2005.01480.x; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Lu Y, 2006, PLANT PHYSIOL, V142, P878, DOI 10.1104/pp.106.086850; Lu Y, 2006, PLANTA, V224, P935, DOI 10.1007/s00425-006-0263-7; Machovic M, 2005, FEBS J, V272, P5497, DOI 10.1111/j.1742-4658.2005.04942.x; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; PALM D, 1990, BIOCHEMISTRY-US, V29, P1099, DOI 10.1021/bi00457a001; Reimann R, 2002, PHYSIOL PLANTARUM, V114, P2, DOI 10.1034/j.1399-3054.2002.1140102.x; Ritte G, 2004, PLANT PHYSIOL, V135, P2068, DOI 10.1104/pp.104.041301; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Shirokane Y, 2000, CARBOHYD RES, V329, P699, DOI 10.1016/S0008-6215(00)00232-9; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; TAKAHA T, 1993, J BIOL CHEM, V268, P1391; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Weise SE, 2005, PLANT PHYSIOL, V137, P756, DOI 10.1104/pp.104.055996; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YANG Y, 1990, PLANT PHYSIOL, V94, P960, DOI 10.1104/pp.94.3.960; Zeeman SC, 2007, FUNCT PLANT BIOL, V34, P465, DOI 10.1071/FP06313	31	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20797	20804		10.1074/jbc.M803051200	http://dx.doi.org/10.1074/jbc.M803051200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499663	hybrid, Green Published			2022-12-27	WOS:000257746100021
J	Carlsson, P; Presto, J; Spillmann, D; Lindahl, U; Kjellen, L				Carlsson, Pernilla; Presto, Jenny; Spillmann, Dorothe; Lindahl, Ulf; Kjellen, Lena			Heparin/heparan sulfate biosynthesis - Processive formation of N-sulfated domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; 5'-PHOSPHOSULFATE TRANSPORTER; MOLECULAR DIVERSITY; GOLGI LOCALIZATION; TUMOR SUPPRESSORS; ENZYME-ACTIVITY; MAST-CELLS; SULFOTRANSFERASE; EXPRESSION; CLONING	Heparan sulfate (HS) proteoglycans influence embryonic development as well as adult physiology through interactions with various proteins, including growth factors/morphogens and their receptors. The interactions depend on HS structure, which is largely determined during biosynthesis by Golgi enzymes. A key step is the initial generation of N-sulfated domains, primary sites for further polymer modification and ultimately for functional interactions with protein ligands. Such domains, generated through action of a bifunctional GlcNAc N-deacetylase/ N-sulfotransferase (NDST) on a [GlcUA-GlcNAc](n) substrate, are of variable size due to regulatory mechanisms that remain poorly understood. We have studied the action of recombinant NDSTs on the [GlcUA-GlcNAc] n precursor in the presence and absence of the sulfate donor, 3'-phosphoadenosine 5'-phosphosulfate (PAPS). In the absence of PAPS, NDST catalyzes limited and seemingly random N-deacetylation of GlcNAc residues. By contrast, access to PAPS shifts the NDST toward generation of extended N-sulfated domains that are formed through coupled N-deacetylation/N-sulfation in an apparent processive mode. Variations in N-substitution pattern could be obtained by varying PAPS concentration or by experimentally segregating the N-deacetylation and N-sulfation steps. We speculate that similar mechanisms may apply also to the regulation of HS biosynthesis in the living cell.	[Carlsson, Pernilla; Presto, Jenny; Spillmann, Dorothe; Lindahl, Ulf; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University	Kjellen, L (corresponding author), Box 582, SE-75123 Uppsala, Sweden.	lena.kjellen@imbim.uu.se	Kjellen, Lena/F-1362-2011	Presto, Jenny/0000-0001-5102-6815				Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Crawford BE, 2001, J BIOL CHEM, V276, P21538, DOI 10.1074/jbc.M100880200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; HOOK M, 1975, J BIOL CHEM, V250, P6065; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; KJELLEN L, 1992, ADV EXP MED BIOL, V313, P107; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; Kreuger J, 2002, EMBO J, V21, P6303, DOI 10.1093/emboj/cdf638; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; LIDHOLT K, 1989, BIOCHEM J, V261, P999, DOI 10.1042/bj2610999; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nagai N, 2004, J CELL SCI, V117, P3331, DOI 10.1242/jcs.01191; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; PINHAL MA, 2001, P NATL ACAD SCI USA, V30, P30; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; RIESENFELD J, 1982, J BIOL CHEM, V257, P421; RIESENFELD J, 1982, J BIOL CHEM, V257, P7050; Roman E, 2003, BIOCHEM J, V374, P767, DOI 10.1042/BJ20030365; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885	38	96	98	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20008	20014		10.1074/jbc.M801652200	http://dx.doi.org/10.1074/jbc.M801652200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487608	hybrid			2022-12-27	WOS:000257565300016
J	Mazauric, MH; Licznar, P; Prere, MF; Canal, I; Fayet, O				Mazauric, Marie-Helene; Licznar, Patricia; Prere, Marie-Francoise; Canal, Isabelle; Fayet, Olivier			Apical loop-internal loop RNA pseudoknots - A new type of stimulator of-1 translational frameshifting in bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BICOID MESSENGER-RNA; RIBOSOMAL FRAMESHIFT; ESCHERICHIA-COLI; GENE-EXPRESSION; SEQUENCE; SIGNAL; TRANSPOSITION; DIMERIZATION; INITIATION; MECHANISM	Nearly all members of a widespread family of bacterial transposable elements related to insertion sequence 3 (IS3), therefore called the IS3 family, very likely use programmed -1 ribosomal frameshifting to produce their transposase, a protein required for mobility. Comparative analysis of the potential frameshift signals in this family suggested that most of the insertion sequences from the IS51 group contain in their mRNA an elaborate pseudoknot that could act as a recoding stimulator. It results from a specific intramolecular interaction between an apical loop and an internal loop from two stem-loop structures. Directed mutagenesis, chemical probing, and gel mobility assays of the frameshift region of one element from the IS51 group, IS3411, provided clear evidences of the existence of the predicted structure. Modeling was used to generate a three-dimensional molecular representation of the apical loop-internal loop complex. We could demonstrate that mutations affecting the stability of the structure reduce both frameshifting and transposition, thus establishing the biological importance of this new type of RNA structure for the control of transposition level.	CNRS, UMR5100, Lab Microbiol & Genet Mol, F-31062 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fayet, O (corresponding author), Univ Toulouse 3, CNRS, UMR5100, Bat IBCG,118 Route Narbonne, F-31062 Toulouse 9, France.	Olivier.Fayet@ibcg.biotoul.fr						Aldaz-Carroll L, 2002, BIOCHEMISTRY-US, V41, P5883, DOI 10.1021/bi0121508; Bao TH, 1997, EMBO J, V16, P3357, DOI 10.1093/emboj/16.11.3357; Baranov PV, 2006, TRENDS GENET, V22, P174, DOI 10.1016/j.tig.2006.01.005; Barry JK, 2002, P NATL ACAD SCI USA, V99, P11133, DOI 10.1073/pnas.162223099; Bertrand C, 2002, RNA, V8, P16, DOI 10.1017/S1355838202012086; Brierley I, 2001, COLD SPRING HARB SYM, V66, P233, DOI 10.1101/sqb.2001.66.233; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Brunel C, 2002, BIOCHIMIE, V84, P925, DOI 10.1016/S0300-9084(02)01401-3; Chandler M, 2002, MOBILE DNA, V2, P305; Chen CC, 2006, J BIOL CHEM, V281, P21617, DOI 10.1074/jbc.M602437200; Chen CP, 1999, RNA, V5, P805, DOI 10.1017/S1355838299990350; Clever JL, 1996, J VIROL, V70, P5902, DOI 10.1128/JVI.70.9.5902-5908.1996; Dulude D, 2002, NUCLEIC ACIDS RES, V30, P5094, DOI 10.1093/nar/gkf657; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; Gaudin C, 2005, J MOL BIOL, V349, P1024, DOI 10.1016/j.jmb.2005.04.045; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Gomes SD, 2004, BIOCHEM BIOPH RES CO, V322, P820, DOI 10.1016/j.bbrc.2004.07.185; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Horiya S, 2003, CHEM BIOL, V10, P645, DOI 10.1016/S1074-5521(03)00146-7; ISHIGURO N, 1988, J BACTERIOL, V170, P1902, DOI 10.1128/jb.170.4.1902-1906.1988; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Kanevsky I, 2003, NUCLEIC ACIDS RES, V31, P7070, DOI 10.1093/nar/gkg942; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Larsen B, 1997, J MOL BIOL, V271, P47, DOI 10.1006/jmbi.1997.1162; Licznar P, 2003, EMBO J, V22, P4770, DOI 10.1093/emboj/cdg465; Lodmell JS, 2000, RNA, V6, P1267, DOI 10.1017/S1355838200000698; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Mejlhede N, 2004, J BACTERIOL, V186, P3274, DOI 10.1128/JB.186.10.3274-3277.2004; Michiels PJA, 2001, J MOL BIOL, V310, P1109, DOI 10.1006/jmbi.2001.4823; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Napthine S, 2003, EMBO J, V22, P3941, DOI 10.1093/emboj/cdg365; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLARD P, 1991, J MOL BIOL, V222, P465, DOI 10.1016/0022-2836(91)90490-W; Rettberg CC, 1999, J MOL BIOL, V286, P1365, DOI 10.1006/jmbi.1999.2546; ROMBY P, 1987, J MOL BIOL, V195, P193, DOI 10.1016/0022-2836(87)90336-6; SEKINE Y, 1994, J MOL BIOL, V235, P1406, DOI 10.1006/jmbi.1994.1097; SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; ten Dam E B, 1990, Virus Genes, V4, P121, DOI 10.1007/BF00678404; TU CL, 1992, P NATL ACAD SCI USA, V89, P8636, DOI 10.1073/pnas.89.18.8636; VOGELE K, 1991, NUCLEIC ACIDS RES, V19, P4377, DOI 10.1093/nar/19.16.4377; Wagner C, 2004, J BIOL CHEM, V279, P4560, DOI 10.1074/jbc.M306511200; ZHENG JH, 1995, MOL MICROBIOL, V16, P669, DOI 10.1111/j.1365-2958.1995.tb02429.x	50	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20421	20432		10.1074/jbc.M802829200	http://dx.doi.org/10.1074/jbc.M802829200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18474594	hybrid			2022-12-27	WOS:000257565300057
J	Perello, M; Stuart, R; Nillni, EA				Perello, Mario; Stuart, Ronald; Nillni, Eduardo A.			Prothyrotropin-releasing hormone targets its processing products to different vesicles of the secretory pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; PITUITARY-TUMOR-CELLS; PRO-ACTH-ENDORPHIN; ATT20 CELLS; PARAVENTRICULAR NUCLEUS; ATT-20 CELLS; ENDOPROTEOLYTIC CLEAVAGE; HYPOTHALAMIC NEURONS; INTRACELLULAR SITES; FOOD-INTAKE	Prothyrotropin-releasing hormone (pro-TRH) is initially cleaved by the prohormone convertase-1/3 (PC1/3) in the transGolgi network generating N- and C-terminal intermediate forms that are then packed into secretory vesicles. However, it is not known whether these peptides are differentially sorted within the secretory pathway. This is of key importance because the processing products of several prohormones fulfill different biological functions. Using AtT20 cells stably transfected with prepro-TRH cDNA, we found that two specific N- and C-terminal peptides were located in different vesicles. Furthermore, the C-terminal pro-TRH-derived peptides were more efficiently released in response to KCl and norepinephrine, a natural secretagogue of TRH. Similar sorting and secretion of N- and C-terminal peptides occurs in vivo. When we blocked the initial proteolytic processing by a mutagenic approach, the differential sorting and secretion of these peptides were prevented. In summary, our data show that pro-TRH-derived peptides are differentially sorted within the secretory pathway and that the initial cleavage in the trans-Golgi network is key to this process. This could be a common mechanism used by neuroendocrine cells to regulate independently the secretion of different bioactive peptides derived from the same gene product.	[Perello, Mario; Stuart, Ronald; Nillni, Eduardo A.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch,Dept Med, Div Endocrinol, Providence, RI 02903 USA; [Nillni, Eduardo A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Nillni, EA (corresponding author), 55 Claverick St,Rm 320, Providence, RI 02903 USA.	Eduardo_Nillni@brown.edu		Perello, Mario/0000-0003-2114-6765	NIDDK NIH HHS [R01 DK 58148] Funding Source: Medline; NINDS NIH HHS [R01 NS 045231] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045231] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki Y, 1997, ENDOCRINOLOGY, V138, P1923, DOI 10.1210/en.138.5.1923; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; BULANT M, 1990, P NATL ACAD SCI USA, V87, P4439, DOI 10.1073/pnas.87.12.4439; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cote-Velez A, 2005, J MOL ENDOCRINOL, V34, P177, DOI 10.1677/jme.1.01634; delaCruz IP, 1996, J BIOL CHEM, V271, P22736, DOI 10.1074/jbc.271.37.22736; DEVI L, 1991, FEBS LETT, V280, P189, DOI 10.1016/0014-5793(91)80290-J; Diano S, 1998, J NEUROENDOCRINOL, V10, P647, DOI 10.1046/j.1365-2826.1998.00261.x; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; FISHER JM, 1988, J BIOL CHEM, V263, P16515; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; Glass MJ, 1999, NEUROPEPTIDES, V33, P360, DOI 10.1054/npep.1999.0050; Glombik MM, 2000, BIOCHIMIE, V82, P315, DOI 10.1016/S0300-9084(00)00195-4; Goldstein J, 2007, J MOL NEUROSCI, V31, P69, DOI 10.1007/BF02686119; Josic D, 2005, ELECTROPHORESIS, V26, P2809, DOI 10.1002/elps.200500060; Klumperman J, 1996, J NEUROSCI, V16, P7930; MAINS RE, 1981, J CELL BIOL, V89, P21, DOI 10.1083/jcb.89.1.21; MERIGHI A, 1992, ELECT MICROSCOPIC IM, P51; Mulcahy LR, 2005, J BIOL CHEM, V280, P39818, DOI 10.1074/jbc.M507193200; NILLNI EA, 1993, ENDOCRINOLOGY, V132, P1260, DOI 10.1210/en.132.3.1260; NILLNI EA, 1993, ENDOCRINOLOGY, V132, P1271, DOI 10.1210/en.132.3.1271; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; NILLNI EA, 1995, J NEUROCHEM, V65, P2462; Nillni EA, 2002, J NEUROCHEM, V80, P874, DOI 10.1046/j.0022-3042.2002.00763.x; Nillni EA, 2001, ENDOCRINOLOGY, V142, P896, DOI 10.1210/en.142.2.896; Perello M, 2007, FRONT BIOSCI-LANDMRK, V12, P3554, DOI 10.2741/2334; Perello M, 2006, ENDOCRINOLOGY, V147, P3296, DOI 10.1210/en.2005-1533; Perello M, 2006, ENDOCRINOLOGY, V147, P2705, DOI 10.1210/en.2005-1609; Perone MJ, 1998, MOL CELL ENDOCRINOL, V142, P191, DOI 10.1016/S0303-7207(98)00104-X; REISINE TD, 1983, J NEUROSCI, V3, P725; Schaner P, 1997, J BIOL CHEM, V272, P19958, DOI 10.1074/jbc.272.32.19958; SCHMIDT WK, 1994, J BIOL CHEM, V269, P27115; SCHMIDT WK, 1995, MOL BIOL CELL, V6, P1271, DOI 10.1091/mbc.6.10.1271; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; SOSSIN WS, 1990, J CELL BIOL, V110, P1, DOI 10.1083/jcb.110.1.1; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; TANAKA S, 1991, J HISTOCHEM CYTOCHEM, V39, P809, DOI 10.1177/39.6.1851777; TOOZE J, 1987, J CELL BIOL, V105, P155, DOI 10.1083/jcb.105.1.155; TOOZE J, 1987, J CELL BIOL, V105, P1215, DOI 10.1083/jcb.105.3.1215; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; VANHEUMEN WRA, 1991, CELL TISSUE RES, V264, P185, DOI 10.1007/BF00305737; Villeneuve P, 2000, NEUROREPORT, V11, P3443; WATTENBERG BW, 1990, J CELL PHYSIOL, V143, P287, DOI 10.1002/jcp.1041430212; XU H, 1994, BIOCHIMIE, V76, P257, DOI 10.1016/0300-9084(94)90155-4; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	48	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19936	19947		10.1074/jbc.M800732200	http://dx.doi.org/10.1074/jbc.M800732200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18474603	Green Published, hybrid			2022-12-27	WOS:000257565300009
J	Haring, SJ; Mason, AC; Binz, SK; Wold, MS				Haring, Stuart J.; Mason, Aaron C.; Binz, Sara K.; Wold, Marc S.			Cellular functions of human RPA1 - Multiple roles of domains in replication, repair, and checkpoints	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; PROTEIN-A RPA; DAMAGE CHECKPOINTS; BINDING-PROTEIN; 32-KDA SUBUNIT; IN-VITRO; PHOSPHORYLATION; RECOMBINATION; COMPLEX; MECHANISM	In eukaryotes, the single strand DNA (ssDNA)-binding protein, replication protein A (RPA), is essential for DNA replication, repair, and recombination. RPA is composed of the following three subunits: RPA1, RPA2, and RPA3. The RPA1 subunit contains four structurally related domains and is responsible for high affinity ssDNA binding. This study uses a depletion/replacement strategy in human cells to reveal the contributions of each domain to RPA cellular functions. Mutations that substantially decrease ssDNA binding activity do not necessarily disrupt cellular RPA function. Conversely, mutations that only slightly affect ssDNA binding can dramatically affect cellular function. The N terminus of RPA1 is not necessary for DNA replication in the cell; however, this region is important for the cellular response to DNA damage. Highly conserved aromatic residues in the high affinity ssDNA-binding domains are essential for DNA repair and cell cycle progression. Our findings suggest that as long as a threshold of RPA-ssDNA binding activity is met, DNA replication can occur and that an RPA activity separate from ssDNA binding is essential for function in DNA repair.	[Haring, Stuart J.; Mason, Aaron C.; Binz, Sara K.; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Wold, MS (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, 3107 MERF, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu	Wold, Marc/F-5806-2010; Haring, Stuart/E-7481-2012	Wold, Marc/0000-0002-4580-1624	NIGMS NIH HHS [GM44721, R01 GM044721] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Araya R, 2005, FEBS LETT, V579, P157, DOI 10.1016/j.febslet.2004.11.066; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Braun KA, 1997, BIOCHEMISTRY-US, V36, P8443, DOI 10.1021/bi970473r; Cuvier O, 2006, CURR BIOL, V16, P516, DOI 10.1016/j.cub.2006.01.059; Deng XY, 2007, J MOL BIOL, V374, P865, DOI 10.1016/j.jmb.2007.09.074; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; ERDILE LF, 1990, J BIOL CHEM, V265, P3177; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Galgoczy DJ, 2001, MOL CELL BIOL, V21, P1710, DOI 10.1128/MCB.21.5.1710-1718.2001; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; GOMES XV, 1995, J BIOL CHEM, V270, P4534, DOI 10.1074/jbc.270.9.4534; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517; Grandin N, 2007, NUCLEIC ACIDS RES, V35, P822, DOI 10.1093/nar/gkl1081; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Ishibashi T, 2006, J BIOCHEM, V139, P99, DOI 10.1093/jb/mvj014; Kanoh Y, 2006, GENE, V377, P88, DOI 10.1016/j.gene.2006.03.019; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; KENNY MK, 1990, J BIOL CHEM, V265, P769; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kumaran S, 2006, BIOCHEMISTRY-US, V45, P11958, DOI 10.1021/bi060994r; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Lee SE, 2003, MOL CELL BIOL, V23, P8913, DOI 10.1128/MCB.23.23.8913-8923.2003; Liu LF, 1996, ANN NY ACAD SCI, V803, P44, DOI 10.1111/j.1749-6632.1996.tb26375.x; LIU PK, 1983, P NATL ACAD SCI-BIOL, V80, P797, DOI 10.1073/pnas.80.3.797; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Murti KG, 1996, EXP CELL RES, V223, P279, DOI 10.1006/excr.1996.0083; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pestryakov PE, 2004, NUCLEIC ACIDS RES, V32, P1894, DOI 10.1093/nar/gkh346; Pfuetzner RA, 1997, J BIOL CHEM, V272, P430; Philipova D, 1996, GENE DEV, V10, P2222, DOI 10.1101/gad.10.17.2222; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Soustelle C, 2002, GENETICS, V161, P535; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Syljuasen RG, 2007, ONCOGENE, V26, P5833, DOI 10.1038/sj.onc.1210402; Tuteja N, 2001, CRIT REV BIOCHEM MOL, V36, P261, DOI 10.1080/20014091074192; Umezu K, 1998, GENETICS, V148, P989; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	70	88	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19095	19111		10.1074/jbc.M800881200	http://dx.doi.org/10.1074/jbc.M800881200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18469000	Green Published, hybrid			2022-12-27	WOS:000257165600065
J	Schwenk, J; Zolles, G; Kandias, NG; Neubauer, I; Kalbacher, H; Covarrubias, M; Fakler, B; Bentrop, D				Schwenk, Jochen; Zolles, Gerd; Kandias, Nikolaos G.; Neubauer, Isabel; Kalbacher, Hubert; Covarrubias, Manuel; Fakler, Bernd; Bentrop, Detlef			NMR analysis of KChIP4a reveals structural basis for control of surface expression of Kv4 channel complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; RESIDUAL DIPOLAR COUPLINGS; K+ CHANNELS; POTASSIUM CHANNELS; LARGE PROTEINS; BIOLOGICAL MACROMOLECULES; TERMINAL DOMAIN; MODULATION; BINDING; INACTIVATION	Potassium channel-interacting proteins ( KChIPs) are EF-hand calcium-binding proteins of the recoverin/neuronal calcium sensor 1 family that co-assemble with the pore-forming Kv4 alpha-subunits and thus control surface trafficking of the voltage-gated potassium channels mediating the neuronal IA and cardiac I-to currents. Different from the other KChIPs, KChIP4a largely reduces surface expression of the Kv4 channel complexes. Using solution NMR we show that the unique N terminus of KChIP4a forms a 6-turn alpha-helix that is connected to the highly conserved core of the KChIP protein via a solvent-exposed linker. As identified by chemical shift changes, N-terminal alpha-helix and core domain of KChIP4a interact with each other through the same hydrophobic surface pocket that is involved in intermolecular interaction between the N-terminal helix of Kv4 alpha and KChIP in Kv4-KChIP complexes. Electro-physiological recordings and biochemical interaction assays of complexes formed by wild-type and mutant Kv4 alpha and KChIP4a proteins suggest that competition of these two helical domains for the surface groove is responsible for the reduced trafficking of Kv4- KChIP4a complexes to the plasma membrane. Surface expression of Kv4 complexes may thus be controlled by an auto-inhibitory domain in the KChIP subunit.	[Schwenk, Jochen; Zolles, Gerd; Neubauer, Isabel; Fakler, Bernd; Bentrop, Detlef] Univ Freiburg, Inst Physiol 2, D-79104 Freiburg, Germany; [Kandias, Nikolaos G.] Univ Patras, Dept Pharm, Sch Hlth Sci, GR-26500 Patras, Greece; [Kalbacher, Hubert] Univ Tubingen, Interfacultary Inst Biochem, D-72074 Tubingen, Germany; [Kalbacher, Hubert] Univ Tubingen, Nat Sci Res Ctr, D-72074 Tubingen, Germany; [Covarrubias, Manuel] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	University of Freiburg; University of Patras; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Jefferson University	Bentrop, D (corresponding author), Hermann Herder Str 7, D-79104 Freiburg, Germany.	detlef.bentrop@physiologie.uni-freiburg.de		Schwenk, Jochen/0000-0003-3664-9795; Covarrubias, Manuel/0000-0002-0881-4143	NINDS NIH HHS [R01 NS032337] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032337] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Baker KA, 2006, BIOCHEMISTRY-US, V45, P1663, DOI 10.1021/bi0516430; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Berjanskii M, 2006, NAT PROTOC, V1, P683, DOI 10.1038/nprot.2006.108; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; Han W, 2006, J BIOL CHEM, V281, P27134, DOI 10.1074/jbc.M604843200; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nietlispach D, 2002, J AM CHEM SOC, V124, P11199, DOI 10.1021/ja025865m; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ou HD, 2001, J BIOMOL NMR, V21, P269, DOI 10.1023/A:1012920832184; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; Reese ML, 2003, J AM CHEM SOC, V125, P14250, DOI 10.1021/ja037640x; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	49	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18937	18946		10.1074/jbc.M800976200	http://dx.doi.org/10.1074/jbc.M800976200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18458082	Green Published, hybrid			2022-12-27	WOS:000257165600050
J	Yamaguchi, H; Woods, NT; Dorsey, JF; Takahashi, Y; Gjertsen, NR; Yeatman, T; Wu, J; Wang, HG				Yamaguchi, Hirohito; Woods, Nicholas T.; Dorsey, Jay F.; Takahashi, Yoshinori; Gjertsen, Nicole R.; Yeatman, Timothy; Wu, Jie; Wang, Hong-Gang			Src directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CURVATURE; MITOCHONDRIAL APOPTOSIS; CONFORMATIONAL-CHANGE; BH3 DOMAINS; PROTEIN; ACTIVATION; INDUCTION; BCL-2; METASTASIS; MECHANISMS	Bif-1 interacts with Bax and enhances its conformational rearrangement, resulting in apoptosis. However, the molecular mechanism governing the interaction between Bif-1 and Bax is poorly defined. Here we provide evidence that Bif-1 is phosphorylated, an event that can be repressed by apoptotic stimuli. The protein kinase c-Src binds to and directly phosphorylates Bif-1 on tyrosine 80. Moreover, Src phosphorylation of Bif-1 suppresses the interaction between Bif-1 and Bax, resulting in the inhibition of Bax activation during anoikis. Together, these results suggest that phosphorylation of Bif-1 impairs its binding to Bax and represses apoptosis, providing another mechanism by which Src oncogenic signaling can prevent cell death.	[Yamaguchi, Hirohito; Woods, Nicholas T.; Dorsey, Jay F.; Takahashi, Yoshinori; Gjertsen, Nicole R.; Yeatman, Timothy; Wu, Jie; Wang, Hong-Gang] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Wang, HG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Hong-Gang.Wang@Moffitt.org	Wu, Jie/R-2404-2019; Wang, Hong-Gang/A-3018-2015	Wu, Jie/0000-0002-2864-1606; Wang, Hong-Gang/0000-0003-0551-0571; Woods, Nicholas/0000-0002-4962-9083; Takahashi, Yoshinori/0000-0002-8004-4817	NCI NIH HHS [R01 CA090315, R01 CA077467, P01 CA118210, R01 CA082197] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090315, P01CA118210, R01CA077467, R01CA082197] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chung KC, 2001, J BIOL CHEM, V276, P2132, DOI 10.1074/jbc.M007492200; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Green DR, 2006, CANCER CELL, V9, P328, DOI 10.1016/j.ccr.2006.05.004; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Ott M, 2007, J BIOL CHEM, V282, P27633, DOI 10.1074/jbc.M703155200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Yamaguchi H, 2002, CANCER RES, V62, P466; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503	34	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19112	19118		10.1074/jbc.M709882200	http://dx.doi.org/10.1074/jbc.M709882200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18474606	hybrid, Green Published			2022-12-27	WOS:000257165600066
J	Keren, I; Klipcan, L; Bezawork-Geleta, A; Kolton, M; Shaya, F; Ostersetzer-Biran, O				Keren, Ido; Klipcan, Liron; Bezawork-Geleta, Ayenachew; Kolton, Max; Shaya, Felix; Ostersetzer-Biran, Oren			Characterization of the molecular basis of group II intron RNA recognition by CRS1-CRM domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; MULTIPLE SEQUENCE ALIGNMENT; SINGLE-STRANDED-DNA; PRE-MESSENGER-RNA; ESCHERICHIA-COLI; SPLICING FACTORS; KH DOMAINS; MAIZE CHLOROPLASTS; BINDING PROTEINS; CRM DOMAIN	CRM (chloroplast RNA splicing and ribosome maturation) is a recently recognized RNA-binding domain of ancient origin that has been retained in eukaryotic genomes only within the plant lineage. Whereas in bacteria CRM domains exist as single domain proteins involved in ribosome maturation, in plants they are found in a family of proteins that contain between one and four repeats. Several members of this family with multiple CRM domains have been shown to be required for the splicing of specific plastidic group II introns. Detailed biochemical analysis of one of these factors in maize, CRS1, demonstrated its high affinity and specific binding to the single group II intron whose splicing it facilitates, the plastid-encoded atpF intron RNA. Through its association with two intronic regions, CRS1 guides the folding of atpF intron RNA into its predicted "catalytically active" form. To understand how multiple CRM domains cooperate to achieve high affinity sequence-specific binding to RNA, we analyzed the RNA binding affinity and specificity associated with each individual CRM domain in CRS1; whereas CRM3 bound tightly to the RNA, CRM1 associated specifically with a unique region found within atpF intron domain I. CRM2, which demonstrated only low binding affinity, also seems to form specific interactions with regions localized to domains I, III, and IV. We further show that CRM domains share structural similarities and RNA binding characteristics with the well known RNA recognition motif domain.	[Keren, Ido; Klipcan, Liron; Bezawork-Geleta, Ayenachew; Kolton, Max; Shaya, Felix; Ostersetzer-Biran, Oren] Agr Res Org, Inst Plant Sci, IL-50250 Bet Dagan, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Ostersetzer-Biran, O (corresponding author), Agr Res Org, Inst Plant Sci, POB 6, IL-50250 Bet Dagan, Israel.	biranos@volcani.agri.gov.il	/AAM-4620-2021; Kolton, Max/J-1753-2019; Bezawork-Geleta, A/J-9567-2012; keren, ido/I-7727-2019	Kolton, Max/0000-0002-8166-3572; keren, ido/0000-0002-1872-8337; Bezawork-Geleta, Ayenachew/0000-0001-5404-5093; Bezawork-Geleta, Ayenachew/0000-0003-2739-8023				Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Asakura Y, 2007, PLANT CELL, V19, P3864, DOI 10.1105/tpc.107.055160; Asakura Y, 2006, PLANT PHYSIOL, V142, P1656, DOI 10.1104/pp.106.088096; Barkan A., 2004, MOL BIOL BIOTECHNOLO, P281, DOI DOI 10.1007/978-1-4020-3166-3_; Barkan A, 2007, RNA, V13, P55, DOI 10.1261/rna.139607; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; Brykailo MA, 2007, NUCLEIC ACIDS RES, V35, P1108, DOI 10.1093/nar/gkl1160; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Efimov AV, 1997, PROTEINS, V28, P241, DOI 10.1002/(SICI)1097-0134(199706)28:2<241::AID-PROT12>3.0.CO;2-I; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Huang YPJ, 2003, J MOL BIOL, V327, P521, DOI 10.1016/S0022-2836(03)00061-5; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jenkins BD, 1997, PLANT CELL, V9, P283, DOI 10.1105/tpc.9.3.283; Jenkins BD, 2001, EMBO J, V20, P872, DOI 10.1093/emboj/20.4.872; Jiang M, 2007, J BACTERIOL, V189, P3434, DOI 10.1128/JB.00090-07; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Liu DJ, 2004, J BIOMOL NMR, V29, P391, DOI 10.1023/B:JNMR.0000032524.62229.93; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ostersetzer O, 2005, PLANT CELL, V17, P241, DOI 10.1105/tpc.104.027516; Ostheimer GJ, 2003, EMBO J, V22, P3919, DOI 10.1093/emboj/cdg372; Ostheimer GJ, 2002, STRUCTURE, V10, P1593, DOI 10.1016/S0969-2126(02)00886-9; Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Terribilini M, 2006, RNA, V12, P1450, DOI 10.1261/rna.2197306; Till B, 2001, RNA, V7, P1227, DOI 10.1017/S1355838201010445; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Watkins KP, 2007, PLANT CELL, V19, P2606, DOI 10.1105/tpc.107.053736; Willis MA, 2002, PROTEINS, V49, P423, DOI 10.1002/prot.10225; Zhou Y, 2002, J MOL BIOL, V318, P1175, DOI 10.1016/S0022-2836(02)00238-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23333	23342		10.1074/jbc.M710488200	http://dx.doi.org/10.1074/jbc.M710488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18559344	hybrid			2022-12-27	WOS:000258455400043
J	Boeckstaens, M; Andre, B; Marini, AM				Boeckstaens, Melanie; Andre, Bruno; Marini, Anna Maria			Distinct transport mechanisms in yeast ammonium transport/sensor proteins of the Mep/Amt/Rh family and impact on filamentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CHANNEL AMTB; PSEUDOHYPHAL DIFFERENTIATION; ARCHAEOGLOBUS-FULGIDUS; CRYSTAL-STRUCTURE; HYDROPHOBIC PORE; NPR1 KINASE; CROSS-TALK; PERMEASE	Ammonium transport proteins of the Mep/Amt/Rh family include microbial and plant Mep/Amt members, crucial for ammonium scavenging, and animal Rhesus factors likely involved in ammonium disposal. Recent structural information on two bacterial Mep/Amt proteins has revealed the presence, in the hydrophobic conducting pore, of a pair of preserved histidines proposed to play an important role in substrate conductance, by participating either in NH4+ deprotonation or in shaping the pore. Here we highlight the existence of two functional Mep/Amt subfamilies distinguishable according to whether the first of these histidines is conserved, as in yeast ScMep2, or replaced by glutamate, as in ScMep1. Replacement of the native histidine of ScMep2 with glutamate leads to conversion from ScMep2 to ScMep1-like properties. This includes a two-unit up-shift of the optimal pH for transport and an increase of the transport rate, consistent with alleviation of an energy-limiting step. Similar effects are observed when the same substitution is introduced into the Escherichia coli AmtB protein. In contrast to ScMep1, ScMep2 is proposed to play an additional signaling role in the induction of filamentous growth, a dimorphic change often associated with virulence in pathogenic fungi. We show here that the histidine to glutamate substitution in ScMep2 leads to uncoupling of the transport and sensor functions, suggesting that a ScMep2-specific transport mechanism might be responsible for filamentation. Our overall data suggest the existence of two functional groups of Mep/Amt-type proteins with different transport mechanisms and distinct impacts on cell physiology and signaling.	[Boeckstaens, Melanie; Andre, Bruno; Marini, Anna Maria] Univ Libre Bruxelles, IBMM, Lab Physiol Mol Cellule, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles		ammarini@dbm.ulb.ac.be	André, Bruno/D-1725-2010	Boeckstaens, Melanie/0000-0003-1629-7403				Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Andrade SLA, 2005, ACTA CRYSTALLOGR F, V61, P861, DOI 10.1107/S1744309105027004; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022; Bostick DL, 2007, BIOPHYS J, V92, pL103, DOI 10.1529/biophysj.107.109165; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; CIMPRICH P, 1995, FEMS MICROBIOL LETT, V130, P245; DAVIES L, 1993, CELL, V75, P321, DOI 10.1016/0092-8674(93)80073-N; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Javelle A, 2003, TRENDS MICROBIOL, V11, P53, DOI 10.1016/S0966-842X(02)00012-4; Javelle A, 2001, FEBS LETT, V505, P393, DOI 10.1016/S0014-5793(01)02802-2; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Lorenz MC, 1998, GENETICS, V150, P1443; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Marini AM, 2000, MOL MICROBIOL, V38, P552, DOI 10.1046/j.1365-2958.2000.02151.x; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Pau VPT, 2007, J BIOL CHEM, V282, P29163, DOI 10.1074/jbc.M703277200; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; von Wiren N, 2004, TOP CURR GENET, V9, P95; Weiner ID, 2003, GASTROENTEROLOGY, V124, P1432, DOI 10.1016/S0016-5085(03)00277-4; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood CC, 2006, FEBS LETT, V580, P3931, DOI 10.1016/j.febslet.2006.06.026; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	58	52	54	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21362	21370		10.1074/jbc.M801467200	http://dx.doi.org/10.1074/jbc.M801467200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508774	hybrid			2022-12-27	WOS:000257898800007
J	Dodeller, F; Gottar, M; Huesken, D; Iourgenko, V; Cenni, B				Dodeller, Francis; Gottar, Marie; Huesken, Dieter; Iourgenko, Vadim; Cenni, Bruno			The lysosomal transmembrane protein 9B regulates the activity of inflammatory signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TAK1; IKK; ACTIVATION; UBIQUITIN; TRANSDUCTION; ENDOSOMES; COMPLEXES; KINASE; TAB2	The intracellular signaling pathway by which tumor necrosis factor (TNF) induces its pleiotropic actions is well characterized and includes unique components as well as modules shared with other signaling pathways. In addition to the currently known key effectors, further molecules may however modulate the biological response to TNF. In our attempt to characterize novel regulators of the TNF signaling cascade, we have identified transmembrane protein 9B (TMEM9B, c11orf15) as an important component of TNF signaling and a module shared with the interleukin 1 beta (IL-1 beta) and Toll-like receptor (TLR) pathways. TMEM9B is a glycosylated protein localized in membranes of the lysosome and partially in early endosomes. The expression of TMEM9B is required for the production of proinflammatory cytokines induced by TNF, IL-1 beta, and TLR ligands but not for apoptotic cell death triggered by TNF or Fas ligand. TMEM9B is essential in TNF activation of both the NF-kappa B and MAPK pathways. It acts downstream of RIP1 and upstream of the MAPK and I kappa B kinases at the level of the TAK1 complex. These findings indicate that TMEM9B is a key component of inflammatory signaling pathways and suggest that endosomal or lysosomal compartments regulate these pathways.	[Dodeller, Francis; Gottar, Marie; Huesken, Dieter; Iourgenko, Vadim; Cenni, Bruno] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland	Novartis	Cenni, B (corresponding author), Novartis Pharma AG, CH-4002 Basel, Switzerland.	bruno.cenni@novartis.com		Cenni, Bruno/0000-0002-8603-2032				Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Guijarro MV, 2007, J CELL BIOCHEM, V101, P112, DOI 10.1002/jcb.21163; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kveine M, 2002, BIOCHEM BIOPH RES CO, V297, P912, DOI 10.1016/S0006-291X(02)02228-3; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Palanki MSS, 2002, CURR MED CHEM, V9, P219, DOI 10.2174/0929867023371265; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	23	36	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21487	21494		10.1074/jbc.M801908200	http://dx.doi.org/10.1074/jbc.M801908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541524	hybrid			2022-12-27	WOS:000257898800021
J	Iwasa, M; Maeda, K; Narita, A; Maeda, Y; Oda, T				Iwasa, Mitsusada; Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro; Oda, Toshiro			Dual roles of Gln(137) of actin revealed by recombinant human cardiac muscle alpha-actin mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING CLEFT; P-I RELEASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MONOMERIC ACTIN; ATP HYDROLYSIS; RATE-CONSTANT; POLYMERIZATION; FILAMENT; DYNAMICS	The actin filament is quite dynamic in the cell. To determine the relationship between the structure and the dynamic properties of the actin filament, experiments using actin mutants are indispensable. We focused on Gln(137) to understand the relationships between two activities: the conformational changes relevant to the G- to F-actin transition and the activation of actin ATPase upon actin polymerization. To elucidate the function of Gln137 in these activities, we characterized Gln137 mutants of human cardiac muscle alpha-actin. Although all of the single mutants, Q137E, Q137K, Q137P, and Q137A, as well as the wild type were expressed by a baculovirus-based system, only Q137A and the wild type were purified to high homogeneity. The CD spectrum of Q137A was similar to that of the wild type, and Q137A showed the typical morphology of negatively stained Q137A F-actin images. However, Q137A had an extremely low critical concentration for polymerization. Furthermore, we found that Q137A polymerized 4-fold faster, cleaved the gamma-phosphate group of bound ATP 4-fold slower, and depolymerized 5-fold slower, as compared with the wild-type rates. These results suggest that Gln137 plays dual roles in actin polymerization, in both the conformational transition of the actin molecule and the mechanism of ATP hydrolysis.	[Iwasa, Mitsusada; Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro; Oda, Toshiro] Japan Sci & Technol Agcy, ERATO Actin Filament Dynam Project, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Struct Biol Res Ctr, Nagoya, Aichi 4648602, Japan; [Oda, Toshiro] RIKEN SPring 8 Ctr, Xray Struct Anal Team, Sayo, Hyogo 6795148, Japan	Japan Science & Technology Agency (JST); RIKEN; Nagoya University; Nagoya University; RIKEN	Oda, T (corresponding author), Japan Sci & Technol Agcy, ERATO Actin Filament Dynam Project, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan.	toda@spring8.or.jp	Oda, Toshiro/F-6151-2011					Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Belmont LD, 1999, J CELL SCI, V112, P1325; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CARLIER MF, 1984, J BIOL CHEM, V259, P9983; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; ESNOUF RM, 1997, J MOL GRAPH MODEL, V15, P112; GERSHMAN LC, 1984, BIOCHEMISTRY-US, V23, P2199, DOI 10.1021/bi00305a015; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Joel PB, 2004, BIOCHEMISTRY-US, V43, P11554, DOI 10.1021/bi048899a; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Moraczewska J, 1996, BIOCHEM J, V317, P605, DOI 10.1042/bj3170605; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Oda T, 2007, ADV EXP MED BIOL, V592, P385; Oosawa F., 1975, THERMODYNAMICS POLYM; Orlova A, 1997, J MOL BIOL, V271, P235, DOI 10.1006/jmbi.1997.1163; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; PINDER JC, 1995, ANAL BIOCHEM, V225, P291, DOI 10.1006/abio.1995.1157; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Samizo K, 2001, ANAL BIOCHEM, V293, P212, DOI 10.1006/abio.2001.5146; Sano KI, 2002, FEBS LETT, V532, P143, DOI 10.1016/S0014-5793(02)03659-1; Schafer DA, 1998, CELL MOTIL CYTOSKEL, V39, P166, DOI 10.1002/(SICI)1097-0169(1998)39:2<166::AID-CM7>3.0.CO;2-4; SHEFF DR, 1992, J BIOL CHEM, V267, P20217; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEBER A, 1994, BIOCHEMISTRY-US, V33, P4780, DOI 10.1021/bi00182a005	40	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21045	21053		10.1074/jbc.M800570200	http://dx.doi.org/10.1074/jbc.M800570200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515362	hybrid, Green Published			2022-12-27	WOS:000257746100046
J	Rodgers, L; Gamez, A; Riek, R; Ghosh, P				Rodgers, Loren; Gamez, Alicia; Riek, Roland; Ghosh, Partho			The type III secretion chaperone SycE promotes a localized disorder-to-order transition in the natively unfolded effector YopE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA-ENTEROCOLITICA; CRYSTAL-STRUCTURE; SHIGELLA-FLEXNERI; LARGE PROTEINS; NMR; SYSTEM; PESTIS; ASSIGNMENTS; FRAGMENT; SIGNALS	Many virulence-related, bacterial effector proteins are translocated directly into the cytosol of host cells by the type III secretion (TTS) system. Translocation of most TTS effectors requires binding by specific chaperones in the bacterial cytosol, although how chaperones promote translocation is unclear. To provide insight into the action of such chaperones, we studied the consequences of binding by the Yersinia chaperone SycE to the effector YopE by NMR. These studies examined the intact form of the effector, whereas prior studies have been limited to well ordered fragments. We found that YopE had the characteristics of a natively unfolded protein, with its N-terminal 100 residues, including its chaperone-binding (Cb) region, flexible and disordered in the absence of SycE. SycE binding caused a pronounced disorder-to-order transition in the Cb region of YopE. The effect of SycE was strictly localized to the Cb region, with other portions of YopE being unperturbed. These results provide stringent limits on models of chaperone action and are consistent with the chaperone promoting formation of a three-dimensional targeting signal in the Cb region of the effector. The target of this putative signal is unknown but appears to be a bacterial component other than the TTS ATPase YscN.	[Rodgers, Loren; Ghosh, Partho] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA; [Gamez, Alicia; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Riek, Roland] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Riek, Roland] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem 0375, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pghosh@ucsd.edu		Riek, Roland/0000-0002-6333-066X	NIAID NIH HHS [R01 AI 061452, R01 AI061452] Funding Source: Medline; NIGMS NIH HHS [T32 GM 007240] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098; Buttner CR, 2005, PROTEIN SCI, V14, P1993, DOI 10.1110/ps.051474605; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Daughdrill GW, 1997, NAT STRUCT BIOL, V4, P285, DOI 10.1038/nsb0497-285; Evdokimov AG, 2002, PROTEIN SCI, V11, P401, DOI 10.1110/ps.34102; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Guntert P, 2000, J BIOMOL NMR, V18, P129, DOI 10.1023/A:1008318805889; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R., 2004, COMPUTER AIDED RESON, V1; Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Ramamurthi KS, 2005, J BACTERIOL, V187, P707, DOI 10.1128/JB.187.2.707-715.2005; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1999, J BIOMOL NMR, V14, P85, DOI 10.1023/A:1008346931993; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; van Eerde A, 2004, EMBO REP, V5, P477, DOI 10.1038/sj.embor.7400144; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Xia YL, 2000, J BIOMOL NMR, V18, P261, DOI 10.1023/A:1026590201757	36	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20857	20863		10.1074/jbc.M802339200	http://dx.doi.org/10.1074/jbc.M802339200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502763	Green Published, hybrid			2022-12-27	WOS:000257746100028
J	Luo, XB; Lin, HX; Pan, ZW; Xiao, JN; Zhang, Y; Lu, YJ; Yang, BF; Wang, ZG				Luo, Xiaobin; Lin, Huixian; Pan, Zhengwei; Xiao, Jiening; Zhang, Yong; Lu, Yanjie; Yang, Baofeng; Wang, Zhiguo			Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERPOLARIZATION-ACTIVATED CURRENT; SEE VOL. 227; MUSCLE-SPECIFIC MICRORNA; CURRENT I-F; VENTRICULAR MYOCYTES; PG. 877; CARDIAC-HYPERTROPHY; INWARD CURRENT; EXPRESSION; OVEREXPRESSION	Cardiac hypertrophy is characterized by electrical remolding with increased risk of arrhythmogenesis. Enhanced abnormal automaticity of ventricular cells contributes critically to hypertrophic arrhythmias. The pacemaker current If, carried by the hyperpolarization-activated channels encoded mainly by the HCN2 and HCN4 genes in the heart, plays an important role in determining cardiac automaticity. Their expressions reportedly increase in hypertrophic and failing hearts, contributing to arrhythmogenesis under these conditions. We performed a study on post-transcriptional regulation of expression of HCN2 and HCN4 genes by microRNAs. We experimentally established HCN2 as a target for repression by the muscle-specific microRNAs miR-1 and miR-133 and established HCN4 as a target for miR-1 only. We unraveled robust increases in HCN2 and HCN4 protein levels in a rat model of left ventricular hypertrophy and in angiotensin II-induced neonatal ventricular hypertrophy. The up-regulation of HCN2/HCN4 was accompanied by pronounced reduction of miR-1/miR-133 levels. Forced expression of miR-1/miR-133 by transfection prevented overexpression of HCN2/HCN4 in hypertrophic cardiomyocytes. The serum-responsive factor protein level was found significantly decreased in hypertrophic hearts, and silencing of this protein by RNA interference resulted in increased levels of miR-1/miR-133 and concomitant increases in HCN2 and HCN4 protein levels. We conclude that down-regulation of miR-1 and miR-133 expression contributes to re-expression of HCN2/HCN4 and thereby the electrical remodeling process in hypertrophic hearts. Our study also sheds new light on the cellular function and pathological role of miR-1/miR-133 in the heart.	[Pan, Zhengwei; Zhang, Yong; Lu, Yanjie; Yang, Baofeng] Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Harbin 150086, Heilongjiang, Peoples R China; [Lu, Yanjie; Yang, Baofeng; Wang, Zhiguo] Harbin Med Univ, Inst Cardiovasc Res, Harbin 150086, Heilongjiang, Peoples R China; [Luo, Xiaobin; Lin, Huixian; Xiao, Jiening; Wang, Zhiguo] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Luo, Xiaobin; Wang, Zhiguo] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Harbin Medical University; Harbin Medical University; Universite de Montreal; Universite de Montreal	Yang, BF (corresponding author), Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Harbin 150086, Heilongjiang, Peoples R China.	yangbf@ems.hrbmu.edu.cn; wz.email@gmail.com	Wang, Zhiguo/GRS-4339-2022; wang, zhiguo/AAN-4182-2021	Wang, Zhiguo/0000-0002-0811-2045; 				Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baruscotti M, 2004, ANN NY ACAD SCI, V1015, P111, DOI 10.1196/annals.1302.009; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; CERBAI E, 1994, J PHYSIOL-LONDON, V481, P585, DOI 10.1113/jphysiol.1994.sp020465; Cerbai E, 1996, CIRCULATION, V94, P1674, DOI 10.1161/01.CIR.94.7.1674; Cerbai E, 1997, CIRCULATION, V95, P568, DOI 10.1161/01.CIR.95.3.568; Cerbai E, 1999, CARDIOVASC RES, V42, P416, DOI 10.1016/S0008-6363(99)00037-1; Cerbai E, 2001, J MOL CELL CARDIOL, V33, P441, DOI 10.1006/jmcc.2000.1316; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cohen IS, 2006, HANDB EXP PHARMACOL, V171, P41; Davis FJ, 2002, AM J PHYSIOL-HEART C, V282, pH1521, DOI 10.1152/ajpheart.00844.2001; de Virginy DRB, 2006, HEART FAIL REV, V11, P333, DOI 10.1007/s10741-006-0234-x; Fernandez-Velasco M, 2003, J PHYSIOL-LONDON, V553, P395, DOI 10.1113/jphysiol.2003.041954; FERNANDEZVELASC.M, 2005, PFLUEGERS ARCH EUR J, V452, P146; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Han W, 2002, CIRC RES, V91, P790, DOI 10.1161/01.RES.0000039534.18114.D9; Hoppe UC, 1998, CIRCULATION, V97, P55, DOI 10.1161/01.CIR.97.1.55; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Lebeche D, 2006, J MOL CELL CARDIOL, V40, P725, DOI 10.1016/j.yjmcc.2006.01.018; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin HX, 2007, J CELL PHYSIOL, V212, P137, DOI 10.1002/jcp.21015; Lonardo G, 2004, CIRCULATION, V110, P129; Luo XB, 2007, J CELL PHYSIOL, V212, P358, DOI 10.1002/jcp.21030; Qu JH, 2001, CIRC RES, V89, pE8, DOI 10.1161/hh1301.094395; Rajapurohitam V, 2006, J MOL CELL CARDIOL, V41, P265, DOI 10.1016/j.yjmcc.2006.05.001; Robinson RB, 1997, PFLUG ARCH EUR J PHY, V433, P533, DOI 10.1007/s004240050309; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sridhar A, 2006, AM J PHYSIOL-HEART C, V291, pH2192, DOI 10.1152/ajpheart.01146.2005; Stilli D, 2001, AM J PHYSIOL-HEART C, V280, pH142, DOI 10.1152/ajpheart.2001.280.1.H142; THURINGER D, 1992, J MOL CELL CARDIOL, V24, P451, DOI 10.1016/0022-2828(92)91833-Q; Tian R, 2003, CURR HYPERTENS REP, V5, P454, DOI 10.1007/s11906-003-0052-7; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Xiao JN, 2007, J CELL PHYSIOL, V212, P285, DOI 10.1002/jcp.21062; Xiao JN, 2007, J BIOL CHEM, V282, P12363, DOI 10.1074/jbc.C700015200; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yasui K, 2001, CIRC RES, V88, P536, DOI 10.1161/01.RES.88.5.536; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	40	145	175	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20045	20052		10.1074/jbc.M801035200	http://dx.doi.org/10.1074/jbc.M801035200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18458081	Green Published, hybrid			2022-12-27	WOS:000257565300020
J	Mukhopadhyay, D; Howell, KS; Riezman, H; Capitani, G				Mukhopadhyay, Debdyuti; Howell, Kate S.; Riezman, Howard; Capitani, Guido			Identifying key residues of sphinganine-1-phosphate lyase for function in vivo and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE KINASE LCB4; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; SPHINGOSINE-PHOSPHATE LYASE; SACCHAROMYCES-CEREVISIAE; SPHINGOSINE-1-PHOSPHATE LYASE; SUBCELLULAR-LOCALIZATION; SPHINGOLIPID METABOLISM; TRANSMEMBRANE TOPOLOGY; CERAMIDE SYNTHASE; HEAT-STRESS	Sphinganine-1-phosphate lyase (Dpl1p) is a highly conserved enzyme of sphingolipid metabolism that catalyzes the irreversible degradation of sphingoid base phosphates, which are potent signaling molecules. Sphingoid base phosphates play a vital role in cell survival, proliferation, migration, heat stress, and cell wall integrity pathways. Little is known about the structure and regulation of Dpl1p. In this study, we have undertaken a combined computational modeling and mutagenesis approach for structure-function analysis of Dpl1p to discover possible modes of regulation. Our results identify important residues for catalysis in Dpl1p and confirm it as an integral endoplasmic reticulum-resident protein. Results further indicate that Dpl1p is most likely not regulated spatially. Importantly, we demonstrate that Dpl1p exists as an oligomer and that polar residues in its transmembrane domain are required for its full function in vivo but not for its localization or for its catalytic activity in vitro.	[Mukhopadhyay, Debdyuti; Howell, Kate S.; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Capitani, Guido] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Geneva; University of Zurich	Riezman, H (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	howard.riezman@biochem.unige.ch	Howell, Kate/M-2370-2013	Howell, Kate/0000-0001-6498-0472; Riezman, Howard/0000-0003-4680-9422				Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Birchwood CJ, 2001, J BIOL CHEM, V276, P11712, DOI 10.1074/jbc.M010221200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Capitani G, 2003, FEBS LETT, V554, P41, DOI 10.1016/S0014-5793(03)01079-2; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Funato K, 2003, J BIOL CHEM, V278, P7325, DOI 10.1074/jbc.M209925200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gottlieb D, 1999, Mol Cell Biol Res Commun, V1, P66, DOI 10.1006/mcbr.1999.0109; Grote E, 2000, MOL BIOL CELL, V11, P4051, DOI 10.1091/mbc.11.12.4051; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Hait NC, 2002, FEBS LETT, V532, P97, DOI 10.1016/S0014-5793(02)03636-0; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Herr DR, 2003, DEVELOPMENT, V130, P2443, DOI 10.1242/dev.00456; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Iwaki S, 2005, J BIOL CHEM, V280, P6520, DOI 10.1074/jbc.M410908200; Iwaki S, 2007, J BIOL CHEM, V282, P28485, DOI 10.1074/jbc.M701607200; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; Kihara A, 2003, GENES CELLS, V8, P525, DOI 10.1046/j.1365-2443.2003.00653.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667; Mendel J, 2003, J BIOL CHEM, V278, P22341, DOI 10.1074/jbc.M302857200; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; ROTHMAN JH, 1986, P NATL ACAD SCI USA, V83, P3248, DOI 10.1073/pnas.83.10.3248; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Sullards M C, 2001, Sci STKE, V2001, ppl1; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; VANVELDHOVEN PP, 1991, J BIOL CHEM, V266, P12502; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; Watanabe R, 2002, J BIOL CHEM, V277, P49538, DOI 10.1074/jbc.M206209200; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6	49	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20159	20169		10.1074/jbc.M709753200	http://dx.doi.org/10.1074/jbc.M709753200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487605	hybrid, Green Accepted			2022-12-27	WOS:000257565300032
J	Zhou, S; Si, J; Liu, T; DeWille, JW				Zhou, Shanggen; Si, Junling; Liu, Tong; DeWille, James W.			PIASy represses CCAAT/enhancer-binding protein delta(C/EBP delta) transcriptional activity by sequestering C/EBP delta to the nuclear periphery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; GROWTH ARREST; FAMILY-MEMBERS; EXPRESSION; GENE; ACTIVATION; PROLIFERATION; INTEGRIN; SUMO; SEQUESTRATION	CCAAT/enhancerbindingprotein delta(C/EBP delta) plays a key role in mammary epithelial cell G(0) growth arrest, and "loss of function" alterations in C/EBP delta have been reported in breast cancer and acute myeloidleukemia. C/EBP delta isregulatedatthetranscriptional, post-transcriptional, and post-translational levels, suggesting tight control of C/EBP delta content and function. Protein inhibitors of activated STATs (PIASs) regulate a growing number of transcription factors, including C/EBPs. HC11 nontransformed mammary epithelial cells express PIAS3, PIASx beta, and PIASy, and all three PIAS family members repress C/EBP delta transcriptional activity. PIASy is the most potent, however, repressing C/EBP delta transcriptional activity by > 80%. PIASy repression of C/EBP delta transcriptional activity is dependent upon interaction between the highly conserved PIASy N-terminal nuclear matrix binding domain (SAPD) and the C/EBP delta transactivation domain (TAD). PIASy repression of C/EBP delta transcriptional activity is independent of histone deacetylase activity, PIASy E3 SUMO ligase activity, and C/EBP delta sumoylation status. PIASy expression is associated with C/EBP delta translocation from nuclear foci, where C/EBP delta co-localizes with p300, to the nuclear periphery. PIASy- mediated translocation of C/EBP delta is dependent upon the PIASy SAPD and C/EBP delta TAD. PIASy reduces the expression of C/EBP delta adhesion-related target genes and enhances repopulation of open areas within a cell monolayer in the in vitro "scratch" assay. These results demonstrate that PIASy represses C/EBP delta by a mechanism that requires interaction between the PIASy SAPD and C/EBP delta TAD and does not require PIASy SUMO ligase activity or C/EBP delta sumoylation. PIASy alters C/EBP delta nuclear localization, reduces C/EBP delta transcriptional activity, and enhances cell proliferation/ migration.	[Zhou, Shanggen; Si, Junling; Liu, Tong; DeWille, James W.] Ohio State Univ, Dept Vet Biosci, Ohio State Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	DeWille, JW (corresponding author), Ohio State Univ, Dept Vet Biosci, Ohio State Biochem Program, 1925 Coffey Rd, Columbus, OH 43210 USA.	dewille.1@osu.edu			NCI NIH HHS [P30 CA 16058, CA 57607-14] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058, R29CA057607, R01CA057607] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Balda MS, 2003, TRENDS CELL BIOL, V13, P310, DOI 10.1016/S0962-8924(03)00105-3; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; BOWCOCK A M, 1988, Genomics, V3, P8, DOI 10.1016/0888-7543(88)90152-8; Cambier S, 2000, CANCER RES, V60, P7084; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Charles A, 2001, J CELL BIOCHEM, V83, P414, DOI 10.1002/jcb.1239; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Dearth LR, 2003, J BIOL CHEM, V278, P11246, DOI 10.1074/jbc.M207930200; Diaz G, 2008, HISTOCHEM CELL BIOL, V129, P611, DOI 10.1007/s00418-008-0402-2; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fjellbirkeland L, 2003, AM J PATHOL, V163, P533, DOI 10.1016/S0002-9440(10)63681-4; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Gery S, 2005, ONCOGENE, V24, P1589, DOI 10.1038/sj.onc.1208393; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; Hutt JA, 2000, J BIOL CHEM, V275, P29123, DOI 10.1074/jbc.M004476200; Hutt JA, 2002, MOL CANCER THER, V1, P601; Ikuzawa M, 2005, COMP BIOCHEM PHYS B, V140, P505, DOI 10.1016/j.cbpc.2004.11.015; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kim JY, 2005, J BIOL CHEM, V280, P12246, DOI 10.1074/jbc.M413771200; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu XW, 2007, J BIOL CHEM, V282, P20868, DOI 10.1074/jbc.M702547200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Lyons SE, 2001, GENE, V281, P43, DOI 10.1016/S0378-1119(01)00774-0; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Nelson PJ, 2002, KIDNEY INT S1, V61, P99, DOI DOI 10.1046/J.1523-1755.2002.0610S1099.X; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; O'Rourke JP, 1999, J BIOL CHEM, V274, P16582, DOI 10.1074/jbc.274.23.16582; O'Rourke JP, 1999, BIOCHEM BIOPH RES CO, V262, P696, DOI 10.1006/bbrc.1999.1256; ORourke J, 1997, J BIOL CHEM, V272, P6291, DOI 10.1074/jbc.272.10.6291; Porter D, 2003, MOL CANCER RES, V1, P362; Porter DA, 2001, CANCER RES, V61, P5697; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; SCOTT LM, 1992, BLOOD, V80, P1725; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Sivko GS, 2004, J CELL BIOCHEM, V93, P844, DOI 10.1002/jcb.20224; Sivko GS, 2004, J CELL BIOCHEM, V93, P830, DOI 10.1002/jcb.20223; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TANG D, 2005, BREAST CANC RES TREA, P1; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; von Mikecz A, 2000, J CELL BIOL, V150, P265, DOI 10.1083/jcb.150.1.265; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wang JM, 2006, NUCLEIC ACIDS RES, V34, P217, DOI 10.1093/nar/gkj422; Yamamoto N, 1999, J NEUROCHEM, V73, P2415, DOI 10.1046/j.1471-4159.1999.0732415.x; Zhang YJ, 2007, J CELL BIOCHEM, V102, P1256, DOI 10.1002/jcb.21356; Zhou SG, 2007, BIOCHEM J, V405, P341, DOI 10.1042/BJ20070082	64	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20137	20148		10.1074/jbc.M801307200	http://dx.doi.org/10.1074/jbc.M801307200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18477566	hybrid, Green Published			2022-12-27	WOS:000257565300030
J	Allard, D; Figg, N; Bennett, MR; Littlewood, TD				Allard, David; Figg, Nichola; Bennett, Martin R.; Littlewood, Trevor D.			Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; FORKHEAD TRANSCRIPTION FACTOR; OXIDATIVE STRESS; ATHEROSCLEROTIC PLAQUES; SIGNALING PATHWAY; NEOINTIMAL HYPERPLASIA; KINASE ACTIVATION; DOWN-REGULATION; MYELOMA CELLS; APOPTOSIS	Apoptosis of vascular smooth muscle cells (VSMCs) may lead to atherosclerotic plaque instability and rupture, resulting in myocardial infarction, stroke, and sudden death. However, the molecular mechanisms mediating survival of VSMCs in atherosclerotic plaques remain unknown. Although plaque VSMCs exhibit increased susceptibility to apoptosis and reduced expression of the IGF1 receptor (IGF1R) when compared with normal VSMCs, a causative effect has not been established. Here we show that increased expression of the IGF1R can rescue plaque VSMCs from oxidative stress-induced apoptosis, demonstrating that IGF-1 signaling is a critical regulator of VSMC survival. Akt mediates the majority of the IGF1R survival signaling, and ectopic activation of Akt was sufficient to protect VSMCs in vitro. Both IGF1R and phospho-Akt expression were reduced in human plaque (intimal) VSMCs when compared with medial VSMCs, suggesting that Akt mediates survival signaling in atherosclerosis. Importantly, downstream targets of Akt were identified that mediate its protective effect as inhibition of FoxO3a or GSK3 by Akt-dependent phosphorylation protected VSMCs in vitro. We conclude that Akt and its downstream targets FoxO3a and GSK3 regulate a survival pathway in VSMCs and that their deregulation due to a reduction of IGF1R signaling may promote apoptosis in atherosclerosis.	[Allard, David; Figg, Nichola; Bennett, Martin R.; Littlewood, Trevor D.] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Littlewood, TD (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Box 110, Cambridge CB2 2QQ, England.	tdl2@cam.ac.uk		Bennett, Martin/0000-0002-2565-1825	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Alves NL, 2007, TRENDS IMMUNOL, V28, P26, DOI 10.1016/j.it.2006.11.003; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bai HZ, 1999, CIRC RES, V85, P229, DOI 10.1161/01.RES.85.3.229; BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; Bennett MR, 1997, CIRC RES, V81, P591, DOI 10.1161/01.RES.81.4.591; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Chan SW, 2000, CIRC RES, V86, P1038, DOI 10.1161/01.RES.86.10.1038; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Garton KJ, 2002, BIOTECHNIQUES, V32, P830, DOI 10.2144/02324rr01; Higashi Y, 2005, J LIPID RES, V46, P1266, DOI 10.1194/jlr.M400478-JLR200; Huang HM, 2000, BLOOD, V96, P1764, DOI 10.1182/blood.V96.5.1764.h8001764_1764_1771; Jourdan M, 2003, ONCOGENE, V22, P2950, DOI 10.1038/sj.onc.1206423; Jung F, 2000, CARDIOVASC RES, V48, P148, DOI 10.1016/S0008-6363(00)00152-8; Kavurma MM, 2007, BIOCHEM J, V407, P79, DOI 10.1042/BJ20070380; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lawlor MA, 2001, J CELL SCI, V114, P2903; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200; LI SW, 1994, J BIOL CHEM, V269, P32558; Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Okura Y, 2001, J MOL CELL CARDIOL, V33, P1777, DOI 10.1006/jmcc.2001.1441; Paik JH, 2006, BIOCHEM SOC T, V34, P731, DOI 10.1042/BST0340731; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park KW, 2005, ARTERIOSCL THROM VAS, V25, P742, DOI 10.1161/01.ATV.0000156288.70849.26; Patel VA, 2001, CIRC RES, V88, P895, DOI 10.1161/hh0901.090305; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; Sandberg EM, 2004, J BIOL CHEM, V279, P34547, DOI 10.1074/jbc.M405045200; Scheidegger KJ, 2000, J BIOL CHEM, V275, P26864; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Song HJ, 2005, J PHARMACOL EXP THER, V312, P391, DOI 10.1124/jpet.104.074401; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stocker R, 2005, J THROMB HAEMOST, V3, P1825, DOI 10.1111/j.1538-7836.2005.01370.x; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Vantler M, 2005, J BIOL CHEM, V280, P14168, DOI 10.1074/jbc.M413310200; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	50	70	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19739	19747		10.1074/jbc.M710098200	http://dx.doi.org/10.1074/jbc.M710098200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18458087	hybrid			2022-12-27	WOS:000257387600058
J	Zhu, M; Wang, FS; Yan, F; Yao, PY; Du, J; Gao, XJ; Wang, XW; Wu, Q; Ward, T; Li, JJ; Kioko, S; Hu, RM; Xie, W; Ding, X; Yao, XB				Zhu, Mei; Wang, Fengsong; Yan, Feng; Yao, Phil Y.; Du, Jian; Gao, Xinjiao; Wang, Xiwei; Wu, Quan; Ward, Tarsha; Li, Jingjing; Kioko, Steve; Hu, Renming; Xie, Wei; Ding, Xia; Yao, Xuebiao			Septin 7 interacts with centromere-associated protein E and is required for its kinetochore localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-E; MITOTIC CHECKPOINT; MAMMALIAN SEPTINS; CHROMOSOME CONGRESSION; SPINDLE MICROTUBULES; BUDDING YEAST; FILAMENTS; ATTACHMENT; METAPHASE; PHOSPHORYLATION	Chromosome segregation in mitosis is orchestrated by dynamic interaction between spindle microtubules and the kinetochore. Septin (SEPT) belongs to a conserved family of polymerizing GTPases localized to the metaphase spindle during mitosis. Previous study showed that SEPT2 depletion results in chromosome mis-segregation correlated with a loss of centromere-associated protein E ( CENP-E) from the kinetochores of congressing chromosomes ( 1). However, it has remained elusive as to whether CENP-E physically interacts with SEPT and how this interaction orchestrates chromosome segregation in mitosis. Here we show that SEPT7 is required for a stable kinetochore localization of CENP-E in HeLa and MDCK cells. SEPT7 stabilizes the kinetochore association of CENP-E by directly interacting with its C-terminal domain. The region of SEPT7 binding to CENP- E was mapped to its C-terminal domain by glutathione S-transferase pull-down and yeast two-hybrid assays. Immunofluorescence study shows that SEPT7 filaments distribute along the mitotic spindle and terminate at the kinetochore marked by CENP-E. Remarkably, suppression of synthesis of SEPT7 by small interfering RNA abrogated the localization of CENP- E to the kinetochore and caused aberrant chromosome segregation. These mitotic defects and kinetochore localization of CENP- E can be successfully rescued by introducing exogenous GFP-SEPT7 into the SEPT7-depleted cells. These SEPT7-suppressed cells display reduced tension at kinetochores of bi- orientated chromosomes and activated mitotic spindle checkpoint marked by Mad2 and BubR1 labelings on these misaligned chromosomes. These findings reveal a key role for the SEPT7-CENP-E interaction in the distribution of CENP-E to the kinetochore and achieving chromosome alignment.	[Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Zhu, Mei; Wang, Fengsong; Yan, Feng; Du, Jian; Gao, Xinjiao; Wang, Xiwei; Wu, Quan; Li, Jingjing; Yao, Xuebiao] Hefei Natl Lab Phys Sci Microscale, Div Cellular Dynam, Hefei 230027, Peoples R China; [Zhu, Mei; Wang, Fengsong; Yan, Feng; Du, Jian; Gao, Xinjiao; Wang, Xiwei; Wu, Quan; Li, Jingjing; Yao, Xuebiao] Univ Sci & Technol China, Hefei 230027, Peoples R China; [Wang, Fengsong; Yan, Feng; Yao, Phil Y.; Wu, Quan; Ward, Tarsha; Kioko, Steve] Morehouse Sch Med, Canc Biol Program, Atlanta, GA 30310 USA; [Hu, Renming] Fudan Univ, Sch Med, Dept Endocrinol & Metab, Shanghai 200040, Peoples R China; [Xie, Wei] Southeast Univ, Sch Med, MOE Key Lab Dev Genes & Human Dis, Nanjing 210009, Peoples R China	Beijing University of Chinese Medicine; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Fudan University; Southeast University - China	Ding, X (corresponding author), Beijing Univ Chinese Med, Beijing 100029, Peoples R China.	xiading6@yahoo.com; yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014	Li, Jingjing/0000-0003-4435-7573	NCI NIH HHS [CA92080, CA89019] Funding Source: Medline; NIDDK NIH HHS [DK-56292] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA089019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cooper JA, 1996, J CELL BIOL, V134, P1345, DOI 10.1083/jcb.134.6.1345; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dou Z, 2004, FEBS LETT, V572, P51, DOI 10.1016/j.febslet.2004.06.092; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kartmann B, 2001, J CELL SCI, V114, P839; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Low C, 2006, J BIOL CHEM, V281, P30697, DOI 10.1074/jbc.M605179200; Macara IG, 2002, MOL BIOL CELL, V13, P4111, DOI 10.1091/mbc.E02-07-0438; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Peterson EA, 2007, MAMM GENOME, V18, P796, DOI 10.1007/s00335-007-9065-x; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Xue Y, 2006, CHINESE SCI BULL, V51, P1836, DOI 10.1007/s11434-006-2054-8; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Yu HJ, 2008, CELL RES, V18, P218, DOI 10.1038/cr.2008.20	33	59	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18916	18925		10.1074/jbc.M710591200	http://dx.doi.org/10.1074/jbc.M710591200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18460473	Green Published, hybrid			2022-12-27	WOS:000257165600048
J	Postmus, J; Canelas, AB; Bouwman, J; Bakker, BM; van Gulik, W; de Mattos, MJT; Brul, S; Smits, GJ				Postmus, Jarne; Canelas, Andre B.; Bouwman, Jildau; Bakker, Barbara M.; van Gulik, Walter; de Mattos, M. Joost Teixeira; Brul, Stanley; Smits, Gertien J.			Quantitative analysis of the high temperature-induced glycolytic flux increase in Saccharomyces cerevisiae reveals dominant metabolic regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK RESPONSE; IN-VIVO KINETICS; PYRUVATE-KINASE; GENE-EXPRESSION; STRESS-RESPONSE; ENVIRONMENTAL-CHANGES; MOLECULAR CHAPERONES; MEMBRANE-PROPERTIES; THERMAL ADAPTATION; CHEMOSTAT CULTURE	A major challenge in systems biology lies in the integration of processes occurring at different levels, such as transcription, translation, and metabolism, to understand the functioning of a living cell in its environment. We studied the high temperature-induced glycolytic flux increase in Saccharomyces cerevisiae and investigated the regulatory mechanisms underlying this increase. We used glucose-limited chemostat cultures to separate regulatory effects of temperature from effects on growth rate. Growth at increased temperature (38 C versus 30 C) resulted in a strongly increased glycolytic flux, accompanied by a switch from respiration to a partially fermentative metabolism. We observed an increased flux through all enzymes, ranging from 5- to 10- fold. Wequantified the contributions of direct temperature effects on enzyme activities, the gene expression cascade and shifts in the metabolic network, to the increased flux through each enzyme. To do this we adapted flux regulation analysis. We show that the direct effect of temperature on enzyme kinetics can be included as a separate term. Together with hierarchical regulation and metabolic regulation, this term explains the total flux change between two steady states. Surprisingly, the effect of the cultivation temperature on enzyme catalytic capacity, both directly through the Arrhenius effect and indirectly through adapted gene expression, is only a moderate contribution to the increased glycolytic flux for most enzymes. The changes in flux are therefore largely caused by changes in the interaction of the enzymes with substrates, products, and effectors.	[Postmus, Jarne; Brul, Stanley; Smits, Gertien J.] Univ Amsterdam, Dept Mol Biol & Microbial Food Safety, NL-1018 WV Amsterdam, Netherlands; [Canelas, Andre B.; van Gulik, Walter] Kluyver Lab Biotechnol, NL-2628 BC Delft, Netherlands; [Bouwman, Jildau; Bakker, Barbara M.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, NL-1081 HV Amsterdam, Netherlands; [de Mattos, M. Joost Teixeira] Univ Amsterdam, Dept Mol Microbial Physiol, NL-1018 WV Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Smits, GJ (corresponding author), Univ Amsterdam, Dept Mol Biol & Microbial Food Safety, Nieuwe Achtergracht 166, NL-1018 WV Amsterdam, Netherlands.	gertien@science.uva.nl	Smits, Gertien J./I-4327-2014	Smits, Gertien J./0000-0002-8439-7791; Bakker, Barbara/0000-0001-6274-3633				ARRHENIUS S, 1884, RES GALVANIC CONDUCT; BARWELL CJ, 1971, EUR J BIOCHEM, V18, P59, DOI 10.1111/j.1432-1033.1971.tb01214.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; BOLES E, 1993, YEAST, V9, P761, DOI 10.1002/yea.320090710; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hochachka PW, 1997, J EXP BIOL, V200, P381; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kim IS, 2006, J MICROBIOL, V44, P492; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Koebmann BJ, 2002, MOL BIOL REP, V29, P41, DOI 10.1023/A:1020398117281; KONINGS AWT, 1985, RADIAT RES, V102, P86, DOI 10.2307/3576432; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P406, DOI 10.1002/bit.10048; Larsson C, 1997, J BACTERIOL, V179, P7243, DOI 10.1128/jb.179.23.7243-7250.1997; Liu LM, 2006, FEMS YEAST RES, V6, P1117, DOI 10.1111/j.1567-1364.2006.00153.x; MacDonald JA, 2005, FEBS J, V272, P120, DOI 10.1111/j.1432-1033.2004.04388.x; MAEBA P, 1968, J BIOL CHEM, V243, P448; MAGER WH, 1993, BIOCHEM J, V290, P1; MARTIN CE, 1976, BIOCHEMISTRY-US, V15, P5218, DOI 10.1021/bi00669a004; Mashego MR, 2003, BIOTECHNOL BIOENG, V83, P395, DOI 10.1002/bit.10683; MILLER MJ, 1982, J BACTERIOL, V151, P311, DOI 10.1128/JB.151.1.311-327.1982; Morano KA, 1998, CURR OPIN MICROBIOL, V1, P197, DOI 10.1016/S1369-5274(98)80011-8; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Moro F, 2006, J MOL BIOL, V358, P1367, DOI 10.1016/j.jmb.2006.03.027; MORRIS CN, 1986, BIOCHEM J, V234, P691, DOI 10.1042/bj2340691; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Riezman H, 2004, CELL CYCLE, V3, P61; Rodicio R, 2000, J BIOL CHEM, V275, P40952, DOI 10.1074/jbc.M007131200; Rossell S, 2006, P NATL ACAD SCI USA, V103, P2166, DOI 10.1073/pnas.0509831103; Rossell S, 2005, FEMS YEAST RES, V5, P611, DOI 10.1016/j.femsyr.2004.11.003; Rossell S, 2008, FEMS YEAST RES, V8, P155, DOI 10.1111/j.1567-1364.2007.00282.x; Sasaki T, 2006, J EXP BIOL, V209, P3580, DOI 10.1242/jeb.02426; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SHULMAN RG, 1995, P NATL ACAD SCI USA, V92, P8535, DOI 10.1073/pnas.92.19.8535; SIMOESMENDES B, 1978, Z ALLG MIKROBIOL, V18, P275, DOI 10.1002/jobm.3630180406; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Suarez RK, 2005, J EXP BIOL, V208, P3603, DOI 10.1242/jeb.01778; Tai SL, 2007, J BIOL CHEM, V282, P10243, DOI 10.1074/jbc.M610845200; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; THEVELEIN JM, 1982, P NATL ACAD SCI-BIOL, V79, P3503, DOI 10.1073/pnas.79.11.3503; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; van Dam JC, 2002, ANAL CHIM ACTA, V460, P209, DOI 10.1016/S0003-2670(02)00240-4; Van Hoek P, 1998, APPL ENVIRON MICROB, V64, P2133; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; WALSH MC, 1994, J BACTERIOL, V176, P953, DOI 10.1128/JB.176.4.953-958.1994; Wu L, 2006, METAB ENG, V8, P160, DOI 10.1016/j.ymben.2005.09.005; Wu L, 2006, APPL ENVIRON MICROB, V72, P3566, DOI 10.1128/AEM.72.5.3566-3577.2006; Zaitzeva EA, 1996, APPL BIOCHEM BIOTECH, V61, P67, DOI 10.1007/BF02785689	68	47	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23524	23532		10.1074/jbc.M802908200	http://dx.doi.org/10.1074/jbc.M802908200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18562308	hybrid, Green Published			2022-12-27	WOS:000258638900005
J	Basu, NK; Kole, L; Basu, M; Chakraborty, K; Mitra, PS; Owens, IS				Basu, Nikhil K.; Kole, Labanyamoy; Basu, Mousumi; Chakraborty, Kushal; Mitra, Partha S.; Owens, Ida S.			The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CARDIAC MYOCYTES; GLUCURONIDATION; BILIRUBIN; CURCUMIN; INHIBITION; ANTAGONIST; ACTIVATION; EXPRESSION; PROTECTION	Finding rapid, reversible down-regulation of human UDP-glucuronosyltransferases (UGTs) in LS180 cells following curcumin treatment led to the discovery that UGTs require phosphorylation. UGTs, distributed primarily in liver, kidney, and gastrointestinal tract, inactivate aromatic-like metabolites and a vast number of dietary and environmental chemicals, which reduces the risk of toxicities, mutagenesis, and carcinogenesis. Our aim here is to determine relevant kinases and mechanism(s) regulating phosphorylation of constitutive UGTs in LS180 cells and 10 different human UGT cDNA-transfected COS-1 systems. Time- and concentration-dependent inhibition of immunodetectable [P-33] orthophosphate in UGTs and protein kinase C is an element of(PKC is an element of), following treatment of LS180 cells with curcumin or the PKC inhibitor calphostin-C, suggested UGT phosphorylation is supported by active PKC( s). Immunofluorescent and co-immunoprecipitation studies with UGT-transfected cells showed co-localization of UGT1A7His and PKC is an element of and of UGT1A10His and PKC alpha orPKC delta. Inhibition of UGT activity by PKC is an element of-specific antagonist peptide or by PKC is an element of-targeted destruction with PKC is an element of-specific small interference RNA and activation of curcumin-down-regulated UGTs with typical PKC agonists verified a central PKC role in glucuronidation. Moreover, in vitro phosphorylation of nascent UGT1A7His by PKC is an element of confirms it is a bona fide PKC substrate. Finally, catalase or herbimycin-A inhibition of constitutive or hydrogen peroxide-activated UGTs demonstrated that reactive oxygen species-related oxidants act as second messengers in maintaining constitutive PKC-dependent signaling evidently sustaining UGT phosphorylation and activity. Because cells use signal transduction collectively to detect and respond appropriately to environmental changes, this report, combined with our earlier demonstration that specific phospho-groups in UGT1A7 determined substrate selections, suggests regulated phosphorylation allows adaptations regarding differential phosphate utilization by UGTs to function efficiently.	[Basu, Nikhil K.; Kole, Labanyamoy; Basu, Mousumi; Chakraborty, Kushal; Mitra, Partha S.; Owens, Ida S.] NICHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Owens, IS (corresponding author), NICHD, Heritable Disorders Branch, NIH, 9000 Rockville Pike,Bldg 10, Rm 9D-42, Bethesda, MD 20892 USA.	owensi@mail.nih.gov			National Institutes of Health NICHD Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008751] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008751] Funding Source: NIH RePORTER	National Institutes of Health NICHD Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health NICHD Intramural Research Program.	Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; [Anonymous], 1980, GLUCURONIDATION DRUG; Armstrong SC, 1998, J MOL CELL CARDIOL, V30, P61, DOI 10.1006/jmcc.1997.0572; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Basu NK, 2007, BIOCHEM BIOPH RES CO, V360, P7, DOI 10.1016/j.bbrc.2007.05.224; Basu NK, 2005, P NATL ACAD SCI USA, V102, P6285, DOI 10.1073/pnas.0407872102; Basu NK, 2004, J BIOL CHEM, V279, P28320, DOI 10.1074/jbc.M401396200; Basu NK, 2004, J BIOL CHEM, V279, P1429, DOI 10.1074/jbc.M306439200; Basu NK, 2003, BIOCHEM BIOPH RES CO, V303, P98, DOI 10.1016/S0006-291X(03)00241-9; CHEN F, 1993, BIOCHEMISTRY-US, V32, P10648, DOI 10.1021/bi00091a015; Chen HW, 1998, BRIT J PHARMACOL, V124, P1029, DOI 10.1038/sj.bjp.0701914; Ciotti M, 1997, PHARMACOGENETICS, V7, P485, DOI 10.1097/00008571-199712000-00007; Ciotti M, 1999, BIOCHEM BIOPH RES CO, V260, P199, DOI 10.1006/bbrc.1999.0453; Ciotti M, 1996, BIOCHEMISTRY-US, V35, P10119, DOI 10.1021/bi960584a; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; DEMPSEY EC, 2000, AM J PHYSIOL, V279, P1429; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Fournes B, 2001, ONCOGENE, V20, P219, DOI 10.1038/sj.onc.1204058; Gopalakrishna R, 2002, J NUTR, V132, p3819S, DOI 10.1093/jn/132.12.3819S; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Harmala-Brasken AS, 2003, ONCOGENE, V22, P7677, DOI 10.1038/sj.onc.1207077; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Jiang LJ, 1998, P NATL ACAD SCI USA, V95, P3483, DOI 10.1073/pnas.95.7.3483; Jobin C, 1999, J IMMUNOL, V163, P3474; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; KELLIS JT, 1984, SCIENCE, V225, P1032, DOI 10.1126/science.6474163; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; LANG DR, 1974, BIOCHIM BIOPHYS ACTA, V333, P180, DOI 10.1016/0005-2728(74)90002-4; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Meech R, 1997, CLIN EXP PHARMACOL P, V24, P907, DOI 10.1111/j.1440-1681.1997.tb02718.x; Min DS, 1998, J BIOL CHEM, V273, P29986, DOI 10.1074/jbc.273.45.29986; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; RAO CV, 1995, CANCER RES, V55, P259; Rendon-Huerta E, 1999, BIOCHEM J, V344, P469, DOI 10.1042/0264-6021:3440469; Ricciarelli R, 1998, BIOCHEM J, V334, P243, DOI 10.1042/bj3340243; RITTER JK, 1993, J BIOL CHEM, V268, P23573; RITTER JK, 1991, J BIOL CHEM, V266, P1043; RITTER JK, 1990, J BIOL CHEM, V265, P7900; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Surh YJ, 2002, FOOD CHEM TOXICOL, V40, P1091, DOI 10.1016/S0278-6915(02)00037-6; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Wells PG, 2004, DRUG METAB DISPOS, V32, P281, DOI 10.1124/dmd.32.3.281; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zhang F, 1999, CARCINOGENESIS, V20, P445, DOI 10.1093/carcin/20.3.445	52	27	27	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23048	23061		10.1074/jbc.M800032200	http://dx.doi.org/10.1074/jbc.M800032200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556656	Green Published, hybrid			2022-12-27	WOS:000258455400018
J	Chen, LJ; Wang, K; Shao, YM; Huang, J; Li, XF; Shan, JF; Wu, DQ; Zheng, JJ				Chen, Lijun; Wang, Ke; Shao, Youming; Huang, Jin; Li, Xiaofeng; Shan, Jufang; Wu, Dianqing; Zheng, Jie J.			Structural insight into the mechanisms of Wnt signaling antagonism by Dkk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; DOMAIN; BINDING; DICKKOPF-1; RECEPTORS; PROGRAMS; PATHWAY; HADDOCK; KREMEN; FAMILY	Dickkopf (Dkk) proteins are antagonists of the canonical Wnt signaling pathway and are crucial for embryonic cell fate and bone formation. Wnt antagonism of Dkk requires the binding of the C-terminal cysteine-rich domain of Dkk to the Wnt coreceptor, LRP5/6. However, the structural basis of the interaction between Dkk and low density lipoprotein receptor-related protein (LRP) 5/6 is unknown. In this study, we examined the structure of the Dkk functional domain and elucidated its interactions with LRP5/6. Using NMR spectroscopy, we determined the solution structure of the C-terminal cysteine-rich domain of mouse Dkk2 (Dkk2C). Then, guided by mutagenesis studies, we docked Dkk2C to the YWTD beta-propeller domains of LRP5/6 and showed that the ligand binding site of the third LRP5/6 beta-propeller domain matches Dkk2C best, suggesting that this domain binds to Dkk2C with higher affinity. Such differential binding affinity is likely to play an essential role in Dkk function in the canonical Wnt pathway.	[Chen, Lijun; Shao, Youming; Huang, Jin; Shan, Jufang; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wang, Ke; Li, Xiaofeng; Wu, Dianqing] Yale Univ, Dept Pharmacol, Sch Med, New Haven, CT 06520 USA; [Wang, Ke; Li, Xiaofeng; Wu, Dianqing] Yale Univ, Program Vasc Biol & Therapeut, Sch Med, New Haven, CT 06520 USA; [Chen, Lijun] Nankai Univ, Dept Biophys, Tianjin 300071, Peoples R China	St Jude Children's Research Hospital; Yale University; Yale University; Nankai University	Wu, DQ (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale, Memphis, TN 38105 USA.	dan.wu@yale.edu; jie.zheng@stjude.org		huang, jin/0000-0002-0698-1693; Zheng, Jie/0000-0001-6524-6800	NATIONAL CANCER INSTITUTE [R01CA139395, R01CA132317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492, R01GM112182] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA139395, R01 CA132317, CA132317, R01 CA132317-01A2] Funding Source: Medline; NIAMS NIH HHS [R01 AR051476-02, R01 AR051476-03, AR051476, R01 AR051476-05, R01 AR051476-04, R01 AR051476, R01 AR051476-01A1] Funding Source: Medline; NIGMS NIH HHS [R01 GM081492, R01 GM081492-02, GM081492, R01 GM112182] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; ECCLES C, 1991, Journal of Biomolecular NMR, V1, P111, DOI 10.1007/BF01877224; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Springer TA, 2002, CURR OPIN STRUC BIOL, V12, P802, DOI 10.1016/S0959-440X(02)00384-6; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; VAN DM, 2006, NUCLEIC ACIDS RES, V34, P3317; VAN TH, 1992, NATURE, V359, P159; VAN TH, 1999, BIOCHIM BIOPHYS ACTA, V1441, P173; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	41	56	70	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23364	23370		10.1074/jbc.M802375200	http://dx.doi.org/10.1074/jbc.M802375200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18524778	Green Published, hybrid			2022-12-27	WOS:000258455400046
J	Lies, M; Maurizi, MR				Lies, Mark; Maurizi, Michael R.			Turnover of endogenous SsrA-tagged proteins mediated by ATP-dependent proteases in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; CLPXP DEGRADATION MACHINE; TRANS-TRANSLATION; 10SA RNA; STOP CODONS; STABLE RNA; SYNTHESIS INHIBITORS; TAGGING ACTIVITY; MESSENGER-RNA; PEPTIDE	Formation and degradation of SsrA-tagged proteins enable ribosome recycling and elimination of defective products of incomplete translation. We produced an antibody against the SsrA peptide and used it to measure the amounts of SsrA-tagged proteins in Escherichia coli cells without interfering with tagging or altering the context of the tag added at the ends of nascent polypeptides. SsrA-tagged proteins were present in very small amounts unless a component of the ClpXP protease was missing. From the levels of tagged proteins in cells in which degradation is essentially blocked, we calculate that >= 1 in 200 translation products receives an SsrA tag. ClpXP is responsible for >= 90% of the degradation of SsrA-tagged proteins. The degradation rate in wild type cells is >= 1.4 min(-1) and decreases to similar to 0.10 min(-1) in a clpX mutant. The rate of degradation by ClpXP is decreased similar to 3-fold in mutants lacking the adaptor SspB, whereas degradation by ClpAP is increased 3-5-fold. However, ClpAP degrades SsrA-tagged proteins slowly even in the absence of SspB, possibly because of interference from ClpA-specific substrates. Lon protease degrades SsrA-tagged proteins at a rate of similar to 0.05 min(-1) in the presence or absence of SspB. We conclude that ClpXP, together with SspB, is uniquely adapted for degradation of SsrA-tagged proteins and is responsible for the major part of their degradation in vivo.	[Lies, Mark; Maurizi, Michael R.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Maurizi, MR (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37, Rm 2128,37 Convent Dr, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov			National Institutes of Health; NATIONAL CANCER INSTITUTE [Z01BC005597, ZIABC005597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was authored, in whole or in part, by National Institutes of Health staff.	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; Asano K, 2005, NUCLEIC ACIDS RES, V33, P5544, DOI 10.1093/nar/gki871; Bohn C, 2002, MOL GENET GENOMICS, V266, P827, DOI 10.1007/s00438-001-0601-1; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; de la Cruz J, 2001, RNA, V7, P1708; Defenbaugh DA, 2003, J BIOL CHEM, V278, P52333, DOI 10.1074/jbc.M308724200; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Fredriksson A, 2007, GENE DEV, V21, P862, DOI 10.1101/gad.409407; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Levchenko I, 2005, NAT STRUCT MOL BIOL, V12, P520, DOI 10.1038/nsmb934; Levchenko I, 1997, CELL, V91, P939, DOI 10.1016/S0092-8674(00)80485-7; Maurizi MR, 2002, ARCH BIOCHEM BIOPHYS, V397, P206, DOI 10.1006/abbi.2001.2703; McGinness KE, 2007, J BIOL CHEM, V282, P11465, DOI 10.1074/jbc.M610671200; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; MOESTELLER RD, 1980, J BIOL CHEM, V255, P2524; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Muto A, 1996, BIOCHIMIE, V78, P985, DOI 10.1016/S0300-9084(97)86721-1; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, V1, P3; O'Handley D, 2002, J MOL BIOL, V322, P311, DOI 10.1016/S0022-2836(02)00755-6; OH BK, 1990, J BACTERIOL, V172, P4708, DOI 10.1128/jb.172.8.4708-4709.1990; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Ranquet C, 2001, P NATL ACAD SCI USA, V98, P10220, DOI 10.1073/pnas.171620598; RAY BK, 1979, MOL GEN GENET, V174, P25, DOI 10.1007/BF00433301; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Saguy M, 2005, BIOCHIMIE, V87, P897, DOI 10.1016/j.biochi.2005.03.014; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; Sunohara T, 2002, RNA, V8, P1416, DOI 10.1017/S1355838202020198; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; Ueda K, 2002, GENES CELLS, V7, P509, DOI 10.1046/j.1365-2443.2002.00537.x; Vioque A, 2003, FEMS MICROBIOL LETT, V218, P9, DOI 10.1016/S0378-1097(02)01110-2; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Williams KP, 1999, EMBO J, V18, P5423, DOI 10.1093/emboj/18.19.5423; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0	52	57	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					22918	22929		10.1074/jbc.M801692200	http://dx.doi.org/10.1074/jbc.M801692200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550539	Green Published, hybrid			2022-12-27	WOS:000258455400005
J	Ozsoy, HZ; Sivasubramanian, N; Wieder, ED; Pedersen, S; Mann, DL				Ozsoy, Hatice Z.; Sivasubramanian, Natarajan; Wieder, Eric D.; Pedersen, Steen; Mann, Douglas L.			Oxidative stress promotes ligand-independent and enhanced ligand-dependent tumor necrosis factor receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; H2O2 PRODUCTION; DISULFIDE BOND; MELANOMA-CELLS; FREE-RADICALS; TNF; REDOX; EXPRESSION; IDENTIFICATION; SUPERFAMILY	Tumor necrosis factor (TNF) receptor 1 (TNFR1, p55) and 2 (TNFR2, p75) are characterized by several cysteine-rich modules in the extracellular domain, raising the possibility that redox-induced modifications of these cysteine residues might alter TNFR function. To test this possibility, we examined fluorescence resonance energy transfer (FRET) in 293T cells transfected with CFP- and YFP-tagged TNFRs exposed to the thiol oxidant diamide. Treatment with high concentrations of diamide (1 mM) resulted in an increase in the FRET signal that was sensitive to inhibition with the reducing agent dithiothreitol, suggesting that oxidative stress resulted in TNFR self-association. Treatment of cells with low concentrations of diamide (1 mu M) that was not sufficient to provoke TNFR self-association resulted in increased TNF-induced FRET signals relative to the untreatedcells, suggesting that oxidative stress enhanced ligand-dependent TNFR signaling. Similar findings were obtained when the TNFR1- and TNFR2-transfected cells were pretreated with a cell-impermeable oxidase, DsbA, that catalyzes disulfide bond formation between thiol groups on cysteine residues. The changes in TNFR self-association were functionally significant, because pretreating the HeLa cells and 293T cells resulted in increased TNF-induced NF-kappa B activation and TNF-induced expression of I kappa B and syndecan-4 mRNA levels. Although pretreatment with DsbA did not result in an increase in TNF binding to TNFRs, it resulted in increased TNF-induced activation of NF-kappa B, consistent with an allosteric modification of the TNFRs. Taken together, these results suggest that oxidative stress promotes TNFR receptor self-interaction and ligand-independent and enhanced ligand-dependent TNF signaling.	[Ozsoy, Hatice Z.; Sivasubramanian, Natarajan; Mann, Douglas L.] Baylor Coll Med, Winters Ctr Heart Failure Res, Cardiol Sect, Dept Med, Houston, TX 77030 USA; [Pedersen, Steen; Mann, Douglas L.] Baylor Coll Med, Winters Ctr Heart Failure Res, Cardiol Sect, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wieder, Eric D.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Wieder, Eric D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Mann, DL (corresponding author), Fac Ctr, 1709 Dryden Rd,BCM620,FC 9-83, Houston, TX 77030 USA.	dmann@bcm.tmc.edu	Mann, Douglas Lowell/AAQ-3524-2021	Mann, Douglas/0000-0002-2516-0145; Pedersen, Steen E./0000-0001-8755-8899	National Institutes of Health [P50 HL-O6H, R01 HL58081, R01 HL61543, HL42250]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058081, R01HL061543, R01HL042250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 HL-O6H, R01 HL58081, R01 HL61543, and HL42250.	BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Baumgarten G, 2001, J INFECT DIS, V183, P1617, DOI 10.1086/320712; Bazzoni F, 1995, J INFLAMM, V45, P221; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; De Wit R, 2000, FREE RADICAL BIO MED, V28, P28, DOI 10.1016/S0891-5849(99)00199-9; DING AH, 1989, J BIOL CHEM, V264, P3924; Dominici S, 1999, FREE RADICAL BIO MED, V27, P623, DOI 10.1016/S0891-5849(99)00111-2; Dominici S, 2004, ANN NY ACAD SCI, V1030, P62, DOI 10.1196/annals.1329.008; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Gautam A, 2001, MOL THER, V3, P551, DOI 10.1006/mthe.2001.0300; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Knuefermann P, 2002, J BIOL CHEM, V277, P23888, DOI 10.1074/jbc.M202937200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Maellaro E, 2000, J CELL SCI, V113, P2671; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Peus D, 1999, J INVEST DERMATOL, V112, P751, DOI 10.1046/j.1523-1747.1999.00584.x; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; Schmid E, 1998, FASEB J, V12, P863, DOI 10.1096/fasebj.12.10.863; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	30	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23419	23428		10.1074/jbc.M802967200	http://dx.doi.org/10.1074/jbc.M802967200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18544535	Green Published, hybrid			2022-12-27	WOS:000258455400051
J	Wang, K; Zhang, YZ; Li, XF; Chen, LJ; Wang, H; Wu, JG; Zheng, J; Wu, DQ				Wang, Ke; Zhang, Yazhou; Li, Xiaofeng; Chen, Lijun; Wang, He; Wu, Jianguo; Zheng, Jie; Wu, Dianqing			Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; DICKKOPF-1; PROTEINS; MECHANISMS; RECEPTOR; FAMILY; LEF-1	Wnt signaling is involved in a wide range of developmental, physiological, and pathophysiological processes and is negatively regulated by Dickkopf1 (Dkk1). Dkk1 has been shown to bind to two transmembrane proteins, the low density lipoprotein receptor-related proteins (LRP) 5/6 and Kremen. Here, we show that Dkk1 residues Arg(197), Ser(198), and Lys(232) are specifically involved in its binding to Kremen rather than to LRP6. These residues are localized at a surface that is at the opposite side of the LRP6-binding surface based on a three-dimensional structure of Dkk1 deduced from that of Dkk2. We were surprised to find that the Dkk1 mutants carrying a mutation at Arg(197), Ser(198), or Lys(232), the key Kremen-binding residues, could antagonize Wnt signaling as well as the wild-type Dkk1. These mutations only affected their ability to antagonize Wnt signaling when both LRP6 and Kremen were coexpressed. These results suggest that Kremen may not be essential for Dkk1-mediated Wnt antagonism and that Kremen may only play a role when cells express a high level of LRP 5/6.	[Wang, Ke; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Wang, Ke; Zhang, Yazhou; Li, Xiaofeng; Wang, He; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Chen, Lijun; Zheng, Jie] St Jude Hosp, Dept Biol Struct, Memphis, TN 38105 USA	Wuhan University; Yale University; St Jude Children's Research Hospital	Wu, JG (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	wu9988@vip.sina.com; jie.zheng@stjude.org; dan.wu@yale.edu		Zheng, Jie/0000-0001-6524-6800; Wu, Jianguo/0000-0002-8326-2895	NCI NIH HHS [R01 CA132317-01A2, R01 CA132317, R01 CA139395, CA132317] Funding Source: Medline; NIAMS NIH HHS [R01 AR051476-03, R01 AR051476, R01 AR051476-05, R01 AR051476-04, AR051476, R01 AR051476-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM081492, R01 GM081492-02, GM081492] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA139395, R01CA132317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Chen LJ, 2008, J BIOL CHEM, V283, P23364, DOI 10.1074/jbc.M802375200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	23	71	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23371	23375		10.1074/jbc.M802376200	http://dx.doi.org/10.1074/jbc.M802376200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18502762	Green Published, hybrid			2022-12-27	WOS:000258455400047
J	Osenkowski, P; Ye, W; Wang, R; Wolfe, MS; Selkoe, DJ				Osenkowski, Pamela; Ye, Wenjuan; Wang, Rong; Wolfe, Michael S.; Selkoe, Dennis J.			Direct and potent regulation of gamma-secretase by its lipid microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; IN-VIVO; MEMBRANE-PROTEINS; TOTAL CHOLESTEROL; CELL-SURFACE; BETA-PROTEIN; PRESENILIN; COMPLEX; RECONSTITUTION	gamma-Secretase is an unusual and ubiquitous aspartyl protease with an intramembrane catalytic site that cleaves many type-I integral membrane proteins, most notably APP and Notch. Several reports suggest that cleavage of APP to produce the A beta peptide is regulated in part by lipids. As gamma-secretase is a multi-pass protein complex with 19 transmembrane domains, it is likely that the local lipid composition of the membrane can regulate gamma-activity. To determine the direct contribution of the lipid microenvironment to gamma-secretase activity, we purified the human protease from overexpressing mammalian cells, reconstituted it in vesicles of varying lipid composition, and examined the effects of individual phospholipids, sphingolipids, cholesterol, and complex lipid mixtures on substrate cleavage. A conventional gamma-activity assay was modified to include a detergent-removal step to facilitate proteoliposome formation, and this increased baseline activity over 2-fold. Proteoliposomes containing sphingolipids significantly increased gamma-secretase activity over a phosphatidylcholine-only baseline, whereas the addition of phosphatidylinositol significantly decreased activity. Addition of soluble cholesterol in the presence of phospholipids and sphingolipids robustly increased the cleavage of APP- and Notch-like substrates in a dose-dependent manner. Reconstitution of gamma-secretase in complex lipid mixtures revealed that a lipid raft-like composition supported the highest level of activity compared with other membrane compositions. Taken together, these results demonstrate that membrane lipid composition is a direct and potent modulator of gamma-secretase and that cholesterol, in particular, plays a major regulatory role.	[Osenkowski, Pamela; Ye, Wenjuan; Wolfe, Michael S.; Selkoe, Dennis J.] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Osenkowski, Pamela; Ye, Wenjuan; Wolfe, Michael S.; Selkoe, Dennis J.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai	Wolfe, MS (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu; dselkoe@rics.bwh.harvard.edu	Wang, Rong/A-8721-2009		NIA NIH HHS [AG00222-15, AG15379, AG17574] Funding Source: Medline; NINDS NIH HHS [NS41355] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG017574] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEEL AJ, 2008, CELL MOL LIFE SCI; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Burns M, 2003, J NEUROSCI, V23, P5645; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; KADOWAKI H, 1994, J LIPID RES, V35, P1956; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kalanj S, 1991, Neurol Croat, V40, P269; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7; NITSCH RM, 1992, P NATL ACAD SCI USA, V89, P1671, DOI 10.1073/pnas.89.5.1671; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; SANDERMANN H, 1978, BIOCHIM BIOPHYS ACTA, V515, P209, DOI 10.1016/0304-4157(78)90015-1; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; Vance DE, 2002, BIOCH LIPIDS LIPOPRO; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Wells K, 1995, NEUROCHEM RES, V20, P1329, DOI 10.1007/BF00992508; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Zha Q, 2004, MOL PSYCHIATR, V9, P946, DOI 10.1038/sj.mp.4001509	53	209	214	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22529	22540		10.1074/jbc.M801925200	http://dx.doi.org/10.1074/jbc.M801925200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18539594	Green Published, hybrid			2022-12-27	WOS:000258321000021
J	Weaver, MS; Workman, G; Sage, EH				Weaver, Matt S.; Workman, Gail; Sage, E. Helene			The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta 1 and activation of integrin-linked kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRICELLULAR PROTEIN SPARC; LENS EPITHELIAL-CELLS; NULL MICE EXHIBIT; EXTRACELLULAR-MATRIX; MURINE LENS; CATARACT FORMATION; BASEMENT-MEMBRANE; ENHANCED GROWTH; CYSTEINE SPARC; APOPTOSIS	Secreted protein acidic and rich in cysteine (SPARC) is important for the normal growth and maintenance of the murine lens. SPARC-null animals develop cataracts associated with a derangement of the lens capsule basement membrane and alterations in lens fiber morphology. Cellular stress and disregulation of apoptotic pathways within lens epithelial cells (LEC) are linked to cataract formation. To identify molecular targets of SPARC that are linked to this disorder, we stressed wild-type (WT) and SPARC-null LEC by serum deprivation or exposure to tunicamycin. SPARC enhanced signaling by integrin-linked kinase (ILK), a serine/ threonine kinase known to enhance cell survival in vitro. In response to stress, an ILK-dependent decrease in apoptosis was observed in WT relative to SPARC-null LEC. Co-immunoprecipitation and cross-linking of cell lysates revealed enhanced levels of a SPARC-integrin beta 1 complex during stress. Competition with monoclonal antibodies and peptides indicated that the copper binding domain of SPARC is required for SPARC-mediated response to stress. Inhibiting the binding and/ or activity of ILK, integrin beta 1, or SPARC resulted in increased apoptosis of stressed LEC. We conclude that SPARC protects cells from stress-induced apoptosis in vitro via an interaction with integrin beta 1 heterodimers that enhances ILK activation and pro-survival activity.	[Weaver, Matt S.; Workman, Gail; Sage, E. Helene] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA; [Sage, E. Helene] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Sage, EH (corresponding author), 1201 9th Ave, Seattle, WA 98101 USA.	hsage@benaroyaresearch.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER; NEI NIH HHS [EY07031] Funding Source: Medline; NIGMS NIH HHS [GM40711] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Emerson RO, 2006, J CELL BIOCHEM, V98, P701, DOI 10.1002/jcb.20867; FUNK SE, 1993, J CELL PHYSIOL, V154, P53, DOI 10.1002/jcp.1041540108; Gasiorowski K, 2001, CELL MOL BIOL LETT, V6, P141; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; Mills J, 2003, J NEUROSCI, V23, P1638; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; NERI M, 1992, EUR J BIOCHEM, V205, P569, DOI 10.1111/j.1432-1033.1992.tb16814.x; Norose K, 2000, EXP EYE RES, V71, P295, DOI 10.1006/exer.2000.0884; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; Puolakkainen PA, 2005, J HISTOCHEM CYTOCHEM, V53, P571, DOI 10.1369/jhc.4A6425.2005; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; SAGE H, 1986, J CELL PHYSIOL, V127, P373, DOI 10.1002/jcp.1041270305; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; SAUK JJ, 1992, TOXICOL APPL PHARM, V116, P240, DOI 10.1016/0041-008X(92)90303-A; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Shi Q, 2004, J BIOL CHEM, V279, P52200, DOI 10.1074/jbc.M409630200; Sweetwyne MT, 2004, J HISTOCHEM CYTOCHEM, V52, P723, DOI 10.1369/jhc.3A6153.2004; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tartare-Deckert S, 2001, J BIOL CHEM, V276, P22231, DOI 10.1074/jbc.M010634200; Weaver MS, 2007, MOL VIS, V13, P707; Weaver MS, 2006, J CELL BIOCHEM, V97, P423, DOI 10.1002/jcb.20654; Yan Q, 2005, J CELL PHYSIOL, V203, P286, DOI 10.1002/jcp.20226; Yan Q, 2003, J HISTOCHEM CYTOCHEM, V51, P503, DOI 10.1177/002215540305100412; Yan Q, 2002, J CELL SCI, V115, P2747; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x	40	93	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22826	22837		10.1074/jbc.M706563200	http://dx.doi.org/10.1074/jbc.M706563200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18503049	Green Published, hybrid			2022-12-27	WOS:000258321000050
J	Doege, H; Grimm, D; Falcon, A; Tsang, B; Storm, TA; Xu, H; Ortegon, AM; Kazantzis, M; Kay, MA; Stahl, A				Doege, Holger; Grimm, Dirk; Falcon, Alaric; Tsang, Bernice; Storm, Theresa A.; Xu, Hui; Ortegon, Angelica M.; Kazantzis, Melissa; Kay, Mark A.; Stahl, Andreas			Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves Hyperglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID TRANSPORT PROTEIN; INSULIN-RESISTANCE; UNITED-STATES; MICE; STEATOSIS; OBESITY; INHIBITION; PREVALENCE; MECHANISM; VECTORS	Non-alcoholic fatty liver disease is a serious health problem linked to obesity and type 2 diabetes. To investigate the biological outcome and therapeutic potential of hepatic fatty acid uptake inhibition, we utilized an adeno-associated virus-mediated RNA interference technique to knock down the expression of hepatic fatty acid transport protein 5 in vivo prior to or after establishing non-alcoholic fatty liver disease in mice. Using this approach, we demonstrate here the ability to achieve specific, non-toxic, and persistent knockdown of fatty acid transport protein 5 in mouse livers from a single adeno-associated virus injection, resulting in a marked reduction of hepatic dietary fatty acid uptake, reduced caloric uptake, and concomitant protection from diet-induced non-alcoholic fatty liver disease. Importantly, knockdown of fatty acid transport protein 5 was also able to reverse already established non-alcoholic fatty liver disease, resulting in significantly improved whole-body glucose homeostasis. Thus, continued activity of hepatic fatty acid transport protein 5 is required to sustain caloric uptake and fatty acid flux into the liver during high fat feeding and may present a novel avenue for the treatment of non-alcoholic fatty liver disease.	[Falcon, Alaric; Ortegon, Angelica M.; Kazantzis, Melissa; Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Doege, Holger] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Doege, Holger; Tsang, Bernice] Stanford Univ, Dept GI Hepatol, Stanford, CA 94305 USA; [Grimm, Dirk; Storm, Theresa A.; Xu, Hui; Kay, Mark A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Grimm, Dirk; Storm, Theresa A.; Xu, Hui; Kay, Mark A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Palo Alto Medical Foundation Research Institute; Stanford University; Stanford University; Stanford University	Stahl, A (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 119 Morgan Hall, Berkeley, CA 94720 USA.	AStahl@Berkeley.edu		Kay, Mark/0000-0002-2799-2615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078424, R01DK066336, R56DK066336] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK78424, DK066336] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; FOLCH J, 1957, J BIOL CHEM, V226, P497; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Laurin J, 1996, HEPATOLOGY, V23, P1464; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; STREMMEL W, 1989, J HEPATOL, V9, P374, DOI 10.1016/0168-8278(89)90148-7; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	31	108	115	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22186	22192		10.1074/jbc.M803510200	http://dx.doi.org/10.1074/jbc.M803510200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18524776	Green Published, hybrid			2022-12-27	WOS:000258114700038
J	Smith, L; Smallwood, N; Altman, A; Liedtke, CM				Smith, Laura; Smallwood, Nicole; Altman, Amnon; Liedtke, Carole M.			PKC delta acts upstream of SPAK in the activation of NKCC1 by hyperosmotic stress in human airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; ALANINE-RICH KINASE; NA-K-2CL COTRANSPORTER; PROTEIN-KINASE; NA+-K+-2CL(-) COTRANSPORTER; WNK KINASES; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; SUBSTRATE	Airway epithelial Na-K-2Cl (NKCC1) cotransport is activated through hormonal stimulation and hyperosmotic stress via a protein kinase C (PKC) delta-mediated intracellular signaling pathway. Down-regulation of PKC delta prevents activation of NKCC1 expressed in Calu-3 cells. Previous studies of this signaling pathway identified coimmunoprecipitation of PKC delta with SPAK (Ste20-related proline alanine-rich kinase). We hypothesize that endogenous PKC delta activates SPAK, which subsequently activates NKCC1 through phosphorylation. Double-stranded silencing RNA directed against SPAK reduced SPAK protein expression by 65.8% and prevented increased phosphorylation of NKCC1 and functional activation of NKCC1 during hyperosmotic stress, measured as bumetanide-sensitive basolateral to apical 86Rb flux. Using recombinant proteins, we demonstrate direct binding of PKC delta to SPAK, PKC delta-mediated activation of SPAK, binding of SPAK to the amino terminus of NKCC1 (NT-NKCC1, amino acids 1-286), and competitive inhibition of SPAK-NKCC1 binding by a peptide encoding a SPAK binding site on NT-NKCC1. The carboxyl terminus of SPAK (amino acids 316-548) pulls down endogenous NKCC1 from Calu-3 total cell lysates and glutathione S-transferase-tagged NT-NKCC1 pulls down endogenous SPAK. In intact cells, hyperosmotic stress increased phosphorylated PKC delta, indicating activation of PKC delta, and activity of endogenous SPAK kinase. Inhibition of PKC delta activity with rottlerin blocked the increase in SPAK kinase activity. The results indicate that PKC delta acts upstream of SPAK to increase activity of NKCC1 during hyperosmotic stress.	[Smith, Laura; Smallwood, Nicole; Liedtke, Carole M.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Smith, Laura; Smallwood, Nicole; Liedtke, Carole M.] Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA; [Smith, Laura; Smallwood, Nicole; Liedtke, Carole M.] Case Western Reserve Univ, Dept Biophys, Cleveland, OH 44106 USA; [Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; La Jolla Institute for Immunology	Liedtke, CM (corresponding author), Case Western Reserve Univ, Dept Pediat, 2109 Adelbert Rd,824 BRB, Cleveland, OH 44106 USA.	carole.liedtke@case.edu			NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058598] Funding Source: NIH RePORTER; NCI NIH HHS [CA-35299] Funding Source: Medline; NHLBI NIH HHS [HL-58598] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andersen GO, 2004, AM J PHYSIOL-HEART C, V286, pH1354, DOI 10.1152/ajpheart.00549.2003; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Galan A, 2005, NEUROSCIENCE, V133, P245, DOI 10.1016/j.neuroscience.2005.02.025; Goto S, 1997, BRAIN RES, V765, P324, DOI 10.1016/S0006-8993(97)00679-3; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kurihara K, 2002, AM J PHYSIOL-CELL PH, V282, pC817, DOI 10.1152/ajpcell.00352.2001; Kurihara K, 1999, AM J PHYSIOL-CELL PH, V277, pC1184, DOI 10.1152/ajpcell.1999.277.6.C1184; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Liedtke CM, 2005, J BIOL CHEM, V280, P25491, DOI 10.1074/jbc.M504473200; Liedtke CM, 2003, AM J PHYSIOL-CELL PH, V284, pC487, DOI 10.1152/ajpcell.00357.2002; Liedtke CM, 2002, BBA-MOL CELL RES, V1589, P77, DOI 10.1016/S0167-4889(01)00189-6; Liedtke CM, 2001, AM J PHYSIOL-LUNG C, V280, pL739, DOI 10.1152/ajplung.2001.280.4.L739; Liedtke CM, 1997, AM J PHYSIOL-CELL PH, V273, pC1632, DOI 10.1152/ajpcell.1997.273.5.C1632; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Marshall WS, 2005, J EXP BIOL, V208, P1063, DOI 10.1242/jeb.01491; Mizuta K, 1997, HEARING RES, V106, P154, DOI 10.1016/S0378-5955(97)00010-5; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Smallwood ND, 2005, AM J PHYSIOL-CELL PH, V288, pC906, DOI 10.1152/ajpcell.00484.2004; Sung KW, 2000, J NEUROSCI, V20, P7531; Ushiro H, 1998, ARCH BIOCHEM BIOPHYS, V355, P233, DOI 10.1006/abbi.1998.0736; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	42	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22147	22156		10.1074/jbc.M801752200	http://dx.doi.org/10.1074/jbc.M801752200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550547	Green Published, hybrid			2022-12-27	WOS:000258114700034
J	Schmidt, A; Gruber, K; Kratky, C; Lamzin, VS				Schmidt, Andrea; Gruber, Karl; Kratky, Christoph; Lamzin, Victor S.			Atomic resolution crystal structures and quantum chemistry meet to reveal subtleties of hydroxynitrile lyase catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; HEVEA-BRASILIENSIS; (S)-HYDROXYNITRILE LYASE; ACTIVE-SITE; MECHANISM; BOND; (S)-CYANOHYDRINS; REFINEMENT; PROGRAM	Hydroxynitrile lyases are versatile enzymes that enantiospecifically cope with cyanohydrins, important intermediates in the production of various agrochemicals or pharmaceuticals. We determined four atomic resolution crystal structures of hydroxynitrile lyase from Hevea brasiliensis: one native and three complexes with acetone, isopropyl alcohol, and thiocyanate. We observed distinct distance changes among the active site residues related to proton shifts upon substrate binding. The combined use of crystallography and ab initio quantum chemical calculations allowed the determination of the protonation states in the enzyme active site. We show that His(235) of the catalytic triad must be protonated in order for catalysis to proceed, and we could reproduce the cyanohydrin synthesis in ab initio calculations. We also found evidence for the considerable pK(a) shifts that had been hypothesized earlier. We envision that this knowledge can be used to enhance the catalytic properties and the stability of the enzyme for industrial production of enantiomerically pure cyanohydrins.	[Schmidt, Andrea; Lamzin, Victor S.] DESY, EMBL Hamburg, D-22607 Hamburg, Germany; [Gruber, Karl; Kratky, Christoph] Karl Franzens Univ Graz, Inst Chem, A-8010 Graz, Austria	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Graz	Schmidt, A (corresponding author), DESY, EMBL Hamburg, Notkestr 85, D-22607 Hamburg, Germany.	andrea@embl-hamburg.de	Gruber, Karl/GPP-6706-2022	Gruber, Karl/0000-0002-3485-9740; Lamzin, Victor/0000-0002-6058-7793				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer M, 1999, BIOTECHNOL BIOENG, V62, P20, DOI 10.1002/(SICI)1097-0290(19990105)62:1&lt;20::AID-BIT3&gt;3.0.CO;2-I; Conn EE, 1981, BIOCH PLANTS COMPREH; EFFENBERGER F, 1994, ANGEW CHEM INT EDIT, V33, P1555, DOI 10.1002/anie.199415551; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Gartler G, 2007, J BIOTECHNOL, V129, P87, DOI 10.1016/j.jbiotec.2006.12.009; Gruber K, 2004, J BIOL CHEM, V279, P20501, DOI 10.1074/jbc.M401575200; Gruber K, 1999, BIOL CHEM, V380, P993, DOI 10.1515/BC.1999.123; Hanefeld U, 2001, BBA-PROTEIN STRUCT M, V1544, P133, DOI 10.1016/S0167-4838(00)00212-0; Hasslacher M, 1997, PROTEINS, V27, P438; Hasslacher M, 1996, J BIOL CHEM, V271, P5884, DOI 10.1074/jbc.271.10.5884; Hickel A, 1996, PHYSIOL PLANTARUM, V98, P891, DOI 10.1111/j.1399-3054.1996.tb06700.x; Johnson DV, 1997, TETRAHEDRON, V53, P617, DOI 10.1016/S0040-4020(96)01023-X; Johnson DV, 2000, CURR OPIN CHEM BIOL, V4, P103, DOI 10.1016/S1367-5931(99)00059-9; JOHNSON DV, 1998, ADV BIOCHEM ENG BIOT, V63, P31; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEMPIER N, 1995, TETRAHEDRON-ASYMMETR, V6, P845, DOI 10.1016/0957-4166(95)00085-4; KLEMPIER N, 1993, TETRAHEDRON LETT, V34, P4769, DOI 10.1016/S0040-4039(00)74084-6; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRUSE CG, 1992, CHIRALITY IND; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1993, GRASP; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sheldrick G. M., 1997, SHELXL 97; Stranzl GR, 2004, J BIOL CHEM, V279, P3699, DOI 10.1074/jbc.M306814200; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wagner UG, 1996, ACTA CRYSTALLOGR D, V52, P591, DOI 10.1107/S0907444995016830; Wagner UG, 1996, STRUCTURE, V4, P811, DOI 10.1016/S0969-2126(96)00088-3; Wajant H, 1996, BIOL CHEM, V377, P611; Zuegg J, 1999, PROTEIN SCI, V8, P1990, DOI 10.1110/ps.8.10.1990	33	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21827	21836		10.1074/jbc.M801056200	http://dx.doi.org/10.1074/jbc.M801056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524775	hybrid			2022-12-27	WOS:000257898800056
J	Belyaeva, OV; Johnson, MP; Kedishvili, NY				Belyaeva, Olga V.; Johnson, Mary P.; Kedishvili, Natalia Y.			Kinetic analysis of human enzyme RDH10 defines the characteristics of a physiologically relevant retinol dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; ALL-TRANS-RETINOL; DELAYED DARK-ADAPTATION; BINDING PROTEIN-I; NULL MUTANT MICE; ALCOHOL-DEHYDROGENASE; VITAMIN-A; GENE-EXPRESSION; HUMAN TISSUES; VISUAL CYCLE	Human retinol dehydrogenase 10 (RDH10) was implicated in the oxidation of all-trans-retinol for biosynthesis of all-trans-retinoic acid, however, initial assays suggested that RDH10 prefers NADP(+) as a cofactor, undermining its role as an oxidative enzyme. Here, we present evidence that RDH10 is, in fact, a strictly NAD(+)-dependent enzyme with multisubstrate specificity that recognizes cis-retinols as well as all-trans-retinol as substrates. RDH10 has a relatively high apparent Km value for NAD(+) (similar to 100 mu M) but the lowest apparent Km value for all-trans-retinol (similar to 0.035 mu M) among all NAD(+) -dependent retinoid oxidoreductases. Due to its high affinity for all-trans-retinol, RDH10 exhibits a greater rate of retinol oxidation in the presence of cellular retinol-binding protein type I (CRBPI) than human microsomal RoDH4, but like RoDH4, RDH10 does not recognize retinol bound to CRBPI as a substrate. Consistent with its preference for NAD(+), RDH10 functions exclusively in the oxidative direction in the cells, increasing the levels of retinaldehyde and retinoic acid. Targeted small interfering RNAmediated silencing of endogenous RDH10 or RoDH4 expression in human cells results in a significant decrease in retinoic acid production from retinol, identifying both human enzymes as physiologically relevant retinol dehydrogenases. The dual cis/trans substrate specificity suggests a dual physiological role for RDH10: in the biosynthesis of 11-cis-retinaldehyde for vision as well as the biosynthesis of all-trans-retinoic acid for differentiation and development.	Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), 720 20th St S,440B Kaul Genet Bldg, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Beliaeva, Olga/0000-0003-2512-925X; Kedishvili, Natalia/0000-0001-6917-4891	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA012153-07, R01 AA012153, AA 12153] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adams James D. Jr., 2001, Current Topics in Medicinal Chemistry, V1, P473, DOI 10.2174/1568026013394778; Belyaeva OV, 2007, ENDOCRINOLOGY, V148, P2148, DOI 10.1210/en.2006-1491; Belyaeva OV, 2006, GENOMICS, V88, P820, DOI 10.1016/j.ygeno.2006.06.004; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; BLANER WS, 1986, J LIPID RES, V10, P1084; BOERMAN MHEM, 1995, BIOCHEMISTRY-US, V34, P7027, DOI 10.1021/bi00021a014; BOK D, 1984, INVEST OPHTH VIS SCI, V25, P877; Brereton P, 2001, MOL CELL ENDOCRINOL, V171, P111, DOI 10.1016/S0303-7207(00)00417-2; BUBLITZ C, 1987, BIOCHEM J, V245, P263, DOI 10.1042/bj2450263; Chen Y, 2003, MOL VIS, V9, P345; Chen YM, 2003, VISION RES, V43, P3037, DOI 10.1016/j.visres.2003.08.001; Chetyrkin SV, 2001, ARCH BIOCHEM BIOPHYS, V386, P1, DOI 10.1006/abbi.2000.2203; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Duester G, 1996, BIOCHEMISTRY-US, V35, P12221, DOI 10.1021/bi961176+; FISHER GJ, 1995, J INVEST DERMATOL, V105, P80, DOI 10.1111/1523-1747.ep12313352; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; GIBLIN FJ, 1980, EXP EYE RES, V31, P601, DOI 10.1016/S0014-4835(80)80019-4; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; HARADA H, 1995, ENDOCRINOLOGY, V136, P5329, DOI 10.1210/en.136.12.5329; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Hu PR, 2007, BBA-GEN SUBJECTS, V1770, P694, DOI 10.1016/j.bbagen.2006.12.008; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; KATO M, 1985, J BIOL CHEM, V260, P4832; Kedishvili NY, 1998, BIOCHEM BIOPH RES CO, V249, P191, DOI 10.1006/bbrc.1998.9105; Kedishvili NY, 2002, CURR ORG CHEM, V6, P1247, DOI 10.2174/1385272023373400; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Lapshina EA, 2003, BIOCHEMISTRY-US, V42, P776, DOI 10.1021/bi026836r; Lee SA, 2007, J BIOL CHEM, V282, P35621, DOI 10.1074/jbc.M706372200; Liu S, 2007, ACTA BIOCHIM POL, V54, P213, DOI 10.18388/abp.2007_3289; Mangelsdorf David J., 1994, P319; MATSCHINSKY FM, 1968, J NEUROCHEM, V15, P643, DOI 10.1111/j.1471-4159.1968.tb08963.x; Matsuzaka Y, 2002, BIOCHEM BIOPH RES CO, V297, P1171, DOI 10.1016/S0006-291X(02)02344-6; Matt N, 2005, DEV DYNAM, V233, P167, DOI 10.1002/dvdy.20313; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; Molotkov A, 2002, J BIOL CHEM, V277, P13804, DOI 10.1074/jbc.M112039200; Molotkov A, 2002, P NATL ACAD SCI USA, V99, P5337, DOI 10.1073/pnas.082093299; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Napoli JL, 1998, METH MOL B, V89, P29; OKUNO M, 1995, J LIPID RES, V36, P137; ONG DE, 1986, AM J CLIN NUTR, V44, P425, DOI 10.1093/ajcn/44.3.425; RAJAN N, 1990, J LIPID RES, V31, P821; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com	53	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20299	20308		10.1074/jbc.M800019200	http://dx.doi.org/10.1074/jbc.M800019200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502750	Green Published, hybrid			2022-12-27	WOS:000257565300046
J	Ghosh, RP; Horowitz-Scherer, RA; Nikitina, T; Gierasch, LM; Woodcock, CL				Ghosh, Rajarshi P.; Horowitz-Scherer, Rachel A.; Nikitina, Tatiana; Gierasch, Lila M.; Woodcock, Christopher L.			Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CPG BINDING DOMAIN; TRANSCRIPTIONAL REPRESSOR; HISTONE DEACETYLASE; INTRINSIC DISORDER; METHYLATED DNA; P53; ASSOCIATION; SELECTIVITY; EXPRESSION	Most cases of Rett syndrome (RTT) are caused by mutations in the methylated DNA-binding protein, MeCP2. Here, we have shown that frequent RTT-causing missense mutations (R106W, R133C, F155S, T158M) located in the methylated DNA-binding domain (MBD) of MeCP2 have profound and diverse effects on its structure, stability, and DNA-binding properties. Fluorescence spectroscopy, which reports on the single tryptophan in the MBD, indicated that this residue is strongly protected from the aqueous environment in the wild type but is more exposed in the R133C and F155S mutations. In the mutant proteins R133C, F155S, and T158M, the thermal stability of the domain was strongly reduced. Thermal stability of the wild-type protein was increased in the presence of unmethylated DNA and was further enhanced by DNA methylation. DNA-induced thermal stability was also seen, but to a lesser extent, in each of the mutant proteins. Circular dichroism (CD) of the MBD revealed differences in the secondary structure of the four mutants. Upon binding to methylated DNA, the wild type showed a subtle but reproducible increase in alpha-helical structure, whereas the F155S and R106W did not acquire secondary structure with DNA. Each of the mutant proteins studied is unique in terms of the properties of the MBD and the structural changes induced by DNA binding. For each mutation, we examined the extent to which the magnitude of these differences correlated with the severity of RTT patient symptoms.	[Horowitz-Scherer, Rachel A.; Nikitina, Tatiana; Woodcock, Christopher L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Ghosh, Rajarshi P.; Gierasch, Lila M.; Woodcock, Christopher L.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Woodcock, CL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	chris@bio.umass.edu	Gierasch, Lila M/D-1494-2009	ghosh, rajarshi/0000-0002-0020-6194; ghosh, rajarshi/0000-0003-2348-6333	NIGMS NIH HHS [GM 070897, GM 027616] Funding Source: Medline; NIH HHS [DP1 OD000945, DP1 OD000945-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616, R01GM070897] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000945] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Carpenter Mark L., 1994, V30, P313; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chadwick LH, 2007, CURR OPIN GENET DEV, V17, P121, DOI 10.1016/j.gde.2007.02.003; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Del Vecchio P, 2002, BIOCHEM J, V367, P857, DOI 10.1042/BJ20020695; Dlakic M, 2001, EMBO J, V20, P828, DOI 10.1093/emboj/20.4.828; Fasman G D, 1996, CIRCULAR DICHROISM C, P69; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kudo S, 2001, BRAIN DEV-JPN, V23, pS165, DOI 10.1016/S0387-7604(01)00345-X; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LaSalle JM, 2004, CURR TOP DEV BIOL, V59, P61, DOI 10.1016/S0070-2153(04)59003-8; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Marchi M, 2007, EPIGENETICS-US, V2, P187, DOI 10.4161/epi.2.3.5057; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Muller HM, 2003, BRIT J CANCER, V89, P1934, DOI 10.1038/sj.bjc.6601392; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; PANCOSKA P, 1995, PROTEIN SCI, V4, P1384, DOI 10.1002/pro.5560040713; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; PERCY AK, 2007, J CHILD NEUROL, V20, P1; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Philippe C, 2006, EUR J MED GENET, V49, P9, DOI 10.1016/j.ejmg.2005.04.003; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Vila R, 2001, J BIOL CHEM, V276, P46429, DOI 10.1074/jbc.M106952200; Villard L, 2007, J MED GENET, V44, P417, DOI 10.1136/jmg.2007.049452; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Wakefield RID, 1999, J MOL BIOL, V291, P1055, DOI 10.1006/jmbi.1999.3023; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wellman SE, 1996, BIOPOLYMERS, V39, P491, DOI 10.1002/(SICI)1097-0282(199610)39:4<491::AID-BIP2>3.3.CO;2-8; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172	64	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20523	20534		10.1074/jbc.M803021200	http://dx.doi.org/10.1074/jbc.M803021200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499664	Green Published, hybrid			2022-12-27	WOS:000257565300065
J	Bu, S; Kapanadze, B; Hsu, T; Trojanowska, M				Bu, Shizhong; Kapanadze, Bagrat; Hsu, Tien; Trojanowska, Maria			Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; TUMOR-SUPPRESSOR PTEN; FACTOR-BETA; TGF-BETA; MYOFIBROBLAST DIFFERENTIATION; NUCLEAR-LOCALIZATION; PHOSPHATASE; EXPRESSION; KINASE; SPHINGOSINE-1-PHOSPHATE	Transforming growth factor-beta (TGF-beta) is an important regulator of physiological connective tissue biosynthesis and plays a central role in pathological tissue fibrosis. Previous studies have established that a biologically active lipid mediator, sphingosine 1-phosphate (S1P), mimics some of the profibrotic functions of TGF-beta through cross-activation of Smad signaling. Here we report that another product of sphingosine kinase, dihydrosphingosine 1-phosphate (dhS1P), has an opposite role in the regulation of TGF-beta signaling. In contrast to S1P, dhS1P inhibits TGF-beta-induced Smad2/3 phosphorylation and up-regulation of collagen synthesis. The effects of dhS1P require a lipid phosphatase, PTEN, a key modulator of cell growth and survival. dhS1P stimulates phosphorylation of the C-terminal domain of PTEN and its subsequent translocation into the nucleus. We demonstrate a novel function of nuclear PTEN as a co-factor of the Smad2/3 phosphatase, PPM1A. Complex formation of PTEN with PPM1A does not require the lipid phosphatase activity but depends on phosphorylation of the serine/threonine residues located in the C-terminal domain of PTEN. Upon complex formation with PTEN, PPM1A is protected from degradation induced by the TGF-beta signaling. Consequently, overexpression of PTEN abrogates TGF-beta-induced Smad2/3 phosphorylation. This study establishes a novel role for nuclear PTEN in the stabilization of PPM1A. PTEN-mediated cross-talk between the sphingolipid and TGF-beta signaling pathways may play an important role in physiological and pathological TGF-beta signaling.	[Bu, Shizhong; Kapanadze, Bagrat; Trojanowska, Maria] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Hsu, Tien] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Trojanowska, M (corresponding author), Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	trojanme@musc.edu		Trojanowska, Maria/0000-0001-9550-7178; Hsu, Tien/0000-0003-2308-4297	NCI NIH HHS [P01 CA78582, R01 CA109860] Funding Source: Medline; NIAMS NIH HHS [P60 AR049459, R01 AR44883] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109860, P01CA078582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR049459, R01AR044883] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bu Shizhong, 2006, FASEB J, V20, P184; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; French KJ, 2003, CANCER RES, V63, P5962; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Guzeloglu-Kayisli O, 2003, J CLIN ENDOCR METAB, V88, P5017, DOI 10.1210/jc.2003-030414; Hjelmeland AB, 2005, CANCER RES, V65, P11276, DOI 10.1158/0008-5472.CAN-05-3016; Keller CD, 2007, AM J PATHOL, V170, P281, DOI 10.2353/ajpath.2007.060485; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yamanaka M, 2004, J BIOL CHEM, V279, P53994, DOI 10.1074/jbc.M410144200	42	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19593	19602		10.1074/jbc.M802417200	http://dx.doi.org/10.1074/jbc.M802417200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482992	Green Published, hybrid			2022-12-27	WOS:000257387600045
J	Chu, LR; Lai, YL; Xu, XP; Eddy, S; Yang, S; Song, L; Kolodrubetz, D				Chu, Lianrui; Lai, Yanlai; Xu, Xiaoping; Eddy, Scott; Yang, Shuang; Song, Li; Kolodrubetz, David			A 52-kDa leucyl aminopeptidase from Treponema denticola is a cysteinylglycinase that mediates the second step of glutathione metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE PRODUCTION; GAMMA-GLUTAMYL-TRANSFERASE; VOLATILE SULFUR-COMPOUNDS; L-CYSTEINE DESULFHYDRASE; METHYL MERCAPTAN; CYSTALYSIN; BINDING; PURIFICATION; HEMOLYSIN; CAPACITY	The metabolism of glutathione by the periodontal pathogen Treponema denticola produces hydrogen sulfide, which may play a role in the host tissue destruction seen in periodontitis. H2S production in this organism has been proposed to occur via a three enzyme pathway, gamma-glutamyltransferase, cysteinylglycinase (CGase), and cystalysin. In this study, we describe the purification and characterization of T. denticola CGase. Standard approaches were used to purify a 52-kDa CGase activity from T. denticola, and high pressure liquid chromatography electrospray ionization tandem mass spectrometry analysis of this molecule showed that it matches the amino acid sequence of a predicted 52-kDa protein in the T. denticola genome data base. A recombinant version of this protein was overexpressed in and purified from Escherichia coli and shown to catalyze the hydrolysis of cysteinylglycine (Cys-Gly) with the same kinetics as the native protein. Surprisingly, because sequence homology indicates that this protein is a member of a family of metalloproteases called M17 leucine aminopeptidases, the preferred substrate for the T. denticola protein is Cys-Gly (k(cat)/K-m of 8.2 mu M-1 min(-1)) not L-Leu-p-NA (k(cat)/K-m of 1.1 mu M-1 min(-1)). The activity of CGase for Cys-Gly is optimum at pH 7.3 and is enhanced by Mn2+, Co2+, or Mg2+ but not by Zn2+ or Ca2+. Importantly, in combination with the two other previously purified T. denticola enzymes, gamma-glutamyltransferase and cystalysin, CGase mediates the in vitro degradation of glutathione into the expected end products, including H2S. These results prove that T. denticola contains the entire three-step pathway to produce H2S from glutathione, which may be important for pathogenesis.	[Chu, Lianrui; Lai, Yanlai; Eddy, Scott; Yang, Shuang; Song, Li] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthodont, San Antonio, TX 78229 USA; [Xu, Xiaoping] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA; [Kolodrubetz, David] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Chu, LR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Orthodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chul@uthscsa.edu			NIDCR NIH HHS [R01 DE-13819] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013819] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aimetti M, 2007, J PERIODONTOL, V78, P1718, DOI 10.1902/jop.2007.060473; [Anonymous], 2004, HDB PROTEOLYTIC ENZY; [Anonymous], CLIN LAB METHODS; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bertoldi M, 2002, BIOCHEMISTRY-US, V41, P9153, DOI 10.1021/bi025649q; BLAKEMORE RP, 1976, J BACTERIOL, V128, P616, DOI 10.1128/JB.128.2.616-622.1976; Cappiello M, 2006, BIOCHEMISTRY-US, V45, P3226, DOI 10.1021/bi052069v; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; CARLSSON J, 1994, ORAL MICROBIOL IMMUN, V9, P297, DOI 10.1111/j.1399-302X.1994.tb00074.x; CARLSSON J, 1993, ORAL MICROBIOL IMMUN, V8, P42, DOI 10.1111/j.1399-302X.1993.tb00541.x; Cellini B, 2004, J BIOL CHEM, V279, P36898, DOI 10.1074/jbc.M404449200; Cellini B, 2006, BIOCHEMISTRY-US, V45, P14140, DOI 10.1021/bi061496l; Cellini B, 2006, ARCH BIOCHEM BIOPHYS, V455, P31, DOI 10.1016/j.abb.2006.08.020; CHU L, 1994, MICROB PATHOGENESIS, V16, P197, DOI 10.1006/mpat.1994.1020; CHU L, 1995, INFECT IMMUN, V63, P4448, DOI 10.1128/IAI.63.11.4448-4455.1995; Chu L, 1997, INFECT IMMUN, V65, P3231, DOI 10.1128/IAI.65.8.3231-3238.1997; Chu L, 1999, ORAL MICROBIOL IMMUN, V14, P293, DOI 10.1034/j.1399-302X.1999.140505.x; CHU L, 1986, SHANGHAI J IMMUNOL, V6, P243; Chu LR, 2003, INFECT IMMUN, V71, P335, DOI 10.1128/IAI.71.1.335-342.2003; Chu LR, 2002, INFECT IMMUN, V70, P1113, DOI 10.1128/IAI.70.3.1113-1120.2002; Chu LR, 1999, CLIN INFECT DIS, V28, P442, DOI 10.1086/515164; CLAESSON R, 1990, ORAL MICROBIOL IMMUN, V5, P137, DOI 10.1111/j.1399-302X.1990.tb00411.x; Dong L, 2005, MICROBIOL-SGM, V151, P2017, DOI 10.1099/mic.0.27767-0; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HOROWITZ A, 1973, J PERIODONTOL, V44, P390, DOI 10.1902/jop.1973.44.7.390; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; Kurzban GP, 1999, ORAL MICROBIOL IMMUN, V14, P153, DOI 10.1034/j.1399-302X.1999.140303.x; Makinen PL, 1997, INFECT IMMUN, V65, P685; MOORE WEC, 1987, J PERIODONTAL RES, V22, P335, DOI 10.1111/j.1600-0765.1987.tb01595.x; MORHART RE, 1970, J PERIODONTOL, V41, P644, DOI 10.1902/jop.1970.41.11.644; Morty RE, 2002, J BIOL CHEM, V277, P26057, DOI 10.1074/jbc.M202779200; PERSSON S, 1992, ORAL MICROBIOL IMMUN, V7, P378, DOI 10.1111/j.1399-302X.1992.tb00641.x; PERSSON S, 1990, ORAL MICROBIOL IMMUN, V5, P195, DOI 10.1111/j.1399-302X.1990.tb00645.x; PERSSON S, 1989, ORAL MICROBIOL IMMUN, V4, P169, DOI 10.1111/j.1399-302X.1989.tb00246.x; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; RIZZO AA, 1967, PERIODONTICS, V5, P233; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; SIMONSON LG, 1988, INFECT IMMUN, V56, P726, DOI 10.1128/IAI.56.4.726-728.1988; [Смирнова Г.В. Smirnova G.V.], 2005, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V70, P1459; STRATER N, 2004, HDB PROTEOLYTIC ENZY, P896; Suzuki H, 2001, J BACTERIOL, V183, P1489, DOI 10.1128/JB.183.4.1489-1490.2001; Suzuki H, 2001, BIOSCI BIOTECH BIOCH, V65, P1549, DOI 10.1271/bbb.65.1549; TANGLARSEN J, 1995, J PERIODONTAL RES, V30, P390, DOI 10.1111/j.1600-0765.1995.tb01292.x; Thomas JA, 2007, VIROLOGY, V368, P405, DOI 10.1016/j.virol.2007.06.043; *US NAT RES COUNC, 1979, HYDR SULF, P1; WEINBERG A, 1990, INFECT IMMUN, V58, P1720, DOI 10.1128/IAI.58.6.1720-1729.1990; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	51	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19351	19358		10.1074/jbc.M801034200	http://dx.doi.org/10.1074/jbc.M801034200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482986	Green Published, hybrid			2022-12-27	WOS:000257387600021
J	Mesnage, S; Chau, F; Dubost, L; Arthur, M				Mesnage, Stephane; Chau, Francoise; Dubost, Lionel; Arthur, Michel			Role of N-acetylglucosaminidase and N-acetylmuramidase activities in Enterococcus faecalis peptidoglycan metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LYTIC TRANSGLYCOSYLASE; STREPTOCOCCUS-FAECALIS; BACILLUS-SUBTILIS; MUREIN SACCULUS; PENICILLIN; HYDROLASES; RESISTANCE; FAECIUM; SYSTEM	Identification of the full complement of peptidoglycan hydrolases detected by zymogram in Enterococcus faecalis extracts led to the characterization of two novel hydrolases that we named AtlB and AtlC. Both enzymes have a similar modular organization comprising a central catalytic domain fused to two LysM peptidoglycan-binding modules. AtlB and AtlC displayed N-acetylmuramidase activity, as demonstrated by tandem mass spectrometry analyses of peptidoglycan fragments generated by the purified enzymes. The genes encoding AtlB and AtlC were deleted either alone or in combination with the gene encoding AtlA, a previously describedN-acetylglucosaminidase. No autolytic activity was detected in the triple mutant indicating that AtlA, AtlB, and AtlC account for the major hydrolytic activities in E. faecalis. Analysis of cell size distribution by flow cytometry showed that deletion of atlA resulted in the formation of long chains. Thus, AtlA digests the septum and is required for cell separation after cell division. We found that AtlB could act as a surrogate for AtlA, although the enzyme was less efficient at septum digestion. Deletion of atlC had no impact on cell morphology. Labeling of the peptidoglycan with N-[C-14] acetylglucosamine revealed an unusually slow turnover as compared with model organisms, almost completely dependent upon the combined activities of AtlA and AtlB. In contrast to atlA, the atlB and atlC genes are located in putative prophages. Because AtlB and AtlC were produced in the absence of cell lysis or production of phage progeny, these enzymes may have been hijacked by E. faecalis to contribute to peptidoglycan metabolism.	[Mesnage, Stephane; Arthur, Michel] Univ Paris 06, UMR S 872, Equipe 12, Ctr Rech Cordeliers,LRMA, F-75006 Paris, France; [Mesnage, Stephane; Arthur, Michel] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Mesnage, Stephane; Arthur, Michel] INSERM, U872, F-75006 Paris, France; [Chau, Francoise] Univ Paris 07, Fac Med Xavier Bichat, EA3964, F-75018 Paris, France; [Dubost, Lionel] Museum Natl Hist Nat, USM0502, F-75005 Paris, France; [Dubost, Lionel] CNRS, UMR8041, Plateforme Spectrometrie Masse & Prote Museum, Dept Rech Dev & Diversite Mol, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Mesnage, S (corresponding author), Univ Paris 06, INSERM, U872, LRMA,Ctr Rech Cordeliers,Equipe 12, 15 Rue Ecole Med, F-75270 Paris 06, France.	stephane.mesnage@crc.jussieu.fr	MESNAGE, Stephane/H-7156-2019; Arthur, Michel/G-3680-2013	Arthur, Michel/0000-0003-1007-636X; MESNAGE, Stephane/0000-0003-1648-4890				Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Archibald A. R., 1993, P381; Baptista M, 1999, MOL MICROBIOL, V32, P17, DOI 10.1046/j.1365-2958.1999.01308.x; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bouhss A, 2002, J BIOL CHEM, V277, P45935, DOI 10.1074/jbc.M207449200; Cencic A, 2002, EUR J BIOCHEM, V269, P2772, DOI 10.1046/j.1432-1033.2002.02950.x; CHU CP, 1992, J BACTERIOL, V174, P1619, DOI 10.1128/jb.174.5.1619-1625.1992; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; DOLINGER DL, 1989, J BACTERIOL, V171, P4355, DOI 10.1128/JB.171.8.4355-4361.1989; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Holtje JV, 1996, MICROBIOL-SGM, V142, P1911, DOI 10.1099/13500872-142-8-1911; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; KAWAMURA T, 1983, J BIOL CHEM, V258, P9514; LECLERC D, 1989, CAN J MICROBIOL, V35, P749, DOI 10.1139/m89-125; Lepage E, 2006, J BACTERIOL, V188, P6858, DOI 10.1128/JB.00421-06; Meberg BM, 2004, J BACTERIOL, V186, P8326, DOI 10.1128/JB.186.24.8326-8336.2004; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; ROMEIS T, 1994, J BIOL CHEM, V269, P21603; RUSSOMARIE F, 1993, P NATL ACAD SCI USA, V90, P8194, DOI 10.1073/pnas.90.17.8194; SHOCKMAN GD, 1969, J BACTERIOL, V98, P1199, DOI 10.1128/JB.98.3.1199-1207.1969; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; vonRechenberg M, 1996, MICROB DRUG RESIST, V2, P155, DOI 10.1089/mdr.1996.2.155; WEIDEL W, 1964, ADV ENZYMOL REL S BI, V26, P193	29	51	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19845	19853		10.1074/jbc.M802323200	http://dx.doi.org/10.1074/jbc.M802323200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18490448	hybrid			2022-12-27	WOS:000257387600068
J	Suzuki, K; Juelich, T; Lim, H; Ishida, T; Watanebe, T; Cooper, DA; Rao, S; Kelleher, AD				Suzuki, Kazuo; Juelich, Torsten; Lim, Heidi; Ishida, Takaomi; Watanebe, Toshiki; Cooper, David A.; Rao, Sudha; Kelleher, Anthony D.			Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; H3 LYSINE-9 METHYLATION; DOUBLE-STRANDED-RNA; GENE-EXPRESSION; HUMAN-CELLS; TRANSCRIPTIONAL ACTIVATION; DNA METHYLATION; IN-VITRO; HETEROCHROMATIN PROTEIN-1; HISTONE METHYLATION	In some mammalian systems small interfering RNAs (siRNA) targeting homologous sequences in promoter regions of genes induce transcriptional gene silencing (TGS). We have previously reported the induction of TGS by an siRNA (prom-A siRNA) targeting the tandem NF-kappa B-binding motifs with in the human immunodeficiency virus, type 1 (HIV-1), promoter region. Here we report that induction of TGS by prom-A siRNA is accompanied by immediate and sustained local recruitment of Argonaute-1(Ago1), histone deacetylase-1 (HDAC1), and induction of dimethylation of histone 3 at lysine 9 (H3K9me2), processes known to be associated with transcriptional silencing. Elevated levels of H3K9me2 and HDAC1 spread upstream of the target sequence, and elevated H3K9me2 levels also spread downstream into the coding region. Moreover, this siRNA induces an immediate change in DNA accessibility to restriction enzyme digestion in the region of the transcription initiation site of the HIV-1. This change in accessibility is because of the relocation of a nucleosome known to be associated with this region of the integrated pro-virus. Although there is a theoretical possibility that the observed viral suppression could be mediated by the PTGS mechanism with this siRNA acting at the 3'-long term repeat of the virus, we demonstrate that this siRNA, and three other U3 targeted siRNAs, are inefficient inducers of PTGS. These data strongly suggest that siRNA targeting the promoter region acts predominantly at a site within the 5'-long term repeat of HIV to induce transcriptional silencing and alterations to chromatin structure of the HIV promoter region that extend well beyond the immediate siRNA target site. These induced changes are consistent with those described in latent HIV-1 infection.	[Suzuki, Kazuo; Lim, Heidi; Cooper, David A.; Kelleher, Anthony D.] St Vincents Hosp, Ctr Immunol, Immunovirol Lab, Darlinghurst, NSW 2010, Australia; [Juelich, Torsten; Rao, Sudha] John Curtin Sch Med Res, Div Immunol & Genet, Canc Vasc Biol Grp, Canberra, ACT 2601, Australia; [Ishida, Takaomi; Watanebe, Toshiki] Univ Tokyo, Tumor Cell Biol Lab, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 1088639, Japan; [Lim, Heidi; Cooper, David A.; Kelleher, Anthony D.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia	St Vincents Hospital Sydney; Australian National University; John Curtin School of Medical Research; University of Tokyo; University of New South Wales Sydney; Kirby Institute	Suzuki, K (corresponding author), St Vincents Hosp, Ctr Immunol, Immunovirol Lab, Darlinghurst, NSW 2010, Australia.	k.suzuki@cfi.unsw.edu.au	Rao, Sudha/AAW-5192-2020	Rao, Sudha/0000-0001-9547-947X; Suzuki, Kazuo/0000-0002-2531-794X				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALDOVINI A, 1990, TECHNIQUES HIV RES H, P51; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Castanotto D, 2005, MOL THER, V12, P179, DOI 10.1016/j.ymthe.2005.03.003; CLARKE MF, 1984, VIROLOGY, V135, P97, DOI 10.1016/0042-6822(84)90120-X; COFFIN JM, 1997, RETROVIRUSES, P205; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; HARBERS K, 1981, P NATL ACAD SCI-BIOL, V78, P7609, DOI 10.1073/pnas.78.12.7609; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; HU WS, 1984, J VIROL, V49, P66, DOI 10.1128/JVI.49.1.66-71.1984; Hutvagner G, 2008, NAT REV MOL CELL BIO, V105, P512; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kirn JW, 2007, BIOCHEM BIOPH RES CO, V359, P292, DOI 10.1016/j.bbrc.2007.05.080; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Koiwa T, 2002, J VIROL, V76, P9389, DOI 10.1128/JVI.76.18.9389-9397.2002; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim HG, 2008, MOL THER, V16, P565, DOI 10.1038/sj.mt.6300380; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lu BY, 2000, GENETICS, V155, P699; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Pulukuri SMK, 2007, CANCER RES, V67, P6637, DOI 10.1158/0008-5472.CAN-07-0751; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith AE, 2008, J BIOL CHEM, V283, P9878, DOI 10.1074/jbc.M710393200; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; SUZUKI K, 1993, J VIROL METHODS, V44, P189, DOI 10.1016/0166-0934(93)90054-U; Suzuki Kazuo, 2005, J RNAi Gene Silencing, V1, P66; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang XL, 2007, MOL CELL BIOCHEM, V301, P259, DOI 10.1007/s11010-007-9427-4; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Weinberg MS, 2007, NUCLEIC ACIDS RES, V35, P1; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102	79	80	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23353	23363		10.1074/jbc.M709651200	http://dx.doi.org/10.1074/jbc.M709651200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18519571	Green Published, hybrid			2022-12-27	WOS:000258455400045
J	Roussel, X; Bechade, G; Kriznik, A; Van Dorsselaer, A; Sanglier-Cianferani, S; Branlant, G; Rahuel-Clermont, S				Roussel, Xavier; Bechade, Guillaume; Kriznik, Alexandre; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah; Branlant, Guy; Rahuel-Clermont, Sophie			Evidence for the formation of a covalent thiosulfinate intermediate with peroxiredoxin in the catalytic mechanism of sulfiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; PHENYL BENZENETHIOLSULFINATE; MAMMALIAN SULFIREDOXIN; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; REDUCTION; HYDROLYSIS; SULPHIREDOXIN; ANTIOXIDANT	The typical 2-Cys peroxiredoxins are thiol-peroxidases involved in the physiology of hydrogen peroxide not only as a toxic but also as a signaling molecule. Coordination of these functions depends on the sulfinylation of the catalytic Cys, a modification reversed by ATP-dependent sulfiredoxin, which specifically reduces the sulfinic acid group of overoxidized 2-Cys peroxiredoxins into a sulfenic acid. Sulfiredoxin was originally proposed to operate by covalent catalysis, with formation of a peroxiredoxin-sulfiredoxin intermediate linked by a thiosulfinate bond between the catalytic Cys of both partners, a hypothesis rejected by a study of the human enzyme. To settle the argument, we investigated the catalytic mechanism of Saccharomyces cerevisiae sulfiredoxin, by the characterization of the nature and kinetics of formation of the protein species formed between sulfiredoxin and its substrate in the presence of ATP, using mutants of the non-essential Cys residues of both proteins. We observed the formation of a dithiothreitol-reducible peroxiredoxin-sulfiredoxin species using SDS-PAGE and Western blot analysis, and its mass was shown to correspond to a thiosulfinate complex by high resolution mass spectrometry coupled to liquid chromatography. We next measured indirectly and directly a rate constant of formation of the thiosulfinate species of similar to 2 min(-1), for both wild-type and mutant sulfiredoxins, at least equal to the steady-state rate constant of the reaction, with a stoichiometry of 1:1 relative to peroxiredoxin. Taken altogether, our results strongly argue in favor of the formation of a covalent thiosulfinate peroxiredoxin-sulfiredoxin species as an intermediate on the catalytic pathway.	[Roussel, Xavier; Kriznik, Alexandre; Branlant, Guy; Rahuel-Clermont, Sophie] Nancy Univ, Fac Sci, Unite Mixte Rech, CNRS UHP Maturat Acide Ribonucle & Enzymol Mol 75, F-54506 Vandoeuvre Les Nancy, France; [Bechade, Guillaume; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah] Ecole Chim Polymeres & Mat, Dept Analyt Sci,UMR,CNRS ULP 7178, Lab Spectrometrie Masse Bioorgan, Inst Pluridisciplinaire Hubert Curien, F-67087 Strasbourg, France	Universite de Lorraine	Branlant, G (corresponding author), Nancy Univ, Fac Sci, Unite Mixte Rech, CNRS UHP Maturat Acide Ribonucle & Enzymol Mol 75, Bld Aiguillettes,BP 239, F-54506 Vandoeuvre Les Nancy, France.	guy.branlant@maem.uhp-nancy.fr; sophie.rahuel@maem.uhp-nancy.fr	Rahuel-Clermont, Sophie/AAB-3451-2020; Kriznik, Alexandre/S-1523-2019	Rahuel-Clermont, Sophie/0000-0001-5143-0105; Kriznik, Alexandre/0000-0003-2627-8273; Roussel, Xavier/0000-0003-2923-4559; Bechade, Guillaume/0000-0002-3087-7132; Cianferani, Sarah/0000-0003-4013-4129				BANIK U, 1990, BIOCHEM J, V266, P611; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Glauser DA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-54; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; KICE JL, 1974, J AM CHEM SOC, V96, P8015, DOI 10.1021/ja00833a029; KICE JL, 1979, J ORG CHEM, V44, P1918, DOI 10.1021/jo01326a005; KICE JL, 1974, J AM CHEM SOC, V96, P8009, DOI 10.1021/ja00833a028; Lee DY, 2006, BIOCHEMISTRY-US, V45, P15301, DOI 10.1021/bi061824h; Liu XP, 2006, CELL RES, V16, P287, DOI 10.1038/sj.cr.7310036; Lundell N, 1999, ANAL BIOCHEM, V266, P31, DOI 10.1006/abio.1998.2919; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Nagy P, 2007, CHEM RES TOXICOL, V20, P1364, DOI 10.1021/tx700168z; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; VENIAMIN N, 2000, J MASS SPECTROM, V35, P572; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405	31	44	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22371	22382		10.1074/jbc.M800493200	http://dx.doi.org/10.1074/jbc.M800493200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18552404	Green Published, hybrid			2022-12-27	WOS:000258321000005
J	Yao, P; Zhou, XL; He, R; Xue, MQ; Zheng, YG; Wang, YF; Wang, ED				Yao, Peng; Zhou, Xiao-Long; He, Ran; Xue, Mei-Qin; Zheng, Yong-Gang; Wang, Yue-Fei; Wang, En-Duo			Unique residues crucial for optimal editing in yeast cytoplasmic leucyl-tRNA synthetase are revealed by using a novel knockout yeast strain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO SELECTION; ESCHERICHIA-COLI; GENETIC-CODE; AMINO-ACIDS; MITOCHONDRIAL; DOMAIN; AMINOACYLATION; RECOGNITION; EXPRESSION; TRNA(LEU)	Leucyl-tRNA synthetase (LeuRS) contains an editing domain that discriminates leucine from noncognate amino acids to ensure translational fidelity. In this study, a knock-out strain for Saccharomyces cerevisiae LeuRS was constructed to analyze in vivo the tRNA aminoacylation properties of S. cerevisiae and human cytoplasmic LeuRSs. The activities of several editing-defective mutants of ycLeuRS were determined in vitro and compared with those obtained in vivo in a complementation assay performed in the knock-out strain. The editing activities of these mutants were analyzed in the presence of either norvaline, a leucine analogue, or AN2690, a specific inhibitor that targets the editing active site. In general, the in vivo data are consistent with those obtained in vitro. Our results show that ycLeuRS post-transfer editing plays a crucial role in the establishment of the aminoacylation fidelity. When impaired, the viability of cells bearing editing-defective mutants is drastically decreased in the presence of noncognate amino acid. This study also emphasizes the crucial function of some semi-conserved residues around the editing site in modulating the editing efficiency. The assay system can be used to test the effect of compounds that potentially target the aminoacylation or editing active site of fungal LeuRS.	[Yao, Peng; Zhou, Xiao-Long; He, Ran; Xue, Mei-Qin; Zheng, Yong-Gang; Wang, Yue-Fei; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch,State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch,State Key Lab Mol Biol, Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn	Zheng, Yonggang/B-5009-2011; Yao, Peng/G-5218-2015; Yao, Peng/J-4492-2013; Yao, Peng/Y-8047-2019	Yao, Peng/0000-0003-1022-3948; Yao, Peng/0000-0002-7029-8629; Yao, Peng/0000-0002-1145-3967				Ador L, 1999, J MOL BIOL, V288, P231, DOI 10.1006/jmbi.1999.2679; Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JF, 1999, PROTEIN EXPRES PURIF, V15, P115, DOI 10.1006/prep.1998.0999; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Geslain R, 2000, RNA, V6, P434, DOI 10.1017/S1355838200992331; Hendrickson TL, 2003, MOL B INT U, P34; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JAKUBOWSKI H, 1991, EMBO J, V10, P593, DOI 10.1002/j.1460-2075.1991.tb07986.x; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Mocibob M, 2008, ARCH BIOCHEM BIOPHYS, V470, P129, DOI 10.1016/j.abb.2007.11.014; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Schimmel P, 2001, COLD SPRING HARB SYM, V66, P161, DOI 10.1101/sqb.2001.66.161; Senger B, 2001, J MOL BIOL, V311, P205, DOI 10.1006/jmbi.2001.4844; Soma A, 1996, J MOL BIOL, V263, P707, DOI 10.1006/jmbi.1996.0610; Soma A, 1998, NUCLEIC ACIDS RES, V26, P4374, DOI 10.1093/nar/26.19.4374; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618	42	25	27	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22591	22600		10.1074/jbc.M801181200	http://dx.doi.org/10.1074/jbc.M801181200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550527	hybrid			2022-12-27	WOS:000258321000028
J	Guastafierro, T; Cecchinelli, B; Zampieri, M; Reale, A; Riggio, G; Sthandier, O; Zupi, G; Calabrese, L; Caiafa, P				Guastafierro, Tiziana; Cecchinelli, Barbara; Zampieri, Michele; Reale, Anna; Riggio, Giuseppe; Sthandier, Olga; Zupi, Gabriella; Calabrese, Lilia; Caiafa, Paola			CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; ADP-RIBOSE POLYMERS; POLY(ADP-RIBOSE) GLYCOHYDROLASE; CELL-DEATH; QUANTITATIVE-ANALYSIS; MAMMALIAN-CELLS; CTCF; CHROMATIN; INHIBITION; TRANSCRIPTION	Our previous data have shown that in L929 mouse fibroblasts the control of methylation pattern depends in part on poly(ADP-ribosyl) ation and that ADP-ribose polymers (PARs), both present on poly(ADP-ribosyl) ated PARP-1 and/or protein-free, have an inhibitory effect on Dnmt1 activity. Here we show that transient ectopic overexpression of CCCTC-binding factor (CTCF) induces PAR accumulation, PARP-1, and CTCF poly(ADP-ribosyl) ation in the same mouse fibroblasts. The persistence in time of a high PAR level affects the DNA methylation machinery; the DNA methyltransferase activity is inhibited with consequences for the methylation state of genome, which becomes diffusely hypomethylated affecting centromeric minor satellite and B1 DNA repeats. In vitro data show that CTCF is able to activate PARP-1 automodification even in the absence of nicked DNA. Our new finding that CTCF is able per se to activate PARP-1 automodification in vitro is of great interest as so far a burst of poly(ADP-ribosyl) ated PARP-1 has generally been found following introduction of DNA strand breaks. CTCF is unable to inhibitDNMT1activity, whereas poly(ADP-ribosyl) ated PARP-1 plays this inhibitory role. These data suggest that CTCF is involved in the cross-talk between poly(ADP-ribosyl) ation and DNA methylation and underscore the importance of a rapid reversal of PARP activity, as DNA methylation pattern is responsible for an important epigenetic code.	[Guastafierro, Tiziana; Cecchinelli, Barbara; Zampieri, Michele; Reale, Anna; Riggio, Giuseppe; Sthandier, Olga; Caiafa, Paola] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, I-00161 Rome, Italy; [Calabrese, Lilia] Univ Roma La Sapienza, Dept Biochem Sci, I-00161 Rome, Italy; [Guastafierro, Tiziana; Zampieri, Michele; Reale, Anna; Riggio, Giuseppe; Caiafa, Paola] Fondaz Cenci Bolognetti, Inst Pasteur, I-00161 Rome, Italy; [Zupi, Gabriella] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, I-00158 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Caiafa, P (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Viale Regina Elena 324, I-00161 Rome, Italy.	caiafa@bce.uniroma1.it	Reale, Anna/J-5933-2016; Zampieri, Michele/AGF-5460-2022; Zampieri, Michele/F-7099-2013; guastafeierro, tiziana/J-8006-2016	Reale, Anna/0000-0001-8988-2342; Zampieri, Michele/0000-0002-6799-2492; Zampieri, Michele/0000-0002-6799-2492; guastafeierro, tiziana/0000-0001-9433-2759				ALTHAUS FR, 1992, J CELL SCI, V102, P663; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Beneke S, 2007, NUCLEIC ACIDS RES, V35, P7456, DOI 10.1093/nar/gkm735; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Bonicalzi ME, 2003, BIOL CELL, V95, P635, DOI 10.1016/j.biolcel.2003.10.003; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; Carbone M, 2006, J MOL BIOL, V363, P773, DOI 10.1016/j.jmb.2006.05.077; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; D'Alessio AC, 2006, BIOCHEM CELL BIOL, V84, P463, DOI 10.1139/O06-090; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; De Capoa A, 1999, FASEB J, V13, P89; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ethier C, 2007, APOPTOSIS, V12, P2037, DOI 10.1007/s10495-007-0127-z; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Griesenbeck J, 1999, FEBS LETT, V443, P20, DOI 10.1016/S0014-5793(98)01671-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karymov MA, 2001, FASEB J, V15, P2631, DOI 10.1096/fj.01-0345com; Klenova E, 2005, CELL CYCLE, V4, P96, DOI 10.4161/cc.4.1.1398; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Ohashi S, 2003, BIOCHEM BIOPH RES CO, V307, P915, DOI 10.1016/S0006-291X(03)01272-5; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; PANZETER PL, 1992, BIOCHEMISTRY-US, V31, P1379, DOI 10.1021/bi00120a014; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rasko JEJ, 2001, CANCER RES, V61, P6002; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; REALINI CA, 1992, J BIOL CHEM, V267, P18858; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schmid C, 2001, MOL HUM REPROD, V7, P903, DOI 10.1093/molehr/7.10.903; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zardo G, 1999, FASEB J, V13, P1518, DOI 10.1096/fasebj.13.12.1518; Zardo G, 2002, FASEB J, V16, P1319, DOI 10.1096/fj.01-0827fje; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; Zardo G, 1997, BIOCHEMISTRY-US, V36, P7937, DOI 10.1021/bi970241s; ZARDO G, 1999, GENE THER MOL BIOL, V4, P291	57	105	113	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21873	21880		10.1074/jbc.M801170200	http://dx.doi.org/10.1074/jbc.M801170200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18539602	Green Published, hybrid			2022-12-27	WOS:000258114700006
J	Oh-Oka, K; Nakatogawa, H; Ohsumi, Y				Oh-oka, Kyoko; Nakatogawa, Hitoshi; Ohsumi, Yoshinori			Physiological pH and acidic phospholipids contribute to substrate specificity in lipidation of Atg8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO RECONSTITUTION; UBIQUITIN-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MAMMALIAN HOMOLOG; CRYSTAL-STRUCTURE; E2 ENZYME; AUTOPHAGY; CONJUGATION; GABARAP	Yeast Atg8 and its mammalian homolog LC3 are ubiquitin-like proteins involved in autophagy, a primary pathway for degradation of cytosolic constituents in vacuoles/lysosomes. Whereas the lipid phosphatidylethanolamine (PE) was identified as the sole in vivo target of their conjugation reactions, in vitro studies showed that the same system can mediate the conjugation of these proteins with phosphatidylserine as efficiently as with PE. Here, we show that, in contrast to PE conjugation, the in vitro phosphatidylserine conjugation of Atg8 is markedly suppressed at physiological pH. Furthermore, the addition of acidic phospholipids to liposomes also results in the preferential formation of the Atg8-PE conjugate. We have successfully captured authentic thioester intermediates, allowing us to elucidate which step in the conjugation reaction is affected by these changes in pH and membrane lipid composition. We propose that these factors contribute to the selective formation of Atg8-PE in the cell.	[Oh-oka, Kyoko; Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; [Oh-oka, Kyoko; Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Nakatogawa, Hitoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan.	yohsumi@nibb.ac.jp	Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009	Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166				CEVC G, 1993, PHOSPHOLIPIDS HDB, P512; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Valli M, 2005, APPL ENVIRON MICROB, V71, P1515, DOI 10.1128/AEM.71.3.1515-1521.2005; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	32	40	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21847	21852		10.1074/jbc.M801836200	http://dx.doi.org/10.1074/jbc.M801836200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544538	hybrid			2022-12-27	WOS:000258114700003
J	Becker, HM; Deitmer, JW				Becker, Holger M.; Deitmer, Joachim W.			Nonenzymatic proton handling by carbonic anhydrase II during H+-lactate cotransport via monocarboxylate transporter 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; HYDROPHOBIC POCKET; SKELETAL-MUSCLE; O-18 EXCHANGE; BINDING-SITE; SURFACE; MCT1; EXPRESSION; MEMBRANE; NEURONS	Carbonic anhydrase (CA) is a ubiquitous enzyme catalyzing the equilibration of carbon dioxide, protons, and bicarbonate. For several acid/base-coupled membrane carriers it has been shown that the catalytic activity of CA supports transport activity, an interaction coined "transport metabolon." We have reported that CA isoform II (CAII) enhances lactate transport activity of the monocarboxylate transporter isoform I (MCT1) expressed in Xenopus oocytes, which does not require CAII catalytic activity (Becker, H. M., Fecher-Trost, C., Hirnet, D., Sultemeyer, D., and Deitmer, J. W. (2005) J. Biol. Chem. 280, 39882-39889). Coexpression of MCT1 with either wild type CAII or the catalytically inactive mutant CAII-V143Y similarly enhanced MCT1 activity, although injection of CAI or coexpression of an N-terminal mutant of CAII had no effect on MCT1 transport activity, demonstrating a specific, nonenzymatic action of CAII on lactate transport via MCT1. If the H+ gradient was set to dominate the rate of lactate transport by applying low concentrations of lactate at a high H+ concentration, the effect of CAII was largest. We tested the hypothesis of whether CAII helps to shuttle H+ along the inner face of the cell membrane by measuring the pH change with fluorescent dye in different areas of interest during focal lactate application. Intracellular pH shifts decayed from the focus of lactate application to more distant sites much less when CAII had been injected. We present a hypothetical model in which the effective movement of H+ into the bulk cytosol is increased by CAII, thus slowing the dissipation of the H+ gradient across the cell membrane, which drives MCT1 activity.	[Becker, Holger M.; Deitmer, Joachim W.] Tech Univ Kaiserslautern, FB Biol, Abt Allgemeine Zool, D-67653 Kaiserslautern, Germany	University of Kaiserslautern	Becker, HM (corresponding author), Tech Univ Kaiserslautern, FB Biol, Abt Allgemeine Zool, POB 3049, D-67653 Kaiserslautern, Germany.	h.becker@biologie.uni-kl.de	Becker, Holger/AAB-4322-2020					ALEXANDER RS, 1991, BIOCHEMISTRY-US, V30, P11064, DOI 10.1021/bi00110a008; ALEXIEV U, 1995, P NATL ACAD SCI USA, V92, P372, DOI 10.1073/pnas.92.2.372; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Barros LF, 2007, BIOPHYS J, V92, P3878, DOI 10.1529/biophysj.106.100925; Becker HM, 2004, J BIOL CHEM, V279, P28057, DOI 10.1074/jbc.M402401200; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; Branden M, 2006, P NATL ACAD SCI USA, V103, P19766, DOI 10.1073/pnas.0605909103; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; FIERKE CA, 1991, BIOCHEMISTRY-US, V30, P11054, DOI 10.1021/bi00110a007; Galic S, 2003, BIOCHEM J, V376, P413, DOI 10.1042/BJ20030799; Gopta OA, 1999, P NATL ACAD SCI USA, V96, P13159, DOI 10.1073/pnas.96.23.13159; Gross E, 2002, J PHYSIOL-LONDON, V544, P679, DOI 10.1113/jphysiol.2002.029777; Gutman M, 2006, PHOTOCH PHOTOBIO SCI, V5, P531, DOI 10.1039/b515887g; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; HEBERLE J, 1992, P NATL ACAD SCI USA, V89, P5996, DOI 10.1073/pnas.89.13.5996; HEBERLE J, 1994, NATURE, V370, P379, DOI 10.1038/370379a0; JAMESKRACKE MR, 1992, J CELL PHYSIOL, V151, P596, DOI 10.1002/jcp.1041510320; Juel C, 2001, EUR J APPL PHYSIOL, V86, P12, DOI 10.1007/s004210100517; Juel C, 2003, J PHYSIOL-LONDON, V548, P639, DOI 10.1113/jphysiol.2002.035899; KRAFTE DS, 1989, J NEUROSCI METH, V26, P211, DOI 10.1016/0165-0270(89)90118-0; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Nett W, 1996, BIOPHYS J, V71, P394, DOI 10.1016/S0006-3495(96)79240-8; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pfeuffer J, 2005, J MAGN RESON, V177, P129, DOI 10.1016/j.jmr.2005.07.010; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; Roy A, 2007, J PHYS CHEM B, V111, P10563, DOI 10.1021/jp073499t; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Scozzafava A, 2002, BIOORG MED CHEM LETT, V12, P1177, DOI 10.1016/S0960-894X(02)00121-X; Silverman DN, 2007, ACCOUNTS CHEM RES, V40, P669, DOI 10.1021/ar7000588; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sterling D, 2001, JOP, V2, P165; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Svichar N, 2003, GLIA, V41, P415, DOI 10.1002/glia.10187; TAOKA S, 1994, J BIOL CHEM, V269, P17988; Vanysek P., 1999, CRC HDB CHEM PHYS, P93; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wetzel P, 2001, J PHYSIOL-LONDON, V531, P743, DOI 10.1111/j.1469-7793.2001.0743h.x; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65	53	74	74	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21655	21667		10.1074/jbc.M802134200	http://dx.doi.org/10.1074/jbc.M802134200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539591	hybrid			2022-12-27	WOS:000257898800039
J	Genest, O; Neumann, M; Seduk, F; Stocklein, W; Mejean, V; Leimkuhler, S; Iobbi-Nivol, C				Genest, Olivier; Neumann, Meina; Seduk, Farida; Stoecklein, Walter; Mejean, Vincent; Leimkuehler, Silke; Iobbi-Nivol, Chantal			Dedicated metallochaperone connects apoenzyme and molybdenum cofactor biosynthesis components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; N-OXIDE REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RHODOBACTER-CAPSULATUS; SHEWANELLA-MASSILIA; NITRATE REDUCTASE; MOLYBDOPTERIN SYNTHASE; ANGSTROM RESOLUTION; MOLYBDOENZYME TORA	The biogenesis of molybdenum-containing enzymes is a sophisticated process involving the insertion of a complex molybdenum cofactor into competent apoproteins. As for many molybdoenzymes, the maturation of trimethylamine-oxide reductase TorA requires a private chaperone. This chaperone (TorD) interacts with the signal peptide and the core of apo-TorA. Using random mutagenesis, we established that alpha-helix 5 of TorD plays a key role in the core binding and that this binding drives the maturation of TorA. In addition, we showed for the first time that TorD interacts with molybdenum cofactor biosynthesis components, including MobA, the last enzyme of cofactor synthesis, and Mo-molybdopterin, the precursor form of the cofactor. Finally we demonstrated that TorD also binds the mature molybdopterin-guanine dinucleotide form of the cofactor. Wethus propose that TorD acts as a platform connecting the last step of the synthesis of the molybdenum cofactor just before its insertion into the catalytic site of TorA.	[Genest, Olivier; Seduk, Farida; Mejean, Vincent; Iobbi-Nivol, Chantal] IBSM CNRS, Chim Bacterienne Lab, F-13402 Marseille 20, France; [Neumann, Meina; Stoecklein, Walter; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany	Centre National de la Recherche Scientifique (CNRS); University of Potsdam	Iobbi-Nivol, C (corresponding author), IBSM CNRS, Chim Bacterienne Lab, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	iobbi@ibsm.cnrs-mrs.fr	Neumann-Schaal, Meina/AAM-6389-2021; Genest, Olivier/GQZ-3215-2022	Genest, Olivier/0000-0003-1240-2827; Leimkuhler, Silke/0000-0003-3238-2122; Mejean, Vincent/0000-0001-6533-5846				Baraquet C, 2006, J BIOL CHEM, V281, P38189, DOI 10.1074/jbc.M604321200; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; Bordi C, 2003, MOL MICROBIOL, V48, P211, DOI 10.1046/j.1365-2958.2003.03428.x; CHUNG CT, 1988, NUCLEIC ACIDS RES, V16, P3580, DOI 10.1093/nar/16.8.3580; Czjzek M, 1998, J MOL BIOL, V284, P435, DOI 10.1006/jmbi.1998.2156; Genes O, 2005, J BIOL CHEM, V280, P15644, DOI 10.1074/jbc.M501119200; Genest O, 2006, BIOCHEM BIOPH RES CO, V339, P991, DOI 10.1016/j.bbrc.2005.11.107; Genest O, 2006, FEMS MICROBIOL LETT, V265, P51, DOI 10.1111/j.1574-6968.2006.00468.x; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hatzixanthis K, 2005, P NATL ACAD SCI USA, V102, P8460, DOI 10.1073/pnas.0500737102; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ilbert M, 2004, MICROBIOL-SGM, V150, P935, DOI 10.1099/mic.0.26909-0; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Leimkuhler S, 2005, HUM GENET, V117, P565, DOI 10.1007/s00439-005-1341-9; McAlpine AS, 1998, J MOL BIOL, V275, P613, DOI 10.1006/jmbi.1997.1513; MEJEAN V, 1994, MOL MICROBIOL, V11, P1169, DOI 10.1111/j.1365-2958.1994.tb00393.x; Miller J. H., 1972, EXPT MOL GENETICS, P72; Neumann M, 2007, J BIOL CHEM, V282, P28493, DOI 10.1074/jbc.M704020200; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Tranier S, 2003, STRUCTURE, V11, P165, DOI 10.1016/S0969-2126(03)00008-X; Tranier S, 2002, PROTEIN SCI, V11, P2148, DOI 10.1110/ps.0202902; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Vergnes A, 2004, J BIOL CHEM, V279, P41398, DOI 10.1074/jbc.M407087200	38	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21433	21440		10.1074/jbc.M802954200	http://dx.doi.org/10.1074/jbc.M802954200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522945	hybrid			2022-12-27	WOS:000257898800015
J	Niapour, M; Yu, Y; Berger, SA				Niapour, Maryam; Yu, Yongmao; Berger, Stuart A.			Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; PROTEASOME INHIBITORS; MEDIATED PROTEOLYSIS; TARGET GENES; EXPRESSION; ADHESION; GROWTH; FIBROBLASTS; PHENOTYPES; INDUCTION	The c-Myc transcription factor is commonly dysregulated in cancer. c-Myc also sensitizes cells to apoptosis induced by a variety of toxic events. c-Myc turnover is rapid and mediated by the proteasome and intracellular calpains. Therefore, c-Myc accumulation could contribute to cell death associated with protease inhibitors. We investigated the response of c-Myc-positive and c-Myc-negative rat fibroblast cells to proteasome and calpain inhibitors. Apoptosis induced by the proteasome inhibitor, epoxomycin, was c-Myc-independent, whereas apoptosis induced by the calpain inhibitor, PD150606, or by knockdown of calpain small subunit 1 (CPNS1) was strongly dependent on c-Myc. HL60 cells knocked down for c-Myc expression exhibited reduced calpain activity and decreased sensitivity to PD150606 but not epoxomycin. Calpain inhibitor- or CPNS1 knockdown-induced apoptosis in c-Myc-positive fibroblasts was associated with cell detachment and could be prevented by plating cells on fibronectin, suggesting an anoikis phenomenon. c-Myc stimulated calpain activity by suppressing calpastatin expression, the endogenous calpain inhibitor. Knockdown of calpastatin in c-Myc-negative cells led to a restoration of calpain activity, enhanced cell growth, cell cycle redistribution, anchorage independence, and tumorigenicity in immunodeficient mice. Taken together, these results indicate that c-Myc regulates calpain activity through calpastatin; apoptosis induced by calpain inhibition is dependent on c-Myc, and calpastatin knockdown promotes transformation in c-Myc-negative cells.	Univ Hlth Network, Arthrit & Immune Disorder Res Ctr, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Berger, SA (corresponding author), Univ Hlth Network, Arthrit & Immune Disorder Res Ctr, Toronto Med Discovery Tower,8th Floor,Rm 8-354,1, Toronto, ON M5G 1L7, Canada.	Berger@UHNRES.UTORONTO.CA						Albihn A, 2006, J CELL BIOCHEM, V98, P1597, DOI 10.1002/jcb.20816; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Chana JS, 1999, BRIT J OPHTHALMOL, V83, P110, DOI 10.1136/bjo.83.1.110; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Crouch DH, 1996, ONCOGENE, V12, P2689; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eischen CM, 2001, ONCOGENE, V20, P6983, DOI 10.1038/sj.onc.1204892; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; GIBSON AW, 1995, EXP CELL RES, V218, P351, DOI 10.1006/excr.1995.1166; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guan N, 2006, INT J ONCOL, V29, P655; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lewis BC, 2000, CANCER RES, V60, P6178; Li HQ, 2004, BBA-MOL CELL RES, V1691, P91, DOI 10.1016/j.bbamcr.2003.12.006; Louro ID, 2002, CANCER RES, V62, P5867; Maclean KH, 2003, MOL CELL BIOL, V23, P7256, DOI 10.1128/MCB.23.20.7256-7270.2003; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Mitchell KO, 2000, CANCER RES, V60, P6318; Nass SJ, 1997, BREAST CANCER RES TR, V44, P1, DOI 10.1023/A:1005858611585; Niapour M, 2007, CYTOM PART A, V71A, P475, DOI 10.1002/cyto.a.20399; Nikiforov MA, 2000, ONCOGENE, V19, P4828, DOI 10.1038/sj.onc.1203880; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Orlowski RZ, 1998, CANCER RES, V58, P4342; Orre RS, 2001, J BIOL CHEM, V276, P1794, DOI 10.1074/jbc.M008560200; PRAGNELL IB, 1985, PROC R SOC SER B-BIO, V226, P107, DOI 10.1098/rspb.1985.0085; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Rogulski KR, 2005, P NATL ACAD SCI USA, V102, P18968, DOI 10.1073/pnas.0507902102; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; WATT F, 1993, NUCLEIC ACIDS RES, V21, P5092, DOI 10.1093/nar/21.22.5092; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; WRIGHT TC, 1977, P NATL ACAD SCI USA, V74, P258, DOI 10.1073/pnas.74.1.258; Xu Y, 2002, J BIOL CHEM, V277, P21474, DOI 10.1074/jbc.M111689200; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Zhu DM, 2000, CLIN CANCER RES, V6, P2456; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683; ZHU W, 1995, BIOCHEM BIOPH RES CO, V214, P1130, DOI 10.1006/bbrc.1995.2403	59	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21371	21381		10.1074/jbc.M801462200	http://dx.doi.org/10.1074/jbc.M801462200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18544539	hybrid			2022-12-27	WOS:000257898800008
J	Oezguen, N; Kumar, S; Hindupur, A; Braun, W; Muralidhara, BK; Halpert, JR				Oezguen, Numan; Kumar, Santosh; Hindupur, Aditya; Braun, Werner; Muralidhara, B. K.; Halpert, James R.			Identification and analysis of conserved sequence motifs in cytochrome P450 family 2 - Functional and structural role of a motif (RFDYKD192)-R-187 in CYP2B enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; DIRECTED EVOLUTION; ACTIVE-SITE; ALLELE FREQUENCIES; CATALYTIC-ACTIVITY; SUBSTRATE; P4502B4; BINDING; MUTAGENESIS; VARIABILITY	Using a multiple alignment of 175 cytochrome P450 ( CYP) family 2 sequences, 20 conserved sequence motifs (CSMs) were identified with the program PCPMer. Functional importance of the CSM in CYP2B enzymes was assessed from available data on site-directed mutants and genetic variants. These analyses suggested an important role of the CSM 8, which corresponds to (RFDYKD192)-R-187 in CYP2B4. Further analysis showed that residues 187, 188, 190, and 192 have a very high rank order of conservation compared with 189 and 191. Therefore, eight mutants (R187A, R187K, F188A, D189A, Y190A, K191A, D192A, and a negative control K186A) were made in an N-terminal truncated and modified form of CYP2B4 with an internal mutation, which is termed 2B4dH/H226Y. Function was examined with the substrates 7-methoxy-4-(trifluoromethyl) coumarin (7-MFC), 7-ethoxy-4-(trifluoromethyl) coumarin (7-EFC), 7-benzyloxy-4(trifluoromethyl) coumarin (7-BFC), and testosterone and with the inhibitors 4-(4-chlorophenyl) imidazole (4-CPI) and bifonazole (BIF). Compared with the template and K186A, the mutants R187A, R187K, F188A, Y190A, and D192A showed >= 2-fold altered substrate specificity, k(cat), K-m, and/or k(cat)/K-m for 7-MFC and 7-EFC and 3- to 6-fold decreases in differential inhibition (IC50, BIF/IC50,4-CPI). Subsequently, these mutants displayed 5-12 degrees C decreases in thermal stability (T-m) and 2-8 degrees C decreases in catalytic tolerance to temperature (T-50) compared with the template and K186A. Furthermore, when R187A and D192A were introduced in CYP2B1dH, the P450 expression and thermal stability were decreased. In addition, R187A showed increased activity with 7-EFC and decreased IC50,BIF/IC50,4-CPI compared with 2B1dH. Analysis of long range residue-residue interactions in the CYP2B4 crystal structures indicated strong hydrogen bonds involving Glu(149)-Asn(177)-Arg(187) -Tyr(190) and Asp(192)-Val(194), which were significantly reduced/abolished by the Arg(187) --> Ala and Asp(192) --> Ala substitutions, respectively.	[Kumar, Santosh; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Oezguen, Numan; Hindupur, Aditya; Braun, Werner] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Oezguen, Numan; Hindupur, Aditya; Braun, Werner] Univ Texas Galveston, Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Muralidhara, B. K.] Pfizer Inc, PhRD Global Biol, Chesterfield, MO 63017 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Pfizer	Kumar, S (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,Rm 2231, La Jolla, CA 92093 USA.	s8kumar@ucsd.edu	Oezguen, Numan/C-9267-2009; Braun, Werner/A-6642-2012	Oezguen, Numan/0000-0002-3175-2382; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064913, R56AI064913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R01ES003619] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 064913] Funding Source: Medline; NIEHS NIH HHS [ES 03619, ES 06676] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Blobaum AL, 2005, BIOCHEMISTRY-US, V44, P3831, DOI 10.1021/bi0478953; Bracey MH, 2004, FEBS LETT, V567, P159, DOI 10.1016/j.febslet.2004.04.084; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Case D.A., 2006, AMBER, V9; Chen CD, 1996, J BIOL CHEM, V271, P28607, DOI 10.1074/jbc.271.45.28607; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; Davydov DR, 2004, BIOCHEMISTRY-US, V43, P6475, DOI 10.1021/bi036260l; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; Domanski TL, 1999, J PHARMACOL EXP THER, V290, P1141; Domanski TL, 2001, CURR DRUG METAB, V2, P117, DOI 10.2174/1389200013338612; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; GOTOH O, 1992, J BIOL CHEM, V267, P83; Harlow GR, 1997, BBA-PROTEIN STRUCT M, V1338, P259, DOI 10.1016/S0167-4838(96)00209-9; Hernandez CE, 2006, ARCH BIOCHEM BIOPHYS, V455, P61, DOI 10.1016/j.abb.2006.08.024; Hesse LM, 2004, PHARMACOGENETICS, V14, P225, DOI 10.1097/00008571-200404000-00002; Hiraoka K, 2004, DYSPHAGIA, V19, P155, DOI 10.1007/s00455-004-0002-9; Honma W, 2005, ARCH BIOCHEM BIOPHYS, V435, P157, DOI 10.1016/j.abb.2004.12.014; Johnson EF, 2005, BIOCHEM BIOPH RES CO, V338, P331, DOI 10.1016/j.bbrc.2005.08.190; Kim D, 2004, BIOCHEMISTRY-US, V43, P981, DOI 10.1021/bi035593f; Kim D, 2004, ARCH BIOCHEM BIOPHYS, V432, P102, DOI 10.1016/j.abb.2004.09.001; Kirchheiner J, 2003, PHARMACOGENETICS, V13, P619, DOI 10.1097/00008571-200310000-00005; Klein K, 2005, PHARMACOGENET GENOM, V15, P861, DOI 10.1097/01213011-200512000-00004; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar S, 2003, J BIOL CHEM, V278, P17178, DOI 10.1074/jbc.M212515200; Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200; Kumar S, 2005, BIOCHEM BIOPH RES CO, V338, P456, DOI 10.1016/j.bbrc.2005.08.080; Kumar S, 2007, MOL PHARMACOL, V72, P1191, DOI 10.1124/mol.107.039693; Kumar S, 2006, DRUG METAB DISPOS, V34, P1958, DOI 10.1124/dmd.106.012054; Kumar S, 2006, PROTEIN ENG DES SEL, V19, P547, DOI 10.1093/protein/gzl042; Lang T, 2004, J PHARMACOL EXP THER, V311, P34, DOI 10.1124/jpet.104.068973; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Lehnerer M, 2000, J BIOCHEM, V127, P163, DOI 10.1093/oxfordjournals.jbchem.a022578; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Lin HL, 2005, CHEM RES TOXICOL, V18, P1203, DOI 10.1021/tx050100o; Muralidhara BK, 2007, DRUG METAB REV, V39, P539, DOI 10.1080/03602530701498182; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Nakamura K, 2001, ARCH BIOCHEM BIOPHYS, V395, P25, DOI 10.1006/abbi.2001.2569; Negi SS, 2006, J MOL MODEL, V12, P921, DOI 10.1007/s00894-006-0101-7; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Schein CH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-40; Schein CH, 2005, PROTEINS, V58, P200, DOI 10.1002/prot.20253; Schein CH, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-37; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Scott EE, 2002, CHEM RES TOXICOL, V15, P1407, DOI 10.1021/tx020057u; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Stout CD, 2004, STRUCTURE, V12, P1921, DOI 10.1016/j.str.2004.10.002; Sun L, 2007, ARCH BIOCHEM BIOPHYS, V458, P167, DOI 10.1016/j.abb.2006.12.021; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Venkatarajan SM, 2003, BIOINFORMATICS, V19, P1381; Waller SC, 1999, CHEM RES TOXICOL, V12, P690, DOI 10.1021/tx990030j; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Wu ZL, 2005, J BIOL CHEM, V280, P41090, DOI 10.1074/jbc.M508182200; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Yun CH, 2000, BIOCHEMISTRY-US, V39, P11319, DOI 10.1021/bi000869u; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614; Zhao YH, 2007, BBA-GEN SUBJECTS, V1770, P402, DOI 10.1016/j.bbagen.2006.07.006	60	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21808	21816		10.1074/jbc.M708582200	http://dx.doi.org/10.1074/jbc.M708582200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18495666	Green Published, hybrid			2022-12-27	WOS:000257898800054
J	Brazier-Hicks, M; Evans, KM; Cunningham, OD; Hodgson, DRW; Steel, PG; Edwards, R				Brazier-Hicks, Melissa; Evans, Kathryn M.; Cunningham, Oliver D.; Hodgson, David R. W.; Steel, Patrick G.; Edwards, Robert			Catabolism of glutathione conjugates in Arabidopsis thaliana - Role in metabolic reactivation of the herbicide safener fenclorim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-S LYASE; TANDEM MASS-SPECTROMETRY; PHYTOCHELATIN SYNTHASE; TRANSFERASES; PLANTS; IDENTIFICATION; DETOXIFICATION; DEGRADATION; GLUCOSYLTRANSFERASE; PURIFICATION	The safener fenclorim (4,6-dichloro-2-phenylpyrimidine) increases tolerance to chloroacetanilide herbicides in rice by enhancing the expression of detoxifying glutathione S-transferases (GSTs). Fenclorim also enhances GSTs in Arabidopsis thaliana, and while investigating the functional significance of this induction in suspension cultures, we determined that these enzymes glutathionylated the safener. The resulting S-(fenclorim)glutathione conjugate was sequentially processed to S-(fenclorim)-gamma-glutamyl-cysteine and S-(fenclorim)-cysteine (FC), the latter accumulating in both the cells and the medium. FC was then either catabolized to 4-chloro-6-(methylthio)-phenylpyrimidine (CMTP) or N-acylated with malonic acid. These cysteine derivatives had distinct fates, with the enzymes responsible for their formation being induced by fenclorim and FC. Fenclorim-N-malonylcysteine was formed from FC by the action of a malonyl-CoA-dependent N-malonyltransferase. A small proportion of the fenclorim-N-malonylcysteine then underwent decarboxylation to yield a putative S-fenclorim-Nacetylcysteine intermediate, which underwent a second round of GST-mediated S-glutathionylation and subsequent proteolytic processing. The formation of CMTP was catalyzed by the concerted action of a cysteine conjugate beta-lyase and an S-methyltransferase, with the two activities being coordinately regulated. Although the fenclorim conjugates tested showed little GST-inducing activity in Arabidopsis, the formation of CMTP resulted in metabolic reactivation, with the product showing good enhancing activity. In addition, CMTP induced GSTs and herbicide-safening activity in rice. The bioactivated CMTP was in turn glutathione-conjugated and processed to a malonyl cysteine derivative. These results reveal the surprisingly complex set of competing catabolic reactions acting on xenobiotics entering the S-glutathionylation pathway in plants, which can result in both detoxification and bioactivation.	[Brazier-Hicks, Melissa; Evans, Kathryn M.; Cunningham, Oliver D.; Hodgson, David R. W.; Steel, Patrick G.; Edwards, Robert] Univ Durham, Dept Chem, Ctr Bioact Chem, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Univ Durham, Dept Chem, Ctr Bioact Chem, South Rd, Durham DH1 3LE, England.		Steel, Patrick/G-3187-2012; Hodgson, David/F-7174-2011	Steel, Patrick/0000-0002-2493-5826; Hodgson, David/0000-0003-4517-9166; Edwards, Robert/0000-0003-0809-5991; Brazier-Hicks, Melissa/0000-0001-5993-1940; EVANS, KATE/0000-0002-2184-7433	BBSRC [BB/D005620/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005620/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; BENICHOU M, 1995, PHYSIOL PLANTARUM, V94, P629, DOI 10.1111/j.1399-3054.1995.tb00977.x; Blum R, 2007, PLANT J, V49, P740, DOI 10.1111/j.1365-313X.2006.02993.x; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Cummins I, 1997, PESTIC SCI, V51, P244, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;244::AID-PS643&gt;3.0.CO;2-2; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; De Veylder L, 1997, PLANT CELL PHYSIOL, V38, P568, DOI 10.1093/oxfordjournals.pcp.a029206; Deng F, 2002, PESTIC BIOCHEM PHYS, V72, P10, DOI 10.1006/pest.2001.2580; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Edwards R, 2005, Z NATURFORSCH C, V60, P307; Edwards R, 2005, ADV BOT RES, V42, P1, DOI 10.1016/S0065-2296(05)42001-7; Grzam A, 2007, FEBS LETT, V581, P3131, DOI 10.1016/j.febslet.2007.05.071; Grzam A, 2006, FEBS LETT, V580, P6384, DOI 10.1016/j.febslet.2006.10.050; HARDEN DB, 1988, J ORG CHEM, V53, P4137, DOI 10.1021/jo00252a057; Hatzios KK, 2003, PHYTOPARASITICA, V31, P3, DOI 10.1007/BF02979761; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Kiddle GA, 1999, PLANT CELL ENVIRON, V22, P433, DOI 10.1046/j.1365-3040.1999.00416.x; LAMOUREUX GL, 1993, PESTIC BIOCHEM PHYS, V47, P8, DOI 10.1006/pest.1993.1058; LAMOUREUX GL, 1980, PESTIC BIOCHEM PHYS, V14, P50, DOI 10.1016/0048-3575(80)90022-X; LAMOUREUX GL, 1993, SULFUR NUTRITION AND ASSIMILATION IN HIGHER PLANTS, P221; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; Liu GS, 2001, J BIOL CHEM, V276, P8648, DOI 10.1074/jbc.M009690200; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; MCCARTHY RI, 1994, TOXICOL IND HEALTH, V10, P103, DOI 10.1177/074823379401000107; Miller KD, 1996, J AGR FOOD CHEM, V44, P3335, DOI 10.1021/jf9505436; Miller KD, 1996, J AGR FOOD CHEM, V44, P3326, DOI 10.1021/jf950542d; Ohkama-Ohtsu N, 2007, PLANT J, V49, P878, DOI 10.1111/j.1365-313X.2006.03005.x; ONISKO BC, 1994, BIOL MASS SPECTROM, V23, P626, DOI 10.1002/bms.1200231005; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; Wolf AE, 1996, FEBS LETT, V384, P31, DOI 10.1016/0014-5793(96)00272-4	33	48	52	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21102	21112		10.1074/jbc.M801998200	http://dx.doi.org/10.1074/jbc.M801998200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18522943	Green Published, hybrid			2022-12-27	WOS:000257746100052
J	Chen, S; Hall, C; Barbieri, JT				Chen, Sheng; Hall, Cherisse; Barbieri, Joseph T.			Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTYPE-A; ENDOPEPTIDASE ACTIVITY; ANGSTROM RESOLUTION; LIGHT-CHAIN; SNARE MOTIF; TOXIN; CLEAVAGE; SPECIFICITY; SYNAPTOBREVIN; MECHANISM	Botulinum neurotoxin (BoNT; serotypes A-G) and tetanus neurotoxin elicit flaccid and spastic paralysis, respectively. These neurotoxins are zinc proteases that cleave SNARE proteins to inhibit synaptic vesicle fusion to the plasma membrane. Although BoNT/B and tetanus neurotoxin ( TeNT) cleave VAMP-2 at the same scissile bond, their mechanism(s) of VAMP-2 recognition is not clear. Mapping experiments showed that residues 60 - 87 of VAMP-2 were sufficient for efficient cleavage by BoNT/B and that residues 40 - 87 of VAMP-2 were sufficient for efficient TeNT cleavage. Alanine-scanning mutagenesis and kinetic analysis identified three regions within VAMP-2 that were recognized by BoNT/B and TeNT: residues adjacent to the site of scissile bond cleavage ( cleavage region) and residues located within N-terminal and C-terminal regions relative to the cleavage region. Analysis of residues within the cleavage region showed that mutations at the P7, P4, P2, and P1' residues of VAMP-2 had the greatest inhibition of LC/B cleavage (>= 32-fold), whereas mutations at P7, P4, P1', and P2' residues of VAMP-2 had the greatest inhibition of LC/TeNT cleavage (>= 64-fold). Residues within the cleavage region influenced catalysis, whereas residues N-terminal and C-terminal to the cleavage region influenced binding affinity. Thus, BoNT/B and TeNT possess similar organization but have unique residues to recognize and cleave VAMP-2. These studies provide new insights into how the clostridial neurotoxins recognize their substrates.	[Chen, Sheng; Hall, Cherisse; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Barbieri, JT (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	jtb01@mcw.edu		Chen, Sheng/0000-0003-3526-7808	NIAID NIH HHS [U54 AI 057153] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Brandt FS, 1998, DERMATOL SURG, V24, P1232, DOI 10.1111/j.1524-4725.1998.tb04103.x; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Cornille F, 1997, J BIOL CHEM, V272, P3459, DOI 10.1074/jbc.272.6.3459; DASGUPTA BR, 1972, BIOCHIM BIOPHYS ACTA, V268, P719, DOI 10.1016/0005-2744(72)90276-8; Deinhardt K, 2005, BIOCHEM SOC SYMP, V72, P139, DOI 10.1042/bss0720139; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Klein AW, 2004, DERMATOL CLIN, V22, P197, DOI 10.1016/S0733-8635(03)00122-0; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; Perpetuo EA, 2002, BIOTECHNOL APPL BIOC, V36, P155, DOI 10.1042/BA20020011; Purcell AL, 2007, ANAL BIOCHEM, V366, P207, DOI 10.1016/j.ab.2007.04.048; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; Rupp B, 2001, NAT STRUCT BIOL, V8, P663, DOI 10.1038/90361; SCHIAVO G, 1994, ANN NY ACAD SCI, V710, P65, DOI 10.1111/j.1749-6632.1994.tb26614.x; Schiavo G, 1995, CURR TOP MICROBIOL, V195, P257; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; SHONE CC, 1994, EUR J BIOCHEM, V225, P263, DOI 10.1111/j.1432-1033.1994.00263.x; SIEGEL LS, 1979, APPL ENVIRON MICROB, V38, P606, DOI 10.1128/AEM.38.4.606-611.1979; Sikorra S, 2006, J MOL BIOL, V357, P574, DOI 10.1016/j.jmb.2005.12.075; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tonello F, 1996, ADV EXP MED BIOL, V389, P251; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8; Wictome M, 1996, FEBS LETT, V386, P133, DOI 10.1016/0014-5793(96)00431-0; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764; ZUBER M, 1993, NEUROLOGY, V43, P1715, DOI 10.1212/WNL.43.9.1715	35	53	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21153	21159		10.1074/jbc.M800611200	http://dx.doi.org/10.1074/jbc.M800611200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511417	Green Published, hybrid			2022-12-27	WOS:000257746100057
J	Ifergan, I; Jansen, G; Assaraf, YG				Ifergan, Ilan; Jansen, Gerrit; Assaraf, Yehuda G.			The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation - RFC as a double edged sword in folate homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE PROTEIN BCRP/ABCG2; GAMMA-GLUTAMYL HYDROLASE; ONE-CARBON METABOLISM; ANTIFOLATE RESISTANCE; BINDING-PROTEIN; FOLYLPOLYGLUTAMATE SYNTHETASE; METHOTREXATE TRANSPORT; MEMBRANE-TRANSPORT; MAMMALIAN-CELLS; DNA METHYLATION	The reduced folate carrier (RFC), a bidirectional anion transporter, is the major uptake route of reduced folates essential for a spectrum of biochemical reactions and thus cellular proliferation. However, here we show that ectopic overexpression of the RFC, but not of folate receptor alpha, a high affinity unidirectional folate uptake route serving here as a negative control, resulted in an similar to 15-fold decline in cellular viability in medium lacking folates but not in folate-containing medium. Moreover to explore possible mechanisms of adaptation to folate deficiency in various cell lines that express the endogenous RFC, we first determined the gene expression status of the following genes: (a) RFC, (b) ATP-driven folate exporters (i. e. MRP1, MRP5, and breast cancer resistance protein), and (c) folylpoly-gamma-glutamate synthetase and gamma-glutamate hydrolase (GGH), enzymes catalyzing folate polyglutamylation and hydrolysis, respectively. Upon 3 -7 days of folate deprivation, semiquantitative reverse transcription-PCR analysis revealed a specific similar to 2.5-fold decrease in RFC mRNA levels in both breast cancer and T-cell leukemia cell lines that was accompanied by a consistent fall in methotrexate influx, serving here as an RFC transport activity assay. Likewise a 2.4-fold decrease in GGH mRNA levels and similar to 19% decreased GGH activity was documented for folate-deprived breast cancer cells. These results along with those of a novel mathematical biomodeling devised here suggest that upon severe short term (i. e. up to 7 days) folate deprivation RFC transport activity becomes detrimental as RFC, but not ATP-driven folate exporters, efficiently extrudes folate monoglutamates out of cells. Hence down-regulation of RFC and GGH may serve as a novel adaptive response to severe folate deficiency.	[Ifergan, Ilan; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel; [Jansen, Gerrit] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, NL-1081 Amsterdam, Netherlands	Technion Israel Institute of Technology; Vrije Universiteit Amsterdam	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il		Jansen, Gerrit/0000-0001-8190-8368; Assaraf, Yehuda G./0000-0001-6692-8221				ANTONY AC, 1992, BLOOD, V79, P2807; Assantachai P, 2007, PUBLIC HEALTH NUTR, V10, P65, DOI 10.1017/S136898000720494X; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Assaraf YG, 2006, J THEOR BIOL, V240, P637, DOI 10.1016/j.jtbi.2005.11.001; Assaraf YG, 2006, DRUG RESIST UPDATE, V9, P227, DOI 10.1016/j.drup.2006.09.001; Assaraf YG, 2003, J BIOL CHEM, V278, P6680, DOI 10.1074/jbc.M209186200; Assaraf YG, 1998, J BIOL CHEM, V273, P8106, DOI 10.1074/jbc.273.14.8106; Backus HHJ, 2000, INT J CANCER, V87, P771, DOI 10.1002/1097-0215(20000915)87:6<771::AID-IJC2>3.0.CO;2-V; BAILEY LB, 1982, AM J CLIN NUTR, V35, P1023, DOI 10.1093/ajcn/35.5.1023; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; BRIGLE KE, 1994, BIOCHEM PHARMACOL, V47, P337, DOI 10.1016/0006-2952(94)90025-6; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; Chen ZS, 2002, CANCER RES, V62, P3144; Chen ZS, 2003, CANCER RES, V63, P4048; Cole PD, 2001, CANCER RES, V61, P4599; Elnakat H, 2006, FRONT BIOSCI-LANDMRK, V11, P506, DOI 10.2741/1815; ELWOOD PC, 1989, J BIOL CHEM, V264, P14893; Gates SB, 1996, CLIN CANCER RES, V2, P1135; GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400; Hooijberg JH, 2004, BIOCHEM PHARMACOL, V67, P1541, DOI 10.1016/j.bcp.2003.12.022; Ifergan I, 2005, MOL PHARMACOL, V67, P1349, DOI 10.1124/mol.104.008250; Ifergan I, 2004, J BIOL CHEM, V279, P25527, DOI 10.1074/jbc.M401725200; JANSEN G, 1990, J BIOL CHEM, V265, P18272; Jordheim LP, 2004, CLIN CANCER RES, V10, P5614, DOI 10.1158/1078-0432.CCR-04-0506; Kanzaki A, 2001, JPN J CANCER RES, V92, P452, DOI 10.1111/j.1349-7006.2001.tb01115.x; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; LACEY SW, 1989, J CLIN INVEST, V84, P715, DOI 10.1172/JCI114220; Lamers Y, 2006, AM J CLIN NUTR, V84, P156, DOI 10.1093/ajcn/84.1.156; LIN BF, 1993, J BIOL CHEM, V268, P21674; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; McGuire JJ, 2000, J BIOL CHEM, V275, P13012, DOI 10.1074/jbc.275.17.13012; Michaelis L, 1913, BIOCHEM Z, V49, P333; OCONNOR BM, 1991, CANCER RES, V51, P3874; OSBORNE CB, 1993, J BIOL CHEM, V268, P21657; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; QURESHI AA, 1994, CRIT REV ONCOL HEMAT, V17, P133, DOI 10.1016/1040-8428(94)90022-1; RATNAM M, 1989, BIOCHEMISTRY-US, V28, P8249, DOI 10.1021/bi00446a042; Rothem L, 2005, MOL PHARMACOL, V68, P616, DOI 10.1124/mol.105.013540; Rothem L, 2004, MOL PHARMACOL, V66, P1536, DOI 10.1124/mol.104.004135; Rothem L, 2003, J BIOL CHEM, V278, P8935, DOI 10.1074/jbc.M209578200; Rothem L, 2002, BIOCHEM J, V367, P741, DOI 10.1042/BJ20020801; Rots MG, 1999, BLOOD, V93, P1677, DOI 10.1182/blood.V93.5.1677.405a16_1677_1683; RUBIN RC, 1967, CANCER RES, V27, P553; SADASIVAN E, 1989, J BIOL CHEM, V264, P5806; Scott JM, 1999, P NUTR SOC, V58, P441, DOI 10.1017/S0029665199000580; SHANE B, 1989, VITAM HORM, V45, P263; SHANE B, 1995, FOLATE HLTH DIS; SHEN F, 1995, BIOCHEMISTRY-US, V34, P5660, DOI 10.1021/bi00016a042; SHEN F, 1994, BIOCHEMISTRY-US, V33, P1209, DOI 10.1021/bi00171a021; Sierra EE, 1997, BIOCHEM PHARMACOL, V53, P223, DOI 10.1016/S0006-2952(96)00730-7; SIROTNAK F M, 1987, NCI (National Cancer Institute) Monographs, P27; SIROTNAK FM, 1985, CANCER RES, V45, P3992; Spiegelstein O, 2000, GENE, V258, P117, DOI 10.1016/S0378-1119(00)00418-2; Stokstad ELR, 1990, FOLIC ACID METABOLIS, P1; Volk EL, 2003, CANCER RES, V63, P5538; Walling J, 2006, INVEST NEW DRUG, V24, P37, DOI 10.1007/s10637-005-4541-1; WANG X, 1992, BIOCHEM PHARMACOL, V44, P1898; Wielinga P, 2005, CANCER RES, V65, P4425, DOI 10.1158/0008-5472.CAN-04-2810; Worm J, 2001, J BIOL CHEM, V276, P39990, DOI 10.1074/jbc.M103181200; Zeng H, 2001, CANCER RES, V61, P7225; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001; Zhao RB, 2001, J BIOL CHEM, V276, P10224, DOI 10.1074/jbc.C000905200; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhu Wei-Yong, 2002, J Exp Ther Oncol, V2, P264, DOI 10.1046/j.1359-4117.2002.01049.x	66	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20687	20695		10.1074/jbc.M802812200	http://dx.doi.org/10.1074/jbc.M802812200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499665	Green Published, hybrid			2022-12-27	WOS:000257746100009
J	Remacle, AG; Shiryaev, SA; Oh, ES; Cieplak, P; Srinivasan, A; Wei, G; Liddington, RC; Ratnikov, BI; Parent, A; Desjardins, R; Day, R; Smith, JW; Lebl, M; Strongin, AY				Remacle, Albert G.; Shiryaev, Sergey A.; Oh, Eok-Soo; Cieplak, Piotr; Srinivasan, Anupama; Wei, Ge; Liddington, Robert C.; Ratnikov, Boris I.; Parent, Amelie; Desjardins, Roxane; Day, Robert; Smith, Jeffrey W.; Lebl, Michal; Strongin, Alex Y.			Substrate cleavage analysis of furin and related proprotein convertases - A comparative study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROTEOLYTIC ACTIVATION; BACTERIAL TOXINS; PROHORMONE; PC7; SPECIFICITY; INFLUENZA; PROTEASES; VIRUS; PATHOGENICITY	We present the data and the technology, a combination of which allows us to determine the identity of proprotein convertases (PCs) related to the processing of specific protein targets including viral and bacterial pathogens. Our results, which support and extend the data of other laboratories, are required for the design of effective inhibitors of PCs because, in general, an inhibitor design starts with a specific substrate. Seven proteinases of the human PC family cleave the multibasic motifs R-X-(R/K/X)-R down arrow and, as a result, transform proproteins, including those from pathogens, into biologically active proteins and peptides. The precise cleavage preferences of PCs have not been known in sufficient detail; hence we were unable to determine the relative importance of the individual PCs in infectious diseases, thus making the design of specific inhibitors exceedingly difficult. To determine the cleavage preferences of PCs in more detail, we evaluated the relative efficiency of furin, PC2, PC4, PC5/6, PC7, and PACE4 in cleaving over 100 decapeptide sequences representing the R-X-(R/K/X)-R down arrow motifs of human, bacterial, and viral proteins. Our computer analysis of the data and the follow-on cleavage analysis of the selected full-length proteins corroborated our initial results thus allowing us to determine the cleavage preferences of the PCs and to suggest which PCs are promising drug targets in infectious diseases. Our results also suggest that pathogens, including anthrax PA83 and the avian influenza A H5N1 (bird flu) hemagglutinin precursor, evolved to be as sensitive to PC proteolysis as the most sensitive normal human proteins.	[Remacle, Albert G.; Shiryaev, Sergey A.; Oh, Eok-Soo; Cieplak, Piotr; Wei, Ge; Liddington, Robert C.; Ratnikov, Boris I.; Smith, Jeffrey W.; Strongin, Alex Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Srinivasan, Anupama; Lebl, Michal] Illumina Inc, San Diego, CA 92121 USA; [Parent, Amelie; Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Sherbrooke, PQ J1H SN4, Canada	Sanford Burnham Prebys Medical Discovery Institute; Illumina; University of Sherbrooke	Strongin, AY (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Lebl, Michal/GZG-9703-2022	Strongin, Alex/0000-0003-3765-3016; 	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061139, P01AI055789] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 020843, U54 RR020843] Funding Source: Medline; NIAID NIH HHS [AI 061139, AI 055789] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basak A, 1999, BIOCHEM J, V343, P29, DOI 10.1042/0264-6021:3430029; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Beinfeld MC, 1998, ENDOCRINE, V8, P1, DOI 10.1385/ENDO:8:1:1; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chiron MF, 1997, J BIOL CHEM, V272, P31707, DOI 10.1074/jbc.272.50.31707; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Creemers JWM, 1998, SEMIN CELL DEV BIOL, V9, P3, DOI 10.1006/scdb.1997.0195; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Decha P, 2008, BIOPHYS J, V95, P128, DOI 10.1529/biophysj.107.127456; Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7; Denault JB, 2000, PROTEIN EXPRES PURIF, V19, P113, DOI 10.1006/prep.2000.1215; Dey A, 2004, ENDOCRINOLOGY, V145, P1961, DOI 10.1210/en.2003-1472; Feldmann H, 1999, ARCH VIROL, P159; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gensberg K, 1998, SEMIN CELL DEV BIOL, V9, P11, DOI 10.1006/scdb.1997.0196; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Hachmann J, 2006, BIOPOLYMERS, V84, P340, DOI 10.1002/bip.20482; Hachmann J, 2006, J COMB CHEM, V8, P149, DOI 10.1021/cc050123l; Jiao GS, 2006, P NATL ACAD SCI USA, V103, P19707, DOI 10.1073/pnas.0606555104; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Kozlov IA, 2008, COMB CHEM HIGH T SCR, V11, P24; Kozlov IA, 2006, COMB CHEM HIGH T SCR, V9, P481, DOI 10.2174/138620706777698535; Lebl M, 2001, COLLECT CZECH CHEM C, V66, P1299, DOI 10.1135/cccc20011299; Lebl M, 1999, BIOORG MED CHEM LETT, V9, P1305, DOI 10.1016/S0960-894X(99)00176-6; Lebl M., 2003, JALA J ASS LAB AUTOM, V8, P30; Lissitzky JC, 2000, BIOCHEM J, V346, P133, DOI 10.1042/0264-6021:3460133; MAINS RE, 2004, HDB PROTEOLYTIC ENZY, P1871; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Paquet L, 1996, MOL CELL ENDOCRINOL, V120, P161, DOI 10.1016/0303-7207(96)03834-8; PATEL YC, 1995, CIBA F SYMP, V190, P26; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Peinado JR, 2003, J NEUROCHEM, V87, P868, DOI 10.1046/j.1471-4159.2003.02043.x; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; ROTT R, 1995, AM J RESP CRIT CARE, V152, pS16, DOI 10.1164/ajrccm/152.4_Pt_2.S16; Sarac MS, 2002, INFECT IMMUN, V70, P7136, DOI 10.1128/IAI.70.12.7136-7139.2002; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; SEIDAH NG, 1993, BIOCHEM SOC T, V21, P685, DOI 10.1042/bst0210685; SEIDAH NG, 2004, HDB PROTEOLYTIC ENZY, P1861; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stawowy P, 2005, J MOL MED, V83, P865, DOI 10.1007/s00109-005-0723-8; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Zambon MC, 2001, REV MED VIROL, V11, P227, DOI 10.1002/rmv.319	56	94	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20897	20906		10.1074/jbc.M803762200	http://dx.doi.org/10.1074/jbc.M803762200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18505722	hybrid, Green Published			2022-12-27	WOS:000257746100032
J	Cheng, SL; Shao, JS; Cai, J; Sierra, OL; Towler, DA				Cheng, Su-Li; Shao, Jian-Su; Cai, Jun; Sierra, Oscar L.; Towler, Dwight A.			Msx2 exerts bone anabolism via canonical Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCALCIN GENE-EXPRESSION; RECEPTOR-DEFICIENT MICE; CRANIAL NEURAL CREST; HOMEODOMAIN PROTEINS; TRANSCRIPTION FACTOR; FUNCTIONAL ANTAGONISM; PROMOTES OSTEOGENESIS; OVARIECTOMIZED RATS; HOMEOBOX GENE; STEM-CELLS	Msx2 is a homeodomain transcription factor first identified in craniofacial bone and human femoral osteoblasts. We hypothesized that Msx2 might activate skeletal Wnt signaling. Therefore, we analyzed the effects of CMV-Msx2 transgene (Msx2Tg) expression on skeletal physiology and composition. Skeletal Msx2 expression was increased 2-3-fold by Msx2Tg, with expanded protein accumulation in marrow, secondary ossification centers, and periosteum. Microcomputed tomography established increased bone volume in Msx2Tg mice, with increased numbers of plate-like trabeculae. Histomorphometry revealed increased bone formation in Msx2Tg mice versus non-Tg siblings, arising from increased osteoblast numbers. While decreasing adipogenesis, Msx2Tg increased osteogenic differentiation via mechanisms inhibited by Dkk1, an antagonist of Wnt receptors LRP5 and LRP6. Bone from Msx2Tg mice elaborated higher levels of Wnt7 canonical agonists, with diminished Dkk1, changes that augment canonical signaling. Analysis of non-Tg and Msx2Tg siblings possessing the TOP-GAL reporter confirmed this; Msx2Tg up-regulated skeletal beta-galactosidase expression (p <= 0.01), along with Wnt7a and Wnt7b, and reduced circulating Dkk1. To better understand molecular mechanisms, we studied C3H10T1/2 osteoprogenitor cells. As in bone, Msx2 increased Wnt7 genes and down-regulated Dkk1, while inducing the osteoblast gene alkaline phosphatase. Msx2-directed RNA interference increased Dkk1 expression and promoter activity, while reducing Wnt7a, Wnt7b, and alkaline phosphatase. Moreover, Msx2 inhibited Dkk1 promoter activity and reduced RNA polymerase association with Dkk1 chromatin. RNA interference-mediated knockdown of Wnt7a, Wnt7b, and LRP6 significantly reduced Msx2-induced alkaline phosphatase. Msx2 exerts bone anabolism in part by reducing Dkk1 expression and enhancing Wnt signaling, thus promoting osteogenic differentiation of skeletal progenitors.	[Cheng, Su-Li; Shao, Jian-Su; Cai, Jun; Sierra, Oscar L.; Towler, Dwight A.] Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA	Washington University (WUSTL)	Towler, DA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, Campus Box 8301,660 S Euclid Ave St, St Louis, MO 63110 USA.	dtowler@dom.wustl.edu		Towler, Dwight/0000-0003-2107-7923	NHLBI NIH HHS [R01 HL081138, HL 81138] Funding Source: Medline; NIAMS NIH HHS [AR 43731] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043731] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adamska M, 2005, DEV DYNAM, V233, P368, DOI 10.1002/dvdy.20437; Adamska M, 2003, DEV BIOL, V255, P350, DOI 10.1016/S0012-1606(02)00114-8; Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Ali MM, 2007, J CELL SCI, V120, P2565, DOI 10.1242/jcs.005090; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Barnes GL, 2003, CANCER RES, V63, P2631; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bidder M, 1998, J BONE MINER RES, V13, P609, DOI 10.1359/jbmr.1998.13.4.609; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; Brazas RM, 2005, METHOD ENZYMOL, V392, P112, DOI 10.1016/S0076-6879(04)92007-1; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; CAMACHO P, 2006, PRIMER METABOLIC BON, P127; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Chai Y, 2000, DEVELOPMENT, V127, P1671; Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Donahue LR, 2003, J BONE MINER RES, V18, P1612, DOI 10.1359/jbmr.2003.18.9.1612; Eriksen EF., 1994, BONE HISTOMORPHOMETR; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Fu H, 2007, GENESIS, V45, P477, DOI 10.1002/dvg.20316; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2006, ANN NY ACAD SCI, V1068, P117, DOI 10.1196/annals.1346.015; Gotoh M, 2002, EUR J PHARMACOL, V451, P19, DOI 10.1016/S0014-2999(02)02183-0; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; HODGKINSON JE, 1993, BIOCHIM BIOPHYS ACTA, V1174, P11, DOI 10.1016/0167-4781(93)90086-S; HOFFMANN HM, 1994, P NATL ACAD SCI USA, V91, P12887, DOI 10.1073/pnas.91.26.12887; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hoshino T, 2000, J BIOMED MATER RES, V51, P299, DOI 10.1002/1097-4636(20000905)51:3<299::AID-JBM2>3.3.CO;2-#; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Ke HZ, 2006, J BONE MINER RES, V21, P565, DOI 10.1359/JBMR.051110; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Kishimoto K, 2006, HISTOCHEM CELL BIOL, V125, P593, DOI 10.1007/s00418-005-0103-z; KOEDOOD M, 1995, J VIROL, V69, P2194, DOI 10.1128/JVI.69.4.2194-2207.1995; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Minguell JJ, 2005, STEM CELLS DEV, V14, P408, DOI 10.1089/scd.2005.14.408; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rifas L, 1997, P NATL ACAD SCI USA, V94, P7549, DOI 10.1073/pnas.94.14.7549; Roemmich JN, 1999, ENDOCRIN METAB CLIN, V28, P749, DOI 10.1016/S0889-8529(05)70100-6; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shao JS, 2003, J BIOL CHEM, V278, P50195, DOI 10.1074/jbc.M308825200; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Sierra OL, 2004, J BIOL CHEM, V279, P32913, DOI 10.1074/jbc.M314098200; Stratman JL, 2003, TRANSGENIC RES, V12, P521, DOI 10.1023/A:1024225408961; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P1484, DOI 10.1210/me.8.11.1484; Towler DA, 1998, J BIOL CHEM, V273, P30427, DOI 10.1074/jbc.273.46.30427; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; VanHouten JN, 2003, J CLIN INVEST, V112, P1429, DOI 10.1172/JCI200319504; Wang FS, 2007, BONE, V40, P485, DOI 10.1016/j.bone.2006.09.004; Wang JC, 2007, AM J MED GENET A, V143A, P2931, DOI 10.1002/ajmg.a.31946; Willis DM, 2002, J BIOL CHEM, V277, P37280, DOI 10.1074/jbc.M206482200; Wu L, 1997, MECH DEVELOP, V65, P3, DOI 10.1016/S0925-4773(97)00032-4; Wuyts W, 2000, HUM MOL GENET, V9, P1251, DOI 10.1093/hmg/9.8.1251; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhou YL, 2000, J BIOL CHEM, V275, P29066, DOI 10.1074/jbc.M002031200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	91	76	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20505	20522		10.1074/jbc.M800851200	http://dx.doi.org/10.1074/jbc.M800851200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487199	Green Published, hybrid			2022-12-27	WOS:000257565300064
J	Han, GS; O'Hara, L; Carman, GM; Siniossoglou, S				Han, Gil-Soo; O'Hara, Laura; Carman, George M.; Siniossoglou, Symeon			An unconventional diacylglycerol kinase that regulates phospholipid synthesis and nuclear membrane growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; LIPIN HOMOLOG; CELL-CYCLE; YEAST; ACID; CTP; PROLIFERATION	Changes in nuclear size and shape during the cell cycle or during development require coordinated nuclear membrane remodeling, but the underlying molecular events are largely unknown. We have shown previously that the activity of the conserved phosphatidate phosphatase Pah1p/Smp2p regulates nuclear structure in yeast by controlling phospholipid synthesis and membrane biogenesis at the nuclear envelope. Two screens for novel regulators of phosphatidate led to the identification of DGK1. We show that Dgk1p is a unique diacylglycerol kinase that uses CTP, instead of ATP, to generate phosphatidate. DGK1 counteracts the activity of PAH1 at the nuclear envelope by controlling phosphatidate levels. Overexpression of DGK1 causes the appearance of phosphatidate-enriched membranes around the nucleus and leads to its expansion, without proliferating the cortical endoplasmic reticulum membrane. Mutations that decrease phosphatidate levels decrease nuclear membrane growth in pah1 Delta cells. We propose that phosphatidate metabolism is a critical factor determining nuclear structure by regulating nuclear membrane biogenesis.	[O'Hara, Laura; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	University of Cambridge; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Siniossoglou, S (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	ss560@cam.ac.uk		O'Hara, Laura/0000-0001-7790-9261	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER; Medical Research Council [G0701446] Funding Source: Medline; NIGMS NIH HHS [GM 28140, R01 GM028140] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0701446] Funding Source: UKRI	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BELENDIUK G, 1978, J BIOL CHEM, V253, P4555; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; CARMAN GM, 1992, METHOD ENZYMOL, V209, P305; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; KELLEY MJ, 1987, J BIOL CHEM, V262, P14563; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kosodo Y, 2001, YEAST, V18, P1003, DOI 10.1002/yea.747.abs; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lagace TA, 2005, MOL BIOL CELL, V16, P1120, DOI 10.1091/mbc.E04-10-0874; Leitch AR, 2000, MICROBIOL MOL BIOL R, V64, P138, DOI 10.1128/MMBR.64.1.138-152.2000; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Mounkes L, 2003, CURR OPIN GENET DEV, V13, P223, DOI 10.1016/S0959-437X(03)00058-3; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; NASMYTH KA, 1980, P NATL ACAD SCI-BIOL, V77, P2119, DOI 10.1073/pnas.77.4.2119; NIKAWA J, 1984, EUR J BIOCHEM, V143, P251, DOI 10.1111/j.1432-1033.1984.tb08366.x; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; PARRISH ML, 1995, MOL BIOL CELL, V6, P1535, DOI 10.1091/mbc.6.11.1535; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Shridas P, 2006, J BIOL CHEM, V281, P31696, DOI 10.1074/jbc.M604087200; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; SZKOPINSKA A, 1988, ARCH BIOCHEM BIOPHYS, V266, P124, DOI 10.1016/0003-9861(88)90242-1; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANCE JE, 1991, J CELL BIOL, V115, P1061, DOI 10.1083/jcb.115.4.1061; VERGERES G, 1993, J CELL SCI, V106, P249; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	43	115	122	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20433	20442		10.1074/jbc.M802903200	http://dx.doi.org/10.1074/jbc.M802903200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18458075	Green Published, hybrid			2022-12-27	WOS:000257565300058
J	Zhong, MC; Veillette, A				Zhong, Ming-Chao; Veillette, Andre			Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED LYMPHOPROLIFERATIVE DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTEIN-KINASE P56LCK; NATURAL-KILLER-CELLS; HUMAN NK CELLS; NTB-A; HOMOPHILIC INTERACTION; IMMUNE REGULATION; CUTTING EDGE; GENE-PRODUCT	The signaling lymphocytic activation molecule family of receptors has been implicated in the pathophysiology of autoimmunity in humans and mice. One member of the family, Ly108, was strongly linked to lupus susceptibility in mice. High expression of a Ly108 isoform, Ly108-1, was observed in lymphocytes of lupus-prone mice. Herein, we examined the molecular basis for the influence of Ly108 on lupus susceptibility by studying Ly108 signal transduction in T cells. We observed that Ly108 was able to mediate a tyrosine phosphorylation signal implicating Ly108, Vav-1, and c-Cbl in a manner strictly dependent on engagement of the extracellular domain of Ly108 and co-expression of the Src homology 2 (SH2) domain-containing adaptor signaling lymphocytic activation molecule (SLAM)-associated protein (SAP). Evaluation of T cells from mice carrying mutations in the SAP-FynT pathway indicated that Ly108-triggered protein tyrosine phosphorylation was due to the capacity of SAP to recruit FynT. Importantly, Ly108-1 was more apt at triggering tyrosine phosphorylation signals in T cells when compared with the predominant Ly108 isoform found in non-lupus-prone mice, Ly108-2. This difference was due in part to the presence in Ly108-1 of a unique intra-cytoplasmic tyrosine-based motif that promoted Ly108 signal transduction. Together these data provided a molecular explanation for the involvement of Ly108 in lupus susceptibility in mice.	[Zhong, Ming-Chao; Veillette, Andre] Inst Rech Clin Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Veillette, A (corresponding author), Inst Rech Clin Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Calpe S, 2006, IMMUNOGENETICS, V58, P15, DOI 10.1007/s00251-005-0056-3; Castro AG, 1999, J IMMUNOL, V163, P5860; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Falco M, 2004, EUR J IMMUNOL, V34, P1663, DOI 10.1002/eji.200424886; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Flaig RM, 2004, J IMMUNOL, V172, P6524, DOI 10.4049/jimmunol.172.11.6524; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Peck SR, 2000, IMMUNOGENETICS, V52, P63, DOI 10.1007/s002510000252; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Simarro M, 2004, INT IMMUNOL, V16, P727, DOI 10.1093/intimm/dxh074; Stark S, 2006, INT IMMUNOL, V18, P241, DOI 10.1093/intimm/dxh358; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Yin L, 2003, J MED VIROL, V71, P446, DOI 10.1002/jmv.10504	36	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19255	19264		10.1074/jbc.M800209200	http://dx.doi.org/10.1074/jbc.M800209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482989	hybrid			2022-12-27	WOS:000257387600011
J	Svensson, LA; Bondensgaard, K; Norskov-Lauritsen, L; Christensen, L; Becker, P; Andersen, MD; Maltesen, MJ; Rand, KD; Breinholt, J				Svensson, L. Anders; Bondensgaard, Kent; Norskov-Lauritsen, Leif; Christensen, Leif; Becker, Peter; Andersen, Mette D.; Maltesen, Morten J.; Rand, Kasper D.; Breinholt, Jens			Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; BINDING-SITES; ERYTHROPOIETIN RECEPTOR; ACTIVATION; AFFINITY; COMPLEX; TRANSMEMBRANE; ROTATION; LACTOGEN; EXCHANGE	The crystal structure of the complex between an N-terminally truncated G129R human prolactin (PRL) variant and the extracellular domain of the human prolactin receptor (PRLR) was determined at 2.5 angstrom resolution by x-ray crystallography. This structure represents the first experimental structure reported for a PRL variant bound to its cognate receptor. The binding of PRL variants to the PRLR extracellular domain was furthermore characterized by the solution state techniques, hydrogen exchange mass spectrometry, and NMR spectroscopy. Compared with the binding interface derived from mutagenesis studies, the structural data imply that the definition of PRL binding site 1 should be extended to include residues situated in the N-terminal part of loop 1 and in the C terminus. Comparison of the structure of the receptor-bound PRL variant with the structure reported for the unbound form of a similar analogue (Jomain, J. B., Tallet, E., Broutin, I., Hoos, S., van Agthoven, J., Ducruix, A., Kelly, P. A., Kragelund, B. B., England, P., and Goffin, V. (2007) J. Biol. Chem. 282, 33118-33131) demonstrates that receptor-induced changes in the backbone of the four-helix bundle are subtle, whereas large scale rearrangements and structuring occur in the flexible N-terminal part of loop 1. Hydrogen exchange mass spectrometry data imply that the dynamics of the four-helix bundle in solution generally become stabilized upon receptor interaction at binding site 1.	[Svensson, L. Anders; Bondensgaard, Kent; Norskov-Lauritsen, Leif; Christensen, Leif; Becker, Peter; Andersen, Mette D.; Maltesen, Morten J.; Rand, Kasper D.; Breinholt, Jens] Novo Nordisk AS, Prot Engn, DK-2760 Malov, Denmark	Novo Nordisk	Breinholt, J (corresponding author), Novo Nordisk AS, Prot Engn, Novo Nordisk Pk, DK-2760 Malov, Denmark.	jbre@novonordisk.com	Rand, Kasper/ABG-7446-2021	Rand, Kasper/0000-0002-6337-5489				BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Chen NY, 2002, INT J ONCOL, V20, P813; Chen TJ, 1998, ENDOCRINOLOGY, V139, P609, DOI 10.1210/en.139.2.609; CHEN WY, 1994, J BIOL CHEM, V269, P20806; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Duda KM, 2003, J BIOL CHEM, V278, P22734, DOI 10.1074/jbc.M212550200; Elkins PA, 2000, NAT STRUCT BIOL, V7, P808, DOI 10.1038/79047; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Garcia RA, 2004, ASSAY DRUG DEV TECHN, V2, P81, DOI 10.1089/154065804322966342; GOFFIN V, 1992, MOL ENDOCRINOL, V6, P1381, DOI 10.1210/me.6.9.1381; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keeler C, 2003, J MOL BIOL, V328, P1105, DOI 10.1016/S0022-2836(03)00367-X; Kinet S, 1999, J BIOL CHEM, V274, P26033, DOI 10.1074/jbc.274.37.26033; Kinet S, 1996, J BIOL CHEM, V271, P14353, DOI 10.1074/jbc.271.24.14353; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; LUCK DN, 1991, MOL ENDOCRINOL, V5, P1880, DOI 10.1210/mend-5-12-1880; Peterson FC, 2004, PROTEIN ENG DES SEL, V17, P417, DOI 10.1093/protein/gzh051; Qazi AM, 2006, MOL ENDOCRINOL, V20, P1912, DOI 10.1210/me.2005-0291; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Sivaprasad U, 2004, BIOCHEMISTRY-US, V43, P13755, DOI 10.1021/bi049333p; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; Ursby T, 2004, AIP CONF PROC, V705, P1241, DOI 10.1063/1.1758025; Walsh STR, 2004, P NATL ACAD SCI USA, V101, P17078, DOI 10.1073/pnas.0403336101; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623	35	29	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19085	19094		10.1074/jbc.M801202200	http://dx.doi.org/10.1074/jbc.M801202200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18467331	hybrid			2022-12-27	WOS:000257165600064
J	Gan, GL; Yi, H; Chen, MR; Sun, L; Li, WX; Wu, YL; Ding, JP				Gan, Geliang; Yi, Hong; Chen, Maorong; Sun, Liang; Li, Wenxin; Wu, Yingliang; Ding, Jiuping			Structural basis for toxin resistance of beta 4-associated calcium-activated potassium (BK) channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; ADRENAL CHROMAFFIN CELLS; AUXILIARY BETA-SUBUNITS; LARGE-CONDUCTANCE; MOLECULAR-BASIS; SMOOTH-MUSCLE; CHARYBDOTOXIN; VOLTAGE; INACTIVATION; PEPTIDE	The functional diversity of large conductance Ca2+ - and voltage-dependent K+ (BK) channels arises mainly from co-assembly of the pore-forming mSlo alpha subunits with four tissue-enriched auxiliary beta subunits. The structural basis of the interaction between alpha subunits with beta subunits is not well understood. Using computational and experimental methods, we demonstrated that four mSlo turrets decentralized distally from the channel pore to provide a wide open conformation and that the mSlo and h beta 4 subunits together formed a "helmet" containing three basic residues (Lys-120, Arg-121, and Lys-125), which impeded the entry of charybdotoxin ( ChTX) by both the electrostatic interaction and limited space. In addition, the tyrosine insert mutant (in100Y) showed 56% inhibition, with a K-d = 17 nM, suggesting that the h beta 4 lacks an external ChTX-binding site (Tyr-100). We also found that mSlo had an internal binding site (Tyr-294) in the alpha subunits that could "permanently" block 15% of mSlo+h beta 4 currents in the presence of 100 nM ChTX. These findings provide a better understanding of the diverse interactions between alpha and beta subunits and will improve the design of channel inhibitors.	[Yi, Hong; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Gan, Geliang; Chen, Maorong; Sun, Liang; Ding, Jiuping] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	ylwu@whu.edu.cn; jpding@mail.hust.edu.cn	Chen, Maorong/AAF-4006-2019; Sun, Liang/D-4857-2018	Chen, Maorong/0000-0003-3744-8864; Sun, Liang/0000-0002-7817-5121	National Science Foundation of China [30770522, 30470449, 30530140, 30770519]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China Grants 30770522, 30470449, 30530140, and 30770519. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; Gao YD, 2003, PROTEINS, V52, P146, DOI 10.1002/prot.10341; Hanner M, 1997, P NATL ACAD SCI USA, V94, P2853, DOI 10.1073/pnas.94.7.2853; Jin P, 2002, J BIOL CHEM, V277, P43724, DOI 10.1074/jbc.M205795200; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Thompson J, 2000, BIOPHYS J, V78, P2382, DOI 10.1016/S0006-3495(00)76782-8; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Yao J, 2006, ACTA PHARMACOL SIN, V27, P945, DOI 10.1111/j.1745-7254.2006.00385.x; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932	26	32	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24177	24184		10.1074/jbc.M800179200	http://dx.doi.org/10.1074/jbc.M800179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18559348	Green Published, hybrid			2022-12-27	WOS:000258638900071
J	Hu, SJ; Ren, G; Liu, JL; Zhao, ZA; Yu, YS; Su, RW; Ma, XH; Ni, H; Lei, W; Yang, ZM				Hu, Shi-Jun; Ren, Gang; Liu, Ji-Long; Zhao, Zhen-Ao; Yu, Yong-Sheng; Su, Ren-Wei; Ma, Xing-Hong; Ni, Hua; Lei, Wei; Yang, Zeng-Ming			MicroRNA expression and regulation in mouse uterus during embryo implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTERINE RECEPTIVITY; GENE-EXPRESSION; MAMMALIAN MICRORNAS; STAT3 ACTIVATION; RECK; RNA; IDENTIFICATION; REVEALS; TARGETS; CELLS	MicroRNAs (miRNAs) are 21-24-nucleotide non-coding RNAs found in diverse organisms. Although hundreds of miRNAs have been cloned or predicted, only very few miRNAs have been functionally characterized. Embryo implantation is a crucial step in mammalian reproduction. Many genes have been shown to be significantly changed in mouse uterus during embryo implantation. However, miRNA expression profiles in the mouse uterus between implantation sites and inter-implantation sites are still unknown. In this study, miRNA microarray was used to examine differential expression of miRNAs in the mouse uterus between implantation sites and inter-implantation sites. Compared with inter-implantation sites, there were 8 up-regulated miRNAs at implantation sites, which were confirmed by both Northern blot and in situ hybridization. miR-21 was highly expressed in the subluminal stromal cells at implantation sites on day 5 of pregnancy. Because miR-21 was not detected in mouse uterus during pseudopregnancy and under delayed implantation, miR-21 expression at implantation sites was regulated by active blastocysts. Furthermore, we showed that Reck was the target gene of miR-21. Our data suggest that miR-21 may play a key role during embryo implantation.	[Hu, Shi-Jun; Yang, Zeng-Ming] Xiamen Univ, Coll Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Hu, Shi-Jun; Ren, Gang; Liu, Ji-Long; Zhao, Zhen-Ao; Yu, Yong-Sheng; Su, Ren-Wei; Ma, Xing-Hong; Ni, Hua; Lei, Wei; Yang, Zeng-Ming] NE Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China	Xiamen University; Northeast Agricultural University - China	Yang, ZM (corresponding author), Xiamen Univ, Coll Life Sci, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China.	zmyang@xmu.edu.cn	Yang, ZM/G-4627-2010; Lei, Wei/I-3640-2014; Hu, Shijun/I-5818-2012; Lei, Wei/N-7611-2013	Lei, Wei/0000-0002-8342-8859; Ren, Gang/0000-0002-2555-7804; Liu, Ji-Long/0000-0002-6948-2576; Hu, Shijun/0000-0002-0068-8429	National Basic Research Program of China [2006CB504005, 2006CB944006]; Chinese National Natural Science Foundation [30570198, 30770244]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2006CB504005 and 2006CB944006 and Chinese National Natural Science Foundation Grants 30570198 and 30770244.	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Brown JR, 2005, DRUG DISCOV TODAY, V10, P595, DOI 10.1016/S1359-6446(05)03399-4; Castoldi M, 2007, METHODS, V43, P146, DOI 10.1016/j.ymeth.2007.04.009; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Cheon YP, 2002, MOL ENDOCRINOL, V16, P2853, DOI 10.1210/me.2002-0270; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Edwards RG, 1995, HUM REPROD, V10, P60, DOI 10.1093/humrep/10.suppl_2.60; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HARVEY MB, 1995, DEVELOPMENT, V121, P1005; Herrler Andreas, 2003, Reprod Biomed Online, V6, P244; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Ni H, 2002, BIOL REPROD, V67, P351, DOI 10.1095/biolreprod67.1.351; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takenaka K, 2004, EUR J CANCER, V40, P1617, DOI 10.1016/j.ejca.2004.02.028; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	54	178	198	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23473	23484		10.1074/jbc.M800406200	http://dx.doi.org/10.1074/jbc.M800406200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556655	hybrid			2022-12-27	WOS:000258455400056
J	Koh, CS; Navrot, N; Didierjean, C; Rouhier, N; Hirasawa, M; Knaff, DB; Wingsle, G; Samian, R; Jacquot, JP; Corbier, C; Gelhaye, E				Koh, Cha San; Navrot, Nicolas; Didierjean, Claude; Rouhier, Nicolas; Hirasawa, Masakazu; Knaff, David B.; Wingsle, Gunnar; Samian, Razip; Jacquot, Jean-Pierre; Corbier, Catherine; Gelhaye, Eric			An atypical catalytic mechanism involving three cysteines of thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; CRYSTAL-STRUCTURE; FUNCTIONAL-CHARACTERIZATION; CHLAMYDOMONAS-REINHARDTII; GLUTATHIONE PEROXIDASES; REDOX POTENTIALS; DIFFRACTION DATA; ACTIVE-SITE; SYSTEM; EXPRESSION	Unlike other thioredoxins h characterized so far, a poplar thioredoxin of the h type, PtTrxh4, is reduced by glutathione and glutaredoxin (Grx) but not NADPH: thioredoxin reductase (NTR). PtTrxh4 contains three cysteines: one localized in an N-terminal extension (Cys(4)) and two (Cys(58) and Cys(61)) in the classical thioredoxin active site ( (57)WCGPC(61)). The property of a mutant in which Cys(58) was replaced by serine demonstrates that it is responsible for the initial nucleophilic attack during the catalytic cycle. The observation that the C4S mutant is inactive in the presence of Grx but fully active when dithiothreitol is used as a reductant indicates that Cys(4) is required for the regeneration of PtTrxh4 by Grx. Biochemical and x-ray crystallographic studies indicate that two intramolecular disulfide bonds involving Cys(58) can be formed, linking it to either Cys(61) or Cys(4). We propose thus a four-step disulfide cascade mechanism involving the transient glutathionylation of Cys(4) to convert this atypical thioredoxin h back to its active reduced form.	[Gelhaye, Eric] Nancy Univ, Fac Sci & Tech, INRA, UHP,UMR 1136, F-54506 Vandoeuvre Les Nancy, France; [Koh, Cha San; Didierjean, Claude] Univ Henri Poincare, CNRS, LCM3B, Equipe Biocristallog,UMR 7036, F-54506 Vandoeuvre Les Nancy, France; [Corbier, Catherine] Nancy Univ, Fac Sci & Tech, Equipe PB2P, URAFPA, F-54506 Vandoeuvre Les Nancy, France; [Hirasawa, Masakazu; Knaff, David B.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Hirasawa, Masakazu; Knaff, David B.] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA; [Koh, Cha San; Samian, Razip] Univ Sains Malaysia, Sch Biol, Minden 11800, Penang, Malaysia; [Wingsle, Gunnar] Swedish Univ Agr Sci, Fac Forestry, Dept Forest Genet & Plant Physiol, SE-90183 Umea, Sweden	INRAE; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Universite de Lorraine; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Universiti Sains Malaysia; Swedish University of Agricultural Sciences	Gelhaye, E (corresponding author), Nancy Univ, Fac Sci & Tech, INRA, UHP,UMR 1136, BP 239, F-54506 Vandoeuvre Les Nancy, France.	gelhaye@lcb.uhp-nancy.fr	gelhaye, eric/K-7390-2013; Samian, Mohammed Razip/A-7074-2011; DIDIERJEAN, Claude/L-1493-2013; Jacquot, Jean-Pierre/A-1571-2012	gelhaye, eric/0000-0002-0699-9113; DIDIERJEAN, Claude/0000-0002-3176-8974; Jacquot, Jean-Pierre/0000-0003-4975-8587; Rouhier, Nicolas/0000-0002-2036-7884; Navrot, Nicolas/0000-0002-2141-1808	Robert A. Welch Foundation [D-0710]	Robert A. Welch Foundation(The Welch Foundation)	This work was supported in part by Grant D-0710 (to D. B. K.) from the Robert A. Welch Foundation.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Brehelin C, 2004, PHOTOSYNTH RES, V79, P295, DOI 10.1023/B:PRES.0000017165.55488.ca; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Coudevylle N, 2005, BIOCHEMISTRY-US, V44, P2001, DOI 10.1021/bi047816n; CRAWFORD NA, 1989, ARCH BIOCHEM BIOPHYS, V271, P223, DOI 10.1016/0003-9861(89)90273-7; Deiana L, 1999, FREE RADICAL RES, V31, P237, DOI 10.1080/10715769900300801; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Friemann R, 2003, FEBS LETT, V554, P301, DOI 10.1016/S0014-5793(03)01173-6; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Gelhaye E, 2004, PLANT PHYSIOL BIOCH, V42, P265, DOI 10.1016/j.plaphy.2004.03.002; Gelhaye E, 2003, FEBS LETT, V555, P443, DOI 10.1016/S0014-5793(03)01301-2; Hirasawa M, 2000, BIOCHEMISTRY-US, V39, P3344, DOI 10.1021/bi9916731; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Juttner J, 2000, EUR J BIOCHEM, V267, P7109, DOI 10.1046/j.1432-1327.2000.01811.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; Krimm I, 1998, EUR J BIOCHEM, V255, P185, DOI 10.1046/j.1432-1327.1998.2550185.x; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065; Meyer Y, 2002, METHOD ENZYMOL, V347, P394; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peterson FC, 2005, PROTEIN SCI, V14, P2195, DOI 10.1110/ps.051477905; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2002, PROTEIN EXPRES PURIF, V24, P234, DOI 10.1006/prep.2001.1574; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; SAARINEN M, 1995, STRUCTURE, V3, P1097, DOI 10.1016/S0969-2126(01)00245-3; Saviano M, 2000, BIOPOLYMERS, V53, P200, DOI 10.1002/(SICI)1097-0282(200002)53:2<200::AID-BIP10>3.0.CO;2-L; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Schmidt H, 2003, J BIOL CHEM, V278, P46329, DOI 10.1074/jbc.M305338200; Schurmann P, 2003, ANTIOXID REDOX SIGN, V5, P69, DOI 10.1089/152308603321223559; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wangensteen OS, 2001, BBA-PROTEIN STRUCT M, V1547, P156, DOI 10.1016/S0167-4838(01)00178-9; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2	59	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23062	23072		10.1074/jbc.M802093200	http://dx.doi.org/10.1074/jbc.M802093200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18552403	Green Published, hybrid			2022-12-27	WOS:000258455400019
J	Hammes, GG				Hammes, Gordon G.			How do enzymes really work?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							LASER TEMPERATURE-JUMP; MECHANISM; KINETICS; ACID; RIBONUCLEASE; CATALYSIS; DYNAMICS; ENERGY		Duke Univ, Dept Biochem, Durham, NC 27710 USA	Duke University	Hammes, GG (corresponding author), Duke Univ, Dept Biochem, Durham, NC 27710 USA.	hamme001@mc.duke.edu						Antikainen NM, 2005, BIOCHEMISTRY-US, V44, P16835, DOI 10.1021/bi051378i; BAIRD BA, 1979, BIOCHIM BIOPHYS ACTA, V549, P31, DOI 10.1016/0304-4173(79)90017-X; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; BRUICE TC, 1976, ANNU REV BIOCHEM, V45, P331, DOI 10.1146/annurev.bi.45.070176.001555; CHANCE B, 1956, CURRENTS BIOCH RES, P308; CHANG SI, 1990, ACCOUNTS CHEM RES, V23, P363, DOI 10.1021/ar00179a003; DEWEY TG, 1981, P NATL ACAD SCI-BIOL, V78, P7422, DOI 10.1073/pnas.78.12.7422; DEWEY TG, 1979, BIOCHEMISTRY-US, V18, P5757, DOI 10.1021/bi00593a002; DEWEY TG, 1981, J BIOL CHEM, V256, P8941; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; EIGEN M, 1963, INVESTIGATION RATE 2, P895; ERMAN JE, 1966, J AM CHEM SOC, V88, P5607, DOI 10.1021/ja00975a046; FAEDER EJ, 1971, BIOCHEMISTRY-US, V10, P1041; FASELLA P, 1967, BIOCHEMISTRY-US, V6, P1798, DOI 10.1021/bi00858a031; Gloss LM, 1996, PROTEINS, V24, P195, DOI 10.1002/(SICI)1097-0134(199602)24:2<195::AID-PROT6>3.0.CO;2-I; GUTFREUND H, 1956, BIOCHEM J, V63, P656, DOI 10.1042/bj0630656; Hammes G., 1982, ENZYME CATALYSIS REG; Hammes G.G., 1970, ENZYMES, V2, P67; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; HAMMES GG, 1974, ANNU REV BIOPHYS BIO, V3, P1, DOI 10.1146/annurev.bb.03.060174.000245; Hammes GG, 1998, PROTEIN SCI, V7, P799, DOI 10.1002/pro.5560070331; HAMMES GG, 1969, J AM CHEM SOC, V91, P1812, DOI 10.1021/ja01035a036; HAMMES GG, 1970, BIOCHIM BIOPHYS ACTA, V198, P604, DOI 10.1016/0005-2744(70)90138-5; HAMMES GG, 1964, NATURE, V204, P342, DOI 10.1038/204342a0; HAMMES GG, 1969, BIOCHEMISTRY-US, V8, P1591, DOI 10.1021/bi00832a040; HAMMES GG, 1968, ACCOUNTS CHEM RES, V1, P321, DOI 10.1021/ar50011a001; Hammes-Schiffer S, 2002, BIOCHEMISTRY-US, V41, P13335, DOI 10.1021/bi0267137; HESS GP, 1971, ENZYMES, V3, P213; Jansonius J.N., 1987, BIOL MACROMOLECULES, P187; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; KOSHLAND DE, 1960, ADV ENZYMOL REL S BI, V22, P45; LAD PM, 1973, BIOCHEMISTRY-US, V12, P4303, DOI 10.1021/bi00746a001; MCCARTY RE, 1987, TRENDS BIOCHEM SCI, V12, P234, DOI 10.1016/0968-0004(87)90116-2; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; PELLER L, 1959, J AM CHEM SOC, V81, P5907, DOI 10.1021/ja01531a017; RICHARDS FM, 1971, ENZYMES, V4, P647; Thompson PA, 1997, BIOCHEMISTRY-US, V36, P9200, DOI 10.1021/bi9704764; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Williams S, 1996, BIOCHEMISTRY-US, V35, P691, DOI 10.1021/bi952217p	42	16	17	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22337	22346		10.1074/jbc.X800005200	http://dx.doi.org/10.1074/jbc.X800005200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18477561	hybrid			2022-12-27	WOS:000258321000001
J	Pettersson, F; Hanna, N; Lagodich, M; Dupere-Richer, D; Couture, MC; Choi, C; Miller, WH				Pettersson, Filippa; Hanna, Nessrine; Lagodich, Marina; Dupere-Richer, Daphne; Couture, Marie-Claude; Choi, Catherine; Miller, Wilson H., Jr.			Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; OVERCOMES MULTIDRUG-RESISTANCE; CELL LUNG-CANCER; NUCLEAR RECEPTOR; MAMMARY-CARCINOMA; SELECTIVE LIGAND; BEXAROTENE LGD1069; TARGRETIN PREVENTS; PACLITAXEL TAXOL; PROSTATE-CANCER	The steroid and xenobiotic receptor SXR (human pregnane X receptor) is a nuclear receptor that plays a key role in the body's detoxification response by regulating genes involved in drug metabolism and transport. SXR ligands include a wide range of compounds, which induce transcription of SXR target genes via activation of a heterodimeric transcription factor consisting of SXR and the related nuclear receptor retinoid X receptor (RXR). We investigated the effect of RXR-selective ligands, rexinoids, on SXR/RXR activity. In agreement with previous reports, we found that rexinoids are weak activators of SXR, but we also found that they can antagonize SXR activation by the potent SXR agonist rifampicin. This antagonism included suppression of rifampicin-induced expression of SXR target genes, as well as reduced binding of SXR/RXR to SXR response elements both in vivo and in vitro. Interestingly, two rexinoids, bexarotene (LGD1069/Targretin (R)) and LG100268, caused a rapid and sustained decrease in the protein levels of both SXR and RXR. The decrease in SXR level was due to an enhanced rate of protein degradation and was dependent on calpain activity, as opposed to rexinoid-induced RXR degradation, which is mediated via the proteasome. Thus, we have demonstrated a novel, rexinoid-modulated mechanism regulating SXR protein stability, which may explain why rexinoids are only weak activators of SXR/RXR-mediated transcription, despite reports that they bind to SXR with high affinity. We suggest that the ability of rexinoids to induce degradation of both SXR and RXR, in combination with competition for binding to SXR, can also explain why rexinoids antagonize the activation of SXR by drugs like rifampicin.	[Pettersson, Filippa; Hanna, Nessrine; Lagodich, Marina; Dupere-Richer, Daphne; Couture, Marie-Claude; Choi, Catherine; Miller, Wilson H., Jr.] McGill Univ, Lady Davis Inst Med Res, Segal Canc Ctr, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University	Miller, WH (corresponding author), McGill Univ, Lady Davis Inst Med Res, Segal Canc Ctr, Sir Mortimer B Davis Jewish Hosp, Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	wmiller@ldi.jgh.mcgill.ca	Dupéré-Richer, Daphne/AAF-9922-2021					Ahuja HS, 2003, J BIOL REG HOMEOS AG, V17, P29; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Bischoff ED, 1998, CANCER RES, V58, P479; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gottardis MM, 1996, CANCER RES, V56, P5566; Govindan R, 2006, J CLIN ONCOL, V24, P4848, DOI 10.1200/JCO.2006.07.7404; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kassam A, 2003, J BIOL CHEM, V278, P10028, DOI 10.1074/jbc.M208312200; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kim HT, 2006, CANCER RES, V66, P12009, DOI 10.1158/0008-5472.CAN-05-2515; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Masuyama H, 2005, MOL ENDOCRINOL, V19, P1170, DOI 10.1210/me.2004-0434; Masuyama H, 2002, ENDOCRINOLOGY, V143, P55, DOI 10.1210/en.143.1.55; MatsushimaNishiwaki R, 1996, BIOCHEM BIOPH RES CO, V225, P946, DOI 10.1006/bbrc.1996.1276; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nagaoka R, 2006, ENDOCRINE, V30, P261, DOI 10.1007/s12020-006-0003-6; Osburn DL, 2001, MOL CELL BIOL, V21, P4909, DOI 10.1128/MCB.21.15.4909-4918.2001; PARIAT M, 1995, BIOL CELL, V84, P107; Pelley RP, 2006, CANCER RES, V66, P11754, DOI 10.1158/0008-5472.CAN-06-2918; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Pignatello MA, 1997, TOXICOL APPL PHARM, V142, P319, DOI 10.1006/taap.1996.8047; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Szanto A, 2004, CELL DEATH DIFFER, V11, pS126, DOI 10.1038/sj.cdd.4401533; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Teng S, 2003, DRUG METAB DISPOS, V31, P1296, DOI 10.1124/dmd.31.11.1296; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P467; Yen WC, 2006, PROSTATE, V66, P305, DOI 10.1002/pros.20347; Yen WC, 2005, MOL CANCER THER, V4, P824, DOI 10.1158/1535-7163.MCT-05-0018; Yen WC, 2004, CLIN CANCER RES, V10, P8656, DOI 10.1158/1078-0432.CCR-04-0979; Yen WC, 2004, BREAST CANCER RES TR, V88, P141, DOI 10.1007/s10549-004-1426-5; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	44	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21945	21952		10.1074/jbc.M710358200	http://dx.doi.org/10.1074/jbc.M710358200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544536	hybrid			2022-12-27	WOS:000258114700014
J	Upadhyay, A; Burman, JD; Clark, EA; Leung, E; Isenman, DE; van den Elsen, JMH; Bagby, S				Upadhyay, Abhishek; Burman, Julia D.; Clark, Elizabeth A.; Leung, Elisa; Isenman, David E.; van den Elsen, Jean M. H.; Bagby, Stefan			Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTAXIS INHIBITORY PROTEIN; COMPLEMENT INHIBITOR; SURFACE PROTEIN; CHEMICAL-SHIFT; XPLOR-NIH; EVASION; IGG; SYSTEM; IMMUNOLOGY; EXPRESSION	Among the recently discovered Staphylococcus aureus immune evasion proteins, Sbi is unique in its ability to interact with components of both the adaptive and innate immune systems of the host. Sbi domains I and II (Sbi-I and Sbi-II) bind IgG. Sbi domain IV (residues 198 - 266) binds the central complement protein C3. When linked to Sbi-III, Sbi-IV induces a futile consumption of complement via alternative pathway activation, whereas isolated Sbi-IV specifically inhibits the alternative pathway without complement consumption. Here we have determined the three- dimensional structure of Sbi-IV by NMR spectroscopy, showing that Sbi-IV adopts a three- helix bundle fold similar to those of the S. aureus complement inhibitors Efb-C, Ehp, and SCIN. The H-1-N-15 HSQC spectrum of Sbi-III indicates that this domain, essential for futile complement consumption, is natively unfolded, at least when isolated from the rest of Sbi. Sbi-IV and Sbi-III-IV both bind C3dg with 1: 1 stoichiometry and submicromolar affinity. Despite low overall sequence identity, Sbi possesses the same residues as Efb at two positions essential for Efb-C binding to C3d. Mutation to alanine of either of these residues, Arg-231 and Asn-238, abolishes both Sbi-IV binding to C3dg and Sbi-IV alternative pathway inhibition. The almost complete conservation of Sbi-III and Sbi-IV amino acid sequences across more than 30 strains isolated from human and animal hosts indicates that the unique mechanism of Sbi in complement system subversion is a feature of infections of both humans and economically important animals.	[Upadhyay, Abhishek; Burman, Julia D.; Clark, Elizabeth A.; van den Elsen, Jean M. H.; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Leung, Elisa; Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Bath; University of Toronto	van den Elsen, JMH (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssjmhve@bath.ac.uk; bsssb@bath.ac.uk	van den Elsen, Jean/D-9274-2011	Bagby, Stefan/0000-0003-2302-9511; van den Elsen, Jean/0000-0002-0367-1956	Biotechnology and Biological Sciences Research Council [BBS/B/12121] Funding Source: Medline; Medical Research Council [MC_U117533887] Funding Source: Medline; Wellcome Trust [076124] Funding Source: Medline; MRC [MC_U117533887] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FRIES LF, 1984, J EXP MED, V160, P1640, DOI 10.1084/jem.160.6.1640; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; JIANG H, 2004, MOL IMMUNOL, V41, P252; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Lutz HU, 2006, MOL IMMUNOL, V43, P2, DOI 10.1016/j.molimm.2005.06.020; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sato S, 2004, P NATL ACAD SCI USA, V101, P6952, DOI 10.1073/pnas.0401396101; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wright AJ, 2007, MOL IMMUNOL, V44, P2507, DOI 10.1016/j.molimm.2006.12.022; Zhang LH, 1999, MICROBIOL-UK, V145, P177, DOI 10.1099/13500872-145-1-177; Zhang LH, 1998, MICROBIOL-UK, V144, P985, DOI 10.1099/00221287-144-4-985; Zhang LH, 2000, FEMS IMMUNOL MED MIC, V28, P211, DOI 10.1111/j.1574-695X.2000.tb01479.x	41	35	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22113	22120		10.1074/jbc.M802636200	http://dx.doi.org/10.1074/jbc.M802636200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550524	Green Published, hybrid			2022-12-27	WOS:000258114700030
J	Lu, Z; Beck, MH; Wang, Y; Jiang, H; Strand, MR				Lu, Zhiqiang; Beck, Markus H.; Wang, Yang; Jiang, Haobo; Strand, Michael R.			The viral protein Egf1.0 is a dual activity inhibitor of prophenoloxidase-activating proteinases 1 and 3 from Manduca sexta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-PHENOL-OXIDASE; HOLOTRICHIA-DIOMPHALIA LARVAE; PSEUDOPLUSIA-INCLUDENS; MOLECULAR-CLONING; COLEOPTERAN INSECT; ANOPHELES-GAMBIAE; IMMUNE-RESPONSE; IN-VITRO; HEMOLYMPH; CELLS	Some pathogens are capable of suppressing the melanization response of host insects, but the virulence factors responsible are largely unknown. The insect pathogen Microplitis demolitor bracovirus encodes the Egf family of small serine proteinase inhibitors. One family member, Egf1.0, was recently shown to suppress melanization of hemolymph in Manduca sexta in part by inhibiting the enzymatic activity of prophenoloxidase activating proteinase 3 (PAP3). However, other experiments suggested this viral protein suppresses melanization by more than one mechanism. Here we report that Egf1.0 inhibited the amidolytic activity of PAP1 and dose-dependently blocked processing of pro-PAP1 and pro-PAP3. Consistent with its PAP inhibitory activity, Egf1.0 also prevented processing of pro-phenoloxidase, serine proteinase homolog (SPH) 1, and SPH2. Isolation of Egf1.0-protein complexes from plasma indicated that Egf1.0 binds PAPs through its C-terminal repeat domain. Egf1.0 also potentially interacts with SPH2 and two other proteins, ferritin and gloverin, not previously associated with the phenoloxidase cascade. Overall, our results indicate that Egf1.0 is a dual activity PAP inhibitor that strongly suppresses the insect melanization response.	[Lu, Zhiqiang; Beck, Markus H.; Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Wang, Yang; Jiang, Haobo] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	University System of Georgia; University of Georgia; Oklahoma State University System; Oklahoma State University - Stillwater	Strand, MR (corresponding author), Univ Georgia, Dept Entomol, 413 Biol Sci Bldg, Athens, GA 30602 USA.	mrstrand@uga.edu		Jiang, Haobo/0000-0003-1357-1315	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058634] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR 016464, P20 RR016464] Funding Source: Medline; NIGMS NIH HHS [GM 58634] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Beck M, 2003, VIROLOGY, V314, P521, DOI 10.1016/S0042-6822(03)00463-X; Beck M, 2005, J VIROL, V79, P1861, DOI 10.1128/JVI.79.3.1861-1870.2005; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Gupta S, 2005, PROTEIN EXPRES PURIF, V39, P261, DOI 10.1016/j.pep.2004.10.011; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; Ji CY, 2003, PROTEIN EXPRES PURIF, V29, P235, DOI 10.1016/S1046-5928(03)00020-2; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lavine MD, 2005, INSECT BIOCHEM MOLEC, V35, P1335, DOI 10.1016/j.ibmb.2005.08.005; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Lu ZQ, 2008, INSECT BIOCHEM MOLEC, V38, P89, DOI 10.1016/j.ibmb.2007.09.011; Lundstrom A, 2002, INSECT BIOCHEM MOLEC, V32, P795, DOI 10.1016/S0965-1748(01)00162-X; Maresca V, 2006, J CELL PHYSIOL, V206, P843, DOI 10.1002/jcp.20543; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Park DS, 2000, MOL CELLS, V10, P186, DOI 10.1007/s10059-000-0186-2; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; Paskewitz SM, 2006, INSECT BIOCHEM MOLEC, V36, P701, DOI 10.1016/j.ibmb.2006.06.001; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schmidt O, 2001, BIOESSAYS, V23, P344, DOI 10.1002/bies.1049; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Strand MR, 1997, J VIROL, V71, P2146, DOI 10.1128/JVI.71.3.2146-2156.1997; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Trudeau D, 2000, J GEN VIROL, V81, P3049, DOI 10.1099/0022-1317-81-12-3049; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang Y, 2006, J BIOL CHEM, V281, P9271, DOI 10.1074/jbc.M513797200; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8; Zhang GM, 2004, INSECT BIOCHEM MOLEC, V34, P477, DOI 10.1016/j.ibmb.2004.02.009; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200	50	62	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21325	21333		10.1074/jbc.M801593200	http://dx.doi.org/10.1074/jbc.M801593200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18519564	hybrid, Green Published			2022-12-27	WOS:000257898800004
J	Perrino, FW; de Silva, U; Harvey, S; Pryor, EE; Cole, DW; Hollis, T				Perrino, Fred W.; de Silva, Udesh; Harvey, Scott; Pryor, Edward E., Jr.; Cole, Daniel W.; Hollis, Thomas			Cooperative DNA binding and communication across the dimer interface in the TREX2 3 '-> 5 '-exonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; NUCLEIC ACID INTERACTIONS; FAMILIAL CHILBLAIN LUPUS; MEDIATED CELL-DEATH; EXONUCLEASE TREX1; POLYMERASE-DELTA; PROOFREADING EXONUCLEASE; RECOMBINANT PROTEINS; STRUCTURAL BASIS; 3' TERMINI	The activity of human TREX2-catalyzed 3' -> 5'-deoxyribonuclease has been analyzed in steady-state and single turnover kinetic assays and in equilibrium DNA binding studies. These kinetic data provide evidence for cooperative DNA binding within TREX2 and for coordinated catalysis between the TREX2 active sites supporting a model for communication between the protomers of a TREX2 dimer. Mobile loops positioned adjacent to the active sites provide the major DNA binding contribution and facilitate subsequent binding into the active sites. Mutations of three arginine residues on these loops cause decreased TREX2 activities by up to 60-fold. Steady-state kinetic assays of these arginine to alanine TREX2 variants result in increased Km values for DNA substrate with no effect on k(cat) values indicating contributions exclusively to DNA binding by all three of the loop arginines. TREX2 heterodimers were prepared to determine whether exonuclease activity in one protomer is communicated to the opposing protomer. Evidence for communication across the dimer interface is provided by the 7-fold lower catalytic activity measured in the TREX2(WT/H188A) heterodimer compared with the TREX2(WT) homodimer, contrasting the 2-fold lower activity measured in the TREX2(WT/R163A,R165A,R167A) heterodimer. The measured activity in TREX2(WT/H188A) heterodimer indicates that defective catalysis in one protomer reduces activity in the opposing protomer. A DNA binding analysis of TREX2 and the heterodimers indicates a cooperative binding effect within the TREX2 protomer. Finally, single turnover kinetic assays identify DNA binding as the rate-limiting step in TREX2 catalysis.	[Perrino, Fred W.; de Silva, Udesh; Harvey, Scott; Pryor, Edward E., Jr.; Cole, Daniel W.; Hollis, Thomas] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University School of Medicine	Perrino, FW (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu		Pryor, Edward/0000-0001-8328-9126	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 069962] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson TM, 2006, CURR BIOL, V16, pR209, DOI 10.1016/j.cub.2006.02.031; BARNES MH, 1995, GENE, V165, P45, DOI 10.1016/0378-1119(95)00530-J; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; Chen MJ, 2007, CANCER RES, V67, P9077, DOI 10.1158/0008-5472.CAN-07-1146; Chen MJ, 2007, NUCLEIC ACIDS RES, V35, P2682, DOI 10.1093/nar/gkm151; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; DeRose EF, 2002, BIOCHEMISTRY-US, V41, P94, DOI 10.1021/bi0114170; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Harrigan JA, 2007, MECH AGEING DEV, V128, P259, DOI 10.1016/j.mad.2006.12.005; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hill T. L., 1985, COOPERATIVITY THEORY; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Inamdar KV, 2002, RADIAT RES, V157, P306, DOI 10.1667/0033-7587(2002)157[0306:ROPDET]2.0.CO;2; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 2003, BIOCHEMISTRY-US, V42, P5955, DOI 10.1021/bi030046f; Jezewska MJ, 1998, J MOL BIOL, V284, P1113, DOI 10.1006/jmbi.1998.2252; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; Marti TM, 2004, CELL MOL LIFE SCI, V61, P336, DOI 10.1007/s00018-003-3223-4; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McElhinny SAN, 2006, CELL CYCLE, V5, P958, DOI 10.4161/cc.5.9.2736; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Miller H, 1996, BIOCHEMISTRY-US, V35, P12919, DOI 10.1021/bi960326d; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Perrino FW, 2004, ADV ENZYME REGUL, V44, P37, DOI 10.1016/j.advenzreg.2003.11.010; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Saecker RM, 2002, CURR OPIN STRUC BIOL, V12, P311, DOI 10.1016/S0959-440X(02)00326-3; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Strauss BS, 1997, NUCLEIC ACIDS RES, V25, P806, DOI 10.1093/nar/25.4.806; Taft-Benz SA, 1998, NUCLEIC ACIDS RES, V26, P4005, DOI 10.1093/nar/26.17.4005; Townson SA, 2007, STRUCTURE, V15, P449, DOI 10.1016/j.str.2007.03.002; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	54	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21441	21452		10.1074/jbc.M803629200	http://dx.doi.org/10.1074/jbc.M803629200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18534978	Green Published, hybrid			2022-12-27	WOS:000257898800016
J	Noureddine, H; Carvalho, S; Schmitt, C; Massoulie, J; Bon, S				Noureddine, Hiba; Carvalho, Stephanie; Schmitt, Claudine; Massoulie, Jean; Bon, Suzanne			Acetylcholinesterase associates differently with its anchoring proteins ColQ and PRiMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL T-PEPTIDE; QUATERNARY ASSOCIATIONS; MEMBRANE ANCHOR; CAUDATE-NUCLEUS; COLLAGEN TAIL; FORMS; DEGRADATION; SECRETION; SUBUNIT; BOVINE	Acetylcholinesterase tetramers are inserted in the basal lamina of neuromuscular junctions or anchored in cell membranes through the interaction of four C-terminal t peptides with proline-rich attachment domains (PRADs) of cholinesterase-associated collagen Q (ColQ) or of the transmembrane protein PRiMA (proline-rich membrane anchor). ColQ and PRiMA differ in the length of their proline-rich motifs (10 and 15 residues, respectively). ColQ has two cysteines upstream of the PRAD, which are disulfide-linked to two AChE(T) subunits ("heavy" dimer), and the other two subunits are disulfide-linked together ("light" dimer). In contrast, PRiMA has four cysteines upstream of the PRAD. We examined whether these cysteines could be linked to AChET subunits in complexes formed with PRiMA in transfected COS cells and in the mammalian brain. For comparison, we studied complexes formed with N-terminal fragments of ColQ, N-terminal fragments of PRiMA, and chimeras in which the upstream regions containing the cysteines were exchanged. We also compared the effect of mutations in the t peptides on their association with the two PRADs. We report that the two PRADs differ in their interaction with AChET subunits; in complexes formed with the PRAD of PRiMA, we observed light dimers, but very few heavy dimers, even though such dimers were formed with the PQ chimera in which the N-terminal region of PRiMA was associated with the PRAD of ColQ. Complexes with PQ or with PRiMA contained heavy components, which migrated abnormally in SDS-PAGE but probably resulted from disulfide bonding of four AChE(T) subunits with the four upstream cysteines of the associated protein.	[Noureddine, Hiba; Carvalho, Stephanie; Schmitt, Claudine; Massoulie, Jean; Bon, Suzanne] Ecole Normale Super, CNRS UMR 8544, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Massoulie, J (corresponding author), Ecole Normale Super, CNRS UMR 8544, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	jean.massoulie@biologie.ens.fr						Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; BON S, 1979, P NATL ACAD SCI USA, V76, P2546, DOI 10.1073/pnas.76.6.2546; Bon S, 2004, EUR J BIOCHEM, V271, P33, DOI 10.1046/j.1432-1033.2003.03892.x; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BON S, 1991, J NEUROCHEM, V57, P1100, DOI 10.1111/j.1471-4159.1991.tb08267.x; BRODBECK U, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P33; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; LIAO J, 1993, EUR J BIOCHEM, V215, P333, DOI 10.1111/j.1432-1033.1993.tb18039.x; Massoulie J, 2005, CHEM-BIOL INTERACT, V157, P3, DOI 10.1016/j.cbi.2005.10.002; Massoulie J, 2006, J MOL NEUROSCI, V30, P233, DOI 10.1385/JMN:30:1:233; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Moussa CEH, 2004, NEUROSCI LETT, V371, P239, DOI 10.1016/j.neulet.2004.09.004; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; ROBERTS WL, 1991, J BIOL CHEM, V266, P7481; Xie WH, 1999, CHEM-BIOL INTERACT, V119, P289, DOI 10.1016/S0009-2797(99)00039-3	26	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20722	20732		10.1074/jbc.M801364200	http://dx.doi.org/10.1074/jbc.M801364200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511416	Green Published, hybrid			2022-12-27	WOS:000257746100013
J	Pal, A; Chu, UB; Ramachandran, S; Grawoig, D; Guo, LW; Hajipour, AR; Ruoho, AE				Pal, Arindam; Chu, Uyen B.; Ramachandran, Subramaniam; Grawoig, David; Guo, Lian-Wang; Hajipour, Abdol R.; Ruoho, Arnold E.			Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 SIGMA-RECEPTOR; TRANSDUCIN ALPHA-SUBUNIT; AMINO-ACID-RESIDUES; CGMP PHOSPHODIESTERASE; GAMMA-SUBUNIT; LIMITED PROTEOLYSIS; LOCOMOTOR-ACTIVITY; MOLECULAR-CLONING; SELECTIVE LIGAND; OPIOID RECEPTOR	sigma-1 receptors represent unique binding sites that are capable of interacting with a wide range of compounds to mediate different cellular events. The composition of the ligand binding site of this receptor is unclear, since no NMR or crystal structures are available. Recent studies in our laboratory using radiolabeled photoreactive ligands suggested that the steroid binding domain-like I (SBDLI) (amino acids 91-109) and the steroid binding domain-like II (SBDLII) (amino acids 176-194) regions are involved in forming the ligand binding site(s) (Chen, Y., Hajipour, A. R., Sievert, M. K., Arbabian, M., and Ruoho, A. E. (2007) Biochemistry 46, 3532-3542; Pal, A., Hajipour, A. R., Fontanilla, D., Ramachandran, S., Chu, U. B., Mavlyutov, T., and Ruoho, A. E. (2007) Mol. Pharmacol. 72, 921-933). In this report, we have further addressed this issue by utilizing our previously developed sulfhydryl-reactive, cleavable, radioiodinated photocross-linking reagent: methanesulfonothioic acid, S-((4(4-amino-3-[I-125] iodobenzoyl) phenyl) methyl) ester (Guo, L. W., Hajipour, A. R., Gavala, M. L., Arbabian, M., Martemyanov, K. A., Arshavsky, V. Y., and Ruoho, A. E. (2005) Bioconjugate Chem. 16, 685-693). This photoprobe was shown to derivatize the single cysteine residues as mixed disulfides at position 94 in the SBDLI region of the wild type guinea pig sigma-1 receptor (Cys(94)) and at position 190 in the SBDLII region of a mutant guinea pig sigma-1 receptor (C94A, V190C), both in a sigma-ligand (haloperidol or (+)-pentazocine)-sensitive manner. Significantly, photocross-linking followed by Endo Lys-C cleavage under reducing conditions and intramolecular radiolabel transfer from the SBDLI to the SBDLII region in the wild type receptor and, conversely, from the SBDLII to the SBDLI region in the mutant receptor were observed. These data support a model in which the SBDLI and SBDLII regions are juxtaposed to form, at least in part, a ligand binding site of the sigma-1 receptor.	[Pal, Arindam; Chu, Uyen B.; Ramachandran, Subramaniam; Grawoig, David; Guo, Lian-Wang; Ruoho, Arnold E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53705 USA; [Hajipour, Abdol R.] Isfahan Univ Technol, Coll Chem, Pharmaceut Res Lab, Esfahan 84156, Iran	University of Wisconsin System; University of Wisconsin Madison; Isfahan University of Technology	Ruoho, AE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.	aeruoho@wisc.edu	Ramachandran, Subramaniam/B-8247-2013		NIMH NIH HHS [R01 MH065503] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065503] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aydar E, 2004, CANCER RES, V64, P5029, DOI 10.1158/0008-5472.CAN-03-2329; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bermack JE, 2005, J PHARMACOL SCI, V97, P317, DOI 10.1254/jphs.CRJ04005X; Bowen W D, 2000, Pharm Acta Helv, V74, P211; CAMPBELL BG, 1989, J NEUROSCI, V9, P3380; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CONTRERAS PC, 1988, SYNAPSE, V2, P240, DOI 10.1002/syn.890020311; Dokudovskaya S, 2006, STRUCTURE, V14, P653, DOI 10.1016/j.str.2006.02.006; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Guo LW, 2007, PROTEIN EXPRES PURIF, V51, P187, DOI 10.1016/j.pep.2006.07.012; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2005, BIOCONJUGATE CHEM, V16, P685, DOI 10.1021/bc050016k; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; HAYASHI T, 2001, P NATL ACAD SCI US; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; HELLEWELL SB, 1994, EUR J PHARM-MOLEC PH, V268, P9, DOI 10.1016/0922-4106(94)90115-5; IWAMOTO ET, 1981, J PHARMACOL EXP THER, V217, P451; KAHOUN JR, 1992, P NATL ACAD SCI USA, V89, P1393, DOI 10.1073/pnas.89.4.1393; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Leoni M, 2004, J APPL CRYSTALLOGR, V37, P166, DOI 10.1107/S0021889803022787; Liu Y, 1999, BIOCHEM J, V337, P281, DOI 10.1042/0264-6021:3370281; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; LYSKO PG, 1992, STROKE, V23, P414, DOI 10.1161/01.STR.23.3.414; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MATSUNO K, 1993, J PHARMACOL EXP THER, V265, P851; McCracken KA, 1999, EUR J PHARMACOL, V370, P225, DOI 10.1016/S0014-2999(99)00113-2; McCracken KA, 1999, EUR J PHARMACOL, V365, P35, DOI 10.1016/S0014-2999(98)00876-0; Mei JF, 2001, BIOCHEM PHARMACOL, V62, P349, DOI 10.1016/S0006-2952(01)00666-9; Moebius FF, 1997, BRIT J PHARMACOL, V121, P1, DOI 10.1038/sj.bjp.0701079; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Nguyen EC, 2005, NEUROPHARMACOLOGY, V49, P638, DOI 10.1016/j.neuropharm.2005.04.016; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Pan YX, 1998, J NEUROCHEM, V70, P2279; PAUL R, 1994, J NEUROIMMUNOL, V52, P183, DOI 10.1016/0165-5728(94)90112-0; de Laureto PP, 2006, BIOCHEMISTRY-US, V45, P11523, DOI 10.1021/bi052614s; Prasad PD, 1998, J NEUROCHEM, V70, P443; QUIRION R, 1992, TRENDS PHARMACOL SCI, V13, P85, DOI 10.1016/0165-6147(92)90030-A; Ramachandran S, 2007, PROTEIN EXPRES PURIF, V51, P283, DOI 10.1016/j.pep.2006.07.019; Seth P, 1997, BIOCHEM BIOPH RES CO, V241, P535, DOI 10.1006/bbrc.1997.7840; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Seth P, 1998, J NEUROCHEM, V70, P922; SHARKEY J, 1988, EUR J PHARMACOL, V149, P171, DOI 10.1016/0014-2999(88)90058-1; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; SU TP, 1982, J PHARMACOL EXP THER, V223, P284; TAM SW, 1983, P NATL ACAD SCI-BIOL, V80, P6703, DOI 10.1073/pnas.80.21.6703; TorrenceCampbell C, 1996, EUR J PHARMACOL, V304, P201, DOI 10.1016/0014-2999(96)00109-4; VAUPEL DB, 1983, EUR J PHARMACOL, V92, P269; WALKER JM, 1990, PHARMACOL REV, V42, P355; WEBER E, 1986, P NATL ACAD SCI USA, V83, P8784, DOI 10.1073/pnas.83.22.8784; Wheeler KT, 2000, BRIT J CANCER, V82, P1223, DOI 10.1054/bjoc.1999.1067; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8	58	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19646	19656		10.1074/jbc.M802192200	http://dx.doi.org/10.1074/jbc.M802192200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18467334	Green Published, hybrid			2022-12-27	WOS:000257387600050
J	Breloy, I; Schwientek, T; Gries, B; Razawi, H; Macht, M; Albers, C; Hanisch, FG				Breloy, Isabelle; Schwientek, Tilo; Gries, Barbara; Razawi, Hanieh; Macht, Marcus; Albers, Christian; Hanisch, Franz-Georg			Initiation of mammalian O-mannosylation in Vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; LAMININ-BINDING; GENE FAMILY; UDP-GALNAC; GLYCOSYLATION; MANNOSE; PROTEINS; GLYCANS; BRAIN	To reveal insight into the initiation of mammalian O-mannosylation in vivo, recombinant glycosylation probes containing sections of human alpha-dystroglycan (hDG) were expressed in epithelial cell lines. We demonstrate that O-mannosylation within the mucin domain of hDG occurs preferentially at Thr/Ser residues that are flanked by basic amino acids. Protein O-mannosylation is independent of a consensus sequence, but strictly dependent on a peptide region located upstream of the mucin domain. This peptide region cannot be replaced by other N-terminal peptides, however, it is not sufficient to induce O-mannosylation on a structurally distinct mucin domain in hybrid constructs. The presented in vivo evidence for a more complex regulation of mammalian O-mannosylation contrasts with a recent in vitro study of O-mannosylation in human alpha-dystroglycan peptides indicating the existence of an 18-meric consensus sequence. We demonstrate in vivo that the entire region p377-417 is necessary and sufficient for O-mannosylation initiation of hDG, but not of MUC1 tandem repeats. The feature of a doubly controlled initiation process distinguishes mammalian O-mannosylation from other types of O-glycosylation, which are largely controlled by structural properties of the substrate positions and their local peptide environment.	[Breloy, Isabelle; Schwientek, Tilo; Gries, Barbara; Razawi, Hanieh; Hanisch, Franz-Georg] Univ Cologne, Fac Med, Inst Biochem 2, D-50931 Cologne, Germany; [Macht, Marcus; Albers, Christian] Bruker Daltonics Inc, D-28359 Bremen, Germany; [Hanisch, Franz-Georg] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cologne; Bruker Corporation; Bruker Daltonik GmbH; University of Cologne	Hanisch, FG (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	franz.hanisch@uni-koeln.de	Breloy, Isabelle/E-3804-2012					Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; BUTLER WT, 1966, J BIOL CHEM, V241, P3882; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Chiba A, 1997, J BIOL CHEM, V272, P2156; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; ELHAMMER AP, 1993, J BIOL CHEM, V268, P10029; Endo T, 1999, BBA-GEN SUBJECTS, V1473, P237, DOI 10.1016/S0304-4165(99)00182-8; Engelmann K, 2005, GLYCOBIOLOGY, V15, P1111, DOI 10.1093/glycob/cwi099; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; IMMERVOLL T, 1995, YEAST, V11, P1345, DOI 10.1002/yea.320111403; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; KLINGER MM, 1981, J BIOL CHEM, V256, P7932; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; LUSSIER M, 1995, J CELL BIOL, V131, P913, DOI 10.1083/jcb.131.4.913; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; Martin PT, 2003, GLYCOBIOLOGY, V13, p55R, DOI 10.1093/glycob/cwg076; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Muller S, 2002, J BIOL CHEM, V277, P26103, DOI 10.1074/jbc.M202921200; Muntoni F, 2002, LANCET, V360, P1419, DOI 10.1016/S0140-6736(02)11397-3; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; SASAKI T, 1998, BIOCHIM BIOPHYS ACTA, V27, P599; SETANDREU R, 1969, CARBOHYD RES, V10, P584; SILBERT JE, 1979, NEW COMPREHENSIVE B, V29, P1; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; STRAHLBOLSINGER S, 1991, EUR J BIOCHEM, V196, P185, DOI 10.1111/j.1432-1033.1991.tb15802.x; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Yuen CT, 1997, J BIOL CHEM, V272, P8924	42	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18832	18840		10.1074/jbc.M802834200	http://dx.doi.org/10.1074/jbc.M802834200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18456664	hybrid			2022-12-27	WOS:000257165600040
J	Linster, CL; Adler, LN; Webb, K; Christensen, KC; Brenner, C; Clarke, SG				Linster, Carole L.; Adler, Lital N.; Webb, Kristofor; Christensen, Kathryn C.; Brenner, Charles; Clarke, Steven G.			A second GDP-L-galactose phosphorylase in Arabidopsis en route to vitamin C - Covalent intermediate and substrate requirements for the conserved reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO BIOSYNTHESIS; L-ASCORBIC-ACID; MANNOSE 3'',5''-EPIMERASE; GENETIC-EVIDENCE; HIGHER-PLANTS; THALIANA; PATHWAY; ENZYME; IDENTIFICATION; PHOSPHATASE	The Arabidopsis thaliana VTC2 gene encodes an enzyme that catalyzes the conversion of GDP-L-galactose to L-galactose 1-phosphate in the first committed step of the Smirnoff-Wheeler pathway to plant vitamin C synthesis. Mutations in VTC2 had previously been found to lead to only partial vitamin C deficiency. Here we show that the Arabidopsis gene At5g55120 encodes an enzyme with high sequence identity to VTC2. Designated VTC5, this enzyme displays substrate specificity and enzymatic properties that are remarkably similar to those of VTC2, suggesting that it may be responsible for residual vitamin C synthesis in vtc2 mutants. The exact nature of the reaction catalyzed by VTC2/VTC5 is controversial because of reports that kiwifruit and Arabidopsis VTC2 utilize hexose 1-phosphates as phosphorolytic acceptor substrates. Using liquid chromatography-mass spectroscopy and a VTC2-H238N mutant, we provide evidence that the reaction proceeds through a covalent guanylylated histidine residue within the histidine triad motif. Moreover, we show that both the Arabidopsis VTC2 and VTC5 enzymes catalyze simple phosphorolysis of the guanylylated enzyme, forming GDP and L-galactose 1-phosphate from GDP-L-galactose and phosphate, with poor reactivity of hexose 1-phosphates as phosphorolytic acceptors. Indeed, the endogenous activities from Japanese mustard spinach, lemon, and spinach have the same substrate requirements. These results show that Arabidopsis VTC2 and VTC5 proteins and their homologs in other plants are enzymes that guanylylate a conserved active site His residue with GDP-L-galactose, forming L-galactose 1-phosphate for vitamin C synthesis, and regenerate the enzyme with phosphate to form GDP.	[Linster, Carole L.; Adler, Lital N.; Webb, Kristofor; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Linster, Carole L.; Adler, Lital N.; Webb, Kristofor; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Christensen, Kathryn C.; Brenner, Charles] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; [Christensen, Kathryn C.; Brenner, Charles] Dartmouth Med Sch, Dept Biochem, Lebanon, NH 03756 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Dartmouth College; Dartmouth College	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	; Brenner, Charles/D-6339-2014	Webb, Kristofor/0000-0001-8111-9756; Brenner, Charles/0000-0002-4955-3226; Linster, Carole/0000-0001-7143-0719	NCI NIH HHS [CA75954] Funding Source: Medline; NIA NIH HHS [AG018000] Funding Source: Medline; NIGMS NIH HHS [GM026020] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Conklin PL, 2000, GENETICS, V154, P847; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Hancock RD, 2005, CRIT REV PLANT SCI, V24, P167, DOI 10.1080/07352680591002165; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; LEE RB, 1990, J EXP BOT, V41, P1063, DOI 10.1093/jxb/41.9.1063; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; REBEILLE F, 1984, PLANT PHYSIOL, V74, P355, DOI 10.1104/pp.74.2.355; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002; Watanabe K, 2006, PHYTOCHEMISTRY, V67, P338, DOI 10.1016/j.phytochem.2005.12.003; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Whitelegge Julian P, 2004, Methods Mol Biol, V251, P323; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Wolucka BA, 2001, P NATL ACAD SCI USA, V98, P14843, DOI 10.1073/pnas.011578198; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	28	36	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18483	18492		10.1074/jbc.M802594200	http://dx.doi.org/10.1074/jbc.M802594200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18463094	hybrid, Green Published			2022-12-27	WOS:000257165600003
J	Clark, AR; Martins, JRS; Tchen, CR				Clark, Andrew R.; Martins, Joana R. S.; Tchen, Carmen R.			Role of dual specificity phosphatases in biological responses to glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACTIVATED PROTEIN-KINASE; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; LENS EPITHELIAL-CELLS; DIET-INDUCED OBESITY; MAP KINASE; GENE-EXPRESSION; INSULIN-RESISTANCE; BREAST-CANCER; TRANSCRIPTIONAL ACTIVATION	The powerful anti-inflammatory effects of glucocorticoids (GCs) have been known for more than sixty years, but their molecular mechanisms are still incompletely understood and hotly debated. The GC receptor (GR) was cloned in 1985 and shown to be a transcription factor. Initially, the anti-inflammatory actions of GCs were explained in terms of genes that were up-regulated by the receptor. However, none of these putative mediators seemed able to account for the spectrum of anti-inflammatory responses to GCs. The discovery of a negative regulatory function of GR then shifted the focus away from GC-induced genes as anti-inflammatory mediators. In recent years, attention has begun to move back toward the idea that the anti-inflammatory response to GCs is partially dependent on the positive regulation of gene expression by GR.	[Clark, Andrew R.; Martins, Joana R. S.; Tchen, Carmen R.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England	Imperial College London; University of Oxford	Clark, AR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, 1 Aspenlea Rd, London W6 8LH, England.	andy.clark@imperial.ac.uk	Clark, Andrew/AAN-4043-2021	Clark, Andy/0000-0003-4996-8322				Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Abrams MT, 2005, J CANCER RES CLIN, V131, P347, DOI 10.1007/s00432-004-0659-3; Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; Adcock Ian M, 2004, Proc Am Thorac Soc, V1, P247, DOI 10.1513/pats.200402-001MS; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Bantel H, 2002, FASEB J, V16, P1832, DOI 10.1096/fj.02-0223fje; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Bazuine M, 2004, MOL ENDOCRINOL, V18, P1697, DOI 10.1210/me.2003-0213; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bhavsar P, 2008, THORAX; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Buttgereit F, 2005, SCAND J RHEUMATOL, V34, P14, DOI 10.1080/03009740510017706; Carayol N, 2006, J BIOL CHEM, V281, P31142, DOI 10.1074/jbc.M603417200; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clark AR, 2003, CURR OPIN PHARMACOL, V3, P404, DOI 10.1016/S1471-4892(03)00073-0; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Conradie MM, 2007, J ENDOCRINOL, V195, P229, DOI 10.1677/JOE-07-0217; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Engelbrecht Y, 2003, ENDOCRINOLOGY, V144, P412, DOI 10.1210/en.2002-220769; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; Gupta V, 2005, MOL VIS, V11, P1018; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Horsch K, 2007, MOL ENDOCRINOL, V21, P2929, DOI 10.1210/me.2007-0153; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Hulley PA, 2002, BONE, V31, P220, DOI 10.1016/S8756-3282(02)00807-4; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Issa R, 2007, J IMMUNOL, V178, P7366, DOI 10.4049/jimmunol.178.11.7366; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; James ER, 2005, J OCUL PHARMACOL TH, V21, P11, DOI 10.1089/jop.2005.21.11; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeong HJ, 2003, ENDOCRINOLOGY, V144, P4080, DOI 10.1210/en.2003-0115; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; Leclerc N, 2004, J MOL ENDOCRINOL, V33, P175, DOI 10.1677/jme.0.0330175; Liu WH, 1996, MOL ENDOCRINOL, V10, P1399, DOI 10.1210/me.10.11.1399; Loke TK, 2006, J ALLERGY CLIN IMMUN, V118, P368, DOI 10.1016/j.jaci.2006.04.055; Maier JV, 2007, MOL ENDOCRINOL, V21, P2663, DOI 10.1210/me.2007-0067; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Pang D, 2006, CANCER BIOL THER, V5, P933, DOI 10.4161/cbt.5.8.2875; Phillips JE, 2006, J CELL SCI, V119, P581, DOI 10.1242/jcs.02758; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Price DM, 2007, MOL CELL ENDOCRINOL, V263, P134, DOI 10.1016/j.mce.2006.09.009; Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006; QUANTE T, 2008, AM J RESP CELL  0228; Rauhala HE, 2005, INT J CANCER, V117, P738, DOI 10.1002/ijc.21270; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Sousa AR, 1999, J ALLERGY CLIN IMMUN, V104, P565, DOI 10.1016/S0091-6749(99)70325-8; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Szatmary Z, 2004, J BIOL CHEM, V279, P43708, DOI 10.1074/jbc.M406568200; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Toh ML, 2004, ARTHRITIS RHEUM-US, V50, P3118, DOI 10.1002/art.20580; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; van Staa TP, 2006, CALCIFIED TISSUE INT, V79, P129, DOI 10.1007/s00223-006-0019-1; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang X, 2004, MOL PSYCHIATR, V9, P65, DOI 10.1038/sj.mp.4001339; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wu GS, 2007, CANCER METAST REV, V26, P579, DOI 10.1007/s10555-007-9079-6; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Xu QH, 2004, FREE RADICAL BIO MED, V36, P985, DOI 10.1016/j.freeradbiomed.2004.01.009; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x	82	64	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25765	25769		10.1074/jbc.R700053200	http://dx.doi.org/10.1074/jbc.R700053200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18541529	Green Published, hybrid			2022-12-27	WOS:000259200100001
J	Wang, KH; Oakes, ESC; Sauer, RT; Baker, TA				Wang, Kevin H.; Oakes, Elizabeth S. C.; Sauer, Robert T.; Baker, Tania A.			Tuning the strength of a bacterial N-end rule degradation signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLPX-RECOGNITION SIGNALS; ESCHERICHIA-COLI; CHAPERONE CLPA; DNA-DAMAGE; PROTEIN; MACHINE; PROTEOLYSIS; PROTEASES; BINDING; SSPB	The N-end rule is a degradation pathway conserved from bacteria to mammals that links a protein's stability in vivo to the identity of its N-terminal residue. In Escherichia coli, the components of this pathway directly responsible for protein degradation are the ClpAP protease and its adaptor ClpS. We recently demonstrated that ClpAP is able to recognize N-end motifs in the absence of ClpS although with significantly reduced substrate affinity. In this study, a systematic sequence analysis reveals new features of N-end rule degradation signals. To achieve specificity, recognition of an N-end motif by the protease-adaptor complex uses both the identity of the N-terminal residue and a free alpha-amino group. Acidic residues near the first residue decrease substrate affinity, demonstrating that the identity of adjacent residues can affect recognition although significant flexibility is tolerated. However, shortening the distance between the N-end residue and the stably folded portion of a protein prevents degradation entirely, indicating that an N-end signal alone is not always sufficient for degradation. Together, these data define in vitro the sequence and structural requirements for the function of bacterial N-end signals.	[Oakes, Elizabeth S. C.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Wang, Kevin H.; Sauer, Robert T.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), 31 Ames St 68-523, Cambridge, MA 02139 USA.	tabaker@mit.edu		Sauer, Robert/0000-0002-1719-5399	NIAID NIH HHS [AI-16892] Funding Source: Medline; NIGMS NIH HHS [R01 GM049224-17, R01 GM049224, GM-49224] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BALZI E, 1990, J BIOL CHEM, V265, P7464; Benaroudj N, 2001, BIOCHIMIE, V83, P311, DOI 10.1016/S0300-9084(01)01244-5; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; LITTLE JW, 1983, J MOL BIOL, V167, P791, DOI 10.1016/S0022-2836(83)80111-9; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Song HK, 2003, MOL CELL, V12, P75, DOI 10.1016/S1097-2765(03)00271-5; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turgay K, 1998, EMBO J, V17, P6730; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; WALKER GC, 1985, ENVIRON HEALTH PERSP, V62, P115, DOI 10.2307/3430102; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Willam C, 2002, P NATL ACAD SCI USA, V99, P10423, DOI 10.1073/pnas.162119399	33	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2008	283	36					24600	24607		10.1074/jbc.M802213200	http://dx.doi.org/10.1074/jbc.M802213200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	342YR	18550545	hybrid, Green Published			2022-12-27	WOS:000258820000032
J	Narzi, D; Winkler, K; Saidowsky, J; Misselwitz, R; Ziegler, A; Bockmann, RA; Alexiev, U				Narzi, Daniele; Winkler, Kathrin; Saidowsky, Juergen; Misselwitz, Rolf; Ziegler, Andreas; Boeckmann, Rainer A.; Alexiev, Ulrike			Molecular determinants of major histocompatibility complex class I complex stability - Shaping antigenic features through short and long range electrostatic interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POISSON-BOLTZMANN EQUATION; CYTOTOXIC T-LYMPHOCYTES; ANKYLOSING-SPONDYLITIS; SELF-PEPTIDES; HLA-B27; DYNAMICS; IMMUNOGENICITY; SUSCEPTIBILITY; DISSOCIATION; PATHOGENESIS	A single amino acid exchange between the major histocompatibility complex molecules HLA-B* 2705 and HLA-B* 2709 (Asp116/His) is responsible for the emergence of distinct HLA-B27-restricted T cell repertoires in individuals harboring either of these two subtypes and could correlate with their differential association with the autoimmune disease ankylosing spondylitis. By using fluorescence depolarization and pK(a) calculations, we investigated to what extent electrostatic interactions contribute to shape antigenic differences between these HLA molecules complexed with viral, self, and non-natural peptide ligands. In addition to the established main anchor of peptides binding to HLA-B27, arginine at position 2 (pArg-2), and the secondary anchors at the peptide termini, at least two further determinants contribute to stable peptide accommodation. 1) The interaction of Asp-116 with arginine at peptide position 5, as found in pLMP2 (RRRWRRLTV; viral) and pVIPR (RRKWRRWHL; self), and with lysine in p Omega, as found in gag (KRWIILGLNK; viral), additionally stabilizes the B*2705 complexes by similar to 5 and similar to 27 kJ/mol, respectively, in comparison with B*2709. 2) The protonation state of the key residues Glu-45 and Glu-63 in the B-pocket, which accommodates pArg-2, affects peptide binding strength in a peptide- and subtype-dependent manner. In B*2705/pLMP2, protonation of Glu-45/Glu-63 reduces the interaction energy of pArg-2 by similar to 24 kJ/mol as compared with B*2705/pVIPR. B*2705/pVIPR is stabilized by a deprotonated Glu45/Glu-63 pair, evoked by allosteric interactions with pHis-8. The mutual electrostatic interactions of peptide and HLA molecule, including peptide- and subtype-dependent protonation of key residues, modulate complex stability and antigenic features of the respective HLA-B27 subtype.	[Narzi, Daniele; Boeckmann, Rainer A.] Univ Saarland, Ctr Bioinformat, D-66041 Saarbrucken, Germany; [Winkler, Kathrin; Saidowsky, Juergen; Alexiev, Ulrike] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Misselwitz, Rolf; Ziegler, Andreas] Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, D-14195 Berlin, Germany	Saarland University; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bockmann, RA (corresponding author), Univ Saarland, Ctr Bioinformat, POB 15 11 50, D-66041 Saarbrucken, Germany.	rainer@bioinformatik.uni-saarland.de; alexiev@physik.fu-berlin.de	Alexiev, Ulrike/L-8478-2016; Böckmann, Rainer A/G-7863-2015	Böckmann, Rainer A/0000-0002-9325-5162; Narzi, Daniele/0000-0003-2731-6286	VolkswagenStiftung [1/79 983]; Deutsche Forschungsgemeinschaf [Sfb 449 TPA5, BIZ 4/1]; European Union [EFRE 2000-2006 2u/2]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaf(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by VolkswagenStiftung Grant 1/79 983 ( to U. A., R. B., and A.Z.) and in part by Deutsche Forschungsgemeinschaft Grant Sfb 449 TPA5 ( to U. A.), Deutsche Forschungsgemeinschaft Grant BIZ 4/1 ( to R. A. B.), and European Union Grant EFRE 2000-2006 2u/2 ( to A.Z.).	Alexiev U, 2003, J MOL BIOL, V328, P705, DOI 10.1016/S0022-2836(03)00326-7; Allen RL, 1999, IMMUNOGENETICS, V50, P220, DOI 10.1007/s002510050596; Allen RL, 1999, J IMMUNOL, V162, P5045; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Binz AK, 2003, BIOCHEMISTRY-US, V42, P4954, DOI 10.1021/bi034077m; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; BOWNESS P, 1993, EUR J IMMUNOL, V23, P1417, DOI 10.1002/eji.1830230702; BROOKS JM, 1993, J EXP MED, V178, P879, DOI 10.1084/jem.178.3.879; Cascino I, 2007, ARTHRITIS RHEUM-US, V56, P2640, DOI 10.1002/art.22820; Chen ZW, 2000, J IMMUNOL, V164, P6474, DOI 10.4049/jimmunol.164.12.6474; CHINEA G, 1995, PROTEINS, V23, P415, DOI 10.1002/prot.340230315; Colbert RA, 2000, MOL MED TODAY, V6, P224, DOI 10.1016/S1357-4310(00)01699-3; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; De Groot AS, 2004, METHODS, V34, P425, DOI 10.1016/j.ymeth.2004.06.004; Dedier S, 2001, J IMMUNOL METHODS, V255, P57, DOI 10.1016/S0022-1759(01)00423-9; Edwards JCW, 2000, IMMUNOL TODAY, V21, P256, DOI 10.1016/S0167-5699(00)01625-X; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Ferrara GB, 2001, BLOOD, V98, P3150, DOI 10.1182/blood.V98.10.3150; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Kim TH, 2005, CURR OPIN RHEUMATOL, V17, P400, DOI 10.1097/01.bor.0000163447.44037.c4; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; de Castro JAL, 2007, IMMUNOL LETT, V108, P27, DOI 10.1016/j.imlet.2006.10.004; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; Marelius J, 1998, J COMPUT AID MOL DES, V12, P119, DOI 10.1023/A:1007929626986; Mear JP, 1999, J IMMUNOL, V163, P6665; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 2003, PROTEIN SCI, V12, P313, DOI 10.1110/ps.0229903; Pohlmann T, 2004, J BIOL CHEM, V279, P28197, DOI 10.1074/jbc.C400128200; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Uchanska-Ziegler B, 2003, TRENDS IMMUNOL, V24, P73, DOI 10.1016/S1471-4906(02)00028-5; UCHANSKAZIEGLER B, 2006, IMMUNOBIOLOGY HUMAN, V1, P138; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; Winkler K, 2007, BIOPHYS J, V93, P2743, DOI 10.1529/biophysj.106.096602; Yu ZY, 2004, J CLIN INVEST, V114, P551, DOI 10.1172/JCI200421695	55	18	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23093	23103		10.1074/jbc.M710234200	http://dx.doi.org/10.1074/jbc.M710234200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18505734	hybrid			2022-12-27	WOS:000258455400022
J	McFate, T; Mohyeldin, A; Lu, H; Thakar, J; Henriques, J; Halim, ND; Wu, H; Schell, MJ; Tsang, TM; Teahan, O; Zhou, S; Califano, JA; Jeoung, NH; Harris, RA; Verma, A				McFate, Thomas; Mohyeldin, Ahmed; Lu, Huasheng; Thakar, Jay; Henriques, Jeremy; Halim, Nader D.; Wu, Hong; Schell, Michael J.; Tsang, Tsz Mon; Teahan, Orla; Zhou, Shaoyu; Califano, Joseph A.; Jeoung, Nam Ho; Harris, Robert A.; Verma, Ajay			Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; IN-VIVO; AEROBIC GLYCOLYSIS; PROLYL HYDROXYLASE; FACTOR HIF; DICHLOROACETATE; INHIBITION; EXPRESSION; GROWTH; ACID	High lactate generation and low glucose oxidation, despite normal oxygen conditions, are commonly seen in cancer cells and tumors. Historically known as the Warburg effect, this altered metabolic phenotype has long been correlated with malignant progression and poor clinical outcome. However, the mechanistic relationship between altered glucose metabolism and malignancy remains poorly understood. Here we show that inhibition of pyruvate dehydrogenase complex (PDC) activity contributes to the Warburg metabolic and malignant phenotype in human head and neck squamous cell carcinoma. PDC inhibition occurs via enhanced expression of pyruvate dehydrogenase kinase-1 (PDK-1), which results in inhibitory phosphorylation of the pyruvate dehydrogenase alpha(PDH alpha) subunit. We also demonstrate that PDC inhibition in cancer cells is associated with normoxic stabilization of the malignancy-promoting transcription factor hypoxia-inducible factor-1 alpha(HIF-1 alpha) by glycolytic metabolites. Knockdown of PDK-1 via short hairpin RNA lowers PDH alpha phosphorylation, restores PDC activity, reverts the Warburg metabolic phenotype, decreases normoxic HIF-1 alpha expression, lowers hypoxic cell survival, decreases invasiveness, and inhibits tumor growth. PDK-1 is an HIF-1-regulated gene, and these data suggest that the buildup of glycolytic metabolites, resulting from high PDK-1 expression, may in turn promote HIF-1 activation, thus sustaining a feed-forward loop for malignant progression. In addition to providing anabolic support for cancer cells, altered fuel metabolism thus supports a malignant phenotype. Correction of metabolic abnormalities offers unique opportunities for cancer treatment and may potentially synergize with other cancer therapies.	[McFate, Thomas; Mohyeldin, Ahmed; Lu, Huasheng; Thakar, Jay; Henriques, Jeremy; Halim, Nader D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Wu, Hong; Schell, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Tsang, Tsz Mon; Teahan, Orla] Univ London Imperial Coll Sci Technol & Med, Div SORA, Dept Biomol Med, London SW7 2AZ, England; [Zhou, Shaoyu; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD 21204 USA; [Jeoung, Nam Ho; Harris, Robert A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Imperial College London; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Verma, A (corresponding author), Merck & Co Inc, Dept Expt Med, UG4D-34,POB 1000, N Wales, PA 19454 USA.	ajay_verma@merck.com		Schell, Michael/0000-0003-1553-3582; Verma, Ajay/0000-0001-7715-0443; Jeoung, Nam Ho/0000-0002-7584-3761	NATIONAL CANCER INSTITUTE [P50CA096784, R21CA113506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047844] Funding Source: NIH RePORTER; NCI NIH HHS [CA113506, P50 CA96784] Funding Source: Medline; NIDCR NIH HHS [R01DE015939] Funding Source: Medline; NIDDK NIH HHS [DK47844] Funding Source: Medline; NINDS NIH HHS [NS73814] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blum R, 2005, CANCER RES, V65, P999; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boulatnikov I, 2003, BBA-PROTEINS PROTEOM, V1645, P183, DOI 10.1016/S1570-9639(02)00542-3; Cairns RA, 2007, P NATL ACAD SCI USA, V104, P9445, DOI 10.1073/pnas.0611662104; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hassoun EA, 2003, COMP BIOCHEM PHYS C, V135, P119, DOI 10.1016/S1532-0456(03)00082-6; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeoung NH, 2006, ANAL BIOCHEM, V356, P44, DOI 10.1016/j.ab.2006.06.017; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knowles HJ, 2003, CANCER RES, V63, P1764; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koukourakis MI, 2007, CANCER BIOL THER, V6, P1476, DOI 10.4161/cbt.6.9.4635; Laughter AR, 2004, TOXICOLOGY, V203, P83, DOI 10.1016/j.tox.2004.06.014; Lee MS, 2001, CANCER RES, V61, P3290; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mabjeesh NJ, 2007, HISTOL HISTOPATHOL, V22, P559, DOI 10.14670/HH-22.559; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Sattlar UGA, 2007, LAB INVEST, V87, P84, DOI 10.1038/labinvest.3700493; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; STACPOOLE PW, 1992, DIABETES CARE, V15, P785, DOI 10.2337/diacare.15.6.785; Tzeng HF, 2000, CHEM RES TOXICOL, V13, P231, DOI 10.1021/tx990175q; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104; Zou CP, 2001, ONCOGENE, V20, P6820, DOI 10.1038/sj.onc.1204846	45	274	287	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22700	22708		10.1074/jbc.M801765200	http://dx.doi.org/10.1074/jbc.M801765200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18541534	Green Published, hybrid			2022-12-27	WOS:000258321000039
J	Zhang, LB; Lee, JE; Wilusz, J; Wilusz, CJ				Zhang, Libin; Lee, Jerome E.; Wilusz, Jeffrey; Wilusz, Carol J.			The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells - Implications for myotonic dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLET REPEAT; FACTOR-ALPHA; MOLECULAR-BASIS; MIS-REGULATION; MOUSE MODEL; CTG REPEAT; DIFFERENTIATION; EXPRESSION; EXPANSION; MUTATION	Type I myotonic dystrophy(DM1) is caused by a triplet repeat expansion in the 3'-untranslated region (UTR) of the dystrophia myotonia protein kinase (DMPK) gene. Pathogenesis is closely linked with production of a toxic RNA from the mutant allele, which interferes with function of several RNA-binding proteins, including CUGBP1. Here we show that expression of a mutant DMPK 3'-UTR containing 960 CUG repeats is sufficient to increase expression and stability of an mRNA encoding the potent proinflammatory cytokine, tumor necrosis factor (TNF). CUGBP1 specifically recognizes sequences within the TNF 3'-UTR that are dissimilar from its canonical UG-rich binding site. Depletion of CUGBP1 from mouse myoblasts results in increased abundance of TNF mRNA through stabilization of the transcript. Moreover, activation of the protein kinase C pathway by treatment with phorbol ester, which has been shown previously to result in CUGBP1 phosphorylation, also causes TNF mRNA stabilization. Our results suggest that the elevated serum TNF seen in DM1 patients may be derived from muscle where it is induced by expression of toxic DMPK RNA. Importantly, overexpression of this potent cytokine could contribute to the muscle wasting and insulin resistance that are characteristic of this debilitating disease.	[Zhang, Libin; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Lee, Jerome E.; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Wilusz, CJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, 1682 Campus Delivery, Ft Collins, CO 80523 USA.	cwilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072481] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 072481] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2001, HUM MOL GENET, V10, P1879, DOI 10.1093/hmg/10.18.1879; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cosson B, 2006, BIOL CELL, V98, P653, DOI 10.1042/BC20060054; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Johansson A, 2000, J CLIN ENDOCR METAB, V85, P3169, DOI 10.1210/jc.85.9.3169; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; LE MG, 2008, PLOS ONE, V3, pE1466; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; Liu WL, 1998, AM J PHYSIOL-RENAL, V275, pF361, DOI 10.1152/ajprenal.1998.275.3.F361; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mammarella A, 2002, J NEUROL SCI, V201, P59, DOI 10.1016/S0022-510X(02)00193-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Marquis J, 2006, BIOCHEM J, V400, P291, DOI 10.1042/BJ20060490; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308	36	86	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22457	22463		10.1074/jbc.M802803200	http://dx.doi.org/10.1074/jbc.M802803200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18559347	hybrid, Green Published			2022-12-27	WOS:000258321000013
J	Baral, PK; Jajcanin-Jozic, N; Deller, S; Macheroux, P; Abramic, M; Gruber, K				Baral, Pravas Kumar; Jajcanin-Jozic, Nina; Deller, Sigrid; Macheroux, Peter; Abramic, Marija; Gruber, Karl			The first structure of dipeptidyl-peptidase III provides insight into the catalytic mechanism and mode of substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE ALIGNMENT; DROSOPHILA-MELANOGASTER; ALANYL AMINOPEPTIDASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; PURIFICATION; THERMOLYSIN; LIVER; EXOPEPTIDASE; SIMILARITIES	Dipeptidyl-peptidases III (DPP III) are zinc-dependent enzymes that specifically cleave the first two amino acids from the N terminus of different length peptides. In mammals, DPP III is associated with important physiological functions and is a potential biomarker for certain types of cancer. Here, we present the 1.95-angstrom A crystal structure of yeast DPP III representing the prototype for the M49 family of metallopeptidases. It shows a novel fold with two domains forming a wide cleft containing the catalytic metal ion. DPP III exhibits no overall similarity to other metallopeptidases, such as thermolysin and neprilysin, but zinc coordination and catalytically important residues are structurally conserved. Substrate recognition is accomplished by a binding site for the N terminus of the peptide at an appropriate distance from the metal center and by a series of conserved arginine residues anchoring the C termini of different length substrates.	[Baral, Pravas Kumar; Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Jajcanin-Jozic, Nina; Abramic, Marija] Rudjer Boskovic Inst, Div Organ Chem & Biochem, HR-10002 Zagreb, Croatia; [Deller, Sigrid; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	University of Graz; Rudjer Boskovic Institute; Graz University of Technology	Gruber, K (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-3, A-8010 Graz, Austria.	karl.gruber@uni-graz.at	Jajčanin Jozić, Nina/G-7077-2012; Gruber, Karl/GPP-6706-2022; Macheroux, Peter/AAB-5157-2019	Gruber, Karl/0000-0002-3485-9740; Macheroux, Peter/0000-0002-0242-454X	Austrian Science Fund (FWF) [W 901] Funding Source: researchfish; Austrian Science Fund FWF [W 901] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		ABRAMIC M, 1988, BIOL CHEM H-S, V369, P29, DOI 10.1515/bchm3.1988.369.1.29; Abramic M, 2004, INT J BIOCHEM CELL B, V36, P434, DOI 10.1016/S1357-2725(03)00267-X; Abramic M, 2004, PERIOD BIOL, V106, P161; Abramic M, 2000, BIOL CHEM, V381, P1233, DOI 10.1515/BC.2000.151; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agic D, 2007, BIOORG CHEM, V35, P153, DOI 10.1016/j.bioorg.2006.11.002; Barsun M, 2007, BIOL CHEM, V388, P343, DOI 10.1515/BC.2007.039; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Chen J.-M., 2004, HDB PROTEOLYTIC ENZY, P809; Chiba T, 2003, PEPTIDES, V24, P773, DOI 10.1016/S0196-9781(03)00119-0; DALE GE, 2004, HDB METALLOPROTEINS, P104; Dhanda S, 2007, PROTEIN EXPRES PURIF, V52, P297, DOI 10.1016/j.pep.2006.10.004; ELLIS S, 1967, J BIOL CHEM, V242, P4623; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukasawa K, 1998, BIOCHEM J, V329, P275, DOI 10.1042/bj3290275; Fukasawa K, 1999, BIOCHEMISTRY-US, V38, P8299, DOI 10.1021/bi9904959; Hirose J, 2001, BIOCHEMISTRY-US, V40, P11860, DOI 10.1021/bi0110903; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HUANG JX, 1992, EXP MYCOL, V16, P102, DOI 10.1016/0147-5975(92)90016-K; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LEE CM, 1982, J BIOL CHEM, V257, P2043; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Marie-Claire C, 1998, FEBS LETT, V438, P215, DOI 10.1016/S0014-5793(98)01267-8; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MATTHEWS BW, 2004, HDB METALLOPROTEINS, P85; Mazzocco C, 2006, FEBS J, V273, P1056, DOI 10.1111/j.1742-4658.2006.05132.x; Mazzocco C, 2003, EUR J BIOCHEM, V270, P3074, DOI 10.1046/j.1432-1033.2003.03689.x; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Ohkubo I, 1999, BIOL CHEM, V380, P1421, DOI 10.1515/BC.1999.182; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sato Hiroshi, 2003, Masui, V52, P257; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Simaga S, 2003, GYNECOL ONCOL, V91, P194, DOI 10.1016/S0090-8258(03)00462-1; SWANSON AA, 1984, CURR EYE RES, V3, P287, DOI 10.3109/02713688408997211; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; VANHAPERTTULA T, 1988, CLIN CHIM ACTA, V177, P179, DOI 10.1016/0009-8981(88)90140-4; Waeber BNJ, 1990, HYPERTENSION PATHOPH, P2209; Zhang H, 2001, HISTOCHEM J, V33, P511, DOI 10.1023/A:1014943522613	52	64	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22316	22324		10.1074/jbc.M803522200	http://dx.doi.org/10.1074/jbc.M803522200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550518	Green Published, hybrid			2022-12-27	WOS:000258114700050
J	Bradley, CA; Taghibiglou, C; Collingridge, GL; Wang, YT				Bradley, Clarrisa A.; Taghibiglou, Changiz; Collingridge, Graham L.; Wang, Yu Tian			Mechanisms involved in the reduction of GABA(A) receptor alpha 1-subunit expression caused by the epilepsy mutation A322D in the trafficking-competent receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYOCLONIC EPILEPSY; ENDOPLASMIC-RETICULUM; ALPHA-1 SUBUNIT; DEPENDENT ENDOCYTOSIS; A RECEPTORS; RAT-BRAIN; DEGRADATION; LOCALIZATION; STABILITY; DYNAMIN	A mutation in the alpha 1-subunit (A322D) of GABA(A)Rs is responsible for juvenile myoclonic epilepsy in a large Canadian family. Previous work has identified that this mutant affects the cell expression and function of recombinant GABAARs, expressed in HEK293 cells. Here we have extended these observations by showing that the mutation promotes association with the endoplasmic reticulum chaperone calnexin and accelerates the degradation rate of the subunits similar to 2.5-fold. We also find that the mutation causes the subunit to be degraded largely by a lysosomal-dependent process. Furthermore, we find that the mutation results in receptors that are inserted into the plasma membrane but are more rapidly endocytosed by a dynamin and caveolin1-dependent mechanism. These results suggest that the mutant subunit can form functional receptors, but that these have a shorter lifetime on the plasma membrane.	[Bradley, Clarrisa A.; Taghibiglou, Changiz; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada; [Bradley, Clarrisa A.; Taghibiglou, Changiz; Collingridge, Graham L.; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Collingridge, Graham L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Collingridge, Graham L.] Univ Bristol, Dept Anat, Bristol BS8 1TD, Avon, England; [Collingridge, Graham L.] Univ Bristol, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of British Columbia; University of British Columbia; University of British Columbia; University of Bristol; University of Bristol	Wang, YT (corresponding author), UBC Hosp, Brain Res Ctr, 2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	ytwang@brain.ubc.ca	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Wang, Yu Tian/J-8255-2015; Taghibiglou, Changiz/H-4590-2019	Collingridge, Graham L/0000-0002-9572-5359; 	Medical Research Council [G0601813] Funding Source: Medline; MRC [G0601813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; BRADLEY CA, 2004, SOC NEUROSCI; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Dalskov SM, 2005, NEUROCHEM INT, V46, P489, DOI 10.1016/j.neuint.2004.11.010; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Fisher JL, 2004, NEUROPHARMACOLOGY, V46, P629, DOI 10.1016/j.neuropharm.2003.11.015; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Krampfl K, 2005, EUR J NEUROSCI, V22, P10, DOI 10.1111/j.1460-9568.2005.04168.x; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Taghibiglou C, 2000, J LIPID RES, V41, P499; TEHRANI MHJ, 1993, J NEUROCHEM, V60, P1755; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; WISDEN W, 1992, J NEUROSCI, V12, P1040	33	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22043	22050		10.1074/jbc.M801708200	http://dx.doi.org/10.1074/jbc.M801708200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18534981	hybrid			2022-12-27	WOS:000258114700023
J	Mustafa, G; Ishikawa, Y; Kobayashi, K; Migita, CT; Elias, MD; Nakamura, S; Tagawa, S; Yamada, M				Mustafa, Golam; Ishikawa, Yoshinori; Kobayashi, Kazuo; Migita, Catharina T.; Elias, M. D.; Nakamura, Satsuki; Tagawa, Seiichi; Yamada, Mamoru			Amino acid residues interacting with both the bound quinone and coenzyme, pyrroloquinoline quinone, in Escherichia coli membrane-bound glucose dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; UBIQUINONE-BINDING-SITE; CYTOCHROME BO COMPLEX; PULSE-RADIOLYSIS; FUMARATE REDUCTASE; ACINETOBACTER-CALCOACETICUS; SUCCINATE-DEHYDROGENASE; TRANSIENT FORMATION; NITRITE REDUCTASE; CRYSTAL-STRUCTURE	The Escherichia coli membrane-bound glucose dehydrogenase (mGDH) as the primary component of the respiratory chain possesses a tightly bound ubiquinone (UQ) flanking pyrroloquinoline quinone (PQQ) as a coenzyme. Several mutants for Asp-354, Asp-466, and Lys-493, located close to PQQ, that were constructed by site-specific mutagenesis were characterized by enzymatic, pulse radiolysis, and EPR analyses. These mutants retained almost no dehydrogenase activity or ability of PQQ reduction. CD and high pressure liquid chromatography analyses revealed that K493A, D466N, and D466E mutants showed no significant difference in molecular structure from that of the wild-type mGDH but showed remarkably reduced content of bound UQ. A radiolytically generated hydrated electron (e(aq)(-)) reacted with the bound UQ of the wild enzyme and K493R mutant to form a UQ neutral semiquinone with an absorption maximum at 420 nm. Subsequently, intramolecular electron transfer from the bound UQ semiquinone to PQQ occurred. In K493R, the rate of UQ to PQQ electron transfer is about 4-fold slower than that of the wild enzyme. With D354N and D466N mutants, on the other hand, transient species with an absorption maximum at 440 nm, a characteristic of the formation of a UQ anion radical, appeared in the reaction of e(aq)(-), although the subsequent intramolecular electron transfer was hardly affected. This indicates that D354N and D466N are prevented from protonation of the UQ semiquinone radical. Moreover, EPR spectra showed that mutations on Asp-466 or Lys-493 residues changed the semiquinone state of bound UQ. Taken together, we reported here for the first time the existence of a semiquinone radical of bound UQ in purified mGDH and the difference in protonation of ubisemiquinone radical because of mutations in two different amino acid residues, located around PQQ. Furthermore, based on the present results and the spatial arrangement around PQQ, Asp-466 and Lys-493 are suggested to interact both with the bound UQ and PQQ in mGDH.	[Mustafa, Golam; Migita, Catharina T.; Elias, M. D.; Nakamura, Satsuki; Yamada, Mamoru] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Ishikawa, Yoshinori; Yamada, Mamoru] Yamaguchi Univ, Grad Sch Med, Appl Mol Biosci, Ube, Yamaguchi 7558505, Japan; [Kobayashi, Kazuo; Tagawa, Seiichi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Yamaguchi University; Yamaguchi University; Osaka University	Yamada, M (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan.	m-yamada@yamaguchi-u.ac.jp	Kobayashi, Kazuo/H-9279-2012	Kobayashi, Kazuo/0000-0002-5586-9112; Yamada, Mamoru/0000-0003-4354-7324				Abramson J, 2000, NAT STRUCT BIOL, V7, P910; AMEYAMA M, 1985, AGR BIOL CHEM TOKYO, V49, P1227, DOI 10.1080/00021369.1985.10866884; AMEYAMA M, 1981, FEBS LETT, V130, P179, DOI 10.1016/0014-5793(81)81114-3; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Cozier GE, 1999, BIOCHEM J, V340, P639, DOI 10.1042/0264-6021:3400639; Cozier GE, 1995, BIOCHEM J, V312, P679, DOI 10.1042/bj3120679; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Elias MD, 2000, J BIOL CHEM, V275, P7321, DOI 10.1074/jbc.275.10.7321; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; Elias MD, 2001, J BIOL CHEM, V276, P48356, DOI 10.1074/jbc.M107355200; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; GORDON S, 1964, J AM CHEM SOC, V86, P5343, DOI 10.1021/ja01077a067; Grimaldi S, 2001, BIOCHEMISTRY-US, V40, P1037, DOI 10.1021/bi001641+; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; HOMMES RWJ, 1984, FEMS MICROBIOL LETT, V24, P329, DOI 10.1016/0378-1097(84)90274-X; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Kobayashi K, 2003, J AM CHEM SOC, V125, P10213, DOI 10.1021/ja036211w; Kobayashi K, 2000, BIOCHEMISTRY-US, V39, P15620, DOI 10.1021/bi0014094; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Matsumoto Y, 2006, J BIOL CHEM, V281, P1905, DOI 10.1074/jbc.M508206200; MATSUSHITA K, 1987, J BACTERIOL, V169, P205, DOI 10.1128/jb.169.1.205-209.1987; Matsushita K, 1997, MICROBIOL-UK, V143, P3149, DOI 10.1099/00221287-143-10-3149; Matsushita K, 1999, BBA-BIOENERGETICS, V1409, P154, DOI 10.1016/S0005-2728(98)00158-3; Miyoshi H, 1999, BBA-BIOENERGETICS, V1412, P29, DOI 10.1016/S0005-2728(99)00009-2; OKUDA J, 2000, J BIOCH MOL BIOL BIO, V4, P415; PETER LJ, 2003, BIOCHIM BIOPHYS ACTA, V1647, P200; SALERNO JC, 1980, BIOCHEM J, V192, P769, DOI 10.1042/bj1920769; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28899; Sode K, 1997, BIOTECHNOL LETT, V19, P1073, DOI 10.1023/A:1018428224215; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; SUZUKI S, 1994, J AM CHEM SOC, V116, P11145, DOI 10.1021/ja00103a035; VANSCHIE BJ, 1985, J BACTERIOL, V163, P493, DOI 10.1128/JB.163.2.493-499.1985; Yamada M, 1998, J BIOL CHEM, V273, P22021, DOI 10.1074/jbc.273.34.22021; YAMADA M, 1993, J BIOL CHEM, V268, P12812; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	44	14	15	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22215	22221		10.1074/jbc.M800911200	http://dx.doi.org/10.1074/jbc.M800911200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550551	hybrid			2022-12-27	WOS:000258114700041
J	Gauguin, L; Delaine, C; Alvino, CL; McNeil, KA; Wallace, JC; Forbes, BE; De Meyts, P				Gauguin, Lisbeth; Delaine, Carlie; Alvino, Clair L.; McNeil, Kerrie A.; Wallace, John C.; Forbes, Briony E.; De Meyts, Pierre			Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; CHAIN ALPHA-HELIX; B-DOMAIN ANALOGS; LIGAND-BINDING; IGF-I; NEGATIVE COOPERATIVITY; FUSION PROTEINS; POSTNATAL-GROWTH; FACTOR (IGF)-I; TYPE-1 IGF	Current evidence supports a binding model in which the insulin molecule contains two binding surfaces, site 1 and site 2, which contact the two halves of the insulin receptor. The interaction of these two surfaces with the insulin receptor results in a high affinity cross-linking of the two receptor alpha subunits and leads to receptor activation. Evidence suggests that insulin-like growth factor-I (IGF-I) may activate the IGF-I receptor in a similar mode. So far IGF-I residues structurally corresponding to the residues of the insulin site 1 together with residues in the C-domain of IGF-I have been found to be important for binding of IGF-I to the IGF-I receptor (e. g. Phe(23), Tyr(24), Tyr(31), Arg(36), Arg(37), Val(44), Tyr(60), and Ala(62)). However, an IGF-I second binding surface similar to site 2 of insulin has not been identified yet. In this study, we have analyzed whether IGF-I residues corresponding to the six residues of the insulin site 2 have a role in high affinity binding of IGF-I to the IGF-I receptor. Six single-substituted IGF-I analogues were produced, each containing an alanine substitution in one of the following positions (corresponding insulin residues in parentheses): Glu(9) (His(B10)), Asp(12) (Glu(B13)), Phe(16) (Leu(B17)), Asp(53) (Ser(A12)), Leu(54) (Leu(A13)), and Glu(58) (Glu(A17)). In addition, two analogues with 2 and 3 combined alanine substitutions were also produced (E9A, D12A IGF-I and E9A, D12A, E58A IGF-I). The results show that introducing alanine in positions Glu9, Asp12, Phe16, Leu54, and Glu58 results in a significant reduction in IGF-I receptor binding affinity, whereas alanine substitution at position 53 had no effect on IGF-I receptor binding. The multiple substitutions resulted in a 33 -100-fold reduction in IGF-I receptor binding affinity. These data suggest that IGF-I, in addition to the C-domain, uses surfaces similar to those of insulin in contacting its cognate receptor, although the relative contribution of the side chains of homologous residues varies.	[Gauguin, Lisbeth; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, Gentofte 2820, Denmark; [Delaine, Carlie; Alvino, Clair L.; McNeil, Kerrie A.; Wallace, John C.; Forbes, Briony E.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Novo Nordisk; Hagedorn Research Institute; University of Adelaide	Gauguin, L (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, Gentofte 2820, Denmark.	lgau@hagedorn.dk	Forbes, Briony/R-1838-2019; , John/AAP-5150-2020	Forbes, Briony/0000-0003-4360-9927; De Meyts, Pierre/0000-0001-6214-0824				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; CASCIERI MA, 2008, BIOCHEMISTRY-US, V27, P3229; Chakravarty A, 2005, BIOCHEM BIOPH RES CO, V331, P74, DOI 10.1016/j.bbrc.2005.03.122; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; CHRISTOFFERSEN CT, 1994, ENDOCRINOLOGY, V135, P472, DOI 10.1210/en.135.1.472; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Epa VC, 2006, PROTEIN ENG DES SEL, V19, P377, DOI 10.1093/protein/gzl022; FABRY M, 1992, J BIOL CHEM, V267, P8950; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Gill R, 1999, PROTEIN ENG, V12, P297, DOI 10.1093/protein/12.4.297; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Hao CL, 2006, BIOCHEM BIOPH RES CO, V347, P334, DOI 10.1016/j.bbrc.2006.06.089; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Jansson M, 1998, J BIOL CHEM, V273, P24701, DOI 10.1074/jbc.273.38.24701; Jansson M, 1997, FEBS LETT, V416, P259, DOI 10.1016/S0014-5793(97)01149-6; Jansson M, 1997, BIOCHEMISTRY-US, V36, P4108, DOI 10.1021/bi961553i; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kristensen C, 2002, J BIOL CHEM, V277, P18340, DOI 10.1074/jbc.M112249200; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Lien S, 2001, BIOTECHNOL BIOENG, V74, P335, DOI 10.1002/bit.1124; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Magee BA, 1999, BIOCHEMISTRY-US, V38, P15863, DOI 10.1021/bi9910070; Molina L, 2000, FEBS LETT, V467, P226, DOI 10.1016/S0014-5793(00)01161-3; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; SATO A, 1993, INT J PEPT PROT RES, V41, P433; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Shooter GK, 1996, J MOL ENDOCRINOL, V17, P237, DOI 10.1677/jme.0.0170237; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1993, BIOCHEM J, V290, P419, DOI 10.1042/bj2900419; Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200; Surinya KH, 2008, J BIOL CHEM, V283, P5355, DOI 10.1074/jbc.M707054200; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805	56	46	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20821	20829		10.1074/jbc.M802620200	http://dx.doi.org/10.1074/jbc.M802620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502759	Green Published, hybrid			2022-12-27	WOS:000257746100024
J	Wang, XX; Fukuda, K; Byeon, IJ; Velyvis, A; Wu, CY; Gronenborn, A; Qin, J				Wang, Xiaoxia; Fukuda, Koichi; Byeon, In-Ja; Velyvis, Algirdas; Wu, Chuanyue; Gronenborn, Angela; Qin, Jun			The structure of alpha-parvin CH2-paxillin LD1 complex reveals a novel modular recognition for focal adhesion assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES CELL-ADHESION; INTEGRIN-LINKED KINASE; TARGETING DOMAIN; BINDS PAXILLIN; PROTEIN; MOTIFS; ACTIN; ACTOPAXIN; INTERACTS; DYNAMICS	alpha-Parvin is an essential component of focal adhesions (FAs), which are large multiprotein complexes that link the plasma membrane and actin cytoskeleton. alpha-Parvin contains two calponin homology (CH) domains and its C-terminal CH2 domain binds multiple targets including paxillin LD motifs for regulating the FA network and signaling. Here we describe the solution structure of alpha-parvin CH2 bound to paxillin LD1. We show that although CH2 contains the canonical CH-fold, a previously defined N-terminal linker forms an alpha-helix that packs unexpectedly with the C-terminal helix of CH2, resulting in a novel variant of the CH domain. Importantly, such packing generates a hydrophobic surface that recognizes the Leu-rich face of paxillin-LD1, and the binding pattern differs drastically from the classical paxillin-LD binding to four-helix bundle proteins such as focal adhesion kinase. These results define a novel modular recognition mode and reveal how alpha-parvin associates with paxillin to mediate the FA assembly and signaling.	[Wang, Xiaoxia; Fukuda, Koichi; Velyvis, Algirdas; Qin, Jun] Cleveland Clin, Lerner Res Inst, Struct Biol Program, Cleveland, OH 44195 USA; [Wang, Xiaoxia; Qin, Jun] Cleveland State Univ, Dept Chem, Cleveland, OH 44195 USA; [Byeon, In-Ja; Gronenborn, Angela] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Qin, J (corresponding author), Cleveland Clin, Lerner Res Inst, Struct Biol Program, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Qin, Jun/D-5559-2009	Gronenborn, Angela M/0000-0001-9072-3525; Qin, Jun/0000-0002-2647-9270	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 073311, HL 58757] Funding Source: Medline; NIGMS NIH HHS [GM 65188] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Olski TM, 2001, J CELL SCI, V114, P525; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Velyvis A, 2003, NAT STRUCT BIOL, V10, P558, DOI 10.1038/nsb938; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	33	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21113	21119		10.1074/jbc.M801270200	http://dx.doi.org/10.1074/jbc.M801270200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508764	hybrid, Green Published			2022-12-27	WOS:000257746100053
J	Carlson, CB; Liu, YY; Keck, JL; Mosher, DF				Carlson, C. Britt; Liu, Yuanyuan; Keck, James L.; Mosher, Deane F.			Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; SIGNATURE DOMAINS; CALCIUM-BINDING; PREMATURE; PSEUDOACHONDROPLASIA; MULTIPLE; MUTATION; MICE; REVEALS; DENSITY	Thrombospondins (THBSs) are multimodular, secreted proteins characterized by a signature domain comprising a unique set of 13 calcium-binding repeats flanked by epidermal growth factor (EGF)-like and lectin-like modules. A polymorphism that changes a conserved Asn to Ser at residue 700 in the most N-terminal calcium-binding repeat of THBS-1 (repeat 1C) is found in 8-10% of European populations and has been linked to increased risk of premature coronary artery disease. The Ser substitution leads to altered stability in the EGF-like and wire modules of the THBS-1 signature domain as assessed by differential scanning calorimetry carried out in 2 mM or 200 mu M calcium. Studies of the melting profiles of the THBS-2 signature domain proteins with Asn or Ser at position 702 (homologous to 700 in THBS-1) revealed that the impact of the Ser allele is similar in both THBS-1 and THBS-2. Structure determination of the Ser(702) THBS-2 variant in 2 mM calcium showed that repeat 1C contains two bound calcium ions as in the crystal of the Asn(702) protein, including the ion that is coordinated by Asn(702), and is associated with changes in conformation of repeat 1C and the adjacent EGF-like modules. The Ser substitution leads to the decreased ability of soluble THBS-2 signature domain protein to bind 4B6.13, a conformation-sensitive monoclonal antibody that recognizes an epitope in repeat 1C. These results indicate that although THBS harboring the Ser allele binds a full complement of calcium ions, repeat 1C is altered, leading to destabilization of surrounding structures.	[Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, 4285 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu	Liu, Yuanyuan/E-9439-2013	Keck, James/0000-0002-5961-0220	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR 13790] Funding Source: Medline; NHLBI NIH HHS [HL 07899, HL 54462] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; ADAMS JC, 1995, THROMBOSPONDIN GENE, P11; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boekholdt SM, 2002, ARTERIOSCL THROM VAS, V22, pE24, DOI 10.1161/01.ATV.0000046235.22451.66; Breitwieser GE, 2008, INT J BIOCHEM CELL B, V40, P1467, DOI 10.1016/j.biocel.2008.01.019; CALZADA MJ, 2008, MATRIX BIOL IN PRESS; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; Deere M, 1999, AM J MED GENET, V85, P486, DOI 10.1002/(SICI)1096-8628(19990827)85:5<486::AID-AJMG10>3.0.CO;2-O; DeLano W, 2002, PYMOL 0 99; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; Hannah BLA, 2003, J BIOL CHEM, V278, P8929, DOI 10.1074/jbc.M211185200; Hou J, 2000, CELL CALCIUM, V27, P309, DOI 10.1054/ceca.2000.0125; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; Kennedy J, 2005, EUR J HUM GENET, V13, P547, DOI 10.1038/sj.ejhg.5201374; Kleerekoper Q, 2002, J BIOL CHEM, V277, P10581, DOI 10.1074/jbc.M109944200; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Maddox BK, 2000, J BIOL CHEM, V275, P11412, DOI 10.1074/jbc.275.15.11412; McKenzie P, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-33; Miao WM, 2001, CANCER RES, V61, P7830; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Misenheimer TM, 2003, BIOCHEMISTRY-US, V42, P5125, DOI 10.1021/bi026983p; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Narizhneva NV, 2004, J BIOL CHEM, V279, P21651, DOI 10.1074/jbc.M311090200; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tooney PA, 1998, MATRIX BIOL, V17, P131, DOI 10.1016/S0945-053X(98)90026-9; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Zwicker JI, 2006, BLOOD, V108, P1280, DOI 10.1182/blood-2006-04-015701	39	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20069	20076		10.1074/jbc.M800223200	http://dx.doi.org/10.1074/jbc.M800223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499674	hybrid, Green Published			2022-12-27	WOS:000257565300023
J	Han, GS; O'Hara, L; Siniossoglou, S; Carman, GM				Han, Gil-Soo; O'Hara, Laura; Siniossoglou, Symeon; Carman, George M.			Characterization of the yeast DGK1-encoded CTP-dependent diacylglycerol kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; PHOSPHOLIPID BIOSYNTHETIC GENES; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SN-1,2-DIACYLGLYCEROL KINASE; DOLICHOL KINASE; PHOSPHATIDYLINOSITOL 4-KINASES; TRANSCRIPTIONAL REGULATION; SPHINGOLIPID FUNCTIONS; MEMBRANE-PROTEIN	The Saccharomyces cerevisiae DGK1 gene encodes a diacylglycerol kinase enzyme that catalyzes the formation of phosphatidate from diacylglycerol. Unlike the diacylglycerol kinases from bacteria, plants, and animals, the yeast enzyme utilizes CTP, instead of ATP, as the phosphate donor in the reaction. Dgk1p contains a CTP transferase domain that is present in the SEC59-encoded dolichol kinase and CDS1-encoded CDP-diacylglycerol synthase enzymes. Deletion analysis showed that the CTP transferase domain was sufficient for diacylglycerol kinase activity. Point mutations (R76A, K77A, D177A, and G184A) of conserved residues within the CTP transferase domain caused a loss of diacylglycerol kinase activity. Analysis of DGK1 alleles showed that the in vivo functions of Dgk1p were specifically due to its diacylglycerol kinase activity. The DGK1-encoded enzyme had a pH optimum at 7.0-7.5, required Ca2(+) or Mg2(+) ions for activity, was potently inhibited by N-ethylmaleimide, and was labile at temperatures above 40 C. The enzyme exhibited positive cooperative (Hill number = 2.5) kinetics with respect to diacylglycerol (apparent K-m = 6.5 mol %) and saturation kinetics with respect to CTP (apparent K-m = 0.3mM). dCTP was both a substrate (apparent K-m = 0.4 mM) and competitive inhibitor (apparent K-i = 0.4 mM) of the enzyme. Diacylglycerol kinase activity was stimulated by major membrane phospholipids and was inhibited by CDP-diacylglycerol and sphingoid bases.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [O'Hara, Laura; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		O'Hara, Laura/0000-0001-7790-9261	Medical Research Council [G0701446] Funding Source: Medline; NIGMS NIH HHS [R01 GM028140, GM 28140] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0701446] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; BAELEE MS, 1984, J BIOL CHEM, V259, P857; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; BELENDIUK G, 1978, J BIOL CHEM, V253, P4555; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; CARMAN GM, 1992, METHOD ENZYMOL, V209, P242; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CARMAN GM, 1983, CAN J MICROBIOL, V29, P1452, DOI 10.1139/m83-222; CARMAN GM, 1991, EUR J BIOCHEM, V209, P305; CARTER JR, 1966, J LIPID RES, V7, P678; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; DAWSON RMC, 1986, DATA BIOCH RES, P384; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P5762; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; DONAHUE TF, 1981, GENETICS, V98, P491; Fernandez F, 2002, GLYCOBIOLOGY, V12, P555, DOI 10.1093/glycob/cwf068; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, GENETICS, V100, P19; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harlow E., 1999, USING ANTIBODIES LAB; HELLER L, 1992, P NATL ACAD SCI USA, V89, P7013, DOI 10.1073/pnas.89.15.7013; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; KELLEY MJ, 1987, J BIOL CHEM, V262, P14563; Kennedy E. P., 1986, LIPIDS MEMBRANES PRE, P171; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KENNEDY EP, 1959, J BIOL CHEM, V234, P1998; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kosodo Y, 2001, YEAST, V18, P1003, DOI 10.1002/yea.747.abs; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIDICH SD, 1994, J BIOL CHEM, V269, P10193; Leidich SD, 1996, J BIOL CHEM, V271, P27829, DOI 10.1074/jbc.271.44.27829; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; LIN YP, 1989, J BIOL CHEM, V264, P8641; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; LOEWY BS, 1984, MOL CELL BIOL, V4, P2479, DOI 10.1128/MCB.4.11.2479; LOOMIS CR, 1985, J BIOL CHEM, V260, P4091; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; MinSeok R, 1996, J BIOCHEM, V120, P1040; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; NIKAWA J, 1983, EUR J BIOCHEM, V131, P223, DOI 10.1111/j.1432-1033.1983.tb07253.x; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; RODRIGUEZLINARES B, 1991, BIOCHEM PHARMACOL, V41, P835, DOI 10.1016/0006-2952(91)90089-N; Rose MD., 1990, METHODS YEAST GENETI; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHWANK S, 1995, NUCLEIC ACIDS RES, V23, P230, DOI 10.1093/nar/23.2.230; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Shridas P, 2006, J BIOL CHEM, V281, P31696, DOI 10.1074/jbc.M604087200; SMITH SW, 1957, J BIOL CHEM, V228, P915; Sorger D, 2003, APPL MICROBIOL BIOT, V61, P289, DOI 10.1007/s00253-002-1212-4; SPYROU G, 1987, J BIOL CHEM, V262, P16425; SZKOPINSKA A, 1988, ARCH BIOCHEM BIOPHYS, V266, P124, DOI 10.1016/0003-9861(88)90242-1; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; TSUKAGOSHI Y, 1987, EUR J BIOCHEM, V169, P477, DOI 10.1111/j.1432-1033.1987.tb13635.x; WALSH JP, 1986, J BIOL CHEM, V261, P5062; WALSH JP, 1986, J BIOL CHEM, V261, P6239; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; YANG WL, 1994, BIOCHEMISTRY-US, V33, P10785, DOI 10.1021/bi00201a028	87	73	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20443	20453		10.1074/jbc.M802866200	http://dx.doi.org/10.1074/jbc.M802866200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18458076	hybrid, Green Published			2022-12-27	WOS:000257565300059
J	Vargas, WA; Djonovic, S; Sukno, SA; Kenerley, CM				Vargas, Walter A.; Djonovic, Slavica; Sukno, Serenella A.; Kenerley, Charles M.			Dimerization controls the activity of fungal elicitors that trigger systemic resistance in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE CROSS-LINKING; TRICHODERMA-VIRENS; ACQUIRED-RESISTANCE; SECRETED PROTEIN; INNATE IMMUNITY; DEFENSE; GLYCOSYLATION; HYDROPHOBINS; ARABIDOPSIS; PATHOGEN	The soilborne fungus Trichoderma virens secretes a small protein (Sm1) that induces local and systemic defenses in plants. This protein belongs to the ceratoplatanin protein family and is mainly present as a monomer in culture filtrates. However, Hypocrea atroviride (the telomorph form of Trichoderma atroviride) secretes an Sm1-homologous protein, Epl1, with high levels of dimerization. Nonetheless, the molecular mechanisms involved in recognition and the signaling pathways involved in the induction of systemic resistance in plants are still unclear. In this report, we demonstrate that Sm1 and Epl1 are mainly produced as monomer and a dimer, respectively, in the presence of maize seedlings. The results presented show that the ability to induce plant defenses reside only in the monomeric form of both Sm1 and Epl1, and we demonstrate for the first time that the monomeric form of Epl1, likewise Sm1, induces defenses in maize plants. Biochemical analyses indicate that monomeric Sm1 is produced as a glycoprotein, but the glycosyl moiety is missing from its dimeric form, and Epl1 is produced as a nonglycosylated protein. Moreover, for Sm1 homologues in various fungal strains, there is a negative correlation between the presence of the glycosylation site and their ability to aggregate. We propose a subdivision in the ceratoplatanin protein family according to the presence of the glycosylation site and the ability of the proteins to aggregate. The data presented suggest that the elicitor's aggregation may control the Trichoderma-plant molecular dialogue and block the activation of induced systemic resistance in plants.	[Vargas, Walter A.; Djonovic, Slavica; Kenerley, Charles M.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Sukno, Serenella A.] Univ Salamanca, Dept Genet & Microbiol, Ctr Hispano Luso Invest Agr, Salamanca 37007, Spain	Texas A&M University System; Texas A&M University College Station; University of Salamanca	Kenerley, CM (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, 413C LF Peterson, College Stn, TX 77843 USA.	c-kenerley@tamu.edu	Sukno, Serenella/T-5919-2019; Sukno, Serenella A/K-1449-2014	Sukno, Serenella/0000-0003-3248-6490; Sukno, Serenella A/0000-0003-3248-6490				Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; BRISSON LF, 1994, PLANT CELL, V6, P1703, DOI 10.1105/tpc.6.12.1703; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; Djonovic S, 2007, PLANT PHYSIOL, V145, P875, DOI 10.1104/pp.107.103689; Djonovic S, 2007, MOL PLANT PATHOL, V8, P469, DOI [10.1111/j.1364-3703.2007.00407.x, 10.1111/J.1364-3703.2007.00407.X]; Djonovic S, 2006, MOL PLANT MICROBE IN, V19, P838, DOI 10.1094/MPMI-19-0838.02006; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Fu XY, 2004, J BIOL CHEM, V279, P6209, DOI 10.1074/jbc.C300506200; Hall N, 1999, PHYSIOL MOL PLANT P, V55, P69, DOI 10.1006/pmpp.1999.0203; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Hemmann S, 1997, AM J RESP CRIT CARE, V156, P1956, DOI 10.1164/ajrccm.156.6.9702087; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kullnig-Gradinger CM, 2002, MYCOL RES, V106, P757, DOI 10.1017/S0953756202006172; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larios JM, 2001, J BIOL CHEM, V276, P17437, DOI 10.1074/jbc.M100426200; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Mattinen ML, 2008, J BIOTECHNOL, V133, P395, DOI 10.1016/j.jbiotec.2007.10.009; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; PAN SC, 1995, INFECT IMMUN, V63, P3994, DOI 10.1128/IAI.63.10.3994-4002.1995; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; *PE APPL BIOS, 2001, SEQ DET US B, V2, P1; Penas MM, 1998, APPL ENVIRON MICROB, V64, P4028; Pozo MJ, 2004, J PLANT GROWTH REGUL, V23, P211, DOI 10.1007/s00344-004-003105; Ramonell KM, 2002, MOL PLANT PATHOL, V3, P301, DOI 10.1046/j.1364-3703.2002.00123.x; RENART J, 1984, METHOD ENZYMOL, V104, P455; REYMOND P, 1995, P NATL ACAD SCI USA, V92, P4145, DOI 10.1073/pnas.92.10.4145; Seidl V, 2006, FEBS J, V273, P4346, DOI 10.1111/j.1742-4658.2006.05435.x; Shoresh M, 2005, PHYTOPATHOLOGY, V95, P76, DOI 10.1094/PHYTO-95-0076; Sukno SA, 2008, APPL ENVIRON MICROB, V74, P823, DOI 10.1128/AEM.01165-07; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Takeuchi K, 2007, J BACTERIOL, V189, P6945, DOI 10.1128/JB.00500-07; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torkkeli M, 2002, BIOPHYS J, V83, P2240, DOI 10.1016/S0006-3495(02)73984-2; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; Viterbo A, 2007, MOL PLANT PATHOL, V8, P737, DOI 10.1111/J.1364-3703.2007.00430.X; Vogel H.J., 1956, MICROBIAL GENET B, V13, P42; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Weaver M, 2005, BIOCONTROL SCI TECHN, V15, P847, DOI 10.1080/09583150500187108; WESSELS JGH, 1994, ANNU REV PHYTOPATHOL, V32, P413, DOI 10.1146/annurev.py.32.090194.002213; Wilson LM, 2002, MOL PLANT PATHOL, V3, P487, DOI 10.1046/j.1364-3703.2002.00144.x; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Yedidia I, 2003, APPL ENVIRON MICROB, V69, P7343, DOI 10.1128/AEM.69.12.7343-7353.2003; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	59	83	87	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19804	19815		10.1074/jbc.M802724200	http://dx.doi.org/10.1074/jbc.M802724200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487198	hybrid			2022-12-27	WOS:000257387600064
J	Yoda, A; Toyoshima, K; Watanabe, Y; Onishi, N; Hazaka, Y; Tsukuda, Y; Tsukada, J; Kondo, T; Tanaka, Y; Minami, Y				Yoda, Akinori; Toyoshima, Kyoko; Watanabe, Yasuhide; Onishi, Nobuyuki; Hazaka, Yuki; Tsukuda, Yusuke; Tsukada, Junichi; Kondo, Takeshi; Tanaka, Yoshiya; Minami, Yasuhiro			Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PATHWAY; DNA-DAMAGE-RESPONSE; CHK2 KINASE; IN-VITRO; HEMATOLOGIC MALIGNANCIES; GENOMIC INSTABILITY; SIGNALING PATHWAYS; DEPENDENT PATHWAY; DOWN-REGULATION; CELL APOPTOSIS	The oncogenic Wip1 phosphatase (PPM1D) is induced upon DNA damage in a p53-dependent manner and is required for inactivation or suppression of DNA damage-induced cell cycle checkpoint arrest and of apoptosis by dephosphorylating and inactivating phosphorylated Chk2, Chk1, and ATM kinases. It has been reported that arsenic trioxide (ATO), a potent cancer chemotherapeutic agent, in particular for acute promyelocytic leukemia, activates the Chk2/p53 pathway, leading to apoptosis. ATO is also known to activate the p38 MAPK/p53 pathway. Here we show that phosphatase activities of purified Wip1 toward phosphorylated Chk2 and p38 in vitro are inhibited by ATO in a dose-dependent manner. Furthermore, DNA damage-induced phosphorylation of Chk2 and p38 in cultured cells is suppressed by ectopic expression of Wip1, and this Wip1-mediated suppression can be restored by the presence of ATO. We also show that treatment of acute promyelocytic leukemia cells with ATO resulted in induction of phosphorylation and activation of Chk2 and p38 MAPK, which are required for ATO-induced apoptosis. Importantly, this ATO-induced activation of Chk2/p53 and p38 MAPK/p53 apoptotic pathways can be enhanced by siRNA-mediated suppression of Wip1 expression, further indicating that ATO inhibits Wip1 phosphatase in vivo. These results exemplify that Wip1 is a direct molecular target of ATO.	[Yoda, Akinori; Toyoshima, Kyoko; Watanabe, Yasuhide; Onishi, Nobuyuki; Hazaka, Yuki; Tsukuda, Yusuke; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Fac Med Sci, Dept Physiol & Cell Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Tsukuda, Yusuke] Univ Occupat & Environm Hlth, Sch Med, Ctr Canc Chemotherapy, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Kondo, Takeshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Kobe University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Hokkaido University	Minami, Y (corresponding author), Kobe Univ, Grad Sch Med, Fac Med Sci, Dept Physiol & Cell Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	minami@kobe-u.ac.jp	Kondo, Takeshi/G-2103-2012; ONISHI, Nobuyuki/L-6296-2013	Kondo, Takeshi/0000-0001-7455-5824; 				Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Chen GQ, 1997, BLOOD, V89, P3345; Chen GQ, 1996, BLOOD, V88, P1052; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Cheng YH, 2006, ARCH TOXICOL, V80, P310, DOI 10.1007/s00204-005-0045-1; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Chouchane S, 2001, CHEM RES TOXICOL, V14, P517, DOI 10.1021/tx000123x; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Eyfjord JE, 2005, MUTAT RES-FUND MOL M, V592, P18, DOI 10.1016/j.mrfmmm.2005.05.010; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Harrison M, 2004, TRENDS MOL MED, V10, P359, DOI 10.1016/j.molmed.2004.06.010; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Iwama K, 2001, INT J CANCER, V92, P518, DOI 10.1002/ijc.1220; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Joe YS, 2006, J BIOL CHEM, V281, P28764, DOI 10.1074/jbc.M604392200; Kani S, 2007, GENES CELLS, V12, P919, DOI 10.1111/j.1365-2443.2007.01100.x; Kitamura K, 2000, LEUKEMIA, V14, P1743, DOI 10.1038/sj.leu.2401900; LEONARD A, 1980, MUTAT RES, V75, P49, DOI 10.1016/0165-1110(80)90027-5; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Miller WH, 2002, ONCOLOGIST, V7, P14; Miller WH, 2002, CANCER RES, V62, P3893; MINAMI Y, 1991, J BIOL CHEM, V266, P9222; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Oishi I, 1998, MECH DEVELOP, V71, P49, DOI 10.1016/S0925-4773(97)00200-1; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shim MJ, 2002, J BIOCHEM MOL BIOL, V35, P377; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tseng CH, 2004, TOXICOL APPL PHARM, V197, P67, DOI 10.1016/j.taap.2004.02.009; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Yih LH, 2000, CANCER RES, V60, P6346; Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200; Zhang TD, 2001, ONCOGENE, V20, P7146, DOI 10.1038/sj.onc.1204762	60	47	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18969	18979		10.1074/jbc.M800560200	http://dx.doi.org/10.1074/jbc.M800560200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18482988	hybrid			2022-12-27	WOS:000257165600053
J	Stienstra, R; Duval, C; Keshtkar, S; van der Laak, J; Kersten, S; Muller, M				Stienstra, Rinke; Duval, Caroline; Keshtkar, Shohreh; van der Laak, Jeroen; Kersten, Sander; Muller, Michael			Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; OBESITY; GENE; DIFFERENTIATION; POLARIZATION; INFLAMMATION; ADIPOCYTES; MUSCLE	Obesity is associated with infiltration of macrophages into adipose tissue. Adipose macrophages may contribute to an elevated inflammatory status by secreting a variety of proinflammatory mediators, including tumor necrosis factor alpha and interleukin-6 (IL-6). Recent data suggest that during diet-induced obesity the phenotypeofadipose-resident macrophages changes from alternatively activated macrophages toward a more classical and pro-inflammatory phenotype. Here, we explore the effect of peroxisome proliferator-activated receptor gamma activation on obesity-induced inflammation in 129SV mice fed a high fat diet for 20 weeks. High fat feeding increased bodyweight gain, adipose tissue mass, and liver triglycerides. Rosiglitazone treatment further increased adipose mass, reduced liver triglycerides, and changed adipose tissue morphology toward smaller adipocytes. Surprisingly, rosiglitazone markedly increased the number of macrophages in adipose tissue, as shown by immunohistochemical analysis and quantification of macrophage marker genes CD68 and F4/80 +. In adipose tissue, markers for classically activated macrophages including IL-18 were down-regulated, whereas markers characteristic for alternatively activated macrophages (arginase 1, IL-10) were up-regulated by rosiglitazone. Importantly, conditioned media from rosiglitazone-treated alternatively activated macrophages neutralized the inhibitory effect of macrophages on 3T3-L1 adipocyte differentiation, suggesting that alternatively activated macrophages may be involved in mediating the effects of rosiglitazone on adipose tissue morphology and mass. Our results suggest that short term rosiglitazone treatment increases infiltration of alternatively activated macrophages in adipose tissue. The alternatively activated macrophages might play a role in peroxisome proliferator-activated receptor gamma-dependent expansion and remodeling of adipose tissue.	[Stienstra, Rinke; Duval, Caroline; Keshtkar, Shohreh; Kersten, Sander; Muller, Michael] Univ Wageningen & Res Ctr, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 EV Wageningen, Netherlands; [Stienstra, Rinke; Duval, Caroline; Keshtkar, Shohreh; Kersten, Sander; Muller, Michael] Top Inst Food & Nutr, Wageningen, Netherlands; [van der Laak, Jeroen] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 GA Nijmegen, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition; Radboud University Nijmegen	Muller, M (corresponding author), Univ Wageningen & Res Ctr, Div Human Nutr, Nutr Metab & Genom Grp, POB 8129, NL-6700 EV Wageningen, Netherlands.	michael.muller@wur.nl	Kersten, Sander/A-1116-2011; van der Laak, Jeroen AWM/D-3057-2015; Muller, Michael/B-5795-2008; Muller, Michael/M-5724-2019; Stienstra, Rinke/A-4763-2015	Kersten, Sander/0000-0003-4488-7734; van der Laak, Jeroen AWM/0000-0001-7982-0754; Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Stienstra, Rinke/0000-0001-6729-7193				Berthiaume M, 2004, AM J PHYSIOL-REG I, V287, pR1116, DOI 10.1152/ajpregu.00339.2004; Bodles AM, 2006, J LIPID RES, V47, P2080, DOI 10.1194/jlr.M600235-JLR200; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Charo IF, 2007, CELL METAB, V6, P96, DOI 10.1016/j.cmet.2007.07.006; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hammarstedt A, 2005, PROSTAG LEUKOTR ESS, V73, P65, DOI 10.1016/j.plefa.2005.04.008; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Oakes ND, 2001, DIABETES, V50, P1158, DOI 10.2337/diabetes.50.5.1158; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974; Swain SL, 2001, J EXP MED, V194, pF11, DOI 10.1084/jem.194.3.F11; Tan GD, 2005, DIABETOLOGIA, V48, P83, DOI 10.1007/s00125-004-1619-9; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	32	150	152	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22620	22627		10.1074/jbc.M710314200	http://dx.doi.org/10.1074/jbc.M710314200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18541527	hybrid			2022-12-27	WOS:000258321000031
J	Ji, ZY; Mei, FC; Miller, AL; Thompson, EB; Cheng, XD				Ji, Zhenyu; Mei, Fang C.; Miller, Aaron L.; Thompson, E. Brad; Cheng, Xiaodong			Protein kinase A (PKA) isoform RII beta mediates the synergistic killing effect of cAMP and glucocorticoid in acute lymphoblastic leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I REGULATORY SUBUNIT; MOLECULAR-CLONING; INDUCED APOPTOSIS; GENE-EXPRESSION; CYCLIC-AMP; CATALYTIC SUBUNIT; LYMPHOID-CELLS; RESISTANCE; ACTIVATION; SENSITIVITY	Protein kinase A (PKA) or cAMP-dependent protein kinase (cAPK) mediates the synergistic effects of cAMP-and glucocorticoid (GC)-induced apoptosis in lymphoid cells. Using two human acute lymphoblastic leukemia cell (CEM) clones with respective GC-sensitive and GC-resistant phenotypes, we discovered that the PKA regulatory subunit isoform RII beta is preferentially expressed in the GC-sensitive clone C7-14 cells, whereas other intracellular cAMP receptors, including the exchange proteins directly activated by cAMP (Epac), are expressed at similar levels in both GC-sensitive and GC-resistant clones. High RII beta expression level in C7-14 cells is associated with elevated total PKA cellular activity and cAMP sensitivity, which consequently lead to an increased basal PKA activity. cAMP analogs that selectively activate type II PKA recapitulate the effects of forskolin of promoting apoptosis and antagonizing AKT/PKB activity in both GC-sensitive and GC-resistant clones, whereas type I PKA-selective agonists do not. Furthermore, down-regulation of RII beta leads to increased AKT/PKB activation and enhanced GC resistance in C7-14 cells. These results demonstrate that PKA RII beta is responsible for increased GC sensitivity, critical for cAMP-mediated synergistic cell killing in CEM cells, and may represent a novel therapeutic target for GC-resistant lymphoid malignancy.	[Ji, Zhenyu; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Galveston, Med Branch, Dept Pharmacol & Toxicol, Sch Med,Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Miller, Aaron L.; Thompson, E. Brad] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Sch Med,Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cheng, XD (corresponding author), Univ Texas Galveston, Med Branch, Dept Pharmacol & Toxicol, Sch Med,Sealy Ctr Canc Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	NATIONAL CANCER INSTITUTE [R01CA041407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071505, T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170] Funding Source: NIH RePORTER; NCI NIH HHS [CA041407] Funding Source: Medline; NIDDK NIH HHS [1 T90 DK070109-01, 1 R90 DK071505-01] Funding Source: Medline; NIGMS NIH HHS [GM066170] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Brandon EP, 1998, J NEUROSCI, V18, P3639; Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; ChoChung YS, 1995, CRIT REV ONCOL HEMAT, V21, P33, DOI 10.1016/1040-8428(94)00166-9; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; DANELMOORE L, 1993, LEUKEMIA RES, V17, P501, DOI 10.1016/0145-2126(93)90125-5; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Hongo T, 1997, BLOOD, V89, P2959, DOI 10.1182/blood.V89.8.2959; JAHNSEN T, 1986, J BIOL CHEM, V261, P2352; Ji ZY, 2007, J BIOL CHEM, V282, P37370, DOI 10.1074/jbc.M703697200; Kaspers GJL, 1998, BLOOD, V92, P259, DOI 10.1182/blood.V92.1.259.413k21_259_266; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Kofler R, 2003, J ENDOCRINOL, V178, P19, DOI 10.1677/joe.0.1780019; Kofler R, 2000, HISTOCHEM CELL BIOL, V114, P1; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; Medh RD, 1998, CANCER RES, V58, P3684; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-3; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; MOALLI PA, 1994, LEUKEMIA LYMPHOMA, V15, P363, DOI 10.3109/10428199409049738; Myklebust JH, 1999, J CELL PHYSIOL, V180, P71; NORMAN MR, 1977, CANCER RES, V37, P3785; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tissing WJE, 2003, LEUKEMIA, V17, P17, DOI 10.1038/sj.leu.2402733; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	31	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21920	21925		10.1074/jbc.M803193200	http://dx.doi.org/10.1074/jbc.M803193200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544528	Green Published, hybrid			2022-12-27	WOS:000258114700011
J	Sheridan, C; Brumatti, G; Martin, SJ				Sheridan, Clare; Brumatti, Gabriela; Martin, Seamus J.			Oncogenic B-Raf(V600E) inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAPK SIGNALING PATHWAY; BH3-ONLY PROTEINS; MITOCHONDRIAL-MEMBRANE; THERAPEUTIC TARGET; MELANOMA-CELLS; BH3 DOMAINS; B-RAF; DEATH; BRAF; SURVIVAL	Recent studies have revealed that B-Raf mutations are very common in malignant melanoma and are required for tumor growth and maintenance. The majority of melanoma-associated B-Raf mutations involve a single point mutation, V600E, which results in greatly elevated B-Raf kinase activity and constitutive activation of MAPK/ERK downstream. Here we show that B-Raf(V600E) increases resistance to apoptosis induced by chemotherapeutic drugs and promotes ERK-dependent phosphorylation of the BH3-only proteins Bim and Bad that are involved in setting thresholds for apoptosis. ERK-dependent phosphorylation of Bim resulted in degradation of this BH3-only protein, whereas phosphorylation of Bad has previously been shown to result in its sequestration by 14-3-3 proteins. Consistent with this, inhibition of ERK activity in a panel of melanoma cell lines resulted in stabilization of Bim and dephosphorylation of Bad. Furthermore, apoptosis induced through overexpression of Bad or Bim was efficiently blocked by coexpression of mutant B-Raf(V600E). However, small interfering RNA-mediated silencing of Bim and Bad expression conferred only modest protection against cytotoxic drugs, whereas oncogenic B-Raf strongly protected against the same stimuli. These observations suggest that B-Raf-initiated inactivation of Bad and Bim only partly contributes to the anti-apoptotic activities of this oncogene and that other points within the cell death machinery are also targeted by deregulated ERK signaling.	[Sheridan, Clare; Brumatti, Gabriela; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland	Trinity College Dublin	Martin, SJ (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie		Martin, Seamus/0000-0002-8539-3143				Adrain C, 2006, SCIENCE, V311, P785, DOI 10.1126/science.1124154; Adrain C, 2006, TRENDS BIOCHEM SCI, V31, P243, DOI 10.1016/j.tibs.2006.03.004; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Collisson EA, 2003, CANCER RES, V63, P5669; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; SHARMA A, 2005, CANCER RES, V24, P12; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Tuveson DA, 2003, CANCER CELL, V4, P95, DOI 10.1016/S1535-6108(03)00189-2; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	36	57	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22128	22135		10.1074/jbc.M800271200	http://dx.doi.org/10.1074/jbc.M800271200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508762	hybrid			2022-12-27	WOS:000258114700032
J	Yang, LL; Kombu, RS; Kasumov, T; Zhu, SH; Cendrowski, AV; David, F; Anderson, VE; Kelleher, JK; Brunengraber, H				Yang, Lili; Kombu, Rajan S.; Kasumov, Takhar; Zhu, Shu-Han; Cendrowski, Andrea V.; David, France; Anderson, Vernon E.; Kelleher, Joanne K.; Brunengraber, Henri			Metabolomic and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle - I. Interrelation between gluconeogenesis and cataplerosis; Formation of methoxamates from aminooxyacetate and ketoacids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED RAT-LIVER; LIPOGENESIS; KIDNEY; HEPATOCYTES; INHIBITION; PYRUVATE; GLUCOSE; PHOSPHOENOLPYRUVATE; PRODUCTS; ZONATION	We conducted a study coupling metabolomics and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle. Rat livers were perfused with lactate or pyruvate +/- aminooxyacetate or mercaptopicolinate in the presence of 40% enriched (NaHCO3)-C-13. Other livers were perfused with dimethyl [1,4-C-13(2)] succinate +/- mercaptopicolinate. In this first of two companion articles, we show that a substantial fraction of gluconeogenic carbon leaves the liver as citric acid cycle intermediates, mostly alpha-ketoglutarate. The efflux of gluconeogenic carbon ranges from 10 to 200% of the rate of liver gluconeogenesis. This cataplerotic efflux of gluconeogenic carbon may contribute to renal gluconeogenesis in vivo. Multiple crossover analyses of concentrations of gluconeogenic intermediates and redox measurements expand previous reports on the regulation of gluconeogenesis and the effects of inhibitors. We also demonstrate the formation of adducts from the condensation, in the liver, of (i) aminooxyacetate with pyruvate, alpha-ketoglutarate, and oxaloacetate and (ii) mercaptopicolinate and pyruvate. These adducts may exert metabolic effects unrelated to their effect on gluconeogenesis.	[Brunengraber, Henri] Case Western Reserve Univ, Sch Med WG48, Dept Nutr, Cleveland, OH 44106 USA; [Anderson, Vernon E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kelleher, Joanne K.] MIT, Dept Chem Engn, Cambridge, MA 02154 USA	Case Western Reserve University; Case Western Reserve University; Massachusetts Institute of Technology (MIT)	Brunengraber, H (corresponding author), Case Western Reserve Univ, Sch Med WG48, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxb8@case.edu	Kombu, Rajan/A-6752-2008; Anderson, Vernon/W-2673-2019	Anderson, Vernon Emmett/0000-0002-1699-7621	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NIDDK NIH HHS [R33DK070291] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bederman IR, 2004, J BIOL CHEM, V279, P43207, DOI 10.1074/jbc.M403838200; BLACKSHEAR PJ, 1975, BIOCHEM J, V148, P353, DOI 10.1042/bj1480353b; Borek E, 1936, J AM CHEM SOC, V58, P2020, DOI 10.1021/ja01301a058; Brunengraber H, 1997, ANNU REV NUTR, V17, P559, DOI 10.1146/annurev.nutr.17.1.559; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; CHANCE B, 1959, J BIOL CHEM, V234, P3036; COOPER AJL, 1983, ANNU REV BIOCHEM, V52, P187, DOI 10.1146/annurev.bi.52.070183.001155; CORNELL NW, 1984, BIOCHEM J, V220, P707, DOI 10.1042/bj2200707; EKBERG K, 1995, J BIOL CHEM, V270, P21715, DOI 10.1074/jbc.270.37.21715; ESENMO E, 1992, AM J PHYSIOL, V263, pE36, DOI 10.1152/ajpendo.1992.263.1.E36; FOLCH J, 1951, J BIOL CHEM, V191, P819; Fridman E, 2005, CURR OPIN PLANT BIOL, V8, P242, DOI 10.1016/j.pbi.2005.03.004; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hellerstein MK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1146, DOI 10.1152/ajpendo.1999.276.6.E1146; JOMAINBAUM M, 1976, J BIOL CHEM, V251, P37; JUNGERMANN K, 1987, Diabetes Metabolism Reviews, V3, P269; KEECH DB, 1963, J BIOL CHEM, V238, P2609; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; LANDAU BR, 1995, AM J PHYSIOL-ENDOC M, V269, pE18, DOI 10.1152/ajpendo.1995.269.1.E18; LARDY HA, 1965, P NATL ACAD SCI USA, V53, P1410, DOI 10.1073/pnas.53.6.1410; LONGSHAW ID, 1972, EUR J BIOCHEM, V25, P366, DOI 10.1111/j.1432-1033.1972.tb01705.x; Meyer C, 1999, DIABETES, V48, P943, DOI 10.2337/diabetes.48.5.943; NISHIITS.JM, 1967, BIOCHEM J, V103, P852, DOI 10.1042/bj1030852; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; OCHS RS, 1980, BIOCHIM BIOPHYS ACTA, V632, P260, DOI 10.1016/0304-4165(80)90084-7; PREVIS SF, 1995, J BIOL CHEM, V270, P19806, DOI 10.1074/jbc.270.34.19806; Puchowicz MA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1022, DOI 10.1152/ajpendo.1999.277.6.E1022; Rochfort S, 2005, J NAT PROD, V68, P1813, DOI 10.1021/np050255w; ROGNSTAD R, 1970, BIOCHEM J, V116, P483, DOI 10.1042/bj1160483; ROGNSTAD R, 1974, ARCH BIOCHEM BIOPHYS, V161, P638, DOI 10.1016/0003-9861(74)90348-8; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; ROGNSTAD R, 1984, ARCH BIOCHEM BIOPHYS, V230, P605, DOI 10.1016/0003-9861(84)90441-7; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; VENEZIAL.CM, 1970, BIOCHEMISTRY-US, V9, P3960, DOI 10.1021/bi00822a014; Weckwerth W, 2005, DRUG DISCOV TODAY, V10, P1551, DOI 10.1016/S1359-6446(05)03609-3; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; Yang DW, 2000, AM J PHYSIOL-ENDOC M, V278, pE469, DOI 10.1152/ajpendo.2000.278.3.E469; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200; Yang L, 2006, METABOLOMICS, V2, P85, DOI 10.1007/s11306-006-0019-1	41	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21978	21987		10.1074/jbc.M803454200	http://dx.doi.org/10.1074/jbc.M803454200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544527	Green Published, hybrid			2022-12-27	WOS:000258114700017
J	Bhalla, A; Chicka, MC; Chapman, ER				Bhalla, Akhil; Chicka, Michael C.; Chapman, Edwin R.			Analysis of the synaptotagmin family during reconstituted membrane fusion - Uncovering a class of inhibitory isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGGER NEUROTRANSMITTER RELEASE; CRACKED PC12 CELLS; TANDEM C2 DOMAINS; SNARE COMPLEX; T-SNARE; FAST EXOCYTOSIS; CA2+ SENSOR; BINDING; PROTEIN; CORE	Ca2+-triggered exocytosis in neurons and neuroendocrine cells is regulated by the Ca2+-binding protein synaptotagmin (syt) I. Sixteen additional isoforms of syt have been identified, but little is known concerning their biochemical or functional properties. Here, we assessed the abilities of fourteen syt isoforms to directly regulate SNARE ( soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor)-catalyzed membrane fusion. One group of isoforms stimulated neuronal SNARE-mediated fusion in response to Ca2+, while another set inhibited SNARE catalyzed fusion in both the absence and presence of Ca2+. Biochemical analysis revealed a strong correlation between the ability of syt isoforms to bind 1,2-dioleoyl phosphatidylserine ( PS) and t-SNAREs in a Ca2+-promoted manner with their abilities to enhance fusion, further establishing PS and SNAREs as critical effectors for syt action. The ability of syt I to efficiently stimulate fusion was specific for certain SNARE pairs, suggesting that syts might contribute to the specificity of intracellular membrane fusion reactions. Finally, a subset of inhibitory syts down-regulated the ability of syt I to activate fusion, demonstrating that syt isoforms can modulate the function of each other.	[Bhalla, Akhil; Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Bhalla, Akhil; Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Dept Cellular & Mol Biol, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1300 Univ Ave,SMI 129, Madison, WI 53706 USA.	chapman@physiology.wisc.edu		Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ahras M, 2006, J CELL BIOL, V173, P241, DOI 10.1083/jcb.200506163; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Machado HB, 2004, J NEUROSCI RES, V76, P334, DOI 10.1002/jnr.20072; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P3089, DOI 10.1021/bi001968a; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shin OH, 2004, P NATL ACAD SCI USA, V101, P2554, DOI 10.1073/pnas.0308477100; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Shin OH, 2002, NAT NEUROSCI, V5, P649, DOI 10.1038/nn869; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	51	48	53	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21799	21807		10.1074/jbc.M709628200	http://dx.doi.org/10.1074/jbc.M709628200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508778	hybrid, Green Published			2022-12-27	WOS:000257898800053
J	Giraudo, CG; Garcia-Diaz, A; Eng, WS; Yamamoto, A; Melia, TJ; Rothman, JE				Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Yamamoto, Ai; Melia, Thomas J.; Rothman, James E.			Distinct domains of complexins bind SNARE complexes and clamp fusion in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN-I; MEMBRANE-FUSION; CA2+ SENSOR; HEMIFUSION; ABSENCE; SWITCH	In regulated exocytosis, the core membrane fusion machinery proteins, the SNARE proteins, are assisted by a group of regulatory factors in order to couple membrane fusion to an increase of intracellular calcium ion (Ca2(+)) concentration. Complexin-I and synaptotagmin-I have been shown to be key elements for this tightly regulated process. Many studies suggest that complexin-I can arrest the fusion reaction and that synaptotagmin-I can release the complexin-I blockage in a calcium-dependent manner. Although the actual molecular mechanism by which they exert their function is still unknown, recent in vivo experiments postulate that domains of complexin-I produce different effects on neurotransmitter release. Herein, by using an in vitro flipped SNARE cell fusion assay, we have identified and characterized the minimal functional domains of complexin-I necessary to couple calcium and synaptotagmin-I to membrane fusion. Moreover, we provide evidence that other isoforms of complexin, complexin-II, -III, and -IV, can also be functionally coupled to synaptotagmin-I and calcium. These correspond closely to results from in vivo experiments, providing further validation of the physiological relevance of the flipped SNARE system.	[Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Melia, Thomas J.; Rothman, James E.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Yamamoto, Ai] Columbia Univ, Dept Neurol, New York, NY 10032 USA	Columbia University; Columbia University	Giraudo, CG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 1150 St Nicholas Ave,Russ Berrie Bldg,Rm 520, New York, NY 10032 USA.	cgg2103@columbia.edu; jr2269@columbia.edu	Yamamoto, Ai/D-1100-2011		NIGMS NIH HHS [R01 GM 071458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Melia TJ, 2007, FEBS LETT, V581, P2131, DOI 10.1016/j.febslet.2007.02.066; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Peng RW, 2005, THESCIENTIFICWORLDJO, V5, P471, DOI 10.1100/tsw.2005.53; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292	37	39	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21211	21219		10.1074/jbc.M803478200	http://dx.doi.org/10.1074/jbc.M803478200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499660	Green Published, hybrid			2022-12-27	WOS:000257746100063
J	Kang, NJ; Lee, KW; Lee, DE; Rogozin, EA; Bode, AM; Lee, HJ; Dong, ZG				Kang, Nam Joo; Lee, Ki Won; Lee, Dong Eun; Rogozin, Evgeny A.; Bode, Ann M.; Lee, Hyong Joo; Dong, Zigang			Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CACAO LIQUOR PROANTHOCYANIDINS; NF-KAPPA-B; MAP KINASE; TEA POLYPHENOLS; IN-VIVO; NEOPLASTIC TRANSFORMATION; CANCER CHEMOPREVENTION; SIGNALING PATHWAY; PROSTAGLANDIN E-2; GREEN TEA	Cocoa was shown to inhibit chemically induced carcinogenesis in animals and exert antioxidant activity in humans. However, the molecular mechanisms of the chemopreventive potential of cocoa and its active ingredient(s) remain unknown. Here we report that cocoa procyanidins inhibit neoplastic cell transformation by suppressing the kinase activity of mitogen-activated protein kinase kinase (MEK). A cocoa procyanidin fraction (CPF) and procyanidin B2 at 5 mu g/ml and 40 mu M, respectively, inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced neoplastic transformation of JB6 P+ mouse epidermal (JB6 P+) cells by 47 and 93%, respectively. The TPA-induced promoter activity and expression of cyclooxygenase-2, which is involved in tumor promotion and inflammation, were dose-dependently inhibited by CPF or procyanidin B2. The activation of activator protein-1 and nuclear factor-kappa B induced by TPA was also attenuated by CPF or procyanidin B2. The TPA-induced phosphorylation of MEK, extracellular signal-regulated kinase, and p90 ribosomal s6 kinase was suppressed by CPF or procyanidin B2. In vitro and ex vivo kinase assay data demonstrated that CPF or procyanidin B2 inhibited the kinase activity of MEK1 and directly bound with MEK1. CPF or procyanidin B2 suppressed JB6 P+ cell transformation induced by epidermal growth factor or H-Ras, both of which are known to be involved in MEK/ERK signal activation. In contrast, theobromine (up to 80 mu M) had no effect on TPA-induced transformation, cyclooxygenase-2 expression, the transactivation of activator protein-1 or nuclear factor-kappa B, or MEK. Notably, procyanidin B2 exerted stronger inhibitory effects compared with PD098059 (a well known pharmacological inhibitor of MEK) on MEK1 activity and neoplastic cell transformation.	[Kang, Nam Joo; Lee, Ki Won; Rogozin, Evgeny A.; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Kang, Nam Joo; Lee, Dong Eun; Lee, Hyong Joo] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea; [Kang, Nam Joo; Lee, Dong Eun; Lee, Hyong Joo] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151742, South Korea; [Lee, Ki Won] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea	University of Minnesota System; Seoul National University (SNU); Seoul National University (SNU); Konkuk University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Lee, Ki Won/M-4114-2018		NCI NIH HHS [CA 81064, CA 88961, CA 120388, CA 111536] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111536, R37CA081064, R01CA081064, P01CA088961, R01CA120388] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bode AM, 2005, PROG NUCLEIC ACID RE, V79, P237, DOI 10.1016/S0079-6603(04)79005-4; Carnesecchi S, 2002, CANCER LETT, V175, P147, DOI 10.1016/S0304-3835(01)00731-5; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chung JY, 1999, CANCER RES, V59, P4610; Chung JY, 2001, FASEB J, V15, P2022, DOI 10.1096/fj.01-0031fje; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DONG Z, 2002, SCI STKE, pPL7; Dong ZG, 1997, MOL CARCINOGEN, V19, P204, DOI 10.1002/(SICI)1098-2744(199707)19:3<204::AID-MC8>3.0.CO;2-D; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; He ZW, 2003, CANCER RES, V63, P4396; Hou DX, 2004, CARCINOGENESIS, V25, P29, DOI 10.1093/carcin/bgg184; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Lee KW, 2006, BIOFACTORS, V26, P105, DOI 10.1002/biof.5520260202; Lee KW, 2003, J AGR FOOD CHEM, V51, P7292, DOI 10.1021/jf0344385; Lee KW, 2006, J NUTR, V136, P1150, DOI 10.1093/jn/136.5.1150; Lee KW, 2005, J AGR FOOD CHEM, V53, P1990, DOI 10.1021/jf0486040; Li JJ, 1997, CANCER RES, V57, P3569; Liu GM, 2003, J BIOL CHEM, V278, P2124, DOI 10.1074/jbc.M202443200; Lu YP, 2002, P NATL ACAD SCI USA, V99, P12455, DOI 10.1073/pnas.182429899; Lu YP, 2001, CANCER RES, V61, P5002; Miller KB, 2006, J AGR FOOD CHEM, V54, P4062, DOI 10.1021/jf060290o; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Prosperi JR, 2004, PROSTAG OTH LIPID M, V73, P249, DOI 10.1016/j.prostaglandis.2004.03.004; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sang SM, 2005, ANTIOXID REDOX SIGN, V7, P1704, DOI 10.1089/ars.2005.7.1704; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shapiro P, 2002, CRIT REV CL LAB SCI, V39, P285, DOI 10.1080/10408360290795538; Sheng HM, 1998, CANCER RES, V58, P362; Smit HJ, 2004, PSYCHOPHARMACOLOGY, V176, P412, DOI 10.1007/s00213-004-1898-3; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Suzukawa K, 2002, ENVIRON HEALTH PERSP, V110, P865, DOI 10.1289/ehp.02110865; Weisburger JH, 2001, EXP BIOL MED, V226, P891, DOI 10.1177/153537020122601003; Wong BCY, 2004, GASTROENTEROLOGY, V126, P136, DOI 10.1053/j.gastro.2003.10.063; Yamagishi M, 2003, CANCER LETT, V191, P49, DOI 10.1016/S0304-3835(02)00629-8; Yamagishi M, 2002, CANCER LETT, V185, P123, DOI 10.1016/S0304-3835(02)00276-8; Yan Y, 2006, J CELL SCI, V119, P2985, DOI 10.1242/jcs.03014	47	62	62	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20664	20673		10.1074/jbc.M800263200	http://dx.doi.org/10.1074/jbc.M800263200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18519570	Green Published, hybrid			2022-12-27	WOS:000257746100007
J	Marro, ML; Peiro, C; Panayiotou, CM; Baliga, RS; Meurer, S; Schmidt, HHHW; Hobbs, AJ				Marro, Martin L.; Peiro, Concepcion; Panayiotou, Catherine M.; Baliga, Reshma S.; Meurer, Sabine; Schmidt, Harald H. H. W.; Hobbs, Adrian J.			Characterization of the human alpha(1)beta(1) soluble guanylyl cyclase promoter - Key role for NF-kappa B(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SIGNAL-TRANSDUCTION SYSTEM; CYCLIC-GMP; DOWN-REGULATION; PULMONARY-HYPERTENSION; BETA(1) SUBUNIT; DNA-BINDING; NF-Y; GENES; RAT	Soluble guanylyl cyclase (sGC) is the principal receptor for NO and plays a ubiquitous role in regulating cellular function. This is exemplified in the cardiovascular system where sGC governs smooth muscle tone and growth, vascular permeability, leukocyte flux, and platelet aggregation. As a consequence, aberrant NO-sGC signaling has been linked to diseases including hypertension, atherosclerosis, and stroke. Despite these key (patho) physiological roles, little is known about the expressional regulation of sGC. To address this deficit, we have characterized the promoter activity of human alpha(1) and beta(1) sGC genes in a cell type relevant to cardiovascular (patho) physiology, primary human aortic smooth muscle cells. Luciferase reporter constructs revealed that the 0.3-and 0.5-kb regions upstream of the transcription start sites were optimal for alpha(1) and beta(1) sGC promoter activity, respectively. Deletion of consensus sites for c-Myb, GAGA, NFAT, NF-kappa B(p50), and CCAAT-binding factor(s) (CCAAT-BF) revealed that these are the principal transcription factors regulating basal sGC expression. In addition, under pro-inflammatory conditions, the effects of the strongest alpha(1) and beta(1) sGC repressors were enhanced, and enzyme expression and activity were reduced; in particular, NF-kappa B(p50) is pivotal in regulating enzyme expression under such conditions. NO itself also elicited a cGMP-independent negative feedback effect on sGC promoter activity that is mediated, in part, via CCAAT-BF activity. In sum, these data provide a systematic characterization of the promoter activity of human sGC alpha(1) and beta(1) subunits and identify key transcription factors that govern subunit expression under basal and pro-inflammatory (i.e. atherogenic) conditions and in the presence of ligand NO.	[Marro, Martin L.; Panayiotou, Catherine M.; Baliga, Reshma S.; Hobbs, Adrian J.] UCL, Dept Pharmacol, London WC1E 6BT, England; [Peiro, Concepcion] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, E-28029 Madrid, Spain; [Meurer, Sabine; Schmidt, Harald H. H. W.] Monash Univ, Fac Med, Dept Pharmacol, Melbourne, Vic 3168, Australia	University of London; University College London; Autonomous University of Madrid; Monash University	Hobbs, AJ (corresponding author), UCL, Dept Pharmacol, Med Sci Bldg,Gower St, London WC1E 6BT, England.	a.hobbs@ucl.ac.uk	Schmidt, Harald HHW/B-1549-2008; Peiro, Concepcion/B-9545-2017	Schmidt, Harald HHW/0000-0003-0419-5549; Peiro, Concepcion/0000-0002-9690-7816; Hobbs, Adrian/0000-0002-3589-7108	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Andreopoulos S, 2000, GEN PHARMACOL-VASC S, V34, P147, DOI 10.1016/S0306-3623(00)00062-8; Azam M, 1998, HYPERTENSION, V32, P149, DOI 10.1161/01.HYP.32.1.149; Bauersachs J, 1999, CIRCULATION, V100, P292, DOI 10.1161/01.CIR.100.3.292; Brandes RP, 2000, P NATL ACAD SCI USA, V97, P9747, DOI 10.1073/pnas.97.17.9747; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Chen LH, 2000, CIRC RES, V86, P520, DOI 10.1161/01.RES.86.5.520; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Filippov G, 1997, J CLIN INVEST, V100, P942, DOI 10.1172/JCI119610; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GIUILI G, 1993, HUM GENET, V91, P257; Guan HC, 2005, J BIOL CHEM, V280, P9957, DOI 10.1074/jbc.M412180200; Hassoun PM, 2004, AM J RESP CELL MOL, V30, P908, DOI 10.1165/rcmb.2003-0287OC; Hill-Eubanks DC, 2003, TRENDS CARDIOVAS MED, V13, P56, DOI 10.1016/S1050-1738(02)00212-8; Hobbs AJ, 1996, METHOD ENZYMOL, V269, P134; Hobbs AJ, 1997, TRENDS PHARMACOL SCI, V18, P484, DOI 10.1016/S0165-6147(97)01137-1; Hobbs AJ, 2003, VASC PHARMACOL, V40, P149, DOI 10.1016/S1537-1891(03)00046-6; Hut QH, 2002, J BIOL CHEM, V277, P37191, DOI 10.1074/jbc.M205985200; Jin VX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-114; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; Kloss S, 2000, HYPERTENSION, V35, P43; KUBES P, 1993, AM J PHYSIOL, V265, pH1909, DOI 10.1152/ajpheart.1993.265.6.H1909; KUROSE I, 1993, CIRC RES, V73, P164, DOI 10.1161/01.RES.73.1.164; Madhani M, 2006, BRIT J PHARMACOL, V149, P797, DOI 10.1038/sj.bjp.0706920; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; MORLEY D, 1993, P NATL ACAD SCI USA, V22, pS3; Murad F, 1994, Adv Pharmacol, V26, P19, DOI 10.1016/S1054-3589(08)60049-6; Niu XF, 1996, CIRC RES, V79, P992, DOI 10.1161/01.RES.79.5.992; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Papapetropoulos A, 1996, BRIT J PHARMACOL, V118, P1359, DOI 10.1111/j.1476-5381.1996.tb15545.x; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281; Ritter D, 2000, BIOCHEM J, V346, P811, DOI 10.1042/0264-6021:3460811; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Sabrane K, 2003, J BIOL CHEM, V278, P17963, DOI 10.1074/jbc.M213113200; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Scott WS, 1998, J SURG RES, V79, P66, DOI 10.1006/jsre.1998.5382; Sharina IG, 2000, P NATL ACAD SCI USA, V97, P10878, DOI 10.1073/pnas.190331697; Sharina IG, 2003, P NATL ACAD SCI USA, V100, P11523, DOI 10.1073/pnas.1934338100; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Takata M, 2001, AM J PHYSIOL-LUNG C, V280, pL272, DOI 10.1152/ajplung.2001.280.2.L272; Tong X, 2004, MOL CELL BIOCHEM, V265, P171, DOI 10.1023/B:MCBI.0000044394.66951.4d; Tzao C, 2001, PEDIATR PULM, V31, P97, DOI 10.1002/1099-0496(200102)31:2<97::AID-PPUL1016>3.0.CO;2-K; Vazquez-Padron RI, 2004, BIOCHEM BIOPH RES CO, V314, P208, DOI 10.1016/j.bbrc.2003.12.078; Wang ZM, 2000, J BIOL CHEM, V275, P20260, DOI 10.1074/jbc.M909168199; Wedgwood S, 2005, AM J PHYSIOL-LUNG C, V289, pL660, DOI 10.1152/ajplung.00369.2004; Yamamoto T, 2002, BIOCHEM J, V361, P337, DOI 10.1042/0264-6021:3610337; You XM, 2003, CIRC RES, V92, P314, DOI 10.1161/01.RES.0000056758.73215.5A; Zabel U, 1998, BIOCHEM J, V335, P51, DOI 10.1042/bj3350051	54	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20027	20036		10.1074/jbc.M801223200	http://dx.doi.org/10.1074/jbc.M801223200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18474600	Green Published, hybrid			2022-12-27	WOS:000257565300018
J	Signorell, A; Jelk, J; Rauch, M; Butikofer, P				Signorell, Aita; Jelk, Jennifer; Rauch, Monika; Buetikofer, Peter			Phosphatidylethanolamine is the precursor of the ethanolamine phosphoglycerol moiety bound to eukaryotic elongation factor 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; FACTOR 1-ALPHA; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR; H-3 ETHANOLAMINE; SURFACE PROTEIN; CULTURE FORMS; TRANSLATION; PHOSPHORYLATION; BIOSYNTHESIS; EF-1-ALPHA	In addition to its conventional role during protein synthesis, eukaryotic elongation factor 1A is involved in other cellular processes. Several regions of interaction between eukaryotic elongation factor 1A and the translational apparatus or the cytoskeleton have been identified, yet the roles of the different post-translational modifications of eukaryotic elongation factor 1A are completely unknown. One amino acid modification, which so far has only been found in eukaryotic elongation factor 1A, consists of ethanolamine-phosphoglycerol attached to two glutamate residues that are conserved between mammals and plants. We now report that ethanolamine-phosphoglycerol is also present in eukaryotic elongation factor 1A of the protozoan parasite Trypanosoma brucei, indicating that this unique protein modification is of ancient origin. In addition, using RNA-mediated gene silencing against enzymes of the Kennedy pathway, we demonstrate that phosphatidylethanolamine is a direct precursor of the ethanolamine-phosphoglycerol moiety. Down-regulation of the expression of ethanolamine kinase and ethanolamine-phosphate cytidylyltransferase results in inhibition of phosphatidylethanolamine synthesis in T. brucei procyclic forms and, concomitantly, in a block in glycosylphosphatidylinositol attachment to procyclins and ethanolamine-phosphoglycerol modification of eukaryotic elongation factor 1A.	[Signorell, Aita; Jelk, Jennifer; Rauch, Monika; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	University of Bern	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@mci.unibe.ch						Acosta-Serrano A, 2000, J MOL BIOL, V304, P633, DOI 10.1006/jmbi.2000.4246; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Birner R, 2003, INT REV CYTOL, V225, P273, DOI 10.1016/S0074-7696(05)25007-6; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 1999, J CELL SCI, V112, P1785; Butikofer P, 1996, J BIOL CHEM, V271, P15533, DOI 10.1074/jbc.271.26.15533; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Choi JY, 2005, ANAL BIOCHEM, V347, P165, DOI 10.1016/j.ab.2005.03.017; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Field M. C., 1992, LIPID MODIFICATION P, P155; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; INGLIS AS, 1983, METHOD ENZYMOL, V91, P324; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kiel JAKW, 2007, FEMS YEAST RES, V7, P1114, DOI 10.1111/j.1567-1364.2007.00232.x; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leclercq TM, 2008, J BIOL CHEM, V283, P9606, DOI 10.1074/jbc.M708782200; MENON AK, 1992, J BIOL CHEM, V267, P15277; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Ransom WD, 1998, PLANT PHYSIOL, V117, P949, DOI 10.1104/pp.117.3.949; RIFKIN MR, 1995, J BIOL CHEM, V270, P16160, DOI 10.1074/jbc.270.27.16160; Roditi I, 2002, TRENDS MICROBIOL, V10, P128, DOI 10.1016/S0966-842X(02)02309-0; ROSENBERRY TL, 1989, J BIOL CHEM, V264, P7096; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; van Hellemond JJ, 2006, FEBS LETT, V580, P5552, DOI 10.1016/j.febslet.2006.07.056; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vance JE, 2003, PROG NUCLEIC ACID RE, V75, P69, DOI 10.1016/S0079-6603(03)75003-X; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; WHITEHEART SW, 1994, ARCH BIOCHEM BIOPHYS, V309, P387, DOI 10.1006/abbi.1994.1128; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	51	36	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20320	20329		10.1074/jbc.M802430200	http://dx.doi.org/10.1074/jbc.M802430200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499667	hybrid			2022-12-27	WOS:000257565300048
J	Kwak, JH; Kim, SI; Kim, JK; Choi, ME				Kwak, Joon Hyeok; Kim, Sung Il; Kim, Jin Kuk; Choi, Mary E.			BAT3 interacts with transforming growth factor-beta (TGF-beta) receptors and enhances TGF-beta 1-induced type I collagen expression in mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-ASSOCIATED TRANSCRIPT-3; SIGNAL-TRANSDUCTION; DOMAIN PROTEIN; SCYTHE; REAPER; ACTIVATION; APOPTOSIS; PATHWAY	Transforming growth factor-beta 1 (TGF-beta 1) plays essential roles in a wide array of cellular processes, such as in development and the pathogenesis of tissue fibrosis, including that associated with progressive kidney diseases. Tight regulation of its signaling pathways is critical, and proteins that associate with the TGF-beta receptors may exert positive or negative regulatory effects on TGF-beta signaling. In the present study we employed a yeast-based two-hybrid screening system to identify BAT3 (HLA-B-associated transcript 3) as a TGF-beta receptor-interacting protein. Analysis of endogenously expressed BAT3 in various tissues including the kidney reveals the existence of similar to 140kDa full-length protein as well as truncated forms of BAT3 whose expression is developmentally regulated. Endogenous BAT3 protein interacts with TGF-beta receptors type I and type II in renal mesangial cells. Functional assays show that expression of full-length BAT3 results in enhancement of TGF-beta 1-stimulated transcriptional activation of p3TP-Lux reporter, and these effects require the presence of functional TGF-beta signaling receptors as demonstrated in R-1B and DR-26 mutant cells. Moreover, expression of full-length BAT3, but not C-terminal truncated mutant of BAT3, enhanced TGF-beta 1-induced type I collagen expression in mesangial cells, whereas knock down of BAT3 protein expression by small interfering RNA suppressed the expression of type I collagen induced by TGF-beta 1. Our findings suggest that BAT3, a TGF-beta receptor-interacting protein, is capable of modulating TGF-beta signaling and acts as a positive regulator of TGF-beta 1 stimulation of type I collagen expression in mesangial cells.	[Kwak, Joon Hyeok; Kim, Sung Il; Kim, Jin Kuk; Choi, Mary E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Renal Div, Boston, MA 02115 USA; [Kim, Jin Kuk] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon 420767, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Soonchunhyang University	Choi, ME (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Renal Div, 4 Blackfan Circle,HIM-5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK57661] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Charng MJ, 1998, J BIOL CHEM, V273, P9365, DOI 10.1074/jbc.273.16.9365; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Choi ME, 1999, AM J PHYSIOL-RENAL, V276, pF88, DOI 10.1152/ajprenal.1999.276.1.F88; Choi ME, 1997, AM J PHYSIOL-RENAL, V273, pF386, DOI 10.1152/ajprenal.1997.273.3.F386; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kim S. I., 2007, AM J PHYSIOL-RENAL, V292, P1471; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kumar R, 2004, BIOCHEM BIOPH RES CO, V323, P1293, DOI 10.1016/j.bbrc.2004.09.006; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2001, J CELL SCI, V114, P4359; Ozaki T, 1999, DNA CELL BIOL, V18, P503, DOI 10.1089/104454999315222; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; WeisGarcia F, 1996, EMBO J, V15, P276, DOI 10.1002/j.1460-2075.1996.tb00358.x; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200	37	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19816	19825		10.1074/jbc.M802285200	http://dx.doi.org/10.1074/jbc.M802285200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487607	Green Published, hybrid			2022-12-27	WOS:000257387600065
J	Tolia, A; Horre, K; De Strooper, B				Tolia, Alexandra; Horre, Katrien; De Strooper, Bart			Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; AMYLOID PRECURSOR PROTEIN; INTRAMEMBRANE CLEAVAGE; MECHANISM; NICASTRIN; DOMAIN; APH-1; IDENTIFICATION; COMPLEX; ENDOPROTEOLYSIS	One of the most prominent drug targets for the treatment of Alzheimer disease is gamma-secretase, a multi-protein complex responsible for the generation of the amyloid-beta peptide. The catalytic core of the complex lies on presenilin, a multi-spanning membrane protease, the activity of which depends on two aspartate residues located in transmembrane domains 6 and 7. We have recently shown by cysteine-scanning mutagenesis that these aspartates are facing a water-filled cavity in the lipid bilayer, demonstrating how proteolytic cleavage of the substrates can be taking place within the membrane. Here, we demonstrate that transmembrane domain 9 and hydrophobic domain VII in the large cytoplasmic loop of presenilin are dynamic structural parts of this cavity. Hydrophobic domain VII is associated with transmembrane domain 7 in the membrane, probably facilitating the entrance of water molecules in the catalytic site. Transmembrane domain 9, on the other hand, exhibits a highly flexible structure, potentially involved in the transport of substrates to the catalytic site, as well as in the binding of gamma-secretase inhibitors. The conserved proline-alanine-leucine motif at the cytoplasmic part of this domain is extremely close to the catalytic Asp(257) and is crucial for conformational changes leading to the activation of the catalytic site. We, also, identify a unique mutant in this domain (I437C) that specifically blocks amyloid-beta peptide production without affecting the processing of the physiologically indispensable Notch substrate. Our data are finally combined to propose a model for the architectural organization and activation of the catalytic site of presenilin.	[Tolia, Alexandra; Horre, Katrien; De Strooper, Bart] Katholieke Univ Leuven, VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Tolia, Alexandra; Horre, Katrien; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	De Strooper, B (corresponding author), Herestr 49, B-3000 Louvain, Belgium.	Bart.destrooper@med.kuleuven.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Horre, Katrien/0000-0002-6801-3137				Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Laudon H, 2004, J BIOL CHEM, V279, P23925, DOI 10.1074/jbc.M401277200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Politzer P, 2003, J COMPUT CHEM, V24, P505, DOI 10.1002/jcc.10209; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Tamura N, 2003, CURR OPIN CHEM BIOL, V7, P570, DOI 10.1016/j.cbpa.2003.08.014; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	52	61	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19793	19803		10.1074/jbc.M802461200	http://dx.doi.org/10.1074/jbc.M802461200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482978	hybrid			2022-12-27	WOS:000257387600063
J	Li, X; Lou, ZY; Li, XM; Zhou, WH; Ma, M; Cao, YJ; Geng, YQ; Bartlam, M; Zhang, XC; Rao, ZH				Li, Xin; Lou, Zhiyong; Li, Xuemei; Zhou, Weihong; Ma, Ming; Cao, Youjia; Geng, Yunqi; Bartlam, Mark; Zhang, Xuejun C.; Rao, Zihe			Structure of human cytosolic X-prolyl aminopeptidase - A double Mn(II)-dependent dimeric enzyme with a novel three-domain subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SECONDARY-STRUCTURE; KIDNEY; PURIFICATION; BRADYKININ; INHIBITOR; PEPTIDES; APSTATIN; RECOGNITION; DEGRADATION	X-prolyl aminopeptidases catalyze the removal of a penultimate prolyl residue from the N termini of peptides. Mammalian X-prolyl aminopeptidases are shown to be responsible for the degradation of bradykinin, a blood pressure regulator peptide, and have been linked to myocardial infarction. The x-ray crystal structure of human cytosolic X-prolyl aminopeptidase (XPNPEP1) was solved at a resolution of 1.6 angstrom. The structure reveals a dimer with a unique three-domain organization in each subunit, rather than the two domains common to all other known structures of X-prolyl aminopeptidase and prolidases. The C-terminal catalytic domain of XPNPEP1 coordinates two metal ions and shares a similar fold with other prolyl aminopeptidases. Metal content analysis and activity assays confirm that the enzyme is double Mn(II) dependent for its activity, which contrasts with the previous notion that each XPNPEP1 subunit contains only one Mn(II) ion. Activity assays on an E41A mutant demonstrate that the acidic residue, which was considered as a stabilizing factor in the protonation of catalytic residue His(498), plays only a marginal role in catalysis. Further mutagenesis reveals the significance of the N-terminal domain and dimerization for the activity of XPNPEP1, and we provide putative structural explanations for their functional roles. Structural comparisons further suggest mechanisms for substrate selectivity in different X-prolyl peptidases.	[Li, Xin; Zhou, Weihong; Cao, Youjia; Geng, Yunqi; Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Li, Xin; Zhou, Weihong; Cao, Youjia; Geng, Yunqi; Bartlam, Mark; Rao, Zihe] Nankai Univ, Tianjin State Lab Prot Sci, Tianjin 300071, Peoples R China; [Li, Xin; Li, Xuemei; Ma, Ming; Zhang, Xuejun C.; Rao, Zihe] Chinese Acad Sci, Natl Lab Biol Macromol, Inst Biophys, Beijing 100101, Peoples R China; [Lou, Zhiyong; Bartlam, Mark; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Zhang, Xuejun C.] Oklahoma Med Res Fdn, Crystallog Res Program, Oklahoma City, OK 73104 USA	Nankai University; Nankai University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Oklahoma Medical Research Foundation	Cao, YJ (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	caoyj@nankai.edu.cn; Cai-Zhang@omrf.org	li, xin/HHS-9461-2022; Li, Lambert LL/F-7146-2015; Rao, Zihe/HCH-6944-2022	Bartlam, Mark/0000-0001-5173-5080				BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; DEHM P, 1970, EUR J BIOCHEM, V17, P372, DOI 10.1111/j.1432-1033.1970.tb01175.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO F, 1991, MOL BIOL MED, V8, P117; Gilmartin L, 1999, NEUROSCI RES, V34, P1, DOI 10.1016/S0168-0102(99)00025-5; Graham SC, 2006, BIOCHEMISTRY-US, V45, P964, DOI 10.1021/bi0518904; Graham SC, 2004, ACTA CRYSTALLOGR D, V60, P1770, DOI 10.1107/S0907444904018724; HARBECK HT, 1991, EUR J BIOCHEM, V198, P451, DOI 10.1111/j.1432-1033.1991.tb16035.x; HOOPER NM, 1990, BIOCHEM J, V267, P509, DOI 10.1042/bj2670509; Hyde RJ, 1996, BIOCHEM J, V319, P197, DOI 10.1042/bj3190197; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lloyd GS, 1996, BIOCHEM PHARMACOL, V52, P229, DOI 10.1016/0006-2952(96)00180-3; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; Regoli D, 1983, Adv Exp Med Biol, V156, P569; RUSU I, 1992, EUR J BIOCHEM, V210, P93, DOI 10.1111/j.1432-1033.1992.tb17395.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANHOOF G, 1992, BIOCHEM PHARMACOL, V44, P479, DOI 10.1016/0006-2952(92)90439-P; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236	27	26	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22858	22866		10.1074/jbc.M710274200	http://dx.doi.org/10.1074/jbc.M710274200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18515364	hybrid			2022-12-27	WOS:000258321000053
J	Strom, AL; Shi, P; Zhang, FJ; Gal, J; Kilty, R; Hayward, LJ; Zhu, HN				Strom, Anna-Lena; Shi, Ping; Zhang, Fujian; Gal, Jozsef; Kilty, Renee; Hayward, Lawrence J.; Zhu, Haining			Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALS-LINKED SOD1; FAST AXONAL-TRANSPORT; MOTOR-NEURON DISEASE; BODY-LIKE INCLUSIONS; HYALINE INCLUSIONS; TRANSGENIC MICE; CU,ZN-SUPEROXIDE DISMUTASE; MOLECULAR PATHOLOGY; CYTOPLASMIC DYNEIN; CLINICAL-FEATURES	An important consequence of protein misfolding related to neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), is the formation of proteinaceous inclusions or aggregates within the central nervous system. We have previously shown that several familial ALS-linked copper-zinc superoxide dismutase (SOD1) mutants (A4V, G85R, and G93A) interact and co-localize with the dynein-dynactin complex in cultured cells and affected tissues of ALS mice. In this study, we report that the interaction between mutant SOD1 and the dynein motor plays a critical role in the formation of large inclusions containing mutant SOD1. Disruption of the motor by overexpression of the p50 subunit of dynactin in neuronal and non-neuronal cell cultures abolished the association between aggregation-prone SOD1 mutants and the dynein-dynactin complex. The p50 overexpression also prevented mutant SOD1 inclusion formation and improved the survival of cells expressing A4V SOD1. Furthermore, we observed that two ALS-linked SOD1 mutants, H46R and H48Q, which showed a lower propensity to interact with the dynein motor, also produced less aggregation and fewer large inclusions. Overall, these data suggest that formation of large inclusions depends upon association of the abnormal SOD1s with the dynein motor. Whether the misfolded SOD1s directly perturb axonal transport or impair other functional properties of the dynein motor, this interaction could propagate a toxic effect that ultimately causes motor neuron death in ALS.	[Strom, Anna-Lena; Gal, Jozsef; Kilty, Renee; Zhu, Haining] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Shi, Ping; Zhu, Haining] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Zhang, Fujian; Zhu, Haining] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Hayward, Lawrence J.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Massachusetts System; University of Massachusetts Worcester	Zhu, HN (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, 741 S Limestone, Lexington, KY 40536 USA.	haining@uky.edu	Zhu, Haining/A-6076-2008	Zhu, Haining/0000-0001-5498-6694; Gal, Jozsef/0000-0002-5865-6534; Hayward, Lawrence/0000-0003-0579-0358	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044170, R01NS049126] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS44170, R01-NS49126, R01 NS044170] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki M, 1998, CELL MOL NEUROBIOL, V18, P639, DOI 10.1023/A:1020217818245; Arisato T, 2003, ACTA NEUROPATHOL, V106, P561, DOI 10.1007/s00401-003-0763-5; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BREUER AC, 1987, NEUROLOGY, V37, P738, DOI 10.1212/WNL.37.5.738; BREUER AC, 1988, CELL MOTIL CYTOSKEL, V10, P321, DOI 10.1002/cm.970100136; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Chevalier-Larsen ES, 2008, HUM MOL GENET, V17, P1946, DOI 10.1093/hmg/ddn092; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Fanara P, 2007, J BIOL CHEM, V282, P23465, DOI 10.1074/jbc.M703434200; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gaudette M, 2000, AMYOTROPH LATERAL SC, V1, P83, DOI 10.1080/14660820050515377; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; He CZ, 2004, J NEUROL SCI, V217, P47, DOI 10.1016/j.jns.2003.08.016; Hirano A, 1996, NEUROLOGY, V47, pS63, DOI 10.1212/WNL.47.4_Suppl_2.63S; Ikemoto A, 2000, AMYOTROPH LATERAL SC, V1, P97, DOI 10.1080/14660820050515395; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kato S, 2001, ACTA NEUROPATHOL, V102, P233; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Lai C, 2007, J NEUROSCI, V27, P13982, DOI 10.1523/JNEUROSCI.4226-07.2007; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Matsumoto S, 1996, CLIN NEUROPATHOL, V15, P41; Melkonian KA, 2007, J BIOL CHEM, V282, P19355, DOI 10.1074/jbc.M700003200; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; Ohi T, 2004, J NEUROL SCI, V225, P19, DOI 10.1016/j.jns.2004.06.008; Ohi T, 2002, J NEUROL SCI, V197, P73, DOI 10.1016/S0022-510X(02)00054-0; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Piao YS, 2003, BRAIN PATHOL, V13, P10; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1998, ACTA NEUROPATHOL, V95, P136, DOI 10.1007/s004010050777; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Watanabe Y, 2005, MOL BRAIN RES, V135, P12, DOI 10.1016/j.molbrainres.2004.11.019; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	61	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22795	22805		10.1074/jbc.M800276200	http://dx.doi.org/10.1074/jbc.M800276200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18515363	Green Published, hybrid			2022-12-27	WOS:000258321000047
J	Kanungo, AK; Hao, ZY; Elia, AJ; Mak, TW; Henderson, JT				Kanungo, Anish Kumar; Hao, Zhenyue; Elia, Andrew James; Mak, Tak Wah; Henderson, Jeffrey Theodore			Inhibition of apoptosome activation protects injured motor neurons from cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; AXOTOMY-INDUCED DEATH; CYTOCHROME-C BINDING; DIFFERENTIAL REQUIREMENT; MITOCHONDRIAL RELEASE; CASPASE ACTIVATION; FACTOR AIF; MOTONEURONS; PATHWAYS; SURVIVAL	Within the mammalian central nervous system many forms of neurodegenerative injury are regulated via programmed cell death, a highly conserved program of cellular suicide. Programmed cell death is regulated by multiple signaling pathways, which have been identified within mammalian cells, although several lines of evidence suggest that the intrinsic pathway predominately regulates the death of motor neurons following acute injury in vivo. We have tested this hypothesis by performing facial axotomies on cytochrome c knock-in mice containing a point mutation in the genomic locus of cytochrome c resulting in a lysine to alanine conversion at position 72 of the protein. The introduced mutation inhibits the ability of cytochrome c to induce the formation of the apoptosome, a protein complex that is principally required for the activation of the intrinsic pathway, but does not alter its function in oxidative phosphorylation. Homozygous cytochrome c knock-in mutants displayed a significant enhancement in motor neuron survival following injury when compared with littermate controls, thus establishing the apoptosome as a viable target for protecting motor neurons from neural injury. However, protection of facial motor neurons differs from that previously reported in mice either overexpressing anti-apoptotic or lacking pro-apoptotic members of the Bcl-2 family, which are thought to regulate several aspects of mitochondrial dysfunction including the release of cytochrome c from the mitochondria to the cytoplasm. Therefore, these results directly demonstrate for the first time the influence of the apoptosome on injury-induced neuronal programmed cell death in vivo isolated from upstream Bcl-2 family-mediated effects.	[Henderson, Jeffrey Theodore] Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Hao, Zhenyue; Elia, Andrew James; Mak, Tak Wah] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Henderson, JT (corresponding author), Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, 144 Coll St,Rm 903, Toronto, ON M5S 3M2, Canada.	jeff.henderson@utoronto.ca						Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Alberi S, 1996, P NATL ACAD SCI USA, V93, P3978, DOI 10.1073/pnas.93.9.3978; Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bao Q, 2005, CELL CYCLE, V4, P1001, DOI 10.4161/cc.4.8.1849; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; CLATTERBUCK RE, 1994, J COMP NEUROL, V342, P45, DOI 10.1002/cne.903420106; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Colussi PA, 1999, IMMUNOL CELL BIOL, V77, P58, DOI 10.1046/j.1440-1711.1999.00788.x; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DeBilbao F, 1996, NEUROSCIENCE, V71, P1111, DOI 10.1016/0306-4522(95)00505-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Guegan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Henderson JT, 1996, CYTOKINE, V8, P784, DOI 10.1006/cyto.1996.0104; Houde C, 2004, J NEUROSCI, V24, P9977, DOI 10.1523/JNEUROSCI.3356-04.2004; Houenou LJ, 1996, CELL TISSUE RES, V286, P219, DOI 10.1007/s004410050690; Keramaris E, 2005, J BIOL CHEM, V280, P1132, DOI 10.1074/jbc.M410127200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; RIEDL SJ, 2007, NAT REV MOL CELL BIO; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Sendtner M, 1997, J NEUROSCI, V17, P6999; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Ugolini G, 2003, J NEUROSCI, V23, P8526; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Woo M, 2000, CELL RES, V10, P267, DOI 10.1038/sj.cr.7290054; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Zhao ZQ, 2004, EXP NEUROL, V190, P356, DOI 10.1016/j.expneurol.2004.06.015	71	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22105	22112		10.1074/jbc.M800988200	http://dx.doi.org/10.1074/jbc.M800988200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550520	hybrid			2022-12-27	WOS:000258114700029
J	Ozden, S; Lucas-Hourani, M; Ceccaldi, PE; Basak, A; Valentine, M; Benjannet, S; Hamelin, J; Jacob, Y; Mamchaoui, K; Mouly, V; Despres, P; Gessain, A; Butler-Browne, G; Chretien, M; Tangy, F; Vidalain, PO; Seidah, NG				Ozden, Simona; Lucas-Hourani, Marianne; Ceccaldi, Pierre-Emmanuel; Basak, Ajoy; Valentine, Menogh; Benjannet, Suzanne; Hamelin, Josee; Jacob, Yves; Mamchaoui, Kamel; Mouly, Vincent; Despres, Philippe; Gessain, Antoine; Butler-Browne, Gillian; Chretien, Michel; Tangy, Frederic; Vidalain, Pierre-Olivier; Seidah, Nabil G.			Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors - Impairment of the maturation of the E2 surface glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMLIKI-FOREST-VIRUS; PROPROTEIN CONVERTASES; MEMBRANE-FUSION; WEAK BASES; CHLOROQUINE; CLEAVAGE; MOUSE; IDENTIFICATION; CONSEQUENCES; ACTIVATION	Chikungunya virus (CHIKV) is a mosquito-transmitted Alphavirus that causes in humans an acute infection characterized by polyarthralgia, fever, myalgia, and headache. Since 2005 this virus has been responsible for an epidemic outbreak of unprecedented magnitude. By analogy with other alphaviruses, it is thought that cellular proteases are able to process the viral precursor protein E3E2 to produce the receptor-binding E2 protein that associates as a heterodimer with E1. Destabilization of the heterodimer by exposure to low pH allows viral fusion and infection. We show that among a large panel of proprotein convertases, membranous furin but also PC5B can process E3E2 from African CHIKV strains at the HRQRR(64) down arrow ST site, whereas a CHIKV strain of Asian origin is cleaved at RRQRR(64) down arrow SI by membranous and soluble furin, PC5A, PC5B, and PACE4 but not by PC7 or SKI-1. Using fluorogenic model peptides and recombinant convertases, we observed that the Asian strain E3E2 model peptide is cleaved most efficiently by furin and PC5A. This cleavage was also observed in CHIKV-infected cells and could be blocked by furin inhibitor decanoyl-RVKR-chloromethyl ketone. This inhibitor was compared with chloroquine for its ability to inhibit CHIKV spreading in myoblast cell cultures, a cell-type previously described as a natural target of this virus. Our results demonstrate the role of furin-like proteases in the processing of CHIKV particles and point out new approaches to inhibit this infection.	[Benjannet, Suzanne; Hamelin, Josee; Chretien, Michel; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Ozden, Simona; Ceccaldi, Pierre-Emmanuel; Gessain, Antoine] Inst Pasteur, CNRS, URA 3015, Unite Epidemiol & Physiopathol Virus Oncogenes, F-75724 Paris, France; [Lucas-Hourani, Marianne; Tangy, Frederic; Vidalain, Pierre-Olivier] Inst Pasteur, CNRS, URA 3015, Lab Genom Virale & Vaccinat, F-75724 Paris, France; [Basak, Ajoy; Valentine, Menogh] Ottawa Hlth Res Inst, Reg Prot Chem Ctr, Chron Dis Program, Ottawa, ON K1Y 4E9, Canada; [Jacob, Yves] Inst Pasteur, Unite Postulante Genet Papillomavirus & Canc Huma, F-75724 Paris, France; [Mamchaoui, Kamel; Mouly, Vincent; Butler-Browne, Gillian] Univ Paris 06, UMR S 787, F-75634 Paris, France; [Mamchaoui, Kamel; Mouly, Vincent; Butler-Browne, Gillian] Univ Paris 06, INSERM, U787, F-75634 Paris, France; [Despres, Philippe] Inst Pasteur, Unite Interact Mol Flavivirus Hotes, F-75724 Paris, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Ottawa; Ottawa Hospital Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Vidalain, Pierre-Olivier/F-9778-2019; Seidah, Nabil/I-3596-2013; CECCALDI, Pierre-Emmanuel/J-6628-2017; Mouly, Gillian/G-6595-2017	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Seidah, Nabil/0000-0001-6503-9342; CECCALDI, Pierre-Emmanuel/0000-0002-2736-2314; butler-browne, gillian/0000-0002-3431-242X; CHRETIEN, Michel/0000-0002-8588-4460; Mamchaoui, kamel/0000-0002-0323-9290; Mouly, Vincent/0000-0003-3809-4033; Jacob, Yves/0000-0001-9125-2374				BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Basak S, 2006, PROTEIN PEPTIDE LETT, V13, P863, DOI 10.2174/092986606778256199; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Bolt G, 2000, VIRUS RES, V68, P25, DOI 10.1016/S0168-1702(00)00149-0; Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028; BRIGHTON SW, 1984, S AFR MED J, V66, P217; CASSELL S, 1984, J VIROL, V52, P857, DOI 10.1128/JVI.52.3.857-864.1984; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; DECROLY E, 1994, J BIOL CHEM, V269, P12240; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Ferreira DF, 2000, J MED MICROBIOL, V49, P313, DOI 10.1099/0022-1317-49-4-313; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HEIDNER HW, 1994, J VIROL, V68, P8064, DOI 10.1128/JVI.68.12.8064-8070.1994; Heidner HW, 1996, J VIROL, V70, P2069, DOI 10.1128/JVI.70.3.2069-2073.1996; HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47; Klimstra WB, 1999, J VIROL, V73, P6299, DOI 10.1128/JVI.73.8.6299-6306.1999; Komiyama T, 2005, ANTIMICROB AGENTS CH, V49, P3875, DOI 10.1128/AAC.49.9.3875-3882.2005; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9; MAYNE JT, 1984, VIROLOGY, V134, P338, DOI 10.1016/0042-6822(84)90302-7; Mohan A, 2006, INDIAN J MED RES, V124, P471; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; PASQUATO A, 2008, J MOL NEURO IN PRESS; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; SALMINEN A, 1992, J CELL BIOL, V116, P349, DOI 10.1083/jcb.116.2.349; Savarino A, 2004, JAIDS-J ACQ IMM DEF, V35, P223, DOI 10.1097/00126334-200403010-00002; Savarino A, 2007, LANCET INFECT DIS, V7, P633, DOI 10.1016/S1473-3099(07)70217-7; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Stroher U, 2007, J INFECT DIS, V196, pS271, DOI 10.1086/520592; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Weaver S., 2005, TOPLEY WILSONS MICRO; Xiao Y, 2008, VIROLOGY, V372, P384, DOI 10.1016/j.virol.2007.10.036; Zhang XY, 2003, J VIROL, V77, P2981, DOI 10.1128/JVI.77.5.2981-2989.2003; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	46	101	104	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21899	21908		10.1074/jbc.M802444200	http://dx.doi.org/10.1074/jbc.M802444200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18559340	hybrid			2022-12-27	WOS:000258114700009
J	Sacchi, S; Bernasconi, M; Martineau, M; Mothet, JP; Ruzzene, M; Pilone, MS; Pollegioni, L; Molla, G				Sacchi, Silvia; Bernasconi, Mariagrazia; Martineau, Magalie; Mothet, Jean-Pierre; Ruzzene, Maria; Pilone, Mirella S.; Pollegioni, Loredano; Molla, Gianluca			pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase - Effect on schizophrenia susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-D-ASPARTATE; NMDA RECEPTORS; GENE G72; PROTEIN; LOCALIZATION; PEROXISOMES; ASTROCYTES; BRAIN; ACTIVATION; EXPRESSION	Human genes coding for pLG72 and D-amino acid oxidase have recently been linked to the onset of schizophrenia. pLG72 was proposed as an activator of the human FAD-containing flavoprotein D-amino acid oxidase (hDAAO). In the brain this oxidizes D-serine, a potent activator of N-methyl-D-aspartate receptor. We have investigated the mechanistic regulation of hDAAO by pLG72. Immunohistochemical analyses revealed that hDAAO and pLG72 are both expressed in astrocytes of the human cortex, where they most likely interact, considering their partial overlapping subcellular distribution and their coimmunoprecipitation. We demonstrated that the specific in vitro interaction of the two proteins yields a complex composed of 2 hDAAO homodimers and 2 pLG72 molecules. Binding of pLG72 did not affect the kinetic properties and FAD binding ability of hDAAO; instead, a time-dependent loss of hDAAO activity in the presence of an excess of pLG72 was found. The binding affects the tertiary structure of hDAAO, altering the amount of the active form. We finally demonstrated that overexpression of hDAAO in glioblastoma cells decreases the levels of D-serine, an effect that is null when pLG72 is coexpressed. These data indicate that pLG72 acts as a negative effector of hDAAO. Therefore, a decrease in the synaptic concentration of D-serine as the result of an anomalous increase in hDAAO activity related to hypoexpression of pLG72 may represent a molecular mechanism by which hDAAO and pLG72 are involved in schizophrenia susceptibility.	[Sacchi, Silvia; Bernasconi, Mariagrazia; Pilone, Mirella S.; Pollegioni, Loredano; Molla, Gianluca] Univ Insubria, Dept Biotechnol & Mol Sci, I-21100 Varese, Italy; [Martineau, Magalie; Mothet, Jean-Pierre] INSERM, Bordeaux Neurosci Res Ctr, U862, F-33077 Bordeaux, France; [Martineau, Magalie; Mothet, Jean-Pierre] Univ Bordeaux 2, F-33077 Bordeaux, France; [Ruzzene, Maria] Univ Padua, Dept Biol Chem, I-35121 Padua, Italy; [Ruzzene, Maria] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy	University of Insubria; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Padua; University of Padua	Pollegioni, L (corresponding author), Univ Insubria, Dept Biotechnol & Mol Sci, Via JH Dunant 3, I-21100 Varese, Italy.	loredano.pollegioni@uninsubria.it	Mothet, Jean-Pierre/ABE-3066-2020	Ruzzene, Maria/0000-0001-8712-8151; Molla, Gianluca/0000-0003-3688-3397; SACCHI, SILVIA/0000-0002-2338-2561; Martineau, Magalie/0000-0003-1817-2372; MOTHET, Jean-Pierre/0000-0003-4991-0614; POLLEGIONI, LOREDANO/0000-0003-1733-7243				Almond SL, 2006, MOL CELL NEUROSCI, V32, P324, DOI 10.1016/j.mcn.2006.05.003; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Cristiano L, 2001, J NEUROCYTOL, V30, P671, DOI 10.1023/A:1016525716209; Detera-Wadleigh SD, 2006, BIOL PSYCHIAT, V60, P106, DOI 10.1016/j.biopsych.2006.01.019; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Kvajo M, 2008, MOL PSYCHIATR, V13, P685, DOI 10.1038/sj.mp.4002052; Lang C, 2001, J MICROSC-OXFORD, V203, P303, DOI 10.1046/j.1365-2818.2001.00899.x; Martineau M, 2006, TRENDS NEUROSCI, V29, P481, DOI 10.1016/j.tins.2006.06.008; Molla G, 2006, PROTEIN EXPRES PURIF, V46, P150, DOI 10.1016/j.pep.2005.08.003; Molla G, 2006, FEBS LETT, V580, P2358, DOI 10.1016/j.febslet.2006.03.045; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Park HK, 2006, J BIOCHEM, V139, P295, DOI 10.1093/jb/mvj036; Pilone MS, 2000, CELL MOL LIFE SCI, V57, P1732, DOI 10.1007/PL00000655; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Puyal J, 2006, J COMP NEUROL, V497, P610, DOI 10.1002/cne.21016; Ruzzene M, 1999, FEBS LETT, V461, P32, DOI 10.1016/S0014-5793(99)01409-X; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; Urai Y, 2002, NEUROSCI LETT, V324, P101, DOI 10.1016/S0304-3940(02)00184-2; USUDA N, 1986, J HISTOCHEM CYTOCHEM, V34, P1709, DOI 10.1177/34.12.2878022; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wu SZ, 2004, ANN NY ACAD SCI, V1035, P133, DOI 10.1196/annals.1332.009; YAGI K, 1956, NATURE, V177, P891, DOI 10.1038/177891a0; Yang Y, 2003, J NEUROSURG, V98, P397, DOI 10.3171/jns.2003.98.2.0397; Yue WH, 2007, NEUROSCI LETT, V416, P96, DOI 10.1016/j.neulet.2007.01.056	34	123	123	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22244	22256		10.1074/jbc.M709153200	http://dx.doi.org/10.1074/jbc.M709153200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544534	Green Published, hybrid			2022-12-27	WOS:000258114700044
J	Hellwig, CT; Kohler, BF; Lehtivarjo, AK; Dussmann, H; Courtney, MJ; Prehn, JHM; Rehm, M				Hellwig, Christian T.; Kohler, Barbara F.; Lehtivarjo, Anna-Kaisa; Dussmann, Heiko; Courtney, Michael J.; Prehn, Jochen H. M.; Rehm, Markus			Real time analysis of tumor necrosis factor-related apoptosis-inducing ligand/cycloheximide-induced caspase activities during apoptosis initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CELL ANALYSIS; CYTOCHROME-C; LINKED INHIBITOR; ACTIVATION; TRAIL; CLEAVAGE; RELEASE; CD95; PROTEIN; PHOSPHORYLATION	Employing fluorescence resonance energy transfer (FRET) imaging, we previously demonstrated that effector caspase activation is often an all-or-none response independent of drug choice or dose administered. We here investigated the signaling dynamics during apoptosis initiation via the tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptor pathway to investigate how variability in drug exposure can be translated into largely kinetically invariant cell death execution pathways. FRET-based microscopy demonstrated dose-dependent responses of caspase-8 activation and activity within individual living HeLa cells. Caspase-8 on average was activated 45-600 min after TRAIL/cycloheximide addition. Caspase-8 like activities persisted for 15-60 min before eventually inducing mitochondrial outer membrane permeabilization. Independent of the TRAIL concentrations used or the resulting caspase-8-like activities, mitochondrial outer membrane permeabilization was induced when 10% of the FRET substrate was cleaved. In contrast, in Bid-depleted cells, caspase-8-like activity persisted for hours without causing immediate cell death. Our findings provide detailed insight into the intracellular signaling kinetics during apoptosis initiation and describe a threshold mechanism controlling the induction of apoptosis execution.	[Hellwig, Christian T.; Kohler, Barbara F.; Dussmann, Heiko; Prehn, Jochen H. M.; Rehm, Markus] RCSI York House, Royal Coll Surg Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Lehtivarjo, Anna-Kaisa; Courtney, Michael J.] Univ Kuopio, Dept Neurobiol, Kuopio 70210, Finland	Royal College of Surgeons - Ireland; University of Eastern Finland	Rehm, M (corresponding author), RCSI York House, Royal Coll Surg Ireland, Dept Physiol & Med Phys, York St, Dublin 2, Ireland.	mrehm@rcsi.ie	Prehn, Jochen HM/A-3928-2010; Rehm, Markus/C-3398-2012; Courtney, Michael J/D-6648-2016	Prehn, Jochen HM/0000-0003-3479-7794; Rehm, Markus/0000-0001-6149-9261; Courtney, Michael J/0000-0001-8693-3933; Dussmann, Heiko/0000-0002-3582-8057				Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; Eberhardt O, 2000, J NEUROSCI, V20, P9126; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Esposti MD, 2003, J BIOL CHEM, V278, P15749, DOI 10.1074/jbc.M209208200; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Messam CA, 1998, EXP CELL RES, V238, P389, DOI 10.1006/excr.1997.3845; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Seol DW, 2001, CANCER RES, V61, P1138; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tepper CG, 1999, BLOOD, V94, P1727, DOI 10.1182/blood.V94.5.1727.417k03_1727_1737; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Vogel A, 2006, GASTROENTEROLOGY, V130, P104, DOI 10.1053/j.gastro.2005.10.012; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yamada H, 1999, BIOCHEM BIOPH RES CO, V265, P130, DOI 10.1006/bbrc.1999.1641	48	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21676	21685		10.1074/jbc.M802889200	http://dx.doi.org/10.1074/jbc.M802889200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522940	hybrid			2022-12-27	WOS:000257898800041
J	Ho, TTG; Merajver, SD; Lapiere, CM; Nusgens, BV; Deroanne, CF				Ho, T. T. Giang; Merajver, Sofia D.; Lapiere, Charles M.; Nusgens, Betty V.; Deroanne, Christophe F.			RhoA-GDP regulates RhoB protein stability - Potential involvement of RhoGDI alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; DISSOCIATION INHIBITOR; CLOSTRIDIUM-DIFFICILE; INDUCED APOPTOSIS; CANCER-CELLS; MAP KINASE; IN-VITRO; TOXIN-B; GTPASES; EXPRESSION	RhoA plays a significant role in actin stress fibers formation. However, silencing RhoA alone or RhoA and RhoC did not completely suppress the stress fibers suggesting a residual "Rho-like" activity. RhoB, the third member of the Rho subclass, is a short-lived protein barely detectable in basal conditions. In various cell types, the silencing of RhoA induced a strong up-regulation of both total and active RhoB protein levels that were rescued by re-expressing RhoA and related to an enhanced half-life of the protein. The RhoA-dependent regulation of RhoB does not depend on the activity of RhoA but is mediated by its GDP-bound form. The stabilization of RhoB was not dependent on isoprenoid biosynthesis, Rho kinase, extracellular signal-regulated kinase, p38 mitogen-activated kinase, or phosphatidylinositol 3'-OH kinase pathways but required RhoGDI alpha. The forced expression of RhoGDI alpha increased RhoB half-life, whereas its knock-down antagonized the induction of RhoB following RhoA silencing. Moreover, a RhoA mutant (RhoAR68E) unable to bind RhoGDI alpha was significantly less efficient as compared with wild-type RhoA in reversing RhoB up-regulation upon RhoA silencing. These results suggest that, in basal conditions, RhoGDI alpha is rate-limiting and the suppression of RhoA makes it available to stabilize RhoB. Our results highlight RhoGDI alpha dependent cross-talks that regulate the stability of RhoGTPases.	[Ho, T. T. Giang; Lapiere, Charles M.; Nusgens, Betty V.; Deroanne, Christophe F.] Univ Liege, GIGA R, Lab Connect Tissue Biol, B-4000 Sart Tilman Par Liege, Belgium; [Merajver, Sofia D.] Univ Michigan, Ctr Comprehens Canc, Breast & Ovarian Canc Risk Evaluat Program, Ann Arbor, MI 48109 USA	University of Liege; University of Michigan System; University of Michigan	Deroanne, CF (corresponding author), Univ Liege, GIGA R, Lab Connect Tissue Biol, Tour Pathologie B23-3, B-4000 Sart Tilman Par Liege, Belgium.	c.deroanne@ulg.ac.be						Adnane J, 2002, CLIN CANCER RES, V8, P2225; Arozarena I, 2001, J BIOL CHEM, V276, P21878, DOI 10.1074/jbc.M011383200; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Chaplet ML, 2004, BIOCHEM J, V384, P591, DOI 10.1042/BJ20040380; Couderc B, 2008, CANCER GENE THER, V15, P456, DOI 10.1038/cgt.2008.12; Delarue FL, 2007, ONCOGENE, V26, P633, DOI 10.1038/sj.onc.1209819; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Deroanne CF, 2005, J CELL SCI, V118, P1173, DOI 10.1242/jcs.01707; Di-Poi N, 2001, BIOCHEMISTRY-US, V40, P10014, DOI 10.1021/bi010289c; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Du W, 1999, CANCER RES, V59, P5492; Faure J, 2001, BIOCHIMIE, V83, P409, DOI 10.1016/S0300-9084(01)01263-9; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; PULVERER B, 2003, NAT CELL BIOL, V5, P489; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Wong KW, 2006, J BIOL CHEM, V281, P40379, DOI 10.1074/jbc.M605387200; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143; Zalcman G, 1996, J BIOL CHEM, V271, P30366, DOI 10.1074/jbc.271.48.30366; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175	39	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21588	21598		10.1074/jbc.M710033200	http://dx.doi.org/10.1074/jbc.M710033200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524772	hybrid, Green Submitted			2022-12-27	WOS:000257898800032
J	Wan, GH; Zhaorigetu, S; Liu, ZH; Kaini, R; Jiang, ZY; Hu, CAA				Wan, Guanghua; Zhaorigetu, Siqin; Liu, Zhihe; Kaini, Ramesh; Jiang, Zeyu; Hu, Chien-an A.			Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; L GENE; APOPTOSIS; FAMILY; BECLIN-1; DEGRADATION; OVEREXPRESSION; IDENTIFICATION; TUMORIGENESIS; MECHANISMS	The Bcl-2 family proteins are important regulators of type I programmed cell death apoptosis; however, their role in autophagic cell death (AuCD) or type II programmed cell death is still largely unknown. Here we report the cloning and characterization of a novel Bcl-2 homology domain 3 (BH3)-only protein, apolipoprotein L1 (apoL1), that, when overexpressed and accumulated intracellularly, induces AuCD in cells as characterized by the increasing formation of autophagic vacuoles and activating the translocation of LC3-II from the cytosol to the autophagic vacuoles. Wortmannin and 3-methyladenine, inhibitors of class III phosphatidylinostol 3-kinase and, subsequently, autophagy, blocked apoL1-induced AuCD. In addition, apoL1 failed to induce AuCD in autophagy-deficient ATG5(-/-) and ATG7(-/-) mouse embryonic fibroblast cells, suggesting that apoL1-induced cell death is indeed autophagy-dependent. Furthermore, a BH3 domain deletion construct of apoL1 failed to induce AuCD, demonstrating that apoL1 is a bona fide BH3-only pro-death protein. Moreover, we showed that apoL1 is inducible by p53 in p53-induced cell death and is a lipid-binding protein with high affinity for phosphatidic acid (PA) and cardiolipin (CL). Previously, it has been shown that PA directly interacted with mammalian target of rapamycin and positively regulated the ability of mammalian target of rapamycin to activate downstream effectors. In addition, CL has been shown to activate mitochondria-mediated apoptosis. Sequestering of PA and CL with apoL1 may alter the homeostasis between survival and death leading to AuCD. To our knowledge, this is the first BH3-only protein with lipid binding activity that, when overproduced intracellularly, induces AuCD.	[Wan, Guanghua; Zhaorigetu, Siqin; Liu, Zhihe; Kaini, Ramesh; Jiang, Zeyu; Hu, Chien-an A.] Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, Albuquerque, NM 87131 USA	University of New Mexico	Hu, CAA (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, MSC08 4670,1, Albuquerque, NM 87131 USA.	Ahu@salud.unm.edu			NATIONAL CANCER INSTITUTE [R01CA106644] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NCI NIH HHS [5R01 CA 106644-01A1, R01 CA106644, R01 CA106644-05] Funding Source: Medline; NCRR NIH HHS [P20 RR 016480-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Bystroff Christopher, 2002, Bioinformatics, V18 Suppl 1, pS54; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gu S, 2004, MOL CELL PROTEOMICS, V3, P998, DOI 10.1074/mcp.M400033-MCP200; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaneda D, 2003, NEUROLOGY, V61, P128, DOI 10.1212/01.WNL.0000069605.00498.BD; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lamparska-Przybysz M, 2005, J Physiol Pharmacol, V56 Suppl 3, P159; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Liu ZH, 2005, MOL CANCER RES, V3, P21; Liu ZH, 2007, MOL CELL BIOCHEM, V297, P179, DOI 10.1007/s11010-006-9345-x; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sasaki T, 2007, BIOL PHARM BULL, V30, P1599, DOI 10.1248/bpb.30.1599; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	63	164	175	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21540	21549		10.1074/jbc.M800214200	http://dx.doi.org/10.1074/jbc.M800214200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18505729	hybrid, Green Published			2022-12-27	WOS:000257898800027
J	Emter, R; Natsch, A				Emter, Roger; Natsch, Andreas			The sequential action of a dipeptidase and a beta-lyase is required for the release of the human body odorant 3-methyl-3-sulfanylhexan-1-ol from a secreted Cys-Gly-(S) conjugate by Corynebacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AXILLA-SWEAT; BACTERIAL AMINOACYLASE; ESCHERICHIA-COLI; FELIS-CATUS; IDENTIFICATION; CARBOXYPEPTIDASE-G2; DEACETYLASE; PRECURSORS; PHEROMONE; PROTEIN	Human axillary odor is formed by the action of Corynebacteria on odorless axilla secretions. Sulfanylalkanols, 3-methyl-3sulfanylhexan-1-ol in particular, form one key class of the odoriferous compounds. A conjugate with the dipeptide Cys-Gly has been reported as the secreted precursor for 3-methyl-3-sulfanylhexan-1-ol. Here, we confirm the Cys-Gly-(S) conjugate as the major precursor of this odorant, with lower levels of the Cys-(S) conjugate being present in axilla secretions. The enzymatic release of 3-methyl-3-sulfanylhexan-1-ol from the Cys-Gly-(S) conjugate by the axilla isolate Corynebacterium Ax20 was thus investigated. Cellular extracts of Ax20 released 3-methyl-3-sulfanylhexan-1-ol from the Cys-Gly-(S) conjugate and from the Cys-(S) conjugate, whereas the previously isolated C-S lyase of this bacterial strain was only able to cleave the Cys-(S) conjugate. o-Phenanthroline blocked the release from the Cys-Gly-(S) conjugate but did not affect cleavage of the Cys-(S) conjugate, indicating that in a first step, a metal-dependent dipeptidase hydrolyzes the Cys-Gly bond. This enzyme was purified by four chromatographic steps and gel electrophoresis, and the partial amino acid sequence was determined. The corresponding gene was cloned and expressed in Escherichia coli. It codes for a novel dipeptidase with a high affinity toward the Cys-Gly-(S) conjugate of 3-methyl-3-sulfanylhexan-1-ol. Co-incubating either the synthetic Cys-Gly-(S) conjugate or fresh axilla secretions with both the C-S lyase and the novel dipeptidase did release 3-methyl-3-sulfanylhexan-1-ol, proving that the sequential action of these two enzymes from the skin bacterium Corynebacterium Ax20 does release the odorant from the key secreted precursor.	[Emter, Roger; Natsch, Andreas] Givaudan Schweiz AG, Dept Biosci, CH-8600 Dubendorf, Switzerland	Givaudan SA	Natsch, A (corresponding author), Ueberlandstr 138, CH-8600 Dubendorf, Switzerland.	andreas.natsch@givaudan.com	natsch, andreas/AAM-7042-2020	Natsch, Andreas/0000-0003-2231-2489				BIRD S, 1981, J STEROID BIOCHEM, V14, P213, DOI 10.1016/0022-4731(81)90176-X; BOUVIER J, 1992, J BACTERIOL, V174, P5265, DOI 10.1128/JB.174.16.5265-5271.1992; BOYEN A, 1992, GENE, V116, P1, DOI 10.1016/0378-1119(92)90621-U; BROOKSBA.BW, 1974, EXPERIENTIA, V30, P864, DOI 10.1007/BF01938327; CLAUS R, 1976, J ENDOCRINOL, V68, P483, DOI 10.1677/joe.0.0680483; Gonzalez W, 1996, CARDIOVASC DRUG REV, V14, P166, DOI 10.1111/j.1527-3466.1996.tb00225.x; Hasegawa Y, 2004, CHEM BIODIVERS, V1, P2042, DOI 10.1002/cbdv.200490157; Hendriks WH, 2004, COMP BIOCHEM PHYS B, V139, P245, DOI 10.1016/j.cbpc.2004.07.007; JACKMAN PJH, 1983, CLIN EXP DERMATOL, V8, P259, DOI 10.1111/j.1365-2230.1983.tb01778.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYDEN JJ, 1981, J INVEST DERMATOL, V77, P413, DOI 10.1111/1523-1747.ep12494624; McGregor WC, 2005, J AM CHEM SOC, V127, P14100, DOI 10.1021/ja054081g; MINTON NP, 1984, GENE, V31, P31, DOI 10.1016/0378-1119(84)90192-6; Miyazaki M, 2003, BIOCHEM J, V370, P101, DOI 10.1042/BJ20021446; Miyazaki M, 2006, CHEM BIOL, V13, P1071, DOI 10.1016/j.chembiol.2006.08.013; Moore DD, 1995, GLOB MOB SURV; Natsch A, 2006, CHEM BIODIVERS, V3, P1, DOI 10.1002/cbdv.200690015; Natsch A, 2004, CHEM BIODIVERS, V1, P1058, DOI 10.1002/cbdv.200490079; Natsch A, 2003, J BIOL CHEM, V278, P5718, DOI 10.1074/jbc.M210142200; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Shehadeh N, 1963, J INVEST DERMATOL, V41, P1; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Starkenmann C, 2005, CHEM BIODIVERS, V2, P705, DOI 10.1002/cbdv.200590048; STARKENMANN C, 2006, Patent No. 2006079934; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; Taylor D., 2003, International Journal of Cosmetic Science, V25, P137, DOI 10.1046/j.1467-2494.2003.00181.x; Troccaz M, 2004, CHEM BIODIVERS, V1, P1022, DOI 10.1002/cbdv.200490077; WESTALL RG, 1953, BIOCHEM J, V55, P244, DOI 10.1042/bj0550244; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777	29	45	50	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20645	20652		10.1074/jbc.M800730200	http://dx.doi.org/10.1074/jbc.M800730200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515361	Green Published, hybrid			2022-12-27	WOS:000257746100005
J	Fox, D; Le Trong, I; Rajagopal, P; Brzovic, PS; Stenkamp, RE; Klevit, RE				Fox, David, III; Le Trong, Isolde; Rajagopal, Ponni; Brzovic, Peter S.; Stenkamp, Ronald E.; Klevit, Rachel E.			Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MOLECULAR REPLACEMENT; DNA-DAMAGE; IDENTIFICATION; MUTATIONS; CYS557SER; BRCA1; COMPLEX; VARIANT; RISK	BARD1 is the constitutive nuclear partner to the breast and ovarian cancer-specific tumor suppressor BRCA1. Together, they form a heterodimeric complex responsible for maintaining genomic stability through nuclear functions involving DNA damage signaling and repair, transcriptional regulation, and cell cycle control. We report the 2.0 angstrom structure of the BARD1 ankyrin repeat domain. The structure includes four ankyrin repeats with a non-canonical C-terminal capping ankyrin repeat and a well ordered extended loop preceding the first repeat. Conserved surface features show an acidic patch and an acidic pocket along the surface typically used by ankyrin repeat domains for binding cognate proteins. We also demonstrate that two reported mutations, N470S and V507M, in the ankyrin repeat domain do not result in observable structural defects. These results provide a structural basis for exploring the biological function of the ankyrin repeat domain and for modeling BARD1 isoforms.	[Fox, David, III; Rajagopal, Ponni; Brzovic, Peter S.; Stenkamp, Ronald E.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Le Trong, Isolde; Stenkamp, Ronald E.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Le Trong, Isolde; Stenkamp, Ronald E.] Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	NCI NIH HHS [1R01 CA 79963] Funding Source: Medline; NIGMS NIH HHS [T32 GM 008268-17-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Ishitobi M, 2003, CANCER LETT, V200, P1, DOI 10.1016/S0304-3835(03)00387-2; Jefford CE, 2004, ONCOGENE, V23, P3509, DOI 10.1038/sj.onc.1207427; Karppinen SM, 2006, J MED GENET, V43, P856, DOI 10.1136/jmg.2006.041731; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li L, 2007, CANCER RES, V67, P11876, DOI 10.1158/0008-5472.CAN-07-2370; Li L, 2007, INT J BIOCHEM CELL B, V39, P1659, DOI 10.1016/j.biocel.2007.04.018; Lombardi G, 2007, GENE CHROMOSOME CANC, V46, P791, DOI 10.1002/gcc.20460; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Stacey SN, 2006, PLOS MED, V3, P1103, DOI 10.1371/journal.pmed.0030217; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Tsuzuki M, 2006, CANCER LETT, V233, P108, DOI 10.1016/j.canlet.2005.03.012; US Cancer Statistics Working Group, 2007, US CANC STAT 2004 IN; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vahteristo P, 2006, EUR J HUM GENET, V14, P167, DOI 10.1038/sj.ejhg.5201542; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Williams RS, 2003, J BIOL CHEM, V278, P53007, DOI 10.1074/jbc.M310182200	34	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21179	21186		10.1074/jbc.M802333200	http://dx.doi.org/10.1074/jbc.M802333200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18480049	hybrid, Green Published			2022-12-27	WOS:000257746100060
J	Hussainzada, N; Da Silva, TC; Zhang, EY; Swaan, PW				Hussainzada, Naissan; Da Silva, Tatiana Claro; Zhang, Eric Y.; Swaan, Peter W.			Conserved aspartic acid residues lining the extracellular loop I of sodium-coupled bile acid transporter ASBT interact with Na+ and 7 alpha-OH moieties on the ligand cholestane skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED ALKYLATION; ALPHA-OST-BETA; SCANNING MUTAGENESIS; HEPATIC CHOLESTEROL; LACTOSE PERMEASE; GUINEA-PIGS; ILEAL; COTRANSPORTER; INHIBITOR; SLC10A2	Functional contributions of residues Val-99-Ser-126 lining extracellular loop (EL) 1 of the apical sodium-dependent bile acid transporter were determined via cysteine-scanning mutagenesis, thiol modification, and in silico interpretation. Despite membrane expression for all but three constructs (S112C, Y117C, S126C), most EL1 mutants (64%) were inactivated by cysteine mutation, suggesting a functional role during sodium/bile acid co-transport. A negative charge at conserved residues Asp-120 and Asp-122 is required for transport function, whereas neutralization of charge at Asp-124 yields a functionally active transporter. D124A exerts low affinity for common bile acids except deoxycholic acid, which uniquely lacks a 7 alpha-hydroxyl (OH) group. Overall, we conclude that (i) Asp-122 functions as a Na+ sensor, binding one of two co-transported Na+ ions, (ii) Asp-124 interacts with 7 alpha-OH groups of bile acids, and (iii) apolar EL1 residues map to hydrophobic ligand pharmacophore features. Based on these data, we propose a comprehensive mechanistic model involving dynamic salt bridge pairs and hydrogen bonding involving multiple residues to describe sodium-dependent bile acid transporter-mediated bile acid and cation translocation.	[Hussainzada, Naissan; Da Silva, Tatiana Claro; Zhang, Eric Y.; Swaan, Peter W.] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Swaan, PW (corresponding author), Univ Maryland, Dept Pharmaceut Sci, 621 HSF 2,20 Penn St, Baltimore, MD 21201 USA.	pswaan@rx.umaryland.edu		Swaan, Peter/0000-0003-1767-1487	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK061425, DK 61425] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Alrefai WA, 2005, AM J PHYSIOL-GASTR L, V288, pG978, DOI 10.1152/ajpgi.00379.2004; Balakrishnan A, 2006, MOL PHARMACEUT, V3, P282, DOI 10.1021/mp0600135; Balakrishnan A, 2006, MOL PHARMACEUT, V3, P223, DOI 10.1021/mp060022d; Balakrishnan A, 2006, PHARM RES, V23, P1451, DOI 10.1007/s11095-006-0219-4; Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; Banerjee A, 2008, BIOCHEM J, V410, P391, DOI 10.1042/BJ20071300; Baringhaus KH, 1999, J LIPID RES, V40, P2158; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Huang HC, 2005, J MED CHEM, V48, P5853, DOI 10.1021/jm0402162; Huff MW, 2002, ARTERIOSCL THROM VAS, V22, P1884, DOI 10.1161/01.ATV.0000035390.87288.26; Hussainzada N, 2008, MOL PHARMACOL, V73, P305, DOI 10.1124/mol.107.041640; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kitayama K, 2006, EUR J PHARMACOL, V539, P89, DOI 10.1016/j.ejphar.2006.04.005; Kramer W, 2001, J BIOL CHEM, V276, P36020, DOI 10.1074/jbc.M104665200; Li H, 2004, METABOLISM, V53, P927, DOI 10.1016/j.metabol.2004.01.017; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Pajor AM, 2005, J BIOL CHEM, V280, P18728, DOI 10.1074/jbc.M501265200; Pauli-Magnus C, 2005, J HEPATOL, V43, P342, DOI 10.1016/j.jhep.2005.03.017; Schlattjan JH, 2003, ARZNEIMITTEL-FORSCH, V53, P837; Sun AQ, 2006, J BIOL CHEM, V281, P16410, DOI 10.1074/jbc.M600034200; Swaan PW, 1997, J COMPUT AID MOL DES, V11, P581, DOI 10.1023/A:1007919704457; Swaan PW, 1997, BIOCONJUGATE CHEM, V8, P520, DOI 10.1021/bc970076t; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; West KL, 2005, J NUTR BIOCHEM, V16, P722, DOI 10.1016/j.jnutbio.2005.06.009; West KL, 2002, J PHARMACOL EXP THER, V303, P293, DOI 10.1124/jpet.102.038711; WHITESIDE CH, 1966, P SOC EXP BIOL MED, V121, P153; WONG MH, 1995, J BIOL CHEM, V270, P27228, DOI 10.1074/jbc.270.45.27228; Zahner D, 2003, EUR J BIOCHEM, V270, P1117, DOI 10.1046/j.1432-1033.2003.03463.x; Zhang EY, 2004, BIOCHEMISTRY-US, V43, P11380, DOI 10.1021/bi049270a	39	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20653	20663		10.1074/jbc.M802885200	http://dx.doi.org/10.1074/jbc.M802885200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508772	Green Published, hybrid			2022-12-27	WOS:000257746100006
J	Oh, DY; Yoon, JM; Moon, MJ; Hwang, JI; Choe, H; Lee, JY; Kim, JI; Kim, S; Rhim, H; O'Dell, DK; Walker, JM; Na, HS; Lee, MG; Kwon, HB; Kim, K; Seong, JY				Oh, Da Young; Yoon, Jung Min; Moon, Mi Jin; Hwang, Jong-Ik; Choe, Han; Lee, Ju Yeon; Kim, Jae Il; Kim, Sunoh; Rhim, Hyewhon; O'Dell, David K.; Walker, J. Michael; Na, Heung Sik; Lee, Min Goo; Kwon, Hyuk Bang; Kim, Kyungjin; Seong, Jae Young			Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; CANNABINOID RECEPTOR; BRAIN; PAIN; MEMBRANE; CLONING; PLASMA; BINDS; GPR18	A series of small compounds acting at the orphan G protein-coupled receptor GPR92 were screened using a signaling pathway-specific reporter assay system. Lipid-derived molecules including farnesyl pyrophosphate (FPP), N-arachidonylglycine (NAG), and lysophosphatidic acid were found to activate GPR92. FPP and lysophosphatidic acid were able to activate both G(q/11)- and G(s)-mediated signaling pathways, whereas NAG activated only the G(q/11)-mediated signaling pathway. Computer-simulated modeling combined with site-directed mutagenesis of GPR92 indicated that Thr97, Gly98, Phe101, and Arg267 of GPR92 are responsible for the interaction of GPR92 with FPP and NAG. Reverse transcription-PCR analysis revealed that GPR92 mRNA is highly expressed in the dorsal root ganglia (DRG) but faint in other brain regions. Peripheral tissues including, spleen, stomach, small intestine, and kidney also expressed GPR92 mRNA. Immunohistochemical analysis revealed that GPR92 is largely co-localized with TRPV1, a nonspecific cation channel that responds to noxious heat, in mouse and human DRG. FPP and NAG increased intracellular Ca2+ levels in cultured DRG neurons. These results suggest that FPP and NAG play a role in the sensory nervous system through activation of GPR92.	[Oh, Da Young; Yoon, Jung Min; Moon, Mi Jin; Seong, Jae Young] Korea Univ, Coll Med, Lab G Prot Coupled Receptors, Seoul 136705, South Korea; [Na, Heung Sik; Lee, Min Goo] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Choe, Han] Univ Ulsan, Dept Physiol, Seoul 138736, South Korea; [Choe, Han] Univ Ulsan, Res Inst Biomacromol, Seoul 138736, South Korea; [Lee, Ju Yeon; Kim, Jae Il] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Kim, Sunoh] Chonnam Natl Univ, Biosafety Res Inst, Jeonju 561756, South Korea; [Kim, Sunoh] Chonnam Natl Univ, Coll Vet Med, Jeonju 561756, South Korea; [Rhim, Hyewhon] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [O'Dell, David K.; Walker, J. Michael] Indiana Univ, Gill Ctr Biomol Sci, Bloomington, IN 47405 USA; [O'Dell, David K.; Walker, J. Michael] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Kwon, Hyuk Bang] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; University of Ulsan; Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University; Korea Institute of Science & Technology (KIST); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Chonnam National University; Seoul National University (SNU)	Seong, JY (corresponding author), Korea Univ, Coll Med, Lab G Prot Coupled Receptors, Seoul 136705, South Korea.	jyseong@korea.ac.kr	choe, han/A-5679-2010; Seong, Jae Young/A-5794-2012; OH, DA YOUNG/B-2369-2008	choe, han/0000-0003-4604-647X; Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	NIDA NIH HHS [DA 16825, DA 018224] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA016825, R01DA018224] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Acharjee S, 2004, J BIOL CHEM, V279, P54445, DOI 10.1074/jbc.M408909200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Burstein SH, 2002, BIOCHEM PHARMACOL, V64, P1147, DOI 10.1016/S0006-2952(02)01301-1; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Choi S, 2007, AM J PHYSIOL-GASTR L, V292, pG1366, DOI 10.1152/ajpgi.00516.2006; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Das S, 2007, MOL ENDOCRINOL, V21, P2672, DOI 10.1210/me.2007-0080; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Gantz I, 1997, GENOMICS, V42, P462, DOI 10.1006/geno.1997.4752; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Kinloch RA, 2005, EXPERT OPIN THER TAR, V9, P685, DOI 10.1517/14728222.9.4.685; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Oh DY, 2006, INT REV CYTOL, V252, P163, DOI 10.1016/S0074-7696(06)52003-0; Oh DY, 2005, MOL ENDOCRINOL, V19, P722, DOI 10.1210/me.2004-0220; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Rhim H, 2002, EUR J PHARMACOL, V436, P151, DOI 10.1016/S0014-2999(01)01613-2; RUNQUIST M, 1995, J NEUROCHEM, V65, P2299; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Sheskin T, 1997, J MED CHEM, V40, P659, DOI 10.1021/jm960752x; Succar R, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-24; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wilson S, 2000, Drug Des Discov, V17, P105; Wise A, 2004, ANNU REV PHARMACOL, V44, P43, DOI 10.1146/annurev.pharmtox.44.101802.121419; Wong LAQ, 2008, NEUROPHARMACOLOGY, V54, P189, DOI 10.1016/j.neuropharm.2007.05.004	33	104	111	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21054	21064		10.1074/jbc.M708908200	http://dx.doi.org/10.1074/jbc.M708908200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499677	Green Published, hybrid			2022-12-27	WOS:000257746100047
J	Zhou, XB; Wulfsen, I; Lutz, S; Utku, E; Sausbier, U; Ruth, P; Wieland, T; Korth, M				Zhou, Xiao-Bo; Wulfsen, Iris; Lutz, Susanne; Utku, Emine; Sausbier, Ulrike; Ruth, Peter; Wieland, Thomas; Korth, Michael			M-2 muscarinic receptors induce airway smooth muscle activation via a dual, G beta gamma-mediated inhibition of large conductance Ca2+-activated K+ channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RAT UTERINE MYOCYTES; BKCA CHANNEL; PHOSPHOINOSITIDE METABOLISM; CHOLINERGIC INHIBITION; POTASSIUM CHANNELS; ADENYLYL-CYCLASE; KNOCKOUT MICE; BINDING; SUBTYPES	Airway smooth muscle is richly endowed with muscarinic receptors of the M-2 and M-3 subtype. Stimulation of these receptors inhibits large conductance calcium-activated K+ (BK) channels, a negative feed back regulator, in a pertussis toxin-sensitive manner and thus facilitates contraction. The underlying mechanism, however, is unknown. We therefore studied the activity of bovine trachea BK channels in HEK293 cells expressing the M-2 or M-3 receptor (M2R or M3R). In M2R- but not (MR)-R-3-expressing cells, maximal effective concentrations of carbamoylcholine (CCh) inhibited whole cell BK currents by 53%. This M2R- induced inhibition was abolished by pertussis toxin treatment or overexpression of the G beta gamma scavenger transducin-alpha. In inside-out patches, direct application of 300 nM purified G beta gamma decreased channel open probability by 55%. The physical interaction of G beta gamma with BK channels was confirmed by co-immunoprecipitation. Interestingly, inhibition of phospholipase C as well as protein kinase C activities also reversed the CCh effect but to a smaller (similar to 20%) extent. Mouse tracheal cells responded similarly to CCh, purified G beta gamma and phospholipase C/protein kinase C inhibition as M2R-expressing HEK293 cells. Our results demonstrate that airway M(2)Rs inhibit BK channels by a dual, G beta gamma-mediated mechanism, a direct membrane-delimited interaction, and the activation of the phospholipase C/protein kinase C pathway.	[Zhou, Xiao-Bo; Wulfsen, Iris; Utku, Emine; Korth, Michael] Univ Klinikum Hamburg Eppendorf, Inst Pharmakol Pharmazeuten, D-20246 Hamburg, Germany; [Sausbier, Ulrike; Ruth, Peter] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Lutz, Susanne; Wieland, Thomas] Heidelberg Univ, Med Fak Mannheim, Inst Expt & Klin Pharmakol & Toxikol, D-68169 Mannheim, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Korth, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Pharmakol Pharmazeuten, Martinistr 52, D-20246 Hamburg, Germany.	korth@uke.uni-hamburg.de	Wieland, Thomas/Q-1506-2019; Zhou, Xiaobo/AAH-4320-2019; Wieland, Thomas/G-1772-2012	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261				ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; Barman SA, 2004, AM J PHYSIOL-LUNG C, V286, pL149, DOI 10.1152/ajplung.00207.2003; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; Caulfield MP, 1998, PHARMACOL REV, V50, P279; DE WM, 1997, NATURE, V385, P446; DELLACQUA ML, 1993, J BIOL CHEM, V268, P5676; Eglen RM, 1996, PHARMACOL REV, V48, P531; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FERNANDES LB, 1992, J PHARMACOL EXP THER, V262, P119; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; GRANDORDY BM, 1986, J PHARMACOL EXP THER, V238, P273; HADDAD EB, 1994, AM J PHYSIOL, V266, pL642, DOI 10.1152/ajplung.1994.266.6.L642; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; JONES CA, 1987, AM J PHYSIOL, V253, pC97, DOI 10.1152/ajpcell.1987.253.1.C97; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KUME H, 1992, P NATL ACAD SCI USA, V89, P11051, DOI 10.1073/pnas.89.22.11051; KUME H, 1991, AM J PHYSIOL, V261, pC1204, DOI 10.1152/ajpcell.1991.261.6.C1204; KUME H, 1995, AM J PHYSIOL-LUNG C, V268, pL221, DOI 10.1152/ajplung.1995.268.2.L221; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; MAK JCW, 1993, LIFE SCI, V53, P1501, DOI 10.1016/0024-3205(93)90624-C; MAK JCW, 1990, AM REV RESPIR DIS, V141, P1559, DOI 10.1164/ajrccm/141.6.1559; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; MEURS H, 1988, EUR J PHARMACOL, V156, P271, DOI 10.1016/0014-2999(88)90331-7; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; ROFFEL A F, 1990, Pulmonary Pharmacology, V3, P47, DOI 10.1016/0952-0600(90)90009-8; ROFFEL AF, 1990, BRIT J PHARMACOL, V99, P293, DOI 10.1111/j.1476-5381.1990.tb14697.x; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; SANDMANN J, 1991, J BIOL CHEM, V266, P6031; SANKARY RM, 1988, AM REV RESPIR DIS, V138, P145, DOI 10.1164/ajrccm/138.1.145; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Schubert R, 1999, AM J PHYSIOL-CELL PH, V276, pC648, DOI 10.1152/ajpcell.1999.276.3.C648; Shipston MJ, 1996, J PHYSIOL-LONDON, V493, P665, DOI 10.1113/jphysiol.1996.sp021413; Steffens F, 2003, MOL ENDOCRINOL, V17, P2103, DOI 10.1210/me.2003-0047; Stengel PW, 2002, AM J PHYSIOL-REG I, V282, pR1443, DOI 10.1152/ajpregu.00486.2001; Stengel PW, 2000, J PHARMACOL EXP THER, V292, P877; Taguchi K, 2000, BIOL PHARM BULL, V23, P1450; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Voigt N, 2007, CARDIOVASC RES, V74, P426, DOI 10.1016/j.cardiores.2007.02.009; WIELAND T, 1991, EUR J BIOCHEM, V196, P707, DOI 10.1111/j.1432-1033.1991.tb15869.x; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhou XB, 2000, J PHYSIOL-LONDON, V524, P339, DOI 10.1111/j.1469-7793.2000.t01-1-00339.x; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200; Zhou XB, 2007, MOL ENDOCRINOL, V21, P740, DOI 10.1210/me.2006-0220	55	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21036	21044		10.1074/jbc.M800447200	http://dx.doi.org/10.1074/jbc.M800447200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524769	Green Published, hybrid			2022-12-27	WOS:000257746100045
J	Schindl, R; Bergsmann, J; Frischauf, I; Derler, I; Fahrner, M; Muik, M; Fritsch, R; Groschner, K; Romanin, C				Schindl, Rainer; Bergsmann, Judith; Frischauf, Irene; Derler, Isabella; Fahrner, Marc; Muik, Martin; Fritsch, Reinhard; Groschner, Klaus; Romanin, Christoph			2-aminoethoxydiphenyl borate alters selectivity of Orai3 channels by increasing their pore size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; CA2+ CHANNELS; INHIBITION; POTENTIATION; 2-APB; STIM1; ATP	Stim1 in the endoplasmic reticulum and the three Orai (also termed CRACM) channels in the plasma-membrane are main components of native Ca2+ release-activated Ca2+ channels. A pharmacological hallmark of these channels is their distinct sensitivity to 2-aminoethoxydiphenyl borate (2-APB). Here we report that Orai3 currents can be robustly stimulated by 75 mu M 2-APB independent of Stim1, whereas 2-APB at similar concentrations inhibited store-operated Orai1 currents. 2-APB did not only promote currents through Orai3 channels but also dramatically altered ion selectivity of Orai3 channels. This allowed for permeation of monovalent cations both in the inward as well as outward direction, which is in sharp contrast to the high Ca2+ selectivity of store-operated Orai3 currents. An Orai3-R66W mutant, which lacked in analogy to the severe combined immune deficiency mutant Orai1-R91W store-operated activation, was also found to be resistant to 2-APB stimulation. The change in selectivity by 2-APB was associated with an increase in Orai3 minimum pore size from about 3.8 A to more than 5.34 A. In line with a potential interaction of 2-APB with the Orai3 pore, among three pore mutants tested, the Orai3 E165Q mutant particularly resembled in its permeation properties those of 2-APB stimulated Orai3 and additionally exhibited a reduced response to 2-APB. In aggregate, stimulation of Orai3 currents by 2-APB occurred along with an alteration of the permeation pathway that represents a unique mechanism for regulating ion channel selectivity by chemical compounds.	[Schindl, Rainer; Bergsmann, Judith; Frischauf, Irene; Derler, Isabella; Fahrner, Marc; Muik, Martin; Fritsch, Reinhard; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Schindl, R (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	rainer.schindl@jku.at; christoph.romanin@jku.at	Schindl, Rainer/E-3959-2013; Derler, Isabella/B-7871-2019; Schindl, Rainer/V-4205-2019; Fahrner, Marc/AAI-7927-2021; Romanin, Christoph/D-5399-2009; Frischauf, Irene/AAG-2007-2019; Groschner, Klaus/A-2550-2010	Schindl, Rainer/0000-0003-0896-8887; Derler, Isabella/0000-0002-4768-146X; Romanin, Christoph/0000-0003-3756-4136; Frischauf, Irene/0000-0003-0661-2932; Groschner, Klaus/0000-0002-8659-377X; Fahrner, Marc/0000-0002-2689-0158				Bilmen JG, 2002, EUR J BIOCHEM, V269, P3678, DOI 10.1046/j.1432-1033.2002.03060.x; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu DM, 2001, J PHYSIOL-LONDON, V534, P423, DOI 10.1111/j.1469-7793.2001.00423.x; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; PEINELT C, 2008, J PHYSL, V283, P17662; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	23	123	124	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20261	20267		10.1074/jbc.M803101200	http://dx.doi.org/10.1074/jbc.M803101200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499656	hybrid			2022-12-27	WOS:000257565300042
J	Stowell, SR; Arthur, CM; Slanina, KA; Horton, JR; Smith, DF; Cummings, RD				Stowell, Sean R.; Arthur, Connie M.; Slanina, Kristin A.; Horton, John R.; Smith, David F.; Cummings, Richard D.			Dimeric galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ASPARAGINE-LINKED OLIGOSACCHARIDES; CARBOHYDRATE-BINDING PROTEIN-35; POLY-N-ACETYLLACTOSAMINE; RAY CRYSTAL-STRUCTURE; HAMSTER OVARY CELLS; HIGH-AFFINITY; DIFFERENTIAL GLYCOSYLATION; STRUCTURAL DETERMINANTS; PULMONARY-FIBROSIS	Human galectins have distinct and overlapping biological roles in immunological homeostasis. However, the underlying differences among galectins in glycan binding specificity regulating these functions are unclear. Galectin-8 (Gal-8), a tandem repeat galectin, has two distinct carbohydrate recognition domains (CRDs) that may cross-link cell surface counter receptors. Here we report that each Gal-8 CRD has differential glycan binding specificity and that cell signaling activity resides in the C-terminal CRD. Full-length Gal-8 and recombinant individual domains (Gal-8N and Gal-8C) bound to human HL60 cells, but only full-length Gal-8 signaled phosphatidylserine (PS) exposure in cells, which occurred independently of apoptosis. Although desialylation of cells did not alter Gal-8 binding, it enhanced cellular sensitivity to Gal-8-induced PS exposure. By contrast, HL60 cell desialylation increased binding by Gal-8C but reduced Gal-8N binding. Enzymatic reduction in surface poly-N-acetyllactosamine (polyLacNAc) glycans in HL60 cells reduced cell surface binding by Gal-8C but did not alter Gal-8N binding. Cross-linking and light scattering studies showed that Gal-8 is dimeric, and studies on individual subunits indicate that dimerization occurs through the Gal-8N domain. Mutations of individual domains within full-length Gal-8 showed that signaling activity toward HL60 cells resides in the C-terminal domain. In glycan microarray analyses, each CRD of Gal-8 showed different binding, with Gal-8N recognizing sulfated and sialylated glycans and Gal-8C recognizing blood group antigens and polyLacNAc glycans. These results demonstrate that Gal-8 dimerization promotes functional bivalency of each CRD, which allows Gal-8 to signal PS exposure in leukocytes entirely through C-terminal domain recognition of polyLacNAc glycans.	[Stowell, Sean R.; Arthur, Connie M.; Slanina, Kristin A.; Horton, John R.; Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rdcummi@emory.edu	Horton, John R/ABB-4770-2020; Horton, John/F-2375-2010	Horton, John/0000-0001-9749-8068	NHLBI NIH HHS [P01 HL085607, HL 085607] Funding Source: Medline; NIGMS NIH HHS [GM 62116, T32 GM008169] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, T32GM008169] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRWAL N, 1993, J BIOL CHEM, V268, P14932; Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bidon N, 2001, INT J MOL MED, V8, P245; Bidon-Wagner N, 2002, GLYCOCONJUGATE J, V19, P557, DOI 10.1023/B:GLYC.0000014086.38343.98; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; BOURNE Y, 1994, NAT STRUCT BIOL, V1, P863, DOI 10.1038/nsb1294-863; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Carlsson S, 2007, GLYCOBIOLOGY, V17, P906, DOI 10.1093/glycob/cwm059; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Cho M, 1996, BIOCHEMISTRY-US, V35, P13081, DOI 10.1021/bi961181d; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Dias-Baruffi M, 2003, J BIOL CHEM, V278, P41282, DOI 10.1074/jbc.M306624200; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Fecho K, 1998, J LEUKOCYTE BIOL, V64, P373, DOI 10.1002/jlb.64.3.373; Fecho K, 1998, CELL IMMUNOL, V188, P19, DOI 10.1006/cimm.1998.1339; HADARI YR, 1995, J BIOL CHEM, V270, P3447, DOI 10.1074/jbc.270.7.3447; Hagimoto N, 1997, AM J RESP CELL MOL, V17, P272, DOI 10.1165/ajrcmb.17.3.2893; HSU DK, 1992, J BIOL CHEM, V267, P14167; IWAI K, 1994, BLOOD, V84, P1201; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Kwon SW, 2003, VOX SANG, V85, P307, DOI 10.1111/j.0042-9007.2003.00374.x; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Misawa R, 2001, APOPTOSIS, V6, P411, DOI 10.1023/A:1012406121993; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Nishi N, 2006, GLYCOBIOLOGY, V16, p15C, DOI 10.1093/glycob/cwl028; OCHIENG J, 1993, BIOCHEMISTRY-US, V32, P4455, DOI 10.1021/bi00067a038; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 2002, J LEUKOCYTE BIOL, V71, P741; Rabinovich GA, 1999, BRAZ J MED BIOL RES, V32, P383, DOI 10.1590/S0100-879X1999000400002; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; Umemoto K, 2003, BIOCHEMISTRY-US, V42, P3688, DOI 10.1021/bi026671m; VIITALA J, 1984, EUR J BIOCHEM, V138, P393, DOI 10.1111/j.1432-1033.1984.tb07928.x; WOO HJ, 1990, J BIOL CHEM, V265, P7097	67	113	116	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20547	20559		10.1074/jbc.M802495200	http://dx.doi.org/10.1074/jbc.M802495200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18456665	Green Published, hybrid			2022-12-27	WOS:000257565300067
J	Thebault, S; Cao, G; Venselaar, H; Xi, Q; Bindels, RJM; Hoenderop, JGJ				Thebault, Stephanie; Cao, Gang; Venselaar, Hanka; Xi, Qi; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Role of the alpha-kinase domain in transient receptor potential melastatin 6 channel and regulation by intracellular ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY HYPOCALCEMIA; MIC CHANNELS; CARDIAC MYOCYTES; MG2+ HOMEOSTASIS; CATION CHANNEL; TRPM7 CHANNEL; MAGNESIUM; PROTEIN; HYPOMAGNESEMIA; CELLS	Transient receptor potential melastatin 6 (TRPM6) plays an essential role in epithelial Mg2+ transport. TRPM6 and its closest homologue, TRPM7, both combine a cation channel with an alpha-kinase domain. However, the role of this alpha-kinase domain in TRPM6 channel activity remains elusive. The aim of this study was to investigate the regulation of TRPM6 channel activity by intracellular ATP and the involvement of its alpha-kinase domain. We demonstrated that intracellular Na- and Mg-ATP decreased the TRPM6 current in HEK293 cells heterogeneously expressing the channel, whereas Na-CTP or Na-GTP had no effect on channel activity. Whole cell recordings in TRPM6-expressing HEK293 cells showed that deletion of the alpha-kinase domain prevented the inhibitory effect of intracellular ATP without abrogating channel activity. Mutation of the conserved putative ATP-binding motif GXG(A) XXG (G1955D) in the alpha-kinase domain of TRPM6 inhibited the ATP action, whereas this effect remained preserved in the TRPM6 phosphotransferase-deficient mutant K1804R. Mutation of the TRPM6 autophosphorylation site, Thr(1851), into either an alanine or an aspartate, resulted in functional channels that could still be inhibited by ATP. In conclusion, intracellular ATP regulates TRPM6 channel activity via its alpha-kinase domain independently of alpha-kinase activity.	[Thebault, Stephanie; Cao, Gang; Xi, Qi; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Physiol 286, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Physiol 286, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@ncmls.ru.nl	Bindels, René JM/B-9824-2013; Thébault, Stéphanie/AAD-8350-2019; Hoenderop, Joost G.J./H-8047-2014; Venselaar, Hanka/D-2009-2016	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Venselaar, Hanka/0000-0001-9824-6559; Thebault, Stephanie/0000-0003-3233-282X				Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Hermosura MC, 2005, P NATL ACAD SCI USA, V102, P11510, DOI 10.1073/pnas.0505149102; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; MADSEN KM, 1988, J ELECTRON MICR TECH, V9, P187, DOI 10.1002/jemt.1060090206; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Romani AMP, 2002, BIOMETALS, V15, P271, DOI 10.1023/A:1016082900838; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Scharenberg AM, 2005, PFLUG ARCH EUR J PHY, V451, P220, DOI 10.1007/s00424-005-1444-0; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Spitaler M, 2000, J BIOL CHEM, V275, P33289, DOI 10.1074/jbc.M002742200; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Trouet D, 1997, PFLUG ARCH EUR J PHY, V434, P632, DOI 10.1007/s004240050445; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wang M, 2004, J PHYSIOL-LONDON, V555, P383, DOI 10.1113/jphysiol.2003.048538; Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P11, DOI 10.1016/S0098-2997(02)00088-2; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	38	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19999	20007		10.1074/jbc.M800167200	http://dx.doi.org/10.1074/jbc.M800167200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18490453	Green Published, hybrid			2022-12-27	WOS:000257565300015
J	Dehner, M; Hadjihannas, M; Weiske, J; Huber, O; Behrens, J				Dehner, Manuel; Hadjihannas, Michel; Weiske, Joerg; Huber, Otmar; Behrens, Juergen			Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THREONINE PROTEIN-KINASE; COLORECTAL-CANCER CELLS; APC TUMOR-SUPPRESSOR; BETA-CATENIN; DEPENDENT TRANSCRIPTION; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; EPITHELIAL-CELLS; COLON-CARCINOMA; NUCLEAR EXPORT	In human cancers, mutations in components of the Wnt signaling pathway lead to beta-catenin stabilization and result in augmented gene transcription. HCT116 colon cancer cells carry stabilizing mutations in beta-catenin and exhibit an elevated activation of Wnt signaling. To clarify the role of an overactive Wnt signaling, we used DNA microarray analysis to search for genes whose expression is up-regulated after knockdown of the wild type adenomatous polyposis coli (APC) tumor suppressor in HCT116 cells, which further enhances Wnt signaling activation. Serum and glucocorticoid-inducible kinase 1 (SGK1) was among the most up-regulated genes following APC knockdown through small interfering RNA. Up-regulation of SGK1 in response to small interfering RNA against APC was inhibited by concomitant knockdown of beta-catenin. Quantitative real time reverse transcription-PCR, Western blot, and chromatin immunoprecipitation analyses confirmed that SGK1 is a direct beta-catenin target gene. SGK1 negatively regulates the pro-apoptotic transcription factor Forkhead box O3a (FoxO3a) via phosphorylation and exclusion from the nucleus. We show that Wnt signaling activation results in FoxO3a exclusion from the nucleus and inhibits expression of FoxO3a target genes. Importantly, FoxO3a mutants that fail to be phosphorylated and therefore are regulated by SGK1 are not influenced by activation of Wnt signaling. In line, knockdown of SGK1 relieves the effects of Wnt signaling on FoxO3a localization and FoxO3a-dependent transcription. Finally, we show that induction of Wnt signaling inhibits FoxO3a-induced apoptosis. Collectively our results indicate that evasion of apoptosis is another feature employed by an overactive Wnt signaling.	[Dehner, Manuel; Hadjihannas, Michel; Behrens, Juergen] Univ Erlangen Nurnberg, Dept Expt Med 2, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Weiske, Joerg; Huber, Otmar] Charite Univ Med Berlin, Dept Lab Med & Pathobiochem, D-12200 Berlin, Germany	University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Dept Expt Med 2, Nikolaus Fiebiger Ctr Mol Med, Glueckstr 6, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de	Huber, Otmar/AAA-4548-2021	Huber, Otmar/0000-0003-4359-1747				Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bhargava A, 2001, ENDOCRINOLOGY, V142, P1587, DOI 10.1210/en.142.4.1587; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Durig J, 2003, BLOOD, V101, P2748, DOI 10.1182/blood-2002-09-2683; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giarre M, 1998, ANN NY ACAD SCI, V857, P43, DOI 10.1111/j.1749-6632.1998.tb10106.x; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kadowaki M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-77; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Krueger C, 2003, NUCLEIC ACIDS RES, V31, P3050, DOI 10.1093/nar/gkg421; Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perreault N, 2001, J BIOL CHEM, V276, P43328, DOI 10.1074/jbc.M104366200; Polakis P, 2000, GENE DEV, V14, P1837; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Shelly C, 2002, J CELL SCI, V115, P1985; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; Tapia JC, 2006, P NATL ACAD SCI USA, V103, P15079, DOI 10.1073/pnas.0606845103; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torres VA, 2006, J CELL SCI, V119, P1812, DOI 10.1242/jcs.02894; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Weiske J, 2007, P NATL ACAD SCI USA, V104, P20344, DOI 10.1073/pnas.0703664105; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	59	100	103	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19201	19210		10.1074/jbc.M710366200	http://dx.doi.org/10.1074/jbc.M710366200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487207	hybrid			2022-12-27	WOS:000257387600005
J	Ilagan, RP; Tiso, M; Konas, DW; Hemann, C; Durra, D; Hille, R; Stuehr, DJ				Ilagan, Robielyn P.; Tiso, Mauro; Konas, David W.; Hemann, Craig; Durra, Deborah; Hille, Russ; Stuehr, Dennis J.			Differences in a conformational equilibrium distinguish catalysis by the endothelial and neuronal nitric-oxide synthase flavoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CYTOCHROME-P450 REDUCTASE; AUTOINHIBITORY CONTROL ELEMENT; HUMAN METHIONINE SYNTHASE; ONE-ELECTRON TRANSFER; C-TERMINAL TAIL; FERREDOXIN-NADP(+) REDUCTASE; COENZYME BINDING; REDOX PROPERTIES; 2 FLAVINS; CRYSTAL-STRUCTURE	Nitric oxide (NO) is a physiological mediator synthesized by NO synthases (NOS). Despite their structural similarity, endothelial NOS (eNOS) has a 6-fold lower NO synthesis activity and 6-16-fold lower cytochrome c reductase activity than neuronal NOS (nNOS), implying significantly different electron transfer capacities. We utilized purified reductase domain constructs of either enzyme (bovine eNOSr and rat nNOSr) to investigate the following three mechanisms that may control their electron transfer: (i) the set point and control of a two-state conformational equilibrium of their FMN subdomains; (ii) the flavin midpoint reduction potentials; and (iii) the kinetics of NOSr-NADP(+) interactions. Although eNOSr and nNOSr differed in their NADP(H) interaction and flavin thermodynamics, the differences were minor and unlikely to explain their distinct electron transfer activities. In contrast, calmodulin (CaM)-free eNOSr favored the FMN-shielded (electron-accepting) conformation over the FMN-deshielded (electron-donating) conformation to a much greater extent than did CaM-free nNOSr when the bound FMN cofactor was poised in each of its three possible oxidation states. NADPH binding only stabilized the FMN-shielded conformation of nNOSr, whereas CaM shifted both enzymes toward the FMN-deshielded conformation. Analysis of cytochrome c reduction rates measured within the first catalytic turnover revealed that the rate of conformational change to the FMN-deshielded state differed between eNOSr and nNOSr and was rate-limiting for either CaM-free enzyme. We conclude that the set point and regulation of the FMN conformational equilibrium differ markedly in eNOSr and nNOSr and can explain the lower electron transfer activity of eNOSr.	[Ilagan, Robielyn P.; Durra, Deborah; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Tiso, Mauro] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Konas, David W.] Montclair State Univ, Dept Chem & Biochem, Montclair, NJ 07043 USA; [Hemann, Craig] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Montclair State University; University System of Ohio; Ohio State University; University of California System; University of California Riverside	Stuehr, DJ (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org		Hemann, Craig/0000-0002-7380-4072	NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER; NCI NIH HHS [CA53914] Funding Source: Medline; NHLBI NIH HHS [HL76491] Funding Source: Medline; NIEHS NIH HHS [ES012658] Funding Source: Medline; NIGMS NIH HHS [GM075036] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABU SH, 1993, P NATL ACAD SCI USA, V90, P10769; Adak S, 2002, P NATL ACAD SCI USA, V99, P13516, DOI 10.1073/pnas.192283399; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Aliverti A, 1998, J BIOL CHEM, V273, P34008, DOI 10.1074/jbc.273.51.34008; Chen PF, 1996, J BIOL CHEM, V271, P14631, DOI 10.1074/jbc.271.24.14631; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; DOLPHIN D, 1987, COENZYMES COFACTORS, P776; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; DUTTON PL, 1970, BIOCHEMISTRY-US, V9, P5077, DOI 10.1021/bi00828a006; Feng CJ, 2007, J AM CHEM SOC, V129, P5621, DOI 10.1021/ja068685b; Finn RD, 2003, EUR J BIOCHEM, V270, P1164, DOI 10.1046/j.1432-1033.2003.03474.x; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garnaud PE, 2004, BIOCHEMISTRY-US, V43, P11035, DOI 10.1021/bi049312v; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Guan ZW, 2003, J BIOL CHEM, V278, P30859, DOI 10.1074/jbc.M301929200; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Gutierrez A, 2003, BIOCHEM SOC T, V31, P497, DOI 10.1042/BST0310497; Gutierrez A, 2003, EUR J BIOCHEM, V270, P2612, DOI 10.1046/j.1432-1033.2003.03633.x; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Higashimoto Y, 2005, J BIOL CHEM, V280, P729, DOI 10.1074/jbc.M406203200; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; INNES JB, 1989, BIOCHEMISTRY-US, V28, P1116, DOI 10.1021/bi00429a028; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; MCTIGUE MA, 1993, BIOCHEMISTRY-US, V32, P6855, DOI 10.1021/bi00078a008; Miyajima M, 2000, BIOCHEM BIOPH RES CO, V275, P752, DOI 10.1006/bbrc.2000.3367; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Nishino Y, 2007, ARCH BIOCHEM BIOPHYS, V465, P254, DOI 10.1016/j.abb.2007.05.021; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Panda SP, 2006, J BIOL CHEM, V281, P34246, DOI 10.1074/jbc.M601041200; Piubelli L, 2000, J BIOL CHEM, V275, P10472, DOI 10.1074/jbc.275.14.10472; Ray SS, 2007, BIOCHEMISTRY-US, V46, P11865, DOI 10.1021/bi700805x; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Singh A, 2003, J BIOL CHEM, V278, P33208, DOI 10.1074/jbc.M303061200; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Thomas DD, 2003, ANTIOXID REDOX SIGN, V5, P307, DOI 10.1089/152308603322110887; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Wolthers KR, 2003, BIOCHEMISTRY-US, V42, P3911, DOI 10.1021/bi027290b; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200; Zhao Q, 1999, PROTEIN SCI, V8, P298	67	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19603	19615		10.1074/jbc.M802914200	http://dx.doi.org/10.1074/jbc.M802914200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487202	Green Published, hybrid			2022-12-27	WOS:000257387600046
J	Osawa, S; Funamoto, S; Nobuhara, M; Wada-Kakuda, S; Shimojo, M; Yagishita, S; Ihara, Y				Osawa, Satoko; Funamoto, Satoru; Nobuhara, Mika; Wada-Kakuda, Satoko; Shimojo, Masafumi; Yagishita, Sosuke; Ihara, Yasuo			Phosphoinositides suppress gamma-secretase in both the detergent-soluble and -insoluble states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PLECKSTRIN HOMOLOGY DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; BETA-PROTEIN; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; INTRAMEMBRANE CLEAVAGE; TERMINAL FRAGMENT; ASPARTIC PROTEASE; ACTIN DYNAMICS	gamma-Secretase is an aspartic protease that hydrolyzes type I membrane proteins within the hydrophobic environment of the lipid bilayer. Using the CHAPSO-solubilized gamma-secretase assay system, we previously found that gamma-secretase activity was sensitive to the concentrations of detergent and phosphatidylcholine. This strongly suggests that the composition of the lipid bilayer has a significant impact on the activity of gamma-secretase. Recently, level of secreted beta-amyloid protein was reported to be attenuated by increasing levels of phosphatidylinositol 4,5-diphosphate (PI(4,5)P-2) in cultured cells. However, it is not clear whether PI(4,5)P-2 has a direct effect on gamma-secretase activity. In this study, we found that phosphoinositides directly inhibited CHAPSO-solubilized gamma-secretase activity. Interestingly, neither phosphatidylinositol nor inositol triphosphate altered gamma-secretase activity. PI(4,5)P-2 was also found to inhibit gamma-secretase activity in CHAPSO-insoluble membrane microdomains (rafts). Kinetic analysis of beta-amyloid protein production in the presence of PI(4,5)P-2 suggested a competitive inhibition. Even though phosphoinositides are minor phospholipids of the membrane, the concentration of PI(4,5)P-2 within the intact membrane has been reported to be in the range of 4-8 mM. The presence of PI(4,5)P-2-rich rafts in the membrane has been reported in a range of cell types. Furthermore, gamma-secretase is enriched in rafts. Taking these data together, we propose that phosphoinositides potentially regulate gamma-secretase activity by suppressing its association with the substrate.	[Funamoto, Satoru; Nobuhara, Mika; Ihara, Yasuo] Doshisha Univ, Dept Neuropathol, Fac Life & Med Sci, Kyoto 6100394, Japan; [Osawa, Satoko; Funamoto, Satoru; Wada-Kakuda, Satoko; Ihara, Yasuo] Univ Tokyo, Dept Neuropathol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Shimojo, Masafumi] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; [Yagishita, Sosuke] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo 1538902, Japan	Doshisha University; University of Tokyo; RIKEN; University of Tokyo	Funamoto, S (corresponding author), Doshisha Univ, Dept Neuropathol, Fac Life & Med Sci, Kyoto 6100394, Japan.	sfunamot@mail.doshisha.ac.jp						Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BUNCE CM, 1993, BIOCHEM J, V289, P667, DOI 10.1042/bj2890667; Dhe-Paganon S, 1999, P NATL ACAD SCI USA, V96, P8378, DOI 10.1073/pnas.96.15.8378; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hinchliffe KA, 1998, BBA-MOL CELL BIOL L, V1436, P87, DOI 10.1016/S0005-2760(98)00140-4; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; KOO EH, 1994, J BIOL CHEM, V269, P17386; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SHEETZ MP, 1982, NATURE, V296, P91, DOI 10.1038/296091a0; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; SHIMOHAMA S, 1991, AM J PATHOL, V139, P737; Shimojo M, 2007, NEUROSCI RES, V57, P446, DOI 10.1016/j.neures.2006.12.005; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200	57	36	36	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19283	19292		10.1074/jbc.M705954200	http://dx.doi.org/10.1074/jbc.M705954200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480063	hybrid			2022-12-27	WOS:000257387600014
J	Radu, RA; Hu, J; Peng, J; Bok, D; Mata, NL; Travis, GH				Radu, Roxana A.; Hu, Jane; Peng, Jennifer; Bok, Dean; Mata, Nathan L.; Travis, Gabriel H.			Retinal pigment epithelium-retinal G protein receptor-opsin mediates light-dependent translocation of all-trans-retinyl esters for synthesis of visual chromophore in retinal pigment epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; LIPID DROPLETS; VERTEBRATE RETINA; DARK-ADAPTATION; KNOCKOUT MICE; CYCLE; ACYLTRANSFERASE; RHODOPSIN; LECITHIN; RPE65	Visual perception begins with the absorption of a photon by an opsin pigment, inducing isomerization of its 11-cis-retinaldehyde chromophore. After a brief period of activation, the resulting all-trans-retinaldehyde dissociates from the opsin apoprotein rendering it insensitive to light. Restoring light sensitivity to apo-opsin requires thermal re-isomerization of all-trans-retinaldehyde to 11-cis-retinaldehyde via an enzyme pathway called the visual cycle in retinal pigment epithelial (RPE) cells. Vertebrates can see over a 108-fold range of background illumination. This implies that the visual cycle can regenerate a visual chromophore over a similarly broad range. However, nothing is known about how the visual cycle is regulated. Here we show that RPE cells, functionally or physically separated from photoreceptors, respond to light by mobilizing all-trans-retinyl esters. These retinyl esters are substrates for the retinoid isomerase and hence critical for regenerating visual chromophore. We show in knock-out mice and by RNA interference in human RPE cells that this mobilization is mediated by a protein called "RPE-retinal G protein receptor" (RGR) opsin. These data establish that RPE cells are intrinsically sensitive to light. Finally, we show that in the dark, RGR-opsin inhibits lecithin: retinol acyltransferase and all-trans-retinyl ester hydrolase in vitro and that this inhibition is released upon exposure to light. The results of this study suggest that RGR-opsin mediates light-dependent translocation of all-trans-retinyl esters from a storage pool in lipid droplets to an "isomerase pool" in membranes of the endoplasmic reticulum. This translocation permits insoluble all-trans-retinyl esters to be utilized as substrate for the synthesis of a new visual chromophore.	[Radu, Roxana A.; Hu, Jane; Peng, Jennifer; Bok, Dean; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bok, Dean] Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Bok, Dean; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Mata, Nathan L.] Sirion Therapeut, San Diego, CA 92121 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	travis@jsei.ucla.edu	Radu, Roxana A./K-8924-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Radu, Roxana/0000-0002-5064-6403	NATIONAL EYE INSTITUTE [R01EY011713] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011713-14, R01 EY011713-16, R01 EY011713-15, R01 EY011713, R01-EY01584] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; BOK D, 1992, EXP EYE RES, V55, P853, DOI 10.1016/0014-4835(92)90011-G; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; BRIDGES CDB, 1982, METHOD ENZYMOL, V81, P463; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen P, 2001, J BIOL CHEM, V276, P21098, DOI 10.1074/jbc.M010441200; Fu YB, 2005, CURR OPIN NEUROBIOL, V15, P415, DOI 10.1016/j.conb.2005.06.011; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; GROENENDIJK GWT, 1980, BIOCHIM BIOPHYS ACTA, V617, P430, DOI 10.1016/0005-2760(80)90009-0; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; HAMSDORF K, 1979, HDB SENSORY PHYSL, V7, P45; Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HARANISHIMURA I, 1990, FEBS LETT, V271, P106, DOI 10.1016/0014-5793(90)80383-T; HO MTP, 1989, J BIOL CHEM, V264, P17759; Hu J, 2001, MOL VIS, V7, P14; HUBBARD R, 1962, NATURE, V193, P341, DOI 10.1038/193341a0; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; JIANG MS, 1991, P NATL ACAD SCI USA, V88, P3907, DOI 10.1073/pnas.88.9.3907; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Mata JR, 1998, J LIPID RES, V39, P604; MATA NL, 1992, J BIOL CHEM, V267, P9794; Mata NL, 1996, J LIPID RES, V37, P1947; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Nayak SK, 2007, CELL MOL LIFE SCI, V64, P144, DOI 10.1007/s00018-006-5581-1; OZAKI K, 1986, VISION RES, V26, P691, DOI 10.1016/0042-6989(86)90083-0; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; RANDO RR, 1991, BIOCHEMISTRY-US, V30, P595, DOI 10.1021/bi00217a001; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; SAARI JC, 1988, J BIOL CHEM, V263, P8084; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; SCHWEMER J, 1985, MOL MECH PHOTORECEPT, P326; SHEN DW, 1994, BIOCHEMISTRY-US, V33, P13117, DOI 10.1021/bi00248a022; Simon A, 1999, J CELL SCI, V112, P549; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsuiki E, 2007, INVEST OPHTH VIS SCI, V48, P2858, DOI 10.1167/iovs.06-0768; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; Yang M, 2002, J BIOL CHEM, V277, P3318, DOI 10.1074/jbc.M108946200	59	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19730	19738		10.1074/jbc.M801288200	http://dx.doi.org/10.1074/jbc.M801288200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18474598	Green Published, hybrid			2022-12-27	WOS:000257387600057
J	Christoffersen, C; Ahnstrom, J; Axler, O; Christensen, EI; Dahlback, B; Nielsen, LB				Christoffersen, Christina; Ahnstrom, Josefin; Axler, Olof; Christensen, Erik Ilso; Dahlback, Bjorn; Nielsen, Lars Bo			The signal peptide anchors apolipoprotein m in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAPTOGLOBIN-RELATED PROTEIN; TRYPANOSOME LYTIC FACTOR; ANTIINFLAMMATORY PROPERTIES; EXPRESSION; IDENTIFICATION; DEGRADATION; CHOLESTEROL; SECRETION; LIGAND	Lipoproteins consist of lipids solubilized by apolipoproteins. The lipid-binding structural motifs of apolipoproteins include amphipathic alpha-helixes and beta-sheets. Plasma apolipoprotein (apo) M lacks an external amphipathic motif but, nevertheless, is exclusively associated with lipoproteins ( mainly high density lipoprotein). Uniquely, however, apoM is secreted to plasma without cleavage of its hydrophobic NH2-terminal signal peptide. To test whether the signal peptide serves as a lipoprotein anchor for apoM in plasma, we generated mice expressing a mutated apoM(Q22A) cDNA in the liver ( apoM(Q22A)-Tg mice (transgenic mice)) and compared them with mice expressing wild-type human apoM( apoM-Tg mice). The substitution of the amino acid glutamine 22 with alanine in apoMQ22A results in secretion of human apoM without a signal peptide. The human apoM mRNA level in liver and the amount of human apoM protein secretion from hepatocytes were similar in apoM-Tg and apoMQ22A-Tg mice. Nevertheless, human apoM was not detectable in plasma of apoMQ22A-Tg mice, whereas it was easily measured in the apoM-Tg mice. To examine the plasma metabolism, recombinant apoM lacking the signal peptide was produced in Escherichia coli and injected into wild-type mice. The apoM without signal peptide did not associate with lipoproteins and was rapidly cleared in the kidney. Accordingly, ligation of the kidney arteries in apoMQ22A-Tg mice resulted in rapid accumulation of human apoM in plasma. The data suggest that hydrophobic signal peptide sequences, if preserved upon secretion, can anchor plasma proteins in lipoproteins. In the case of apoM, this mechanism prevents rapid loss by filtration in the kidney.	[Christoffersen, Christina; Nielsen, Lars Bo] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Ahnstrom, Josefin; Axler, Olof; Dahlback, Bjorn] Lund Univ, Univ Hosp, Dept Lab Med, Div Clin Chem, S-21401 Malmo, Sweden; [Christensen, Erik Ilso] Univ Aarhus, Inst Anat, Dept Cell Biol, DK-8000 Aarhus, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Lund University; Skane University Hospital; Aarhus University; University of Copenhagen	Nielsen, LB (corresponding author), Univ Copenhagen, Rigshosp, Dept Clin Biochem, KB3011,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	larsbo@rh.dk		Dahlback, Bjorn/0000-0003-1546-0328; Christoffersen, Christina/0000-0003-3751-5203				Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; ATKINSON D, 1986, ANNU REV BIOPHYS BIO, V15, P403; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Axler O, 2007, J LIPID RES, V48, P1772, DOI 10.1194/jlr.M700113-JLR200; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bro S, 2004, J AM SOC NEPHROL, V15, P1495, DOI 10.1097/01.ASN.0000128371.33195.7B; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; CHEUNG MC, 1986, J LIPID RES, V27, P1135; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; COOL DR, 1995, J BIOL CHEM, V270, P8723, DOI 10.1074/jbc.270.15.8723; Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Duan JX, 2001, FEBS LETT, V499, P127, DOI 10.1016/S0014-5793(01)02544-3; Faber K, 2006, MOL ENDOCRINOL, V20, P212, DOI 10.1210/me.2005-0209; Faber K, 2004, J LIPID RES, V45, P1272, DOI 10.1194/jlr.M300451-JLR200; Juul K, 1996, CIRCULATION, V94, P1698, DOI 10.1161/01.CIR.94.7.1698; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; PALMITER RD, 1978, P NATL ACAD SCI USA, V75, P94, DOI 10.1073/pnas.75.1.94; PITTMAN RC, 1983, BIOCHEM J, V212, P791, DOI 10.1042/bj2120791; Raper J, 1999, INFECT IMMUN, V67, P1910; Sabol SL, 2005, J LIPID RES, V46, P2151, DOI 10.1194/jlr.M500080-JLR200; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Segrest JP, 2001, J LIPID RES, V42, P1346; Sorenson RC, 1999, ARTERIOSCL THROM VAS, V19, P2214, DOI 10.1161/01.ATV.19.9.2214; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; VON HG, 1991, J BIOL CHEM, V266, P15240; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; YE RD, 1988, J BIOL CHEM, V263, P4869	36	60	71	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18765	18772		10.1074/jbc.M800695200	http://dx.doi.org/10.1074/jbc.M800695200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18460466	hybrid			2022-12-27	WOS:000257165600033
J	Wei, YY; Jiang, JH; Liu, D; Zhou, J; Chen, XN; Zhang, S; Zong, HL; Yun, XJ; Gu, JX				Wei, Yuanyan; Jiang, Jianhai; Liu, Dan; Zhou, Jin; Chen, Xiaoning; Zhang, Si; Zong, Hongliang; Yun, Xiaojing; Gu, Jianxin			Cdc34-mediated degradation of ATF5 is blocked by cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL RESIDUE; ACTIVATING TRANSCRIPTION FACTOR-5; UBIQUITIN-PROTEASOME SYSTEM; NEURAL PROGENITOR CELLS; INDUCED APOPTOSIS; FUNCTIONAL INTERACTION; ATF/CREB FAMILY; CARCINOMA-CELLS; UP-REGULATION; HUMAN CDC34	ATF5, a member of activating transcription factor (ATF)/cAMP-response element-binding protein ( CREB) family of b-ZIP transcription factors, contributes to neural cell differentiation and is involved in cell apoptosis in response to cisplatin and a number of environment factors. However, the mechanisms governing the regulation of ATF5 protein during apoptosis are largely unknown. In this study we reported that ATF5 protein was a substrate of the ubiquitin-proteasome pathway. Interestingly, the ubiquitin-dependent degradation of exogenous ATF5 protein was independent of lysine residues. Instead, the addition of a large N-terminal enhanced green fluorescence protein tag increased the stability of ATF5 protein, and the free amino acid group of the N-terminal methionine of ATF5 protein was a site for ubiquitinylation, indicating that exogenous ATF5 was degraded via the ubiquitin-proteasome system through N-terminal ubiquitinylation. Furthermore, cisplatin increased ATF5 protein expression via preventing its ubiquitin-dependent degradation, which might be associated with its promoting the nucleus-to-cytoplasm translocation of E2 ubiquitin-conjugating enzyme Cdc34 and reducing the interaction between ATF5 and Cdc34. In summary, a down-regulation of proteasome-mediated degradation of ATF5 might contribute to cisplatin-induced apoptosis, providing a new mechanism of cisplatin-induced apoptosis.	[Gu, Jianxin] Fudan Univ, Ctr Gene Res, Key Lab Med Mol Virol, Minist Educ & Hlth, Shanghai 200032, Peoples R China; Fudan Univ, Shanghai Med Coll, Key Lab Glycoconjuates Res, Minist Publ Hlth, Shanghai 200032, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Gu, JX (corresponding author), Fudan Univ, Ctr Gene Res, Key Lab Med Mol Virol, Minist Educ & Hlth, Shanghai 200032, Peoples R China.	jxgu@shmu.edu.cn	Zong, Hongliang/F-9366-2013; zhang, si/AAG-9094-2021	Zong, Hongliang/0000-0002-5855-5733; zhang, Si/0000-0002-5682-4995				ALBERTS DS, 1991, SEMIN ONCOL, V18, P11; Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Angelastro JM, 2005, J NEUROSCI, V25, P3889, DOI 10.1523/JNEUROSCI.3447-04.2005; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Funaoka K, 1996, CANCER LETT, V108, P15, DOI 10.1016/S0304-3835(96)04362-5; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GOPALAN B, 2006, AACR M WASH APR 2006, P880; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoff Henry, 2004, Methods Mol Biol, V285, P79; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Hwang GW, 2007, BIOCHEM BIOPH RES CO, V363, P873, DOI 10.1016/j.bbrc.2007.09.064; Johnson CL, 2002, MOL CANCER THER, V1, P861; Jones NA, 1998, MOL PHARMACOL, V53, P819; Kubbutat MHG, 1998, MOL MED TODAY, V4, P250, DOI 10.1016/S1357-4310(98)01260-X; Liu WJ, 2004, BIOCHEM BIOPH RES CO, V321, P954, DOI 10.1016/j.bbrc.2004.07.053; Macdonald M, 2004, ONCOGENE, V23, P5643, DOI 10.1038/sj.onc.1207733; Mason JL, 2005, MOL CELL NEUROSCI, V29, P372, DOI 10.1016/j.mcn.2005.03.004; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Pati D, 1999, MOL CELL BIOL, V19, P5001; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Pintard L, 2003, NAT CELL BIOL, V5, P856, DOI 10.1038/ncb1003-856; Raymond F, 2000, J CELL SCI, V113, P1687; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sun MY, 2006, BIOCHEM BIOPH RES CO, V340, P209, DOI 10.1016/j.bbrc.2005.12.003; Wei YY, 2006, BIOCHEM BIOPH RES CO, V339, P591, DOI 10.1016/j.bbrc.2005.11.054; Wood A, 2007, J BIOL CHEM, V282, P20256, DOI 10.1074/jbc.M702366200; Yang YZ, 2007, J CELL BIOCHEM, V101, P167, DOI 10.1002/jcb.21164	43	20	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18773	18781		10.1074/jbc.M707879200	http://dx.doi.org/10.1074/jbc.M707879200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18458088	hybrid			2022-12-27	WOS:000257165600034
J	Bannister, RA; Grabner, M; Beam, KG				Bannister, Roger A.; Grabner, Manfred; Beam, Kurt G.			The alpha(1S) III-IV loop influences 1,4-dihydropyridine receptor gating but is not directly involved in excitation-contraction coupling interactions with the type 1 ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE DIHYDROPYRIDINE RECEPTOR; DYSGENIC SKELETAL-MUSCLE; CHANNEL BETA-SUBUNIT; SLOW CALCIUM CURRENT; CARBOXYL-TERMINUS; CA2+ CHANNELS; EXPRESSION; CURRENTS; MUTATION; ABSENCE	In skeletal muscle, coupling between the 1,4-dihydropyridine receptor (DHPR) and the type 1 ryanodine receptor (RyR1) underlies excitation-contraction (EC) coupling. The III-IV loop of the DHPR alpha(1S) subunit binds to a segment of RyR1 in vitro, and mutations in the III-IV loop alter the voltage dependence of EC coupling, raising the possibility that this loop is directly involved in signal transmission from the DHPR to RyR1. To clarify the role of the alpha(1S) III-IV loop in EC coupling, we examined the functional properties of a chimera (GFP-alpha(1S)[III-IVa]) in which the III-IV loop of the divergent alpha(1A) isoform replaced that of alpha(1S). Dysgenic myotubes expressing GFP-alpha(1S)[III-IVa] yielded myoplasmic Ca2+ transients that activated at similar to 10 mV more hyperpolarized potentials and that were similar to 65% smaller than those of GFP-alpha(1S). A similar reduction was observed in voltage-dependent charge movements for GFP-alpha(1S)[III-IVa], indicating that the chimeric channels trafficked less well to the membrane but that those that were in the membrane functioned as efficiently in EC coupling as GFP-alpha(1S). Relative to GFP-alpha(1S), L-type currents mediated by GFP-alpha(1S)[III-IVa] were similar to 40% smaller and activated at similar to 5 mV more hyperpolarized potentials. The altered gating of GFP-alpha(1S)[III-IVa] was accentuated by exposure to +/- Bay K 8644, which caused a much larger hyperpolarizing shift in activation compared with its effect on GFP-alpha(1S). Taken together, our observations indicate that the alpha(1S) III-IV loop is not directly involved in EC coupling but does influence DHPR gating transitions important both for EC coupling and activation of L-type conductance.	[Bannister, Roger A.; Beam, Kurt G.] Univ Colorado Denver, Dept Physiol & Biophys, Aurora, CO 80045 USA; [Grabner, Manfred] Innsbruck Med Univ, Dept Med Genet Clin & Mol Pharmacol, A-6020 Innsbruck, Austria	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of Innsbruck	Beam, KG (corresponding author), Univ Colorado Denver, Dept Physiol & Biophys, POB 6511,Mail Stop F8307, Aurora, CO 80045 USA.	kurt.beam@uchsc.edu	Tuluc, Petronel/C-2527-2011		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR044750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024444] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44750] Funding Source: Medline; NINDS NIH HHS [NS24444] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS BA, 1994, J GEN PHYSIOL, V104, P985, DOI 10.1085/jgp.104.5.985; ADAMS BA, 1989, J GEN PHYSIOL, V94, P429, DOI 10.1085/jgp.94.3.429; ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Ahern CA, 2001, BIOPHYS J, V81, P3294, DOI 10.1016/S0006-3495(01)75963-2; Avila G, 2000, J GEN PHYSIOL, V115, P467, DOI 10.1085/jgp.115.4.467; Avila G, 2001, J BIOL CHEM, V276, P17732, DOI 10.1074/jbc.M009685200; Bannister RA, 2008, BIOPHYS J, V94, P2631, DOI 10.1529/biophysj.107.116467; Bannister RA, 2005, BIOPHYS J, V88, p640A; Bannister RA, 2005, BIOCHEM BIOPH RES CO, V336, P134, DOI 10.1016/j.bbrc.2005.08.047; Bannister RA, 2007, J MUSCLE RES CELL M, V28, P275, DOI 10.1007/s10974-007-9118-5; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; Beam KG, 1997, METHOD CELL BIOL, V52, P283, DOI 10.1016/S0091-679X(08)60384-2; BEAM KG, 2004, MYOLOGY, P257; Beurg M, 1999, BIOPHYS J, V77, P2953, DOI 10.1016/S0006-3495(99)77128-6; CACHELIN AB, 1983, NATURE, V304, P462, DOI 10.1038/304462a0; Carbonneau L, 2005, BIOPHYS J, V89, P243, DOI 10.1529/biophysj.104.056218; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; DIRKSEN RT, 1995, J GEN PHYSIOL, V105, P227, DOI 10.1085/jgp.105.2.227; Flucher BE, 2000, J CELL BIOL, V151, P467, DOI 10.1083/jcb.151.2.467; Freise D, 2000, J BIOL CHEM, V275, P14476, DOI 10.1074/jbc.275.19.14476; Gach MP, 2008, BIOPHYS J, V94, P3023, DOI 10.1529/biophysj.107.118893; GARCI AK, 2007, J PHYSL, V586, P727; GARCIA J, 1994, J GEN PHYSIOL, V103, P125, DOI 10.1085/jgp.103.1.125; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leong P, 1998, J BIOL CHEM, V273, P29958, DOI 10.1074/jbc.273.45.29958; LLINAS RR, 1989, ANN NY ACAD SCI, V560, P103, DOI 10.1111/j.1749-6632.1989.tb24084.x; Lorenzon NM, 2007, J GEN PHYSIOL, V130, P379, DOI 10.1085/jgp.200609730; Lorenzon NM, 2004, J BIOL CHEM, V279, P44057, DOI 10.1074/jbc.M405318200; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Obermair GJ, 2005, J BIOL CHEM, V280, P2229, DOI 10.1074/jbc.M411501200; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Proenza C, 2000, J BIOL CHEM, V275, P23169, DOI 10.1074/jbc.M003389200; SANGUINETTI MC, 1984, J MOL CELL CARDIOL, V16, P667, DOI 10.1016/S0022-2828(84)80631-8; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Sencer S, 2001, J BIOL CHEM, V276, P38237; Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103; Sheridan DC, 2004, BIOPHYS J, V87, P929, DOI 10.1529/biophysj.104.043810; Sheridan DC, 2003, BIOPHYS J, V85, P3739, DOI 10.1016/S0006-3495(03)74790-0; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Slavik KJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1475, DOI 10.1152/ajpcell.1997.272.5.C1475; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; Takekura H, 2004, MOL BIOL CELL, V15, P5408, DOI 10.1091/mbc.E04-05-0414; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; THOMAS G, 1985, CIRC RES, V56, P87, DOI 10.1161/01.RES.56.1.87; Ursu D, 2001, J PHYSIOL-LONDON, V533, P367, DOI 10.1111/j.1469-7793.2001.0367a.x; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; Wilkens CM, 2001, J GEN PHYSIOL, V118, P495, DOI 10.1085/jgp.118.5.495; Wilkens CM, 2001, P NATL ACAD SCI USA, V98, P5892, DOI 10.1073/pnas.101618098	58	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23217	23223		10.1074/jbc.M804312200	http://dx.doi.org/10.1074/jbc.M804312200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18556650	Green Published, hybrid			2022-12-27	WOS:000258455400035
J	Radzimanowski, J; Ravaud, S; Schlesinger, S; Koch, J; Beyreuther, K; Sinning, I; Wild, K				Radzimanowski, Jens; Ravaud, Stephanie; Schlesinger, Sabine; Koch, Joachim; Beyreuther, Konrad; Sinning, Irmgard; Wild, Klemens			Crystal structure of the human Fe65-PTB1 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PHOSPHOTYROSINE-BINDING DOMAIN; BETA-PROTEIN; FE65; RECOGNITION; INTERNALIZATION; DISABLED-1; DISTINCT; IRS-1; MOTIF	The neuronal adaptor protein Fe65 is involved in brain development, Alzheimer disease amyloid precursor protein (APP) signaling, and proteolytic processing of APP. It contains three protein-protein interaction domains, one WW domain, and a unique tandem array of phosphotyrosine-binding (PTB) domains. The N-terminal PTB domain (Fe65-PTB1) was shown to interact with a variety of proteins, including the low density lipoprotein receptor-related protein (LRP-1), the ApoEr2 receptor, and the histone acetyltransferase Tip60. We have determined the crystal structures of human Fe65-PTB1 in its apo- and in a phosphate-bound form at 2.2 and 2.7 angstrom resolution, respectively. The overall fold shows a PTB-typical pleckstrin homology domain superfold. Although Fe65-PTB1 has been classified on an evolutionary basis as a Dab-like PTB domain, it contains attributes of other PTB domain subfamilies. The phosphotyrosine-binding pocket resembles IRS-like PTB domains, and the bound phosphate occupies the binding site of the phosphotyrosine (Tyr(P)) within the canonical NPXpY recognition motif. In addition Fe65-PTB1 contains a loop insertion between helix alpha 2 and strand beta 2 (alpha 2/beta 2 loop) similar to members of the Shc-like PTB domain subfamily. The structural comparison with the Dab1-PTB domain reveals a putative phospholipid-binding site opposite the peptide binding pocket. We suggest Fe65-PTB1 to interact with its target proteins involved in translocation and signaling of APP in a phosphorylation- dependent manner.	[Radzimanowski, Jens; Ravaud, Stephanie; Schlesinger, Sabine; Sinning, Irmgard; Wild, Klemens] Heidelberg Univ, Biochem Ctr, INF328, D-69120 Heidelberg, Germany; [Koch, Joachim] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-69438 Frankfurt, Germany; [Beyreuther, Konrad] Heidelberg Univ, Ctr Mol Biol, INF282, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Goethe University Frankfurt; Ruprecht Karls University Heidelberg	Wild, K (corresponding author), Heidelberg Univ, Biochem Ctr, INF328, D-69120 Heidelberg, Germany.	klemens.wild@bzh.uni-heidelberg.de	Sinning, Irmgard/A-2982-2010		Deutsche Forschungsgemeinschaft [WI2649/1-1, WI2649/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants WI2649/1-1 and WI2649/1-2 ( to K. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Farooq A, 1999, J BIOL CHEM, V274, P6114, DOI 10.1074/jbc.274.10.6114; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Holm L, 1996, METHOD ENZYMOL, V266, P653; Howell BW, 1999, MOL CELL BIOL, V19, P5179; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; KOCH J, 2002, SPRING LAB MAN, P69; KOO EH, 1994, J BIOL CHEM, V269, P17386; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Radzimanowski J, 2008, ACTA CRYSTALLOGR F, V64, P382, DOI 10.1107/S174430910800835X; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 2001, J BIOL CHEM, V276, P19787, DOI 10.1074/jbc.M100792200; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	54	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23113	23120		10.1074/jbc.M800861200	http://dx.doi.org/10.1074/jbc.M800861200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18550529	hybrid			2022-12-27	WOS:000258455400024
J	Li, Y; Bevilacqua, E; Chiribau, CB; Majumder, M; Wang, CP; Croniger, CM; Snider, MD; Johnson, PF; Hatzoglou, M				Li, Yi; Bevilacqua, Elena; Chiribau, Calin-Bogdan; Majumder, Mithu; Wang, Chuanping; Croniger, Colleen M.; Snider, Martin D.; Johnson, Peter F.; Hatzoglou, Maria			Differential control of the CCAAT/enhancer-binding protein beta (C/EBP beta) products liver-enriched transcriptional activating protein (LAP) and liver- enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; SITE-MEDIATED TRANSLATION; AMINO-ACID TRANSPORTER; ER STRESS; ARGININE/LYSINE TRANSPORTER; NEGATIVE FEEDBACK; NF-Y; PHOSPHORYLATION; INDUCTION; CHOP	The accumulation of unfolded proteins in the endoplasmic reticulum (ER) triggers a stress response program that protects cells early in the response and can lead to apoptosis during prolonged stress. The basic leucine zipper transcription factor, CCAAT/enhancer-binding protein beta (C/EBP beta), is one of the genes with increased expression during ER stress. Translation of the C/EBP beta mRNA from different initiation codons leads to the synthesis of two transcriptional activators (LAP-1 and -2) and a transcriptional repressor (LIP). The LIP/LAP ratio is a critical factor in C/EBP beta-mediated gene transcription. It is shown here that the LIP/LAP ratio decreased by 5-fold during the early phase of ER stress and increased by 20-fold during the late phase, mostly because of changes in LIP levels. The early decrease in LIP required degradation via the proteasome pathway and phosphorylation of the translation initiation factor, eIF2 alpha. The increased LIP levels during the late phase were due to increased synthesis and increased stability of the protein. It is proposed that regulation of synthesis and degradation rates during ER stress controls the LIP/LAP ratio. The importance of C/EBP beta in the ER-stress response program was demonstrated using C/EBP beta-deficient mouse embryonic fibroblasts. It is shown that C/EBP beta attenuates expression of pro-survival ATF4 target genes in late ER stress and enhances expression of cell death-associated genes downstream of CHOP. The inhibitory effect of LIP on ATF4-induced transcription was demonstrated for the cat-1 amino acid transporter gene. We conclude that regulation of LIP/LAP ratios during ER stress is a novel mechanism for modulating the cellular stress response.	[Li, Yi; Bevilacqua, Elena; Chiribau, Calin-Bogdan; Majumder, Mithu; Wang, Chuanping; Croniger, Colleen M.; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Johnson, Peter F.] NCI Frederick, Basic Res Lab, Natl Inst Hlth, Frederick, MD 21702 USA	Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Dept Nutr, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxh8@case.edu	Johnson, Peter/A-1940-2012	Johnson, Peter/0000-0002-4145-4725; Li, Yi/0000-0002-5048-6075	NATIONAL CANCER INSTITUTE [ZIABC010328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075040, R01DK060596, R01DK053307, R37DK060596] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [DK075040, R01 DK075040-03, R01 DK075040, DK053307, DK060596] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; Basu A, 2002, INT J ONCOL, V21, P597; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; CHODOSH LA, 2001, CURRENT PROTOCOLS MO; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hai T, 1999, GENE EXPRESSION, V7, P321; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hu B, 2004, J IMMUNOL, V173, P4661, DOI 10.4049/jimmunol.173.7.4661; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kapadia R, 2006, J NEUROCHEM, V98, P1718, DOI 10.1111/j.1471-4159.2006.04056.x; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; RAUGHT B, 1995, MOL ENDOCRINOL, V9, P1223, DOI 10.1210/me.9.9.1223; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rorth P, 2000, MOL CELL, V6, P23; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Selim E, 2007, MOL IMMUNOL, V44, P1218, DOI 10.1016/j.molimm.2006.06.006; Shang J, 2004, BIOCHEM BIOPH RES CO, V317, P390, DOI 10.1016/j.bbrc.2004.03.058; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sok J, 1999, MOL CELL BIOL, V19, P495; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yerlikaya A, 2008, BIOCHEM J, V412, P579, DOI 10.1042/BJ20080324; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	80	71	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22443	22456		10.1074/jbc.M801046200	http://dx.doi.org/10.1074/jbc.M801046200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18550528	hybrid, Green Published			2022-12-27	WOS:000258321000012
J	Mathew, S; George, SP; Wang, YH; Siddiqui, MR; Srinivasan, K; Tan, LZ; Khurana, S				Mathew, Sijo; George, Sudeep P.; Wang, Yaohong; Siddiqui, Mohammad Rizwan; Srinivasan, Kamalakkannan; Tan, Langzhu; Khurana, Seema			Potential molecular mechanism for C-Src kinase-mediated regulation of intestinal cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CARCINOMA; TYROSINE-PHOSPHATASE SHP-2; COMMON GAMMA-CHAIN; MICE LACKING JAK3; FAMILY KINASES; PTP-PEST; PHOSPHOLIPASE C-GAMMA(1); COMPLEX-FORMATION; EPITHELIAL-CELLS; PROTEIN VILLIN	The ubiquitously expressed Src tyrosine kinases (c-Src, c-Yes, and c-Fyn) regulate intestinal cell growth and differentiation. Src activity is also elevated in the majority of malignant and premalignant tumors of the colon. The development of fibroblasts with the three ubiquitously expressed kinases deleted (SYF cells) has identified the role of Src proteins in the regulation of actin dynamics associated with increased cell migration and invasion. Despite this, unexpectedly nothing is known about the role of the individual Src kinases on intestinal cell cytoskeleton and/or cell migration. We have previously reported that villin, an epithelial cell-specific actin-modifying protein that regulates actin reorganization, cell morphology, cell migration, cell invasion, and apoptosis, is tyrosine-phosphorylated. In this report using the SYF cells reconstituted individually with c-Src, c-Yes, c-Fyn, and wild type or phosphorylation site mutants of villin, we demonstrate for the first time the absolute requirement for c-Src in villin-induced regulation of cell migration. The other major finding of our study is that contrary to previous reports, the nonreceptor tyrosine kinase, Jak3 (Janus kinase 3), does not regulate phosphorylation of villin or villin-induced cell migration and is, in fact, not expressed in intestinal epithelial cells. Further, we identify SHP-2 and PTPPEST (protein-tyrosine phosphatase proline-, glutamate-, serine, and threonine-rich sequence) as negative regulators of c-Src kinase and demonstrate a new function for these phosphatases in intestinal cell migration. Together, these data suggest that in colorectal carcinogenesis, elevation of c-Src or down-regulation of SHP-2 and/ or PTP-PEST may promote cancer metastases and invasion by regulating villin-induced cell migration and cell invasion.	[Mathew, Sijo; George, Sudeep P.; Wang, Yaohong; Siddiqui, Mohammad Rizwan; Srinivasan, Kamalakkannan; Tan, Langzhu; Khurana, Seema] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Khurana, S (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Nash 402,894 Union Ave, Memphis, TN 38163 USA.	skhurana@utmem.edu		Khurana, Seema/0000-0002-6884-810X	NIDDK NIH HHS [DK-65006, DK-54755] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065006, R01DK054755] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Barraclough J, 2007, NEOPLASIA, V9, P745, DOI 10.1593/neo.07442; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; CARTWRIGHT CA, 1993, ONCOGENE, V8, P1033; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; DiDomenico M, 1996, CANCER RES, V56, P4516; Doan T, 2004, CELL SIGNAL, V16, P301, DOI 10.1016/j.cellsig.2003.08.001; Emami S, 2001, FASEB J, V15, P351, DOI 10.1096/fj.00-0355com; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; FRANCK Z, 1990, J CELL BIOL, V111, P2475, DOI 10.1083/jcb.111.6.2475; FRIEDERICH E, 1989, CELL, V59, P461, DOI 10.1016/0092-8674(89)90030-5; Fuhrer DK, 1996, BIOCHEM BIOPH RES CO, V224, P289, DOI 10.1006/bbrc.1996.1023; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Hall CL, 1996, ONCOGENE, V13, P2213; Han NM, 1996, CLIN CANCER RES, V2, P1397; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Huang CS, 2005, J NUTR, V135, P2119, DOI 10.1093/jn/135.9.2119; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Khurana S, 1997, J BIOL CHEM, V272, P30115, DOI 10.1074/jbc.272.48.30115; Khurana S, 2006, ADV MOL CEL, V37, P89, DOI 10.1016/S1569-2558(06)37005-1; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Khurana S, 2008, EXP CELL RES, V314, P530, DOI 10.1016/j.yexcr.2007.10.028; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kumar N, 2004, J BIOL CHEM, V279, P24915, DOI 10.1074/jbc.C400110200; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; Malaviya R, 1999, J BIOL CHEM, V274, P27028, DOI 10.1074/jbc.274.38.27028; Malaviya R, 2001, IMMUNITY, V15, P313, DOI 10.1016/S1074-7613(01)00184-4; Marchetti D, 1998, ONCOGENE, V16, P3253, DOI 10.1038/sj.onc.1201877; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Murata T, 1995, J BIOL CHEM, V270, P30829, DOI 10.1074/jbc.270.51.30829; Murata T, 1996, J IMMUNOL, V156, P2972; Murata Y, 2002, INT IMMUNOL, V14, P627, DOI 10.1093/intimm/dxf031; Narisawa-Saito M, 1999, P NATL ACAD SCI USA, V96, P2461, DOI 10.1073/pnas.96.5.2461; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; PARK J, 1995, MOL CELL BIOL, V15, P2374; PARK JS, 1993, ONCOGENE, V8, P2627; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Playford MP, 2006, J BIOL CHEM, V281, P34104, DOI 10.1074/jbc.M606277200; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Qiu L, 2006, BLOOD, V108, P2407, DOI 10.1182/blood-2006-04-020305; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; RODIER JM, 1995, J CELL BIOL, V131, P761, DOI 10.1083/jcb.131.3.761; Rossi L, 2007, PHARMACOL RES, V56, P248, DOI 10.1016/j.phrs.2007.07.001; Sastry SK, 2002, J CELL SCI, V115, P4305, DOI 10.1242/jcs.00105; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Streit S, 2006, CANCER GENET CYTOGEN, V170, P48, DOI 10.1016/j.cancergencyto.2006.05.013; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Tomar A, 2004, MOL BIOL CELL, V15, P4807, DOI 10.1091/mbc.E04-05-0431; Tomar A, 2006, J BIOL CHEM, V281, P31972, DOI 10.1074/jbc.M604323200; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang YH, 2008, J BIOL CHEM, V283, P9454, DOI 10.1074/jbc.M707962200; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; WHITE E, 1984, MOL CELL BIOL, V4, P2865, DOI 10.1128/MCB.4.12.2865; Zhai LW, 2002, BIOCHEMISTRY-US, V41, P11750, DOI 10.1021/bi0263762; ZHAO YH, 1993, MOL CELL BIOL, V13, P7507, DOI 10.1128/MCB.13.12.7507	79	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22709	22722		10.1074/jbc.M801319200	http://dx.doi.org/10.1074/jbc.M801319200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18482983	Green Published, hybrid			2022-12-27	WOS:000258321000040
J	Ehteshami, M; Beilhartz, GL; Scarth, BJ; Tchesnokov, EP; McCormick, S; Wynhoven, B; Harrigan, PR; Gotte, M				Ehteshami, Maryam; Beilhartz, Greg L.; Scarth, Brian J.; Tchesnokov, Egor P.; McCormick, Suzanne; Wynhoven, Brian; Harrigan, P. Richard; Gotte, Matthias			Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3 '-azido-3 '-deoxythymidine through both RNase H-dependent and -independent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE ACTIVE-SITE; DOUBLE-STRANDED DNA; DRUG-RESISTANCE; ANGSTROM RESOLUTION; PRIMER UNBLOCKING; CRYSTAL-STRUCTURE; TRANSLOCATION STATUS; ANALOG INHIBITORS; DUAL RESISTANCE	Thymidine analogue-associated mutations (TAMs) in reverse transcriptase (RT) of the human immunodeficiency virus type 1 (HIV-1) cause resistance to 3'-azido-3'-deoxythymidine (AZT) through excision of the incorporated monophosphate. Mutations in the connection domain of HIV-1 RT can augment AZT resistance. It has been suggested that these mutations compromise RNase H cleavage, providing more time for AZT excision to occur. However, the underlying mechanism remains elusive. Here, we focused on connection mutations N348I and A360V that are frequently observed in clinical samples of treatment-experienced patients. We show that both N348I and A360V, in combination with TAMs, decrease the efficiency of RNase H cleavage and increase excision of AZT in the presence of the pyrophosphate donor ATP. The TAMs/N348I/A360V mutant accumulates transiently formed, shorter hybrids that can rebind to RT before the template is irreversibly degraded. These hybrids dissociate selectively from the RNase H-competent complex, whereas binding in the polymerase-competent mode is either not affected with N348I or modestly improved with A360V. Both connection domain mutations can compensate for TAM-mediated deficits in processive DNA synthesis, and experiments with RNase H negative mutant enzymes confirman RNase H-independent contribution to increased levels of resistance to AZT. Moreover, the combination of diminished RNase H cleavage and increased processivity renders the use of both PPi and ATP advantageous, whereas classic TAMs solely enhance the ATP-dependent reaction. Taken together, our findings demonstrate that distinct, complementary mechanisms can contribute to higher levels of excision of AZT, which in turn can amplify resistance to this drug.	[Ehteshami, Maryam; Beilhartz, Greg L.; Scarth, Brian J.; Tchesnokov, Egor P.; McCormick, Suzanne; Gotte, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Wynhoven, Brian; Harrigan, P. Richard] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada	McGill University; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca						ARTS EJ, 1994, J BIOL CHEM, V269, P14672; Basavapathruni A, 2006, CURR PHARM DESIGN, V12, P1857, DOI 10.2174/138161206776873617; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Cane PA, 2007, AIDS, V21, P447, DOI 10.1097/QAD.0b013e3280129964; Cingolani A, 2002, AIDS, V16, P369, DOI 10.1097/00002030-200202150-00008; Cristofaro JV, 2002, BIOCHEMISTRY-US, V41, P10968, DOI 10.1021/bi025871v; De Clercq E, 2007, Verh K Acad Geneeskd Belg, V69, P81; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; El Safadi Y, 2007, APPL MICROBIOL BIOT, V75, P723, DOI 10.1007/s00253-007-0919-7; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; Gotte M, 2007, PLOS MED, V4, P1858, DOI 10.1371/journal.pmed.0040346; Gotte Matthias, 2004, Expert Rev Anti Infect Ther, V2, P707, DOI 10.1586/14789072.2.5.707; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Harrigan PR, 2002, J VIROL, V76, P6836, DOI 10.1128/JVI.76.13.6836-6840.2002; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ilina T, 2008, ADV PHARMACOL, V56, P121, DOI 10.1016/S1054-3589(07)56005-9; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Johnson Victoria A, 2008, Top HIV Med, V16, P62; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kemp SD, 1998, J VIROL, V72, P5093, DOI 10.1128/JVI.72.6.5093-5098.1998; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 2007, J MOL BIOL, V369, P41, DOI 10.1016/j.jmb.2007.03.006; Meyer PR, 2002, ANTIMICROB AGENTS CH, V46, P1540, DOI 10.1128/AAC.46.5.1540-1545.2002; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P3861, DOI 10.1128/AAC.00646-07; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Radzio J, 2008, MOL PHARMACOL, V73, P601, DOI 10.1124/mol.107.038596; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; Ren J, 2005, TRENDS PHARMACOL SCI, V26, P4, DOI 10.1016/j.tips.2004.11.003; Santos AFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001781; Sarafianos SG, 1999, CHEM BIOL, V6, pR137, DOI 10.1016/S1074-5521(99)80071-4; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SCHATZ O, 1990, EMBO J, V9, P1171, DOI 10.1002/j.1460-2075.1990.tb08224.x; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Smith AJ, 2006, CURR PHARM DESIGN, V12, P1827, DOI 10.2174/138161206776873572; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tural C, 2002, AIDS, V16, P209, DOI 10.1097/00002030-200201250-00010; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zelina S, 2008, ANTIMICROB AGENTS CH, V52, P157, DOI 10.1128/AAC.00904-07; Zolopa AR, 2005, CLIN INFECT DIS, V41, P92, DOI 10.1086/430706	60	68	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22222	22232		10.1074/jbc.M803521200	http://dx.doi.org/10.1074/jbc.M803521200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18547911	Green Published, hybrid			2022-12-27	WOS:000258114700042
J	Fenske, SA; Yesilaltay, A; Pal, R; Daniels, K; Rigotti, A; Krieger, M; Kocher, O				Fenske, Sara A.; Yesilaltay, Ayce; Pal, Rinku; Daniels, Kathleen; Rigotti, Attilio; Krieger, Monty; Kocher, Olivier			Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SR-BI; TARGETED DISRUPTION; CHOLESTEROL EFFLUX; LIPID-METABOLISM; APOLIPOPROTEIN-E; HDL CHOLESTEROL; EXPRESSION; PROTEIN; GENE	PDZK1 is a four-PDZ domain-containing scaffold protein that, via its first PDZ domain (PDZ1), binds to the C terminus of the high density lipoprotein (HDL) receptor scavenger receptor, class B, type I (SR-BI). Abolishing PDZK1 expression in PDZK1 knock-out (KO) mice leads to a post-transcriptional, tissue-specific decrease in SR-BI protein level and an increase in total plasma cholesterol carried in abnormally large HDL particles. Here we show that, although hepatic overexpression of PDZK1 restored normal SR-BI protein abundance and function in PDZK1 KO mice, hepatic overexpression of only the PDZ1 domain was not sufficient to restore normal SR-BI function. In wild-type mice, overexpression of the PDZ1 domain overcame the activity of the endogenous hepatic PDZK1, resulting in a 75% reduction in hepatic SR-BI protein levels and intracellular mislocalization of the remaining SR-BI. As a consequence, the plasma lipoproteins in PDZ1 transgenic mice resembled those in PDZK1 KO mice (hypercholesterolemia due to large HDL). These results indicate that the PDZ1 domain can control the abundance and localization, and therefore the function, of hepatic SR-BI and that structural features of PDZK1 in addition to its SR-BI-binding PDZ1 domain are required for normal hepatic SR-BI regulation.	[Fenske, Sara A.; Yesilaltay, Ayce; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pal, Rinku; Daniels, Kathleen; Kocher, Olivier] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Pal, Rinku; Daniels, Kathleen; Kocher, Olivier] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Rigotti, Attilio] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago 8330024, Chile	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Pontificia Universidad Catolica de Chile	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.	krieger@mit.edu; okocher@bidmc.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077780, P01HL066105, R01HL064737, R01HL052212] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64737, HL66105, HL077780, HL52212] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Eckhardt ERM, 2004, J BIOL CHEM, V279, P14372, DOI 10.1074/jbc.M313793200; Fu T, 2003, J BIOL CHEM, V278, P52559, DOI 10.1074/jbc.M310892200; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mardones P, 2001, J LIPID RES, V42, P170; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Miettinen HE, 2001, J CLIN INVEST, V108, P1717, DOI 10.1172/JCI13288; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Out R, 2005, J LIPID RES, V46, P1172, DOI 10.1194/jlr.M400361-JLR200; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Treguier M, 2007, BBA-MOL CELL BIOL L, V1771, P129, DOI 10.1016/j.bbalip.2006.12.004; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Van Eck M, 2008, J LIPID RES, V49, P136, DOI 10.1194/jlr.M700355-JLR200; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wang PJ, 2005, J BIOL CHEM, V280, P30143, DOI 10.1074/jbc.M503969200; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Webb NR, 1997, J LIPID RES, V38, P1490; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Zhang XH, 2007, ENDOCRINOLOGY, V148, P5295, DOI 10.1210/en.2007-0376; Zimetti F, 2006, J LIPID RES, V47, P605, DOI 10.1194/jlr.M500466-JLR200	51	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22097	22104		10.1074/jbc.M800029200	http://dx.doi.org/10.1074/jbc.M800029200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18544532	Green Published, hybrid			2022-12-27	WOS:000258114700028
J	Granum, S; Andersen, TCB; Sorlie, M; Jorgensen, M; Koll, L; Berge, T; Lea, T; Fleckenstein, B; Spurkland, A; Sundvold-Gjerstad, V				Granum, Stine; Andersen, Thorny Cesilie Bie; Sorlie, Morten; Jorgensen, Marit; Koll, Lise; Berge, Tone; Lea, Tor; Fleckenstein, Burkhard; Spurkland, Anne; Sundvold-Gjerstad, Vibeke			Modulation of Lck function through multisite docking to T cell-specific adapter protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE HCK; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; SH2 DOMAIN; PROCESSIVE PHOSPHORYLATION; BINDING-SITES; C-SRC; ACTIVATION; ZAP-70; SUBSTRATE	T cell-specific adapter protein (TSAd), encoded by the SH2D2A gene, interacts with Lck through its C terminus and thus modulates Lck activity. Here we mapped Lck phosphorylation and interaction sites on TSAd and evaluated their functional importance. The three C-terminal TSAd tyrosines Tyr(280), Tyr(290), and Tyr(305) were phosphorylated by Lck and functioned as docking sites for the Lck Src homology 2 (SH2) domain. Binding affinities of the TSAd Tyr(P)(280) and Tyr(P)(290) phosphopeptides to the isolated Lck SH2 domain were similar to that observed for the Lck Tyr(P)(505) phosphopeptide, whereas the TSAd Tyr(P)(305) peptide displayed a 10-fold higher affinity. The proline-rich Lck SH3-binding site on TSAd as well as the Lck SH2 domain were required for efficient tyrosine phosphorylation of TSAd by Lck. Interaction sites on TSAd for both Lck SH2 and Lck SH3 were necessary for TSAd-mediated modulation of proximal TCR signaling events. We found that 20-30% of TSAd molecules are phosphorylated in activated T cells and that the proportion of TSAd to Lck molecules in such cells is similar to 1:1. Therefore, in activated T cells, a considerable number of Lck molecules may potentially be engaged by TSAd. In conclusion, Lck binds to TSAd prolines and phosphorylates and interacts with the three C-terminal TSAd tyrosines. We propose that through multivalent interactions with Lck, TSAd diverts Lck from phosphorylating other substrates, thus modulating its functional activity through substrate competition.	[Granum, Stine; Andersen, Thorny Cesilie Bie; Koll, Lise; Berge, Tone; Sundvold-Gjerstad, Vibeke] Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0317 Oslo, Norway; [Sorlie, Morten; Lea, Tor] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Jorgensen, Marit; Lea, Tor; Fleckenstein, Burkhard; Spurkland, Anne] Natl Hosp Norway, Med Ctr, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; Norwegian University of Life Sciences; University of Oslo; National Hospital Norway	Granum, S (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Box 1105, N-0317 Oslo, Norway.	stine.granum@medisin.uio.no	Spurkland, Anne/L-3369-2019	Spurkland, Anne/0000-0003-4421-0766				AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; Choi YB, 1999, J IMMUNOL, V163, P5242; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Dai KZ, 2004, J IMMUNOL, V172, P6144, DOI 10.4049/jimmunol.172.10.6144; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Drappa J, 2003, J EXP MED, V198, P809, DOI 10.1084/jem.20021358; Granum S, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-15; HIRAI H, 1990, P NATL ACAD SCI USA, V87, P8592, DOI 10.1073/pnas.87.21.8592; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Kolltveit KM, 2008, MOL IMMUNOL, V45, P2380, DOI 10.1016/j.molimm.2007.11.005; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; LEMMON MA, 1994, BIOCHEMISTRY-US, V33, P5070, DOI 10.1021/bi00183a010; Liu HH, 2006, ACTA PHYS-CHIM SIN, V22, P868, DOI 10.3866/PKU.WHXB20060720; Marti F, 2006, J EXP MED, V203, P281, DOI 10.1084/jem.20051637; Marti F, 2005, IMMUNOL LETT, V97, P235, DOI 10.1016/j.imlet.2004.10.021; MARTI F, 2004, CLIN INVEST MED, V37; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Methi T, 2007, EUR J IMMUNOL, V37, P2539, DOI 10.1002/eji.200636973; Miller WT, 2003, ACCOUNTS CHEM RES, V36, P393, DOI 10.1021/ar020116v; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Park DS, 2001, BIOCHEM BIOPH RES CO, V284, P275, DOI 10.1006/bbrc.2001.4957; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Simeoni L, 2004, CURR OPIN IMMUNOL, V16, P304, DOI 10.1016/j.coi.2004.03.001; Spurkland A, 1998, J BIOL CHEM, V273, P4539, DOI 10.1074/jbc.273.8.4539; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Sundvold V, 2000, J IMMUNOL, V165, P2927, DOI 10.4049/jimmunol.165.6.2927; Sundvold-Gjerstad V, 2005, EUR J IMMUNOL, V35, P1612, DOI 10.1002/eji.200425638; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VEILLETTE A, 1990, ONCOGENE, V5, P1455; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WEIL R, 1994, J BIOL CHEM, V269, P22830; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xing LZ, 2004, MOL CELL BIOL, V24, P4581, DOI 10.1128/MCB.24.10.4581-4592.2004; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	54	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21909	21919		10.1074/jbc.M800871200	http://dx.doi.org/10.1074/jbc.M800871200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18541536	hybrid			2022-12-27	WOS:000258114700010
J	Nirthanan, S; Garcia, G; Chiara, DC; Husain, SS; Cohen, JB				Nirthanan, Selvanayagam; Garcia, Galo, III; Chiara, David C.; Husain, S. Shaukat; Cohen, Jonathan B.			Identification of binding sites in the nicotinic acetylcholine receptor for TDBzl-etomidate, a photoreactive positive allosteric effector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL ANESTHETIC ETOMIDATE; LIPID-PROTEIN INTERFACE; GATED ION CHANNELS; NONCOMPETITIVE ANTAGONIST; MOLECULAR-MECHANISMS; SUBUNIT INTERFACES; AMINO-ACIDS; GABA(A); LIGAND; GALANTAMINE	Etomidate, one of the most potent general anesthetics used clinically, acts at micromolar concentrations as an anesthetic and positive allosteric modulator of gamma-aminobutyric acid responses, whereas it inhibits muscle-type nicotinic acetylcholine receptors (nAChRs) at concentrations above 10 mu M. We report here that TDBzl-etomidate, a photoreactive etomidate analog, acts as a positive allosteric nAChR modulator rather than an inhibitor, and we identify its binding sites by photoaffinity labeling. TDBzl-etomidate (> 10 mu M) increased the submaximal response to acetylcholine (10 mu M) with a 2.5-fold increase at 60 mu M. At higher concentrations, it inhibited the binding of the noncompetitive antagonists [H-3] tetracaine and [3H] phencyclidine to Torpedo nAChR-rich membranes (IC50 values of 0.8 mM). nAChR-rich membranes were photolabeled with [3H] TDBzl-etomidate, and labeled amino acids were identified by Edman degradation. For nAChRs photolabeled in the absence of agonist (resting state), there was tetracaine-inhibitable photolabeling of amino acids in the ion channel at positions M2-9 (delta Leu-265) and M2-13 (alpha Val-255 and delta Val-269), whereas labeling of alpha M2-10 (alpha Ser-252) was not inhibited by tetracaine but was enhanced 10-fold by proadifen or phencyclidine. In addition, there was labeling in gamma M3 (gamma Met-299), a residue that contributes to the same pocket in the nAChR structure as alpha M2-10. The pharmacological specificity of labeling of residues, together with their locations in the nAChR structure, indicate that TDBzl-etomidate binds at two distinct sites: one within the lumen of the ion channel (labeling of M2-9 and -13), an inhibitory site, and another at the interface between the alpha and gamma subunits (labeling of alpha M2-10 and gamma Met-299) likely to be a site for positive allosteric modulation.	[Nirthanan, Selvanayagam; Garcia, Galo, III; Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Husain, S. Shaukat] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu	Nirthanan, Selvanayagam/ABI-4281-2020	Nirthanan, S. Niru/0000-0001-9888-8447	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [P01 GM058448, GM-58448] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akk G, 2005, J NEUROSCI, V25, P1992, DOI 10.1523/JNEUROSCI.4985-04.2005; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Blanton MP, 1998, J BIOL CHEM, V273, P8659, DOI 10.1074/jbc.273.15.8659; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broad LM, 2006, J PHARMACOL EXP THER, V318, P1108, DOI 10.1124/jpet.106.104505; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Gallagher MJ, 1999, MOL PHARMACOL, V56, P300, DOI 10.1124/mol.56.2.300; Garcia G, 2007, BIOCHEMISTRY-US, V46, P10296, DOI 10.1021/bi7008163; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Middleton RE, 1999, MOL PHARMACOL, V56, P290, DOI 10.1124/mol.56.2.290; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; OKONJO KO, 1991, EUR J BIOCHEM, V200, P671, DOI 10.1111/j.1432-1033.1991.tb16231.x; OSWALD RE, 1983, BIOCHEMISTRY-US, V22, P3128, DOI 10.1021/bi00282a015; REVAH F, 1990, P NATL ACAD SCI USA, V87, P4675, DOI 10.1073/pnas.87.12.4675; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; Ryan SE, 2001, J BIOL CHEM, V276, P4796, DOI 10.1074/jbc.M007063200; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHRATTENHOLZ A, 1993, EUR J BIOCHEM, V216, P671, DOI 10.1111/j.1432-1033.1993.tb18187.x; SIGRIST H, 1990, J PHOTOCH PHOTOBIO B, V7, P277, DOI 10.1016/1011-1344(90)85162-P; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vodovozova EL, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1, DOI 10.1134/S0006297907010014; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1991, J BIOL CHEM, V266, P21595; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Yamakura T, 2001, ANNU REV PHARMACOL, V41, P23, DOI 10.1146/annurev.pharmtox.41.1.23; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	48	58	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22051	22062		10.1074/jbc.M801332200	http://dx.doi.org/10.1074/jbc.M801332200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18524766	Green Published, hybrid			2022-12-27	WOS:000258114700024
J	Sama, MA; Mathis, DM; Furman, JL; Abdul, HM; Artiushin, IA; Kraner, SD; Norris, CM				Sama, Michelle A.; Mathis, Diana M.; Furman, Jennifer L.; Abdul, Hafiz Mohmmad; Artiushin, Irina A.; Kraner, Susan D.; Norris, Christopher M.			Interleukin-1 beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE ASTROCYTES; GLUTAMATE TRANSPORT; CALCIUM-CHANNELS; TRANSCRIPTIONAL REGULATION; NEURODEGENERATIVE DISEASE; INFLAMMATORY CYTOKINE; INTRACELLULAR CALCIUM; HIPPOCAMPAL-NEURONS; CORTICAL ASTROCYTES; ALZHEIMERS-DISEASE	Interleukin-1 beta (IL-1 beta) and the Ca2+/calmodulin-dependent protein phosphatase, calcineurin, have each been shown to play an important role in neuroinflammation. However, whether these signaling molecules interact to coordinate immune/inflammatory processes and neurodegeneration has not been investigated. Here, we show that exogenous application of IL-1 beta (10 ng/ml) recruited calcineurin/NFAT (nuclear factor of activated T cells) activation in primary astrocyte-enriched cultures within minutes, through a pathway involving IL-1 receptors and L-type Ca2+ channels. Adenovirus-mediated delivery of the NFAT inhibitor, VIVIT, suppressed the IL-1 beta-dependent induction of several inflammatory mediators and/or markers of astrocyte activation, including tumor necrosis factor alpha, granulocyte/ macrophage colony-stimulating factor, and vimentin. Expression of an activated form of calcineurin in one set of astrocyte cultures also triggered the release of factors that, in turn, stimulated NFAT activity in a second set of "naive" astrocytes. This effect was prevented when calcineurin-expressing cultures co-expressed VIVIT, suggesting that the calcineurin/ NFAT pathway coordinates positive feedback signaling between astrocytes. In the presence of astrocytes and neurons, 48-h delivery of IL-1 beta was associated with several excitotoxic effects, including NMDA receptor-dependent neuronal death, elevated extracellular glutamate, and hyperexcitable synaptic activity. Each of these effects were reversed or ameliorated by targeted delivery of VIVIT to astrocytes. IL-1 beta also caused an NFAT-dependent reduction in excitatory amino acid transporter levels, indicating a possible mechanism for IL-1 beta-mediated excitotoxicity. Taken together, the results have potentially important implications for the propagation and maintenance of neuroinflammatory signaling processes associated with many neurodegenerative conditions and diseases.	[Norris, Christopher M.] Univ Kentucky, Coll Dent, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Mathis, Diana M.] Univ Kentucky, Grad Ctr Gerontol, Lexington, KY 40536 USA; [Abdul, Hafiz Mohmmad; Artiushin, Irina A.; Norris, Christopher M.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Norris, CM (corresponding author), Univ Kentucky, Coll Dent, Dept Mol & Biomed Pharmacol, 131 Sanders Brown Bldg,800 S Limestone St, Lexington, KY 40536 USA.	cnorr2@uky.edu		Kraner, Susan/0000-0002-1062-4007	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010836, R01AG027297, K01AG024190] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR020171, RR020171] Funding Source: Medline; NIAMS NIH HHS [AR046477] Funding Source: Medline; NIA NIH HHS [AG 024190, K01 AG024190, R01 AG027297, AG 027297, AG010836] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abdul HM, 2006, J NEUROCHEM, V96, P1322, DOI 10.1111/j.1471-4159.2005.03647.x; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; ALOISI F, 1992, J IMMUNOL, V149, P2358; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BARRES BA, 1989, J NEUROSCI, V9, P3169; Basu A, 2005, J CEREBR BLOOD F MET, V25, P17, DOI 10.1038/sj.jcbfm.9600002; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Beskina O, 2007, AM J PHYSIOL-CELL PH, V293, pC1103, DOI 10.1152/ajpcell.00249.2007; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2003, J NEUROSCI, V23, P3807; Boycott HE, 2008, GLIA, V56, P998, DOI 10.1002/glia.20673; Burgos M, 2007, GLIA, V55, P1437, DOI 10.1002/glia.20555; Campbell SL, 2004, NEUROSCIENCE, V127, P625, DOI 10.1016/j.neuroscience.2004.05.030; Casamenti F, 1999, NEUROSCIENCE, V91, P831, DOI 10.1016/S0306-4522(98)00680-0; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; D'ascenzo M, 2004, GLIA, V45, P354, DOI 10.1002/glia.10336; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Fiedler B, 2002, P NATL ACAD SCI USA, V99, P11363, DOI 10.1073/pnas.162100799; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; Foster TC, 2001, J NEUROSCI, V21, P4066, DOI 10.1523/JNEUROSCI.21-11-04066.2001; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Halpain S, 1998, J NEUROSCI, V18, P9835; Hashimoto T, 1998, J NEUROCHEM, V70, P1289; Henze C, 2005, J NEUROCHEM, V95, P1069, DOI 10.1111/j.1471-4159.2005.03416.x; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; John GR, 2001, J NEUROSCI, V21, P4134, DOI 10.1523/JNEUROSCI.21-12-04134.2001; John GR, 1999, P NATL ACAD SCI USA, V96, P11613, DOI 10.1073/pnas.96.20.11613; Keller JN, 1996, J NEUROCHEM, V67, P2300; Kim SY, 2003, J NEUROCHEM, V87, P1485, DOI 10.1046/j.1471-4159.2003.02128.x; Kim Y, 2004, BIOCHEM BIOPH RES CO, V314, P695, DOI 10.1016/j.bbrc.2003.12.153; Kordula T, 2000, J NEUROSCI, V20, P7510; Labourdette Gerard, 2002, P157; LANGLEY D, 1994, GLIA, V12, P128, DOI 10.1002/glia.440120206; Lee SC, 1995, BRAIN BEHAV IMMUN, V9, P345, DOI 10.1006/brbi.1995.1032; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Lund P, 1986, METHOD ENZYMAT AN, P357; Luo C, 1996, MOL CELL BIOL, V16, P3955; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mallolas J, 2006, J EXP MED, V203, P711, DOI 10.1084/jem.20051979; Mansuy IM, 2006, TRENDS NEUROSCI, V29, P679, DOI 10.1016/j.tins.2006.10.004; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; MATHIS DM, 2007, C M SOC NEUROSCI ABS, V37, P360; Matsuda T, 1998, J NEUROCHEM, V70, P2004; Molina-Holgado F, 2003, J NEUROSCI, V23, P6470; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Norris CM, 2006, J NEUROPHYSIOL, V96, P2488, DOI 10.1152/jn.00593.2005; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Norris CM, 2002, NEUROSCIENCE, V110, P213, DOI 10.1016/S0306-4522(01)00574-7; NORRIS CM, 2008, NEUROBIOL A IN PRESS; Oka T, 2005, MOL CELL BIOL, V25, P6649, DOI 10.1128/MCB.25.15.6649-6659.2005; Pita I, 1999, INT J DEV NEUROSCI, V17, P813, DOI 10.1016/S0736-5748(99)00063-5; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Porter NM, 1997, J NEUROSCI, V17, P5629; Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ringheim GE, 2004, J NEUROIMMUNOL, V147, P43, DOI 10.1016/j.jneuroim.2003.10.013; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Saito S, 2000, J BIOL CHEM, V275, P34528, DOI 10.1074/jbc.M002844200; SALTER MW, 1995, J NEUROSCI, V15, P2961; SAMA MA, 2006, SOC NEUROSCI ABS, V36; SAMA MA, 2007, NEURODEGENER DIS S1, V4, P636; Scemes E, 2000, MOL NEUROBIOL, V22, P167, DOI 10.1385/MN:22:1-3:167; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; SHAO Y, 1995, CELL CALCIUM, V17, P187, DOI 10.1016/0143-4160(95)90033-0; Sharifullina E, 2006, J PHYSIOL-LONDON, V572, P407, DOI 10.1113/jphysiol.2005.100412; Sheng JG, 1996, NEUROBIOL AGING, V17, P761; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Tsukada S, 2005, NEUROPHARMACOLOGY, V48, P479, DOI 10.1016/j.neuropharm.2004.11.006; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; TWEARDY DJ, 1990, J IMMUNOL, V144, P2233; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Vinade L, 1997, DEV BRAIN RES, V104, P11, DOI 10.1016/S0165-3806(97)00114-4; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Westenbroek RE, 1998, J NEUROSCI, V18, P2321; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yang TTC, 2006, J BIOL CHEM, V281, P11541, DOI 10.1074/jbc.M511214200; Yatani A, 2001, J MOL CELL CARDIOL, V33, P249, DOI 10.1006/jmcc.2000.1296; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x; Zaheer A, 2002, BIOCHEM BIOPH RES CO, V294, P238, DOI 10.1016/S0006-291X(02)00467-9; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092	100	87	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21953	21964		10.1074/jbc.M800148200	http://dx.doi.org/10.1074/jbc.M800148200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18541537	Green Published, hybrid			2022-12-27	WOS:000258114700015
J	Saura-Valls, M; Faure, R; Brumer, H; Teeri, TT; Cottaz, S; Driguez, H; Planas, A				Saura-Valls, Marc; Faure, Regis; Brumer, Harry; Teeri, Tuula T.; Cottaz, Sylvain; Driguez, Hugues; Planas, Antoni			Active-site mapping of a Populus xyloglucan endo-transglycosylase with a library of xylogluco-oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-CELL WALL; GLYCOSYL-ENZYME INTERMEDIATE; ENDOXYLOGLUCAN TRANSFERASE; ENDOTRANSGLYCOSYLASE; MECHANISM; ACCEPTOR; BINDING; SEEDS; PURIFICATION; NOMENCLATURE	Restructuring the network of xyloglucan (XG) and cellulose during plant cell wall morphogenesis involves the action of xyloglucan endo-transglycosylases (XETs). They cleave the XG chains and transfer the enzyme-bound XG fragment to another XG molecule, thus allowing transient loosening of the cell wall and also incorporation of nascent XG during expansion. The substrate specificity of a XET from Populus (PttXET16-34) has been analyzed by mapping the enzyme binding site with a library of xylogluco-oligosaccharides as donor substrates using a labeled heptasaccharide as acceptor. The extended binding cleft of the enzyme is composed of four negative and three positive subsites (with the catalytic residues between subsites -1 and + 1). Donor binding is dominated by the higher affinity of the XXXGmoiety (G = Glc beta(1 -> 4) and X = Xyl alpha(1 -> 6)Glc beta(1 -> 4)) of the substrate for positive subsites, whereas negative subsites have a more relaxed specificity, able to bind (and transfer to the acceptor) a cello-oligosaccharyl moiety of hybrid substrates such as GGGGXXXG. Subsite mapping with k(cat)/K-m values for the donor substrates showed that a GG-unit on negative and-XXG on positive subsites are the minimal requirements for activity. Subsites -2 and -3 (for backbone Glc residues) and +2' (for Xyl substitution at Glc in subsite +2) have the largest contribution to transition state stabilization. GalGXXXGXXXG (Gal = Gal beta(1 -> 4)) is the best donor substrate with a "blocked" nonreducing end that prevents polymerization reactions and yields a single transglycosylation product. Its kinetics have unambiguously established that the enzyme operates by a ping-pong mechanism with competitive inhibition by the acceptor.	[Saura-Valls, Marc; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain; [Faure, Regis; Cottaz, Sylvain; Driguez, Hugues] CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France; [Brumer, Harry; Teeri, Tuula T.] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden	Universitat Ramon Llull; Institut Quimic de Sarria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Royal Institute of Technology	Planas, A (corresponding author), Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain.	antoni.planas@iqs.edu	Teeri, Tuula T/E-7509-2013; PLANAS, ANTONI/I-4803-2015; Fauré, Régis/ABB-4847-2021	PLANAS, ANTONI/0000-0001-7073-3320; Fauré, Régis/0000-0002-5107-9009; cottaz, sylvain/0000-0001-8674-0162				Alkazaz M, 1996, EUR J BIOCHEM, V241, P787, DOI 10.1111/j.1432-1033.1996.00787.x; Allen J D, 1980, Methods Enzymol, V64, P248; Baran R, 2000, GEN PHYSIOL BIOPHYS, V19, P427; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Buckeridge MS, 2000, PLANT PHYSIOL BIOCH, V38, P141, DOI 10.1016/S0981-9428(00)00162-5; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; Coutinho PM, 1999, ROY SOC CH, P3; Fairweather JK, 2002, CHEMBIOCHEM, V3, P866, DOI 10.1002/1439-7633(20020902)3:9<866::AID-CBIC866>3.0.CO;2-R; FANUTTI C, 1993, PLANT J, V3, P691, DOI 10.1111/j.1365-313X.1993.00691.x; Fanutti C, 1996, PLANTA, V200, P221, DOI 10.1007/BF00208312; FARKAS V, 1992, ARCH BIOCHEM BIOPHYS, V298, P365, DOI 10.1016/0003-9861(92)90423-T; Farkas V, 2005, PLANT PHYSIOL BIOCH, V43, P431, DOI 10.1016/j.plaphy.2005.03.006; FAURE R, 2008, EUR J ORG CHEM, V26, P4313; Faure R, 2006, J ORG CHEM, V71, P5151, DOI 10.1021/jo0525682; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Fry SC, 1997, PLANT J, V11, P1141, DOI 10.1046/j.1365-313X.1997.11051141.x; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HIROMI K, 1970, BIOCHEM BIOPH RES CO, V40, P1, DOI 10.1016/0006-291X(70)91037-5; Hrmova M, 2007, J BIOL CHEM, V282, P12951, DOI 10.1074/jbc.M611487200; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; JUNCOSA M, 1994, J BIOL CHEM, V269, P14530; Kallas AM, 2005, BIOCHEM J, V390, P105, DOI 10.1042/BJ20041749; LORENCES EP, 1993, PHYSIOL PLANTARUM, V88, P105, DOI 10.1111/j.1399-3054.1993.tb01767.x; MACLACHLAN G, 1994, PLANT PHYSIOL, V105, P965, DOI 10.1104/pp.105.3.965; Malet C, 1997, BIOCHEMISTRY-US, V36, P13838, DOI 10.1021/bi9711341; Malet C, 1998, FEBS LETT, V440, P208, DOI 10.1016/S0014-5793(98)01448-3; Mohand FA, 2006, CARBOHYD RES, V341, P577, DOI 10.1016/j.carres.2006.01.018; Nishitani K, 1998, J PLANT RES, V111, P159, DOI 10.1007/BF02507162; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; NISHITANI K, 1992, PLANT CELL PHYSIOL, V33, P1159; Pauly M, 1999, GLYCOBIOLOGY, V9, P93, DOI 10.1093/glycob/9.1.93; Piens K, 2008, J BIOL CHEM, V283, P21864, DOI 10.1074/jbc.M803057200; Piens K, 2007, ORG BIOMOL CHEM, V5, P3971, DOI 10.1039/b714570e; Planas N, 2000, BBA-PROTEIN STRUCT M, V1543, P361, DOI 10.1016/S0167-4838(00)00231-4; Reiter WD, 2002, CURR OPIN PLANT BIOL, V5, P536, DOI 10.1016/S1369-5266(02)00306-0; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Saura-Valls M, 2006, BIOCHEM J, V395, P99, DOI 10.1042/BJ20051396; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulova Z, 1998, BIOCHEM J, V330, P1475, DOI 10.1042/bj3301475; Tabuchi A, 1997, PLANT CELL PHYSIOL, V38, P653, DOI 10.1093/oxfordjournals.pcp.a029217; Takeda T, 2008, PLANTA, V227, P893, DOI 10.1007/s00425-007-0665-1; Thompson JE, 1997, BIOCHEM J, V327, P699; Vincken JP, 1997, PLANT PHYSIOL, V114, P9, DOI 10.1104/pp.114.1.9	48	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21853	21863		10.1074/jbc.M803058200	http://dx.doi.org/10.1074/jbc.M803058200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18511421	hybrid			2022-12-27	WOS:000258114700004
J	Zibouche, M; Vincent, M; Illien, F; Gallay, J; Ayala-Sanmartin, J				Zibouche, Malik; Vincent, Michel; Illien, Francoise; Gallay, Jacques; Ayala-Sanmartin, Jesus			The N-terminal domain of annexin 2 serves as a secondary binding site during membrane bridging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-RESOLVED FLUORESCENCE; TRYPTOPHAN RESIDUE TRP-59; HEART APOCYTOCHROME-C; MILDLY ACIDIC PH; CRYSTAL-STRUCTURE; SPECTRAL PROPERTIES; PENETRATION DEPTH; CHROMAFFIN CELLS; MODEL MEMBRANES; CORE DOMAIN	Annexin A2 (AnxA2) is a Ca2+- and acidic phospholipid-binding protein involved in many cellular processes. It undergoes Ca2+-mediated membrane bridging at neutral pH and has been demonstrated to be involved in an H+-mediated mechanism leading to a novel AnxA2-membrane complex structure. We used fluorescence techniques to characterize this H+-dependent mechanism at the molecular level; in particular, the involvement of the AnxA2 N-terminal domain. This domain was labeled at Cys-8 either with acrylodan or pyrene-maleimide fluorescent probes. Steady- state and time-resolved fluorescence analysis for acrylodan and fluorescence quenching by doxyl-labeled phospholipids revealed direct interaction between the N-terminal domain and the membrane. The absence of pyrene excimer suggested that interactions between N termini are not involved in the H+-mediated mechanism. These findings differ from those previously observed for the Ca2+-mediated mechanism. Protein titration experiments showed that the protein concentration for half-maximal membrane aggregation was twice for Ca2+-mediated compared with H+-mediated aggregation, suggesting that AnxA2 was able to bridge membranes either as a dimer or as a monomer, respectively. An N-terminally deleted AnxA2 was 2 - 3 times less efficient than the wild-type protein for H+-mediated membrane aggregation. We propose a model of AnxA2-membrane assemblies, highlighting the different roles of the N-terminal domain in the H+- and Ca2+-mediated membrane bridging mechanisms.	[Vincent, Michel; Gallay, Jacques] Univ Paris 11, CNRS, IBBMC, UMR8619, F-91405 Orsay, France; [Zibouche, Malik; Illien, Francoise; Ayala-Sanmartin, Jesus] CdR St Antoine, INSERM, UMRS893, F-75012 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Gallay, J (corresponding author), Univ Paris 11, CNRS, IBBMC, UMR8619, Batiment 430, F-91405 Orsay, France.	jacques.gallay@u-psud.fr; jayala@chusa.jussieu.fr		ILLIEN, Francoise/0000-0003-3414-8452				ABRAMS FS, 1993, BIOCHEMISTRY-US, V32, P10826, DOI 10.1021/bi00091a038; Ayala-Sanmartin J, 2001, BIOCHEM BIOPH RES CO, V283, P72, DOI 10.1006/bbrc.2001.4748; Ayala-Sanmartin J, 2001, BBA-BIOMEMBRANES, V1510, P18, DOI 10.1016/S0005-2736(00)00262-5; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15179, DOI 10.1021/bi000501x; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15190, DOI 10.1021/bi000764r; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; AYALASANMARTIN J, 2004, ANNEXINS, V1, P19; Bitto E, 2000, BIOCHEMISTRY-US, V39, P13469, DOI 10.1021/bi001275u; Bitto E, 1999, BIOCHEMISTRY-US, V38, P14094, DOI 10.1021/bi990457p; ChasserotGolaz S, 1996, J CELL BIOL, V133, P1217, DOI 10.1083/jcb.133.6.1217; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; Faure AV, 2002, EXP CELL RES, V276, P79, DOI 10.1006/excr.2002.5512; GALLA HJ, 1980, CHEM PHYS LIPIDS, V27, P199, DOI 10.1016/0009-3084(80)90036-5; Gallay J, 2004, EUR J BIOCHEM, V271, P821, DOI 10.1111/j.1432-1033.2004.03987.x; GENGE BR, 1991, J BIOL CHEM, V266, P10678; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Golczak Marcin, 2001, FASEB Journal, V15, P1083; Hong YH, 2003, J BIOCHEM, V134, P427, DOI 10.1093/jb/mvg160; Hu NJ, 2008, BIOPHYS J, V94, P1773, DOI 10.1529/biophysj.107.119685; Isas JM, 2000, BIOCHEMISTRY-US, V39, P3015, DOI 10.1021/bi9922401; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Jost M, 1997, J CELL SCI, V110, P221; Kim YE, 2005, J BIOL CHEM, V280, P32398, DOI 10.1074/jbc.M505017200; Kohler G, 1997, BIOCHEMISTRY-US, V36, P8189, DOI 10.1021/bi9703960; Ladokhin AS, 2005, BIOCHEMISTRY-US, V44, P3402, DOI 10.1021/bi047805u; Lamaziere A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001938; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Langen R, 1998, J BIOL CHEM, V273, P22453, DOI 10.1074/jbc.273.35.22453; Langen R, 1998, P NATL ACAD SCI USA, V95, P14060, DOI 10.1073/pnas.95.24.14060; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1932, DOI 10.1021/bi00510a032; Monastyrskaya K, 2008, BIOCHEM J, V409, P65, DOI 10.1042/BJ20071116; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; MOSSER G, 1991, J MOL BIOL, V217, P241, DOI 10.1016/0022-2836(91)90538-H; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; PIGAULT C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P106, DOI 10.1016/0167-4838(90)90108-R; PIGAULT C, 1994, J MOL BIOL, V236, P199, DOI 10.1006/jmbi.1994.1129; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rosengarth A, 1998, FEBS LETT, V438, P279, DOI 10.1016/S0014-5793(98)01318-0; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Rosengarth A., 2004, ANNEXINS, V1, P129; Santos JSD, 2001, FEBS LETT, V493, P122, DOI 10.1016/S0014-5793(01)02285-2; SOPKOVA J, 1994, BIOCHEMISTRY-US, V33, P4490, DOI 10.1021/bi00181a008; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; Sopkova J, 1999, BIOCHEMISTRY-US, V38, P5447, DOI 10.1021/bi982760g; VINCENT M, 1988, BIOCHEMISTRY-US, V27, P8752, DOI 10.1021/bi00424a010; VINCENT M, 1991, EUR BIOPHYS J, V20, P183, DOI 10.1007/BF01561141; WANG W, 1994, BIOCHEMISTRY-US, V33, P275, DOI 10.1021/bi00167a036; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025	56	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22121	22127		10.1074/jbc.M801000200	http://dx.doi.org/10.1074/jbc.M801000200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508775	hybrid, Green Submitted			2022-12-27	WOS:000258114700031
J	Hosokawa, N; Wada, I; Nagasawa, K; Moriyama, T; Okawa, K; Nagata, K				Hosokawa, Nobuko; Wada, Ikuo; Nagasawa, Koji; Moriyama, Tatsuya; Okawa, Katsuya; Nagata, Kazuhiro			Human XTP3-B forms an endoplasmic reticulum quality control scaffold with the HRD1-SEL1L ubiquitin ligase complex and BiP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; MISFOLDED GLYCOPROTEINS; SECRETORY PATHWAY; IDENTIFIES YOS9P; OS-9; ALPHA-1-ANTITRYPSIN; MEMBRANE; GENE; EXTRACTION	The recognition of terminally misfolded proteins in the endoplasmic reticulum (ER) and the extraction of these proteins to the cytoplasm for proteasomal degradation are determined by a quality control mechanism in the ER. In yeast, Yos9p, an ER lectin containing a mannose 6-phosphate receptor homology (MRH) domain, enhances ER-associated degradation (ERAD) of glycoproteins. We show here that human XTP3-B (hXTP3-B), an ER lectin containing two MRH domains, has two transcriptional variants, and both isoforms retard ERAD of the human alpha(1)-antitrypsin variant null Hong Kong (NHK), a terminally misfolded glycoprotein. The hXTP3-B long isoform strongly inhibited ERAD of NHK-QQQ, which lacks all of the N-glycosylation sites of NHK, but the short transcriptional variant of hXTP3-B had almost no effect. Examination of complex formation by immunoprecipitation and by fractionation using sucrose density gradient centrifugation revealed that the hXTP3-B long isoform associates with the HRD1-SEL1L membrane-anchored ubiquitin ligase complex and BiP, forming a 27 S ER quality control scaffold complex. The hXTP3-B short isoform, however, is excluded from scaffold formation. Another MRH domain-containing ER lectin, hOS-9, is incorporated into this large complex, but gp78, another mammalian homolog of the yeast ubiquitin ligase Hrd1p, is not. Based on these results, we propose that this large ER quality control scaffold complex, containing ER lectins, a chaperone, and a ubiquitin ligase, provides a platform for the recognition and sorting of misfolded glycoproteins as well as nonglycosylated proteins prior to retrotranslocation into the cytoplasm for degradation.	[Hosokawa, Nobuko; Nagasawa, Koji; Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, Kyoto 6068397, Japan; [Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima 9601295, Japan; [Hosokawa, Nobuko; Wada, Ikuo; Nagasawa, Koji; Nagata, Kazuhiro] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Moriyama, Tatsuya] Kinki Univ, Grad Sch Agr, Dept Appl Cell Biol, Nara 6318505, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto 6068501, Japan	Kyoto University; Fukushima Medical University; Japan Science & Technology Agency (JST); Kindai University (Kinki University); Kyoto University	Hosokawa, N (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068397, Japan.	nobuko@frontier.kyoto-u.ac.jp		Wada, Ikuo/0000-0001-5668-6994; Moriyama, Tatsuya/0000-0002-6861-926X	Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cruciat CM, 2006, J BIOL CHEM, V281, P12986, DOI 10.1074/jbc.M511872200; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 2001, EMBO REP, V2, P423; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nakayama T, 1999, FEBS LETT, V453, P77, DOI 10.1016/S0014-5793(99)00700-0; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949	38	134	140	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20914	20924		10.1074/jbc.M709336200	http://dx.doi.org/10.1074/jbc.M709336200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502753	Green Published, hybrid			2022-12-27	WOS:000257746100034
J	Nelson, CD; Kovacs, JJ; Nobles, KN; Whalen, EJ; Lefkowitz, RJ				Nelson, Christopher D.; Kovacs, Jeffery J.; Nobles, Kelly N.; Whalen, Erin J.; Lefkowitz, Robert J.			beta-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase I alpha promotes agonist-stimulated sequestration of the beta 2-adrenergic receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; PLASMA-MEMBRANE; PHOSPHOINOSITIDE REGULATION; ACTIN CYTOSKELETON; KINASE; ACTIVATION; DESENSITIZATION	Members of the seven-transmembrane receptor (7TMR) superfamily are sequestered from the plasma membrane following stimulation both to limit cellular responses as well as to initiate novel G protein-independent signaling pathways. The best studied mechanism for 7TMR internalization is via clathrin-coated pits, where clathrin and adaptor protein complex 2 nucleate and polymerize upon encountering the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) to form the outer layer of the clathrin-coated vesicle. Activated receptors are recruited to clathrin-coated pits by beta-arrestins, scaffolding proteins that interact with agonist-occupied 7TMRs as well as adaptor protein complex 2 and clathrin. We report here that following stimulation of the beta 2-adrenergic receptor (beta 2-AR), a prototypical 7TMR, beta-arrestins bind phosphatidylinositol 4-phosphate 5-kinase (PIP5K) I alpha, a PIP2-producing enzyme. Furthermore, beta-arrestin2 is required to form a complex with PIP5K I alpha and agonist- occupied beta 2-AR, and beta-arrestins synergize with the kinase to produce PIP2 in response to isoproterenol stimulation. Interestingly, beta-arrestins themselves bind PIP2, and a beta-arrestin mutant deficient in PIP2 binding no longer internalizes 7TMRs, fails to interact with PIP5K I alpha, and is not associated with PIP kinase activity assayed in vitro. However, a chimeric protein in which the core kinase domain of PIP5K I alpha has been fused to the same beta-arrestin mutant rescues internalization of beta 2-ARs. Collectively, these data support a model in which beta-arrestins direct the localization of PIP5K I alpha and PIP2 production to agonist- activated 7TMRs, thereby regulating receptor internalization.	[Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Howard Hughes Med Inst, Durham, NC 27710 USA; [Nelson, Christopher D.; Kovacs, Jeffery J.; Whalen, Erin J.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Kovacs, Jeffery J.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Howard Hughes Med Inst, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037, R01HL070631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007217] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL 16037, R01 HL070631-04, R01 HL016037-35, HL 70631, R01 HL070631, R01 HL016037] Funding Source: Medline; NIAID NIH HHS [T32 AI007217, T32 AI007217-26] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Baker JG, 2002, BRIT J PHARMACOL, V137, P400, DOI 10.1038/sj.bjp.0704855; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; Loijens JC, 1996, ADV ENZYME REGUL, V36, P115, DOI 10.1016/0065-2571(95)00005-4; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Petrofski JA, 2003, J MOL CELL CARDIOL, V35, P1167, DOI 10.1016/S0022-2828(03)00243-8; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sechi AS, 2000, J CELL SCI, V113, P3685; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	53	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21093	21101		10.1074/jbc.M800431200	http://dx.doi.org/10.1074/jbc.M800431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18534983	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000257746100051
J	Doherty, KR; Demonbreun, AR; Wallace, GQ; Cave, A; Posey, AD; Heretis, K; Pytel, P; McNally, EM				Doherty, Katherine R.; Demonbreun, Alexis R.; Wallace, Gregory Q.; Cave, Andrew; Posey, Avery D.; Heretis, Konstantina; Pytel, Peter; McNally, Elizabeth M.			The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAIN; MEMBRANE; RME-1; EPS15; COMPARTMENT; MOLECULES; FAMILY; GENE; CELL	Skeletal muscle is a multinucleated syncytium that develops and is maintained by the fusion of myoblasts to the syncytium. Myoblast fusion involves the regulated coalescence of two apposed membranes. Myoferlin is a membrane-anchored, multiple C2 domain-containing protein that is highly expressed in fusing myoblasts and required for efficient myoblast fusion to myotubes. We found that myoferlin binds directly to the eps15 homology domain protein, EHD2. Members of the EHD family have been previously implicated in endocytosis as well as endocytic recycling, a process where membrane proteins internalized by endocytosis are returned to the plasma membrane. EHD2 binds directly to the second C2 domain of myoferlin, and EHD2 is reduced in myoferlin null myoblasts. In contrast to normal myoblasts, myoferlin null myoblasts accumulate labeled transferrin and have delayed recycling. Introduction of dominant negative EHD2 into myoblasts leads to the sequestration of myoferlin and inhibition of myoblast fusion. The interaction of myoferlin with EHD2 identifies molecular overlap between the endocytic recycling pathway and the machinery that regulates myoblast membrane fusion.	[Doherty, Katherine R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Demonbreun, Alexis R.; McNally, Elizabeth M.] Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; [Wallace, Gregory Q.; Cave, Andrew; McNally, Elizabeth M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Posey, Avery D.; McNally, Elizabeth M.] Univ Chicago, Comm Genet, Chicago, IL 60637 USA; [Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	McNally, EM (corresponding author), 5841 S Maryland Ave,MC6088, Chicago, IL 60632 USA.	emcnally@uchicago.edu	McNally, Elizabeth/W-4909-2019; Posey, Avery D./P-4890-2019; Sadleir, Katherine R/N-1199-2019	Posey, Avery D./0000-0001-8711-629X; Sadleir, Katherine R/0000-0001-8310-841X; McNally, Elizabeth/0000-0002-1221-719X; Demonbreun, Alexis/0000-0001-6823-125X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047726] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL 007381] Funding Source: Medline; NINDS NIH HHS [R01 NS 047726, R01 NS047726] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achanzar WE, 1997, J CELL SCI, V110, P1073; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chan YM, 1997, FEBS LETT, V410, P153, DOI 10.1016/S0014-5793(97)00454-7; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; KALDERON N, 1979, J CELL BIOL, V81, P411, DOI 10.1083/jcb.81.2.411; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Mayer BJ, 1999, CURR BIOL, V9, pR70, DOI 10.1016/S0960-9822(99)80014-1; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; POLO S, 2003, SCI STKE, pRE17, DOI DOI 10.1126/STKE.2132003RE17; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Taylor MV, 2003, CURR BIOL, V13, pR964, DOI 10.1016/j.cub.2003.11.044; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530	46	81	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20252	20260		10.1074/jbc.M802306200	http://dx.doi.org/10.1074/jbc.M802306200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502764	Green Published, hybrid			2022-12-27	WOS:000257565300041
J	Duverger, O; Lee, D; Hassan, MQ; Chen, SX; Jaisser, F; Lian, JB; Morasso, MI				Duverger, Olivier; Lee, Delia; Hassan, Mohammad Q.; Chen, Susie X.; Jaisser, Frederic; Lian, Jane B.; Morasso, Maria I.			Molecular consequences of a frameshifted DLX3 mutant leading to Tricho-Dento-Osseous syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTAL-LESS GENE; HOMEODOMAIN PROTEINS; MUTATIONS; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; SEQUENCE; RECRUITMENT; PATTERN; BINDING	The homeodomain protein Distal-less-3 (Dlx3) plays a crucial role during embryonic development. This transcription factor is known to be essential for placental formation and to be involved in skin and skeletal organogenesis. In humans, a frameshift mutation in the coding sequence of the DLX3 gene results in an ectodermal dysplasia called Tricho-Dento-Osseous syndrome (TDO). The main features of this autosomal dominant disorder are defects in hair, teeth, and bone. To investigate the functional alterations caused by the mutated DLX3(TDO) isoform ex vivo, we used tetracycline-inducible osteoblastic and keratinocyte cell lines and calvarial derived osteoblasts in which the expression of DLX3(WT) and/ or DLX3(TDO) could be regulated and monitored. Immunocytochemical analysis revealed that both DLX3(WT) and DLX3(TDO) recombinant proteins are targeted to the nucleus. However, as demonstrated by electrophoresis mobility shift assay, DLX3(TDO) is not able to bind to the canonical Dlx3 binding site. Furthermore, we demonstrate that the frameshifted C-terminal domain in DLX3(TDO) is accountable for the loss of DNA binding activity because the C-terminal domain in DLX3(WT) is not required for DNA binding activity. Although DLX3(TDO) alone cannot bind to a Dlx3 responsive element, when DLX3(WT) and DLX3(TDO) are co-expressed they form a complex that can bind DNA. Concomitant with the inability to bind DNA, DLX3(TDO) has a defective transcriptional activity. Moreover, the transcriptional activity of DLX3(WT) is significantly reduced in the presence of the mutated isoform, indicating that DLX3(TDO) has a dominant negative effect on DLX3(WT) transcriptional activity.	[Duverger, Olivier; Lee, Delia; Chen, Susie X.; Morasso, Maria I.] NIAMS, Dev Skin Biol Unit, NIH, Bethesda, MD 20892 USA; [Hassan, Mohammad Q.; Lian, Jane B.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Jaisser, Frederic] Univ Paris 05, Coll France, INSERM, U772, F-75005 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Massachusetts System; University of Massachusetts Worcester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite	Morasso, MI (corresponding author), NIAMS, Dev Skin Biol Unit, NIH, Bethesda, MD 20892 USA.	morassom@mail.nih.gov	Hassan, Mohammad/GZA-7507-2022; Jaisser, Frederic/P-4287-2017	Hassan, Mohammad/0000-0002-1712-0004; Jaisser, Frederic/0000-0001-9051-1901	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDCR NIH HHS [R37 DE 012528, R37 DE012528] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Barbacci E, 2004, HUM MOL GENET, V13, P3139, DOI 10.1093/hmg/ddh338; Bryan JT, 2000, J CELL SCI, V113, P4013; Choi SJ, 2008, BONE, V42, P162, DOI 10.1016/j.bone.2007.08.047; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Espinoza HM, 2005, BIOCHEMISTRY-US, V44, P3942, DOI 10.1021/bi048362x; Feledy JA, 1999, NUCLEIC ACIDS RES, V27, P764, DOI 10.1093/nar/27.3.764; Ghoul-Mazgar S, 2005, BONE, V37, P799, DOI 10.1016/j.bone.2005.03.020; Haldeman RJ, 2004, BONE, V35, P988, DOI 10.1016/j.bone.2004.06.003; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Lines MA, 2002, HUM MOL GENET, V11, P1177, DOI 10.1093/hmg/11.10.1177; McGuinness T, 1996, GENOMICS, V35, P473, DOI 10.1006/geno.1996.0387; Morasso MI, 1996, J CELL BIOL, V135, P1879, DOI 10.1083/jcb.135.6.1879; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; MORASSO MI, 1995, P NATL ACAD SCI USA, V92, P3968, DOI 10.1073/pnas.92.9.3968; Nakamura S, 1996, GENOMICS, V38, P314, DOI 10.1006/geno.1996.0634; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Price JA, 1998, J MED GENET, V35, P825, DOI 10.1136/jmg.35.10.825; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; QUATTROMANI F, 1983, HUM GENET, V64, P116, DOI 10.1007/BF00327105; Roberson MS, 2001, J BIOL CHEM, V276, P10016, DOI 10.1074/jbc.M007481200; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Saadi I, 2006, BIRTH DEFECTS RES A, V76, P175, DOI 10.1002/bdra.20226; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; WRIGHT JT, 1994, ORAL SURG ORAL MED O, V77, P487, DOI 10.1016/0030-4220(94)90228-3; Wright JT, 1997, AM J MED GENET, V72, P197; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; YUSPA SH, 1980, CANCER RES, V40, P4694; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	33	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20198	20208		10.1074/jbc.M709562200	http://dx.doi.org/10.1074/jbc.M709562200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18492670	hybrid, Green Published			2022-12-27	WOS:000257565300036
J	Adachi, N; Kobayashi, T; Takahashi, H; Kawasaki, T; Shirai, Y; Ueyama, T; Matsuda, T; Seki, T; Sakai, N; Saito, N				Adachi, Naoko; Kobayashi, Takeshi; Takahashi, Hideyuki; Kawasaki, Takumi; Shirai, Yasuhito; Ueyama, Takehiko; Matsuda, Toshio; Seki, Takahiro; Sakai, Norio; Saito, Naoaki			Enzymological analysis of mutant protein kinase C gamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPAIRED MOTOR COORDINATION; CLIMBING FIBER INNERVATION; PHORBOL ESTER BINDING; ATAXIA TYPE-14; TRPC3 CHANNELS; LIVING CELLS; PKC-GAMMA; SYNAPSE ELIMINATION; CEREBELLAR-ATAXIA; PLASMA-MEMBRANE	Spinocerebellar ataxia type 14 (SCA14) is an autosomal dominant neurodegenerative disease caused by mutations in protein kinase C gamma(PKC gamma). Interestingly, 18 of 22 mutations are concentrated in the C1 domain, which binds diacylglycerol and is necessary for translocation and regulation of PKC gamma kinase activity. To determine the effect of these mutations on PKC gamma function and the pathology of SCA14, we investigated the enzymological properties of the mutant PKC gamma s. We found that wild-type PKC gamma, but not C1 domain mutants, inhibits Ca2+ influx in response to muscarinic receptor stimulation. The sustained Ca2+ influx induced by muscarinic receptor ligation caused prolonged membrane localization of mutant PKC gamma. Pharmacological experiments showed that canonical transient receptor potential (TRPC) channels are responsible for the Ca2+ influx regulated by PKC gamma. Although in vitro kinase assays revealed that most C1 domain mutants are constitutively active, they could not phosphorylate TRPC3 channels in vivo. Single molecule observation by the total internal reflection fluorescence microscopy revealed that the membrane residence time of mutant PKC gamma s was significantly shorter than that of the wild-type. This fact indicated that, although membrane association of the C1 domain mutants was apparently prolonged, these mutants have a reduced ability to bind diacylglycerol and be retained on the plasma membrane. As a result, they fail to phosphorylate TRPC channels, resulting in sustained Ca2+ entry. Such an alteration in Ca2+ homeostasis and Ca2+-mediated signaling in Purkinje cells may contribute to the neurodegeneration characteristic of SCA14.	[Adachi, Naoko; Takahashi, Hideyuki; Kawasaki, Takumi; Shirai, Yasuhito; Ueyama, Takehiko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan; [Kobayashi, Takeshi] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4668550, Japan; [Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Osaka 5650871, Japan; [Seki, Takahiro; Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan	Kobe University; Nagoya University; Osaka University; Hiroshima University	Saito, N (corresponding author), Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan.	naosaito@kobe-u.ac.jp	Sakai, Norio/AAM-5822-2021; Shirai, Yasuhito/O-3255-2018; Saito, Nagahiro/I-6113-2014	Sakai, Norio/0000-0002-6648-8761; Saito, Nagahiro/0000-0001-8757-3933; Kobayashi, Takeshi/0000-0002-4372-5285; Seki, Takahiro/0000-0002-9894-4768; Adachi, Naoko/0000-0002-8797-0717				Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Dalski A, 2006, J NEUROL, V253, P1111, DOI 10.1007/s00415-006-0209-9; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Hiramoto K, 2006, MOVEMENT DISORD, V21, P1355, DOI 10.1002/mds.20970; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Klebe S, 2007, ARCH NEUROL-CHICAGO, V64, P913, DOI 10.1001/archneur.64.6.913; KONNERTH A, 2007, CALCIUM BINDING PROT, V2, P60; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Mori Y, 1998, NEUROREPORT, V9, P507; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Nolte D, 2007, MOVEMENT DISORD, V22, P265, DOI 10.1002/mds.21269; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Oyasu M, 2008, J HISTOCHEM CYTOCHEM, V56, P253, DOI 10.1369/jhc.7A7291.2007; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; Seki T, 2005, J BIOL CHEM, V280, P29096, DOI 10.1074/jbc.M501716200; Seki T, 2007, EUR J NEUROSCI, V26, P3126, DOI 10.1111/j.1460-9568.2007.05933.x; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; TANAKA C, 1992, NEUROCHEM INT, V21, P499, DOI 10.1016/0197-0186(92)90081-2; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Uchino M, 2004, J BIOL CHEM, V279, P2254, DOI 10.1074/jbc.M309894200; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Verbeek DS, 2005, BRAIN, V128, P436, DOI 10.1093/brain/awh378; Vlak MHM, 2006, MOVEMENT DISORD, V21, P1025, DOI 10.1002/mds.20851; Wieczorek S, 2007, MOVEMENT DISORD, V22, P2135, DOI 10.1002/mds.21673	42	82	83	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19854	19863		10.1074/jbc.M801492200	http://dx.doi.org/10.1074/jbc.M801492200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18499672	hybrid			2022-12-27	WOS:000257387600069
J	Emami, N; Deperthes, D; Malm, J; Diamandis, EP				Emami, Nashmil; Deperthes, David; Malm, Johan; Diamandis, Eleftherios P.			Major role of human KLK14 in seminal clot liquefaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; PROTEIN-C INHIBITOR; FACTOR PATHWAY INHIBITOR; HUMAN-SEMEN; PLASMA BIOCHEMISTRY; SERINE-PROTEASE; SEMENOGELIN-I; TISSUE FACTOR; PREDOMINANT PROTEIN; PROTEOLYTIC CASCADE	Liquefaction of human semen involves proteolytic degradation of the seminal coagulum and release of motile spermatozoa. Several members of human kallikrein-related peptidases (KLKs) have been implicated in semen liquefaction, functioning through highly regulated proteolytic cascades. Among these, KLK3 (also known as prostate-specific antigen) is the main executor enzyme responsible for processing of the primary components of semen coagulum, semenogelins I and II. We have recently identified KLK14 as a potential activator of KLK3 and other KLKs. This study aims to elucidate the cascade-mediated role of KLK14 ex vivo. KLK14 expression was significantly lower (p = 0.0252) in individuals with clinically delayed liquefaction. Concordantly, KLK14 expression was significantly (p = 0.0478) lower in asthenospermic cases. Specific inhibition of KLK14 activity by the synthetic inhibitor ACT(G9) resulted in a significant delay in semen liquefaction, a drop in the "early" (30 min postejaculation) "chymotrypsin- like" and KLK1 activity, and an increase in the "late" (90 min postejaculation) chymotrypsin-like activity. Conversely, the addition of recombinant active KLK14 facilitated the liquefaction process, augmented the early chymotrypsin-like activity, and lowered late chymotrypsin-like activity. Given that the observed chymotrypsin-like activity was almost completely attributed to KLK3 activity, KLK3 seems to be regulated bidirectionally. Accordingly, a higher level of KLK3 fragmentation was observed in KLK14-induced coagula, suggesting an inactivation mechanism via internal cleavage. Finally, semenogelins I and II were directly cleaved by KLK14. Semenogelins were also able to reverse KLK14 inhibition by Zn2+, providing a novel regulatory mechanism for KLK14 activity. Our results show that KLK14 exerts a significant and dose-dependent effect in the process of semen liquefaction.	[Emami, Nashmil; Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Emami, Nashmil; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; [Deperthes, David] Med Discovery SA, Biopole, CH-1066 Epalinges, Switzerland; [Malm, Johan] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Sect Clin Chem, SE-20502 Malmo, Sweden	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Lund University; Skane University Hospital	Diamandis, EP (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				AMELAR RD, 1962, J UROLOGY, V87, P187, DOI 10.1016/S0022-5347(17)64936-X; Amour A, 2004, BIOCHEM SOC T, V32, P15, DOI 10.1042/BST0320015; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bhattacharyya AK, 2003, MOL CELL BIOCHEM, V253, P255, DOI 10.1023/A:1026024202288; Borgono CA, 2007, J BIOL CHEM, V282, P2405, DOI 10.1074/jbc.M608348200; CHRISTENSSON A, 1994, EUR J BIOCHEM, V220, P45, DOI 10.1111/j.1432-1033.1994.tb18597.x; COSENTINO MJ, 1986, UROL RES, V14, P229; DAUNTER B, 1981, ANDROLOGIA, V13, P131; De Jonge CJ, 1998, SEMIN REPROD ENDOCR, V16, P209, DOI 10.1055/s-2007-1016279; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; Denmeade SR, 2001, PROSTATE, V48, P122, DOI 10.1002/pros.1088; Deperthes D, 1996, J ANDROL, V17, P659; DUBE JY, 1989, ANDROLOGIA, V21, P136; Emami N, 2007, MOL ONCOL, V1, P269, DOI 10.1016/j.molonc.2007.09.003; Emami N, 2008, J BIOL CHEM, V283, P3031, DOI 10.1074/jbc.M707253200; Espana F, 2007, SEMIN THROMB HEMOST, V33, P41, DOI 10.1055/s-2006-958460; Felber LM, 2005, BIOL CHEM, V386, P291, DOI 10.1515/BC.2005.035; Felber LM, 2006, FEBS J, V273, P2505, DOI 10.1111/j.1742-4658.2006.05257.x; Fernandez JA, 2007, SEMIN THROMB HEMOST, V33, P13, DOI 10.1055/s-2006-958457; Goossens E, 2006, SEMIN REPROD MED, V24, P370, DOI 10.1055/s-2006-952158; HINRICHSENKOHANE AC, 1984, ANDROLOGIA, V16, P321; HOSKINS DD, 1978, FED PROC, V37, P2534; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; Kise H, 1996, EUR J BIOCHEM, V238, P88, DOI 10.1111/j.1432-1033.1996.0088q.x; KOREN E, 1979, J REPROD FERTIL, V56, P493; Kumar A, 1997, CANCER RES, V57, P3111; Leinonen J, 1996, J UROLOGY, V155, P1099, DOI 10.1016/S0022-5347(01)66399-7; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1984, SCAND J CLIN LAB INV, V44, P447, DOI 10.3109/00365518409083836; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; LILJA H, 1985, SCAND J CLIN LAB INV, V45, P635, DOI 10.3109/00365518509155271; LUKAC J, 1979, J REPROD FERTIL, V56, P501; Lwaleed BA, 2005, THROMB HAEMOSTASIS, V93, P847, DOI 10.1160/TH04-09-0600; Lwaleed BA, 2004, THROMB HAEMOSTASIS, V92, P752, DOI 10.1160/TH04-03-0142; Lwaleed BA, 2007, SEMIN THROMB HEMOST, V33, P3, DOI 10.1055/s-2006-958456; LYNCH MJ, 1994, J PHARMACEUT BIOMED, V12, P5, DOI 10.1016/0731-7085(94)80004-9; MANDAL A, 1988, ARCH ANDROLOGY, V20, P141, DOI 10.3109/01485018808987065; Matsuda Y, 2002, ARCH ANDROLOGY, V48, P295, DOI 10.1080/01485010290031600; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Michel S, 2005, J MOL RECOGNIT, V18, P225, DOI 10.1002/jmr.729; Mikhailichenko VV, 2005, FERTIL STERIL, V84, P256, DOI 10.1016/j.fertnstert.2004.11.086; POLAK B, 1990, EUR J OBSTET GYN R B, V35, P223, DOI 10.1016/0028-2243(90)90166-X; POLAK B, 1989, INT J ANDROL, V12, P187, DOI 10.1111/j.1365-2605.1989.tb01303.x; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Robert M, 1999, CELL MOL LIFE SCI, V55, P944, DOI 10.1007/s000180050346; SCHILL WB, 1992, ANDROLOGIA, V24, P69; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Siems WE, 2003, ANDROLOGIA, V35, P44, DOI 10.1046/j.1439-0272.2003.00536.x; Suzuki K, 2007, SEMIN THROMB HEMOST, V33, P46, DOI 10.1055/s-2006-958461; TAUBER PF, 1981, BIOCH ANDROLOGY, P153; Thyzel E, 2003, THROMB RES, V109, P329, DOI 10.1016/S0049-3848(03)00210-X; Vaisanen V, 1999, PROSTATE CANCER P D, V2, P91, DOI 10.1038/sj.pcan.4500289; Van Dreden P, 2007, SEMIN THROMB HEMOST, V33, P21, DOI 10.1055/s-2006-958458; WILSON VB, 1975, J UROLOGY, V113, P509, DOI 10.1016/S0022-5347(17)59513-0; Wu P, 2004, PROSTATE, V58, P345, DOI 10.1002/pros.10337; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; ZHANG WM, 1995, CLIN CHEM, V41, P1567	59	40	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19561	19569		10.1074/jbc.M801194200	http://dx.doi.org/10.1074/jbc.M801194200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482984	hybrid			2022-12-27	WOS:000257387600042
J	Spitaleri, A; Mari, S; Curnis, F; Traversari, C; Longhi, R; Bordignon, C; Corti, A; Rizzardi, GP; Musco, G				Spitaleri, Andrea; Mari, Silvia; Curnis, Flavio; Traversari, Catia; Longhi, Renato; Bordignon, Claudio; Corti, Angelo; Rizzardi, Gian-Paolo; Musco, Giovanna			Structural basis for the interaction of isoDGR with the RGD-binding site of alpha v beta 3 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONTE-CARLO METHOD; BASEMENT-MEMBRANE; TUMOR VESSELS; FORCE-FIELD; AMINO-ACID; PROTEIN; FIBRONECTIN; DOCKING; AMINOPEPTIDASE; PEPTIDES	Asparagine deamidation at the NGR sequence in the 5th type I repeat of fibronectin (FN-I-5) generates isoDGR, an alpha v beta 3 integrin-binding motif regulating endothelial cell adhesion and proliferation. By NMR and molecular dynamics studies, we analyzed the structure of CisoDGRC (isoDGR-2C), a cyclic beta-peptide mimicking the FN-I-5 site, and compared it with NGR, RGD, or DGR-containing cyclopeptides. Docking experiments show that isoDGR, exploiting an inverted orientation as compared with RGD, favorably interacts with the RGD-binding site of alpha v beta 3, both recapitulating canonical RGD-alpha v beta 3 contacts and establishing additional polar interactions. Conversely, NGR and DGR motifs lack the fundamental pharmacophoric requirements for high receptor affinity. Therefore, unlike NGR and DGR, isoDGR is a new natural recognition motif of the RGD-binding pocket of alpha v beta 3. These findings contribute to explain the different functional properties of FN-I-5 before and after deamidation, and provide support for the hypothesis that NGR 3 isoDGR transition can work as a molecular timer for activating latent integrin-binding sites in proteins, thus regulating protein function.	[Traversari, Catia; Bordignon, Claudio; Corti, Angelo; Rizzardi, Gian-Paolo] MolMed SpA, I-20132 Milan, Italy; [Spitaleri, Andrea; Mari, Silvia; Musco, Giovanna] Ist Sci San Raffaele, Dulbecco Telethon Inst, Biomol NMR Lab, I-20132 Milan, Italy; [Curnis, Flavio; Corti, Angelo] Ist Sci San Raffaele, Dept Oncol, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy; [Curnis, Flavio; Corti, Angelo] Ist Sci San Raffaele, Italian Inst Technol Network, Res Unit Mol Neurosci, I-20132 Milan, Italy; [Longhi, Renato] CNR, Ist Chim Riconoscimento Mol, I-20131 Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Corti, A (corresponding author), MolMed SpA, Via Olgettina 58, I-20132 Milan, Italy.	corti.angelo@hsr.it; paolo.rizzardi@molmed.com; musco.giovanna@hsr.it	Corti, Angelo/F-7046-2012; Curnis, Flavio/AAK-3542-2020; musco, giovanna/I-7122-2012; Musco, Giovanna/Q-2756-2019; Spitaleri, Andrea/S-9368-2019	Corti, Angelo/0000-0002-0893-6191; Curnis, Flavio/0000-0002-7231-9569; musco, giovanna/0000-0002-0469-2994; Spitaleri, Andrea/0000-0003-3012-3557; Subba, Rajkrishna/0000-0003-0051-0062	Telethon [TCR07003] Funding Source: Medline	Telethon(Fondazione Telethon)		ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belvisi L, 2005, MOL CANCER THER, V4, P1670, DOI 10.1158/1535-7163.MCT-05-0120; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casiraghi G, 2005, J MED CHEM, V48, P7675, DOI 10.1021/jm050698x; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Curnis F, 2005, CANCER RES, V65, P2906, DOI 10.1158/0008-5472.CAN-04-4282; Curnis F, 2002, CANCER RES, V62, P867; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daura X, 1999, PROTEINS, V36, P542, DOI 10.1002/(SICI)1097-0134(19990901)36:4<542::AID-PROT17>3.0.CO;2-M; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Matteo P, 2006, MOL IMMUNOL, V43, P1509, DOI 10.1016/j.molimm.2005.10.009; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Gottschalk KE, 2002, ANGEW CHEM INT EDIT, V41, P3767, DOI 10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T; Hansmann UHE, 1997, PHYS REV E, V56, P2228, DOI 10.1103/PhysRevE.56.2228; Heckmann D, 2007, METHOD ENZYMOL, V426, P463, DOI 10.1016/S0076-6879(07)26020-3; Heckmann D, 2007, ANGEW CHEM INT EDIT, V46, P3571, DOI 10.1002/anie.200700008; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kiyozumi D, 2005, EXP CELL RES, V306, P9, DOI 10.1016/j.yexcr.2005.01.020; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Luan YP, 2007, CURR MED CHEM, V14, P639, DOI 10.2174/092986707780059571; Marinelli L, 2003, J MED CHEM, V46, P4393, DOI 10.1021/jm020577m; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Mohri H, 1997, PEPTIDES, V18, P899, DOI 10.1016/S0196-9781(97)00027-2; Moitessier N, 2004, J MED CHEM, V47, P4178, DOI 10.1021/jm0311386; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pasqualini R, 2000, CANCER RES, V60, P722; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Scarborough RM, 1999, CURR MED CHEM, V6, P971; Steck E, 2007, MATRIX BIOL, V26, P30, DOI 10.1016/j.matbio.2006.09.006; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; TRAVERSARI C, 1992, IMMUNOGENETICS, V35, P145, DOI 10.1007/BF00185107; van Well RM, 2003, J AM CHEM SOC, V125, P10822, DOI 10.1021/ja035461+; Wermuth J, 1997, J AM CHEM SOC, V119, P1328, DOI 10.1021/ja961908l; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamada KM, 1989, CURR OPIN CELL BIOL, V1, P956, DOI 10.1016/0955-0674(89)90065-3	59	79	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19757	19768		10.1074/jbc.M710273200	http://dx.doi.org/10.1074/jbc.M710273200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480047	hybrid			2022-12-27	WOS:000257387600060
J	Miyamoto, N; Izumi, H; Noguchi, T; Nakajima, Y; Ohmiya, Y; Shiota, M; Kidani, A; Tawara, A; Kohno, K				Miyamoto, Naoya; Izumi, Hiroto; Noguchi, Takako; Nakajima, Yoshihiro; Ohmiya, Yoshihiro; Shiota, Masaki; Kidani, Akihiko; Tawara, Akihiko; Kohno, Kimitoshi			Tip60 is regulated by circadian transcription factor clock and is involved in cisplatin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-LINES; ADENOSINE-TRIPHOSPHATASE ATP7B; DNA-REPAIR; DRUG-RESISTANCE; HISTONE ACETYLTRANSFERASE; LUNG-CANCER; ACETYLATION; PROTEIN; CHEMOTHERAPY; GLUTATHIONE	Histone modification is important for maintaining chromatin structure and function. Recently, histone acetylation has been shown to have a critical regulatory role in both transcription and DNA repair. Wereport here that expression of histone acetyltransferase (HAT) genes is associated with cisplatin resistance. We found that Tip60 is overexpressed in cisplatin-resistant cells. The expression of two other HAT genes, HAT1 and MYST1, did not differ between drug-sensitive and -resistant cells. Knockdown of Tip60 expression rendered cells sensitive to cisplatin but not to oxaliplatin, vincristine, and etoposide. Tip60 expression is significantly correlated with cisplatin sensitivity in human lung cancer cell lines. Interestingly, the promoter region of the Tip60 gene contains several E boxes, and its expression was regulated by the E-box binding circadian transcription factor Clock but not by other E-box binding transcription factors such as c-Myc, Twist, and USF1. Hyperacetylation of H3K14 and H4K16 was found in cisplatin-resistant cells. The microarray study reveals that several genes for DNA repair are down-regulated by the knockdown of Tip60 expression. Our data show that HAT gene expression is required for cisplatin resistance and suggest that Clock and Tip60 regulate not only transcription, but also DNA repair, through periodic histone acetylation.	[Miyamoto, Naoya; Izumi, Hiroto; Shiota, Masaki; Kidani, Akihiko; Kohno, Kimitoshi] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 8078555, Japan; [Miyamoto, Naoya; Tawara, Akihiko] Univ Occupat & Environm Hlth, Sch Med, Dept Ophthalmol, Kitakyushu, Fukuoka 8078555, Japan; [Noguchi, Takako; Nakajima, Yoshihiro; Ohmiya, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Osaka 5638577, Japan; [Ohmiya, Yoshihiro] Hokkaido Univ, Grad Sch Med, Dept Photobiol, Sapporo, Hokkaido 0608633, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University	Kohno, K (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 8078555, Japan.	k-kohno@med.uoeh-u.ac.jp	Ohmiya, Yoshihiro/J-7143-2013; Shiota, Masaki/Q-9387-2019; Nakajima, Yoshihiro/M-6935-2018	Ohmiya, Yoshihiro/0000-0002-4944-509X; Nakajima, Yoshihiro/0000-0002-7422-730X; Shiota, Masaki/0000-0002-3306-4858				Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Chaney SG, 1996, JNCI-J NATL CANCER I, V88, P1346, DOI 10.1093/jnci/88.19.1346; Cohen SM, 2001, PROG NUCLEIC ACID RE, V67, P93, DOI 10.1016/S0079-6603(01)67026-0; DANIEL RM, 2007, MOL CANCER RES, V5, P61; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; FUJII R, 1994, JPN J CANCER RES, V85, P426, DOI 10.1111/j.1349-7006.1994.tb02376.x; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Husain A, 1998, CANCER RES, V58, P1120; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kimura A, 2005, J BIOCHEM, V138, P647, DOI 10.1093/jb/mvi184; Kohno K, 2005, EUR J CANCER, V41, P2577, DOI 10.1016/j.ejca.2005.08.007; Komatsu M, 2000, CANCER RES, V60, P1312; LAI GM, 1989, JNCI-J NATL CANCER I, V81, P535, DOI 10.1093/jnci/81.7.535; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Murakami T, 2001, INT J CANCER, V93, P869, DOI 10.1002/ijc.1418; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Nakayama K, 2002, INT J CANCER, V101, P488, DOI 10.1002/ijc.10608; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Takenaka T, 2007, INT J CANCER, V121, P895, DOI 10.1002/ijc.22738; Tanabe M, 2003, CANCER RES, V63, P8592; TEW KD, 1994, CANCER RES, V54, P4313; Torigoe Takayuki, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P15, DOI 10.2174/1568011053352587; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wakasugi T, 2007, ONCOGENE, V26, P5194, DOI 10.1038/sj.onc.1210326; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7	30	65	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					18218	18226		10.1074/jbc.M802332200	http://dx.doi.org/10.1074/jbc.M802332200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18458078	hybrid			2022-12-27	WOS:000256949200050
J	Furukawa, Y; Kaneko, K; Yamanaka, K; O'Halloran, TV; Nukina, N				Furukawa, Yoshiaki; Kaneko, Kumi; Yamanaka, Koji; O'Halloran, Thomas V.; Nukina, Nobuyuki			Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; PROTEIN-DISULFIDE-ISOMERASE; MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; ALS-LINKED SOD1; TRANSGENIC MICE; MUTANT SOD1; CU,ZN-SUPEROXIDE DISMUTASE; SPINAL-CORDS; MUTATIONS	Dominant mutations in Cu,Zn-superoxide dismutase (SOD1) cause a familial form of amyotrophic lateral sclerosis (fALS), and aggregation of mutant SOD1 has been proposed to play a role in neurodegeneration. A growing body of evidence suggests that fALS-causing mutations destabilize the native structure of SOD1, leading to aberrant protein interactions for aggregation. SOD1 becomes stabilized and enzymatically active after copper and zinc binding and intramolecular disulfide formation, but it remains unknown which step(s) in the SOD1 maturation process is important in the pathological aggregation. In this study we have shown that apoSOD1 without disulfide is the most facile state for formation of amyloid-like fibrillar aggregates. fALS mutations impair either zinc binding, disulfide formation, or both, leading to accumulation of the aggregation-prone, apo, and disulfide-reduced SOD1. Moreover, we have found that the copper chaperone for SOD1 (CCS) facilitates maturation of SOD1 and that CCS overexpression ameliorates intracellular aggregation of mutant SOD1 in vivo. Based on our in vivo and in vitro results, we propose that facilitation of post-translational modifications is a promising strategy to reduce SOD1 aggregation in the cell.	[Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Yamanaka, Koji] RIKEN, Brain Sci Inst, Yamanaka Res Unit, Wako, Saitama 3510198, Japan; [O'Halloran, Thomas V.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	RIKEN; RIKEN; Northwestern University	Furukawa, Y (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	furukawa@brain.riken.jp; nukina@brain.riken.jp	Yamanaka, Koji/ABD-1034-2020; Yamanaka, Koji/H-5806-2011; Furukawa, Yoshiaki/F-2871-2014; O'Halloran, Thomas/ABE-6125-2021; Nukina, Nobuyuki/GPP-6265-2022	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Furukawa, Yoshiaki/0000-0002-1918-372X; O'Halloran, Thomas/0000-0001-8732-5059; 	Scientific Research on Priority Areas Research on Pathomechanisms of Brain Disorders [17025044]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [18031044, 18770143]; Ministry of Health, Welfare, and Labor, Japan; Nakabayashi Trust for ALS Research	Scientific Research on Priority Areas Research on Pathomechanisms of Brain Disorders(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor, Japan(Ministry of Health, Labour and Welfare, Japan); Nakabayashi Trust for ALS Research	This work was supported by Grant-in-aid 17025044 for Scientific Research on Priority Areas Research on Pathomechanisms of Brain Disorders (to N.N.) and Grants-in-aid 18031044 and 18770143 (to Y.F.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant-in-aid for the Research on Measures for Intractable Diseases from the Ministry of Health, Welfare, and Labor, Japan (to N.N.), and by the Nakabayashi Trust for ALS Research (to Y.F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Banci L, 1995, EUR J BIOCHEM, V234, P855, DOI 10.1111/j.1432-1033.1995.855_a.x; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bertini I, 1998, ADV INORG CHEM, V45, P127, DOI 10.1016/S0898-8838(08)60026-4; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Crow JP, 1997, J NEUROCHEM, V69, P1945; Crow JP, 1997, J NEUROCHEM, V69, P1936; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shivaprasad S, 2006, J BIOL CHEM, V281, P993, DOI 10.1074/jbc.M505091200; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Stieber A, 2000, J NEUROL SCI, V173, P53, DOI 10.1016/S0022-510X(99)00300-7; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200	58	156	158	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24167	24176		10.1074/jbc.M802083200	http://dx.doi.org/10.1074/jbc.M802083200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18552350	Green Published, hybrid			2022-12-27	WOS:000258638900070
J	Bruss, MD; Richter, W; Horner, K; Jin, SLC; Conti, M				Bruss, Matthew D.; Richter, Wito; Horner, Kathleen; Jin, S-L Catherine; Conti, Marco			Critical role of PDE4D in beta(2)-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BETA-ADRENERGIC-RECEPTOR; CYCLIC-AMP; BETA(2)-ADRENERGIC RECEPTOR; CARDIAC MYOCYTES; CROSS-TALK; PHOSPHODIESTERASE; PHOSPHORYLATION; ADRENOCEPTOR; ACTIVATION	One of the defining properties of beta(2)-adrenergic receptor (beta(2)AR) signaling is the transient and rapidly reversed accumulation of cAMP. Here we have investigated the contribution of different PDE4 proteins to the generation of this transient response. To this aim, mouse embryonic fibroblasts deficient in PDE4A, PDE4B, or PDE4D were generated, and the regulation of PDE activity, the accumulation of cAMP, and CREB phosphorylation in response to isoproterenol were monitored. Ablation of PDE4D, but not PDE4A or PDE4B, had a major effect on the beta-agonist-induced PDE activation, with only a minimal increase in PDE activity being retained in PDE4D knock-out (KO) cells. Accumulation of cAMP was markedly enhanced, and the kinetics of cAMP accumulation were altered in their properties in PDE4DKO but not PDE4BKO cells. Modest effects were observed in PDE4AKO mouse embryonic fibroblasts. The return to basal levels of both cAMP accumulation and CREB phosphorylation was greatly delayed in the PDE4DKO cells, suggesting that PDE4D is critical for dissipation of the beta(2)AR stimulus. This effect of PDE4D ablation was in large part due to inactivation of a negative feedback mechanism consisting of the PKA-mediated activation of PDE4D in response to elevated cAMP levels, as indicated by experiments using the cAMP-dependent protein kinase inhibitors H89 and PKI. Finally, PDE4D ablation affected the kinetics of beta(2)AR desensitization as well as the interaction of the receptor with G alpha(i). These findings demonstrate that PDE4D plays a major role in shaping the beta(2)AR signal.	[Richter, Wito; Horner, Kathleen; Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Bruss, Matthew D.; Jin, S-L Catherine] Stanford Univ, Sch Med, Div Reprod Biol, Dept Obstet & Gynecol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Conti, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,HSW 1656,Box 0556, San Francisco, CA 94143 USA.	contim@obgyn.ucsf.edu		Richter, Wito/0000-0001-5588-9060	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020788] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092788] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL092788] Funding Source: Medline; NICHD NIH HHS [HD20788] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BRECHLER V, 1992, J BIOL CHEM, V267, P15496; Conner DA, 1997, CIRC RES, V81, P1021; CONTI M, 1995, ENDOCR REV, V16, P370, DOI 10.1210/er.16.3.370; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Devic E, 2001, MOL PHARMACOL, V60, P577; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jin S.L.C., 2006, CYCLIC NUCLEOTIDE PH, P323; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Mongillo M, 2006, BIOCHEM SOC T, V34, P510, DOI 10.1042/BST0340510; Oki N, 2000, J BIOL CHEM, V275, P10831, DOI 10.1074/jbc.275.15.10831; Park JY, 2003, MOL ENDOCRINOL, V17, P1117, DOI 10.1210/me.2002-0435; Parker D, 1996, MOL CELL BIOL, V16, P694; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Richter W, 2002, J BIOL CHEM, V277, P40212, DOI 10.1074/jbc.M203585200; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Willoughby D, 2007, J BIOL CHEM, V282, P34235, DOI 10.1074/jbc.M706765200; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Xiao RP, 2000, CIRC RES, V87, P635, DOI 10.1161/01.RES.87.8.635; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200	45	36	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22430	22442		10.1074/jbc.M803306200	http://dx.doi.org/10.1074/jbc.M803306200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18508768	Green Published, hybrid			2022-12-27	WOS:000258321000011
J	Cebotaru, L; Vij, N; Ciobanu, I; Wright, J; Flotte, T; Guggino, WB				Cebotaru, Liudmila; Vij, Neeraj; Ciobanu, Igor; Wright, Jerry; Flotte, Terence; Guggino, William B.			Cystic fibrosis transmembrane regulator missing the first four transmembrane segments increases wild type and Delta F508 processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; CONDUCTANCE REGULATOR; CFTR; PROTEIN; GENE; CHAPERONES; EXPRESSION; MUTATION; VECTOR	We previously generated an adenoassociated viral gene therapy vector, rAAV-Delta 264 cystic fibrosis transmembrane conductance regulator (CFTR), missing the first four transmembrane domains of CFTR. When infected into monkey lungs, Delta 264 CFTR increased the levels of endogenous wild type CFTR protein. To understand this process, we transfected Delta 264 CFTR plasmid cDNA into COS7 cells, and we noted that protein expression from the truncation mutant is barely detectable when compared with wild type or Delta F508 CFTR. Delta 264 CFTR protein expression increases dramatically when cells are treated with proteasome inhibitors. Cycloheximide experiments show that Delta 264 CFTR is degraded faster than Delta F508 CFTR. VCP and HDAC6, two proteins involved in retrograde translocation from endoplasmic reticulum to cytosol for proteasomal and aggresomal degradation, coimmunoprecipitate with Delta 264 CFTR. In cotransfection studies in COS7 cells and in transfection of Delta 264 CFTR into cells stably expressing wild type and Delta F508 CFTR, Delta 264 CFTR increases wild type CFTR protein and increases levels of maturation of immature band B to mature band C of Delta F508 CFTR. Thus the adenoassociated viral vector, rAAV-Delta 264 CFTR, is a highly promising cystic fibrosis gene therapy vector because it increases the amount of mature bandC protein both from wild type and Delta F508 CFTR and associates with key elements in quality control mechanism of CFTR.	[Cebotaru, Liudmila; Ciobanu, Igor; Wright, Jerry; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Vij, Neeraj] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Flotte, Terence] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Wood Basic Sci Bldg 214A,725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL51811-06] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Brooks DA, 1999, SEMIN CELL DEV BIOL, V10, P441, DOI 10.1006/scdb.1999.0314; CARROLL TP, 1995, J BIOL CHEM, V270, P11941, DOI 10.1074/jbc.270.20.11941; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Farinha Carlos M, 2004, J Cyst Fibros, V3 Suppl 2, P73, DOI 10.1016/j.jcf.2004.05.017; Fischer AC, 2007, MOL THER, V15, P756, DOI 10.1038/sj.mt.6300059; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Goldstein RF, 2007, AM J RESP CELL MOL, V36, P706, DOI 10.1165/rcmb.2006-0365OC; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mueller C, 2008, J GENE MED, V10, P51, DOI 10.1002/jgm.1119; Muller C, 2006, LAB INVEST, V86, P130, DOI 10.1038/labinvest.3700379; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sirninger J, 2004, HUM GENE THER, V15, P832, DOI 10.1089/1043034041839262; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Zeitlin Pamela L, 2003, Expert Opin Emerg Drugs, V8, P523, DOI 10.1517/eoed.8.2.523.21136; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	33	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21926	21933		10.1074/jbc.M709156200	http://dx.doi.org/10.1074/jbc.M709156200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508776	Green Published, hybrid			2022-12-27	WOS:000258114700012
J	Schroeder, CI; Ekberg, J; Nielsen, KJ; Adams, D; Loughnan, ML; Thomas, L; Adams, DJ; Alewood, PF; Lewis, RJ				Schroeder, Christina I.; Ekberg, Jenny; Nielsen, Katherine J.; Adams, Denise; Loughnan, Marion L.; Thomas, Linda; Adams, David J.; Alewood, Paul F.; Lewis, Richard J.			Neuronally selective mu-conotoxins from Conus striatus utilize an alpha-helical motif to target mammalian sodium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; POTENT INHIBITOR; GIIIA; PEPTIDE; BLOCKER; NMR; PROTEINS; ANALOGS; TOXINS; PIIIA	mu-Conotoxins are small peptide inhibitors of muscle and neuronal tetrodotoxin (TTX)-sensitive voltage-gated sodium channels (VGSCs). Here we report the isolation of mu-conotoxins SIIIA and SIIIB by I-125-TIIIA-guided fractionation of milked Conus striatus venom. SIIIA and SIIIB potently displaced I-125-TIIIA from native rat brain Na(v)1.2 (IC50 values 10 and 5 nM, respectively) and muscle Na(v)1.4 (IC50 values 60 and 3 nM, respectively) VGSCs, and both inhibited current through Xenopus oocyte-expressed Na(v)1.2 and Na(v)1.4. An alanine scan of SIIIA-(2-20), a pyroglutamate-truncated analogue with enhanced neuronal activity, revealed residues important for affinity and selectivity. Alanine replacement of the solvent-exposed Trp-12, Arg-14, His-16, Arg-18 resulted in large reductions in SIIIA-(2-20) affinity, with His-16 replacement affecting structure. In contrast, [D15A]SIIIA-(2-20) had significantly enhanced neuronal affinity (IC50 0.65 nM), while the double mutant [D15A/H16R]SIIIA-(2-20) showed greatest Na(v)1.2 versus 1.4 selectivity (136-fold). H-1 NMR studies revealed that SIIIA adopted a single conformation in solution comprising a series of turns and an alpha-helical motif across residues 11-16 that is not found in larger mu-conotoxins. The structure of SIIIA provides a new structural template for the development of neuronally selective inhibitors of TTX-sensitive VGSCs based on the smaller mu-conotoxin pharmacophore.	[Schroeder, Christina I.; Adams, Denise; Loughnan, Marion L.; Thomas, Linda; Alewood, Paul F.; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Ekberg, Jenny; Adams, David J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Nielsen, Katherine J.] Xenome Ltd, Indooroopilly, Qld 4069, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	r.lewis@imb.uq.edu.au	Loughnan, Marion/B-4508-2009; Schroeder, Cristina I./K-2042-2014; Lewis, Richard/T-8763-2019; Alewood, Paul F/J-2412-2014; Adams, David John/K-3578-2019; Lewis, Richard J/E-8674-2013; Ekberg, Jenny/AAV-2006-2020; Adams, David/J-9125-2014	Schroeder, Cristina I./0000-0002-6737-6374; Lewis, Richard/0000-0003-3470-923X; Adams, David John/0000-0002-7030-2288; Lewis, Richard J/0000-0003-3470-923X; Adams, David/0000-0002-7030-2288; Ekberg, Jenny/0000-0001-5151-4966; Alewood, Paul/0000-0001-7454-6522				BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chahine M, 1995, RECEPTOR CHANNEL, V3, P161; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; French RJ, 2004, CURR MED CHEM, V11, P3053, DOI 10.2174/0929867043363866; Goddard T.D., 2004, SPARKY 3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; Kalso E, 2005, CURR PHARM DESIGN, V11, P3005, DOI 10.2174/1381612054865028; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; Lewis RJ, 2007, MOL PHARMACOL, V71, P676, DOI 10.1124/mol.106.028225; Luy Y.S., 2000, BRAIN RES, V871, P98; Moffatt F, 2000, J CHROMATOGR A, V891, P235, DOI 10.1016/S0021-9673(00)00620-8; Nakamura M, 2001, FEBS LETT, V503, P107, DOI 10.1016/S0014-5793(01)02714-4; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nielsen KJ, 1999, J MOL BIOL, V289, P1405, DOI 10.1006/jmbi.1999.2817; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; OTT KH, 1991, FEBS LETT, V278, P160, DOI 10.1016/0014-5793(91)80107-E; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Safo P, 2000, J NEUROSCI, V20, P76, DOI 10.1523/JNEUROSCI.20-01-00076.2000; SATO K, 1991, J BIOL CHEM, V266, P16989; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; Shon KJ, 1998, J NEUROSCI, V18, P4473; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; Wang CZ, 2006, TOXICON, V47, P122, DOI 10.1016/j.toxicon.2005.10.008; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j	41	38	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21621	21628		10.1074/jbc.M802852200	http://dx.doi.org/10.1074/jbc.M802852200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522941	hybrid			2022-12-27	WOS:000257898800035
J	Chi, RJ; Simon, AR; Bienkiewicz, EA; Felix, A; Keller, TCS				Chi, Richard J.; Simon, Alanna R.; Bienkiewicz, Ewa A.; Felix, Augustine; Keller, Thomas C. S., III			Smooth muscle titin Zq domain interaction with the smooth muscle alpha-actinin central rod	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Z-DISC; MOLECULAR-MECHANISMS; EXPRESSION; ISOFORM; BINDING; PROTEINS; IDENTIFICATION; CYTOSKELETON; PLASTICITY; NONMUSCLE	Actin-myosin II filament-based contractile structures in striated muscle, smooth muscle, and nonmuscle cells contain the actin filament-cross-linking protein alpha-actinin. In striated muscle Z-disks, alpha-actinin interacts with N-terminal domains of titin to provide a structural linkage crucial for the integrity of the sarcomere. We previously discovered a long titin isoform, originally smitin, hereafter sm-titin, in smooth muscle and demonstrated that native sm-titin interacts with C-terminal EF hand region and central rod R2-R3 spectrin-like repeat region sites in alpha-actinin. Reverse transcription-PCR analysis of RNA from human adult smooth muscles and cultured rat smooth muscle cells and Western blot analysis with a domain-specific antibody presented here revealed that sm-titin contains the titin gene-encoded Zq domain that may bind to the alpha-actinin R2-R3 central rod domain as well as Z-repeat domains that bind to the EF hand region. We investigated whether the sm-titin Zq domain binds to alpha-actinin R2 and R3 spectrin repeat-like domain loops that lie in proximity with two-fold symmetry on the surface of the central rod. Mutations in alpha-actinin R2 and R3 domain loop residues decreased interaction with expressed sm-titin Zq domain in glutathione S-transferase pull-down and solid phase binding assays. Alanine mutation of a region of the Zq domain with high propensity for alpha-helix formation decreased apparent Zq domain dimer formation and decreased Zq interaction with the alpha-actinin R2-R3 region in surface plasmon resonance assays. We present a model in which two sm-titin Zq domains interact with each other and with the two R2-R3 sites in the alpha-actinin central rod.	[Bienkiewicz, Ewa A.] Florida State Univ, Coll Med, BIO 303, Tallahassee, FL 32306 USA; [Chi, Richard J.; Simon, Alanna R.; Keller, Thomas C. S., III] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Felix, Augustine] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bienkiewicz, EA (corresponding author), Florida State Univ, Coll Med, BIO 303, Tallahassee, FL 32306 USA.	tkeller@bio.fsu.edu		Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006158] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB 006158] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Atkinson RA, 2000, BIOCHEMISTRY-US, V39, P5255, DOI 10.1021/bi991891u; Ayoob JC, 2000, CELL MOTIL CYTOSKEL, V45, P67, DOI 10.1002/(SICI)1097-0169(200001)45:1<67::AID-CM7>3.3.CO;2-K; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Cavnar PJ, 2007, CELL MOTIL CYTOSKEL, V64, P418, DOI 10.1002/cm.20193; Chi RJ, 2005, INT J BIOCHEM CELL B, V37, P1470, DOI 10.1016/j.biocel.2005.02.014; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; EILERTSEN KJ, 1992, J CELL BIOL, V119, P549, DOI 10.1083/jcb.119.3.549; Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761; FORD LE, 1994, CAN J PHYSIOL PHARM, V72, P1320, DOI 10.1139/y94-190; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Herrera AM, 2005, J CELL SCI, V118, P2381, DOI 10.1242/jcs.02368; Joseph C, 2001, BIOCHEMISTRY-US, V40, P4957, DOI 10.1021/bi002739r; Keller TCS, 2000, ADV EXP MED BIOL, V481, P265; Kim K, 2002, J CELL BIOL, V156, P101, DOI 10.1083/jcb.200107037; Labeit S, 2006, J MOL BIOL, V362, P664, DOI 10.1016/j.jmb.2006.07.077; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lee EH, 2006, STRUCTURE, V14, P497, DOI 10.1016/j.str.2005.12.005; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Nakamura A, 1998, MICROVASC RES, V55, P14, DOI 10.1006/mvre.1997.2050; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Orford JL, 2000, AM J CARDIOL, V86, p6H, DOI 10.1016/S0002-9149(00)01094-8; Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015; Sanger JW, 2000, ADV EXP MED BIOL, V481, P89; Seow CY, 2000, J APPL PHYSIOL, V89, P2065, DOI 10.1152/jappl.2000.89.5.2065; Seow CY, 2000, J APPL PHYSIOL, V89, P869, DOI 10.1152/jappl.2000.89.3.869; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Tskhovrebova L, 2005, NAT MED, V11, P478, DOI 10.1038/nm0505-478; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Young P, 2000, EMBO J, V19, P6331, DOI 10.1093/emboj/19.23.6331; ZANELLATO AMC, 1990, ARTERIOSCLEROSIS, V10, P996, DOI 10.1161/01.ATV.10.6.996	37	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20959	20967		10.1074/jbc.M709621200	http://dx.doi.org/10.1074/jbc.M709621200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18519573	Green Published, hybrid			2022-12-27	WOS:000257746100038
J	Jiang, W; Betson, M; Mulloy, R; Foster, R; Levay, M; Ligeti, E; Settleman, J				Jiang, Wei; Betson, Martha; Mulloy, Roseann; Foster, Rosemary; Levay, Magdolna; Ligeti, Erzsebet; Settleman, Jeffrey			p190A RhoGAP is a glycogen synthase kinase-3-beta substrate required for polarized cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES CELL; DIRECTIONAL MIGRATION; MEMBRANE PROTRUSION; FAMILY GTPASES; RHOA ACTIVITY; BETA-CATENIN; LIPID RAFTS; C-SRC; P190RHOGAP; ADHESION	The Rho GTPases are critical regulators of the actin cytoskeleton and are required for cell adhesion, migration, and polarity. Among the key Rho regulatory proteins in the context of cell migration are the p190 RhoGAPs (p190A and p190B), which function to modulate Rho signaling in response to integrin engagement. The p190 RhoGAPs undergo complex regulation, including phosphorylation by several identified kinases, interactions with phospholipids, and association with a variety of cellular proteins. Here, we have identified an additional regulatory mechanism unique to p190A RhoGAP that involves priming-dependent phosphorylation by glycogen synthase-3-beta (GSK-3 beta), a kinase previously implicated in establishing cell polarity. We found that p190A-deficient fibroblasts exhibit a defect in directional cell migration reflecting a requirement for GSK-3 beta-mediated phosphorylation of amino acids in the C-terminal "tail" of p190A. This phosphorylation leads to inhibition of p190A RhoGAP activity in vitro and in vivo. These studies identify p190A as a novel GSK-3 beta substrate and reveal a mechanism by which GSK-3 beta contributes to cellular polarization in directionally migrating cells via effects on Rho GTPase activity.	[Jiang, Wei; Betson, Martha; Mulloy, Roseann; Settleman, Jeffrey] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Jiang, Wei; Betson, Martha; Mulloy, Roseann; Foster, Rosemary; Settleman, Jeffrey] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Levay, Magdolna] Semmelweis Univ, Dept Physiol, H-1444 Budapest, Hungary	Harvard University; Massachusetts General Hospital; Harvard University; Semmelweis University	Settleman, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149 13th St, Charlestown, MA 02129 USA.	settleman@helix.mgh.harvard.edu	Betson, Martha/D-3818-2014	Betson, Martha/0000-0002-4220-3290	NCI NIH HHS [R01 CA 62142] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA062142] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; Dumenil G, 2000, J CELL SCI, V113, P71; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Foster R, 1996, MOL CELL BIOL, V16, P2689; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Harwood AJ, 2002, DEV CELL, V2, P384, DOI 10.1016/S1534-5807(02)00156-9; Haskell MD, 2001, J CELL SCI, V114, P1699; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Kusama T, 2006, CANCER SCI, V97, P848, DOI 10.1111/j.1349-7006.2006.00242.x; Li R, 2005, CURR BIOL, V15, pR198, DOI 10.1016/j.cub.2005.03.008; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Ligeti E, 2006, METHOD ENZYMOL, V406, P104, DOI 10.1016/S0076-6879(06)06009-5; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Wickstrom SA, 2003, J BIOL CHEM, V278, P37895, DOI 10.1074/jbc.M303569200; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020	36	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20978	20988		10.1074/jbc.M802588200	http://dx.doi.org/10.1074/jbc.M802588200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502760	hybrid, Green Published			2022-12-27	WOS:000257746100040
J	Ponguta, LA; Gregory, CW; French, FS; Wilson, EM				Ponguta, Liliana A.; Gregory, Christopher W.; French, Frank S.; Wilson, Elizabeth M.			Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; GLUCOCORTICOID-RECEPTOR; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; RESPONSE ELEMENTS; TYROSINE PHOSPHORYLATION; NUCLEAR RECEPTORS; REGULATED GENES; TERMINAL DOMAIN; KU AUTOANTIGEN	The androgen receptor (AR) is required for prostate cancer development and contributes to tumor progression after remission in response to androgen deprivation therapy. Epidermal growth factor (EGF) increases AR transcriptional activity at low levels of androgen in the CWR-R1 prostate cancer cell line derived from the castration-recurrent CWR22 prostate cancer xenograft. Here we report that knockdown of AR decreases EGF stimulation of prostate cancer cell growth and demonstrate a mechanistic link between EGF and AR signaling. The EGF-induced increase in AR transcriptional activity is dependent on phosphorylation at mitogen-activated protein kinase consensus site Ser-515 in the AR NH2-terminal region and at protein kinase C consensus site Ser-578 in the AR DNA binding domain. Phosphorylation at these sites alters the nuclear-cytoplasmic shuttling of AR and AR interaction with the Ku-70/80 regulatory subunits of DNA-dependent protein kinase. Abolishing AR Ser-578 phosphorylation by introducing an S578A mutation eliminates the AR transcriptional response to EGF and increases both AR binding of Ku-70/80 and nuclear retention of AR in association with hyperphosphorylation of AR Ser-515. The results support a model in which AR transcriptional activity increases castration-recurrent prostate cancer cell growth in response to EGF by site-specific serine phosphorylation that regulates nuclear- cytoplasmic shuttling through interactions with the Ku-70/80 regulatory complex.	[Ponguta, Liliana A.; Gregory, Christopher W.; French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Ponguta, Liliana A.; Gregory, Christopher W.; French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ponguta, Liliana A.; Gregory, Christopher W.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			NCI NIH HHS [P01 CA 77739, P01 CA077739] Funding Source: Medline; NICHD NIH HHS [R01 HD016910, HD 16910] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Carrigan A, 2007, J BIOL CHEM, V282, P10963, DOI 10.1074/jbc.M602931200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CULIG Z, 1994, CANCER RES, V54, P5474; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; FREEDMAN LP, 1992, ENDOCR REV, V13, P129, DOI 10.1210/er.13.2.129; Furutani T, 2005, BIOSCI BIOTECH BIOCH, V69, P2236, DOI 10.1271/bbb.69.2236; Galigniana MD, 1999, J BIOL CHEM, V274, P16222, DOI 10.1074/jbc.274.23.16222; Giffin W, 1999, MOL CELL BIOL, V19, P4065; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Giwercman YL, 2000, HORM RES, V53, P83, DOI 10.1159/000023519; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gregory CW, 2005, CLIN CANCER RES, V11, P1704, DOI 10.1158/1078-0432.CCR-04-1158; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P2892; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Hamy F, 2003, PROSTATE CANCER P D, V6, P27, DOI 10.1038/sj.pcan.4500603; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Ilagan R, 2005, MOL CANCER THER, V4, P1662, DOI 10.1158/1535-7163.MCT-05-0197; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Kaarbo M, 2007, BIOESSAYS, V29, P1227, DOI 10.1002/bies.20676; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; KUNKEL GR, 1989, NUCLEIC ACIDS RES, V17, P7371, DOI 10.1093/nar/17.18.7371; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Linja MJ, 2001, CANCER RES, V61, P3550; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MARSCHKE KB, 1995, ENDOCRINE, V3, P819, DOI 10.1007/BF02935687; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Schauwaers K, 2007, P NATL ACAD SCI USA, V104, P4961, DOI 10.1073/pnas.0610814104; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SCHER HI, 1993, J CLIN ONCOL, V11, P1566, DOI 10.1200/JCO.1993.11.8.1566; Schoenmakers E, 1999, BIOCHEM J, V341, P515, DOI 10.1042/0264-6021:3410515; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shank LC, 2008, J BIOL CHEM, V283, P10568, DOI 10.1074/jbc.M800810200; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taneja SS, 2005, J BIOL CHEM, V280, P40916, DOI 10.1074/jbc.M508442200; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Wong HY, 2004, BIOCHEM J, V383, P267, DOI 10.1042/BJ20040683; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Zhang LQ, 2003, CANCER RES, V63, P4552; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115; ZILLIACUS J, 1994, P NATL ACAD SCI USA, V91, P4175, DOI 10.1073/pnas.91.10.4175; ZILLIACUS J, 1995, MOL ENDOCRINOL, V9, P389, DOI 10.1210/me.9.4.389	81	78	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20989	21001		10.1074/jbc.M802392200	http://dx.doi.org/10.1074/jbc.M802392200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511414	hybrid, Green Published			2022-12-27	WOS:000257746100041
J	Samavati, L; Lee, I; Mathes, I; Lottspeich, F; Huttemann, M				Samavati, Lobelia; Lee, Icksoo; Mathes, Isabella; Lottspeich, Friedrich; Huttemann, Maik			Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED SIGNAL-TRANSDUCTION; PROTEIN-KINASE-A; TNF-ALPHA; MITOCHONDRIAL-DNA; MYOCARDIAL-ISCHEMIA; INDUCED APOPTOSIS; SEPTIC SHOCK; SEPSIS; RESPIRATION; MECHANISMS	Mitochondrial oxidative phosphorylation provides most cellular energy. As part of this process, cytochrome c oxidase (CcO) pumps protons across the inner mitochondrial membrane, contributing to the generation of the mitochondrial membrane potential, which is used by ATP synthase to produce ATP. During acute inflammation, as in sepsis, aerobic metabolism appears to malfunction and switches to glycolytic energy production. The pro-inflammatory cytokine tumor necrosis factor alpha(TNF alpha) has been shown to play a central role in inflammation. We hypothesized that TNF alpha-triggered cell signaling targets CcO, which is a central enzyme of the aerobic energy metabolism and can be regulated through phosphorylation. Using total bovine and murine hepatocyte homogenates TNF alpha treatment led to an similar to 60% reduction in CcO activity. In contrast, there was no direct effect of TNF alpha on CcO activity using isolated mitochondria and purified CcO, indicating that a TNF alpha-triggered intracellular signaling cascade mediates CcO inhibition. CcO isolated after TNF alpha treatment showed tyrosine phosphorylation on CcO catalytic subunit I and was similar to 50 and 70% inhibited at high cytochrome c concentrations in the presence of allosteric activator ADP and inhibitor ATP, respectively. CcO phosphorylation occurs on tyrosine 304 as demonstrated with a phosphoepitope-specific antibody. Furthermore, the mitochondrial membrane potential was decreased in H2.35 cells in response to TNF alpha. Concomitantly, cellular ATP was more than 35 and 64% reduced in murine hepatocytes and H2.35 cells. We postulate that an important contributor in TNF alpha-mediated pathologies, such as sepsis, is energy paucity, which parallels the poor tissue oxygen extraction and utilization found in such patients.	[Lee, Icksoo; Huttemann, Maik] Wayne State Univ, Ctr Mol Med & Genet, Sch Med, Detroit, MI 48201 USA; [Samavati, Lobelia] Wayne State Univ, Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, Detroit, MI 48201 USA; [Mathes, Isabella; Lottspeich, Friedrich] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Wayne State University; Wayne State University; Max Planck Society	Huttemann, M (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Sch Med, 3214 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu		Huttemann, Maik/0000-0001-6310-7081				Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; Berg S, 2003, CRIT CARE MED, V31, P1203, DOI 10.1097/01.CCM.0000059647.92390.92; Boneh A, 2006, CELL MOL LIFE SCI, V63, P1236, DOI 10.1007/s00018-005-5585-2; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Busquets S, 2003, CYTOKINE, V22, P1, DOI 10.1016/S1043-4666(03)00098-X; Callahan LA, 2005, J APPL PHYSIOL, V99, P1120, DOI 10.1152/japplphysiol.01157.2004; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Griffioen G, 2002, CURR GENET, V41, P199, DOI 10.1007/s00294-002-0308-9; Huttemann M, 2007, FEBS J, V274, P5737, DOI 10.1111/j.1742-4658.2007.06093.x; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Huttemann M, 2003, GENE, V312, P95, DOI 10.1016/S0378-1119(03)00604-8; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; KADENBACH B, 1986, METHOD ENZYMOL, V126, P32; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kimura H, 2006, LIFE SCI, V78, P1901, DOI 10.1016/j.lfs.2005.08.040; KREYMANN G, 1993, CRIT CARE MED, V21, P1012, DOI 10.1097/00003246-199307000-00015; Kunz WS, 2000, J BIOL CHEM, V275, P27741; Ledgerwood EC, 1998, LAB INVEST, V78, P1583; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lee I, 2001, EUR J BIOCHEM, V268, P6329, DOI 10.1046/j.0014-2956.2001.02602.x; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; LEE MD, 1987, P NATL ACAD SCI USA, V84, P2590, DOI 10.1073/pnas.84.9.2590; Levy RJ, 2004, SHOCK, V21, P110, DOI 10.1097/01.shk.0000108400.56565.ab; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Liu HT, 2004, J IMMUNOL, V172, P1907, DOI 10.4049/jimmunol.172.3.1907; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Rosser DM, 1995, J APPL PHYSIOL, V79, P1878, DOI 10.1152/jappl.1995.79.6.1878; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singer M, 2005, CRIT CARE MED, V33, pS539, DOI 10.1097/01.CCM.0000186080.13402.96; Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9; TRACEY KJ, 1987, SURG GYNECOL OBSTET, V164, P415; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; VONJAGOW G, 1972, FEBS LETT, V24, P278, DOI 10.1016/0014-5793(72)80372-7; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zhu JX, 2006, CYTOKINE, V34, P96, DOI 10.1016/j.cyto.2006.04.010	58	134	137	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21134	21144		10.1074/jbc.M801954200	http://dx.doi.org/10.1074/jbc.M801954200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18534980	Green Published, hybrid			2022-12-27	WOS:000257746100055
J	Rajala, A; Tanito, M; Le, YZ; Kahn, CR; Rajala, RVS				Rajala, Ammaji; Tanito, Masaki; Le, Yun Z.; Kahn, C. Ronald; Rajala, Raju V. S.			Loss of neuroprotective survival signal in mice lacking insulin receptor gene in rod photoreceptor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT DAMAGE; PHOSPHOINOSITIDE 3-KINASE; BRAIN INSULIN; IN-VIVO; KNOCKOUT; PHOSPHORYLATION; DEATH; APOPTOSIS; RESISTANCE; MUSCLE	Insulin receptor (IR) signaling provides a trophic signal for transformed retinal neurons in culture, but the role of IR activity in vivo is unknown. We previously reported that light causes increased tyrosine phosphorylation of the IR in vivo, which leads to the downstream activation of the phosphoinositide 3-kinase and Akt pathway in rod photoreceptor cells. The functional role of IR in rod photoreceptor cells is not known. We observed that light stress induced tyrosine phosphorylation of the IR in rod photoreceptor cells, and we hypothesized that IR activation is neuroprotective. To determine whether IR has a neuroprotective role on rod photoreceptor cells, we used the Cre/ lox system to specifically inactivate the IR gene in rod photoreceptors. Rod-specific IR knock-out mice have reduced the phosphoinositide 3-kinase and Akt survival signal in rod photoreceptors. The resultant mice exhibited no detectable phenotype when they were raised in dim cyclic light. However, reduced IR expression in rod photoreceptors significantly decreased retinal function and caused the loss of photoreceptors in mice exposed to bright light stress. These results indicate that reduced expression of IR in rod photoreceptor cells increases their susceptibility to light-induced photoreceptor degeneration. These data suggest that the IR pathway is important for photoreceptor survival and that activation of the IR may be an essential element of photoreceptor neuroprotection.	[Rajala, Ammaji; Tanito, Masaki; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Le, Yun Z.; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Rajala, Ammaji; Tanito, Masaki; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; [Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane 6938501, Japan; [Le, Yun Z.] Univ Oklahoma, Hlth Sci Ctr, Dept Med & Endocrinol, Oklahoma City, OK 73104 USA; [Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Kahn, C. Ronald] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Shimane University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Rajala, RVS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NCRR NIH HHS [P20-RR17703] Funding Source: Medline; NEI NIH HHS [EY016507, EY00871] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016507, R01EY000871] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Danciger M, 2005, MOL VIS, V11, P374; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Hafezi F, 1997, EXP EYE RES, V64, P963, DOI 10.1006/exer.1997.0288; Hahn P, 2004, CELL DEATH DIFFER, V11, P1192, DOI 10.1038/sj.cdd.4401486; Hetman M, 2000, J NEUROSCI, V20, P2567; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; Kondo T, 2004, J BIOL CHEM, V279, P37997, DOI 10.1074/jbc.M401339200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Krishnamoorthy RR, 1999, J BIOL CHEM, V274, P3734, DOI 10.1074/jbc.274.6.3734; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lauro D, 1998, NAT GENET, V20, P294, DOI 10.1038/3112; LaVail M M, 1987, Prog Clin Biol Res, V247, P439; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; LAVAIL MM, 1987, CURR EYE RES, V6, P825, DOI 10.3109/02713688709034850; Lawlor MA, 2001, J CELL SCI, V114, P2903; Le YZ, 2006, MOL VIS, V12, P389; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Luo J, 2005, MOL CELL BIOL, V25, P9491, DOI 10.1128/MCB.25.21.9491-9502.2005; Marti A, 1998, INVEST OPHTH VIS SCI, V39, P846; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Noell W K, 1966, Invest Ophthalmol, V5, P450; Organisciak DT, 1998, INVEST OPHTH VIS SCI, V39, P1107; Ouwens DM, 2001, BBA-MOL CELL RES, V1540, P97, DOI 10.1016/S0167-4889(01)00126-4; Rajala A, 2007, J BIOL CHEM, V282, P9865, DOI 10.1074/jbc.M608845200; Rajala RVS, 2004, BIOCHEMISTRY-US, V43, P5637, DOI 10.1021/bi035913v; Rajala RVS, 2002, J BIOL CHEM, V277, P43319, DOI 10.1074/jbc.M206355200; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tanito M, 2007, FREE RADICAL BIO MED, V42, P1838, DOI 10.1016/j.freeradbiomed.2007.03.018; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1864, DOI 10.1167/iovs.06-1065; Wenzel A, 2003, INVEST OPHTH VIS SCI, V44, P2798, DOI 10.1167/iovs.02-1134; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wetzel RK, 1999, J NEUROSCI, V19, P9878; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yi XJ, 2005, J NEUROSCI, V25, P1240, DOI 10.1523/JNEUROSCI.3664-04.2005; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zheng LX, 2006, INVEST OPHTH VIS SCI, V47, P5583, DOI 10.1167/iovs.06-0163	58	71	71	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19781	19792		10.1074/jbc.M802374200	http://dx.doi.org/10.1074/jbc.M802374200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480052	Green Published, hybrid			2022-12-27	WOS:000257387600062
J	Narayanan, U; Nalavadi, V; Nakamoto, M; Thomas, G; Ceman, S; Bassell, GJ; Warren, ST				Narayanan, Usha; Nalavadi, Vijayalaxmi; Nakamoto, Mika; Thomas, George; Ceman, Stephanie; Bassell, Gary J.; Warren, Stephen T.			S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; MESSENGER-RNA TRANSLATION; RECEPTOR ACTIVATION; KINASE-ACTIVITY; MOUSE MODEL; LOCALIZATION; PATHWAY; MICE; IDENTIFICATION; INACTIVATION	Fragile X syndrome is a common form of cognitive deficit caused by the functional absence of fragile X mental retardation protein (FMRP), a dendritic RNA-binding protein that represses translation of specific messages. Although FMRP is phosphorylated in a group I metabotropic glutamate receptor (mGluR) activity-dependent manner following brief protein phosphatase 2A (PP2A)-mediated dephosphorylation, the kinase regulating FMRP function in neuronal protein synthesis is unclear. Here we identify ribosomal protein S6 kinase (S6K1) as a major FMRP kinase in the mouse hippocampus, finding that activity-dependent phosphorylation of FMRP by S6K1 requires signaling inputs from mammalian target of rapamycin (mTOR), ERK1/2, and PP2A. Further, the loss of hippocampal S6K1 and the subsequent absence of phospho-FMRP mimic FMRP loss in the increased expression of SAPAP3, a synapse-associated FMRP target mRNA. Together these data reveal a S6K1-PP2A signaling module regulating FMRP function and place FMRP phosphorylation in the mGluR-triggered signaling cascade required for protein-synthesis-dependent synaptic plasticity.	[Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Nalavadi, Vijayalaxmi; Bassell, Gary J.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Thomas, George] Genome Res Inst, Cincinnati, OH 45215 USA; [Ceman, Stephanie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Emory University; Emory University; Emory University; Emory University; University of Illinois System; University of Illinois Urbana-Champaign	Warren, ST (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St,Ste 305E, Atlanta, GA 30322 USA.	swarren@genetics.emory.edu	Warren, Stephen T/A-2498-2012; Thomas, George/K-9235-2014	Thomas, George/0000-0003-3518-8149	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, R01HD041591, R01HD020521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051127] Funding Source: NIH RePORTER; NICHD NIH HHS [HD41591, HD24064, HD020521] Funding Source: Medline; NINDS NIH HHS [NS051127] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; FERRARI S, 1993, J BIOL CHEM, V268, P16091; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kimball SR, 2002, J NUTR, V132, P883; Kindler S, 2004, MOL BRAIN RES, V126, P14, DOI 10.1016/j.molbrainres.2004.03.014; Kosik KS, 2005, BBA-MOL BASIS DIS, V1739, P298, DOI 10.1016/j.bbadis.2004.10.011; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Namboodiripad AN, 1996, AM J PHYSIOL-CELL PH, V270, pC449, DOI 10.1152/ajpcell.1996.270.2.C449; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; NOVAKHOFER I, 1985, J BIOL CHEM, V260, P314; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Phin S, 2003, BIOCHEM J, V373, P583, DOI 10.1042/BJ20021794; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Routtenberg A, 2005, TRENDS NEUROSCI, V28, P12, DOI 10.1016/j.tins.2004.11.006; Saitoh M, 1998, BIOCHEM BIOPH RES CO, V253, P470, DOI 10.1006/bbrc.1998.9784; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93	46	170	172	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18478	18482		10.1074/jbc.C800055200	http://dx.doi.org/10.1074/jbc.C800055200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18474609	Green Published, hybrid			2022-12-27	WOS:000257165600002
J	Reineke, LC; Komar, AA; Caprara, MG; Merrick, WC				Reineke, Lucas C.; Komar, Anton A.; Caprara, Mark G.; Merrick, William C.			A small stem loop element directs internal initiation of the URE2 internal ribosome entry site in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-INDEPENDENT TRANSLATION; MESSENGER-RNAS; SECONDARY STRUCTURE; GENE-EXPRESSION; YEAST-CELLS; IRES; LOCALIZATION; PREDICTION; PROMOTER; SEQUENCE	Internal initiation of translation is the process of beginning protein synthesis independent of the m(7)G cap structure at the 5'-end of an mRNA molecule. We have previously shown that the URE2 mRNA in the yeast Saccharomyces cerevisiae contains an internal ribosome entry site (IRES) whose activity is suppressed by eukaryotic initiation factor 2A (eIF2A; YGR054W). In this study, the minimal sequence required to efficiently direct internal initiation was determined using a system that abrogates cap-dependent scanning of the 40 S ribosomal subunit in both wild-type and eIF2A knock-out cells. Subsequently, secondary structural elements within the minimal sequence were determined by probing with RNases T1 and V1 and the small molecule diethylpyrocarbonate. It was found that the URE2 minimal IRES comprises a 104 nucleotide A-rich stem loop element encompassing the internal AUG codon. Interestingly, the internal AUG seems to be involved in base-pairing interactions that would theoretically hamper its ability to interact with incoming initiator tRNA molecules. Furthermore, none of the truncations used to identify the minimal IRES element were capable of abrogating the suppressive effect of eIF2A. Our data provide the first insight into the RNA structural requirements of the yeast translational machinery for cap-independent initiation of protein synthesis.	[Reineke, Lucas C.; Merrick, William C.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Caprara, Mark G.] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Komar, Anton A.] Cleveland State Univ, Biol Geol & Environm Sci Dept, Cleveland, OH 44115 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Cleveland State University	Merrick, WC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	wcm2@case.edu		Komar, Anton/0000-0003-4188-0633	NIGMS NIH HHS [GM-68079, GM-62853, T32 GM-08056] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062853, R01GM068079, T32GM008056] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; Chappell SA, 2004, P NATL ACAD SCI USA, V101, P9590, DOI 10.1073/pnas.0308759101; Chappell SA, 2003, J BIOL CHEM, V278, P33793, DOI 10.1074/jbc.M303495200; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Garlapati S, 2004, J BIOL CHEM, V279, P3389, DOI 10.1074/jbc.M307565200; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; GROEBE DR, 1988, NUCLEIC ACIDS RES, V16, P11725, DOI 10.1093/nar/16.24.11725; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Hecht K, 2002, FEMS YEAST RES, V2, P215, DOI 10.1111/j.1567-1364.2002.tb00086.x; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Komar AA, 2003, EMBO J, V22, P1199, DOI 10.1093/emboj/cdg103; Komar AA, 2005, J BIOL CHEM, V280, P15601, DOI 10.1074/jbc.M413728200; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; PILIPENKO EV, 1989, NUCLEIC ACIDS RES, V17, P5701, DOI 10.1093/nar/17.14.5701; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Raychaudhuri S, 2006, BIOCHEM BIOPH RES CO, V350, P788, DOI 10.1016/j.bbrc.2006.09.124; Rosenfeld AB, 2005, J VIROL, V79, P10126, DOI 10.1128/JVI.79.16.10126-10137.2005; Seino A, 2005, BBA-GENE STRUCT EXPR, V1681, P166, DOI 10.1016/j.bbaexp.2004.11.009; SILVER PA, 1984, P NATL ACAD SCI-BIOL, V81, P5951, DOI 10.1073/pnas.81.19.5951; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Verge V, 2004, RNA, V10, P277, DOI 10.1261/rna.5910104; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Zhou W, 2001, P NATL ACAD SCI USA, V98, P1531, DOI 10.1073/pnas.98.4.1531; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	21	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19011	19025		10.1074/jbc.M803109200	http://dx.doi.org/10.1074/jbc.M803109200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18460470	hybrid, Green Published			2022-12-27	WOS:000257165600057
J	Thomas, CJ; Tall, GG; Adhikari, A; Sprang, SR				Thomas, Celestine J.; Tall, Gregory G.; Adhikari, Anirban; Sprang, Stephen R.			Ric-8A catalyzes guanine nucleotide exchange on G alpha(i1) bound to the GPR/GoLoco exchange inhibitor AGS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INDEPENDENT ACTIVATORS; G-PROTEIN SIGNALING-3; G-ALPHA; CORTICAL LOCALIZATION; ASYMMETRIC DIVISION; DROSOPHILA RIC-8; MITOTIC SPINDLE; PLASMA-MEMBRANE; ELEGANS; GTP	Microtubule pulling forces that govern mitotic spindle movement of chromosomes are tightly regulated by G-proteins. A host of proteins, including G alpha subunits, Ric-8, AGS3, regulators of G-protein signalings, and scaffolding proteins, coordinate this vital cellular process. Ric-8A, acting as a guanine nucleotide exchange factor, catalyzes the release of GDP from various G alpha(.)GDP subunits and forms a stable nucleotide-free Ric-8A: G alpha complex. AGS3, a guanine nucleotide dissociation inhibitor (GDI), binds and stabilizes G alpha subunits in their GDP-bound state. Because Ric-8A and AGS3 may recognize and compete for G alpha(.)GDP in this pathway, we probed the interactions of a truncated AGS3 (AGS3-C; containing only the residues responsible for GDI activity), with Ric-8A: G alpha(i1) and that of Ric-8A with the AGS3-C:G alpha(.)(i1)GDP complex. Pulldown assays, gel filtration, isothermal titration calorimetry, and rapid mixing stopped-flow fluorescence spectroscopy indicate that Ric-8A catalyzes the rapid release of GDP from AGS3-C:G alpha(.)(i1)GDP. Thus, Ric-8A forms a transient ternary complex with AGS3-C:G alpha(.)(i1)GDP. Subsequent dissociation of AGS3-C and GDP from G alpha(i1) yields a stable nucleotide free Ric-8A(.)G alpha(i1) complex that, in the presence of GTP, dissociates to yield Ric-8A and G alpha(.)(i1)GTP. AGS3-C does not induce dissociation of the Ric-8A(.)G alpha(i1) complex, even when present at very high concentrations. The action of Ric-8A on AGS3:G alpha(.)(i1)GDP ensures unidirectional activation of G alpha subunits that cannot be reversed by AGS3.	[Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Ctr Bimol Struct & Dynam, Missoula, MT 59812 USA; [Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Tall, Gregory G.] Univ Rochester, Dept Physiol & Pharmacol, Med Ctr, Rochester, NY 14642 USA; [Adhikari, Anirban] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Rochester; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sprang, SR (corresponding author), Univ Montana, Ctr Bimol Struct & Dynam, Missoula, MT 59812 USA.	stephen.sprang@umontana.edu			NIDDK NIH HHS [R01-DK46371, R56 DK046371] Funding Source: Medline; NIGMS NIH HHS [GM34497] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046371, R56DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034497, R37GM034497] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Bastiani Carol, 2006, WormBook, P1; Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; BLUMER JB, 2008, ENDOCRINOLO IN PRESS; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bringmann H, 2007, CURR BIOL, V17, P185, DOI 10.1016/j.cub.2006.11.070; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cho H, 2008, CELL CYCLE, V7, P573, DOI 10.4161/cc.7.5.5526; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Lanier SM, 2004, BIOL CELL, V96, P369, DOI 10.1016/j.biolcel.2004.03.012; LEE E, 1994, METHOD ENZYMOL, V237, P146; MANNING DR, 2003, SCI STKE, pPE35; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reynolds NK, 2005, GENETICS, V169, P651, DOI 10.1534/genetics.104.031286; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008	49	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23150	23160		10.1074/jbc.M802422200	http://dx.doi.org/10.1074/jbc.M802422200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18541531	Green Published, hybrid			2022-12-27	WOS:000258455400028
J	Friedland, RP; Tedesco, JM; Wilson, AC; Atwood, CS; Smith, MA; Perry, G; Zagorski, MG				Friedland, Robert P.; Tedesco, Johnathan M.; Wilson, Andrea C.; Atwood, Craig S.; Smith, Mark A.; Perry, George; Zagorski, Michael G.			Antibodies to potato virus Y bind the amyloid beta peptide - Immunohistochemical and NMR studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE PATIENTS; A-BETA; MOUSE MODEL; NEUROFIBRILLARY TANGLES; APOLIPOPROTEIN-E; COAT PROTEIN; AUTOANTIBODIES; IMMUNIZATION; PATHOGENESIS; AGGREGATION	Studies in transgenic mice bearing mutated human Alzheimer disease (AD) genes show that active vaccination with the amyloid beta(A beta) protein or passive immunization with anti-A beta antibodies has beneficial effects on the development of disease. Although a trial of A beta vaccination in humans was halted because of autoimmune meningoencephalitis, favorable effects on A beta deposition in the brain and on behavior were seen. Conflicting results have been observed concerning the relationship of circulating anti-A beta antibodies and AD. Although these autoantibodies are thought to arise from exposure to A beta, it is also possible that homologous proteins may induce antibody synthesis. We propose that the long-standing presence of anti-A beta antibodies or antibodies to immunogens homologous to the A beta protein may produce protective effects. The amino acid sequence of the potato virus Y (PVY) nuclear inclusion b protein is highly homologous to the immunogenic N-terminal region of A beta. PVY infects potatoes and related crops worldwide. Here, we show through immunocytochemistry, enzyme-linked immunosorbent assay, and NMR studies that mice inoculated with PVY develop antibodies that bind to A beta in both neuritic plaques and neurofibrillary tangles, whereas antibodies to material from uninfected potato leaf show only modest levels of background immunoreactivity. NMR data show that the anti-PVY antibody binds to A beta within the Phe(4) - Ser(8) and His(13)-Leu(17) regions. Immune responses generated from dietary exposure to proteins homologous to A beta may induce antibodies that could influence the normal physiological processing of the protein and the development or progression of AD.	[Friedland, Robert P.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Tedesco, Johnathan M.; Zagorski, Michael G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Smith, Mark A.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Wilson, Andrea C.; Atwood, Craig S.] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Wilson, Andrea C.; Atwood, Craig S.] William S Middleton Mem Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA; [Perry, George] Univ Texas San Antonio, Coll Sci, San Antonio, TX 78249 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Texas System; University of Texas at San Antonio (UTSA)	Friedland, RP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurol, 10900 Euclid Ave,T504 SOM, Cleveland, OH 44122 USA.	robert.friedland@case.edu	Perry, George/A-8611-2009; Friedland, Robert/A-2834-2010; Smith, Mark A/A-9053-2009; , Craig/AAB-3963-2022	Perry, George/0000-0002-6547-0172; Friedland, Robert/0000-0001-5721-1843; 	NIA NIH HHS [R01 AG017173-07, R01-AG027853, R01-AG017173] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG017173, R01AG027853] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; [Anonymous], 1994, POTYVIRIDAE; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Baratova LA, 2001, J VIROL, V75, P9696, DOI 10.1128/JVI.75.20.9696-9702.2001; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DOUGHERTY WG, 1988, ANNU REV PHYTOPATHOL, V26, P123, DOI 10.1146/annurev.py.26.090188.001011; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Esler WP, 1996, BIOCHEMISTRY-US, V35, P13914, DOI 10.1021/bi961302+; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fanigliulo A, 2005, ARCH VIROL, V150, P709, DOI 10.1007/s00705-004-0449-x; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; FEDEROFF HJ, 2005, SCI AGING KNOWLEDGE, V46, pPE35; Furlan R, 2003, BRAIN, V126, P285, DOI 10.1093/brain/awg031; GEARING M, 1995, NEUROLOGY, V45, P461, DOI 10.1212/WNL.45.3.461; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hara H, 2004, J ALZHEIMERS DIS, V6, P483; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hock C, 2005, NEURODEGENER DIS, V2, P273, DOI 10.1159/000090368; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hyman BT, 2001, ANN NEUROL, V49, P808, DOI 10.1002/ana.1061; Inouye H, 1996, CIBA F SYMP, V199, P22; Johnstone EM, 1996, BIOCHEM BIOPH RES CO, V220, P710, DOI 10.1006/bbrc.1996.0469; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levine H, 2005, AMYLOID, V12, P5, DOI 10.1080/13506120500032295; LeVine H, 2002, CURR MED CHEM, V9, P1121, DOI 10.2174/0929867023370167; Lichtlen P, 2008, J NEUROCHEM, V104, P859, DOI 10.1111/j.1471-4159.2007.05064.x; Lv JP, 2006, ALZ DIS ASSOC DIS, V20, P127, DOI 10.1097/00002093-200607000-00001; Maier M, 2005, NEURODEGENER DIS, V2, P267, DOI 10.1159/000090367; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Mostafae S, 2006, Commun Agric Appl Biol Sci, V71, P1335; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Moury B, 2002, J GEN VIROL, V83, P2563, DOI 10.1099/0022-1317-83-10-2563; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; PERRY G, 1993, AM J PATHOL, V143, P1586; Petrushina I, 2007, J NEUROSCI, V27, P12721, DOI 10.1523/JNEUROSCI.3201-07.2007; RIECHMANN JL, 1992, J GEN VIROL, V73, P1, DOI 10.1099/0022-1317-73-1-1; Rogaeva E, 2006, J ALZHEIMERS DIS, V9, P381; Rosenmann H, 2006, NEUROSCI LETT, V410, P90, DOI 10.1016/j.neulet.2006.01.072; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk DB, 2005, NEURODEGENER DIS, V2, P255, DOI 10.1159/000090365; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Youm JW, 2005, FEBS LETT, V579, P6737, DOI 10.1016/j.febslet.2005.11.003; Zeng H, 2001, BIOL PSYCHIAT, V49, P248, DOI 10.1016/S0006-3223(00)01111-2	60	19	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22550	22556		10.1074/jbc.M802088200	http://dx.doi.org/10.1074/jbc.M802088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18505725	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000258321000023
J	Heikaus, CC; Stout, JR; Sekharan, MR; Eakin, CM; Rajagopal, P; Brzovic, PS; Beavo, JA; Klevit, RE				Heikaus, Clemens C.; Stout, Joseph R.; Sekharan, Monica R.; Eakin, Catherine M.; Rajagopal, Ponni; Brzovic, Peter S.; Beavo, Joseph A.; Klevit, Rachel E.			Solution structure of the cGMP binding GAF domain from phosphodiesterase 5 - Insights into nucleotide specificity, dimerization, and cGMP-dependent conformational change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIAL ADENYLYL-CYCLASE; TORSION ANGLE DYNAMICS; PROTEIN STRUCTURES; REGULATORY DOMAIN; CATALYTIC DOMAIN; CHEMICAL-SHIFT; A DOMAIN; NMR; ASSIGNMENT; PDE5	Phosphodiesterase 5 (PDE5) controls intracellular levels of cGMP through its regulation of cGMP hydrolysis. Hydrolytic activity of the C-terminal catalytic domain is increased bycGMP binding to the N-terminal GAF A domain. We present theNMR solution structure of the cGMP-bound PDE5A GAF A domain. The cGMP orientation in the buried binding pocket was defined through 37 intermolecular nuclear Overhauser effects. Comparison withGAFdomains from PDE2A and adenylyl cyclase cyaB2 reveals a conserved overall domain fold of a six-stranded beta-sheet and four alpha-helices that form a well defined cGMP binding pocket. However, the nucleotide coordination is distinct with a series of altered binding contacts. The structure suggests that nucleotide binding specificity is provided by Asp-196, which is positioned to form two hydrogen bonds to the guanine ring of cGMP. An alanine mutation of Asp-196 disrupts cGMP binding and increases cAMP affinity in constructs containing only GAF A causing an altered cAMP-bound structural conformation. NMRstudies on the tandem GAF domains reveal a flexible GAF A domain in the absence of cGMP, and indicate a large conformational change upon ligand binding. Furthermore, we identify a region of similar to 20 residues directly N-terminal of GAF A as critical for tight dimerization of the tandem GAF domains. The features of the PDE5 regulatory domain revealed here provide an initial structural basis for future investigations of the regulatory mechanism of PDE5 and the design of GAF-specific regulators of PDE5 function.	[Heikaus, Clemens C.; Stout, Joseph R.; Sekharan, Monica R.; Eakin, Catherine M.; Rajagopal, Ponni; Brzovic, Peter S.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Beavo, Joseph A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sekharan, Monica R.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	NHLBI NIH HHS [1 P01 HL44948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bischoff E, 2001, J UROLOGY, V165, P1316, DOI 10.1016/S0022-5347(01)69891-4; Blount MA, 2006, MOL PHARMACOL, V70, P1822, DOI 10.1124/mol.106.028688; Boolell M, 1996, Int J Impot Res, V8, P47; Bruder S, 2006, J BIOL CHEM, V281, P19969, DOI 10.1074/jbc.M603374200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; CHARBONNEAU H, 1990, P NATL ACAD SCI USA, V87, P288, DOI 10.1073/pnas.87.1.288; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fink TL, 1999, J BIOL CHEM, V274, P34613, DOI 10.1074/jbc.274.49.34613; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; FRANCIS SH, 2007, CYCLIC NUCLEOTIDE PH, P131; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HANDA N, 2008, J BIOL CHEM     0513; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; HURLEY JH, 2003, SCI STKE, pPE1; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kleywegt G. J., 1995, CCP4 ESF EACBM NEWSL, V31, P45; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Padma-Nathan H, 2001, INT J IMPOT RES, V13, P2, DOI 10.1038/sj.ijir.3900631; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Rybalkin SD, 2002, J BIOL CHEM, V277, P3310, DOI 10.1074/jbc.M106562200; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sekharan MR, 2005, J BIOMOL NMR, V33, P75, DOI 10.1007/s10858-005-1615-5; STROOP SD, 1991, J BIOL CHEM, V266, P23802; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; THOMAS MK, 1990, J BIOL CHEM, V265, P14964; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turko IV, 1996, J BIOL CHEM, V271, P22240, DOI 10.1074/jbc.271.36.22240; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	52	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22749	22759		10.1074/jbc.M801577200	http://dx.doi.org/10.1074/jbc.M801577200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18534985	Green Published, hybrid			2022-12-27	WOS:000258321000043
J	Hauenstein, SI; Hou, YM; Perona, JJ				Hauenstein, Scott I.; Hou, Ya-Ming; Perona, John J.			The homotetrameric phosphoseryl-tRNA synthetase from Methanosarcina mazei exhibits half-of-the-sites activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CYSTEINE BIOSYNTHESIS; CRYSTAL-STRUCTURE; GENETIC-CODE; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; SUBUNIT STRUCTURE; PROTEIN-SYNTHESIS; LIGAND-BINDING; AMINO-ACIDS; RECOGNITION	Synthesis of cysteinyl-tRNA(Cys) in methanogenic archaea proceeds by a two-step pathway in which tRNACys is first aminoacylated with phosphoserine by phosphoseryl-tRNA synthetase (SepRS). Characterization of SepRS from the mesophile Methanosarcina mazei by gel filtration and nondenaturing mass spectrometry shows that the native enzyme exists as an alpha 4 tetramer when expressed at high levels in Escherichia coli. However, active site titrations monitored by ATP/PPi burst kinetics, together with analysis of tRNA binding stoichiometry by fluorescence spectroscopy, show that the tetrameric enzyme binds two tRNAs and that only two of the four chemically equivalent subunits catalyze formation of phosphoseryl adenylate. Therefore, the phenomenon of half-of-the-sites activity, previously described for synthesis of 1 mol of tyrosyl adenylate by the dimeric class I tyrosyl-tRNA synthetase, operates as well in this homotetrameric class II tRNA synthetase. Analysis of cognate and noncognate reactions by ATP/PPi and aminoacylation kinetics strongly suggests that SepRS is able to discriminate against the noncognate amino acids glutamate, serine, and phosphothreonine without the need for a separate hydrolytic editing site. tRNACys binding to SepRS also enhances the capacity of the enzyme to discriminate among amino acids, indicating the existence of functional connectivity between the tRNA and amino acid binding sites of the enzyme.	[Hauenstein, Scott I.; Perona, John J.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Hauenstein, Scott I.; Perona, John J.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA; [Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Jefferson University	Perona, JJ (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	perona@chem.ucsb.edu		Hou, Ya-Ming/0000-0001-6546-2597	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063713, R01GM066267] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM066267, GM63713] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambrogelly A, 2005, FEBS LETT, V579, P6017, DOI 10.1016/j.febslet.2005.09.025; Arnez JG, 1999, J MOL BIOL, V286, P1449, DOI 10.1006/jmbi.1999.2562; BEDOUELLE H, 1990, BIOCHIMIE, V72, P589, DOI 10.1016/0300-9084(90)90122-W; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Chen ZD, 1996, BIOTECHNIQUES, V21, P820; Christian T, 2004, J MOL BIOL, V339, P707, DOI 10.1016/j.jmb.2004.04.025; dePouplana LR, 1997, BIOCHEMISTRY-US, V36, P15041, DOI 10.1021/bi971788+; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Ehlers C, 2005, MOL GENET GENOMICS, V273, P290, DOI 10.1007/s00438-005-1128-7; FASIOLO F, 1977, EUR J BIOCHEM, V73, P7, DOI 10.1111/j.1432-1033.1977.tb11286.x; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; HANKE T, 1974, EUR J BIOCHEM, V43, P601, DOI 10.1111/j.1432-1033.1974.tb03447.x; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; Hou YM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj018; HOU YM, 1993, P NATL ACAD SCI USA, V90, P6776, DOI 10.1073/pnas.90.14.6776; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Kamtekar S, 2007, P NATL ACAD SCI USA, V104, P2620, DOI 10.1073/pnas.0611504104; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; KOMATSOULIS GA, 1993, BIOCHEMISTRY-US, V32, P7435, DOI 10.1021/bi00080a014; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P53; Lipman RSA, 2003, BIOCHEMISTRY-US, V42, P7487, DOI 10.1021/bi0344533; Liu CP, 2007, J MOL BIOL, V367, P1063, DOI 10.1016/j.jmb.2007.01.050; Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; MOSYAK L, 1993, BIOCHIMIE, V75, P1091, DOI 10.1016/0300-9084(93)90008-G; MULVEY RS, 1977, BIOCHEMISTRY-US, V16, P4005, DOI 10.1021/bi00637a011; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; PUTNEY SD, 1981, J BIOL CHEM, V256, P198; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Sankaranarayanan R, 2001, ACTA BIOCHIM POL, V48, P323; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Sherlin LD, 2001, RNA, V7, P1671; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P1041, DOI 10.1021/bi00403a029; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P5525, DOI 10.1021/bi00415a021; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	57	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21997	22006		10.1074/jbc.M801838200	http://dx.doi.org/10.1074/jbc.M801838200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18559342	hybrid, Green Published			2022-12-27	WOS:000258114700019
J	Michelet, L; Zaffagnini, M; Vanacker, H; Le Marechal, P; Marchand, C; Schroda, M; Lemaire, SD; Decottignies, P				Michelet, Laure; Zaffagnini, Mirko; Vanacker, Helene; Le Marechal, Pierre; Marchand, Christophe; Schroda, Michael; Lemaire, Stephane D.; Decottignies, Paulette			In vivo targets of S-thiolation in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; DISULFIDE-ISOMERASE RB60; PSBA MESSENGER-RNA; ENDOPLASMIC-RETICULUM; PROTEOMIC ANALYSIS; REDOX-REGULATION; PHOSPHOGLYCERATE KINASE; ARABIDOPSIS-THALIANA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GLUTATHIONYLATED PROTEINS	Glutathionylation is the major form of S-thiolation in cells. This reversible redox post-translational modification consists of the formation of a mixed disulfide between a free thiol on a protein and a molecule of glutathione. This recently described modification, which is considered to occur under oxidative stress, can protect cysteine residues from irreversible oxidation, and alter positively or negatively the activity of diverse proteins. This modification and its targets have been mainly studied in non-photosynthetic organisms so far. We report here the first proteomic approach performed in vivo on photosynthetically competent cells, using the eukaryotic unicellular green alga Chlamydomonas reinhardtii with radiolabeled [S-35] cysteine to label the glutathione pool and diamide as oxidant. This method allowed the identification of 25 targets, mainly chloroplastic, involved in various metabolic processes. Several targets are related to photosynthesis, such as the Calvin cycle enzymes phosphoglycerate kinase and ribose-5-phosphate isomerase. A number of targets, such as chaperones and peroxiredoxins, are related to stress responses. The glutathionylation of HSP70B, chloroplastic 2-Cys peroxiredoxin and isocitrate lyase was confirmed in vitro on purified proteins and the targeted residues were identified.	[Michelet, Laure; Zaffagnini, Mirko; Vanacker, Helene; Lemaire, Stephane D.] Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, F-91405 Orsay, France; [Le Marechal, Pierre; Marchand, Christophe; Decottignies, Paulette] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Schroda, Michael] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg	Lemaire, SD (corresponding author), Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, Batiment 630, F-91405 Orsay, France.	stephane.lemaire@u-psud.fr	Lemaire, Stéphane D/A-3530-2008; MARCHAND, Christophe H/B-5854-2008; Schroda, Michael/A-2651-2015	Lemaire, Stéphane D/0000-0001-6442-0547; MARCHAND, Christophe H/0000-0002-0729-3841; Schroda, Michael/0000-0001-6872-0483; Zaffagnini, Mirko/0000-0001-5115-0859				Alergand T, 2006, PLANT CELL PHYSIOL, V47, P540, DOI 10.1093/pcp/pcj023; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Balmer Y, 2004, PHOTOSYNTH RES, V79, P275, DOI 10.1023/B:PRES.0000017207.88257.d4; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Cotgreave IA, 2002, METHOD ENZYMOL, V348, P175, DOI 10.1016/S0076-6879(02)48636-3; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dixon DP, 2005, BIOCHEMISTRY-US, V44, P7696, DOI 10.1021/bi047324a; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2004, EXPERT REV PROTEOMIC, V1, P365, DOI 10.1586/14789450.1.3.365; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; Gopalan G, 2004, P NATL ACAD SCI USA, V101, P13945, DOI 10.1073/pnas.0405240101; Goyer A, 2002, EUR J BIOCHEM, V269, P272, DOI 10.1046/j.0014-2956.2001.02648.x; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He XD, 2000, J BIOL CHEM, V275, P13250, DOI 10.1074/jbc.275.18.13250; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Hunter SC, 1998, ARCH BIOCHEM BIOPHYS, V359, P170, DOI 10.1006/abbi.1998.0900; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; Ito H, 2003, PLANT CELL PHYSIOL, V44, P655, DOI 10.1093/pcp/pcg098; Kovari Z, 2002, BIOCHEMISTRY-US, V41, P8796, DOI 10.1021/bi020210j; Kozaki AK, 2001, J BIOL CHEM, V276, P39919, DOI 10.1074/jbc.M103525200; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; KUNTZ GWK, 1982, METHOD ENZYMOL, V90, P103; KUNTZ GWK, 1982, METHOD ENZYMOL, V90, P110; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Levitan A, 2005, P NATL ACAD SCI USA, V102, P6225, DOI 10.1073/pnas.0500676102; Lima A, 2006, P NATL ACAD SCI USA, V103, P12631, DOI 10.1073/pnas.0605452103; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Liu CM, 2005, MOL BIOL CELL, V16, P1165, DOI 10.1091/mbc.E04-08-0736; Liu CM, 2007, PLANT J, V50, P265, DOI 10.1111/j.1365-313X.2007.03047.x; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Maeda K, 2004, BIOCHEM J, V378, P497, DOI 10.1042/BJ20031634; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; Ogawa K, 2005, ANTIOXID REDOX SIGN, V7, P973, DOI 10.1089/ars.2005.7.973; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Rochaix J. D., 1988, PLANT MOL BIOL PRACT, P253; Rouhier N, 2005, FREE RADICAL BIO MED, V38, P1413, DOI 10.1016/j.freeradbiomed.2004.07.037; Rouhier N, 2005, ANTIOXID REDOX SIGN, V7, P919, DOI 10.1089/ars.2005.7.919; Rua J, 2002, FUNGAL GENET BIOL, V35, P223, DOI 10.1006/fgbi.2001.1324; SASAKI Y, 1995, PLANT PHYSIOL, V108, P445, DOI 10.1104/pp.108.2.445; Sasaki Y, 1997, P NATL ACAD SCI USA, V94, P11096, DOI 10.1073/pnas.94.20.11096; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shenton D, 2002, J BIOL CHEM, V277, P16853, DOI 10.1074/jbc.M200559200; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; Trebitsh T, 2001, P NATL ACAD SCI USA, V98, P12289, DOI 10.1073/pnas.211440698; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000; Vignols F, 2005, P NATL ACAD SCI USA, V102, P16729, DOI 10.1073/pnas.0506880102; Willmund F, 2005, PLANT PHYSIOL, V138, P2310, DOI 10.1104/pp.105.063578; Wong JH, 2004, PHYTOCHEMISTRY, V65, P1629, DOI 10.1016/j.phytochem.2004.05.010; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	71	88	91	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21571	21578		10.1074/jbc.M802331200	http://dx.doi.org/10.1074/jbc.M802331200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18534986	hybrid			2022-12-27	WOS:000257898800030
J	Ren, JH; Pashkova, N; Winistorfer, S; Piper, RC				Ren, Jihui; Pashkova, Natasha; Winistorfer, Stanley; Piper, Robert C.			Doa1/Ufd3 plays a role in sorting ubiquitinated membrane proteins into multivesicular bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; PROTEASOME SYSTEM; DIVERSE FUNCTIONS; BUDDING YEAST; SH3 DOMAINS; WD REPEAT; ESCRT-I; DEGRADATION	Ubiquitin (Ub) is a sorting signal that targets integral membrane proteins to the interior of the vacuole/lysosome by directing them into lumenal vesicles of multivesicular bodies ( MVBs). The Vps27-Hse1 complex, which is homologous to the Hrs-STAM complex in mammalian cells, serves as a Ub-sorting receptor at the surface of early endosomes. We have found that Hse1 interacts with Doa1/Ufd3. Doa1 is known to interact with Cdc48/p97 and Ub and is required for maintaining Ub levels. We find that the Hse1 Src homology 3 domain binds directly to the central PFU domain of Doa1. Mutations in Doa1 that block Hse1 binding but not Ub binding do not alter Ub levels but do result in the missorting of the MVB cargo GFP-Cps1. Loss of Doa1 also causes a synthetic growth defect when combined with loss of Vps27. Unlike the loss of Doa1 alone, the doa1 Delta vps27 Delta double mutant phenotype is not suppressed by Ub overexpression, demonstrating that the effect is not due to indirect consequence of lowered Ub levels. Loss of Doa1 results in a defect in the accumulation of GFP-Ub within yeast vacuoles, implying that there is a reduction in the flux of ubiquitinated membrane proteins through the MVB pathway. This defect was also reflected by an inability to properly sort Vph1-GFP-Ub, a modified subunit of the multiprotein vacuolar ATPase complex, which carries an in-frame fusion of Ub as an MVB sorting signal. These results reveal novel roles for Doa1 in helping to process ubiquitinated membrane proteins for sorting into MVBs.	[Ren, Jihui; Pashkova, Natasha; Winistorfer, Stanley; Piper, Robert C.] Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	Piper, RC (corresponding author), Univ Iowa, 5-660 BSB Mol Physiol & Biophys, Iowa City, IA 52242 USA.	Robert-Piper@uiowa.edu		Piper, Robert/0000-0001-9995-5699; Pashkova, Natalya/0000-0002-2191-4683	NIGMS NIH HHS [R01 GM 58202, R01 GM058202] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058202] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik A, 2006, J CELL BIOL, V175, P825, DOI 10.1083/jcb.200605134; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Brachmann CB, 1998, YEAST, V14, P115; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hochstrasser M, 1999, PHILOS T ROY SOC B, V354, P1513, DOI 10.1098/rstb.1999.0495; Hu JH, 2007, MOL BIOL CELL, V18, P3277, DOI 10.1091/mbc.E07-03-0239; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Keil RL, 1996, MOL CELL BIOL, V16, P3446; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kunze D, 2007, MICROBIOL-SGM, V153, P1026, DOI 10.1099/mic.0.2006/002741-0; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Rayala SK, 2006, J BIOL CHEM, V281, P4395, DOI 10.1074/jbc.M510368200; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; SMITH DB, 1988, MOL BIOCHEM PARASIT, V27, P249, DOI 10.1016/0166-6851(88)90044-8; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Springael JY, 1999, J CELL SCI, V112, P1375; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Wilson TE, 2002, GENETICS, V162, P677; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	71	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21599	21611		10.1074/jbc.M802982200	http://dx.doi.org/10.1074/jbc.M802982200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508771	hybrid, Green Published			2022-12-27	WOS:000257898800033
J	Whelan, SA; Lane, MD; Hart, GW				Whelan, Stephen A.; Lane, M. Daniel; Hart, Gerald W.			Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TRANSFERASE; POSTTRANSLATIONAL MODIFICATION; NUCLEOCYTOPLASMIC PROTEINS; CYTOPLASMIC PROTEINS; TERMINAL DOMAIN; X-CHROMOSOME; GLYCOSYLATION; ACTIVATION; NUCLEAR; PHOSPHORYLATION	O-Linked beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT) catalyzes the addition of O-linked beta-N-acetylglucosamine (O-GlcNAc) onto serine and threonine residues in response to stimuli or stress analogous to phosphorylation by Ser/Thr-kinases. Like protein phosphatases, OGT appears to be targeted to myriad specific substrates by transiently interacting with specific targeting subunits. Here, we show that OGT is activated by insulin signaling. Insulin treatment of 3T3-L1 adipocytes stimulates both tyrosine phosphorylation and catalytic activity of OGT. A subset of OGT co-immunoprecipitates with the insulin receptor. Insulin stimulates purified insulin receptor to phosphorylate OGT in vitro. OGT is a competitive substrate with reduced and carboxyamidomethylated lysozyme (RCAM-lysozyme), a well characterized insulin receptor substrate. Insulin stimulation of 3T3-L1 adipocytes results in a partial translocation of OGT from the nucleus to the cytoplasm. The insulin activation of OGT results in increased O-GlcNAc modification of OGT and other proteins including, signal transducer and activator of transcription 3 (STAT3). We conclude that insulin stimulates the tyrosine phosphorylation and activity of OGT.	[Whelan, Stephen A.; Lane, M. Daniel; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Whelan, Stephen A/I-9502-2012	Whelan, Stephen A/0000-0002-4740-0795; Whelan, Stephen A/0000-0002-5439-6501; Hart, Gerald/0000-0001-7812-4351	NHLBI NIH HHS [N01 HV 28180] Funding Source: Medline; NIDDK NIH HHS [R01 DK 61671] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akimoto Y, 1999, DIABETES, V48, P2407, DOI 10.2337/diabetes.48.12.2407; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Deng JB, 2000, ENDOCRINOLOGY, V141, P2370, DOI 10.1210/en.141.7.2370; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Ishizuka K, 2007, ENDOCRINOLOGY, V148, P2994, DOI 10.1210/en.2006-1702; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; KELLY WG, 1993, J BIOL CHEM, V268, P10416; KOHANSKI RA, 1986, J BIOL CHEM, V261, P2272; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Marshall S, 2005, BIOCHEM BIOPH RES CO, V332, P263, DOI 10.1016/j.bbrc.2005.04.122; Modan-Moses D, 1998, BIOCHEM J, V333, P825, DOI 10.1042/bj3330825; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Okuyama R, 2004, BIOL PHARM BULL, V27, P1293, DOI 10.1248/bpb.27.1293; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2002, BBA-GEN SUBJECTS, V1573, P121, DOI 10.1016/S0304-4165(02)00369-0; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tao GZ, 2006, BIOCHEM BIOPH RES CO, V351, P708, DOI 10.1016/j.bbrc.2006.10.092; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005	52	120	123	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21411	21417		10.1074/jbc.M800677200	http://dx.doi.org/10.1074/jbc.M800677200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18519567	hybrid, Green Published			2022-12-27	WOS:000257898800012
J	Cunningham, CN; Krukenberg, KA; Agard, DA				Cunningham, Christian N.; Krukenberg, Kristin A.; Agard, David A.			Intra- and intermonomer interactions are required to synergistically facilitate ATP hydrolysis in Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HSP90; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; STEROID-RECEPTOR; PROTEIN-KINASE; CYCLE; DIMERIZATION; MECHANISM; BINDING; MACHINERY	Nucleotide-dependent conformational changes of the constitutively dimeric molecular chaperone Hsp90 are integral to its molecular mechanism. Recent full-length crystal structures (Protein Data Bank codes 2IOQ, 2CG9, AND 2IOP) of Hsp90 homologs reveal large scale quaternary domain rearrangements upon the addition of nucleotides. Although previous work has shown the importance of C-terminal domain dimerization for efficient ATP hydrolysis, which should imply cooperativity, other studies suggest that the two ATPases function independently. Using the crystal structures as a guide, we examined the role of intra- and intermonomer interactions in stabilizing the ATPase activity of a single active site within an intact dimer. This was accomplished by creating heterodimers that allow us to differentially mutate each monomer, probing the context in which particular residues are important for ATP hydrolysis. Although the ATPase activity of each monomer can function independently, we found that the activity of one monomer could be inhibited by the mutation of hydrophobic residues on the trans N-terminal domain ( opposite monomer). Furthermore, these trans interactions are synergistically mediated by a loop on the cis middle domain. This loop contains hydrophobic residues as well as a critical arginine that provides a direct linkage to the gamma-phosphate of bound ATP. Small angle x-ray scattering demonstrates that deleterious mutations block domain closure in the presence of AMPPNP (5'-adenylyl-beta, gamma-imidodiphosphate), providing a direct linkage between structural changes and functional consequences. Together, these data indicate that both the cis monomer and the trans monomer and the intradomain and interdomain interactions cooperatively stabilize the active conformation of each active site and help explain the importance of dimer formation.	[Krukenberg, Kristin A.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Cunningham, Christian N.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Agard, DA (corresponding author), 600 16th St,MC2240,Rm S412D, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM 08284] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Neckers Len, 2002, Expert Opin Emerg Drugs, V7, P277, DOI 10.1517/14728214.7.2.277; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	32	81	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21170	21178		10.1074/jbc.M800046200	http://dx.doi.org/10.1074/jbc.M800046200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18492664	Green Published, hybrid			2022-12-27	WOS:000257746100059
J	Fernandes, AF; Zhou, JL; Zhang, XY; Bian, QN; Sparrow, J; Taylor, A; Pereira, P; Shang, F				Fernandes, Alexandre F.; Zhou, Jilin; Zhang, Xinyu; Bian, Qingning; Sparrow, Janet; Taylor, Allen; Pereira, Paulo; Shang, Fu			Oxidative inactivation of the proteasome in retinal pigment epithelial cells - A potential link between oxidative stress and up-regulation of interleukin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; UBIQUITIN-CONJUGATING ENZYMES; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PROTEOLYTIC PATHWAY; HISTONE ACETYLATION; CYTOKINE EXPRESSION; IL-8 RELEASE; INHIBITION	Oxidative stress and inflammation are implicated in the pathogenesis of many age-related diseases. Stress-induced overproduction of inflammatory cytokines, such as interleukin-8 (IL-8), is one of the early events of inflammation. The objective of this study was to elucidate mechanistic links between oxidative stress and overproduction of IL-8 in retinal pigment epithelial (RPE) cells. We found that exposure of RPE cells to H2O2, paraquat, or A(2)E-mediated photooxidation resulted in increased expression and secretion of IL-8. All of these oxidative stressors also inactivated the proteasome in RPE cells. In contrast, tert-butylhydroperoxide (TBH), a lipophilic oxidant that did not stimulate IL-8 production, also did not inactivate the proteasome. Moreover, prolonged treatment of RPE cells with proteasome-specific inhibitors recapitulated the stimulation of IL-8 production. These data suggest that oxidative inactivation of the proteasome is a potential mechanistic link between oxidative stress and up-regulation of the proinflammatory IL-8. The downstream signaling pathways that govern the production of IL-8 include NF-kappa B and p38 MAPK. Proteasome inhibition both attenuated the activation and delayed the turnoff of NF-kappa B, resulting in biphasic effects on the production of IL-8. Prolonged proteasome inhibition (> 2 h) resulted in activation of p38 MAPK via activation of MKK3/6 and increased the production of IL-8. Chemically inhibiting the p38 MAPK blocked the proteasome inhibition-induced up-regulation of IL-8. Together, these data indicate that oxidative inactivation of the proteasome and the related activation of the p38 MAPK pathway provide a potential link between oxidative stress and overproduction of proinflammatory cytokines, such as IL-8.	[Fernandes, Alexandre F.; Zhang, Xinyu; Bian, Qingning; Taylor, Allen; Shang, Fu] Tufts Univ, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Fernandes, Alexandre F.; Pereira, Paulo] Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol, P-3000354 Coimbra, Portugal; [Zhou, Jilin; Sparrow, Janet] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA	Tufts University; United States Department of Agriculture (USDA); Universidade de Coimbra; Columbia University	Shang, F (corresponding author), 711 Washington St, Boston, MA 02111 USA.	fu.shang@tufts.edu	Pereira, Paulo/AAD-8375-2022	Pereira, Paulo/0000-0002-9908-2290; Fernandes, Alexandre/0000-0001-9489-6167	NATIONAL EYE INSTITUTE [R29EY011717, R01EY011717, R01EY013250, R01EY012951] Funding Source: NIH RePORTER; NEI NIH HHS [EY 11717, EY 12951, EY 13250] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adachi M, 2003, FEBS LETT, V554, P77, DOI 10.1016/S0014-5793(03)01109-8; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Biagioli MC, 1999, FREE RADICAL BIO MED, V26, P454, DOI 10.1016/S0891-5849(98)00233-0; Boulton M, 2004, GRAEF ARCH CLIN EXP, V242, P76, DOI 10.1007/s00417-003-0812-8; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Caballero M, 2003, BIOCHEM BIOPH RES CO, V308, P346, DOI 10.1016/S0006-291X(03)01385-8; Campochiaro P A, 1999, Mol Vis, V5, P34; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; Ciechanover A, 2003, BIOCHEM SOC T, V31, P474, DOI 10.1042/BST0310474; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; Dudek EJ, 2001, FREE RADICAL BIO MED, V31, P651, DOI 10.1016/S0891-5849(01)00634-7; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fernandes AF, 2006, EXP EYE RES, V83, P1472, DOI 10.1016/j.exer.2006.07.024; Fiedler MA, 1998, AM J RESP CELL MOL, V19, P259, DOI 10.1165/ajrcmb.19.2.3149; Fukuoka Y, 2001, CURR EYE RES, V23, P320, DOI 10.1076/ceyr.23.5.320.5437; Fukuoka Y, 2003, CLIN EXP IMMUNOL, V131, P248, DOI 10.1046/j.1365-2249.2003.02087.x; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gerber A, 2004, EUR RESPIR J, V24, P40, DOI 10.1183/09031936.04.00079203; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Hipp MS, 2002, EUR J IMMUNOL, V32, P2208, DOI 10.1002/1521-4141(200208)32:8<2208::AID-IMMU2208>3.0.CO;2-2; Ho AK, 2005, BIOCHEM PHARMACOL, V70, P1840, DOI 10.1016/j.bcp.2005.09.013; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hope AD, 2003, J NEUROCHEM, V86, P394, DOI 10.1046/j.1471-4159.2003.01844.x; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; JAHNGENHODGE J, 1992, EXP EYE RES, V55, P897, DOI 10.1016/0014-4835(92)90016-L; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Joshi-Barve S, 2003, HEPATOLOGY, V38, P1178, DOI 10.1053/jhep.2003.50470; Kalayoglu MV, 2005, GRAEF ARCH CLIN EXP, V243, P1080, DOI 10.1007/s00417-005-1169-y; Kamat AM, 2004, MOL CANCER THER, V3, P279; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McGeer EG, 2005, NEUROBIOL AGING, V26, pS94, DOI 10.1016/j.neurobiolaging.2005.08.008; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Obin M, 1998, FASEB J, V12, P561, DOI 10.1096/fasebj.12.7.561; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Osawa Y, 2002, INFECT IMMUN, V70, P6294, DOI 10.1128/IAI.70.11.6294-6301.2002; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rozanowska M, 1998, FREE RADICAL BIO MED, V24, P1107, DOI 10.1016/S0891-5849(97)00395-X; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Shang F, 2004, EXP EYE RES, V78, P1, DOI 10.1016/j.exer.2003.10.003; Shang F, 1997, EXP EYE RES, V64, P21, DOI 10.1006/exer.1996.0176; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Tomita K, 2003, BIOCHEM BIOPH RES CO, V301, P572, DOI 10.1016/S0006-291X(02)03029-2; Verhasselt V, 1998, EUR J IMMUNOL, V28, P3886; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wen XF, 2006, ONCOGENE, V25, P6986, DOI 10.1038/sj.onc.1209685; Wu HM, 2002, AM J RESP CELL MOL, V27, P234, DOI 10.1165/ajrcmb.27.2.4792; Wu HM, 2002, FEBS LETT, V526, P101, DOI 10.1016/S0014-5793(02)03151-4; Wu WT, 2004, BIOCHEM J, V379, P587, DOI 10.1042/BJ20031579; Yamamoto K, 2003, INFLAMMATION, V27, P123, DOI 10.1023/A:1023813710941; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yoshida A, 1998, INVEST OPHTH VIS SCI, V39, P1097; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; ZHANG X, 2008, INVESTIG OP IN PRESS, V49; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	86	61	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20745	20753		10.1074/jbc.M800268200	http://dx.doi.org/10.1074/jbc.M800268200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502748	Green Published, hybrid			2022-12-27	WOS:000257746100015
J	Hu, TC; Wu, DL; Chen, J; Ding, JP; Jiang, HL; Shen, X				Hu, Tiancen; Wu, Dalei; Chen, Jing; Ding, Jianping; Jiang, Hualiang; Shen, Xu			The catalytic intermediate stabilized by a "Down" active site loop for diaminopimelate decarboxylase from Helicobacter pylori - Enzymatic characterization with crystal structure analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; BRUCEI ORNITHINE-DECARBOXYLASE; TRYPANOSOMA-BRUCEI; ANTIBIOTIC-RESISTANCE; REACTION SPECIFICITY; ALANINE RACEMASE; ACID; CARBOXYLATE; INHIBITION; MECHANISM	The meso-diaminopimelate decarboxylase (DAPDC, EC 4.1.1.20) catalyzes the final step of L-lysine biosynthesis in bacteria and is regarded as a target for the discovery of antibiotics. Here we report the 2.3 angstrom crystal structure of DAPDC from Helicobacter pylori (HpDAPDC). The structure, in which the product L-lysine forms a Schiff base with the cofactor pyridoxal 5'-phosphate, provides structural insight into the substrate specificity and catalytic mechanism of the enzyme, and implies that the carboxyl to be cleaved locates at the si face of the cofactor. To our knowledge, this might be the first reported external aldimine of DAPDC. Moreover, the active site loop of HpDAPDC is in a "down" conformation and shields the ligand from solvent. Mutations of Ile(148) from the loop greatly impaired the catalytic efficiency. Combining the structural analysis of the I148L mutant, we hypothesize that HpDAPDC adopts an induced-fit catalytic mechanism in which this loop cycles through "down" and "up" conformations to stabilize intermediates and release product, respectively. Our work is expected to provide clues for designing specific inhibitors of DAPDC.	[Hu, Tiancen; Wu, Dalei; Chen, Jing; Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 20031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn		ding, jian ping/0000-0001-7029-7346				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brooks HB, 1997, BIOCHEMISTRY-US, V36, P15147, DOI 10.1021/bi971652b; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DeLano W.L, PYMOL MOL GRAPHICS S; Dufe VT, 2007, BIOCHEM J, V405, P261, DOI 10.1042/BJ20070188; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Kidron H, 2007, MOL BIOL EVOL, V24, P79, DOI 10.1093/molbev/msl133; LABER B, 1989, ANAL BIOCHEM, V181, P297, DOI 10.1016/0003-2697(89)90246-7; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu WZ, 2006, FEBS LETT, V580, P697, DOI 10.1016/j.febslet.2005.12.085; Liu WZ, 2005, BIOCHEM BIOPH RES CO, V333, P1078, DOI 10.1016/j.bbrc.2005.05.197; MISONO H, 1986, AGR BIOL CHEM TOKYO, V50, P1329, DOI 10.1080/00021369.1986.10867567; Momany C, 2002, ACTA CRYSTALLOGR D, V58, P549, DOI 10.1107/S0907444902000148; Morollo AA, 1999, BIOCHEMISTRY-US, V38, P3293, DOI 10.1021/bi9822729; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; ROMAN A, 1993, J APPL CRYSTALLOGR, V26, P283; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Shah R, 2007, BIOCHEMISTRY-US, V46, P2831, DOI 10.1021/bi6023447; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; SUNDHARA.G, 1967, J BIOL CHEM, V242, P3983; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; White P., 1971, METHODS ENZYMOLOGY B, V17, P140	44	17	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21284	21293		10.1074/jbc.M801823200	http://dx.doi.org/10.1074/jbc.M801823200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508763	Green Published, hybrid			2022-12-27	WOS:000257746100070
J	Wang, ZQ; Cao, N; Nantajit, D; Fan, M; Liu, YS; Li, JJ				Wang, Zhaoqing; Cao, Ning; Nantajit, Danupon; Fan, Ming; Liu, Yusen; Li, Jian Jian			Mitogen-activated protein kinase phosphatase-1 represses c-Jun NH2-terminal kinase-mediated apoptosis via NF-kappa B regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; CELL LUNG-CANCER; IONIZING-RADIATION; MAP KINASE; JNK ACTIVATION; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; MKP-1; RESPONSES; PATHWAYS	The mechanism regulating radiation-induced anti-apoptotic response, a limiting factor in improving cell radiosensitivity, remains elusive. Mitogen-activated protein kinase (MAPK) phosphatase (MKP)-1 is the major member of MKPs that dephosphorylates and inactivates MAPK. Here we provide the evidence that MKP-1 was negatively bridging between NF-kappa B-mediated prosurvival pathway and c-Jun N-terminal kinase (JNK)-mediated proapoptotic response. MKP-1 was induced by gamma-radiation and repressed radiation-induced pro-apoptotic status. NF-kappa B RelA/p50 heterodimer was recruited to MKP-1 gene promoter to induce MKP-1 transcription. Deletion of the NF-kappa B-binding site or inactivation of NF-kappa B by its small interfering RNA significantly decreased the radiation-induced MKP-1 promoter activity. In addition, MKP-1-deficient mouse embryonic fibroblasts exhibited a prolonged activation of JNK but not p38 or extracellular signal-regulated kinase subfamilies of MAPKs. The prolonged activation of JNK was not induced by treatment with tumor necrosis factor alpha or interleukin-6, and inactivation of JNK but not p38 or ERK abolished radiation-induced proapoptotic status, indicating that JNK is specifically inhibited by radiation-induced MKP-1. Three MKP-1 wild type human tumor cell lines treated with MKP-1 small interfering RNA showed an increased proapoptotic response that can be rescued by overexpression of wild type mouse MKP-1. Together, these results suggest that MKP-1 is a NF-kappa B-mediated prosurvival effector in attenuating JNK-mediated pro-apoptotic response; NF-kappa B/MKP-1-mediated negative JNK regulation represents a potential therapeutic target for adjusting cell radiosensitivity.	[Wang, Zhaoqing; Cao, Ning; Nantajit, Danupon; Fan, Ming; Li, Jian Jian] Purdue Univ, Sch Hlth Sci, Div Mol Radiobiol, W Lafayette, IN 47907 USA; [Liu, Yusen] Ohio State Univ, Childrens Res Inst, Dept Pediat, Columbus, OH 43205 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Li, JJ (corresponding author), Purdue Univ, Sch Hlth Sci, Div Mol Radiobiol, Rm 1279 Civil Engn Bldg,550 Stadium Mall Dr, W Lafayette, IN 47907 USA.	jjli@purdue.edu	Liu, Yusen/E-3527-2011; Cao, Ning/I-3094-2013; Cao, Ning/F-9480-2013; Nantajit, Danupon/CAF-7353-2022	Li, Jian Jian/0000-0003-3694-9675; Liu, Yusen/0000-0002-0994-0109; Cao, Ning/0000-0002-3929-8604	PHS HHS [R01 101990] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bradbury CM, 2001, CANCER RES, V61, P7689; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Chen XF, 2002, CANCER RES, V62, P1213; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Dong G, 2001, CANCER RES, V61, P4797; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Guo GZ, 2003, MOL CELL BIOL, V23, P2362, DOI 10.1128/MCB.23.7.2362-2378.2003; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hunter I, 2006, J BIOL CHEM, V281, P34705, DOI 10.1074/jbc.M605738200; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jung M, 2001, SEMIN RADIAT ONCOL, V11, P346, DOI 10.1053/srao.2001.26034; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li ZK, 2001, RADIAT RES, V155, P543, DOI 10.1667/0033-7587(2001)155[0543:EGAIMH]2.0.CO;2; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; Nakajima A, 2008, ONCOGENE, V27, P76, DOI 10.1038/sj.onc.1210624; Ozeki M, 2004, ANTICANCER RES, V24, P2657; Pajonk F, 1999, J NATL CANCER I, V91, P1956, DOI 10.1093/jnci/91.22.1956; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Schmidt-Ullrich RK, 2000, RADIAT RES, V153, P245, DOI 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang JL, 2007, CANCER RES, V67, P6737, DOI 10.1158/0008-5472.CAN-06-4402; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200	51	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21011	21023		10.1074/jbc.M802229200	http://dx.doi.org/10.1074/jbc.M802229200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508759	Green Published, hybrid			2022-12-27	WOS:000257746100043
J	Fronz, K; Otto, S; Kolbel, K; Kuhn, U; Friedrich, H; Schierhorn, A; Beck-Sickinger, AG; Ostareck-Lederer, A; Wahle, E				Fronz, Katharina; Otto, Silke; Koelbel, Knut; Kuehn, Uwe; Friedrich, Henning; Schierhorn, Angelika; Beck-Sickinger, Annette G.; Ostareck-Lederer, Antje; Wahle, Elmar			Promiscuous modification of the nuclear poly(A)-binding protein by multiple protein-arginine methyltransferases does not affect the aggregation behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) BINDING-PROTEIN; RNA-POLYMERASE-II; N-METHYLTRANSFERASE; LENGTH CONTROL; SM PROTEINS; HISTONE H4; IN-VIVO; METHYLATION; SUBSTRATE; COMPLEX	The mammalian nuclear poly(A)-binding protein, PABPN1, carries 13 asymmetrically dimethylated arginine residues in its C-terminal domain. By fractionation of cell extracts, we found that protein-arginine methyltransferases (PRMTs)-1, -3, and -6 are responsible for the modification of PABPN1. Recombinant PRMT1, -3, and -6 also methylated PABPN1. Our data suggest that these enzymes act on their own, and additional polypeptides are not involved in recognizing PABPN1 as a substrate. PRMT1 is the predominant methyltransferase acting on PABPN1. Nevertheless, PABPN1 was almost fully methylated in a Prmt1(-/-) cell line; thus, PRMT3 and -6 suffice for methylation. In contrast to PABPN1, the heterogeneous nuclear ribonucleoprotein (hnRNP) K is selectively methylated only by PRMT1. Efficient methylation of synthetic peptides derived from PABPN1 or hnRNP K suggested that PRMT1, -3, and -6 recognize their substrates by interacting with local amino acid sequences and not with additional domains of the substrates. However, the use of fusion proteins suggested that the inability of PRMT3 and -6 to modify hnRNP K is because of structural masking of the methyl-accepting amino acid sequences by neighboring domains. Mutations leading to intracellular aggregation of PABPN1 cause the disease oculopharyngeal muscular dystrophy. The C-terminal domain containing the methylated arginine residues is known to promote PAPBN1 self-association, and arginine methylation has been reported to inhibit self-association of an orthologous protein. Thus, arginine methylation might be relevant for oculopharyngeal muscular dystrophy. However, in two different types of assays we have been unable to detect any effect of arginine methylation on the aggregation of bovine PABPN1.	[Fronz, Katharina; Otto, Silke; Koelbel, Knut; Kuehn, Uwe; Friedrich, Henning; Schierhorn, Angelika; Ostareck-Lederer, Antje; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany	Martin Luther University Halle Wittenberg; Leipzig University	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de		Ostareck-Lederer, Antje/0000-0003-0733-7071; Wahle, Elmar/0000-0003-2504-0677				Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; GARY JD, 1998, NUCLEIC ACIDS RES, V98, P65; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Rennert R, 2006, BBA-BIOMEMBRANES, V1758, P347, DOI 10.1016/j.bbamem.2005.10.006; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Scheuermann T, 2003, PROTEIN SCI, V12, P2685, DOI 10.1110/ps.03214703; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Scorilas A, 2000, BIOCHEM BIOPH RES CO, V278, P349, DOI 10.1006/bbrc.2000.3807; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	63	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20408	20420		10.1074/jbc.M802329200	http://dx.doi.org/10.1074/jbc.M802329200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18495660	hybrid			2022-12-27	WOS:000257565300056
J	Lowey, S; Lesko, LM; Rovner, AS; Hodges, AR; White, SL; Low, RB; Rincon, M; Gulick, J; Robbins, J				Lowey, Susan; Lesko, Leanne M.; Rovner, Arthur S.; Hodges, Alex R.; White, Sheryl L.; Low, Robert B.; Rincon, Mercedes; Gulick, James; Robbins, Jeffrey			Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; CARDIAC MYOSIN; LIGHT-CHAIN; MOUSE MODEL; MECHANICAL PERFORMANCE; MOLECULAR-BASIS; GENETIC-BASIS; POWER STROKE; ACTIN; ISOFORMS	The R403Q mutation in the beta-myosin heavy chain (MHC) was the first mutation to be linked to familial hypertrophic cardiomyopathy (FHC), a primary disease of heart muscle. The initial studies with R403Q myosin, isolated from biopsies of patients, showed a large decrease in myosin motor function, leading to the hypothesis that hypertrophy was a compensatory response. The introduction of the mouse model for FHC (the mouse expresses predominantly alpha-MHC as opposed to the beta-isoform in larger mammals) created a new paradigm for FHC based on finding enhanced motor function for R403Q alpha-MHC. To help resolve these conflicting mechanisms, we used a transgenic mouse model in which the endogenous alpha-MHC was largely replaced with transgenically encoded beta-MHC. A His(6) tag was cloned at the N terminus of the alpha-and beta-MHC to facilitate protein isolation by Ni2+-chelating chromatography. Characterization of the R403Q alpha-MHC by the in vitro motility assay showed a 30-40% increase in actin filament velocity compared with wild type, consistent with published studies. In contrast, the R403Q mutation in a beta-MHC backbone showed no enhancement in velocity. Cleavage of the His-tagged myosin by chymotrypsin made it possible to isolate homogeneous myosin sub-fragment 1 (S1), uncontaminated by endogenous myosin. We find that the actin-activated MgAT Pase activity for R403Q alpha-S1 is similar to 30% higher than for wild type, whereas the enzymatic activity for R403Q beta-S1 is reduced by similar to 10%. Thus, the functional consequences of the mutation are fundamentally changed depending upon the context of the cardiac MHC isoform.	[Lowey, Susan; Lesko, Leanne M.; Rovner, Arthur S.; Hodges, Alex R.; White, Sheryl L.; Low, Robert B.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Rincon, Mercedes] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Gulick, James; Robbins, Jeffrey] Univ Cincinnati, Childrens Hosp, Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	University of Vermont; University of Vermont; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lowey, S (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	lowey@physiology.med.uvm.edu			NCRR NIH HHS [P20 RR 16435] Funding Source: Medline; NHLBI NIH HHS [HL 074728, HL 087862, HL 69799, HL 077101, HL 59408] Funding Source: Medline; NIAMS NIH HHS [AR 053975] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074728, P01HL059408, R01HL087862, P50HL077101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053975] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alpert NR, 2002, AM J PHYSIOL-HEART C, V283, pH1446, DOI 10.1152/ajpheart.00274.2002; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Blanchard E, 1999, CIRC RES, V84, P475, DOI 10.1161/01.RES.84.4.475; BOURDIEU L, 1995, PHYS REV E, V52, P6573, DOI 10.1103/PhysRevE.52.6573; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Fujita H, 1997, J CLIN INVEST, V99, P1010, DOI 10.1172/JCI119228; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; Krenz M, 2003, J BIOL CHEM, V278, P17466, DOI 10.1074/jbc.M210804200; Krenz M, 2007, J BIOL CHEM, V282, P24057, DOI 10.1074/jbc.M704574200; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; Lowey S, 2002, TRENDS CARDIOVAS MED, V12, P348, DOI 10.1016/S1050-1738(02)00181-0; Malinchik S, 1997, J MOL CELL CARDIOL, V29, P667, DOI 10.1006/jmcc.1996.0309; Malmqvist UP, 2004, BIOCHEMISTRY-US, V43, P15058, DOI 10.1021/bi0495329; Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; MCNALLY EM, 1989, J MOL BIOL, V210, P665, DOI 10.1016/0022-2836(89)90141-1; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Palmer BM, 2004, AM J PHYSIOL-HEART C, V287, pH91, DOI 10.1152/ajpheart.01015.2003; Palmer BM, 2008, AM J PHYSIOL-HEART C, V294, pH1939, DOI 10.1152/ajpheart.00644.2007; Palmiter KA, 2000, J MUSCLE RES CELL M, V21, P609, DOI 10.1023/A:1005678905119; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pereira JS, 2001, J BIOL CHEM, V276, P4409, DOI 10.1074/jbc.M006441200; Roopnarine O, 1998, BIOPHYS J, V75, P3023, DOI 10.1016/S0006-3495(98)77743-4; Rovner AS, 2003, J BIOL CHEM, V278, P26938, DOI 10.1074/jbc.M303122200; Sata M, 1996, J CLIN INVEST, V98, P2866, DOI 10.1172/JCI119115; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sherwood JJ, 2004, P NATL ACAD SCI USA, V101, P10973, DOI 10.1073/pnas.0401699101; SWEENEY HL, 1994, J BIOL CHEM, V269, P1603; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; TOBACMAN LS, 1984, J BIOL CHEM, V259, P1226; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Volkmann N, 2003, P NATL ACAD SCI USA, V100, P3227, DOI 10.1073/pnas.0536510100; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; Volkmann N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001123; WAGNER PD, 1979, EUR J BIOCHEM, V99, P385, DOI 10.1111/j.1432-1033.1979.tb13267.x; WORK SS, 1992, ANAL BIOCHEM, V202, P275, DOI 10.1016/0003-2697(92)90106-H; Yamashita H, 2000, J BIOL CHEM, V275, P28045	47	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20579	20589		10.1074/jbc.M800554200	http://dx.doi.org/10.1074/jbc.M800554200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18480046	hybrid, Green Published			2022-12-27	WOS:000257565300070
J	Roberts, JA; Digby, HR; Kara, M; El Ajouz, S; Sutcliffe, MJ; Evans, RJ				Roberts, Jonathan A.; Digby, Helen R.; Kara, Madina; El Ajouz, Sam; Sutcliffe, Michael J.; Evans, Richard J.			Cysteine substitution mutagenesis and the effects of methanethiosulfonate reagents at P2X(2) and P2X(4) receptors support a core common mode of ATP action at P2X receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-PROPERTIES; BINDING-SITE; AMINO-ACIDS; GATED P2X; RESIDUES; IDENTIFICATION; CHANNELS; DOMAIN; PURINOCEPTOR; PAIN	The agonist binding site of ATP-gated P2X receptors is distinct from other ATP-binding proteins. Mutagenesis on P2X(1) receptors of conserved residues in mammalian P2X receptors has established the paradigm that three lysine residues, as well as FT and NFR motifs, play an important role in mediating ATP action. In this study we have determined whether cysteine substitution mutations of equivalent residues in P2X(2) and P2X(4) receptors have similar effects and if these mutant receptors can be regulated by charged methanethiosulfonate (MTS) compounds. All the mutants (except the P2X(2) K69C and K71C that were expressed, but non-functional) showed a significant decrease in ATP potency, with > 300-fold decreases for mutants of the conserved asparagine, arginine, and lysine residues close to the end of the extracellular loop. MTS reagents had no effect at the phenylalanine of the FT motif, in contrast, cysteine mutation of the threonine was sensitive to MTS reagents and suggested a role of this residue in ATP action. The lysine-substituted receptors were sensitive to the charge of the MTS reagent consistent with the importance of positive charge at this position for coordination of the negatively charged phosphate of ATP. At the NFR motif the asparagine and arginine residues were sensitive to MTS reagents, whereas the phenylalanine was either unaffected or showed only a small decrease. These results support a common site of ATP action at P2X receptors and suggest that non-conserved residues also play a regulatory role in agonist action.	[Roberts, Jonathan A.; Digby, Helen R.; Kara, Madina; El Ajouz, Sam; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Sutcliffe, Michael J.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Roberts, Jon/A-6771-2012	Sutcliffe, Mike/0000-0003-0414-1700	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Egan TM, 1998, J NEUROSCI, V18, P2350; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2006, J BIOL CHEM, V281, P15044, DOI 10.1074/jbc.M600442200; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Stojilkovic SS, 2005, ANN NY ACAD SCI, V1048, P116, DOI 10.1196/annals.1342.011; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x	37	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20126	20136		10.1074/jbc.M800294200	http://dx.doi.org/10.1074/jbc.M800294200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487206	hybrid, Green Published			2022-12-27	WOS:000257565300029
J	Xia, H; Nho, R; Kleidon, J; Kahm, J; Henke, CA				Xia, Hong; Nho, Richard; Kleidon, Jill; Kahm, Judy; Henke, Craig A.			Polymerized collagen inhibits fibroblast proliferation via a mechanism involving the formation of a beta 1 integrin-protein phosphatase 2A-tuberous sclerosis complex 2 complex that suppresses S6K1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; VIABILITY SIGNALING PATHWAY; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-GROWTH; EXTRACELLULAR-MATRIX; KINASE ACTIVATION; REGULATED KINASES; DEPENDENT PATHWAY; INDUCED APOPTOSIS	Polymerized type I collagen suppresses fibroblast proliferation. Previous studies have implicated inhibition of fibroblast proliferation with polymerized collagen-mediated suppression of S6K1, but the molecular mechanism of the critical negative feedback loop has not yet been fully elucidated. Here, we demonstrate that polymerized collagen suppresses G(1)/S phase transition and fibroblast proliferation by a novel mechanism involving the formation of a beta 1 integrin-protein phosphatase 2A (PP2A)-tuberous sclerosis complex 2 (TSC2) complex that represses S6K1 activity. In response to fibroblast interaction with polymerized collagen, beta 1 integrin forms a complex with PP2A that targets TSC2 as a substrate. PP2A represses the level of TSC2 phosphorylation and maintains TSC2 in an activated state. Activated TSC2 negatively regulates the downstream kinase S6K1 and inhibits G(1)/S transit. Knockdown of TSC2 enables fibroblasts to overcome the anti-proliferative properties of polymerized collagen. Furthermore, we show that this reduction in TSC2 and S6K1 phosphorylation occurs largely independent of Akt. Although S6K1 activity was markedly suppressed by polymerized collagen, we found that minimal changes in Akt activity occurred. We demonstrate that up-regulation of Akt by overexpression of constitutively active phosphatidylinositol 3-kinase p110 subunit had minor effects on TSC2 and S6K1 phosphorylation. These findings demonstrate that polymerized collagen represses fibroblast proliferation by a mechanism involving the formation of a beta 1 integrin-PP2A-TSC2 complex that negatively regulates S6K1 and inhibits G(1)/S phase transition.	[Xia, Hong; Nho, Richard; Kleidon, Jill; Kahm, Judy; Henke, Craig A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Henke, CA (corresponding author), Univ Minnesota, Dept Med, Box 276,420 Delaware St SE, Minneapolis, MN 55455 USA.	henke002@umn.edu			NHLBI NIH HHS [R01 HL114662] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BITTERMAN PB, 1991, CHEST, V99, pS81, DOI 10.1378/chest.99.3_Supplement.81S; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; HANSEN LK, 1994, MOL BIOL CELL, V5, P967, DOI 10.1091/mbc.5.9.967; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; RHUDY RW, 1988, J CELL PHYSIOL, V137, P185, DOI 10.1002/jcp.1041370123; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schild A, 2006, MECH DEVELOP, V123, P362, DOI 10.1016/j.mod.2006.03.003; SCHOR SL, 1980, J CELL SCI, V41, P159; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	41	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20350	20360		10.1074/jbc.M707489200	http://dx.doi.org/10.1074/jbc.M707489200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487611	hybrid			2022-12-27	WOS:000257565300051
J	Tiainen, P; Pasanen, A; Sormunen, R; Myllyharju, J				Tiainen, Paivi; Pasanen, Annika; Sormunen, Raija; Myllyharju, Johanna			Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE-ASSOCIATED PROTEIN; DISULFIDE-ISOMERASE SUBUNIT; HUMAN PROLYL 4-HYDROXYLASE; OSTEOGENESIS IMPERFECTA; TRIPLE-HELIX; IDENTIFICATION; LEPRECAN; 2-OXOGLUTARATE; 3-HYDROXYLASE; BIOSYNTHESIS	The single 3-hydroxyproline residue in the collagen I polypeptides is essential for proper fibril formation and bone development as its deficiency leads to recessive osteogenesis imperfecta. The vertebrate prolyl 3-hydroxylase (P3H) family consists of three members, P3H1 being responsible for the hydroxylation of collagen I. We expressed human P3H2 as an active recombinant protein in insect cells. Most of the recombinant polypeptide was insoluble, but small amounts were also present in the soluble fraction. P3H1 forms a complex with the cartilage-associated protein (CRTAP) that is required for prolyl 3-hydroxylation of fibrillar collagens. However, coexpression with CRTAP did not enhance the solubility or activity of the recombinant P3H2. A novel assay for P3H activity was developed based on that used for collagen prolyl 4-hydroxylases (C-P4H) and lysyl hydroxylases (LH). A large amount of P3H activity was found in the P3H2 samples with (Gly-Pro-4Hyp) 5 as a substrate. The K-m and K-i values of P3H2 for 2-oxoglutarate and its certain analogues resembled those of the LHs rather than the C-P4Hs. Unlike P3H1, P3H2 was strongly expressed in tissues rich in basement membranes, such as the kidney. P3H2 hydroxylated more effectively two synthetic peptides corresponding to sequences that are hydroxylated in collagen IV than a peptide corresponding to the 3-hydroxylation site in collagen I. These findings suggest that P3H2 is responsible for the hydroxylation of collagen IV, which has the highest 3-hydroxyproline content of all collagens. It is thus possible that P3H2 mutations may lead to a disease with changes in basement membranes.	[Tiainen, Paivi; Pasanen, Annika; Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Tiainen, Paivi; Pasanen, Annika; Sormunen, Raija; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Tiainen, Paivi; Pasanen, Annika; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Myllyharju, J (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi						Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; CROSSEN R, 1998, BACULOVIRUS EXPRESSI; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kaul SC, 2000, ONCOGENE, V19, P3576, DOI 10.1038/sj.onc.1203696; KEFALIDES NA, 1975, J INVEST DERMATOL, V65, P85, DOI 10.1111/1523-1747.ep12598062; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200; Morello R, 1999, MATRIX BIOL, V18, P319, DOI 10.1016/S0945-053X(99)00002-5; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2005, TOP CURR CHEM, V247, P115, DOI 10.1007/b103821; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Passoja K, 1998, FEBS LETT, V434, P145, DOI 10.1016/S0014-5793(98)00966-1; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004	32	59	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19432	19439		10.1074/jbc.M802973200	http://dx.doi.org/10.1074/jbc.M802973200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487197	hybrid			2022-12-27	WOS:000257387600029
J	Yamamoto, M; Unzai, S; Saijo, S; Ito, K; Mizutani, K; Suno-Ikeda, C; Yabuki-Miyata, Y; Terada, T; Toyama, M; Shirouzu, M; Kobayashi, T; Kakinuma, Y; Yamato, I; Yokoyama, S; Iwata, S; Murata, T				Yamamoto, Misaki; Unzai, Satoru; Saijo, Shinya; Ito, Kazuki; Mizutani, Kenji; Suno-Ikeda, Chiyo; Yabuki-Miyata, Yukako; Terada, Takaho; Toyama, Mitsutoshi; Shirouzu, Mikako; Kobayashi, Takuya; Kakinuma, Yoshimi; Yamato, Ichiro; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi			Interaction and stoichiometry of the peripheral stalk subunits NtpE and NtpF and the N-terminal hydrophilic domain of NtpI of Enterococcus hirae V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; SIZE-DISTRIBUTION ANALYSIS; NA+-TRANSLOCATING ATPASE; ANALYTICAL ULTRACENTRIFUGATION; STATOR; SCATTERING; COMPLEX; ATPASE/SYNTHASE; MACROMOLECULES; BINDING	The vacuolar ATPase (V-ATPase) is composed of a soluble catalytic domain and an integral membrane domain connected by a central stalk and a few peripheral stalks. The number and arrangement of the peripheral stalk subunits remain controversial. The peripheral stalk of Na+-translocating V-ATPase from Enterococcus hirae is likely to be composed of NtpE and NtpF(corresponding to subunit G of eukaryotic V-ATPase) subunits together with the N-terminal hydrophilic domain of NtpI (corresponding to subunit a of eukaryotic V-ATPase). Here we purified NtpE, NtpF, and the N-terminal hydrophilic domain of NtpI (NtpI(Nterm)) as separate recombinant His-tagged proteins and examined interactions between these three subunits by pulldown assay using one tagged subunit, CD spectroscopy, surface plasmon resonance, and analytical ultracentrifugation. NtpI(Nterm) directly bound NtpF, but not NtpE. NtpE bound NtpF tightly. NtpI(Nterm) bound the NtpE-F complex stronger than NtpF only, suggesting that NtpE increases the binding affinity between NtpI(Nterm) and NtpF. Purified NtpE-F-I-Nterm complex appeared to be monodisperse, and the molecular masses estimated from analytical ultracentrifugation and small-angle x-ray scattering (SAXS) indicated that the ternary complex is formed with a 1:1:1 stoichiometry. A low resolution structure model of the complex produced from the SAXS data showed an elongated "L" shape.	[Mizutani, Kenji; Kobayashi, Takuya; Iwata, So; Murata, Takeshi] Kyoto Univ, Dept Cell Biol, Fac Med, Sakyo Ku, Kyoto 6068501, Japan; [Yamamoto, Misaki] Tokyo Univ Sci, Dept Biol Sci & Technol, Noda, Chiba 2788510, Japan; [Yamamoto, Misaki; Yabuki-Miyata, Yukako; Terada, Takaho; Toyama, Mitsutoshi; Shirouzu, Mikako; Kakinuma, Yoshimi; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi] RIKEN, Genom Sci Ctr, Prot Res Grp, Yokohama, Kanagawa 2300045, Japan; [Unzai, Satoru] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [Saijo, Shinya] Japan Synchrotron Radiat Res Inst, Res & Utilizat Div, SPring 8, Sayo, Hyogo 6795198, Japan; [Ito, Kazuki] RIKEN, SPring 8 Ctr, Struct Mat Sci Lab, Sayo, Hyogo 6795198, Japan; [Suno-Ikeda, Chiyo; Kobayashi, Takuya; Iwata, So; Murata, Takeshi] Japan Sci & Technol Agcy, ERATO, Iwata Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Kakinuma, Yoshimi] Ehime Univ, Fac Agr, Lab Mol Physiol & Genet, Matsuyama, Ehime 7908566, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	Kyoto University; Tokyo University of Science; RIKEN; Yokohama City University; Japan Synchrotron Radiation Research Institute; Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST); Ehime University; University of Tokyo	Murata, T (corresponding author), Kyoto Univ, Dept Cell Biol, Fac Med, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	t.murata@mfour.med.kyoto-u.ac.jp	Ito, Kazuki/A-8776-2015; Murata, Takeshi/F-6114-2011; Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015; Murata, Takeshi/J-6181-2017; Yamamoto, Masaki/B-7844-2015	Ito, Kazuki/0000-0002-8550-6937; Yokoyama, Shigeyuki/0000-0003-3133-7338; Murata, Takeshi/0000-0002-5748-4670; Yamamoto, Masaki/0000-0002-1311-1768				Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kakinuma Y, 1999, J BIOENERG BIOMEMBR, V31, P7, DOI 10.1023/A:1005499126939; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; Kawano M, 2002, J BIOL CHEM, V277, P24405, DOI 10.1074/jbc.M200973200; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lolkema JS, 2003, J BIOENERG BIOMEMBR, V35, P323, DOI 10.1023/A:1025776831494; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 1997, J BIOL CHEM, V272, P24885, DOI 10.1074/jbc.272.40.24885; Murata T, 2001, J BIOL CHEM, V276, P48337, DOI 10.1074/jbc.M106821200; Murata T, 2001, BBA-BIOENERGETICS, V1505, P75, DOI 10.1016/S0005-2728(00)00278-4; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; Norgett EE, 2007, J BIOL CHEM, V282, P14421, DOI 10.1074/jbc.M701226200; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1	39	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19422	19431		10.1074/jbc.M801772200	http://dx.doi.org/10.1074/jbc.M801772200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18460472	hybrid			2022-12-27	WOS:000257387600028
J	Hauptmann, P; Lehle, L				Hauptmann, Peter; Lehle, Ludwig			Kex1 protease is involved in yeast cell death induced by defective N-glycosylation, acetic acid, and chronological aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; OLIGOSACCHARYLTRANSFERASE COMPLEX; INDUCED APOPTOSIS; MITOCHONDRIAL FISSION; REGULATES APOPTOSIS; MEDIATED APOPTOSIS; CYSTEINE PROTEASES; MESSENGER-RNA; BUDDING YEAST	N-Glycosylation in the endoplasmic reticulum is an essential protein modification and highly conserved in evolution from yeast to humans. The key step of this pathway is the transfer of the lipid-linked core oligosaccharide to the nascent polypeptide chain, catalyzed by the oligosaccharyltransferase complex. Temperature-sensitive oligosaccharyltransferase mutants of Saccharomyces cerevisiae at the restrictive temperature, such as wbp1-1, as well as wild-type cells in the presence of the N-glycosylation inhibitor tunicamycin display typical apoptotic phenotypes like nuclear condensation, DNA fragmentation, phosphatidylserine translocation, caspase-like activity, and reactive oxygen species accumulation. Since deletion of the yeast metacaspase YCA1 did not abrogate this death pathway, we postulated a different proteolytic process to be responsible. Here, we show that Kex1 protease is involved in the programmed cell death caused by defective N-glycosylation. Its disruption decreases caspase-like activity, production of reactive oxygen species, and fragmentation of mitochondria and, conversely, improves growth and survival of cells. Moreover, we demonstrate that Kex1 contributes also to the active cell death program induced by acetic acid stress or during chronological aging, suggesting that Kex1 plays a more general role in cellular suicide of yeast.	[Hauptmann, Peter; Lehle, Ludwig] Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, D-93053 Regensburg, Germany	University of Regensburg	Lehle, L (corresponding author), Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, Univ Str 31, D-93053 Regensburg, Germany.	ludwig.lehle@biologie.uni-regensburg.de						Almeida B, 2007, J CELL SCI, V120, P3279, DOI 10.1242/jcs.010926; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Bettiga M, 2004, FEMS YEAST RES, V5, P141, DOI 10.1016/j.femsyr.2004.07.005; Boise LH, 2001, TRENDS MICROBIOL, V9, P64, DOI 10.1016/S0966-842X(00)01937-5; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Burhans WC, 2003, MUTAT RES-FUND MOL M, V532, P227, DOI 10.1016/j.mrfmmm.2003.08.019; BUSSEY H, 1988, YEAST, V4, P17, DOI 10.1002/yea.320040103; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; COOPER A, 1992, J CELL BIOL, V119, P1459, DOI 10.1083/jcb.119.6.1459; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; Giannattasio S, 2005, GENE, V354, P93, DOI 10.1016/j.gene.2005.03.030; GOURLAY C, 2006, MOL MICROBIOL; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hardwick JM, 2004, DEV CELL, V7, P630, DOI 10.1016/j.devcel.2004.10.013; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HEESEN ST, 1992, EMBO J, V11, P2071, DOI 10.1002/j.1460-2075.1992.tb05265.x; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Jaeken J, 2004, CURR OPIN PEDIATR, V16, P434, DOI 10.1097/01.mop.0000133636.56790.4a; Kerr JFR, 2002, TOXICOLOGY, V181, P471, DOI 10.1016/S0300-483X(02)00457-2; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; KNAUER R, 1994, FEBS LETT, V344, P83, DOI 10.1016/0014-5793(94)00356-4; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; LATCHINIANSADEK L, 1993, J BIOL CHEM, V268, P534; LEHLE L, 1976, FEBS LETT, V71, P167, DOI 10.1016/0014-5793(76)80922-2; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Leist M, 1999, EXP CELL RES, V249, P396, DOI 10.1006/excr.1999.4514; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Ludovico P, 2005, IUBMB LIFE, V57, P129, DOI 10.1080/15216540500090553; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mazzoni C, 2005, EMBO REP, V6, P1076, DOI 10.1038/sj.embor.7400514; Mitsui K, 2005, FEBS LETT, V579, P723, DOI 10.1016/j.febslet.2004.12.051; NAKASHIMA T, 1993, MOL CELL BIOL, V13, P6367, DOI 10.1128/MCB.13.10.6367; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Niederer KE, 2005, CELL SIGNAL, V17, P177, DOI 10.1016/j.cellsig.2004.06.009; Paschen W, 2001, J NEUROCHEM, V79, P719, DOI 10.1046/j.1471-4159.2001.00623.x; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PLUMMER TH, 1980, ANAL BIOCHEM, V108, P348, DOI 10.1016/0003-2697(80)90598-9; Qiu JZ, 2005, J BIOL CHEM, V280, P15370, DOI 10.1074/jbc.M413547200; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Reiter J, 2005, J CELL BIOL, V168, P353, DOI 10.1083/jcb.200408071; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saraiva L, 2006, J CELL SCI, V119, P3171, DOI 10.1242/jcs.03033; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Schulz JB, 1996, J NEUROSCI, V16, P4696; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Skulachev VP, 2002, FEBS LETT, V528, P23, DOI 10.1016/S0014-5793(02)03319-7; Sugiura M, 2006, BIOSCI BIOTECH BIOCH, V70, P1234, DOI 10.1271/bbb.70.1234; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Vachova L, 2004, J BIOL CHEM, V279, P37973, DOI 10.1074/jbc.M404594200; Vachova L, 2007, FEMS YEAST RES, V7, P12, DOI 10.1111/j.1567-1364.2006.00137.x; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Wadskog I, 2004, MOL BIOL CELL, V15, P1436, DOI 10.1091/mbc.E03-02-0114; Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Weinberger M, 2005, J CELL SCI, V118, P3543, DOI 10.1242/jcs.02477; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wysocki R, 2004, J CELL BIOL, V166, P311, DOI 10.1083/jcb.200405016; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	89	32	33	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19151	19163		10.1074/jbc.M801303200	http://dx.doi.org/10.1074/jbc.M801303200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18474590	hybrid			2022-12-27	WOS:000257165600070
J	Lee, AM; Rojek, JM; Spiropoulou, CF; Gundersen, AT; Jin, W; Shaginian, A; York, J; Nunberg, JH; Boger, DL; Oldstone, MBA; Kunz, S				Lee, Andrew M.; Rojek, Jillian M.; Spiropoulou, Christina F.; Gundersen, Anette T.; Jin, Wei; Shaginian, Alex; York, Joanne; Nunberg, Jack H.; Boger, Dale L.; Oldstone, Michael B. A.; Kunz, Stefan			Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PHASE COMBINATORIAL LIBRARIES; STABLE SIGNAL PEPTIDE; LASSA FEVER; ENVELOPE GLYCOPROTEIN; ALPHA-DYSTROGLYCAN; CELLULAR RECEPTOR; INTEGRIN ALPHA(V)BETA(3); IMINODIACETIC ACID; PROTEIN-PROTEIN	Viral hemorrhagic fevers caused by the arenaviruses Lassa virus in Africa and Machupo, Guanarito, Junin, and Sabia virus in South America are among the most devastating emerging human diseases with fatality rates of 15-35% and a limited antiviral therapeutic repertoire available. Here we used high throughput screening of synthetic combinatorial small molecule libraries to identify inhibitors of arenavirus infection using pseudotyped virion particles bearing the glycoproteins (GPs) of highly pathogenic arenaviruses. Our screening efforts resulted in the discovery of a series of novel small molecule inhibitors of viral entry that are highly active against both Old World and New World hemorrhagic arenaviruses. We observed potent inhibition of infection of human and primate cells with live hemorrhagic arenaviruses (IC50 = 500-800 nM). Investigations of the mechanism of action revealed that the candidate compounds efficiently block pH-dependent fusion by the arenavirus GPs (IC50 of 200-350 nM). Although our lead compounds were potent against phylogenetically distant arenaviruses, they did not show activity against other enveloped viruses with class I viral fusion proteins, indicating specificity for arenavirus GP-mediated membrane fusion.	[Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Kunz, Stefan] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Lee, Andrew M.; Rojek, Jillian M.; Gundersen, Anette T.; Oldstone, Michael B. A.; Kunz, Stefan] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Jin, Wei; Shaginian, Alex; Boger, Dale L.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Oldstone, Michael B. A.] Scripps Res Inst, Dept Infectol, La Jolla, CA 92037 USA; [Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA; [York, Joanne; Nunberg, Jack H.] Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA	University of Lausanne; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Centers for Disease Control & Prevention - USA; University of Montana System; University of Montana	Kunz, S (corresponding author), Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland.	Stefan.Kunz@chuv.ch	Pacific-Southwest, RCE/B-6155-2009; Lee, Andrew/G-5470-2011; Kunz, Stefan/K-5840-2017	Kunz, Stefan/0000-0001-6030-9550	NATIONAL CANCER INSTITUTE [P01CA078045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074818, U54AI065359, R21AI055540, R01AI055540] Funding Source: NIH RePORTER; NCI NIH HHS [CA78045] Funding Source: Medline; NIAID NIH HHS [1U54 AI065359, AI55540, R01 AI074818] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Boger DL, 2003, ANGEW CHEM INT EDIT, V42, P4138, DOI 10.1002/anie.200300574; Boger DL, 1998, BIOORGAN MED CHEM, V6, P1347, DOI 10.1016/S0968-0896(98)00128-X; Boger DL, 2001, J AM CHEM SOC, V123, P1280, DOI 10.1021/ja003579+; Boger DL, 2000, HELV CHIM ACTA, V83, P1825, DOI 10.1002/1522-2675(20000809)83:8<1825::AID-HLCA1825>3.0.CO;2-4; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; BORROW P, 1992, J VIROL, V66, P7270, DOI 10.1128/JVI.66.12.7270-7281.1992; BORROW P, 1994, VIROLOGY, V198, P1, DOI 10.1006/viro.1994.1001; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; CASTILLA V, 1994, ARCH VIROL, V136, P363, DOI 10.1007/BF01321064; Cheng S, 1996, BIOORGAN MED CHEM, V4, P727, DOI 10.1016/0968-0896(96)00069-7; Cianci C, 2004, P NATL ACAD SCI USA, V101, P15046, DOI 10.1073/pnas.0406696101; Clegg JCS, 2002, CURR TOP MICROBIOL, V262, P1; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eichler R, 2003, FEBS LETT, V538, P203, DOI 10.1016/S0014-5793(03)00160-1; Eschli B, 2006, J VIROL, V80, P5897, DOI 10.1128/JVI.00008-06; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Flanagan ML, 2008, J VIROL, V82, P938, DOI 10.1128/JVI.01397-07; Frey G, 2006, P NATL ACAD SCI USA, V103, P13938, DOI 10.1073/pnas.0601036103; Froeschke M, 2003, J BIOL CHEM, V278, P41914, DOI 10.1074/jbc.M302343200; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Goldberg J, 2002, J AM CHEM SOC, V124, P544, DOI 10.1021/ja0118789; Isaacson M, 2001, CLIN INFECT DIS, V33, P1707, DOI 10.1086/322620; Kunz S, 2005, J VIROL, V79, P5979, DOI 10.1128/JVI.79.10.5979-5987.2005; Martinez MG, 2007, J GEN VIROL, V88, P1776, DOI 10.1099/vir.0.82808-0; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; Plemper RK, 2004, P NATL ACAD SCI USA, V101, P5628, DOI 10.1073/pnas.0308520101; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Reignier T, 2008, VIROLOGY, V371, P439, DOI 10.1016/j.virol.2007.10.004; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Rojek JA, 2007, J VIROL, V81, P5685, DOI 10.1128/JVI.02574-06; Rojek JM, 2008, J VIROL, V82, P1505, DOI 10.1128/JVI.01331-07; Rojek JM, 2006, VIROLOGY, V349, P476, DOI 10.1016/j.virol.2006.02.033; Rose JK, 2001, FIELDS VIROLOGY, P1221; Schmitz H, 2002, MICROBES INFECT, V4, P43, DOI 10.1016/S1286-4579(01)01508-8; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; Weissenbacher M C, 1987, Curr Top Microbiol Immunol, V134, P79; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004; York J., 2007, J VIROL, V10, P10; York J, 2007, VIROLOGY, V359, P72, DOI 10.1016/j.virol.2006.08.048; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06	44	81	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18734	18742		10.1074/jbc.M802089200	http://dx.doi.org/10.1074/jbc.M802089200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18474596	hybrid, Green Published			2022-12-27	WOS:000257165600030
J	Escalera, J; von Hehn, CA; Bessac, BF; Sivula, M; Jordt, SE				Escalera, Jasmine; von Hehn, Christian A.; Bessac, Bret F.; Sivula, Michael; Jordt, Sven-Eric			TRPA1 mediates the noxious effects of natural sesquiterpene deterrents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR-1 ANTAGONIST; ION-CHANNEL TRPA1; CHEMICAL DEFENSE; COVALENT MODIFICATION; ANALGESIC PROPERTIES; TERPENOIDS; DIALDEHYDE; PHARMACOLOGY; ACTIVATION; FLIPR	Plants, fungi, and animals generate a diverse array of deterrent natural products that induce avoidance behavior in biological adversaries. The largest known chemical family of deterrents are terpenes characterized by reactive alpha,beta-unsaturated dialdehyde moieties, including the drimane sesquiterpenes and other terpene species. Deterrent sesquiterpenes are potent activators of mammalian peripheral chemosensory neurons, causing pain and neurogenic inflammation. Despite their widespread synthesis and medicinal use as desensitizing analgesics, their molecular targets remain unknown. Here we show that isovelleral, a noxious fungal sesquiterpene, excites sensory neurons through activation of TPRA1, an ion channel involved in inflammatory pain signaling. TRPA1 is also activated by polygodial, a drimane sesquiterpene synthesized by plants and animals. TRPA1-deficient mice show greatly reduced nocifensive behavior in response to isovelleral, indicating that TRPA1 is the major receptor for deterrent sesquiterpenes in vivo. Isovelleral and polygodial represent the first fungal and animal small molecule agonists of nociceptive transient receptor potential channels.	[Escalera, Jasmine; von Hehn, Christian A.; Bessac, Bret F.; Sivula, Michael; Jordt, Sven-Eric] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Jordt, SE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	sven.jordt@yale.edu	Jordt, Sven-Eric/ABE-6517-2020; Bessac, Bret/AAZ-1550-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Bessac, Brett/0000-0002-0522-4455	National Institutes of Health; NIEHS [1F31ES015932]; Outstanding New Environmental Scientists (ONES) [ES015056]; Connecticut Department of Public Health [2007-0161 BIOMED]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015674, R01ES015056, F31ES015932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Outstanding New Environmental Scientists (ONES); Connecticut Department of Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, Outstanding New Environmental Scientists (ONES) program Grant ES015056 (to S.E.J.) and NIEHS Predoctoral Fellowship 1F31ES015932 (to J.E.). This work was also supported by Connecticut Department of Public Health Grant 2007-0161 BIOMED (to S. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abe M, 2002, BIOSCI BIOTECH BIOCH, V66, P2698, DOI 10.1271/bbb.66.2698; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Andre E, 2006, BIOCHEM PHARMACOL, V71, P1248, DOI 10.1016/j.bcp.2005.12.030; Andre E, 2004, NEUROPHARMACOLOGY, V46, P590, DOI 10.1016/j.neuropharm.2003.10.008; Asakawa Y, 2001, CHEM PHARM BULL, V49, P1380, DOI 10.1248/cpb.49.1380; BAKER R, 1978, J CHEM SOC CHEM COMM, P410, DOI 10.1039/c39780000410; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BARNES CS, 1962, AUST J CHEM, V15, P322, DOI 10.1071/CH9620322; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; CAMAZINE S, 1984, MYCOLOGIA, V76, P355, DOI 10.2307/3793113; CAMAZINE SM, 1983, J CHEM ECOL, V9, P1439, DOI 10.1007/BF00990749; Cechinel V, 1998, J ETHNOPHARMACOL, V62, P223, DOI 10.1016/S0378-8741(98)00069-5; CIMINO G, 1983, SCIENCE, V219, P1237, DOI 10.1126/science.219.4589.1237; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; ISHII T, 2007, FREE RADICAL RES, V41, P1; Jansen BJM, 2004, NAT PROD REP, V21, P449, DOI 10.1039/b311170a; Jerman JC, 2000, BRIT J PHARMACOL, V130, P916, DOI 10.1038/sj.bjp.0703390; JONASSOHN M, 1996, THESIS LUND U LUND; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KUBO I, 1981, EXPERIENTIA, V37, P1063, DOI 10.1007/BF02085009; KUBO I, 1976, J CHEM SOC CHEM COMM, P1013, DOI 10.1039/c39760001013; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; LIST PH, 1969, ARCHIV PHARM BERICHT, V302, P125, DOI 10.1002/ardp.19693020208; Liu L, 1997, NEUROSCI LETT, V228, P29, DOI 10.1016/S0304-3940(97)00358-3; Long JD, 2006, MAR ECOL PROG SER, V307, P199, DOI 10.3354/meps307199; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MAGNUSSON G, 1972, TETRAHEDRON LETT, V13, P1105; MCCALLION RF, 1982, PLANTA MED, V44, P134, DOI 10.1055/s-2007-971422; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Ohta T, 2005, BIOCHEM PHARMACOL, V71, P173, DOI 10.1016/j.bcp.2005.09.028; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; PONHOLD J, 1942, ARCH DERMATOL RES, V182, P732; Ralevic V, 2003, BIOCHEM PHARMACOL, V65, P143, DOI 10.1016/S0006-2952(02)01451-X; Smart D, 2001, EUR J PHARMACOL, V417, P51, DOI 10.1016/S0014-2999(01)00901-3; Socolsky C, 2005, CHEM BIODIVERS, V2, P1105, DOI 10.1002/cbdv.200590079; Story GM, 2006, NEURON, V50, P177, DOI 10.1016/j.neuron.2006.04.009; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szallasi A, 1996, BRIT J PHARMACOL, V119, P283, DOI 10.1111/j.1476-5381.1996.tb15983.x; Szallasi A, 1998, EUR J PHARMACOL, V356, P81, DOI 10.1016/S0014-2999(98)00514-7; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Wilkins CK, 2001, ENVIRON HEALTH PERSP, V109, P937, DOI 10.2307/3454995; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	55	69	72	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24136	24144		10.1074/jbc.M710280200	http://dx.doi.org/10.1074/jbc.M710280200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550530	hybrid, Green Published			2022-12-27	WOS:000258638900067
J	Kabuta, T; Furuta, A; Aoki, S; Furuta, K; Wada, K				Kabuta, Tomohiro; Furuta, Akiko; Aoki, Shunsuke; Furuta, Koh; Wada, Keiji			Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL HYDROLASE; ALPHA-SYNUCLEIN; LEWY BODIES; NEURODEGENERATIVE DISEASES; SUSCEPTIBILITY GENE; STRUCTURAL BASIS; L1; DEGRADATION; DEMENTIA; MUTATION	Parkinson disease (PD) is the most common neurodegenerative movement disorder. An increase in the amount of alpha-synuclein protein could constitute a cause of PD. alpha-Synuclein is degraded at least partly by chaperone-mediated autophagy (CMA). The I93M mutation in ubiquitin C-terminal hydrolase L1 (UCH- L1) is associated with familial PD. However, the relationship between alpha-synuclein and UCH- L1 in the pathogenesis of PD has remained largely unclear. In this study, we found that UCH- L1 physically interacts with LAMP-2A, the lysosomal receptor for CMA, and Hsc70 and Hsp90, which can function as components of the CMA pathway. These interactions were abnormally enhanced by the I93M mutation and were independent of the monoubiquitin binding of UCH- L1. In a cell-free system, UCH- L1 directly interacted with the cytosolic region of LAMP-2A. Expression of I93M UCH- L1 in cells induced the CMA inhibition-associated increase in the amount of alpha-synuclein. Our findings may provide novel insights into the molecular links between alpha-synuclein and UCH-L1 and suggest that aberrant interaction of mutant UCH- L1 with CMA machinery, at least partly, underlies the pathogenesis of PD associated with I93M UCH-L1.	[Kabuta, Tomohiro; Furuta, Akiko; Aoki, Shunsuke; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Furuta, Koh] Natl Canc Ctr, Div Clin Labs, Chuo Ku, Tokyo 1040045, Japan	National Center for Neurology & Psychiatry - Japan; National Cancer Center - Japan	Kabuta, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	kabuta@ncnp.go.jp; wada@ncnp.go.jp	Kabuta, Tomohiro/B-2948-2015; Wada, Keiji/AAV-1500-2021; Aoki, Shunsuke/A-3059-2011	Kabuta, Tomohiro/0000-0002-3058-2596; 	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; New Energy and Industrial Technology Development Organization, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); New Energy and Industrial Technology Development Organization, Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science; a research grant in priority area research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; grants- in- aid for scientific research from the Ministry of Health, Labor, and Welfare, Japan; and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and the New Energy and Industrial Technology Development Organization, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Baba M, 1998, AM J PATHOL, V152, P879; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Healy DG, 2006, ANN NEUROL, V59, P627, DOI 10.1002/ana.20757; Healy DG, 2004, CELL TISSUE RES, V318, P189, DOI 10.1007/s00441-004-0917-3; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Maraganore DM, 2004, ANN NEUROL, V55, P512, DOI 10.1002/ana.20017; Naito S, 2006, BIOCHEM BIOPH RES CO, V339, P717, DOI 10.1016/j.bbrc.2005.11.066; Nishikawa K, 2003, BIOCHEM BIOPH RES CO, V304, P176, DOI 10.1016/S0006-291X(03)00555-2; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; PERTOFT H, 1978, BIOCHEM J, V174, P309, DOI 10.1042/bj1740309; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Setsuie R, 2007, NEUROCHEM INT, V50, P119, DOI 10.1016/j.neuint.2006.07.015; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Solano SM, 2000, ANN NEUROL, V47, P201, DOI 10.1002/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	41	174	179	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					23731	23738		10.1074/jbc.M801918200	http://dx.doi.org/10.1074/jbc.M801918200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550537	hybrid, Green Published			2022-12-27	WOS:000258638900027
J	Lampert, A; O'Reilly, AO; Dib-Hajj, SD; Tyrrell, L; Wallace, BA; Waxman, SG				Lampert, Angelika; O'Reilly, Andrias O.; Dib-Hajj, Sulayman D.; Tyrrell, Lynda; Wallace, B. A.; Waxman, Stephen G.			A pore-blocking hydrophobic motif at the cytoplasmic aperture of the closed-state Na(v)1.7 channel is disrupted by the erythromelalgia-associated F1449V mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; OF-FUNCTION MUTATION; DORSAL-ROOT-GANGLIA; POTASSIUM CHANNEL; ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; ION-CHANNEL; K+ CHANNEL; CONFORMATIONAL-CHANGES; FAST INACTIVATION	Sodium channel Na(v)1.7 has recently elicited considerable interest as a key contributor to human pain. Gain-of-function mutations of Nav1.7 produce painful disorders, whereas loss-offunction Nav1.7 mutations produce insensitivity to pain. The inherited erythromelalgia Nav1.7/F1449V mutation, within the C terminus of domain III/transmembrane helix S6, shifts channel activation by -7.2 mV and accelerates time to peak, leading to nociceptor hyperexcitability. We constructed a homology model of Nav1.7, based on the KcsA potassium channel crystal structure, which identifies four phylogenetically conserved aromatic residues that correspond to DIII/F1449 at the C-terminal end of each of the four S6 helices. The model predicted that changes in side-chain size of residue 1449 alter the pore's cytoplasmic aperture diameter and reshape inter-domain contact surfaces that contribute to closed state stabilization. To test this hypothesis, we compared activation of wild-type and mutant Nav1.7 channels F1449V/L/Y/W by whole cell patch clamp analysis. All but the F1449V mutation conserve the voltage dependence of activation. Compared with wild type, time to peak was shorter in F1449V, similar in F1449L, but longer for F1449Y and F1449W, suggesting that a bulky, hydrophobic residue is necessary for normal activation. We also substituted the corresponding aromatic residue of S6 in each domain individually with valine, to mimic the naturally occurring Nav1.7 mutation. We show that DII/F960V and DIII/F1449V, but not DI/Y405V or DIV/F1752V, regulate Nav1.7 activation, consistent with well established conformational changes in DII and DIII. We propose that the four aromatic residues contribute to the gate at the cytoplasmic pore aperture, and that their ring side chains form a hydrophobic plug which stabilizes the closed state of Nav1.7.	[O'Reilly, Andrias O.; Wallace, B. A.] Univ London, Dept Crystallog, Birkbeck Coll, London WC1E 7HX, England; [Lampert, Angelika; Dib-Hajj, Sulayman D.; Tyrrell, Lynda; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Lampert, Angelika; Dib-Hajj, Sulayman D.; Tyrrell, Lynda; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA; [Lampert, Angelika; Dib-Hajj, Sulayman D.; Tyrrell, Lynda; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA	University of London; Birkbeck University London; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Wallace, BA (corresponding author), Univ London, Dept Crystallog, Birkbeck Coll, London WC1E 7HX, England.	b.Wallace@mail.cryst.bbk.ac.uk; Stephen.Waxman@yale.edu	Lampert, Angelika/F-7198-2010; Waxman, Stephen/Z-2507-2019; O'Reilly, Andrias/AAC-7628-2022; Wallace, B A/C-3753-2008	Lampert, Angelika/0000-0001-6319-6272; Waxman, Stephen/0000-0001-5718-7177; O'Reilly, Andrias/0000-0003-3449-2368; Wallace, B A/0000-0001-9649-5092	Rehabilitation Research Service and Medical Research Service; Department of Veterans Affairs; National Multiple Sclerosis Society; Erythromelalgia Association; UK Biotechnology and Biological Sciences and Research Council; Biotechnology and Biological Sciences Research Council [BB/C500628/1] Funding Source: researchfish	Rehabilitation Research Service and Medical Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Erythromelalgia Association; UK Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs, the National Multiple Sclerosis Society, and the Erythromelalgia Association. The work in the laboratory of B. A. W. was supported by grants from the UK Biotechnology and Biological Sciences and Research Council. The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Choi JS, 2006, NEUROLOGY, V67, P1563, DOI 10.1212/01.wnl.0000231514.33603.1e; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cosconati S, 2007, J MED CHEM, V50, P1504, DOI 10.1021/jm061245a; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cronin NB, 2005, BIOCHEMISTRY-US, V44, P441, DOI 10.1021/bi048741q; Cronin NB, 2003, J BIOL CHEM, V278, P10675, DOI 10.1074/jbc.M208356200; CUMMINS TR, 1993, NEURON, V10, P667, DOI 10.1016/0896-6273(93)90168-Q; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; DEVOR M, 1990, J NEUROPHYSIOL, V64, P1733, DOI 10.1152/jn.1990.64.6.1733; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Guda P, 2007, BIOCHEM BIOPH RES CO, V352, P292, DOI 10.1016/j.bbrc.2006.10.190; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Harty TP, 2006, J NEUROSCI, V26, P12566, DOI 10.1523/JNEUROSCI.3424-06.2006; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Holyoake J, 2004, EUR BIOPHYS J BIOPHY, V33, P238, DOI 10.1007/s00249-003-0355-2; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lampert A, 2006, J BIOL CHEM, V281, P36029, DOI 10.1074/jbc.M607637200; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Ranatunga KM, 2001, EUR BIOPHYS J BIOPHY, V30, P295, DOI 10.1007/s002490100134; Rice ASC, 2006, ANNU REV MED, V57, P535, DOI 10.1146/annurev.med.57.121304.131324; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Scheib H, 2006, J MOL MODEL, V12, P813, DOI 10.1007/s00894-005-0066-y; Sheets PL, 2007, J PHYSIOL-LONDON, V581, P1019, DOI 10.1113/jphysiol.2006.127027; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2008, J BIOL CHEM, V283, P17594, DOI 10.1074/jbc.M800141200; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; WALL PD, 1974, NATURE, V248, P740, DOI 10.1038/248740a0; Waxman SG, 2005, TRENDS MOL MED, V11, P555, DOI 10.1016/j.molmed.2005.10.004; Waxman SG, 2001, NAT REV NEUROSCI, V2, P652, DOI 10.1038/35090026; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	60	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2008	283	35					24118	24127		10.1074/jbc.M802900200	http://dx.doi.org/10.1074/jbc.M802900200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	340II	18550534	Green Published, hybrid			2022-12-27	WOS:000258638900065
J	Kapoor, P; Sahasrabuddhe, AA; Kumar, A; Mitra, K; Siddiqi, MI; Gupta, CM				Kapoor, Prabodh; Sahasrabuddhe, Amogh A.; Kumar, Ashutosh; Mitra, Kalyan; Siddiqi, Mohammad Imran; Gupta, Chhitar M.			An unconventional form of actin in protozoan hemoflagellate, Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN; F-ACTIN; MOLECULAR-DYNAMICS; TRYPANOSOMA-BRUCEI; FLAGELLAR POCKET; MUSCLE ACTIN; LIFE-CYCLE; WILD-TYPE; PROTEIN; POLYMERIZATION	Leishmania actin was cloned, overexpressed in baculovirusinsect cell system, and purified to homogeneity. The purified protein polymerized optimally in the presence of Mg2+ and ATP, but differed from conventional actins in its following properties: (i) it did not polymerize in the presence of Mg2+ alone, (ii) it polymerized in a restricted range of pH 7.0 -8.5, (iii) its critical concentration for polymerization was found to be 3 -4-fold lower than of muscle actin, (iv) it predominantly formed bundles rather than single filaments at pH 8.0, (v) it displayed considerably higher ATPase activity during polymerization, (vi) it did not inhibit DNase-I activity, and (vii) it did not bind the F-actin-binding toxin phalloidin or the actin polymerization disrupting agent Latrunculin B. Computational and molecular modeling studies revealed that the observed unconventional behavior of Leishmania actin is related to the diverged amino acid stretches in its sequence, which may lead to changes in the overall charge distribution on its solvent-exposed surface, ATP binding cleft, Mg2+ binding sites, and the hydrophobic loop that is involved in monomer-monomer interactions. Phylogenetically, it is related to ciliate actins, but to the best of our knowledge, no other actin with such unconventional properties has been reported to date. It is therefore suggested that actin in Leishmania may serve as a novel target for design of new antileishmanial drugs.	[Kapoor, Prabodh; Sahasrabuddhe, Amogh A.; Kumar, Ashutosh; Siddiqi, Mohammad Imran; Gupta, Chhitar M.] Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India; [Mitra, Kalyan] Cent Drug Res Inst, Electron Microscopy Unit, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Gupta, CM (corresponding author), Cent Drug Res Inst, Div Mol & Struct Biol, Chattar Manzil Palace,MG Rd, Lucknow 226001, Uttar Pradesh, India.	drcmg@sify.com		Gupta, Dr.Chhitar M/0000-0002-7290-627X				Ahmed SA, 2007, ORG LETT, V9, P4773, DOI 10.1021/ol7020675; [Anonymous], 2005, PHYLIP PHYLOGENY INF; BALBER AE, 1990, CRIT REV IMMUNOL, V10, P177; Barry D, 2007, TRYPANOSOMES GENOME, P239; BLIKSTAD I, 1978, CELL, V15, P935, DOI 10.1016/0092-8674(78)90277-5; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buzan J, 1999, P NATL ACAD SCI USA, V96, P2823, DOI 10.1073/pnas.96.6.2823; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1988, FEBS LETT, V235, P211, DOI 10.1016/0014-5793(88)81264-X; CHANG KP, 1983, INT REV CYTOL, P267; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; DRUBIN DG, 1993, MOL BIOL CELL, V4, P1277, DOI 10.1091/mbc.4.12.1277; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; FEI W, 1989, BIOPHYS J, V55, P293, DOI 10.1016/S0006-3495(89)82804-8; Frieden C, 2000, BIOCHEM BIOPH RES CO, V271, P464, DOI 10.1006/bbrc.2000.2650; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gheorghe DM, 2008, J BIOL CHEM, V283, P15037, DOI 10.1074/jbc.M710332200; GLASER TA, 1988, P NATL ACAD SCI USA, V85, P7602, DOI 10.1073/pnas.85.20.7602; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; HIRONO M, 1989, P NATL ACAD SCI USA, V86, P75, DOI 10.1073/pnas.86.1.75; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikkai Takamitsu, 2000, IUBMB Life, V49, P77, DOI 10.1080/713803584; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KILLICKKENDRICK R, 1990, ANN PARASIT HUM COMP, V65, P37, DOI 10.1051/parasite/1990651037; Kudryashov DS, 2005, P NATL ACAD SCI USA, V102, P13105, DOI 10.1073/pnas.0506429102; MARTONOSI A, 1964, J BIOL CHEM, V239, P1057; MEZA I, 1983, J BIOL CHEM, V258, P3936; MITCHELL EJ, 1985, J CELL SCI, V73, P279; MORTARA RA, 1989, J PROTOZOOL, V36, P8; Nayak RC, 2005, MOL BIOCHEM PARASIT, V143, P152, DOI 10.1016/j.molbiopara.2005.06.001; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Ozaki LS, 1984, GENES ANTIGENS PARAS, P165; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Raza S, 2007, MOL BIOCHEM PARASIT, V153, P216, DOI 10.1016/j.molbiopara.2007.02.007; Reisler E, 2007, J BIOL CHEM, V282, P36133, DOI 10.1074/jbc.R700030200; Reisler E, 1993, CURR OPIN CELL BIOL, V5, P41, DOI 10.1016/S0955-0674(05)80006-7; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sahasrabuddhe AA, 2004, MOL BIOCHEM PARASIT, V134, P105, DOI 10.1016/j.molbiopara.2003.11.008; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Sehring IM, 2007, J CELL SCI, V120, P177, DOI 10.1242/jcs.03313; SHETERLINE P, 1994, PROTEIN PROFILE, V1, P1; Shi HF, 2000, RNA, V6, P1069, DOI 10.1017/S1355838200000297; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590; UYEMURA DG, 1978, J BIOL CHEM, V253, P9088; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; WEBSTER P, 1993, PARASITOL TODAY, V9, P201, DOI 10.1016/0169-4758(93)90008-4; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Zeng ZZ, 1997, BIOCHEM BIOPH RES CO, V231, P499, DOI 10.1006/bbrc.1996.5923; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215; [No title captured]	69	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22760	22773		10.1074/jbc.M800213200	http://dx.doi.org/10.1074/jbc.M800213200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18539603	hybrid			2022-12-27	WOS:000258321000044
J	Higgins, MK				Higgins, Matthew K.			The structure of a chondroitin sulfate-binding domain important in placental malaria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; FALCIPARUM-VAR GENES; PLASMODIUM-FALCIPARUM; RECEPTOR-BINDING; VAR2CSA; IDENTIFICATION; ANTIBODIES; ADHESION	Adhesive PfEMP1 proteins are displayed on the surface of malaria-infected red blood cells. They play a critical role in the disease, tethering infected cells away from destruction by the spleen and causing many severe symptoms. A molecular understanding of how these domains maintain their binding properties while evading immune detection will be important in developing therapeutics. In malaria of pregnancy, domains from the var2csa-encoded PfEMP1 protein interact with chondroitin sulfate on the placenta surface. This causes accumulation of infected red blood cells, leading to placental inflammation and block of blood flow to the developing fetus. This is associated with maternal anemia, low birth weight, and premature delivery and can lead to the death of mother and child. Here I present the structure of the chondroitin sulfate-binding DBL3X domain from a var2csa-encoded PfEMP1 protein. The domain adopts a fold similar to malarial invasion proteins, with extensive loop insertions. One loop is flexible in the unliganded structure but observed in the presence of sulfate or disaccharide, where it completes a sulfate-binding site. This loop, and others surrounding this putative carbohydrate-binding site, are flexible and polymorphic, perhaps protecting the binding site from immune detection. This suggests a model for how the domain maintains ligand binding while evading the immune response and will guide future drug and vaccine development.	Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Higgins, MK (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.			Higgins, Matthew/0000-0002-2870-1955	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Badaut C, 2007, MOL BIOCHEM PARASIT, V151, P89, DOI 10.1016/j.molbiopara.2006.10.010; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Duffy PE, 2007, PARASITOLOGY, V134, P1877, DOI 10.1017/S0031182007000170; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Higgins MK, 2008, ACTA CRYSTALLOGR F, V64, P221, DOI 10.1107/S1744309108004211; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rowe JA, 2004, MOL MICROBIOL, V53, P1011, DOI 10.1111/j.1365-2958.2004.04256.x; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith JD, 1998, MOL BIOCHEM PARASIT, V97, P133, DOI 10.1016/S0166-6851(98)00145-5; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	38	78	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21842	21846		10.1074/jbc.C800086200	http://dx.doi.org/10.1074/jbc.C800086200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18550531	hybrid, Green Published			2022-12-27	WOS:000258114700002
J	Kirk, R; Laman, H; Knowles, PP; Murray-Rust, J; Lomonosov, M; Meziane, EK; McDonald, NQ				Kirk, Rebecca; Laman, Heike; Knowles, Phillip P.; Murray-Rust, Judith; Lomonosov, Mikhail; Meziane, El Kahina; McDonald, Neil Q.			Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; SEDIMENTATION-VELOCITY; UBIQUITIN LIGASES; ESCHERICHIA-COLI; CDNA CLONING; PROTEOLYSIS; BINDING; ULTRACENTRIFUGATION; RECOGNITION; ORIENTATION	F-box proteins are the substrate-recognition components of the Skp1-Cul1-F box protein (SCF) E3 ubiquitin ligases. Here we report a structural relationship between Fbxo7, a component of the SCFFbxo7 E3 ligase, and the proteasome inhibitor PI31. SCFFbxo7 is known to catalyze the ubiquitination of hepatoma-up-regulated protein (HURP) and the inhibitor of apoptosis (IAP) protein but also functions as an activator of cyclin D-Cdk6 complexes. We identify PI31 as an Fbxo7 center dot Skp1 binding partner and show that this interaction requires an N-terminal domain present in both proteins that we term the FP (Fbxo7/PI31) domain. The crystal structure of the PI31 FP domain reveals a novel alpha/beta-fold. Biophysical and mutational analyses are used to map regions of the PI31 FP domain mediating homodimerization and required for heterodimerization with Fbxo7 center dot Skp1. Equivalent mutations in Fbxo7 ablate interaction with PI31 and also block Fbxo7 homodimerization. Knockdown of Fbxo7 does not affect PI31 levels arguing against PI31 being a substrate for SCFFbxo7. We present a model for FP domain-mediated dimerization of SCFFbxo7 and PI31.	[Laman, Heike; Lomonosov, Mikhail; Meziane, El Kahina] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Kirk, Rebecca; Knowles, Phillip P.; Murray-Rust, Judith; McDonald, Neil Q.] Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3PX, England; [McDonald, Neil Q.] Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England	University of Cambridge; Cancer Research UK; University of London; Birkbeck University London	Laman, H (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	hl316@cam.ac.uk; neil.mcdonald@cancer.org.uk		Laman, Heike/0000-0002-6089-171X; Kostenko, Anna/0000-0002-6372-778X; Kirk, Rebecca/0000-0003-3541-0168	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; James P, 1996, GENETICS, V144, P1425; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kofler M, 2005, J BIOL CHEM, V280, P33397, DOI 10.1074/jbc.M503989200; Laman H, 2006, CELL CYCLE, V5, P279, DOI 10.4161/cc.5.3.2403; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Zaiss DMW, 1999, FEBS LETT, V457, P333, DOI 10.1016/S0014-5793(99)01072-8; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299	38	62	65	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22325	22335		10.1074/jbc.M709900200	http://dx.doi.org/10.1074/jbc.M709900200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18495667	hybrid			2022-12-27	WOS:000258114700051
J	Li, LS; Morales, JC; Hwang, A; Wagner, MW; Boothman, DA				Li, Long Shan; Morales, Julio C.; Hwang, Arlene; Wagner, Mark W.; Boothman, David A.			DNA mismatch repair-dependent activation of c-Abl/p73 alpha/GADD45 alpha-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPOLYPOSIS COLON-CANCER; CELL-CYCLE CHECKPOINT; KINASE C-ABL; MICROSATELLITE INSTABILITY; IONIZING-RADIATION; METHYLATING AGENTS; G(2) CHECKPOINT; ATR KINASE; P53; DAMAGE	Cells with functional DNA mismatch repair (MMR) stimulate G(2) cell cycle checkpoint arrest and apoptosis in response to N-methyl-N'-nitro-N-nitrosoguanidine ( MNNG). MMR-deficient cells fail to detect MNNG-induced DNA damage, resulting in the survival of "mutator" cells. The retrograde (nucleus-to-cytoplasm) signaling that initiates MMR-dependent G(2) arrest and cell death remains undefined. Since MMR-dependent phosphorylation and stabilization of p53 were noted, we investigated its role(s) in G(2) arrest and apoptosis. Loss of p53 function by E6 expression, dominant-negative p53, or stable p53 knockdown failed to prevent MMR-dependent G(2) arrest, apoptosis, or lethality. MMR-dependent c-Abl-mediated p73 alpha and GADD45 alpha protein up-regulation after MNNG exposure prompted us to examine c-Abl/p73/alpha GADD45 alpha signaling in cell death responses. STI571 (Gleevec, a c-Abl tyrosine kinase inhibitor) and stable c-Abl, p73 alpha, and GADD45 alpha knockdown prevented MMR-dependent apoptosis. Interestingly, stable p73 alpha knockdown blocked MMR-dependent apoptosis, but not G(2) arrest, thereby uncoupling G(2) arrest from lethality. Thus, MMR-dependent intrinsic apoptosis is p53-independent, but stimulated by hMLH1/c-Abl/p73 alpha/GADD45 alpha retrograde signaling.	[Li, Long Shan; Morales, Julio C.; Hwang, Arlene; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses,Dept Oncol, Dallas, TX 75390 USA; [Li, Long Shan; Morales, Julio C.; Hwang, Arlene; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses,Dept Pharmacol, Dallas, TX 75390 USA; [Li, Long Shan; Morales, Julio C.; Hwang, Arlene; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses,Dept Radiat Oncol, Dallas, TX 75390 USA; [Wagner, Mark W.] Case Western Reserve Univ, Dept Environm Hlth Sci, Cleveland, OH 44106 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses,Dept Oncol, 5323 Harry Hines Blvd,ND2-210K, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Boothman, David/Q-7776-2019	Morales, Julio/0000-0002-0854-7866	NCI NIH HHS [R01 CA102792, P30 CA142543, R01 CA139217, CA 102792-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102792, R01CA083196, P30CA142543, R01CA139217] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agami R, 1999, NATURE, V399, P809; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burma S, 1999, J BIOL CHEM, V274, P17139, DOI 10.1074/jbc.274.24.17139; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Choi YR, 2003, CANCER RES, V63, P2188; Davis TW, 1998, CANCER RES, V58, P767; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Gong JG, 1999, NATURE, V399, P806; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; HAWN MT, 1995, CANCER RES, V55, P3721; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kim H, 2003, J PATHOL, V200, P23, DOI 10.1002/path.1325; Kim WJ, 2005, TOXICOL APPL PHARM, V202, P84, DOI 10.1016/j.taap.2004.06.009; Kumar S, 2003, MOL PHARMACOL, V63, P276, DOI 10.1124/mol.63.2.276; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li LS, 2003, AM J PATHOL, V163, P1429, DOI 10.1016/S0002-9440(10)63500-6; Meyers M, 2004, ENVIRON MOL MUTAGEN, V44, P249, DOI 10.1002/em.20056; Meyers M, 2001, CANCER RES, V61, P5193; Nyman U, 2005, J BIOL CHEM, V280, P34159, DOI 10.1074/jbc.M500394200; Patenaude A, 2007, CANCER RES, V67, P2306, DOI 10.1158/0008-5472.CAN-06-3824; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Shimodaira H, 2003, P NATL ACAD SCI USA, V100, P2420, DOI 10.1073/pnas.0438031100; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tsai KKC, 2003, CANCER RES, V63, P3418; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Yan T, 2003, CLIN CANCER RES, V9, P2327; Yanamadala S, 2003, MOL CANCER RES, V1, P747; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zeng XH, 2007, CLIN CANCER RES, V13, P1315, DOI 10.1158/1078-0432.CCR-06-1517; Zhang H, 1999, CANCER RES, V59, P3021	46	28	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21394	21403		10.1074/jbc.M709954200	http://dx.doi.org/10.1074/jbc.M709954200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18480060	Green Published, hybrid			2022-12-27	WOS:000257898800010
J	Viparelli, F; Cassese, A; Doti, N; Paturzo, F; Marasco, D; Dathan, NA; Monti, SM; Basile, G; Ungaro, P; Sabatella, M; Miele, C; Teperino, R; Consiglio, E; Pedone, C; Beguinot, F; Formisano, P; Ruvo, M				Viparelli, Francesca; Cassese, Angela; Doti, Nunzianna; Paturzo, Flora; Marasco, Daniela; Dathan, Nina A.; Monti, Simona M.; Basile, Giancarlo; Ungaro, Paola; Sabatella, Marco; Miele, Claudia; Teperino, Raffaele; Consiglio, Eduardo; Pedone, Carlo; Beguinot, Francesco; Formisano, Pietro; Ruvo, Menotti			Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GLUCOSE-METABOLISM; PEA-15; EXPRESSION; PHOSPHORYLATION; ASTROCYTES; APOPTOSIS; DEATH; GENE; SECRETION	Phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes (PED/PEA-15) is overexpressed in several tissues of individuals affected by type 2 diabetes. In intact cells and in transgenic animal models, PED/PEA-15 overexpression impairs insulin regulation of glucose transport, and this is mediated by its interaction with the C-terminal D4 domain of phospholipase D1 (PLD1) and the consequent increase of protein kinase C-alpha activity. Here we show that interfering with the interaction of PED/PEA-15 with PLD1 in L6 skeletal muscle cells overexpressing PED/PEA-15 (L6(PED/PEA-15)) restores insulin sensitivity. Surface plasmon resonance and ELISA-like assays show that PED/PEA-15 binds in vitro the D4 domain with high affinity (K-D = 0.37 +/- 0.13 mu M), and a PED/PEA-15 peptide, spanning residues 1-24, PED-(1-24), is able to compete with the PED/PEA-15-D4 recognition. When loaded into L6(PED/PEA-15) cells and in myocytes derived from PED/PEA-15-overexpressing transgenic mice, PED-(1-24) abrogates the PED/PEA-15-PLD1 interaction and reduces protein kinase C-alpha activity to levels similar to controls. Importantly, the peptide restores insulin-stimulated glucose uptake by similar to 70%. Similar results are obtained by expression of D4 in L6(PED/PEA-15). All these findings suggest that disruption of the PED/PEA-15-PLD1 molecular interaction enhances insulin sensitivity in skeletal muscle cells and indicate that PED/PEA-15 as an important target for type 2 diabetes.	[Cassese, Angela; Paturzo, Flora; Ungaro, Paola; Miele, Claudia; Teperino, Raffaele; Consiglio, Eduardo; Beguinot, Francesco; Formisano, Pietro] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, I-80134 Naples, Italy; [Viparelli, Francesca; Doti, Nunzianna; Marasco, Daniela; Dathan, Nina A.; Monti, Simona M.; Sabatella, Marco; Pedone, Carlo; Ruvo, Menotti] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Viparelli, Francesca; Pedone, Carlo] Univ Naples Federico 2, Dipartimento Sci Biol, I-80131 Naples, Italy; [Cassese, Angela; Paturzo, Flora; Ungaro, Paola; Miele, Claudia; Teperino, Raffaele; Consiglio, Eduardo; Beguinot, Francesco; Formisano, Pietro] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Doti, Nunzianna] Univ Naples 2, Dipartimento Biochim & Biofis, I-80134 Naples, Italy; [Basile, Giancarlo] Tecnogen SpA, Localita La Fagianeria, I-81015 Piana Di Monte Verna, Caserta, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli	Formisano, P (corresponding author), CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, I-80134 Naples, Italy.	fpietro@unina.it; menotti.ruvo@unina.it	Doti, Nunzianna/ABC-9948-2020; Marasco, Daniela/H-4848-2015; Formisano, Pietro/J-4237-2018; Monti, Simona M/J-5214-2012; MONTI, SIMONA MARIA/GQQ-0129-2022	Marasco, Daniela/0000-0002-6618-2949; MONTI, SIMONA MARIA/0000-0001-9647-7089; Formisano, Pietro/0000-0001-7020-6870; Teperino, Raffaele/0000-0001-8815-1409	Telethon [GGP04041] Funding Source: Medline; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		ARAUJO H, 1993, J BIOL CHEM, V268, P5911; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P6785, DOI 10.1073/pnas.83.18.6785; BONADONNA RC, 1991, DIABETES METAB, V17, P112; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Estelles A, 1999, DEV BIOL, V216, P16, DOI 10.1006/dbio.1999.9510; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; Fiory F, 2004, J BIOL CHEM, V279, P11137, DOI 10.1074/jbc.M308751200; Formisano P, 2005, ONCOGENE, V24, P7012, DOI 10.1038/sj.onc.1208871; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Krueger J, 2005, MOL BIOL CELL, V16, P3552, DOI 10.1091/mbc.E04-11-1007; Kubes M, 1998, J NEUROCHEM, V71, P1307; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Mercado Maria M, 2002, Curr Diab Rep, V2, P83, DOI 10.1007/s11892-002-0063-9; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Owen KR, 2007, CURR OPIN GENET DEV, V17, P239, DOI 10.1016/j.gde.2007.04.003; Slaaby R, 2000, BIOCHEM J, V351, P613, DOI 10.1042/0264-6021:3510613; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Valentino R, 2006, DIABETOLOGIA, V49, P3058, DOI 10.1007/s00125-006-0455-5; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; Viparelli F, 2008, PROTEIN EXPRES PURIF, V59, P302, DOI 10.1016/j.pep.2008.02.012; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200	29	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21769	21778		10.1074/jbc.M803771200	http://dx.doi.org/10.1074/jbc.M803771200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541525	hybrid			2022-12-27	WOS:000257898800050
J	Hu, XH; Murata, LB; Weichsel, A; Brailey, JL; Roberts, SA; Nighorn, A; Montfort, WR				Hu, Xiaohui; Murata, Lauren B.; Weichsel, Andrzej; Brailey, Jacqueline L.; Roberts, Sue A.; Nighorn, Alan; Montfort, William R.			Allostery in recombinant soluble guanylyl cyclase from Manduca sexta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE ACTIVATION; ANTENNAL-LOBE; FUNCTIONAL-CHARACTERIZATION; YC-1 ACTIVATION; DISTAL POCKET; BINDING-SITE; NO; HEME; KINETICS; CO	Soluble guanylyl/guanylate cyclase (sGC), the primary biological receptor for nitric oxide, is required for proper development and health in all animals. We have expressed heterodimeric full-length and N-terminal fragments of Manduca sexta sGC in Escherichia coli, the first time this has been accomplished for any sGC, and have performed the first functional analyses of an insect sGC. Manduca sGC behaves much like its mammalian counterparts, displaying a 170-fold stimulation by NO and sensitivity to compound YC-1. YC-1 reduces the NO and CO off-rates for the similar to 100-kDa N-terminal heterodimeric fragment and increases the CO affinity by similar to 50-fold to 1.7 mu M. Binding of NO leads to a transient six-coordinate intermediate, followed by release of the proximal histidine to yield a five-coordinate nitrosyl complex (k(6-5) = 12.8 s(-1)). The conversion rate is insensitive to nucleotides, YC-1, and changes in NO concentration up to similar to 30 mu M. NO release is biphasic in the absence of YC-1 (k(off1) = 0.10 s(-1) and k(off2) = 0.0015 s(-1)); binding of YC-1 eliminates the fast phase but has little effect on the slower phase. Our data are consistent with a model for allosteric activation in which sGC undergoes a simple switch between two conformations, with an open or a closed heme pocket, integrating the influence of numerous effectors to give the final catalytic rate. Importantly, YC-1 binding occurs in the N-terminal two-thirds of the protein. Homology modeling and mutagenesis experiments suggest the presence of an H-NOX domain in the alpha subunit with importance for heme binding.	[Hu, Xiaohui; Murata, Lauren B.; Brailey, Jacqueline L.; Roberts, Sue A.; Montfort, William R.] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Hu, Xiaohui; Murata, Lauren B.; Weichsel, Andrzej; Brailey, Jacqueline L.; Roberts, Sue A.; Montfort, William R.] Univ Arizona, Arizona Res Labs, Tucson, AZ 85721 USA; [Nighorn, Alan] Univ Arizona, Div Neurobiol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Montfort, WR (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA.	montfort@email.arizona.edu	Hu, Xiaohui/M-1389-2019		NATIONAL CANCER INSTITUTE [T32CA009213] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004292] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA 09213] Funding Source: Medline; NHLBI NIH HHS [R01 HL062969, R01 HL 62969] Funding Source: Medline; NIDCD NIH HHS [R01 DC004292-08, R01 DC004292, R01 DC 004292] Funding Source: Medline; NIGMS NIH HHS [R01 GM 077390] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen JF, 2000, BIOCHEMISTRY-US, V39, P10118, DOI 10.1021/bi000766b; Balashova N, 2005, J BIOL CHEM, V280, P2186, DOI 10.1074/jbc.M411545200; Ballou DP, 2002, P NATL ACAD SCI USA, V99, P12097, DOI 10.1073/pnas.192209799; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Collmann C, 2004, J NEUROSCI, V24, P6070, DOI 10.1523/JNEUROSCI.0710-04.2004; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Friebe A, 1999, BIOCHEMISTRY-US, V38, P15253, DOI 10.1021/bi9908944; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1998, MOL PHARMACOL, V53, P123, DOI 10.1124/mol.53.1.123; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; Gibson NJ, 2001, DEV BIOL, V240, P326, DOI 10.1006/dbio.2001.0463; Gibson NJ, 2000, J COMP NEUROL, V422, P191, DOI 10.1002/(SICI)1096-9861(20000626)422:2<191::AID-CNE4>3.0.CO;2-C; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hanafy KA, 2004, J BIOL CHEM, V279, P46946, DOI 10.1074/jbc.M404134200; Hoenicka M, 1999, J MOL MED-JMM, V77, P14, DOI 10.1007/s001090050292; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Kazerounian S, 2002, BIOCHEMISTRY-US, V41, P3396, DOI 10.1021/bi0110894; Kharitonov VG, 1999, BIOCHEMISTRY-US, V38, P10699, DOI 10.1021/bi990277f; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; KO FN, 1994, BLOOD, V84, P4226, DOI 10.1182/blood.V84.12.4226.bloodjournal84124226; Kondrashov DA, 2007, J PHYS CHEM B, V111, P9244, DOI 10.1021/jp071136n; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Maes EM, 2005, BIOCHEMISTRY-US, V44, P12690, DOI 10.1021/bi0506573; Maes EM, 2004, BIOCHEMISTRY-US, V43, P6679, DOI 10.1021/bi049748a; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; Martin E, 2001, P NATL ACAD SCI USA, V98, P12938, DOI 10.1073/pnas.231486198; Meurer S, 2005, J BIOL CHEM, V280, P33149, DOI 10.1074/jbc.M507565200; Nighorn A, 1998, J NEUROSCI, V18, P7244; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Pyriochou A, 2005, CELL SIGNAL, V17, P407, DOI 10.1016/j.cellsig.2004.09.008; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Ruiz-Stewart I, 2004, P NATL ACAD SCI USA, V101, P37, DOI 10.1073/pnas.0305080101; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Russwurm M, 2004, BIOCHEM SOC SYMP, V71, P51; Russwurm M, 2002, J BIOL CHEM, V277, P24883, DOI 10.1074/jbc.M110570200; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Sharma VS, 1999, BIOCHEM BIOPH RES CO, V254, P188, DOI 10.1006/bbrc.1998.9812; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Stengl M, 2001, CELL TISSUE RES, V304, P409, DOI 10.1007/s004410000336; Stone JR, 1998, CHEM BIOL, V5, P255, DOI 10.1016/S1074-5521(98)90618-4; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Venema RC, 2003, AM J PHYSIOL-HEART C, V285, pH669, DOI 10.1152/ajpheart.01025.2002; Weichsel A, 2000, NAT STRUCT BIOL, V7, P551, DOI 10.1038/76769; Weichsel A, 2007, BIOCHEMISTRY-US, V46, P1219, DOI 10.1021/bi061878r; Wilson CH, 2007, J COMP PHYSIOL A, V193, P715, DOI 10.1007/s00359-007-0227-9; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zayas RM, 2000, J COMP NEUROL, V419, P422; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x	72	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20968	20977		10.1074/jbc.M801501200	http://dx.doi.org/10.1074/jbc.M801501200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515359	Green Published, hybrid			2022-12-27	WOS:000257746100039
J	Kopycki, JG; Stubbs, MT; Brandt, W; Hagemann, M; Porzel, A; Schmidt, J; Schliemann, W; Zenk, MH; Vogt, T				Kopycki, Jakub Grzegorz; Stubbs, Milton T.; Brandt, Wolfgang; Hagemann, Martin; Porzel, Andrea; Schmidt, Juergen; Schliemann, Willibald; Zenk, Meinhart H.; Vogt, Thomas			Functional and structural characterization of a cation-dependent O-methyltransferase from the cyanobacterium Synechocystis sp strain PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LIGNIN; METHYLATION; COENZYME; ACID; GENE; MODULATION; 3-O-METHYLTRANSFERASE; CRYSTALLOGRAPHY; METABOLISM	The coding sequence of the cyanobacterium Synechocystis sp. strain PCC 6803 slr0095 gene was cloned and functionally expressed in Escherichia coli. The corresponding enzyme was classified as a cation- and S-adenosyl-L-methionine-dependent O-methyltransferase (SynOMT), consistent with considerable amino acid sequence identities to eukaryotic O-methyltransferases (OMTs). The substrate specificity of SynOMT was similar with those of plant and mammalian CCoAOMT-like proteins accepting a variety of hydroxycinnamic acids and flavonoids as substrates. In contrast to the known mammalian and plant enzymes, which exclusively methylate the meta-hydroxyl position of aromatic di- and trihydroxy systems, SynOMT also methylates the para-position of hydroxycinnamic acids like 5-hydroxyferulic and 3,4,5-trihydroxycinnamic acid, resulting in the formation of novel compounds. The x-ray structure of SynOMT indicates that the active site allows for two alternative orientations of the hydroxylated substrates in comparison to the active sites of animal and plant enzymes, consistent with the observed preferred para-methylation and position promiscuity. Lys3 close to the N terminus of the recombinant protein appears to play a key role in the activity of the enzyme. The possible implications of these results with respect to modifications of precursors of polymers like lignin are discussed.	[Schliemann, Willibald; Vogt, Thomas] Leibniz Inst Plant Biochem, Dept Metab 2, D-06120 Halle, Saale, Germany; [Kopycki, Jakub Grzegorz; Stubbs, Milton T.] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Dept Phys Biotechnol, D-06099 Halle, Saale, Germany; [Brandt, Wolfgang; Hagemann, Martin; Schmidt, Juergen] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle, Saale, Germany; [Hagemann, Martin] Univ Rostock, Inst Biol Sci, D-18051 Rostock, Germany; [Zenk, Meinhart H.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzenbiochemie; University of Rostock; Donald Danforth Plant Science Center	Vogt, T (corresponding author), Leibniz Inst Plant Biochem, Dept Metab 2, D-06120 Halle, Saale, Germany.	tvogt@ipb-halle.de	Porzel, Andrea/B-1423-2014; Schliemann, Willibald/AAB-5499-2022; Stubbs, Milton/ABC-7585-2020	Porzel, Andrea/0000-0002-8148-6895; Stubbs, Milton/0000-0003-1278-9013				Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chabannes M, 2001, PLANT J, V28, P257, DOI 10.1046/j.1365-313X.2001.01140.x; *CHEM COMP GROUP I, 2007, MOE MOL OP ENV; Chen F, 2006, PLANT J, V48, P113, DOI 10.1111/j.1365-313X.2006.02857.x; Eggen M, 2002, MED RES REV, V22, P85, DOI 10.1002/med.10002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Guo DG, 2001, TRANSGENIC RES, V10, P457, DOI 10.1023/A:1012278106147; Hagemann M, 1997, J BACTERIOL, V179, P1727, DOI 10.1128/jb.179.5.1727-1733.1997; HARA O, 1992, J BACTERIOL, V174, P5141, DOI 10.1128/JB.174.15.5141-5144.1992; Hou XW, 2007, J STRUCT BIOL, V159, P523, DOI 10.1016/j.jsb.2007.04.007; Ibdah M, 2003, J BIOL CHEM, V278, P43961, DOI 10.1074/jbc.M304932200; Ibrahim RK, 2000, RECENT ADV PHYTOCHEM, V34, P349, DOI 10.1016/S0079-9920(00)80012-X; JONES PG, 1993, ACTA CRYSTALLOGR C, V49, P1148, DOI 10.1107/S0108270192012484; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kopycki JG, 2008, J MOL BIOL, V378, P154, DOI 10.1016/j.jmb.2008.02.019; Korb Oliver, 2007, Swarm Intelligence, V1, P115, DOI 10.1007/s11721-007-0006-9; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Marita JM, 2003, PHYTOCHEMISTRY, V62, P53, DOI 10.1016/S0031-9422(02)00434-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milkowski C, 2000, PLANTA, V211, P883, DOI 10.1007/s004250000411; Morreel K, 2004, PLANT PHYSIOL, V136, P3537, DOI 10.1104/pp.104.049304; Nelson JT, 2007, APPL ENVIRON MICROB, V73, P3575, DOI 10.1128/AEM.00011-07; Niemetz R, 2005, PHYTOCHEMISTRY, V66, P2001, DOI 10.1016/j.phytochem.2005.01.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAKUSCH AE, 1989, ARCH BIOCHEM BIOPHYS, V271, P488, DOI 10.1016/0003-9861(89)90299-3; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; Schroder G, 2004, PHYTOCHEMISTRY, V65, P1085, DOI 10.1016/j.phytochem.2004.02.010; STOCKIGT J, 1975, Z NATURFORSCH C, V30, P352; STRACK D, 1987, J PLANT PHYSIOL, V131, P61, DOI 10.1016/S0176-1617(87)80268-7; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vidgren J, 1998, Adv Pharmacol, V42, P328; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Vogt T, 2004, FEBS LETT, V561, P159, DOI 10.1016/S0014-5793(04)00163-2; WOLLENWEBER E, 1988, FLAVONOIDS, P283; YOSHIDA T, 1991, CHEM PHARM BULL, V39, P2247, DOI 10.1248/cpb.39.2247; Zhou JM, 2006, BBA-GEN SUBJECTS, V1760, P1115, DOI 10.1016/j.bbagen.2006.02.008; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412	44	31	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20888	20896		10.1074/jbc.M801943200	http://dx.doi.org/10.1074/jbc.M801943200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502765	hybrid, Green Published			2022-12-27	WOS:000257746100031
J	Malanga, M; Czubaty, A; Girstun, A; Staron, K; Althaus, FR				Malanga, Maria; Czubaty, Alicja; Girstun, Agnieszka; Staron, Krzysztof; Althaus, Felix R.			Poly(ADP-ribose) binds to the splicing factor ASF/SF2 and regulates its phosphorylation by DNA topoisomerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PROTEIN-PHOSPHORYLATION; MAMMALIAN-CELLS; GENE-EXPRESSION; SERINE-RICH; SR PROTEINS; TRANSCRIPTION; NUCLEAR; DOMAINS; LACKING	Human DNA topoisomerase I plays a dual role in transcription, by controlling DNA supercoiling and by acting as a specific kinase for the SR-protein family of splicing factors. The two activities are mutually exclusive, but the identity of the molecular switch is unknown. Here we identify poly(ADP-ribose) as a physiological regulator of the two topoisomerase I functions. We found that, in the presence of both DNA and the alternative splicing factor/splicing factor 2 (ASF/SF2, a prototypical SR-protein), poly(ADP-ribose) affected topoisomerase I substrate selection and gradually shifted enzyme activity from protein phosphorylation to DNA cleavage. A likely mechanistic explanation was offered by the discovery that poly(ADP-ribose) forms a high affinity complex with ASF/SF2 thereby leaving topoisomerase I available for directing its action onto DNA. We identified two functionally important domains, RRM1 and RS, as specific poly(ADP-ribose) binding targets. Two independent lines of evidence emphasize the potential biological relevance of our findings: (i) in HeLa nuclear extracts, ASF/SF2, but not histone, phosphorylation was inhibited by poly(ADP-ribose); (ii) an in silico study based on gene expression profiling data revealed an increased incidence of alternative splicing within a subset of inflammatory response genes that are dysregulated in cells lacking a functional poly(ADP-ribose) polymerase-1. We propose that poly(ADP-ribose) targeting of topoisomerase I and ASF/SF2 functions may participate in the regulation of gene expression.	[Malanga, Maria] Univ Naples Federico 2, Dept Struct & Funct Biol, I-80126 Naples, Italy; [Czubaty, Alicja; Girstun, Agnieszka; Staron, Krzysztof] Univ Warsaw, Inst Biochem, PL-02096 Warsaw, Poland; [Malanga, Maria; Althaus, Felix R.] Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Naples Federico II; University of Warsaw; University of Zurich	Malanga, M (corresponding author), Univ Naples Federico 2, Dept Struct & Funct Biol, Via Cinthia,Monte S Angelio, I-80126 Naples, Italy.	malanga@unina.it		Girstun, Agnieszka/0000-0001-6618-1383				Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; ALTHAUS FR, 1987, ADP RIBOSYLATION PRO, P3; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andersen FF, 2002, J MOL BIOL, V322, P677, DOI 10.1016/S0022-2836(02)00815-X; Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; Baumann C, 2006, NUCLEIC ACIDS RES, V34, P1036, DOI 10.1093/nar/gkj509; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Carrillo A, 2004, NUCLEIC ACIDS RES, V32, P757, DOI 10.1093/nar/gkh239; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Chen HJ, 1999, EUR J BIOCHEM, V265, P367, DOI 10.1046/j.1432-1327.1999.00741.x; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Czubaty A, 2005, BBA-PROTEINS PROTEOM, V1749, P133, DOI 10.1016/j.bbapap.2005.03.007; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; Gagne JP, 2005, BIOCHEM J, V392, P499, DOI 10.1042/BJ20050792; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; JESSER M, 1993, BIOCHEM BIOPH RES CO, V195, P558, DOI 10.1006/bbrc.1993.2082; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Khobta A, 2006, J MOL BIOL, V357, P127, DOI 10.1016/j.jmb.2005.12.069; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kowalska-Loth B, 2005, BIOCHEM BIOPH RES CO, V331, P398, DOI 10.1016/j.bbrc.2005.03.180; Kowalska-Loth B, 2002, EUR J BIOCHEM, V269, P3504, DOI 10.1046/j.1432-1033.2002.03037.x; Labourier E, 1998, NUCLEIC ACIDS RES, V26, P2955, DOI 10.1093/nar/26.12.2955; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; MALANGA M, 1994, J BIOL CHEM, V269, P17691; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Malanga M, 2004, J BIOL CHEM, V279, P5244, DOI 10.1074/jbc.C300437200; Mondal N, 2003, NUCLEIC ACIDS RES, V31, P5016, DOI 10.1093/nar/gkg705; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; PANZETER PL, 1993, J BIOL CHEM, V268, P17662; Parent M, 2005, J BIOL CHEM, V280, P448, DOI 10.1074/jbc.M408435200; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Pilch B, 2001, CANCER RES, V61, P6876; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Soret J, 2003, CANCER RES, V63, P8203; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200; ZHANG H, 1988, P NATL ACAD SCI USA, V85, P1060, DOI 10.1073/pnas.85.4.1060; Zingarelli B, 2004, AM J PHYSIOL-HEART C, V286, pH1408, DOI 10.1152/ajpheart.00953.2003	55	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19991	19998		10.1074/jbc.M709495200	http://dx.doi.org/10.1074/jbc.M709495200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18495665	Green Accepted, hybrid			2022-12-27	WOS:000257565300014
J	Wang, C; Norton, JT; Ghosh, S; Kim, J; Fushimi, K; Wu, JY; Stack, MS; Huang, S				Wang, Chen; Norton, John T.; Ghosh, Supurna; Kim, Julie; Fushimi, Kazuo; Wu, Jane Y.; Stack, M. Sharon; Huang, Sui			Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; PERINUCLEOLAR COMPARTMENT; PLASMINOGEN ACTIVATION; SPLICING REPRESSION; EXON DEFINITION; IN-VITRO; INCLUSION; EXPRESSION; CANCER; POLYADENYLATION	RNA processing is altered during malignant transformation, and expression of the polypyrimidine tract-binding protein (PTB) is often increased in cancer cells. Although some data support that PTB promotes cancer, the functional contribution of PTB to the malignant phenotype remains to be clarified. Here we report that although PTB levels are generally increased in cancer cell lines from multiple origins and in endometrial adenocarcinoma tumors, there appears to be no correlation between PTB levels and disease severity or metastatic capacity. The three isoforms of PTB increase heterogeneously among different tumor cells. PTB knockdown in transformed cells by small interfering RNA decreases cellular growth in monolayer culture and to a greater extent in semi-solid media without inducing apoptosis. Down- regulation of PTB expression in a normal cell line reduces proliferation even more significantly. Reduction of PTB inhibits the invasive behavior of two cancer cell lines in Matrigel invasion assays but enhances the invasive behavior of another. At the molecular level, PTB in various cell lines differentially affects the alternative splicing pattern of the same substrates, such as caspase 2. Furthermore, overexpression of PTB does not enhance proliferation, anchorage-independent growth, or invasion in immortalized or normal cells. These data demonstrate that PTB is not oncogenic and can either promote or antagonize a malignant trait dependent upon the specific intra-cellular environment.	[Wang, Chen; Norton, John T.; Stack, M. Sharon; Huang, Sui] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Ghosh, Supurna] Northwestern Univ, Breast Ctr, Dept Med, Chicago, IL 60611 USA; [Kim, Julie] Northwestern Univ, Prentice Hosp, Dept Med Obstet & Gynecol, Chicago, IL 60611 USA; [Fushimi, Kazuo; Wu, Jane Y.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine	Huang, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Ward Bldg 11-240,303 E Chicago Ave, Chicago, IL 60611 USA.	s-huang2@northwestern.edu		Kim, J Julie/0000-0001-9834-8213	NATIONAL CANCER INSTITUTE [R33CA097761, R21CA127674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967, R01GM078555] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA127674, R21 CA127674-01A2, CA 097761] Funding Source: Medline; NIGMS NIH HHS [GM 078555-01, GM 070967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Cote J, 2001, J BIOL CHEM, V276, P8535, DOI 10.1074/jbc.M008924200; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; Ghosh S, 2000, J BIOL CHEM, V275, P23869, DOI 10.1074/jbc.M000935200; Ghosh S, 2002, CANCER-AM CANCER SOC, V95, P2524, DOI 10.1002/cncr.10997; GIL A, 1991, GENE DEV, V5, P1224, DOI 10.1101/gad.5.7.1224; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; HELLEN CUT, 1994, J VIROL, V68, P941, DOI 10.1128/JVI.68.2.941-950.1994; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Jin W, 2000, CANCER RES, V60, P1221; Jin W, 2003, CANCER RES, V63, P6154; Kamath RV, 2001, MOL BIOL CELL, V12, P3808, DOI 10.1091/mbc.12.12.3808; Kaminski A, 1995, RNA, V1, P924; Kopp K, 2005, J CELL BIOCHEM, V95, P217, DOI 10.1002/jcb.20403; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Lou H, 1999, MOL CELL BIOL, V19, P78; Lou H, 1996, GENE DEV, V10, P208, DOI 10.1101/gad.10.2.208; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; McCutcheon IE, 2004, NEURO-ONCOLOGY, V6, P9, DOI 10.1215/S1152851703000279; Oh YL, 1998, BIOCHEM J, V331, P169, DOI 10.1042/bj3310169; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; Perez I, 1997, BIOCHEMISTRY-US, V36, P11881, DOI 10.1021/bi9711745; Perez I, 1997, RNA, V3, P764; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Robinson F, 2006, J BIOL CHEM, V281, P800, DOI 10.1074/jbc.M510578200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Schneider R, 2001, MOL CELL BIOL, V21, P8238, DOI 10.1128/MCB.21.23.8238-8246.2001; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; STACK S, 1990, BIOCHEMISTRY-US, V29, P4966, DOI 10.1021/bi00472a029; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wagner EJ, 1999, ELECTROPHORESIS, V20, P1082, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<1082::AID-ELPS1082>3.0.CO;2-#; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang C, 2003, MOL BIOL CELL, V14, P2425, DOI 10.1091/mbc.E02-12-0818; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Watahiki A, 2004, NAT METHODS, V1, P233, DOI 10.1038/NMETH719; Witherell GW, 1995, VIROLOGY, V214, P660, DOI 10.1006/viro.1995.0081; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Zhang WJ, 1996, MOL CELL BIOL, V16, P5400	53	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20277	20287		10.1074/jbc.M803682200	http://dx.doi.org/10.1074/jbc.M803682200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499661	Green Published, hybrid			2022-12-27	WOS:000257565300044
J	Hogan, C; Hutchison, C; Marcar, L; Milne, D; Saville, M; Goodlad, J; Kernohan, N; Meek, D				Hogan, Carol; Hutchison, Caroline; Marcar, Lynnette; Milne, Diane; Saville, Mark; Goodlad, John; Kernohan, Neil; Meek, David			Elevated levels of oncogenic protein kinase pim-1 induce the p53 pathway in cultured cells and correlate with increased mdm2 in mantle cell lymphoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSION; CROSS-TALK; PHOSPHORYLATION; AKT; PROTOONCOGENE; HDM2; UBIQUITINATION; DEGRADATION; APOPTOSIS; MULTIPLE	Mutation of the p53 gene is a common event during tumor pathogenesis. Other mechanisms, such as mdm2 amplification, provide alternative routes through which dysfunction of the p53 pathway is promoted. Here, we address the hypothesis that elevated expression of pim oncogenes might suppress p53 by regulating Mdm2. At a physiological level, we show that endogenous Pim-1 and Pim-2 interact with endogenous Mdm2. Additionally, the Pim kinases phosphorylate Mdm2 in vitro and in cultured cells at Ser(166) and Ser(186), two previously identified targets of other signaling pathways, including Akt. Surprisingly, at high levels of Pim expression, as would occur in tumors, active, but not inactive, Pim-1 or Pim-2 blocks the degradation of both p53 and Mdm2 in a manner that is independent of Mdm2 phosphorylation, leading to increased p53 levels and, proportionately, p53-dependent transactivation. Additionally, Pim-1 induces endogenous ARF, p53, Mdm2, and p21 in primary murine embryo fibroblasts and stimulates senescence-associated beta-galactosidase levels, consistent with the induction of senescence. Immunohistochemical analysis of a cohort of 33 human mantle cell lymphomas shows that elevated expression of Pim-1 occurs in 42% of cases, with elevated Pim-2 occurring in 9% of cases, all of which also express Pim-1. Notably, elevated Pim-1 correlates with elevated Mdm2 in MCL with a p value of 0.003. Taken together, our data are consistent with the idea that Pim normally interacts with the p53 pathway but, when expressed at pathological levels, behaves as a classic dominant oncogene that stimulates a protective response through induction of the p53 pathway.	[Hogan, Carol; Marcar, Lynnette; Milne, Diane; Meek, David] Ninewells Hosp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Hutchison, Caroline; Goodlad, John; Kernohan, Neil] Ninewells Hosp, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; [Saville, Mark] Ninewells Hosp, Div Surg & Oncol, Dundee DD1 9SY, Scotland; [Saville, Mark] Univ Dundee, Sch Med, Dundee DD1 4HN, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee	Meek, D (corresponding author), Ninewells Hosp, Biomed Res Ctr, Level 5, Dundee DD1 9SY, Scotland.	d.w.meek@dundee.ac.uk		Goodlad, John Robert/0000-0002-8385-8517	Cancer Research UK [A6613] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Allende-Vega N, 2007, ONCOGENE, V26, P4234, DOI 10.1038/sj.onc.1210209; AMSON R, 1989, P NATL ACAD SCI USA, V86, P8857, DOI 10.1073/pnas.86.22.8857; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Burch LR, 2004, J MOL BIOL, V337, P115, DOI 10.1016/j.jmb.2003.10.081; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; de Vos S, 2003, DIAGN MOL PATHOL, V12, P35, DOI 10.1097/00019606-200303000-00005; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Ionov Y, 2003, ANTICANCER RES, V23, P167; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meek DW, 2003, MOL CANCER RES, V1, P1017; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Milne D, 2004, FEBS LETT, V577, P270, DOI 10.1016/j.febslet.2004.09.081; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Palaty CK, 1997, BIOCHEM CELL BIOL, V75, P153, DOI 10.1139/bcb-75-2-153; Popivanova BK, 2007, CANCER SCI, V98, P321, DOI 10.1111/j.1349-7006.2007.00390.x; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Swerdlow SH, 2002, HUM PATHOL, V33, P7, DOI 10.1053/hupa.2002.30221; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang Z, 2001, J Vet Sci, V2, P167; Weber HO, 2005, ONCOGENE, V24, P1965, DOI 10.1038/sj.onc.1208389; Webster GA, 1999, MOL CELL BIOL, V19, P3485; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhu Y, 2002, BRIT J HAEMATOL, V119, P905, DOI 10.1046/j.1365-2141.2002.03931.x; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	54	61	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					18012	18023		10.1074/jbc.M709695200	http://dx.doi.org/10.1074/jbc.M709695200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18467333	Green Accepted, hybrid			2022-12-27	WOS:000256949200030
J	Shimamura, T; Hiraki, K; Takahashi, N; Hori, T; Ago, H; Masuda, K; Takio, K; Ishiguro, M; Miyano, M				Shimamura, Tatsuro; Hiraki, Kenji; Takahashi, Naoko; Hori, Tetsuya; Ago, Hideo; Masuda, Katsuyoshi; Takio, Koji; Ishiguro, Masaji; Miyano, Masashi			Crystal structure of squid rhodopsin with intracellularly extended cytoplasmic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-ACTIVATED RHODOPSIN; COVALENT CROSS-LINKING; COMPLEX-FORMATION; CONTACT SITES; G-PROTEINS; RECEPTOR; CRYSTALLOGRAPHY; TRANSDUCIN; SEQUENCE; HELIX-8	G-protein-coupled receptors play a key step in cellular signal transduction cascades by transducing various extracellular signals via G-proteins. Rhodopsin is a prototypical G-protein-coupled receptor involved in the retinal visual signaling cascade. We determined the structure of squid rhodopsin at 3.7 A resolution, which transduces signals through the G(q) protein to the phosphoinositol cascade. The structure showed seven transmembrane helices and an amphipathic helix H8 has similar geometry to structures from bovine rhodopsin, coupling to G(t), and human beta(2)-adrenergic receptor, coupling to G(s). Notably, squid rhodopsin contains a well structured cytoplasmic region involved in the interaction with G-proteins, and this region is flexible or disordered in bovine rhodopsin and human beta 2-adrenergicreceptor. The transmembrane helices 5 and 6 are longer and extrude into the cytoplasm. The distal C-terminal tail contains a short hydrophilic alpha-helix CH after the palmitoylated cysteine residues. The residues in the distal C-terminal tail interact with the neighboring residues in the second cytoplasmic loop, the extruded transmembrane helices 5 and 6, and the short helix H8. Additionally, the Tyr-111, Asn-87, and Asn-185 residues are located within hydrogen-bonding distances from the nitrogen atom of the Schiff base.	[Hiraki, Kenji; Masuda, Katsuyoshi; Ishiguro, Masaji] Suntory Inst Bioorgan Res, Mishima, Osaka 6188503, Japan; [Shimamura, Tatsuro; Takahashi, Naoko; Hori, Tetsuya; Ago, Hideo; Takio, Koji; Miyano, Masashi] Harima Inst, RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Suntory Holdings Ltd; RIKEN	Ishiguro, M (corresponding author), Suntory Inst Bioorgan Res, 1-1-1 Wakayamadai,Shimamoto Cho, Mishima, Osaka 6188503, Japan.	ishiguro@sunbor.or.jp; miyano@spring8.or.jp	Miyano, Masashi/R-2785-2016	Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Elefsinioti AL, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-208; Go L, 2003, COMP BIOCHEM PHYS B, V135, P601, DOI 10.1016/S1096-4959(03)00140-4; HARANISHIMURA I, 1993, FEBS LETT, V317, P5, DOI 10.1016/0014-5793(93)81480-N; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KITO Y, 1982, METHOD ENZYMOL, V81, P43; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; Nakamura T, 2004, PROTEOMICS, V4, P2558, DOI 10.1002/pmic.200300812; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAIL HR, 1984, P NATL ACAD SCI USA, V81, P5111; Sgourakis NG, 2005, BIOINFORMATICS, V21, P4101, DOI 10.1093/bioinformatics/bti679; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Terakita A, 1998, FEBS LETT, V439, P110, DOI 10.1016/S0014-5793(98)01340-4; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731	32	105	105	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					17753	17756		10.1074/jbc.C800040200	http://dx.doi.org/10.1074/jbc.C800040200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18463093	hybrid, Green Published			2022-12-27	WOS:000256949200002
J	Cahill, CM; Rogers, JT				Cahill, Catherine M.; Rogers, Jack T.			Interleukin (IL) 1 beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/I kappa B kinase alpha pathway targeting activator protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; IKK-ALPHA; UP-REGULATION; C-FOS; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; GENE-EXPRESSION; INNATE IMMUNITY; NF; RECEPTOR	Here we describe a novel role for the phosphatidylinositol 3-kinase/AKT pathway in mediating induction of interleukin-6 (IL-6) in response to IL-1. Pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) inhibited IL-6 mRNA and protein production. Overexpression of either dominant-negative AKTor I kappa Bkinase alpha mutant, IKK alpha T23A, containing a mutation in a functional AKT phosphorylation site, shown previously to be important for NF kappa B activation, completely abrogated IL-6 promoter activation in response to IL-1. However, mutation of the consensus NF kappa B site on the IL-6 promoter did not abrogate promoter activation by IL-1 in contrast to the AP-1 site mutation. IL-1 induces phosphorylation of IKK alpha on the NF kappa B inducing kinase (NIK) phosphorylation sites Ser(176)/Ser(180) and on the Thr(23) site, and although phosphorylation of IKK alpha T23 is inhibited both by LY294002 and wortmannin, phosphorylation of Ser(176)/Ser(180) is not. Neither inhibition of PI 3-kinase/AKT nor IKK alpha T23A overexpression affected I kappa B alpha degradation in response to IL-1. Only partial inhibition by dominant-negative AKT and no inhibitory effect of IKK alpha T23A was observed on an IL-6 promoter-specific NF kappa B site in contrast to significant inhibitory effects on the AP-1 site. Taken together, we have discovered a novel PI 3-kinase/AKT-dependent pathway in response to IL-1, encompassing PI 3-kinase/AKT/IKK alpha T23 upstream of AP-1. This novel pathway is a parallel pathway to the PI 3-kinase/AKT upstream of NF kappa B and both are involved in IL-6 gene transcription in response to IL-1.	[Cahill, Catherine M.; Rogers, Jack T.] Massachusetts Gen Hosp East, Aging Res Unit, Charlestown, MA 02129 USA; [Cahill, Catherine M.; Rogers, Jack T.] Massachusetts Gen Hosp East, Neurochem Lab, Dept Psychiat Neurosci & Genet, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Cahill, CM (corresponding author), MA Gen Hosp, CNY 149,Rm 2510,13th St, Charlestown, MA 02129 USA.	ccahill@rics.bwh.harvard.edu		Rogers, Jack/0000-0003-1262-8578	National Institutes of Health [R01 AG20181]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG20181. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; An JB, 2002, BLOOD, V99, P649, DOI 10.1182/blood.V99.2.649; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Atreya R, 2005, CLIN REV ALLERG IMMU, V28, P187, DOI 10.1385/CRIAI:28:3:187; Bang OS, 2000, BIOCHEM BIOPH RES CO, V278, P306, DOI 10.1006/bbrc.2000.3805; BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; Belluco C, 2003, CLIN CANCER RES, V9, P2173; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Brozek W, 2005, EUR J CANCER, V41, P2347, DOI 10.1016/j.ejca.2005.07.014; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Chou CH, 2005, CARCINOGENESIS, V26, P45, DOI 10.1093/carcin/bgh301; Coffer PJ, 1998, BIOCHEM J, V335, P1; Dahle MK, 2004, INFECT IMMUN, V72, P5704, DOI 10.1128/IAI.72.10.5704-5711.2004; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Haij S, 2005, J AM SOC NEPHROL, V16, P1603, DOI 10.1681/ASN.2004090781; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guo FK, 2000, INFLAMMATION, V24, P305, DOI 10.1023/A:1007040813331; Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Hirano T, 1998, Int Rev Immunol, V16, P249; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kinoshita T, 1999, CANCER, V85, P2526, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2-3; Koul D, 2001, J BIOL CHEM, V276, P11402, DOI 10.1074/jbc.M007806200; Koul D, 2007, MOL CELL BIOCHEM, V300, P77, DOI 10.1007/s11010-006-9371-8; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Li JX, 2004, J CELL BIOL, V165, P77, DOI 10.1083/jcb.200401004; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Marmiroli S, 1998, FEBS LETT, V438, P49, DOI 10.1016/S0014-5793(98)01270-8; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matsuo K, 2003, J INT MED RES, V31, P69, DOI 10.1177/147323000303100202; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Neumann D, 2002, EUR J IMMUNOL, V32, P3689, DOI 10.1002/1521-4141(200212)32:12<3689::AID-IMMU3689>3.0.CO;2-X; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Okuno Y, 2002, BLOOD, V100, P4420, DOI 10.1182/blood-2002-03-0788; Ozes ON, 1999, NATURE, V401, P82; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Patil C, 2004, IMMUNOL INVEST, V33, P213, DOI 10.1081/IMM-120034231; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Ruffolo C, 2007, J GASTROINTEST SURG, V11, P16, DOI 10.1007/s11605-006-0021-y; Samuel S, 2005, BIOCHEM J, V388, P921, DOI 10.1042/BJ20041497; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SHER ME, 1995, AM J SURG, V169, P133, DOI 10.1016/S0002-9610(99)80121-4; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Suto R, 2004, GENE THER, V11, P187, DOI 10.1038/sj.gt.3302158; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; Wang WY, 1998, J SURG RES, V79, P39, DOI 10.1006/jsre.1998.5385; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025	86	159	165	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25900	25912		10.1074/jbc.M707692200	http://dx.doi.org/10.1074/jbc.M707692200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18515365	Green Published, hybrid			2022-12-27	WOS:000259200100017
J	Imperial, JS; Chen, P; Sporning, A; Terlau, H; Daly, NL; Craik, DJ; Alewood, PF; Olivera, BM				Imperial, Julita S.; Chen, Ping; Sporning, Annett; Terlau, Heinrich; Daly, Norelle L.; Craik, David J.; Alewood, Paul F.; Olivera, Baldomero M.			Tyrosine-rich conopeptides affect voltage-gated K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; KAPPA-CONOTOXIN PVIIA; VENOMOUS CONE SNAILS; SODIUM-CHANNELS; PEPTIDE; FAMILY; GEOGRAPHUS; INHIBITOR; EVOLUTION; ORIGINS	Two venom peptides, CPY-Pl1 (EU000528) and CPY-Fe1 (EU000529), characterized from the vermivorous marine snails Conus planorbis and Conus ferrugineus, define a new class of conopeptides, the conopeptide Y (CPY) family. The peptides have no disulfide cross-links and are 30 amino acids long; the high content of tyrosine is unprecedented for any native gene product. The CPY peptides were chemically synthesized and shown to be biologically active upon injection into both mice and Caenorhabditis elegans; activity on mammalian Kv1 channel isoforms was demonstrated using an oocyte heterologous expression system, and selectivity for Kv1.6 was found. NMR spectroscopy revealed that the peptides were unstructured in aqueous solution; however, a helical region including residues 12-18 for one peptide, CPY-Pl1, formed in trifluoroethanol buffer. Clones obtained from cDNA of both species encoded prepropeptide precursors that shared a unique signal sequence, indicating that these peptides are encoded by a novel gene family. This is the first report of tyrosine-rich bioactive peptides in Conus venom.	[Imperial, Julita S.; Chen, Ping; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Sporning, Annett; Terlau, Heinrich] Max Planck Inst Expt Med, Mol & Cellular Neuropharmacol Grp, D-37075 Gottingen, Germany; [Terlau, Heinrich] Univ Klinikum Schleswig Holstein, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany; [Daly, Norelle L.; Craik, David J.; Alewood, Paul F.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Utah System of Higher Education; University of Utah; Max Planck Society; University of Kiel; Schleswig Holstein University Hospital; University of Queensland	Imperial, JS (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	imperial@biology.utah.edu	Craik, David/B-1695-2010; Daly, Norelle L/D-4302-2013; Alewood, Paul F/J-2412-2014	Craik, David/0000-0003-0007-6796; Daly, Norelle L/0000-0002-4697-6602; Terlau, Heinrich/0000-0002-2206-1221	National Institutes of Health [GM48667]; German Ministry of Education and Research Biofuture Prize [Forderkennzeichen 0311859]; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Education and Research Biofuture Prize; Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48667 (B.M.O.). This work was also supported by the German Ministry of Education and Research Biofuture Prize (Forderkennzeichen 0311859, to H.T.) and the Australian Research Council (to P.F.A. and D.J.C.).	Al-Sabi A, 2004, BIOCHEMISTRY-US, V43, P8625, DOI 10.1021/bi0495681; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Cerda-Reverter JM, 2000, BIOCHEM CELL BIOL, V78, P371, DOI 10.1139/bcb-78-3-371; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Espiritu DJD, 2001, TOXICON, V39, P1899, DOI 10.1016/S0041-0101(01)00175-1; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; HOPKINS C, 1995, J BIOL CHEM, V270, P22361, DOI 10.1074/jbc.270.38.22361; HORTON RM, 1993, NEUROLOGY, V43, P983, DOI 10.1212/WNL.43.5.983; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; IMPERIAL JS, 2007, THESIS U QUEENSLAND; Imperial JS, 2007, P AM PHILOS SOC, V151, P185; Jacobsen RB, 2000, J BIOL CHEM, V275, P24639, DOI 10.1074/jbc.C900990199; Jimenez EC, 1996, J BIOL CHEM, V271, P28002, DOI 10.1074/jbc.271.45.28002; Maillo M, 2002, TOXICON, V40, P401, DOI 10.1016/S0041-0101(01)00176-3; MELLO CC, 1991, EMBO J, V10, P2959; OLIVERA BM, 1985, TOXICON, V23, P277, DOI 10.1016/0041-0101(85)90150-3; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P9581, DOI 10.1021/bi970235w; Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; Sudarslal S, 2004, BIOCHEM BIOPH RES CO, V317, P682, DOI 10.1016/j.bbrc.2004.03.100; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200	30	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23026	23032		10.1074/jbc.M800084200	http://dx.doi.org/10.1074/jbc.M800084200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18505731	hybrid, Green Published			2022-12-27	WOS:000258455400015
J	Mrinal, N; Nagaraju, J				Mrinal, Nirotpal; Nagaraju, Javaregowda			Intron loss is associated with gain of function in the evolution of the gloverin family of antibacterial genes in Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR CF2; MESSENGER-RNA; IMMUNE-RESPONSE; DROSOPHILA; PROTEIN; SEQUENCE; RELISH; PSEUDOGENES; DEFENSE; HEMOLIN	Gene duplication is a characteristic feature of eukaryotic genomes. Here we investigated the role of gene duplication in the evolution of the gloverin family of antibacterial genes (Bmglv1, Bmglv2, Bmglv3, and Bmglv4) in Bombyx mori. We observed the following two significant changes during the first duplication event: (i) loss of intronV, located in the 3'-untranslated region (UTR) of the ancestral gene Bmglv1, and (ii) 12-bp deletion in exon3. We show that loss of intronV during Bmglv1 to Bmglv2 duplication was associated with embryonic expression of Bmglv2. Gel mobility shift, chromatin immunoprecipitation, and immunodepletion assays identified chorion factor 2, a zinc finger protein, as the repressor molecule that bound to a 10-bp regulatory motif in intronV of Bmglv1 and repressed its transcription. gloverin paralogs that lacked intronV were independent of chorion factor 2 regulation and expressed in embryo. These results suggest that change in cis-regulation because of intron loss resulted in embryonic expression of Bmglv2-4, a gain of function over Bmglv1. Studies on the significance of intron loss have focused on introns present within the coding sequences for their potential effect on the open reading frame, whereas introns present in the UTRs of the genes were not given due attention. This study emphasizes the regulatory function of the 3'-UTR intron. In addition, we also studied the genomic loss and show that "in-frame" deletion of 12 nucleotides led to loss of amino acids IHDF resulting in the generation of a prepro-processing site in BmGlv2. As a result, the N-terminal pro-part of BmGlv2, but not of BmGlv1, gets processed in an infection-dependent manner suggesting that prepro-processing is an evolved feature in Gloverins.	[Mrinal, Nirotpal; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Ctr Excellence Genet & Genom Silkmoths, Mol Genet Lab, Hyderabad 500076, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nagaraju, J (corresponding author), Ctr DNA Fingerprinting & Diagnost, Ctr Excellence Genet & Genom Silkmoths, Mol Genet Lab, ECIL Rd, Hyderabad 500076, Andhra Pradesh, India.	jnagaraju@cdfd.org.in						Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; BERNSTEIN LB, 1983, CELL, V32, P461, DOI 10.1016/0092-8674(83)90466-X; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Bourdon V, 2001, EMBO REP, V2, P394, DOI 10.1093/embo-reports/kve090; Carmel L, 2007, GENOME RES, V17, P1045, DOI 10.1101/gr.5978207; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Derr LK, 1998, GENETICS, V148, P937; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gogos JA, 1996, P NATL ACAD SCI USA, V93, P2159, DOI 10.1073/pnas.93.5.2159; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hsu T, 1996, GENE DEV, V10, P1411, DOI 10.1101/gad.10.11.1411; HSU T, 1992, SCIENCE, V257, P1946, DOI 10.1126/science.1411512; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Kanginakudru S, 2007, INSECT MOL BIOL, V16, P635, DOI 10.1111/j.1365-2583.2007.00753.x; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Larizza A, 2002, COMPUT CHEM, V26, P479, DOI 10.1016/S0097-8485(02)00009-8; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lee KY, 2002, INSECT BIOCHEM MOLEC, V32, P1457, DOI 10.1016/S0965-1748(02)00066-8; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; LEWIN R, 1983, SCIENCE, V219, P1052, DOI 10.1126/science.6186029; Llopart A, 2002, P NATL ACAD SCI USA, V99, P8121, DOI 10.1073/pnas.122570299; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; Lundstrom A, 2002, INSECT BIOCHEM MOLEC, V32, P795, DOI 10.1016/S0965-1748(01)00162-X; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mackintosh JA, 1998, DEV COMP IMMUNOL, V22, P387, DOI 10.1016/S0145-305X(98)00025-1; Mantrova EY, 1998, GENE DEV, V12, P1166; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Ptashne M, 2001, ESSAYS BIOCHEM, V37, P1; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; SAKURAI H, 1995, VITRO TRANSCRIPTION, P233; SHEA MJ, 1990, GENE DEV, V4, P1128, DOI 10.1101/gad.4.7.1128; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; SUZUKI Y, 1986, P NATL ACAD SCI USA, V83, P9522, DOI 10.1073/pnas.83.24.9522; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	57	30	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23376	23387		10.1074/jbc.M801080200	http://dx.doi.org/10.1074/jbc.M801080200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18524767	hybrid			2022-12-27	WOS:000258455400048
J	Shao, ZY; Blodgett, JAV; Circello, BT; Eliot, AC; Woodyer, R; Li, GY; van der Donk, WA; Metcalf, WW; Zhao, HM				Shao, Zengyi; Blodgett, Joshua A. V.; Circello, Benjamin T.; Eliot, Andrew C.; Woodyer, Ryan; Li, Gongyong; van der Donk, Wilfred A.; Metcalf, William W.; Zhao, Huimin			Biosynthesis of 2-hydroxyethylphosphonate, an unexpected intermediate common to multiple phosphonate biosynthetic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-P BOND; PHOSPHINOTHRICIN-TRIPEPTIDE; SACCHAROMYCES-CEREVISIAE; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; NATURAL-PRODUCTS; GENE-CLUSTER; FOSFOMYCIN; MECHANISM; PHOSPHONOACETALDEHYDE	Phosphonic acids encompass a common yet chemically diverse class of natural products that often possess potent biological activities. Here we report that, despite the significant structural differences among many of these compounds, their biosynthetic routes contain an unexpected common intermediate, 2-hydroxyethyl-phosphonate, which is synthesized from phosphonoacetaldehyde by a distinct family of metal-dependent alcohol dehydrogenases (ADHs). Although the sequence identity of the ADH family members is relatively low (34-37%), in vitro biochemical characterization of the homologs involved in biosynthesis of the antibiotics fosfomycin, phosphinothricin tripeptide, and dehydrophos (formerly A53868) unequivocally confirms their enzymatic activities. These unique ADHs have exquisite substrate specificity, unusual metal requirements, and an unprecedented monomeric quaternary structure. Further, sequence analysis shows that these ADHs form a monophyletic group along with additional family members encoded by putative phosphonate biosynthetic gene clusters. Thus, the reduction of phosphonoacetaldehyde to hydroxyethyl-phosphonate may represent a common step in the biosynthesis of many phosphonate natural products, a finding that lends insight into the evolution of phosphonate biosynthetic pathways and the chemical structures of new C-P containing secondary metabolites.	[Circello, Benjamin T.; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Shao, Zengyi; Zhao, Huimin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Shao, Zengyi; Zhao, Huimin] Univ Illinois, Dept Biomol Engn, Urbana, IL 61801 USA; [van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Blodgett, Joshua A. V.] Harvard Univ, Dept Biol Chem, Sch Med, Boston, MA 02115 USA; [Blodgett, Joshua A. V.] Harvard Univ, Dept Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Eliot, Andrew C.] Dupont Cent Res & Dev, Wilmington, DE 19880 USA; [Woodyer, Ryan] zuChem Inc, Peoria, IL 61604 USA; [Li, Gongyong] Shanghai Chemspec Corp, Dept R&D, Shanghai 200333, Peoples R China; [van der Donk, Wilfred A.; Zhao, Huimin] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; DuPont; University of Illinois System; University of Illinois Urbana-Champaign	Metcalf, WW (corresponding author), Univ Illinois, Dept Microbiol, B103 CLSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	metcalf@uiuc.edu; zhao5@uiuc.edu	Blodgett, Joshua/AAW-8242-2020; Blodgett, Joshua/G-9355-2011; van der Donk, Wilfred/K-2961-2015	Blodgett, Joshua/0000-0002-7080-5870; Blodgett, Joshua/0000-0002-7080-5870; van der Donk, Wilfred/0000-0002-5467-7071	NIGMS NIH HHS [GM067725, GM059334, GM077596, P01 GM077596, GM070421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596, T32GM070421, R01GM067725, R01GM059334] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUDELO MI, 1983, BIOL BULL, V165, P100, DOI 10.2307/1541357; ALIJAH R, 1991, APPL MICROBIOL BIOT, V34, P749; BARRY RJ, 1988, BIOCHEM BIOPH RES CO, V153, P177, DOI 10.1016/S0006-291X(88)81205-1; Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Blodgett JAV, 2007, NAT CHEM BIOL, V3, P480, DOI 10.1038/nchembio.2007.9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CONWAY T, 1989, J BACTERIOL, V171, P3754, DOI 10.1128/jb.171.7.3754-3759.1989; Crow JP, 1997, J NEUROCHEM, V69, P1936; DREWKE C, 1988, BIOCHIM BIOPHYS ACTA, V950, P54, DOI 10.1016/0167-4781(88)90072-3; Farh L, 2001, J BIOCHEM-TOKYO, V130, P627, DOI 10.1093/oxfordjournals.jbchem.a003028; Fields SC, 1999, TETRAHEDRON, V55, P12237, DOI 10.1016/S0040-4020(99)00701-2; Hilderbrand R. L., 1983, ROLE PHOSPHONATES LI; IMAI S, 1985, AGR BIOL CHEM TOKYO, V49, P873, DOI 10.1080/00021369.1985.10866818; ISBELL AF, 1969, J ORG CHEM, V34, P755, DOI 10.1021/jo01255a067; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; Nakashita H, 1997, J ANTIBIOT, V50, P212, DOI 10.7164/antibiotics.50.212; QUIN LD, 1965, BIOCHEMISTRY-US, V4, P324, DOI 10.1021/bi00878a022; REEVES DS, 1992, INFECTION, V20, pS313, DOI 10.1007/BF01710022; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; SEIDEL HM, 1988, NATURE, V335, P457, DOI 10.1038/335457a0; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i; Stein GE, 1999, INT J FERTIL WOMEN M, V44, P104; Thompson C J, 1995, Biotechnology, V28, P197; van Wageningen AMA, 1998, CHEM BIOL, V5, P155, DOI 10.1016/S1074-5521(98)90060-6; Whitteck JT, 2007, ANGEW CHEM INT EDIT, V46, P9089, DOI 10.1002/anie.200703810; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; Woodyer RD, 2006, CHEM BIOL, V13, P1171, DOI 10.1016/j.chembiol.2006.09.007	28	39	43	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23161	23168		10.1074/jbc.M801788200	http://dx.doi.org/10.1074/jbc.M801788200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18544530	hybrid, Green Published			2022-12-27	WOS:000258455400029
J	Zhang, H; Rider, SD; Henderson, JT; Fountain, M; Chuang, K; Kandachar, V; Simons, A; Edenberg, HJ; Romero-Severson, J; Muir, WM; Ogas, J				Zhang, Heng; Rider, Stanley Dean, Jr.; Henderson, James T.; Fountain, Matthew; Chuang, King; Kandachar, Vasundhara; Simons, Alexis; Edenberg, Howard J.; Romero-Severson, Jeanne; Muir, William M.; Ogas, Joe			The CHD3 remodeler PICKLE promotes trimethylation of histone H3 lysine 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING ARABIDOPSIS SEEDS; POLYCOMB GROUP-COMPLEXES; TRITHORAX GROUP PROTEINS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; DNA METHYLATION; EMBRYO DEVELOPMENT; TRANSCRIPTION FACTOR; REPRESS EXPRESSION; GIBBERELLIN	CHD3 proteins are ATP-dependent chromatin remodelers that contribute to repression of developmentally regulated genes in both animal and plant systems. In animals, this repression has been linked to a multiple subunit complex, Mi-2/ NuRD, whose constituents include aCHD3protein, a histone deacetylase, and a methylCpG-binding domain protein. In Arabidopsis, PICKLE ( PKL) codes for a CHD3 protein that acts during germination to repress expression of seed-associated genes. Repression of seed-associated traits is promoted in pkl seedlings by the plant growth regulator gibberellin (GA). We undertook a microarray analysis to determine how PKL and GA act to promote the transition from seed to seedling. We found that PKL and GA actin separate pathways to repress expression of seed-specific genes. Comparison of genomic datasets revealed that PKL-dependent genes are enriched for trimethylation of histone H3 lysine 27 (H3K27me3), a repressive epigenetic mark. Chromatin immunoprecipitation studies demonstrate that PKL promotes H3K27me3 in both germinating seedlings and in adult plants but do not identify a connection between PKL dependent expression and acetylation levels. Taken together, our analyses illuminate a new pathway by which CHD3 remodelers contribute to repression in eukaryotes.	[Zhang, Heng; Rider, Stanley Dean, Jr.; Henderson, James T.; Fountain, Matthew; Chuang, King; Kandachar, Vasundhara; Simons, Alexis; Ogas, Joe] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Edenberg, Howard J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Edenberg, Howard J.] Indiana Univ, Sch Med, Ctr Med Genom, Indianapolis, IN 46202 USA; [Romero-Severson, Jeanne] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Notre Dame; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ogas, J (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ Ave, W Lafayette, IN 47907 USA.	ogas@purdue.edu	Romero-Severson, Jeanne/B-5259-2011	Romero-Severson, Jeanne/0000-0003-4112-7238; Zhang, Heng/0000-0002-1541-3890; Ogas, Joe/0000-0002-1332-7729; Edenberg, Howard/0000-0003-0344-9690	NIGMS NIH HHS [5R01 GM59770-08, R01GM059770-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059770] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; [Anonymous], 1995, PLANT HORMONES PHYSL, DOI DOI 10.1007/978-94-011-0473-9; BARENDSE GWM, 1986, PHYSIOL PLANTARUM, V67, P315, DOI 10.1111/j.1399-3054.1986.tb02463.x; Benhamed M, 2006, PLANT CELL, V18, P2893, DOI 10.1105/tpc.106.043489; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; CHURCHILL GA, 1994, GENETICS, V138, P963; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; Girke T, 2000, PLANT PHYSIOL, V124, P1570, DOI 10.1104/pp.124.4.1570; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li HC, 2005, PLANT J, V44, P1010, DOI 10.1111/j.1365-313X.2005.02602.x; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Muir W M, 2006, J Data Sci, V4, P323; Ng DWK, 2006, PLANT CELL, V18, P119, DOI 10.1105/tpc.105.037010; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Rider SD, 2004, PLANTA, V219, P489, DOI 10.1007/s00425-004-1254-1; Rider SD, 2003, PLANT J, V35, P33, DOI 10.1046/j.1365-313X.2003.01783.x; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sheldon CC, 2006, PLANT J, V45, P871, DOI 10.1111/j.1365-313X.2006.02652.x; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsukagoshi H, 2005, PLANT PHYSIOL, V138, P675, DOI 10.1104/pp.104.057752; Tsukagoshi H, 2007, P NATL ACAD SCI USA, V104, P2543, DOI 10.1073/pnas.0607940104; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	63	105	111	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22637	22648		10.1074/jbc.M802129200	http://dx.doi.org/10.1074/jbc.M802129200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18539592	Green Published, hybrid			2022-12-27	WOS:000258321000033
J	Desai, R; Kronengold, J; Mei, J; Forman, SA; Kaczmarek, LK				Desai, Rooma; Kronengold, Jack; Mei, Jianfeng; Forman, Stuart A.; Kaczmarek, Leonard K.			Protein kinase C modulates inactivation of Kv3.3 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THRESHOLD POTASSIUM CHANNEL; AUDITORY NEURONS; TRAPEZOID BODY; MEDIAL NUCLEUS; MOUSE-BRAIN; PHOSPHORYLATION; LOCALIZATION; SUBUNITS; CELLS; ORGANIZATION	Modulation of some Kv3 family potassium channels by protein kinase C (PKC) regulates their amplitude and kinetics and adjusts firing patterns of auditory neurons in response to stimulation. Nevertheless, little is known about the modulation of Kv3.3, a channel that is widely expressed throughout the nervous system and is the dominant Kv3 family member in auditory brainstem. We have cloned the cDNA for the Kv3.3 channel from mouse brain and have expressed it in a mammalian cell line and in Xenopus oocytes to characterize its biophysical properties and modulation by PKC. Kv3.3 currents activate at positive voltages and undergo inactivation with time constants of 150-250 ms. Activators of PKC increased current amplitude and removed inactivation of Kv3.3 currents, and a specific PKC pseudosubstrate inhibitor peptide prevented the effects of the activators. Elimination of the first 78 amino acids of the N terminus of Kv3.3 produced noninactivating currents suggesting that PKC modulates N-type inactivation, potentially by phosphorylation of sites in this region. To identify potential phosphorylation sites, we investigated the response of channels in which serines in this N-terminal domain were subjected to mutagenesis. Our results suggest that serines at positions 3 and 9 are potential PKC phosphorylation sites. Computer simulations of model neurons suggest that phosphorylation of Kv3.3 by PKC may allow neurons to maintain action potential height during stimulation at high frequencies, and may therefore contribute to stimulus-induced changes in the intrinsic excitability of neurons such as those of the auditory brainstem.	[Desai, Rooma; Kronengold, Jack; Mei, Jianfeng; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Desai, Rooma; Forman, Stuart A.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA	Yale University; Yale University; Harvard University; Massachusetts General Hospital	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	leonard.kaczmarek@yale.edu	Forman, Stuart/Q-6590-2019	Forman, Stuart/0000-0001-6340-2478	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-01919] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; BROWNELL WE, 1975, BRAIN RES, V94, P413, DOI 10.1016/0006-8993(75)90226-7; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; DESAI R, 2005, SOC NEUR ABSTR, V846, P2; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fernandez FR, 2003, J BIOL CHEM, V278, P40890, DOI 10.1074/jbc.M304235200; Forman SA, 1997, BIOPHYS J, V72, P2170, DOI 10.1016/S0006-3495(97)78860-X; Frohman Michael A., 1995, P381; GHANSHANI S, 1992, GENOMICS, V12, P190, DOI 10.1016/0888-7543(92)90365-Y; GOLDMANWOHL DS, 1994, J NEUROSCI, V14, P511; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Kaczmarek LK, 2005, HEARING RES, V206, P133, DOI 10.1016/j.heares.2004.11.023; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Li W, 2001, J COMP NEUROL, V437, P196, DOI 10.1002/cne.1279; Liu SQJ, 1998, J NEUROSCI, V18, P8758; Lorenzo PS, 1997, J BIOL CHEM, V272, P33338, DOI 10.1074/jbc.272.52.33338; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; Macica CM, 2001, J NEUROSCI, V21, P1160; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; MORENO H, 1995, J NEUROSCI, V15, P5486; Perney TM, 1997, J COMP NEUROL, V386, P178; Rae JL, 2000, EXP EYE RES, V70, P339, DOI 10.1006/exer.1999.0796; Richardson FC, 2000, HEARING RES, V147, P21, DOI 10.1016/S0378-5955(00)00117-9; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; WU SH, 1993, HEARING RES, V68, P189, DOI 10.1016/0378-5955(93)90123-I; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	39	30	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22283	22294		10.1074/jbc.M801663200	http://dx.doi.org/10.1074/jbc.M801663200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18539595	Green Published, hybrid			2022-12-27	WOS:000258114700047
J	Piens, K; Faure, R; Sundqvist, G; Baumann, MJ; Saura-Valls, M; Teeri, TT; Cottaz, S; Planas, A; Driguez, H; Brumer, H				Piens, Kathleen; Faure, Regis; Sundqvist, Gustav; Baumann, Martin J.; Saura-Valls, Marc; Teeri, Tuula T.; Cottaz, Sylvain; Planas, Antoni; Driguez, Hugues; Brumer, Harry			Mechanism-based labeling defines the free energy change for formation of the covalent glycosyl-enzyme intermediate in a xyloglucan endo-transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL WALL COMPOSITION; ACTIVE-SITE; CRYSTAL-STRUCTURES; BACILLUS-SUBTILIS; ENDOTRANSGLYCOSYLASE; EVOLUTION; IDENTIFICATION; OLIGOSACCHARIDES; LEVANSUCRASE; NUCLEOPHILE	Xyloglucan endo-transglycosylases (XETs) are key enzymes involved in the restructuring of plant cell walls during morphogenesis. As members of glycoside hydrolase family 16 (GH16), XETs are predicted to employ the canonical retaining mechanism of glycosyl transfer involving a covalent glycosyl-enzyme intermediate. Here, we report the accumulation and direct observation of such intermediates of PttXET16-34 from hybrid aspen by electrospray mass spectrometry in combination with synthetic "blocked" substrates, which function as glycosyl donors but are incapable of acting as glycosyl acceptors. Thus, GalGXXXGGG and GalGXXXGXXXG react with the wild-type enzyme to yield relatively stable, kinetically competent, covalent GalG-enzyme and GalGXXXG-enzyme complexes, respectively (Gal = Gal beta(1 -> 4), G = Glc beta(1 -> 4), and X = Xyl alpha(1 -> 6) Glc beta(1 -> 4)). Quantitation of ratios of protein and saccharide species at pseudo-equilibrium allowed us to estimate the free energy change (Delta G(0)) for the formation of the covalent GalGXXXG-enzyme as 6.3-8.5 kJ/mol (1.5-2.0 kcal/mol). The data indicate that the free energy of the beta(1 -> 4) glucosidic bond in xyloglucans is preserved in the glycosyl-enzyme intermediate and harnessed for religation of the polysaccharide in vivo.	[Piens, Kathleen; Sundqvist, Gustav; Baumann, Martin J.; Teeri, Tuula T.; Brumer, Harry] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden; [Faure, Regis; Cottaz, Sylvain; Driguez, Hugues] CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France; [Saura-Valls, Marc; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain	Royal Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universitat Ramon Llull; Institut Quimic de Sarria	Brumer, H (corresponding author), AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden.	harry@biotech.kth.se	PLANAS, ANTONI/I-4803-2015; Fauré, Régis/ABB-4847-2021; Teeri, Tuula T/E-7509-2013	PLANAS, ANTONI/0000-0001-7073-3320; Fauré, Régis/0000-0002-5107-9009; cottaz, sylvain/0000-0001-8674-0162				Baran R, 2000, GEN PHYSIOL BIOPHYS, V19, P427; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Braun C, 1996, BIOCHEMISTRY-US, V35, P5458, DOI 10.1021/bi9526488; CHAMBERT R, 1976, EUR J BIOCHEM, V71, P493, DOI 10.1111/j.1432-1033.1976.tb11138.x; CHAMBERT R, 1976, EUR J BIOCHEM, V62, P55, DOI 10.1111/j.1432-1033.1976.tb10097.x; Faure R, 2006, J ORG CHEM, V71, P5151, DOI 10.1021/jo0525682; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Henriksson H, 2003, BIOCHEM J, V375, P61, DOI 10.1042/BJ20030485; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hoffman M, 2005, CARBOHYD RES, V340, P1826, DOI 10.1016/j.carres.2005.04.016; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Kallas AM, 2005, BIOCHEM J, V390, P105, DOI 10.1042/BJ20041749; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Krishnan S, 1995, BIOCHEM J, V312, P971, DOI 10.1042/bj3120971; Martinez-Fleites C, 2006, J BIOL CHEM, V281, P24922, DOI 10.1074/jbc.M603583200; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Mosi R, 1997, BIOCHEMISTRY-US, V36, P9927, DOI 10.1021/bi970618u; Mosi RM, 2002, METHOD ENZYMOL, V354, P64; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Nishikubo N, 2007, PLANT CELL PHYSIOL, V48, P843, DOI 10.1093/pcp/pcm055; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; Nothnagel AL, 2007, J INTEGR PLANT BIOL, V49, P1271, DOI 10.1111/j.1672-9072.2007.00519.x; Piens K, 2007, ORG BIOMOL CHEM, V5, P3971, DOI 10.1039/b714570e; Popper ZA, 2004, NEW PHYTOL, V164, P165, DOI 10.1111/j.1469-8137.2004.01146.x; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Saura-Valls M, 2006, BIOCHEM J, V395, P99, DOI 10.1042/BJ20051396; Saura-Valls M, 2008, J BIOL CHEM, V283, P21853, DOI 10.1074/jbc.M803058200; SILVERSTEIN R, 1967, J BIOL CHEM, V242, P1338; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulova Z, 1998, BIOCHEM J, V330, P1475, DOI 10.1042/bj3301475; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wicki J, 2002, METHOD ENZYMOL, V354, P84; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Yoon SH, 2007, CARBOHYD RES, V342, P55, DOI 10.1016/j.carres.2006.10.028; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	40	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21864	21872		10.1074/jbc.M803057200	http://dx.doi.org/10.1074/jbc.M803057200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508770	hybrid			2022-12-27	WOS:000258114700005
J	Ugolev, Y; Berdichevsky, Y; Weinbaum, C; Pick, E				Ugolev, Yelena; Berdichevsky, Yevgeny; Weinbaum, Carolyn; Pick, Edgar			Dissociation of Rac1(GDP)center dot RhoGDI complexes by the cooperative action of anionic liposomes containing phosphatidylinositol 3,4,5-trisphosphate, rac guanine nucleotide exchange factor, and GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH-OXIDASE ACTIVATION; CELL-FREE SYSTEM; DEPENDENT SUPEROXIDE PRODUCTION; PLECKSTRIN HOMOLOGY DOMAINS; RESPIRATORY BURST OXIDASE; SODIUM DODECYL-SULFATE; BETA-GAMMA-SUBUNITS; MEMBRANE TRANSLOCATION; RHO-GTPASES; PHOSPHOINOSITIDE 3-KINASE	Rac plays a pivotal role in the assembly of the superoxide-generating NADPH oxidase of phagocytes. In resting cells, Rac is found in the cytosol in complex with Rho GDP dissociation inhibitor (RhoGDI). NADPH oxidase assembly involves dissociation of the Rac center dot RhoGDI complex and translocation of Rac to the membrane. We reported that liposomes containing high concentrations of monovalent anionic phospholipids cause Rac center dot RhoGDI complex dissociation (Ugolev, Y., MolshanskiMor, S., Weinbaum, C., and Pick, E. (2006) J. Biol. Chem. 281, 19204 - 19219). We now designed an in vitro model mimicking membrane phospholipid remodeling during phagocyte stimulation in vivo. We showed that liposomes of "resting cell membrane" composition (less than 20 mol % monovalent anionic phospholipids), supplemented with 1 mol % of polyvalent anionic phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) in conjunction with constitutively active forms of the guanine nucleotide exchange factors (GEFs) for Rac, Trio, or Tiam1 and a non-hydrolyzable GTP analogue, cause dissociation of Rac1(GDP)center dot RhoGDI complexes, GDP to GTP exchange on Rac1, and binding of Rac1(GTP) to the liposomes. Complexes were not dissociated in the absence of GEF and GTP, and optimal dissociation required the presence of PtdIns(3,4,5) P-3 in the liposomes. Dissociation of Rac1(GDP)center dot RhoGDI complexes was correlated with the affinity of particular GEF constructs, via the N-terminal pleckstrin homology domain, for PtdIns(3,4,5) P-3 and involved GEF-mediated GDP to GTP exchange on Rac1. Phagocyte membranes enriched in PtdIns(3,4,5) P-3 responded by NADPH oxidase activation upon exposure in vitro to Rac1(GDP)center dot RhoGDI complexes, p67(phox), GTP, and Rac GEF constructs with affinity for PtdIns( 3,4,5) P3 at a level superior to that of native membranes.	[Pick, Edgar] Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, Julius Friedrich Cohnheim Minerva Ctr Phagocyte R, IL-69978 Tel Aviv, Israel; [Ugolev, Yelena; Berdichevsky, Yevgeny; Pick, Edgar] Tel Aviv Univ, Sackler Sch Med, Ela Kodesz Inst Host Def Infect Dis, IL-69978 Tel Aviv, Israel; [Weinbaum, Carolyn] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Duke University	Pick, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, Julius Friedrich Cohnheim Minerva Ctr Phagocyte R, IL-69978 Tel Aviv, Israel.	epick@post.tau.ac.il	Pick, Edgar/B-1795-2008	Pick, Edgar/0000-0003-4625-3233; Berdichevsky, Yevgeny/0000-0002-5038-6816	NIGMS NIH HHS [GM46372] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABO A, 1991, J BIOL CHEM, V266, P23577; ABO A, 1994, BIOCHEM J, V298, P585, DOI 10.1042/bj2980585; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Faure J, 1999, EUR J BIOCHEM, V262, P879, DOI 10.1046/j.1432-1327.1999.00458.x; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Gorzalczany Y, 2002, J BIOL CHEM, V277, P18605, DOI 10.1074/jbc.M202114200; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; JOSEPH G, 1994, J BIOL CHEM, V269, P29024; JOUAN A, 1993, ANAL BIOCHEM, V214, P252, DOI 10.1006/abio.1993.1485; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; MASON RJ, 1972, J CLIN INVEST, V51, P2399, DOI 10.1172/JCI107052; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Missy K, 1998, J BIOL CHEM, V273, P30279, DOI 10.1074/jbc.273.46.30279; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Molshanski-Mor Shahar, 2007, V412, P385, DOI 10.1007/978-1-59745-467-4_25; Muroya K, 2007, BIOCHEM BIOPH RES CO, V355, P85, DOI 10.1016/j.bbrc.2007.01.131; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Pechlivanis M, 2007, BIOCHEMISTRY-US, V46, P5341, DOI 10.1021/bi602353k; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; PICK E, 1993, EUR J BIOCHEM, V217, P441, DOI 10.1111/j.1432-1033.1993.tb18264.x; PICK E, 1987, J BIOL CHEM, V262, P16476; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Quinn Peter J, 2002, Subcell Biochem, V36, P39; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; SASAKI T, 1993, J BIOL CHEM, V268, P23959; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; Sigal N, 2003, INFLAMMATION, V27, P147, DOI 10.1023/A:1023869828688; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Ueyama T, 2005, J IMMUNOL, V175, P2381, DOI 10.4049/jimmunol.175.4.2381; Ugolev Y, 2006, J BIOL CHEM, V281, P19204, DOI 10.1074/jbc.M600042200; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	67	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22257	22271		10.1074/jbc.M800734200	http://dx.doi.org/10.1074/jbc.M800734200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18505730	hybrid, Green Published			2022-12-27	WOS:000258114700045
J	Aqeilan, RI; Hassan, MQ; de Bruin, A; Hagan, JP; Volinia, S; Palumbo, T; Hussain, S; Lee, SH; Gaur, T; Stein, GS; Lian, JB; Croce, CM				Aqeilan, Rami I.; Hassan, Mohammad Q.; de Bruin, Alain; Hagan, John P.; Volinia, Stefano; Palumbo, Titziana; Hussain, Sadiq; Lee, Suk-Hee; Gaur, Tripti; Stein, Gary S.; Lian, Jane B.; Croce, Carlo M.			The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; TRANSCRIPTION FACTOR; BREAST-CANCER; GROWTH; DIFFERENTIATION; PROTEIN; RUNX2; GENE; BINDING; MICE	The WW domain-containing oxidoreductase ( WWOX) gene encodes a tumor suppressor. We have previously shown that targeted ablation of the Wwox gene in mouse increases the incidence of spontaneous and chemically induced tumors. To investigate WWOX function in vivo, we examined Wwox-deficient (Wwox(-/-)) mice for phenotypical abnormalities. Wwox(-/-) mice are significantly reduced in size, die at the age of 2-3 weeks, and suffer a metabolic disorder that affects the skeleton. Wwox(-/-) mice exhibit a delay in bone formation from a cell autonomous defect in differentiation beginning at the mineralization stage shown in calvarial osteoblasts ex vivo and supported by significantly decreased bone formation parameters in Wwox(-/-) mice by microcomputed tomography analyses. Wwox(-/-) mice develop metabolic bone disease, as a consequence of reduced serum calcium, hypoproteinuria, and hypoglycemia leading to increased osteoclast activity and bone resorption. Interestingly, we find WWOX physically associates with RUNX2, the principal transcriptional regulator of osteoblast differentiation, and on osteocalcin chromatin. We show WWOX functionally suppresses RUNX2 transactivation ability in osteoblasts. In breast cancer MDA-MB-242 cells that lack endogenous WWOX protein, restoration of WWOX expression inhibited Runx2 and RUNX2 target genes related to metastasis. Affymetrix mRNA profiling revealed common gene targets in multiple tissues. In Wwox(-/-) mice, genes related to nucleosome assembly and cell growth genes were down-regulated, and negative regulators of skeletal metabolism exhibited increased expression. Our results demonstrate an essential requirement for the WWOX tumor suppressor in postnatal survival, growth, and metabolism and suggest a central role for WWOX in regulation of bone tissue formation.	[Aqeilan, Rami I.; de Bruin, Alain; Hagan, John P.; Volinia, Stefano; Palumbo, Titziana; Croce, Carlo M.] Ohio State Univ, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Aqeilan, Rami I.; de Bruin, Alain; Hagan, John P.; Volinia, Stefano; Palumbo, Titziana; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Hassan, Mohammad Q.; Hussain, Sadiq; Lee, Suk-Hee; Gaur, Tripti; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Hassan, Mohammad Q.; Hussain, Sadiq; Lee, Suk-Hee; Gaur, Tripti; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Aqeilan, RI (corresponding author), Ohio State Univ, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Biomed Res Tower,Rm 1088,460 W 12th Ave, Columbus, OH 43210 USA.	rami.aqeilan@osumc.edu; jane.lian@umassmed.edu	Young, Richard A/F-6495-2012; Volinia, Stefano/AAA-9264-2019; Aqeilan, Rami/AAT-7785-2020; Aqeilan, Rami/R-4443-2016; Volinia, Stefano/A-3029-2010; de Bruin, Alain/AAL-9195-2020; Hassan, Mohammad/GZA-7507-2022	Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Aqeilan, Rami/0000-0002-6034-023X; Volinia, Stefano/0000-0003-0910-3893; Hassan, Mohammad/0000-0002-1712-0004; Hagan, John/0000-0003-0295-4898; de Bruin, Alain/0000-0001-8579-2649	NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048818] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA 082834] Funding Source: Medline; NIAMS NIH HHS [P01 AR048818, P01 AR 048818] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bassett JHD, 2003, TRENDS ENDOCRIN MET, V14, P356, DOI 10.1016/S1043-2760(03)00144-90; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarek AK, 2001, CANCER RES, V61, P8068; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; CENTRELLA M, 1992, J CLIN INVEST, V89, P1076, DOI 10.1172/JCI115687; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Gaudio E, 2006, CANCER RES, V66, P11585, DOI 10.1158/0008-5472.CAN-06-3376; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Javed A, 1999, MOL CELL BIOL, V19, P7491; Javed A, 2005, P NATL ACAD SCI USA, V102, P1454, DOI 10.1073/pnas.0409121102; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Leger J, 2007, EUR J ENDOCRINOL, V157, P685, DOI 10.1530/EJE-07-0402; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Ludes-Meyers JH, 2007, GENE CHROMOSOME CANC, V46, P1129, DOI 10.1002/gcc.20497; McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pratap J, 2003, CANCER RES, V63, P5357; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Silha JV, 2003, J BONE MINER RES, V18, P1834, DOI 10.1359/jbmr.2003.18.10.1834; Sulzbacher I, 2003, MODERN PATHOL, V16, P66, DOI 10.1097/01.MP.0000043522.76788.0A; Sun L, 2006, ANN NY ACAD SCI, V1068, P309, DOI 10.1196/annals.1346.033; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	41	103	105	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21629	21639		10.1074/jbc.M800855200	http://dx.doi.org/10.1074/jbc.M800855200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18487609	Green Published, hybrid			2022-12-27	WOS:000257898800036
J	Fila, C; Metz, C; van der Sluijs, P				Fila, Claudia; Metz, Corina; van der Sluijs, Peter			Juglone inactivates cysteine-rich proteins required for progression through mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL ISOMERASE PIN1; DEPENDENT PROLINE ISOMERIZATION; CELL-CYCLE; CIS/TRANS ISOMERASES; PHOSPHORYLATION; INHIBITION; DEPHOSPHORYLATION; CHECKPOINT; TUBULIN; KINASE	The parvulin peptidyl-prolyl isomerase Pin1 catalyzes cis-trans isomerization of p(S/T)-P bonds and might alter conformation and function of client proteins. Since the trans conformation of p(S/T)-P bonds is preferred by protein phosphatase 2A (PP2A), Pin1 may facilitate PP2A-mediated dephosphorylation. Juglone irreversibly inhibits parvulins and is often used to study the function of Pin1 in vivo. The drug prevents dephosphorylation of mitotic phosphoproteins, perhaps because they bind Pin1 and are dephosphorylated by PP2A. We show here however that juglone inhibited post-mitotic dephosphorylation and the exit of mitosis, independent of Pin1. This effect involved covalent modification of sulfhydryl groups in proteins essential for metaphase/anaphase transition. Particularly cytoplasmic proteins with a high cysteine content were vulnerable to the drug. Alkylation of sulfhydryl groups altered the conformation of such proteins, as evidenced by the disappearance of antibody epitopes on tubulin and the mitotic checkpoint component BubR1. The latter activates the anaphase-promoting complex/cyclosome, which degrades regulatory proteins, such as cyclin B1 and securins, and is required for mitotic exit. Indeed, juglone-treated cells failed to assemble a mitotic spindle, which correlated with perturbed microtubule dynamics, loss of immunodetectable tubulin, and formation of tubulin aggregates. Juglone also prevented degradation of cyclin B1, independently of the Mps1-controlled mitotic spindle checkpoint. Since juglone affected cell cycle progression at several levels, more specific drugs need to be developed for studies of Pin1 function in vivo.	[Fila, Claudia; Metz, Corina; van der Sluijs, Peter] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van der Sluijs, P (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, AZU G02-525,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	p.vandersluijs@umcutrecht.nl						Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Albert AL, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-22; BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Daum S, 2006, ANGEW CHEM INT EDIT, V45, P7454, DOI 10.1002/anie.200601569; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Esnault S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000226; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; FREW T, 1995, ANTI-CANCER DRUG DES, V10, P347; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Gerez L, 2000, MOL BIOL CELL, V11, P2201, DOI 10.1091/mbc.11.7.2201; He JQ, 2003, ONCOGENE, V22, P4524, DOI 10.1038/sj.onc.1206767; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kamei H, 1998, CANCER BIOTHER RADIO, V13, P185, DOI 10.1089/cbr.1998.13.185; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; KURIYAMA R, 1974, J BIOCHEM-TOKYO, V76, P651, DOI 10.1093/oxfordjournals.jbchem.a130609; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; MUTO N, 1987, BIOCHEM BIOPH RES CO, V146, P487, DOI 10.1016/0006-291X(87)90555-9; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Paulsen MT, 2005, TOXICOL APPL PHARM, V209, P1, DOI 10.1016/j.taap.2005.03.005; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pfeiffer E, 1996, CHEM-BIOL INTERACT, V102, P37, DOI 10.1016/0009-2797(96)03730-1; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rippmann JF, 2000, CELL GROWTH DIFFER, V11, P409; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Santa-Maria I, 2005, BBA-MOL BASIS DIS, V1740, P472, DOI 10.1016/j.bbadis.2004.11.024; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Stockwell BR, 1999, CHEM BIOL, V6, P71, DOI 10.1016/S1074-5521(99)80004-0; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; VANDERSLUIJS P, 1992, EMBO J, V11, P4379, DOI 10.1002/j.1460-2075.1992.tb05538.x; Varga Z, 1996, BIOCHEM BIOPH RES CO, V218, P828, DOI 10.1006/bbrc.1996.0147; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	55	46	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21714	21724		10.1074/jbc.M710264200	http://dx.doi.org/10.1074/jbc.M710264200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539601	hybrid			2022-12-27	WOS:000257898800045
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.			Binding of guanylyl cyclase activating protein 1 (GCAP1) to retinal guanylyl cyclase (RetGC1) - The role of individual EF-hands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CALCIUM-SENSOR; ALPHA SUBUNITS; OUTER SEGMENTS; DEGENERATION; VERTEBRATE; RODS; DOMAIN; CA2+; PHOTORECEPTORS	Guanylyl cyclase activating protein 1 (GCAP1), after substitution of Ca2+ by Mg2+ in its EF-hands, stimulates photoreceptor guanylyl cyclase, RetGC1, in response to light. We inactivated metal binding in individual EF-hands of GCAP1 tagged with green fluorescent protein to assess their role in GCAP1 binding to RetGC1 in co-transfected HEK293 cells. When expressed alone, GCAP1 was uniformly distributed throughout the cytoplasm and the nuclei of the cells, but when co-expressed with either fluorescently tagged or non-tagged RetGC1, it co-localized with the cyclase in the membranes. The co-localization did not occur when the C-terminal portion of RetGC1, containing its regulatory and catalytic domains, was removed. Mutations that preserved Mg2+ binding in all three metal-binding EF-hands did not affect GCAP1 association with the cyclase in live cells. Locking EF-hand 4 in its apo-conformation, incapable of binding either Ca2+ or Mg2+, had no effect on GCAP1 association with the cyclase. In contrast to EF-hand 4, inactivation of EF-hand 3 reduced the efficiency of the co-localization, and inactivation of EF-hand 2 drastically suppressed GCAP1 binding to the cyclase. These results directly demonstrate that metal binding in EF-hand 2 is crucial for GCAP1 attachment to RetGC1, and that in EF-hand 3 it is less critical, although it enhances the efficiency of the GCAP1 docking on the target enzyme. Metal binding in EF-hand 4 has no role in the primary attachment of GCAP1 to the cyclase, and it only triggers the activator-to-inhibitor functional switch in GCAP1.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Penn Coll Optometry, Hafter Res Labs, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Penn Coll Optometry, Hafter Res Labs, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@pco.edu		Dizhoor, Alexander/0000-0001-6770-9186	NEI NIH HHS [EY 11522] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1999, METHODS, V19, P521, DOI 10.1006/meth.1999.0894; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; DURONIO RJ, 1991, J BIOL CHEM, V266, P10498; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Krylov DM, 1999, J BIOL CHEM, V274, P10833, DOI 10.1074/jbc.274.16.10833; Lange C, 1999, FEBS LETT, V460, P27, DOI 10.1016/S0014-5793(99)01312-5; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Mountjoy KG, 2001, PHYSIOL GENOMICS, V5, P11, DOI 10.1152/physiolgenomics.2001.5.1.11; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Olshevskaya EV, 2002, MOL CELL BIOCHEM, V230, P139, DOI 10.1023/A:1014248208584; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Quitterer U, 2001, J BIOL CHEM, V276, P6763, DOI 10.1074/jbc.M007727200; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Vogel A, 2007, BBA-BIOMEMBRANES, V1768, P3171, DOI 10.1016/j.bbamem.2007.08.024; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547	43	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21747	21757		10.1074/jbc.M801899200	http://dx.doi.org/10.1074/jbc.M801899200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18541533	Green Published, hybrid			2022-12-27	WOS:000257898800048
J	Yang, LL; Wang, SX; Sung, B; Lim, G; Mao, JR				Yang, Liling; Wang, Shuxing; Sung, Backil; Lim, Grewo; Mao, Jianren			Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C6 GLIOMA-CELLS; ABNORMAL PAIN SENSITIVITY; SURFACE EXPRESSION; RECEPTOR ANTAGONIST; GLIOBLASTOMA CELLS; NEUROPATHIC PAIN; LIGASE NEDD4-2; BETA-ARRESTIN; PTEN; TOLERANCE	Glutamate transporters play a crucial role in physiological glutamate homeostasis, neurotoxicity, and glutamatergic regulation of opioid tolerance. However, how the glutamate transporter turnover is regulated remains poorly understood. Here we show that chronic morphine exposure induced posttranscriptional down-regulation of the glutamate transporter EAAC1 in C6 glioma cells with a concurrent decrease in glutamate uptake and increase in proteasome activity, which were blocked by the selective proteasome inhibitor MG-132 or lactacystin but not the lysosomal inhibitor chloroquin. At the cellular level, chronic morphine induced the PTEN (phosphatase and tensin homolog deleted on chromosome Ten)-mediated up-regulation of the ubiquitin E3 ligase Nedd4 via cAMP/protein kinase A signaling, leading to EAAC1 ubiquitination and proteasomal degradation. Either Nedd4 or PTEN knockdown with small interfering RNA prevented the morphine-induced EAAC1 degradation and decreased glutamate uptake. These data indicate that cAMP/protein kinase A signaling serves as an intracellular regulator upstream to the activation of the PTEN/Nedd4-mediated ubiquitin-proteasome system activity that is critical for glutamate transporter turnover. Under an in vivo condition, chronic morphine exposure also induced posttranscriptional down-regulation of the glutamate transporter EAAC1, which was prevented by MG-132, and transcriptional up-regulation of PTEN and Nedd4 within the spinal cord dorsal horn. Thus, inhibition of the ubiquitin-proteasome-mediated glutamate transporter degradation may be an important mechanism for preventing glutamate overexcitation and may offer a new strategy for treating certain neurological disorders and improving opioid therapy in chronic pain management.	[Yang, Liling; Wang, Shuxing; Sung, Backil; Lim, Grewo; Mao, Jianren] Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Massachusetts Gen Hosp,MGH Ctr Translat Pain Res, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Mao, JR (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Massachusetts Gen Hosp,MGH Ctr Translat Pain Res, WACC 324,15 Parkman St, Boston, MA 02114 USA.	jmao@partners.org			NIDA NIH HHS [R01 DA 08835] Funding Source: Medline; NINDS NIH HHS [NS 45681, NS 42661] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045681, R01NS042661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008835] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 1998, J NEUROCHEM, V70, P1819; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Davis KE, 1998, J NEUROSCI, V18, P2475; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Gegelashvili G, 2001, Prog Brain Res, V132, P267; Gintzler AR, 2000, MOL NEUROBIOL, V21, P21, DOI 10.1385/MN:21:1-2:021; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ingram SL, 1998, J NEUROSCI, V18, P10269; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Joazeiro CAP, 2000, SCIENCE, V289, P2061, DOI 10.1126/science.289.5487.2061; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lievens JC, 2000, GLIA, V29, P222, DOI 10.1002/(SICI)1098-1136(20000201)29:3<222::AID-GLIA4>3.0.CO;2-0; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; MAO J, 1994, J NEUROSCI, V14, P2301; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Mao JR, 2002, J NEUROSCI, V22, P8312; Mao JR, 2002, J NEUROSCI, V22, P7650; Mennerick S, 1999, J NEUROSCI, V19, P9242; Mitrovic AD, 1999, NEUROCHEM INT, V34, P101, DOI 10.1016/S0197-0186(98)00066-7; Morrison SJ, 2002, NAT MED, V8, P16, DOI 10.1038/nm0102-16; Moss A, 2002, J NEUROSCI, V22, P1363, DOI 10.1523/JNEUROSCI.22-04-01363.2002; Musatov S, 2004, P NATL ACAD SCI USA, V101, P3627, DOI 10.1073/pnas.0308289101; Nakagawa T, 2001, EUR J PHARMACOL, V419, P39, DOI 10.1016/S0014-2999(01)00965-7; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Palos TP, 1996, MOL BRAIN RES, V37, P297, DOI 10.1016/0169-328X(95)00331-L; Park MJ, 2002, CANCER RES, V62, P6318; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Rolfe M, 1997, J MOL MED-JMM, V75, P5, DOI 10.1007/s001090050081; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sung BK, 2003, J NEUROSCI, V23, P2899; Thomson LM, 2006, NEUROSCI LETT, V407, P64, DOI 10.1016/j.neulet.2006.08.004; TISEO PJ, 1993, J PHARMACOL EXP THER, V264, P1090; Tolkacheva T, 2001, CANCER RES, V61, P4985; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Trotti D, 2002, ADV EXP MED BIOL, V513, P225; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Vorwerk CK, 2000, INVEST OPHTH VIS SCI, V41, P3615; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Wojcik C, 2004, STROKE, V35, P1506, DOI 10.1161/01.STR.0000126891.93919.4e; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yang WB, 2002, J BIOL CHEM, V277, P38350, DOI 10.1074/jbc.M202052200	60	40	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21703	21713		10.1074/jbc.M800809200	http://dx.doi.org/10.1074/jbc.M800809200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18539596	Green Published, hybrid			2022-12-27	WOS:000257898800044
J	Yao, J; Bajjalieh, SM				Yao, Jia; Bajjalieh, Sandra M.			Synaptic vesicle protein 2 binds adenine nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR-TRANSPORT REGULATION; SUBSTRATE RECOGNITION; IDENTIFICATION; SV2; DETERMINANTS; SUPERFAMILY; RESIDUES; SEQUENCE	Synaptic vesicle protein 2 (SV2) is required for normal calcium-regulated secretion of hormones and neurotransmitters. Neurons lacking the two most widely expressed isoforms, SV2A and SV2B, have a reduced readily releasable pool of synaptic vesicles, indicating that SV2 contributes to vesicle priming. The presence of putative ATP-binding sites in SV2 suggested that SV2 might be an ATP-binding protein. To explore this, we examined the binding of the photoaffinity reagent 8-azidoATP[gamma] biotin to purified, recombinant SV2 in the presence and absence of other nucleotides. Our results indicate that SV2A and SV2B bind nucleotides, with the highest affinity for adenine-containing nucleotides. SV2A contains two binding sites located in the cytoplasmic domains preceding the first and seventh transmembrane domains. These results suggest that SV2-mediated vesicle priming could be regulated by adenine nucleotides, which might provide a link between cellular energy levels and regulated secretion.	[Yao, Jia; Bajjalieh, Sandra M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bajjalieh, SM (corresponding author), Univ Washington, Dept Pharmacol, 1959 NE Pacific St,Box 357750, Seattle, WA 98195 USA.	bajjalie@u.washington.edu	Yao, Jia/E-8711-2011; Yao, Jia/D-3484-2009	Yao, Jia/0000-0003-3235-5351	NIMH NIH HHS [R01 MH 059842] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059842] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; BUCKLEY KM, 1987, J CELL BIOL, V105, P2447, DOI 10.1083/jcb.105.6.2447; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; CARRUTHERS A, 1989, BIOCHEMISTRY-US, V28, P8337, DOI 10.1021/bi00447a011; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kim MH, 2000, J BIOL CHEM, V275, P6175, DOI 10.1074/jbc.275.9.6175; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Levine KB, 1998, BIOCHEMISTRY-US, V37, P12221, DOI 10.1021/bi980585y; Lezzi M, 2005, J CELL SCI, V118, P5647, DOI 10.1242/jcs.02658; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PETER D, 1994, J BIOL CHEM, V269, P7231; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000	29	31	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20628	20634		10.1074/jbc.M800738200	http://dx.doi.org/10.1074/jbc.M800738200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18524768	Green Published, hybrid			2022-12-27	WOS:000257746100003
J	Helmerhorst, EJ; Sun, XL; Salih, E; Oppenheim, FG				Helmerhorst, Eva J.; Sun, Xiuli; Salih, Erdjan; Oppenheim, Frank G.			Identification of Lys-Pro-Gln as a novel cleavage site specificity of saliva-associated proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-RICH PROTEINS; HUMAN PAROTID SALIVA; ENZYMATIC CHARACTERIZATION; DISC ELECTROPHORESIS; STREPTOCOCCUS-MUTANS; NUCLEOTIDE-SEQUENCE; ENAMEL PELLICLE; GENE FAMILY; P-B; CLONING	The nonsterile environment of the oral cavity facilitates substantial proteolytic processing, not only of resident salivary proteins but also of dietary proteins. To gain insight into whole saliva enzymatic processes, the in vivo generated peptides in this oral fluid were subjected to nano-flow liquid chromatography electrospray ionization tandem mass spectrometry. The 182 peptides identified were predominantly derived from acidic and basic proline-rich proteins, statherin, and histatins. The proteolytic cleavages in the basic proline-rich proteins occurred preferentially after a Gln residue with predominant specificity for the tripeptide Xaa-Pro-Gln, where Xaa in the P-3 position was mostly represented by Lys. Using the synthetic substrates Lys-Pro-Gln-pNA and Gly-Gly-Gln-pNA, the overall K-m values were determined to be 97 +/- 7.7 and 611 +/- 28 mu M, respectively, confirming glutamine endoprotease activity in whole saliva and the influence of the amino acids in positions P-2 and P-3 on protease recognition. The pH optimum of Lys-Pro-Gln-pNA hydrolysis was 7.0, and the activity was most effectively inhibited by antipain and 4-(2-aminoethyl) benzenesulfonyl fluoride, was metal ion-dependent, and not inhibited by cysteine protease inhibitors. Asystematic evaluation of enzyme activities in various exocrine and nonexocrine contributors to whole saliva revealed that the glutamine endoprotease is derived from dental plaque and likely microbial in origin. The P-1 site being occupied by a Gln residue is a nonarchetype with respect to known proteases and indicates the presence of novel glutamine-specific endoprotease(s) in oral fluid.	[Helmerhorst, Eva J.; Sun, Xiuli; Salih, Erdjan; Oppenheim, Frank G.] Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA	Boston University	Helmerhorst, EJ (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, 700 Albany St,W-201, Boston, MA 02118 USA.	helmer@bu.edu		Helmerhorst, Eva/0000-0002-4803-3018; Salih, Erdjan/0000-0003-3322-2323	NIAID NIH HHS [R01 AI087803] Funding Source: Medline; NIDCR NIH HHS [DE 07652, DE 18132, DE 05672, DE 16699] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005672, R21DE018132, R03DE016699, R01DE005672] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; ARNEBERG P, 1971, Scandinavian Journal of Dental Research, V79, P60; Azen EA, 1996, AM J HUM GENET, V58, P143; Basak A, 1999, BIOCHEM J, V343, P29, DOI 10.1042/0264-6021:3430029; BAUM BJ, 1977, COMP BIOCHEM PHYS A, V56, P115, DOI 10.1016/0300-9629(77)90171-2; BAUM BJ, 1976, ARCH BIOCHEM BIOPHYS, V177, P427, DOI 10.1016/0003-9861(76)90455-0; BOBEK LA, 1991, BIOCHEM J, V278, P627, DOI 10.1042/bj2780627; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; Chan M, 2001, EUR J BIOCHEM, V268, P3423, DOI 10.1046/j.1432-1327.2001.02241.x; CHAUNCEY HH, 1961, J AM DENT ASSOC, V63, P360, DOI 10.14219/jada.archive.1961.0215; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Dawes C, 2004, CARIES RES, V38, P236, DOI 10.1159/000077760; Desseyn JL, 1997, J BIOL CHEM, V272, P16873, DOI 10.1074/jbc.272.27.16873; Flora B, 2001, PROTEIN EXPRES PURIF, V23, P198, DOI 10.1006/prep.2001.1493; HAY DI, 1988, BIOCHEM J, V255, P15, DOI 10.1042/bj2550015; Hejgaard J, 2005, BIOL CHEM, V386, P1319, DOI 10.1515/BC.2005.150; Helmerhorst EJ, 2007, J DENT RES, V86, P680, DOI 10.1177/154405910708600802; Helmerhorst EJ, 2006, ARCH ORAL BIOL, V51, P1061, DOI 10.1016/j.archoralbio.2006.06.005; Helmerhorst EJ, 2007, ANN NY ACAD SCI, V1098, P454, DOI 10.1196/annals.1384.013; Inzitari R, 2006, PROTEOMICS, V6, P6370, DOI 10.1002/pmic.200600395; Isemura S, 2000, J BIOCHEM-TOKYO, V127, P393, DOI 10.1093/oxfordjournals.jbchem.a022620; Ishihara M, 2002, MICROBIOL IMMUNOL, V46, P299, DOI 10.1111/j.1348-0421.2002.tb02699.x; Li J, 2004, ARCH ORAL BIOL, V49, P379, DOI 10.1016/j.archoralbio.2004.01.002; Li J, 2003, ORAL MICROBIOL IMMUN, V18, P183, DOI 10.1034/j.1399-302X.2003.00065.x; MAEDA N, 1985, J BIOL CHEM, V260, P1123; Makinen K K, 1966, Acta Odontol Scand, V24, P579, DOI 10.3109/00016356609028730; Merrell Karen, 2004, J Biomol Tech, V15, P238; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; MINAGUCHI K, 1988, BIOCHEM J, V250, P171, DOI 10.1042/bj2500171; NISHIDE T, 1986, GENE, V41, P299; OPPENHEIM FG, 1971, BIOCHEMISTRY-US, V10, P4233, DOI 10.1021/bi00799a013; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; PAYNE JB, 1991, ORAL MICROBIOL IMMUN, V6, P169, DOI 10.1111/j.1399-302X.1991.tb00472.x; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; SABATINI LM, 1989, BIOCHEM BIOPH RES CO, V160, P495, DOI 10.1016/0006-291X(89)92460-1; SABATINI LM, 1987, AM J HUM GENET, V41, P1048; SABATINI LM, 1993, MOL BIOL EVOL, V10, P497; SAITOH E, 1991, BIOMED BIOCHIM ACTA, V50, P599; Saitoh E, 1992, Agents Actions Suppl, V38 ( Pt 1), P340; Salih E, 2005, MASS SPECTROM REV, V24, P828, DOI 10.1002/mas.20042; SLOTS J, 1981, J CLIN MICROBIOL, V14, P288, DOI 10.1128/JCM.14.3.288-294.1981; Stubbs M, 1998, ARCH ORAL BIOL, V43, P753, DOI 10.1016/S0003-9969(98)00068-5; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Vora H, 2007, BIOTECHNOL BIOENG, V98, P177, DOI 10.1002/bit.21423; WIKSTROM MB, 1983, APPL ENVIRON MICROB, V45, P393; WONG RSC, 1979, J BIOL CHEM, V254, P4800; WONG RSC, 1980, J BIOL CHEM, V255, P5943	50	50	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19957	19966		10.1074/jbc.M708282200	http://dx.doi.org/10.1074/jbc.M708282200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18463091	hybrid, Green Published			2022-12-27	WOS:000257565300011
J	Kaminski, PA; Dacher, P; Dugue, L; Pochet, S				Kaminski, Pierre Alexandre; Dacher, Priscilla; Dugue, Laurence; Pochet, Sylvie			In vivo reshaping the catalytic site of nucleoside 2 '-deoxyribosyltransferase for dideoxy- and didehydronucleosides via a single amino acid substitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-N-DEOXYRIBOSYLASE; SUBSTRATE-ASSISTED CATALYSIS; ANTI-HIV ACTIVITY; ENZYMATIC-SYNTHESIS; LACTOBACILLUS-HELVETICUS; ESCHERICHIA-COLI; ACTIVE-SITE; ANTIVIRAL ACTIVITY; 2-DEOXYRIBOSYLTRANSFERASE; PURIFICATION	Nucleoside 2'-deoxyribosyltransferases catalyze the transfer of 2-deoxyribose between bases and have been widely used as biocatalysts to synthesize a variety of nucleoside analogs. The genes encoding nucleoside 2'-deoxyribosyltransferase (ndt) from Lactobacillus leichmannii and Lactobacillus fermentum underwent random mutagenesis to select variants specialized for the synthesis of 2', 3'-dideoxynucleosides. An Escherichia coli strain, auxotrophic for uracil and unable to use 2', 3'-dideoxyuridine, cytosine, and 2', 3'-dideoxycytidine as a source of uracil was constructed. Randomly mutated lactobacilli ndt libraries from two species, L. leichmannii and L. fermentum, were screened for the production of uracil with 2', 3'-dideoxyuridine as a source of uracil. Several mutants suitable for the synthesis of 2', 3'-dideoxynucleosides were isolated. The nucleotide sequence of the corresponding genes revealed a single mutation (G -> A transition) leading to the substitution of a small aliphatic amino acid by a nucleophilic one, A15T (L. fermentum) or G9S (L. leichmannii), respectively. We concluded that the " adaptation" of the nucleoside 2'-deoxyribosyltransferase activity to 2,3-dideoxyribosyl transfer requires an additional hydroxyl group on a key amino acid side chain of the protein to overcome the absence of such a group in the corresponding substrate. The evolved proteins also display significantly improved nucleoside 2', 3'-didehydro-2', 3'-dideoxyribosyltransferase activity.	[Kaminski, Pierre Alexandre; Dacher, Priscilla; Dugue, Laurence; Pochet, Sylvie] Inst Pasteur, Unite Chim Organ, CNRS, URA2128, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kaminski, PA (corresponding author), Inst Pasteur, Unite Chim Organ, CNRS, URA2128, 28 Rue Dr Roux, F-75724 Paris 15, France.	akaminsk@pasteur.fr		Kaminski, Pierre Alexandre/0000-0001-9841-6837				ABDELMEGIED AES, 1991, ACTA CHEM SCAND, V45, P1060, DOI 10.3891/acta.chem.scand.45-1060; Anand R, 2004, BIOCHEMISTRY-US, V43, P2384, DOI 10.1021/bi035723k; Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BEAUSSIRE JJ, 1995, NUCLEOS NUCLEOT, V14, P805, DOI 10.1080/15257779508012476; BECK W, 1963, J BIOL CHEM, V238, P702; Becker J, 1996, BIOL CHEM H-S, V377, P357, DOI 10.1515/bchm3.1996.377.6.357; BETBEDER D, 1991, NUCLEOS NUCLEOT, V10, P465, DOI 10.1080/07328319108046499; BETBEDER D, 1989, NUCLEIC ACIDS RES, V17, P4217, DOI 10.1093/nar/17.11.4217; BETBEDER D, 1990, NUCLEOS NUCLEOT, V9, P569, DOI 10.1080/07328319008045188; Bosch J, 2006, J MED CHEM, V49, P5939, DOI 10.1021/jm060429m; CARSON DA, 1988, BIOCHEM BIOPH RES CO, V155, P829, DOI 10.1016/S0006-291X(88)80570-9; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; Catherinot V, 2004, BIOINFORMATICS, V20, P3694, DOI 10.1093/bioinformatics/bth429; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; CHAWDHRI RF, 1991, ARCH MICROBIOL, V155, P409, DOI 10.1007/BF00243463; CHU CK, 1989, J ORG CHEM, V54, P2217, DOI 10.1021/jo00270a036; DANZIN C, 1976, EUR J BIOCHEM, V62, P365, DOI 10.1111/j.1432-1033.1976.tb10168.x; DANZIN C, 1974, EUR J BIOCHEM, V48, P255, DOI 10.1111/j.1432-1033.1974.tb03763.x; FREEMAN GA, 1995, BIOORGAN MED CHEM, V3, P447, DOI 10.1016/0968-0896(95)00030-K; Gallois-Montbrun S, 2002, J BIOL CHEM, V277, P39953, DOI 10.1074/jbc.M206360200; Hammer-Jespersen K., 1983, METABOLISM NUCLEOTID, P203; HICKS N, 1992, ANTIVIR CHEM CHEMOTH, V3, P153, DOI 10.1177/095632029200300304; HOLGUIN J, 1975, EUR J BIOCHEM, V54, P505, DOI 10.1111/j.1432-1033.1975.tb04163.x; HOLGUINH.J, 1972, FEBS LETT, V20, P171, DOI 10.1016/0014-5793(72)80785-3; HUANG MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P133, DOI 10.1016/0003-9861(83)90510-6; HUARD CN, 1992, BIOCATALYSIS, V6, P201; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; KATI WM, 1989, SCIENCE, V243, P1591, DOI 10.1126/science.2928795; LinGoerke JL, 1997, BIOTECHNIQUES, V23, P409, DOI 10.2144/97233bm12; Muller M, 1996, CHEM RES TOXICOL, V9, P1140, DOI 10.1021/tx9600661; Okuyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P989, DOI 10.1271/bbb.67.989; POCHET S, 1995, BIOORG MED CHEM LETT, V5, P1679, DOI 10.1016/0960-894X(95)00280-7; Pochet S., 2007, Enzymatic synthesis of deoxyribonucleosides, Patent No. [7229797B1, 7229797]; Poncet-Montange G, 2007, J BIOL CHEM, V282, P33925, DOI 10.1074/jbc.M701394200; PORTER DJT, 1995, J BIOL CHEM, V270, P15551, DOI 10.1074/jbc.270.26.15551; RICHAUD C, 1993, J BIOL CHEM, V268, P26827; Sala M, 1996, NUCLEIC ACIDS RES, V24, P3302, DOI 10.1093/nar/24.17.3302; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHNETZBOUTAUD NC, 2001, CURRENT PROTOCOLS NU; Sheng J, 2008, J ORG CHEM, V73, P3725, DOI 10.1021/jo7025806; Short SA, 1996, J BIOL CHEM, V271, P4978; Slater MJ, 1996, BIOORG MED CHEM LETT, V6, P2787, DOI 10.1016/S0960-894X(96)00514-8; STEENKAMP DJ, 1992, BIOCHEM J, V287, P125, DOI 10.1042/bj2870125; UERKVITZ W, 1971, EUR J BIOCHEM, V23, P387, DOI 10.1111/j.1432-1033.1971.tb01632.x; VanDraanen NA, 1996, J MED CHEM, V39, P538, DOI 10.1021/jm950701k; Vorbruggen H., 2001, HDB NUCLEOSIDE SYNTH; Wang JH, 1998, ANTIMICROB AGENTS CH, V42, P2620, DOI 10.1128/AAC.42.10.2620	50	28	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20053	20059		10.1074/jbc.M802706200	http://dx.doi.org/10.1074/jbc.M802706200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487606	hybrid			2022-12-27	WOS:000257565300021
J	Jin, J; Ang, XL; Ye, X; Livingstone, M; Harper, JW				Jin, Jianping; Ang, Xiaolu L.; Ye, Xin; Livingstone, Mark; Harper, J. Wade			Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIGASE COMPLEX; S-PHASE CHECKPOINT; F-BOX PROTEINS; BETA-TRCP; MAMMARY TUMORIGENESIS; 14-3-3 BINDING; CELL-CYCLE; IN-VITRO; CHK1; PHOSPHORYLATION	In response to DNA damage, cells activate a signaling pathway that promotes cell cycle arrest and degradation of the cell cycle regulator Cdc25A. Cdc25A degradation occurs via the SCF beta-TRCP pathway and phosphorylation of Ser-76. Previous work indicates that the checkpoint kinase Checkpoint kinase 1 (Chk1) is capable of phosphorylating Ser-76 in Cdc25A, thereby promoting its degradation. In contrast, other experiments involving overexpression of dominant Chk2 mutant proteins point to a role for Chk2 in Cdc25A degradation. However, loss-of-function studies that implicate Chk2 in Cdc25A turnover are lacking, and there is no evidence that Chk2 is capable of phosphorylating Ser-76 in Cdc25A despite the finding that Chk1 and Chk2 sometimes share overlapping primary specificity. We find that although Chk2 can phosphorylate many of the same sites in Cdc25A that Chk1 phosphorylates, albeit with reduced efficiency, Chk2 is unable to efficiently phosphorylate Ser-76. Consistent with this, Chk2, unlike Chk1, is unable to support SCF beta-TRCP mediated ubiquitination of Cdc25A in vitro. In CHK2(-/-) HCT116 cells, the kinetics of Cdc25A degradation in response to ionizing radiation is comparable with that seen in HCT116 cells containing Chk2, indicating that Chk2 is not generally required for timely DNA damage-dependent Cdc25A turnover. In contrast, depletion of Chk1 by RNA interference in CHK2(-/-) cells leads to Cdc25A stabilization in response to ionizing radiation. These data support the idea that Chk1 is the primary signal transducer linking activation of the ATM/ATR kinases to Cdc25A destruction in response to ionizing radiation.	[Jin, Jianping; Ang, Xiaolu L.; Ye, Xin; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Livingstone, Mark] Cell Signaling Technol, Danvers, MA USA	Harvard University; Harvard Medical School	Harper, JW (corresponding author), 77 Ave Louis Pasteur,NRB Rm 940, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Cambronne, Xiaolu Ang/GRY-7149-2022; Jin, Jianping/K-5002-2018; Livingstone, Mark/H-1709-2011	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Jin, Jianping/0000-0003-4175-9104; Harper, Jeffrey/0000-0002-6944-7236; Livingstone, Mark/0000-0002-2757-7008	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; NIA NIH HHS [AG011085] Funding Source: Medline; NIGMS NIH HHS [GM054137, R01 GM054137] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01, F31 NS054507] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Donzelli M, 2004, CELL CYCLE, V3, P469; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HARPER JW, 1993, CELL, V75, P805; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kumagai A, 1998, MOL BIOL CELL, V9, P345, DOI 10.1091/mbc.9.2.345; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Ray D, 2007, CANCER RES, V67, P984, DOI 10.1158/0008-5472.CAN-06-3927; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zeng Y, 1999, MOL CELL BIOL, V19, P7410; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	38	39	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19322	19328		10.1074/jbc.M802474200	http://dx.doi.org/10.1074/jbc.M802474200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480045	hybrid, Green Published			2022-12-27	WOS:000257387600018
J	Alam, SMK; Konno, T; Sahgal, N; Lu, L; Soares, MJ				Alam, S. M. Khorshed; Konno, Toshihiro; Sahgal, Namita; Lu, Lu; Soares, Michael J.			Decidual cells produce a heparin-binding prolactin family cytokine with putative intrauterine regulatory actions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANCY-DEPENDENT ADAPTATIONS; PLACENTAL LACTOGEN-II; GENE FAMILY; HETEROLOGOUS EXPRESSION; ANTIPEPTIDE ANTIBODIES; PHYSIOLOGICAL STRESSOR; MOLECULAR-CLONING; HORMONE FAMILY; GROWTH-HORMONE; STROMAL CELLS	Pregnancy in mice and rats is associated with the production of a large family of hormones/cytokines related to prolactin (PRL). The hormones/cytokines are hypothesized to coordinate maternal and fetal adaptations to pregnancy. In this study, PRL-like protein-J (PLP-J, also known as PRL family 3, subfamily c, member 1 (Prl3c1)) is shown to be a product of the uterine decidua and a regulator of postimplantation intrauterine events. PLP-J-specific antibodies and a series of recombinant PLP-J proteins were generated and used to investigate PLP-J expression and as ligands for investigating biological targets. Decidual PLP-J migrates as a 29-kDa protein and localizes to a band of decidual cells surrounding the trophoblast cell layer on gestation day 8.5. PLP-J ligands specifically bound in situ to the surrounding uterine stromal cells and vasculature within the decidua of gestation day 8.5 implantation sites. We then investigated the in vitro actions of PLP-J on uterine stromal cells and endothelial cells. PLP-J specifically interacted with both cell populations. PLP-J promoted uterine stromal cell proliferation and inhibited endothelial cell proliferation. We determined that PLP-J does not interact with PRL receptors. Instead, PLP-J interacts with heparin-containing molecules, including syndecan-1, which is expressed in gestation day 8.5 pregnant uteri, as well as in uterine stromal cells and endothelial cells. The restricted expression of PLP-J and its specific interactions with uterine stromal cells and endothelial cells suggests that it acts locally and regulates decidual cell development and the endometrial vasculature.	[Soares, Michael J.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Obstet & Gynecol, Div Canc & Dev Biol, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Dept Obstet & Gynecol, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Soares, MJ (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	msoares@kumc.edu	Konno, Toshihiro/AAH-6276-2020	Konno, Toshihiro/0000-0001-8141-6996	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039878, R01HD055523] Funding Source: NIH RePORTER; NICHD NIH HHS [HD039878, HD055523] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ain R, 2006, METH MOLEC MED, V121, P295; Ain R, 2004, P NATL ACAD SCI USA, V101, P16543, DOI 10.1073/pnas.0406185101; Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Alam SMK, 2006, MAMM GENOME, V17, P858, DOI 10.1007/s00335-006-0010-1; Alam SMK, 2007, DEVELOPMENT, V134, P407, DOI 10.1242/dev.02743; ALI S, 1992, MOL ENDOCRINOL, V6, P1242, DOI 10.1210/me.6.8.1242; [Anonymous], 2004, STAT ANAL DATA DISPL; Aplin J, 2000, SEMIN CELL DEV BIOL, V11, P115, DOI 10.1006/scdb.2000.0157; BELL SC, 1983, OXFORD REV REPRODUCT, V5, P220; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Bern H A, 1968, Recent Prog Horm Res, V24, P681; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bittorf T, 2000, J MOL ENDOCRINOL, V25, P253, DOI 10.1677/jme.0.0250253; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Cohick CB, 1997, J ENDOCRINOL, V152, P291, DOI 10.1677/joe.0.1520291; Cooke N E, 1995, Vitam Horm, V50, P385, DOI 10.1016/S0083-6729(08)60659-7; CROZE F, 1990, ENDOCRINOLOGY, V127, P2665, DOI 10.1210/endo-127-6-2665; Dai G, 2000, J ENDOCRINOL, V166, P63, DOI 10.1677/joe.0.1660063; DEB S, 1989, J BIOL CHEM, V264, P14348; DEB S, 1989, MOL CELL ENDOCRINOL, V63, P45, DOI 10.1016/0303-7207(89)90080-4; DEFEO VJ, 1967, CELLULAR BIOL UTERUS, P191; DIMATTIA GE, 1990, J BIOL CHEM, V265, P16412; FARIA TN, 1990, DEV BIOL, V141, P279, DOI 10.1016/0012-1606(90)90384-U; Greca CDS, 2000, ANAT REC, V259, P413; HAMLIN GP, 1995, ENDOCRINOLOGY, V136, P322, DOI 10.1210/en.136.1.322; Hiraoka Y, 1999, BBA-GENE STRUCT EXPR, V1447, P291, DOI 10.1016/S0167-4781(99)00160-8; Ishibashi K, 1999, BIOCHEM BIOPH RES CO, V262, P575, DOI 10.1006/bbrc.1999.1260; Jabbour HN, 2001, REPRODUCTION, V121, P197, DOI 10.1530/rep.0.1210197; Jabbour HN, 1998, J CLIN ENDOCR METAB, V83, P2545, DOI 10.1210/jc.83.7.2545; JACKSON D, 1994, SCIENCE, V266, P1581, DOI 10.1126/science.7527157; Khurana S, 1999, ENDOCRINOLOGY, V140, P1026, DOI 10.1210/en.140.2.1026; Kimura F, 2001, GYNECOL ENDOCRINOL, V15, P426, DOI 10.1080/713602980; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Konno T, 2007, BIOL REPROD, V76, P709, DOI 10.1095/biolreprod.106.056481; Kruse A, 2002, BIOL REPROD, V66, P333, DOI 10.1095/biolreprod66.2.333; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lin JD, 1997, ENDOCRINOLOGY, V138, P5541, DOI 10.1210/en.138.12.5541; Lin JK, 1999, J BIOL CHEM, V274, P21485, DOI 10.1074/jbc.274.30.21485; Mallon AM, 2004, GENOME RES, V14, P1888, DOI 10.1101/gr.2478604; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Muller H, 2006, METH MOLEC MED, V122, P331; Muller H, 1999, ENDOCRINOLOGY, V140, P2711, DOI 10.1210/en.140.6.2711; Muller H, 1998, BIOL REPROD, V58, P45, DOI 10.1095/biolreprod58.1.45; Muller H, 1998, J HISTOCHEM CYTOCHEM, V46, P737, DOI 10.1177/002215549804600606; Najjam S, 1997, CYTOKINE, V9, P1013, DOI 10.1006/cyto.1997.0246; Nicoll C.S., 1972, LACTOGENIC HORMONES, P299; Orwig KE, 1997, ENDOCRINOLOGY, V138, P5511, DOI 10.1210/en.138.12.5511; Parr MB., 1989, BIOL UTERUS, P233; Piva M, 1996, BIOL REPROD, V55, P1333, DOI 10.1095/biolreprod55.6.1333; Prigent-Tessier A, 1999, J BIOL CHEM, V274, P37982, DOI 10.1074/jbc.274.53.37982; Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; Rasmussen CA, 1996, ENDOCRINOLOGY, V137, P5558, DOI 10.1210/en.137.12.5558; Rider V, 2006, METH MOLEC MED, V121, P57; Rider V, 2005, J ENDOCRINOL, V184, P119, DOI 10.1677/joe.1.05957; ROBY KF, 1993, J BIOL CHEM, V268, P3136; Shaw-Bruha CM, 1998, BBA-GENE STRUCT EXPR, V1442, P304, DOI 10.1016/S0167-4781(98)00172-9; Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005; Soares Michael J, 2004, Reprod Biol Endocrinol, V2, P51, DOI 10.1186/1477-7827-2-51; SOARES MJ, 1989, BIOL REPROD, V40, P435, DOI 10.1095/biolreprod40.2.435; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Tessier C, 2001, ENDOCRINOLOGY, V142, P4086, DOI 10.1210/en.142.9.4086; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Toft DJ, 1999, ENDOCRINOLOGY, V140, P5095, DOI 10.1210/en.140.11.5095; Wang D, 2000, J ENDOCRINOL, V167, P15, DOI 10.1677/joe.0.1670015; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724	68	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18957	18968		10.1074/jbc.M801826200	http://dx.doi.org/10.1074/jbc.M801826200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18467328	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000257165600052
J	Han, S; Yi, H; Yin, SJ; Chen, ZY; Liu, H; Cao, ZJ; Wu, YL; Li, WX				Han, Song; Yi, Hong; Yin, Shi-Jin; Chen, Zong-Yun; Liu, Hui; Cao, Zhi-Jian; Wu, Ying-Liang; Li, Wen-Xin			Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMORY T-CELLS; GATED K+ CHANNELS; SCORPION BUTHUS-MARTENSI; MULTIPLE-SCLEROSIS; POTASSIUM CHANNELS; SHK TOXIN; BLOCKERS; MODEL; VENOM; PROLIFERATION	The potassium channel Kv1.3 is an attractive pharmacological target for immunomodulation of T cell-mediated autoimmune diseases. Potent and selective blockers of Kv1.3 are potential therapeutics for treating these diseases. Here we describe the design of a new peptide inhibitor that is potent and selective for Kv1.3. Three residues (Gly(11), Ile(28), and Asp(33)) of a scorpion toxin BmKTX were substituted by Arg(11), Thr(28), and His(33), resulting in a new peptide, named ADWX-1. The ADWX-1 peptide blocked Kv1.3 with picomolar affinity (IC50, 1.89 pM), showing a 100-fold increase in activity compared with the native BmKTX toxin. The ADWX-1 also displayed good selectivity on Kv1.3 over related Kv1.1 and Kv1.2 channels. Furthermore, alanine-scanning mutagenesis was carried out to map the functional residues of ADWX-1 in blocking Kv1.3. Moreover, computational simulation was used to build a structural model of the ADWX-1-Kv1.3 complex. This model suggests that all mutated residues are favorable for both the high potency and selectivity of ADWX-1 toward Kv1.3. While Arg11 of ADWX-1 interacts with Asp386 in Kv1.3, Thr28 and His33 of ADWX-1 locate right above the selectivity filter-S6 linker of Kv1.3. Together, our data indicate that the specific ADWX-1 peptide would be a viable lead in the therapy of T cell-mediated autoimmune diseases, and the successful design of ADWX-1 suggests that rational design based on the structural model of the peptide-channel complex should accelerate the development of diagnostic and therapeutic agents for human channelopathies.	[Han, Song; Yi, Hong; Yin, Shi-Jin; Chen, Zong-Yun; Liu, Hui; Cao, Zhi-Jian; Wu, Ying-Liang; Li, Wen-Xin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	ylwu@whu.edu.cn; liwxlab@whu.edu.cn						Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; CASE DA, 2004, AMBER, V8; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Dai L, 2000, BIOCHEM J, V346, P805, DOI 10.1042/0264-6021:3460805; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; Fan H, 2005, P NATL ACAD SCI USA, V102, P6760, DOI 10.1073/pnas.0408857102; Garber K, 2005, NAT BIOTECHNOL, V23, P399, DOI 10.1038/nbt0405-399; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Gilquin B, 2005, J BIOL CHEM, V280, P27093, DOI 10.1074/jbc.M413626200; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Mouhat S, 2006, MOL PHARMACOL, V69, P354, DOI 10.1124/mol.105.017210; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; PENNINGTON MW, 1995, INT J PEPT PROT RES, V46, P354; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; RomiLebrun R, 1997, BIOCHEMISTRY-US, V36, P13473, DOI 10.1021/bi971044w; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2007, CURR OPIN DRUG DISC, V10, P438; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g	34	116	129	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					19058	19065		10.1074/jbc.M802054200	http://dx.doi.org/10.1074/jbc.M802054200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18480054	hybrid			2022-12-27	WOS:000257165600061
J	Schug, ZT; da Fonseca, PCA; Bhanumathy, CD; Wagner, L; Zhang, XC; Bailey, B; Morris, EP; Yule, DI; Joseph, SK				Schug, Zachary T.; da Fonseca, Paula C. A.; Bhanumathy, Cunnigaiper D.; Wagner, Larry, II; Zhang, Xianchao; Bailey, Bradley; Morris, Edward P.; Yule, David I.; Joseph, Suresh K.			Molecular characterization of the inositol 1,4,5-trisphosphate receptor pore-forming segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL RYANODINE RECEPTOR; INWARD RECTIFIER CHANNEL; CENTRAL CORE DISEASE; LIGAND-BINDING SITE; POTASSIUM-CHANNEL; K+ CHANNEL; CA2+ RELEASE; ION PERMEATION; TRISPHOSPHATE RECEPTORS; FUNCTIONAL-PROPERTIES	Specific residues in the putative pore helix, selectivity filter, and S6 transmembrane helix of the inositol 1,4,5-trisphosphate receptor were mutated in order to examine their effects on channel function. Mutation of 5 of 8 highly conserved residues in the pore helix/selectivity filter region inactivated the channel (C2533A, G2541A, G2545A, G2546A, and G2547A). Of the remaining three mutants, C2527A and R2543A were partially active and G2549A behaved like wild type receptor. Mutation of a putative glycine hinge residue in the S6 helix (G2586A) or a putative gating residue at the cytosolic end of S6 helix (F2592A) had minimal effects on function, although channel function was inactivated by G2586P and F2592D mutations. The mutagenesis data are interpreted in the context of a structural homology model of the inositol 1,4,5-trisphosphate receptor.	[Schug, Zachary T.; Bhanumathy, Cunnigaiper D.; Zhang, Xianchao; Bailey, Bradley; Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; [da Fonseca, Paula C. A.; Morris, Edward P.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [Wagner, Larry, II] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Jefferson University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Rochester	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol & Cell Biol, 1020 Locust St JAH 230A, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu		Schug, Zachary/0000-0003-4197-8227; da Fonseca, Paula/0000-0001-8656-5747; Morris, Edward/0000-0003-3544-0041	British Heart Foundation [PG/07/076/23480] Funding Source: Medline; Cancer Research UK Funding Source: Medline; NIAAA NIH HHS [T32 AA 07463] Funding Source: Medline; NIDCR NIH HHS [DE 14765] Funding Source: Medline; NIDDK NIH HHS [DK 54568, DK 34804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Berridge MJ, 2006, BIOCHEM SOC T, V34, P228, DOI 10.1042/BST0340228; Bhanumathy CD, 2006, J BIOL CHEM, V281, P3722, DOI 10.1074/jbc.M509966200; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Dart C, 1998, J PHYSIOL-LONDON, V511, P25, DOI 10.1111/j.1469-7793.1998.025bi.x; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du GG, 2004, BIOCHEM J, V382, P557, DOI 10.1042/BJ20040580; Du GG, 2001, J BIOL CHEM, V276, P31760, DOI 10.1074/jbc.M102751200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Iqbalsyah TM, 2006, PROTEIN SCI, V15, P1945, DOI 10.1110/ps.062271506; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Sackin H, 2005, BIOPHYS J, V88, P2597, DOI 10.1529/biophysj.104.051474; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Srikanth S, 2004, BIOPHYS J, V86, P3634, DOI 10.1529/biophysj.104.040121; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tikhonov DB, 2004, BIOPHYS J, V87, P1526, DOI 10.1529/biophysj.103.037770; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	57	111	111	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2939	2948		10.1074/jbc.M706645200	http://dx.doi.org/10.1074/jbc.M706645200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18534977	hybrid			2022-12-27	WOS:000252622300050
